Citrus Sinensis ID: 002809

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------88
Protein Sequence
MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHHHHcEEEcccccccEEEcccccccccccccccccEEEccccccccccccEEEcccccccccccEEEEEEcccccEEEEEEcccccEEEEEEEEEcccccccccccEEEEEEcccEEEEEEEEEcccccEEEEEEEEcccccEEEEEEEccccccEEEEEEEEEcccccccccccccEEEEEEEEEcccccccEEccccccccEEEcccccccEEEcccEEEccccccccccHHHHHHHccccccccccEEEEEEccccccEEEEEEEEccccccccccEEEEEEEEccccccccccccccEEEEEEccccccccEEEEEEEEcccccccHHHHHHHHcHHHccccccccccccccHHccccccccccccccccccccccccccEEccccccccccEEEEEEccccccccccHHHcccccccEEEcccccccccccccccccccEEEEccccccccccccHHHcccccccccccccccccccccccccccccccEEEEEEEcHHHHHHHHHHHHHHEEEEEccccccccccccccccccccccccccHHHHHHHHcccccEEEEccccEEEEEEEcccEEEEEEcccccHHHHHHHHHHHHHHHHHcccccccEEEEEcccccEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccccccEEEcccccccccccccccEEEcEEEcccccccHHHHHccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccccEEEcccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHccccccEEEEEccccccccccccccccEEEcccccccccccccccHHHcccccccccEEEEcccccccEEEEEcccccEEEEEEEEEEccccccccccEEEEEEccccEEEEEEccccccEEEEEEEEEcccccEEEEEEEccccccEEEEEEEcccccccccccccccEEEEEEEccccccccEEEccccccccEEEccccccccEEEccccEcccccccccccHHHHHHccccccccccEEEEEccccccccEEEEEEEHEHHccccccEEEEEEEEccccccccccccccEEEEEEccccccccEEEEEEEEccccccccEEEEEEEEEEEEcccccccHHHHHHHHHHHHHcccccccccccccccccccccEEEccccccccEEEEEEEccccccccccHHHHHHHHHHEEccccccccccccHHHHccccEEEEEccccccccccHHHHHccccccEEEEEcccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHEccccccEEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEEHHHEEEEccccHHHccccccccEEEEEEccccccccHHHHHcccccccccHHHHHHEHHHHHccccccccccccccccHHHHHHHHHHccccHHcEccHccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccEEEcccccccccccc
Coil and Loop (DISEMBL)
MLKIFLLALLgslplanvihaqdqtgfisldcglpkdsnytetttginyisddafvetGIGKSILQEFQTGQQKQMRrvrsfpdgirncYRFNLTKGSRYLIRTNFmygnydeknsvpgfdmfigpnkwlsvtfennasFVAIGEIIhilpsdylHICLvntglgtpfisalelrplfenstykaqsgslnlftrldvasttnltirynddvhdrswfpynsanwarINTSLtvdaeshnsyqppavvmntagtpknasqsmdfyletedpsiqfYVYMHFAEVQILQANQsrqfnislngehwygpfspnylltttvfsptaliggnysfslyktgnstlppiiNAIEVYSVKEFLQLQTEQIDVDAITNIKATyglkknwqgdpcaplaywwdglncsygdssspritylnlsssglkgdITSYVSNLTslqfldlsnnnltgsvpdflsklplrtlnlqgnklngsvpvellerskngslslsvggnpglcskisckkkknnvVVPVVASVAGSVFLLAAALAIFFVLKRKRQvgkvkresknkidsfeaksrhlsYSDVVKITNNFertlgkggfgtvyYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLtslvghcdednQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGleylhngckppivhrdvkSTNILLNEKLQAKLAdfglsksfatdanthvstvvagtpgyldpeyytsnrlteksdvySFGVVILEIITckpaisrinEEEKIHIRQWVNSLIakgdiksivdprlqedfdaNSVWKAVELAMAClsptgnqrptMSQVVMELSECLAAEMARansgrgfhskgsIDHLMMSMnlgtelnprar
Flexible Loop (DISEMBL)
MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQefqtgqqkqmrrvrsfpdgirncyrfnltkgsryLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDVASTTNLTirynddvhdrsWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATyglkknwqgdpCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNgslslsvggnpglcSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLkrkrqvgkvkresknkidsfeaksrhlsysdVVKItnnfertlgkggFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSfatdanthvstvvagtpgylDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLsptgnqrptMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMsmnlgtelnprar
Low Complexity Region (SEG)
MLKIFllallgslplANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLcskisckkkknnvvvpvvasvagsvfllaaalaiffvlKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLssssaqgfqqfqaEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR
Disordered region (IsUnstruct)
**KIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTG****MRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVD***************************DFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVE*************VGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQV*******************HLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSP***********VM*L**CL*************************************
Disordered Region (DISOPRED)
MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGI**************QMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNP********************ASVAGSVFLLAAALAIFFVLKR*********************SRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLS******FQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISR**EEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC**************************************
Disordered Region (DISEMBL)
MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQE***********VRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKR**********NKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR
Disordered Region (DISPRO)
MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKR*******************SRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA******************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	878	2.2.26 [Sep-21-2011]
O65924	881	Putative leucine-rich rep	no	no	0.966	0.963	0.522	0.0
C0LGG4	890	Probable LRR receptor-lik	no	no	0.984	0.970	0.512	0.0
Q9FZB1	872	Probable LRR receptor-lik	no	no	0.974	0.981	0.515	0.0
C0LGG6	876	Probable LRR receptor-lik	no	no	0.963	0.965	0.504	0.0
O64556	877	Putative leucine-rich rep	no	no	0.964	0.965	0.518	0.0
O64483	876	Senescence-induced recept	no	no	0.964	0.966	0.513	0.0
C0LGG3	885	Probable LRR receptor-lik	no	no	0.962	0.954	0.499	0.0
Q9LIG2	899	Receptor-like protein kin	no	no	0.981	0.958	0.498	0.0
Q9FZB8	871	Probable LRR receptor-lik	no	no	0.946	0.954	0.491	0.0
C0LGD6	852	Probable LRR receptor-lik	no	no	0.938	0.967	0.508	0.0

>sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1

 Score =  885 bits (2288), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 456/872 (52%), Positives = 599/872 (68%), Gaps = 23/872 (2%)

Query: 18  VIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQ-QKQM 76
           ++ AQDQ+GF+S+DCG+P+DS+Y + TT I Y+SD AFVE+G   SI  EFQT   +KQ 
Sbjct: 22  LVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSIDPEFQTSSLEKQF 81

Query: 77  RRVRSFPDGIRNCYRFNLT--KGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTF 134
           + VRSFP+G RNCY       KG +YLIRT FMYGNYD     P FD+++G N W SVT 
Sbjct: 82  QNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWDSVTI 141

Query: 135 ENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFT 194
           +N A+ +   EIIH L SD++H+CLV+   GTPF+SALE+R L +++TY+    SL LF 
Sbjct: 142 DN-ATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIR-LLKSNTYETPYDSLILFK 199

Query: 195 RLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGT 254
           R D+     L +RY DDV DR W P     +   N SLT+D+ ++  +QP   VMNTA +
Sbjct: 200 RWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNEGFQPARFVMNTATS 259

Query: 255 PKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHW-YGPFSPNYL 313
           P++ SQ + F  E +DP+ +++VYMHFAEV  L +N++R+F + LN +      FSP YL
Sbjct: 260 PEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLNEKEINMSSFSPRYL 319

Query: 314 LTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIK 373
            T T+F    + G    F L +T  STLPPIINAIE Y V EFLQ  T+Q DVDAI  IK
Sbjct: 320 YTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIK 379

Query: 374 ATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSL 433
           + YG+KK+W GDPCAP+ Y W  +NCSY D+ SPRI  +NLSSSGL G+I +  SNLT L
Sbjct: 380 SKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLL 439

Query: 434 QFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPG 492
             LDLSNN+LTG +PDFL  L  L  LNL+GNKL+G++PV+LLERS    + L + GNP 
Sbjct: 440 HILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGNPD 499

Query: 493 LCSKISC-----KKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKRESKNK 547
           LC   SC     K KKN  ++P+VASV G V  L  A+A+F + K++ + G         
Sbjct: 500 LCVSASCQISDEKTKKNVYIIPLVASVVG-VLGLVLAIALFLLYKKRHRRGGSGGVRAGP 558

Query: 548 IDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQ 607
           +D+     R+  YS+VVK+TNNFER LG+GGFG VY+G LN+  VAVK+LS SSAQG+++
Sbjct: 559 LDT---TKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLNDDQVAVKILSESSAQGYKE 615

Query: 608 FQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR 667
           F+AEV+LL+RVHH+NLT+L+G+C E  + ALIYEFMANG L +YLS     VLS +ERL+
Sbjct: 616 FRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYVLSWEERLQ 675

Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
           I++++AQGLEYLHNGCKPPIV RDVK  NIL+NEKLQAK+ADFGLS+S A D N   +T 
Sbjct: 676 ISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTA 735

Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRI-NEEEKIHIRQWVNSL 786
           VAGT GYLDPEY+ + +L+EKSD+YSFGVV+LE+++ +P I+R     E IHI   V+ +
Sbjct: 736 VAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLM 795

Query: 787 IAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA 846
           ++ GDI+ IVDP+L E FDA S WK  E+AMAC S +   RPTMS VV EL E     ++
Sbjct: 796 LSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELKE----SVS 851

Query: 847 RANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           RA +G G  +    D  M + + G  + P+AR
Sbjct: 852 RARAGGGSGASSVTDPAMTNFDSG--MFPQAR 881

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2

 Score =  873 bits (2255), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 461/900 (51%), Positives = 614/900 (68%), Gaps = 36/900 (4%)

Query: 2   LKIFLLALLGSLPLANVIHAQDQTGFISLDCGL-PKDSNYTETTTGINYISDDAFVETGI 60
           L  FL  L+ +  +   + AQ+Q GFISLDCGL PK++ YTE +T I Y SD  ++++G+
Sbjct: 4   LHWFLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGL 63

Query: 61  GKSILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGF 120
              I   ++T  Q+Q+  VRSFP G RNCY  NLT  ++YLIR  F+YGNYD  N  P F
Sbjct: 64  VGKINDAYKTQFQQQVWAVRSFPVGQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQFPSF 123

Query: 121 DMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFEN 180
           D+ IGPNKW SV      +  ++ EIIH++P D L +CLV TG  TPFIS+LE+RPL  N
Sbjct: 124 DLHIGPNKWSSVKILG-VTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPL-NN 181

Query: 181 STYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHN 240
            +Y  QSGSL LF R+   S+++  IRY++D+HDR W  +       I+T L +D  + N
Sbjct: 182 ESYLTQSGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDETVWISTDLPID--TSN 239

Query: 241 SYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLN 300
           SY  P  VM TA  PKNAS+    +   ++ + Q YVYMHFAEVQ L AN++R+FNI+ N
Sbjct: 240 SYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITYN 299

Query: 301 GE-HWYGPFSPNYLLTTTVFSPTALIGGN--YSFSLYKTGNSTLPPIINAIEVYSVKEFL 357
           G   W+    P  L  +T+F+P A+   N  ++F+   TGNSTLPP++NA+E+Y+V + L
Sbjct: 300 GGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDIL 359

Query: 358 QLQTEQIDVDAITNIKATYGLKK--NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLS 415
           QL+T + +V A+ NIK TYGL K  +WQGDPCAP  Y W+GLNCSY DS   RI  LNL+
Sbjct: 360 QLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLN 419

Query: 416 SSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN-KLN-GSVPV 472
            S L G ITS +S LT L  LDLSNN+L+G +P F +++  L+ +NL GN  LN  ++P 
Sbjct: 420 GSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAIPD 479

Query: 473 ELLERSKNGSLSLSVGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLK 532
            L +R  + SL+L +G N  L  K   K+ K   +V + ASVAG VF L   LAIFFV+K
Sbjct: 480 SLQQRVNSKSLTLILGENLTLTPK---KESKKVPMVAIAASVAG-VFALLVILAIFFVIK 535

Query: 533 RKR-------------QVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGF 579
           RK                G VK E+++   S   + R ++Y +V+K+TNNFER LGKGGF
Sbjct: 536 RKNVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGF 595

Query: 580 GTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI 639
           GTVY+G L+  +VAVKMLS SSAQG+++F+AEV+LL+RVHHR+L  LVG+CD+ +  ALI
Sbjct: 596 GTVYHGNLDGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALI 655

Query: 640 YEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNIL 698
           YE+MANG+L+E +S      VL+ + R++IAVE+AQGLEYLHNGC+PP+VHRDVK+TNIL
Sbjct: 656 YEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNIL 715

Query: 699 LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVI 758
           LNE+  AKLADFGLS+SF  D   HVSTVVAGTPGYLDPEYY +N L+EKSDVYSFGVV+
Sbjct: 716 LNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVL 775

Query: 759 LEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMA 818
           LEI+T +P I +    E+ HI  WV  ++ KGDIKSIVDP+L  D+D N  WK VELA+A
Sbjct: 776 LEIVTNQPVIDKT--RERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALA 833

Query: 819 CLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           C++P+ N+RPTM+ VVMEL++C+A E AR       +S GS+D+   S++  ++  P AR
Sbjct: 834 CVNPSSNRRPTMAHVVMELNDCVALENARRQGSEEMYSMGSVDY---SLSSTSDFAPGAR 890

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1

 Score =  863 bits (2230), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 456/884 (51%), Positives = 598/884 (67%), Gaps = 28/884 (3%)

Query: 5   FLLALLGSLPLANVIHAQDQTGFISLDCGL-PKDSNYTETTTGINYISDDAFVETGIGKS 63
           FLL L+ +  +   + AQDQ GFISLDCGL PK++ YTE TT I Y SD  ++++G+   
Sbjct: 7   FLLFLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGR 66

Query: 64  ILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMF 123
           I  E++   Q+Q   VRSFP+G RNCY FNLT  SRYLIR  F YGNYD    VP FD+ 
Sbjct: 67  ISAEYKAQLQQQTWTVRSFPEGERNCYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIH 126

Query: 124 IGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTY 183
           IGP+KW SV  +   +  A+ E+IH+L  D L ICLV TG G PFIS+LELRPL  N+TY
Sbjct: 127 IGPSKWTSVKLDGVGNG-AVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPL-NNNTY 184

Query: 184 KAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQ 243
             QSGSL  F R+  ++T    IRY++D+HDR W          I+T L VD  + N Y 
Sbjct: 185 LTQSGSLIGFARVFFSATPTF-IRYDEDIHDRVWVRQFGNGLKSISTDLLVD--TSNPYD 241

Query: 244 PPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNG-E 302
            P  V  TA  P NASQ + F    ++ + Q YVYMHFAE+Q L+ N  R+FNI+ NG +
Sbjct: 242 VPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNGGQ 301

Query: 303 HWYGPFSPNYLLTTTVFS--PTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQ 360
           + Y    P     +T+F   P +   G++S S  KTGNSTLPP+IN +E+Y V + L+L+
Sbjct: 302 NVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLDLLELE 361

Query: 361 TEQIDVDAITNIKATYGLKK--NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSG 418
           T+Q +V A+ NIKATY L K  +WQGDPCAP +Y W+GLNCSY +S  PRI  LNL+ + 
Sbjct: 362 TDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLNLAENK 421

Query: 419 LKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPL-RTLNLQGN-KLNGSVPVELLE 476
           L G IT  +S LT L  LDLS N+L+G +P+F + + L + +NL GN  LN ++P  + +
Sbjct: 422 LTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGNLGLNSTIPDSIQQ 481

Query: 477 RSKNGSLSLSVGGNPGLCSKISCKKKKNNV-VVPVVASVAGSVFLLAAALAIFFVLKRKR 535
           R  + SL L +     +   ++ K K   V ++P+VASVAG VF L   LAIFFV++RK 
Sbjct: 482 RLDSKSLILILSKT--VTKTVTLKGKSKKVPMIPIVASVAG-VFALLVILAIFFVVRRKN 538

Query: 536 QVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVK 595
                   +K    S   K R ++Y +V+K+TNNFER LGKGGFGTVY+G L +  VAVK
Sbjct: 539 -----GESNKGTNPSIITKERRITYPEVLKMTNNFERVLGKGGFGTVYHGNLEDTQVAVK 593

Query: 596 MLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLS-D 654
           MLS SSAQG+++F+AEV+LL+RVHHRNL  LVG+CD+ +  ALIYE+MANG+L+E +S  
Sbjct: 594 MLSHSSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGK 653

Query: 655 ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK 714
               VL+ + R++IAVE+AQGLEYLHNGC PP+VHRDVK+TNILLNE+  AKLADFGLS+
Sbjct: 654 RGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSR 713

Query: 715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE 774
           SF  D  +HVSTVVAGTPGYLDPEYY +N L+EKSDVYSFGVV+LEI+T +P   +    
Sbjct: 714 SFPVDGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKT--R 771

Query: 775 EKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           E+ HI +WV S++ KGDIKSI+DP+L  D+D N  WK VELA+AC++P+ N+RPTM+ VV
Sbjct: 772 ERTHINEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVV 831

Query: 835 MELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
            EL+EC+A E AR       H+ G +D    S +  +E +P AR
Sbjct: 832 TELNECVALENARRQGREEMHTSGYVD---FSRSSASEFSPGAR 872

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2

 Score =  857 bits (2215), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 453/898 (50%), Positives = 608/898 (67%), Gaps = 52/898 (5%)

Query: 4   IFLLALLGSLPLANVIHAQDQTGFISLDCGL-PKDSNYTETTTGINYISDDAFVETGIGK 62
           IF+ A+LG      ++ AQDQ+GFISLDCGL P +  Y E +T I Y SD  ++++G+  
Sbjct: 8   IFVFAVLG------LVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYIDSGVPG 61

Query: 63  SILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDM 122
            I + ++T  Q+Q+  +RSFP+G RNCY F+LT   +YLIR  F+YGNYD  N +P FD+
Sbjct: 62  KINEVYRTQFQQQIWALRSFPEGQRNCYNFSLTAKRKYLIRGTFIYGNYDGLNQLPSFDL 121

Query: 123 FIGPNKWLSVTFE--NNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFEN 180
           +IGPNKW SV+     N S   + E+IH+L  D+L ICLV TG  TPFIS+LELRPL  N
Sbjct: 122 YIGPNKWTSVSIPGVRNGS---VSEMIHVLRQDHLQICLVKTGETTPFISSLELRPL-NN 177

Query: 181 STYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHN 240
           +TY  +SGSL +  RL  + T    +RY++DVHDR W P+     + ++T L+VD  + N
Sbjct: 178 NTYVTKSGSLIVVARLYFSPTPPF-LRYDEDVHDRIWIPFLDNKNSLLSTELSVD--TSN 234

Query: 241 SYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLN 300
            Y  P  V  TA  P NA+Q +      +D + Q Y+YMHFAE++ L+AN++R+FNI+ N
Sbjct: 235 FYNVPQTVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYN 294

Query: 301 -GEHWYGPFSPNYLLTTTVFSPTAL--IGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFL 357
            GE+W+  F P     TTV++P A+  + GN++F+   TGNST PP+IN +E+Y V E  
Sbjct: 295 GGENWFSYFRPPKFRITTVYNPAAVSSLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELP 354

Query: 358 QLQTEQIDVDAITNIKATYGLKK--NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLS 415
           QL T Q +V A+ NIK  YGL K  +WQGDPCAP  Y W+GLNCSY + + P+I  LNLS
Sbjct: 355 QLDTYQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAPPQIISLNLS 414

Query: 416 SSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK-LNGSVPVE 473
            S L G ITS +S LT L+ LDLSNN+L+G +P   S +  L  +NL GNK LN SVP  
Sbjct: 415 GSNLSGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNKNLNRSVPET 474

Query: 474 LLERSKNGSLSLSVGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKR 533
           L +R  N SL+L           I  +  KN+  V  +A+   SVF +   LAI FV+ R
Sbjct: 475 LQKRIDNKSLTL-----------IRDETGKNSTNVVAIAASVASVFAVLVILAIVFVVIR 523

Query: 534 KRQ------------VGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGT 581
           K+Q             G VK ++++   S   K R  +YS+V+K+T NFER LGKGGFGT
Sbjct: 524 KKQRTNEASGPRSFTTGTVKSDARSSSSSIITKERKFTYSEVLKMTKNFERVLGKGGFGT 583

Query: 582 VYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE 641
           VY+G L++  VAVKMLS SSAQG+++F+AEV+LL+RVHHR+L  LVG+CD+ +  ALIYE
Sbjct: 584 VYHGNLDDTQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYE 643

Query: 642 FMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN 700
           +M  G+L+E +S   S  VLS + R++IAVE+AQGLEYLHNGC+PP+VHRDVK TNILLN
Sbjct: 644 YMEKGDLRENMSGKHSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLN 703

Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE 760
           E+ QAKLADFGLS+SF  D  +HV TVVAGTPGYLDPEYY +N L+EKSDVYSFGVV+LE
Sbjct: 704 ERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLE 763

Query: 761 IITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACL 820
           I+T +P +++    E+ HI +WV  ++  GDIKSIVDP+L ED+D N VWK VELA+AC+
Sbjct: 764 IVTNQPVMNK--NRERPHINEWVMFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELALACV 821

Query: 821 SPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           +P+ ++RPTM  VVMEL+ECLA E+ R    +  + K S++    S +  ++ +P AR
Sbjct: 822 NPSSSRRPTMPHVVMELNECLALEIERKQGSQATYIKESVE---FSPSSASDFSPLAR 876

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3

 Score =  857 bits (2213), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 451/869 (51%), Positives = 592/869 (68%), Gaps = 22/869 (2%)

Query: 18  VIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQ-QKQM 76
           ++ AQDQ+GF+S+DCG+P+DS+Y +  T I YISD AFVE+G   SI  +FQ    +KQ 
Sbjct: 21  LVCAQDQSGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVESGTIHSIDSKFQKKNLEKQF 80

Query: 77  RRVRSFPDGIRNCYRFNLT--KGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTF 134
           ++VRSFP+G +NCY       KG +YLIRT FMYGNYD     P FD+++G N W SVT 
Sbjct: 81  QKVRSFPEGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGVNLWDSVTL 140

Query: 135 ENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFT 194
           EN+ + V   EII+ L SD +H+CLV+   GTPF+S LELR L +N+ Y+  S SL L+ 
Sbjct: 141 ENSTTIVT-KEIIYTLRSDKVHVCLVDKERGTPFLSVLELR-LLKNNIYETASDSLMLYR 198

Query: 195 RLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGT 254
           R D+ +T +L  RY DD+ DR W P    N+  +NTSL +D  S N + PP+VVM+TA  
Sbjct: 199 RWDLGATGDLPARYKDDIFDRFWMPLMFPNFLILNTSLMIDPTSSNGFLPPSVVMSTAVA 258

Query: 255 PKNAS-QSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHW--YGPFSPN 311
           P N+S + +  Y E  DP+ +FY+Y+HFAEV+ L +N++R+F++ LN E       F P+
Sbjct: 259 PMNSSIEQIMVYWEPRDPNWKFYIYIHFAEVEKLPSNETREFSVFLNKEQIDTTSVFRPS 318

Query: 312 YLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITN 371
           YL T T++    + G    F L +   ST PPI+NAIE Y   EFL L T+Q DVDAI  
Sbjct: 319 YLYTDTLYVQNPVSGPFLEFVLRQGVKSTRPPIMNAIETYRTNEFLDLPTDQNDVDAIMK 378

Query: 372 IKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLT 431
           IK  Y +KKNW GDPCAP  Y W G+NCSY  ++ PRI  +NLS SGL G I      LT
Sbjct: 379 IKTKYKVKKNWLGDPCAPFGYPWQGINCSYTANNPPRIISVNLSFSGLTGQIDPVFITLT 438

Query: 432 SLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGN 490
            LQ LDLSNN LTG+VPDFL+ LP L  LNL+ NKL G +P +LLERSK+GSLSL VGGN
Sbjct: 439 PLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSKDGSLSLRVGGN 498

Query: 491 PGLCSKISCKKKK---NNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKRESKNK 547
           P LC   SC+ KK      ++P VASV G  FLL A ++ +   KR++ V     ++K  
Sbjct: 499 PDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLALISFWQFKKRQQSVKTGPLDTK-- 556

Query: 548 IDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQ 607
                   R+  YS++V+ITNNFER LG+GGFG VYYG L    VA+KMLS SSAQG+++
Sbjct: 557 --------RYYKYSEIVEITNNFERVLGQGGFGKVYYGVLRGEQVAIKMLSKSSAQGYKE 608

Query: 608 FQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR 667
           F+AEV+LL+RVHH+NL +L+G+C E +Q ALIYE++ NG L +YLS  +  +LS +ERL+
Sbjct: 609 FRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLSGKNSSILSWEERLQ 668

Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
           I++++AQGLEYLHNGCKPPIVHRDVK TNIL+NEKLQAK+ADFGLS+SF  + ++ VST 
Sbjct: 669 ISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGLSRSFTLEGDSQVSTE 728

Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLI 787
           VAGT GYLDPE+Y+  + +EKSDVYSFGVV+LE+IT +P ISR   EE  HI   V+ ++
Sbjct: 729 VAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRSRTEENRHISDRVSLML 788

Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMAR 847
           +KGDIKSIVDP+L E F+A   WK  E+A+AC S +   R TMSQVV EL E L      
Sbjct: 789 SKGDIKSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTMSQVVAELKESLCRARTS 848

Query: 848 ANSGRGFHSKGSIDHLMMSMNLGTELNPR 876
            +SG    S+ +  ++ M+++ G    PR
Sbjct: 849 GDSGDISFSEPTEMNVSMTVDPGVLPQPR 877

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64483|SIRK_ARATH Senescence-induced receptor-like serine/threonine-protein kinase OS=Arabidopsis thaliana GN=SIRK PE=2 SV=1

 Score =  844 bits (2181), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 447/870 (51%), Positives = 590/870 (67%), Gaps = 23/870 (2%)

Query: 18  VIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQT-GQQKQM 76
           ++HAQDQ+GFIS+DCG+P DS+Y + TTGI Y+SD AFV++G  K I  +FQ+ G  + +
Sbjct: 21  LVHAQDQSGFISIDCGIPDDSSYNDETTGIKYVSDSAFVDSGTTKRIAAQFQSSGFDRHL 80

Query: 77  RRVRSFPDGIRNCYRFNLT--KGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTF 134
             VRSFP   R+CY       KG +YLIRT FMYGNYD+   VP FD+++G N W SV  
Sbjct: 81  LNVRSFPQSKRSCYDVPTPRGKGFKYLIRTRFMYGNYDDLGRVPEFDLYLGVNFWDSVKL 140

Query: 135 ENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFT 194
           ++ A+ +   EII I   D + +C+V+   GTPF+S LE+R L  N+TY+    +L L  
Sbjct: 141 DD-ATTILNKEIITIPLLDNVQVCVVDKNAGTPFLSVLEIR-LLLNTTYETPYDALTLLR 198

Query: 195 RLDVASTTNLTIRYNDDVHDRSWFP-YNSANWARINTSLTVDAESHNSYQPPAVVMNTAG 253
           RLD + T  L  RY DD++DR W P   S+ +  +NTSLTVD   +N YQP + VM+TA 
Sbjct: 199 RLDYSKTGKLPSRYKDDIYDRIWTPRIVSSEYKILNTSLTVDQFLNNGYQPASTVMSTAE 258

Query: 254 TPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYL 313
           T +N S  +       DP+ +FYVYMHFAE+++L++NQ+R+F+I LN +     F   YL
Sbjct: 259 TARNESLYLTLSFRPPDPNAKFYVYMHFAEIEVLKSNQTREFSIWLNEDVISPSFKLRYL 318

Query: 314 LTTTVFSPTALIGGNYSFSLYKT-GNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNI 372
           LT T  +P  + G   +FSL +  G   LPPIINA+EVY V EFLQ+ T   DVDA+  I
Sbjct: 319 LTDTFVTPDPVSGITINFSLLQPPGEFVLPPIINALEVYQVNEFLQIPTHPQDVDAMRKI 378

Query: 373 KATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS-PRITYLNLSSSGLKGDITSYVSNLT 431
           KATY +KKNWQGDPC P+ Y W+G++C   D+++ PR+  LN+S S L+G I    SNLT
Sbjct: 379 KATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTTNPRVVSLNISFSELRGQIDPAFSNLT 438

Query: 432 SLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGN 490
           S++ LDLS N LTG +P FL+ LP L  LN++GNKL G VP  L ERSKNGSLSL  G N
Sbjct: 439 SIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGNKLTGIVPQRLHERSKNGSLSLRFGRN 498

Query: 491 PGLCSKISCK--KKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKRESKNKI 548
           P LC   SC   KKKN     +   V G + +L  ALA+F   K+K+Q G +   +    
Sbjct: 499 PDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVLLTALALFRRFKKKQQRGTLGERN---- 554

Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQF 608
              +   R+  YS+VV ITNNFER +GKGGFG VY+G +N   VAVK+LS  SAQG+++F
Sbjct: 555 GPLKTAKRYFKYSEVVNITNNFERVIGKGGFGKVYHGVINGEQVAVKVLSEESAQGYKEF 614

Query: 609 QAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI 668
           +AEV LLMRVHH NLTSLVG+C+E N   LIYE+MAN NL +YL+     +LS +ERL+I
Sbjct: 615 RAEVDLLMRVHHTNLTSLVGYCNEINHMVLIYEYMANENLGDYLAGKRSFILSWEERLKI 674

Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
           ++++AQGLEYLHNGCKPPIVHRDVK TNILLNEKLQAK+ADFGLS+SF+ + +  +STVV
Sbjct: 675 SLDAAQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVV 734

Query: 729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA 788
           AG+ GYLDPEYY++ ++ EKSDVYS GVV+LE+IT +PAI+  ++ EK+HI   V S++A
Sbjct: 735 AGSIGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQPAIAS-SKTEKVHISDHVRSILA 793

Query: 789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA 848
            GDI+ IVD RL+E +D  S WK  E+A+AC   T  QRPTMSQVVMEL + +   +   
Sbjct: 794 NGDIRGIVDQRLRERYDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELKQIVYG-IVTD 852

Query: 849 NSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
                  +K      M+++NL TE+ PRAR
Sbjct: 853 QENYDDSTK------MLTVNLDTEMVPRAR 876

Involved in innate immune response of plants.

Arabidopsis thaliana (taxid: 3702)

>sp|C0LGG3|Y5182_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51820 OS=Arabidopsis thaliana GN=At1g51820 PE=2 SV=1

 Score =  840 bits (2170), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 447/895 (49%), Positives = 607/895 (67%), Gaps = 50/895 (5%)

Query: 13  LPLANVIHAQDQTGFISLDCGLPK-DSNYTETTTGINYISDDAFVETGIGKSILQEFQTG 71
           L + +++ AQ+QTGFIS+DCGL   +S Y    TG+ Y SD   V +G    + +EF+  
Sbjct: 12  LLIFHLVQAQNQTGFISVDCGLSLLESPYDAPQTGLTYTSDADLVASGKTGRLAKEFEPL 71

Query: 72  QQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLS 131
             K    +R FP+G+RNCY  N+T  + YLI+  F+YGNYD  N  P F++++GPN W +
Sbjct: 72  VDKPTLTLRYFPEGVRNCYNLNVTSDTNYLIKATFVYGNYDGLNVGPNFNLYLGPNLWTT 131

Query: 132 VTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLN 191
           V+  +      I EII +  S+ L +CLV TG+  PFI+ LELRP+ +N  Y  QSGSL 
Sbjct: 132 VSSND-----TIEEIILVTRSNSLQVCLVKTGISIPFINMLELRPMKKN-MYVTQSGSLK 185

Query: 192 LFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNT 251
              R    S ++  IR+ DDV+DR W+P    +W ++ T+L V+     +Y+ P  VM  
Sbjct: 186 YLFR-GYISNSSTRIRFPDDVYDRKWYPLFDDSWTQVTTNLKVNTSI--TYELPQSVMAK 242

Query: 252 AGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPN 311
           A TP  A+ +++     E P+ QFY Y+H AE+Q L+AN++R+FN++LNGE+ +GPFSP 
Sbjct: 243 AATPIKANDTLNITWTVEPPTTQFYSYVHIAEIQALRANETREFNVTLNGEYTFGPFSPI 302

Query: 312 YLLTTTV--FSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAI 369
            L T ++   SP    GG     + KT  STLPP++NAIE ++V +F Q++T + DV  I
Sbjct: 303 PLKTASIVDLSPGQCDGGRCILQVVKTLKSTLPPLLNAIEAFTVIDFPQMETNENDVAGI 362

Query: 370 TNIKATYGLKK-NWQGDPCAPLAYWWDGLNCSYGD-SSSPRITYLNLSSSGLKGDITSYV 427
            N++ TYGL + +WQGDPC P    WDGLNC   D S+ P IT L+LSSSGL G IT  +
Sbjct: 363 KNVQGTYGLSRISWQGDPCVPKQLLWDGLNCKNSDISTPPIITSLDLSSSGLTGIITQAI 422

Query: 428 SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLS 486
            NLT LQ LDLS+NNLTG VP+FL+ +  L  +NL GN L+GSVP  LL++     + L+
Sbjct: 423 KNLTHLQILDLSDNNLTGEVPEFLADIKSLLVINLSGNNLSGSVPPSLLQKK---GMKLN 479

Query: 487 VGGNPG-LCSKISC------KKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQV-- 537
           V GNP  LC+  SC        KK +V+VPVVAS+A S+ +L  AL +F +L++KR    
Sbjct: 480 VEGNPHILCTTGSCVKKKEDGHKKKSVIVPVVASIA-SIAVLIGALVLFLILRKKRSPKV 538

Query: 538 ------------GKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYG 585
                       G++ R S+  I +   K+R  SYS VV +TNNF+R LGKGGFG VY+G
Sbjct: 539 EGPPPSYMQASDGRLPRSSEPAIVT---KNRRFSYSQVVIMTNNFQRILGKGGFGMVYHG 595

Query: 586 RLNEID-VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA 644
            +N  + VAVK+LS SS+QG++QF+AEV+LL+RVHH+NL  LVG+CDE +  ALIYE+MA
Sbjct: 596 FVNGTEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLVGYCDEGDNLALIYEYMA 655

Query: 645 NGNLQEYLSDISKK-VLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL 703
           NG+L+E++S    + +L+   RL+I +ESAQGLEYLHNGCKPP+VHRDVK+TNILLNE  
Sbjct: 656 NGDLKEHMSGTRNRFILNWGTRLKIVIESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHF 715

Query: 704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +AKLADFGLS+SF  +  THVSTVVAGTPGYLDPEY+ +N LTEKSDVYSFG+++LEIIT
Sbjct: 716 EAKLADFGLSRSFLIEGETHVSTVVAGTPGYLDPEYHRTNWLTEKSDVYSFGILLLEIIT 775

Query: 764 CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPT 823
            +  I +    EK HI +WV  ++ KGDI+SI+DP L ED+D+ SVWKAVELAM+CL+ +
Sbjct: 776 NRHVIDQ--SREKPHIGEWVGVMLTKGDIQSIMDPSLNEDYDSGSVWKAVELAMSCLNHS 833

Query: 824 GNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
             +RPTMSQVV+EL+ECLA+E AR  + R   SK SI+   +S+  GTE++P AR
Sbjct: 834 SARRPTMSQVVIELNECLASENARGGASRDMESKSSIE---VSLTFGTEVSPNAR 885

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1

 Score =  825 bits (2131), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/907 (49%), Positives = 610/907 (67%), Gaps = 45/907 (4%)

Query: 2   LKIFLLALLGSLPLANVIHAQDQTGFISLDCG-LPKDSNYTETTTGINYISDDAFVETGI 60
           +++  L  +    L +++ AQDQ GFISLDCG LP +  Y + +TG+ Y +DD FV++G 
Sbjct: 8   IRLCALIFISFYALLHLVEAQDQKGFISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGK 67

Query: 61  GKSILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGF 120
              I + F++   K   ++R FPDG RNCY  N+T+ + YLI+  F+YGNYD  N+ P F
Sbjct: 68  TGRIQKAFESIFSKPSLKLRYFPDGFRNCYTLNVTQDTNYLIKAVFVYGNYDGLNNPPSF 127

Query: 121 DMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFEN 180
           D+++GPN W++V   N  +   I EIIH   S  L +CLV TG  +P I+ LELRPL +N
Sbjct: 128 DLYLGPNLWVTVDM-NGRTNGTIQEIIHKTISKSLQVCLVKTGTSSPMINTLELRPL-KN 185

Query: 181 STYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPY-NSANWARINTSLTVDAESH 239
           +TY  QSGSL  F R    S +   IRY DDV+DR W+P+ ++  W  + T+L ++  S 
Sbjct: 186 NTYNTQSGSLKYFFRY-YFSGSGQNIRYPDDVNDRKWYPFFDAKEWTELTTNLNIN--SS 242

Query: 240 NSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISL 299
           N Y PP VVM +A TP +   + +F       + QFYVYMHFAE+Q L++  +R+F ++L
Sbjct: 243 NGYAPPEVVMASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTL 302

Query: 300 NGEHWYGPFSPNYLLTTTVF--SPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFL 357
           NG+  Y  +SP  L T T+F  +P     G     L KT  STLPP++NA+EV++V +F 
Sbjct: 303 NGKLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFTVIDFP 362

Query: 358 QLQTEQIDVDAITNIKATYGLKK-NWQGDPCAPLAYWWDGLNCSYGDSSSPRI-TYLNLS 415
           Q++T   DV AI +I++TYGL K +WQGDPC P  + W+GLNC+  D+S+P I T LNLS
Sbjct: 363 QMETNPDDVAAIKSIQSTYGLSKISWQGDPCVPKQFLWEGLNCNNLDNSTPPIVTSLNLS 422

Query: 416 SSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVEL 474
           SS L G I   + NLT LQ LDLSNNNLTG +P+FL+ +  L  +NL GN  NGS+P  L
Sbjct: 423 SSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNNFNGSIPQIL 482

Query: 475 LERSKNGSLSLSVGGNPGL-CSKISC-------KKKKNNVVVPVVASVAGSVFLLAAALA 526
           L++     L L + GN  L C    C         KK NVV+P+VASVA  V +L +ALA
Sbjct: 483 LQKK---GLKLILEGNANLICPDGLCVNKAGNGGAKKMNVVIPIVASVA-FVVVLGSALA 538

Query: 527 IFFVLKRKR-------------QVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERT 573
            FF+ K+K+             QV +V R  ++   +   K+R  +YS+VV +TNNFER 
Sbjct: 539 FFFIFKKKKTSNSQDLGPSSYTQVSEV-RTIRSSESAIMTKNRRFTYSEVVTMTNNFERV 597

Query: 574 LGKGGFGTVYYGRLNEID-VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE 632
           LGKGGFG VY+G +N  + VAVKMLS SS+QG+++F+AEV+LL+RVHH+NL  LVG+CDE
Sbjct: 598 LGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDE 657

Query: 633 DNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
               ALIYE+MANG+L+E++S      +L+ + RL+I VESAQGLEYLHNGCKPP+VHRD
Sbjct: 658 GENLALIYEYMANGDLREHMSGKRGGSILNWETRLKIVVESAQGLEYLHNGCKPPMVHRD 717

Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDV 751
           VK+TNILLNE L AKLADFGLS+SF  +  THVSTVVAGTPGYLDPEYY +N L EKSDV
Sbjct: 718 VKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDPEYYRTNWLNEKSDV 777

Query: 752 YSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWK 811
           YSFG+V+LEIIT +  I++    EK HI +WV  ++ KGDI++I+DP+L  D+D+ SVW+
Sbjct: 778 YSFGIVLLEIITNQLVINQ--SREKPHIAEWVGLMLTKGDIQNIMDPKLYGDYDSGSVWR 835

Query: 812 AVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGT 871
           AVELAM+CL+P+  +RPTMSQVV+EL+ECL+ E AR  + +  +S+ SI+   +SMN   
Sbjct: 836 AVELAMSCLNPSSARRPTMSQVVIELNECLSYENARGGTSQNMNSESSIE---VSMNFDI 892

Query: 872 ELNPRAR 878
              P AR
Sbjct: 893 GATPDAR 899

Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1

 Score =  822 bits (2123), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/891 (49%), Positives = 595/891 (66%), Gaps = 60/891 (6%)

Query: 15  LANVIHAQDQTGFISLDCGLP-KDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQ 73
           + +++ AQD  GFI+LDCGL  + S Y E++TG+ Y SDD FV++G    I +E ++  +
Sbjct: 14  ILHLVQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDDGFVQSGKIGKITKELESLYK 73

Query: 74  KQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVT 133
           K  R +R FPDG+RNC+  N+T+G++YLI+  F+YGNYD +N +P FD++IGPN W++V 
Sbjct: 74  KPERTLRYFPDGVRNCFSLNVTRGTKYLIKPTFLYGNYDGRNVIPDFDLYIGPNMWITVN 133

Query: 134 FENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLF 193
            +N      I EI+H+  S+ L +CLV TG   P+I+ LELRPL ++  Y  +SGSLN  
Sbjct: 134 TDN-----TIKEILHVSKSNTLQVCLVKTGTSIPYINTLELRPLADD-IYTNESGSLNYL 187

Query: 194 TRLDVASTTNLTIRYNDDVHDRSW---FPYNSANWARINTSLTVDAESHNSYQPPAVVMN 250
            R+  ++     I Y DDVHDR W    PY   +W  + T+L ++    N Y  P  VM 
Sbjct: 188 FRVYYSNLKGY-IEYPDDVHDRIWKQILPYQ--DWQILTTNLQINVS--NDYDLPQRVMK 242

Query: 251 TAGTP-KNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFS 309
           TA TP K ++ +M+F    E P+ QFY+++HFAE+Q LQAN++R+FN+ LNG   +  +S
Sbjct: 243 TAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREFNVVLNGNVTFKSYS 302

Query: 310 PNYLLTTTVFS--PTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVD 367
           P +L   TV+S  P    GG     L KT  STLPP+INA+E Y+V +F Q++T   +V 
Sbjct: 303 PKFLEMQTVYSTAPKQCDGGKCLLQLVKTSRSTLPPLINAMEAYTVLDFPQIETNVDEVI 362

Query: 368 AITNIKATYGLKKN-WQGDPCAPLAYWWDGLNCSYGDSSSPRI-TYLNLSSSGLKGDITS 425
           AI NI++TYGL K  WQGDPC P  + WDGLNC+  D S+P I T LNLSSSGL G I  
Sbjct: 363 AIKNIQSTYGLSKTTWQGDPCVPKKFLWDGLNCNNSDDSTPPIITSLNLSSSGLTGIIVL 422

Query: 426 YVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS 484
            + NL +LQ LDLSNNNL+G VP+FL+ +  L  +NL GN L+G VP +L+E+     L 
Sbjct: 423 TIQNLANLQELDLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKM---LK 479

Query: 485 LSVGGNPGL-CSKISCKKKK-------NNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQ 536
           L++ GNP L C+  SC  K         ++ +P+VAS+ GSV     AL IF V+++   
Sbjct: 480 LNIEGNPKLNCTVESCVNKDEEGGRQIKSMTIPIVASI-GSVVAFTVALMIFCVVRKNNP 538

Query: 537 VGK-------VKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE 589
                     +  +S++   +   K++  +Y++V+ +TNNF++ LGKGGFG VYYG +N 
Sbjct: 539 SNDEAPTSCMLPADSRSSEPTIVTKNKKFTYAEVLTMTNNFQKILGKGGFGIVYYGSVNG 598

Query: 590 ID-VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL 648
            + VAVKMLS SSAQG++QF+AEV+LL+RVHH+NL  LVG+C+E ++ ALIYE+MANG+L
Sbjct: 599 TEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDL 658

Query: 649 QEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKL 707
            E++S      +L+   RL+IA+E+AQGLEYLHNGCKP +VHRDVK+TNILLNE    KL
Sbjct: 659 DEHMSGKRGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKL 718

Query: 708 ADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA 767
           ADFGLS+SF  +  THVSTVVAGT GYLDPEYY +N LTEKSDVYSFGVV+L +IT +P 
Sbjct: 719 ADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMITNQPV 778

Query: 768 ISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQR 827
           I +    EK HI +WV  ++ KGDIKSI DP L  D+++ SVWKAVELAM+C++P+   R
Sbjct: 779 IDQ--NREKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCMNPSSMTR 836

Query: 828 PTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           PTMSQVV EL ECLA+E +R                 +SM  GTE+ P AR
Sbjct: 837 PTMSQVVFELKECLASESSRE----------------VSMTFGTEVAPMAR 871

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1

 Score =  822 bits (2122), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 432/850 (50%), Positives = 595/850 (70%), Gaps = 26/850 (3%)

Query: 12  SLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTG 71
           +L L   + AQDQ+GFIS+DCG+P  S+Y + TTGINY+SD +FVETG+ KSI       
Sbjct: 16  ALCLVVSVLAQDQSGFISIDCGIPSGSSYKDDTTGINYVSDSSFVETGVSKSI----PFT 71

Query: 72  QQKQMRRVRSFPDGIRNCYRFNLT--KGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKW 129
            Q+Q++ +RSFP+G RNCY       KG +YLIR +FMYGNYD +N  P FD+F+G N W
Sbjct: 72  AQRQLQNLRSFPEGSRNCYTLIPIQGKGKKYLIRASFMYGNYDGENGSPEFDLFLGGNIW 131

Query: 130 LSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLF-ENSTYKAQSG 188
            +V   N +S V+  E++++  S+ + +CL N G GTPFIS LELR L  +N+TY + +G
Sbjct: 132 DTVLLSNGSSIVS-KEVVYLSQSENIFVCLGNKGKGTPFISTLELRFLGNDNTTYDSPNG 190

Query: 189 SLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVV 248
           +L    R D+ S     +RY+DDV+DR W P N      INTSL V ++ +NSY   ++V
Sbjct: 191 ALFFSRRWDLRSLMGSPVRYDDDVYDRIWIPRNFGYCREINTSLPVTSD-NNSYSLSSLV 249

Query: 249 MNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQ--ILQANQSRQFNISLNGEHWYG 306
           M+TA TP N ++ +   LE  DP+++++VYMHFAEV+   L+ NQ+R+F+IS+NG     
Sbjct: 250 MSTAMTPINTTRPITMTLENSDPNVRYFVYMHFAEVEDLSLKPNQTREFDISINGVTVAA 309

Query: 307 PFSPNYLLTTTVF-SPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQID 365
            FSP YL T T F +P +      +FSL +T  STLPPI+NA+E+Y    F Q  T Q D
Sbjct: 310 GFSPKYLQTNTFFLNPES--QSKIAFSLVRTPKSTLPPIVNALEIYVANSFSQSLTNQED 367

Query: 366 VDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITS 425
            DA+T++K +Y +KKNW GDPC P  Y W+GLNCSY   + PRIT LNLSSSGL G I+S
Sbjct: 368 GDAVTSLKTSYKVKKNWHGDPCLPNDYIWEGLNCSYDSLTPPRITSLNLSSSGLTGHISS 427

Query: 426 YVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS 484
             SNLT +Q LDLSNN LTG +P+FLSKL  LR LNL+ N L GSVP ELLERS  GS S
Sbjct: 428 SFSNLTMIQELDLSNNGLTGDIPEFLSKLKFLRVLNLENNTLTGSVPSELLERSNTGSFS 487

Query: 485 LSVGGNPGLCSKISCKKKKNN-VVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKRE 543
           L +G NPGLC++ISC+K  +  +V+P+VAS A    LL  +  +F+ ++ +R     K  
Sbjct: 488 LRLGENPGLCTEISCRKSNSKKLVIPLVASFAALFILLLLS-GVFWRIRNRRN----KSV 542

Query: 544 SKNKIDSFEAKSRH---LSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSS 600
           +     S  AKS +    +++DV+K+TNNF + LGKGGFGTVY+G  + + VAVK+LS +
Sbjct: 543 NSAPQTSPMAKSENKLLFTFADVIKMTNNFGQVLGKGGFGTVYHGFYDNLQVAVKLLSET 602

Query: 601 SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVL 660
           SAQGF++F++EV++L+RVHH NLT+L+G+  E +Q  LIYEFMANGN+ ++L+   +  L
Sbjct: 603 SAQGFKEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFMANGNMADHLAGKYQHTL 662

Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
           S ++RL+IA+++AQGLEYLH GCKPPIVHRDVK++NILLNEK +AKLADFGLS+SF T++
Sbjct: 663 SWRQRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKNRAKLADFGLSRSFHTES 722

Query: 721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR 780
            +HVST+VAGTPGYLDP  + +N L EKSD+YSFGVV+LE+IT K  I   ++ +++H+ 
Sbjct: 723 RSHVSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMITGKTVIKE-SQTKRVHVS 781

Query: 781 QWVNSLI-AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
            WV S++ +  D+ +++D ++ +DFD NSVWK VELA++ +S   + RP M  +V  L+E
Sbjct: 782 DWVISILRSTNDVNNVIDSKMAKDFDVNSVWKVVELALSSVSQNVSDRPNMPHIVRGLNE 841

Query: 840 CLAAEMARAN 849
           CL  E +  N
Sbjct: 842 CLQREESNKN 851

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	878
255549714	915	BRASSINOSTEROID INSENSITIVE 1-associated	0.984	0.944	0.584	0.0
255549712	884	BRASSINOSTEROID INSENSITIVE 1-associated	0.988	0.981	0.572	0.0
255549706	886	BRASSINOSTEROID INSENSITIVE 1-associated	0.990	0.981	0.562	0.0
255549708	883	Nodulation receptor kinase precursor, pu	0.981	0.976	0.556	0.0
255549700	884	BRASSINOSTEROID INSENSITIVE 1-associated	0.992	0.985	0.576	0.0
255549716	892	Nodulation receptor kinase precursor, pu	0.972	0.957	0.556	0.0
356550478	895	PREDICTED: probable LRR receptor-like se	0.990	0.972	0.556	0.0
15218033	894	putative leucine-rich repeat protein kin	0.984	0.966	0.541	0.0
39104601	894	unknown protein [Arabidopsis thaliana]	0.984	0.966	0.540	0.0
356556632	884	PREDICTED: putative leucine-rich repeat	0.968	0.961	0.568	0.0

>gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score = 1024 bits (2647), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/874 (58%), Positives = 652/874 (74%), Gaps = 10/874 (1%)

Query: 1   MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGI 60
           MLK +   LL  + L  V+ AQ Q+GFIS+DCG+ +++ YT++TT I+Y+SD AF++TG 
Sbjct: 32  MLKYYPFPLLSIIALLAVVQAQAQSGFISIDCGISENATYTDSTTSIDYVSDAAFIDTGK 91

Query: 61  GKSILQEF-QTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPG 119
            KSI  E+ +    +Q++ VRSF +G+RNCY+  L KG++YLIR  F+YGNYD +N  P 
Sbjct: 92  SKSIAAEYTRYNINQQLQNVRSFAEGVRNCYKIGLKKGAKYLIRAEFLYGNYDGQNKAPI 151

Query: 120 FDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFE 179
           FD+++G +KW +V    N++ +   EIIH++ + Y+ +CLVNTG GTPF+S LELRP+  
Sbjct: 152 FDLYLGSSKWETVD-TINSTMIITKEIIHLINTSYIDVCLVNTGSGTPFMSKLELRPI-R 209

Query: 180 NSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESH 239
            S Y    GSL  F+R DV STTN T+RY DDV+DR W P +   WA I+TS T+DA + 
Sbjct: 210 ISAYSTSLGSLARFSRSDVGSTTNRTLRYADDVYDRIWTPNHFFKWAEISTSETIDALAQ 269

Query: 240 NSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISL 299
           N Y+PP++VM TAG P N ++ M   ++ ED + +F VYMHFAE+  L+AN+SRQFNISL
Sbjct: 270 NDYRPPSIVMRTAGIPANDNEPMTVSIDFEDTTFRFLVYMHFAEILKLEANESRQFNISL 329

Query: 300 NGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQL 359
           NGEHW+GP  P+YL TTTVFSPT L GG Y FS+YKT NSTLPP++NAIE+Y + +  Q 
Sbjct: 330 NGEHWFGPLRPDYLYTTTVFSPTVLSGGQYEFSIYKTENSTLPPLLNAIEIYYILDLSQP 389

Query: 360 QTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGL 419
           Q+ Q DVDAITNIK++YG+K+NWQGDPCAP AY W+GLNCSY  +  PRI  LNLSSSGL
Sbjct: 390 QSNQEDVDAITNIKSSYGIKRNWQGDPCAPQAYLWEGLNCSYSGNVMPRIISLNLSSSGL 449

Query: 420 KGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERS 478
            G+I S +S+LTSL+ LDLSNN LTGSVPDFLS+LP L  L L GN+L+GSVP  L+E+S
Sbjct: 450 TGEIPSSISSLTSLESLDLSNNYLTGSVPDFLSQLPSLNVLILTGNRLSGSVPPSLVEKS 509

Query: 479 KNGSLSLSVGGNPGLCSKISCK-KKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQV 537
           +   L LSVGGN  LC K SCK +KKNNVVVPVVAS+AG + +++A  AI +  KR++Q 
Sbjct: 510 EQNLLVLSVGGNANLCLKSSCKNEKKNNVVVPVVASIAGVLIIISALAAILYTRKRRKQQ 569

Query: 538 GKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKML 597
            +  + S N     E+K R  +YS+++ ITNNFER LGKGGFGTVY+G L++  VAVK+L
Sbjct: 570 EEDTKTS-NIYGPLESKERQFTYSEILNITNNFERVLGKGGFGTVYHGYLDDTQVAVKIL 628

Query: 598 SSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK 657
           S  SAQG+++F AEVKLL+RVHHRNLTSLVG C+E  +  LIYE+MANG+L+  LS  ++
Sbjct: 629 SPLSAQGYKEFHAEVKLLLRVHHRNLTSLVGFCNEGTKMGLIYEYMANGDLEHLLSGRNR 688

Query: 658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
            VL  + RL IAVE+A+GLEYLHNGCKPPIVHRD+K+ NILLN++ QA+LADFGLSKSF 
Sbjct: 689 HVLKWERRLDIAVEAAKGLEYLHNGCKPPIVHRDIKTANILLNDQFQARLADFGLSKSFP 748

Query: 718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
            +  THVSTVVAGTPGYLDPEY  +N LTEKSDVYSFGVV+L+IIT +P I+ I +E  I
Sbjct: 749 VEGGTHVSTVVAGTPGYLDPEYSMTNWLTEKSDVYSFGVVLLKIITGRPVIAVI-DERSI 807

Query: 778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
           HI  WV+SL+A GDIK+++DP L  DFD NSVWKAVE+AMAC SPT   RPTM+QVV EL
Sbjct: 808 HISHWVSSLVANGDIKTVIDPCLGGDFDINSVWKAVEVAMACTSPTSAGRPTMNQVVREL 867

Query: 838 SECLAAEMARANSGRGFHSKGSIDHLMMSMNLGT 871
            E LA E ARA  G   H   SI  +  S  L +
Sbjct: 868 IESLAEETARAEEG---HKTKSIVMMTESTPLAS 898

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score = 1018 bits (2633), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 504/881 (57%), Positives = 655/881 (74%), Gaps = 13/881 (1%)

Query: 5   FLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSI 64
           FL   L  L LA ++H QDQ+GFIS+DCGLP +S+YT+ TTG+NY+SD AF++TGI  ++
Sbjct: 10  FLFRFLPILALAILVHCQDQSGFISIDCGLPANSSYTDATTGLNYVSDAAFIDTGIINNL 69

Query: 65  LQEFQTGQ-QKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMF 123
                T    +Q   VRSFP+G RNCY+  LT+G++YLIR  F+Y NYD  + +P FD+ 
Sbjct: 70  APGLNTSSIDRQQLSVRSFPEGDRNCYQVELTRGTKYLIRAIFLYRNYDGLSKLPHFDLH 129

Query: 124 IGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTY 183
           +GPNKW++V   N A+   I EII+    +Y+H+CLVNTGLGTPFISALELRPL +N+TY
Sbjct: 130 LGPNKWITVKILN-ATIPVITEIIYTPILNYIHVCLVNTGLGTPFISALELRPL-KNTTY 187

Query: 184 KAQS-GSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSY 242
           + +S G+L  F RLD  S TN T+RY DDV+DR W P +   W  ++T  T+DA+ HN +
Sbjct: 188 EIRSEGALAKFARLDFGSVTNKTVRYPDDVYDRIWTPDHYYKWTDLSTPETIDAQFHNDF 247

Query: 243 QPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGE 302
           QPP++VM+TA  P NAS+ M F+++ ED S+QFY YMHFAE+  L+ANQSRQFNISLNG 
Sbjct: 248 QPPSIVMSTANVPTNASEDMQFFIDNEDTSLQFYFYMHFAEIVKLEANQSRQFNISLNGT 307

Query: 303 HWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTE 362
            ++GP  P+YL T++V++   +  G+  FSL+K G STLPP++NAIE+Y   +  Q QT+
Sbjct: 308 IFFGPVIPDYLYTSSVYNGLPINAGSNVFSLFKIGGSTLPPLLNAIEIYFFVDLSQSQTD 367

Query: 363 QIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGD 422
           Q DVDAIT IK+TYG+ +NWQGD CAP AY W GLNCSY D+  P+IT LNLSSSGL G+
Sbjct: 368 QDDVDAITKIKSTYGITRNWQGDACAPQAYVWQGLNCSYSDNDPPKITSLNLSSSGLTGE 427

Query: 423 ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNG 481
           I S ++NL SL+FLDLSNN+L+G VPDFLS++P L+ LNL GNKL G +PV+L ER++ G
Sbjct: 428 IVSDIANLKSLEFLDLSNNSLSGPVPDFLSQMPSLKVLNLTGNKLTGRIPVDLFERTQKG 487

Query: 482 SLSLSVGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAIFF---VLKRKRQVG 538
           SL LSV GNP LC  +SCKKK+ ++ V  V +   SVF+LAAA+A+     +L+   + G
Sbjct: 488 SLLLSVSGNPELCPSVSCKKKEKSIAV-PVVASVASVFILAAAVAVILRYRILRSVSETG 546

Query: 539 KVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE-IDVAVKML 597
           + K   ++  +  E K++  +YS+V+KITNNFE+ LGKGGFGTVYYG L +   VAVK+L
Sbjct: 547 ETKLSHESN-EPMELKNKQFTYSEVLKITNNFEKVLGKGGFGTVYYGTLADGTQVAVKIL 605

Query: 598 SSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK 657
           S SS QG+++F AEVKLLMRVHHRNLT+LVG C E     LIYE+MANGNL++YLS  + 
Sbjct: 606 SQSSVQGYKEFLAEVKLLMRVHHRNLTTLVGCCIEGTNMGLIYEYMANGNLEDYLSGSNL 665

Query: 658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
             LS + RLRIA+E+ QGLEYLH GCK PIVHRDVK+TNILLN+K QAK++DFGLS+ F 
Sbjct: 666 NTLSWEARLRIALEAGQGLEYLHGGCKLPIVHRDVKTTNILLNDKFQAKISDFGLSRIFP 725

Query: 718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
            D  THVST+VAGTPGYLDPEYY +N LT+KSDVYSFGVV+LEIITC+P I++    E  
Sbjct: 726 ADGGTHVSTIVAGTPGYLDPEYYVTNWLTDKSDVYSFGVVLLEIITCRPVIAQNRNHENS 785

Query: 778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
           HI QWV+S+I  GD+ SI DPRL  +++ NSVWK VELAM CLS T  +RPTM+QVV+EL
Sbjct: 786 HISQWVSSMIENGDVNSIADPRLNGEYEVNSVWKIVELAMECLSTTSARRPTMNQVVIEL 845

Query: 838 SECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           +ECL  EMAR   G+   S  SI+  ++++N+ TE +P AR
Sbjct: 846 NECLKTEMARTREGQSTQSYYSIE--LVTVNVDTESSPLAR 884

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549706|ref|XP_002515904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544809|gb|EEF46324.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score = 1006 bits (2601), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 497/883 (56%), Positives = 640/883 (72%), Gaps = 13/883 (1%)

Query: 5   FLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSI 64
           F     G L L  ++H QDQ+GFISLDCGLP +++Y++ TT +N+ISD +++E GI KS+
Sbjct: 8   FFSKFFGVLALIVLVHCQDQSGFISLDCGLPGNTSYSDATTTLNFISDASYIEIGISKSL 67

Query: 65  LQEFQTGQQ-KQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMF 123
             EF T    + +  VRSFP G RNCY   LTK + YLIR  FMYGNYD  N  P FD++
Sbjct: 68  APEFSTNSIFRPLWYVRSFPQGSRNCYNVTLTKDTEYLIRATFMYGNYDGINQRPSFDLY 127

Query: 124 IGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTY 183
           +GPNKW+SV   N  S     EIIH     Y+H+CLVNT  GTPFISALELRPL +N TY
Sbjct: 128 LGPNKWVSVQILN-GSIPVRKEIIHHPKRKYIHVCLVNTNSGTPFISALELRPL-KNGTY 185

Query: 184 KAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQ 243
            ++SGSL LF R D++S TN T+RY DDV+DR W P++   W  I+T+ T+D    NSYQ
Sbjct: 186 VSESGSLALFDRADISSITNQTVRYPDDVYDRRWSPFHFVEWTDISTTETIDLGKSNSYQ 245

Query: 244 PPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEH 303
            P+ VM +AGTP+N+S  M+  +  EDP+++FY Y HFAE+  L ANQSR+FNI+LNG+ 
Sbjct: 246 LPSTVMRSAGTPRNSSSPMEVTIAAEDPTLKFYAYFHFAEIVKLDANQSREFNITLNGDI 305

Query: 304 WYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQ 363
           WYGP + +YL +TTV S  A+ GG Y F ++K G STLPP++NA+EVY + E LQL+T+Q
Sbjct: 306 WYGPITLHYLYSTTVSSGYAISGGTYDFQIFKVGGSTLPPLLNAVEVYYIVELLQLETKQ 365

Query: 364 IDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDI 423
            DV A+  IK+TY + +NWQGDPCAP  Y W+GL C+Y +S+SP I  L+LSSSGL GD+
Sbjct: 366 EDVYAMIKIKSTYKITRNWQGDPCAPQDYVWEGLKCNYSNSASPVIISLDLSSSGLTGDV 425

Query: 424 TSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS 482
               +NL SL+ LDLSNN+LTG VPDFLS+L  L+ L+L GNKL G +P +L +RS++G 
Sbjct: 426 PPVFANLKSLESLDLSNNSLTGPVPDFLSQLKSLKVLDLTGNKLTGIIPDDLFKRSQSGL 485

Query: 483 LSLSVGGNPGLCSKISCK------KKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQ 536
           L LS GGNP LC+ +SC       KK NN VVPVVAS+A  + ++AA   I    +RK+Q
Sbjct: 486 LLLSFGGNPELCASVSCSNNNKKKKKNNNFVVPVVASIAALLVIVAALTIICCCRRRKQQ 545

Query: 537 VGKVKR-ESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVK 595
           V + +  ++K   +  E ++R  +YS+V+K+T NFE  LG+GGFGTVYYG L +I+VAVK
Sbjct: 546 VARNEEADTKETYEPREMRNRRFTYSEVLKLTKNFESVLGRGGFGTVYYGYLGDIEVAVK 605

Query: 596 MLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI 655
           +LS+SS QG+++F+AEVKLL+RVHH+NLT+LVG+CDE     LIYE+MANGNL+++LS  
Sbjct: 606 VLSTSSVQGYKEFEAEVKLLLRVHHKNLTTLVGYCDEGGNMILIYEYMANGNLRQHLSGE 665

Query: 656 SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS 715
              +LS + RL+IA+E+AQGLEYLHNGCKPPIVHRDVK+ NILL++K QAKLADFGLS+ 
Sbjct: 666 HPDILSWEGRLKIALETAQGLEYLHNGCKPPIVHRDVKTANILLDDKFQAKLADFGLSRM 725

Query: 716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           F  +  THVST+VAGTPGYLDPEYY  N LTEKSDVYSFGVV+LEIIT +  IS+ +  E
Sbjct: 726 FPAEGGTHVSTIVAGTPGYLDPEYYVRNWLTEKSDVYSFGVVLLEIITSRSVISQTS--E 783

Query: 776 KIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM 835
           K H+ QWV  ++ +GDIK+IVD RL  DFD N+ WKA ELAMAC+S T  +RP+MSQVVM
Sbjct: 784 KTHVSQWVKPMLERGDIKNIVDSRLCGDFDTNTAWKAAELAMACVSATSTERPSMSQVVM 843

Query: 836 ELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           ELSECL  EMAR   G       S   LM    L T L+PR+R
Sbjct: 844 ELSECLKTEMARTREGYCSAQSNSSAELMSVNVLSTVLSPRSR 886

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549708|ref|XP_002515905.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544810|gb|EEF46325.1| Nodulation receptor kinase precursor, putative [Ricinus communis]

 Score = 1000 bits (2586), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 495/889 (55%), Positives = 640/889 (71%), Gaps = 27/889 (3%)

Query: 5   FLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSI 64
           F    L  L +  ++H QDQ+GFISLDCGL  +S+YT+  TG+ YISD AF+ETG+ KSI
Sbjct: 7   FFFKFLCILAVRVLVHGQDQSGFISLDCGLQANSSYTDEKTGLKYISDAAFIETGVTKSI 66

Query: 65  LQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFI 124
             EF     +Q+R+VRSFP G RNCY+  L K +RYLIR  F+Y NYD  N +P FD+ I
Sbjct: 67  APEFLGSFNQQLRQVRSFPKGDRNCYKVELVKNTRYLIRATFLYANYDGLNKLPAFDLHI 126

Query: 125 GPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYK 184
           GPNKW++V   N   +  I EIIH    + +++CLV TG  TPFISALE+RPL  NSTY 
Sbjct: 127 GPNKWVNVQITNPLIY-PIKEIIHAPTFNNIYVCLVRTGPWTPFISALEIRPL-HNSTYV 184

Query: 185 AQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQP 244
           AQSGSL+LF R+DV S TN TIRY DDV+DR W P++      I+T   + +   + +Q 
Sbjct: 185 AQSGSLSLFNRVDVGSLTNQTIRYPDDVYDRMWLPFHFDKGTDISTKENITS-GIDYFQL 243

Query: 245 PAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHW 304
           P+ VMN+A  P NAS+ +   ++T+D + Q YVY+HFAE+  L+ NQSR+FNISLNG+  
Sbjct: 244 PSTVMNSATVPLNASEQIILNIDTQDNTFQAYVYIHFAEIVRLEPNQSRRFNISLNGKIL 303

Query: 305 YGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQI 364
           YGP +P +L  TTV+S +A+ GG + FS Y  G STLPP++NA+E+YSV + L  +T Q+
Sbjct: 304 YGPVTPKHLEATTVYSQSAIPGGKFLFSFYGVGGSTLPPLLNALELYSVVDLLHSETNQV 363

Query: 365 DVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDIT 424
           DV+AIT IK+TYG+ +NWQGDPC+P  Y WDGLNC+Y +++SP IT L+ SSSGL G+I 
Sbjct: 364 DVNAITKIKSTYGITRNWQGDPCSPQDYKWDGLNCTYSNTASPVITSLDFSSSGLTGEID 423

Query: 425 SYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLS 484
             +SNL  L+ LDLSNN+LTG VPDFLS+LPL++LNL GN L G++P +L  R ++  L 
Sbjct: 424 PDISNLKWLETLDLSNNSLTGPVPDFLSQLPLKSLNLAGNNLTGTIPADLFNRWQSDLLF 483

Query: 485 LSVGGNPGLCSKISCKKK-KNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKV--- 540
           LSV GNP LC+ +SC    K N+ VPV+ SV     ++A +  I + LK+++Q G V   
Sbjct: 484 LSVSGNPQLCASVSCNSDNKKNITVPVIISVTALFVIIAGSAIILWRLKKRKQQGTVPNG 543

Query: 541 -----------KRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE 589
                      K E++ K +  E + R L Y ++V+ITNNF+R LGKGGFGTVY+G L++
Sbjct: 544 FCWVMIWPVVGKMEAEAKREPLELQKRQLRYFEIVQITNNFQRILGKGGFGTVYHGHLDD 603

Query: 590 IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ 649
           ++VAVKMLS SSAQG+++FQ EVKLL+RVHHRNLTSLVG+CDE N+ ALIYE+MANGNL+
Sbjct: 604 MEVAVKMLSPSSAQGYKEFQTEVKLLLRVHHRNLTSLVGYCDEGNKMALIYEYMANGNLR 663

Query: 650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD 709
           + LSD +   LS +ERLRIA+E+AQGLEYLHNGCKPPI+HRDVK TNILLN K QAKLAD
Sbjct: 664 DNLSDGNGNFLSWEERLRIALEAAQGLEYLHNGCKPPIIHRDVKPTNILLNNKFQAKLAD 723

Query: 710 FGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAIS 769
           FGLS+    +  +HVST+VAGTPGYLDPEYY +N LTEKSDV+SFGVV+LEIIT  P IS
Sbjct: 724 FGLSRICPVEGGSHVSTIVAGTPGYLDPEYYATNWLTEKSDVFSFGVVLLEIITSGPVIS 783

Query: 770 RINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT 829
           +  + +  H+ QW +S++ KGDI+SIVDPRL +DFD NS+WK VELAMAC+S T  QRPT
Sbjct: 784 KTRDGDTTHLSQWFSSMVEKGDIQSIVDPRLGDDFDINSLWKVVELAMACVSATSAQRPT 843

Query: 830 MSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           M+QVV+ELSECLA E  +   G    S  ++ H        TEL P AR
Sbjct: 844 MNQVVIELSECLATETVKT-EGTSSQSYSTVLH--------TELTPLAR 883

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  994 bits (2571), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/886 (57%), Positives = 650/886 (73%), Gaps = 15/886 (1%)

Query: 1   MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGI 60
           ML  FL   +  L L   ++AQDQ+GFIS+DCGLP +S+YT+ TT +NYISD +F++ GI
Sbjct: 6   MLWDFLFRFIPVLFLT-AVYAQDQSGFISIDCGLPANSSYTDETTSLNYISDASFIDVGI 64

Query: 61  GKSILQEFQTGQ-QKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPG 119
             +I  +  T    +Q   VRSFP+G RNC+   L K ++YLIR  F +G+YD  N +P 
Sbjct: 65  ITTITPKVTTNSTDRQQLSVRSFPEGDRNCFNVELAKNTKYLIRAIFAHGDYDGSNELPE 124

Query: 120 FDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFE 179
           FD+ +GPNKW++V   N AS   I EIIH    +Y+HICLVNT  G PFISALELRPL +
Sbjct: 125 FDLHLGPNKWVTVKILN-ASIPVIKEIIHTPTLNYIHICLVNTDSGMPFISALELRPL-K 182

Query: 180 NSTYKAQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESH 239
           N+TY AQSG+L   TRLD+ S TN T+RY DDV DR W P +   W  ++T  TVDA++H
Sbjct: 183 NTTYVAQSGALVKSTRLDLGSLTNKTVRYPDDVFDRIWTPDHFHKWTDLSTPDTVDAQNH 242

Query: 240 NSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISL 299
             +QPP+VVM TA  P NAS++M+FY++ +D +  FYVYMHFAE+  LQANQSR FNISL
Sbjct: 243 IDFQPPSVVMRTANMPTNASENMEFYIDIDDTTSLFYVYMHFAEIVELQANQSRLFNISL 302

Query: 300 NGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQL 359
           NG  WYGP  PN+L + TV+S   +IGGN  FSL+K   STLPP++NAIE+Y V +  Q 
Sbjct: 303 NGTIWYGPVIPNHLSSGTVYSQFPIIGGNNMFSLFKIEGSTLPPLLNAIEIYFVVDLSQS 362

Query: 360 QTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGL 419
           +T+Q DVDAI  IK+TYG+ KNWQGDPCAP AY W GLNCSY D   P +  LNLSSSGL
Sbjct: 363 ETDQDDVDAIMKIKSTYGITKNWQGDPCAPQAYVWHGLNCSYSDDDPPTVKSLNLSSSGL 422

Query: 420 KGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKL-PLRTLNLQGNKLNGSVPVELLERS 478
           +G+I S ++NL SL+ LDLSNN+L+GS+PDFLS++  L+ LNL GNKL G++P +L ERS
Sbjct: 423 RGEIVSEIANLRSLELLDLSNNSLSGSLPDFLSRMTSLKVLNLTGNKLTGTIPADLFERS 482

Query: 479 KNGSLSLSVGGNPGLCSKISCKKKKNNVVVPVVASVAGSVFLLAAALAI----FFVLKR- 533
           + GSL LSV GNP LC  +SC KKK +VVV  V +   + F+LAAAL +    FFV  + 
Sbjct: 483 QQGSLLLSVSGNPELCPSVSCTKKKKSVVV-PVVASVVAFFILAAALVVILRYFFVRSQA 541

Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE-IDV 592
           K    K+  E+ ++    E+K R  SYS+++KITNNF++ LGKGGFGTVY+G LN+   V
Sbjct: 542 KTNEAKISYETNDE-PLVESKKRQFSYSEILKITNNFDKILGKGGFGTVYHGTLNDGTQV 600

Query: 593 AVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL 652
           AVK+LS SSAQG+++FQAEVKLL+RVHHRNLT+LVG+C+E     LIYE+MANGNL++YL
Sbjct: 601 AVKVLSLSSAQGYKEFQAEVKLLLRVHHRNLTTLVGYCNEGTNLGLIYEYMANGNLEDYL 660

Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
           SD     LS + RLRIA E+AQGLEYLHNGCKP IVHRDVK+TNILLN+K QAKLADFGL
Sbjct: 661 SDSCLNTLSWEIRLRIATEAAQGLEYLHNGCKPQIVHRDVKTTNILLNDKFQAKLADFGL 720

Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRIN 772
           S+ F  D +TH+STVVAGTPGYLDPEYY +N LT+KSDV+SFGVV+LEIIT +PAI++  
Sbjct: 721 SRIFPVDGSTHISTVVAGTPGYLDPEYYVNNWLTDKSDVFSFGVVLLEIITGRPAIAQ-- 778

Query: 773 EEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQ 832
             E+ HI QWV+S++ KGDI  IVDPRL  DF+ NSVWKA ELAM C+S +  +RPTM+Q
Sbjct: 779 TRERTHISQWVSSMLEKGDIHGIVDPRLNGDFEINSVWKAAELAMGCVSASSARRPTMNQ 838

Query: 833 VVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
            V+EL++CL  EM R   G+   S  S    +M++N+ TE +P AR
Sbjct: 839 AVVELNDCLNIEMGRTREGQSSQSFNSNSIELMTVNVHTEASPLAR 884

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549716|ref|XP_002515909.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544814|gb|EEF46329.1| Nodulation receptor kinase precursor, putative [Ricinus communis]

 Score =  984 bits (2543), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 490/881 (55%), Positives = 638/881 (72%), Gaps = 27/881 (3%)

Query: 18  VIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQ-QKQM 76
           ++H QDQ+GFISLDCGLP ++ YT+ TT +NY SD +F++TGI KS+   F T   ++Q+
Sbjct: 19  MVHGQDQSGFISLDCGLPANTTYTDETTSLNYNSDASFIDTGISKSLAPGFTTDNLRRQL 78

Query: 77  RRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFEN 136
             +RSFP+G RNCY   L K + YLIR  FMYGNYD  N +P FD+ IGPNKW+SV   N
Sbjct: 79  WYIRSFPEGDRNCYNLTLAKDTEYLIRATFMYGNYDGLNQLPEFDLHIGPNKWVSVKILN 138

Query: 137 NASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNL--FT 194
            ++ V    II    S Y+H+CLV    GTPFISALE RPL +N TY  +SGSL L  FT
Sbjct: 139 ASTSVTEEIIIGSPKSKYIHVCLVTKDTGTPFISALETRPL-KNGTYVTESGSLGLALFT 197

Query: 195 RLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGT 254
           R DV S  N  +RY +DV+DR WFPY+      I+T+LTVD + HN +QPP++VM +A  
Sbjct: 198 REDVGSLNNRIVRYPNDVYDRRWFPYHFKRGTDISTTLTVDLDDHNDFQPPSIVMRSAVI 257

Query: 255 PKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLL 314
             N S  ++FY+   D + + Y YMHFAE+  L+ANQSRQFNISLNG+ WYGP +P YL 
Sbjct: 258 SINTSSPLEFYIN-NDTTYKLYAYMHFAEIVKLEANQSRQFNISLNGKIWYGPVTPTYLY 316

Query: 315 TTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKA 374
           TTTV+S +A+  G Y FSL K   S LPP++NAIE+Y V + LQ +T Q DV  I NIK+
Sbjct: 317 TTTVYSTSAITDGMYEFSLSKVEGSALPPLLNAIELYYVVDLLQPETNQRDVIGIMNIKS 376

Query: 375 TYGLKK-NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSL 433
           TY + + NWQGDPCAP  + W+GL+C Y  +SSP I  LNLSSSGL G+I   ++NL SL
Sbjct: 377 TYRISRTNWQGDPCAPEDFVWEGLSCKYNVTSSPVIISLNLSSSGLHGEIAPDIANLKSL 436

Query: 434 QFLDLSNNNLTGSVPDFLSKL-PLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPG 492
           + LDLSNNNLT  VPDFLS+L  L+ LNL GN+LNG++P +LL+R+ +G L+LSV GNP 
Sbjct: 437 EILDLSNNNLTALVPDFLSQLQSLKFLNLTGNRLNGTIPDDLLKRADSG-LTLSVDGNPE 495

Query: 493 LCSKISCKKK-----KNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQ---------VG 538
           LC  +SC KK       + +VPVVASVA  + ++     I+++ +RK++          G
Sbjct: 496 LCKSVSCNKKKKKKKNTDFIVPVVASVAALLVIIVVLTTIWYLKRRKQKGTYLHKYILAG 555

Query: 539 KVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLS 598
           + + E+K   +  E   R  +YSDV+KITNNF   LG+GGFGTVY+G L++++VAVKMLS
Sbjct: 556 RTEAEAKKTHEPLELNKRQFTYSDVLKITNNFGSVLGRGGFGTVYHGYLDDVEVAVKMLS 615

Query: 599 SSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK- 657
            SS QG+++F AEV+LL+RVHH+NLT+LVG+CDE N   LIYE+MANGNL+ +LS     
Sbjct: 616 PSSVQGYKEFHAEVRLLLRVHHKNLTTLVGYCDEGNNMGLIYEYMANGNLKHHLSGCDHP 675

Query: 658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
            +LS + RL+IA+E+AQGL+YLHNGCKPPIVHRDVK+TNILLN++ QAKLADFGLS++F 
Sbjct: 676 SILSWEGRLQIALEAAQGLDYLHNGCKPPIVHRDVKTTNILLNDRFQAKLADFGLSRTFP 735

Query: 718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
            +  +HVSTVVAGTPGYLDP+YY +N LTEKSDVYS+GVV+LEIIT +P I+R    +K 
Sbjct: 736 VEDGSHVSTVVAGTPGYLDPDYYVTNWLTEKSDVYSYGVVLLEIITSRPVIART--RDKT 793

Query: 778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
           H+ QWV +++ KGDIK+IVDPRL+ DFD NSVWK  ELAMACLS T  +RP+MSQVVMEL
Sbjct: 794 HVSQWVKAMLDKGDIKNIVDPRLRGDFDNNSVWKVTELAMACLSTTSGERPSMSQVVMEL 853

Query: 838 SECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           ++CL  EMARA  GR   S  S++  ++S++L T ++P AR
Sbjct: 854 NDCLTTEMARAREGRSTQSSSSVE--VISLHLHTGVSPLAR 892

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356550478|ref|XP_003543614.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51860-like [Glycine max]

 Score =  967 bits (2499), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 501/901 (55%), Positives = 638/901 (70%), Gaps = 31/901 (3%)

Query: 1   MLKIFLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTE-TTTGINYISDDAFVETG 59
           M + FL+  +G L LA +I AQDQ+GFIS+DCG P   +YTE T TGINYISD  F++TG
Sbjct: 3   MSRSFLVGFIGGLVLAVLIQAQDQSGFISIDCGAPAGVSYTELTRTGINYISDANFIDTG 62

Query: 60  IGKSILQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPG 119
           + + I+ E ++  Q+Q+  VRSFP+G RNCY+ ++T+GS YLIRT+F+YGNYD  N+ P 
Sbjct: 63  VSRKIVSELKSVYQQQLWDVRSFPEGKRNCYKISITRGSTYLIRTSFLYGNYDGLNTEPQ 122

Query: 120 FDMFIGPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFE 179
           FD+ +G N+W +V   N   + A  EIIH+   DY+ ICLVNTG G PFISA+ELR L +
Sbjct: 123 FDIHLGANRWATVIIYNATIYYA-KEIIHVPSQDYVQICLVNTGHGIPFISAIELRTL-K 180

Query: 180 NSTYKAQSGSL---NLFTRLDVASTTNLTIRYNDDVHDRSWFPYN-SANWARI-NTSLTV 234
           N TY  Q GSL   N + R D+ S T    RY DDV+DR W   +   +W  + N S+  
Sbjct: 181 NDTYVTQFGSLETYNDYERCDLGSNTG-GYRYKDDVYDRFWNTCDFDEDWTPVLNASIPA 239

Query: 235 DAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQ 294
           D+   N Y+PPA+V++TA TP N S  +      +DP+ QFYVYMHF E+Q+L  NQ+RQ
Sbjct: 240 DSLEQNDYEPPAIVLSTAVTPANVSVPLVIKWVPQDPTDQFYVYMHFLEIQVLATNQTRQ 299

Query: 295 FNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVK 354
           F+I+ NG+ W+   SP      T++S  A+ G    +S   T NSTLPPII+AIE+Y V 
Sbjct: 300 FSITENGKTWFPNLSPTNQSVDTIYSLRAVSGEQIKYSFEMTENSTLPPIISAIEIYRVI 359

Query: 355 EFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNL 414
           +F Q  T Q DVDAIT IK+ YG+ ++WQGDPCAP+ Y WDGLNC+Y  + SPRIT LNL
Sbjct: 360 DFQQSDTFQGDVDAITAIKSVYGVTRDWQGDPCAPIDYLWDGLNCTYPGNDSPRITTLNL 419

Query: 415 SSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVE 473
           SSSGL G I   + NLT L+ LDLSNN+L   VPDFLS+L  L+ LNL+ N L+GS+P  
Sbjct: 420 SSSGLSGKIDPSILNLTMLENLDLSNNSLKDEVPDFLSQLQHLKILNLEKNNLSGSIPST 479

Query: 474 LLERSKNGSLSLSVGGNPGLCSKISCKK---------KKNNVVVPVVASVAGSVFLLAAA 524
           L+E+SK GSL+LSVG NP LC    C +          + ++V PVVASV G+V LL   
Sbjct: 480 LVEKSKEGSLALSVGQNPYLCESGQCNQKEKEKEKGKDEKSIVTPVVASVGGAVILLVVL 539

Query: 525 LAIFFVLKRKRQVGK----VKRESKNKIDSF-EAKSRHLSYSDVVKITNNFERTLGKGGF 579
           +AI + LKR++   K    +  +  ++ DSF ++K +  SYSDV+KITNNF   LGKGGF
Sbjct: 540 VAILWTLKRRKSKEKDQSQISLQYTDQDDSFLQSKKQIYSYSDVLKITNNFNAILGKGGF 599

Query: 580 GTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI 639
           GTVY G +++  VAVKMLS SS  G+QQFQAEVKLLMRVHH+ LTSLVG+C+E N   LI
Sbjct: 600 GTVYLGYIDDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKCLTSLVGYCNEGNDKCLI 659

Query: 640 YEFMANGNLQEYLSDISKKV--LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           YE+MANGNLQE+L+    K    + +ERLRIAV++A GLEYL NGCKPPI+HRDVKSTNI
Sbjct: 660 YEYMANGNLQEHLTGKRSKTKFFTWEERLRIAVDAALGLEYLQNGCKPPIIHRDVKSTNI 719

Query: 698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           LLNE  QAKL+DFGLSK   TD  THVSTVVAGTPGYLDPEY+ +NRLTEKSDVYSFGVV
Sbjct: 720 LLNEHFQAKLSDFGLSKIIPTDGVTHVSTVVAGTPGYLDPEYFITNRLTEKSDVYSFGVV 779

Query: 758 ILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAM 817
           +LEIIT +P I+R  +EE IHI +WV+SLIAKGDI++IVDPRL+ DFD+NSVWKAVE+A 
Sbjct: 780 LLEIITSQPVIAR--KEESIHISEWVSSLIAKGDIEAIVDPRLEGDFDSNSVWKAVEIAT 837

Query: 818 ACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRA 877
           ACLSP  N+RP  S +V+EL E LA E+AR     G  ++ S+    ++MNL TE +P+A
Sbjct: 838 ACLSPNMNKRPITSVIVIELKESLAMELARTKYS-GVETRDSVK--TVTMNLNTEFSPQA 894

Query: 878 R 878
           R
Sbjct: 895 R 895

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15218033|ref|NP_175591.1| putative leucine-rich repeat protein kinase [Arabidopsis thaliana] gi|12321672|gb|AAG50874.1|AC025294_12 receptor protein kinase, putative [Arabidopsis thaliana] gi|224589424|gb|ACN59246.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332194596|gb|AEE32717.1| putative leucine-rich repeat protein kinase [Arabidopsis thaliana]

 Score =  962 bits (2486), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 486/898 (54%), Positives = 639/898 (71%), Gaps = 34/898 (3%)

Query: 5   FLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSI 64
           FLL LL       +  AQDQ+GFISLDCG P+++++ E TT I YISD  F+ TG+G SI
Sbjct: 7   FLLVLLQIFSALLLCLAQDQSGFISLDCGSPRETSFREKTTNITYISDANFINTGVGGSI 66

Query: 65  LQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFI 124
            Q ++T  Q+Q   +RSFP GIRNCY  NLT G  YLIR NF++G YD+K S   F++++
Sbjct: 67  KQGYRTQFQQQTWNLRSFPQGIRNCYTLNLTIGDEYLIRANFLHGGYDDKPSTQ-FELYL 125

Query: 125 GPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYK 184
           GPN W +VT  N     +I E+IHIL +D L ICLV TG  TPFISALELR L  N+TY 
Sbjct: 126 GPNLWSTVTTTNETE-ASIFEMIHILTTDRLQICLVKTGNATPFISALELRKLM-NTTYL 183

Query: 185 AQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQP 244
            + GSL  F R DV +T N   RY  DV DR W PYN  NW++I+T+ +V+   +N YQP
Sbjct: 184 TRQGSLQTFIRADVGATVNQGYRYGIDVFDRVWTPYNFGNWSQISTNQSVNI--NNDYQP 241

Query: 245 PAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHW 304
           P + M TA  P +   +M+  L   + ++QFYV+MHFAE+Q L++N +R+FNI  N +H 
Sbjct: 242 PEIAMVTASVPTDPDAAMNISLVGVERTVQFYVFMHFAEIQELKSNDTREFNIMYNNKHI 301

Query: 305 YGPFSPNYLLTTTVFSPTALIG---GNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQT 361
           YGPF P    T++VF+PT ++    G Y FSL +TGNSTLPP++NA+E+YSV    Q +T
Sbjct: 302 YGPFRPLNFTTSSVFTPTEVVADANGQYIFSLQRTGNSTLPPLLNAMEIYSVNLLPQQET 361

Query: 362 EQIDVDAITNIKATYGLKK-NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLK 420
           ++ +VDA+ NIK+ YG+ K +W+GDPC PL Y W G+NC+Y D+ +P+I  L+LS+SGL 
Sbjct: 362 DRKEVDAMMNIKSAYGVNKIDWEGDPCVPLDYKWSGVNCTYVDNETPKIISLDLSTSGLT 421

Query: 421 GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSK 479
           G+I  ++S+LTSL+ LDLSNN+LTGSVP+FL+ +  L+ +NL GN+LNGS+P  LL++ +
Sbjct: 422 GEILEFISDLTSLEVLDLSNNSLTGSVPEFLANMETLKLINLSGNELNGSIPATLLDKER 481

Query: 480 NGSLSLSVGGNPGLCSKISCKKKK----NNVVVPVVASVAGSVFLLAAALAIFFVLKRKR 535
            GS++LS+ GN GLCS  SC   K    N V+ PV AS+  SVFL+ A +  F +LKRK+
Sbjct: 482 RGSITLSIEGNTGLCSSTSCATTKKKKKNTVIAPVAASLV-SVFLIGAGIVTFLILKRKK 540

Query: 536 QV----------GKVKRESKNKIDSFE----AKSRHLSYSDVVKITNNFERTLGKGGFGT 581
           +           G     S++    FE    AK+R L+Y DVVKITNNFER LG+GGFG 
Sbjct: 541 RTKLGLNPNSGTGTTPLHSRSH-HGFEPPVIAKNRKLTYIDVVKITNNFERVLGRGGFGV 599

Query: 582 VYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE 641
           VYYG LN   VAVKML+ S+A G++QF+AEV+LL+RVHH++LT LVG+C+E ++ +LIYE
Sbjct: 600 VYYGVLNNEPVAVKMLTESTALGYKQFKAEVELLLRVHHKDLTCLVGYCEEGDKMSLIYE 659

Query: 642 FMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN 700
           FMANG+L+E+LS      +L+ + RLRIA ESAQGLEYLHNGCKP IVHRD+K+TNILLN
Sbjct: 660 FMANGDLKEHLSGKRGPSILTWEGRLRIAAESAQGLEYLHNGCKPQIVHRDIKTTNILLN 719

Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE 760
           EK QAKLADFGLS+SF     THVST+VAGTPGYLDPEYY +N LTEKSDV+SFGVV+LE
Sbjct: 720 EKFQAKLADFGLSRSFPLGTETHVSTIVAGTPGYLDPEYYRTNWLTEKSDVFSFGVVLLE 779

Query: 761 IITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACL 820
           ++T +P I    + EK HI +WV  ++++GDI SIVDP+LQ DFD N++WK VE AM CL
Sbjct: 780 LVTNQPVIDM--KREKSHIAEWVGLMLSRGDINSIVDPKLQGDFDPNTIWKVVETAMTCL 837

Query: 821 SPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           +P+ ++RPTM+QVVM+L ECL  EMAR N G       +   + +SMN  TELNP AR
Sbjct: 838 NPSSSRRPTMTQVVMDLKECLNMEMAR-NMGSRMTDSTNDSSIELSMNFTTELNPGAR 894

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|39104601|dbj|BAC43425.2| unknown protein [Arabidopsis thaliana]

 Score =  961 bits (2483), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 485/898 (54%), Positives = 639/898 (71%), Gaps = 34/898 (3%)

Query: 5   FLLALLGSLPLANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSI 64
           FLL LL       +  AQDQ+GFISLDCG P+++++ E TT I YISD  F+ TG+G SI
Sbjct: 7   FLLVLLQIFSALLLCLAQDQSGFISLDCGSPRETSFREKTTNITYISDANFINTGVGGSI 66

Query: 65  LQEFQTGQQKQMRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFI 124
            Q ++T  Q+Q   +R+FP GIRNCY  NLT G  YLIR NF++G YD+K S   F++++
Sbjct: 67  KQGYRTQFQQQTWNLRNFPQGIRNCYTLNLTIGDEYLIRANFLHGGYDDKPSTQ-FELYL 125

Query: 125 GPNKWLSVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYK 184
           GPN W +VT  N     +I E+IHIL +D L ICLV TG  TPFISALELR L  N+TY 
Sbjct: 126 GPNLWSTVTTTNETE-ASIFEMIHILTTDRLQICLVKTGNATPFISALELRKLM-NTTYL 183

Query: 185 AQSGSLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQP 244
            + GSL  F R DV +T N   RY  DV DR W PYN  NW++I+T+ +V+   +N YQP
Sbjct: 184 TRQGSLQTFIRADVGATVNQGYRYGIDVFDRVWTPYNFGNWSQISTNQSVNI--NNDYQP 241

Query: 245 PAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHW 304
           P + M TA  P +   +M+  L   + ++QFYV+MHFAE+Q L++N +R+FNI  N +H 
Sbjct: 242 PEIAMVTASVPTDPDAAMNISLVGVERTVQFYVFMHFAEIQELKSNDTREFNIMYNNKHI 301

Query: 305 YGPFSPNYLLTTTVFSPTALIG---GNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQT 361
           YGPF P    T++VF+PT ++    G Y FSL +TGNSTLPP++NA+E+YSV    Q +T
Sbjct: 302 YGPFRPLNFTTSSVFTPTEVVADANGQYIFSLQRTGNSTLPPLLNAMEIYSVNLLPQQET 361

Query: 362 EQIDVDAITNIKATYGLKK-NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLK 420
           ++ +VDA+ NIK+ YG+ K +W+GDPC PL Y W G+NC+Y D+ +P+I  L+LS+SGL 
Sbjct: 362 DRKEVDAMMNIKSAYGVNKIDWEGDPCVPLDYKWSGVNCTYVDNETPKIISLDLSTSGLT 421

Query: 421 GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSK 479
           G+I  ++S+LTSL+ LDLSNN+LTGSVP+FL+ +  L+ +NL GN+LNGS+P  LL++ +
Sbjct: 422 GEILEFISDLTSLEVLDLSNNSLTGSVPEFLANMETLKLINLSGNELNGSIPATLLDKER 481

Query: 480 NGSLSLSVGGNPGLCSKISCKKKK----NNVVVPVVASVAGSVFLLAAALAIFFVLKRKR 535
            GS++LS+ GN GLCS  SC   K    N V+ PV AS+  SVFL+ A +  F +LKRK+
Sbjct: 482 RGSITLSIEGNTGLCSSTSCATTKKKKKNTVIAPVAASLV-SVFLIGAGIVTFLILKRKK 540

Query: 536 QV----------GKVKRESKNKIDSFE----AKSRHLSYSDVVKITNNFERTLGKGGFGT 581
           +           G     S++    FE    AK+R L+Y DVVKITNNFER LG+GGFG 
Sbjct: 541 RTKLGLNPNSGTGTTPLHSRSH-HGFEPPVIAKNRKLTYIDVVKITNNFERVLGRGGFGV 599

Query: 582 VYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE 641
           VYYG LN   VAVKML+ S+A G++QF+AEV+LL+RVHH++LT LVG+C+E ++ +LIYE
Sbjct: 600 VYYGVLNNEPVAVKMLTESTALGYKQFKAEVELLLRVHHKDLTCLVGYCEEGDKMSLIYE 659

Query: 642 FMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN 700
           FMANG+L+E+LS      +L+ + RLRIA ESAQGLEYLHNGCKP IVHRD+K+TNILLN
Sbjct: 660 FMANGDLKEHLSGKRGPSILTWEGRLRIAAESAQGLEYLHNGCKPQIVHRDIKTTNILLN 719

Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE 760
           EK QAKLADFGLS+SF     THVST+VAGTPGYLDPEYY +N LTEKSDV+SFGVV+LE
Sbjct: 720 EKFQAKLADFGLSRSFPLGTETHVSTIVAGTPGYLDPEYYRTNWLTEKSDVFSFGVVLLE 779

Query: 761 IITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACL 820
           ++T +P I    + EK HI +WV  ++++GDI SIVDP+LQ DFD N++WK VE AM CL
Sbjct: 780 LVTNQPVIDM--KREKSHIAEWVGLMLSRGDINSIVDPKLQGDFDPNTIWKVVETAMTCL 837

Query: 821 SPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           +P+ ++RPTM+QVVM+L ECL  EMAR N G       +   + +SMN  TELNP AR
Sbjct: 838 NPSSSRRPTMTQVVMDLKECLNMEMAR-NMGSRMTDSTNDSSIELSMNFTTELNPGAR 894

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356556632|ref|XP_003546627.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max]

 Score =  959 bits (2480), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 497/874 (56%), Positives = 626/874 (71%), Gaps = 24/874 (2%)

Query: 19  IHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQMRR 78
           I AQDQ+GFIS+DCG P D NYTE+TTGINY SD  F+ TG+ + I  E + G QKQ   
Sbjct: 21  IQAQDQSGFISIDCGAP-DVNYTESTTGINYTSDANFINTGVSRIIASELKNGYQKQAWY 79

Query: 79  VRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENNA 138
           VRSFP+G+RNCY+ N+T+GS YLIR +F+YGNYD  N +P FD+ +G N+W +VT  N A
Sbjct: 80  VRSFPEGVRNCYKINITRGSTYLIRASFLYGNYDGLNMLPQFDLLLGANRWATVTIYN-A 138

Query: 139 SFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLDV 198
           S     EIIH+   D + +CLVNTG GTPFISA+ELR L +N TY  + GSL  + R D+
Sbjct: 139 SLDQFNEIIHVPSLDSVQLCLVNTGHGTPFISAVELRTL-KNDTYVTRFGSLETYNRWDL 197

Query: 199 ASTTNLTIRYNDDVHDRSWFPY-NSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKN 257
            S  N   RYN DV+DR+WF Y N+ +W ++N S++VD+ S + ++PPA+VM+TA TP N
Sbjct: 198 GS--NQAYRYNYDVYDRAWFTYGNNNDWTQLNVSISVDSLSQSDFKPPAIVMSTAVTPVN 255

Query: 258 ASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTT 317
           AS  +    E +D +  +YVYMHF EV++L+ NQ+R+FNI+ NG+ WY   SP Y    T
Sbjct: 256 ASAPLVISWEPQDQTELYYVYMHFTEVEVLEKNQTREFNINQNGKPWYQNLSPRYQKADT 315

Query: 318 VFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYG 377
           ++S     G    +SL  T NS LPPIINAIE+Y +K+F Q  T Q DVD IT IK+ Y 
Sbjct: 316 IYSGIGTSGEKIKYSLEMTENSNLPPIINAIEIYRLKDFQQSDTYQGDVDVITTIKSVYK 375

Query: 378 LKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLD 437
           + ++WQGDPC P+AY W GLNC+Y  + SPRIT LNLSSSGL G I   +S L  L+ LD
Sbjct: 376 VTRDWQGDPCGPVAYLWHGLNCTYAANQSPRITTLNLSSSGLLGKIDPSISKLAMLEKLD 435

Query: 438 LSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCSK 496
           LSNN+L G VPDFLS+L  L+ LNL+ N L+GS+P  L+E+SK GSLSLSVG N  LC  
Sbjct: 436 LSNNSLNGEVPDFLSQLQHLKILNLEKNNLSGSIPSTLVEKSKEGSLSLSVGQNSFLCES 495

Query: 497 ISC-----KKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGK----VKRESKNK 547
             C     +KKKNN+V P+VASV+G V LL    AI + LKR++   K    +  +   +
Sbjct: 496 DQCNEKQKEKKKNNIVTPLVASVSGVVILLVVMAAILWTLKRRKSKEKDQSQISPQYTEQ 555

Query: 548 IDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQ 606
            DS  + K +  S+SDV+KITNNF  TLGKGGFGTVY G +N+  VAVKMLS SS  G+Q
Sbjct: 556 DDSLLQFKKQIYSFSDVLKITNNFNTTLGKGGFGTVYLGHINDTPVAVKMLSPSSVHGYQ 615

Query: 607 QFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI--SKKVLSSQE 664
           QFQAEVKLLMRVHH+NLTSLVG+C+E     LIYE+MANGNL E+LS      K  + +E
Sbjct: 616 QFQAEVKLLMRVHHKNLTSLVGYCNEGTSKGLIYEYMANGNLLEHLSGKHGKTKFFTWEE 675

Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           RLRIAV++A GLEYL NGCKPPI+HRDVKSTNILLNE  QAKL+DFGLSK   T+  THV
Sbjct: 676 RLRIAVDAALGLEYLQNGCKPPIIHRDVKSTNILLNELFQAKLSDFGLSKVIPTEGVTHV 735

Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN 784
           STVVAGTPGYLDPEY+ +NRLTEKSDVYSFGVV+LEIIT +P I+R   +E IHI +WV+
Sbjct: 736 STVVAGTPGYLDPEYFITNRLTEKSDVYSFGVVLLEIITSQPVIAR--NQENIHISEWVS 793

Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE 844
           SLI KGDIK+IVD RL+  +D NSVWKAVE+A AC+SP  N+RP  S +V+EL E LA E
Sbjct: 794 SLIMKGDIKAIVDSRLEGAYDTNSVWKAVEIATACVSPNLNKRPITSVIVVELKESLAME 853

Query: 845 MARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
           +AR  + RG +++ S+  +  +MNL TE  P+AR
Sbjct: 854 LARTKN-RGTNTRDSVTSV--TMNLNTEFIPQAR 884

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	878
TAIR|locus:2126540	876	AT4G29990 [Arabidopsis thalian	0.968	0.970	0.510	1.1e-220
TAIR|locus:2047675	881	AT2G19210 [Arabidopsis thalian	0.539	0.538	0.517	1.4e-218
TAIR|locus:2195850	890	AT1G51860 [Arabidopsis thalian	0.533	0.525	0.486	2.3e-218
TAIR|locus:2195825	865	AT1G51850 [Arabidopsis thalian	0.378	0.383	0.581	3.5e-216
TAIR|locus:2195855	876	AT1G51910 [Arabidopsis thalian	0.535	0.536	0.491	3.6e-211
TAIR|locus:2059093	876	FRK1 "FLG22-induced receptor-l	0.964	0.966	0.493	4.4e-210
TAIR|locus:2017647	885	AT1G51820 [Arabidopsis thalian	0.527	0.523	0.457	1.1e-209
TAIR|locus:2059804	892	AT2G04300 [Arabidopsis thalian	0.970	0.955	0.474	3.7e-206
TAIR|locus:2824870	884	AT1G51805 [Arabidopsis thalian	0.527	0.523	0.443	7.1e-204
TAIR|locus:2028446	888	AT1G49100 [Arabidopsis thalian	0.535	0.529	0.461	3.1e-201

TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)]

 Score = 2131 (755.2 bits), Expect = 1.1e-220, P = 1.1e-220
 Identities = 444/870 (51%), Positives = 567/870 (65%)

Query:    18 VIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQ-QKQM 76
             ++ AQDQ+GFIS+DCG+P DS+YT+  T + Y+SD  FVE+G   SI+ + QT   ++Q 
Sbjct:    18 LVFAQDQSGFISIDCGIPDDSSYTDEKTNMKYVSDLGFVESGTSHSIVSDLQTTSLERQF 77

Query:    77 RRVRSFPDGIRNCY--RFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTF 134
             + VRSFP+G RNCY  R    KG +YLIRT FMYGNYD  +  P FD++IG N W SV  
Sbjct:    78 QNVRSFPEGKRNCYDIRPQQGKGFKYLIRTRFMYGNYDGFSKTPEFDLYIGANLWESVVL 137

Query:   135 ENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFT 194
              N  + +   EII+  PSD++H+CLV+   GTPF+S LE+R L +N TY     +L L  
Sbjct:   138 INETAIMT-KEIIYTPPSDHIHVCLVDKNRGTPFLSVLEIRFL-KNDTYDTPYEALMLGR 195

Query:   195 RLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGT 254
             R D  + TNL IRY DD +DR W PY S     +NTSLT+D  +HN ++P ++VM +A  
Sbjct:   196 RWDFGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSLTIDETNHNGFRPASIVMRSAIA 255

Query:   255 PKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLL 314
             P N S  + F    +DP  +FY+YMHFAEV+ LQ N++R+F+I +N       F P YL 
Sbjct:   256 PGNESNPLKFNWAPDDPRSKFYIYMHFAEVRELQRNETREFDIYINDVILAENFRPFYLF 315

Query:   315 TTTVFSPTALIGGNYS-FSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIK 373
             T T  S    +G   +   L +TG STLPPIINAIE+Y + EFLQL T+Q DVDA+T IK
Sbjct:   316 TDTR-STVDPVGRKMNEIVLQRTGVSTLPPIINAIEIYQINEFLQLPTDQQDVDAMTKIK 374

Query:   374 ATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSS-SPRITYLNLSSSGLKGDITSYVSNLTS 432
               Y +KKNWQGDPC P+   W+GL C + D++ SP+   LNLSSSGL G I    +NLTS
Sbjct:   375 FKYRVKKNWQGDPCVPVDNSWEGLECLHSDNNTSPKSIALNLSSSGLTGQIDPAFANLTS 434

Query:   433 LQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNP 491
             +  LDLSNN+LTG VPDFL+ LP L  LNL+GNKL GS+P +LLE+SK+GSLSL  GGNP
Sbjct:   435 INKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNP 494

Query:   492 GLXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX--XKRKRQVGKVKRESKN-KI 548
              L                                        K++ + G +  +      
Sbjct:   495 DLCQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALALIWHFKKRSRRGTISNKPLGVNT 554

Query:   549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXX 608
                +   R+  YS+VV ITNNFER LGKGGFG VY+G LN   VAVK+L           
Sbjct:   555 GPLDTAKRYFIYSEVVNITNNFERVLGKGGFGKVYHGFLNGDQVAVKILSEESTQGYKEF 614

Query:   609 XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI 668
               EV+LLMRVHH NLTSL+G+C+EDN  ALIYE+MANGNL +YLS  S  +LS +ERL+I
Sbjct:   615 RAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSGKSSLILSWEERLQI 674

Query:   669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
             ++++AQGLEYLH GCKPPIVHRDVK  NILLNE LQAK+ADFGLS+SF  + ++ VSTVV
Sbjct:   675 SLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVV 734

Query:   729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA 788
             AGT GYLDPEYY + ++ EKSDVYSFGVV+LE+IT KPAI   +  E +H+   V S++A
Sbjct:   735 AGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAIWH-SRTESVHLSDQVGSMLA 793

Query:   789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA 848
              GDIK IVD RL + F+  S WK  ELA+AC S +  QRPTMSQVVMEL + +     R 
Sbjct:   794 NGDIKGIVDQRLGDRFEVGSAWKITELALACASESSEQRPTMSQVVMELKQSI---FGRV 850

Query:   849 NSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
             N+ R  H K  +   M++MNL TE+ PRAR
Sbjct:   851 NN-RSDH-KDPVR--MVTMNLDTEMVPRAR 876

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)]

 Score = 1245 (443.3 bits), Expect = 1.4e-218, Sum P(2) = 1.4e-218
 Identities = 249/481 (51%), Positives = 325/481 (67%)

Query:    18 VIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQ-QKQM 76
             ++ AQDQ+GF+S+DCG+P+DS+Y + TT I Y+SD AFVE+G   SI  EFQT   +KQ 
Sbjct:    22 LVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSIDPEFQTSSLEKQF 81

Query:    77 RRVRSFPDGIRNCYRFNLT--KGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTF 134
             + VRSFP+G RNCY       KG +YLIRT FMYGNYD     P FD+++G N W SVT 
Sbjct:    82 QNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWDSVTI 141

Query:   135 ENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFT 194
             +N A+ +   EIIH L SD++H+CLV+   GTPF+SALE+R L +++TY+    SL LF 
Sbjct:   142 DN-ATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIR-LLKSNTYETPYDSLILFK 199

Query:   195 RLDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGT 254
             R D+     L +RY DDV DR W P     +   N SLT+D+ ++  +QP   VMNTA +
Sbjct:   200 RWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNEGFQPARFVMNTATS 259

Query:   255 PKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHW-YGPFSPNYL 313
             P++ SQ + F  E +DP+ +++VYMHFAEV  L +N++R+F + LN +      FSP YL
Sbjct:   260 PEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLNEKEINMSSFSPRYL 319

Query:   314 LTTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIK 373
              T T+F    + G    F L +T  STLPPIINAIE Y V EFLQ  T+Q DVDAI  IK
Sbjct:   320 YTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIK 379

Query:   374 ATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSL 433
             + YG+KK+W GDPCAP+ Y W  +NCSY D+ SPRI  +NLSSSGL G+I +  SNLT L
Sbjct:   380 SKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLL 439

Query:   434 QFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPG 492
               LDLSNN+LTG +PDFL  L  L  LNL+GNKL+G++PV+LLERS    + L + GNP 
Sbjct:   440 HILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGNPD 499

Query:   493 L 493
             L
Sbjct:   500 L 500

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)]

 Score = 1136 (405.0 bits), Expect = 2.3e-218, Sum P(2) = 2.3e-218
 Identities = 234/481 (48%), Positives = 316/481 (65%)

Query:    19 IHAQDQTGFISLDCGL-PKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQMR 77
             + AQ+Q GFISLDCGL PK++ YTE +T I Y SD  ++++G+   I   ++T  Q+Q+ 
Sbjct:    21 VEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAYKTQFQQQVW 80

Query:    78 RVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENN 137
              VRSFP G RNCY  NLT  ++YLIR  F+YGNYD  N  P FD+ IGPNKW SV     
Sbjct:    81 AVRSFPVGQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDLHIGPNKWSSVKILGV 140

Query:   138 ASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTRLD 197
              +  ++ EIIH++P D L +CLV TG  TPFIS+LE+RPL  N +Y  QSGSL LF R+ 
Sbjct:   141 TN-TSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPL-NNESYLTQSGSLMLFARVY 198

Query:   198 VASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKN 257
               S+++  IRY++D+HDR W  +       I+T L +D    NSY  P  VM TA  PKN
Sbjct:   199 FPSSSSSFIRYDEDIHDRVWNSFTDDETVWISTDLPIDTS--NSYDMPQSVMKTAAVPKN 256

Query:   258 ASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGE-HWYGPFSPNYLLTT 316
             AS+    +   ++ + Q YVYMHFAEVQ L AN++R+FNI+ NG   W+    P  L  +
Sbjct:   257 ASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITYNGGLRWFSYLRPPNLSIS 316

Query:   317 TVFSPTALIGGN--YSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKA 374
             T+F+P A+   N  ++F+   TGNSTLPP++NA+E+Y+V + LQL+T + +V A+ NIK 
Sbjct:   317 TIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDILQLETNKDEVSAMMNIKE 376

Query:   375 TYGLKK--NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTS 432
             TYGL K  +WQGDPCAP  Y W+GLNCSY DS   RI  LNL+ S L G ITS +S LT 
Sbjct:   377 TYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLNGSELTGSITSDISKLTL 436

Query:   433 LQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN-KLN-GSVPVELLERSKNGSLSLSVGG 489
             L  LDLSNN+L+G +P F +++  L+ +NL GN  LN  ++P  L +R  + SL+L +G 
Sbjct:   437 LTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAIPDSLQQRVNSKSLTLILGE 496

Query:   490 N 490
             N
Sbjct:   497 N 497

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2195825 AT1G51850 [Arabidopsis thaliana (taxid:3702)]

 Score = 1003 (358.1 bits), Expect = 3.5e-216, Sum P(3) = 3.5e-216
 Identities = 197/339 (58%), Positives = 250/339 (73%)

Query:   542 RESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID-VAVKMLXXX 600
             R  ++   +   K+R  +YS V  +TNNF+R LGKGGFG VY+G +N  + VAVK+L   
Sbjct:   532 RSPRSSEPAIVTKNRRFTYSQVAIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHS 591

Query:   601 XXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK-V 659
                       EV+LL+RVHH+NL  LVG+CDE    ALIYE+MANG+L+E++S    +  
Sbjct:   592 SSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFT 651

Query:   660 LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD 719
             L+   RL+I VESAQGLEYLHNGCKPP+VHRDVK+TNILLNE  QAKLADFGLS+SF  +
Sbjct:   652 LNWGTRLKIVVESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFQAKLADFGLSRSFPIE 711

Query:   720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
               THVSTVVAGTPGYLDPEYY +N LTEKSDVYSFG+V+LE+IT +P I +    EK HI
Sbjct:   712 GETHVSTVVAGTPGYLDPEYYKTNWLTEKSDVYSFGIVLLELITNRPVIDK--SREKPHI 769

Query:   780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +WV  ++ KGDI SI+DP L ED+D+ SVWKAVELAM+CL+P+  +RPTMSQVV+EL+E
Sbjct:   770 AEWVGVMLTKGDINSIMDPNLNEDYDSGSVWKAVELAMSCLNPSSARRPTMSQVVIELNE 829

Query:   840 CLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
             C+A+E +R  + R   SK SI+   +S+   TEL+P AR
Sbjct:   830 CIASENSRGGASRDMDSKSSIE---VSLTFDTELSPTAR 865

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

TAIR|locus:2195855 AT1G51910 [Arabidopsis thaliana (taxid:3702)]

 Score = 1130 (402.8 bits), Expect = 3.6e-211, Sum P(2) = 3.6e-211
 Identities = 237/482 (49%), Positives = 315/482 (65%)

Query:    17 NVIHAQDQTGFISLDCGL-PKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQ 75
             +++ AQ Q+GFISLDCGL PKD+ YTE  T I YISD  ++++G+ + I   +++  Q+Q
Sbjct:    19 HLVQAQSQSGFISLDCGLIPKDTTYTEQITNITYISDADYIDSGLTERISDSYKSQLQQQ 78

Query:    76 MRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFE 135
                +RSFP+G RNCY FNL    +YLIR  F+YGNYD  N +P FD+ IGPNKW SV  E
Sbjct:    79 TWTLRSFPEGQRNCYNFNLKANLKYLIRGTFVYGNYDGLNQMPKFDLHIGPNKWTSVILE 138

Query:   136 NNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTR 195
               A+   I EIIH+L  D L +CLV TG  TPFIS+LELRPL  N TY  Q GSL  F R
Sbjct:   139 GVAN-ATIFEIIHVLTQDRLQVCLVKTGQTTPFISSLELRPL-NNDTYVTQGGSLMSFAR 196

Query:   196 LDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTP 255
             +    T    +RY+DD++DR W P++      ++T+L VD  S NSY  P  V N+A  P
Sbjct:   197 IYFPKTAYF-LRYSDDLYDRVWVPFSQNETVSLSTNLPVDTSS-NSYNVPQNVANSAIIP 254

Query:   256 KNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNG-EHWYGPFSPNYLL 314
               A+  ++ + + ++ +   YVYMHFAE+Q L+AN  R+FNI+ NG + W     P+ L 
Sbjct:   255 AEATHPLNIWWDLQNINAPSYVYMHFAEIQNLKANDIREFNITYNGGQVWESSIRPHNLS 314

Query:   315 TTTVFSPTALIG--GNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNI 372
              TT+ SPTAL    G ++F+   T  STLPP+INA+EVY++ E L L+T Q +V A+ NI
Sbjct:   315 ITTISSPTALNSSDGFFNFTFTMTTTSTLPPLINALEVYTLVENLLLETYQDEVSAMMNI 374

Query:   373 KATYGLKK--NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNL 430
             K TYGL K  +WQGDPC+P  Y W+GLNC Y DS  P IT LNL +SGL G IT  +SNL
Sbjct:   375 KKTYGLSKKISWQGDPCSPQIYRWEGLNCLYLDSDQPLITSLNLRTSGLTGIITHDISNL 434

Query:   431 TSLQFLDLSNNNLTGSVPDFLSKLPLRTL-NLQGN-KLNGSVPVELLERSKNGSLSLSVG 488
               L+ LDLS+N+L+G +PDFL+ + + TL NL+GN KLN +VP  +  R  N SL L + 
Sbjct:   435 IQLRELDLSDNDLSGEIPDFLADMKMLTLVNLKGNPKLNLTVPDSIKHRINNKSLKLIID 494

Query:   489 GN 490
              N
Sbjct:   495 EN 496

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2031 (720.0 bits), Expect = 4.4e-210, P = 4.4e-210
 Identities = 429/870 (49%), Positives = 564/870 (64%)

Query:    18 VIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQT-GQQKQM 76
             ++HAQDQ+GFIS+DCG+P DS+Y + TTGI Y+SD AFV++G  K I  +FQ+ G  + +
Sbjct:    21 LVHAQDQSGFISIDCGIPDDSSYNDETTGIKYVSDSAFVDSGTTKRIAAQFQSSGFDRHL 80

Query:    77 RRVRSFPDGIRNCYRFNLT--KGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTF 134
               VRSFP   R+CY       KG +YLIRT FMYGNYD+   VP FD+++G N W SV  
Sbjct:    81 LNVRSFPQSKRSCYDVPTPRGKGFKYLIRTRFMYGNYDDLGRVPEFDLYLGVNFWDSVKL 140

Query:   135 ENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFT 194
             ++ A+ +   EII I   D + +C+V+   GTPF+S LE+R L  N+TY+    +L L  
Sbjct:   141 DD-ATTILNKEIITIPLLDNVQVCVVDKNAGTPFLSVLEIRLLL-NTTYETPYDALTLLR 198

Query:   195 RLDVASTTNLTIRYNDDVHDRSWFP-YNSANWARINTSLTVDAESHNSYQPPAVVMNTAG 253
             RLD + T  L  RY DD++DR W P   S+ +  +NTSLTVD   +N YQP + VM+TA 
Sbjct:   199 RLDYSKTGKLPSRYKDDIYDRIWTPRIVSSEYKILNTSLTVDQFLNNGYQPASTVMSTAE 258

Query:   254 TPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYL 313
             T +N S  +       DP+ +FYVYMHFAE+++L++NQ+R+F+I LN +     F   YL
Sbjct:   259 TARNESLYLTLSFRPPDPNAKFYVYMHFAEIEVLKSNQTREFSIWLNEDVISPSFKLRYL 318

Query:   314 LTTTVFSPTALIGGNYSFSLYKT-GNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNI 372
             LT T  +P  + G   +FSL +  G   LPPIINA+EVY V EFLQ+ T   DVDA+  I
Sbjct:   319 LTDTFVTPDPVSGITINFSLLQPPGEFVLPPIINALEVYQVNEFLQIPTHPQDVDAMRKI 378

Query:   373 KATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS-PRITYLNLSSSGLKGDITSYVSNLT 431
             KATY +KKNWQGDPC P+ Y W+G++C   D+++ PR+  LN+S S L+G I    SNLT
Sbjct:   379 KATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTTNPRVVSLNISFSELRGQIDPAFSNLT 438

Query:   432 SLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGN 490
             S++ LDLS N LTG +P FL+ LP L  LN++GNKL G VP  L ERSKNGSLSL  G N
Sbjct:   439 SIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGNKLTGIVPQRLHERSKNGSLSLRFGRN 498

Query:   491 PGLXXXXXXXXXXXXXXXXXXX--XXXXXXXXXXXXXXXXXXXKRKRQVGKVKRESKNKI 548
             P L                                        K+K+Q G +  E    +
Sbjct:   499 PDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVLLTALALFRRFKKKQQRGTLG-ERNGPL 557

Query:   549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXX 608
              +  AK R+  YS+VV ITNNFER +GKGGFG VY+G +N   VAVK+L           
Sbjct:   558 KT--AK-RYFKYSEVVNITNNFERVIGKGGFGKVYHGVINGEQVAVKVLSEESAQGYKEF 614

Query:   609 XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI 668
               EV LLMRVHH NLTSLVG+C+E N   LIYE+MAN NL +YL+     +LS +ERL+I
Sbjct:   615 RAEVDLLMRVHHTNLTSLVGYCNEINHMVLIYEYMANENLGDYLAGKRSFILSWEERLKI 674

Query:   669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
             ++++AQGLEYLHNGCKPPIVHRDVK TNILLNEKLQAK+ADFGLS+SF+ + +  +STVV
Sbjct:   675 SLDAAQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVV 734

Query:   729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA 788
             AG+ GYLDPEYY++ ++ EKSDVYS GVV+LE+IT +PAI+  ++ EK+HI   V S++A
Sbjct:   735 AGSIGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQPAIAS-SKTEKVHISDHVRSILA 793

Query:   789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA 848
              GDI+ IVD RL+E +D  S WK  E+A+AC   T  QRPTMSQVVMEL + +   +   
Sbjct:   794 NGDIRGIVDQRLRERYDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELKQIVYG-IVTD 852

Query:   849 NSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
                    +K      M+++NL TE+ PRAR
Sbjct:   853 QENYDDSTK------MLTVNLDTEMVPRAR 876

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=RCA;IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016045 "detection of bacterium" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2017647 AT1G51820 [Arabidopsis thaliana (taxid:3702)]

 Score = 1053 (375.7 bits), Expect = 1.1e-209, Sum P(2) = 1.1e-209
 Identities = 220/481 (45%), Positives = 306/481 (63%)

Query:    17 NVIHAQDQTGFISLDCGLPK-DSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQ 75
             +++ AQ+QTGFIS+DCGL   +S Y    TG+ Y SD   V +G    + +EF+    K 
Sbjct:    16 HLVQAQNQTGFISVDCGLSLLESPYDAPQTGLTYTSDADLVASGKTGRLAKEFEPLVDKP 75

Query:    76 MRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFE 135
                +R FP+G+RNCY  N+T  + YLI+  F+YGNYD  N  P F++++GPN W +V+  
Sbjct:    76 TLTLRYFPEGVRNCYNLNVTSDTNYLIKATFVYGNYDGLNVGPNFNLYLGPNLWTTVS-S 134

Query:   136 NNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTR 195
             N+     I EII +  S+ L +CLV TG+  PFI+ LELRP+ +N  Y  QSGSL    R
Sbjct:   135 NDT----IEEIILVTRSNSLQVCLVKTGISIPFINMLELRPMKKNM-YVTQSGSLKYLFR 189

Query:   196 LDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTP 255
                 S ++  IR+ DDV+DR W+P    +W ++ T+L V+     +Y+ P  VM  A TP
Sbjct:   190 -GYISNSSTRIRFPDDVYDRKWYPLFDDSWTQVTTNLKVNTSI--TYELPQSVMAKAATP 246

Query:   256 KNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLT 315
               A+ +++     E P+ QFY Y+H AE+Q L+AN++R+FN++LNGE+ +GPFSP  L T
Sbjct:   247 IKANDTLNITWTVEPPTTQFYSYVHIAEIQALRANETREFNVTLNGEYTFGPFSPIPLKT 306

Query:   316 TTV--FSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIK 373
              ++   SP    GG     + KT  STLPP++NAIE ++V +F Q++T + DV  I N++
Sbjct:   307 ASIVDLSPGQCDGGRCILQVVKTLKSTLPPLLNAIEAFTVIDFPQMETNENDVAGIKNVQ 366

Query:   374 ATYGLKK-NWQGDPCAPLAYWWDGLNCSYGDSSSPRI-TYLNLSSSGLKGDITSYVSNLT 431
              TYGL + +WQGDPC P    WDGLNC   D S+P I T L+LSSSGL G IT  + NLT
Sbjct:   367 GTYGLSRISWQGDPCVPKQLLWDGLNCKNSDISTPPIITSLDLSSSGLTGIITQAIKNLT 426

Query:   432 SLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGN 490
              LQ LDLS+NNLTG VP+FL+ +  L  +NL GN L+GSVP  LL+  K G + L+V GN
Sbjct:   427 HLQILDLSDNNLTGEVPEFLADIKSLLVINLSGNNLSGSVPPSLLQ--KKG-MKLNVEGN 483

Query:   491 P 491
             P
Sbjct:   484 P 484

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0015824 "proline transport" evidence=RCA

TAIR|locus:2059804 AT2G04300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1994 (707.0 bits), Expect = 3.7e-206, P = 3.7e-206
 Identities = 418/881 (47%), Positives = 558/881 (63%)

Query:    17 NVIHAQDQTGFISLDCGL-PKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQ 75
             +V+ A +Q GFISLDCGL P +  Y +  T + Y +D+ FV++G   +I +E ++   K 
Sbjct:    22 HVVEAGNQEGFISLDCGLSPNEPPYVDAATDLTYTTDNDFVQSGKTGTIDKELESTYNKP 81

Query:    76 MRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFE 135
             + ++R FP+G+RNCY  N+T G+ YLIR +F+YGNYD  N    FD+++GPN W +V   
Sbjct:    82 ILQLRYFPEGVRNCYTLNVTLGTNYLIRASFVYGNYDGLNKELEFDLYLGPNLWANV--- 138

Query:   136 NNASFVAIG----EIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLN 191
             N A ++  G    EIIH   S  L +CL+ TG   P I++LELRPL  N TY  QSGSL 
Sbjct:   139 NTAVYLMNGVTTEEIIHSTKSKVLQVCLIKTGESIPIINSLELRPLI-NDTYNTQSGSLK 197

Query:   192 LFTRLDVASTTNLTIRYNDDVHDRSWFPYNSAN-WARINTSLTVDAESHNSYQPPAVVMN 250
                R +  ST+   IRY +DV+DR W+P+   + W  + T+L V+  S N Y PP  VM 
Sbjct:   198 YLFR-NYFSTSRRIIRYPNDVNDRHWYPFFDEDAWTELTTNLNVN--SSNGYDPPKFVMA 254

Query:   251 TAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSP 310
             +A TP + +   +F       + +FY YMHFA++Q LQAN++R+F++ LNG      + P
Sbjct:   255 SASTPISKNAPFNFTWSLIPSTAKFYSYMHFADIQTLQANETREFDMMLNGNLALERYRP 314

Query:   311 NYLLTTTVF--SPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDA 368
                 T T++   P    GG     L KT  STLPP+ +A+EV++V +F +L+T Q DV A
Sbjct:   315 KTFATGTIYFIKPQICEGGQCIIELLKTSKSTLPPLCSALEVFTVIDFPELETNQDDVIA 374

Query:   369 ITNIKATYGLKK-NWQGDPCAPLAYWWDGLNC--SYGDSSSPRITYLNLSSSGLKGDITS 425
             I NI+ TYG+ K +WQGDPC P  + WDGLNC  SY  S+ P IT+LNLSSS L G I S
Sbjct:   375 IKNIQNTYGVSKTSWQGDPCVPKRFMWDGLNCNNSY-ISTPPTITFLNLSSSHLTGIIAS 433

Query:   426 YVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLER-----SK 479
              + NLT LQ LDLSNNNLTG VP+FL+ L  L  +NL GN L+GSVP  LL++     + 
Sbjct:   434 AIQNLTHLQNLDLSNNNLTGGVPEFLAGLKSLLVINLSGNNLSGSVPQTLLQKKGLKLNL 493

Query:   480 NGSLSLSVGGNPGLXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKRKRQVGK 539
              G++ L+      +                                      KRK    +
Sbjct:   494 EGNIYLNCPDGSCVSKDGNGGAKKKNVVVLVVVSIALVVVLGSALALFLVFRKRKTPRNE 553

Query:   540 VKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID-VAVKMLX 598
             V R S++   +   K+R  +YS+VVK+TNNFE+ LGKGGFG VY+G +N+ + VAVKML 
Sbjct:   554 VSRTSRSLDPTITTKNRRFTYSEVVKMTNNFEKILGKGGFGMVYHGTVNDAEQVAVKMLS 613

Query:   599 XXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEY-LSDISK 657
                         EV+LL+RVHH+NL  LVG+CDE    +LIYE+MA G+L+E+ L +   
Sbjct:   614 PSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENLSLIYEYMAKGDLKEHMLGNQGV 673

Query:   658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
              +L  + RL+I  ESAQGLEYLHNGCKPP+VHRDVK+TNILL+E  QAKLADFGLS+SF 
Sbjct:   674 SILDWKTRLKIVAESAQGLEYLHNGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFP 733

Query:   718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
              +  T V TVVAGTPGYLDPEYY +N L EKSDVYSFG+V+LEIIT +  I++    EK 
Sbjct:   734 LEGETRVDTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQHVINQ--SREKP 791

Query:   778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
             HI +WV  ++ KGDIKSI+DP+   D+DA SVW+AVELAM+C++P+   RPTMSQVV+EL
Sbjct:   792 HIAEWVGVMLTKGDIKSIIDPKFSGDYDAGSVWRAVELAMSCVNPSSTGRPTMSQVVIEL 851

Query:   838 SECLAAEMARANSGRGFHSKGSIDHLMMSMNLGTELNPRAR 878
             +ECLA+E +R    +   SKGSI +  +S N GTE  P AR
Sbjct:   852 NECLASENSRRGMSQNMESKGSIQYTEVSTNFGTEYTPEAR 892

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)]

 Score = 1028 (366.9 bits), Expect = 7.1e-204, Sum P(2) = 7.1e-204
 Identities = 214/482 (44%), Positives = 296/482 (61%)

Query:    17 NVIHAQDQTGFISLDCGL-PKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQ 75
             +++ AQDQ GFI++DCGL P+DS Y    TG+ Y SD   V +G    I +EF+      
Sbjct:    16 HLVQAQDQPGFINVDCGLLPRDSPYNALGTGLVYTSDVGLVSSGKTGKIAKEFEENNSTP 75

Query:    76 MRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFE 135
                +R FPDG RNCY  N+++ + Y+I+  F+YGNYD     P FD+++GPN W +V+  
Sbjct:    76 NLTLRYFPDGARNCYNLNVSRDTNYMIKATFVYGNYDGHKDEPNFDLYLGPNLWATVSRS 135

Query:   136 NNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTR 195
                    + EIIH+  SD L +CL  TG   PFI+ LELRPL +N  Y  +SGSL L  R
Sbjct:   136 ET-----VEEIIHVTKSDSLQVCLAKTGDFIPFINILELRPLKKN-VYVTESGSLKLLFR 189

Query:   196 LDVASTTNLTIRYNDDVHDRSWFP-YNSANWARINTSLTVDAESHNSYQPPAVVMNTAGT 254
                 S +  TIRY DD++DR W   +   NWA+++T+L V+    ++Y     VM T  T
Sbjct:   190 -KYFSDSGQTIRYPDDIYDRVWHASFLENNWAQVSTTLGVNVT--DNYDLSQDVMATGAT 246

Query:   255 PKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLL 314
             P N S++++     E P+ + Y YMHFAE++ L+AN +R+FN+ LNG   +GP+SP  L 
Sbjct:   247 PLNDSETLNITWNVEPPTTKVYSYMHFAELETLRANDTREFNVMLNGNDLFGPYSPIPLK 306

Query:   315 TTTV--FSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNI 372
             T T     P     G     L KT  STLPP++NAIE ++V +FLQ++T++ D  AI N+
Sbjct:   307 TETETNLKPEECEDGACILQLVKTSKSTLPPLLNAIEAFTVIDFLQVETDEDDAAAIKNV 366

Query:   373 KATYGL--KKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNL 430
             +  YGL  + +WQGDPC P  Y WDGL CSY DS+ P I +L+LS+SGL G I   + NL
Sbjct:   367 QNAYGLINRSSWQGDPCVPKQYSWDGLKCSYSDSTPPIINFLDLSASGLTGIIAPAIQNL 426

Query:   431 TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGG 489
             T L+ L LSNNNLTG VP+FL+ L  +  ++L+GN L+G VP  LL+  K G L L +  
Sbjct:   427 THLEILALSNNNLTGEVPEFLADLKSIMVIDLRGNNLSGPVPASLLQ--KKG-LMLHLDD 483

Query:   490 NP 491
             NP
Sbjct:   484 NP 485

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)]

 Score = 1068 (381.0 bits), Expect = 3.1e-201, Sum P(2) = 3.1e-201
 Identities = 224/485 (46%), Positives = 310/485 (63%)

Query:    17 NVIHAQDQTGFISLDCGL-PKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQ 75
             +V+ AQD  GFI+LDCGL P  S YT  +TG+ + SD +F+E+G    + ++ +   +K 
Sbjct:    20 HVVQAQDPNGFITLDCGLLPDGSPYTNPSTGLTFTSDSSFIESGKNGRVSKDSERNFEKA 79

Query:    76 MRRVRSFPDGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFE 135
                +R FPDG RNCY  N+T+G+ YLIR  F+YGNYD  N+VP FD+FIGPNK  +V F 
Sbjct:    80 FVTLRYFPDGERNCYNLNVTQGTNYLIRAAFLYGNYDGLNTVPNFDLFIGPNKVTTVNFN 139

Query:   136 NNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSLNLFTR 195
                  V + EIIH+  S  L ICLV TG  TP IS LELRPL  ++   A   SL L+ R
Sbjct:   140 ATGGGVFV-EIIHMSRSTPLDICLVKTGTTTPMISTLELRPLRSDTYISAIGSSLLLYFR 198

Query:   196 LDVASTTNLTIRYNDDVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTP 255
                 + + + +RY DDV+DR WFP++   W  + T+L V+    N +  P   M +A T 
Sbjct:   199 -GYLNDSGVVLRYPDDVNDRRWFPFSYKEWKIVTTTLNVNTS--NGFDLPQGAMASAATR 255

Query:   256 KNASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLT 315
              N + + +F    ED + +F++Y+HFAE+Q L AN++R+FN+ LNG+ +YGP+SP  L  
Sbjct:   256 VNDNGTWEFPWSLEDSTTRFHIYLHFAELQTLLANETREFNVLLNGKVYYGPYSPKMLSI 315

Query:   316 TTVF-SPTALI---GGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITN 371
              T+   P + +   GG+    L KT  STLPP+INAIE+++V EF Q +T Q +V AI  
Sbjct:   316 DTMSPQPDSTLTCKGGSCLLQLVKTTKSTLPPLINAIELFTVVEFPQSETNQDEVIAIKK 375

Query:   372 IKATYGLKK-NWQGDPCAPLAYWWDGLNCSYGDSSSP-RITYLNLSSSGLKGDITSYVSN 429
             I+ TYGL + NWQGDPC P  + W GL CS  +SS+P  IT+LNLSSSGL G I+  + N
Sbjct:   376 IQLTYGLSRINWQGDPCVPEQFLWAGLKCSNINSSTPPTITFLNLSSSGLTGIISPSIQN 435

Query:   430 LTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG 488
             LT LQ LDLSNN+LTG VP+FL+ +  L  +NL GN  +G +P +L+++ +   L L+V 
Sbjct:   436 LTHLQELDLSNNDLTGDVPEFLADIKSLLIINLSGNNFSGQLPQKLIDKKR---LKLNVE 492

Query:   489 GNPGL 493
             GNP L
Sbjct:   493 GNPKL 497

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	AT1G51800	leucine-rich repeat protein kinase, putative; leucine-rich repeat protein kinase, putative; FUNCTIONS IN- kinase activity; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- endomembrane system; EXPRESSED IN- 11 plant structures; EXPRESSED DURING- 6 growth stages; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Leucine-rich repeat (InterPro-IPR001611), Serine/threonine protein kinase-related (InterPro-IPR017442), Protein kinase-like (InterPro-IPR011009), Serine/threonine protein kinase, active site [...] (894 aa)
		(Arabidopsis thaliana)
Predicted Functional Partners:
	AT1G51790	kinase; kinase; FUNCTIONS IN- kinase activity; INVOLVED IN- protein amino acid phosphorylation; [...] (882 aa)				•				•	0.851
	AT1G51850	leucine-rich repeat protein kinase, putative; leucine-rich repeat protein kinase, putative; FUN [...] (865 aa)				•				•	0.788
	AT1G52200	unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- respon [...] (190 aa)				•					0.782
	AT3G46280	protein kinase-related; protein kinase-related; FUNCTIONS IN- molecular_function unknown; INVOL [...] (471 aa)				•				•	0.758
	MLO12	MLO12 (MILDEW RESISTANCE LOCUS O 12); calmodulin binding; A member of a large family of seven-t [...] (576 aa)				•					0.740
	AT2G27660	DC1 domain-containing protein; DC1 domain-containing protein; FUNCTIONS IN- zinc ion binding; L [...] (718 aa)				•					0.700
	AT1G51890	leucine-rich repeat protein kinase, putative; leucine-rich repeat protein kinase, putative; FUN [...] (888 aa)				•				•	0.694
	PER71	peroxidase, putative; encodes a cell wall bound peroxidase that is induced by hypo-osmolarity ; [...] (328 aa)				•					0.681
	AT3G11340	UDP-glucoronosyl/UDP-glucosyl transferase family protein; UDP-glucoronosyl/UDP-glucosyl transfe [...] (447 aa)				•			•		0.670
	AT1G18390	ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein tyrosine kinase; [...] (654 aa)				•				•	0.663

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	878
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	1e-122
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-40
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-35
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-32
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-31
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-30
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-30
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-28
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-27
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-27
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-26
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-26
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-24
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-23
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-22
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-21
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-21
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-21
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-21
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-15
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-04
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	7e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.002

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  373 bits (959), Expect = e-122
 Identities = 154/340 (45%), Positives = 217/340 (63%), Gaps = 21/340 (6%)

Query: 30  LDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQ-QKQMRRVRSFPDGIRN 88
           +DCGLP + +YT+ +TGI ++SD  F++TG   +I +E  +    K  + +RSFPDG RN
Sbjct: 1   IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFPDGKRN 60

Query: 89  CYRFNLT--KGSRYLIRTNFMYGNYDEKNSV---PGFDMFIGPNKWLSVTFENNASFVAI 143
           CY   +T  KG++YLIR  F+YGNYD  NSV   P FD+++G N W +V   N++    +
Sbjct: 61  CYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSVV 120

Query: 144 GE-IIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTY--KAQSGSLNLFTRLDVAS 200
            E IIH+  SD L +CLVNTG GTPFISALELRPL  +S Y     S +L L  RL+   
Sbjct: 121 KEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPL-PDSLYPSSGGSQALKLVARLNFGG 179

Query: 201 TTNLTIRYNDDVHDRSWFPY-NSANWARINTSLTVDA-ESHNSYQPPAVVMNTAGTPKNA 258
           +   TIRY DDV+DR W P+ +S  W++I+TSL+VD   ++  Y PP+ V+ TA TP NA
Sbjct: 180 S-EGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNA 238

Query: 259 SQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLLTTTV 318
           S  ++F  +  DP+ ++YVY+HFAE   +Q+ ++R+F+I +NG+  YG  SP YL T T 
Sbjct: 239 SAPLNFTWDLVDPNFEYYVYLHFAE---IQSLETREFDIYINGKTVYGDVSPKYLGTDTG 295

Query: 319 -----FSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSV 353
                F      GG  + SL  T  STLPP++NA+E++ V
Sbjct: 296 ALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (449), Expect = 5e-50
 Identities = 71/204 (34%), Positives = 110/204 (53%), Gaps = 17/204 (8%)

Query: 570 FERTLGKGGFGTVYYGRLN------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
             + LG+G FG VY G L       E++VAVK L   +S Q  ++F  E +++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L+G C E+    ++ E+M  G+L +YL     K LS  + L  A++ A+G+EYL + 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG---YLDPEY 739
                +HRD+ + N L+ E L  K++DFGLS+    D        V G      ++ PE 
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               + T KSDV+SFGV++ EI T
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (448), Expect = 7e-50
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 18/204 (8%)

Query: 570 FERTLGKGGFGTVYYGRLN------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
             + LG+G FG VY G+L       +++VAVK L   +S Q  ++F  E +++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L+G C E+    ++ E+M  G+L  YL   ++  LS  + L  A++ A+G+EYL + 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG---YLDPEY 739
                +HRD+ + N L+ E L  K++DFGLS+    D          G      ++ PE 
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               + T KSDV+SFGV++ EI T
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (432), Expect = 3e-48
 Identities = 79/222 (35%), Positives = 128/222 (57%), Gaps = 16/222 (7%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLS-SSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC 630
           LG+GGFGTVY  R  +    VA+K++    S+   ++   E+++L +++H N+  L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVH 689
           +++N   L+ E+   G+L++ L +   K LS  E LRI ++  +GLEYLH NG    I+H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNG----IIH 115

Query: 690 RDVKSTNILLNEK-LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR-LTE 747
           RD+K  NILL+    + KLADFGLSK   +D +   + V  GTP Y+ PE        +E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSE 173

Query: 748 KSDVYSFGVVILEIITCKPAISRI---NEEEKIHIRQWVNSL 786
           KSD++S GV++ E+   K  I ++   + E++   ++ +  L
Sbjct: 174 KSDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  168 bits (427), Expect = 6e-47
 Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 17/204 (8%)

Query: 570 FERTLGKGGFGTVYYGRLN------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
             + LG+G FG VY G L       E  VAVK L   +S +  ++F  E  ++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L+G C +     ++ E+M  G+L ++L     + L+ ++ L++A++ A+G+EYL + 
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG---YLDPEY 739
                VHRD+ + N L+ E L  K++DFGLS+    D          G      ++ PE 
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPES 175

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               + T KSDV+SFGV++ EI T
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  167 bits (425), Expect = 1e-46
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 26/210 (12%)

Query: 572 RTLGKGGFGTVYYGRL-----NEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTS 625
           + LG+G FG VY G+L        +VAVK L   +S +  + F  E +++ ++ H N+  
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYL-------SDISKKVLSSQERLRIAVESAQGLEY 678
           L+G C E+    L+ E+M  G+L +YL           K  LS ++ L  A++ A+G+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG----- 733
           L        VHRD+ + N L+ E L  K++DFGLS+    D           T G     
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTGGKLPIR 172

Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           ++ PE       T KSDV+SFGV++ EI T
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (424), Expect = 1e-46
 Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 28/269 (10%)

Query: 570 FERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRNLTSL 626
               LG+G FG VY  R  +    VA+K++     +   ++   E+K+L ++ H N+  L
Sbjct: 3   ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKP 685
               +++++  L+ E+   G+L + L    +  LS  E      +    LEYLH  G   
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALEYLHSKG--- 117

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            IVHRD+K  NILL+E    KLADFGL++           T   GTP Y+ PE       
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 746 TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD 805
            +  D++S GV++ E++T KP     ++  ++               K I  P+      
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLEL--------------FKKIGKPKPPFPPP 219

Query: 806 ANSVWK-AVELAMACLSPTGNQRPTMSQV 833
              +   A +L    L     +R T  + 
Sbjct: 220 EWDISPEAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (403), Expect = 1e-43
 Identities = 92/278 (33%), Positives = 142/278 (51%), Gaps = 38/278 (13%)

Query: 570 FERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTS 625
             R LG G FGTVY  +       VAVK+L   S   +  Q  + E+++L R+ H N+  
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCK 684
           L+   ++ +   L+ E+   G+L +YLS      LS  E  +IA++  +GLEYLH NG  
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNG-- 118

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE------ 738
             I+HRD+K  NILL+E    K+ADFGL+K      ++   T   GTP Y+ PE      
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
            Y       K DV+S GV++ E++T KP  S  N  +++ +            I+ I+ P
Sbjct: 175 GYGP-----KVDVWSLGVILYELLTGKPPFSGENILDQLQL------------IRRILGP 217

Query: 799 RLQEDFDA-NSVWK-AVELAMACLSPTGNQRPTMSQVV 834
            L+ D    +S  + A +L   CL+   ++RPT  +++
Sbjct: 218 PLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (381), Expect = 1e-40
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 35/272 (12%)

Query: 572 RTLGKGGFGTVYYGRLN---EIDVAVK--MLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
             LG+G FG+VY        E+ +AVK   LS  S +  +  + E+++L  + H N+   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGEL-MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 627 VGHC-DEDNQTALIY-EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ---GLEYLH- 680
            G   DE+  T  I+ E+++ G+L    S + KK     E + I   + Q   GL YLH 
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSL----SSLLKKFGKLPEPV-IRKYTRQILEGLAYLHS 119

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           NG    IVHRD+K  NIL++     KLADFG +K          +  V GTP ++ PE  
Sbjct: 120 NG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
                   +D++S G  ++E+ T KP  S +               I          P +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGEP----PEI 225

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQ 832
            E        +A +    CL     +RPT  +
Sbjct: 226 PEHLSE----EAKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  134 bits (339), Expect = 3e-35
 Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 11/198 (5%)

Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
             +GKGGFG VY  R      +VA+K++   S +  ++   E+++L +  H N+    G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIV 688
             + ++  ++ EF + G+L++ L   + + L+  +   +  E  +GLEYLH NG    I+
Sbjct: 66  YLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNG----II 120

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+K+ NILL    + KL DFGLS      ++T     + GTP ++ PE         K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 749 SDVYSFGVVILEIITCKP 766
           +D++S G+  +E+   KP
Sbjct: 178 ADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score =  140 bits (355), Expect = 1e-34
 Identities = 122/479 (25%), Positives = 203/479 (42%), Gaps = 76/479 (15%)

Query: 75  QMRRVRSFP--DGIRNCYRFNLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKW--L 130
            ++ +R FP  DG  NCY  N      Y +R  F        +S P FD+ +   +   L
Sbjct: 68  PLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSL 127

Query: 131 SVTFENNASFVAIGEIIHILPSDYLHICLVNTGLGTPFISALELRPLFENSTYKAQSGSL 190
              + ++   V    ++ +       IC  +TG G P I ++E+  + + +     S   
Sbjct: 128 KSGWSSHDEQVFAEALVFLTDGS-ASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQ 186

Query: 191 NLF----TRLDVAS-TTNLTIRYNDDVH---DRSW-----FPYNSANWARINTSLTVDAE 237
            +      RL   +  +     Y+ D H   DR W     F   S         +   + 
Sbjct: 187 GVILRTAKRLSCGAGKSKFDEDYSGD-HWGGDRFWNRMQTFGSGSDQAISTENVIKKASN 245

Query: 238 SHNSYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEV-QILQANQSRQFN 296
           + N Y  P  +  +A    +    + + ++  DP+  + V++HFAE+   + A   R F+
Sbjct: 246 APNFY--PESLYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFD 302

Query: 297 ISLNGEHWY----------GPFSPNYLLTTTVFSPTALIGGNYSFSLY-KTGNSTLPPII 345
           + +NG+  +            ++   +L  TV    A+ G   +  L  K G      II
Sbjct: 303 VLINGDTAFKDVDIVKMSGERYTA-LVLNKTV----AVSGRTLTIVLQPKKGTHA---II 354

Query: 346 NAIEVYSV--KEFLQLQTEQIDVDAITNIKATYGL--KKNWQGDPCAPLAYWWDGLNCSY 401
           NAIEV+ +   E   L  E   V A+  +K++ GL  +  W GDPC P  + W G +C +
Sbjct: 355 NAIEVFEIITAESKTLLEE---VSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQF 411

Query: 402 GDSSS----------------------PRITYL---NLSSSGLKGDITSYVSNLTSLQFL 436
             +                         ++ +L   NLS + ++G+I   + ++TSL+ L
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471

Query: 437 DLSNNNLTGSVPDFLSKL-PLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLC 494
           DLS N+  GS+P+ L +L  LR LNL GN L+G VP  L  R  + + S +   N GLC
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA-SFNFTDNAGLC 529

Length = 623

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  130 bits (329), Expect = 7e-34
 Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 8/195 (4%)

Query: 571 ERTLGKGGFGTVYYGR-LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
           ER LG G FG V+ G   N + VA+K+L S      Q FQ EV+ L R+ H++L SL   
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
           C       +I E M  G+L  +L     +VL     + +A + A+G+ YL    +   +H
Sbjct: 71  CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEK 748
           RD+ + NIL+ E L  K+ADFGL++    D        +   P  +  PE  +    + K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGTFSTK 184

Query: 749 SDVYSFGVVILEIIT 763
           SDV+SFG+++ E+ T
Sbjct: 185 SDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  128 bits (324), Expect = 3e-33
 Identities = 66/190 (34%), Positives = 105/190 (55%), Gaps = 11/190 (5%)

Query: 573 TLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE 632
           T+GKG FG V  G      VAVK L   S    Q F AE  ++  + H NL  L+G   +
Sbjct: 13  TIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDV 692
            N   ++ E+MA G+L +YL    + V++  ++L  A++  +G+EYL    +   VHRD+
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128

Query: 693 KSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDV 751
            + N+L++E L AK++DFGL+K    +A+    +     P  +  PE     + + KSDV
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK----EASQGQDS--GKLPVKWTAPEALREKKFSTKSDV 182

Query: 752 YSFGVVILEI 761
           +SFG+++ EI
Sbjct: 183 WSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  125 bits (317), Expect = 3e-32
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 574 LGKGGFGTVYYGRLNEID---VAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           +G+G FG VY G LN      VA+K +S      +  +    E+ LL  + H N+   +G
Sbjct: 8   IGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ---GLEYLHN-GCK 684
             +  +   +I E+  NG+L+     I KK     E L +AV   Q   GL YLH  G  
Sbjct: 67  SIETSDSLYIILEYAENGSLR----QIIKKFGPFPESL-VAVYVYQVLQGLAYLHEQG-- 119

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K+ NIL  +    KLADFG++     +  +     V GTP ++ PE    + 
Sbjct: 120 --VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 745 LTEKSDVYSFGVVILEIITCKP 766
            +  SD++S G  ++E++T  P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  134 bits (339), Expect = 4e-32
 Identities = 125/475 (26%), Positives = 223/475 (46%), Gaps = 61/475 (12%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L LS + L G+I   +S+   L  LDLS+N L+G +P   S++P L  L+L  N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558

Query: 466 LNGSVPVEL--------LERSKN---GSL----------SLSVGGNPGLCSKIS------ 498
           L+G +P  L        +  S N   GSL          + +V GN  LC   +      
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618

Query: 499 CKK-KKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKR-ESKN---KIDSFEA 553
           CK+ +K       +    G  FL+ A +A  FV  R R   ++KR E+++   ++  F++
Sbjct: 619 CKRVRKTPSWWFYITCTLG-AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDS 677

Query: 554 K-SRHLSYSDVVKITNNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQA 610
           K S+ ++ +D++      E  + +G  G  Y G+   N +   VK ++  ++       +
Sbjct: 678 KVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SS 732

Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+  + ++ H N+  L+G C  +    LI+E++   NL E L +     LS + R +IA+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAI 787

Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
             A+ L +LH  C P +V  ++    I+++ K +  L    L     TD    +S+    
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS---- 842

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH--IRQWVNSLIA 788
              Y+ PE   +  +TEKSD+Y FG++++E++T K   S  + E  +H  I +W     +
Sbjct: 843 --AYVAPETRETKDITEKSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCYS 897

Query: 789 KGDIKSIVDPRLQED--FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              +   +DP ++ D   + N + + + LA+ C +     RP  + V+  L    
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952

Length = 968

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (318), Expect = 2e-31
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 21/279 (7%)

Query: 569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLS---SSSAQGFQQFQAEVKLLMRV-HHRNLT 624
              R LG+G FG VY  R  ++ VA+K+L+    S ++  ++F  E+++L  + H  N+ 
Sbjct: 3   RILRKLGEGSFGEVYLARDRKL-VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYL-SDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
            L     ++    L+ E++  G+L++ L     K  LS  E L I  +    LEYLH+  
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121

Query: 684 KPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFA----TDANTHVSTVVAGTPGYLDPE 738
              I+HRD+K  NILL+      KL DFGL+K       T +   + +   GTPGY+ PE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 739 YYTSNRL---TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI 795
                 L   +  SD++S G+ + E++T  P                    I        
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELPTPS 234

Query: 796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           +   L           A +L    L+     R + S  +
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 4e-31
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 12/198 (6%)

Query: 570 FERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
             R LG G FG V+ G  N    VAVK L   +    + F AE +++ ++ H  L  L  
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYA 68

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HNGCKPP 686
            C  +    ++ E M  G+L EYL   + + L   + + +A + A G+ YL   N     
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----- 123

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRL 745
            +HRD+ + N+L+ E    K+ADFGL++      + + +   A  P  +  PE    NR 
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKFPIKWTAPEAALYNRF 181

Query: 746 TEKSDVYSFGVVILEIIT 763
           + KSDV+SFG+++ EI+T
Sbjct: 182 SIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  121 bits (304), Expect = 1e-30
 Identities = 64/197 (32%), Positives = 108/197 (54%), Gaps = 9/197 (4%)

Query: 570 FERTLGKGGFGTVYYGR-LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           F + LG G FG V+ G+   +IDVA+KM+   +      F  E K++M++ H NL  L G
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYG 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
            C +     ++ E+MANG L  YL +  K  L ++  L +  +  + +EYL +      +
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+ + N L+ E    K++DFGL++ +  D + + S+     P  +  PE +  +R + 
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLAR-YVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 748 KSDVYSFGVVILEIITC 764
           KSDV+SFGV++ E+ + 
Sbjct: 181 KSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (300), Expect = 6e-30
 Identities = 75/271 (27%), Positives = 117/271 (43%), Gaps = 33/271 (12%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVK--MLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           + +GKG FG VY  R         +K   LS+ S +  +    EVK+L +++H N+    
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSD--ISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
              +E  +  ++ E+   G+L + +       K    ++ L   V+    L+YLH     
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I+HRD+K  NI L      KL DFG+SK  ++  +    TVV GTP YL PE   +   
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTVV-GTPYYLSPELCQNKPY 180

Query: 746 TEKSDVYSFGVVILEIITCKPAISRINEEE---KIHIRQWVNSLIAKGDIKSIVDPRLQE 802
             KSD++S G V+ E+ T K      N  E   KI     +        I S     L+ 
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-----LKGQYPP--IPSQYSSELR- 232

Query: 803 DFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
                       L  + L     +RP+++Q+
Sbjct: 233 -----------NLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (299), Expect = 8e-30
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 8/195 (4%)

Query: 571 ERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
           ER LG G FG V+ G  N    VAVK L   +    + F  E +++ ++ H  L  L   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
           C E+    ++ E+M+ G+L ++L     K L   + + +A + A+G+ YL        +H
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEK 748
           RD+ + NIL+ E L  K+ADFGL++    D  T  +   A  P  +  PE     R T K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYT--AREGAKFPIKWTAPEAANYGRFTIK 184

Query: 749 SDVYSFGVVILEIIT 763
           SDV+SFG+++ EI+T
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  118 bits (298), Expect = 2e-29
 Identities = 79/241 (32%), Positives = 127/241 (52%), Gaps = 35/241 (14%)

Query: 570 FERTLGKGGFGTVYYG-------RLNEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHR 621
           F   LG+G FG VY G       RL+   VA+K L  ++  +  Q+F+ E +L+  + H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYL------SDIS--------KKVLSSQERLR 667
           N+  L+G C ++  T +++E++A+G+L E+L      SD+         K  L   + L 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 668 IAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           IA++ A G+EYL  H+      VHRD+ + N L+ E L  K++DFGLS+  ++ D     
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183

Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEE--EKIHIR 780
           S  +     ++ PE     + T +SD++SFGVV+ EI +   +P     N+E  E I  R
Sbjct: 184 SKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242

Query: 781 Q 781
           Q
Sbjct: 243 Q 243

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 6e-29
 Identities = 84/278 (30%), Positives = 131/278 (47%), Gaps = 33/278 (11%)

Query: 571 ERTLGKGGFGTVYYGRLN-----EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           E+ +G G FG V  GRL      EIDVA+K L + SS +    F  E  ++ +  H N+ 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L G   +     +I E+M NG+L ++L +   K  +  + + +    A G++YL     
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMN- 126

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + NIL+N  L  K++DFGLS+    D+    +T     P  +  PE     
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 744 RLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP-RL 800
           + T  SDV+SFG+V+ E+++   +P     N++                 IK++ D  RL
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV----------------IKAVEDGYRL 227

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D  S     +L + C     N+RPT SQ+V  L 
Sbjct: 228 PPPMDCPSA--LYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  116 bits (291), Expect = 7e-29
 Identities = 75/273 (27%), Positives = 133/273 (48%), Gaps = 32/273 (11%)

Query: 574 LGKGGFGTVYYGRLNEID-VAVKMLS------SSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
           LGKG +GTVY G  N+   +AVK +        ++ + +++ Q EV LL  + H N+   
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
           +G C +DN  ++  EF+  G++   L+      L      +   +   G+ YLHN C   
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNC--- 122

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS-----TVVAGTPGYLDPEYYT 741
           +VHRD+K  N++L      KL DFG ++  A     H +       + GTP ++ PE   
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW-VGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ 801
            +    KSD++S G  + E+ T KP ++ ++          + ++   G  + ++ PRL 
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDR---------LAAMFYIGAHRGLM-PRLP 231

Query: 802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           + F A     A++   +CL+   ++RP+  Q++
Sbjct: 232 DSFSAA----AIDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (287), Expect = 4e-28
 Identities = 75/242 (30%), Positives = 114/242 (47%), Gaps = 41/242 (16%)

Query: 570 FERTLGKGGFGTVYYGRL-------NEIDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHR 621
            +R LG+G FG V+ G         ++  VAVK L  ++S    + F+ E +LL    H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYL------------SDISKKVLSSQERLRIA 669
           N+    G C E +   +++E+M +G+L ++L             D     L+  + L+IA
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 670 VESAQGLEYL---HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVS 725
           V+ A G+ YL   H       VHRD+ + N L+   L  K+ DFG+S+  + TD      
Sbjct: 129 VQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR--- 179

Query: 726 TVVAGTP----GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
             V G       ++ PE     + T +SDV+SFGVV+ EI T   +P     NEE    I
Sbjct: 180 --VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237

Query: 780 RQ 781
            Q
Sbjct: 238 TQ 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  114 bits (287), Expect = 5e-28
 Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 58/298 (19%)

Query: 570 FERTLGKGGFGTVYYGRL-------NEIDVAVKMLSS-SSAQGFQQFQAEVKLLMRVHHR 621
           + R +G+G FG V+  R            VAVKML   +SA     FQ E  L+    H 
Sbjct: 9   YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS------------------- 662
           N+  L+G C       L++E+MA G+L E+L   S +   S                   
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 663 -QERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATD- 719
             E+L IA + A G+ YL    +   VHRD+ + N L+ E +  K+ADFGLS++ ++ D 
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 720 --ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEEE 775
             A+ + +  +   P    PE    NR T +SDV+++GVV+ EI +   +P     +EE 
Sbjct: 186 YKASENDAIPIRWMP----PESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241

Query: 776 KIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
             ++R         G++ S  D    E ++         L   C S   + RP+ + +
Sbjct: 242 IYYVRD--------GNVLSCPDNCPLELYN---------LMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (286), Expect = 7e-28
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 15/211 (7%)

Query: 570 FERTLGKGGFGTVYYGRLNEID------VAVKMLSSSSAQGFQQ-FQAEVKLLMRVHHRN 622
           F + LG+G FG V   R + +       VAVK L+ S  +  +  F+ E+++L  + H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 623 LTSLVGHCDEDNQTA--LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           +    G C++    +  LI E++ +G+L++YL     ++   +  L  + +  +G++YL 
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR-LLLFSSQICKGMDYLG 126

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG-YLDPEY 739
           +      +HRD+ + NIL+  +   K++DFGL+K    D + +       +P  +  PE 
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAIS 769
             +++ +  SDV+SFGV + E+ T   P+ S
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (281), Expect = 2e-27
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 568 NNFERT--LGKGGFGTVY---YGRLNEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRVHHR 621
           ++ ER   LG+G  G VY   +    +I  A+K +     + F +Q   E+K L      
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKI-YALKKIHVDGDEEFRKQLLRELKTLRSCESP 59

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD---ISKKVLSSQERLRIAVESAQGLEY 678
            +    G   ++ + +++ E+M  G+L + L     I + VL+      IA +  +GL+Y
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDY 114

Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT---DANTHVSTVVAGTPGYL 735
           LH      I+HRD+K +N+L+N K + K+ADFG+SK         NT V TV   +P  +
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             E Y+       +D++S G+ +LE   
Sbjct: 173 QGESYSYA-----ADIWSLGLTLLECAL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  112 bits (281), Expect = 2e-27
 Identities = 75/302 (24%), Positives = 139/302 (46%), Gaps = 46/302 (15%)

Query: 557 HLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID-------VAVKMLSSSSAQGFQQ-F 608
               S++ +IT     TLG+G FG V+  +   I+       V VK L  +  +  Q  F
Sbjct: 1   AFPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF 55

Query: 609 QAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV-------LS 661
           + E+ +  ++ H+N+  L+G C E     +I E+   G+L+++L     K        LS
Sbjct: 56  RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 662 SQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDA 720
           +++++ +  + A G+++L N      VHRD+ + N L++ + + K++   LSK  + ++ 
Sbjct: 116 TKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Query: 721 NTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK--PAISRINEEEKI 777
               + ++   P  +L PE    +  + KSDV+SFGV++ E+ T    P     +EE   
Sbjct: 173 YKLRNALI---PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--- 226

Query: 778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
                +N L A          +L+         +  +L   C +     RP+ S++V  L
Sbjct: 227 ----VLNRLQAG---------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Query: 838 SE 839
            E
Sbjct: 274 GE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  111 bits (278), Expect = 3e-27
 Identities = 74/268 (27%), Positives = 130/268 (48%), Gaps = 26/268 (9%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           F + LG G FG V YG+   + DVA+KM+   S     +F  E K++M++ H  L  L G
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYG 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
            C +     ++ E+M+NG L  YL +  K+     + L +  +  +G+ YL +      +
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLES---KQFI 122

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+ + N L++++   K++DFGLS+    D   + S+V +  P  +  PE    ++ + 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLLYSKFSS 180

Query: 748 KSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA 806
           KSDV++FGV++ E+ +  K    R N  E           +++G    +  P L  +   
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQG--LRLYRPHLASE--- 228

Query: 807 NSVWKAVELAMACLSPTGNQRPTMSQVV 834
               K   +  +C      +RPT  Q++
Sbjct: 229 ----KVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  109 bits (275), Expect = 9e-27
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 9/193 (4%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +    VAVK L   + +  ++F  E  ++  + H NL  L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129

Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 188 VWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  111 bits (278), Expect = 1e-26
 Identities = 76/220 (34%), Positives = 111/220 (50%), Gaps = 22/220 (10%)

Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQ---AEVKLLMRVHHRNLTSL 626
           R +G G FG VY+ R       VA+K +S S  Q  +++Q    EV+ L ++ H N    
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 627 VGHCDEDNQTA-LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
            G C     TA L+ E+   G+  + L ++ KK L   E   I   + QGL YLH+  + 
Sbjct: 81  KG-CYLREHTAWLVMEYCL-GSASDIL-EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS--- 742
             +HRD+K+ NILL E    KLADFG S S  + AN+ V     GTP ++ PE   +   
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFV-----GTPYWMAPEVILAMDE 188

Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQ 781
            +   K DV+S G+  +E+   KP +  +N    + HI Q
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 1e-26
 Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 14/198 (7%)

Query: 574 LGKGGFGTVYYG------RLNEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
           LG G FGTVY G         +I VA+K+L   +S +  ++   E  ++  V H ++  L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
           +G C   +Q  LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL    +  
Sbjct: 75  LGIC-LSSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLE---EKR 129

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRL 745
           +VHRD+ + N+L+      K+ DFGL+K    D            P  ++  E       
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-EYHAEGGKVPIKWMALESILHRIY 188

Query: 746 TEKSDVYSFGVVILEIIT 763
           T KSDV+S+GV + E++T
Sbjct: 189 THKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 22/203 (10%)

Query: 574 LGKGGFGTVYYGRLNEIDV--AVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVG 628
           LGKG FG V   R  +     A+K+L        +  +    E  +L R++H  +  L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 629 HC---DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHN-GC 683
           H     E+    L+ E+   G L    S +SK+   S+ER R  A E    LEYLH+ G 
Sbjct: 59  HYAFQTEEK-LYLVLEYAPGGEL---FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG- 113

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I++RD+K  NILL+     KL DFGL+K  +++  +  +T   GTP YL PE     
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFC-GTPEYLAPEVLLGK 168

Query: 744 RLTEKSDVYSFGVVILEIITCKP 766
              +  D +S GV++ E++T KP
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (270), Expect = 5e-26
 Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 18/205 (8%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC 630
           LG+G +G+VY        ++ VA+K++        Q+   E+ +L +     +    G  
Sbjct: 11  LGEGSYGSVYKAIHKETGQV-VAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISK---KVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
            ++    ++ E+   G++    SDI K   K L+ +E   I  ++ +GLEYLH+      
Sbjct: 68  FKNTDLWIVMEYCGAGSV----SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KK 120

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+K+ NILLNE+ QAKLADFG+S    TD     +TV+ GTP ++ PE         
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178

Query: 748 KSDVYSFGVVILEIITCKPAISRIN 772
           K+D++S G+  +E+   KP  S I+
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIH 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  107 bits (268), Expect = 7e-26
 Identities = 77/274 (28%), Positives = 135/274 (49%), Gaps = 30/274 (10%)

Query: 570 FERTLGKGGFGTVYYGR-LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
             + +G G FG V+ G  L +  VA+K +    A   + F  E +++M++ H  L  L G
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER-LRIAVESAQGLEYLHNGCKPPI 687
            C E +   L++EFM +G L +YL   +++   SQE  L + ++  +G+ YL +     +
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+ E    K++DFG+++ F  D     ST       +  PE ++ ++ + 
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS---IVDPRLQEDF 804
           KSDV+SFGV++ E+ +          E K       NS + +  I +   +  PRL    
Sbjct: 181 KSDVWSFGVLMWEVFS----------EGKTPYENRSNSEVVE-TINAGFRLYKPRLA--- 226

Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
            + SV+   EL   C       RP+ S ++ +L+
Sbjct: 227 -SQSVY---ELMQHCWKERPEDRPSFSLLLHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  107 bits (268), Expect = 8e-26
 Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 11/193 (5%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
             +T+GKG FG V  G      VAVK + + +    Q F AE  ++ ++ H NL  L+G 
Sbjct: 10  LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67

Query: 630 CDEDNQTALIY-EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
             E+     I  E+MA G+L +YL    + VL     L+ +++  + +EYL        V
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+ + N+L++E   AK++DFGL+K  ++  +T    V      +  PE     + + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTK 179

Query: 749 SDVYSFGVVILEI 761
           SDV+SFG+++ EI
Sbjct: 180 SDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  106 bits (266), Expect = 2e-25
 Identities = 70/238 (29%), Positives = 117/238 (49%), Gaps = 29/238 (12%)

Query: 570 FERTLGKGGFGTVYYGRL------NEIDVAVKMLSS-SSAQGFQQFQAEVKLLMRVHHRN 622
           F   LG+  FG +Y G L      +   VA+K L   ++ Q + +FQ E  L+  +HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYL------SDIS---------KKVLSSQERLR 667
           +  L+G   ++    +++E++  G+L E+L      SD+          K  L   + L 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
           IA++ A G+EYL +      VH+D+ + NIL+ E+L  K++D GLS+   +     V   
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEE--EKIHIRQ 781
                 ++ PE     + +  SD++SFGVV+ EI +   +P     N+E  E +  RQ
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  105 bits (264), Expect = 4e-25
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 20/200 (10%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVK-MLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
             LG G  G V     R     +AVK +    +    +Q   E+ +L + +   +    G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKK----VLSSQERLRIAVESAQGLEYLHNGCK 684
               +   ++  E+M  G+L + L ++  +    +L      +IAV   +GL YLH   K
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK 121

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVAGTPGYLDPEYYTSN 743
             I+HRDVK +NIL+N + Q KL DFG+S       A T V     GT  Y+ PE    N
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGN 174

Query: 744 RLTEKSDVYSFGVVILEIIT 763
             + KSD++S G+ ++E+ T
Sbjct: 175 DYSVKSDIWSLGLSLIELAT 194

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  104 bits (261), Expect = 5e-25
 Identities = 59/193 (30%), Positives = 103/193 (53%), Gaps = 17/193 (8%)

Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG---HC 630
           +G+G FG V  G      VAVK +        Q F  E  ++ ++HH+NL  L+G   H 
Sbjct: 14  IGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH- 70

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
              N   ++ E M+ GNL  +L    + ++S  + L+ +++ A+G+EYL +     +VHR
Sbjct: 71  ---NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124

Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+ + NIL++E   AK++DFGL++  +   +     V      +  PE     + + KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSKSD 179

Query: 751 VYSFGVVILEIIT 763
           V+S+GV++ E+ +
Sbjct: 180 VWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  103 bits (258), Expect = 2e-24
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 11/206 (5%)

Query: 572 RTLGKGGFGTVYY--GRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           R +G+G FG V+    + ++  V +K +     +       Q E ++L  + H N+    
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
            +  ED    ++ E+   G L EY+      +L     L   V+    L ++H      I
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLI 122

Query: 688 VHRDVKSTNILLNE-KLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +HRD+K+ NILL++ K+  K+ DFG+SK  ++   +   TVV GTP Y+ PE        
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSS--KSKAYTVV-GTPCYISPELCEGKPYN 179

Query: 747 EKSDVYSFGVVILEIITCKPAISRIN 772
           +KSD+++ G V+ E+ + K A    N
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  103 bits (258), Expect = 3e-24
 Identities = 67/220 (30%), Positives = 92/220 (41%), Gaps = 44/220 (20%)

Query: 573 TLGKGGFGTVY-----------------YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLL 615
           T+GKG FGTV                  YG + E             +  QQ  +EV +L
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-------------KEKQQLVSEVNIL 53

Query: 616 MRVHHRNLTSLVGH-CDEDNQTALIY-EFMANGNLQEYLSDISKKVLSSQER--LRIAVE 671
             + H N+        D  NQT  I  E+   G+L + +    K+    +E    RI  +
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 672 SAQGLEYLHNGCKPP--IVHRDVKSTNILLNEKLQAKLADFGLSKSFATD---ANTHVST 726
               L   HN   P   ++HRD+K  NI L+     KL DFGL+K    D   A T+V  
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-- 171

Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
              GTP Y+ PE        EKSD++S G +I E+    P
Sbjct: 172 ---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  102 bits (256), Expect = 3e-24
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)

Query: 572 RTLGKGGFG--TVYYGRLNEIDVAVKM--LSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           R LGKG FG  T+Y    ++  V  K   L+  S +  +    E+ +L  + H N+ +  
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 628 GHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            H   D+ T LI  E+   G L + +     ++   +  L    +    + Y+H   K  
Sbjct: 66  NHF-MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           I+HRD+K+ NI L +    KL DFG+SK   ++  +   TVV GTP Y+ PE     +  
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SMAETVV-GTPYYMSPELCQGVKYN 179

Query: 747 EKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA 806
            KSD+++ G V+ E++T K      N          V   I +G+   +V     E    
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLN------LVVK-IVQGNYTPVVSVYSSE---- 228

Query: 807 NSVWKAVELAMACLSPTGNQRPTMSQVV 834
                 + L  + L     +RPT  +V+
Sbjct: 229 -----LISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (259), Expect = 3e-24
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 22/213 (10%)

Query: 558 LSYSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQQFQA---EV 612
           +S  D  ++  N E+ +G+G  G VY    R    +VA+K +        Q  +    E+
Sbjct: 12  VSEGDPRELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRK----QNKELIINEI 66

Query: 613 KLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES 672
            ++    H N+          ++  ++ E+M  G+L + +   +   ++  +   +  E 
Sbjct: 67  LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREV 125

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS---TVVA 729
            QGLEYLH+     ++HRD+KS NILL++    KLADFG    FA       S   +VV 
Sbjct: 126 LQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVV- 177

Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII 762
           GTP ++ PE         K D++S G++ +E+ 
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  103 bits (259), Expect = 4e-24
 Identities = 85/270 (31%), Positives = 132/270 (48%), Gaps = 36/270 (13%)

Query: 574 LGKGGFGTVYYG---RLNEIDVAVKMLSSSSAQGFQQFQ---AEVKLLMRVHHRNLTSLV 627
           +G G FG VY+      NE+ VAVK +S S  Q  +++Q    EVK L ++ H N     
Sbjct: 29  IGHGSFGAVYFATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G   +++   L+ E+   G+  + L ++ KK L   E   I   + QGL YLH+      
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHNM--- 142

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS---NR 744
           +HRD+K+ NILL E  Q KLADFG S S ++ AN+ V     GTP ++ PE   +    +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFG-SASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
              K DV+S G+  +E+   KP +  +N    ++        IA+ D      P LQ + 
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQND-----SPTLQSNE 244

Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVV 834
             +S    V+    CL     +RP  ++++
Sbjct: 245 WTDSFRGFVDY---CLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (253), Expect = 7e-24
 Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 25/270 (9%)

Query: 573 TLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLVG 628
            +GKG FG V+      ++   A+K +  S     ++ +A  E ++L ++    +     
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              +  +  ++ E+  NG+L + L     + L   +  R  ++   GL +LH      I+
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKIL 123

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+KS N+ L+     K+ D G++K  +   NT+ +  + GTP YL PE        EK
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPYNEK 181

Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDV++ GVV+ E  T K      N+   I         I +G    +     Q+      
Sbjct: 182 SDVWALGVVLYECCTGKHPFDANNQGALIL-------KIIRGVFPPVSQMYSQQ------ 228

Query: 809 VWKAVELAMACLSPTGNQRPTMSQVVMELS 838
                +L   CL+    QRP   Q++   S
Sbjct: 229 ---LAQLIDQCLTKDYRQRPDTFQLLRNPS 255

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  101 bits (253), Expect = 8e-24
 Identities = 76/273 (27%), Positives = 135/273 (49%), Gaps = 28/273 (10%)

Query: 570 FERTLGKGGFGTVYYGRL-NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           F + LG G FG V+ G+   +I VA+K ++   A   + F  E K++M++ H  L  L G
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
            C +     ++ EFM NG L  YL    +  LS    L +  +  +G+EYL    +   +
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFI 122

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+ + N L++     K++DFG+++    D   + S+  A  P  +  PE +  ++ + 
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 748 KSDVYSFGVVILEIIT--CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD 805
           KSDV+SFGV++ E+ T    P   + N E        V  +I++G    +  P+L     
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYE--------VVEMISRGF--RLYRPKLA---- 226

Query: 806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
           + +V+   E+  +C       RPT ++++  ++
Sbjct: 227 SMTVY---EVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  102 bits (254), Expect = 1e-23
 Identities = 81/307 (26%), Positives = 139/307 (45%), Gaps = 55/307 (17%)

Query: 570 FERTLGKGGFGTVYYGRL----NEIDVAVKMLSS-SSAQGFQQFQAEVKLLMRV-HHRNL 623
           FE  +G+G FG V    +     +++ A+KML   +S    + F  E+++L ++ HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDI--------------SKKVLSSQERLRIA 669
            +L+G C+      +  E+   GNL ++L                 +   L+SQ+ L+ A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            + A G++YL        +HRD+ + N+L+ E L +K+ADFGLS+        +V   + 
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVYVKKTMG 178

Query: 730 GTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT------CKPAISRINEEEKIHIRQW 782
             P  ++  E    +  T KSDV+SFGV++ EI++      C    + + E+     R  
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-- 236

Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
                       +  PR  +D       +  EL   C      +RP  +Q+ ++LS  L 
Sbjct: 237 ------------MEKPRNCDD-------EVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Query: 843 AEMARAN 849
           A  A  N
Sbjct: 278 ARKAYVN 284

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  101 bits (253), Expect = 1e-23
 Identities = 70/222 (31%), Positives = 113/222 (50%), Gaps = 25/222 (11%)

Query: 551 FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLSSSSAQG 604
           FE   RHL +           + LGKG FG+V   R + +       VAVK L  S+A+ 
Sbjct: 1   FEE--RHLKFI----------QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH 48

Query: 605 FQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALIYEFMANGNLQEYLSDISKKVLSS 662
            + F+ E+++L  + H N+    G C         L+ E++  G+L++YL    ++ L  
Sbjct: 49  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK-HRERLDH 107

Query: 663 QERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
           ++ L  A +  +G+EYL  G K   VHRD+ + NIL+  + + K+ DFGL+K    D   
Sbjct: 108 RKLLLYASQICKGMEYL--GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164

Query: 723 HVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +       +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  102 bits (254), Expect = 1e-23
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 22/220 (10%)

Query: 572 RTLGKGGFGTVYYG---RLNEIDVAVKMLSSSSAQGFQQFQ---AEVKLLMRVHHRNLTS 625
           R +G G FG VY+    R NE+ VA+K +S S  Q  +++Q    EVK L R+ H N   
Sbjct: 31  REIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
             G    ++   L+ E+   G+  + L ++ KK L   E   I   + QGL YLH+    
Sbjct: 90  YKGCYLREHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSH--- 144

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS--- 742
            ++HRD+K+ NILL E  Q KLADFG S S A+ AN+ V     GTP ++ PE   +   
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFG-SASIASPANSFV-----GTPYWMAPEVILAMDE 198

Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQ 781
            +   K DV+S G+  +E+   KP +  +N    + HI Q
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  100 bits (252), Expect = 2e-23
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 31/222 (13%)

Query: 570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQF-QAEVKLLMRV-HHRNL 623
           F + +G+G F TV   +  E   + A+K+L       +   ++ + E ++L R+  H  +
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NG 682
             L     ++     + E+  NG L +Y+       L  +     A E    LEYLH  G
Sbjct: 65  IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKG 122

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSK---------SFATDANTHVSTVVA---- 729
               I+HRD+K  NILL++ +  K+ DFG +K         S   DA    S +      
Sbjct: 123 ----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 730 -----GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
                GT  Y+ PE        + SD+++ G +I +++T KP
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 572 RTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRNLTSLVGH 629
             +GKG FG VY G L    +VAVK   S+      ++F  E ++L +  H N+  L+G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
           C +     ++ E +  G+L  +L    K  L+ ++ L++++++A G+EYL +      +H
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP----GYLDPEYYTSNRL 745
           RD+ + N L+ E    K++DFG+S+    +    + TV  G       +  PE     R 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 746 TEKSDVYSFGVVILEIIT 763
           T +SDV+S+G+++ E  +
Sbjct: 173 TSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 65/241 (26%), Positives = 110/241 (45%), Gaps = 22/241 (9%)

Query: 569 NFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHR 621
           +FE  R +GKG FG V   +  +     A+K ++          +    E ++L  ++H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 622 NLTSL-VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYL 679
            L +L     DE+N   L+ + +  G+L+ +   +S+KV  S+E+++    E    LEYL
Sbjct: 61  FLVNLWYSFQDEEN-MYLVVDLLLGGDLRYH---LSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           H+     I+HRD+K  NILL+E+    + DF ++     D  T   T  +GTPGY+ PE 
Sbjct: 117 HS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEV 170

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKIHIRQWVNSLIAKGDIKSIV 796
                 +   D +S GV   E +  K      SR   ++    ++  + L         +
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI 230

Query: 797 D 797
           D
Sbjct: 231 D 231

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 13/199 (6%)

Query: 572 RTLGKGGFGTVYYGRL-----NEIDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHRNLTS 625
           + LG G FG+V  G        E++VAVK L     A G ++F  E  ++ ++ H  +  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G C  +    L+ E    G L +YL    ++ +   +   +A + A G+ YL      
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLE-SKH- 115

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             VHRD+ + N+LL  + QAK++DFG+S++    ++ + +T     P  +  PE     +
Sbjct: 116 -FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 745 LTEKSDVYSFGVVILEIIT 763
            + KSDV+S+GV + E  +
Sbjct: 175 FSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  100 bits (250), Expect = 5e-23
 Identities = 60/205 (29%), Positives = 108/205 (52%), Gaps = 16/205 (7%)

Query: 570 FERTLGKGGFGTVY----YGRLNE---IDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HH 620
           F +TLG G FG V     YG       + VAVKML  ++ +   +   +E+K++  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+ +L+G C       +I E+   G+L  +L    +  L+ ++ L  + + A+G+ +L 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 681 N-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPE 738
           +  C    +HRD+ + N+LL      K+ DFGL++    D+N +V    A  P  ++ PE
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN-YVVKGNARLPVKWMAPE 213

Query: 739 YYTSNRLTEKSDVYSFGVVILEIIT 763
              +   T +SDV+S+G+++ EI +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 99.3 bits (247), Expect = 8e-23
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 28/227 (12%)

Query: 557 HLSYSDVVKITNNFERTLGKGGFGTVYYGR----LNEID---VAVKMLSSSSAQGFQQFQ 609
           H+   D+V      +  LG+G FG V+       L E D   VAVK L  +S    Q FQ
Sbjct: 1   HIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ 55

Query: 610 AEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL-------------SDIS 656
            E +LL  + H+++    G C E     +++E+M +G+L  +L              D++
Sbjct: 56  REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115

Query: 657 KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF 716
              L+  + L IA + A G+ YL        VHRD+ + N L+ + L  K+ DFG+S+  
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172

Query: 717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            +     V         ++ PE     + T +SD++SFGVV+ EI T
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 8e-23
 Identities = 79/292 (27%), Positives = 130/292 (44%), Gaps = 45/292 (15%)

Query: 572 RTLGKGGFGTVYYGRLNEID-----VAVKM--LSSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           + LG+G FG+V  G+L++ D     VAVK   L   +    ++F +E   +    H N+ 
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 625 SLVGHC---DEDNQTA---LIYEFMANGNLQEYL-----SDISKKVLSSQERLRIAVESA 673
            L+G C       +     +I  FM +G+L  +L       + +K L  Q  L+  V+ A
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFMVDIA 123

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP- 732
            G+EYL N      +HRD+ + N +L E +   +ADFGLSK   +  + +    +A  P 
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS-GDYYRQGRIAKMPV 179

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEEEKIHIRQWVNSLIAKG 790
            ++  E       T KSDV++FGV + EI T    P     N E        +   +  G
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------IYDYLRHG 231

Query: 791 DIKSIVDPRLQEDFDA-NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
           +       RL++  D  + ++   +L  +C       RPT +++   L   L
Sbjct: 232 N-------RLKQPEDCLDELY---DLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 43/271 (15%)

Query: 574 LGKGGFGTVYYGRL---NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC 630
           +G G +G VY  R     E+ VA+K++       F+  Q E+ +L    H N+ +  G  
Sbjct: 11  IGSGTYGDVYKARDIATGEL-VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA---VESAQGLEYLHNGCKPPI 687
              ++  ++ E+   G+LQ    DI +        L+IA    E+ +GL YLH   K   
Sbjct: 70  LRRDKLWIVMEYCGGGSLQ----DIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK--- 122

Query: 688 VHRDVKSTNILLNEKLQAKLADFG----LSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
           +HRD+K  NILL E    KLADFG    L+ + A    + +     GTP ++ PE     
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-RKSFI-----GTPYWMAPEVAAVE 176

Query: 744 RL---TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
           R      K D+++ G+  +E+   +P +        +H  +    LI+K +      P+L
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMF------DLHPMR-ALFLISKSNFPP---PKL 226

Query: 801 QEDFDANSVWKAV--ELAMACLSPTGNQRPT 829
           ++       W  V  +    CL+    +RPT
Sbjct: 227 KD----KEKWSPVFHDFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 98.5 bits (245), Expect = 2e-22
 Identities = 79/320 (24%), Positives = 146/320 (45%), Gaps = 60/320 (18%)

Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGRLNE----IDVAVK-MLSSSSAQGFQQFQAEV 612
           L ++D+      F+  +G+G FG V   R+ +    +D A+K M   +S    + F  E+
Sbjct: 4   LEWNDI-----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58

Query: 613 KLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISK 657
           ++L ++ HH N+ +L+G C+      L  E+  +GNL ++L              ++ + 
Sbjct: 59  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118

Query: 658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
             LSSQ+ L  A + A+G++YL    +   +HRD+ + NIL+ E   AK+ADFGLS+   
Sbjct: 119 STLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-- 173

Query: 718 TDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT------CKPAISR 770
                +V   +   P  ++  E    +  T  SDV+S+GV++ EI++      C    + 
Sbjct: 174 --QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231

Query: 771 INEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTM 830
           + E                   K     RL++  + +   +  +L   C      +RP+ 
Sbjct: 232 LYE-------------------KLPQGYRLEKPLNCDD--EVYDLMRQCWREKPYERPSF 270

Query: 831 SQVVMELSECLAAEMARANS 850
           +Q+++ L+  L       N+
Sbjct: 271 AQILVSLNRMLEERKTYVNT 290

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 98.2 bits (244), Expect = 2e-22
 Identities = 73/220 (33%), Positives = 111/220 (50%), Gaps = 22/220 (10%)

Query: 572 RTLGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQGFQQFQ---AEVKLLMRVHHRNLTS 625
           R +G G FG VY+ R    +E+ VA+K +S S  Q  +++Q    EV+ L ++ H N   
Sbjct: 21  REIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
             G    ++   L+ E+   G+  + L ++ KK L   E   +   + QGL YLH+    
Sbjct: 80  YRGCYLREHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSH--- 134

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS--- 742
            ++HRDVK+ NILL+E    KL DFG S S    AN  V     GTP ++ PE   +   
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFV-----GTPYWMAPEVILAMDE 188

Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQ 781
            +   K DV+S G+  +E+   KP +  +N    + HI Q
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 58/278 (20%)

Query: 574 LGKGGFGTVYYG---RLNEIDVAVKM--LSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           +GKG FG VY     R N++ VA+K+  L  +  +  +  Q E++ L +     +T   G
Sbjct: 9   IGKGSFGEVYKAIDKRTNQV-VAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYITKYYG 66

Query: 629 HCDEDNQTALIYEFMANGNL----------QEYLSDISKKVLSSQERLRIAVESAQGLEY 678
              + ++  +I E+   G+           + Y++ I ++VL              GLEY
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-------------LGLEY 113

Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS---KSFATDANTHVSTVVAGTPGYL 735
           LH   K   +HRD+K+ NILL+E+   KLADFG+S    S  +  NT V     GTP ++
Sbjct: 114 LHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWM 165

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNSLIAKGDIKS 794
            PE    +   EK+D++S G+  +E+   +P +S       +H +R  V  LI K +  S
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLS------DLHPMR--VLFLIPKNNPPS 217

Query: 795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQ 832
           +   +  + F         +    CL+    +RP+  +
Sbjct: 218 LEGNKFSKPFK--------DFVSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 574 LGKGGFGTVYYGRLNEIDVAV---KMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLVG 628
           +G+G +G VY  R       V   K+     ++G  +  A  E+KLL  ++H N+  L+ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK-TALREIKLLKELNHPNIIKLLD 65

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNGCKPPI 687
                    L++EFM + +L + + D  + +   +  ++    +  QGL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGL--PESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-YYTSNRLT 746
           +HRD+K  N+L+N +   KLADFGL++SF +    +   VV  T  Y  PE        +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAPELLLGDKGYS 177

Query: 747 EKSDVYSFGVVILEIITCKP 766
              D++S G +  E+++ +P
Sbjct: 178 TPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 68/230 (29%), Positives = 108/230 (46%), Gaps = 24/230 (10%)

Query: 572 RTLGKGGFGTVYYGRLNEID--------VAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
             LG G FG VY G   +I         VAVK L   ++ Q  ++F  E  L+   +H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK-----VLSSQERLRIAVESAQGLE 677
           +  L+G C  +    +I E M  G+L  YL D   +     +L+ +E L I ++ A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQA-----KLADFGLSKSFATDANTHVSTVVAGTP 732
           YL    +   +HRD+ + N L++EK        K+ DFGL++                  
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIR 780
            ++ PE     + T +SDV+SFGV++ EI+T   +P  +  N+E   H+ 
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 72/282 (25%), Positives = 138/282 (48%), Gaps = 40/282 (14%)

Query: 572 RTLGKGGFGTVYYGRL-----NEIDVAVKMLSS-SSAQGFQQFQAEVKLLMRVHHRNLTS 625
           R +GKG FG VY+G L      +I  AVK L+  +  +  +QF  E  ++    H N+ S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 626 LVGHC-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
           L+G C   +    ++  +M +G+L+ ++   +    + ++ +   ++ A+G+EYL +   
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYLAS--- 116

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKS------FATDANTHVSTVVAGTPGYLDPE 738
              VHRD+ + N +L+E    K+ADFGL++       ++   +T     V     ++  E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALE 172

Query: 739 YYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
              + + T KSDV+SFGV++ E++T   P    ++  +       +   + +G       
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-------ITVYLLQGR------ 219

Query: 798 PRL-QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
            RL Q ++  + ++   E+ ++C  P    RPT S++V  + 
Sbjct: 220 -RLLQPEYCPDPLY---EVMLSCWHPKPEMRPTFSELVSRIE 257

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 96.3 bits (239), Expect = 8e-22
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 570 FERTLGKGGFGTVYYGRL-------NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN 622
            +R LG+G FG V+           ++I VAVK L  +S    + F  E +LL  + H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV-----------LSSQERLRIAVE 671
           +    G C E +   +++E+M +G+L ++L                  L+  + L IA +
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 672 SAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGT 731
            A G+ YL        VHRD+ + N L+ E L  K+ DFG+S+   +     V       
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 732 PGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             ++ PE     + T +SDV+S GVV+ EI T
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 25/207 (12%)

Query: 574 LGKGGFGTVYY------GRLNEIDVAVKM-----LSSSSAQGFQQFQAEVKLLMRVHHRN 622
           LG+G FG VY       GR    ++AVK       S  + +     + E++LL  + H  
Sbjct: 10  LGQGAFGRVYLCYDVDTGR----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65

Query: 623 LTSLVGHCDEDNQTALIY-EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           +    G C  D++T  I+ E+M  G++++ L   +   L+     +   +  +G+EYLH+
Sbjct: 66  IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHS 122

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT--DANTHVSTVVAGTPGYLDPEY 739
                IVHRD+K  NIL +     KL DFG SK   T   + T + +V  GTP ++ PE 
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEV 178

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKP 766
            +      K+DV+S G  ++E++T KP
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 10/195 (5%)

Query: 572 RTLGKGGFGTVYYGRL-NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC 630
           + LG G FG V+ G   N   VAVK L   +    Q F  E  L+  + H  L  L    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 631 DEDNQTALIYEFMANGNLQEYL-SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
            ++    +I E+MA G+L ++L SD   KVL  +  +  + + A+G+ Y+    +   +H
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK-LIDFSAQIAEGMAYIE---RKNYIH 126

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEK 748
           RD+++ N+L++E L  K+ADFGL++    + N + +   A  P  +  PE       T K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 749 SDVYSFGVVILEIIT 763
           SDV+SFG+++ EI+T
Sbjct: 185 SDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 83/283 (29%), Positives = 122/283 (43%), Gaps = 35/283 (12%)

Query: 572 RTLGKGGFGTVYYGRLNEID-----VAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLT 624
           R LGKG FG+V   +L   D     VAVKML +   S+   ++F  E   +    H N+ 
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 625 SLVG---HCDEDNQTAL---IYEFMANGNLQEYL--SDISKK--VLSSQERLRIAVESAQ 674
            L+G         +  +   I  FM +G+L  +L  S I ++   L  Q  +R  ++ A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           G+EYL +      +HRD+ + N +LNE +   +ADFGLSK   +               +
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS 794
           L  E    N  T  SDV++FGV + EI+T         E  +I+     N LI    +K 
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY-----NYLIKGNRLKQ 236

Query: 795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
              P   ED          EL   C SP    RP+   +  +L
Sbjct: 237 --PPDCLEDV--------YELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 69/202 (34%), Positives = 111/202 (54%), Gaps = 14/202 (6%)

Query: 572 RTLGKGGFGTVYYGRLN-EID-----VAVKMLS-SSSAQGFQQFQAEVKLLMRVHHRNLT 624
           R LG+G FG V   R + E D     VAVK L   S        + E+++L  ++H N+ 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 625 SLVGHCDED--NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C ED  N   LI EF+ +G+L+EYL   +K  ++ +++L+ AV+  +G++YL  G
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYL--G 126

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
            +   VHRD+ + N+L+  + Q K+ DFGL+K+  TD   +       +P +   PE   
Sbjct: 127 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
            ++    SDV+SFGV + E++T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 95.8 bits (238), Expect = 1e-21
 Identities = 82/303 (27%), Positives = 138/303 (45%), Gaps = 57/303 (18%)

Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLSS-SSAQGFQQFQAEVKLLMRV-HH 620
           + LG+G FG V       +D         VAVKML S ++ +      +E++++  +  H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ LS ++ +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL        +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-----HIDY 195

Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 250

Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 251 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298

Query: 840 CLA 842
            LA
Sbjct: 299 ILA 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 11/200 (5%)

Query: 571 ERTLGKGGFGTVYYGRL-----NEIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLT 624
           ++ +G G FG V+ G L      E+ VA+K L    + +  Q F +E  ++ +  H N+ 
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L G   +     +I E+M NG L +YL D   +  SS + + +    A G++YL +   
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSD--- 125

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + NIL+N  L+ K++DFGLS+    D     +T     P  +  PE     
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + T  SDV+SFG+V+ E+++
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.7 bits (235), Expect = 3e-21
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 29/228 (12%)

Query: 557 HLSYSDVVKITNNFERTLGKGGFGTVYYGRL-------NEIDVAVKMLSSSSAQGFQQFQ 609
           H+   D+V      +R LG+G FG V+           +++ VAVK L   +    + FQ
Sbjct: 1   HIKRRDIV-----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ 55

Query: 610 AEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD--------------I 655
            E +LL  + H ++    G C + +   +++E+M +G+L ++L                 
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 656 SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS 715
           +K  L   + L IA + A G+ YL        VHRD+ + N L+   L  K+ DFG+S+ 
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 172

Query: 716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             +     V         ++ PE     + T +SDV+SFGV++ EI T
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 48/292 (16%)

Query: 571 ERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRN 622
            R LG+G FG VY G          E  VA+K ++ +++   + +F  E  ++   +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK--------VLSSQERLRIAVESAQ 674
           +  L+G       T ++ E MA G+L+ YL     +          + Q+ +++A E A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           G+ YL        VHRD+ + N ++ E L  K+ DFG+      D          G  G 
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGM----TRDIYET-DYYRKGGKGL 182

Query: 735 L-----DPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLI 787
           L      PE       T KSDV+SFGVV+ E+ T   +P     NEE        V   +
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------VLKFV 234

Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
             G    +  P    D         +EL   C       RPT  ++V  L +
Sbjct: 235 IDGGH--LDLPENCPDK-------LLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 93.2 bits (231), Expect = 7e-21
 Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 28/211 (13%)

Query: 574 LGKGGFGTVYYGRLNE----IDVAVKMLSS-SSAQGFQQFQAEVKLLMRV-HHRNLTSLV 627
           +G+G FG V   R+ +    +D A+K +   +S    + F  E+++L ++ HH N+ +L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDI--------------SKKVLSSQERLRIAVESA 673
           G C+      L  E+  +GNL ++L                 +   LSSQ+ L  A + A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP- 732
           +G++YL    +   +HRD+ + NIL+ E   AK+ADFGLS+        +V   +   P 
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMGRLPV 175

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            ++  E    +  T  SDV+S+GV++ EI++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.5 bits (230), Expect = 9e-21
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 24/205 (11%)

Query: 574 LGKGGFGTVYYGRLNEID---VAVKMLS-----SSSAQGFQQFQAEVKLLMRVHHRNLTS 625
           LG G FG+VY G LN  D    AVK +S      +  +  +Q + E+ LL ++ H N+  
Sbjct: 8   LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ---GLEYLHNG 682
            +G   E++   +  E +  G+L + L    KK  S  E + I + + Q   GLEYLH+ 
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPV-IRLYTRQILLGLEYLHDR 121

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
                VHRD+K  NIL++     KLADFG++K     +         G+P ++ PE    
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMAPEVIAQ 175

Query: 743 -NRLTEKSDVYSFGVVILEIITCKP 766
                  +D++S G  +LE+ T KP
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.8 bits (231), Expect = 9e-21
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 31/271 (11%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGH 629
           +G G    VY       NE  VA+K +     Q    + + EV+ + + +H N+      
Sbjct: 9   IGVGATAVVYAAICLPNNEK-VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV---ESAQGLEYLH-NGCKP 685
               ++  L+  +++ G+L + +     +     +   IA    E  +GLEYLH NG   
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPR--GGLDEAIIATVLKEVLKGLEYLHSNG--- 122

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT--DANTHVSTVVAGTPGYLDPEYYTSN 743
             +HRD+K+ NILL E    K+ADFG+S S A   D    V     GTP ++ PE     
Sbjct: 123 -QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181

Query: 744 R-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE 802
                K+D++SFG+  +E+ T     S+    +       V  L  + D      P L+ 
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQND-----PPSLET 229

Query: 803 DFDANSVWKAV-ELAMACLSPTGNQRPTMSQ 832
             D     K+  ++   CL    ++RPT  +
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.4 bits (230), Expect = 9e-21
 Identities = 78/264 (29%), Positives = 119/264 (45%), Gaps = 31/264 (11%)

Query: 574 LGKGGFGTVYYG-RLNEIDV-AVKM--LSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
           +G G FG VY    L+  ++ AVK   +  +  +  ++   E+K+L  + H NL    G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ---GLEYLH-NGCKP 685
                +  +  E+ + G L+E L     ++L   E + I V + Q   GL YLH +G   
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLE--HGRIL--DEHV-IRVYTLQLLEGLAYLHSHG--- 119

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV--VAGTPGYLDPEYYTSN 743
            IVHRD+K  NI L+     KL DFG +     +  T    V  +AGTP Y+ PE  T  
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 744 RLTEK---SDVYSFGVVILEIITCKPAISRINEEEKI-------HIRQWVNSLIAKGDIK 793
           +       +D++S G V+LE+ T K   S ++ E +I       H     +SL    + K
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238

Query: 794 SIVDPRLQEDFDANSVWKAVELAM 817
             +D  L+   D      A EL  
Sbjct: 239 DFLDRCLE--SDPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 9/195 (4%)

Query: 571 ERTLGKGGFGTVYYGRL-NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
            + LG G FG V+ G       VA+K L   S    + F AE  L+ ++ H  L  L   
Sbjct: 11  VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAV 69

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
             ++    +I E+M NG+L ++L       L+  + + +A + A+G+ ++    +   +H
Sbjct: 70  VTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEK 748
           RD+++ NIL++E L  K+ADFGL++    + N + +   A  P  +  PE       T K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 749 SDVYSFGVVILEIIT 763
           SDV+SFG+++ EI+T
Sbjct: 184 SDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 25/205 (12%)

Query: 574 LGKGGFGTVYYGR---------LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           LGKG +G+VY  +         L E+D     L S S +  +    E+++L  V+H N+ 
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVD-----LGSMSQKEREDAVNEIRILASVNHPNII 62

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSD--ISKKVLSSQERLRIAVESAQGLEYLHNG 682
           S      + N+  ++ E+   G+L + +S     +K++  QE  RI ++  +GL+ LH  
Sbjct: 63  SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVAGTPGYLDPEYYT 741
               I+HRD+KS NILL      K+ D G+SK    + A T +     GTP Y+ PE + 
Sbjct: 123 ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYMAPEVWK 174

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP 766
               + KSD++S G ++ E+ T  P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAP 199

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 86/287 (29%), Positives = 130/287 (45%), Gaps = 40/287 (13%)

Query: 564 VKITNNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSS-SAQGFQQFQAEVKLLMR 617
           VKI    E  +G G FG V  GRL      EI VA+K L S  + +  + F +E  ++ +
Sbjct: 6   VKI----EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 61

Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQG 675
             H N+  L G   +     +I EFM NG L  +L  +D    V+     LR     A G
Sbjct: 62  FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAG 118

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN--THVSTVVAGTP- 732
           ++YL    +   VHRD+ + NIL+N  L  K++DFGLS+    D +  T+ S++    P 
Sbjct: 119 MKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKG 790
            +  PE     + T  SDV+S+G+V+ E+++   +P     N++    I Q         
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ--------- 226

Query: 791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
                 D RL    D  +     +L + C     N RP   Q+V  L
Sbjct: 227 ------DYRLPPPMDCPTALH--QLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 61/219 (27%), Positives = 110/219 (50%), Gaps = 36/219 (16%)

Query: 573 TLGKGGFGTVYYGRLNEID-------VAVKML-SSSSAQGFQQFQAEVKLLMRV-HHRNL 623
            LG+G FG V       +D       VAVKML   ++ +      +E++++  +  H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSD--------------ISKKVLSSQERLRIA 669
            +L+G C ++    ++ E+ A+GNL+++L                  ++ L+ ++ +  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            + A+G+E+L +      +HRD+ + N+L+ E    K+ADFGL++    D + H+     
Sbjct: 139 YQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIH-HIDYYRK 190

Query: 730 GTPGYLD-----PEYYTSNRLTEKSDVYSFGVVILEIIT 763
            T G L      PE       T +SDV+SFGV++ EI T
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 70/232 (30%), Positives = 106/232 (45%), Gaps = 44/232 (18%)

Query: 569 NFERTLGKGGFGTVYYG---RLNEID---------------VAVKML-SSSSAQGFQQFQ 609
           NF   LG+G FG V+      L +                 VAVK+L   +S    + F 
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 610 AEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD---------ISKKVL 660
            EVK+L R+   N+  L+G C  D    +I E+M NG+L ++L            + K L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 661 SSQERLRIAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT 718
           S    L +A + A G+ YL   N      VHRD+ + N L+ +    K+ADFG+S+    
Sbjct: 128 SFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSR---- 178

Query: 719 DANTHVSTVVAGTP----GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CK 765
           +  +     V G       ++  E     + T KSDV++FGV + EI+T C+
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 56/194 (28%), Positives = 103/194 (53%), Gaps = 11/194 (5%)

Query: 574 LGKGGFGTVYYGRL-NEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVGHCD 631
           LGKG FG V+ G L ++  VAVK       Q  + +F +E ++L +  H N+  L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHR 690
           +     ++ E +  G+   +L    K  L +++ ++ A+++A G+ YL +  C    +HR
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESKNC----IHR 117

Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKS 749
           D+ + N L+ E    K++DFG+S+    D   + S+ +   P  +  PE     R + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 750 DVYSFGVVILEIIT 763
           DV+S+G+++ E  +
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 9/196 (4%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
             + LG G FG V+ G  N    VAVK L   +    + F  E +++ ++ H  L  L  
Sbjct: 10  LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYA 68

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L D   + L     + +A + A G+ Y+    +   +
Sbjct: 69  VVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 124

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD++S NIL+ + L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E++T
Sbjct: 183 KSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 2e-20
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 28/211 (13%)

Query: 570 FERT--LGKGGFGTVYYGR---LNEIDVAVKML-SSSSAQGFQQFQA--EVKLLMRVHHR 621
           +E+   LG+G +G VY  R     EI VA+K +   +  +G     A  E+ LL  + H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEI-VALKKIRLDNEEEGIPS-TALREISLLKELKHP 58

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           N+  L+     + +  L++E+    +L++YL       LS      I  +  +GL Y H+
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHS 116

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE--- 738
                I+HRD+K  NIL+N     KLADFGL+++F     T+   VV  T  Y  PE   
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILL 171

Query: 739 ---YYTSNRLTEKSDVYSFGVVILEIITCKP 766
              +Y++       D++S G +  E+IT KP
Sbjct: 172 GSKHYST-----AVDIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 91.3 bits (226), Expect = 3e-20
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 9/196 (4%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L   +    + F  E +++ ++ H  L  L  
Sbjct: 10  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 68

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+    +   V
Sbjct: 69  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 183 KSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 37/224 (16%)

Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLSSSSAQG-FQQFQAEVKLLMRVHHRNL 623
           +TLG+G FG V       +        VAVKML  +++    +   +E  LL +V+H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV-----------------------L 660
             L G C +D    LI E+   G+L+ +L + S+KV                       L
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRE-SRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
           +  + +  A + ++G++YL    +  +VHRD+ + N+L+ E  + K++DFGLS+    + 
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE- 180

Query: 721 NTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +++V       P  ++  E    +  T +SDV+SFGV++ EI+T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 59/196 (30%), Positives = 103/196 (52%), Gaps = 9/196 (4%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            +  LG+G FG V+ G  N    VA+K L   +    + F  E +++ ++ H  L  L  
Sbjct: 10  LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYA 68

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ EFM  G+L ++L +   K L   + + +A + A G+ Y+    +   +
Sbjct: 69  VVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ + L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E++T
Sbjct: 183 KSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 29/225 (12%)

Query: 572 RTLGKGGFGTVYYGRLN-------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNL 623
           R LG G FG VY G          E+ VAVK L  S S Q    F  E  ++ + +H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV-----LSSQERLRIAVESAQGLEY 678
             L+G   E     ++ E MA G+L+ +L +   +      L+ ++ L  A + A+G +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 679 LHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKS-FATD---ANTHVSTVVAGT 731
           L        +HRD+ + N LL  K     AK+ADFG+++  +              +   
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 732 PGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEE 774
           P    PE +     T K+DV+SFGV++ EI +    P   R N+E
Sbjct: 189 P----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.3 bits (224), Expect = 6e-20
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 15/202 (7%)

Query: 571 ERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLT 624
           E+ +G G FG V  GRL      EI VA+K L +  + +  + F +E  ++ +  H N+ 
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLHNG 682
            L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL + 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSD- 124

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYT 741
                VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE   
Sbjct: 125 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
             + T  SDV+S+G+V+ E+++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.7 bits (225), Expect = 6e-20
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 18/222 (8%)

Query: 572 RTLGKGGFGTVYYGRLNEID------VAVKMLSSSSAQGFQQ-FQAEVKLLMRVHHRNLT 624
           R LG+G FG V     +  +      VAVK L     Q     ++ E+ +L  ++H N+ 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 625 SLVGHCDE--DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C E       LI E++  G+L++YL    K  L+  + L  A +  +G+ YLH+ 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHS- 125

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
                +HRD+ + N+LL+     K+ DFGL+K+       +       +P +    E   
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 742 SNRLTEKSDVYSFGVVILEIIT-CKPAIS-RINEEEKIHIRQ 781
            N+ +  SDV+SFGV + E++T C    S     EE I  +Q
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ 225

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 60/244 (24%), Positives = 94/244 (38%), Gaps = 29/244 (11%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQG---FQQFQAEVKLLMRVHHRNLTSLV 627
           + KG +G V+  +     +I  A+K++  +         Q   E  +L +     +  L 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDI-YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPP 686
                     L+ E++  G+L   L ++    L          E    LEYLH NG    
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---- 113

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSK-------SFATDANTHVSTVVAGTPGYLDPEY 739
           I+HRD+K  NIL++     KL DFGLSK           D       +V GTP Y+ PE 
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEV 172

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR 799
                 ++  D +S G ++ E +   P       EE           I  G I+   D  
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF-------QNILNGKIEWPEDVE 225

Query: 800 LQED 803
           + ++
Sbjct: 226 VSDE 229

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 7/190 (3%)

Query: 574 LGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVGHC 630
           +G+G FG V+ GRL  +   VAVK    +     + +F  E ++L +  H N+  L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +     ++ E +  G+   +L     + L  +E +++   +A G+EYL +      +HR
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CIHR 118

Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+ + N L+ EK   K++DFG+S+            +      +  PE     R + +SD
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 751 VYSFGVVILE 760
           V+SFG+++ E
Sbjct: 179 VWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 90.8 bits (225), Expect = 1e-19
 Identities = 85/301 (28%), Positives = 143/301 (47%), Gaps = 51/301 (16%)

Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLS-SSSAQGFQQFQAEVKLLMRV--H 619
           + LG+G FG V       ID         VAVKML  +++ +      +E++L M++   
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL-MKLIGK 76

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQER 665
           H+N+ +L+G C ++    +I E+ A GNL+E+L              + + ++ LS ++ 
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 666 LRIAVESAQGLEYLHNG-CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           +  A + A+G+EYL +  C    +HRD+ + N+L+ E    K+ADFGL++    D + + 
Sbjct: 137 VSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARG-VHDIDYYK 191

Query: 725 STVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQW 782
            T     P  ++ PE       T +SDV+SFG+++ EI T   +    I  EE       
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE------- 244

Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
           +  L+ +G          + D  +N   +   L   C      QRPT  Q+V  L + LA
Sbjct: 245 LFKLLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295

Query: 843 A 843
           A
Sbjct: 296 A 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 11/194 (5%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           LGKGGFG V   ++       A K L        +G Q    E K+L +V  R + SL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
             +  +   L+   M  G+L+ ++ ++ +        +  A +   GLE+LH      IV
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIV 117

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           +RD+K  N+LL++    +++D GL+               AGTPGY+ PE          
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYDFS 174

Query: 749 SDVYSFGVVILEII 762
            D ++ G  + E+I
Sbjct: 175 VDWFALGCTLYEMI 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 570 FERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQ---FQA--EVKLLMRVHHRN 622
             + LG+G +  VY  R  E    VA+K +     +  +    F A  E+KLL  + H N
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L+      +   L++EFM   +L++ + D    VL+  +     + + +GLEYLH+ 
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIKD-KSIVLTPADIKSYMLMTLRGLEYLHSN 121

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE---- 738
               I+HRD+K  N+L+      KLADFGL++SF +        VV  T  Y  PE    
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELLFG 176

Query: 739 --YYTSNRLTEKSDVYSFGVVILEIITCKP 766
             +Y         D++S G +  E++   P
Sbjct: 177 ARHYGVG-----VDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 90.1 bits (223), Expect = 2e-19
 Identities = 79/298 (26%), Positives = 136/298 (45%), Gaps = 47/298 (15%)

Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLSSSSA-QGFQQFQAEVKLLMRV-HH 620
           + LG+G FG V       ID         VAVKML   +  +      +E++++  +  H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLS--------------DISKKVLSSQERL 666
           +N+ +L+G C +D    ++ E+ + GNL+EYL                + ++ L+ ++ +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL        +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD-VHNIDYYKKT 193

Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LF 246

Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L 
Sbjct: 247 KLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 75/279 (26%), Positives = 118/279 (42%), Gaps = 30/279 (10%)

Query: 567 TNNFERT-LGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL 623
             N ER  LGKG +G VY  R    ++ +A+K +    ++  Q    E+ L   + HRN+
Sbjct: 8   DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ---GLEYLH 680
              +G   E+    +  E +  G+L   L   SK          I   + Q   GL+YLH
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           +     IVHRD+K  N+L+N      K++DFG SK  A   N    T   GT  Y+ PE 
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTET-FTGTLQYMAPEV 180

Query: 740 YTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
                      +D++S G  I+E+ T KP    + E +         ++   G  K  + 
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--------AMFKVGMFK--IH 230

Query: 798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME 836
           P + E   A     A    + C  P  ++R +   ++ +
Sbjct: 231 PEIPESLSAE----AKNFILRCFEPDPDKRASAHDLLQD 265

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 14/197 (7%)

Query: 572 RTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVG 628
             LG+G  G+V   RL    +  A+K +++      Q Q   E+++        +    G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 629 HC--DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER--LRIAVESAQGLEYLHNGCK 684
               +  +   +  E+   G+L      + K+     E+   +IA    +GL YLH+   
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--- 123

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I+HRD+K +NILL  K Q KL DFG+S       N+   T   GT  Y+ PE      
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL---VNSLAGTFT-GTSFYMAPERIQGKP 179

Query: 745 LTEKSDVYSFGVVILEI 761
            +  SDV+S G+ +LE+
Sbjct: 180 YSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 44/280 (15%)

Query: 574 LGKGGFGTVYYGRLNEID---VAVKM--LSSSSAQG-------FQQFQAEVKLLMRVHHR 621
           +G G FG+VY G +N      +AVK   L S SA               E+ LL  + H 
Sbjct: 8   IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL--RIAVESAQGLEYL 679
           N+   +G   + +   +  E++  G++   L++      + +E L      +  +GL YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYL 122

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK-----SFATDANTHVSTVVAGTPGY 734
           HN     I+HRD+K  NIL++ K   K++DFG+SK     S +T  N    + + G+  +
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178

Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS 794
           + PE       T K+D++S G +++E++T K       + + I              I  
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF------------KIGE 226

Query: 795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
              P    +  +N   +A++          N+RPT ++++
Sbjct: 227 NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 87.7 bits (217), Expect = 4e-19
 Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 20/204 (9%)

Query: 572 RTLGKGGFGTVYYGR---------LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN 622
           + +G+G FG +Y  +         + EID+    +    A      + EV LL ++ H N
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-----KKEVILLAKMKHPN 60

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           + +      E+ +  ++ E+   G+L + ++     + S  + L   V+ + GL+++H+ 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD- 119

Query: 683 CKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
               I+HRD+KS NI L++  + AKL DFG+++    + +  ++    GTP YL PE   
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPEICQ 175

Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
           +     K+D++S G V+ E+ T K
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 11/197 (5%)

Query: 574 LGKGGFGTVYYGRLNE-----IDVAVKMLSSSSAQGFQQ-FQAEVKLLMRVHHRNLTSLV 627
           LG G FG V  G  +      I VAVK L S         F  E  ++  + H NL  L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G     +   ++ E    G+L + L   +            AV+ A G+ YL        
Sbjct: 63  GVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+ + NILL    + K+ DFGL ++   + + +V       P  +  PE   +   +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 747 EKSDVYSFGVVILEIIT 763
             SDV+ FGV + E+ T
Sbjct: 179 HASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 88.5 bits (219), Expect = 5e-19
 Identities = 77/297 (25%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLS-SSSAQGFQQFQAEVKLLMRV-HH 620
           + LG+G FG V       ID         VAVKML   ++ +      +E++++  +  H
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + +  + ++ ++ +
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL        +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-VNNIDYYKKT 196

Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 249

Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     + RPT  Q+V +L   L
Sbjct: 250 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 5e-19
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)

Query: 574 LGKGGFGTVYYGRLNEID---VAVK-MLSSSSAQGFQQFQA-EVKLLMRVHHRNLTSL-- 626
           +G+G +G VY  R N+     VA+K +   +  +GF      E+KLL ++ H N+  L  
Sbjct: 7   IGEGTYGQVYKAR-NKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKP 685
           +          +++E+M + +L   L     K   SQ +     +  +GL+YLH NG   
Sbjct: 66  IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK-CYMKQLLEGLQYLHSNG--- 120

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNR 744
            I+HRD+K +NIL+N     KLADFGL++ +    +   +  V  T  Y  PE    + R
Sbjct: 121 -ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATR 178

Query: 745 LTEKSDVYSFGVVILEIITCKP 766
              + D++S G ++ E+   KP
Sbjct: 179 YGPEVDMWSVGCILAELFLGKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 27/264 (10%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQG-FQQFQAEVKLLMRVHHRNLTSLVGHC 630
           +GKG FG V+ G  N     VA+K++    A+   +  Q E+ +L +     +T   G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +D +  +I E++  G+  + L       L   +   I  E  +GL+YLH+  K   +HR
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKK---IHR 125

Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+K+ N+LL+E  + KLADFG++    TD     +T V GTP ++ PE    +    K+D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 183

Query: 751 VYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVW 810
           ++S G+  +E+   +P  S ++  + +        LI K +      P L+ ++      
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLF-------LIPKNN-----PPTLEGNYSK---- 227

Query: 811 KAVELAMACLSPTGNQRPTMSQVV 834
              E   ACL+   + RPT  +++
Sbjct: 228 PLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 75/289 (25%), Positives = 134/289 (46%), Gaps = 56/289 (19%)

Query: 577 GGFGTVYYGRLNEI------DVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGH 629
           G FG ++YG L +       +V VK +   +++        E  LL  + H+N+  ++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 630 CDEDNQTALI-YEFMANGNLQEYLSD------ISKKVLSSQERLRIAVESAQGLEYLHNG 682
           C ED +   + Y +M  GNL+ +L         + + LS+Q+ + +A++ A G+ YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATD-------ANTHVSTVVAGTPGY 734
            K  ++H+D+ + N +++E+LQ K+ D  LS+  F  D        N  V         +
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK--------W 185

Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIK 793
           +  E   +   +  SDV+SFGV++ E++T  +     I+  E       + + +  G   
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYLKDGY-- 236

Query: 794 SIVDPRLQEDFDANSVWKAVELAMAC---LSPTGNQRPTMSQVVMELSE 839
                RL +  +      AV   MAC   L P   +RP+ SQ+V  L++
Sbjct: 237 -----RLAQPINCPDELFAV---MACCWALDP--EERPSFSQLVQCLTD 275

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 21/209 (10%)

Query: 572 RTLGKGGFGTVYYGRLNEID----VAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTS 625
           +TLG+G FG+V  G+LN+ D    VAVK +  +  +    + F +E   +    H N+  
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 626 LVGHCDEDNQT------ALIYEFMANGNLQEYL--SDISKK--VLSSQERLRIAVESAQG 675
           L+G C +  ++       +I  FM +G+L  +L  S +      L +Q  ++   + A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GY 734
           +EYL +      +HRD+ + N +LNE +   +ADFGLSK    + + +    +A  P  +
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVKW 180

Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +  E       T KSDV+SFGV + EI T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 13/206 (6%)

Query: 574 LGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD 631
           LG G FG VY  +  E  +  A K++   S +  + F  E+ +L    H N+  L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +N+  ++ EF   G L   + ++ + +   Q R  +  +  + L +LH+     ++HRD
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHRD 128

Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY-----YTSNRLT 746
           +K+ NILL      KLADFG+S    +      + +  GTP ++ PE      +  N   
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKDNPYD 186

Query: 747 EKSDVYSFGVVILEIITCKPAISRIN 772
            K+D++S G+ ++E+   +P    +N
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)

Query: 567 TNNF--ERTLGKGGFGTVYYGR--LNEIDVA---VKMLSSSSAQGFQQFQAEVKLLMRVH 619
             NF  E+ +GKG F  VY     L+   VA   V++     A+  Q    E+ LL ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL-------RIAVES 672
           H N+   +    E+N+  ++ E    G+L   +     K    Q+RL       +  V+ 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTIWKYFVQL 115

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
              LE++H      I+HRD+K  N+ +      KL D GL + F++      S V  GTP
Sbjct: 116 CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTP 170

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
            Y+ PE    N    KSD++S G ++ E+     A+      +K+++       I K D 
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKK-IEKCDY 225

Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
             +      E+          +L   C++P   +RP +S V
Sbjct: 226 PPLPADHYSEELR--------DLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 69/298 (23%), Positives = 122/298 (40%), Gaps = 50/298 (16%)

Query: 568 NNFER--TLGKGGFGTVYYGR---LNEIDVAVK-MLSSSSAQGFQQF-QAEVKLLMRVHH 620
           N +E    +G+G +G V   R     EI VA+K    S   +  ++    EVK+L ++ H
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEI-VAIKKFKESEDDEDVKKTALREVKVLRQLRH 59

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+ +L        +  L++E++    L E L + S   L          +  Q + Y H
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVER-TLLELL-EASPGGLPPDAVRSYIWQLLQAIAYCH 117

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NIL++E    KL DFG +++      + ++  VA T  Y  PE  
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELL 173

Query: 741 TSNRLTEKS-DVYSFGVVILEIITCKPAISRINEEEKI-HIRQWVNSLIAKGDIKSIVDP 798
             +    K  DV++ G ++ E++  +P     ++ +++  I++ +  L           P
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP----------P 223

Query: 799 RLQEDFDANSVW------------------------KAVELAMACLSPTGNQRPTMSQ 832
             QE F +N  +                         A++   ACL     +R T  +
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 19/207 (9%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKML-----SSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           + LG+G FG VY  Y      ++AVK +     S  +++     + E++LL  + H  + 
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 625 SLVGHC---DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
              G C    E+ + ++  E+M  G++++ L   +   L+     R   +  QG+ YLH+
Sbjct: 68  QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHS 124

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT--DANTHVSTVVAGTPGYLDPEY 739
                IVHRD+K  NIL +     KL DFG SK   T   + T + + V GTP ++ PE 
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEV 180

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKP 766
            +      K+DV+S    ++E++T KP
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 31/224 (13%)

Query: 570 FERTLGKGGFGTVYYGRL-----------NEID-----VAVKML-SSSSAQGFQQFQAEV 612
            +  LG+G FG V+                E D     VAVKML +  +      F  E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 613 KLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKV--------LSS 662
           K++ R+ + N+  L+G C  D+   +I E+M NG+L ++LS  +I            +S 
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 663 QERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
              L +AV+ A G++YL        VHRD+ + N L+      K+ADFG+S++  +    
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CK 765
            +         ++  E     + T  SDV++FGV + E+ T CK
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 17/212 (8%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQGFQQFQA-EVKLLMRVHHRNLTSLVGH 629
           LG+G + TVY GR     EI VA+K +   + +G       E+ L+  + H N+  L   
Sbjct: 8   LGEGTYATVYKGRNRTTGEI-VALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLH-NGCKPP 686
              +N+  L++E+M + +L++Y+ D    +  L          +  +G+ + H N     
Sbjct: 67  IHTENKLMLVFEYM-DKDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---- 120

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           ++HRD+K  N+L+N++ + KLADFGL+++F    NT  + VV  T  Y  P+    +R  
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTY 178

Query: 747 EKS-DVYSFGVVILEIITCKPAISRINEEEKI 777
             S D++S G ++ E+IT +P     N E+++
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 29/269 (10%)

Query: 574 LGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD 631
           LG G FG VY  +  E  V  A K++ + S +  + +  E+ +L    H N+  L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +N   ++ EF A G +   + ++ + +   Q R+ +  ++ + L YLH      I+HRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIHRD 128

Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE---- 747
           +K+ NIL       KLADFG+S           S +  GTP ++ PE        +    
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPYD 186

Query: 748 -KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP-RLQEDFD 805
            K+DV+S G+ ++E+   +P    +N          V   IAK +  ++  P R   +F 
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWSSEFK 239

Query: 806 ANSVWKAVELAMACLSPTGNQRPTMSQVV 834
                   +    CL    + R T +Q++
Sbjct: 240 --------DFLKKCLEKNVDARWTTTQLL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 71/243 (29%), Positives = 106/243 (43%), Gaps = 40/243 (16%)

Query: 606 QQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           +Q   E++++       + S  G    +N   +  EFM  G+L      I KK       
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR----IYKKGGPIPVE 103

Query: 666 L--RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANT 722
           +  +IAV   +GL YL+N     I+HRD+K +NIL+N + Q KL DFG+S       A+T
Sbjct: 104 ILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161

Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
            V     GT  Y+ PE     + T KSDV+S G+ I+E+   K   +  N ++       
Sbjct: 162 FV-----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------ 210

Query: 783 VNSLIAKGDIKSIVD----------PRL-QEDFDANSVWKAVELAMACLSPTGNQRPTMS 831
                 + D   I+D          PRL   DF  +      +   ACL     +RPT  
Sbjct: 211 -----GQDDPMGILDLLQQIVQEPPPRLPSSDFPED----LRDFVDACLLKDPTERPTPQ 261

Query: 832 QVV 834
           Q+ 
Sbjct: 262 QLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 74/267 (27%), Positives = 125/267 (46%), Gaps = 33/267 (12%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQG-FQQFQAEVKLLMRVHHRNLTSLVGHC 630
           +GKG FG V+ G  N     VA+K++    A+   +  Q E+ +L +     +T   G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV---ESAQGLEYLHNGCKPPI 687
            +  +  +I E++  G+  + L           +  +IA    E  +GL+YLH+  K   
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLR------AGPFDEFQIATMLKEILKGLDYLHSEKK--- 122

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+K+ N+LL+E+   KLADFG++    TD     +T V GTP ++ PE    +    
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180

Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDAN 807
           K+D++S G+  +E+   +P  S ++          V  LI K +      P L  +F   
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLIPKNN-----PPTLTGEFSKP 228

Query: 808 SVWKAVELAMACLSPTGNQRPTMSQVV 834
                 E   ACL+   + RPT  +++
Sbjct: 229 ----FKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 86.4 bits (214), Expect = 4e-18
 Identities = 68/237 (28%), Positives = 114/237 (48%), Gaps = 48/237 (20%)

Query: 544 SKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYY------GRLNEIDVAVKML 597
           S +   S  A S   S S++ ++       +G G  GTVY       GRL     A+K++
Sbjct: 57  SSSSSASGSAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRL----YALKVI 107

Query: 598 SSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL-------Q 649
             +     + Q   E+++L  V+H N+       D + +  ++ EFM  G+L       +
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE 167

Query: 650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD 709
           ++L+D+++++LS             G+ YLH   +  IVHRD+K +N+L+N     K+AD
Sbjct: 168 QFLADVARQILS-------------GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIAD 211

Query: 710 FGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE------KSDVYSFGVVILE 760
           FG+S+  A   +   S+V  GT  Y+ PE   ++ L          D++S GV ILE
Sbjct: 212 FGVSRILAQTMDPCNSSV--GTIAYMSPERINTD-LNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 6e-18
 Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 31/240 (12%)

Query: 573 TLGKGGFGTVYYGRLNEID--VAVKMLS-SSSAQGFQQFQAEVKLLMRVHH---RNLTSL 626
            +G+G +G VY G+       VA+K+++  +        Q EV LL ++      N+T  
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            G   +  +  +I E+   G+++  +    I++K +S   R     E    L+Y+H   K
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIH---K 119

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K+ NIL+      KL DFG++       N+   +   GTP ++ PE  T  +
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEVITEGK 177

Query: 745 LTE-KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED 803
             + K+D++S G+ I E+ T  P  S ++    +        LI K        PRL+++
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKSK-----PPRLEDN 225

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 7e-18
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 569 NFER--TLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQ---AEVKLLMRVHHR 621
           + ER  T+G G FG V+  R  ++E   A+K+++       +Q Q    E ++L  V H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
            +  L     +     ++ E++  G L  YL   +    S+   L  A E    LEYLH+
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHS 119

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                IV+RD+K  NILL+++   KL DFG +K       T     + GTP YL PE   
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPEVIQ 171

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP 766
           S    +  D ++ G++I E++   P
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 14/215 (6%)

Query: 562 DVVKITNNFERTLGKGGFGTVYYG---RLNEIDVAVKMLSSSSAQG-FQQFQAEVKLLMR 617
           D  ++    ER +GKG FG VY G   R  E+ VA+K++    A+   +  Q E+ +L +
Sbjct: 1   DPEELFTKLER-IGKGSFGEVYKGIDNRTKEV-VAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
                +T   G   +  +  +I E++  G+  + L       L       I  E  +GL+
Sbjct: 59  CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLD 115

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           YLH+  K   +HRD+K+ N+LL+E+   KLADFG++    TD     +T V GTP ++ P
Sbjct: 116 YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAP 170

Query: 738 EYYTSNRLTEKSDVYSFGVVILEIITCKPAISRIN 772
           E    +    K+D++S G+  +E+   +P  S ++
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 12/197 (6%)

Query: 572 RTLGKGGFGTVYYG-----RLNEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRNLTS 625
           R +G+G FG VY G        +I VAVK   + ++    ++F  E  ++ +  H ++  
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G    +N   ++ E    G L+ YL  ++K  L     +  + + +  L YL +    
Sbjct: 72  LIGVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D + + ++       ++ PE     R 
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 186 TSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 83.9 bits (207), Expect = 9e-18
 Identities = 69/273 (25%), Positives = 130/273 (47%), Gaps = 32/273 (11%)

Query: 570 FERTLGKGGFGTV---YYGRLNEIDVAVKM-LSSSSAQGFQQFQAEVKLLMRVHHRNLTS 625
           F R +GKG +G V    +    +  V  K+ L ++S +  +  + E +LL ++ H N+ +
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 626 LVGHCD-EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
                + ED    ++  F   G+L   L +   K+L   + +   V+ A  L+YLH   +
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---E 120

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I+HRD+K+ N+ L      K+ D G+++    +     ST++ GTP Y+ PE +++  
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLI-GTPYYMSPELFSNKP 178

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD---PRLQ 801
              KSDV++ G  + E+ T K A +  +          +NSL+ +     I++   P + 
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKD----------MNSLVYR-----IIEGKLPPMP 223

Query: 802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           +D+      +  EL    LS    +RP++  ++
Sbjct: 224 KDYSP----ELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 66/196 (33%), Positives = 98/196 (50%), Gaps = 18/196 (9%)

Query: 570 FERTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSL 626
           ++  LG G  GTVY  Y  L    +AVK++        Q Q  +E+++L +     +   
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G    +N+ ++  EFM  G+L  Y   I + VL      RIAV   +GL YL    K  
Sbjct: 65  YGAFFVENRISICTEFMDGGSLDVYRK-IPEHVLG-----RIAVAVVKGLTYLW-SLK-- 115

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVAGTPGYLDPEYYTSNRL 745
           I+HRDVK +N+L+N + Q KL DFG+S       A T+V     GT  Y+ PE  +  + 
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQY 170

Query: 746 TEKSDVYSFGVVILEI 761
              SDV+S G+  +E+
Sbjct: 171 GIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLVGH 629
           +G+G  G V+  +  E    VA+K ++    +G    QA  E+K L    H  +  L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIV 688
               +   L+ E+M +  L E L D  +  L   +         +G+ Y+H NG    I+
Sbjct: 68  FPHGSGFVLVMEYMPSD-LSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHANG----IM 121

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-YYTSNRLTE 747
           HRD+K  N+L++     K+ADFGL++ F+ +     S  VA T  Y  PE  Y + +   
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARKYDP 180

Query: 748 KSDVYSFGVVILEIITCKP 766
             D+++ G +  E++   P
Sbjct: 181 GVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 17/206 (8%)

Query: 572 RTLGKGGFGTVYY------GR-LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           + LG+G FG VY       GR L    V     S  +++     + E++LL  + H  + 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 625 SLVGHC--DEDNQTALIY-EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
              G C  D   +T  I+ E+M  G++++ L   +   L+     +   +  +G+ YLH+
Sbjct: 68  QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHS 124

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST-VVAGTPGYLDPEYY 740
                IVHRD+K  NIL +     KL DFG SK   T   +      V GTP ++ PE  
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
           +      K+DV+S G  ++E++T KP
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 25/270 (9%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVK---MLSSSSAQGFQQFQAEVKLLMRVHHRNLTS 625
           E+ +G+G F  VY     L+   VA+K   +     A+  Q    E+ LL +++H N+  
Sbjct: 7   EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL--RIAVESAQGLEYLHNGC 683
            +    EDN+  ++ E    G+L + +    K+     ER   +  V+    +E++H+  
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-- 124

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              ++HRD+K  N+ +      KL D GL + F++      S V  GTP Y+ PE    N
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHEN 181

Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED 803
               KSD++S G ++ E+     A+      +K+++     SL  K  I+    P L  +
Sbjct: 182 GYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLF----SLCQK--IEQCDYPPLPTE 231

Query: 804 FDANSVWKAVELAMACLSPTGNQRPTMSQV 833
             +    K  EL   C+ P  +QRP +  V
Sbjct: 232 HYSE---KLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 35/275 (12%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHC 630
           +G G +G VY GR  +     A+K++  +  +  ++ + E+ +L +  HHRN+ +  G  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 631 DE------DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            +      D+Q  L+ EF   G++ + + +     L  +    I  E  +GL +LH   +
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---Q 129

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K  N+LL E  + KL DFG+S     D          GTP ++ PE    + 
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 745 LTE-----KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR 799
             +     KSD++S G+  +E+    P +  ++    + +            I     PR
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------------IPRNPAPR 235

Query: 800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           L+    +      +E   +CL    +QRPT  Q++
Sbjct: 236 LKSKKWSKKFQSFIE---SCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 83.8 bits (207), Expect = 2e-17
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 46/236 (19%)

Query: 570 FERTLGKGGFGTVYYGRLNEID---------------------VAVKML-SSSSAQGFQQ 607
           F+  LG+G FG V+   L E+                      VAVK+L   ++      
Sbjct: 9   FKEKLGEGQFGEVH---LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65

Query: 608 FQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLS-------------- 653
           F  EVK+L R+   N+  L+G C +++   +I E+M NG+L ++LS              
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 654 ---DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF 710
                    +S    L +A++ A G++YL +      VHRD+ + N L+ E L  K+ADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADF 182

Query: 711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CK 765
           G+S++        +         ++  E     + T  SDV++FGV + EI+  CK
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 56/234 (23%)

Query: 567 TNNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRV---- 618
           T  FE    +G+G +G VY  R  +    VA+K++     +     + E+K    +    
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-----EEEIKEEYNILRKY 59

Query: 619 -HHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR---- 667
            +H N+ +  G          D+Q  L+ E    G++    +D+ K +    +RL+    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV----TDLVKGLRKKGKRLKEEWI 115

Query: 668 --IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS---KSFATDANT 722
             I  E+ +GL YLH      ++HRD+K  NILL +  + KL DFG+S    S     NT
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 723 HVSTVVAGTPGYLDPE----------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
            +     GTP ++ PE           Y +     +SDV+S G+  +E+   KP
Sbjct: 173 FI-----GTPYWMAPEVIACDEQPDASYDA-----RSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 59/229 (25%), Positives = 110/229 (48%), Gaps = 17/229 (7%)

Query: 551 FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQQF 608
           +E   R L  ++V +I       LG G FG VY  +  E     A K++ + S +  + +
Sbjct: 1   YEHVRRDLDPNEVWEIIGE----LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 56

Query: 609 QAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI 668
             E+++L   +H  +  L+G    D +  ++ EF   G +   + ++ + +   Q ++ I
Sbjct: 57  MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-I 115

Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
             +  + L+YLH+     I+HRD+K+ N+LL      KLADFG+S           S + 
Sbjct: 116 CRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI- 171

Query: 729 AGTPGYLDPEYYTSNRLTE-----KSDVYSFGVVILEIITCKPAISRIN 772
            GTP ++ PE      + +     K+D++S G+ ++E+   +P    +N
Sbjct: 172 -GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 83.6 bits (206), Expect = 2e-17
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 12/199 (6%)

Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K+L+ ++  +   +F  E  ++  + H +L 
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C       L+ + M +G L +Y+ +  K  + SQ  L   V+ A+G+ YL    +
Sbjct: 73  RLLGVCLSPT-IQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---E 127

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL++    D   + +        ++  E     +
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187

Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV I E++T
Sbjct: 188 FTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 9/196 (4%)

Query: 570 FERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            E+ LG G FG V+    N+   VAVK +   S    + F AE  ++  + H  L  L  
Sbjct: 10  LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 68

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              ++    +I EFMA G+L ++L           + +  + + A+G+ ++    +   +
Sbjct: 69  VVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 124

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL++  L  K+ADFGL++    + N + +   A  P  +  PE       T 
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG++++EI+T
Sbjct: 183 KSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKML-----SSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           + LG+G FG VY  Y      ++AVK +     S  +++     + E++LL  + H  + 
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 625 SLVGHCDEDNQT---ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
              G C  D      ++  E M  G++++ L   S   L+     +   +  +G+ YLH+
Sbjct: 68  QYYG-CLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYLHS 124

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD--ANTHVSTVVAGTPGYLDPEY 739
                IVHRD+K  NIL +     KL DFG SK   T   + T + + V GTP ++ PE 
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEV 180

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKP 766
            +      K+D++S G  ++E++T KP
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 18/217 (8%)

Query: 569 NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQ---AEVKLLMRVHHRNL 623
            F +TLG G FG V   R        A+K+LS +     +Q +    E ++L  + H  L
Sbjct: 4   EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
            +L G   +D+   L+ E++  G L  +L    +           A +    LEYLH+  
Sbjct: 64  VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHS-L 120

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              IV+RD+K  N+LL+     K+ DFG +K       T     + GTP YL PE   S 
Sbjct: 121 D--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEYLAPEIILSK 173

Query: 744 RLTEKSDVYSFGVVILEIITCKP---AISRINEEEKI 777
              +  D ++ G++I E++   P     + I   EKI
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 70/274 (25%), Positives = 126/274 (45%), Gaps = 27/274 (9%)

Query: 569 NF--ERTLGKGGFGTVYYGR--LNEIDVAVK---MLSSSSAQGFQQFQAEVKLLMRVHHR 621
           NF  E+ +G+G F  VY     L+ + VA+K   +     A+       E+ LL +++H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK--KVLSSQERLRIAVESAQGLEYL 679
           N+        EDN+  ++ E    G+L   +    K  +++  +   +  V+    LE++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           H+     ++HRD+K  N+ +      KL D GL + F++      S V  GTP Y+ PE 
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPER 177

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR 799
              N    KSD++S G ++ E+     A+      +K+++     SL  K  I+    P 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLY----SLCKK--IEQCDYPP 227

Query: 800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
           L  D  +  + + V +   C++P   +RP ++ V
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 82.3 bits (203), Expect = 7e-17
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 12/199 (6%)

Query: 572 RTLGKGGFGTVYYGRLN------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L  ++S +  ++   E  ++  V + ++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL    +
Sbjct: 73  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---E 127

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    D   + +        ++  E      
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187

Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 188 YTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.1 bits (200), Expect = 9e-17
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 28/210 (13%)

Query: 574 LGKGGFGTVYYGRLNEIDV------AVKMLS----SSSAQG--FQQFQAEVKLLMRVHHR 621
           LG G F + Y  R    DV      AVK ++    +SS Q    +  + E++L+ R++H 
Sbjct: 8   LGTGAFSSCYQAR----DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV--ESAQGLEYL 679
           ++  ++G   ED+   L  E+MA G++   LS       + +E + I    +  +GL YL
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYL 119

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQ-AKLADFGLSKSFATDAN--THVSTVVAGTPGYLD 736
           H      I+HRDVK  N+L++   Q  ++ADFG +   A            + GT  ++ 
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           PE     +     DV+S G VI+E+ T KP
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 52/193 (26%), Positives = 101/193 (52%), Gaps = 11/193 (5%)

Query: 574 LGKGGFGTVYYG----RLNEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVG 628
           LG G FG V  G    R  +IDVA+K+L + + +  + +   E +++ ++ +  +  ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
            C+ +    L+ E  + G L ++LS   K  ++    + +  + + G++YL        V
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+ + N+LL  +  AK++DFGLSK+   D + + +      P  +  PE     + + 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 748 KSDVYSFGVVILE 760
           +SDV+S+G+ + E
Sbjct: 178 RSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.0 bits (201), Expect = 1e-16
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 50/217 (23%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQA--------EVKLLMRV-HHRN 622
           LG G FG+VY  R  E    VA+K +        ++F +        EVK L ++  H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLH- 680
           +  L     E+++   ++E+M  GNL + + D   K  S    +R I  +  QGL ++H 
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSE-SVIRSIIYQILQGLAHIHK 117

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA-----TDANTHVSTVVAGTPGYL 735
           +G      HRD+K  N+L++     K+ADFGL++        TD   +VS     T  Y 
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD---YVS-----TRWYR 165

Query: 736 DPE------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE       Y+S       D+++ G ++ E+ T +P
Sbjct: 166 APEILLRSTSYSS-----PVDIWALGCIMAELYTLRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 83.4 bits (206), Expect = 1e-16
 Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 33/230 (14%)

Query: 571 ERTLGKGGFGTVYYGRLNEID--VAVKM--LSSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
            R LG G  GTV   +        AVK+  +   S     + QAEV  L+     +  S+
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC---DFFSI 93

Query: 627 VGHCDED------------NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
           V  C ED               AL+ ++   G+L++ +   +K         R   E   
Sbjct: 94  V-KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-------RTFREHEA 145

Query: 675 GLEYL------HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
           GL ++      H+     ++HRD+KS NILL      KL DFG SK +A   +  V    
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205

Query: 729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH 778
            GTP Y+ PE +     ++K+D++S GV++ E++T K      N EE +H
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255

Length = 496

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 62/242 (25%), Positives = 115/242 (47%), Gaps = 31/242 (12%)

Query: 567 TNNFERTLGKGGFGTVYYGRL-------NEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRV 618
           T  F   LG+  FG VY G L           VA+K L   +     ++F+ E  +  R+
Sbjct: 6   TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------SDIS--------KKVLSSQE 664
            H N+  L+G   ++   ++I+ + ++ +L E+L      SD+         K  L   +
Sbjct: 66  QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125

Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTH 723
            + I  + A G+E+L +     +VH+D+ + N+L+ +KL  K++D GL +  +A D    
Sbjct: 126 FVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182

Query: 724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEE--EKIHI 779
           +   +     ++ PE     + +  SD++S+GVV+ E+ +   +P     N++  E I  
Sbjct: 183 MGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241

Query: 780 RQ 781
           RQ
Sbjct: 242 RQ 243

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 11/209 (5%)

Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVGHC 630
           LG+G + TVY GR  L +  VA+K +     +G       EV LL  + H N+ +L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
             +    L++E++ + +L++YL D    +     +L +  +  +GL Y H   +  ++HR
Sbjct: 74  HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCH---RRKVLHR 128

Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKS 749
           D+K  N+L+NE+ + KLADFGL+++ +    T+ + VV  T  Y  P+    S   + + 
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQI 186

Query: 750 DVYSFGVVILEIITCKPAISRINEEEKIH 778
           D++  G +  E+ T +P       EE++H
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 31/214 (14%)

Query: 572 RTLGKGGFGTVYYGRLN-------EIDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHRNL 623
           R LG+G FG VY G          E  VA+K ++ ++S +   +F  E  ++   +  ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESAQG 675
             L+G   +   T +I E M  G+L+ YL  +  ++ ++        ++ +++A E A G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTVVAGTPG- 733
           + YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD          G  G 
Sbjct: 132 MAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK------GGKGL 182

Query: 734 ----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
               ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 47/289 (16%)

Query: 574 LGKGGFGTVYYGRLNEI----DVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           +G G FG V  G  +       V VK L +S++      F  EV+    ++H N+   +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 629 HCDEDNQTALIYEFMANGNLQEYL-SDISKKVLSSQERL--RIAVESAQGLEYLHNGCKP 685
            C E     L+ EF   G+L+ YL S+       +Q+ +  R+A E A GL +LH   + 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKS------FATDANTHVSTVVAGTPGYLDPEY 739
             +H D+   N  L   L  K+ D+GL+        + T  + H   +      +L PE 
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK-DCHAVPL-----RWLAPEL 173

Query: 740 YTS-------NRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKG 790
                        T+KS+++S GV + E+ T   +P     +E       Q +  ++ + 
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQ 226

Query: 791 DIKSIVDPRLQEDFDANSVWKAVELAMAC-LSPTGNQRPTMSQVVMELS 838
           DIK    P+ Q D   +  W   E+   C L P    RPT  +V   L+
Sbjct: 227 DIKL---PKPQLDLKYSDRW--YEVMQFCWLDP--ETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 59/210 (28%), Positives = 109/210 (51%), Gaps = 11/210 (5%)

Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVGHC 630
           LG+G + TV+ GR  L E  VA+K +     +G       EV LL  + H N+ +L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
             D    L++E++ + +L++Y+ D    ++S         +  +GL Y H   +  ++HR
Sbjct: 74  HTDKSLTLVFEYL-DKDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCH---RRKVLHR 128

Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKS 749
           D+K  N+L+NE+ + KLADFGL+++ +    T+ + VV  T  Y  P+    S+  + + 
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQI 186

Query: 750 DVYSFGVVILEIITCKPAISRINEEEKIHI 779
           D++  G +  E+ + +P       E+++H+
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHL 216

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 33/238 (13%)

Query: 570 FERTLGKGGFGTVYY----GRLNEID--------------VAVKMLSSSSAQGFQQ-FQA 610
           F+  LG+G FG V+     G    +D              VAVKML   + +  +  F  
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLS--------DISKKVLSS 662
           E+K++ R+   N+  L+  C   +   +I E+M NG+L ++LS        + +  V  S
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 663 QERLR-IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN 721
              L  +A + A G++YL +      VHRD+ + N L+ +    K+ADFG+S++  +   
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPA-ISRINEEEKI 777
             +         ++  E     + T  SDV++FGV + EI+T CK    S++++E+ I
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 13/211 (6%)

Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVGHC 630
           LG+G + TV+ GR  L E  VA+K +     +G       EV LL  + H N+ +L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNGCKPPIVH 689
             +    L++E++ + +L++YL +     L S   ++I + +  +GL Y H   K  I+H
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILH 126

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEK 748
           RD+K  N+L+NEK + KLADFGL+++ +    T+ + VV  T  Y  P+    S   +  
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYSTP 184

Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHI 779
            D++  G ++ E+ T +P       +E++H+
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 70/275 (25%), Positives = 127/275 (46%), Gaps = 30/275 (10%)

Query: 569 NFE--RTLGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL 623
           +FE  + +G G +G VY  R     E+  A+K++     + F   Q E+ ++    H N+
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGEL-AAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
            +  G     ++  +  EF   G+LQ+         LS  +   ++ E+ QGL YLH+  
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKG 126

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
           K   +HRD+K  NILL +    KLADFG+S           S +  GTP ++ PE     
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVE 181

Query: 744 R---LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
           R     +  D+++ G+  +E+   +P +  ++    +        L+ K + +    P+L
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMTKSNFQP---PKL 231

Query: 801 QEDFD-ANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           ++    +NS    V++A   L+    +RPT  +++
Sbjct: 232 KDKMKWSNSFHHFVKMA---LTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 17/200 (8%)

Query: 574 LGKGGFGTVYYGRLNEIDV--AVKMLSSSS--AQGFQQ-FQAEVKLLMRVHHRNLTSLVG 628
           LG GGFG V   ++   +   A+K +        G Q+   +E ++L   +H  +  L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA--VESAQGLEYLHNGCKPP 686
              +     ++ E+   G L   L D          R  IA  V      EYLHN     
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVL---AFEYLHN---RG 113

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           I++RD+K  N+LL+     KL DFG +K   +   T   T   GTP Y+ PE   +    
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYD 170

Query: 747 EKSDVYSFGVVILEIITCKP 766
              D +S G+++ E++T +P
Sbjct: 171 FSVDYWSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           LGKGGFG V   ++       A K L+       +G++    E ++L +VH R + SL  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ---GLEYLHNGCKP 685
                    L+   M  G+L+ ++ ++ ++     E  R    +AQ   GLE+LH   + 
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP-RACFYTAQIISGLEHLH---QR 116

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I++RD+K  N+LL+     +++D GL+       +   +   AGTPG++ PE       
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEY 174

Query: 746 TEKSDVYSFGVVILEIITCK 765
               D ++ GV + E+I  +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 80.3 bits (199), Expect = 4e-16
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 47/233 (20%)

Query: 572 RTLGKGGFGTVYYG---RLNEIDVAVKMLSSSSAQGFQQFQ---------AEVKLLMRV- 618
           + LGKG +G V+     R  E+ VA+K +       F  F+          E+  L  + 
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEV-VALKKI-------FDAFRNATDAQRTFREIMFLQELG 64

Query: 619 HHRNLTSL--VGHCDEDNQTALIYEFMANGNLQEYLSD----ISKKVLSSQERLRIAVES 672
            H N+  L  V   + D    L++E+M         +D    I   +L    +  I  + 
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYME--------TDLHAVIRANILEDVHKRYIMYQL 116

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV----V 728
            + L+Y+H+G    ++HRD+K +NILLN   + KLADFGL++S +       + V    V
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 729 AGTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKPAI---SRINEEEKI 777
           A T  Y  PE    S R T+  D++S G ++ E++  KP     S +N+ EKI
Sbjct: 174 A-TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 8/197 (4%)

Query: 572 RTLGKGGFGT---VYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           R +G+G FG    V +   ++     ++    S+   +  + E  LL ++ H N+ +   
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
             + D    ++ E+   G+L + +     K+      L+  V+   G++++H   +  ++
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVL 122

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+KS NI L +  + KL DFG S    T    +  T V GTP Y+ PE + +     K
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFG-SARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNK 180

Query: 749 SDVYSFGVVILEIITCK 765
           SD++S G ++ E+ T K
Sbjct: 181 SDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 79.2 bits (195), Expect = 5e-16
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 12/199 (6%)

Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLSS-SSAQGFQQFQAEVKLLMRVHHRNLT 624
           + LG G FGTV+ G         +I VA+K +   S  Q FQ+    +  +  + H  + 
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C       L+ +    G+L +++    +  L  Q  L   V+ A+G+ YL     
Sbjct: 73  RLLGIC-PGASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHR++ + NILL      ++ADFG++     D   +  +       ++  E     R
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E+++
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)

Query: 574 LGKGGFGTVYYGR-LNE-IDVAVKMLS-SSSAQGFQQFQA-EVKLLMRV---HHRNLTSL 626
           +G+G +GTVY  R LN    VA+K +    S +G       E+ LL ++    H N+  L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 627 --VGH-CDEDNQT--ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
             V H    D +    L++E + + +L  YLS   K  L  +    +  +  +G+++LH+
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE--- 738
                IVHRD+K  NIL+    Q K+ADFGL++ +       +++VV  T  Y  PE   
Sbjct: 126 HR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVV-TLWYRAPEVLL 179

Query: 739 ---YYTSNRLTEKSDVYSFGVVILEIITCKP 766
              Y T        D++S G +  E+   +P
Sbjct: 180 QSSYATP------VDMWSVGCIFAELFRRRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.8 bits (202), Expect = 1e-15
 Identities = 54/190 (28%), Positives = 94/190 (49%), Gaps = 19/190 (10%)

Query: 592 VAVKMLSSSSAQG---FQQFQAEVKLLMRVHHRNLTSLV--GHCDEDNQTALIYEFMANG 646
           VA+K+L + + +      +F+ E  L  R++H N+ +L+  G          ++E++   
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGR 64

Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KL 703
            L+E L+  +   L + E  R+ ++    L   HN     IVHRD+K  NI++++   + 
Sbjct: 65  TLREVLA--ADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRP 119

Query: 704 QAKLADFG----LSKSFATDANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVI 758
            AK+ DFG    L      D  T   +T V GTP Y  PE      +T  SD+Y++G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 759 LEIITCKPAI 768
           LE +T +  +
Sbjct: 180 LECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 12/196 (6%)

Query: 574 LGKGGFGTVYYGRLNEI--DVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD 631
           +G+G  G V   R       VAVKM+     Q  +    EV ++    H+N+  +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESA-QGLEYLHNGCKPPIVHR 690
              +  ++ EF+  G L    +DI  +   ++E++    ES  Q L YLH+     ++HR
Sbjct: 89  VGEELWVLMEFLQGGAL----TDIVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHR 141

Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+KS +ILL    + KL+DFG     + D     S V  GTP ++ PE  +      + D
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVD 199

Query: 751 VYSFGVVILEIITCKP 766
           ++S G++++E++  +P
Sbjct: 200 IWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 46/264 (17%)

Query: 574 LGKGGFGTV------YYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           +G+G  G V        GR     VAVK +     Q  +    EV ++    H N+  + 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQ----VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL-RIAVESAQGLEYLHNGCKPP 686
                 ++  ++ EF+  G L    +DI      ++E++  + +   + L +LH      
Sbjct: 83  SSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIATVCLAVLKALSFLHA---QG 135

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           ++HRD+KS +ILL    + KL+DFG     + +     S V  GTP ++ PE  +     
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEVISRLPYG 193

Query: 747 EKSDVYSFGVVILEIITCKP---------AISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
            + D++S G++++E++  +P         A+ RI +     ++               V 
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK-----------VS 242

Query: 798 PRLQEDF------DANSVWKAVEL 815
           PRL+         D      A EL
Sbjct: 243 PRLRSFLDRMLVRDPAQRATAAEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGH- 629
           +G G +G VY GR  +     A+K++  +  +  ++ + E+ +L +  HHRN+ +  G  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 630 -----CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
                   D+Q  L+ EF   G++ + + +     L       I  E  +GL +LH    
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---A 139

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K  N+LL E  + KL DFG+S     D          GTP ++ PE    + 
Sbjct: 140 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 197

Query: 745 LTE-----KSDVYSFGVVILEIITCKPAI 768
             +     +SD++S G+  +E+    P +
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 31/217 (14%)

Query: 569 NFERTLGKGGFGTVYYGRLNEI-------DVAVKMLS-SSSAQGFQQFQAEVKLLMRVHH 620
              R LG+G FG VY G   +I        VAVK ++ S+S +   +F  E  ++     
Sbjct: 9   TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVES 672
            ++  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E 
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTVVAGT 731
           A G+ YL N  K   VHRD+ + N ++      K+ DFG+++  + TD          G 
Sbjct: 129 ADGMAYL-NAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK------GG 179

Query: 732 PG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            G     ++ PE       T  SD++SFGVV+ EI +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 64/220 (29%), Positives = 93/220 (42%), Gaps = 26/220 (11%)

Query: 569 NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLM---------- 616
                LG+G FG V      +     A+K L     +G    + EV+ LM          
Sbjct: 2   RCLAVLGRGHFGKVLLAEYKKTGELYAIKALK----KGDIIARDEVESLMCEKRIFETAN 57

Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
              H  L +L      ++    + E+ A G+L   +  I   V S    +  A     GL
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGL 114

Query: 677 EYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           +YLH N     IV+RD+K  N+LL+ +   K+ADFGL K      +   ST   GTP +L
Sbjct: 115 QYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST-FCGTPEFL 168

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
            PE  T    T   D +  GV+I E++  +      +EEE
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 12/199 (6%)

Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K+L  ++S +  ++   E  ++  V    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   L+ + M  G L +Y+ + +K  + SQ+ L   V+ A+G+ YL    +
Sbjct: 73  RLLGIC-LTSTVQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLE---E 127

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL++    D   + +        ++  E     R
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187

Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 188 FTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 63/278 (22%), Positives = 111/278 (39%), Gaps = 57/278 (20%)

Query: 582 VYYGRLNEIDVAVKML---SSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH----CDEDN 634
           +Y G  N  +V ++                + E+K L R+   N+  + G      D+  
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 635 QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKS 694
           + +LI E+   G L+E L    +K LS + +L +A++  +GL  L+     P  ++++ S
Sbjct: 96  RLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151

Query: 695 TNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS--NRLTEKSDVY 752
            + L+ E  + K+   GL K  ++    +V+ +V     Y   +      +  T K D+Y
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIY 206

Query: 753 SFGVVILEIITCK------------PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
           S GVV+ EI T K              I   N   K+ +           +IK IV+   
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLD-------CPLEIKCIVE--- 256

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
                            AC S    +RP + +++  LS
Sbjct: 257 -----------------ACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 46/217 (21%)

Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
             LG+G +G V   R       +AVK + ++        Q + +LLM +   +++     
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATV-----NSQEQKRLLMDL---DISMRSVD 58

Query: 630 CDEDNQTALIY-------------EFMANGNLQEYLSDISKKVLSSQERL------RIAV 670
           C     T   Y             E M        L    KKV      +      +IAV
Sbjct: 59  CP---YTVTFYGALFREGDVWICMEVMDTS-----LDKFYKKVYDKGLTIPEDILGKIAV 110

Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
              + LEYLH+     ++HRDVK +N+L+N   Q KL DFG+S       ++   T+ AG
Sbjct: 111 SIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL---VDSVAKTIDAG 165

Query: 731 TPGYLDPEYYTSNRLTE----KSDVYSFGVVILEIIT 763
              Y+ PE        +    KSDV+S G+ ++E+ T
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 36/276 (13%)

Query: 574 LGKGGFGTVYYGR----------LNEIDV---AVKMLSSSSAQGFQQFQAEVKLLM-RVH 619
           LG G FG VY  R          L EI+V   A         +      +EV ++  ++ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI-SKKVLSSQERL-RIAVESAQGLE 677
           H N+        E+++  ++ + +    L E+ + +  KK   ++ER+  I V+    L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           YLH   +  IVHRD+   NI+L E  +  + DFGL+K    ++     T V GT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSCP 182

Query: 738 EYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
           E   +    EK+DV++FG ++ ++ T +P     N          + SL  K  ++++ +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----------MLSLATK-IVEAVYE 231

Query: 798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
           P L E   +  V    ++  +CL+P    RP + QV
Sbjct: 232 P-LPEGMYSEDV---TDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 76.0 bits (187), Expect = 8e-15
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 36/223 (16%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLS-SSSAQGFQQFQA-EVKLLMRVHHRNLTSLVGH 629
           +G+G +G VY  R  +    VA+K +   +  +GF      E+K+L +++HRN+ +L   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL--- 71

Query: 630 CD--EDNQTA-----------LIYEFMAN---GNLQEYLSDISKKVLSSQERLRIAVESA 673
            +   D Q A           L++E+M +   G L+  L   S+  + S        +  
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS-----FMKQLL 126

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF-ATDANTHVSTVVAGTP 732
           +GL Y H   K   +HRD+K +NILLN K Q KLADFGL++ + + ++  + + V+  T 
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181

Query: 733 GYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEE 774
            Y  PE      R     DV+S G ++ E+ T KP I + N+E
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP-IFQANQE 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 14/200 (7%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLVG 628
           +G+G +G VY GR     +I VA+K +   S +      A  E+ LL  + H N+  L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQI-VAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNGCKPPI 687
              ++++  LI+EF++  +L++YL  + K      E ++  + +  QG+ + H      +
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRV 122

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLT 746
           +HRD+K  N+L++ K   KLADFGL+++F      +   VV  T  Y  PE    S R +
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSPRYS 180

Query: 747 EKSDVYSFGVVILEIITCKP 766
              D++S G +  E+ T KP
Sbjct: 181 TPVDIWSIGTIFAEMATKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 76.3 bits (187), Expect = 9e-15
 Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 14/197 (7%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSL 626
           + LGKG FG V   R        A+K+L      +         E ++L    H  LTSL
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGCKP 685
                  ++   + E++  G L  +LS   ++ + S++R R    E    L+YLH+G   
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            IV+RD+K  N++L++    K+ DFGL K   TDA T       GTP YL PE    N  
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--MKTFCGTPEYLAPEVLEDNDY 172

Query: 746 TEKSDVYSFGVVILEII 762
               D +  GVV+ E++
Sbjct: 173 GRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.0 bits (187), Expect = 9e-15
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 18/201 (8%)

Query: 572 RTLGKGGFGTVYYGR-LNEIDV----AVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLT 624
           + LG+G FG V+  R +   D     A+K+L  ++   +   + + E  +L  V+H  + 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHN-G 682
            L      + +  LI +F+  G+L    + +SK+V+ ++E ++  + E A  L++LH+ G
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I++RD+K  NILL+E+   KL DFGLSK          S    GT  Y+ PE    
Sbjct: 119 ----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNR 172

Query: 743 NRLTEKSDVYSFGVVILEIIT 763
              T+ +D +SFGV++ E++T
Sbjct: 173 RGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 17/197 (8%)

Query: 576 KGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQ---FQAEVKLLM-RVHHRNLTSLVGH 629
           KG FG+VY    R      A+K+L  S      Q    +AE  ++M +     +  L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
               +   L+ E++  G+    +  +    L      +   E   G+E LH   +  I+H
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIH 120

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKS 749
           RD+K  N+L+++    KL DFGLS+      N   +    GTP YL PE        + S
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILGVGDDKMS 174

Query: 750 DVYSFGVVILEIITCKP 766
           D +S G VI E +   P
Sbjct: 175 DWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 11/211 (5%)

Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLL 615
           +S  D  K    FE+ +G+G  GTVY         +VA+K ++       +    E+ ++
Sbjct: 12  VSVGDPKKKYTRFEK-IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVM 70

Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
               H N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q 
Sbjct: 71  RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQA 127

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH+     ++HRD+KS NILL      KL DFG       + +   ST+V GTP ++
Sbjct: 128 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWM 182

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE  T      K D++S G++ +E++  +P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 24/244 (9%)

Query: 592 VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEY 651
           VAVK +     Q  +    EV ++   HH N+  +       ++  ++ EF+  G L   
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL--- 106

Query: 652 LSDISKKVLSSQERL-RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF 710
            +DI      ++E++  + +   + L YLHN     ++HRD+KS +ILL    + KL+DF
Sbjct: 107 -TDIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDF 162

Query: 711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISR 770
           G     + +     S V  GTP ++ PE  +      + D++S G++++E+I  +P    
Sbjct: 163 GFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY-- 218

Query: 771 INEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTM 830
            NE     +R+          I+  + PR+++    +SV +     M    P+  QR T 
Sbjct: 219 FNEPPLQAMRR----------IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPS--QRATA 266

Query: 831 SQVV 834
            +++
Sbjct: 267 QELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 17/196 (8%)

Query: 574 LGKGGFGTVYYGRLN----EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLV 627
           LG G FGTV  G       E  VAVK+L + +       +   E  ++ ++ +  +  ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HNGCKP 685
           G C+ ++   L+ E    G L ++L     K ++ +    +  + + G++YL   N    
Sbjct: 63  GICEAESWM-LVMELAELGPLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEETN---- 115

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 745 LTEKSDVYSFGVVILE 760
            + KSDV+SFGV++ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 58/228 (25%)

Query: 569 NFER--TLGKGGFGTVYYGR---LNEIDVAVKM---------LSSSSAQGFQQFQAEVKL 614
            FE+   +G+G +G VY  R     EI VA+K          +  SS +       E+ L
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEI-VALKKVRMDNERDGIPISSLR-------EITL 59

Query: 615 LMRVHHRNLTSL---------------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKV 659
           L+ + H N+  L               + +C++D   +L+       N+    S+   K 
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQD-LASLLD------NMPTPFSESQVKC 112

Query: 660 LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD 719
           L  Q  LR       GL+YLH      I+HRD+K +N+LL +K   K+ADFGL++++   
Sbjct: 113 LMLQ-LLR-------GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161

Query: 720 ANTHVSTVVAGTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKP 766
           A      VV  T  Y  PE        T   D+++ G ++ E++  KP
Sbjct: 162 AKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 22/201 (10%)

Query: 572 RTLGKGGFGTVYY------GRLNEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRN 622
           + LGKG FG V        G+      A+K+L      +         E ++L    H  
Sbjct: 1   KLLGKGTFGKVILVREKATGKY----YAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHN 681
           LT+L       ++   + E+ ANG   E    +S++ + S++R R    E    L YLH+
Sbjct: 57  LTALKYSFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFSEDRARFYGAEIVSALGYLHS 113

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL PE   
Sbjct: 114 C---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 168

Query: 742 SNRLTEKSDVYSFGVVILEII 762
            N      D +  GVV+ E++
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.4 bits (182), Expect = 2e-14
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 11/211 (5%)

Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGRLNEI--DVAVKMLSSSSAQGFQQFQAEVKLL 615
           +S  D  K    +E+ +G+G  GTV+         +VA+K ++       +    E+ ++
Sbjct: 12  VSIGDPKKKYTRYEK-IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVM 70

Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
             + + N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q 
Sbjct: 71  KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV---VTETCMDEAQIAAVCRECLQA 127

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH      ++HRD+KS N+LL      KL DFG      T   +  ST+V GTP ++
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI-TPEQSKRSTMV-GTPYWM 182

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE  T      K D++S G++ +E++  +P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 60/224 (26%), Positives = 110/224 (49%), Gaps = 26/224 (11%)

Query: 569 NFERT--LGKGGFGTVYYGRLNEID--VAVKMLS-SSSAQGFQQFQA-EVKLLMRVHHRN 622
           NF++   +G+G +G VY  R       VA+K +   +  +G       E+ LL  ++H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L+     +N+  L++EF+ + +L++++       +          +  QGL + H+ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE---- 738
               ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  PE    
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 174

Query: 739 --YYTSNRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI 777
             YY++       D++S G +  E++T +   P  S I++  +I
Sbjct: 175 CKYYST-----AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 76.2 bits (187), Expect = 3e-14
 Identities = 46/143 (32%), Positives = 79/143 (55%), Gaps = 8/143 (5%)

Query: 626 LVGHCDE---DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR--IAVESAQGLEYLH 680
           +V H D+   D++  LI E+ + G+L + +    K+ L  QE     +  +    L+ +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+KS NI L      KL DFG SK ++   +  V++   GTP YL PE +
Sbjct: 187 SRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW 243

Query: 741 TSNRLTEKSDVYSFGVVILEIIT 763
              R ++K+D++S GV++ E++T
Sbjct: 244 ERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 41/215 (19%)

Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G V     +   + VA+K +S    Q F Q+   E+K+L R  H N+  ++   
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGIL--- 69

Query: 631 DEDNQTALIYEFMANGNL-QEYLSDISKKVLSSQER------------LRIAVESAQGLE 677
             D      +E   +  + QE +     K++ +Q              LR       GL+
Sbjct: 70  --DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR-------GLK 120

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST-----VVAGTP 732
           Y+H+     ++HRD+K +N+LLN     K+ DFGL++        H  T      VA T 
Sbjct: 121 YIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI---ADPEHDHTGFLTEYVA-TR 173

Query: 733 GYLDPEYYTSNRLTEKS-DVYSFGVVILEIITCKP 766
            Y  PE   +++   K+ D++S G ++ E+++ +P
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)

Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR 617
           +S  D  K    FE+ +G+G  GTVY      +DVA     +      QQ Q + +L++ 
Sbjct: 13  VSVGDPKKKYTRFEK-IGQGASGTVY----TAMDVATGQEVAIRQMNLQQ-QPKKELIIN 66

Query: 618 ----VHHRNLTSLVGHCDE---DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
               +      ++V + D     ++  ++ E++A G+L +    +++  +   +   +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCR 123

Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           E  Q LE+LH+     ++HRD+KS NILL      KL DFG       + +   + V  G
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--G 178

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           TP ++ PE  T      K D++S G++ +E+I  +P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 45/280 (16%)

Query: 574 LGKGGFGTVYYGRLNEIDVAVKM----LSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
           LGKG +G+VY        V + M    L    ++ F Q   E+ +L +     +    G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYGA 67

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL-RIAVESAQGLEYL---HNGCKP 685
              +    +  E+M  G+L +  +         ++ L RI     +GL++L   HN    
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---- 123

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSF-ATDANTHVSTVVAGTPGYLDPEYYTSNR 744
            I+HRDVK TN+L+N   Q KL DFG+S +  A+ A T++     G   Y+ PE   S  
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177

Query: 745 LTE------KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD- 797
             +      +SDV+S G+ ILE+     A+ R     + +      ++ A+  + +IVD 
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEM-----ALGRYPYPPETY-----ANIFAQ--LSAIVDG 225

Query: 798 --PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM 835
             P L   +  +    A +    CL+   N+RPT +Q++ 
Sbjct: 226 DPPTLPSGYSDD----AQDFVAKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 18/216 (8%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           +G+GG+G V+  +     EI VA+K +  S        +    E  +L       L  L+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEI-VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               +D    L  E++  G+ +  L+  +  VLS         E  + ++ LH   +   
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALH---ELGY 122

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+K  N L++     KL DFGLSK   T AN+     V G+P Y+ PE         
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKGYDF 177

Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEK-IHIRQW 782
             D +S G ++ E +   P  S     E   +++ W
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 27/217 (12%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLM---RV-----HHR 621
           + LGKG FG V    L   D   AVK+L     +       +V+  M   RV      H 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLK----KDVILQDDDVECTMTEKRVLALAGKHP 56

Query: 622 NLTSLVGHCDEDNQTALIY--EFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEY 678
            LT L  H     +  L +  E++  G+L  ++    +     + R R  A E   GL++
Sbjct: 57  FLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQF 111

Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH   +  I++RD+K  N+LL+ +   K+ADFG+ K       T  ++   GTP Y+ PE
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE 166

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
             +        D ++ GV++ E++  +      +E+E
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.2 bits (179), Expect = 6e-14
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 11/211 (5%)

Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLL 615
           +S  D  K    FE+ +G+G  GTVY         +VA+K ++       +    E+ ++
Sbjct: 12  VSVGDPKKKYTRFEK-IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVM 70

Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
               + N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q 
Sbjct: 71  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQA 127

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           L++LH+     ++HRD+KS NILL      KL DFG      T   +  ST+V GTP ++
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMV-GTPYWM 182

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE  T      K D++S G++ +E++  +P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 6e-14
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 51/235 (21%)

Query: 568 NNFER--TLGKGGFGTVYYGRLNEID--VAVKMLSSSSA--QGF-QQFQAEVKLLMRVHH 620
           ++FE    +G+G FG V+  R  +     A+K+L  S    +      +AE  +L     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 621 RNLTSLVGHC---DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE-RLRIAVESAQGL 676
             +  L  +    DE++   L+ E+M  G+L   L    K V   +  R  IA E    L
Sbjct: 61  PWIVKL--YYSFQDEEH-LYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIA-ELVLAL 114

Query: 677 EYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA------------------ 717
           + +H  G     +HRD+K  NIL++     KLADFGL K                     
Sbjct: 115 DSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 718 ----------TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII 762
                            ++ V GTP Y+ PE         + D +S GV++ E++
Sbjct: 171 DNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.1 bits (179), Expect = 6e-14
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQA--EVKLLMRVH---HRNLTSL 626
           +G G +GTVY  R       VA+K +   + +         EV LL R+    H N+  L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 627 VGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           +  C     D + +  L++E + + +L+ YL  +    L ++    +  +  +GL++LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
            C   IVHRD+K  NIL+    Q KLADFGL++ ++        T V  T  Y  PE   
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLL 180

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP 766
            +      D++S G +  E+   KP
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.9 bits (182), Expect = 6e-14
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 39/217 (17%)

Query: 569 NFERTLGKGGFGTV--YYGRLNEIDVAVKMLSSSSAQGFQQFQA---------EVKLLMR 617
                +G G +G V   +       VA+K LS       + FQ+         E++LL  
Sbjct: 18  QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKH 70

Query: 618 VHHRNLTSL--VGHCDEDN----QTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAV 670
           + H N+  L  V              L+   M        L++I K + LS      +  
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGAD-----LNNIVKCQKLSDDHIQFLVY 125

Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           +  +GL+Y+H+     I+HRD+K +NI +NE  + K+ DFGL++    +   +V      
Sbjct: 126 QILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----A 177

Query: 731 TPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKP 766
           T  Y  PE         +  D++S G ++ E++T K 
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC 630
           +G G +G VY  R     E+  AVK++       F   Q E+ ++    H N+ +  G  
Sbjct: 17  VGSGTYGDVYKARNLHTGEL-AAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV---ESAQGLEYLHNGCKPPI 687
               +  +  E+   G+LQ+        V      L+IA    E+ QGL YLH+  K   
Sbjct: 76  LSREKLWICMEYCGGGSLQDIY-----HVTGPLSELQIAYVCRETLQGLAYLHSKGK--- 127

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR--- 744
           +HRD+K  NILL +    KLADFG++           S +  GTP ++ PE     +   
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGG 185

Query: 745 LTEKSDVYSFGVVILEIITCKPAI 768
             +  D+++ G+  +E+   +P +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.4 bits (178), Expect = 9e-14
 Identities = 68/279 (24%), Positives = 136/279 (48%), Gaps = 31/279 (11%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLVGH 629
           +G+G +G V   +  E    VA+K    S      +  A  E+++L ++ H NL +L+  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 630 CDEDNQTALIYEFMAN---GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +  L++EF+ +    +L++Y + + +  +      +   +  +G+E+ H+     
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-----KYLFQILRGIEFCHSH---N 120

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN-RL 745
           I+HRD+K  NIL+++    KL DFG +++ A  A   V T    T  Y  PE    + + 
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVYTDYVATRWYRAPELLVGDTKY 178

Query: 746 TEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQWVNSLIAKGDIKSIVDPRLQEDF 804
               D+++ G ++ E++T +P     ++ +++ HI + + +LI          PR QE F
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI----------PRHQEIF 228

Query: 805 DANSVWKAVELA-MACLSPTGNQRPTMSQVVMEL-SECL 841
             N ++  + L  +  + P   + P +S +V++L  +CL
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCL 267

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 33/221 (14%)

Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSL--V 627
           LG+G + TVY GR  L    VA+K +     +G   F A  E  LL  + H N+ +L  +
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDI 71

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
            H  +     L++E++ + +L++Y+ D    +     RL    +  +GL Y H   +  +
Sbjct: 72  IHTKK--TLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRL-FLFQLLRGLAYCH---QRRV 124

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP-------EYY 740
           +HRD+K  N+L++E+ + KLADFGL+++ +  + T+ + VV  T  Y  P       EY 
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYS 182

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPA---ISRINEE-EKI 777
           TS       D++  G +  E+ T +P     + + ++  KI
Sbjct: 183 TS------LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 34/211 (16%)

Query: 574 LGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQ-QFQAEVKLLMR-------VHHRNL 623
           +G+G FGTV            AVK + S+  +  Q +   ++ ++MR       V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 624 TSLVGHCDEDNQTALIYEFMANG--NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
               G C       +  E M        +Y+ ++ K V+  +   +IAV + + L YL  
Sbjct: 72  LFREGDC------WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLS----KSFATDANTHVSTVVAGTPGYLDP 737
             K  I+HRDVK +NILL+     KL DFG+S     S A        T  AG   Y+ P
Sbjct: 126 ELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-------KTRDAGCRPYMAP 176

Query: 738 EYYTSNRLTE---KSDVYSFGVVILEIITCK 765
           E    +       +SDV+S G+ + E+ T K
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 60/229 (26%), Positives = 112/229 (48%), Gaps = 35/229 (15%)

Query: 569 NFER--TLGKGGFGTVYYGR---LNEIDVAVKMLS-SSSAQGFQ-QFQAEVKLLMRVHHR 621
            +E+   + +G +G VY  R     EI VA+K L      +GF      E+ +L+++ H 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEI-VALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 622 NLTSL----VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
           N+ ++    VG     ++  ++ E++ + +L+  +  + +  L S E   + ++   G+ 
Sbjct: 65  NIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS-EVKCLMLQLLSGVA 120

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           +LH      I+HRD+K++N+LLN +   K+ DFGL++ + +    +   VV  T  Y  P
Sbjct: 121 HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAP 175

Query: 738 E------YYTSNRLTEKSDVYSFGVVILEIITCKPAI---SRINEEEKI 777
           E       Y     +   D++S G +  E++T KP     S I++  KI
Sbjct: 176 ELLLGAKEY-----STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 571 ERTLGKGGFGTVYYGRLN-----EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           ER LG G FG +  G L      E+ VA+  L +  S +  + F AE   L +  H N+ 
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L G     N   ++ E+M+NG L  +L     ++++ Q  + +    A G++YL    +
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ-LMGMLPGLASGMKYL---SE 125

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL--DPEYYTS 742
              VH+ + +  +L+N  L  K++ F        D +  + T ++G    L   PE    
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 743 NRLTEKSDVYSFGVVILEIIT 763
           +  +  SDV+SFG+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSA---QGFQQFQAEVKLL-MRVHHRNLTS 625
           + LGKG FG V+   L   +   A+K L           +    E ++L +   H  LT 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L            + E++  G+L  ++    K  L        A E   GL++LH+    
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHS---K 115

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSK-SFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
            IV+RD+K  NILL+     K+ADFG+ K +   DA T       GTP Y+ PE     +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILLGQK 172

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIH 778
                D +SFGV++ E++  +      +EEE   
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 44/135 (32%), Positives = 70/135 (51%), Gaps = 16/135 (11%)

Query: 633 DNQTALIYEFMANGNLQEYLSD---ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
           D + ++  E M  G+L + L     I + +L      +I++   +GL YL    K  I+H
Sbjct: 71  DGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMH 123

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           RDVK +NIL+N + + KL DFG+S       AN+ V     GT  Y+ PE       T +
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYTVQ 178

Query: 749 SDVYSFGVVILEIIT 763
           SD++S G+ ++E+  
Sbjct: 179 SDIWSLGLSLVEMAI 193

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 79/286 (27%), Positives = 121/286 (42%), Gaps = 37/286 (12%)

Query: 572 RTLGKGGFGTVYYGRLNE----IDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
           + +G G FG V  G +N       V VK L  S+S Q   +F  E +    + H NL   
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL---RIAVESAQGLEYLHNGC 683
           +G C E     L+ EF   G+L+ YL    K  L + +     R+A E A GL +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKS------FATDANTHVSTV-VAGTPGYLD 736
           K   +H D+   N LL   L  K+ D+GLS +      + T     V    +A  P  +D
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIA--PELVD 175

Query: 737 PEYYTSNRL----TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
             +   N L    T++S+V+S GV I E+          ++  +    + V +   +   
Sbjct: 176 EVH--GNLLVVDQTKESNVWSLGVTIWELFELG------SQPYRHLSDEQVLTYTVREQQ 227

Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
             +  PRL+     +  W   E+   C      QRP+  +V + LS
Sbjct: 228 LKLPKPRLK--LPLSDRW--YEVMQFCWLQP-EQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 67/245 (27%), Positives = 101/245 (41%), Gaps = 56/245 (22%)

Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLS----SSSAQGFQQ--------FQA--EVKLLMR 617
           LG+G +G V   Y  L    VA+K +     S+     +Q        F    E+K++  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR------IAVE 671
           + H N+  LV    E +   L+ + MA        SD+ KKV+  + RL       I ++
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA--------SDL-KKVVDRKIRLTESQVKCILLQ 127

Query: 672 SAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT--------- 722
              GL  LH   K   +HRD+   NI +N K   K+ADFGL++ +     +         
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 723 -----HVSTVVAGTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK 776
                  S VV  T  Y  PE    + +     D++S G +  E++T KP     NE   
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE--- 239

Query: 777 IHIRQ 781
             I Q
Sbjct: 240 --IDQ 242

Length = 335

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 51/205 (24%), Positives = 99/205 (48%), Gaps = 19/205 (9%)

Query: 572 RTLGKGGFGTVYYGR---------LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN 622
           + +G+G FG     +         + EI+++ KM    S +  ++ + EV +L  + H N
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINIS-KM----SPKEREESRKEVAVLSNMKHPN 60

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +       +E+    ++ ++   G+L + ++     +    + L   V+    L+++H+ 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD- 119

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+KS NI L +    KL DFG+++    ++   ++    GTP YL PE   +
Sbjct: 120 --RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPEICEN 175

Query: 743 NRLTEKSDVYSFGVVILEIITCKPA 767
                KSD+++ G V+ E+ T K A
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 18/218 (8%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLT 624
           N E+ LG+G + TVY G  R+N   VA+K++S  + +G   F A  E  LL  + H N+ 
Sbjct: 9   NLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV 66

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L            ++E+M + +L +Y+      +     RL    +  +GL Y+H    
Sbjct: 67  LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---G 121

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SN 743
             I+HRD+K  N+L++   + KLADFGL+++ +  + T+ S VV  T  Y  P+    + 
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179

Query: 744 RLTEKSDVYSFGVVILEIITCKPA---ISRINEE-EKI 777
             +   D++  G + +E++  +PA   +S + E+ EKI
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.6 bits (173), Expect = 6e-13
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 563 VVKITNNFE--RTLGKGGFGTV--YYGRLNEIDVAVKMLS---SSSAQGFQQFQAEVKLL 615
           V +ITN +   + +G G FG V     +L   +VA+K +    S+     + ++ E+KLL
Sbjct: 5   VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLL 63

Query: 616 MRVHHRNLTSLVGHCD------EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
             + H N+ SL    D      ED     + E +   +L   L+    + L  Q      
Sbjct: 64  KHLRHENIISL---SDIFISPLED--IYFVTELLGT-DLHRLLT---SRPLEKQFIQYFL 114

Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            +  +GL+Y+H+     +VHRD+K +NIL+NE    K+ DFGL++        +VST   
Sbjct: 115 YQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY- 170

Query: 730 GTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKP 766
               Y  PE   T  +   + D++S G +  E++  KP
Sbjct: 171 ----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 70.5 bits (172), Expect = 7e-13
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 27/211 (12%)

Query: 569 NFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQ---FQAEVKLLMRVHHR 621
           +FE  + +G+G FG V   +L   D   A+K+L+        +   F+ E  +L+   ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER-----LRIAVESAQGL 676
            +T+L     ++N   L+ ++   G+L   LS    ++     R     + IA++S   L
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            Y         VHRD+K  NIL++     +LADFG       D     S+V  GTP Y+ 
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYIS 171

Query: 737 PEYYTS-----NRLTEKSDVYSFGVVILEII 762
           PE   +      +   + D +S GV + E++
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 70.0 bits (171), Expect = 9e-13
 Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 14/197 (7%)

Query: 572 RTLGKGGFGTVYYGRLNEIDV--AVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSL 626
           + LGKG FG V   R        A+K+L      +         E ++L    H  LT+L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGCKP 685
                  ++   + E+ ANG   E    +S++ + ++ER R    E    LEYLH+    
Sbjct: 61  KYAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFTEERARFYGAEIVSALEYLHS---R 114

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL PE    N  
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDY 172

Query: 746 TEKSDVYSFGVVILEII 762
               D +  GVV+ E++
Sbjct: 173 GRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 9e-13
 Identities = 57/226 (25%), Positives = 87/226 (38%), Gaps = 41/226 (18%)

Query: 572 RTLGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQG---FQQFQAEVKLLMRVHHRNLTSL 626
           + LGKG  G V+  RL       A+K+L           ++   E ++L  + H  L +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKP 685
                 +    L+ ++   G L   L     K LS +     A E    LEYLH  G   
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--- 123

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV-------------------ST 726
            IV+RD+K  NILL+E     L+DF LSK   +D                         T
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQ--SDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 727 VVA----------GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII 762
                        GT  Y+ PE  + +      D ++ G+++ E++
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 29/206 (14%)

Query: 573 TLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQ---AEVKLLMRVHHRNLTSLV 627
           TLG G FG V   +        A+K L        +Q Q    E  +LM + H  + +++
Sbjct: 25  TLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84

Query: 628 GHCDEDNQTALIYEFMANGNLQEYL-------SDISKKVLSSQERLRIAVESAQGLEYLH 680
               ++N+   + EF+  G L  +L       +D++K             E     EYLH
Sbjct: 85  CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK---------FYHAELVLAFEYLH 135

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I++RD+K  N+LL+ K   K+ DFG +K          +  + GTP YL PE  
Sbjct: 136 S---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-----PDRTFTLCGTPEYLAPEVI 187

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV++ E I   P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 571 ERTLGKGGFGTVYY------GRLNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRN 622
           ++ LGKG FGTVY            + V +K +        +  QA  E +LL ++ H  
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK--KVLSSQERLRIAVESAQGLEYLH 680
           +        E +   +I E+    +L   L ++    K LS  +     ++   G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
              +  I+HRD+K+ NI L   L  K+ DFG+S+      +  ++T   GTP Y+ PE  
Sbjct: 124 ---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177

Query: 741 TSNRLTEKSDVYSFGVVILEI 761
                  KSD++S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.9 bits (172), Expect = 1e-12
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 51/226 (22%)

Query: 569 NFERTLGKGGFGTV---YYGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLLMRVH 619
              + +G G +G V      R     VA+K +S+     F     A     E+KLL  + 
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGR-KVAIKKISNV----FDDLIDAKRILREIKLLRHLR 57

Query: 620 HRNLTSLV-----GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
           H N+  L+        ++ N   ++ E M         +D+  KV+ S + L    +  Q
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELME--------TDL-HKVIKSPQPL--TDDHIQ 106

Query: 675 --------GLEYLH--NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTH 723
                   GL+YLH  N     ++HRD+K +NIL+N     K+ DFGL++    D     
Sbjct: 107 YFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 724 VST--VVAGTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKP 766
             T  VV  T  Y  PE   +S+R T+  D++S G +  E++T KP
Sbjct: 162 FLTEYVV--TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVK------LLMRVHHRNL 623
           + LGKG FG V    L   D   A+K+L        Q    +        L +   H  L
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFL 58

Query: 624 TSLVGHCDEDNQTALIY--EFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLH 680
           T+L  HC    +  L +  E++  G+L   +  I +     + R R  A E    L +LH
Sbjct: 59  TAL--HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113

Query: 681 -NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
            +G    +++RD+K  NILL+ +   KLADFG+ K    +  T  +T   GTP Y+ PE 
Sbjct: 114 RHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEI 167

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
                     D ++ GV++ E++  +P     NE++
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 40/227 (17%)

Query: 572 RTLGKGGFGTVY-----YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
           + LGKGG+G V+      G       A+K+L  ++    Q+  A  K       RN+   
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-----ERNILEA 56

Query: 627 VGH---CDEDNQTALIYEFMANGNLQ---EYLSDISKKVLSSQERLRIAVESAQ------ 674
           V H    D      LIY F   G L    EYLS    ++    ER  I +E         
Sbjct: 57  VKHPFIVD------LIYAFQTGGKLYLILEYLS--GGELFMHLEREGIFMEDTACFYLSE 108

Query: 675 ---GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK-SFATDANTHVSTVVAG 730
               LE+LH   +  I++RD+K  NILL+ +   KL DFGL K S      TH      G
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH---TFCG 162

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
           T  Y+ PE    +   +  D +S G ++ +++T  P  +  N ++ I
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 15/211 (7%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVH-HRNLTS 625
           R LGKG FG V   RL E     AVK+L           +    E ++L     H  LT 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGCK 684
           L       ++   + EF+  G+L   +  I K     + R R  A E    L +LH+   
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHD--- 114

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I++RD+K  N+LL+ +   KLADFG+ K    +  T  ++   GTP Y+ PE      
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEML 172

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEE 775
                D ++ GV++ E++         NE++
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 72/241 (29%), Positives = 108/241 (44%), Gaps = 35/241 (14%)

Query: 551 FEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEID---VAVKMLSSSSAQGF 605
           F   S  L    +   T+ +E   T+GKG +G VY    N+ D    AVK+L   S    
Sbjct: 5   FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYK-VTNKKDGSLAAVKILDPISDVD- 62

Query: 606 QQFQAEVKLLMRV-HHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKK 658
           ++ +AE  +L  + +H N+    G            Q  L+ E    G++ E +    K 
Sbjct: 63  EEIEAEYNILQSLPNHPNVVKFYGMFYKADKL-VGGQLWLVLELCNGGSVTELV----KG 117

Query: 659 VLSSQERLRIAVES------AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
           +L   +RL  A+ S        GL++LHN     I+HRDVK  NILL  +   KL DFG+
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV 174

Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKS-----DVYSFGVVILEIITCKPA 767
           S    T      +T V GTP ++ PE     +  + S     DV+S G+  +E+    P 
Sbjct: 175 SAQL-TSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Query: 768 I 768
           +
Sbjct: 233 L 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 54/282 (19%)

Query: 574 LGKGGFGTVYYGRLNEID---VAVKM--LSSSSAQGFQQFQ--------AEVKLLMRVHH 620
           +GKG +G VY   LN      +AVK   L ++ A      Q        +E++ L  + H
Sbjct: 9   IGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 621 RNLTSLVGHCDEDNQTALIY-EFMANGNLQEYLSDISK------KVLSSQERLRIAVESA 673
            N+   +G  +   +   I+ E++  G++   L    +      +  + Q          
Sbjct: 68  LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS----FATDANTHVSTVVA 729
           +GL YLH+     I+HRD+K+ N+L++     K++DFG+SK     +  D N  +     
Sbjct: 119 EGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---- 171

Query: 730 GTPGYLDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLI 787
           G+  ++ PE   S     + K D++S G V+LE+   +   S    EE I       ++ 
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD---EEAI------AAMF 222

Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT 829
             G+ +S   P +  D   N    A++   AC +   + RPT
Sbjct: 223 KLGNKRSA--PPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 11/196 (5%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSL 626
           R LGKGGFG V   ++       A K L        +G      E ++L +V+ R + SL
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
               +  +   L+   M  G+L+ ++  + +        +  A E   GLE LH   +  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QER 122

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IV+RD+K  NILL++    +++D GL+                GT GY+ PE   + R T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKNERYT 179

Query: 747 EKSDVYSFGVVILEII 762
              D ++ G ++ E+I
Sbjct: 180 FSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 30/234 (12%)

Query: 569 NFERTLGKGGFGTVYYGRLNEIDVAV---KMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLT 624
                LG+G FG VY  R  +    V   K+L  +   GF      E+K+L ++ H N+ 
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVV 70

Query: 625 SLV--------GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
            L+            +     ++  +M + +L   L + S K+  SQ +    ++  +G+
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKC-YMLQLLEGI 128

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD---------ANTHVSTV 727
            YLH   +  I+HRD+K+ NIL++ +   K+ADFGL++ +              T   T 
Sbjct: 129 NYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185

Query: 728 VAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAI---SRINEEEKI 777
           +  T  Y  PE     R  T   D++  G V  E+ T +P +   S I++   I
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 44/176 (25%), Positives = 84/176 (47%), Gaps = 10/176 (5%)

Query: 592 VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEY 651
           VAVK +     Q  +    EV ++    H N+  +       ++  ++ EF+  G L   
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--- 104

Query: 652 LSDISKKVLSSQERLR-IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF 710
            +DI      ++E++  + +   + L  LH      ++HRD+KS +ILL    + KL+DF
Sbjct: 105 -TDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 160

Query: 711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           G     + +     S V  GTP ++ PE  +      + D++S G++++E++  +P
Sbjct: 161 GFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 35/210 (16%)

Query: 574 LGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD 631
           +G G +GTV     R     VA+K L       ++ FQ+E  L  +  +R L  L+ H  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSE--LFAKRAYREL-RLLKHMK 72

Query: 632 EDNQTALIYEFMANGNLQEY-------------LSDISKKVLSSQERLRIAV-ESAQGLE 677
            +N   L+  F  + +L  +             L  + K    S++R++  V +  +GL+
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           Y+H      I+HRD+K  N+ +NE  + K+ DFGL++   ++   +V      T  Y  P
Sbjct: 133 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV-----TRWYRAP 184

Query: 738 EYYTS-NRLTEKSDVYSFGVVILEIITCKP 766
           E   +    T+  D++S G ++ E++T KP
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 11/210 (5%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSL 626
           R LGKGGFG V   ++       A K L        +G      E ++L +V+ R + SL
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
               +  +   L+   M  G+L+ ++ ++       Q  +  A E   GLE L    +  
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IV+RD+K  NILL+++   +++D GL+     +  T    V  GT GY+ PE   + + T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGETVRGRV--GTVGYMAPEVINNEKYT 179

Query: 747 EKSDVYSFGVVILEIITCKPAISRINEEEK 776
              D +  G +I E+I  +    +  E  K
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 18/244 (7%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSL 626
           R LGKGGFG V   ++       A K L        +G      E ++L +V+ + + +L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
               +  +   L+   M  G+L+ ++ ++       +  L  A E   GLE LH   +  
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---REN 122

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
            V+RD+K  NILL++    +++D GL+       +        GT GY+ PE   + R T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQRYT 179

Query: 747 EKSDVYSFGVVILEIITC-------KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR 799
              D +  G +I E+I         K  + R   + ++   + V S     + KSI    
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239

Query: 800 LQED 803
           L +D
Sbjct: 240 LTKD 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 9/101 (8%)

Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
           ++ V   + L YL    K  ++HRDVK +NILL+     KL DFG+S     D+     T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS-GRLVDSKAK--T 172

Query: 727 VVAGTPGYLDPEYYTSNRLTEK----SDVYSFGVVILEIIT 763
             AG   Y+ PE         K    +DV+S G+ ++E+ T
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.2 bits (166), Expect = 4e-12
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 568 NNFERT--LGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRN 622
           ++FER   LG G  G V     + + + +A K++        + Q   E+++L   +   
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSD---ISKKVLSSQERLRIAVESAQGLEYL 679
           +    G    D + ++  E M  G+L + L +   I +++L      ++++   +GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVAGTPGYLDPE 738
               K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     GT  Y+ PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPE 172

Query: 739 YYTSNRLTEKSDVYSFGVVILEI 761
                  + +SD++S G+ ++E+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.5 bits (165), Expect = 7e-12
 Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 20/224 (8%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL--- 626
           R LG G  G V+    ++ D  VAVK +  +  Q  +    E+K++ R+ H N+  +   
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 627 VGHCDEDNQTAL--IYEFMANGNLQEYLSDISKKVLS----SQERLRI-AVESAQGLEYL 679
           +G    D    +  + E  +   +QEY+      VL     S+E  R+   +  +GL+Y+
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130

Query: 680 HNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDAN--THVSTVVAGTPGYLD 736
           H+     ++HRD+K  N+ +N E L  K+ DFGL++      +   ++S  +  T  Y  
Sbjct: 131 HSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRS 186

Query: 737 PEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
           P    S N  T+  D+++ G +  E++T KP  +  +E E++ +
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 67.3 bits (164), Expect = 7e-12
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 22/220 (10%)

Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID---VAVKMLSSSSAQGFQQFQ- 609
           +   + Y D      NF RTLG G FG V        D   VA+K    S     +Q   
Sbjct: 23  RKNKMKYEDF-----NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77

Query: 610 --AEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR 667
             +E K+L  ++H    +L G   +++   L+ EF+  G    +L     K   +     
Sbjct: 78  VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR--RNKRFPNDVGCF 135

Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            A +     EYL +     IV+RD+K  N+LL++    K+ DFG +K   T   T     
Sbjct: 136 YAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT----- 187

Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKP 766
           + GTP Y+ PE   +    + +D ++ G+ I EI+  C P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.0 bits (163), Expect = 9e-12
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 10/156 (6%)

Query: 607 QFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL 666
           Q   E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILG 106

Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVS 725
           ++++   +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V 
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163

Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
               GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 164 ----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 30/204 (14%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV--GH 629
           +G+GGFG VY  R  +     A+K L        +  Q E    + ++ R + SLV  G 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGET---LALNERIMLSLVSTGD 55

Query: 630 C----------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           C             ++   I + M  G+L  +LS     V S +E    A E   GLE++
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHM 113

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           HN     +V+RD+K  NILL+E    +++D GL+  F +    H S    GT GY+ PE 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASV---GTHGYMAPEV 166

Query: 740 YTSNRLTEKS-DVYSFGVVILEII 762
                  + S D +S G ++ +++
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 9/141 (6%)

Query: 639 IYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           + E++  G+L  ++    +     + R R  A E   GL++LH   K  I++RD+K  N+
Sbjct: 74  VMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNV 127

Query: 698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           LL++    K+ADFG+ K          ++   GTP Y+ PE     +  E  D +SFGV+
Sbjct: 128 LLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVL 185

Query: 758 ILEIITCKPAISRINEEEKIH 778
           + E++  +      +E+E   
Sbjct: 186 LYEMLIGQSPFHGEDEDELFD 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 30/204 (14%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV--GH 629
           +G+GGFG VY  R  +     A+K L        +  Q E    + ++ R + SLV  G 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGET---LALNERIMLSLVSTGD 55

Query: 630 C----------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           C             ++ + I + M  G+L  +LS     V S  E    A E   GLE++
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHM 113

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           HN     +V+RD+K  NILL+E    +++D GL+  F +    H S    GT GY+ PE 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASV---GTHGYMAPEV 166

Query: 740 YTSNRLTEKS-DVYSFGVVILEII 762
                  + S D +S G ++ +++
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 33/231 (14%)

Query: 561 SDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV 618
           SD  +I      T+GKG +G V+    + N    AVK+L        ++ +AE  +L  +
Sbjct: 17  SDTWEII----ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKAL 71

Query: 619 H-HRNLTSLVG-HCDED----NQTALIYEFMANGNLQEYLSDISKKVLSSQERLR----- 667
             H N+    G +  +D    +Q  L+ E    G++    +D+ K  L   ER+      
Sbjct: 72  SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV----TDLVKGFLKRGERMEEPIIA 127

Query: 668 -IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
            I  E+  GL++LH       +HRDVK  NILL  +   KL DFG+S    +      ++
Sbjct: 128 YILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184

Query: 727 VVAGTPGYLDPEYYTSNR-----LTEKSDVYSFGVVILEIITCKPAISRIN 772
           V  GTP ++ PE     +        + DV+S G+  +E+    P ++ ++
Sbjct: 185 V--GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 51/194 (26%), Positives = 97/194 (50%), Gaps = 14/194 (7%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLS-SSSAQGFQQFQA-EVKLLMRVHHRNLTSLVG 628
           +G+G +GTV+  +    +EI VA+K +      +G       E+ LL  + H+N+  L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEI-VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
               D +  L++E+  + +L++Y    +  +     +     +  +GL + H+     ++
Sbjct: 67  VLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKS-FMFQLLKGLAFCHS---HNVL 121

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+K  N+L+N+  + KLADFGL+++F      + + VV  T  Y  P+     +L   
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYST 179

Query: 749 S-DVYSFGVVILEI 761
           S D++S G +  E+
Sbjct: 180 SIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)

Query: 572 RTLGKGGFGTV----------YYGRLNEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRV 618
           + LGKG FG V          YY        A+K+L      +         E ++L   
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYY--------AMKILKKEVIVAKDEVAHTLTENRVLQNS 52

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLE 677
            H  LT+L       ++   + E+ ANG   E    +S++ + S++R R    E    L+
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFSEDRARFYGAEIVSALD 109

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           YLH+  +  +V+RD+K  N++L++    K+ DFGL K    D  T       GTP YL P
Sbjct: 110 YLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAP 165

Query: 738 EYYTSNRLTEKSDVYSFGVVILEII 762
           E    N      D +  GVV+ E++
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMM 190

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 21/216 (9%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQGFQQFQA-EVKLLMRVHHRNLTSL--V 627
           +G+G +G VY  R    NE     K+      +G       E+ LL  + H N+  L  V
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNGCKPP 686
            H ++  +  L++E++ + +L++++ D S     +   ++  + +  +G+ Y H+     
Sbjct: 70  VHSEK--RLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCHSH---R 122

Query: 687 IVHRDVKSTNILLNEKLQA-KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR- 744
           ++HRD+K  N+L++ +  A KLADFGL+++F     T    VV  T  Y  PE    +R 
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGSRH 180

Query: 745 LTEKSDVYSFGVVILEIITCKPAI---SRINEEEKI 777
            +   D++S G +  E++  KP     S I+E  KI
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216

Length = 294

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 17/217 (7%)

Query: 567 TNNFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVK------LLMRV 618
             NF   LGKG FG V        D   A+K+L        Q    E        L ++ 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQD 58

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
               LT L       ++   + E++  G+L  ++  + K      + +  A E + GL +
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFF 116

Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH   +  I++RD+K  N++L+ +   K+ADFG+ K    D  T  +    GTP Y+ PE
Sbjct: 117 LH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPE 171

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
                   +  D +++GV++ E++  +P     +E+E
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 21/213 (9%)

Query: 569 NFE--RTLGKGGFGTVY---------YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR 617
           NFE  R LG G +G V+          G+L  + V  K      A+  +  + E ++L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 618 VHHRN-LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
           V     L +L      D +  LI +++  G L  +L    +    S+ R+ IA E    L
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIA-EIVLAL 118

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           ++LH   +  I++RD+K  NILL+ +    L DFGLSK F  +     +    GT  Y+ 
Sbjct: 119 DHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMA 174

Query: 737 PEYYTSNRLTEKS--DVYSFGVVILEIIT-CKP 766
           PE             D +S GV+  E++T   P
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 37/226 (16%)

Query: 572 RTLGKGGFGT---VYYG--RLNEIDVAVKMLSSSSAQGFQQFQ--------AEVKLLMRV 618
           + LGK G GT   V     R      A+K +        + F+         E++ L R+
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRL 54

Query: 619 -HHRNLTSLVGHCDEDNQT---ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
             H N+  L+     D +T   AL++E M + NL E +    K+ L  +       +  +
Sbjct: 55  SPHPNILRLIEVL-FDRKTGRLALVFELM-DMNLYELIKG-RKRPLPEKRVKSYMYQLLK 111

Query: 675 GLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            L+++H NG    I HRD+K  NIL+ + +  KLADFG   S     +    T    T  
Sbjct: 112 SLDHMHRNG----IFHRDIKPENILIKDDI-LKLADFG---SCRGIYSKPPYTEYISTRW 163

Query: 734 YLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH 778
           Y  PE   T      K D+++ G V  EI++  P     NE ++I 
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA 209

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 22/210 (10%)

Query: 569 NFE--RTLGKGGFGTVYY---------GRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR 617
           NFE  + LG G +G V+          G+L  + V  K      A+  +  + E ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 618 VHHRN-LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQG 675
           +     L +L      D +  LI +++  G   E  + +S++    ++ ++I   E    
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGG---ELFTHLSQRERFKEQEVQIYSGEIVLA 117

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH   K  I++RD+K  NILL+      L DFGLSK F  D      +   GT  Y+
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173

Query: 736 DPEYYTSNRLTEKS--DVYSFGVVILEIIT 763
            P+             D +S GV++ E++T
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 26/218 (11%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLS--------SSSAQGFQQFQAEVKLLMRVHHRNL 623
           +G+G +G VY  R       VA+K +          S+A        E+ LL  ++H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKELNHPNI 60

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L+     +N+  L++EF+ + +L++Y+       L          +  QG+ Y H+  
Sbjct: 61  VRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              ++HRD+K  N+L++ +   KLADFGL+++F     T+   VV  T  Y  PE    +
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGS 174

Query: 744 RLTEKS-DVYSFGVVILEIITCKPAI---SRINEEEKI 777
           R      D++S G +  E++  +P     S I++  +I
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 18/198 (9%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           +GKG FG VY  R  +     A+K+LS     + +       E  +L+R        +VG
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 629 ---HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNGCK 684
                  D+   L+ ++M+ G L  +L    K+   S++R +  + E    LE+LH   K
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLH---K 114

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             IV+RD+K  NILL+      L DFGLSK+  TD  T  +    GT  YL PE     +
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEK 172

Query: 745 -LTEKSDVYSFGVVILEI 761
             T+  D +S GV++ E+
Sbjct: 173 GYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)

Query: 569 NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLL-MRVHHRN--- 622
           NF   LGKG FG V        D   A+K+L        Q    E  ++  RV   +   
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKP 60

Query: 623 --LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             LT L       ++   + E++  G+L   +  + +        +  A E A GL +LH
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLH 118

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I++RD+K  N++L+ +   K+ADFG+ K    D  T  +    GTP Y+ PE  
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEII 173

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
                 +  D ++FGV++ E++  +      +E+E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 5e-11
 Identities = 63/245 (25%), Positives = 101/245 (41%), Gaps = 62/245 (25%)

Query: 568 NNFE--RTLGKGGFGTVYYGRL------NEIDVAVKMLSSSSAQGFQQ---FQAEVKLLM 616
           ++FE  + +G+G FG V   RL        I  A+K L  S     +Q    +AE  +L 
Sbjct: 1   DDFESIKVIGRGAFGEV---RLVQKKDTGHI-YAMKKLRKSEMLEKEQVAHVRAERDILA 56

Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE-RLRIAVESAQG 675
              +  +  L     ++N   LI E++  G++   L  + K   + +E R  IA E+   
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIA-ETILA 113

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-------HV---- 724
           ++ +H   K   +HRD+K  N+LL+ K   KL+DFGL         T       H     
Sbjct: 114 IDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 725 ---------------------------STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
                                      STV  GTP Y+ PE +      ++ D +S GV+
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECDWWSLGVI 228

Query: 758 ILEII 762
           + E++
Sbjct: 229 MYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)

Query: 569 NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLL-MRV-----HH 620
           NF   LGKG FG V        D   A+K+L        Q    E  ++  RV       
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKP 60

Query: 621 RNLTSLVGHCDEDNQTALIY--EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
             LT L  H        L +  E++  G+L  ++  + K        +  A E A GL +
Sbjct: 61  PFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFF 116

Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH      I++RD+K  N++L+ +   K+ADFG+ K       T  +    GTP Y+ PE
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAPE 171

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
                   +  D ++FGV++ E++  +P     +E+E
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 574 LGKGGFGTVYYGRLNEID---VAVKMLSSSSAQGFQQFQA--EVKLLMRVH---HRNLTS 625
           +G+G +G V+  R  +     VA+K +   + +         EV +L  +    H N+  
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 626 LVGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           L   C     D + +  L++E + + +L  YL  + +  + ++    +  +  +GL++LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +VHRD+K  NIL+    Q KLADFGL++ ++        T V  T  Y  PE  
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVL 181

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
             +      D++S G +  E+   KP
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 36/217 (16%)

Query: 572 RTLGKGGFGTV----YYGRLNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVH-HRNLT 624
           + LG+G +G V          E  VA+K +++  ++     +A  E+KLL     H+N+T
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 625 SLVGHCDED-------NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES----- 672
            L    D D       N+  L  E M      E   D+ + + S Q       +S     
Sbjct: 66  CLY---DMDIVFPGNFNELYLYEELM------EA--DLHQIIRSGQPLTDAHFQSFIYQI 114

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAG 730
             GL+Y+H+     ++HRD+K  N+L+N   + K+ DFGL++ F+ +   N    T    
Sbjct: 115 LCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 731 TPGYLDPEYYTSNRLTEKS-DVYSFGVVILEIITCKP 766
           T  Y  PE   S +   K+ DV+S G ++ E++  KP
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 11/196 (5%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQ---GFQQFQAEVKLLMRVHHRNLTSL 626
           R LGKGGFG V     R      A K L     +   G      E ++L +V+ R + SL
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
               +  +   L+   M  G+L+ ++ ++       +  +  A E   GLE LH   +  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RER 122

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IV+RD+K  NILL++    +++D GL+     +  T    V  GT GY+ PE   + R T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGETIRGRV--GTVGYMAPEVVKNERYT 179

Query: 747 EKSDVYSFGVVILEII 762
              D +  G +I E+I
Sbjct: 180 FSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 13/197 (6%)

Query: 572 RTLGKGGFGTVYYGRLNEIDV--AVKMLSSSS---AQGFQQFQAEVKLLMR-VHHRNLTS 625
           + +GKG FG V   +        AVK+L   +    +  +   AE  +L++ V H  L  
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L       ++   + +++  G L  +L    +     + R   A E A  L YLH+    
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARF-YAAEIASALGYLHS---L 115

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I++RD+K  NILL+ +    L DFGL K    + +   ST   GTP YL PE       
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTST-FCGTPEYLAPEVLRKQPY 173

Query: 746 TEKSDVYSFGVVILEII 762
               D +  G V+ E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 67/235 (28%), Positives = 109/235 (46%), Gaps = 35/235 (14%)

Query: 560 YSDVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKM-LSSSSAQGFQQFQA--EVKL 614
           Y  + KI        G+G FG V+  R    +  VA+K  L  +  +GF    A  E+K+
Sbjct: 14  YEKLAKI--------GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP-ITALREIKI 64

Query: 615 LMRVHHRNLTSLVGHCD-----EDNQTA---LIYEFMANGNLQEYLSDISKKVLSSQERL 666
           L  + H N+ +L+  C       +       L++EF  + +L   LS+ + K  +  E  
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK-FTLSEIK 122

Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF----ATDANT 722
           ++      GL Y+H      I+HRD+K+ NIL+ +    KLADFGL+++F     +  N 
Sbjct: 123 KVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 723 HVSTVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEK 776
           + + VV  T  Y  PE     R      D++  G ++ E+ T  P I + N E+ 
Sbjct: 180 YTNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP-IMQGNTEQH 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 27/212 (12%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQ---FQAEVKLLMRVHH 620
           ++FE  + +G+G FG V   ++       A+K+L+        +   F+ E  +L+    
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-----AVESAQG 675
           R +T+L     ++N   L+ ++   G+L   LS    ++     R  +     A++S   
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           L Y         VHRD+K  N+LL++    +LADFG       D  T  S V  GTP Y+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQSNVAVGTPDYI 170

Query: 736 DPEYYTS-----NRLTEKSDVYSFGVVILEII 762
            PE   +      R   + D +S GV + E++
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.9 bits (153), Expect = 3e-10
 Identities = 73/249 (29%), Positives = 108/249 (43%), Gaps = 51/249 (20%)

Query: 542 RESKNKIDSFEAKSRHLSYSDVV-KITN--------NFERTLGKGGFGTVYYGRLNEID- 591
           R++KN ID+F ++     Y     KIT         +  + +G+G FG V   R      
Sbjct: 16  RKNKN-IDNFLSR-----YEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQ 69

Query: 592 -VAVKMLS-------SSSAQGFQQFQAEVKLLMRVHHRNLTSLVG-HC--DEDNQTALIY 640
             A+K+LS       S SA     F  E + +M   H N   +V  H    +D    ++ 
Sbjct: 70  VYAMKLLSKFEMIKRSDSA-----FFWEERDIMA--HANSEWIVQLHYAFQDDKYLYMVM 122

Query: 641 EFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNI 697
           E+M  G+L   +S  DI +K      R   A E    L+ +H+ G     +HRDVK  N+
Sbjct: 123 EYMPGGDLVNLMSNYDIPEK----WARFYTA-EVVLALDAIHSMG----FIHRDVKPDNM 173

Query: 698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT----EKSDVYS 753
           LL++    KLADFG       +      T V GTP Y+ PE   S         + D +S
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 232

Query: 754 FGVVILEII 762
            GV + E++
Sbjct: 233 VGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 17/207 (8%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQ---FQAEVKLLMRVHH 620
           ++FE  + +G+G FG V   ++   +   A+K+L+        +   F+ E  +L+    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + +T+L     ++N   L+ ++   G+L   LS    ++     R  IA E    +  +H
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIH 119

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
              +   VHRD+K  N+LL+     +LADFG       D     S+V  GTP Y+ PE  
Sbjct: 120 ---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SSVAVGTPDYISPEIL 175

Query: 741 TS-----NRLTEKSDVYSFGVVILEII 762
            +      +   + D +S GV + E++
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.2 bits (151), Expect = 4e-10
 Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 31/202 (15%)

Query: 650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLA 708
           E   ++ K+ L+ ++ +  + + A+G+E+L +  C    +HRD+ + NILL+E    K+ 
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKIC 215

Query: 709 DFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-- 765
           DFGL++    D + +V    A  P  ++ PE       T +SDV+SFGV++ EI +    
Sbjct: 216 DFGLARDIYKDPD-YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS 274

Query: 766 --PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE-DFDANSVWKAVELAMACLSP 822
             P + +I+EE    +++                 R++  ++    ++  +   + C   
Sbjct: 275 PYPGV-QIDEEFCRRLKEGT---------------RMRAPEYATPEIYSIM---LDCWHN 315

Query: 823 TGNQRPTMSQVVMELSECLAAE 844
               RPT S++V  L + L   
Sbjct: 316 NPEDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 29/196 (14%)

Query: 654 DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS 713
           D+ KKVL+ ++ +  + + A+G+E+L        +HRD+ + NILL+E    K+ DFGL+
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 226

Query: 714 KSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAI 768
           +    D + +V    A  P  ++ PE       T +SDV+SFGV++ EI +      P +
Sbjct: 227 RDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285

Query: 769 SRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE-DFDANSVWKAVELAMACLSPTGNQR 827
            +I+EE    +++                 R++  D+    +++ +   + C     +QR
Sbjct: 286 -KIDEEFCRRLKE---------------GTRMRAPDYTTPEMYQTM---LDCWHGEPSQR 326

Query: 828 PTMSQVVMELSECLAA 843
           PT S++V  L   L A
Sbjct: 327 PTFSELVEHLGNLLQA 342

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.1 bits (151), Expect = 5e-10
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 43/215 (20%)

Query: 571 ERTLGKGGFGTVYY------GRLNEIDVAVKMLSSSSAQGFQQFQA------EVKLLMRV 618
           +R +G G FG V+       G+     VA+K + +     FQ   +      E+K+L   
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGK----RVALKKMPNV----FQNLVSCKRVFRELKMLCFF 56

Query: 619 HHRNLTSLV-----GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQ----ERLRIA 669
            H N+ S +      H D   +  ++ E M         SD+ K ++S Q    + +++ 
Sbjct: 57  KHDNVLSALDILQPPHIDPFEEIYVVTELMQ--------SDLHKIIVSPQPLSSDHVKVF 108

Query: 670 V-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
           + +  +GL+YLH+     I+HRD+K  N+L+N     K+ DFGL++    D + H++  V
Sbjct: 109 LYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165

Query: 729 AGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEII 762
             T  Y  PE    S   T   D++S G +  E++
Sbjct: 166 V-TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)

Query: 572 RTLGKGGFGTVYYGRL---NEIDVAVKMLSSSSA---QGFQQFQAEVKLL-MRVHHRNLT 624
           + LGKG FG V    L    E   AVK L           +    E ++L +   +  LT
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEY-FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L            + EF+  G+L  ++ D  K           A E   GL++LH+   
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK-- 115

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I++RD+K  N++L+     K+ADFG+ K      N   ++   GTP Y+ PE     +
Sbjct: 116 -GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEE 775
            T   D +SFGV++ E++  +      +E+E
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.2 bits (148), Expect = 7e-10
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 15/202 (7%)

Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLSSS---SAQGFQQFQAEVKLLMR-VHHRNLTS 625
           + +GKG FG V   +  L+    AVK+L      + +  +   AE  +L++ V H  L  
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGCK 684
           L        +   + +F+  G L  +L    ++    + R R  A E A  L YLH+   
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS--- 114

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             IV+RD+K  NILL+ +    L DFGL K     ++T  +T   GTP YL PE      
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQP 172

Query: 745 LTEKSDVYSFGVVILEIITCKP 766
                D +  G V+ E++   P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 8e-10
 Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 13/210 (6%)

Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSS---AQGFQQFQAEVKLLMR-VHHRNLTS 625
           + +GKG FG V   R    E   AVK+L   +    +  +   +E  +L++ V H  L  
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L       ++   + +++  G L  +L    +  L  + R   A E A  L YLH+    
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARF-YAAEIASALGYLHS---L 115

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            IV+RD+K  NILL+ +    L DFGL K    + N   ST   GTP YL PE       
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTST-FCGTPEYLAPEVLHKQPY 173

Query: 746 TEKSDVYSFGVVILEIITCKPAISRINEEE 775
               D +  G V+ E++   P     N  E
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.9 bits (147), Expect = 8e-10
 Identities = 56/196 (28%), Positives = 103/196 (52%), Gaps = 17/196 (8%)

Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLVGH 629
           LG+G + TVY G+  +N   VA+K++     +G   F A  E  LL  + H N+  L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
                   L++E++ + +L +Y+      +     +L +  +  +GL Y+H   +  I+H
Sbjct: 72  IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIH---QRYILH 126

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKS 749
           RD+K  N+L+++  + KLADFGL+++ +  ++T+ + VV  T  Y  P+    +  TE S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS--TEYS 182

Query: 750 ---DVYSFGVVILEII 762
              D++  G + +E+I
Sbjct: 183 TCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.8 bits (148), Expect = 8e-10
 Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 26/206 (12%)

Query: 572 RTLGKGGFGTVYYGRLNEIDVAVKM--LSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
           +         +   +     VAVK   L S S +  +  Q E+    ++ H N+   V  
Sbjct: 8   KCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67

Query: 630 CDEDNQTALIYEFMANGN----LQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCK 684
              D++  ++   MA G+    L+ +  +   ++  +     I  +    L+Y+H  G  
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF----ILKDVLNALDYIHSKGF- 122

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-------LDP 737
              +HR VK+++ILL+   +  L+    S S           VV   P         L P
Sbjct: 123 ---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ--RVVHDFPKSSVKNLPWLSP 177

Query: 738 EYYTSNRL--TEKSDVYSFGVVILEI 761
           E    N     EKSD+YS G+   E+
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 62.2 bits (151), Expect = 9e-10
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 34/136 (25%)

Query: 385 DPCAPLAYW--------WDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFL 436
           DP   L+ W        W G+ C+    +S R+  ++LS   + G I+S +  L  +Q +
Sbjct: 43  DPLKYLSNWNSSADVCLWQGITCN----NSSRVVSIDLSGKNISGKISSAIFRLPYIQTI 98

Query: 437 DLSNNNLTGSVPD--FLSKLPLRTLNLQGNKLNGSVP------VELLERSKN-------- 480
           +LSNN L+G +PD  F +   LR LNL  N   GS+P      +E L+ S N        
Sbjct: 99  NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPN 158

Query: 481 --GSLS----LSVGGN 490
             GS S    L +GGN
Sbjct: 159 DIGSFSSLKVLDLGGN 174

Length = 968

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 43/125 (34%), Positives = 57/125 (45%), Gaps = 20/125 (16%)

Query: 665 RLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK----SFAT- 718
           R+  A E+   LEYLHN G    IVHRD+K  N+L+      KL DFGLSK    S  T 
Sbjct: 104 RMYFA-ETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158

Query: 719 --------DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI-ITCKPAIS 769
                   D    +   V GTP Y+ PE        +  D ++ G+++ E  + C P   
Sbjct: 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218

Query: 770 RINEE 774
              EE
Sbjct: 219 DTPEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 23/244 (9%)

Query: 573 TLGKGGFGTVYYGRLNEI-DV-AVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLV 627
            +G+G FG V   R     D+ A+K++  S   + +    F+ E  +L   +   +  L 
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               + +   L+ E+   G+L   L+    +      +  +A E    +  +H   +   
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVH---QMGY 123

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV-STVVAGTPGYLDPEYYTSNRLT 746
           VHRD+K  N+L++     KLADFG   +    AN  V S +  GTP Y+ PE  T+    
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFG--SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 747 EKS------DVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
            K       D +S GV+  E+I       R    E    + + N +  +  +K   DP++
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMI-----YGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236

Query: 801 QEDF 804
             DF
Sbjct: 237 SSDF 240

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)

Query: 574 LGKGGFGTVYYGRL----NEIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHRNLTSLVG 628
           +G G FG V    +        V VK L ++++   Q +F  +      + H N+   +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL--RIAVESAQGLEYLHNGCKPP 686
            C E     L++E+   G+L+ YLS       +SQ  L  R+A E A G+ ++H   K  
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTVVAGTPGYLDPEYYTS--N 743
            +H D+   N  L   L  K+ D+G+  S +  D              +L PE       
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR-WLAPELVGEFHG 178

Query: 744 RL-----TEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
            L     T+ S+V++ GV + E+        S +++      R+ +N +I    +K +  
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQQVK-LFK 231

Query: 798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
           P+L+  +     W  V L    LSP   +R T  +V
Sbjct: 232 PQLELPYSER--WYEV-LQFCWLSP--EKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 14/162 (8%)

Query: 611 EVKLLMRVHHRNLTSLVG-----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           E+KLL  + H N+ ++       H +  N   ++YE M + +L + +   S + LS    
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIR--SSQTLSDDHC 110

Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
                +  +GL+Y+H+     ++HRD+K +N+LLN     K+ DFGL+++ +   +    
Sbjct: 111 QYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167

Query: 726 TVVAGTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKP 766
            VV  T  Y  PE     +  T   DV+S G +  E++  KP
Sbjct: 168 YVV--TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 66/289 (22%), Positives = 114/289 (39%), Gaps = 52/289 (17%)

Query: 572 RTLGKGGFGTVYYGRL------------NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH 619
             LG+G F  +Y G L             E+ V +K+L S   +    F     L+ ++ 
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLS 59

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           H++L  L G C  D +  ++ E++  G L  +L    K  +S   +L +A + A  L YL
Sbjct: 60  HKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLH-REKNNVSLHWKLDVAKQLASALHYL 117

Query: 680 HNGCKPPIVHRDVKSTNILL-----NEKLQ--AKLADFGLSKSFATDANTHVSTVVAGTP 732
            +     +VH +V   NIL+     NE      KL+D G+  +  +         V   P
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIP 169

Query: 733 GYLDPEYY--TSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAK 789
            ++ PE        LT  +D +SFG  +LEI +  +  +S ++  EK          +  
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQHRLPM 227

Query: 790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
            D   +                   L   C +    +RP+   ++ +L+
Sbjct: 228 PDCAELA-----------------NLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 48/194 (24%), Positives = 90/194 (46%), Gaps = 11/194 (5%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQ---GFQQFQAEVKLLMRVHHRNLTSLVG 628
           LGKGGFG V   ++       A K L     +   G +    E ++L +V+   + +L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
             +      L+   M  G+L+ ++ ++ ++ L  +  +  + +   G+ +LH+     IV
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           +RD+K  N+LL+++   +L+D GL+            T  AGT GY+ PE       +  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSYP 174

Query: 749 SDVYSFGVVILEII 762
            D ++ G  I E++
Sbjct: 175 VDWFAMGCSIYEMV 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)

Query: 569 NFE--RTLGKGGFGTVYY---------GRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR 617
           NFE  + LG G +G V+          G+L  + V  K      A+  +  + E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 618 VHHRN-LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQG 675
           V     L +L      + +  LI ++++ G   E  + + ++   S++ +R    E    
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGG---EMFTHLYQRDNFSEDEVRFYSGEIILA 117

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH   K  IV+RD+K  NILL+ +    L DFGLSK F ++      +   GT  Y+
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYM 173

Query: 736 DPEYYTSNRLTEKS-DVYSFGVVILEIIT 763
            PE         K+ D +S G++I E++T
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 39/126 (30%), Positives = 69/126 (54%), Gaps = 7/126 (5%)

Query: 640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNIL 698
           Y+   +  ++  LSD   + L++ + L    + A+G+E+L +  C    VHRD+ + N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVL 269

Query: 699 LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVV 757
           L +    K+ DFGL++    D+N +VS      P  ++ PE    N  T  SDV+S+G++
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328

Query: 758 ILEIIT 763
           + EI +
Sbjct: 329 LWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 55/222 (24%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSL 626
              +G G +G V       +   VA+K +  +       ++   E+K+L    H      
Sbjct: 10  IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH------ 63

Query: 627 VGHCDEDNQTALIYEFMANGN----------LQEYLSDISKKVLSSQ------------E 664
                 DN  A+       G           L E  SD+   + S Q            +
Sbjct: 64  ------DNIIAIRDILRPPGADFKDVYVVMDLME--SDLHHIIHSDQPLTEEHIRYFLYQ 115

Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK---SFATDAN 721
            LR       GL+Y+H+     ++HRD+K +N+L+NE  + ++ DFG+++   S  T+  
Sbjct: 116 LLR-------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165

Query: 722 THVSTVVAGTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEII 762
             ++  VA T  Y  PE   +    T   D++S G +  E++
Sbjct: 166 YFMTEYVA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.5 bits (141), Expect = 7e-09
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 7/158 (4%)

Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E  +L  ++H ++  L G    +  T LI       +L  YL+   K+ ++  + L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAA--KRNIAICDILAIER 189

Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
              + ++YLH      I+HRD+K+ NI +N      L DFG +  F  D N +     AG
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAI 768
           T     PE    +      D++S G+V+ E+ TC  ++
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 12/198 (6%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
           +GKG FG V   R  +     A+K +  +   S        AE  +L +V+   +  L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
                 +  L+  F+  G L  +L     +   S+ R   A E    LE LH   K  ++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTA-ELLCALENLH---KFNVI 115

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           +RD+K  NILL+ +    L DFGL K      +   +    GTP YL PE    +  T+ 
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCK--LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 749 SDVYSFGVVILEIITCKP 766
            D ++ GV++ E++T  P
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 12/205 (5%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQA----EVKLLMRVHHR 621
           N FE    +G+G +G V   R  E    V +     ++  ++ +     E+K+L  +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           N+  L        +  L++E++   N+ E L ++   V   + R  I     Q ++ +H 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIY----QLIKAIHW 115

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
             K  IVHRD+K  N+L++     KL DFG +++ +  +N + +  VA T  Y  PE   
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPELLL 174

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP 766
                +  D++S G ++ E+   +P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.2 bits (141), Expect = 1e-08
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 33/222 (14%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLS---SSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
           R +GKGG G VY  Y  +    VA+K +    S +    ++F  E K+   + H  +  +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLS-----DISKKVLSSQER----LRIAVESAQGLE 677
              C + +       ++    L+  L      +   K L+ +      L I  +    +E
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS--------FATDANT-----HV 724
           Y+H+     ++HRD+K  NILL    +  + D+G +             D +        
Sbjct: 128 YVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 725 STV---VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            T+   + GTP Y+ PE       +E +D+Y+ GV++ +++T
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 58.2 bits (140), Expect = 2e-08
 Identities = 63/247 (25%), Positives = 105/247 (42%), Gaps = 38/247 (15%)

Query: 560 YSDVVKITNNFE--RTLGKGGFGTVY---YGRLNEIDVAVKMLSSSSAQGFQQFQ--AEV 612
           Y D     N +E  + +G G FG V+   + R  E     K +S    +  ++ Q   EV
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEF-FCWKAISYRGLKEREKSQLVIEV 63

Query: 613 KLLMRVHHRNLTSLVGH-CDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQER--LRI 668
            ++  + H+N+   +    ++ NQ   I  EF   G+L   +    K     +E   + I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 669 AVESAQGLEYLHNGCKPP----IVHRDVKSTNILLNEKLQ-----------------AKL 707
             +    L Y HN    P    ++HRD+K  NI L+  ++                 AK+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 708 ADFGLSKSFATDANTHVSTVVAGTPGYLDPE--YYTSNRLTEKSDVYSFGVVILEIITCK 765
            DFGLSK+   ++  H      GTP Y  PE   + +    +KSD+++ G +I E+ + K
Sbjct: 184 GDFGLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 766 PAISRIN 772
               + N
Sbjct: 241 TPFHKAN 247

Length = 1021

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 41/126 (32%), Positives = 69/126 (54%), Gaps = 10/126 (7%)

Query: 654 DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS 713
           D+ K  L+ ++ +  + + A+G+E+L        +HRD+ + NILL+E    K+ DFGL+
Sbjct: 165 DLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 221

Query: 714 KSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAI 768
           +    D + +V    A  P  ++ PE       T +SDV+SFGV++ EI +      P +
Sbjct: 222 RDIYKDPD-YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280

Query: 769 SRINEE 774
            +INEE
Sbjct: 281 -QINEE 285

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 8/152 (5%)

Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E  LL  V+H ++  +         T ++     + +L  YL+  S+  L   + L I  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP-LPIDQALIIEK 164

Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           +  +GL YLH      I+HRDVK+ NI +N+  Q  + D G ++             +AG
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAG 218

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEII 762
           T     PE    ++   K+D++S G+V+ E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 61/260 (23%), Positives = 107/260 (41%), Gaps = 46/260 (17%)

Query: 569 NFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQ---FQAEVKLLMRVHHR 621
           +FE  + +G+G FG V   +  +     A+K+L  +     +Q    +AE  +L+     
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
            +  +     +     LI EF+  G++   L  + K  L+ +E      E+   ++ +H 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIH- 118

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFG----------------LSKSFATD------ 719
             +   +HRD+K  N+LL+ K   KL+DFG                L+ S  +D      
Sbjct: 119 --QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 720 -----ANT------HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE-IITCKPA 767
                A T       ++    GTP Y+ PE +      +  D +S GV++ E +I   P 
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 768 ISRINEEEKIHIRQWVNSLI 787
            S   +E    +  W  +LI
Sbjct: 237 CSETPQETYKKVMNWKETLI 256

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 64/253 (25%), Positives = 116/253 (45%), Gaps = 33/253 (13%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLVGH 629
           +G+G +G V+  R  E    VA+K    S      +  A  E+++L ++ H NL +L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIV 688
                +  L++E+  +  L E   + + + +      +I  ++ Q + + H + C    +
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC----I 122

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFAT--DANT-HVSTVVAGTPGYL--DPEYYTSN 743
           HRDVK  NIL+ ++ Q KL DFG ++      D  T +V+T     P  L  D +Y    
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPP- 181

Query: 744 RLTEKSDVYSFGVVILEIITCKPAI-SRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE 802
                 DV++ G V  E++T +P    + + ++   IR+ +  LI          PR Q+
Sbjct: 182 -----VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLI----------PRHQQ 226

Query: 803 DFDANSVWKAVEL 815
            F  N  +K + +
Sbjct: 227 IFSTNQFFKGLSI 239

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 7/107 (6%)

Query: 659 VLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
            LS  + +  + + A G+E+L +  C    VHRD+ + N+L+ E    K+ DFGL++   
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIM 290

Query: 718 TDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            D+N ++S      P  ++ PE   +N  T  SDV+SFG+++ EI T
Sbjct: 291 RDSN-YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 57/261 (21%), Positives = 102/261 (39%), Gaps = 46/261 (17%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQ---FQAEVKLLMRVHH 620
           ++FE  + +G+G FG V   +  +     A+K+L  +     +Q    +AE  +L+    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             +  +     +     LI EF+  G++   L  + K  LS +       E+   ++ +H
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIH 118

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT------------------ 722
              +   +HRD+K  N+LL+ K   KL+DFGL         T                  
Sbjct: 119 ---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 723 ---------------HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE-IITCKP 766
                           ++    GTP Y+ PE +      +  D +S GV++ E +I   P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 767 AISRINEEEKIHIRQWVNSLI 787
             S   +E    +  W  +L+
Sbjct: 236 FCSETPQETYRKVMNWKETLV 256

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 30/232 (12%)

Query: 542 RESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLSS 599
           +++ NKI     K+      +VVK+       +G+G FG V   R        A+K+LS 
Sbjct: 29  KDTINKIRDLRMKAEDY---EVVKV-------IGRGAFGEVQLVRHKSTRKVYAMKLLSK 78

Query: 600 -----SSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD 654
                 S   F  F  E  ++   +   +  L     +D    ++ E+M  G+L   +S+
Sbjct: 79  FEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 136

Query: 655 ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK 714
               V     R   A E    L+ +H+      +HRDVK  N+LL++    KLADFG   
Sbjct: 137 YD--VPEKWARFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190

Query: 715 SFATDANTHVSTVVAGTPGYLDPEYYTSN----RLTEKSDVYSFGVVILEII 762
               +      T V GTP Y+ PE   S         + D +S GV + E++
Sbjct: 191 KMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 35/103 (33%), Positives = 57/103 (55%), Gaps = 13/103 (12%)

Query: 666 LRIAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           LR + + AQG+++L    C    +HRDV + N+LL +   AK+ DFGL++    D+N   
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--- 267

Query: 725 STVVAGTP----GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             VV G       ++ PE       T +SDV+S+G+++ EI +
Sbjct: 268 -YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 28/219 (12%)

Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLSS--SSAQGFQQFQAEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK LS    S    ++   E++LL  + H N+  L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNG 682
                  +E N   L+   M        L++I K + L+      +  +  +GL+Y+H+ 
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 191

Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI 777
                +  D++S G ++ E++T +   P    I++ + I
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.5 bits (133), Expect = 5e-08
 Identities = 45/197 (22%), Positives = 91/197 (46%), Gaps = 13/197 (6%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSS---SSAQGFQQFQAEVKLLMRV-HHRNLTS 625
           R +G+G +  V   RL + +   A+K++     +  +     Q E  +  +  +H  L  
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L      +++   + E++  G+L  ++    ++ L  +     + E +  L YLH   + 
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLH---ER 115

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I++RD+K  N+LL+ +   KL D+G+ K      +T  ++   GTP Y+ PE       
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDY 173

Query: 746 TEKSDVYSFGVVILEII 762
               D ++ GV++ E++
Sbjct: 174 GFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 6e-08
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 42/212 (19%)

Query: 574 LGKGGFGTVYYGRLNEID------VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           +G G +G+V     + ID      VA+K LS       + FQ+E+    +  +R LT L+
Sbjct: 23  VGSGAYGSV----CSAIDKRTGEKVAIKKLS-------RPFQSEI--FAKRAYRELT-LL 68

Query: 628 GHCDEDNQTALIYEFMANGNLQEY-------------LSDISKKVLSSQERLRIAVESAQ 674
            H   +N   L+  F +  +  E+             L  I    LS  +   +  +   
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC 128

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           GL+Y+H      I+HRD+K  N+ +NE  + K+ DFGL++     A+  ++  V  T  Y
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH----ADAEMTGYVV-TRWY 180

Query: 735 LDPEYYTS-NRLTEKSDVYSFGVVILEIITCK 765
             PE   +     +  D++S G ++ E++T K
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 27/212 (12%)

Query: 562 DVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLSS-----SSAQGFQQFQAEVKL 614
           DVVK+       +G+G FG V   R   ++   A+K+LS       S   F  F  E  +
Sbjct: 46  DVVKV-------IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDI 96

Query: 615 LMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
           +   +   +  L     +D    ++ E+M  G+L   +S+    V     +   A E   
Sbjct: 97  MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTA-EVVL 153

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
            L+ +H+     ++HRDVK  N+LL++    KLADFG              T V GTP Y
Sbjct: 154 ALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDY 209

Query: 735 LDPEYYTSN----RLTEKSDVYSFGVVILEII 762
           + PE   S         + D +S GV + E++
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 17/203 (8%)

Query: 572 RTLGKGGFGTVYYGRLNEID---VAVKMLSSSS---AQGFQQFQAEVKLLMR-VHHRNLT 624
           + +GKG FG V   +  + D    AVK+L   +    +      AE  +L++ + H  L 
Sbjct: 1   KVIGKGSFGKVLLAK-RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGC 683
            L        +   + +++  G L  +L    ++    + R R  A E A  + YLH+  
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHS-- 114

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I++RD+K  NILL+ +    L DFGL K       T  ++   GTP YL PE     
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171

Query: 744 RLTEKSDVYSFGVVILEIITCKP 766
                 D +  G V+ E++   P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 55.2 bits (133), Expect = 1e-07
 Identities = 28/80 (35%), Positives = 45/80 (56%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKL 466
           P + +L++S++ L+G I S   ++ SLQ L L+ N   G +PD      L  L+L  N+ 
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF 487

Query: 467 NGSVPVELLERSKNGSLSLS 486
           +G+VP +L   S+   L LS
Sbjct: 488 SGAVPRKLGSLSELMQLKLS 507

Length = 968

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 36/226 (15%)

Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLLMRVHHRNL 623
           + +G G  G V   Y  +   +VA+K LS    + FQ    A     E+ L+  V+H+N+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLS----RPFQNVTHAKRAYRELVLMKLVNHKNI 77

Query: 624 TSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGL 676
             L+         +E     L+ E M + NL + +     ++    ER+   + +   G+
Sbjct: 78  IGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI-----QMDLDHERMSYLLYQMLCGI 131

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           ++LH+     I+HRD+K +NI++      K+ DFGL+++ A  +      VV  T  Y  
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 185

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
           PE        E  D++S G ++ E+I        +      HI QW
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIR-----GTVLFPGTDHIDQW 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 53.7 bits (130), Expect = 1e-07
 Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 13/155 (8%)

Query: 612 VKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVE 671
           V  LM+  + N   L           LI +++ +G+L + L    +  LS  E  +I  +
Sbjct: 61  VHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQ 117

Query: 672 SAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSKSFATDANTHVSTVVAG 730
             + L  LH   K  I+H D+K  N+L +  K +  L D+GL K           +   G
Sbjct: 118 LVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDG 168

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           T  Y  PE    +      D ++ GV+  E++T K
Sbjct: 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 64/260 (24%), Positives = 119/260 (45%), Gaps = 50/260 (19%)

Query: 572 RTLGKGGFGTV---YYGRLNEIDVAVKMLSS--SSAQGFQQFQAEVKLLMRVHHRNLTSL 626
             +G G +G+V   Y  RL +  VAVK LS    S    ++   E++LL  + H N+  L
Sbjct: 21  TPVGSGAYGSVCSAYDTRLRQ-KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79

Query: 627 V------GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYL 679
           +         +  N+  L+   M        L++I K    S E ++  + +  +GL+Y+
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGAD-----LNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           H+     I+HRD+K +N+ +NE  + ++ DFGL++    +   +V+     T  Y  PE 
Sbjct: 135 HSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVA-----TRWYRAPEI 186

Query: 740 YTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI------------------ 777
             +     +  D++S G ++ E++  K   P    I++ ++I                  
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246

Query: 778 HIRQWVNSL--IAKGDIKSI 795
           H R+++ SL  + + D+K I
Sbjct: 247 HARKYIQSLPHMPQQDLKKI 266

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 48/228 (21%), Positives = 98/228 (42%), Gaps = 13/228 (5%)

Query: 572 RTLGKGGFGTVYYGRL--NEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSL 626
           R +G+G +  V   RL  N+   A+K++        +     Q E  +  +         
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 627 VGHC-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           +  C    ++  L+ E++  G+L  ++    ++ L  +     A E    L +LH   + 
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLH---ER 115

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I++RD+K  N+LL+     KL D+G+ K      +T  ++   GTP Y+ PE       
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEY 173

Query: 746 TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK 793
               D ++ GV++ E++  +     I +   ++   ++  +I +  I+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 24/151 (15%)

Query: 576 KGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHC 630
           +G FG VY GR        AVK++  +   +     Q QAE   L       +  L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 631 DEDNQTALIYEFMANGNLQEYL-------SDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
              N   L+ E++  G+++  L        +++ K +S         E A  L+YLH   
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS---------EVALALDYLH--- 121

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSK 714
           +  I+HRD+K  N+L++ +   KL DFGLSK
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 5/105 (4%)

Query: 660 LSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT 718
           L +++ L  + + A+G+ +L +  C    +HRD+ + NILL      K+ DFGL++    
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           D+N  V         ++ PE   +   T +SDV+S+G+++ EI +
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 26/221 (11%)

Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLV 627
           + +G G  G V   +  +  I+VAVK LS          +A  E+ LL  V+H+N+ SL+
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     L+ E M     Q    ++  + +S      +  +   G+++LH+
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHS 141

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T+    + T    T  Y  PE   
Sbjct: 142 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVIL 195

Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
                E  D++S G ++ E++         +     HI QW
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTD-----HIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 6/96 (6%)

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS-TVVAGTP 732
           + L+Y+H      + HRD+K  NIL N   + K+ DFGL++    D  T +  T    T 
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 733 GYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKP 766
            Y  PE   S  ++ T   D++S G +  E++T KP
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 4e-07
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 412 LNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSV 470
           L+LS + L G+I   V  L +L+ L L +NN TG +P  L+ LP L+ L L  NK +G +
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348

Query: 471 PVELLERSKNGSLSLSV----GGNP-GLCS 495
           P  L + +    L LS     G  P GLCS
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378

Length = 968

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 41/225 (18%)

Query: 568 NNFER--TLGKGGFGTVY------YGRLNEIDVAVK-MLSSSSAQGFQQFQ-AEVKLLMR 617
           + +E+   +G+G +G VY       G+L    VA+K        +G       E+ LL  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKL----VALKKTRLEMDEEGIPPTALREISLLQM 56

Query: 618 VHHRN-LTSL--VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER--------- 665
           +     +  L  V H +E N    +Y         EYL    KK + S  R         
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVF------EYLDSDLKKFMDSNGRGPGRPLPAK 110

Query: 666 --LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANT 722
                  +  +G+ + H   K  ++HRD+K  N+L++ +K   K+AD GL ++F+    +
Sbjct: 111 TIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167

Query: 723 HVSTVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEIITCKP 766
           +   +V  T  Y  PE    S   +   D++S G +  E+   +P
Sbjct: 168 YTHEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.0 bits (124), Expect = 7e-07
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 26/220 (11%)

Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + + +VA+K LS          +A  E+ L+  V+H+N+ SL+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     L+ E M AN      L  + +  L  +    +  +   G+++LH
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDAN------LCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 190

Query: 741 TSNRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI 777
                 E  D++S G ++ E++  K   P    I++  K+
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 1e-06
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 40/225 (17%)

Query: 569 NFERTLGKGGFGTVYYGRLNEIDV----AVKMLSSSSAQ--GFQQFQA-EVKLLMRVHHR 621
             E  +G+G +G VY  +          A+K       Q  G  Q    E+ LL  + H 
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62

Query: 622 NLTSLVGHCDEDNQTA--LIYEFMANGNLQEYLSDIS-KKVLSSQERLRIAVESA----- 673
           N+ SLV    E    +  L++++ A  +L + +      K +S    +   V+S      
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSM---VKSLLWQIL 118

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSKSFATDANT--HVSTV 727
            G+ YLH+     ++HRD+K  NIL+     E+   K+ D GL++ F         +  V
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 728 VAGTPGYLDPE------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
           V  T  Y  PE      +YT        D+++ G +  E++T +P
Sbjct: 176 VV-TIWYRAPELLLGARHYTK-----AIDIWAIGCIFAELLTLEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.4 bits (123), Expect = 2e-06
 Identities = 28/71 (39%), Positives = 43/71 (60%), Gaps = 1/71 (1%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
           S P +  L+LS++ L G+I + + + +SL+ LDL  N L G +P+ L+ L  L  L L  
Sbjct: 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS 197

Query: 464 NKLNGSVPVEL 474
           N+L G +P EL
Sbjct: 198 NQLVGQIPREL 208

Length = 968

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 73/284 (25%), Positives = 104/284 (36%), Gaps = 70/284 (24%)

Query: 568 NNFE--RTLGKGGFGTVYYGRL-NEIDV----AVKMLSSSSAQGFQQF---QAEVKLLMR 617
            +F   + +GKG FG V   RL  + D     A+K L  S      Q    +AE  +L  
Sbjct: 1   EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57

Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQ-ERLRIAVESAQGL 676
                + SL     +     LI EF+  G+L   L  I     S    R  +A E    +
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--IKYDTFSEDVTRFYMA-ECVLAI 114

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF-------------------- 716
           E +H   K   +HRD+K  NIL++     KL+DFGLS  F                    
Sbjct: 115 EAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171

Query: 717 -ATDANTHV--------------------------STVVAGTPGYLDPEYYTSNRLTEKS 749
              + N+                            STV  GTP Y+ PE +      ++ 
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV--GTPDYIAPEIFLQQGYGQEC 229

Query: 750 DVYSFGVVILE-IITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
           D +S G ++ E +I   P  S  + E    I  W  +L    DI
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 32/210 (15%)

Query: 574 LGKGGFGTVYYGRLN--------------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH 619
           LG+G    +Y G LN              EI V +K+L  S       F     ++ +V 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           H+++  L G C  D +  ++ EF+  G L  ++   S  VL++  + ++A + A  L YL
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYL 121

Query: 680 HNGCKPPIVHRDVKSTNILL-NEKLQA------KLADFGLSKSFATDANTHVSTVVAGTP 732
            +     +VH +V + NILL  E +        KL+D G+  +  +         V   P
Sbjct: 122 ED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC-----VERIP 173

Query: 733 GYLDPEYYTSNR-LTEKSDVYSFGVVILEI 761
            ++ PE    ++ L+  +D +SFG  + EI
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 42/169 (24%), Positives = 76/169 (44%), Gaps = 26/169 (15%)

Query: 607 QFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI--------YEFMANGNLQEYLSDISKK 658
           Q + E+  L R++H N+  +      +  T +I        Y FM +         + K+
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268

Query: 659 VLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT 718
             +  ++L  AVE      Y+H+     ++HRD+K  NI LN   +  L DFG +  F  
Sbjct: 269 TRAIMKQLLCAVE------YIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 719 DANTH----VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +        V TV   +P  L  + Y      E +D++S G+++L++++
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGY-----CEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.2 bits (108), Expect = 2e-06
 Identities = 25/60 (41%), Positives = 34/60 (56%), Gaps = 1/60 (1%)

Query: 408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
            +  L+LS++ L          L +L+ LDLS NNLT   P+  S LP LR+L+L GN L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 3e-06
 Identities = 25/68 (36%), Positives = 42/68 (61%), Gaps = 1/68 (1%)

Query: 408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKL-PLRTLNLQGNKL 466
            +  L+L  + L G I + ++NLTSL+FL L++N L G +P  L ++  L+ + L  N L
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224

Query: 467 NGSVPVEL 474
           +G +P E+
Sbjct: 225 SGEIPYEI 232

Length = 968

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 46/205 (22%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 573 TLGKGGFGTVY---------YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL 623
           +LG+G F  ++         YG L++ +V +K+L  S     + F     ++ ++ H++L
Sbjct: 2   SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
               G C   +++ ++ E++  G+L  YL   +K +++   +L +A + A  L +L +  
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLED-- 118

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD------P 737
              + H +V + N+LL  +   K      +  F   ++  +S  V      L+      P
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTG----NPPFIKLSDPGISITVLPKEILLERIPWVPP 173

Query: 738 EYYTSNR-LTEKSDVYSFGVVILEI 761
           E   + + L+  +D +SFG  + EI
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.8 bits (119), Expect = 4e-06
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 23/207 (11%)

Query: 563 VVKITNNFERTLGKGGFGTVY----YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV 618
           VV++  N   +L  G  G V+    +G      V VK ++     G      E+ +L  +
Sbjct: 89  VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG-----REIDILKTI 143

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDIS----KKVLSSQERLRIAVESAQ 674
            HR + +L+ H      T  +       +L  Y+        ++ ++ Q RL  A     
Sbjct: 144 SHRAIINLI-HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEA----- 197

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
            L YLH      I+HRDVK+ NI L+E   A L DFG +       +T      +GT   
Sbjct: 198 -LAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEI 761
             PE    +    K+D++S G+V+ E+
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K LS          +A  E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      L  + +  L  +    +  +   G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN------LCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197

Query: 741 TSNRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI 777
                 E  D++S G ++ E+I      P    I++  K+
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.8 bits (119), Expect = 6e-06
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLPLRTLNLQ 462
           ++S  + YLNLS++   G I     ++ +L+ LDLSNN L+G +P D  S   L+ L+L 
Sbjct: 115 TTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172

Query: 463 GNKLNGSVPVELLERSKNGSLSLS----VGGNP 491
           GN L G +P  L   +    L+L+    VG  P
Sbjct: 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205

Length = 968

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 10/93 (10%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKMLS-SSSAQGFQQFQAEVKLLMRV-HH 620
             + LG+G FG V       I+       VAVKML   ++A  ++    E+K+L+ + HH
Sbjct: 11  LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70

Query: 621 RNLTSLVGHCDEDNQTAL-IYEFMANGNLQEYL 652
            N+ +L+G C +     + I E+   GNL  YL
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 33/125 (26%), Positives = 62/125 (49%), Gaps = 7/125 (5%)

Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
            + EF++ G+L  ++    +K+     R   + E +  L +LH      I++RD+K  N+
Sbjct: 73  FVIEFVSGGDLMFHMQR-QRKLPEEHARF-YSAEISLALNFLHER---GIIYRDLKLDNV 127

Query: 698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           LL+ +   KL D+G+ K      +T  ++   GTP Y+ PE           D ++ GV+
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185

Query: 758 ILEII 762
           + E++
Sbjct: 186 MFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 61/276 (22%), Positives = 103/276 (37%), Gaps = 62/276 (22%)

Query: 572 RTLGKGGFGTVYYGRLNEIDV----AVKMLSSSSAQGFQQF---QAEVKLLMRVHHRNLT 624
           +TLG G FG V      ++D     A+K L         Q    +AE  +L    +  + 
Sbjct: 7   KTLGIGAFGEVCLAC--KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVV 64

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQ-ERLRIAVESAQGLEYLHNGC 683
            L     + +    + +++  G++   L  I  +V      R  IA E    +E +H   
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMEVFPEVLARFYIA-ELTLAIESVH--- 118

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-------HV------------ 724
           K   +HRD+K  NIL++     KL DFGL   F    N+       H+            
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 725 --------------------------STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVI 758
                                     +  + GTP Y+ PE       T+  D +S GV++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 759 LEIITCKPA-ISRINEEEKIHIRQWVNSLIAKGDIK 793
            E++  +P  ++    E ++ +  W N+L     +K
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVK 274

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 32/74 (43%), Positives = 40/74 (54%), Gaps = 1/74 (1%)

Query: 414 LSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPV 472
           L  + L G+I   +  LTSL  LDL  NNLTG +P  L  L  L+ L L  NKL+G +P 
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278

Query: 473 ELLERSKNGSLSLS 486
            +    K  SL LS
Sbjct: 279 SIFSLQKLISLDLS 292

Length = 968

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 55/263 (20%), Positives = 98/263 (37%), Gaps = 54/263 (20%)

Query: 572 RTLGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQQ---FQAEVKLLMRVHHRNLTSL 626
           +T+G G FG V   R  + +   A+K L  +      Q    +AE  +L    +  +  L
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQ-ERLRIAVESAQGLEYLHNGCKP 685
                + +    + +++  G++   L  I   +      R  IA E    +E +H   K 
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDLARFYIA-ELTCAIESVH---KM 120

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSF--------------------------ATD 719
             +HRD+K  NIL++     KL DFGL   F                          +  
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 720 ANTHVSTV---------------VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC 764
               +  +               + GTP Y+ PE       T+  D +S GV++ E++  
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 765 KPA-ISRINEEEKIHIRQWVNSL 786
           +P  ++    E ++ +  W  +L
Sbjct: 241 QPPFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 2e-05
 Identities = 47/192 (24%), Positives = 78/192 (40%), Gaps = 35/192 (18%)

Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK---KVLSSQERLR 667
           E +LL R+ H  + +L+        T L+        L +Y SD+       L      +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV--------LPKYRSDLYTYLGARLRPLGLAQ 261

Query: 668 IAVESAQ---GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA-NTH 723
           +   + Q    ++Y+H      I+HRD+K+ N+L+N      L DFG +  FA  + +T 
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTP 317

Query: 724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT----------------CKPA 767
               +AGT     PE    +  T   D++S G+VI E                       
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ 377

Query: 768 ISRINEEEKIHI 779
           I RI  + ++H+
Sbjct: 378 ILRIIRQAQVHV 389

Length = 461

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 9/92 (9%)

Query: 570 FERTLGKGGFGTVY----YGRLNE---IDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HH 620
           F +TLG G FG V     YG       + VAVKML  S+     +   +E+K+L  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL 652
            N+ +L+G C     T +I E+   G+L  +L
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 574 LGKGGFGTVYYGRL----NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL--V 627
           +G+G +G VY  +     +E + A+K +  +          E+ LL  + H N+ +L  V
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66

Query: 628 GHCDEDNQTALIYEFMANGNLQEYL-----SDISKKVLSSQERL--RIAVESAQGLEYLH 680
                D +  L++++ A  +L   +     S  +KK +     +   +  +   G+ YLH
Sbjct: 67  FLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 681 NGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSKSFATDAN--THVSTVVAGTPGY 734
                 ++HRD+K  NIL+     E+ + K+AD G ++ F +       +  VV  T  Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181

Query: 735 LDPEYYTSNR-LTEKSDVYSFGVVILEIITCKP 766
             PE     R  T+  D+++ G +  E++T +P
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 574 LGKGGFGTVYYGRL----NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL--V 627
           +G+G +G VY  +     ++ D A+K +  +          E+ LL  + H N+ SL  V
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 66

Query: 628 GHCDEDNQTALIYEFMANGNLQEYL-----SDISKKVLSSQERL--RIAVESAQGLEYLH 680
                D +  L++++ A  +L   +     S  +KK +     +   +  +   G+ YLH
Sbjct: 67  FLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 681 NGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSKSFATDAN--THVSTVVAGTPGY 734
                 ++HRD+K  NIL+     E+ + K+AD G ++ F +       +  VV  T  Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181

Query: 735 LDPEYYTSNR-LTEKSDVYSFGVVILEIITCKP 766
             PE     R  T+  D+++ G +  E++T +P
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 58/273 (21%), Positives = 103/273 (37%), Gaps = 70/273 (25%)

Query: 572 RTLGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQQF---QAEVKLLMRVHHRNLTSL 626
           +TLG G FG V   R  +     A+K L         Q    +AE  +L    +  +  L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYL-------SDISKKVLSSQERLRIAVESAQGLEYL 679
                + +    + +++  G++   L        D+++  ++    L  AVES   + + 
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA---ELTCAVESVHKMGF- 122

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL----------------------SKSFA 717
                   +HRD+K  NIL++     KL DFGL                      S  F+
Sbjct: 123 --------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174

Query: 718 TD--------------------ANTH---VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSF 754
            +                    A  H   ++  + GTP Y+ PE       T+  D +S 
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234

Query: 755 GVVILEIITCKPA-ISRINEEEKIHIRQWVNSL 786
           GV++ E++  +P  +++   E ++ +  W  SL
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 9e-05
 Identities = 29/72 (40%), Positives = 38/72 (52%), Gaps = 1/72 (1%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFL-SKLPLRTLNLQ 462
           +S PR+  L L S+   G+I   +    +L  LDLS NNLTG +P+ L S   L  L L 
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388

Query: 463 GNKLNGSVPVEL 474
            N L G +P  L
Sbjct: 389 SNSLEGEIPKSL 400

Length = 968

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 9e-05
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 570 FERTLGKGGFGTVY----YGRLNE---IDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HH 620
           F +TLG G FG V     +G   E   + VAVKML +S+     +   +E+K+L  +  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL 652
           +N+ +L+G C       +I E+   G+L  +L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 1e-04
 Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 3/76 (3%)

Query: 400 SYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRT 458
           S G+  +  + YL L  + L G I   + +L  L  LDLS+N+L+G +P+ + +L  L  
Sbjct: 255 SLGNLKN--LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312

Query: 459 LNLQGNKLNGSVPVEL 474
           L+L  N   G +PV L
Sbjct: 313 LHLFSNNFTGKIPVAL 328

Length = 968

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 61/271 (22%)

Query: 589 EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL 648
           E+ V +K+L  S       F     L+ +V H +L  + G C   ++  ++ EF+ +G L
Sbjct: 44  ELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103

Query: 649 QEYLSDISKKVLSSQERLRIAVE--------SAQGLEYLHNGCKPPIVHRDVKSTNILLN 700
                     V   +E+ R+ V          A  L YL +     +VH +V + NILL 
Sbjct: 104 D---------VCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLA 151

Query: 701 EKLQA-------KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVY 752
               A       KL+D G+S + A      V  +      ++ PE     N L+  +D +
Sbjct: 152 RLGLAEGTSPFIKLSDPGVSFT-ALSREERVERI-----PWIAPECVPGGNSLSTAADKW 205

Query: 753 SFGVVILEIITC----KPAISRI-NEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDAN 807
           SFG  +LEI  C     P   R  +E+E+ + ++                 RL E     
Sbjct: 206 SFGTTLLEI--CFDGEVPLKERTPSEKERFYEKKH----------------RLPEP---- 243

Query: 808 SVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
           S  +   L   CL+    QRP+   ++ +L+
Sbjct: 244 SCKELATLISQCLTYEPTQRPSFRTILRDLT 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 22/206 (10%)

Query: 574 LGKG--GFGTVYYGRLNEID--VAVKM--LSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           +G+G     +VY  R       V V++  L + + +  +  Q EV L     H N+ +  
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPP 686
                 +   +I  FMA G+    L     + +S      I   + +GL YLH NG    
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY--- 122

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-------LDPEY 739
            +HR++K+++IL++      L+  GLS  ++   N   + VV   P +       L PE 
Sbjct: 123 -IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 740 YTSNR--LTEKSDVYSFGVVILEIIT 763
              +      KSD+YS G+   E+ T
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELAT 205

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 30/175 (17%)

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL--RIAVESAQGLEYL 679
           N+  L  +   ++   L+ +    G L  ++S    K L+  E    R A E    L+ L
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS----KFLNIPEECVKRWAAEMVVALDAL 101

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFG----LSKSFATDANTHVSTVVAGTPGYL 735
           H   +  IV RD+   NILL+++   +L  F     +  S   +A  ++         Y 
Sbjct: 102 H---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM---------YC 149

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIIT------CKPAISRINEEEKIHIRQWVN 784
            PE    +  TE  D +S G ++ E++T      C P  S IN    ++I +WV+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHP--SGINTHTTLNIPEWVS 202

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 4e-04
 Identities = 27/73 (36%), Positives = 44/73 (60%), Gaps = 2/73 (2%)

Query: 409 ITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN 467
           + +L+L  + L G I S + NL +LQ+L L  N L+G +P  +  L  L +L+L  N L+
Sbjct: 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297

Query: 468 GSVPVELLERSKN 480
           G +P EL+ + +N
Sbjct: 298 GEIP-ELVIQLQN 309

Length = 968

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.1 bits (101), Expect = 6e-04
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 9/90 (10%)

Query: 572 RTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQQ-FQAEVKLLMRVH-HRN 622
           RTLG G FG V     +        + VAVKML S++    +Q   +E+K++  +  H N
Sbjct: 43  RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLN 102

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYL 652
           + +L+G C +     +I E+   G+L +YL
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 19/115 (16%)

Query: 646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA 705
            +L + L  +  + L+ +E   + ++    L  LH         R  KS NILL      
Sbjct: 1   VSLADILE-VRGRPLNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWDGLL 50

Query: 706 KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE 760
           KL   G S +F T   +         P ++ PE       TEK+D+YS G+ + E
Sbjct: 51  KL--DG-SVAFKTPEQSRP------DPYFMAPEVIQGQSYTEKADIYSLGITLYE 96

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 37.9 bits (89), Expect = 7e-04
 Identities = 21/37 (56%), Positives = 27/37 (72%), Gaps = 3/37 (8%)

Query: 431 TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
           T+L+ LDLSNN +T  +P  LS LP L TL+L GNK+
Sbjct: 1   TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKI 35

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 7/103 (6%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
               +  L+LS + ++  + S + NL +L+ LDLS N+L+  +P  LS L  L  L+L G
Sbjct: 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSG 195

Query: 464 NKLNGSVPVELLERSKNGSLSLSVGGNPGLCSKISCKKKKNNV 506
           NK++  +P E+     +    L +  N  +   +S      N+
Sbjct: 196 NKIS-DLPPEIEL--LSALEELDLSNNS-IIELLSSLSNLKNL 234

Length = 394

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	878
PLN03150	623	hypothetical protein; Provisional	100.0
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.98
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.98
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.98
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.98
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.98
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.98
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.98
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.98
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.98
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.98
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.98
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.98
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.77
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.76
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.74
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.68
PRK10345	210	hypothetical protein; Provisional	99.68
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.66
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
smart00090	237	RIO RIO-like kinase.	99.62
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.61
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.6
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.59
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.52
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.48
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.48
PLN03150	623	hypothetical protein; Provisional	99.47
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.2
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.06
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.01
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.97
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.97
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.94
KOG3087	229	consensus Serine/threonine protein kinase [General	98.94
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.9
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.73
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.64
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.58
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.53
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.52
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.5
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.46
PRK09902	216	hypothetical protein; Provisional	98.42
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.37
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.36
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.31
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.3
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.19
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	98.19
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.16
COG4248	637	Uncharacterized protein with protein kinase and he	98.16
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.13
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.11
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.09
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.04
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.04
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.03
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.98
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.96
PF01636	239	APH: Phosphotransferase enzyme family This family	97.92
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.91
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	97.9
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	97.9
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.81
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.8
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.78
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.77
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.76
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.7
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	97.66
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.64
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	97.62
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.62
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.6
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.58
PRK10593	297	hypothetical protein; Provisional	97.54
PLN02876	822	acyl-CoA dehydrogenase	97.52
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.51
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.45
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.42
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.41
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.37
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.3
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.28

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=5.6e-83  Score=759.82  Aligned_cols=476  Identities=26%  Similarity=0.431  Sum_probs=355.7

Q ss_pred             hhhhhhccCCCCceEeccCCCCCCCCccCCCceeeecCccccccCccceeecccccccccccCceeccC--CCCcceeEe
Q 002809           15 LANVIHAQDQTGFISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQEFQTGQQKQMRRVRSFP--DGIRNCYRF   92 (878)
Q Consensus        15 ~~~~~~~~~~~~~~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~~~~~~~~~~~~~~~tlR~Fp--~g~~nCY~l   92 (878)
                      ++...+++++.++++||||++.+.  +++.+|++|++|.+|+. |.....+..  +...++++|+|+||  +|+||||+|
T Consensus        13 ~~~~~~~~~~~~~~~I~CGs~~~~--~~d~~~~~w~~D~~~~~-~~~~~~~~~--~~~~~~~~t~R~F~~~~g~~~cY~~   87 (623)
T PLN03150         13 AVLASLASPEPFTMRISCGARVNV--RTAPTNTLWYKDFAYTG-GIPANATRP--SFIAPPLKTLRYFPLSDGPENCYNI   87 (623)
T ss_pred             HhhcccccCCCccEEEeCCCCCCc--ccCCCCCEEcCCccccc-CccccccCc--ccccchhhccccCCcccccccceEe
Confidence            334444555789999999986443  23458999999999863 444433321  22334459999999  688999999


Q ss_pred             eccCCCeeEEEEEeeecCCCCCCCCCceeEEEccceeeEEEecCC-ccceeeeeEEEEccCCceEEEEeecCCCCcceee
Q 002809           93 NLTKGSRYLIRTNFMYGNYDEKNSVPGFDMFIGPNKWLSVTFENN-ASFVAIGEIIHILPSDYLHICLVNTGLGTPFISA  171 (878)
Q Consensus        93 ~~~~~~~ylvR~~f~ygnyd~~~~~p~Fd~~~~~~~w~~v~~~~~-~~~~~~~e~~~~~~~~~~~vCl~~~~~~~Pfis~  171 (878)
                      |++++||||||++|+|||||+++++|.|||++|+|+|.+|+.+.+ .....+.|+|+.+++++++|||+++++|+||||+
T Consensus        88 ~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~  167 (623)
T PLN03150         88 NRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILS  167 (623)
T ss_pred             eecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeE
Confidence            999999999999999999999999999999999999999987421 2334558999999999999999999999999999


Q ss_pred             eeeeecCCcccccccC-----CceeEEEEEeeccC-CCceeecCCCCC--CceeecCCC---CCceeeccccccccCCCC
Q 002809          172 LELRPLFENSTYKAQS-----GSLNLFTRLDVAST-TNLTIRYNDDVH--DRSWFPYNS---ANWARINTSLTVDAESHN  240 (878)
Q Consensus       172 lel~~l~~~~~y~~~~-----~~l~~~~r~~~g~~-~~~~~ryp~D~~--dR~W~~~~~---~~~~~~~t~~~~~~~~~~  240 (878)
                      ||||||+ +.+|....     ..|.++.|.++|+. ....+|||||+|  ||+|.|...   +.|..+++...++...+.
T Consensus       168 iEv~~l~-~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~  246 (623)
T PLN03150        168 IEILQVD-DKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNA  246 (623)
T ss_pred             EEEEEcC-cccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCC
Confidence            9999998 66665331     25999999999986 334589999999  999987544   568888888777655567


Q ss_pred             CCCChhhhhccccccCCCCccceeeccCCCCCceEEEEEeeccccc-cccCceeEEEEEECCccccCCCCCC-----ccc
Q 002809          241 SYQPPAVVMNTAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQI-LQANQSRQFNISLNGEHWYGPFSPN-----YLL  314 (878)
Q Consensus       241 ~~~~P~~v~~tA~t~~~~~~~l~~~~~~~~~~~~~~~~l~Fae~~~-~~~~~~R~F~i~in~~~~~~~~~p~-----~~~  314 (878)
                      ++.+|+.|||||.++.++..++.+.|+ .++...|+|+|||||++. .+..++|+|||++||+...+.+++.     +..
T Consensus       247 ~~~~P~~VyqTA~~~~~~~~~lty~~~-v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~  325 (623)
T PLN03150        247 PNFYPESLYQSALVSTDTQPDLSYTMD-VDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYT  325 (623)
T ss_pred             CccChHHHhhhhccccCCCCceEEEee-cCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCccc
Confidence            788999999999998876666766665 467789999999999984 5567899999999999877665432     222


Q ss_pred             eeEEEcceeecCceeEEEEEecCCCCCchhhhhhhhheeccccccccccchHHHHHHHHHhhCCCC--CCCCCCCCCCCC
Q 002809          315 TTTVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKK--NWQGDPCAPLAY  392 (878)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~t~~s~lpp~inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~--~w~~~pc~~~~~  392 (878)
                      +..........+|..+|++.++..+  ||+|||+|||.+.+. ...|.+.|+.||+++|..+....  +|+||||.|..+
T Consensus       326 ~~~~~~~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~-~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~  402 (623)
T PLN03150        326 ALVLNKTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITA-ESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQH  402 (623)
T ss_pred             ceEEEeEEeecCCeEEEEEeeCCCC--cceeeeeeeeecccc-ccccCchHHHHHHHHHHhcCCcccCCCCCCCCCCccc
Confidence            2222222233457899999997755  799999999999995 47899999999999999887543  899999998888


Q ss_pred             cccceecCCCCC-------------------------CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcC
Q 002809          393 WWDGLNCSYGDS-------------------------SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSV  447 (878)
Q Consensus       393 ~w~gv~C~~~~~-------------------------~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i  447 (878)
                      .|.||.|+....                         .+++|+.|+|++|+|+|.+|+.+++|++|+.|||++|+|+|.+
T Consensus       403 ~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~i  482 (623)
T PLN03150        403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI  482 (623)
T ss_pred             ccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCC
Confidence            899999963211                         1244555555555555555555555555555555555555555


Q ss_pred             CccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccCCCCCCCCC---ccccC
Q 002809          448 PDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCSK---ISCKK  501 (878)
Q Consensus       448 P~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~lc~~---~~c~~  501 (878)
                      |..+++|+ |+.|+|++|+|+|.+|..++.+. +....+.+.+|+++|+.   ..|..
T Consensus       483 P~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~-~~~~~l~~~~N~~lc~~p~l~~C~~  539 (623)
T PLN03150        483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAGLCGIPGLRACGP  539 (623)
T ss_pred             chHHhcCCCCCEEECcCCcccccCChHHhhcc-ccCceEEecCCccccCCCCCCCCcc
Confidence            55555555 55555555555555555554432 11224567789999985   45754

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=100.00  E-value=1.9e-69  Score=599.45  Aligned_cols=322  Identities=43%  Similarity=0.763  Sum_probs=274.7

Q ss_pred             eccCCCCCCC-CccCCCceeeecCccccccCccceeeccc--cccc-ccccCceeccCCCCcceeEeecc--CCCeeEEE
Q 002809           30 LDCGLPKDSN-YTETTTGINYISDDAFVETGIGKSILQEF--QTGQ-QKQMRRVRSFPDGIRNCYRFNLT--KGSRYLIR  103 (878)
Q Consensus        30 idCG~~~~~~-~~~~~~~~~~~~D~~~~~~g~~~~~~~~~--~~~~-~~~~~tlR~Fp~g~~nCY~l~~~--~~~~ylvR  103 (878)
                      ||||++.+++ |+|+.||++|++|.+|+++|++++|++..  .... .++++|+|+||+|.||||+||+.  +|+|||||
T Consensus         1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliR   80 (347)
T PF12819_consen    1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIR   80 (347)
T ss_pred             CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEE
Confidence            8999988887 99999999999999999999999994221  1223 34449999999999999999997  67799999


Q ss_pred             EEeeecCCCCCC-----CCCceeEEEccceeeEEEecCCccceeeee-EEEEccCCceEEEEeecCCCC-cceeeeeeee
Q 002809          104 TNFMYGNYDEKN-----SVPGFDMFIGPNKWLSVTFENNASFVAIGE-IIHILPSDYLHICLVNTGLGT-PFISALELRP  176 (878)
Q Consensus       104 ~~f~ygnyd~~~-----~~p~Fd~~~~~~~w~~v~~~~~~~~~~~~e-~~~~~~~~~~~vCl~~~~~~~-Pfis~lel~~  176 (878)
                      +.|+||||||++     ++|.|||++|+|.|.+|+.+++...+.+.| +|++.++++++|||+++++|+ ||||+|||||
T Consensus        81 l~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~  160 (347)
T PF12819_consen   81 LHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRP  160 (347)
T ss_pred             EEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEE
Confidence            999999999985     367899999999999999987433345589 666666899999999999999 9999999999


Q ss_pred             cCCccccc--ccCC--ceeEEEEEeeccCCCceeecCCCCCCceeecCC-CCCceeeccccccc-cCCCCCCCChhhhhc
Q 002809          177 LFENSTYK--AQSG--SLNLFTRLDVASTTNLTIRYNDDVHDRSWFPYN-SANWARINTSLTVD-AESHNSYQPPAVVMN  250 (878)
Q Consensus       177 l~~~~~y~--~~~~--~l~~~~r~~~g~~~~~~~ryp~D~~dR~W~~~~-~~~~~~~~t~~~~~-~~~~~~~~~P~~v~~  250 (878)
                      |+ +.+|+  ...+  +|.++.|.++|+..+. ||||+|+|||+|+|+. .+.|..++|..+++ ...++.|.||.+|||
T Consensus       161 lp-~~ly~~~~~~~s~~L~~~~R~n~G~~~~~-iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~  238 (347)
T PF12819_consen  161 LP-DSLYPDTDANSSQALETVYRLNVGGSSSF-IRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQ  238 (347)
T ss_pred             CC-ccceeccccCCCceeEEEEeecCCCcccc-cCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHH
Confidence            98 66664  2233  6999999999987553 9999999999999875 56799999987765 556788999999999


Q ss_pred             cccccCCCCccceeeccCCCCCceEEEEEeeccccccc-cCceeEEEEEECCccccCCCCCCccceeEE--Ecce---ee
Q 002809          251 TAGTPKNASQSMDFYLETEDPSIQFYVYMHFAEVQILQ-ANQSRQFNISLNGEHWYGPFSPNYLLTTTV--FSPT---AL  324 (878)
Q Consensus       251 tA~t~~~~~~~l~~~~~~~~~~~~~~~~l~Fae~~~~~-~~~~R~F~i~in~~~~~~~~~p~~~~~~~~--~~~~---~~  324 (878)
                      ||+++.+.+.+++++|..+++..+|||+||||||+.+. +.++|+|||+|||+.++++++|.++.+..+  +...   ..
T Consensus       239 TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  318 (347)
T PF12819_consen  239 TARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVP  318 (347)
T ss_pred             hhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEec
Confidence            99999998888999999989999999999999999864 444899999999999988999988877655  4322   22


Q ss_pred             cCceeEEEEEecCCCCCchhhhhhhhhee
Q 002809          325 IGGNYSFSLYKTGNSTLPPIINAIEVYSV  353 (878)
Q Consensus       325 ~~~~~~~~l~~t~~s~lpp~inalEi~~l  353 (878)
                      .++..+|+|.++..|+|||+|||+|||.+
T Consensus       319 ~~~~~~isL~~t~~S~lppiLNalEIy~v  347 (347)
T PF12819_consen  319 DSGFLNISLGPTPDSTLPPILNALEIYKV  347 (347)
T ss_pred             CCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence            45678999999999999999999999975

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-53  Score=471.38  Aligned_cols=288  Identities=49%  Similarity=0.816  Sum_probs=254.7

Q ss_pred             cCCCCCHHHHHHHHhhhc--ccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecc
Q 002809          554 KSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC  630 (878)
Q Consensus       554 ~~~~~s~~dl~~~t~~f~--~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~  630 (878)
                      ..+.|++.++.++|++|.  +.||+|+||.||+|.+.+ +.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999997  699999999999999998 89999988876543145699999999999999999999999


Q ss_pred             cCCC-cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEee
Q 002809          631 DEDN-QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD  709 (878)
Q Consensus       631 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~D  709 (878)
                      .+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 599999999999999999874433899999999999999999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          710 FGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       710 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      ||+|+..... ..+......||.+|+|||++..+..++|+|||||||+|+||+||+++.+.........+.+|+...+.+
T Consensus       221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            9999765331 122111117999999999999999999999999999999999999998876545555699999999999


Q ss_pred             CCcccccCCccc-cccCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQ-EDFDA-NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       790 ~~~~~iid~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      +.+.+++|+++. ..++. +++.++.+++.+|++.+|++||+|.||+++|+.+..
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            999999999987 55554 788899999999999999999999999999966543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-51  Score=517.62  Aligned_cols=418  Identities=26%  Similarity=0.459  Sum_probs=293.7

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|+++|.+|..+++|++|+.|+|++|+++|.+|..+..++ |+.|+|++|+++|.+|..+..+..|..|+
T Consensus       498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~  577 (968)
T PLN00113        498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN  577 (968)
T ss_pred             hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence            34566666666666666666666666666666666666666666666666 66666666666666666666655554443


Q ss_pred             c---------------------ccCCCCCCCCCc------cccCCCCceE-EEEeehhhHHHHHHHHHHHHHhhhhhccc
Q 002809          485 L---------------------SVGGNPGLCSKI------SCKKKKNNVV-VPVVASVAGSVFLLAAALAIFFVLKRKRQ  536 (878)
Q Consensus       485 l---------------------~~~~n~~lc~~~------~c~~k~~~ii-i~iv~~v~~~vvll~~~~~i~~~~rrk~~  536 (878)
                      +                     ++.||+++|+..      .|...+.... ..+++.++++++++++++++++++|++++
T Consensus       578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  657 (968)
T PLN00113        578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN  657 (968)
T ss_pred             ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhc
Confidence            3                     456888899752      4643211111 11222222222222222222333333221


Q ss_pred             ccccccccccc----ccccc-ccCCCCCHHHHHHHHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHH
Q 002809          537 VGKVKRESKNK----IDSFE-AKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQ  609 (878)
Q Consensus       537 ~~~~~~~~~~~----~~~~~-~~~~~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~  609 (878)
                       .+.++.....    ...+. .....++++++... ....+.||+|+||.||+|+..  +..||||++......    ..
T Consensus       658 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~  731 (968)
T PLN00113        658 -LELKRVENEDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PS  731 (968)
T ss_pred             -ccccccccccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cH
Confidence             1111111000    00000 11123455555443 234568999999999999864  488999998754322    23


Q ss_pred             HHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 002809          610 AEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH  689 (878)
Q Consensus       610 ~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH  689 (878)
                      +|++.+++++|||||+++++|.+++..++||||+++|+|.++++.     ++|..+.+++.|+|+||+|||+.+.++|+|
T Consensus       732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  806 (968)
T PLN00113        732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVV  806 (968)
T ss_pred             HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence            568899999999999999999999999999999999999999964     899999999999999999999877789999


Q ss_pred             cCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 002809          690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAIS  769 (878)
Q Consensus       690 rDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~  769 (878)
                      |||||+||+++.++.+++. ||........      ....++..|+|||++.+..++.|+|||||||++|||+||+.||+
T Consensus       807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             CCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            9999999999999988876 6655433111      12357899999999999999999999999999999999999996


Q ss_pred             CCChHHHHHHHHHHHHHHhcCCcccccCCccccc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          770 RINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED--FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       770 ~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .... ....+.+|++..........++|+.+...  .+.++..++.+++.+|++.+|++||+|+||+++|+++.+
T Consensus       880 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        880 AEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            5332 23457778877666666667777776543  345677789999999999999999999999999998764

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9e-44  Score=393.50  Aligned_cols=253  Identities=35%  Similarity=0.569  Sum_probs=213.5

Q ss_pred             cccccccccEEEEEEEEccee-EEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCC-cceeEeeeccCC
Q 002809          571 ERTLGKGGFGTVYYGRLNEID-VAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN-QTALIYEFMANG  646 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~~~-vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~~g  646 (878)
                      .+.||+|+||+||+|.+.++. ||||++.....  ...+.|.+|+.+|.+++|||||+++|.|.+.. ..++|||||++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            356999999999999999977 99999986532  22569999999999999999999999999888 799999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCccEEEcCCC-cEEEeecCCccccccCCCCcc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP-IVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|.++++......+++..+++++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++......  ..
T Consensus       126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~  200 (362)
T KOG0192|consen  126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS  200 (362)
T ss_pred             cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence            999999876577899999999999999999999998   6 99999999999999997 99999999998764321  22


Q ss_pred             cccccCCCCccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          725 STVVAGTPGYLDPEYYT--SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .+...||..|||||++.  ...++.|+|||||||++|||+||+.||.......   +..   .....+         .+.
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~---~v~~~~---------~Rp  265 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VAS---AVVVGG---------LRP  265 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhcC---------CCC
Confidence            23367999999999999  6699999999999999999999999999876522   111   111111         122


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ..+..+...+..++..||+.+|++||++.+++..|+.+...
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            23333566788999999999999999999999999987754

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=386.23  Aligned_cols=254  Identities=28%  Similarity=0.485  Sum_probs=218.2

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|-||.||.|++++ .+||+|.++..... .+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            566889999999999999999 59999999876433 4789999999999999999999999999989999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++|+...+..+...+.+.++.|||+||+||+++   ++|||||.++|||++++..+||+|||||+....+ .......
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~  363 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEG  363 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCC
Confidence            99999986788899999999999999999999999   9999999999999999999999999999954332 2223333


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..-...|.|||.+..++++.|||||||||+||||+| |+.||..+...+-       -+.+.+|.         +-..+.
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-------~~~le~Gy---------Rlp~P~  427 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-------LELLERGY---------RLPRPE  427 (468)
T ss_pred             CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-------HHHHhccC---------cCCCCC
Confidence            334568999999999999999999999999999999 8899988776542       22333332         223455


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      .|+..+.+++..||+.+|++|||++.+...|+++...
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            6778899999999999999999999999999886644

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=364.82  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=211.9

Q ss_pred             CCCCHHHHHHHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccC
Q 002809          556 RHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE  632 (878)
Q Consensus       556 ~~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~  632 (878)
                      ..++.+|+.+.     +.||+|..|+||+++++.  +-+|+|++... .+...+++.+|++++++.+||+||.++|.|..
T Consensus        74 ~~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   74 NGISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            34667777554     689999999999999874  77999999644 45567899999999999999999999999998


Q ss_pred             CC-cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          633 DN-QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       633 ~~-~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      .. ...++||||++|+|+++++.  .+.+++...-+|+.++++||.|||+.  .+||||||||+|||++..|++||||||
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence            88 59999999999999999986  46799999999999999999999963  299999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHHHHHhc
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINE--EEKIHIRQWVNSLIAK  789 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~v~~~~~~  789 (878)
                      .++.+...    ......||..|||||.+++..|+.++||||||+.++|+++|+.|+.....  .....+..+   ... 
T Consensus       225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~---Iv~-  296 (364)
T KOG0581|consen  225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA---IVD-  296 (364)
T ss_pred             ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH---Hhc-
Confidence            99876433    45567899999999999999999999999999999999999999987521  111122221   111 


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.     -|++...   ....++..++..||++||.+||+++|++++
T Consensus       297 ~p-----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  297 EP-----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CC-----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11     1222221   245678899999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=360.89  Aligned_cols=198  Identities=28%  Similarity=0.560  Sum_probs=180.6

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.||+|+||+||+|++..  ..||||.+.+.  ..+..+....|+.+|+.++|||||.+++++..++.+++|||||.+
T Consensus        14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG   93 (429)
T ss_pred             ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence            34569999999999999865  88999999876  566778889999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC------CcEEEeecCCccccccC
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK------LQAKLADFGLSKSFATD  719 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~------~~~kL~DFGla~~~~~~  719 (878)
                      |+|.++++.  +..+++.....++.|+|.||++||++   +||||||||+||||+..      -.+||+|||+|+.+...
T Consensus        94 GDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   94 GDLSDYIRR--RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999987  55899999999999999999999999   99999999999999875      46899999999988633


Q ss_pred             CCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE  775 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  775 (878)
                         ......+|++-|||||+++.++|+.|+|+||+|+++|||++|++||+..+..+
T Consensus       169 ---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  169 ---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             ---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence               34566899999999999999999999999999999999999999999877654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-41  Score=373.89  Aligned_cols=247  Identities=26%  Similarity=0.455  Sum_probs=211.0

Q ss_pred             HHhhhcccccccccEEEEEEEE--cceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          566 ITNNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+|...+.||+|||+.||.++.  .+..||+|++.+.   +....+...+||++.++|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            3445568999999999999987  3488999999864   3445678899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      |+|++++|.+++++  ++.+++.++..+++||+.||.|||+.   +|+|||||..|++|+++.++||+|||||..+..+.
T Consensus        98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            99999999999985  88899999999999999999999999   99999999999999999999999999999886443


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      .  ...+.|||+.|+|||++....++..+||||+||++|.|+.|+|||+.....+...       .+...+.        
T Consensus       173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~-------~Ik~~~Y--------  235 (592)
T KOG0575|consen  173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN-------KIKLNEY--------  235 (592)
T ss_pred             c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-------HHHhcCc--------
Confidence            3  3456899999999999999999999999999999999999999998765544221       1111110        


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .++.....+..+|+.++|+.+|.+|||+++|+..
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              1122334467799999999999999999999863

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-41  Score=388.94  Aligned_cols=256  Identities=31%  Similarity=0.519  Sum_probs=220.8

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||+||+|+..+       ..||||.+++.... ..++|++|++++..++|||||+++|.|.+++..++|+
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF  568 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF  568 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence            456789999999999998642       56999999987655 7899999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhcccc--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          641 EFMANGNLQEYLSDIS--------KKV----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      |||..|+|.++|....        ++.    ++..+.+.||.|||.||+||-++   .+|||||.++|+||.++..+||+
T Consensus       569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIs  645 (774)
T KOG1026|consen  569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKIS  645 (774)
T ss_pred             EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEec
Confidence            9999999999996532        233    88999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      ||||++..-..+.........-..+|||||.+..+++|.+||||||||+|||+++ |+.||.+...++       |-..+
T Consensus       646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~i  718 (774)
T KOG1026|consen  646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIECI  718 (774)
T ss_pred             ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHHH
Confidence            9999987654444333333345679999999999999999999999999999999 899999888766       44556


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ++|++-         ..+..++.++..|++.||+..|++||+++||-..|+...+.
T Consensus       719 ~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  719 RAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            666542         34566778999999999999999999999999999985543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-41  Score=356.29  Aligned_cols=250  Identities=24%  Similarity=0.379  Sum_probs=203.9

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChh-------hHHHHHHHHHHHHHhcccceeeeeecccCCCcce
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ-------GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~  637 (878)
                      .+-+.+.||+|+||.|-+|.-.  ++.||||++++....       ......+|+++|++|+|||||++++++...+..|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            3445789999999999999654  489999999864221       1223579999999999999999999999999999


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC---CcEEEeecCCcc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSK  714 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~  714 (878)
                      +||||++||.|.+.+-.  ...+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||+|+
T Consensus       253 mVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999976  56688888899999999999999999   99999999999999866   789999999999


Q ss_pred             ccccCCCCcccccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSNR---LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      ..+.   .....+.|||+.|.|||++.+..   +..|+|+||+||+||-+++|.+||.+.....  .    ..+.+.+|+
T Consensus       328 ~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~eQI~~G~  398 (475)
T KOG0615|consen  328 VSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKEQILKGR  398 (475)
T ss_pred             cccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHHHHhcCc
Confidence            8753   33456689999999999998654   3348899999999999999999998754322  1    122233333


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...      ......+..++.++++.+||..||++|||+.|+++.
T Consensus       399 y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  399 YAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            211      112234556788999999999999999999999985

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-41  Score=339.11  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=210.5

Q ss_pred             HhhhcccccccccEEEEEEEE--cceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeee-cccCCCc-ceeEe
Q 002809          567 TNNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVG-HCDEDNQ-TALIY  640 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g-~~~~~~~-~~lV~  640 (878)
                      .+.+.+.||.|.||+||++..  ++..||.|.++-.  +.+..+....|+.+|++|+|||||+.++ .+.++.+ +.+||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            345678999999999999975  4588999988743  4556778899999999999999999999 4555555 89999


Q ss_pred             eeccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          641 EFMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKP-PIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      ||++.|+|...++..+  ++.++++.+++++.|++.||.++|++... -|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            9999999999997644  67899999999999999999999984322 38999999999999999999999999999875


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ..  .......+||+.||+||.+.+..|+.|+||||+||++|||+.-++||.+.+-.+       ....+..++...+  
T Consensus       180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~~~--  248 (375)
T KOG0591|consen  180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYPPL--  248 (375)
T ss_pred             ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCCCCC--
Confidence            33  334456789999999999999999999999999999999999999998764321       3344555543222  


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                         +   +..-..++.+++..|+..||+.||+.-.+++.+..-
T Consensus       249 ---p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  249 ---P---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             ---c---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence               1   123345788999999999999999977777666653

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=358.39  Aligned_cols=264  Identities=31%  Similarity=0.503  Sum_probs=213.8

Q ss_pred             CCCCHHHHHHHHhhhcccccccccEEEEEEEEcceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC
Q 002809          556 RHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED  633 (878)
Q Consensus       556 ~~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~  633 (878)
                      ..+.++++.     +.+.||+|.||+||+|++-+ .||||++...  .+...+.|+.|+..+++-||.||+-++|+|...
T Consensus       387 WeIp~~ev~-----l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  387 WEIPPEEVL-----LGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccCHHHhh-----ccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            444555553     45789999999999999987 6999999865  445678999999999999999999999999988


Q ss_pred             CcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCc
Q 002809          634 NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS  713 (878)
Q Consensus       634 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla  713 (878)
                      .. ++|+.+|+|.+|+.++|.. +..+...+.+.|++|||+|+.|||.+   +|||||||+.||++.+++.|||+|||++
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             ce-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence            87 9999999999999999863 46799999999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCCCcccccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          714 KSFATDANTHVSTVVAGTPGYLDPEYYTS---NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       714 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      ..-..-..........|...|||||++..   .+|++.+||||||+|+|||+||..||.....+...       -++..|
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi-------fmVGrG  608 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII-------FMVGRG  608 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE-------EEeccc
Confidence            65432222222233457789999999864   46899999999999999999999999843332211       111222


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .+    .+++. .....+..++.+|+..||..++++||.+.+|+..|++++.
T Consensus       609 ~l----~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 YL----MPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cc----Cccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11    11111 1224566788999999999999999999999999999887

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=374.35  Aligned_cols=269  Identities=26%  Similarity=0.442  Sum_probs=229.4

Q ss_pred             CCCCCHHHHHHHHhhh-----------cccccccccEEEEEEEEcc-----eeEEEEEeccCC-hhhHHHHHHHHHHHHH
Q 002809          555 SRHLSYSDVVKITNNF-----------ERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSSS-AQGFQQFQAEVKLLMR  617 (878)
Q Consensus       555 ~~~~s~~dl~~~t~~f-----------~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~  617 (878)
                      ...++|+|.-++...|           +++||.|.||.||+|+++-     ..||||.++... .+.+.+|+.|..+|.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            3567888877776655           4789999999999999852     569999999764 4567899999999999


Q ss_pred             hcccceeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccE
Q 002809          618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI  697 (878)
Q Consensus       618 l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NI  697 (878)
                      ..||||++|-|........++|.|||++|+|+.+|+.+.++ +.+.+..-++++||.|++||-+.   ++|||||.++||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI  762 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI  762 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence            99999999999999999999999999999999999987655 99999999999999999999988   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCCCc-ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHH
Q 002809          698 LLNEKLQAKLADFGLSKSFATDANTH-VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEE  775 (878)
Q Consensus       698 Ll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  775 (878)
                      |++.+..+|++|||+++.+..+.... ....-.-..+|.|||.+...+++.++|||||||||||.++ |.+||-+++.++
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence            99999999999999999875554221 1111223468999999999999999999999999999887 999999888765


Q ss_pred             HHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          776 KIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       776 ~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      -.       +.+.+         ..+-..+++|+..+.+|++.||++|-.+||.+.||+..|.++++.
T Consensus       843 VI-------kaIe~---------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  843 VI-------KAIEQ---------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HH-------HHHHh---------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            32       22222         233345678888999999999999999999999999999998865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=339.55  Aligned_cols=237  Identities=26%  Similarity=0.402  Sum_probs=198.7

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.++||+|+||+||.++..+  +-+|+|++++..   ....+...+|..+|.+++||.||++.-.|++.+.+++|+||+
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~  107 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL  107 (357)
T ss_pred             eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence            346899999999999998766  679999998753   234677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      .||.|..+|++  ...+++..+.-++.+|+.||.|||++   +||||||||+|||||.+|+++|+|||+++.....  ..
T Consensus       108 ~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~  180 (357)
T KOG0598|consen  108 NGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GD  180 (357)
T ss_pred             CCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC--CC
Confidence            99999999986  66799999999999999999999999   9999999999999999999999999999854322  22


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ....++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+...      +..... .+++.         .
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~-~~k~~---------~  244 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKIL-KGKLP---------L  244 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHh-cCcCC---------C
Confidence            3445899999999999999999999999999999999999999998765432      222222 22210         0


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCC
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRP  828 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RP  828 (878)
                      .+.--..+..+++...|..+|++|-
T Consensus       245 ~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCccCCHHHHHHHHHHhccCHHHhc
Confidence            1111223567899999999999995

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-38  Score=351.06  Aligned_cols=257  Identities=28%  Similarity=0.458  Sum_probs=202.7

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCC-Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDED-NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-~~~~  637 (878)
                      +.+.+.||+|+||.||+|...       +..||||++.... ....+.+.+|+.++.++ +||||++++++|... ...+
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (338)
T cd05102           9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM   88 (338)
T ss_pred             ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence            456789999999999999742       2569999987543 33456799999999999 899999999988764 4578


Q ss_pred             eEeeeccCCChhhhhcccc------------------------------------------------------------C
Q 002809          638 LIYEFMANGNLQEYLSDIS------------------------------------------------------------K  657 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------~  657 (878)
                      +||||+++|+|.+++....                                                            .
T Consensus        89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (338)
T cd05102          89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK  168 (338)
T ss_pred             EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence            9999999999999986421                                                            1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCc
Q 002809          658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP  737 (878)
Q Consensus       658 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP  737 (878)
                      ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus       169 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         169 SPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence            3478889999999999999999998   9999999999999999999999999999865332221122233466789999


Q ss_pred             cccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHH
Q 002809          738 EYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELA  816 (878)
Q Consensus       738 E~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~  816 (878)
                      |++.+..++.++|||||||++|||++ |+.||......+.  +    ...+..+...     ..    +......+.+++
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~----~~~~~~~~~~-----~~----~~~~~~~l~~li  310 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F----CQRLKDGTRM-----RA----PENATPEIYRIM  310 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H----HHHHhcCCCC-----CC----CCCCCHHHHHHH
Confidence            99999999999999999999999997 9999976543221  1    1112222111     11    112334688999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          817 MACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       817 ~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .+||+.+|++||++.|+++.|++++.
T Consensus       311 ~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         311 LACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=337.91  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=203.6

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC--cceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN--QTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV~Ey~~  644 (878)
                      ...+.||+|+||.||++....  ...|||.....+....+.+.+|+.+|.+++|||||+.+|.....+  ...+.|||++
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~   99 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP   99 (313)
T ss_pred             hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence            345789999999999999875  889999987664444678999999999999999999999855544  6899999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-CCcEEEeecCCcccccc-CCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSKSFAT-DANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~-~~~~  722 (878)
                      +|+|.+++.+... .+++..+..+..||++||+|||++   +||||||||+|||++. ++.+||+|||+++.... ....
T Consensus       100 ~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen  100 GGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             CCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            9999999987655 799999999999999999999998   9999999999999999 79999999999987653 1111


Q ss_pred             cccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .......||+.|||||++..+ ....++||||+||++.||+||++||....     ...+++-....+...     |   
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~~~-----P---  242 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGREDSL-----P---  242 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccCCC-----C---
Confidence            223346799999999999953 33459999999999999999999998641     111122222222211     1   


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                       ..+.....+..+++.+|+..+|++|||++++++.---.
T Consensus       243 -~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  243 -EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             -CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence             22333445778999999999999999999999876543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=343.48  Aligned_cols=246  Identities=25%  Similarity=0.406  Sum_probs=206.5

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .|.+.||+|+|++|++|+...  +.+|||++.+.   .....+-...|-++|.+| .||.|++|+..|+++..+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            578899999999999998754  88999999764   223345677899999999 899999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      .++|+|.++|+.  -..+++.....++.+|+.||+|||+.   |||||||||+|||||+||++||+|||.|+.+.+....
T Consensus       156 A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  156 APNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             cCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            999999999987  46799999999999999999999998   9999999999999999999999999999988543221


Q ss_pred             ---------ccc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          723 ---------HVS--TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       723 ---------~~~--~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                               ...  ..++||..|.+||++.....+..+|+|+|||+||+|+.|++||...++.-...       .+.+  
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq-------kI~~--  301 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ-------KIQA--  301 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH-------HHHH--
Confidence                     112  45789999999999999999999999999999999999999999877532111       1110  


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          +|-.+...++    ..+.+|+.+.|..||.+|++.+||-++
T Consensus       302 ----l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  302 ----LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ----hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence                1222333333    467799999999999999999888765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=345.18  Aligned_cols=250  Identities=28%  Similarity=0.459  Sum_probs=212.9

Q ss_pred             CCCCCHHHHHHHHhhhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC
Q 002809          555 SRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN  634 (878)
Q Consensus       555 ~~~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~  634 (878)
                      ...+-|+++...     +-||+|+.|.||+|++.++.||||+++..+       ..+|+-|++|+|+||+.+.|+|....
T Consensus       118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP  185 (904)
T KOG4721|consen  118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP  185 (904)
T ss_pred             hccCCHHHhhhh-----hhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc
Confidence            355666666554     359999999999999999999999876543       34678899999999999999999999


Q ss_pred             cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          635 QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ..++|||||..|-|.+.|+.  ++.+.......+..+||.|+.|||.+   .|||||||+-||||..+..+||+|||-++
T Consensus       186 cyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  186 CYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             eeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence            99999999999999999987  77888999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      .....   .....++||..|||||++...+.++|+||||||||||||+||..||......-               -+--
T Consensus       261 e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIwG  322 (904)
T KOG4721|consen  261 ELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIWG  322 (904)
T ss_pred             hhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEEe
Confidence            65322   33445789999999999999999999999999999999999999997644311               0111


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      +-...|.-..+..++.-+.-|+.+||+..|..||+++|++..|.-
T Consensus       323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            222334445567788888889999999999999999999999864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-38  Score=344.78  Aligned_cols=243  Identities=25%  Similarity=0.432  Sum_probs=206.7

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      +.||+|+.|.||.++...  ..||||++........+-+.+|+.+|+..+|+|||.++..|..++++++|||||++|+|.
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            579999999999997644  789999998877777778899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      +.+..   ..+++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+.....  ......
T Consensus       359 DvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmV  430 (550)
T KOG0578|consen  359 DVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMV  430 (550)
T ss_pred             hhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cccccc
Confidence            99875   4499999999999999999999999   999999999999999999999999999988754432  345577


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHH
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV  809 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~  809 (878)
                      ||+.|||||++....|..|+||||||++++||+-|.+||...++-....+       ++....     +++.  .+....
T Consensus       431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------Ia~ng~-----P~lk--~~~klS  496 (550)
T KOG0578|consen  431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGT-----PKLK--NPEKLS  496 (550)
T ss_pred             CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------HhhcCC-----CCcC--CccccC
Confidence            99999999999999999999999999999999999999986544332221       121111     1221  223344


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          810 WKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       810 ~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..+.+++.+||+.|+++||+++|+|+.
T Consensus       497 ~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  497 PELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            578899999999999999999999984

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.9e-38  Score=319.22  Aligned_cols=258  Identities=21%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      ..+|+|++|+||+++.++  +-||||++.....  ...+-.++|+++|++++|+|+|.++..|.....++||+||++.--
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv   87 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV   87 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence            468999999999998865  7799999976543  345667999999999999999999999999999999999998744


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |++ |.+ ....++.+...+++.|+++|+.|+|++   ++|||||||+|||++.++.+||||||.|+.+....  ...+-
T Consensus        88 L~e-Le~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTD  160 (396)
T KOG0593|consen   88 LHE-LER-YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTD  160 (396)
T ss_pred             HHH-HHh-ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc--chhhh
Confidence            444 433 256689999999999999999999999   99999999999999999999999999999885322  23344


Q ss_pred             ccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HHHH-------HhcCC------c
Q 002809          728 VAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW-VNSL-------IAKGD------I  792 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~-v~~~-------~~~~~------~  792 (878)
                      ...|..|+|||++.+ .+|...+||||+||++.||++|.+.|.+.+.-+..+...- +..+       .....      +
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            567899999999987 7899999999999999999999999988776555543322 1111       11111      1


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+.-++.-.+..-.....-+++++..||+.||++|++-+|++..
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            11111111011112233467899999999999999999999863

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-37  Score=336.33  Aligned_cols=246  Identities=22%  Similarity=0.330  Sum_probs=201.5

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhh---HHHHHHHHHHHHHhcccceeeeeecccC----CCcceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQG---FQQFQAEVKLLMRVHHRNLTSLVGHCDE----DNQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~---~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~  644 (878)
                      ..||+|++|.||+|+.+++.||||++.......   .+.|.+|+.+|.+++||||+++++++.+    ....++||||++
T Consensus        26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            479999999999999999999999997653322   5778899999999999999999999866    346789999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.++++.  .+.+++...+.++.|++.||.|||+..  +++||||||+|||+++++.+||+|||+++.+....    
T Consensus       106 ~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        106 RGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            9999999976  457899999999999999999999732  67899999999999999999999999987653221    


Q ss_pred             cccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          725 STVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+.      .......+. .    +    
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~------~~~i~~~~~-~----~----  241 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI------YDLIINKNN-S----L----  241 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCC-C----C----
Confidence             12357889999999976  6899999999999999999999999987654321      111111111 0    0    


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      ..+..+...+.+++.+||+.+|++||+++|+++.|+...
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            112233457889999999999999999999999998753

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=371.06  Aligned_cols=256  Identities=30%  Similarity=0.490  Sum_probs=215.9

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|...+       ..||||.+.+. +.+...+|++|..+|++++|||||+++|.|.+....++++
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l  774 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL  774 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence            345789999999999998754       24999998865 5667889999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          641 EFMANGNLQEYLSDIS-----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      |||++|+|..+|++.+     ...++....+.++.|||+|+.||+++   ++|||||.++|+||++...+||+|||+|+.
T Consensus       775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence            9999999999998753     45689999999999999999999998   999999999999999999999999999995


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      +...+.........-...|||||.+..+.++.|+|||||||++||++| |..||...+..+...  .    ....|+   
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~----~~~ggR---  922 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--D----VLEGGR---  922 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--H----HHhCCc---
Confidence            543333322222234578999999999999999999999999999999 889998877654322  1    122232   


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                           |  +.+..|...+.+++..||+.+|++||++..+++++..++..
T Consensus       923 -----L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  923 -----L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             -----c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                 2  23456777888999999999999999999999999887754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=330.67  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=208.9

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      |.+.+.||.|..++||+|+..  +..||||++.-.. ....+.+.+|++.|+.++||||++++..|..+..+++||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            456789999999999999874  4889999997543 3346889999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|++.++++..-...+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.+||+|||.+..+........
T Consensus       108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~  184 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV  184 (516)
T ss_pred             CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence            99999999987788899999999999999999999999   999999999999999999999999998776644332111


Q ss_pred             -c-ccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          725 -S-TVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       725 -~-~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                       . ....||+.|||||++..  ..|+.|+||||||+..+||.+|..||....+-....      ..+. +......-..+
T Consensus       185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl------~tLq-n~pp~~~t~~~  257 (516)
T KOG0582|consen  185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL------LTLQ-NDPPTLLTSGL  257 (516)
T ss_pred             EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH------HHhc-CCCCCcccccC
Confidence             1 45679999999999543  469999999999999999999999999876533211      1111 22211111111


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..+....-...+.+++..||+.||++|||++++++.
T Consensus       258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            111112223367899999999999999999999873

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-37  Score=334.00  Aligned_cols=249  Identities=35%  Similarity=0.583  Sum_probs=198.8

Q ss_pred             hcccccccccEEEEEEEEc------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          570 FERTLGKGGFGTVYYGRLN------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.||.|.||.||+|.+.      +..|+||+++... ....+.|.+|++.+.+++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999988      4789999997643 34578999999999999999999999999988889999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.++|+......+++..+..|+.||++||+|||+.   +++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999986567899999999999999999999998   9999999999999999999999999999876322222


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      ...........|+|||.+.+..++.++||||||+++|||++ |+.|+......+   +   .... .++...        
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~---~~~~-~~~~~~--------  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---I---IEKL-KQGQRL--------  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---H---HHHH-HTTEET--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---cccc-cccccc--------
Confidence            22333446778999999999899999999999999999999 779987765433   1   1111 222211        


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                       ..+..+...+.+++..||+.+|++||+++++++.|
T Consensus       225 -~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 -PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             11122334677999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2e-37  Score=338.02  Aligned_cols=242  Identities=28%  Similarity=0.445  Sum_probs=209.1

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.||+|.||.||||+.+.  +.||+|.+.+.  ..+..+.+.+|++++++++|||||.++++|+...++++|.||+.+
T Consensus         6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g   85 (808)
T KOG0597|consen    6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG   85 (808)
T ss_pred             HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence            34679999999999998876  77999998764  455678899999999999999999999999999999999999977


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                       +|..+|..  ...++++.+..++.++..||.|||+.   +|+|||+||+|||++.++.+|++|||+|+.+..  +....
T Consensus        86 -~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vl  157 (808)
T KOG0597|consen   86 -DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVL  157 (808)
T ss_pred             -hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc--Cceee
Confidence             99999986  67899999999999999999999999   999999999999999999999999999998743  45666


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      +...||+-|||||+..++.|+..+|.||+||++||+++|++||...      .+.+.++....+.        -.   .+
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~--------v~---~p  220 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP--------VK---PP  220 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC--------CC---Cc
Confidence            7788999999999999999999999999999999999999999753      2333343333221        11   12


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+....+..++...|.+||.+|.+..+++..
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            2445577889999999999999999999874

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.4e-37  Score=346.59  Aligned_cols=255  Identities=26%  Similarity=0.422  Sum_probs=202.5

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+..       +..||||+++... ....+.+.+|++++..+ +||||++++++|..++..++
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l  116 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV  116 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence            456789999999999999741       2579999987543 33456789999999999 89999999999999999999


Q ss_pred             EeeeccCCChhhhhcccc--------------------------------------------------------------
Q 002809          639 IYEFMANGNLQEYLSDIS--------------------------------------------------------------  656 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~--------------------------------------------------------------  656 (878)
                      ||||+++|+|.++++...                                                              
T Consensus       117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (375)
T cd05104         117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID  196 (375)
T ss_pred             eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence            999999999999986421                                                              


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          657 -----------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       657 -----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                                 ...+++..+++++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++...........
T Consensus       197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence                       12478899999999999999999998   9999999999999999999999999999866433222222


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......  .+.++    +..+...         ..
T Consensus       274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~~---------~~  338 (375)
T cd05104         274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYRM---------LS  338 (375)
T ss_pred             CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCccC---------CC
Confidence            22335668999999999999999999999999999998 888987654322  11222    1111100         00


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      +.....++.+++.+|++.+|++||+++||++.|++.
T Consensus       339 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            111234688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-37  Score=332.68  Aligned_cols=257  Identities=26%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~~~  645 (878)
                      +.||+|.||.||+|+...  +.||+|++....  ........+||.+|++|.||||++|.+...+.  ..+|||+|||++
T Consensus       123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh  202 (560)
T KOG0600|consen  123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH  202 (560)
T ss_pred             HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence            579999999999998754  779999987654  44556778999999999999999999998766  689999999976


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                       +|.-++.. ..-.+++.++..+++|++.||+|||++   +|+|||||.+|||||.+|.+||+|||||+++....... .
T Consensus       203 -DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~  276 (560)
T KOG0600|consen  203 -DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-Y  276 (560)
T ss_pred             -hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-c
Confidence             88777764 345799999999999999999999998   99999999999999999999999999999885544332 3


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc-------cccC
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK-------SIVD  797 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~-------~iid  797 (878)
                      +..+-|..|.|||++.+. .|+.++|+||.||||.||++|++.|.+..+-++.+..--...-..+....       ..+.
T Consensus       277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k  356 (560)
T KOG0600|consen  277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK  356 (560)
T ss_pred             ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence            445678999999998865 79999999999999999999999999988766655432221111111111       0010


Q ss_pred             C------ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 P------RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 ~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +      ++.+. -..-....++|+..+|..||.+|.|+.++++
T Consensus       357 p~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  357 PQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            0      01100 0011235678999999999999999999876

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.5e-36  Score=305.92  Aligned_cols=260  Identities=24%  Similarity=0.354  Sum_probs=205.0

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCChh--hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ--GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~--~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      -.+.||+|.||.||+|+..  ++.||||+++.....  ......+|++.|+.++|+||+.+++.|...+.+.+|+|||+.
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t   85 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT   85 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence            3578999999999999875  488999999865333  345678999999999999999999999999999999999965


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                       +|+..+++ +...++..++..++.++++|++|||.+   .|+||||||.|+|++++|.+||+|||+++.+.........
T Consensus        86 -dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   86 -DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             -cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence             99999986 356788999999999999999999998   9999999999999999999999999999998655433322


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc---C----
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV---D----  797 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii---d----  797 (878)
                        ..-|..|.|||++.+. .|+..+|+||.||++.||+-|.+-|.+.+.-++....--+..........++.   |    
T Consensus       161 --~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  161 --QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             --ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence              2568899999998764 69999999999999999999998888776655443321111111111111110   0    


Q ss_pred             ---Ccc-ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          798 ---PRL-QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       798 ---~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         |.. ....-..+...+++++..++..+|.+|++++|++++
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence               000 011123345567999999999999999999999875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=343.96  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=209.6

Q ss_pred             hcccccccccEEEEEEEEcc-----ee-EEEEEecc---CChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          570 FERTLGKGGFGTVYYGRLNE-----ID-VAVKMLSS---SSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~-----~~-vAvK~l~~---~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      +.+.||+|+||.||+|++.-     .. ||||..+.   ......++|++|.++|++++|||||+++|++..+..+++||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            34789999999999998743     13 89999885   34567789999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      |+|.||+|.++|+... ..++..+++.++.++|+||+|||++   ++|||||.++|+|++.++.+||+|||+++.-.   
T Consensus       241 El~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---  313 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS---  313 (474)
T ss_pred             EecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc---
Confidence            9999999999998743 3699999999999999999999999   99999999999999999999999999987532   


Q ss_pred             CCcccc-cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          721 NTHVST-VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       721 ~~~~~~-~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ...... ...-...|+|||.+....++.++|||||||++||+++ |..||.+....+   +..++   ..++.       
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI---~~~~~-------  380 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKI---VKNGY-------  380 (474)
T ss_pred             ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHH---HhcCc-------
Confidence            111111 1235579999999999999999999999999999999 889998876543   22222   12221       


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                        +...+...+..+..+..+|+..+|++||+|.++.+.|+.+......
T Consensus       381 --r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  381 --RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             --cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence              1122224455677888899999999999999999999998766443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-36  Score=333.56  Aligned_cols=260  Identities=27%  Similarity=0.437  Sum_probs=203.1

Q ss_pred             hhhcccccccccEEEEEEEEcc------------------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE------------------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVG  628 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~------------------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g  628 (878)
                      +.+.+.||+|+||.||++...+                  ..||+|.+.... .....+|.+|++++.+++||||+++++
T Consensus         7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   86 (304)
T cd05096           7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG   86 (304)
T ss_pred             CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence            4567899999999999997532                  369999987653 334568999999999999999999999


Q ss_pred             cccCCCcceeEeeeccCCChhhhhcccc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 002809          629 HCDEDNQTALIYEFMANGNLQEYLSDIS-----------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD  691 (878)
Q Consensus       629 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrD  691 (878)
                      ++...+..++||||+++|+|.+++....                 ...+++..+++++.|++.||+|||+.   +|+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d  163 (304)
T cd05096          87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD  163 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            9999999999999999999999885421                 13478899999999999999999998   999999


Q ss_pred             CCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCC
Q 002809          692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAIS  769 (878)
Q Consensus       692 LKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~  769 (878)
                      |||+|||+++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++  +..||.
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            999999999999999999999986543322222223345788999999998899999999999999999987  557777


Q ss_pred             CCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          770 RINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       770 ~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .....+   ..+.+............      ...+..+...+.+++.+||+.+|++||+++||.+.|++
T Consensus       244 ~~~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         244 ELTDEQ---VIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCHHH---HHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            654432   22222222221111000      01112234578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-36  Score=343.12  Aligned_cols=256  Identities=28%  Similarity=0.451  Sum_probs=202.5

Q ss_pred             hhhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+++...       ..||+|++.... ......+.+|+++++.+ +|+||++++++|......++
T Consensus        40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l  119 (374)
T cd05106          40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV  119 (374)
T ss_pred             ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence            4567899999999999987421       469999997543 33456789999999999 89999999999999999999


Q ss_pred             EeeeccCCChhhhhcccc--------------------------------------------------------------
Q 002809          639 IYEFMANGNLQEYLSDIS--------------------------------------------------------------  656 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~--------------------------------------------------------------  656 (878)
                      ||||+++|+|.++++...                                                              
T Consensus       120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (374)
T cd05106         120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD  199 (374)
T ss_pred             eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence            999999999999885421                                                              


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccC
Q 002809          657 ------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG  730 (878)
Q Consensus       657 ------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  730 (878)
                            ...+++.++++++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++...............+
T Consensus       200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~  276 (374)
T cd05106         200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL  276 (374)
T ss_pred             hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence                  12478899999999999999999998   999999999999999999999999999976543322222222335


Q ss_pred             CCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHH
Q 002809          731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV  809 (878)
Q Consensus       731 t~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~  809 (878)
                      +..|+|||++.+..++.++|||||||++|||++ |+.||........  +.    .....+.     .+.    .+....
T Consensus       277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~~-----~~~----~~~~~~  341 (374)
T cd05106         277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRGY-----QMS----RPDFAP  341 (374)
T ss_pred             ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHccc-----Ccc----CCCCCC
Confidence            678999999998899999999999999999997 9999976543221  11    1111111     000    011123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          810 WKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       810 ~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .++.+++.+||+.+|++||++.+|++.|++++
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            46789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=336.62  Aligned_cols=244  Identities=26%  Similarity=0.421  Sum_probs=203.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC----Ch-hhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS----SA-QGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~----~~-~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.|+.|+..  +..||+|++...    .. ...+.+.+|+.++++++ ||||++++.++......++|
T Consensus        19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv   98 (370)
T KOG0583|consen   19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV   98 (370)
T ss_pred             eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence            456789999999999999764  589999977653    12 23456778999999999 99999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEEeecCCcccccc
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSFAT  718 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~  718 (878)
                      |||+.+|+|.+++.+  ...+.+..+..++.|++.|++|||+.   +|+||||||+|||++.+ +++||+|||++.... 
T Consensus        99 mEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-  172 (370)
T KOG0583|consen   99 MEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-  172 (370)
T ss_pred             EEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence            999999999999987  67789999999999999999999998   99999999999999999 999999999998763 


Q ss_pred             CCCCcccccccCCCCccCccccccCC-CC-CccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNR-LT-EKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~-~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                       .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+....      . ..+..+..    
T Consensus       173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l------~-~ki~~~~~----  240 (370)
T KOG0583|consen  173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL------Y-RKIRKGEF----  240 (370)
T ss_pred             -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH------H-HHHhcCCc----
Confidence             2233455678999999999999877 75 789999999999999999999998443221      1 11333321    


Q ss_pred             CCccccccCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          797 DPRLQEDFDANS-VWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       797 d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                            .++... ..++..++.+|+..+|.+|+++.++++
T Consensus       241 ------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 ------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                  111111 457889999999999999999999983

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=331.28  Aligned_cols=261  Identities=27%  Similarity=0.360  Sum_probs=205.7

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCChh-hHHHHHHHHHHHHHhc-ccceeeeeecccCCC-cceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDN-QTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~-~~~lV~Ey  642 (878)
                      |...+.||.|.||.||+|+-..  ..||||+++..-.. +...=++|++.|+++. |||||++.+.+.+.+ .+++||||
T Consensus        12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~   91 (538)
T KOG0661|consen   12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF   91 (538)
T ss_pred             HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence            4456789999999999998654  77999999865322 2223368999999998 999999999998887 99999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      |+ .+|++++++. ++.+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+||.+....  
T Consensus        92 Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp--  164 (538)
T KOG0661|consen   92 MD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP--  164 (538)
T ss_pred             hh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC--
Confidence            95 5999999985 88899999999999999999999998   99999999999999999999999999999775432  


Q ss_pred             cccccccCCCCccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC------cccc
Q 002809          723 HVSTVVAGTPGYLDPEYY-TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD------IKSI  795 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~------~~~i  795 (878)
                       ..+..+.|..|+|||++ +..-|+.+.|+||+|||++|+.+-++.|.+.++-++.....-|.....+..      +...
T Consensus       165 -PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  165 -PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             -CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence             23445688999999987 467899999999999999999999999998877555432221111111111      1111


Q ss_pred             cCCcccc-------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          796 VDPRLQE-------DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       796 id~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.=++..       ..-.....+.++++.+|+..||.+|||++|++++
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1111110       0112255688899999999999999999999885

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-36  Score=325.39  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=203.3

Q ss_pred             hhhcccccccccEEEEEEEEc-----ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|.+.     +..||+|+++... ......|.+|+.++.+++||||+++++++..++..++|||
T Consensus         7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   86 (266)
T cd05064           7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE   86 (266)
T ss_pred             eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence            456789999999999999764     3679999988653 3345679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++... ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+|++|||.+....... 
T Consensus        87 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~-  161 (266)
T cd05064          87 YMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA-  161 (266)
T ss_pred             eCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc-
Confidence            99999999999753 34689999999999999999999988   99999999999999999999999999876432211 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+.   .+    .+.++...       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~----~~~~~~~~-------  227 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK----AVEDGFRL-------  227 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH----HHHCCCCC-------
Confidence            111112235678999999999999999999999999999875 9999987654331   11    11111110       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                        ..+..+...+.+++.+||+.+|++||+++|+++.|+++
T Consensus       228 --~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 --PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              11223345788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.6e-36  Score=326.15  Aligned_cols=252  Identities=29%  Similarity=0.536  Sum_probs=205.8

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|...+       ..||+|.+.... ......|.+|++++.+++||||+++++++...+..+++|
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            456789999999999998643       469999987543 344567899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEE
Q 002809          641 EFMANGNLQEYLSDISK--------------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK  706 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~k  706 (878)
                      ||+++|+|.+++.....              ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence            99999999999975321              5688999999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHH
Q 002809          707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNS  785 (878)
Q Consensus       707 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~  785 (878)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+   +.+    
T Consensus       165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~----  237 (283)
T cd05048         165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE----  237 (283)
T ss_pred             ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----
Confidence            999999876543322222333456788999999998899999999999999999998 999998765533   111    


Q ss_pred             HHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          786 LIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       786 ~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .+..+...         ..+.....++.+++.+||+.+|.+||+++||++.|+.
T Consensus       238 ~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            12222211         1122344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.7e-36  Score=321.37  Aligned_cols=251  Identities=29%  Similarity=0.476  Sum_probs=205.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|++|.||+|...  ++.||+|.+.... ...+++.+|++++++++|+||+++++++..++..++||||++++
T Consensus         9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (263)
T cd05052           9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   87 (263)
T ss_pred             EEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence            45678999999999999875  4789999987543 34578999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++.......+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||++......... ...
T Consensus        88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~  163 (263)
T cd05052          88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHA  163 (263)
T ss_pred             cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccC
Confidence            999999765566799999999999999999999988   9999999999999999999999999998766432211 111


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||.+.+..++.++|||||||+++||++ |..||.....++..       ..+..+.         ....+
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~---------~~~~~  227 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKGY---------RMERP  227 (263)
T ss_pred             CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCC---------CCCCC
Confidence            2234568999999999999999999999999999998 89998765443211       1111110         11112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ......+.+++.+|++.+|++||++.++++.|+++
T Consensus       228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            22345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=332.21  Aligned_cols=260  Identities=26%  Similarity=0.450  Sum_probs=218.1

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .|.+.||+|-||.|..+...+ ..||||+++..... ..++|.+|+++|.+++||||++++|.|..++.+++|+|||++|
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG  620 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence            467899999999999999988 99999999976544 4589999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++..+....+.-...+.|+.|||.||+||.+-   ++|||||.++|+|++.++++||+|||+++.+-.+...+...
T Consensus       621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg  697 (807)
T KOG1094|consen  621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG  697 (807)
T ss_pred             cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence            999999876544456667788999999999999998   99999999999999999999999999999776666555555


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ...-..+|||+|.+.-++++.++|||+||+.+||+++  ...||.....+..   ++=...+...+....+      ...
T Consensus       698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~------l~~  768 (807)
T KOG1094|consen  698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVV------LSR  768 (807)
T ss_pred             ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCccee------ccC
Confidence            5667789999999999999999999999999999866  6789887765432   2222222222221111      123


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      +.-+..++.++++.||..+-++||+++++...|++.
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            455677889999999999999999999999999873

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-36  Score=319.78  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=205.2

Q ss_pred             HhhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ...+.+.||+|++|.||+|...+ +.||+|.++.... ..+++.+|++++++++|+||+++++++...+..++||||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY   85 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence            34667899999999999998765 7899999875432 356789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.......+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++....... ...
T Consensus        86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~  161 (261)
T cd05068          86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAR  161 (261)
T ss_pred             CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-ccc
Confidence            9999999765556789999999999999999999998   999999999999999999999999999987642211 111


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....+..|+|||++.+..++.++||||||++++||+| |+.||.........       ..+.....         ...
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~---------~~~  225 (261)
T cd05068         162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQVDQGYR---------MPC  225 (261)
T ss_pred             CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC---------CCC
Confidence            11223457999999999999999999999999999999 99999765543211       11111110         011


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      +......+.+++.+|++.+|++||++.++++.|++
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            12233578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-35  Score=323.58  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=198.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ...+.||+|+||.||++...  ++.||+|.+....   ......+.+|++++.+++|+||+++.+++.+++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            34578999999999999874  4889999987542   223356789999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++.......   
T Consensus        83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---  156 (285)
T cd05631          83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---  156 (285)
T ss_pred             CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---
Confidence            999999888654455789999999999999999999998   99999999999999999999999999997653221   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||..........  . +...+....          ..
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~-~~~~~~~~~----------~~  223 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--E-VDRRVKEDQ----------EE  223 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--H-HHHHhhccc----------cc
Confidence            1223468999999999999999999999999999999999999998654322111  0 111111111          01


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPT-----MSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~  835 (878)
                      ++......+.+++.+||+.+|++||+     ++++++
T Consensus       224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11122346789999999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.1e-36  Score=332.29  Aligned_cols=258  Identities=28%  Similarity=0.465  Sum_probs=203.2

Q ss_pred             HhhhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccC-CCcc
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDE-DNQT  636 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~-~~~~  636 (878)
                      .+.+.+.||+|+||.||+|...+       +.||+|++.... ....+.+.+|++++.++ +|+||++++++|.. +...
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            34667899999999999996432       579999987543 33456788999999999 79999999998864 4568


Q ss_pred             eeEeeeccCCChhhhhcccc-----------------------------------------------------------C
Q 002809          637 ALIYEFMANGNLQEYLSDIS-----------------------------------------------------------K  657 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------~  657 (878)
                      ++++||+++|+|.+++....                                                           .
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            89999999999999885422                                                           1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCc
Q 002809          658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP  737 (878)
Q Consensus       658 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP  737 (878)
                      ..+++..+.+++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+.............++..|+||
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence            3689999999999999999999998   9999999999999999999999999999876433222122233456789999


Q ss_pred             cccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHH
Q 002809          738 EYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELA  816 (878)
Q Consensus       738 E~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~  816 (878)
                      |++.+..++.++|||||||+++||++ |+.||......+.  +.    ..+..+...         ..+.....++.+++
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~~---------~~~~~~~~~~~~l~  309 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEGTRM---------RAPEYATPEIYSIM  309 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhccCCC---------CCCccCCHHHHHHH
Confidence            99999999999999999999999998 9999976433221  11    111221111         01112234688999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          817 MACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       817 ~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .+|++.+|++||++.||+++|+++++
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-35  Score=322.07  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=208.7

Q ss_pred             hhcccccccccEEEEEEEEc-------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+++..       ...+++|.+........+.+.+|++++++++|+||+++++++......++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            44678999999999999742       24589999887776667889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEE
Q 002809          642 FMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKL  707 (878)
Q Consensus       642 y~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL  707 (878)
                      |+++++|.+++....              ...+++..+++++.|++.||+|||++   +|+||||||+|||++.++.++|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence            999999999996532              23589999999999999999999998   9999999999999999999999


Q ss_pred             eecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHH
Q 002809          708 ADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSL  786 (878)
Q Consensus       708 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~  786 (878)
                      +|||++................++..|+|||.+.+..++.++|||||||+++||+| |+.||......+.   .+    .
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~----~  237 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE----C  237 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----H
Confidence            99999976543322222233446788999999999999999999999999999999 9999877654331   11    1


Q ss_pred             HhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          787 IAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       787 ~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      ...+.....         .......+.+++.+||+.+|++||++++|+++|+++..
T Consensus       238 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         238 ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            222222111         11223468899999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=332.96  Aligned_cols=252  Identities=29%  Similarity=0.470  Sum_probs=217.7

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      ....||-|.+|.||.|.|+.  ..||||.++.... ..++|++|..+|+.++|||+|+|+|.|..+..+|+|+|||..|+
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            45789999999999999986  7899999987643 46899999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++|++.+++.++--..+.++.||+.|++||..+   ++|||||.++|+|+.++..+||+|||+++++..+.... ...
T Consensus       350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-HAG  425 (1157)
T KOG4278|consen  350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-HAG  425 (1157)
T ss_pred             HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-ccC
Confidence            99999999999999999999999999999999988   99999999999999999999999999999985443321 111


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..=.+.|.|||-+....++.|+|||+|||+|||+.| |..||.+.+...       |-.+         +....+-+.+.
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~L---------LEkgyRM~~Pe  489 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGL---------LEKGYRMDGPE  489 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHH---------HhccccccCCC
Confidence            223468999999999999999999999999999998 888887765433       2222         22333444566


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .|..++.+|+++||+.+|.+||+++|+-+.++.+..
T Consensus       490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            788899999999999999999999999999987663

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.8e-35  Score=319.55  Aligned_cols=256  Identities=28%  Similarity=0.464  Sum_probs=207.8

Q ss_pred             hhcccccccccEEEEEEEEc-------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||++...       ...+|+|.+........+.+.+|++++.+++||||+++++++...+..++|||
T Consensus         8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (288)
T cd05093           8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   87 (288)
T ss_pred             eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            45688999999999999752       25589999887766667789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcccc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          642 FMANGNLQEYLSDIS-----------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       642 y~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                      |+++++|.+++....           ...+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccC
Confidence            999999999986432           23589999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      |+++...............++..|+|||.+.+..++.++|||||||+++||++ |++||......+.   .    ..+..
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~----~~i~~  237 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I----ECITQ  237 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHc
Confidence            99876533222112222335678999999998899999999999999999999 8999877654321   1    11222


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      +....     .    +......+.+++.+|++.+|.+||+++++++.|+++...
T Consensus       238 ~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         238 GRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            22111     1    111234688999999999999999999999999987744

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.3e-36  Score=338.98  Aligned_cols=256  Identities=25%  Similarity=0.421  Sum_probs=203.7

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV  639 (878)
                      .+.+.||+|+||.||+|+...       ..||||++.... ....+.+.+|++++.++. ||||++++++|.+....++|
T Consensus        40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv  119 (400)
T cd05105          40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII  119 (400)
T ss_pred             ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence            456889999999999998632       469999997543 334567999999999996 99999999999999999999


Q ss_pred             eeeccCCChhhhhcccc---------------------------------------------------------------
Q 002809          640 YEFMANGNLQEYLSDIS---------------------------------------------------------------  656 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~---------------------------------------------------------------  656 (878)
                      |||+++|+|.++++...                                                               
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (400)
T cd05105         120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK  199 (400)
T ss_pred             EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence            99999999999886421                                                               


Q ss_pred             -------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcE
Q 002809          657 -------------------------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA  705 (878)
Q Consensus       657 -------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~  705 (878)
                                                     ...+++..++.++.|+++||+|||+.   +|+||||||+|||+++++.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~  276 (400)
T cd05105         200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIV  276 (400)
T ss_pred             hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEE
Confidence                                           12478889999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHH
Q 002809          706 KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVN  784 (878)
Q Consensus       706 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~  784 (878)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........  +    .
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~----~  350 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F----Y  350 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H----H
Confidence            9999999986543222222223446788999999998899999999999999999997 8899876543221  1    1


Q ss_pred             HHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       785 ~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      ..+..+..         ...+......+.+++.+||+.+|++||++.+|.+.|+++++
T Consensus       351 ~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         351 NKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11111110         01112234578899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.4e-36  Score=330.19  Aligned_cols=241  Identities=27%  Similarity=0.373  Sum_probs=197.5

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||+|+||.||+++..  ++.||+|++...   .......+.+|++++.+++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875  478999998753   2234567889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~  153 (323)
T cd05571          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK  153 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence            99999875  45789999999999999999999998   99999999999999999999999999987532211  1223


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||...+......       .+..+.      ..+    +.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~-------~~~~~~------~~~----p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILMEE------IRF----PR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH-------HHHcCC------CCC----CC
Confidence            4569999999999999999999999999999999999999997655432111       111111      111    11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                      ....++.+++.+||+.||++||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            2234678999999999999999     78888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=318.09  Aligned_cols=253  Identities=28%  Similarity=0.453  Sum_probs=205.3

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|++..     ..||||.+.... ......|.+|+.++.+++||||+++++.+...+..++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            3456899999999999998742     579999987543 3345689999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++++|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+||++++++.++|+|||+++.......
T Consensus        86 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          86 YMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             cCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            99999999999753 34689999999999999999999998   999999999999999999999999999987742222


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........++..|+|||.+.+..++.++||||||++++||++ |..||.......   +.+.    +..+...       
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~~~~-------  227 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKA----VEDGYRL-------  227 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHH----HHcCCCC-------
Confidence            222222345678999999998899999999999999999998 999987655432   1111    1111100       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                        ..+......+.+++.+|++.+|++||+++||++.|+++
T Consensus       228 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              01112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-35  Score=318.08  Aligned_cols=251  Identities=30%  Similarity=0.491  Sum_probs=209.0

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.+.||+|+||.||+|+..+ ..+|+|.+..........+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence            4566899999999999999876 889999998776666778999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.++++......+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+........  ...
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--~~~  162 (261)
T cd05148          88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--LSS  162 (261)
T ss_pred             CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc--ccc
Confidence            999999876667799999999999999999999998   999999999999999999999999999976633211  111


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||.+....++.++||||||+++++|++ |+.||......+..   +...    .+.         ....+
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~~~~----~~~---------~~~~~  226 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---DQIT----AGY---------RMPCP  226 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHH----hCC---------cCCCC
Confidence            2345678999999998889999999999999999998 89999766543211   1111    110         01112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ......+.+++.+|++.+|++||+++++++.|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            2334567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-35  Score=321.78  Aligned_cols=254  Identities=29%  Similarity=0.479  Sum_probs=206.1

Q ss_pred             HHhhhcccccccccEEEEEEEEc-------ceeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcce
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~  637 (878)
                      .++.+.+.||+|+||.||+|+..       ...||+|.+...... ..+.+.+|++++.+++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            34566789999999999999763       267999998765444 5678999999999999999999999999999999


Q ss_pred             eEeeeccCCChhhhhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcE
Q 002809          638 LIYEFMANGNLQEYLSDIS------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA  705 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~  705 (878)
                      +||||+++++|.+++....            ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999997532            24588999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHH
Q 002809          706 KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVN  784 (878)
Q Consensus       706 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~  784 (878)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |+.||.....++.   .+.  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~--  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IEC--  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH--
Confidence            9999999876533222122223345678999999999999999999999999999999 9999876654331   111  


Q ss_pred             HHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       785 ~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                        +..+....         .+......+.+++.+||+.+|++||++.||++.|+
T Consensus       237 --~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 --ITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              11222111         11123357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=304.86  Aligned_cols=238  Identities=28%  Similarity=0.422  Sum_probs=198.8

Q ss_pred             CCHHHHHHHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccC
Q 002809          558 LSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDE  632 (878)
Q Consensus       558 ~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~  632 (878)
                      .+++|.     ++.+.||.|+||+|...+.+.  .-+|+|++.+...   +..+...+|..+|+.+.||.++++.+.|.+
T Consensus        41 ~~l~df-----e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDF-----ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhh-----hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            555554     345789999999999998754  7799999987643   334566789999999999999999999999


Q ss_pred             CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       633 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      .+.+++||||++||.|.++|++  .++++++.++.++.||+.||+|||+.   .|++|||||+|||||.+|.+||+|||.
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGF  190 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGF  190 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccc
Confidence            9999999999999999999987  66799999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      |+.+...     .-+.|||+.|+|||.+++..+..++|.|||||++|||+.|.+||...++-.       .-+.+.++++
T Consensus       191 AK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v  258 (355)
T KOG0616|consen  191 AKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKV  258 (355)
T ss_pred             eEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcc
Confidence            9876422     345799999999999999999999999999999999999999998876622       1122333332


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCC
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQR  827 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  827 (878)
                            +    ++..-..++.+|+...|+.|-.+|
T Consensus       259 ------~----fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 ------K----FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ------c----CCcccCHHHHHHHHHHHhhhhHhh
Confidence                  1    122222356678888888888888

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-35  Score=327.61  Aligned_cols=255  Identities=26%  Similarity=0.418  Sum_probs=203.5

Q ss_pred             hhhcccccccccEEEEEEEEc--c----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--E----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      +...+.||+|+||.||+|++.  +    ..||+|++.... ....+++.+|+.+++.++||||++++++|... ...+|+
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            344578999999999999863  2    248999987543 34567899999999999999999999999765 577999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++|+|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        88 e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          88 QLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             ecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            999999999999753 34588999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .........++..|+|||++.+..++.++|||||||++|||++ |+.||......+.   ..    ....+..       
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~~-------  229 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGER-------  229 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHhCCCC-------
Confidence            2222222334678999999999999999999999999999998 9999986554331   11    1111110       


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      +  ..+..+...+.+++.+|+..+|++||++.++++.|.++...
T Consensus       230 ~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         230 L--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             C--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            0  01112334678999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-36  Score=334.16  Aligned_cols=243  Identities=25%  Similarity=0.383  Sum_probs=206.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+++.||.|+.|.|-.|++.  |+.+|||++.+..   ......+.+|+.+|+.+.|||++++++.++...++|+|.||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            45689999999999999874  5889999997652   233467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|-|.+++-+  ++.+++.++.+++.||+.|+.|+|..   +|+||||||+|+|||..+++||+|||+|..-..   ..
T Consensus        95 ~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---gk  166 (786)
T KOG0588|consen   95 PGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP---GK  166 (786)
T ss_pred             CCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC---Cc
Confidence            99999999976  67899999999999999999999998   999999999999999999999999999976432   23


Q ss_pred             ccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .-.+.||.+.|.|||++.+.+| ..++||||.||||+.|+||+.||++.+-..       ....++.|..          
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-------LLlKV~~G~f----------  229 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-------LLLKVQRGVF----------  229 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-------HHHHHHcCcc----------
Confidence            4456799999999999999988 568999999999999999999999654322       1122333321          


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +++.....++.+|+.+|+..||++|.|++||+++
T Consensus       230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            1223344577899999999999999999999986

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-35  Score=322.18  Aligned_cols=252  Identities=28%  Similarity=0.503  Sum_probs=202.5

Q ss_pred             hhcccccccccEEEEEEEE------cceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRL------NEIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|+.      .+..+|+|.+.... ......|.+|++++++++||||+++++++..+...++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   87 (283)
T cd05090           8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE   87 (283)
T ss_pred             eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence            5668899999999999985      23679999987543 3445789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcccc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEE
Q 002809          642 FMANGNLQEYLSDIS---------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK  706 (878)
Q Consensus       642 y~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~k  706 (878)
                      |+++++|.+++....               ...+++.+.+.++.|++.||+|||+.   +++||||||+|||+++++.+|
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~k  164 (283)
T cd05090          88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVK  164 (283)
T ss_pred             cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEE
Confidence            999999999985321               23588999999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHH
Q 002809          707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNS  785 (878)
Q Consensus       707 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~  785 (878)
                      |+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |..||.......   +.+    
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~----  237 (283)
T cd05090         165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE----  237 (283)
T ss_pred             eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----
Confidence            999999986643332222333446678999999988889999999999999999999 999987654432   111    


Q ss_pred             HHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          786 LIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       786 ~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .+......         ..+.....++.+++.+|++.+|++||++.+|.+.|+.
T Consensus       238 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111111         1112233467889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=325.78  Aligned_cols=242  Identities=26%  Similarity=0.460  Sum_probs=204.9

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      +.||+|.||.||+|....  +.||+|++.-. ......++++|+.+|.+++++||.++++.+..+..++++||||.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            689999999999998765  78999999754 344568899999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      .+.|+.  ...+.+..+.-|+++++.||.|||.+   +.+|||||+.|||+..+|.+|++|||.+..+.......  ..+
T Consensus        99 ~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tf  171 (467)
T KOG0201|consen   99 LDLLKS--GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTF  171 (467)
T ss_pred             hhhhcc--CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--ccc
Confidence            999986  44558888889999999999999999   99999999999999999999999999998775443322  557


Q ss_pred             cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      .||+.|||||++....|+.|+||||||++.+||++|.+|+....+..                +.-++-+......+...
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~~~~  235 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLDGDF  235 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCcccccc
Confidence            89999999999998899999999999999999999999998765521                11122222222222233


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          809 VWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...+.+++..||+.+|+.||++++++++
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            4468899999999999999999999874

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-35  Score=321.63  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=204.6

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|+...       ..+++|.+.... ......+.+|++++..++||||+++++.|..++..++|+
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            345789999999999998642       568999887553 344578999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhcccc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEE
Q 002809          641 EFMANGNLQEYLSDIS----------------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNIL  698 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NIL  698 (878)
                      ||+.+|+|.+++....                      ...+++..++.++.|++.||+|||+.   +++||||||+|||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence            9999999999986421                      23588999999999999999999988   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 002809          699 LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKI  777 (878)
Q Consensus       699 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  777 (878)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||.....+.  
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--  237 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--  237 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence            99999999999999876533222111223345678999999988889999999999999999999 999997655432  


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                       +.++    ..++.         ....+......+.+++.+|++.+|++||+++++++.|++++.
T Consensus       238 -~~~~----~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 -LFNL----LKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHHH----HhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             1111    11111         001112223468899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-35  Score=316.93  Aligned_cols=250  Identities=26%  Similarity=0.447  Sum_probs=204.1

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|++|.||+|...+ ..||+|.+..... ..+.+.+|+.++++++|+||+++++.+...+..++||||+++|+
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05072           9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS   87 (261)
T ss_pred             EEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence            456789999999999998766 7799998765432 35789999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++++......+++..++.++.|+++||+|||+.   +++||||||+||++++++.++|+|||++........ .....
T Consensus        88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~  163 (261)
T cd05072          88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREG  163 (261)
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce-eccCC
Confidence            99999765566789999999999999999999988   999999999999999999999999999986533221 11122


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||++....++.++|||||||++|||+| |+.||.......   ...++    ..+...    +     ...
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~~----~-----~~~  227 (261)
T cd05072         164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----QRGYRM----P-----RME  227 (261)
T ss_pred             CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCCC----C-----CCC
Confidence            335678999999998889999999999999999998 999997654432   11111    111100    0     111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ....++.+++.+|++.+|++||+++++.+.|++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            223467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.2e-35  Score=314.46  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=197.9

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      +.||+|+||.||+|+..  ++.+|+|...... ......|.+|++++++++||||++++++|......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999874  4889999876543 34456799999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      .+++... ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++...............
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9998642 34689999999999999999999988   9999999999999999999999999998754322111111112


Q ss_pred             cCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHH
Q 002809          729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDAN  807 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~  807 (878)
                      ..+..|+|||.+.+..++.++|||||||+++||++ |..||..........       .+....         ....+..
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------~~~~~~---------~~~~~~~  220 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------AIEQGV---------RLPCPEL  220 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCC---------CCCCccc
Confidence            23457999999998899999999999999999998 888887655432111       111110         0111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          808 SVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       808 ~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ....+.+++.+|++.+|++||++.+++++|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3447889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=323.19  Aligned_cols=241  Identities=27%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   83 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence            45678999999999999876  5889999986532   234567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....    
T Consensus        84 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          84 PGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            99999999975  45689999999999999999999998   9999999999999999999999999998765322    


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                       .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.      .. .+..+..      .+   
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~-~i~~~~~------~~---  217 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YE-KILAGKL------EF---  217 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHHhCCc------CC---
Confidence             1234689999999999998999999999999999999999999987654321      11 1111111      11   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPT-----MSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~~  836 (878)
                       +......+.+++.+||+.||.+||+     ++|+++.
T Consensus       218 -~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         218 -PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             1112346789999999999999995     7777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=329.49  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=202.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+|+..  ++.||+|++....   ....+.+.+|++++..++||||+++++++..++..++||||+
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   83 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV   83 (333)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence            45678999999999999885  4789999987542   234567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....     
T Consensus        84 ~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----  153 (333)
T cd05600          84 PGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----  153 (333)
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence            99999999975  45689999999999999999999998   999999999999999999999999999876532     


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. .+..|.          ..+......
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------~~~~~~~~~  223 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK----------ETLQRPVYD  223 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc----------ccccCCCCC
Confidence            223356899999999999999999999999999999999999999876654321 111111          000000000


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ........++.+++.+||..+|++||+++++++.
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0001233467889999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-35  Score=319.71  Aligned_cols=253  Identities=25%  Similarity=0.442  Sum_probs=201.7

Q ss_pred             hhhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|...+       ..||+|++.... .....+|.+|+.+++.++|+||+++++++..+...++|
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   87 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI   87 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence            4456889999999999987642       569999986543 34456789999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          640 YEFMANGNLQEYLSDIS--------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      |||+++|+|.++++...        ...+++..++.++.|+++||+|||+.   +++||||||+||++++++.++|+|||
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg  164 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCC
Confidence            99999999999986532        12467889999999999999999988   99999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      +++...............++..|+|||++.+..++.++|||||||+++||++ |..||.....+...   +    .+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~----~~~~~  237 (277)
T cd05062         165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---R----FVMEG  237 (277)
T ss_pred             CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----HHHcC
Confidence            9876543222222222345778999999998899999999999999999999 78888766543211   1    11112


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ....         .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus       238 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         238 GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1111         112233468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3e-35  Score=314.28  Aligned_cols=247  Identities=28%  Similarity=0.499  Sum_probs=199.7

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||++++++ ..+|+|.+..... ....|.+|++++++++||||+++++++..++..++||||+++|+
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC   85 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence            456789999999999999876 6899998764432 34678999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++++... ..+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....... .....
T Consensus        86 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~  160 (256)
T cd05114          86 LLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSG  160 (256)
T ss_pred             HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCC
Confidence            999987532 3589999999999999999999998   999999999999999999999999999876532211 11122


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ...+    ..+..  ...+.       
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i----~~~~~--~~~~~-------  224 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMI----SRGFR--LYRPK-------  224 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCCCC--CCCCC-------
Confidence            235568999999998889999999999999999999 8999976654321   1111    11111  01111       


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      .....+.+++.+|++.+|++||+++++++.|
T Consensus       225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1224678999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=325.72  Aligned_cols=238  Identities=26%  Similarity=0.345  Sum_probs=194.4

Q ss_pred             ccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          574 LGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      ||+|+||.||+++..+  +.||+|++...   .......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999998754  77999998753   234456788999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      .+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ......
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~  153 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF  153 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence            999975  45689999999999999999999998   99999999999999999999999999987542221  222345


Q ss_pred             cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      .||+.|+|||++.+..++.++|||||||+++||++|+.||......+      ....... +..      .    ++...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~~~------~----~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-EPL------R----FPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-CCC------C----CCCcC
Confidence            69999999999999999999999999999999999999998654432      1111111 111      1    11122


Q ss_pred             HHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 002809          809 VWKAVELAMACLSPTGNQRPT---MSQVVM  835 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPs---m~evl~  835 (878)
                      ...+.+++.+||+.+|++||+   +.|++.
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            346779999999999999985   556554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.8e-35  Score=318.95  Aligned_cols=261  Identities=20%  Similarity=0.274  Sum_probs=199.7

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++...  ..||+|++....  ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07848           4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE   83 (287)
T ss_pred             eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence            456789999999999999864  789999987542  2345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      ++.+..+...  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........ .
T Consensus        84 ~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~  157 (287)
T cd07848          84 KNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-N  157 (287)
T ss_pred             CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-c
Confidence            8877655432  45689999999999999999999988   9999999999999999999999999999876332211 1


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---------HHHHhcCCcccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWV---------NSLIAKGDIKSI  795 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v---------~~~~~~~~~~~i  795 (878)
                      .....|+..|+|||++.+..++.++|||||||++|||++|++||......+........         ............
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            22346899999999999888999999999999999999999999876543322111110         000000000000


Q ss_pred             cCCcccc------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          796 VDPRLQE------DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       796 id~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..+....      .........+.+++.+||+.+|++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0010000      001112346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-35  Score=329.08  Aligned_cols=242  Identities=25%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++...  +.||+|++....   ....+.+.+|++++.+++||||+++++++..++..++||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            3567899999999999998854  789999987542   23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus       100 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263        100 VVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             CCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            999999999976  45689999999999999999999998   99999999999999999999999999998653221  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                         ....|++.|+|||++.+..++.++|||||||++|||++|+.||........       ...+.++...      +  
T Consensus       173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~~------~--  234 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGRLK------F--  234 (329)
T ss_pred             ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCCcC------C--
Confidence               234689999999999999999999999999999999999999976554321       1112222210      1  


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPT-----MSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~~  836 (878)
                        +......+.+++.+||+.||++||+     +++++..
T Consensus       235 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 --PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              1112235779999999999999997     6777754

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-35  Score=314.80  Aligned_cols=253  Identities=28%  Similarity=0.470  Sum_probs=201.6

Q ss_pred             hhcccccccccEEEEEEEEcc-----eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCc------
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQ------  635 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~------  635 (878)
                      .+.+.||+|+||.||+|+...     ..||+|+++..  .......+.+|++.++.++|+||+++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            356789999999999998743     56999998754  23445689999999999999999999998866554      


Q ss_pred             ceeEeeeccCCChhhhhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          636 TALIYEFMANGNLQEYLSDIS----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       636 ~~lV~Ey~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      .++|+||+++|+|..++....    ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence            789999999999999985432    34689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      +++.+.............++..|+|||.+.+..++.++|||||||+++||++ |.+||......+   +.+++    ..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~~  231 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RHG  231 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC
Confidence            9987643322222222335678999999988899999999999999999999 889987654322   11221    111


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ...         ..+.....++.+++.+|++.+|++||++.|+++.|+++
T Consensus       232 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111         11123345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=321.74  Aligned_cols=263  Identities=28%  Similarity=0.429  Sum_probs=201.2

Q ss_pred             hcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHH--hcccceeeeeecccCCC----cceeEeeec
Q 002809          570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR--VHHRNLTSLVGHCDEDN----QTALIYEFM  643 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~--l~H~nIv~l~g~~~~~~----~~~lV~Ey~  643 (878)
                      +.++||+|.||.||||++.++.||||++....   .+.|++|-++...  ++|+||+++++.-....    +.+||+||.
T Consensus       214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hHHHhhcCccceeehhhccCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            45789999999999999999999999997543   4567777666654  58999999999876655    889999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG------CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      ++|+|.++|+.   ..++|....+|+..+++||+|||+.      .+|+|+|||||++|||+..|+++.|+|||+|..+.
T Consensus       291 ~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  291 PKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             cCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            99999999984   5699999999999999999999965      47899999999999999999999999999999887


Q ss_pred             cCCCCcccccccCCCCccCccccccCC-CC-----CccchhhHHHHHHHHHhCCCCCC--------CCChHHH---HHHH
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNR-LT-----EKSDVYSFGVVILEIITCKPAIS--------RINEEEK---IHIR  780 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t-----~ksDV~S~Gvvl~elltG~~p~~--------~~~~~~~---~~l~  780 (878)
                      .+.........+||.+|||||++.+.. +.     .+.||||+|.|||||+++-..++        ...+.+.   ..+.
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            655544445578999999999997642 22     36899999999999999654332        1111110   0111


Q ss_pred             HHHHHHHhcCCcccccCCcccccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          781 QWVNSLIAKGDIKSIVDPRLQEDF-DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       781 ~~v~~~~~~~~~~~iid~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      +.....+++..     .|.++... .-..+..+.+.+..||..||+.|-|+.=|-+.+.++...
T Consensus       448 ~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  448 EMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             HHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            11111111111     12221111 113456788999999999999999999888888876544

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-34  Score=312.54  Aligned_cols=252  Identities=28%  Similarity=0.469  Sum_probs=199.6

Q ss_pred             hcccccccccEEEEEEEEcc----eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC------Ccce
Q 002809          570 FERTLGKGGFGTVYYGRLNE----IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTA  637 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~  637 (878)
                      +.+.||+|+||.||+|+...    ..+|+|.++..  .....+.+.+|+++++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            56789999999999998754    25899988754  344567899999999999999999999987432      2568


Q ss_pred             eEeeeccCCChhhhhccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCc
Q 002809          638 LIYEFMANGNLQEYLSDI----SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS  713 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla  713 (878)
                      +|+||+++|+|.+++...    ....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence            999999999999987432    234589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          714 KSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       714 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      +.+.............++..|+|||++.+..++.++||||||+++|||++ |+.||......+   +.    ..+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~~  232 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY----DYLRQGNR  232 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCC
Confidence            87643322112223346678999999999999999999999999999999 889987654322   11    11222221


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ..         .+......+.+++.+||+.+|++||++.++++.|+++
T Consensus       233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11         1112334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3e-35  Score=320.74  Aligned_cols=254  Identities=28%  Similarity=0.479  Sum_probs=205.1

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      .+.+.||+|+||.||++...+       ..+|+|.+... ..+....+.+|++++.++ +|+||+++++++..++..++|
T Consensus        15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li   94 (293)
T cd05053          15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV   94 (293)
T ss_pred             EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence            456789999999999998642       56999998754 334456789999999999 799999999999999999999


Q ss_pred             eeeccCCChhhhhccc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcE
Q 002809          640 YEFMANGNLQEYLSDI--------------SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA  705 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~  705 (878)
                      |||+++|+|.++++..              ....+++..+++++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~  171 (293)
T cd05053          95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM  171 (293)
T ss_pred             EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeE
Confidence            9999999999998642              245689999999999999999999988   99999999999999999999


Q ss_pred             EEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHH
Q 002809          706 KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVN  784 (878)
Q Consensus       706 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~  784 (878)
                      ||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||......+..       
T Consensus       172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------  244 (293)
T cd05053         172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-------  244 (293)
T ss_pred             EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-------
Confidence            9999999987643222112222335678999999998899999999999999999998 99998765543311       


Q ss_pred             HHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       785 ~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .....+..         ...+......+.+++.+|+..+|++|||++|+++.|++++
T Consensus       245 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            11111111         0112223457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.2e-35  Score=322.77  Aligned_cols=255  Identities=25%  Similarity=0.436  Sum_probs=204.9

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      ..+.+.||+|+||.||+++..       ...||+|+++... ....+.+.+|+++++++ +|+||+++++++...+..++
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  116 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV  116 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence            355789999999999999742       2579999987653 34456789999999999 79999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+.+|+|.++++......+++.+++.++.|++.||+|||+.   +|+|+||||+|||++.++.++++|||+++....
T Consensus       117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999764445589999999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.  ...    ....+..     
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~-----  262 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK----LIKEGYR-----  262 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH----HHHcCCc-----
Confidence            322111222345678999999998899999999999999999998 9999876554321  111    1111110     


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                          ...+.....++.+++.+|++.+|++||++.|+++.|+++
T Consensus       263 ----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 ----MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                011111234688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-35  Score=341.97  Aligned_cols=249  Identities=22%  Similarity=0.350  Sum_probs=203.7

Q ss_pred             hhhcccccccccEEEEEEEEc---ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN---EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||++...   +..||+|.+..........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            456789999999999999754   36788888766555556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +|+|.++++..  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+......
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988642  245688999999999999999999998   9999999999999999999999999999876433322


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......+||+.|+|||++.+..++.++|||||||+++||++|+.||......+.      ..... .+...         
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~------~~~~~-~~~~~---------  289 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI------MQQVL-YGKYD---------  289 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hCCCC---------
Confidence            233456799999999999999999999999999999999999999976554321      11111 11111         


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..+......+.+++.+||+.+|++||+++++++
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            011122346789999999999999999999875

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.8e-35  Score=319.32  Aligned_cols=253  Identities=23%  Similarity=0.416  Sum_probs=202.7

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|+..       +..||+|++..... .....|.+|+.++.+++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            455678999999999999863       26799999975543 3346788999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhccc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcE
Q 002809          640 YEFMANGNLQEYLSDI--------------SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA  705 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~  705 (878)
                      +||+.+++|.+++...              ....+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence            9999999999998521              123588999999999999999999988   99999999999999999999


Q ss_pred             EEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHH
Q 002809          706 KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVN  784 (878)
Q Consensus       706 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~  784 (878)
                      ||+|||+++...............+++.|+|||.+.+..++.++|||||||+++||++ |..||......+.      ..
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~  237 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------IE  237 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence            9999999886543322222223346779999999988889999999999999999998 8888876554321      11


Q ss_pred             HHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       785 ~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                       .+..+...         ..+......+.+++..|++.+|++||++++|++.|+.
T Consensus       238 -~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 -MIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             12222211         1122334568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=340.26  Aligned_cols=255  Identities=23%  Similarity=0.379  Sum_probs=211.2

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeee-cccC------CCccee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVG-HCDE------DNQTAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g-~~~~------~~~~~l  638 (878)
                      .+++.|.+|||+.||.++..+  .++|+|++-..+....+...+|+++|++|+ |+|||.+++ ....      .-+.+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            356899999999999998754  799999998888888999999999999997 999999999 3311      236789


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      .||||.+|.|-++|...-...|++.++++|+.|+++|+++||.. +++|||||||-+||||+.+++.||||||.+.-...
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            99999999999999865566699999999999999999999975 88999999999999999999999999998864322


Q ss_pred             CCCCc-------ccccccCCCCccCcccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh
Q 002809          719 DANTH-------VSTVVAGTPGYLDPEYY---TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA  788 (878)
Q Consensus       719 ~~~~~-------~~~~~~gt~~Y~APE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~  788 (878)
                      .....       .......|+.|+|||++   .+...++|+|||+|||+||-|+....||+....               
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------------  263 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------------  263 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------------
Confidence            21110       11234578999999987   467899999999999999999999999986422               


Q ss_pred             cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       789 ~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                          ..+++....-.-.......+.+|+..||+.+|.+||++-||+..+.++...
T Consensus       264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                233444433333356677899999999999999999999999999987643

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-35  Score=321.15  Aligned_cols=260  Identities=28%  Similarity=0.462  Sum_probs=208.0

Q ss_pred             HHhhhcccccccccEEEEEEEEc---------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCC
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN---------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDN  634 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~  634 (878)
                      ..+.+.+.||+|+||.||+++..         ...||+|.+.... ....+.+.+|+.++..+ +||||+++++++....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            33456789999999999999742         2469999987542 34557899999999999 8999999999999999


Q ss_pred             cceeEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc
Q 002809          635 QTALIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN  700 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~  700 (878)
                      ..++||||+++|+|.+++....              ...+++.+++.++.|+++||+|||+.   +++||||||+||+++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~  171 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVT  171 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEc
Confidence            9999999999999999997532              24588999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002809          701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHI  779 (878)
Q Consensus       701 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  779 (878)
                      +++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||......+.   
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---  248 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---  248 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---
Confidence            999999999999987643322222223345678999999998889999999999999999998 7888876544321   


Q ss_pred             HHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       780 ~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                         .. .+..+...         ..+..+...+.+++.+||+.+|++||++.|+++.|++++..+
T Consensus       249 ---~~-~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         249 ---FK-LLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             ---HH-HHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence               11 11111110         111233457888999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.4e-35  Score=322.20  Aligned_cols=259  Identities=30%  Similarity=0.469  Sum_probs=206.4

Q ss_pred             HhhhcccccccccEEEEEEEEcc---------eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCc
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE---------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQ  635 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~  635 (878)
                      .+.+.+.||+|+||.||+++..+         ..+|+|.+... ......++.+|++++.++ +|+||+++++++..++.
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   98 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            35667899999999999997532         46999998754 234456788999999999 79999999999999999


Q ss_pred             ceeEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC
Q 002809          636 TALIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE  701 (878)
Q Consensus       636 ~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~  701 (878)
                      .++||||+++|+|.+++....              ...+++.+++.++.|++.||+|||+.   +++||||||+||++++
T Consensus        99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~  175 (307)
T cd05098          99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE  175 (307)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcC
Confidence            999999999999999997532              23589999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002809          702 KLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIR  780 (878)
Q Consensus       702 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~  780 (878)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||.....++..   
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~---  252 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---  252 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH---
Confidence            99999999999876532211111112224568999999998889999999999999999998 88888765433211   


Q ss_pred             HHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          781 QWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       781 ~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                          ..+..+..         ...+.....++.+++.+|+..+|++||+|.+|++.|+++++..
T Consensus       253 ----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         253 ----KLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             ----HHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                11111111         1112223457788999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.3e-35  Score=318.38  Aligned_cols=261  Identities=22%  Similarity=0.344  Sum_probs=194.6

Q ss_pred             hhhcccccccccEEEEEEEEc---ceeEEEEEeccCC--hhhHHHHHHHHHHHHHh---cccceeeeeeccc-----CCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN---EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRV---HHRNLTSLVGHCD-----EDN  634 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~-----~~~  634 (878)
                      +.+.+.||+|+||.||+++..   +..||+|++....  ......+.+|+.++.++   +||||++++++|.     ...
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            345678999999999999863   3679999987542  22234566788777766   6999999999874     345


Q ss_pred             cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          635 QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ..++||||+. ++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            6899999996 6999999765566789999999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHHHHhcCCc-
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQWVNSLIAKGDI-  792 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~-  792 (878)
                      .....   .......|+..|+|||.+.+..++.++|||||||++|||++|++||......+.. .+.+.......+... 
T Consensus       159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            65322   2223456899999999999889999999999999999999999999876543321 111110000000000 


Q ss_pred             -----ccccCCcccc---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          793 -----KSIVDPRLQE---DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       793 -----~~iid~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                           ...+.+.-..   .........+.+++.+||+.+|++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                 0001100000   001122346679999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.5e-35  Score=333.25  Aligned_cols=255  Identities=29%  Similarity=0.437  Sum_probs=202.9

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV  639 (878)
                      .+.+.||+|+||.||+|++.+       +.||+|++.... ....+.+.+|+++|.++. ||||++++++|...+..++|
T Consensus        40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv  119 (401)
T cd05107          40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII  119 (401)
T ss_pred             ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence            356899999999999998632       579999997643 333457899999999997 99999999999999999999


Q ss_pred             eeeccCCChhhhhcccc---------------------------------------------------------------
Q 002809          640 YEFMANGNLQEYLSDIS---------------------------------------------------------------  656 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~---------------------------------------------------------------  656 (878)
                      +||+++|+|.++++...                                                               
T Consensus       120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (401)
T cd05107         120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV  199 (401)
T ss_pred             EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence            99999999999996532                                                               


Q ss_pred             ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          657 ---------------------------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       657 ---------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                                                       ...+++..++.++.|++.||+|||+.   +++||||||+|||+++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCC
Confidence                                             12467888899999999999999987   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQW  782 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  782 (878)
                      .+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||......+.      
T Consensus       277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~------  350 (401)
T cd05107         277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ------  350 (401)
T ss_pred             EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH------
Confidence            999999999986533222111222346788999999998889999999999999999998 8889876443221      


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      ....+..+..         ...+.....++.+++.+|++.+|++||+++||++.|++++
T Consensus       351 ~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 FYNAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1111111210         0111223457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.4e-35  Score=315.92  Aligned_cols=253  Identities=25%  Similarity=0.377  Sum_probs=201.1

Q ss_pred             hhcccccccccEEEEEEEEc--ce----eEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EI----DVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~----~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|++.  +.    .+++|.+.... .....++..|+..+.+++||||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e   88 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ   88 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence            34578999999999999873  22    47888876443 2345678889999999999999999998864 45788999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.......
T Consensus        89 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          89 LSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             eCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            99999999999753 35689999999999999999999998   999999999999999999999999999987644333


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |+.||........   .++    +.++....  .+. 
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~----~~~~~~~~--~~~-  234 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDL----LEKGERLA--QPQ-  234 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHCCCcCC--CCC-
Confidence            223334557789999999998899999999999999999998 9999987654332   111    22222111  111 


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                            .+...+.+++.+|+..+|++||++.|+++.|+.+.+
T Consensus       235 ------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         235 ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                  122356788999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.7e-35  Score=325.32  Aligned_cols=241  Identities=29%  Similarity=0.400  Sum_probs=197.2

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||+|+||.||+++..  ++.||+|++...   .......+.+|+++++.++||||+++.+++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875  478999998754   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  153 (328)
T cd05593          81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK  153 (328)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence            99998865  45689999999999999999999998   99999999999999999999999999987532211  1223


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||......+...       .+..+.      ..+    +.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~-------~~~~~~------~~~----p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILMED------IKF----PR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH-------HhccCC------ccC----CC
Confidence            3569999999999999899999999999999999999999997654432111       111111      111    11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                      ....++.+++.+||+.+|++||     +++|+++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2234677899999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-34  Score=322.91  Aligned_cols=258  Identities=22%  Similarity=0.333  Sum_probs=201.1

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+++...  ..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   87 (331)
T cd06649           8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   87 (331)
T ss_pred             eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence            345789999999999998864  77999998754 334457899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++......    ..
T Consensus        88 ~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~  159 (331)
T cd06649          88 GSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA  159 (331)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----cc
Confidence            999999975  456899999999999999999999752  6999999999999999999999999998765322    12


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc--cc---------
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI--KS---------  794 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~--~~---------  794 (878)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+..   .........+..  ..         
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhcccccccccCCccccCcccccc
Confidence            2346899999999999999999999999999999999999999765443211   111110000000  00         


Q ss_pred             -----------------------ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          795 -----------------------IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       795 -----------------------iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                                             +...............++.+++.+||+.+|++||+++|+++.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                   0000000000011234688999999999999999999998764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3e-35  Score=322.40  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=201.5

Q ss_pred             cccccccccEEEEEEEEcc--eeEEEEEeccCChh---hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          571 ERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQ---GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~---~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.||+|+||.||.++-.+  .-+|+|++++....   ..+....|-.+|....+|.||+|+-.|++.+.+||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            3789999999999998755  77999999986443   456788999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC------
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD------  719 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~------  719 (878)
                      |++..+|..  ...|++..+..++.+++.|+..||+.   |+|||||||+|+|||..|++||+||||+.-+...      
T Consensus       226 GD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~  300 (550)
T KOG0605|consen  226 GDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY  300 (550)
T ss_pred             ccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence            999999976  67899999999999999999999998   9999999999999999999999999998533110      


Q ss_pred             ---------------CCCc-----c-------------------cccccCCCCccCccccccCCCCCccchhhHHHHHHH
Q 002809          720 ---------------ANTH-----V-------------------STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE  760 (878)
Q Consensus       720 ---------------~~~~-----~-------------------~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~e  760 (878)
                                     ....     .                   .-..+|||-|||||++.+..|+..+|.||+|||+||
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE  380 (550)
T KOG0605|consen  301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE  380 (550)
T ss_pred             cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence                           0000     0                   012479999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChHHH-HHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 002809          761 IITCKPAISRINEEEK-IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT---MSQVVM  835 (878)
Q Consensus       761 lltG~~p~~~~~~~~~-~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~evl~  835 (878)
                      |+.|.+||...++.+. ..+..|...+...              .......+..+|+.+|+. ||++|--   ++||-+
T Consensus       381 mLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  381 MLVGYPPFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            9999999998876543 4566664332211              111222578899999999 9999975   444443

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-35  Score=311.33  Aligned_cols=246  Identities=30%  Similarity=0.494  Sum_probs=205.9

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      .+.+.||+|++|.||++...++.||+|.+..... ..+++.+|+.++++++|+||+++++++..+...++||||+++++|
T Consensus         9 ~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   87 (256)
T cd05039           9 KLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL   87 (256)
T ss_pred             cceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence            4568999999999999999999999999986654 567899999999999999999999999989999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      .+++.......+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.++.......     ..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~  159 (256)
T cd05039          88 VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SG  159 (256)
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----cC
Confidence            9999875555799999999999999999999998   999999999999999999999999999976532111     22


Q ss_pred             cCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHH
Q 002809          729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDAN  807 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~  807 (878)
                      ..+..|+|||++.+..++.++||||||++++||++ |+.||......+   +.    .....+...         ..+..
T Consensus       160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~~~  223 (256)
T cd05039         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PHVEKGYRM---------EAPEG  223 (256)
T ss_pred             CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhcCCCC---------CCccC
Confidence            34568999999998889999999999999999997 999987665432   11    111111110         11112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          808 SVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       808 ~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ....+.+++.+|+..+|++||++++++++|++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            23578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.8e-35  Score=324.53  Aligned_cols=241  Identities=27%  Similarity=0.382  Sum_probs=196.5

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||+|+||.||+++..  +..||+|++...   .......+.+|++++++++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999874  478999998754   2334567788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|..++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  153 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK  153 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence            99998865  45689999999999999999999998   99999999999999999999999999987532221  1223


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||...+......      . +..+..      .+.    .
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~-~~~~~~------~~p----~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------L-ILMEEI------RFP----R  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH------H-HhcCCC------CCC----C
Confidence            3568999999999999999999999999999999999999997665432111      1 111110      111    1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                      .....+.+++.+||+.+|++||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            2234677999999999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.2e-35  Score=318.70  Aligned_cols=261  Identities=23%  Similarity=0.346  Sum_probs=197.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+|+..  +..||+|++.... ......+.+|++++++++||||+++++++..++..++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            345678999999999999875  4789999987543 2234577899999999999999999999999999999999997


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                       |+|.+++... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        87 -~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~  159 (288)
T cd07871          87 -SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--T  159 (288)
T ss_pred             -cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--c
Confidence             4899888642 34578999999999999999999998   999999999999999999999999999875432211  1


Q ss_pred             cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc---------CCccc
Q 002809          725 STVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK---------GDIKS  794 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~---------~~~~~  794 (878)
                      .....++..|+|||++.+ ..++.++||||+||++|||+||++||......+..............         .....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            223457899999999865 56899999999999999999999999876654432211100000000         00001


Q ss_pred             ccCCccccc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 IVDPRLQED----FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 iid~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ...+.....    .......+..+++.+||+.||.+|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111111000    00112346789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.6e-35  Score=312.63  Aligned_cols=248  Identities=28%  Similarity=0.498  Sum_probs=200.5

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+++..+ ..+|+|.+..... ....|.+|++++.+++||||+++++++......++||||+.+|+
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC   85 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence            456789999999999998876 5699998875432 34678999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.... ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++....... .....
T Consensus        86 l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~  160 (256)
T cd05113          86 LLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVG  160 (256)
T ss_pred             HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCC
Confidence            999987533 3689999999999999999999988   999999999999999999999999999876533221 11112


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||.+.+..++.++|||||||++|||++ |+.||........   ..   . +..+...         ..+.
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~---~-~~~~~~~---------~~~~  224 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VE---K-VSQGLRL---------YRPH  224 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH---H-HhcCCCC---------CCCC
Confidence            235678999999998889999999999999999999 9999976654321   11   1 1111110         0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      .....+.+++.+||+.+|++||++.++++.|+
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            12357889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.5e-35  Score=315.08  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=206.5

Q ss_pred             HhhhcccccccccEEEEEEEEcc------eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccC-CCccee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-DNQTAL  638 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~l  638 (878)
                      .+.+.+.||+|+||.||+|...+      ..|++|++... .....+.+.+|+.++++++|+||+++++++.. +...++
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   86 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV   86 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence            34567899999999999998754      77999988754 33456778999999999999999999998765 567899


Q ss_pred             EeeeccCCChhhhhccccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          639 IYEFMANGNLQEYLSDISK------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      ++||+++|+|.+++.....      ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+
T Consensus        87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCC
Confidence            9999999999999865432      5689999999999999999999988   999999999999999999999999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      ++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||......+   +..+..    .+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~  236 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK----DGY  236 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----cCC
Confidence            986643322222223346778999999998889999999999999999999 999998765432   222221    111


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                             .+  .........+.+++.+|+..+|++||++.++++.|+++..
T Consensus       237 -------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 -------RL--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -------CC--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   00  0111223467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.6e-35  Score=316.62  Aligned_cols=266  Identities=25%  Similarity=0.362  Sum_probs=201.8

Q ss_pred             hhcccccccccEEEEEEEE------cceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRL------NEIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV  639 (878)
                      .+.+.||+|+||+||+++.      .+..||+|.+.... ......|.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4567899999999988653      23679999987653 33457889999999999999999999987653  457899


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++|+|.+++..   ..+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            999999999999874   3599999999999999999999998   9999999999999999999999999999866432


Q ss_pred             CCCc-ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          720 ANTH-VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       720 ~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .... ......++..|+|||.+....++.++||||||++++||+||+.|+......- .....+.........+.+.++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence            2111 1122335667999999998889999999999999999999999986543211 0111110000000111111222


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      ......+.....++.+++.+|++.+|++||+++++++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2221223334568889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-35  Score=310.84  Aligned_cols=247  Identities=28%  Similarity=0.494  Sum_probs=198.9

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+++..+ ..+|+|++..... ....|.+|++++++++|+||+++++++...+..++|+||+++++
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC   85 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence            466889999999999998866 6799999865432 23578899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.... ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++....... .....
T Consensus        86 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~~  160 (256)
T cd05059          86 LLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQG  160 (256)
T ss_pred             HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc-cccCC
Confidence            999997533 3689999999999999999999998   999999999999999999999999999876532211 11111


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   .    ....+.     ..    ..+.
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----~~~~~~-----~~----~~~~  224 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E----SVSAGY-----RL----YRPK  224 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H----HHHcCC-----cC----CCCC
Confidence            223457999999999899999999999999999999 89999765543211   1    111110     00    1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      ....++.+++.+|++.+|++||++.|+++.|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            2345788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-34  Score=311.00  Aligned_cols=251  Identities=27%  Similarity=0.425  Sum_probs=202.8

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.+.||+|+||.||+|+..+ ..||+|++..... ..+.|.+|++++++++|+||+++++.+.+ ...++||||+++|
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~   85 (262)
T cd05071           8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG   85 (262)
T ss_pred             eeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCC
Confidence            5677899999999999998866 6799999875432 34678999999999999999999998754 5678999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++.......+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||.++.+...... ...
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~  161 (262)
T cd05071          86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQ  161 (262)
T ss_pred             cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc-ccc
Confidence            999999765556789999999999999999999998   9999999999999999999999999999766432211 112


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||+..+..++.++||||||++++||+| |+.||......+...       ....+..         ....
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~-------~~~~~~~---------~~~~  225 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVERGYR---------MPCP  225 (262)
T ss_pred             CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH-------HHhcCCC---------CCCc
Confidence            2345678999999998899999999999999999999 888887655432111       1111110         0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ......+.+++.+|++.+|++||+++++++.|++.
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            23345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=329.59  Aligned_cols=237  Identities=25%  Similarity=0.396  Sum_probs=200.4

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +|.++||+|.||+|+++..++  +.+|||++++..   ....+..+.|..++.... ||.+++++..|+..++++.||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            567899999999999998876  779999999763   345677788888888774 99999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +.||++..+.+   .+.+++..+.-++..|+.||+|||++   +||+||||.+|||||.+|.+||+|||+++.-..  ..
T Consensus       451 ~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g  522 (694)
T KOG0694|consen  451 VAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QG  522 (694)
T ss_pred             cCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC--CC
Confidence            99999665554   46799999999999999999999999   999999999999999999999999999985421  22


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ....+++||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+.++++..+-       +...      |+    
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds-------I~~d------~~----  585 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS-------IVND------EV----  585 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HhcC------CC----
Confidence            345678999999999999999999999999999999999999999998777653221       1100      11    


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                      .++.....+.+.++.++|..+|++|--+
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1334455678899999999999999877

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-34  Score=310.12  Aligned_cols=246  Identities=26%  Similarity=0.447  Sum_probs=197.4

Q ss_pred             cccccccEEEEEEEEc----ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          573 TLGKGGFGTVYYGRLN----EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .||+|+||.||+|.+.    +..+|+|++....  ....+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999652    3779999986543  334578999999999999999999999886 45678999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc-c
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV-S  725 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~  725 (878)
                      +|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.......... .
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            99999975  45689999999999999999999988   999999999999999999999999999987643322111 1


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||......+   +.+    .+.++...         ..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~i~~~~~~---------~~  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQ----MIESGERM---------EC  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHCCCCC---------CC
Confidence            12234578999999988889999999999999999998 999998765432   111    12222111         11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      +.....++.+++.+|++.+|++||++++|++.|++.
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            122334678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=311.99  Aligned_cols=252  Identities=28%  Similarity=0.438  Sum_probs=203.9

Q ss_pred             hhhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|...+       ..||+|.+.... ......+.+|++++..++|+||+++++++......++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   87 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV   87 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence            3456889999999999998753       569999987553 34456789999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          640 YEFMANGNLQEYLSDIS--------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      |||+++|+|.+++....        ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg  164 (277)
T cd05032          88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcc
Confidence            99999999999996532        23478999999999999999999988   99999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      +++...............++..|+|||.+.+..++.++|||||||+++|++| |+.||......+.   ..+.    ..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~----~~~  237 (277)
T cd05032         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFV----IDG  237 (277)
T ss_pred             cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHH----hcC
Confidence            9876643322222233446789999999988889999999999999999998 9999976654332   1111    122


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ....         .+......+.+++.+|++.+|++||++.++++.|+
T Consensus       238 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         238 GHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111         11122457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-34  Score=317.34  Aligned_cols=256  Identities=30%  Similarity=0.500  Sum_probs=203.3

Q ss_pred             hhcccccccccEEEEEEEEcc----eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+|...+    ..+++|.++.. .....+.|.+|++++.++ +||||+++++++......++|+||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            456889999999999998754    24788888753 344557899999999999 799999999999999999999999


Q ss_pred             ccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          643 MANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       643 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      +++|+|.++++...              ...+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence            99999999996532              13588999999999999999999988   99999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      |||++.......   .......+..|+|||++.+..++.++|||||||+++||++ |+.||......+.      .... 
T Consensus       162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~~~-  231 (297)
T cd05089         162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YEKL-  231 (297)
T ss_pred             CcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHH-
Confidence            999986432110   1111223457999999998889999999999999999998 9999977654321      1111 


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                      ..+.         ....+......+.+++.+|++.+|.+||+++++++.|++++....+
T Consensus       232 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         232 PQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1111         0011122334678999999999999999999999999998876533

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.4e-35  Score=326.17  Aligned_cols=262  Identities=23%  Similarity=0.352  Sum_probs=195.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC-----Cccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED-----NQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+..  +..||||++...  .......+.+|++++++++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            345688999999999999875  488999998743  223456789999999999999999999987432     34799


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+. ++|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        82 v~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          82 VFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            999995 689998875  45689999999999999999999998   999999999999999999999999999976532


Q ss_pred             CCCC-cccccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH-HHH-------HHHH
Q 002809          719 DANT-HVSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR-QWV-------NSLI  787 (878)
Q Consensus       719 ~~~~-~~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~v-------~~~~  787 (878)
                      .... .......|+..|+|||++.+  ..++.++|||||||+++||+||++||............ +..       ...+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            2211 11233568999999999875  67899999999999999999999999765542221110 000       0000


Q ss_pred             hcCCccccc---CC----ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          788 AKGDIKSIV---DP----RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       788 ~~~~~~~ii---d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ......+.+   .+    .+...+ ......+.+++.+||+.+|++||+++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000000   00    000000 1123457799999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-34  Score=310.40  Aligned_cols=250  Identities=27%  Similarity=0.463  Sum_probs=201.1

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.+.||+|++|.||++...+ ..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~   85 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG   85 (260)
T ss_pred             hhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence            4567889999999999998765 7799999876433 2467899999999999999999999885 45688999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.++++......+++..++.++.|++.||+|||+.   +++||||||+||++++++.++|+|||++..+...... ...
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  161 (260)
T cd05070          86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQ  161 (260)
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-ccc
Confidence            999999765556689999999999999999999998   9999999999999999999999999999765432211 111


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||++.+..++.++||||||++++||++ |+.||......+   ..+..    ..+.         ....+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~---------~~~~~  225 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV----ERGY---------RMPCP  225 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCC---------CCCCC
Confidence            2235568999999988899999999999999999999 889997654332   11111    1110         00111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ......+.+++.+|+..+|++|||++++.+.|++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2233468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.1e-35  Score=315.65  Aligned_cols=251  Identities=28%  Similarity=0.460  Sum_probs=203.1

Q ss_pred             hhcccccccccEEEEEEEEc-------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||++...       +..+|+|.+..........|.+|++++..++|+||+++++++......++|+|
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            34678999999999999642       35799999887777777889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          642 FMANGNLQEYLSDISK-------------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      |+++|+|.+++.....             ..+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence            9999999999875321             3589999999999999999999988   99999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      |||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |++||......+...      . .
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~-~  237 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE------C-I  237 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH------H-H
Confidence            9999876533222122222335678999999998899999999999999999998 899987655433211      1 1


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ..+...         ..+......+.+++.+||+.+|++||++++|++.|+
T Consensus       238 ~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            111100         011122346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.3e-34  Score=308.73  Aligned_cols=252  Identities=27%  Similarity=0.408  Sum_probs=193.8

Q ss_pred             ccccccccEEEEEEEEcc----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLNE----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||+|+||.||+|+..+    ..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998643    568999887653 334457899999999999999999999999999999999999999


Q ss_pred             Chhhhhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          647 NLQEYLSDIS---KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       647 sL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      +|.++++...   ....++..+..++.|++.||+|||+.   +++||||||+||+++.++++||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532   23567788889999999999999998   99999999999999999999999999987543222212


Q ss_pred             ccccccCCCCccCccccccC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSN-------RLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~-------~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      ......++..|+|||++...       .++.++||||||++++||++ |+.||......+...   +   .. .+.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~---~~-~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y---TV-REQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H---Hh-hcccCCC
Confidence            22234577889999998642       35789999999999999996 999997765433211   1   01 1111122


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      .++.+...    ....+.+++..|+ .+|++||+++||++.|+
T Consensus       231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22222211    2234667888998 57999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-34  Score=310.43  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             HHHhhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          565 KITNNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       565 ~~t~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ...+++.+.||+|+||.||+|...+ +.||+|.+..... ....+.+|+.++++++|+|++++++++. .+..++|+||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            4456678899999999999998765 8899999876543 3467899999999999999999999874 45789999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++++|.+++....+..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            999999999765566799999999999999999999988   999999999999999999999999999876542211 1


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......++..|+|||++.+..++.++||||||++++||++ |+.||......+.   .+.    +..+...         
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~~~---------  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQN----LERGYRM---------  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----HHcCCCC---------
Confidence            1222345678999999998889999999999999999999 9999976554321   111    1111100         


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ..+.....++.+++.+|++.+|++||++++++..|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1111223468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-34  Score=321.69  Aligned_cols=241  Identities=26%  Similarity=0.393  Sum_probs=195.8

Q ss_pred             ccccccccEEEEEEEE-----cceeEEEEEeccC----ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          572 RTLGKGGFGTVYYGRL-----NEIDVAVKMLSSS----SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~----~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.||+|+||.||+++.     .++.||+|++...    .......+.+|+++++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999875     3477999998753    223345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (323)
T cd05584          82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--  154 (323)
T ss_pred             CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence            999999999875  45688899999999999999999998   99999999999999999999999999987542221  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||........      ... +..+..      .   
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~-~~~~~~------~---  218 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDK-ILKGKL------N---  218 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHH-HHcCCC------C---
Confidence            122335689999999999988899999999999999999999999987654321      111 111111      1   


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                       .+......+.+++.+|++.+|++||     +++++++.
T Consensus       219 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         219 -LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             1111234677999999999999999     78888773

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-35  Score=326.05  Aligned_cols=247  Identities=25%  Similarity=0.424  Sum_probs=210.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCc-ceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQ-TALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~-~~lV~Ey~  643 (878)
                      ...+.+|+|+||.++..+++  ++.+++|.+...  .....+...+|+.++++++|||||.+.+.+.+++. .++||+|+
T Consensus         7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~   86 (426)
T KOG0589|consen    7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYC   86 (426)
T ss_pred             hhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeec
Confidence            44578999999999977665  488999988744  34455678999999999999999999999999998 99999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      +||+|.+.+.+.++..++++.+..++.|++.|+.|||++   .|+|||||++||+++.+..+||+|||+|+.+....  .
T Consensus        87 eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~  161 (426)
T KOG0589|consen   87 EGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S  161 (426)
T ss_pred             CCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence            999999999887778899999999999999999999988   99999999999999999999999999999886543  2


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+...-      +.+..+          .....
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L------i~ki~~----------~~~~P  225 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL------ILKINR----------GLYSP  225 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH------HHHHhh----------ccCCC
Confidence            34557899999999999999999999999999999999999999988765331      111111          11222


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+.....++..++..||..+|+.||++.+++.+
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            334455678899999999999999999999997

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=316.79  Aligned_cols=261  Identities=27%  Similarity=0.424  Sum_probs=201.5

Q ss_pred             HhhhcccccccccEEEEEEEEcc----------------eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeec
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE----------------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGH  629 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~----------------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~  629 (878)
                      .+.+.+.||+|+||.||+++..+                ..||+|.+... .......|.+|++++.+++|+|+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            34566889999999999987532                34899998764 33445679999999999999999999999


Q ss_pred             ccCCCcceeEeeeccCCChhhhhcccc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE
Q 002809          630 CDEDNQTALIYEFMANGNLQEYLSDIS----------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL  699 (878)
Q Consensus       630 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl  699 (878)
                      +...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||+.   +++||||||+||++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill  162 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLV  162 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEE
Confidence            999999999999999999999986432          12478999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCChHHHH
Q 002809          700 NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEEEKI  777 (878)
Q Consensus       700 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~~  777 (878)
                      ++++.+||+|||++................++..|+|||.+.+..++.++|||||||+++||++  |..||......+..
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~  242 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI  242 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence            9999999999999876533322222222345678999999998899999999999999999998  56788765543321


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .   ...............      ..+......+.+++.+|++.+|++||+|++|++.|++
T Consensus       243 ~---~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         243 E---NTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             H---HHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            1   111111111000000      0111123478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=311.59  Aligned_cols=260  Identities=23%  Similarity=0.362  Sum_probs=203.1

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEec--cCChhhHHHHHHHHHHHHHhcccceeeeeecccC-----CCcceeEee
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLS--SSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-----DNQTALIYE  641 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~--~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-----~~~~~lV~E  641 (878)
                      .+.||+|++|.|+.+..+  ++.||||++.  -.+....++..+|+++|+.++|+||+.+.+.+..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            367999999999998775  4889999998  4566677899999999999999999999998754     457899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      +| +.+|...++.  ++.++......++.|+++||.|+|+.   +|+||||||+|+|++.+...||+|||+|+.......
T Consensus       107 lM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  107 LM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             HH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            99 5699999986  55699999999999999999999998   999999999999999999999999999998754422


Q ss_pred             CcccccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH--------HHHhcCCc
Q 002809          722 THVSTVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN--------SLIAKGDI  792 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~--------~~~~~~~~  792 (878)
                      ....+....|..|.|||++. ...|+.+.||||.||++.||++|++.|.+.+.-.+..+.--+.        ..+.....
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence            33335566889999999975 5689999999999999999999999998876544433321111        11110000


Q ss_pred             ccccC--Ccc-c---cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 KSIVD--PRL-Q---EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 ~~iid--~~l-~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...+.  +.. .   ...-.......++|+.+||..||.+|+|++|.++.
T Consensus       261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000  000 0   00111334477899999999999999999999875

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-34  Score=320.08  Aligned_cols=240  Identities=25%  Similarity=0.389  Sum_probs=192.0

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+|+..+  +.||+|+++...   ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998865  679999987532   23345566777777654 799999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            999999875  45689999999999999999999998   99999999999999999999999999997543222  223


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      .. +....      +.    .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~-i~~~~------~~----~~  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DS-ILNDR------PH----FP  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHcCC------CC----CC
Confidence            3456999999999999989999999999999999999999999876543211      11 11110      11    11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMS-QVVM  835 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~-evl~  835 (878)
                      .....++.+++.+||+.+|++||++. ++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            12234567899999999999999986 4443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-34  Score=314.08  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=199.3

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|++|.||+|...+       ..||+|...... ......|.+|+.++++++|+||+++++++.+.+..++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            345789999999999998753       678999887543 334567999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---cEEEeecCC
Q 002809          641 EFMANGNLQEYLSDIS-----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---QAKLADFGL  712 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~DFGl  712 (878)
                      ||+++++|.++++...     ...+++..+++++.||+.||+|||+.   +++||||||+||+++.++   .+||+|||+
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999997643     23589999999999999999999998   999999999999998765   599999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      ++................+..|+|||++.+..++.++|||||||+++||++ |+.||.....++..   +    .+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~----~~~~~~  238 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E----FVTGGG  238 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----HHHcCC
Confidence            986632221111112223568999999998899999999999999999997 99999876543321   1    111111


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      .         ...+......+.+++.+|++.+|++||++.+|++.|+
T Consensus       239 ~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 R---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0         0111223357889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-34  Score=317.70  Aligned_cols=255  Identities=28%  Similarity=0.493  Sum_probs=202.3

Q ss_pred             hhcccccccccEEEEEEEEcc----eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+|+...    ..+|+|.+... .....+.+.+|++++.++ +|+||+++++++..++..++|+||
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   89 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   89 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence            456899999999999998643    34688877653 334557889999999999 899999999999999999999999


Q ss_pred             ccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          643 MANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       643 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      +++|+|.++++...              ...+++.+++.++.|++.||+|||+.   +++||||||+|||+++++.+||+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence            99999999996532              23588999999999999999999988   99999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      |||+++.....   .......++..|+|||++.+..++.++|||||||+++||+| |..||......+.      ... .
T Consensus       167 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~-~  236 (303)
T cd05088         167 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEK-L  236 (303)
T ss_pred             ccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------HHH-H
Confidence            99998643111   11111224567999999988889999999999999999998 9999976554321      111 1


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      ..+.         ....+......+.+++.+|++.+|++||+++++++.|++++..+.
T Consensus       237 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         237 PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            1110         001111223467899999999999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-34  Score=314.93  Aligned_cols=259  Identities=28%  Similarity=0.451  Sum_probs=204.1

Q ss_pred             hhhcccccccccEEEEEEEEcc------------------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE------------------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVG  628 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~------------------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g  628 (878)
                      +.+.+.||+|+||.||+++..+                  ..||+|++.... ....+.+.+|++++.+++||||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   86 (296)
T cd05051           7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG   86 (296)
T ss_pred             CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            4566899999999999987643                  458999987653 345678999999999999999999999


Q ss_pred             cccCCCcceeEeeeccCCChhhhhcccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE
Q 002809          629 HCDEDNQTALIYEFMANGNLQEYLSDIS---------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL  699 (878)
Q Consensus       629 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl  699 (878)
                      ++..++..++|+||+++++|.+++....         ...+++..++.++.|++.||+|||+.   +++||||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili  163 (296)
T cd05051          87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhceee
Confidence            9999999999999999999999997533         23689999999999999999999988   99999999999999


Q ss_pred             cCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCChHHHH
Q 002809          700 NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEEEKI  777 (878)
Q Consensus       700 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~~  777 (878)
                      +.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..||.......  
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~--  241 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ--  241 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH--
Confidence            9999999999999876533322222233446778999999998889999999999999999998  677886654322  


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                       +.................      ..+.....++.+++.+|++.+|++||++.||++.|+
T Consensus       242 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 -VIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -HHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             111221111111111111      111223357889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.2e-35  Score=323.14  Aligned_cols=248  Identities=20%  Similarity=0.364  Sum_probs=197.5

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++...  +.||+|+++..   .....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            469999999999998754  78999999753   223456688999999998 699999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTT  153 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccc
Confidence            999998865  45799999999999999999999998   99999999999999999999999999987432111  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE--KIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+  .....++....+.+...      .+   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---  224 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI---  224 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC---
Confidence            34578999999999999999999999999999999999999997432211  11122333333333221      11   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPT------MSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPs------m~evl~~  836 (878)
                       +.....++.+++.+||+.+|.+||+      ++++++.
T Consensus       225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             1122346789999999999999997      6677653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.6e-35  Score=315.69  Aligned_cols=261  Identities=26%  Similarity=0.446  Sum_probs=199.1

Q ss_pred             hhcccccccccEEEEEEEEc------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLN------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+++..      +..||+|.+........+.|.+|++++.+++||||+++++++..  ....++|+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            45678999999999999753      46799999987776677889999999999999999999998643  34678999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++|+|.+++... +..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......
T Consensus        87 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          87 EYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            999999999999753 34689999999999999999999998   99999999999999999999999999998764322


Q ss_pred             CCcc-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC-------c
Q 002809          721 NTHV-STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD-------I  792 (878)
Q Consensus       721 ~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~-------~  792 (878)
                      .... .....++..|+|||++.+..++.++|||||||+++||++|..++......       +....-....       +
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccchHHH
Confidence            2111 11122345699999999888999999999999999999987765432211       0000000000       0


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      .+.+........+.....++.+++.+||..+|++|||++||++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000110001111223345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-34  Score=311.39  Aligned_cols=253  Identities=28%  Similarity=0.451  Sum_probs=203.7

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +++.+.||+|+||.||+|+...     ..||||++... .....++|..|+.++++++||||+++.+++..+...++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            4577899999999999998753     35999998764 34456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++... ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          86 FMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             cCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999999998753 34689999999999999999999998   999999999999999999999999999876543222


Q ss_pred             Cccccc-cc--CCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          722 THVSTV-VA--GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       722 ~~~~~~-~~--gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ...... ..  .+..|+|||.+.+..++.++|||||||+++||++ |..||......+   +.+++.    ...      
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~----~~~------  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE----QDY------  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----cCC------
Confidence            111111 11  2357999999999999999999999999999987 999997765432   222221    110      


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                       .+  ..+.+.+..+.+++.+|++.+|++||++++|++.|+++
T Consensus       229 -~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 -RL--PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -cC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00  11122344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.6e-35  Score=324.74  Aligned_cols=242  Identities=26%  Similarity=0.343  Sum_probs=199.1

Q ss_pred             hhhcccccccccEEEEEEEEcc---eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE---IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~---~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|+..+   ..||+|++...   .....+.+.+|++++..++||||+++++++..++..++|||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E  111 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE  111 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence            4567899999999999998643   57999998643   22345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       112 y~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        112 FVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            9999999999976  45689999999999999999999998   9999999999999999999999999999865321  


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                         .....||+.|+|||++.+..++.++|||||||++|||++|++||...+....       ...+..+..      .+.
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~~------~~p  248 (340)
T PTZ00426        185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGII------YFP  248 (340)
T ss_pred             ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCC------CCC
Confidence               1235689999999999998899999999999999999999999987654321       111122211      011


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                          ......+.+++.+|++.+|++|+     +++++++.
T Consensus       249 ----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        249 ----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                11223567899999999999995     88888775

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-34  Score=321.34  Aligned_cols=262  Identities=29%  Similarity=0.469  Sum_probs=208.1

Q ss_pred             HHHhhhcccccccccEEEEEEEEcc---------eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCC
Q 002809          565 KITNNFERTLGKGGFGTVYYGRLNE---------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDED  633 (878)
Q Consensus       565 ~~t~~f~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~  633 (878)
                      ...+.+.+.||+|+||.||+++..+         ..||+|.+... .....+++.+|++++.++ +|+||++++++|..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3455678899999999999997521         36899988754 334567899999999999 799999999999999


Q ss_pred             CcceeEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE
Q 002809          634 NQTALIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL  699 (878)
Q Consensus       634 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl  699 (878)
                      +..++++||+++|+|.+++....              ...+++.+++.++.|++.||+|||+.   +++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            99999999999999999986532              24588999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 002809          700 NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIH  778 (878)
Q Consensus       700 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  778 (878)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....++.. 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence            9999999999999876543221111222234567999999999999999999999999999998 88888765543311 


Q ss_pred             HHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          779 IRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       779 l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                           .. +..+...         ..+.....++.+++.+|++.+|++||++.|+++.|+++.....
T Consensus       247 -----~~-~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         247 -----KL-LKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             -----HH-HHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence                 11 1111111         1112233478899999999999999999999999999885543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.1e-34  Score=319.41  Aligned_cols=258  Identities=22%  Similarity=0.345  Sum_probs=199.7

Q ss_pred             HhhhcccccccccEEEEEEEEcc--eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.+.||+|+||.||+++...  ..+|+|.+... .......+.+|++++++++|+||++++++|..++..++||||+
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence            34556889999999999998864  77899988754 3344567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++..  ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++......    
T Consensus        86 ~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----  157 (333)
T cd06650          86 DGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  157 (333)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence            99999999975  456899999999999999999999742  7999999999999999999999999998755322    


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc--------
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI--------  795 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i--------  795 (878)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||..........+   .... ..+.....        
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM---FGCP-VEGDPAESETSPRPRP  233 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH---hcCc-ccCCccccccCcccCC
Confidence            12234688999999999988999999999999999999999999976543221111   0000 00000000        


Q ss_pred             -------cCCcc--------------c---cccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          796 -------VDPRL--------------Q---EDFD-ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       796 -------id~~l--------------~---~~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                             ..+..              .   ...+ .....++.+++.+||+.+|++||+++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                   00000              0   0000 0122467899999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.4e-34  Score=308.01  Aligned_cols=247  Identities=25%  Similarity=0.439  Sum_probs=197.8

Q ss_pred             cccccccEEEEEEEEc----ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          573 TLGKGGFGTVYYGRLN----EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .||+|+||.||+|++.    +..||+|++..... ...+.|.+|+.++++++|+||+++++++.. ...++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999764    24699999876543 345679999999999999999999998864 57899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc-cc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV-ST  726 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~  726 (878)
                      |.+++... ...+++..+++++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........... ..
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99998642 45689999999999999999999998   999999999999999999999999999976543322111 11


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||.+....++.++|||||||++||+++ |+.||......+.   .    ..+..+..         ...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~~~---------~~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---M----SFIEQGKR---------LDCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---H----HHHHCCCC---------CCCC
Confidence            1223578999999988889999999999999999996 9999987654331   1    11222211         1122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ..+..++.+++.+||..+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-34  Score=308.85  Aligned_cols=245  Identities=29%  Similarity=0.478  Sum_probs=200.8

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecc-cCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC-DEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~-~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||++...+..||+|.+....  ..+.+.+|+.++++++|+|++++++++ ..++..++|+||+++++
T Consensus         9 ~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~   86 (256)
T cd05082           9 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   86 (256)
T ss_pred             eeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence            456899999999999999999999999986543  346789999999999999999999975 45567899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++++......+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++......     ..
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~  158 (256)
T cd05082          87 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT  158 (256)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----CC
Confidence            99999875556689999999999999999999988   99999999999999999999999999987543221     12


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||......+   +..+    +..+...         ....
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~~~~~---------~~~~  222 (256)
T cd05082         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM---------DAPD  222 (256)
T ss_pred             CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcCCCC---------CCCC
Confidence            234568999999998899999999999999999998 999987654322   1111    1111111         1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .....+.+++.+|++.+|++||+++++++.|++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            233477899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-34  Score=310.04  Aligned_cols=248  Identities=29%  Similarity=0.491  Sum_probs=197.6

Q ss_pred             ccccccccEEEEEEEEcc----eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+|+..+    ..+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999998754    35788888754 344557889999999999 799999999999999999999999999


Q ss_pred             CChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          646 GNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       646 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      |+|.++++...              ...+++.+++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532              13588999999999999999999988   99999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      ++......   ........+..|+|||++....++.++|||||||+++||++ |+.||......+.      .... ..+
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~-~~~  227 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKL-PQG  227 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH------HHHH-hCC
Confidence            98532111   11111224567999999988889999999999999999997 9999976543321      1111 111


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      ..         ...+......+.+++.+|++.+|.+||++.++++.|++++
T Consensus       228 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 YR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            10         0111122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-34  Score=307.20  Aligned_cols=248  Identities=33%  Similarity=0.547  Sum_probs=204.9

Q ss_pred             ccccccccEEEEEEEEc-----ceeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLN-----EIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||++...     +..|++|.+...... ..+.+.+|++.+..++|+|++++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46999999999999876     578999999876443 367899999999999999999999999999999999999999


Q ss_pred             CChhhhhcccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          646 GNLQEYLSDIS-------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       646 gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ++|.+++....       ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999998642       36799999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ...........++..|+|||.+....++.++||||+|++++||++ |+.||......+   +.+.    +..+..     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~~~~-----  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEY----LRKGYR-----  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcCCC-----
Confidence            332222334557889999999998889999999999999999999 699998764432   1111    111110     


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                          ...+.....++.+++.+|++.+|++||++.|+++.|+
T Consensus       226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                0111222457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-34  Score=322.62  Aligned_cols=248  Identities=21%  Similarity=0.371  Sum_probs=196.1

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++...  +.||+|++...   .....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999998754  78999998754   233456678899988877 799999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|..++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~  153 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT  153 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence            999998865  45699999999999999999999998   99999999999999999999999999987532211  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE--KIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.......  ......++...+.....      .    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~----  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R----  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C----
Confidence            34568999999999999999999999999999999999999996422111  11122233333332221      1    


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPT------MSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPs------m~evl~~  836 (878)
                      .+.....++.+++.+||+.+|++||+      +.++++.
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            11222346779999999999999998      4666543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-35  Score=294.00  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=211.3

Q ss_pred             CCCCHHHHHHHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecc
Q 002809          556 RHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHC  630 (878)
Q Consensus       556 ~~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~  630 (878)
                      +.++.+|+     ++++.||+|-||.||.|+.+.  --||+|++.+..   .+...++.+|+++-..|+||||++++++|
T Consensus        17 ~~~~l~df-----eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWTLDDF-----EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccchhhc-----cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            44555554     567999999999999998865  569999987653   22346889999999999999999999999


Q ss_pred             cCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       631 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                      .+....+|++||..+|.|...|.+.....+++.....++.|+|.||.|+|..   ++|||||||+|+|++.++..||+||
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence            9999999999999999999999976677899999999999999999999988   9999999999999999999999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      |.+..-.    .......+||.-|.+||...+..++.++|+|++|++.+|++.|.+||......+..       +.+.+-
T Consensus       169 GwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY-------krI~k~  237 (281)
T KOG0580|consen  169 GWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY-------KRIRKV  237 (281)
T ss_pred             CceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH-------HHHHHc
Confidence            9886432    23345678999999999999999999999999999999999999999876633211       111111


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         ++.       ++......+.+++..|+..+|.+|.+..|+++.
T Consensus       238 ---~~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  238 ---DLK-------FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---ccc-------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence               111       123334467899999999999999999999875

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.8e-34  Score=304.25  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=204.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+++..  +..|++|.+...  .......+.+|++++++++|||++++++++..++..++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE   82 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence            35678999999999999875  488999998643  34456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.++++......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.+....  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~  157 (256)
T cd08529          83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NF  157 (256)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc--ch
Confidence            99999999875567799999999999999999999988   99999999999999999999999999988664322  12


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....|+..|+|||++.+..++.++|||||||+++||++|+.||........   ..    ....+....         .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~~---------~  221 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL----KIIRGVFPP---------V  221 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHcCCCCC---------C
Confidence            2334688999999999998999999999999999999999999986653221   11    111121111         1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .......+.+++.+|++.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11233468899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=332.64  Aligned_cols=250  Identities=28%  Similarity=0.446  Sum_probs=216.2

Q ss_pred             cccccccccEEEEEEEEc------ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          571 ERTLGKGGFGTVYYGRLN------EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .++||+|+||+||+|.+-      ..+||+|++... ..+..+++++|+-+|.+++|||+++|+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            479999999999999872      267999998754 5566789999999999999999999999998776 89999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      +.|+|.++++. .+..+..+..+.+..|||+||.|||++   ++|||||.++|||+.+-..+||.|||+++.+..++...
T Consensus       780 P~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  780 PLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             ccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99999999987 456788999999999999999999998   99999999999999999999999999999988777666


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......-.+.|||-|.+....++.++|||||||.+||++| |..|++....++..++       ++.|.         +-
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~ge---------RL  919 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGE---------RL  919 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhccc---------cC
Confidence            5555556678999999999999999999999999999999 9999998887664332       23332         12


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .-+..+..++..++.+||..|++.||+++++.....++.
T Consensus       920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            234556778889999999999999999999999988754

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-34  Score=307.30  Aligned_cols=247  Identities=25%  Similarity=0.450  Sum_probs=199.0

Q ss_pred             ccccccccEEEEEEEEcc-----eeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+|+...     ..+|+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997633     5799999886543 34568999999999999999999999876 4567999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc-
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV-  724 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-  724 (878)
                      |+|.+++..  ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.+........ 
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            999999976  34789999999999999999999988   999999999999999999999999999987643322111 


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |++||......+   +..++.    .+...         .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~~~---------~  218 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGERL---------P  218 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCCcC---------C
Confidence            111223467999999998899999999999999999998 999997765432   222221    11110         1


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      .+......+.+++.+|++.+|++||++.++++.|+++
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1122334788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-34  Score=323.96  Aligned_cols=259  Identities=29%  Similarity=0.463  Sum_probs=200.9

Q ss_pred             HhhhcccccccccEEEEEEEE-------cceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccC-CCcc
Q 002809          567 TNNFERTLGKGGFGTVYYGRL-------NEIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDE-DNQT  636 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~-~~~~  636 (878)
                      .+.+.+.||+|+||.||+|+.       .++.||||+++... ......+.+|+.++.++ +|+||++++++|.. +...
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   87 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence            346778999999999999973       23679999997543 33456788999999999 68999999998865 4567


Q ss_pred             eeEeeeccCCChhhhhcccc------------------------------------------------------------
Q 002809          637 ALIYEFMANGNLQEYLSDIS------------------------------------------------------------  656 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------  656 (878)
                      ++||||+++|+|.++++...                                                            
T Consensus        88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (343)
T cd05103          88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE  167 (343)
T ss_pred             EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence            89999999999999986421                                                            


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCC
Q 002809          657 -----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGT  731 (878)
Q Consensus       657 -----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt  731 (878)
                           ...+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++...............++
T Consensus       168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                 12478889999999999999999998   9999999999999999999999999998765332221112223356


Q ss_pred             CCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHH
Q 002809          732 PGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVW  810 (878)
Q Consensus       732 ~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~  810 (878)
                      ..|+|||.+.+..++.++||||||++++||++ |..||........  +    ...+.++....     ..    .....
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~~~~-----~~----~~~~~  309 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTRMR-----AP----DYTTP  309 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccCCCC-----CC----CCCCH
Confidence            78999999998899999999999999999997 8999876432211  1    11112221110     01    11123


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          811 KAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       811 ~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ++.+++..||+.+|++||++.||++.|+.+++.
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            578999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-34  Score=310.64  Aligned_cols=252  Identities=27%  Similarity=0.456  Sum_probs=202.5

Q ss_pred             hhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      ...+.||+|+||.||+|+...     ..+|+|.+... .....+.+.+|++++.+++|+|++++.+++...+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            346789999999999998742     36999998755 344467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.+++... ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.........
T Consensus        88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          88 MENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            9999999999753 35689999999999999999999998   9999999999999999999999999998766432221


Q ss_pred             cc-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          723 HV-STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       723 ~~-~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      .. ......+..|+|||++....++.++|||||||++|||++ |+.||......+   +   .... ..+.         
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~---~~~i-~~~~---------  227 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---V---MKAI-NDGF---------  227 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHH-hcCC---------
Confidence            11 111223457999999998889999999999999999998 999997655432   1   1111 1111         


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ...........+.+++.+|++.+|++||++.+|++.|+++
T Consensus       228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0011112335678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.7e-34  Score=305.41  Aligned_cols=246  Identities=24%  Similarity=0.429  Sum_probs=198.8

Q ss_pred             ccccccccEEEEEEEEcc-eeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      +.||+|+||.||+|...+ ..+|+|.+..... .....|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            468999999999998765 7899999876543 33457899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      +++... ...+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||++....... ........
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~  155 (250)
T cd05085          81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQ  155 (250)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCC
Confidence            998653 34588999999999999999999988   99999999999999999999999999987543221 11111223


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      ++..|+|||++.+..++.++||||||++++|+++ |..||.........       ..+..+...         ..+...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~~~~---------~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKGYRM---------SCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCCCC---------CCCCCC
Confidence            4568999999998899999999999999999998 99999766543211       111111110         111223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          809 VWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ...+.+++.+|++.+|++||++.+++++|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.3e-35  Score=323.33  Aligned_cols=241  Identities=26%  Similarity=0.379  Sum_probs=196.2

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||+|+||.||+++..  +..||+|++...   .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864  478999998753   2234567788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      +|.+++..  ...+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (325)
T cd05594          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM  153 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence            99998865  4568999999999999999999997 5   89999999999999999999999999987542221  112


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||.....+.....       +..+..      .+.    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~-------i~~~~~------~~p----  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-------ILMEEI------RFP----  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH-------HhcCCC------CCC----
Confidence            235699999999999999999999999999999999999999977654332111       111110      111    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                      .....++.+++.+||+.+|++|+     +++++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            11234677899999999999996     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=338.60  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=201.7

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC--------
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN--------  634 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--------  634 (878)
                      .+.+.+.||+|+||.||+++..  ++.||||++...  .......+.+|+..+..++|+|++++...+....        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            3456789999999999999864  488999998654  3445667889999999999999999988764332        


Q ss_pred             cceeEeeeccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          635 QTALIYEFMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      ..++||||+++|+|.++++...  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence            3679999999999999986532  45689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      ++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .+.... .+..
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~~~-~~~~  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHKTL-AGRY  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHh-cCCC
Confidence            987643322233345679999999999999999999999999999999999999998655432      111111 1111


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .         ..+.....++.+++.+||+.+|++||++.++++.
T Consensus       263 ~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 D---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1         1122233468899999999999999999999864

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.3e-34  Score=316.33  Aligned_cols=256  Identities=30%  Similarity=0.484  Sum_probs=203.6

Q ss_pred             hhcccccccccEEEEEEEEc---------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcce
Q 002809          569 NFERTLGKGGFGTVYYGRLN---------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~  637 (878)
                      .+.+.||+|+||.||+++..         ...+|+|.+.... ......+.+|++++.++ +||||++++++|..+...+
T Consensus        15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   94 (314)
T cd05099          15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY   94 (314)
T ss_pred             eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence            46789999999999999752         2468999987543 34566789999999999 6999999999999999999


Q ss_pred             eEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          638 LIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      +|+||+++|+|.+++....              ...+++.+++.++.|++.||+|||+.   +++||||||+|||+++++
T Consensus        95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCC
Confidence            9999999999999996532              24589999999999999999999988   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQW  782 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  782 (878)
                      .+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+..     
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-----  246 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF-----  246 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-----
Confidence            999999999986542221111111224467999999998899999999999999999999 88898765543311     


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                        ..+..+...         ..+.....++.+++.+|++.+|++||++.|+++.|+++...
T Consensus       247 --~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         247 --KLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             --HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence              111222111         11122334677999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.6e-34  Score=308.00  Aligned_cols=250  Identities=26%  Similarity=0.430  Sum_probs=201.0

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.+.||+|++|.||++...+ ..+|+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||+++|
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~   85 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG   85 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence            4566789999999999998876 6799998765432 3467899999999999999999999875 45688999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.++++......+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++......... ...
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~  161 (260)
T cd05069          86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQ  161 (260)
T ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccC
Confidence            999999765556689999999999999999999988   9999999999999999999999999999765332211 111


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||...+..++.++||||||++++||+| |+.||......+.   .++.    ..+...         ..+
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~~~---------~~~  225 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV----ERGYRM---------PCP  225 (260)
T ss_pred             CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCCCC---------CCC
Confidence            2335678999999998899999999999999999999 8999977554321   1111    111100         111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ......+.+++.+|++.+|++||++++|++.|++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1233568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-34  Score=320.07  Aligned_cols=241  Identities=25%  Similarity=0.394  Sum_probs=195.7

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+|+..+  +.||+|++...   .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999998864  68999998753   233456678899998876 799999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (321)
T cd05591          81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT  153 (321)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence            999998875  45689999999999999999999998   99999999999999999999999999987542221  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+..      .. +..+..   .       .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------~~-i~~~~~---~-------~p  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------ES-ILHDDV---L-------YP  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------HH-HHcCCC---C-------CC
Confidence            3456899999999999999999999999999999999999999876643311      11 111111   0       11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRP-------TMSQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RP-------sm~evl~~  836 (878)
                      .....++.+++.+||+.+|++||       +++++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11224677899999999999999       77887754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.8e-34  Score=308.20  Aligned_cols=248  Identities=24%  Similarity=0.379  Sum_probs=202.4

Q ss_pred             ccccccccEEEEEEEEcc-----eeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|++|.||+|.+..     ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643     3699999987765 567889999999999999999999999888 889999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-cc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-HV  724 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~  724 (878)
                      |+|.+++.+.....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++.+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999999764435789999999999999999999998   9999999999999999999999999999876442221 11


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....++..|+|||++.+..++.++|||||||+++||++ |+.||...+..+...   ..   ...+...         .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~---~~~~~~~---------~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK---KI---DKEGERL---------E  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH---HhcCCcC---------C
Confidence            223457789999999999899999999999999999999 999997665433211   11   1111100         0


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      .+......+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.5e-34  Score=311.42  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=200.2

Q ss_pred             hhcccccccccEEEEEEEEcc--e----eEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--I----DVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~----~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|++..  .    .||+|++... .....+.+.+|+.++..++|+||+++++++... ..++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~   88 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQ   88 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEE
Confidence            345789999999999998632  2    4899998754 334467889999999999999999999998754 5789999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.++++.. ...+++..++.++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus        89 ~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          89 LMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            99999999999753 34689999999999999999999998   999999999999999999999999999987643322


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........++..|+|||...+..++.++|||||||++|||++ |..||.......   +..++.    .+...       
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~-------  230 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGERL-------  230 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCcC-------
Confidence            111122235678999999998899999999999999999998 899987654432   222221    11110       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                        ..+......+.+++.+|++.+|++||++.++++.|+++.
T Consensus       231 --~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         231 --PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             --CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence              011123346789999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-34  Score=313.47  Aligned_cols=255  Identities=26%  Similarity=0.432  Sum_probs=202.2

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|...       +..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|
T Consensus         8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   87 (288)
T cd05061           8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV   87 (288)
T ss_pred             ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            455689999999999999754       2479999886543 23445688999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          640 YEFMANGNLQEYLSDIS--------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      |||+++|+|.++++...        ....++..+.+++.|++.||+|||+.   +|+||||||+||++++++.++|+|||
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg  164 (288)
T cd05061          88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFG  164 (288)
T ss_pred             EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCC
Confidence            99999999999997532        23456788899999999999999988   99999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      +++...............++..|+|||.+.+..++.++|||||||+++||++ |..||.....++.   ..   . +..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~~---~-~~~~  237 (288)
T cd05061         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---LK---F-VMDG  237 (288)
T ss_pred             ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---H-HHcC
Confidence            9886543222222222345678999999998899999999999999999998 7888876554331   11   1 1111


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      ....         .+......+.+++.+|++.+|++||++.++++.|++.+
T Consensus       238 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         238 GYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111         11122357889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=304.96  Aligned_cols=248  Identities=23%  Similarity=0.417  Sum_probs=210.1

Q ss_pred             HHHhhhcccccccccEEEEEEEE--cceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          565 KITNNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       565 ~~t~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +-.+.|.+.||+|.+|.|-++..  .++.||||.+++.   +.+..-.+.+|+++|..|+||||+.++..|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            44566778999999999999865  4599999999875   344556788999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||..+|.|++++.+  ++.+++.++..++.||..|+.|+|.+   +++|||||.+|||||+|+++||+|||++..+...
T Consensus       132 MEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  132 MEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            999999999999987  77899999999999999999999998   9999999999999999999999999999877533


Q ss_pred             CCCcccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                         ...+.+||++-|.+||.+.+.+| .+.+|.||+||+||.|+.|..||++.+...      .++ .+..|...+    
T Consensus       207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~------lvr-QIs~GaYrE----  272 (668)
T KOG0611|consen  207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR------LVR-QISRGAYRE----  272 (668)
T ss_pred             ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH------HHH-HhhcccccC----
Confidence               34466899999999999999887 568999999999999999999999765321      122 233333222    


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                             .+.+....-|+++||..+|++|.|+.+|....+
T Consensus       273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  273 -------PETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             -------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                   122235567999999999999999999988753

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.6e-34  Score=310.64  Aligned_cols=249  Identities=31%  Similarity=0.494  Sum_probs=199.2

Q ss_pred             ccccccccEEEEEEEEcc--------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          572 RTLGKGGFGTVYYGRLNE--------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.||+|+||.||+|+..+        ..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998754        468999876543 34467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-----cEEEeecCC
Q 002809          643 MANGNLQEYLSDIS-----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-----QAKLADFGL  712 (878)
Q Consensus       643 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-----~~kL~DFGl  712 (878)
                      +++++|.+++....     ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996532     24488999999999999999999988   899999999999999887     899999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      ++...............++..|+|||++.+..++.++|||||||++|||+| |+.||......+   ....+    ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC
Confidence            876533222222222345678999999999999999999999999999998 999987654432   11111    1111


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .       .  ..+......+.+++.+||+.+|++||++++|++.|++
T Consensus       231 ~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 R-------L--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             c-------c--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0       0  1112234567899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.9e-34  Score=319.43  Aligned_cols=235  Identities=26%  Similarity=0.401  Sum_probs=191.8

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++...  +.||+|++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998754  78999998753   223456778899988877 699999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~  153 (320)
T cd05590          81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT  153 (320)
T ss_pred             chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence            999999875  45689999999999999999999998   99999999999999999999999999987542221  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.      .. .+..+..   .       .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~-~i~~~~~---~-------~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FE-AILNDEV---V-------YP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HH-HHhcCCC---C-------CC
Confidence            345699999999999998999999999999999999999999987654321      11 1111111   0       11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                      .....++.+++.+||+.+|++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1123467899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=327.33  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=201.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++....   ......+.+|++++..++|+||+++++.+.+++..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM   83 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence            45678999999999999986  5889999987532   234567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC---
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA---  720 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---  720 (878)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        84 ~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          84 PGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            99999999976  36799999999999999999999998   99999999999999999999999999998664332   


Q ss_pred             ------------------------CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 002809          721 ------------------------NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK  776 (878)
Q Consensus       721 ------------------------~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  776 (878)
                                              .........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                    00122335689999999999999999999999999999999999999987664321


Q ss_pred             H-HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 002809          777 I-HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT-MSQVVME  836 (878)
Q Consensus       777 ~-~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~evl~~  836 (878)
                      . .+..|.      ...      .+.  ........+.+++.+|+. +|.+||+ ++++++.
T Consensus       239 ~~~i~~~~------~~~------~~p--~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 YNKIINWK------ESL------RFP--PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHhccC------Ccc------cCC--CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1 111110      000      000  001123467789999997 9999999 9999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=291.64  Aligned_cols=259  Identities=23%  Similarity=0.359  Sum_probs=208.7

Q ss_pred             hhhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC-----cceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN-----QTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~lV~  640 (878)
                      +.+.+.||+|||.-||.++.  ++..+|+|++...+.+..+..++|++..++++|||++++++++..+.     +.++++
T Consensus        23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~  102 (302)
T KOG2345|consen   23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL  102 (302)
T ss_pred             EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence            45678999999999998874  44789999999888788899999999999999999999999985443     489999


Q ss_pred             eeccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          641 EFMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      +|...|+|.+.+....  +..+++.+++.|+.++++||++||+. .+++.||||||.|||+++.+.+++.|||.+.....
T Consensus       103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i  181 (302)
T KOG2345|consen  103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI  181 (302)
T ss_pred             ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence            9999999999997654  55799999999999999999999987 56799999999999999999999999999876532


Q ss_pred             CCCCc-------ccccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh
Q 002809          719 DANTH-------VSTVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA  788 (878)
Q Consensus       719 ~~~~~-------~~~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~  788 (878)
                      .....       .......|..|.|||++.   +...++++|||||||+||+|+.|..||+...+.              
T Consensus       182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------------  247 (302)
T KOG2345|consen  182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------------  247 (302)
T ss_pred             EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------------
Confidence            21110       112234688999999986   446789999999999999999999999764331              


Q ss_pred             cCCcc-cccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          789 KGDIK-SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       789 ~~~~~-~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .+.+. .+..+.+.-.-...-...+.+++.+|++.||.+||++.+++..++..+
T Consensus       248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            12221 222222221112224557889999999999999999999999988754

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.6e-34  Score=321.50  Aligned_cols=243  Identities=24%  Similarity=0.335  Sum_probs=190.5

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.||+|+||.||+++..  ++.||||++.... ....+.+.+|++++++++|+||+++++++..++..++||||+++|
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            3468999999999999875  4889999987543 334567899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+..      ...+..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+....  ....
T Consensus       158 ~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  226 (353)
T PLN00034        158 SLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCN  226 (353)
T ss_pred             cccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cccc
Confidence            987543      346778889999999999999998   99999999999999999999999999998653221  1122


Q ss_pred             cccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          727 VVAGTPGYLDPEYYTS-----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      ...|+..|+|||++..     ...+.++|||||||++|||++|+.||......+...+..   .. .....         
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~-~~~~~---------  293 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AI-CMSQP---------  293 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HH-hccCC---------
Confidence            3468999999998743     234568999999999999999999997433222111111   10 00000         


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .........++.+++.+||+.+|++||+++|+++.
T Consensus       294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01112233468899999999999999999999874

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-34  Score=307.05  Aligned_cols=251  Identities=29%  Similarity=0.486  Sum_probs=204.2

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.+.||+|++|.||++..++ ..+|||.+..... ..+++.+|++++++++|+||+++++++......++||||++++
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   86 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG   86 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCC
Confidence            4567899999999999998766 7799999876443 3467999999999999999999999999989999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++.......+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+||+|||+++.+..... ....
T Consensus        87 ~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~  162 (261)
T cd05034          87 SLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TARE  162 (261)
T ss_pred             CHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh-hhhh
Confidence            999999875556799999999999999999999998   999999999999999999999999999876643211 1111


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||.+.+..++.++||||||++++||++ |+.||........  + +.    +..+. .        ...+
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~-~~----~~~~~-~--------~~~~  226 (261)
T cd05034         163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV--L-EQ----VERGY-R--------MPRP  226 (261)
T ss_pred             ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-HH----HHcCC-C--------CCCC
Confidence            2234568999999998889999999999999999999 9999976554321  1 11    11110 0        0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ......+.+++.+|++.+|++||+++++++.|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1123468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.8e-34  Score=305.29  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=190.9

Q ss_pred             ccccccccEEEEEEEEcc----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLNE----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||+|+||.||+|+...    ..+++|.+.... ......|.+|++.++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997532    468888876543 334567899999999999999999999999999999999999999


Q ss_pred             Chhhhhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          647 NLQEYLSDIS---KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       647 sL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      +|.+++....   ....++...+.++.|++.||+|||+.   +|+||||||+|||+++++++||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999997643   23456888899999999999999998   99999999999999999999999999986543222111


Q ss_pred             ccccccCCCCccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTS-------NRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..||......+.  +    ......+. ..+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~----~~~~~~~~-~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--L----KQVVREQD-IKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--H----HHHhhccC-ccC
Confidence            1223345678999998743       356889999999999999999 7888876554321  1    11112111 112


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      .++.+..    .....+.+++..|+ .+|++||++++|++.|.
T Consensus       231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2222221    22235566778888 49999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.3e-34  Score=325.21  Aligned_cols=248  Identities=22%  Similarity=0.361  Sum_probs=194.1

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.||+|+||+||+|+...  +.||+|++....   ....+.+.+|++++.+++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            45789999999999998754  789999997542   3345678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC---
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN---  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---  721 (878)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....   
T Consensus        85 gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          85 GGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            9999999975  45689999999999999999999998   999999999999999999999999999764311000   


Q ss_pred             ------------------------------------------CcccccccCCCCccCccccccCCCCCccchhhHHHHHH
Q 002809          722 ------------------------------------------THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVIL  759 (878)
Q Consensus       722 ------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~  759 (878)
                                                                ........||..|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~  239 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF  239 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence                                                      00012346999999999999889999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHH-HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHHH
Q 002809          760 EIITCKPAISRINEEEKI-HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMA--CLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       760 elltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPsm~evl~~  836 (878)
                      ||++|+.||......+.. .+..|      ....      ...  .......++.+++.+  |+..+|..||+++|+++.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~------~~~~------~~~--~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINW------ENTL------HIP--PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHcc------cccc------CCC--CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999999999876543221 11111      0000      000  001122355667766  556666679999999885

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.4e-34  Score=320.05  Aligned_cols=249  Identities=26%  Similarity=0.346  Sum_probs=195.9

Q ss_pred             hhcccccccccEEEEEEEE-----cceeEEEEEeccC----ChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCccee
Q 002809          569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLSSS----SAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~----~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~l  638 (878)
                      .+.+.||+|+||.||+++.     .++.||+|++.+.    .....+.+.+|++++.+++ |+||+++++++..++..++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            4568899999999999875     3478999998753    2233466889999999994 9999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+++|+|.+++..  +..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        83 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          83 ILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            9999999999999875  55689999999999999999999998   999999999999999999999999999986533


Q ss_pred             CCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      .... ......||..|+|||++.+. .++.++|||||||++|||+||+.||.........  .. +...+...      +
T Consensus       158 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~-~~~~~~~~------~  227 (332)
T cd05614         158 EEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SE-VSRRILKC------D  227 (332)
T ss_pred             cCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HH-HHHHHhcC------C
Confidence            2221 22235699999999999865 4788999999999999999999999754321111  11 11111111      1


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                      +.+.    ......+.+++.+||+.+|++||     +++++++.
T Consensus       228 ~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 PPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            1111    12234677899999999999999     77788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.3e-34  Score=306.31  Aligned_cols=255  Identities=23%  Similarity=0.404  Sum_probs=204.7

Q ss_pred             hhhcccccccccEEEEEEEE--cceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|++|.||+++.  .+..+|||.+...   ......++.+|+.+++.++|+||+++++++..++..+++|||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            34567899999999999986  4488999987653   233456889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          643 MANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       643 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      +++++|.+++...  ....+++..++.++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++..+....
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            9999999998642  245689999999999999999999998   99999999999999999999999999987653322


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      .  ......|+..|+|||++.+..++.++||||||+++|||++|..||.......    .++... +...     ..+..
T Consensus       161 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-~~~~-----~~~~~  228 (267)
T cd08229         161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK-IEQC-----DYPPL  228 (267)
T ss_pred             c--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhh-hhcC-----CCCCC
Confidence            1  1223458899999999998889999999999999999999999986543221    111111 1111     11111


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      .   .......+.+++.+|++.+|++||||.+|++.++++
T Consensus       229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            1   112344788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=306.48  Aligned_cols=262  Identities=26%  Similarity=0.440  Sum_probs=200.5

Q ss_pred             hcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHH--HhcccceeeeeecccCC----CcceeEeeec
Q 002809          570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLM--RVHHRNLTSLVGHCDED----NQTALIYEFM  643 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~--~l~H~nIv~l~g~~~~~----~~~~lV~Ey~  643 (878)
                      +.+.||+|.||.||+|++.+..||||++....+.   .+.+|.++.+  .|||+||+.+++.-..+    .+++||.+|.
T Consensus       215 L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEEecCccccceeeccccCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            4578999999999999999999999999877654   4455666554  45999999999875433    3689999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-----GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-----~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      +.|||+|+|.+   ..++.+..++++..+|.||+|||.     +.+|.|.|||||+.|||+..++.+.|+|+|||.....
T Consensus       292 e~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~  368 (513)
T KOG2052|consen  292 EHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  368 (513)
T ss_pred             cCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence            99999999984   679999999999999999999994     4689999999999999999999999999999987654


Q ss_pred             CCCC--cccccccCCCCccCccccccCC------CCCccchhhHHHHHHHHHhC----------CCCCCCCChHHHHHHH
Q 002809          719 DANT--HVSTVVAGTPGYLDPEYYTSNR------LTEKSDVYSFGVVILEIITC----------KPAISRINEEEKIHIR  780 (878)
Q Consensus       719 ~~~~--~~~~~~~gt~~Y~APE~~~~~~------~t~ksDV~S~Gvvl~elltG----------~~p~~~~~~~~~~~l~  780 (878)
                      ....  ......+||.+|||||++....      .-..+||||||.|+||++.+          ++||.+..+.+. ...
T Consensus       369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s~e  447 (513)
T KOG2052|consen  369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-SFE  447 (513)
T ss_pred             cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-CHH
Confidence            4221  1233467999999999986532      12368999999999999863          466665433211 111


Q ss_pred             HHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          781 QWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       781 ~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      + +++.+-..++...++.++   ...+++..+.+++..||..+|..|-|+-.+-+.|.++..
T Consensus       448 e-MrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  448 E-MRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             H-HhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            1 111111112222222221   235678889999999999999999999999999998763

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.8e-35  Score=308.68  Aligned_cols=253  Identities=22%  Similarity=0.353  Sum_probs=195.2

Q ss_pred             cccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC-----cceeEeeec
Q 002809          571 ERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN-----QTALIYEFM  643 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~  643 (878)
                      .+++|+|+||.||+|++..  +.||||+......    ---+|+++|+++.|||||+|+-+|....     ...+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            4789999999999998865  7899999865532    1246899999999999999998874322     456899999


Q ss_pred             cCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEEeecCCccccccCC
Q 002809          644 ANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSFATDA  720 (878)
Q Consensus       644 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~  720 (878)
                      +. +|.+.++..  .++.++...+.-+..||.+||+|||+.   +|+||||||+|+|+|.+ |.+||||||.|+.+..+.
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            76 999998753  256788888999999999999999997   99999999999999987 899999999999886554


Q ss_pred             CCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH--HHHhcCCc-----
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN--SLIAKGDI-----  792 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~--~~~~~~~~-----  792 (878)
                      ..   ....-+..|+|||++.+. .|+.+.||||.|||+.||+-|++.|.+.+..++.  ++.+.  ....+.++     
T Consensus       181 pn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL--~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  181 PN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL--VEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             Cc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH--HHHHHHhCCCCHHHHhhcCc
Confidence            33   233457889999998764 7999999999999999999999999886654432  22221  11111111     


Q ss_pred             --ccccCCccccc-----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 --KSIVDPRLQED-----FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 --~~iid~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .+.-.+.+...     +......+.++++.+++.-+|.+|.++.|+++.
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence              11111222211     233455688899999999999999999998864

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6e-34  Score=305.89  Aligned_cols=254  Identities=25%  Similarity=0.411  Sum_probs=203.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+|+..  ++.||||.+...   .......+.+|++++++++||||+++++++...+..++|+||+
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence            45678999999999999874  488999987642   2344567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          644 ANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       644 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      ++|+|.+++....  ...+++..++.++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-  160 (267)
T cd08228          85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-  160 (267)
T ss_pred             CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence            9999999885432  35588999999999999999999998   99999999999999999999999999987653321 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......    .++... +.....     +.. 
T Consensus       161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~-----~~~-  228 (267)
T cd08228         161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQK-IEQCDY-----PPL-  228 (267)
T ss_pred             -HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHH-HhcCCC-----CCC-
Confidence             11223458889999999998889999999999999999999999986543211    111111 111111     111 


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                        ........+.+++.+||+.+|++||++++|++.|+++
T Consensus       229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              1122335688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.6e-34  Score=316.55  Aligned_cols=240  Identities=25%  Similarity=0.374  Sum_probs=192.9

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+|+..+  +.||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999998864  679999987542   23345677788888765 899999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT  153 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence            999999875  45689999999999999999999998   99999999999999999999999999987532211  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+..   +.    +..+.      +...    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---~~----i~~~~------~~~~----  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF---QS----IRMDN------PCYP----  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH---HH----HHhCC------CCCC----
Confidence            3356899999999999989999999999999999999999999876543211   11    11111      1111    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMS-QVVM  835 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~-evl~  835 (878)
                      .....++.+++.+||+.+|++||++. ++.+
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            11223577899999999999999997 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-34  Score=310.57  Aligned_cols=249  Identities=26%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ...+.||+|+||.||++...  ++.||+|++.....   .....+.+|++++++++||||+++++.+..++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence            44578999999999999875  48899999875422   22356788999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  156 (285)
T cd05605          83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---  156 (285)
T ss_pred             CCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---
Confidence            999999988764456799999999999999999999998   99999999999999999999999999987653221   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|+..|+|||++.+..++.++||||+||++|||++|+.||.........   +.+...+..+.          ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------~~  223 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ----------EE  223 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc----------cc
Confidence            112346899999999999889999999999999999999999999865432211   11111111111          11


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                      ++......+.+++.+|++.+|++||     +++++++.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            1122334678999999999999999     77777554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.4e-34  Score=309.57  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=195.6

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      ||+|+||.||+++..  ++.+|+|.+....   ....+.+..|++++.+++||||+++.+.+..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875  4889999986432   12234566799999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      .+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            9998765566789999999999999999999998   99999999999999999999999999987653221   12234


Q ss_pred             cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      .|+..|+|||++.+..++.++||||+||++|||++|+.||........  ..+....... ..+..      .   ....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~-~~~~~------~---~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE-DEVKF------E---HQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc-ccccc------c---cccC
Confidence            689999999999988899999999999999999999999976433211  1111111111 11100      0   0012


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          809 VWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ..++.+++.+||+.+|++||+++|+++.+.
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            336789999999999999999988764433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.2e-34  Score=309.80  Aligned_cols=252  Identities=33%  Similarity=0.505  Sum_probs=201.7

Q ss_pred             hhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+++..       +..||+|++.... ....++|.+|++++.+++||||+++++++..+...++|+
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (288)
T cd05050           8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF   87 (288)
T ss_pred             eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence            34578999999999999863       3779999987543 344577999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhcccc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc
Q 002809          641 EFMANGNLQEYLSDIS--------------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN  700 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~  700 (878)
                      ||+++|+|.+++....                    ...+++..++.++.|++.||+|||+.   +++||||||+||+++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~  164 (288)
T cd05050          88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVG  164 (288)
T ss_pred             ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEec
Confidence            9999999999996421                    12478899999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002809          701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHI  779 (878)
Q Consensus       701 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  779 (878)
                      +++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||......+.   
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~---  241 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV---  241 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            999999999999876533222111222234567999999998899999999999999999998 8888876554331   


Q ss_pred             HHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       780 ~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                         .. .+..+....         .+.....++.+++.+|++.+|++||++.|+++.|++
T Consensus       242 ---~~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         242 ---IY-YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HH-HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               11 122222211         111233578899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=309.52  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=197.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChh--------------hHHHHHHHHHHHHHhcccceeeeeecccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ--------------GFQQFQAEVKLLMRVHHRNLTSLVGHCDE  632 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~  632 (878)
                      .+.+.||+|.||.|-+|+..  ++.||||++.+....              ..+...+||.+|++++|||||+|+.+..+
T Consensus       100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD  179 (576)
T KOG0585|consen  100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD  179 (576)
T ss_pred             ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence            44678999999999999875  488999999753211              13578899999999999999999999865


Q ss_pred             --CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          633 --DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       633 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                        .+.+|||+|||..|.+...-..  ...++..++++++.++..||+|||.+   +||||||||+|+||+++|++||+||
T Consensus       180 P~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  180 PESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             cccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeecc
Confidence              5689999999999888765432  22399999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccccCCC---CcccccccCCCCccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 002809          711 GLSKSFATDAN---THVSTVVAGTPGYLDPEYYTSNR----LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWV  783 (878)
Q Consensus       711 Gla~~~~~~~~---~~~~~~~~gt~~Y~APE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v  783 (878)
                      |.+........   ........||+.|+|||++.++.    .+.+.||||+||+||.|+.|+.||.+....+-.      
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~------  328 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF------  328 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH------
Confidence            99876632211   11122367999999999987643    456889999999999999999999875543311      


Q ss_pred             HHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       784 ~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                       ..        ++...+.-....+....+.+|+.++|++||++|.+..+|..+..-
T Consensus       329 -~K--------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  329 -DK--------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             -HH--------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence             11        222222222223445678899999999999999999999877643

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4e-34  Score=317.25  Aligned_cols=238  Identities=25%  Similarity=0.372  Sum_probs=192.5

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhccc-ceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHR-NLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~-nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+|+..+  +.||+|++...   .....+.+..|.+++..++|+ +|+++.+++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            456889999999999998765  67999998753   233456788899999999764 588899999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        83 ~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--  155 (324)
T cd05587          83 VNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--  155 (324)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--
Confidence            999999999875  45689999999999999999999998   99999999999999999999999999986432211  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......|+..|+|||++.+..++.++|||||||++|||+||+.||......+..   .    .+.+..      ..   
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~----~i~~~~------~~---  219 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---Q----SIMEHN------VS---  219 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H----HHHcCC------CC---
Confidence            1223456899999999999999999999999999999999999999876543211   1    111111      01   


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                       ++.....++.+++.+||+.+|.+|++.
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 -YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             111223467789999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.9e-34  Score=307.42  Aligned_cols=255  Identities=26%  Similarity=0.406  Sum_probs=204.3

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ..+.+.||+|+||.||+|...+     ..|++|...... ....+.+.+|+.++++++||||+++++++.. +..++|||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            4567899999999999998643     368999887654 4556789999999999999999999998875 45789999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++... ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...... 
T Consensus        87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  161 (270)
T cd05056          87 LAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES-  161 (270)
T ss_pred             cCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc-
Confidence            99999999999753 33589999999999999999999988   99999999999999999999999999987654321 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........++..|+|||.+....++.++||||||++++||++ |+.||......+..   .+    +..+...       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~----~~~~~~~-------  227 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GR----IENGERL-------  227 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH----HHcCCcC-------
Confidence            111222334568999999988889999999999999999986 99999876543321   11    1111100       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                        ..+......+.+++.+|+..+|++||++.++++.|+++...|
T Consensus       228 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         228 --PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence              011223347889999999999999999999999999977554

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.8e-34  Score=309.14  Aligned_cols=244  Identities=23%  Similarity=0.372  Sum_probs=193.3

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      ||+|+||+||+++..  ++.||+|.+.....   ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999875  47899999875422   2345678899999999999999999999999999999999999999


Q ss_pred             hhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          649 QEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       649 ~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      .+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            9887542  245689999999999999999999998   999999999999999999999999999876543221  123


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||.........  ...... ...+..          ..+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~-~~~~~~----------~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR-ILNDSV----------TYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHh-hcccCC----------CCcc
Confidence            356899999999999999999999999999999999999999764432110  011111 111110          1112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRP-----TMSQVVM  835 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~  835 (878)
                      .....+.+++.+||+.+|++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            2334678999999999999999     5566655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3e-34  Score=318.76  Aligned_cols=242  Identities=21%  Similarity=0.359  Sum_probs=193.3

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++...  +.||+|++....   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999998754  789999998642   23456788999999888 699999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|..++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (327)
T cd05617          81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTT  153 (327)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cce
Confidence            999998865  45699999999999999999999998   99999999999999999999999999987532211  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||............++....+.....      .+    +
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~----p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI----P  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC----C
Confidence            3456999999999999999999999999999999999999999754322222222233333322211      11    1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                      ......+.+++.+||+.+|++|+++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            1122456789999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-34  Score=304.96  Aligned_cols=248  Identities=26%  Similarity=0.348  Sum_probs=206.6

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.||+|.-|+||.+++.+  ..+|+|++.+..   .+...+.+.|-+||+.+.||.++.|++.++.+...++|||||+
T Consensus        81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp  160 (459)
T KOG0610|consen   81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP  160 (459)
T ss_pred             HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence            34689999999999999987  679999998764   3345677889999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc------
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT------  718 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~------  718 (878)
                      ||+|...+++...+.+++..+..++.+++.||+|||..   |||.|||||+||||.++|++.|+||.|+.....      
T Consensus       161 GGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~  237 (459)
T KOG0610|consen  161 GGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK  237 (459)
T ss_pred             CccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence            99999999988889999999999999999999999988   999999999999999999999999998753310      


Q ss_pred             ---------------------------CCC---------------------CcccccccCCCCccCccccccCCCCCccc
Q 002809          719 ---------------------------DAN---------------------THVSTVVAGTPGYLDPEYYTSNRLTEKSD  750 (878)
Q Consensus       719 ---------------------------~~~---------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksD  750 (878)
                                                 ...                     ...+..++||-.|+|||++.+...+.++|
T Consensus       238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD  317 (459)
T KOG0610|consen  238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD  317 (459)
T ss_pred             cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence                                       000                     00112357999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC-
Q 002809          751 VYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT-  829 (878)
Q Consensus       751 V~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-  829 (878)
                      .|+|||++|||+.|..||.+.+.++...               .++-+.+.-....+.+..+.+|+++.|.+||++|-. 
T Consensus       318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  318 WWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             HHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence            9999999999999999999877654321               122222221222345668889999999999999988 


Q ss_pred             ---HHHHHH
Q 002809          830 ---MSQVVM  835 (878)
Q Consensus       830 ---m~evl~  835 (878)
                         +.||-+
T Consensus       383 ~rGA~eIK~  391 (459)
T KOG0610|consen  383 KRGAAEIKR  391 (459)
T ss_pred             ccchHHhhc
Confidence               666655

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4e-34  Score=316.48  Aligned_cols=241  Identities=24%  Similarity=0.366  Sum_probs=195.7

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++...  ..||+|++...   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998854  78999998754   233456678899999888 699999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (318)
T cd05570          81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT  153 (318)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence            999999875  44699999999999999999999998   99999999999999999999999999986532211  112


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||........      .. .+.....      .    ++
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~------~~-~i~~~~~------~----~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL------FQ-SILEDEV------R----YP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH------HH-HHHcCCC------C----CC
Confidence            234689999999999999999999999999999999999999976554321      11 1111111      1    11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTM-----SQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm-----~evl~~  836 (878)
                      ......+.+++.+||+.+|++||++     .++++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            1223467899999999999999999     777654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=323.62  Aligned_cols=249  Identities=22%  Similarity=0.376  Sum_probs=196.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||||++....   ......+.+|++++..++||||+++++++..++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            34578999999999999875  4789999997532   234466889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-  722 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-  722 (878)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        84 ~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          84 PGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            99999999975  45699999999999999999999998   9999999999999999999999999998754321100 


Q ss_pred             -----------------------------------cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 002809          723 -----------------------------------HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA  767 (878)
Q Consensus       723 -----------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p  767 (878)
                                                         .......||+.|+|||++....++.++|||||||+++||++|++|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                               001124699999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002809          768 ISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT---MSQVVME  836 (878)
Q Consensus       768 ~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~evl~~  836 (878)
                      |......+...      ... .... ..   ....  .......+.+++.+|+. +|.+|++   ++|+++.
T Consensus       239 f~~~~~~~~~~------~i~-~~~~-~~---~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         239 FCSDNPQETYR------KII-NWKE-TL---QFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCHHHHHH------HHH-cCCC-cc---CCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            98765433211      111 1100 00   0000  01122356788888886 8999998   8888874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.8e-34  Score=320.05  Aligned_cols=201  Identities=24%  Similarity=0.431  Sum_probs=173.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++....   ......+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            34578999999999999875  4789999997542   233457888999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-  722 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-  722 (878)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        84 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          84 PGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            99999999975  45799999999999999999999998   9999999999999999999999999998754321100 


Q ss_pred             --------------------------------cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002809          723 --------------------------------HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISR  770 (878)
Q Consensus       723 --------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~  770 (878)
                                                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            001235799999999999999999999999999999999999999987


Q ss_pred             CChH
Q 002809          771 INEE  774 (878)
Q Consensus       771 ~~~~  774 (878)
                      ....
T Consensus       239 ~~~~  242 (363)
T cd05628         239 ETPQ  242 (363)
T ss_pred             CCHH
Confidence            6543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=317.57  Aligned_cols=258  Identities=27%  Similarity=0.435  Sum_probs=217.4

Q ss_pred             hhcccccccccEEEEEEEEcc------eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ...++||.|-||.||+|.+.+      ..||||.-+.. .....+.|++|..+|++++|||||+++|.|.+. ..++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence            345789999999999998743      45999988764 445678899999999999999999999999865 6799999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      .++-|.|..+|+. +...++......++.||+.||+|||+.   ++|||||..+|||+....-+||+|||+++.+..+..
T Consensus       471 L~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  471 LAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             cccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            9999999999986 456799999999999999999999998   999999999999999999999999999998865544


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      .+.+ ...-...|||||.+.-.+++.++|||-|||++||++. |..||.+....+                +--.+...-
T Consensus       547 YkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~iEnGe  609 (974)
T KOG4257|consen  547 YKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHIENGE  609 (974)
T ss_pred             hhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEecCCC
Confidence            4333 4456779999999999999999999999999999977 899998754422                111122222


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                      +...+..|+..+..++.+||..+|.+||.+.++...|+++++.|...+
T Consensus       610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~  657 (974)
T KOG4257|consen  610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINS  657 (974)
T ss_pred             CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhh
Confidence            334567788889999999999999999999999999999988555443

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.1e-34  Score=311.54  Aligned_cols=259  Identities=21%  Similarity=0.317  Sum_probs=194.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+|+..  ++.||+|++..... .....+.+|++++++++||||+++++++..+...++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH   86 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence            345688999999999999875  47899999875432 223567889999999999999999999999999999999995


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                       ++|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        87 -~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  159 (303)
T cd07869          87 -TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HT  159 (303)
T ss_pred             -cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--cc
Confidence             6888887642 35688999999999999999999998   99999999999999999999999999987543221  12


Q ss_pred             cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC---Cccc-----c
Q 002809          725 STVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG---DIKS-----I  795 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~---~~~~-----i  795 (878)
                      .....|+..|+|||++.+ ..++.++||||+||+++||++|+.||........ .+.. +.......   ....     .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLER-IFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHH-HHHHhCCCChhhccchhhccc
Confidence            233457899999999865 4578899999999999999999999986543211 1111 11111000   0000     0


Q ss_pred             cCCc-cc--cccCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          796 VDPR-LQ--EDFDA-------NSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       796 id~~-l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .++. +.  .....       .....+.+++.+||+.+|++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000 00  00000       11235779999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.8e-34  Score=316.63  Aligned_cols=243  Identities=26%  Similarity=0.389  Sum_probs=192.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHH---HHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLL---MRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L---~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+++..  ++.||||++....   ....+.+.+|+.++   .+++||||+++++++..++..++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            35678999999999999875  4789999997532   22345566666655   5667999999999999999999999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++|+|..+++.   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          82 EYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             cCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999988863   4699999999999999999999998   99999999999999999999999999987532211


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                        .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+..      .. +..+..      ..
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~-i~~~~~------~~  220 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DS-IVNDEV------RY  220 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhCCC------CC
Confidence              1223456899999999999999999999999999999999999999876543311      11 111111      11


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                          +......+.+++.+||+.+|++||     ++.++++.
T Consensus       221 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         221 ----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                111234677899999999999999     46666553

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.5e-34  Score=304.23  Aligned_cols=250  Identities=28%  Similarity=0.492  Sum_probs=195.0

Q ss_pred             ccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeeccc-CCCcceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD-EDNQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-~~~~~~lV~Ey~~  644 (878)
                      +.||+|+||.||+|+..+     ..+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998632     56999998643 3445678899999999999999999999775 4556889999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC--
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT--  722 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--  722 (878)
                      +|+|.+++... ....++..++.++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++.+......  
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999999753 33467888899999999999999988   9999999999999999999999999998765322111  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .......++..|+|||.+.+..++.++|||||||++|||++| .+||......+   +...+    ..+...        
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~----~~~~~~--------  221 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL----LQGRRL--------  221 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----hcCCCC--------
Confidence            111223456789999999988999999999999999999995 56666544322   22211    111100        


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                       ..+...+..+.+++.+||+.+|++||++.||++.|+++.
T Consensus       222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             001112346789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.5e-34  Score=306.13  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=202.8

Q ss_pred             hhhcccccccccEEEEEEEEc-----ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|+..     ...+|+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE   85 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            356789999999999999863     2469999987543 3345789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++++|.+++... ...+++.+++.++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++..+.....
T Consensus        86 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          86 YMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            99999999999753 34689999999999999999999998   999999999999999999999999999987643321


Q ss_pred             Ccc-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          722 THV-STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       722 ~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      ... .....++..|+|||++.+..++.++||||||++++|+++ |+.||......+.   ...+    .++..     . 
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~~-----~-  228 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EEGYR-----L-  228 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hCCCc-----C-
Confidence            111 111223567999999998899999999999999999887 9999977654321   1111    11110     0 


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                         .........+.+++.+|++.+|++||+|.++++.|+++
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 ---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               11112334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-34  Score=303.66  Aligned_cols=249  Identities=33%  Similarity=0.537  Sum_probs=201.2

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhH--HHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGF--QQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~--~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||+||+++..+  +.+|+|++........  ....+|+.++.+++||||+++++++......++||||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            456899999999999999876  6799999988765433  234669999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..  ...+++..++.++.|+++||++||+.   +++|+||||+||++++++.++|+|||.+...  ......
T Consensus        82 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~  154 (260)
T PF00069_consen   82 GGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN  154 (260)
T ss_dssp             TEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred             cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccccc
Confidence            9999999983  56789999999999999999999998   9999999999999999999999999998754  112223


Q ss_pred             cccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHH-HHhcCCcccccCCcccc
Q 002809          725 STVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNS-LIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~-~~~~~~~~~iid~~l~~  802 (878)
                      .....++..|+|||.+. +...+.++||||+|+++++|++|..||................. ......         . 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~-  224 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---------Q-  224 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---------T-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---------c-
Confidence            33456889999999998 88899999999999999999999999987743332222111111 000000         0 


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       ........+.+++..||+.+|++||++.++++
T Consensus       225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00001257889999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-34  Score=304.51  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=198.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-----hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-----AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ...+.||+|++|.||++...  +..+|+|.+....     ....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   84 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME   84 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence            34579999999999999864  4889999986432     1234578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++++|.+++..  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||+++.......
T Consensus        85 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          85 YMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             ECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            9999999999875  45688999999999999999999998   999999999999999999999999999876532211


Q ss_pred             Ccc-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THV-STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.........      ........         
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~---------  224 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQPT---------  224 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccCC---------
Confidence            111 12345788999999999989999999999999999999999999765432211      11111110         


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ....+......+.+++.+||..+|++||++.|+++.
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            011122233467899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.8e-34  Score=315.54  Aligned_cols=239  Identities=25%  Similarity=0.358  Sum_probs=192.2

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++...  ..||+|+++...   ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999998864  789999987532   23345677788888765 899999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA  153 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence            999999875  45689999999999999999999998   99999999999999999999999999987432111  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||........   .+    .+..+.      +.+.    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~----~~~~~~------~~~~----  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FE----SIRVDT------PHYP----  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH----HHHhCC------CCCC----
Confidence            345689999999999999999999999999999999999999986654321   11    111111      1111    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMS-QVV  834 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~-evl  834 (878)
                      .....++.+++.+||+.+|++||++. ++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11234677899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.2e-34  Score=308.64  Aligned_cols=238  Identities=28%  Similarity=0.407  Sum_probs=190.1

Q ss_pred             cccccccEEEEEEEEcc--------------------------eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeee
Q 002809          573 TLGKGGFGTVYYGRLNE--------------------------IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL  626 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~--------------------------~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l  626 (878)
                      .||+|+||.||+|++..                          ..|++|++..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997521                          3589999876655556788999999999999999999


Q ss_pred             eecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---
Q 002809          627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---  703 (878)
Q Consensus       627 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---  703 (878)
                      +++|..+...++||||+++|+|..++... ...+++..++.++.|+++||+|||+.   +|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999998642 45689999999999999999999988   999999999999998654   


Q ss_pred             ----cEEEeecCCccccccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHH-hCCCCCCCCChHHHH
Q 002809          704 ----QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEII-TCKPAISRINEEEKI  777 (878)
Q Consensus       704 ----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~  777 (878)
                          .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+..
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                3899999987643221      12346788999998865 56899999999999999994 799998765543321


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                         .+..    ...       .+...    ....+.+++.+||+.+|++||++++|++.|+
T Consensus       232 ---~~~~----~~~-------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 ---RFYE----KKH-------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---HHHH----hcc-------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               1111    100       01111    1135788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-33  Score=309.22  Aligned_cols=260  Identities=26%  Similarity=0.421  Sum_probs=201.3

Q ss_pred             hhhcccccccccEEEEEEEEc------------------ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN------------------EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVG  628 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~------------------~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g  628 (878)
                      +.+.+.||+|+||.||+++..                  ...+|+|++... .....+.|.+|++++++++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            355688999999999988543                  146899998754 3345578999999999999999999999


Q ss_pred             cccCCCcceeEeeeccCCChhhhhcccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE
Q 002809          629 HCDEDNQTALIYEFMANGNLQEYLSDIS---------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL  699 (878)
Q Consensus       629 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl  699 (878)
                      ++..++..++||||+++|+|.+++....         ...+++.++..++.|++.||+|||+.   +++||||||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence            9999999999999999999999987532         13477889999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCChHHHH
Q 002809          700 NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPAISRINEEEKI  777 (878)
Q Consensus       700 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~~  777 (878)
                      +.++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++  |..||......+..
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI  243 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence            9999999999999876543322112222334678999999888889999999999999999998  67888765443221


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .   ...............      ..+..+...+.+++.+||+.+|++||++.+|++.|++
T Consensus       244 ~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         244 E---NTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   111111111100000      1112233578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.4e-34  Score=304.91  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=203.1

Q ss_pred             HHhhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ..+.+.+.||+|+||.||++...+ ..+|+|.+.... .....+.+|++++++++|+||+++.+.+.. ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            345667899999999999998765 679999887543 335678999999999999999999999887 77899999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++.......+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~  159 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TA  159 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc-cc
Confidence            99999999765566789999999999999999999988   999999999999999999999999999876533221 11


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....++..|+|||++....++.++|+|||||+++|++| |+.||.......   +.++.    ..+....         
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~~~---------  223 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGYRMP---------  223 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCCCCCC---------
Confidence            122335678999999998889999999999999999999 899997654432   11211    1111100         


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .......++.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111223468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.2e-33  Score=302.49  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=191.6

Q ss_pred             ccccccccEEEEEEEEcc----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLNE----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||+|+||.||+|+..+    ..+++|.+.... ....+.|.+|+.++..++||||+++++.|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            369999999999997543    345677665443 345678999999999999999999999999999999999999999


Q ss_pred             Chhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          647 NLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       647 sL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|.+++++..  ....++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999997532  34567778889999999999999998   999999999999999999999999999764322211122


Q ss_pred             cccccCCCCccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTS-------NRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+.      ...... +....+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~-~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIK-DQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHh-hcccccC
Confidence            233557889999999753       245789999999999999997 5678876544321      111122 2222333


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ++.+...+.    ..+.+++..|+ .+|++||++++|++.|.
T Consensus       231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            444333222    35667888899 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.3e-34  Score=305.91  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=199.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..  ++.||+|++..........+.+|+.++.+++||||+++++.+..++..++|+||+++
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~   90 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG   90 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence            455688999999999999874  478999999766555556788999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.++++.  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++..+.....  ..
T Consensus        91 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~  163 (267)
T cd06646          91 GSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KR  163 (267)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc--cc
Confidence            999999875  45689999999999999999999988   999999999999999999999999999986632211  12


Q ss_pred             ccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          726 TVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ....|+..|+|||.+.   ...++.++|||||||+++||++|+.|+..........  .     .....   ...+.+..
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~~~~~---~~~~~~~~  233 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----MSKSN---FQPPKLKD  233 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----eecCC---CCCCCCcc
Confidence            2345888999999884   3457889999999999999999999986544322110  0     00000   00111110


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                        .......+.+++.+||+.+|++||+++++++.|
T Consensus       234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              112234788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-33  Score=303.99  Aligned_cols=238  Identities=26%  Similarity=0.414  Sum_probs=190.9

Q ss_pred             ccccccccEEEEEEEEcc--------------eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcce
Q 002809          572 RTLGKGGFGTVYYGRLNE--------------IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--------------~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~  637 (878)
                      +.||+|+||.||+|+...              ..|++|.+..........|.+|+.++..++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532              358999887665555678899999999999999999999999999999


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc-------EEEeec
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ-------AKLADF  710 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~-------~kL~DF  710 (878)
                      +||||+++|+|..+++.. ...+++..+++++.||++||+|||+.   +|+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999888642 34689999999999999999999998   9999999999999987664       899999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHHHHHh
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEII-TCKPAISRINEEEKIHIRQWVNSLIA  788 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~v~~~~~  788 (878)
                      |++......      ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......+...       . .
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~-~  222 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------F-Y  222 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------H-H
Confidence            998654321      1234778899999987 567899999999999999997 5888876544322111       0 1


Q ss_pred             cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       789 ~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      .+.. ...         ......+.+++.+||+.+|++||++++|++.|
T Consensus       223 ~~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 EGQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hcCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1110 000         11124678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-34  Score=317.64  Aligned_cols=236  Identities=26%  Similarity=0.384  Sum_probs=189.3

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHH-HHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVK-LLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++..  ++.||+|++....   ....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999885  4889999987532   223345556655 45778999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (323)
T cd05575          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT  153 (323)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence            999999875  45789999999999999999999998   99999999999999999999999999987532211  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.      ..... .+..      .+..   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~-~~~~------~~~~---  217 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNIL-NKPL------RLKP---  217 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHH-cCCC------CCCC---
Confidence            345689999999999999999999999999999999999999987654321      11111 1111      1111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMS  831 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~  831 (878)
                       .....+.+++.+||+.+|++||+++
T Consensus       218 -~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 -NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             1234677899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-34  Score=324.05  Aligned_cols=255  Identities=21%  Similarity=0.249  Sum_probs=192.0

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||++....  +.||+|...      ...+.+|++++++++||||+++++++..+...++|+|++. 
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            4556899999999999998754  789999753      2457889999999999999999999999999999999995 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus       167 ~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~  240 (391)
T PHA03212        167 TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKY  240 (391)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccc
Confidence            788888865  45689999999999999999999998   99999999999999999999999999987542211 1122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHHHH---hcCC------
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE-----EKIHIRQWVNSLI---AKGD------  791 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~v~~~~---~~~~------  791 (878)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+......     ....+...+...-   .+..      
T Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            3356999999999999989999999999999999999999876543210     0011111110000   0000      


Q ss_pred             cccc---------cCCcccccc--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          792 IKSI---------VDPRLQEDF--DANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       792 ~~~i---------id~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +.+.         ..+......  ......++.+++.+||+.||++|||++|+++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000         000000000  0123446889999999999999999999985

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.6e-34  Score=323.53  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=197.1

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++...  +.||+|++...   .....+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05596          45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY  124 (370)
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence            3456889999999999998754  78999998643   223345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus       125 ~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-  197 (370)
T cd05596         125 MPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-  197 (370)
T ss_pred             CCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence            999999999864   3588889999999999999999998   999999999999999999999999999976532221 


Q ss_pred             cccccccCCCCccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          723 HVSTVVAGTPGYLDPEYYTSN----RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........      ..... .+.. .+   
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~-~~~~-~~---  266 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIM-DHKN-SL---  266 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHH-cCCC-cC---
Confidence            122345699999999998653    478899999999999999999999987654321      11111 1110 00   


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQ--RPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~evl~~  836 (878)
                      .+..  ......++.+++.+||+.+|++  ||+++|+++.
T Consensus       267 ~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0110  1122346778999999999988  9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.2e-34  Score=315.09  Aligned_cols=238  Identities=25%  Similarity=0.370  Sum_probs=192.4

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+++..+  ..||+|++....   ....+.+..|..++..+ +|++|+++.+++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            456789999999999998765  689999987542   22345677788888877 589999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++......  
T Consensus        83 ~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--  155 (323)
T cd05616          83 VNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--  155 (323)
T ss_pred             CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--
Confidence            999999999865  45689999999999999999999998   99999999999999999999999999987542221  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......|++.|+|||++.+..++.++|||||||++|||+||+.||........   .+   . +.+...          
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~---~-i~~~~~----------  218 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQ---S-IMEHNV----------  218 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HH---H-HHhCCC----------
Confidence            122345689999999999999999999999999999999999999987654321   11   1 111111          


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                      .++.....++.+++.+|++.+|++|++.
T Consensus       219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            1111223467899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-33  Score=301.23  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=199.4

Q ss_pred             ccccccccEEEEEEEEc-ceeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      +.||+|++|.||++... ++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999887 588999998765443 5678999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      +++... ...+++..++.++.+++.||+|||++   +++||||||+||+++.++.+||+|||++................
T Consensus        81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            998653 34688999999999999999999998   99999999999999999999999999987653221111111222


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      .+..|+|||.+.+..++.++|||||||+++||+| |..||.........   +.    +..+.         ....+...
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~~----~~~~~---------~~~~~~~~  220 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---ER----IESGY---------RMPAPQLC  220 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---HH----HhcCC---------CCCCCccC
Confidence            3567999999998899999999999999999999 88888765543211   11    11111         00111223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          809 VWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ..++.+++.+|++.+|++||++.|+++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            347889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-34  Score=318.31  Aligned_cols=237  Identities=27%  Similarity=0.367  Sum_probs=192.7

Q ss_pred             ccccccccEEEEEEEE-----cceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRL-----NEIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.||+|+||.||+++.     .++.||+|++....  ......+..|++++.+++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999998864     34789999987542  2234567889999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~  154 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK  154 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence            9999999865  45689999999999999999999998   99999999999999999999999999987653221  12


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..      .. +.....      .    .
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~-i~~~~~------~----~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TM-ILKAKL------G----M  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HH-HHcCCC------C----C
Confidence            23356899999999999888999999999999999999999999875543211      11 111111      0    1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQ  832 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~e  832 (878)
                      +......+.+++.+||+.+|++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1112246778999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-33  Score=305.51  Aligned_cols=253  Identities=28%  Similarity=0.426  Sum_probs=203.2

Q ss_pred             hhcccccccccEEEEEEEEcc------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|....      ..+|+|.+.... ......+.+|++++.+++|+||++++++|.. ...++|+|
T Consensus        10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   88 (279)
T cd05057          10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ   88 (279)
T ss_pred             EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence            456789999999999998642      358999887654 3445788999999999999999999999987 78899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++... ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++.......
T Consensus        89 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          89 LMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             cCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence            99999999999753 34589999999999999999999997   999999999999999999999999999987643322


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........++..|+|||.+....++.++||||||++++|+++ |+.||.....++   +.+.    +..+...       
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~-------  230 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDL----LEKGERL-------  230 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHH----HhCCCCC-------
Confidence            221122224568999999988889999999999999999999 999998765432   1111    1111110       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                        ..+..+...+.+++.+|+..+|.+||++.++++.|+++.+
T Consensus       231 --~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 --PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              1111123467789999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=321.64  Aligned_cols=247  Identities=24%  Similarity=0.387  Sum_probs=209.9

Q ss_pred             cccccccccEEEEEEEEcc-----eeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          571 ERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .++||+|.||.|++|.|+.     ..||||.+...... ....|.+|+.+|.+|+|||+++|+|...+ ....+|+|+++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            4789999999999999864     56999999877554 67899999999999999999999999987 67899999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      .|+|.+.|+...+..+-......++.|||.||.||..+   ++|||||..+|+||-....+||+||||.+.+........
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence            99999999986677888999999999999999999998   999999999999999999999999999998865554432


Q ss_pred             c-ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          725 S-TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       725 ~-~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      . ....-.+.|+|||.+...+++.++|||+|||.+|||+| |..||-+......+.                .+|.+-+-
T Consensus       271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----------------~iD~~erL  334 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----------------NIDAGERL  334 (1039)
T ss_pred             ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH----------------hccccccC
Confidence            2 22334568999999999999999999999999999999 678888776543222                22322222


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      .-+..|.+.+.+++..||..+|++||++..|.+.+
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            34566788999999999999999999999998543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=325.52  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=194.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||||++...   .....+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~   83 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL   83 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence            34578999999999999874  478999998653   2234567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-  722 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-  722 (878)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        84 ~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          84 PGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            99999999975  45689999999999999999999998   9999999999999999999999999998643211000 


Q ss_pred             --------------------------------------------cccccccCCCCccCccccccCCCCCccchhhHHHHH
Q 002809          723 --------------------------------------------HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVI  758 (878)
Q Consensus       723 --------------------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl  758 (878)
                                                                  .......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                        000124699999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHH-HHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCC---CCCHHHHH
Q 002809          759 LEIITCKPAISRINEEEKIH-IRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQ---RPTMSQVV  834 (878)
Q Consensus       759 ~elltG~~p~~~~~~~~~~~-l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~---RPsm~evl  834 (878)
                      |||++|++||......+... +..|.      ..   +   .+..  ......++.+++.+|+. +|.+   |+++.|++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~------~~---~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWR------ET---L---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccC------Cc---c---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            99999999998765432211 11110      00   0   0010  01123467789999997 6665   46999988


Q ss_pred             HH
Q 002809          835 ME  836 (878)
Q Consensus       835 ~~  836 (878)
                      +.
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            86

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.1e-34  Score=302.88  Aligned_cols=245  Identities=26%  Similarity=0.450  Sum_probs=200.1

Q ss_pred             hhhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      +.+.+.||+|+||.||++...++.||+|.+....  ....+.+|+.++.+++|||++++++++..+ ..++||||+++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~   84 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN   84 (254)
T ss_pred             ceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence            3567899999999999999888999999986543  346789999999999999999999998654 4799999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......     ..
T Consensus        85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~  156 (254)
T cd05083          85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DN  156 (254)
T ss_pred             HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-----CC
Confidence            99999865556789999999999999999999988   99999999999999999999999999987542211     11


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...+..|+|||.+.+..++.++|||||||+++||++ |+.||......+..       .....+....         ...
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~---------~~~  220 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKGYRME---------PPE  220 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCCCCCC---------CCC
Confidence            234568999999998899999999999999999998 99999776543311       1111111110         111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .....+.+++.+|++.+|++||+++++++.|++
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            223467899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-33  Score=301.70  Aligned_cols=254  Identities=25%  Similarity=0.413  Sum_probs=205.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|++|.||+|...  ++.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            346688999999999999885  588999988642   233467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          643 MANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       643 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      +++|+|.+++...  ....+++.+++.++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            9999999998653  245689999999999999999999998   99999999999999999999999999987653221


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      .  ......++..|+|||.+.+..++.++|||||||++|||++|+.||......    +.+.... ...+...       
T Consensus       161 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~-------  226 (267)
T cd08224         161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEKCDYP-------  226 (267)
T ss_pred             c--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh-hhcCCCC-------
Confidence            1  122345788999999999888999999999999999999999998654321    1111111 1111111       


Q ss_pred             ccccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          801 QEDFD-ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       801 ~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                        ..+ ......+.+++.+|+..+|++||++.+|+++|+++
T Consensus       227 --~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 --PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             --CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence              111 13344788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.5e-34  Score=295.13  Aligned_cols=258  Identities=21%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCChh--hHHHHHHHHHHHHHhcccceeeeeeccc--CCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQ--GFQQFQAEVKLLMRVHHRNLTSLVGHCD--EDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~--~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~~lV~Ey~~~  645 (878)
                      +.|++|.||.||+|+.+.  +-||+|+++.....  ---.-++||.+|.+++|||||.+-....  +-+..++|||||+.
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            579999999999998764  78999999865432  1234589999999999999999988764  44579999999976


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                       +|...++.. ++.+...+...++.|+++|++|||+.   -|+|||||++|+|++..|.+||+|||+|+.+.....  ..
T Consensus       162 -DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~  234 (419)
T KOG0663|consen  162 -DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--PY  234 (419)
T ss_pred             -hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc--cC
Confidence             899998864 47899999999999999999999998   899999999999999999999999999998864422  23


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC------
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP------  798 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~------  798 (878)
                      +..+-|..|.|||++.+. .|+++.|+||+|||+.||+++++.|.+.++-++.+..--......+.....+...      
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            345578999999998765 6999999999999999999999999988765554432111111111100000000      


Q ss_pred             --------ccccccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          799 --------RLQEDFDAN-SVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       799 --------~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                              .+...+... ....-.+++..++..||.+|.|++|.++.
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                    011112111 22466789999999999999999998764

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.6e-34  Score=303.24  Aligned_cols=237  Identities=25%  Similarity=0.413  Sum_probs=191.0

Q ss_pred             ccccccccEEEEEEEEcce------------eEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          572 RTLGKGGFGTVYYGRLNEI------------DVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~------------~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.||+|+||.||+|...+.            .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4689999999999998653            3788877655433 6789999999999999999999999988 778999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-------cEEEeecCC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-------QAKLADFGL  712 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-------~~kL~DFGl  712 (878)
                      +||+++|+|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            9999999999999763 23689999999999999999999988   999999999999999888       799999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSN--RLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      +.....      .....++..|+|||++.+.  .++.++|||||||++|||++ |..|+......+...   +..   ..
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~---~~  222 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ---DQ  222 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh---cC
Confidence            876532      1223466789999999876  78999999999999999999 577776654322111   110   11


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ..        ..    ......+.+++.+|+..+|++||++.+|++.|+
T Consensus       223 ~~--------~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 HR--------LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC--------CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00        00    001157889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.7e-34  Score=321.76  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=195.0

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++...  +.+|+|++.+.   .....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY  124 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence            4556789999999999998864  78999998642   222345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..   ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++..+.... .
T Consensus       125 ~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~  197 (370)
T cd05621         125 MPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M  197 (370)
T ss_pred             CCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence            999999999864   3588999999999999999999998   99999999999999999999999999998663222 1


Q ss_pred             cccccccCCCCccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          723 HVSTVVAGTPGYLDPEYYTSN----RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||...+....  .    .........     .
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--~----~~i~~~~~~-----~  266 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--Y----SKIMDHKNS-----L  266 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--H----HHHHhCCcc-----c
Confidence            122345699999999998754    378899999999999999999999987654321  1    111111100     0


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQ--RPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~evl~~  836 (878)
                      .+..  .......+.+++..|+...+.+  ||+++|+++.
T Consensus       267 ~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0111  1122345678888888755544  8999999886

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.1e-34  Score=322.62  Aligned_cols=247  Identities=22%  Similarity=0.346  Sum_probs=191.6

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.||+|+||.||+|+...  +.||+|++....   ......+.+|++++++++|+||+++++.+..++..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            45789999999999998754  789999987542   2345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC---
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN---  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---  721 (878)
                      +|+|.+++.+  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+.....   
T Consensus        85 gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          85 GGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            9999999875  45688999999999999999999998   999999999999999999999999999753311000   


Q ss_pred             ------------------------------------------CcccccccCCCCccCccccccCCCCCccchhhHHHHHH
Q 002809          722 ------------------------------------------THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVIL  759 (878)
Q Consensus       722 ------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~  759 (878)
                                                                ........||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~  239 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  239 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence                                                      00012346899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHH-HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 002809          760 EIITCKPAISRINEEEKI-HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT---MSQVVM  835 (878)
Q Consensus       760 elltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~evl~  835 (878)
                      ||++|++||......+.. .+..|        .      ..+..........++.+++.+|+ .+|++|++   +.++++
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~--------~------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINW--------Q------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHcc--------C------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999876543211 11111        0      00000001111234556666655 48999987   887765


Q ss_pred             H
Q 002809          836 E  836 (878)
Q Consensus       836 ~  836 (878)
                      .
T Consensus       305 h  305 (382)
T cd05625         305 H  305 (382)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.1e-34  Score=315.91  Aligned_cols=242  Identities=26%  Similarity=0.378  Sum_probs=190.8

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHH-HHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVK-LLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++...  +.||+|++....   ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999998764  679999987532   122334455544 56778999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~  153 (325)
T cd05602          81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT  153 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence            999999875  45688889999999999999999998   99999999999999999999999999987542221  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|++.|+|||++.+..++.++|||||||++|||++|++||......+.      ..... .....  +.        
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~-~~~~~--~~--------  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNIL-NKPLQ--LK--------  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHHH-hCCcC--CC--------
Confidence            345699999999999999999999999999999999999999987654321      11111 11110  11        


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      ......+.+++.+|++.+|.+||++.+.+.++
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            11233677899999999999999987554433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.1e-34  Score=308.86  Aligned_cols=258  Identities=25%  Similarity=0.452  Sum_probs=202.7

Q ss_pred             hhcccccccccEEEEEEEEc------ceeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLN------EIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV  639 (878)
                      .+.+.||+|+||.||++++.      +..+|||++...... ..+.|.+|++++++++|+||+++++++..  +...++|
T Consensus         7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05038           7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI   86 (284)
T ss_pred             hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence            45578999999999999864      367999999866543 56789999999999999999999999876  5678999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++++|.+++... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        87 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          87 MEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             EecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            9999999999999753 33599999999999999999999998   9999999999999999999999999999876422


Q ss_pred             CCC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH---------HHHHHHHHHHhc
Q 002809          720 ANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI---------HIRQWVNSLIAK  789 (878)
Q Consensus       720 ~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---------~l~~~v~~~~~~  789 (878)
                      ... .......++..|+|||.+.+..++.++||||||++++||+||+.|+.........         ....+. ..+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  241 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELLKE  241 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HHHHc
Confidence            221 1111233556799999999889999999999999999999999987653321100         011111 11111


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      +.         ....+..+..++.+++.+|++.+|++||+|.||+++|+++
T Consensus       242 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         242 GE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11         1111122335788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.7e-34  Score=315.00  Aligned_cols=236  Identities=24%  Similarity=0.365  Sum_probs=188.6

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHH-HHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVK-LLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++...  +.||+|++....   ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998853  789999987532   223345556654 57888999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|..++..  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (321)
T cd05603          81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT  153 (321)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence            999988865  45688999999999999999999998   99999999999999999999999999987532211  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+....      .... ..+..          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i-~~~~~----------~~~  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------YDNI-LHKPL----------QLP  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------HHHH-hcCCC----------CCC
Confidence            345689999999999988999999999999999999999999987653221      1111 11111          111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMS  831 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~  831 (878)
                      ......+.+++.+||+.+|.+||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            22234678999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-33  Score=308.66  Aligned_cols=246  Identities=22%  Similarity=0.364  Sum_probs=200.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|++|.||+|+..  +..||+|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||++++
T Consensus        23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~  102 (296)
T cd06654          23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (296)
T ss_pred             eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence            44578999999999999864  4889999988766556678999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.++++.   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........  ...
T Consensus       103 ~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~  174 (296)
T cd06654         103 SLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS  174 (296)
T ss_pred             CHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccC
Confidence            99999864   4588999999999999999999998   999999999999999999999999999876532211  122


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...|+..|+|||.+.+..++.++|||||||+++||++|+.||.........  ..+    ...+ ...     +  ..+.
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~----~~~~-~~~-----~--~~~~  240 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLI----ATNG-TPE-----L--QNPE  240 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHH----hcCC-CCC-----C--CCcc
Confidence            345889999999999888999999999999999999999999765542211  111    1111 000     0  0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .....+.+++.+|+..+|++||++.++++.
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            223467789999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.7e-34  Score=316.81  Aligned_cols=241  Identities=26%  Similarity=0.385  Sum_probs=191.3

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHH-HHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVK-LLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+++..  ++.+|+|++...   .....+.+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875  478999998753   2233455666665 46778999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|..++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  153 (325)
T cd05604          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTT  153 (325)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCc
Confidence            999998865  55789999999999999999999998   99999999999999999999999999987532211  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.      ..... .+..  .+.+       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~-~~~~--~~~~-------  217 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNIL-HKPL--VLRP-------  217 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHH-cCCc--cCCC-------
Confidence            345689999999999999999999999999999999999999987554321      11111 1111  0111       


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .....+.+++.+|++.+|.+||++++.++.
T Consensus       218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         218 -GASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             -CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence             122356789999999999999998644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-34  Score=305.75  Aligned_cols=239  Identities=22%  Similarity=0.411  Sum_probs=191.8

Q ss_pred             ccccccccEEEEEEEEcc---------eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          572 RTLGKGGFGTVYYGRLNE---------IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.||+|+||.||+|....         ..+++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997632         34888888766555567889999999999999999999999998999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc--------EEEeecCCcc
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ--------AKLADFGLSK  714 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~--------~kL~DFGla~  714 (878)
                      +++|+|.++++.. +..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999753 33689999999999999999999998   9999999999999988765        6999999886


Q ss_pred             ccccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      .....      ....++..|+|||++.+ ..++.++|||||||++|||++|. +|+...........       .. .. 
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~-~~-  221 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YE-DR-  221 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HH-cc-
Confidence            54321      22457889999999986 45799999999999999999985 66654443321111       00 00 


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                           ..    .+.....++.+++.+||+.+|++||+++++++.|+
T Consensus       222 -----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -----HQ----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----cc----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 01    11112246789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-33  Score=318.37  Aligned_cols=259  Identities=23%  Similarity=0.328  Sum_probs=196.2

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC-----cceeEe
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN-----QTALIY  640 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~lV~  640 (878)
                      ..+.||+|+||.||+++..  ++.||+|++...  .....+.+.+|+++++.++|+||+++++++...+     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            4578999999999999864  488999998653  2334578899999999999999999999997766     789999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+. ++|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        84 e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          84 ELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             eccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            9996 578887754  55799999999999999999999998   99999999999999999999999999997653222


Q ss_pred             CCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH----------------HH
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQ----------------WV  783 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~----------------~v  783 (878)
                      . .......++..|+|||++.+. .++.++|||||||+++||++|+.||.............                ..
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         158 S-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             c-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            1 112234578899999998774 47899999999999999999999998766433221110                00


Q ss_pred             HHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       784 ~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...+..........+.+ .........++.+++.+||+.||++||+++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         237 RAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            01110000000000000 00111223467899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.1e-34  Score=318.82  Aligned_cols=249  Identities=21%  Similarity=0.299  Sum_probs=198.4

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++....   ....+.+.+|+.++..++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            45688999999999999875  4789999987542   234567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++... ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||++..+..... .
T Consensus        84 ~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~  158 (330)
T cd05601          84 PGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-V  158 (330)
T ss_pred             CCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-e
Confidence            999999999763 35689999999999999999999998   999999999999999999999999999986643222 1


Q ss_pred             ccccccCCCCccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          724 VSTVVAGTPGYLDPEYYT------SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........      ............   
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~---  229 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRFLK---  229 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCccC---
Confidence            223356899999999986      45678999999999999999999999987654321      111111111000   


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        +.  ........+.+++..|++ +|++||+++++++.
T Consensus       230 --~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 --FP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             --CC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence              00  011223467788999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.5e-34  Score=308.63  Aligned_cols=260  Identities=28%  Similarity=0.452  Sum_probs=200.7

Q ss_pred             HhhhcccccccccEEEEEEEE------cceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCC--Ccce
Q 002809          567 TNNFERTLGKGGFGTVYYGRL------NEIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTA  637 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~  637 (878)
                      ++...+.||+|+||.||.++.      .+..||+|.+.... ......+.+|++++++++|||++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            344567899999999999874      24779999987553 34456899999999999999999999998765  5688


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+++++|.+++.+. ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.+.
T Consensus        85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence            999999999999998653 34689999999999999999999998   99999999999999999999999999998764


Q ss_pred             cCCCC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHHHHHH
Q 002809          718 TDANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE---------EKIHIRQWVNSLI  787 (878)
Q Consensus       718 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~v~~~~  787 (878)
                      ..... .......++..|+|||.+.+..++.++|||||||+++||+|++.|.......         .......++ ...
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHH
Confidence            32221 1112344677899999998888999999999999999999987664321110         000111111 111


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ..+..         ...+......+.+++.+|++.+|++||+++++++.|+++
T Consensus       240 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111         011122345788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.1e-33  Score=301.61  Aligned_cols=248  Identities=24%  Similarity=0.425  Sum_probs=198.9

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||.||+|+...  ..+++|.+........+.+.+|+++++.++|||++++++++..++..++|+||++++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            345789999999999998864  678999987766666788999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++... ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++.......  ....
T Consensus        88 ~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          88 AVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            999987642 35689999999999999999999998   99999999999999999999999999987543221  1223


Q ss_pred             cccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          727 VVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      ...++..|+|||++.     +..++.++|||||||++|||++|++||........  ...    ... ........    
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----~~~-~~~~~~~~----  230 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK----IAK-SEPPTLAQ----  230 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH----Hhh-cCCCCCCC----
Confidence            345889999999984     34577899999999999999999999976553221  111    111 11111111    


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         +.....++.+++.+||+.+|++||++.++++.
T Consensus       231 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         231 ---PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               11123467899999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-33  Score=304.12  Aligned_cols=245  Identities=27%  Similarity=0.436  Sum_probs=199.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +...+.||+|+||.||+|...  +..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            334567999999999999874  3789999987543 3445688999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..   ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++|+|||++..+....  ..
T Consensus        86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            9999999863   4689999999999999999999988   99999999999999999999999999987654321  11


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....++..|+|||++.+..++.++|||||||+++||++|+.|+.........   .    .+..+.     .+    ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~----~~~~~~-----~~----~~  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---F----LIPKNS-----PP----TL  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---h----hhhcCC-----CC----CC
Confidence            22345788999999999989999999999999999999999998755432211   1    111111     11    11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .......+.+++.+|++.+|++||+|.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            22334568899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-33  Score=303.44  Aligned_cols=246  Identities=26%  Similarity=0.456  Sum_probs=195.1

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCC------CcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDED------NQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~------~~~~lV  639 (878)
                      .+.+.||+|+||.||+|+..+  +.||+|++.... .....+.+|+.++.++ +|+||+++++++...      ...++|
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   87 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV   87 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence            445789999999999998754  789999987543 3346788999999998 699999999998643      457899


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+.+|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence            9999999999999875566799999999999999999999998   9999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      .  .......|+..|+|||++.     ...++.++|||||||++|||++|+.||...........       ........
T Consensus       165 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~  235 (272)
T cd06637         165 V--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------IPRNPAPR  235 (272)
T ss_pred             c--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-------HhcCCCCC
Confidence            1  1223456889999999986     34578899999999999999999999976543221110       11111111


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..        .......+.+++.+||..+|.+||+++++++
T Consensus       236 ~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         236 LK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11        1122346789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-33  Score=302.54  Aligned_cols=245  Identities=26%  Similarity=0.459  Sum_probs=195.3

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      ..||+|+||.||+|+..+  ..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            589999999999998654  679999988777667788999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-CCcEEEeecCCccccccCCCCcccc
Q 002809          650 EYLSDISKKVL--SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       650 ~~l~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +++.... ..+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++|+|||++.......  ....
T Consensus        94 ~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~  167 (268)
T cd06624          94 ALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTE  167 (268)
T ss_pred             HHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--Cccc
Confidence            9997532 234  7888999999999999999988   9999999999999986 6799999999987653221  1122


Q ss_pred             cccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          727 VVAGTPGYLDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ...|+..|+|||++....  ++.++||||||+++|||++|++||........   ..|......       ..+    ..
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~-------~~~----~~  233 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK-------IHP----EI  233 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-------cCC----CC
Confidence            345789999999986543  78899999999999999999999975432211   111110000       001    11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.....++.+++.+||+.+|++||++.|+++.
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            22233467899999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-33  Score=301.47  Aligned_cols=247  Identities=22%  Similarity=0.402  Sum_probs=201.9

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+++..  +..+|+|.+... .....+.+.+|+.++++++|+||+++.+.+..++..++||||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            45688999999999999875  488999998643 344567888999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++.......+++..++.++.|++.||.|||+.   +|+|+||||+||++++++.++++|||++.......  ...
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~  157 (255)
T cd08219          83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYA  157 (255)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc--ccc
Confidence            9999998765566789999999999999999999998   99999999999999999999999999987653221  112


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|+..|+|||++.+..++.++|+||||+++++|++|+.||........      .. .+..+....         .+
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~~---------~~  221 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------IL-KVCQGSYKP---------LP  221 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HH-HHhcCCCCC---------CC
Confidence            234588899999999988899999999999999999999999986543221      11 111222111         11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ......+.+++.+||+.+|++||++.+++..
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1223467799999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6e-34  Score=322.51  Aligned_cols=249  Identities=21%  Similarity=0.322  Sum_probs=194.1

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++...  +.||||++....   ......+.+|++++.+++|+||+++++.+.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence            456789999999999998754  789999986532   223466889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC--
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN--  721 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--  721 (878)
                      ++|+|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+.....  
T Consensus        84 ~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          84 PGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            99999999976  45688999999999999999999998   999999999999999999999999999753310000  


Q ss_pred             ---------------------------------------CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHH
Q 002809          722 ---------------------------------------THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII  762 (878)
Q Consensus       722 ---------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ell  762 (878)
                                                             ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                   00011346999999999999999999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 002809          763 TCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRP---TMSQVVME  836 (878)
Q Consensus       763 tG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---sm~evl~~  836 (878)
                      +|+.||......+...      . +..... ....+     ........+.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       239 ~G~~Pf~~~~~~~~~~------~-i~~~~~-~~~~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPAETQL------K-VINWET-TLHIP-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHHHHHH------H-HhccCc-cccCC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999998766433211      0 111000 00000     00112234566777765 4899999   88999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=319.30  Aligned_cols=244  Identities=25%  Similarity=0.446  Sum_probs=205.1

Q ss_pred             cccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChhh
Q 002809          573 TLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQE  650 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  650 (878)
                      +||+|.+|+||.|+..+  ..+|||-+.....+..+...+||.+-++++|+|||+++|.|.+++..-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999998765  6689999998888888889999999999999999999999999999999999999999999


Q ss_pred             hhccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc-CCCcEEEeecCCccccccCCCCcccccc
Q 002809          651 YLSDISKK-VLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       651 ~l~~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      +|+..-+. .-++.+.-.+.+||++||.|||++   .|||||||-+|||++ -.|.+||+|||-++.+..  -......+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            99764321 236788888999999999999999   999999999999996 478999999999987642  23445567


Q ss_pred             cCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          729 AGTPGYLDPEYYTSN--RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      .||..|||||++..+  .|..++|||||||.+.||.||++||.........        +.+-|-.      +...+.+.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGmy------KvHP~iPe  802 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGMY------KVHPPIPE  802 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcce------ecCCCCcH
Confidence            799999999999765  5899999999999999999999999876543211        1111111      11234566


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +...+...++++|+.++|.+||+++++++
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            67778899999999999999999999986

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.2e-33  Score=302.02  Aligned_cols=246  Identities=27%  Similarity=0.424  Sum_probs=194.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+..  +..||+|++... .....+.+.+|++++.+++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            34578999999999999864  478999998654 334456799999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|..+.      .+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++......    ..
T Consensus        84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~  150 (279)
T cd06619          84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IA  150 (279)
T ss_pred             CChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cc
Confidence            9997652      368889999999999999999998   9999999999999999999999999998765322    12


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....|+..|+|||++.+..++.++||||||+++|||++|+.||......... ...++.... ....     .+.+.   
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~---  221 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-VDED-----PPVLP---  221 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-hccC-----CCCCC---
Confidence            2356889999999999989999999999999999999999999754321110 011111111 1111     11111   


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ......++.+++.+|++.+|++||+++|+++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11122367899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-33  Score=309.12  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=199.7

Q ss_pred             cccccccccEEEEEEEEc--ce----eEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          571 ERTLGKGGFGTVYYGRLN--EI----DVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~----~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.||+|+||.||+|+..  +.    .||+|.+..... ....++.+|+.++++++||||++++++|... ...+++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~   90 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM   90 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence            468999999999999863  22    578998875432 3345789999999999999999999998754 467999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.......
T Consensus        91 ~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  166 (303)
T cd05110          91 PHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY  166 (303)
T ss_pred             CCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence            999999998753 34589999999999999999999998   99999999999999999999999999998764332222


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+   +.+++    ..+...         
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~---------  230 (303)
T cd05110         167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGERL---------  230 (303)
T ss_pred             ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCCC---------
Confidence            2223345678999999998899999999999999999998 889987654332   22222    111110         


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      ..+..+...+.+++..|+..+|++||+++++++.|+++...+
T Consensus       231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            011122346789999999999999999999999999865443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-33  Score=312.16  Aligned_cols=239  Identities=23%  Similarity=0.386  Sum_probs=192.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +++.+.||+|+||.||+++..  ++.||+|++...   .....+.+..|..++..+. |++|+++.+++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            356789999999999999875  478999998753   2234466788999998886 5778889999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++..  ...+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 y~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          82 YVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999875  45699999999999999999999998   99999999999999999999999999987542221 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       .......|+..|+|||++.+..++.++|||||||++|||++|+.||........   .   .... ....      .  
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~---~~i~-~~~~------~--  219 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---F---QSIM-EHNV------S--  219 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HHHH-hCCC------C--
Confidence             122345689999999999998999999999999999999999999987654321   1   1111 1111      1  


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                        .+.....++.+++.+|++.+|.+|++.
T Consensus       220 --~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 --YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              111223467789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.3e-33  Score=304.06  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ..+.||+|+||+||+++..  ++.+|+|.+....   ......+.+|++++++++|+|++++.+.+..++..++||||++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            3478999999999999885  4789999987543   2233567889999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.......   .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~  157 (285)
T cd05632          84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---S  157 (285)
T ss_pred             CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---c
Confidence            99999998765555799999999999999999999988   99999999999999999999999999987653221   1


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....|+..|+|||++.+..++.++|+|||||+++||++|+.||..........  . +...+....  ..        +
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~-~~~~~~~~~--~~--------~  224 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--E-VDRRVLETE--EV--------Y  224 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHhhhccc--cc--------c
Confidence            123468999999999998899999999999999999999999998655432211  1 111111111  01        1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPT-----MSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~~  836 (878)
                      .......+.+++..|++.+|++||+     ++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            1112235678999999999999999     5555553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-33  Score=305.20  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=192.9

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCCh--hhHHHHHHHHHHHHHh---cccceeeeeecccC-----CCcc
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA--QGFQQFQAEVKLLMRV---HHRNLTSLVGHCDE-----DNQT  636 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~-----~~~~  636 (878)
                      .+.+.||+|+||.||+++...  +.||+|.+.....  .....+.+|+++++++   +||||+++++++..     ....
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            456789999999999998754  7899999875322  2234566777777666   69999999998754     3457


Q ss_pred             eeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      ++|+||+. ++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          83 TLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             EEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            89999997 5899988765556699999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHHHHhcCCc---
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNSLIAKGDI---  792 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~~~~~~~~~---  792 (878)
                      ....   ......|+..|+|||++.+..++.++||||+||+++||++|++||......+... +..+..........   
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         159 SCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            3221   1223457899999999998899999999999999999999999997655432211 11111000000000   


Q ss_pred             ---ccccCCccc---cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          793 ---KSIVDPRLQ---EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       793 ---~~iid~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                         ...+.+...   .........++.+++.+||+.||++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               000010000   0011123346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-33  Score=305.61  Aligned_cols=247  Identities=25%  Similarity=0.342  Sum_probs=197.4

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ..+.||+|+||.||++....  +.||+|.+....   ......+.+|+.++.+++|+|++++.+.+..++..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            45789999999999998754  789999987542   2233567889999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......   .
T Consensus        84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~  157 (285)
T cd05630          84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T  157 (285)
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---c
Confidence            99999998765556799999999999999999999988   99999999999999999999999999987543221   1


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ......    ..  ..    ...   
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~----~~--~~----~~~---  224 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KE--VQ----EEY---  224 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh----hh--hh----hhc---
Confidence            12346899999999999989999999999999999999999999864322111 111110    00  00    001   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPT-----MSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~~  836 (878)
                       .......+.+++.+||+.+|++||+     ++|+++.
T Consensus       225 -~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         225 -SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence             1112235779999999999999999     7888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-33  Score=298.85  Aligned_cols=248  Identities=32%  Similarity=0.563  Sum_probs=201.7

Q ss_pred             hcccccccccEEEEEEEEcc------eeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          570 FERTLGKGGFGTVYYGRLNE------IDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.||+|+||.||+++..+      ..||+|++...... ..+.+.+|++.+.+++|+||+++++++...+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45789999999999998865      67999999765443 567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            9999999999764443489999999999999999999998   9999999999999999999999999999766433211


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      . .....++..|+|||.+.+..++.++||||+|++++||++ |++||.......   +.+.+    ..+...        
T Consensus       160 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~--------  223 (258)
T smart00219      160 K-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL----KKGYRL--------  223 (258)
T ss_pred             c-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCCCC--------
Confidence            1 112236789999999988889999999999999999998 788887644322   11111    111111        


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                       ........++.+++.+|+..+|++||++.|+++.|
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             11111344688899999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-33  Score=321.17  Aligned_cols=261  Identities=21%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             HHHHhhhcccccccccEEEEEEEEcc----eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          564 VKITNNFERTLGKGGFGTVYYGRLNE----IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       564 ~~~t~~f~~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      ....+.+.+.||+|+||.||++...+    ..||+|.+...     +.+.+|++++++++||||+++++++......++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            33456677899999999999987533    67999987653     3456899999999999999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      ||++. ++|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||+++.....
T Consensus       165 ~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            99995 688888843  56799999999999999999999998   9999999999999999999999999999766443


Q ss_pred             CCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHHHHhcCCcc--c--
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE-KIHIRQWVNSLIAKGDIK--S--  794 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~v~~~~~~~~~~--~--  794 (878)
                      ..........||..|+|||++.+..++.++|||||||++|||++|+.||....... ...+...+. ........  .  
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCcc
Confidence            33333334569999999999999999999999999999999999999997654321 111111111 11100000  0  


Q ss_pred             ---------ccCCccccccC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 ---------IVDPRLQEDFD-------ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 ---------iid~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                               .........+.       .....++.+++.+||..+|++||++.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     00000000000       0112356789999999999999999999875

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-33  Score=326.08  Aligned_cols=255  Identities=20%  Similarity=0.316  Sum_probs=189.9

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCC--------Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--------NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--------~~~~  637 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++....    ....+|+.+|++++||||+++++++...        ...+
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            445689999999999999875  3789999886432    2345799999999999999998876321        2366


Q ss_pred             eEeeeccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCcc
Q 002809          638 LIYEFMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSK  714 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~  714 (878)
                      +||||+++ +|.+++...  ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            89999974 777776532  256799999999999999999999998   999999999999999765 79999999998


Q ss_pred             ccccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc----
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK----  789 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~----  789 (878)
                      .+.....   .....|++.|+|||++.+ ..++.++|||||||++|||++|++||......+...  ..+. ....    
T Consensus       220 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~i~~-~~~~p~~~  293 (440)
T PTZ00036        220 NLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--RIIQ-VLGTPTED  293 (440)
T ss_pred             hccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHH-HhCCCCHH
Confidence            6643221   223468999999999865 468999999999999999999999998765433211  1111 0000    


Q ss_pred             ------CC-----cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          790 ------GD-----IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       790 ------~~-----~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                            ..     ...+....+...++.....++.+++.+||+.+|.+||++.|+++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                  00     001111111111222234578899999999999999999999864

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.4e-33  Score=310.14  Aligned_cols=257  Identities=19%  Similarity=0.293  Sum_probs=195.6

Q ss_pred             hccccccc--ccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          570 FERTLGKG--GFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       570 f~~~LG~G--~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      +.++||+|  +|++||+++..  ++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45689999  78999999875  4889999987542  233456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-  722 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-  722 (878)
                      ++|+|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.++++||+........... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999765556689999999999999999999998   9999999999999999999999999865433211110 


Q ss_pred             ----cccccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          723 ----HVSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       723 ----~~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                          .......++..|+|||++.+  ..++.++|||||||+++||++|+.||........  ......     +.....+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~-----~~~~~~~  231 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLN-----GTVPCLL  231 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhc-----CCccccc
Confidence                01122346778999999976  4689999999999999999999999976543221  111000     1111000


Q ss_pred             C-------------------Ccc-----------------ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          797 D-------------------PRL-----------------QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       797 d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +                   ...                 ...........+.+++.+||+.||++|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0                   000                 000111233478899999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-33  Score=310.61  Aligned_cols=260  Identities=22%  Similarity=0.351  Sum_probs=195.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+..  +..||+|.+..... .....+.+|++++++++||||+++++++..++..++||||+++
T Consensus         9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   88 (309)
T cd07872           9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK   88 (309)
T ss_pred             EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence            44578999999999999875  37799999875432 2345678899999999999999999999999999999999975


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                       +|.+++... +..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        89 -~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~  161 (309)
T cd07872          89 -DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TY  161 (309)
T ss_pred             -CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc--cc
Confidence             888887642 34588999999999999999999998   999999999999999999999999999875432221  12


Q ss_pred             ccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc------cccCC
Q 002809          726 TVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK------SIVDP  798 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~------~iid~  798 (878)
                      ....++..|+|||.+.+ ..++.++|||||||+++||+||++||......+..................      +..+.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            23457889999998865 468899999999999999999999998766543322211110000000000      00000


Q ss_pred             cccc-------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          799 RLQE-------DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       799 ~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ....       ........++.+++.+||+.+|.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000       000112346779999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-33  Score=299.18  Aligned_cols=248  Identities=28%  Similarity=0.528  Sum_probs=199.3

Q ss_pred             hhcccccccccEEEEEEEEc-ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||++... +..+|+|.+..... ....|.+|++++++++|||++++++++......++|+||+++++
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC   85 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence            45688999999999999876 47899998875433 23578999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++... ...++++.++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++....... .....
T Consensus        86 L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~  160 (256)
T cd05112          86 LSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTG  160 (256)
T ss_pred             HHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCC
Confidence            99998753 34588999999999999999999988   999999999999999999999999999876532211 11112


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++.+|+|||++.+..++.++||||||+++|||++ |+.||........      ... +.++.  ....+..      
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~-~~~~~--~~~~~~~------  225 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV------VET-INAGF--RLYKPRL------  225 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH------HHH-HhCCC--CCCCCCC------
Confidence            234578999999998899999999999999999998 9999976543321      111 11111  1111111      


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                       ....+.+++.+||+.+|++||++.+++++|.
T Consensus       226 -~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 -ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             2346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.7e-33  Score=306.37  Aligned_cols=258  Identities=22%  Similarity=0.354  Sum_probs=199.1

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+++...  ..+|+|.+... ......++.+|++++.+++||||+++++.+..++..++|+||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            456789999999999998754  77899988754 334456789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.++++.  ...+++..+..++.|+++||.|||+.+  +++||||||+|||++.++.+||+|||++......    ..
T Consensus        84 ~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~  155 (308)
T cd06615          84 GSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA  155 (308)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc----cc
Confidence            999999976  456899999999999999999999732  8999999999999999999999999998755321    12


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc------------
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK------------  793 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~------------  793 (878)
                      ....|+..|+|||.+.+..++.++|||||||+++||++|+.||.......   ...+...........            
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCC
Confidence            23468899999999988889999999999999999999999987544322   111111100000000            


Q ss_pred             --------cccCCcc---ccccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          794 --------SIVDPRL---QEDFD-ANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       794 --------~iid~~l---~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                              +..+...   ....+ .....++.+++.+|+..+|++||+++||++.-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                    0000000   00000 01234688999999999999999999998873

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-33  Score=302.77  Aligned_cols=253  Identities=27%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||+||++...  ++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||++
T Consensus         7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (284)
T cd06620           7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD   86 (284)
T ss_pred             HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence            345678999999999999876  4789999876543 3446789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..  ...+++..+..++.+++.||.|||+.  .+++||||||+||++++++.++|+|||++.......    
T Consensus        87 ~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----  158 (284)
T cd06620          87 CGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----  158 (284)
T ss_pred             CCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----
Confidence            9999999875  45689999999999999999999973  279999999999999999999999999986542211    


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHHHHhcCCcccccCCc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE-----EKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .....|+..|+|||++.+..++.++|||||||+++||++|+.||......     ....+.++.........      +.
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  232 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PR  232 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------CC
Confidence            12346889999999998888999999999999999999999999865442     11122233333222111      11


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      +.   ......++.+++.+|++.+|++||++.|++++.
T Consensus       233 ~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         233 LP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            11   111334688999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.4e-33  Score=301.33  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=198.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+++..  ++.||+|.++.........+.+|+.+++.++||||+++++.+..++..++|+||+++
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG   90 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence            355678999999999999874  488999998876555566788999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++..  ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......  ...
T Consensus        91 ~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~  163 (267)
T cd06645          91 GSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKR  163 (267)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--ccc
Confidence            999999875  45689999999999999999999998   99999999999999999999999999987653221  112


Q ss_pred             ccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          726 TVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ....|+..|+|||++.   ...++.++|||||||++|||++|+.||...........      . ......   .+....
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~------~-~~~~~~---~~~~~~  233 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------M-TKSNFQ---PPKLKD  233 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh------h-hccCCC---CCcccc
Confidence            3346889999999974   45688999999999999999999999865443221110      0 011100   011110


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .  ......+.+++.+|++.+|++||++++|++
T Consensus       234 ~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 K--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0  011235778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.3e-33  Score=337.08  Aligned_cols=258  Identities=21%  Similarity=0.314  Sum_probs=201.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+|+..  ++.||+|++....   ....++|.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~   84 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence            45678999999999999875  4889999987532   234567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          644 ANGNLQEYLSDIS---------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       644 ~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ++|+|.+++....         ...+++..++.++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence            9999999986421         23466788899999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCC----------------CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 002809          715 SFATDAN----------------THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH  778 (878)
Q Consensus       715 ~~~~~~~----------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  778 (878)
                      .......                ........||+.|+|||++.+..++.++|||||||+++||+||+.||..........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            6521110                001112469999999999999999999999999999999999999997643321100


Q ss_pred             HHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHH
Q 002809          779 IRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRP-TMSQVVMELSECLAA  843 (878)
Q Consensus       779 l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~evl~~L~~~~~~  843 (878)
                           .     ..+   .++.-.. ...+....+.+++.+|++.+|++|| +++++.+.|+..++.
T Consensus       242 -----~-----~~i---~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        242 -----R-----DVI---LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             -----h-----hhc---cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                 0     000   0110000 0012234677899999999999995 677888888887653

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-35  Score=290.06  Aligned_cols=247  Identities=25%  Similarity=0.404  Sum_probs=199.4

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|.|+.||+....  ++++|+|++...  +....+++.+|+.+.+.++|||||++.....+....++|+|+|+
T Consensus        14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~   93 (355)
T KOG0033|consen   14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   93 (355)
T ss_pred             hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence            44578999999999988654  477888887532  34467889999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~~  721 (878)
                      |++|..-+-.  +..+++..+-..++||+++|.|+|.+   +|||||+||+|+|+-.   .--+||+|||++..+..   
T Consensus        94 G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~---  165 (355)
T KOG0033|consen   94 GGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND---  165 (355)
T ss_pred             chHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC---
Confidence            9999876644  46678888999999999999999999   9999999999999953   33689999999998862   


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      ........||++|||||++...+|+..+|||+.||+|+-|+.|.+||.+.+...   +    -+.+..+...  +++.  
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l----ye~I~~g~yd--~~~~--  234 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L----YEQIKAGAYD--YPSP--  234 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H----HHHHhccccC--CCCc--
Confidence            233445779999999999999999999999999999999999999998755432   1    1122223211  1111  


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .......+..+|+++||..||.+|.|+.|.++.
T Consensus       235 --~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  235 --EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             --ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence              112334467799999999999999999887753

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=311.30  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=210.7

Q ss_pred             HHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCChh---hHHHHHHHHHHHHHhc-ccceeeeeecccCCCccee
Q 002809          565 KITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQ---GFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       565 ~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~---~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~l  638 (878)
                      ...+.+.+.||+|.||.||+++...  +.+|+|++.+....   ....+.+|+++|+++. |||||.+.+.++.....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            3445667899999999999998764  78999999876543   3468999999999998 9999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC----CcEEEeecCCcc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSK  714 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~----~~~kL~DFGla~  714 (878)
                      |||++.||.|.+.+...   .+++..+..++.|++.+++|||+.   +|+||||||+|+|+...    +.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999764   399999999999999999999998   99999999999999643    479999999999


Q ss_pred             ccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ....   .......+||+.|+|||++....|+.++||||+||++|.|++|.+||..........       .+..+..  
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~--  255 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF--  255 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC--
Confidence            8754   234456789999999999999999999999999999999999999999877544222       2333332  


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          .+...........+.+++..|+..||.+|+++.++++.
T Consensus       256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                22222223345578899999999999999999999994

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.5e-33  Score=297.97  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=200.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC-CCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-DNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~Ey  642 (878)
                      +.+.+.||+|++|.||+++..  ++.||+|.+...  .....+.+.+|++++++++|+|++++.+.+.. +...++||||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            346789999999999999875  378999998653  23445678999999999999999999988764 4457899999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.+++.......+++.+++.++.|++.|+++||+.   +++||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--  156 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--  156 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC--
Confidence            9999999999875566799999999999999999999998   99999999999999999999999999987663222  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......+++.|+|||++.+..++.++||||||++++||++|+.||........      .... ..+....        
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~-~~~~~~~--------  221 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRI-IEGKLPP--------  221 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHH-HhcCCCC--------
Confidence            122345688999999999999999999999999999999999999976543221      1111 1122111        


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .+......+.+++.+|++.+|++||++.+++++
T Consensus       222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             112233468899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-34  Score=288.13  Aligned_cols=245  Identities=26%  Similarity=0.426  Sum_probs=201.3

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEeccCCh-----h---hHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeE
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-----Q---GFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-----~---~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      .+.||.|..++|-++..+  +.+.|+|++.....     .   -.+.-.+|+.+|+++ .||+|+++.++++.+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            468999999999888665  48899999864311     1   123456799999998 599999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      +|.|+.|.|.|+|.+  .-.++++...+|++|+.+|++|||..   .||||||||+|||++++.++||+|||.++.+.++
T Consensus       102 Fdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCc
Confidence            999999999999986  66799999999999999999999998   9999999999999999999999999999988655


Q ss_pred             CCCcccccccCCCCccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTS------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      .   .-...|||++|+|||.+..      ..|+..+|.|++||++|.|+.|.+||.....   .    .+..++.+|.. 
T Consensus       177 e---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---m----lMLR~ImeGky-  245 (411)
T KOG0599|consen  177 E---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---M----LMLRMIMEGKY-  245 (411)
T ss_pred             h---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---H----HHHHHHHhccc-
Confidence            3   3345799999999999864      3578899999999999999999999964321   1    12344445542 


Q ss_pred             cccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       794 ~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ++-.|.     ..+....+.+|+.+||+.||++|.|++|+++.
T Consensus       246 qF~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  246 QFRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ccCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            111222     23445578899999999999999999999984

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-33  Score=301.21  Aligned_cols=252  Identities=29%  Similarity=0.448  Sum_probs=197.8

Q ss_pred             hcccccccccEEEEEEEEc-----ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC------cc
Q 002809          570 FERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN------QT  636 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~  636 (878)
                      +.+.||+|+||.||+|...     +..||||++...  .....+++.+|++++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4578999999999999763     377999998754  3345677899999999999999999999875432      23


Q ss_pred             eeEeeeccCCChhhhhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          637 ALIYEFMANGNLQEYLSDIS----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      ++++||+.+|+|.+++....    ...+++...++++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence            68899999999998875321    23578999999999999999999988   999999999999999999999999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      ++...............++..|++||.+....++.++|||||||++|||++ |++||......+   +..+..   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---~~~~  233 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---KGNR  233 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---cCCc
Confidence            886643322222223345678999999998889999999999999999999 889987655432   222111   1111


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ..          .+......+.+++.+|++.+|++||++.++++.|+++
T Consensus       234 ~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 LK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10          0112334788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-33  Score=298.51  Aligned_cols=246  Identities=25%  Similarity=0.441  Sum_probs=197.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChh---------hHHHHHHHHHHHHHhcccceeeeeecccCCCcce
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ---------GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~---------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~  637 (878)
                      .+.+.||+|++|.||+|...  ++.+|+|.+......         ..+.+.+|++++++++||||+++++++...+..+
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN   82 (267)
T ss_pred             cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence            35678999999999999874  378999988653221         2356889999999999999999999999999999


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +|+||+++++|.+++..  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++...
T Consensus        83 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          83 IFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            99999999999999975  45688999999999999999999988   99999999999999999999999999988764


Q ss_pred             cCCC----CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          718 TDAN----THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       718 ~~~~----~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      ....    ........|+..|+|||.+.+..++.++|||||||+++||++|+.||.........  .    . ....   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~----~-~~~~---  227 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI--F----K-IGEN---  227 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH--H----H-Hhcc---
Confidence            2211    11112345788999999999888999999999999999999999999865432211  0    0 0111   


Q ss_pred             cccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       794 ~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ..+.+    +......+.+++.+||+.+|++||++.|+++
T Consensus       228 --~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 --ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              11111    1223356789999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-33  Score=322.75  Aligned_cols=257  Identities=22%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||.||+++...  +.||||...      ...+.+|+++|++++|+|||++++++..++..++|||++. +
T Consensus       172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~  244 (461)
T PHA03211        172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S  244 (461)
T ss_pred             EEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence            456789999999999999865  779999633      2346789999999999999999999999999999999994 7


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++... ...+++.+++.++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++............
T Consensus       245 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        245 DLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            898888642 34699999999999999999999998   99999999999999999999999999998664332222233


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHHHHhc-CCcccccCCcc
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE-----EKIHIRQWVNSLIAK-GDIKSIVDPRL  800 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~v~~~~~~-~~~~~iid~~l  800 (878)
                      ...||..|+|||++.+..++.++|||||||++|||++|..++......     ....+.+.+...... .........++
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            456999999999999999999999999999999999988655332211     011111111110000 00000000000


Q ss_pred             ------------ccccC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 ------------QEDFD-------ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ------------~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                                  .....       ......+.+++.+||+.||.+|||+.|+++.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                        00000       0112357789999999999999999999874

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.6e-33  Score=294.62  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||.++..  +..+++|.+...  +....+++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            45678999999998887764  478999987654  34556789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.+++.......+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++........  .
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~  157 (256)
T cd08221          83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M  157 (256)
T ss_pred             CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence            99999999865456789999999999999999999988   999999999999999999999999999876633221  2


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....++..|+|||.+.+...+.++||||||++++||++|+.||......+.      +.... .+.....         
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~~~---------  221 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QGNYTPV---------  221 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCCCCCC---------
Confidence            2334588999999999988899999999999999999999999976543321      11111 1211111         


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      ......++.+++.+|++.+|++||+++++++.+
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            122234678999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.8e-33  Score=293.68  Aligned_cols=259  Identities=25%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccc-eeeeeecccCCC------cceeEe
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRN-LTSLVGHCDEDN------QTALIY  640 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~n-Iv~l~g~~~~~~------~~~lV~  640 (878)
                      +.||+|+||+||+|+..  +.-||+|++.-...  ..-....+|+.+|++++|+| ||.+++++...+      .+++|+
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf   96 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF   96 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence            45999999999999864  47899999876543  23456789999999999999 999999998776      788999


Q ss_pred             eeccCCChhhhhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          641 EFMANGNLQEYLSDISK--KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||++ -+|..++.....  +.++...+..++.||++||+|||++   +|+||||||+|||++++|.+||+|||+|+.+.-
T Consensus        97 e~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i  172 (323)
T KOG0594|consen   97 EFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSI  172 (323)
T ss_pred             Eeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence            9995 499999987553  4678889999999999999999999   999999999999999999999999999997643


Q ss_pred             CCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc-
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV-  796 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii-  796 (878)
                      ....  .+...+|..|+|||++.+. .|+...||||+||++.||+++++.|.+.++.+.....--+.....+.....+. 
T Consensus       173 p~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~  250 (323)
T KOG0594|consen  173 PMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS  250 (323)
T ss_pred             Cccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence            3222  2334578889999999876 79999999999999999999999998877644332111111111111111111 


Q ss_pred             --CC--cccccc---C-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          797 --DP--RLQEDF---D-----ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       797 --d~--~l~~~~---~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        +-  .+....   +     ........+++.+|++.+|.+|.|++.++.+
T Consensus       251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              11  111110   0     0111367899999999999999999999886

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.4e-33  Score=296.14  Aligned_cols=245  Identities=28%  Similarity=0.467  Sum_probs=200.1

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|++|.||+|+...  ..+++|.+.....  .+++.+|++++++++|+||+++++++..+...++++||++++
T Consensus         6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   83 (256)
T cd06612           6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG   83 (256)
T ss_pred             hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence            455789999999999998864  7899999875533  678999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++.. ....+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.+||+|||++........  ...
T Consensus        84 ~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~  157 (256)
T cd06612          84 SVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRN  157 (256)
T ss_pred             cHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccc
Confidence            99999864 245789999999999999999999998   999999999999999999999999999886643221  223


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...++..|+|||++.+..++.++||||||++++||++|++||...........       .....     .+.+.  .+.
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~-----~~~~~--~~~  223 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNKP-----PPTLS--DPE  223 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccCC-----CCCCC--chh
Confidence            34578899999999998999999999999999999999999986544321110       00000     01111  111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .....+.+++.+|++.+|++||+++||++
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            22346789999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=297.86  Aligned_cols=245  Identities=27%  Similarity=0.439  Sum_probs=200.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||.|++|.||+|+..  +..||+|++.... ......+.+|++++++++|+|++++++++..+...++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence            45578999999999999875  3889999987543 34456789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++..   ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||+++.+....  ...
T Consensus        84 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~  155 (274)
T cd06609          84 GSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR  155 (274)
T ss_pred             CcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence            999999875   2789999999999999999999998   99999999999999999999999999998764332  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....++..|+|||++.+..++.++||||||+++|||+||+.||........      . ..+..+....+     ...  
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~-~~~~~~~~~~~-----~~~--  221 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------L-FLIPKNNPPSL-----EGN--  221 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------H-HHhhhcCCCCC-----ccc--
Confidence            234578899999999988899999999999999999999999976543221      1 11111111111     111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .....+.+++.+||..+|++||+++++++.
T Consensus       222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             023367789999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.5e-33  Score=299.59  Aligned_cols=250  Identities=25%  Similarity=0.415  Sum_probs=198.8

Q ss_pred             hhcccccccccEEEEEEEEcc---eeEEEEEeccC----------ChhhHHHHHHHHHHHHH-hcccceeeeeecccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE---IDVAVKMLSSS----------SAQGFQQFQAEVKLLMR-VHHRNLTSLVGHCDEDN  634 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~---~~vAvK~l~~~----------~~~~~~~f~~Ei~~L~~-l~H~nIv~l~g~~~~~~  634 (878)
                      .+.+.||+|+||.||++....   ..+|+|.+...          ......++.+|+.++.+ ++||||+++++++..++
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            345789999999999998754   77999987532          22234567889988875 68999999999999999


Q ss_pred             cceeEeeeccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          635 QTALIYEFMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      ..++||||+++++|.+++...  ....+++..+++++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence            999999999999999988542  245689999999999999999999963  1799999999999999999999999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      +.......   ......|+..|+|||.+.+..++.++||||||+++|||++|++||........      ... +.++..
T Consensus       161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~-~~~~~~  230 (269)
T cd08528         161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATK-IVEAVY  230 (269)
T ss_pred             eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHH-HhhccC
Confidence            87653322   22345688999999999988899999999999999999999999976543221      111 111111


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ....        .......+.+++.+|++.+|++||++.||..+++
T Consensus       231 ~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 EPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1110        1112346789999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-32  Score=297.57  Aligned_cols=244  Identities=25%  Similarity=0.432  Sum_probs=201.4

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ...+.||+|+||.||+|...  +..||+|++.... ....+.+.+|++++++++|+||+++++++..+...++||||+++
T Consensus         7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06640           7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG   86 (277)
T ss_pred             hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence            34467999999999999874  4889999987543 44567899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..   ..+++.+...++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        87 ~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~  158 (277)
T cd06640          87 GSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR  158 (277)
T ss_pred             CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence            999999864   4588999999999999999999988   99999999999999999999999999987653322  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....++..|+|||++.+...+.++|||||||+++||++|+.|+..........       ....+.         .....
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~---------~~~~~  222 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPKNN---------PPTLT  222 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhcCC---------CCCCc
Confidence            23457889999999998889999999999999999999999998655432111       011111         11223


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ......+.+++.+||+.+|++||+++++++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            3455678899999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.5e-33  Score=306.78  Aligned_cols=196  Identities=24%  Similarity=0.376  Sum_probs=159.6

Q ss_pred             cccccccccEEEEEEEEc----ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeEeeecc
Q 002809          571 ERTLGKGGFGTVYYGRLN----EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALIYEFMA  644 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~  644 (878)
                      .+.||+|+||.||+|+..    ++.||+|.+.....  ...+.+|++++++++||||+++++.+..  +...++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            358999999999999864    26799999875432  3457889999999999999999998843  456789999985


Q ss_pred             CCChhhhhcccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE----cCCCcEEEeecCCc
Q 002809          645 NGNLQEYLSDIS-------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLS  713 (878)
Q Consensus       645 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl----~~~~~~kL~DFGla  713 (878)
                       ++|.+++....       ...+++..+..++.|++.||+|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888775321       23589999999999999999999998   99999999999999    45678999999999


Q ss_pred             cccccCCCC-cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002809          714 KSFATDANT-HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRIN  772 (878)
Q Consensus       714 ~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~  772 (878)
                      +.+...... .......||+.|+|||++.+ ..++.++||||+||+++||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876432211 11233568999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.7e-33  Score=300.44  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=199.6

Q ss_pred             hcccccccccEEEEEEEEc-------ceeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          570 FERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ..+.||+|+||.||+|+..       ...+++|.+...... ..+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            3468999999999999863       256999988765444 56789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          642 FMANGNLQEYLSDISK-------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      |+++|+|.++++....       ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||+++
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence            9999999999976431       2689999999999999999999988   99999999999999999999999999986


Q ss_pred             ccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      ....... .......++..|+|||.+.+...+.++||||||++++||++ |..||.......   +..   . ...+...
T Consensus       166 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~---~-~~~~~~~  237 (275)
T cd05046         166 DVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN---R-LQAGKLE  237 (275)
T ss_pred             ccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH---H-HHcCCcC
Confidence            5422211 11122345678999999988888999999999999999999 788886554322   111   1 1111111


Q ss_pred             cccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       794 ~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ..        ........+.+++.+|++.+|++||++.|+++.|+
T Consensus       238 ~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         238 LP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            10        11122347889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.4e-33  Score=315.76  Aligned_cols=249  Identities=22%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++...  +.||+|++...   .......+.+|+.++.+++|+||+++++.+..++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~   83 (360)
T cd05627           4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL   83 (360)
T ss_pred             eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            345789999999999998754  78999998753   2234567888999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-  722 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-  722 (878)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        84 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          84 PGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            99999999975  45689999999999999999999998   9999999999999999999999999998754221100 


Q ss_pred             --------------------------------cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002809          723 --------------------------------HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISR  770 (878)
Q Consensus       723 --------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~  770 (878)
                                                      .......||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                            001234699999999999999999999999999999999999999987


Q ss_pred             CChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002809          771 INEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT---MSQVVME  836 (878)
Q Consensus       771 ~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~evl~~  836 (878)
                      ........      . +........+.+.    .  ....++.+++.+|+ .+|.+|++   ++|+++.
T Consensus       239 ~~~~~~~~------~-i~~~~~~~~~p~~----~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ETPQETYR------K-VMNWKETLVFPPE----V--PISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCHHHHHH------H-HHcCCCceecCCC----C--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            65533211      1 1111000001111    0  11235667777765 49999985   5666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=297.95  Aligned_cols=249  Identities=24%  Similarity=0.423  Sum_probs=200.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|++|.||+++..  +..+|+|.+........+.|.+|++++++++|+||+++++.+..+...++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            345678999999999999875  488999999877666778899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++... ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.......  ...
T Consensus        87 ~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~  160 (280)
T cd06611          87 GALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKR  160 (280)
T ss_pred             CcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc--ccc
Confidence            9999998653 34689999999999999999999998   99999999999999999999999999886543221  112


Q ss_pred             ccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          726 TVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ....++..|+|||.+.     ...++.++||||||+++|||++|++||........  +..    . ..+....+..   
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~----~-~~~~~~~~~~---  230 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLK----I-LKSEPPTLDQ---  230 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHH----H-hcCCCCCcCC---
Confidence            2345889999999975     34567899999999999999999999987654321  111    1 1111111100   


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          +......+.+++.+||+.+|++||++.++++.
T Consensus       231 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         231 ----PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                11123367789999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-33  Score=307.73  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=193.4

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++...  +.||+|++.+.   .....+.+.+|+.++..++|+||+++++++..++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (331)
T cd05597           4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY   83 (331)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence            456889999999999998754  78999998742   2234566889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+.... ..
T Consensus        84 ~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  158 (331)
T cd05597          84 VGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TV  158 (331)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Cc
Confidence            999999999642 45689999999999999999999998   99999999999999999999999999987653322 11


Q ss_pred             ccccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          724 VSTVVAGTPGYLDPEYYTS-----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ......|++.|+|||++..     ..++.++|||||||++|||++|+.||......+.      ............+ .+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~-~~  231 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQF-PP  231 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccC-CC
Confidence            2233468999999999863     4578899999999999999999999976554321      1111111110010 00


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTG--NQRPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP--~~RPsm~evl~~  836 (878)
                      .     .......+.+++.+|+..++  ..||+++++++.
T Consensus       232 ~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         232 D-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             c-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0     01123356677777765533  348899999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7e-33  Score=303.38  Aligned_cols=246  Identities=22%  Similarity=0.377  Sum_probs=199.9

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|++|.||+++..  +..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  100 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence            345678999999999999864  488999999866555567789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.+   ..+++.++..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.......  ...
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~  172 (297)
T cd06656         101 GSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR  172 (297)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cCc
Confidence            999999864   4588999999999999999999998   99999999999999999999999999987653322  112


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....+++.|+|||.+.+..++.++|||||||++++|++|+.||...........       ......     +.+  ..+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~~~~-----~~~--~~~  238 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGT-----PEL--QNP  238 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------eccCCC-----CCC--CCc
Confidence            234588899999999998899999999999999999999999976543221100       000000     000  011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ......+.+++.+|++.+|++||+++++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            122345778999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-32  Score=295.74  Aligned_cols=247  Identities=29%  Similarity=0.508  Sum_probs=197.2

Q ss_pred             hcccccccccEEEEEEEEcc-eeEEEEEeccCC------hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          570 FERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSS------AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~------~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      ..+.||+|+||.||+|+..+ ..+|+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence            45789999999999998744 779999886432      22345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC--
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--  720 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--  720 (878)
                      +++++|.+++.+  ...+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++|+|||++.......  
T Consensus        84 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          84 VPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            999999999975  35688999999999999999999988   99999999999999999999999999987653211  


Q ss_pred             --CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          721 --NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       721 --~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                        .........|+..|+|||++.+..++.++|||||||+++||++|+.||..........  .   .....+..     +
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~---~~~~~~~~-----~  228 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--Y---IGAHRGLM-----P  228 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--H---hhhccCCC-----C
Confidence              1111223458899999999999889999999999999999999999997654332111  0   00000111     1


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .+.    ......+.+++.+|++.+|++||++.|+++
T Consensus       229 ~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         229 RLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111    122346789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.5e-33  Score=315.56  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=195.5

Q ss_pred             HhhhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.+.||+|+||.||+++...  +.+|+|++...   .....+.+.+|+.+++.++||||+++++.+..+...++|||
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  123 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            34556899999999999998864  78999998642   22334567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++..   ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       124 y~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-  196 (371)
T cd05622         124 YMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-  196 (371)
T ss_pred             CCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence            9999999999864   3488899999999999999999998   99999999999999999999999999998663322 


Q ss_pred             CcccccccCCCCccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          722 THVSTVVAGTPGYLDPEYYTSN----RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ........||+.|+|||++...    .++.++|||||||++|||++|+.||...+....      ............+.+
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~  270 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNHKNSLTFPD  270 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCcccCCC
Confidence            1222345699999999998754    378999999999999999999999987654321      111111111001100


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQ--RPTMSQVVMEL  837 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~evl~~L  837 (878)
                             .......+.+++.+|+...+.+  ||+++|+++..
T Consensus       271 -------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         271 -------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                   1122346778899999854443  78999988864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-32  Score=297.72  Aligned_cols=248  Identities=23%  Similarity=0.404  Sum_probs=198.8

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+...  ..+++|.+........+.+.+|++++++++|+|++++++.+..++..++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            3456789999999999998754  78999999877777778899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|..++.+. ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.......  ...
T Consensus        94 ~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~  167 (292)
T cd06644          94 GAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRR  167 (292)
T ss_pred             CcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc--ccc
Confidence            9999887643 34689999999999999999999988   99999999999999999999999999886542221  112


Q ss_pred             ccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          726 TVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ....++..|+|||++.     ...++.++|||||||++|||++|++||........  .    .... ........    
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~~~-~~~~~~~~----  236 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIA-KSEPPTLS----  236 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--H----HHHh-cCCCccCC----
Confidence            2345788999999985     34567899999999999999999999976543221  1    1111 11111110    


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                         .+.....++.+++.+|++.+|++||+++++++
T Consensus       237 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 ---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               11122346788999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-32  Score=301.47  Aligned_cols=246  Identities=21%  Similarity=0.369  Sum_probs=200.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||.|++|.||+|...  ++.|++|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||++++
T Consensus        22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  101 (296)
T cd06655          22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG  101 (296)
T ss_pred             EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence            34578999999999999853  4889999987665555678899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++..   ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........  ...
T Consensus       102 ~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~  173 (296)
T cd06655         102 SLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS  173 (296)
T ss_pred             cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence            99998864   3589999999999999999999998   999999999999999999999999999876533221  122


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||...+.......       +.........       .+.
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-------~~~~~~~~~~-------~~~  239 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGTPELQ-------NPE  239 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcCCcccC-------Ccc
Confidence            34588899999999988899999999999999999999999987655332211       1111111110       111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .....+.+++.+||..+|++||++.++++.
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            223467789999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1e-32  Score=296.70  Aligned_cols=245  Identities=25%  Similarity=0.449  Sum_probs=190.5

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCC-----hhhHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeEe
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-----AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALIY  640 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~  640 (878)
                      ..+.||+|+||.||++...  +..||+|++....     .+..+.+.+|++++++++||||+++++++..  +...++++
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence            4578999999999999874  4789999886432     2334678899999999999999999998765  35678999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++++|.+++..  ...+++...+.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        86 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          86 EYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            99999999999975  44589999999999999999999988   99999999999999999999999999987653211


Q ss_pred             CC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          721 NT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       721 ~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .. .......++..|+|||++.+..++.++|||||||+++||++|+.||........      +.......     ..+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~-----~~~~  229 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP-----TNPQ  229 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-----CCCC
Confidence            11 111224578899999999988899999999999999999999999976543221      11111111     1111


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +    +......+.+++ +|+..+|++||+++||++
T Consensus       230 ~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         230 L----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1    112223444555 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-32  Score=297.06  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=196.4

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCCh----------hhHHHHHHHHHHHHHhcccceeeeeecccCCCcce
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA----------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~----------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~  637 (878)
                      ..+.||+|++|.||+|...  ++.+|+|.+.....          ...+.+.+|++++.+++|+|++++++++...+..+
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (272)
T cd06629           5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS   84 (272)
T ss_pred             ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence            3578999999999999764  47899998753211          12346788999999999999999999999999999


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +|+||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++...
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          85 IFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             EEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            999999999999999763  5689999999999999999999998   99999999999999999999999999987653


Q ss_pred             cCCCCcccccccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      ............|+..|+|||.+....  ++.++||||||++++|+++|+.||......+.  +.    ... .......
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~-~~~~~~~  232 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MF----KLG-NKRSAPP  232 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HH----Hhh-ccccCCc
Confidence            222222223345889999999987654  88999999999999999999999975443221  11    111 1111111


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.+..    .......+.+++.+|+..+|++||++++|++.
T Consensus       233 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         233 IPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111    11234578889999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.7e-33  Score=303.89  Aligned_cols=258  Identities=24%  Similarity=0.388  Sum_probs=196.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+..  +..||+|.+.... ......+.+|++++++++|+||+++++++..++..++|+||++ 
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-   87 (301)
T cd07873           9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   87 (301)
T ss_pred             EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence            44578999999999999875  4789999987543 2334567889999999999999999999999999999999997 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++... ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++........  ..
T Consensus        88 ~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~  161 (301)
T cd07873          88 KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TY  161 (301)
T ss_pred             cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cc
Confidence            5898888653 44688999999999999999999998   999999999999999999999999999875432211  12


Q ss_pred             ccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh---cCCcccccC----
Q 002809          726 TVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA---KGDIKSIVD----  797 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~---~~~~~~iid----  797 (878)
                      ....++..|+|||.+.+ ..++.++|||||||+++||++|++||......+....   +.....   ......+.+    
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCChhhchhhhccccc
Confidence            22346889999999865 4578899999999999999999999987655332211   111100   000001100    


Q ss_pred             -----Cccccc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          798 -----PRLQED----FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       798 -----~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                           +.....    ........+.+++.+|++.+|.+|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                 111000    011223467899999999999999999999873

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.8e-32  Score=292.43  Aligned_cols=247  Identities=23%  Similarity=0.399  Sum_probs=201.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++..  ++.||+|.+...  .....+++.+|+.++++++|+||+++++++...+..++|+||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            45678999999999998874  488999998643  33445689999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++.......+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  157 (256)
T cd08218          83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL  157 (256)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence            99999999765455689999999999999999999998   99999999999999999999999999987653221  11


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....|+..|+|||++.+...+.++|||||||+++||++|+.||......+      .+..... +....         .
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~-~~~~~---------~  221 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIR-GSYPP---------V  221 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhc-CCCCC---------C
Confidence            223457889999999998899999999999999999999999997654332      1212211 11111         1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.....++.+++.+|++.+|++||+|.+|++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            11223468899999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-34  Score=316.97  Aligned_cols=245  Identities=28%  Similarity=0.496  Sum_probs=195.4

Q ss_pred             hhcccccccccEEEEEEEEcce--eEE---EEEec-cCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCc--ceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNEI--DVA---VKMLS-SSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQ--TALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~--~vA---vK~l~-~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~--~~lV~  640 (878)
                      +|..+||+|+|-+||+|.....  +||   ||.-. ..++...++|..|+.+|+.|+|+||++++.++.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4567899999999999987654  443   22211 1345566899999999999999999999999876554  77899


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEEeecCCccccccC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSFATD  719 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~  719 (878)
                      |.|..|+|..|+++  .+.++...++.|++||++||.|||++ .|+|||||||.+||+|+.+ |.+||+|+|||..+...
T Consensus       123 EL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999987  45678889999999999999999997 8999999999999999865 79999999999987533


Q ss_pred             CCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .    ...+.|||.|||||++. ..|++.+||||||++++||+|+..||......-..      -+.+..|.-..-    
T Consensus       200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI------YKKV~SGiKP~s----  264 (632)
T KOG0584|consen  200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI------YKKVTSGIKPAA----  264 (632)
T ss_pred             c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH------HHHHHcCCCHHH----
Confidence            2    22367999999999998 78999999999999999999999999876543221      122223322111    


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          +..-...++.+++.+|+.. .++|||+.|+++.
T Consensus       265 ----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  265 ----LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                1111123677999999999 9999999999863

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.2e-33  Score=299.60  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=195.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+|+..  +..||+|++....  ....+.+.+|+.++.+++||||+++++++..+...++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS   82 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence            34578999999999999875  4789999986432  2234678899999999999999999999999999999999997


Q ss_pred             CCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          645 NGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       645 ~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                       ++|.+++.... ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.......  .
T Consensus        83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (285)
T cd07861          83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--R  156 (285)
T ss_pred             -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--c
Confidence             68988886543 36789999999999999999999998   99999999999999999999999999987653221  1


Q ss_pred             ccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh--c-----------
Q 002809          724 VSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA--K-----------  789 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~--~-----------  789 (878)
                      ......++..|+|||.+.+. .++.++|||||||+++||+||++||..........  ........  .           
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF--RIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCCChhhhhcchhhHH
Confidence            12223468899999988654 57889999999999999999999998655432111  10000000  0           


Q ss_pred             --CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          790 --GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       790 --~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ..........+. ........++.+++.+||+.+|++||++++|+.
T Consensus       235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              000000000000 001112346779999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=294.26  Aligned_cols=249  Identities=25%  Similarity=0.453  Sum_probs=202.5

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|++|.||+++...  +.+++|.+........+.+.+|++++++++||||+++++++..+...+++|||++++
T Consensus         6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~   85 (262)
T cd06613           6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence            456789999999999998753  789999998766666788999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.......  ....
T Consensus        86 ~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~  159 (262)
T cd06613          86 SLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRK  159 (262)
T ss_pred             cHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh--hccc
Confidence            999998753 35689999999999999999999988   99999999999999999999999999987653221  1122


Q ss_pred             cccCCCCccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          727 VVAGTPGYLDPEYYTSN---RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ...++..|+|||.+...   .++.++||||||++++||+||++||...........       .......   .+.+.  
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~~~---~~~~~--  227 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSNFP---PPKLK--  227 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhccCC---Ccccc--
Confidence            34578899999999776   889999999999999999999999987654332111       1111000   01111  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ........+.+++.+|+..+|.+||++++|+.
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11223456889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-33  Score=310.43  Aligned_cols=187  Identities=26%  Similarity=0.377  Sum_probs=160.1

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..+  ..||+|+....      ....|+.++++++|+||+++++++......++|+|++ .
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~  140 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S  140 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence            4567899999999999999865  67999975432      2356999999999999999999999999999999999 4


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.. ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....   ...
T Consensus       141 ~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~  213 (357)
T PHA03209        141 SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAF  213 (357)
T ss_pred             CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC---ccc
Confidence            688888864 245689999999999999999999998   9999999999999999999999999998753221   112


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAI  768 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~  768 (878)
                      ....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            2356899999999999999999999999999999999865444

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-32  Score=291.32  Aligned_cols=246  Identities=27%  Similarity=0.439  Sum_probs=199.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||++...  +..+|+|.+...  .....+.+.+|++++++++|||++++++.+..++..++|+||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            45678999999999998874  478999998754  33456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCCCCc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~  723 (878)
                      +++|.+++.......+++..+++++.|+++||+|||++   +++|+||||+||++++++ .+||+|||++........  
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--  157 (256)
T cd08220          83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--  157 (256)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence            99999999875566789999999999999999999998   999999999999998654 689999999986643221  


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                       .....++..|+|||.+.+...+.++||||||+++++|++|+.||...+....      +..... +....+        
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~-~~~~~~--------  221 (256)
T cd08220         158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMS-GTFAPI--------  221 (256)
T ss_pred             -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHh-cCCCCC--------
Confidence             1234578899999999988899999999999999999999999976543221      111111 111111        


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       +......+.+++.+||+.+|++||+++|+++.
T Consensus       222 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 -SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             11123467899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.7e-33  Score=304.51  Aligned_cols=195  Identities=23%  Similarity=0.377  Sum_probs=159.1

Q ss_pred             ccccccccEEEEEEEEcc----eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeeccc--CCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE----IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD--EDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+|+..+    ..||+|.+.....  ...+.+|++++++++||||+++++++.  .+...++|+||++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            579999999999998643    6799999875432  246789999999999999999999884  4567889999986 


Q ss_pred             CChhhhhccc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE----cCCCcEEEeecCCcc
Q 002809          646 GNLQEYLSDI-------SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSK  714 (878)
Q Consensus       646 gsL~~~l~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl----~~~~~~kL~DFGla~  714 (878)
                      ++|.+++...       ....+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            4777776422       123588999999999999999999998   99999999999999    566799999999998


Q ss_pred             ccccCCCC-cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002809          715 SFATDANT-HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRIN  772 (878)
Q Consensus       715 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~  772 (878)
                      ........ .......||..|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            76432211 11223468899999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=311.99  Aligned_cols=239  Identities=27%  Similarity=0.343  Sum_probs=187.5

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHh---cccceeeeeecccCCCcceeEeeeccC
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRV---HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ||+|+||.||+++..  ++.||+|++....   ......+..|..++.+.   +||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875  4889999986532   22334556677777666   699999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~  153 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT  153 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence            999999875  55689999999999999999999998   99999999999999999999999999987542221  122


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....||..|+|||++.+. .++.++|||||||++|||++|+.||......+.      . ..+..+..      .+... 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~-~~i~~~~~------~~~~~-  219 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------Y-RNIAFGKV------RFPKN-  219 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------H-HHHHcCCC------CCCCc-
Confidence            345699999999998754 489999999999999999999999977554321      1 11111211      11110 


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPT----MSQVVM  835 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPs----m~evl~  835 (878)
                        .....+.+++.+||+.+|++||+    +.++++
T Consensus       220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              11235678999999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.4e-32  Score=307.38  Aligned_cols=258  Identities=22%  Similarity=0.307  Sum_probs=192.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC------cce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN------QTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~  637 (878)
                      +.+.+.||+|+||.||+++..  +..||+|++...  .......+.+|+.+++.++||||+++++++....      ..+
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  102 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY  102 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence            445689999999999999874  478999998653  3344567889999999999999999999885443      468


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+++ +|.+.++    ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         103 LVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             EEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            99999965 5666553    2478899999999999999999998   99999999999999999999999999987542


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH----------------HHH
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH----------------IRQ  781 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~----------------l~~  781 (878)
                      ..   .......||..|+|||++.+..++.++|||||||++|||++|+.||...+......                +..
T Consensus       175 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         175 TN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             cC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            21   11223468899999999999999999999999999999999999998765322110                000


Q ss_pred             HHHHHHhcC-Cc-----ccccCCccc---cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          782 WVNSLIAKG-DI-----KSIVDPRLQ---EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       782 ~v~~~~~~~-~~-----~~iid~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+....... ..     .+.......   .........++.+++.+||+.||++|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            011111100 00     000000000   00011123467899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.4e-33  Score=309.31  Aligned_cols=251  Identities=22%  Similarity=0.335  Sum_probs=194.0

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..+  +.+|+|++.+.   .......+.+|+.++..++|+||+++++.+...+..++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            456789999999999998865  67999998643   2223455888999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++++. ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....... ..
T Consensus        84 ~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~  158 (332)
T cd05623          84 VGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TV  158 (332)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC-cc
Confidence            999999999752 34689999999999999999999998   99999999999999999999999999987653222 22


Q ss_pred             ccccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          724 VSTVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+.      .........  ..   
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~--~~---  227 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKE--RF---  227 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCc--cc---
Confidence            223456999999999986     34678999999999999999999999987554321      111111110  00   


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQ--RPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~evl~~  836 (878)
                      .+. .........+.+++.+|+..++++  |++++|+++.
T Consensus       228 ~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000 001122346677888877654444  7899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-32  Score=308.83  Aligned_cols=258  Identities=22%  Similarity=0.296  Sum_probs=193.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC------Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~  637 (878)
                      +.+.+.||+|+||.||++...  ++.||||++...  .....+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   98 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY   98 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence            345678999999999999764  488999998754  333456788999999999999999999987543      3568


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+++ +|.+.+..    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        99 lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          99 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             EEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            99999965 66666642    488999999999999999999998   99999999999999999999999999997643


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH----------------HH
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI----------------RQ  781 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l----------------~~  781 (878)
                      ..   .......|+..|+|||++.+..++.++|||||||+++||++|+.||......+....                ..
T Consensus       171 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         171 TS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             Cc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            22   122334689999999999999999999999999999999999999987553221110                00


Q ss_pred             HHHHHHhcC-CcccccCCcc-----c---cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          782 WVNSLIAKG-DIKSIVDPRL-----Q---EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       782 ~v~~~~~~~-~~~~iid~~l-----~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+....... .......+..     .   .........++.+++.+||+.+|++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            011111110 0000000000     0   00111223467899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.4e-33  Score=309.22  Aligned_cols=251  Identities=21%  Similarity=0.317  Sum_probs=194.3

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++...  +.||+|++.+.   .......+.+|+.++..++|+||+++.+++..++..++||||+
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            456789999999999998764  77999998753   2223456888999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus        84 ~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~  158 (331)
T cd05624          84 VGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-V  158 (331)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-e
Confidence            999999999753 34689999999999999999999998   999999999999999999999999999976643221 1


Q ss_pred             ccccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          724 VSTVVAGTPGYLDPEYYTS-----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ......|++.|+|||++.+     ..++.++|||||||++|||++|+.||......+.      ...........     
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~-----  227 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERF-----  227 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCcc-----
Confidence            2233569999999999875     4678899999999999999999999986554321      11111111000     


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQ--RPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~evl~~  836 (878)
                      .+... ......++.+++.+|+...+++  |++++++++.
T Consensus       228 ~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            01100 0112346778888888865544  5688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-32  Score=296.49  Aligned_cols=249  Identities=26%  Similarity=0.405  Sum_probs=197.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ++.+.||+|+||.||+++..  +..||+|.+... .......+.+|++++.+++|+||+++++.+...+..++|+||+++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (286)
T cd06622           4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA   83 (286)
T ss_pred             hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence            45678999999999999886  488999988754 344457899999999999999999999999999999999999999


Q ss_pred             CChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          646 GNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       646 gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      ++|.+++.... ...+++..+..++.|++.||.|||+++  +|+||||||+||+++.++.+||+|||++..+...    .
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~  157 (286)
T cd06622          84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----L  157 (286)
T ss_pred             CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----c
Confidence            99999887532 346899999999999999999999632  8999999999999999999999999998765322    1


Q ss_pred             cccccCCCCccCccccccC------CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          725 STVVAGTPGYLDPEYYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .....++..|+|||.+.+.      .++.++|||||||+++||++|+.||...........   .. .+..+...     
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~-~~~~~~~~-----  228 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---LS-AIVDGDPP-----  228 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---HH-HHhhcCCC-----
Confidence            2234578899999998654      358899999999999999999999976433221110   11 11111111     


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          ..+.....++.+++.+|++.+|++||++++++..
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         229 ----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                1122234567899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-32  Score=293.94  Aligned_cols=243  Identities=26%  Similarity=0.425  Sum_probs=197.8

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCC-----hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-----AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      ..+.||+|++|.||+|...  +..|++|.+....     .+..+.+.+|++++++++|+||+++.+++..+...++|+||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            4578999999999999875  4889999986543     23457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.+++..  ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          84 VPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            999999999975  34588999999999999999999998   99999999999999999999999999987653322  


Q ss_pred             cccccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       ......|+..|+|||.+.... ++.++|+||||+++++|++|+.||........  .    ...........       
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~----~~~~~~~~~~~-------  222 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--V----FKIGRSKELPP-------  222 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--H----HHHHhcccCCC-------
Confidence             223455888999999987766 89999999999999999999999977553221  1    11111011111       


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        .+......+.+++.+|++.+|++||+++++++
T Consensus       223 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 --IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              11122346778999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.4e-33  Score=299.69  Aligned_cols=260  Identities=24%  Similarity=0.380  Sum_probs=197.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||++...  ++.||+|++.....  ...+.+.+|++++++++||||+++++++..++..++|+||++
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD   83 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence            45578999999999999985  48899998765422  235678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.++...  ...+++..++.++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++.......  ..
T Consensus        84 ~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~  156 (286)
T cd07846          84 HTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EV  156 (286)
T ss_pred             ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cc
Confidence            9999887754  34589999999999999999999998   99999999999999999999999999987653322  22


Q ss_pred             cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHHHH-------hcCCc-cc
Q 002809          725 STVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQWVNSLI-------AKGDI-KS  794 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~v~~~~-------~~~~~-~~  794 (878)
                      .....++..|+|||++.+ ..++.++||||||++++||++|++||......+.. .+..+.....       ....+ ..
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            223457889999999875 45788999999999999999999999765432211 1111111000       00000 00


Q ss_pred             ccCCccccc-----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 IVDPRLQED-----FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 iid~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ...+.....     ........+.+++.+|++.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000     01123456889999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.5e-33  Score=311.20  Aligned_cols=260  Identities=22%  Similarity=0.287  Sum_probs=205.2

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-c-----cceeeeeecccCCCccee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-H-----RNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H-----~nIv~l~g~~~~~~~~~l  638 (878)
                      +|.+.+.||+|+||.|-++...  ++.||||++++...- ..+...|+.+|..|+ |     -|+|+++++|...++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            5666899999999999999764  488999999876433 466688999999997 3     589999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC--cEEEeecCCcccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL--QAKLADFGLSKSF  716 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~--~~kL~DFGla~~~  716 (878)
                      |+|.+ .-+|+++|+.+.-..++...+..|+.||+.||.+||+.   +|||+||||+||||.+..  .+||+|||.+...
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 45999999998888899999999999999999999988   999999999999997654  7999999999865


Q ss_pred             ccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHH----HHHhcC-
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI-RQWVN----SLIAKG-  790 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~v~----~~~~~~-  790 (878)
                      ....    . ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+.... .+...    .++..+ 
T Consensus       342 ~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  342 SQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             CCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            3221    1 45577899999999999999999999999999999999999988877655432 11110    011100 


Q ss_pred             CcccccCC--------------------------------cccc-c-------cCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          791 DIKSIVDP--------------------------------RLQE-D-------FDANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       791 ~~~~iid~--------------------------------~l~~-~-------~~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                      +....++.                                .... .       ........+++++.+||+.||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence            00000110                                0000 0       011234467899999999999999999


Q ss_pred             HHHHHH
Q 002809          831 SQVVME  836 (878)
Q Consensus       831 ~evl~~  836 (878)
                      .|+++.
T Consensus       497 ~qal~H  502 (586)
T KOG0667|consen  497 AQALNH  502 (586)
T ss_pred             HHHhcC
Confidence            999885

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.6e-32  Score=294.90  Aligned_cols=260  Identities=23%  Similarity=0.349  Sum_probs=197.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+++..  ++.||+|++....  ....+.+.+|++++++++|+|++++++++......++||||++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   83 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence            44578999999999999885  4889999886542  2234568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      ++.|..++..  ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........  .
T Consensus        84 ~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~  156 (286)
T cd07847          84 HTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D  156 (286)
T ss_pred             ccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence            9988887754  44689999999999999999999998   999999999999999999999999999987643321  1


Q ss_pred             cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHHHHh-------cCC-ccc
Q 002809          725 STVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNSLIA-------KGD-IKS  794 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~~~~~-------~~~-~~~  794 (878)
                      .....++..|+|||.+.+ ..++.++||||||++++||++|++||......+... +.........       ... ...
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            223457789999999876 457899999999999999999999998765433221 1111100000       000 000


Q ss_pred             ccCCccccccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 IVDPRLQEDFD-----ANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 iid~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ...+......+     ......+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00011000000     112346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.8e-32  Score=292.98  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=199.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeeccc--CCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD--EDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||++...  +..+|+|.+...  .....+.+.+|++++++++|+||+++++++.  .+...+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            45578999999999999864  378999998743  3445567889999999999999999999775  34567899999


Q ss_pred             ccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          643 MANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGC--KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       643 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      +++++|.+++....  ...+++..++.++.|++.||+|||..+  ..+++|+||||+||++++++.+||+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            99999999996532  457899999999999999999999332  33999999999999999999999999999887643


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ...  ......++..|+|||.+.+..++.++||||||+++++|++|+.||.......   +.+    .+..+...     
T Consensus       163 ~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~-----  228 (265)
T cd08217         163 DSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS----KIKEGKFR-----  228 (265)
T ss_pred             Ccc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH----HHhcCCCC-----
Confidence            221  1223458899999999998889999999999999999999999998765322   111    11222111     


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          ..+......+.+++.+|++.+|++||++++|++.
T Consensus       229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                1122334578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.5e-32  Score=292.62  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=202.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|++|.||+|...  +..+++|++.... ....+.+.+|++.++.++|+|++++++.+..++..++|+|++++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            45678999999999999864  3789999987543 33567899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC--
Q 002809          646 GNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT--  722 (878)
Q Consensus       646 gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--  722 (878)
                      ++|.++++.... ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++..+......  
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            999999976433 5789999999999999999999988   9999999999999999999999999998776443222  


Q ss_pred             cccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .......|+..|+|||++... ..+.++|||||||+++||++|+.||.......  ...+.    ....      .+.+.
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~----~~~~------~~~~~  228 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT----LQND------PPSLE  228 (267)
T ss_pred             cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH----hcCC------CCCcC
Confidence            122334688999999998876 78999999999999999999999997654422  11111    1111      11111


Q ss_pred             ccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          802 EDF-DANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       802 ~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ... .......+.+++.+|++.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111 1123456789999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=307.27  Aligned_cols=238  Identities=32%  Similarity=0.479  Sum_probs=197.5

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEecc---CChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSS---SSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~---~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||.|+||-||-++..  ...||||++.-   .+...+.++..|+..|.+++|||++.+.|+|..+...+|||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            57999999999998764  47899999874   34557889999999999999999999999999999999999999 45


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +-.|++.- -++++.+..+..|..+.+.||+|||+.   +.||||||+.|||+++.|.+||+|||.+..+.+      ..
T Consensus       111 SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An  180 (948)
T KOG0577|consen  111 SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN  180 (948)
T ss_pred             cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence            77777753 256788999999999999999999998   999999999999999999999999999876633      23


Q ss_pred             cccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          727 VVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .+.||+.|||||++.   .+.|+-|+||||+|++..||.-.+||+..++.-....       .+..+.     .|.+.  
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-------HIAQNe-----sPtLq--  246 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNE-----SPTLQ--  246 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-------HHHhcC-----CCCCC--
Confidence            467999999999974   5689999999999999999999999988766533211       111111     12332  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       ..+-...++.++..||+.-|.+|||.+++++
T Consensus       247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             1233457889999999999999999998876

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.3e-32  Score=295.57  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=193.2

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeeccc-----CCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCD-----EDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~-----~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+++...  +.+|+|++..... ....+.+|+.++.++ +|+||+++++++.     .++..++||
T Consensus        21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   99 (286)
T cd06638          21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL   99 (286)
T ss_pred             eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence            345789999999999998754  7899998865432 235688899999999 6999999999873     445689999


Q ss_pred             eeccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          641 EFMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||+++++|.++++..  ....+++..+..++.|+++||.|||+.   +++||||||+||++++++.+||+|||+++.+..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  176 (286)
T cd06638         100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  176 (286)
T ss_pred             eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence            999999999987532  245688999999999999999999998   999999999999999999999999999876532


Q ss_pred             CCCCcccccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTS-----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      ..  .......|+..|+|||++..     ..++.++|||||||++|||++|+.|+.........  ..     .......
T Consensus       177 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~-----~~~~~~~  247 (286)
T cd06638         177 TR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK-----IPRNPPP  247 (286)
T ss_pred             CC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh-----ccccCCC
Confidence            21  12223458899999999853     45788999999999999999999999765432211  00     0111111


Q ss_pred             cccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       794 ~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      ...++.       ....++.+++.+|++.+|++||++.|+++.+
T Consensus       248 ~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         248 TLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             cccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            111111       1123678999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-32  Score=293.83  Aligned_cols=249  Identities=24%  Similarity=0.435  Sum_probs=197.5

Q ss_pred             hcccccccccEEEEEEEE--cceeEEEEEeccCC------hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          570 FERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSS------AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~------~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ..+.||+|++|.||+++.  .+..+|+|++....      ....+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            457899999999999986  34889999987533      1235688999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDA  720 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~  720 (878)
                      |+++++|.+++.+  ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++ .+||+|||.+..+....
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          84 WMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             ccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            9999999999975  45689999999999999999999998   999999999999998776 59999999987664321


Q ss_pred             C--CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          721 N--THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       721 ~--~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .  ........++..|+|||.+.+..++.++||||+|+++++|++|+.||...........   .........       
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~-------  228 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASATT-------  228 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccCC-------
Confidence            1  1112234578899999999888899999999999999999999999975433211111   111100000       


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ....+.....++.+++.+|+..+|++||++.++++
T Consensus       229 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 --APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              11122233457788999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.2e-32  Score=298.81  Aligned_cols=243  Identities=22%  Similarity=0.380  Sum_probs=197.9

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      ..||+|+||.||++...  +..||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            46999999999999874  4789999987766666678999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      +++..   ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++.......  .......
T Consensus       108 ~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~  179 (292)
T cd06658         108 DIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV  179 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence            98853   4589999999999999999999998   99999999999999999999999999987553221  1122345


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHH
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV  809 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~  809 (878)
                      |+..|+|||.+.+..++.++||||||++++||++|+.||...........       +...     +.+.+..  .....
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------~~~~-----~~~~~~~--~~~~~  245 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------IRDN-----LPPRVKD--SHKVS  245 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhc-----CCCcccc--ccccC
Confidence            88999999999888899999999999999999999999976544322111       1110     1111111  01122


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          810 WKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       810 ~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..+.+++.+|+..+|++||+++|+++.
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            357789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=302.91  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=199.1

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ++.+.||+|++|.||+++..+  ..+|+|.+.....   ...+.+.+|++++.+++|+||+++++.+..+...++||||+
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            345789999999999998754  8899999876532   24567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-  722 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-  722 (878)
                      .+++|.+++.......+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++......... 
T Consensus        84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999865567799999999999999999999988   9999999999999999999999999998754321110 


Q ss_pred             --------------------------cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 002809          723 --------------------------HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK  776 (878)
Q Consensus       723 --------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  776 (878)
                                                .......|+..|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                      011123578899999999988899999999999999999999999976654321


Q ss_pred             HHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 002809          777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT----MSQVVM  835 (878)
Q Consensus       777 ~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----m~evl~  835 (878)
                      .  .    .... ..        ............+.+++.+|++.+|++||+    ++|+++
T Consensus       241 ~--~----~~~~-~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 F--S----NILK-KE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             H--H----HHhc-CC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1  1    1111 11        100011113457889999999999999999    555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.1e-32  Score=292.60  Aligned_cols=246  Identities=24%  Similarity=0.422  Sum_probs=192.1

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccC-----ChhhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeEe
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-----SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALIY  640 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-----~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~  640 (878)
                      +.+.||+|+||.||++...+  ..||+|.+...     .....+.+.+|++++.+++||||+++++++.+.  ...++||
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            45789999999999998754  78999987532     123356788999999999999999999988653  4577999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++++|.+++..  ...+++..+++++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        86 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          86 EHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            99999999999875  34588999999999999999999998   99999999999999999999999999987653211


Q ss_pred             CC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          721 NT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       721 ~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .. .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........  +    .......     ..+ 
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~~~~~~-----~~~-  228 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--I----FKIATQP-----TNP-  228 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--H----HHHhcCC-----CCC-
Confidence            11 112234588899999999988899999999999999999999999976533221  1    1111110     011 


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         ..+......+.+++.+|+. +|++||+++||++.
T Consensus       229 ---~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         229 ---VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence               1222334467788888885 89999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=297.70  Aligned_cols=262  Identities=21%  Similarity=0.330  Sum_probs=200.1

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      +++.+.||+|++|.||+|+..+  ..||+|++...  .....+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            3456789999999999998864  78999988753  2334578899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      +++.+..+...  ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||++........ .
T Consensus        83 ~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~  156 (288)
T cd07833          83 ERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S  156 (288)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence            98777766543  45589999999999999999999998   999999999999999999999999999887644332 1


Q ss_pred             ccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHHHH--------hcCCc-
Q 002809          724 VSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI-RQWVNSLI--------AKGDI-  792 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~v~~~~--------~~~~~-  792 (878)
                      ......++..|+|||++.+. .++.++||||||++++||++|++||......+.... ........        ..... 
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            22334578899999999887 889999999999999999999999986554322111 11000000        00000 


Q ss_pred             ----ccccCCcc-ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          793 ----KSIVDPRL-QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       793 ----~~iid~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                          .+..++.. ...++.....++.+++.+||..+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                00000000 00111223567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-32  Score=298.17  Aligned_cols=243  Identities=22%  Similarity=0.354  Sum_probs=197.9

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      ..||+|+||.||++...  +..||+|.+........+.+.+|+.++..++|||++++++++..++..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            46999999999999864  5889999987655555677899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      +++..   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......  .......
T Consensus       107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~  178 (297)
T cd06659         107 DIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLV  178 (297)
T ss_pred             HHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccccee
Confidence            98753   4589999999999999999999998   99999999999999999999999999987553322  1223356


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHH
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV  809 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~  809 (878)
                      |+..|+|||++.+..++.++|||||||+++||++|+.||......+...   .    +.......     ..  ......
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~----~~~~~~~~-----~~--~~~~~~  244 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---R----LRDSPPPK-----LK--NAHKIS  244 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---H----HhccCCCC-----cc--ccCCCC
Confidence            8899999999998889999999999999999999999997655433211   1    11111000     00  001122


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          810 WKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       810 ~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..+.+++.+|++.+|++||+++++++.
T Consensus       245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         245 PVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            357789999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4e-32  Score=298.42  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=198.3

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++...  +.|++|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            345789999999999998865  789999987653   233567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC---
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA---  720 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---  720 (878)
                      ++++|.+++..  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......   
T Consensus        84 ~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          84 EGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            99999999975  35689999999999999999999998   99999999999999999999999999986421100   


Q ss_pred             ----------CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          721 ----------NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       721 ----------~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                                .........++..|+|||.+....++.++|+|||||++|||++|+.||......+      +...... +
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~~~-~  231 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVIS-D  231 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-c
Confidence                      0011112457889999999988889999999999999999999999997654332      1111111 1


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ...   .+...    ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       232 ~~~---~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         232 DIE---WPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ccC---CCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            110   11100    1123467899999999999999997666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.4e-32  Score=295.04  Aligned_cols=246  Identities=26%  Similarity=0.479  Sum_probs=194.3

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccC------CCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDE------DNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~------~~~~~lV  639 (878)
                      .+.+.||+|+||.||+|+...  ..+|+|++.... ....++..|+.++.++ +|+||+++++++..      ....+++
T Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   97 (282)
T cd06636          19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV   97 (282)
T ss_pred             hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence            445789999999999998854  789999886543 3346788999999998 69999999999853      4578999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636          98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             EEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            9999999999999775566789999999999999999999998   9999999999999999999999999998755321


Q ss_pred             CCCcccccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ..  ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||...........       .....   
T Consensus       175 ~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-------~~~~~---  242 (282)
T cd06636         175 VG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-------IPRNP---  242 (282)
T ss_pred             cc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-------HhhCC---
Confidence            11  122345889999999975     34678899999999999999999999976543322111       00010   


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        .+...   .......+.+++.+||..+|.+||++.|+++
T Consensus       243 --~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         243 --PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence              01111   1123347889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-33  Score=297.70  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=208.9

Q ss_pred             HhhhcccccccccEEEEEEEE--cceeEEEEEeccCChh--hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          567 TNNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQ--GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .|++++.||+|-|+.|-.+++  .+..||||++.+....  ....+.+|+..|+.++|||||+|+........+|||+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            467788999999999998864  7899999999887543  345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE-cCCCcEEEeecCCccccccCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL-NEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl-~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      -++|+|++++-.+ ...+.+..+.+++.||+.|+.|+|+.   .+|||||||+||.+ .+-|-+||.|||++-.+.++..
T Consensus        99 GD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             cCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            9999999999653 45689999999999999999999988   89999999999876 5678999999999988765533


Q ss_pred             CcccccccCCCCccCccccccCCCCC-ccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTE-KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                         -...||...|-|||.+.+..|+. ++||||+|||||.|++|++||+..+..+...               -++|-+.
T Consensus       175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCKY  236 (864)
T KOG4717|consen  175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCKY  236 (864)
T ss_pred             ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcccc
Confidence               34578999999999999988864 7899999999999999999999877655322               2333322


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        ..+.....+..+|+..||..||++|.+.++|+..
T Consensus       237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence              2345566788899999999999999999998753

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.4e-32  Score=295.16  Aligned_cols=259  Identities=22%  Similarity=0.328  Sum_probs=199.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+|+..  +..||+|++....  ....+.+.+|+.++++++|+||+++++++..+...++|+||+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence            45678999999999999874  4889999987654  334568999999999999999999999999999999999999 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++... ...+++.+++.++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++........ ..
T Consensus        82 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (286)
T cd07832          82 PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL  156 (286)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence            99999998753 35699999999999999999999998   999999999999999999999999999886643321 11


Q ss_pred             cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC------------C
Q 002809          725 STVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG------------D  791 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~------------~  791 (878)
                      .....|+..|+|||.+.+. .++.++||||+|++++||++|+++|.........   .++.......            +
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccCcch
Confidence            2234588899999998654 4689999999999999999998888765432211   1111111100            0


Q ss_pred             cccccCCcc----ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          792 IKSIVDPRL----QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       792 ~~~iid~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...+..+.-    ......+....+.+++.+|++.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000    000111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.4e-32  Score=305.16  Aligned_cols=258  Identities=21%  Similarity=0.296  Sum_probs=193.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC------Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~  637 (878)
                      +.+.+.||+|+||.||++...  ++.||||++...  .....+.+.+|+.+++.++||||+++++.+...      ...+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~  105 (364)
T cd07875          26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  105 (364)
T ss_pred             eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence            445689999999999999865  478999998753  233456788999999999999999999987543      3579


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+++ +|.+.+..    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       106 lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         106 IVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             EEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            99999965 77776642    478899999999999999999998   99999999999999999999999999997653


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---------HH------
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR---------QW------  782 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~------  782 (878)
                      ..   .......|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+.....         ++      
T Consensus       178 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         178 TS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             CC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            22   1122346899999999999999999999999999999999999999876543221100         00      


Q ss_pred             -HHHHHhcC-Ccc-----cccCCccc---cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          783 -VNSLIAKG-DIK-----SIVDPRLQ---EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       783 -v~~~~~~~-~~~-----~iid~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       +....... ...     ........   .........++.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             00000000 000     00000000   00111123467899999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.6e-32  Score=292.26  Aligned_cols=245  Identities=27%  Similarity=0.450  Sum_probs=199.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+|...  +..||+|.+.... ....+.+.+|++++.+++||||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            445678999999999999864  4789999986543 3345678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..   ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..+....  ..
T Consensus        86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          86 GGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            9999999864   4589999999999999999999998   99999999999999999999999999987653221  11


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....++..|+|||.+.+...+.++|||||||+++||++|..|+........      ... +..+..     +.    .
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~~-----~~----~  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFL-IPKNNP-----PT----L  221 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHH-HhcCCC-----CC----C
Confidence            2234578899999999888899999999999999999999999976543221      111 111111     11    1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .......+.+++.+|++.+|++||+++++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            12233467789999999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.1e-32  Score=290.73  Aligned_cols=249  Identities=28%  Similarity=0.446  Sum_probs=199.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ...+.||+|+||.||+|...  +..|++|.+.....  ...+.+.+|++++++++|+||+++++.+...+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            44578999999999999874  48899999876544  367889999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..  ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++...........
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          83 GGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            9999999975  44588999999999999999999998   999999999999999999999999999887643322111


Q ss_pred             --cccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          725 --STVVAGTPGYLDPEYYTSNR---LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       725 --~~~~~gt~~Y~APE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                        .....++..|+|||++.+..   .+.++||||||++++||++|+.||........  ....    +..+.     .+.
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~----~~~~~-----~~~  226 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFH----VGAGH-----KPP  226 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHH----HhcCC-----CCC
Confidence              11245788999999998766   88999999999999999999999976532211  1111    11111     111


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +..  .......+.+++.+|++.+|++||++.|++.
T Consensus       227 ~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 IPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111  1112346778999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-32  Score=318.78  Aligned_cols=257  Identities=19%  Similarity=0.305  Sum_probs=189.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhccc------ceeeeeecccCC-Cccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHR------NLTSLVGHCDED-NQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~------nIv~l~g~~~~~-~~~~l  638 (878)
                      +.+.+.||+|+||.||++...  ++.||||+++... .....+..|++++.+++|.      +++++++++..+ ...++
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i  209 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI  209 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence            445689999999999999875  4789999997532 2334567788888887654      488888888654 56788


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---------------
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---------------  703 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---------------  703 (878)
                      |||++ +++|.+++..  ...+++..+..|+.||+.||+|||++  .+||||||||+|||++.++               
T Consensus       210 v~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        210 VMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             EEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            99988 7789988865  45799999999999999999999973  2899999999999998765               


Q ss_pred             -cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH-
Q 002809          704 -QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQ-  781 (878)
Q Consensus       704 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~-  781 (878)
                       .+||+|||.+....     .......||..|+|||++.+..++.++|||||||++|||++|++||......+...... 
T Consensus       285 ~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        285 CRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             ceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence             49999999875421     12234679999999999999999999999999999999999999998766543332211 


Q ss_pred             --------HHHH--------HHh-cCCcccccCCcc----cccc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          782 --------WVNS--------LIA-KGDIKSIVDPRL----QEDF---DANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       782 --------~v~~--------~~~-~~~~~~iid~~l----~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                              |...        ... .+.+....++..    ....   .......+.+|+.+||+.||++|||++|+++
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence                    1100        000 000000011100    0000   0011245779999999999999999999987

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.9e-32  Score=291.28  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=200.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|++|.||++...  ++.+|+|.+.... ....+++.+|++++++++||||+++++.+..+...++|+||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            34578999999999999886  4789999987653 34557889999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      ++|.+++.... ..+++..+..++.|++.||+|||+ .   +++|+||||+||++++++.++|+|||.+.......    
T Consensus        84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----  155 (265)
T cd06605          84 GSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----  155 (265)
T ss_pred             CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence            99999997632 678999999999999999999998 6   99999999999999999999999999987553221    


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....++..|+|||.+.+..++.++||||||+++++|++|+.||....... ....+.+........      +.+... 
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~-  227 (265)
T cd06605         156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP------PRLPSG-  227 (265)
T ss_pred             hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC------CCCChh-
Confidence            111568889999999999899999999999999999999999997653211 111222222221110      111111 


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        ....++.+++.+|+..+|++||++.|+++.
T Consensus       228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         228 --KFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             --hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence              133467899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.5e-32  Score=293.51  Aligned_cols=257  Identities=21%  Similarity=0.307  Sum_probs=195.4

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ..+.||+|++|.||+|+..  +..||||++....  ......+.+|++++++++||||+++++++..++..++||||+. 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            4578999999999999875  4789999886432  2234678899999999999999999999999999999999995 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.......+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++........  ..
T Consensus        83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~  157 (284)
T cd07860          83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY  157 (284)
T ss_pred             cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cc
Confidence            6899998765567799999999999999999999988   999999999999999999999999999876532211  12


Q ss_pred             ccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc---------------
Q 002809          726 TVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK---------------  789 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~---------------  789 (878)
                      ....++..|+|||++.+.. ++.++|||||||+++||+||+.||........  +.+.....-..               
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            2234678999999887644 68899999999999999999999976554321  11111100000               


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..........+. .........+.+++.+|++.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000000000000 000112235678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-32  Score=306.00  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=190.6

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCC------Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~  637 (878)
                      +...+.||+|+||.||++....  ..||||++....  ....+.+.+|++++++++||||+++++++...      ...+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY   96 (343)
T ss_pred             hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence            3445789999999999998653  789999987542  23446688999999999999999999987533      3568


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +++|++ +++|.++++   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          97 LVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            999988 789988875   34699999999999999999999998   99999999999999999999999999998653


Q ss_pred             cCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHH----------
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL----------  786 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~----------  786 (878)
                      ..     .....|+..|+|||++.+ ..++.++|||||||+++||++|+.||........  +..+....          
T Consensus       170 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             CC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHh
Confidence            22     123468999999999876 5689999999999999999999999976543221  11111000          


Q ss_pred             HhcCC-------cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          787 IAKGD-------IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       787 ~~~~~-------~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +....       +...-...+...+ ......+.+++.+|++.+|++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000       0000000000000 0112346799999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-32  Score=291.89  Aligned_cols=245  Identities=26%  Similarity=0.444  Sum_probs=197.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhc---ccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVH---HRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+|+..  +..||+|.+... .....+++.+|++++++++   |||++++++++..+...++||||
T Consensus         4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~   83 (277)
T cd06917           4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY   83 (277)
T ss_pred             hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence            34578999999999999974  488999998754 3345567889999999997   99999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.++++.   ..+++..++.++.|++.||.|||+.   +|+||||+|+||++++++.++|+|||++..+..... 
T Consensus        84 ~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06917          84 AEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-  156 (277)
T ss_pred             CCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence            999999999864   3689999999999999999999988   999999999999999999999999999887643321 


Q ss_pred             cccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       ......|+..|+|||.+.+. .++.++|||||||++|+|++|+.||..........       .....     ..+.+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-----~~~~~~  223 (277)
T cd06917         157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-----KPPRLE  223 (277)
T ss_pred             -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-----CCCCCC
Confidence             12234588899999998754 56899999999999999999999997654322110       00110     111111


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..   ....++.+++.+|++.+|++||++.++++.
T Consensus       224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         224 DN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            11   133468899999999999999999999863

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-33  Score=302.81  Aligned_cols=248  Identities=22%  Similarity=0.336  Sum_probs=203.7

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEec--cCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLS--SSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~--~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ...+.||+||.+.||++...+ +.+|+|++.  ..+.+....|..|+..|.+++ |.+||+|++|-..++.+|+||||- 
T Consensus       364 eilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-  442 (677)
T KOG0596|consen  364 EILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-  442 (677)
T ss_pred             hHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-
Confidence            445789999999999999887 778888765  346667789999999999995 999999999999999999999986 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      ..+|..+|+........| .++.+..|++.|+.++|++   +|||.||||.|+|+-. |.+||+|||+|..+..+...-.
T Consensus       443 d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  443 DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence            569999998755544445 7889999999999999999   9999999999999975 5899999999999987777666


Q ss_pred             cccccCCCCccCccccccC-----------CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          725 STVVAGTPGYLDPEYYTSN-----------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~-----------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      ....+||+.||+||.+...           +.+.++||||+||+||+|+.|++||.....       .|.       .+.
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a-------Kl~  583 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA-------KLH  583 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-------HHH
Confidence            7778999999999998533           256799999999999999999999975332       121       233


Q ss_pred             cccCCccccccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          794 SIVDPRLQEDFD-ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       794 ~iid~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+.||.-.-+|+ ....+++++++..||..||++||+..++++.
T Consensus       584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            455554433333 1223348999999999999999999999873

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.1e-32  Score=294.95  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChh-----hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ-----GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-----~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|++|.||+|...  ++.||+|.+......     ....+..|++++++++|+||+++++++..++..++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            44578999999999999875  488999998765322     33567789999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+ +|+|.+++.... ..+++..++.++.|+++||+|||+.   +++||||||+||+++.++.++|+|||+++.......
T Consensus        83 ~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          83 FM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             cc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            99 999999997632 3699999999999999999999998   999999999999999999999999999987643321


Q ss_pred             CcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHHH-----HhcCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNSL-----IAKGDIKS  794 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~~~-----~~~~~~~~  794 (878)
                      .  .....++..|+|||.+.+ ..++.++|||||||+++||++|.++|......+... +.......     ........
T Consensus       158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         158 K--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             c--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            1  122346778999998864 467899999999999999999988887654322111 10000000     00000001


Q ss_pred             ccCCcccccc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDF-----DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..........     .......+.+++.+||+.+|++||+++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1000000011     12234578899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.8e-32  Score=295.54  Aligned_cols=247  Identities=22%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||++...  +..||+|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  100 (293)
T cd06647          21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG  100 (293)
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence            345678999999999999763  478999998765555567889999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.+   ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........  ..
T Consensus       101 ~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~  172 (293)
T cd06647         101 GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR  172 (293)
T ss_pred             CcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence            999999864   3578999999999999999999998   999999999999999999999999998876543221  12


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....++..|+|||.+....++.++|||||||++||+++|+.||..........      .... +..     +.+  ...
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~-~~~-----~~~--~~~  238 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT-NGT-----PEL--QNP  238 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhc-CCC-----CCC--CCc
Confidence            23458889999999988889999999999999999999999997654322110      0000 000     000  011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ......+.+++.+||..+|++||++.+++.+
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1223467789999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.4e-32  Score=288.49  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=203.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|++|.||+++..  ++.|++|++..... ...+.+.+|++.+.+++|+|++++++++......++|+||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            34578999999999999886  48899999876644 4567899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      ++|.+++..  ...+++..++.++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|||++.........  
T Consensus        84 ~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--  156 (264)
T cd06623          84 GSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--  156 (264)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence            999999976  3678999999999999999999998 7   9999999999999999999999999998866432221  


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....++..|+|||.+.+..++.++||||||+++|||+||+.||..........+..++.    .....     .    .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~-----~----~  223 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPP-----S----L  223 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCC-----C----C
Confidence            123457889999999998899999999999999999999999997764311112222211    11111     1    1


Q ss_pred             CHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DAN-SVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~-~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.. ....+.+++.+|++.+|++||++.|+++.
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111 33578899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-31  Score=291.31  Aligned_cols=242  Identities=20%  Similarity=0.348  Sum_probs=197.8

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      +.||+|++|.||++...  +..+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            68999999999999864  3789999987665555677899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      +++..   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.+........  ......
T Consensus       105 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~  176 (285)
T cd06648         105 DIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLV  176 (285)
T ss_pred             HHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccccc
Confidence            99875   4589999999999999999999998   999999999999999999999999998875532221  122345


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHH
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV  809 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~  809 (878)
                      |+..|+|||.+.+..++.++|||||||+++||++|+.||........      .... ..+..     +....  .....
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~-~~~~~-----~~~~~--~~~~~  242 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRI-RDNLP-----PKLKN--LHKVS  242 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHH-HhcCC-----CCCcc--cccCC
Confidence            88999999999888899999999999999999999999876543221      1111 11111     11110  11123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          810 WKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       810 ~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHcc
Confidence            46889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-32  Score=294.76  Aligned_cols=260  Identities=22%  Similarity=0.324  Sum_probs=192.4

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|++|.||+|+..  ++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||+. 
T Consensus         8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   86 (291)
T cd07844           8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-   86 (291)
T ss_pred             eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-
Confidence            44578999999999999875  48899999875432 223567789999999999999999999999999999999997 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++... ...+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        87 ~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~  160 (291)
T cd07844          87 TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TY  160 (291)
T ss_pred             CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cc
Confidence            4999988753 34689999999999999999999998   999999999999999999999999999875422111  11


Q ss_pred             ccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHHHHhcCCcc------cccC
Q 002809          726 TVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEE-EKIHIRQWVNSLIAKGDIK------SIVD  797 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~v~~~~~~~~~~------~iid  797 (878)
                      ....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... +..................      +...
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            22346788999999865 45889999999999999999999999765421 1111100000000000000      0000


Q ss_pred             --------Ccccccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 --------PRLQEDF-DANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 --------~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                              ..+.... .......+.+++.+|++.+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                    0000000 0111246779999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.98  E-value=4.8e-32  Score=294.03  Aligned_cols=258  Identities=20%  Similarity=0.308  Sum_probs=192.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++..  +..+|+|++....  ......+.+|++++++++|+||+++++++.+....++|+||++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            45578999999999999885  4789999986532  2223567889999999999999999999999999999999996


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                       ++|.+++... ...+++..++.++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+++.......  .
T Consensus        83 -~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~  155 (284)
T cd07839          83 -QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--C  155 (284)
T ss_pred             -CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--C
Confidence             5888877643 34689999999999999999999998   999999999999999999999999999876532221  1


Q ss_pred             cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC------cccccC
Q 002809          725 STVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD------IKSIVD  797 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~------~~~iid  797 (878)
                      .....++..|+|||++.+. .++.++|||||||+++||+||+.|+........ .+ +..........      +....+
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhccc
Confidence            2234578899999998764 468999999999999999999888644332111 11 00110000000      000000


Q ss_pred             Cc----cc-----cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 PR----LQ-----EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 ~~----l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..    ..     .........++.+++.+||+.+|.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00    00     0011123357789999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.98  E-value=8.6e-32  Score=287.02  Aligned_cols=247  Identities=24%  Similarity=0.441  Sum_probs=199.6

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||++....  ..+|+|.+...  .....+.+.+|++++++++|+||+++++.+..+...++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            356789999999999998854  78999998653  22345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCCCCc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~  723 (878)
                      +++|.+++.......+++..++.++.|+++||+|||+.   +++|+||||+||++++++ .+||+|||.+.......  .
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~  157 (257)
T cd08225          83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--E  157 (257)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc--c
Confidence            99999999765555689999999999999999999998   999999999999999886 46999999987664322  1


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|+..|+|||++.+..++.++||||||++++||++|+.||.......      ++..... +.....        
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~--------  222 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYFAPI--------  222 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccCCCC--------
Confidence            2223458889999999988889999999999999999999999997654322      2222211 111111        


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .......+.+++.+|+..+|++||++.|+++.
T Consensus       223 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 -SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             11122467899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.98  E-value=2e-31  Score=282.00  Aligned_cols=246  Identities=27%  Similarity=0.497  Sum_probs=202.3

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      ..+.||+|++|.||+++..  +..+++|++........+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            4578999999999999986  48899999987665567889999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.... ..+++..+..++.|+++||++||+.   +++||||+|+||++++++.++|+|||.+........   ...
T Consensus        84 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~  156 (253)
T cd05122          84 LKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNT  156 (253)
T ss_pred             HHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccc
Confidence            999987632 5789999999999999999999997   999999999999999999999999999876643321   234


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDAN  807 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~  807 (878)
                      ..++..|+|||.+.+...+.++||||||+++++|++|+.||...........      .. ........++       ..
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-~~~~~~~~~~-------~~  222 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------IA-TNGPPGLRNP-------EK  222 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------HH-hcCCCCcCcc-------cc
Confidence            5688999999999988899999999999999999999999986543221111      00 1111111111       11


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          808 SVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       808 ~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ....+.+++.+|++.+|++||++.|+++.
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            13468899999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.98  E-value=6.7e-32  Score=289.27  Aligned_cols=235  Identities=24%  Similarity=0.380  Sum_probs=192.0

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      ||+|++|.||+++..  ++.+|+|++....   ....+.+.+|++++++++||||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999987  5889999987542   23456799999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      .+++.+  ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            999976  44589999999999999999999998   99999999999999999999999999998664322   12234


Q ss_pred             cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      .++..|++||.+.+..++.++|+||||+++|||++|+.||.......    .+....... +.        ....++...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~-~~--------~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILK-GN--------GKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhc-cC--------CCCCCCccc
Confidence            57889999999988889999999999999999999999997665211    111111111 00        011112222


Q ss_pred             HHHHHHHHHHccCCCCCCCCC
Q 002809          809 VWKAVELAMACLSPTGNQRPT  829 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPs  829 (878)
                      ...+.+++.+||+.+|++||+
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcC
Confidence            457889999999999999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=8.7e-32  Score=285.99  Aligned_cols=247  Identities=26%  Similarity=0.433  Sum_probs=202.0

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeEeeec
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALIYEFM  643 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~  643 (878)
                      ..+.||+|++|.||+|...  +..|++|++.....  ...+.+.+|++++++++|+||+++++.+...  ...++|+||+
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606           4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence            4578999999999999986  58899999876543  4567899999999999999999999999888  8899999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++++|.+++...  ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        84 ~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          84 SGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999999999763  3799999999999999999999998   99999999999999999999999999988764432211


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......++..|+|||.+.+...+.++||||||+++++|++|+.||........ .    ......         ......
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~~~---------~~~~~~  224 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-A----LYKIGS---------SGEPPE  224 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-H----HHhccc---------cCCCcC
Confidence            12345688899999999988899999999999999999999999987652111 0    111110         001111


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .+......+.+++.+|++.+|++||++.|+++
T Consensus       225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            22223457889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1.4e-31  Score=297.39  Aligned_cols=260  Identities=21%  Similarity=0.311  Sum_probs=195.6

Q ss_pred             cccccc--ccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKG--GFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G--~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ..||+|  +||+||+++..  ++.||+|++...  .....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999874  589999998753  334457889999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc--
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH--  723 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--  723 (878)
                      |+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999999875556799999999999999999999988   99999999999999999999999998654332111110  


Q ss_pred             ---ccccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHH-------------
Q 002809          724 ---VSTVVAGTPGYLDPEYYTSN--RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNS-------------  785 (878)
Q Consensus       724 ---~~~~~~gt~~Y~APE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~-------------  785 (878)
                         ......++..|+|||++.+.  .++.++|||||||+++||++|+.||........  +.+....             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence               01112345679999999763  478999999999999999999999987653221  1110000             


Q ss_pred             -------------------HHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          786 -------------------LIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       786 -------------------~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                                         ....+......+..+...........+.+++.+||+.+|++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                               000000001111111222223455678999999999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=1e-31  Score=296.04  Aligned_cols=262  Identities=19%  Similarity=0.258  Sum_probs=199.1

Q ss_pred             hcccccccccEEEEEEEEcceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      +.+.+|.|+++.||+++..++.||||++...  .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus         6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            3455677788888888888899999998754  34556789999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-----
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-----  722 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----  722 (878)
                      |.+++.......+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.+.........     
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99999865556789999999999999999999998   9999999999999999999999999988755322111     


Q ss_pred             cccccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHH----hcC------
Q 002809          723 HVSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLI----AKG------  790 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~----~~~------  790 (878)
                      .......++..|+|||++..  ..++.++|||||||+++||++|+.||........  +.+-.....    ...      
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhc
Confidence            11123446778999999876  3588999999999999999999999986543221  111111000    000      


Q ss_pred             -Cccc----ccCCccc----cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 -DIKS----IVDPRLQ----EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 -~~~~----iid~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ....    ..++...    .........++.+++.+||+.+|++||+++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             0000    0000000    00112233567899999999999999999999885

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.98  E-value=1.2e-31  Score=294.85  Aligned_cols=243  Identities=30%  Similarity=0.451  Sum_probs=194.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  +..||+|.+....   ....+.+.+|++++++++||||+++.++|..++..++|+||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            445678999999999999874  4889999886432   33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      ++ |+|.+++... ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++......   
T Consensus        97 ~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          97 CL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             hC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            96 5777776532 34689999999999999999999988   9999999999999999999999999998754322   


Q ss_pred             cccccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          723 HVSTVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                         ....++..|+|||++.   ...++.++||||||+++|||+||++||..........      . +.....     +.
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~-~~~~~~-----~~  233 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-IAQNDS-----PT  233 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------H-HhcCCC-----CC
Confidence               2245788999999874   4568889999999999999999999997655432111      1 111111     11


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.   .......+.+++.+||+.+|++||++.+|++.
T Consensus       234 ~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         234 LS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11   11234568899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=9.2e-32  Score=293.24  Aligned_cols=240  Identities=27%  Similarity=0.389  Sum_probs=197.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|++|.||++...  ++.+|+|++....   ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            45678999999999999875  3889999987532   234567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++++|.+++..  ...+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.+||+|||+++.....    
T Consensus        84 ~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          84 PGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            99999999976  46789999999999999999999998   9999999999999999999999999998865432    


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                       .....+++.|+|||.+.+...+.++||||||++++||++|+.||........       ...+..+..      .+.. 
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------~~~~-  219 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-------YEKILEGKV------RFPS-  219 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCc------cCCc-
Confidence             2234688999999999888889999999999999999999999976553211       111111211      1111 


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRP-----TMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~  835 (878)
                         .....+.+++.+||+.+|.+||     +++|+++
T Consensus       220 ---~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         220 ---FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               1134677899999999999999     6677764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.98  E-value=2.1e-31  Score=290.38  Aligned_cols=247  Identities=25%  Similarity=0.392  Sum_probs=193.3

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCC-----CcceeEee
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDED-----NQTALIYE  641 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-----~~~~lV~E  641 (878)
                      +.+.||+|+||.||++...  ++.+|+|++..... ....+.+|+.++.++ +|||++++++++...     +..++|+|
T Consensus        26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e  104 (291)
T cd06639          26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE  104 (291)
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence            3578999999999999875  37899999875432 235678899999999 799999999998643     35899999


Q ss_pred             eccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          642 FMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       642 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |+++|+|.++++..  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus       105 y~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~  181 (291)
T cd06639         105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST  181 (291)
T ss_pred             ECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence            99999999988642  245689999999999999999999988   9999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSN-----RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ..  ......|+..|+|||.+...     .++.++|||||||++|||++|++||........  +..+     .++....
T Consensus       182 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~~-----~~~~~~~  252 (291)
T cd06639         182 RL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFKI-----PRNPPPT  252 (291)
T ss_pred             cc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHHH-----hcCCCCC
Confidence            21  12234578899999998643     368899999999999999999999987654322  1111     1111111


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.++       .+....+.+++.+|++.+|++||++.|+++.
T Consensus       253 ~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         253 LLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1111       1223468899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.8e-32  Score=289.93  Aligned_cols=247  Identities=26%  Similarity=0.453  Sum_probs=195.2

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCC------cceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDN------QTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~------~~~lV  639 (878)
                      .+.+.||+|++|.||+|+...  ..+++|++..... ..+.+.+|+++++++ +|+||+++++++....      ..++|
T Consensus         9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv   87 (275)
T cd06608           9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV   87 (275)
T ss_pred             eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence            456889999999999999854  7899999876543 346799999999999 6999999999986544      48999


Q ss_pred             eeeccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          640 YEFMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      |||+++++|.+++....  ...+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  164 (275)
T cd06608          88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD  164 (275)
T ss_pred             EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence            99999999999987543  56789999999999999999999998   99999999999999999999999999987653


Q ss_pred             cCCCCcccccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTS-----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      ...  .......|+..|+|||.+..     ..++.++|||||||+++||++|+.||........  +.+    . ..+..
T Consensus       165 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~-~~~~~  235 (275)
T cd06608         165 STL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK----I-PRNPP  235 (275)
T ss_pred             cch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----h-hccCC
Confidence            221  12233458889999998753     3467899999999999999999999975443221  111    1 11111


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..     +.  ........+.+++.+||..+|++||++.|+++
T Consensus       236 ~~-----~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         236 PT-----LK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CC-----CC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11     11  11123346789999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=4.9e-32  Score=289.60  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=197.2

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      ||+|+||.||+++..  +..+++|++.....   ...+.+.+|++++.+++|+||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986  58899999876533   4557889999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC------C
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN------T  722 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~------~  722 (878)
                      .+++++  ...+++..++.++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++........      .
T Consensus        81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            999976  33789999999999999999999988   999999999999999999999999999875432211      1


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......++..|+|||.......+.++||||||++++||++|+.||......+..      ... ..+...      ...
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~-~~~~~~------~~~  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNI-LNGKIE------WPE  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-hcCCcC------CCc
Confidence            1223345788999999998888999999999999999999999999876543311      111 111110      000


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                        .......+.+++.+|++.+|++||++.++.+.|+
T Consensus       223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 --DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             --cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence              0011357789999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.98  E-value=9.2e-32  Score=324.41  Aligned_cols=250  Identities=23%  Similarity=0.382  Sum_probs=194.3

Q ss_pred             HhhhcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeEe
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALIY  640 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~  640 (878)
                      .+.+.+.||+|+||.||+++...  ..+|+|.+...  .......|..|+.++.+++|||||+++++|..  ....++||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM   93 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM   93 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence            34567899999999999998765  67899988753  33445788999999999999999999998743  45689999


Q ss_pred             eeccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCccEEEcCC------------
Q 002809          641 EFMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCK----PPIVHRDVKSTNILLNEK------------  702 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~ivHrDLKp~NILl~~~------------  702 (878)
                      ||+++|+|.++|....  ...+++..++.|+.||+.||+|||+...    .+||||||||+||||+.+            
T Consensus        94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~  173 (1021)
T PTZ00266         94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN  173 (1021)
T ss_pred             eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence            9999999999997532  3569999999999999999999998521    359999999999999642            


Q ss_pred             -----CcEEEeecCCccccccCCCCcccccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 002809          703 -----LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAISRINEEE  775 (878)
Q Consensus       703 -----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  775 (878)
                           ..+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||++|||+||+.||.......
T Consensus       174 n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~  250 (1021)
T PTZ00266        174 NLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS  250 (1021)
T ss_pred             ccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence                 358999999998653322   1233568999999999854  458899999999999999999999997644322


Q ss_pred             HHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          776 KIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       776 ~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                           ..+.. +..+.       .+..   .....++.+|+..||..+|.+||++.|+++
T Consensus       251 -----qli~~-lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        251 -----QLISE-LKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             -----HHHHH-HhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence                 11111 11111       1110   011246789999999999999999999985

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.98  E-value=1.2e-31  Score=290.50  Aligned_cols=261  Identities=25%  Similarity=0.321  Sum_probs=197.2

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeEeeec
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALIYEFM  643 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~  643 (878)
                      +.+.||+|++|.||+|+..+  ..+|+|++....  ....+.+.+|++++++++|+|++++++++...  +..++|+||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            45789999999999998764  889999998653  33456788999999999999999999999887  8899999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++ +|.+++... ...+++..++.++.|+++||+|||+.   +++|+||||+||++++++.+||+|||++........ .
T Consensus        83 ~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~  156 (287)
T cd07840          83 DH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A  156 (287)
T ss_pred             cc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence            74 888888653 25789999999999999999999998   999999999999999999999999999986643321 1


Q ss_pred             ccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc-------
Q 002809          724 VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI-------  795 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i-------  795 (878)
                      ......++..|+|||.+.+ ..++.++||||||++++||++|+.||.............-.............       
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            1223346788999998765 45789999999999999999999999876643322111000000000000000       


Q ss_pred             -------cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          796 -------VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       796 -------id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                             ....+...+...+...+.+++.+|+..+|++||+++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   00000000111124578899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=2.6e-31  Score=289.28  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=197.5

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~  644 (878)
                      +.+.||.|++|.||++...  ++.+|+|.+..... .....+.+|++++++++||||++++++|..  ....++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            3468999999999999985  38899999875433 445779999999999999999999998854  346899999999


Q ss_pred             CCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|.+++...  ....+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  159 (287)
T cd06621          85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--  159 (287)
T ss_pred             CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc--
Confidence            99999987542  245689999999999999999999998   99999999999999999999999999987543221  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINE--EEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                        .....++..|+|||.+.+..++.++|||||||++|||++|+.||.....  .....+..|...    .....+ ....
T Consensus       160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~  232 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-KDEP  232 (287)
T ss_pred             --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-ccCC
Confidence              1234578899999999999999999999999999999999999976532  111222233221    111111 0000


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .  ........+.+++.+|++.+|++||++.|+++.
T Consensus       233 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         233 G--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             C--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            0  011224568899999999999999999999883

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.98  E-value=1.2e-31  Score=291.62  Aligned_cols=247  Identities=23%  Similarity=0.386  Sum_probs=200.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|++|.||++...  +..+++|++..... ..+.+.+|++.+++++|+|++++++.+......++|+||++++
T Consensus        22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  100 (286)
T cd06614          22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG  100 (286)
T ss_pred             hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence            34468999999999999986  58899999986654 4578899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......  ....
T Consensus       101 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~  174 (286)
T cd06614         101 SLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRN  174 (286)
T ss_pred             cHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhc
Confidence            9999998632 3799999999999999999999997   99999999999999999999999999886553221  1122


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...++..|++||.+.+..++.++|||||||++|||++|+.||..........  .    . .........+       ..
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~----~-~~~~~~~~~~-------~~  240 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--L----I-TTKGIPPLKN-------PE  240 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----H-HhcCCCCCcc-------hh
Confidence            3457889999999998889999999999999999999999997655432111  1    1 1111111111       11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .....+.+++.+|++.+|.+||++.++++.
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             hCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            123467899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=8.4e-32  Score=287.86  Aligned_cols=244  Identities=24%  Similarity=0.357  Sum_probs=199.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  +..||+|.+....   ....+.+.+|++++++++||||+++++.+..+...++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            45688999999999999886  4889999987542   245678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      .+++|.+++..  ...+++..+..++.|+++||.|||+.   +++|+||||+||++++++.++|+|||++.......   
T Consensus        83 ~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---  154 (258)
T cd05578          83 LGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---  154 (258)
T ss_pred             CCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence            99999999976  35789999999999999999999988   99999999999999999999999999987654332   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|+..|+|||.+.+..++.++|+||||+++++|++|+.||..........    ........  .        ..
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~--~--------~~  220 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQETA--D--------VL  220 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhccc--c--------cc
Confidence            2233558889999999998889999999999999999999999998765421111    11111110  0        01


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTM--SQVV  834 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm--~evl  834 (878)
                      .+......+.+++.+|++.+|.+||++  +|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            112223578899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.98  E-value=1.6e-31  Score=291.65  Aligned_cols=260  Identities=22%  Similarity=0.332  Sum_probs=195.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~Ey  642 (878)
                      .+.+.||+|++|.||+|+..  ++.+++|.++....  .....+.+|++++.+++||||+++++++...  ...++|+||
T Consensus         8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~   87 (293)
T cd07843           8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY   87 (293)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehh
Confidence            44578999999999999986  47899999875432  2234678899999999999999999998776  889999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      ++ ++|.+++... ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++........ 
T Consensus        88 ~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  161 (293)
T cd07843          88 VE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-  161 (293)
T ss_pred             cC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-
Confidence            97 5999888653 23689999999999999999999998   999999999999999999999999999886643321 


Q ss_pred             cccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHH---------HHH--HHH--
Q 002809          723 HVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQ---------WVN--SLI--  787 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~---------~v~--~~~--  787 (878)
                       ......++..|+|||.+.+. ..+.++|+||||++++||++|++||.......... +..         |..  ...  
T Consensus       162 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         162 -PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             -ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence             11234478899999998754 46899999999999999999999998765432211 111         100  000  


Q ss_pred             hcCCcccccCCccccccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDAN-SVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ............+...++.. ....+.+++.+|++.+|++||+++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000011111111112211 2456789999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=290.92  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=195.5

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.||+|++|.||+|+..  +..||+|++....  ......+.+|++++++++|+|++++++++..++..++||||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            4578999999999999874  5889999987543  2234678899999999999999999999999999999999995 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.......+++..+++++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++........  ..
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~  156 (283)
T cd07835          82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TY  156 (283)
T ss_pred             cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--cc
Confidence            6999998764445799999999999999999999998   999999999999999999999999999876532211  11


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC-----------C--
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG-----------D--  791 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~-----------~--  791 (878)
                      ....++..|+|||++.+. .++.++||||||+++|||++|++||........  +....+......           .  
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhhh
Confidence            223467899999988654 578899999999999999999999976554321  111111100000           0  


Q ss_pred             --cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          792 --IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       792 --~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ......... ..........+.+++.+|++.+|++||+++|+++
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              000000000 0011122346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=1.4e-31  Score=291.10  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=192.6

Q ss_pred             cccccccccEEEEEEEEcc--eeEEEEEeccCC-hhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeeccCC
Q 002809          571 ERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.||+|+||.||+++...  +.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+. +
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-I   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-C
Confidence            4679999999999998754  889999987543 344567899999999996 9999999999998899999999986 4


Q ss_pred             Chhhhh---ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          647 NLQEYL---SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       647 sL~~~l---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      +|.++.   .......+++..+..++.|++.||+|||+.+  +++||||||+||+++.++.+||+|||+++.+....   
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---  162 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---  162 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC---
Confidence            555443   2223467999999999999999999999642  89999999999999999999999999987653221   


Q ss_pred             ccccccCCCCccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          724 VSTVVAGTPGYLDPEYYTSN---RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ......|+..|+|||.+.+.   .++.++|||||||+++||++|+.||.....     ..+-+..... +.     .+.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~-----~~~~  231 (288)
T cd06616         163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GD-----PPIL  231 (288)
T ss_pred             ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CC-----CCcC
Confidence            11223578899999999876   689999999999999999999999975431     1111111111 11     1122


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..........++.+++.+|++.+|++||++++|++.
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            222222344578899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=295.61  Aligned_cols=263  Identities=20%  Similarity=0.303  Sum_probs=194.8

Q ss_pred             hhcccccccccEEEEEEEEc----ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLN----EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV  639 (878)
                      .+.+.||+|++|.||+|+..    +..||+|.+....   ....+.+.+|++++.+++||||+++++++...  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            45678999999999999873    4789999998633   33346778999999999999999999999887  789999


Q ss_pred             eeeccCCChhhhhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC----CCcEEEeecCC
Q 002809          640 YEFMANGNLQEYLSDIS---KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGL  712 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~----~~~~kL~DFGl  712 (878)
                      |||+++ +|.+++....   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.    ++.+||+|||+
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999975 6777664322   23689999999999999999999998   9999999999999999    99999999999


Q ss_pred             ccccccCCC-CcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHH-------HHHHHHHH
Q 002809          713 SKSFATDAN-THVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEE-------KIHIRQWV  783 (878)
Q Consensus       713 a~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------~~~l~~~v  783 (878)
                      +........ ........++..|+|||.+.+. .++.++|||||||+++||++|++||.......       ...+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            886643222 1122234578899999988764 57899999999999999999999997654322       11111111


Q ss_pred             HHHHh-----------cCCcccccCCccccccC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          784 NSLIA-----------KGDIKSIVDPRLQEDFD---------A--NSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       784 ~~~~~-----------~~~~~~iid~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..+-.           ........+......++         .  ....++.+++.+|++.+|++|||+.|+++
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11000           00000000000000000         0  23346889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.98  E-value=2.3e-31  Score=294.15  Aligned_cols=244  Identities=30%  Similarity=0.440  Sum_probs=194.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ...+.||+|+||.||+++..  +..+|+|++...   .....+.+.+|++++++++|+|++++++++..+...++||||+
T Consensus        28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  107 (317)
T cd06635          28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC  107 (317)
T ss_pred             hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence            34578999999999999874  478999998743   2234567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      . |+|.+.+... ...+++.++..++.|++.||.|||+.   +|+||||+|+||+++.++.+||+|||++......    
T Consensus       108 ~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         108 L-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             C-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            6 5787777542 45689999999999999999999998   9999999999999999999999999988654321    


Q ss_pred             ccccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          724 VSTVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                        ....|+..|+|||++.   ...++.++|||||||+++||++|+.||........  +..+    ...+. ..     .
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~----~~~~~-~~-----~  244 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI----AQNES-PT-----L  244 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH----HhccC-CC-----C
Confidence              2245788999999974   45688999999999999999999999876543221  1111    11111 00     0


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                         ........+.+++.+|++.+|.+||++.++++.+.
T Consensus       245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             ---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence               01122346789999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.98  E-value=9.3e-32  Score=291.42  Aligned_cols=247  Identities=23%  Similarity=0.377  Sum_probs=189.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHH-HHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKL-LMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~-L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++.... .....++..|+.. ++.++||||+++++++..++..++||||++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD   83 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence            34578999999999999875  4889999987543 2334556667665 555689999999999999999999999996


Q ss_pred             CCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                       |+|.+++...  ....+++..++.++.|++.||+|||+++  +++||||||+||+++.++.+||+|||++.......  
T Consensus        84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (283)
T cd06617          84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--  158 (283)
T ss_pred             -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence             6888887542  2456899999999999999999999753  79999999999999999999999999987653211  


Q ss_pred             cccccccCCCCccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          723 HVSTVVAGTPGYLDPEYYTS----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                       ......++..|+|||.+.+    ..++.++|+|||||+++||++|+.||....... ..+..    ... +...     
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~----~~~-~~~~-----  226 (283)
T cd06617         159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQ----VVE-EPSP-----  226 (283)
T ss_pred             -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHH----HHh-cCCC-----
Confidence             1223457889999998865    456889999999999999999999996533211 11111    111 1111     


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .+..   .....++.+++.+|+..+|++||+++++++
T Consensus       227 ~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         227 QLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1110   112346789999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.98  E-value=1.9e-31  Score=289.40  Aligned_cols=241  Identities=25%  Similarity=0.352  Sum_probs=186.2

Q ss_pred             cccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHH---hcccceeeeeecccCCCcceeEeeecc
Q 002809          573 TLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMR---VHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~---l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .||+|+||.||+++..  ++.+|+|.+.....   .....+.+|..++..   .+|||++.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875  47899998865421   222334455544443   369999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++|+|||++.......    
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            9999999875  45699999999999999999999998   99999999999999999999999999987543221    


Q ss_pred             cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....|+..|+|||.+.. ..++.++|||||||+++||++|+.||..........+.+    ....      ....+   
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~------~~~~~---  218 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------VNVEL---  218 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhhc------CCcCC---
Confidence            123458999999999864 568899999999999999999999997654322111111    1110      01111   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                       +.....++.+++.+|++.+|++||     ++++++++
T Consensus       219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             122334678999999999999999     58887664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=302.76  Aligned_cols=247  Identities=25%  Similarity=0.441  Sum_probs=205.3

Q ss_pred             hhcccccccccEEEEEEEEccee--EEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~--vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      ++...||-|+||.||++..++..  .|.|++.-.+......|+-||++|....||+||+|++.|..++.++++.|||.||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            34467899999999999887643  5788888888888999999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      -++.++-.. ...+.+.++..+++|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+.....  ......
T Consensus       115 AVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRD  188 (1187)
T KOG0579|consen  115 AVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRD  188 (1187)
T ss_pred             hHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HHhhhc
Confidence            999988654 56799999999999999999999999   999999999999999999999999998754321  122344


Q ss_pred             cccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          727 VVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .+.||+.|||||+..     ..+|+.++||||||+.|.||..+.+|-...++-.       |.-.+.+..-..++.|.- 
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-------VllKiaKSePPTLlqPS~-  260 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPPTLLQPSH-  260 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------HHHHHhhcCCCcccCcch-
Confidence            578999999999875     4579999999999999999999999987765422       222233333333443332 


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                            -...+.+++..||..+|..||+++++++
T Consensus       261 ------Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  261 ------WSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------hhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  2346778999999999999999999986

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=4.5e-31  Score=287.75  Aligned_cols=260  Identities=22%  Similarity=0.280  Sum_probs=192.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|...  +..||+|++..... .....+.+|+++++.++|+||+++.+++..++..++|+||+. 
T Consensus         8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-   86 (291)
T cd07870           8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-   86 (291)
T ss_pred             EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence            34678999999999999764  58899999875432 233467899999999999999999999999999999999995 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++... ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++++||+|||+++......  ...
T Consensus        87 ~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~  160 (291)
T cd07870          87 TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTY  160 (291)
T ss_pred             CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCC
Confidence            6787776542 34578889999999999999999998   99999999999999999999999999987543221  112


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHH----------Hhc-CCcc
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL----------IAK-GDIK  793 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~----------~~~-~~~~  793 (878)
                      ....++..|+|||.+.+. .++.++|||||||+++||++|+.||.............|....          ... ....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            233478899999998754 5788999999999999999999999865543221111111000          000 0000


Q ss_pred             cccCCcccccc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          794 SIVDPRLQEDF-----DANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       794 ~iid~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +..........     .......+.+++.+|++.+|++|||++|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000     0011346778999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=317.45  Aligned_cols=255  Identities=29%  Similarity=0.487  Sum_probs=208.3

Q ss_pred             hcccccccccEEEEEEEEc---------ceeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          570 FERTLGKGGFGTVYYGRLN---------EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.||+|+||.|++|...         ...||||+++.. .....+.+..|+++|..+ +|+||+.++|+|..++..++
T Consensus       300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~  379 (609)
T KOG0200|consen  300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV  379 (609)
T ss_pred             ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence            4569999999999999754         256999999865 335678899999999999 59999999999999999999


Q ss_pred             EeeeccCCChhhhhcccc------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc
Q 002809          639 IYEFMANGNLQEYLSDIS------K--------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ  704 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~  704 (878)
                      |+||+..|+|.++|+..+      .        ..++....+.++.|||.|++||++.   ++|||||..+|||+.++..
T Consensus       380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCE
Confidence            999999999999997644      0        2388999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccccCCCCccc-ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002809          705 AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQW  782 (878)
Q Consensus       705 ~kL~DFGla~~~~~~~~~~~~-~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  782 (878)
                      +||+|||+++........... ....-...|||||.+....++.|+|||||||+||||+| |..||.......  .+.+ 
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--~l~~-  533 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE--ELLE-  533 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--HHHH-
Confidence            999999999866443332211 11012456999999999999999999999999999999 789987643222  1122 


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                         .+.+|.         +.+.+..+..++.+++..||+.+|++||+..|+++.++..+.
T Consensus       534 ---~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  534 ---FLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             ---HHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence               334443         122344556688899999999999999999999999999654

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=2.2e-31  Score=283.10  Aligned_cols=247  Identities=27%  Similarity=0.441  Sum_probs=203.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||++...  +..+++|++.....  ...+.+.+|++++++++|+|++++.+.+..+...++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            34578999999999999986  58899999876533  556788999999999999999999999999999999999999


Q ss_pred             CCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|.+++....  ...+++..+..++.++++||.|||+.   +++|+||+|+||++++++.++|+|||.+.......  
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            999999997643  46799999999999999999999998   99999999999999999999999999987654332  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......|+..|+|||.+.+..++.++||||+|+++++|++|+.||.......      ....... ....     .   
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~-----~---  222 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILK-GQYP-----P---  222 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhc-CCCC-----C---
Confidence            12233468889999999998889999999999999999999999997655322      1111111 1111     1   


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .+......+.+++.+||..+|++||++.++++.
T Consensus       223 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         223 -IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             111233467899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-31  Score=283.82  Aligned_cols=243  Identities=25%  Similarity=0.344  Sum_probs=189.8

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHH-HhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLM-RVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~-~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|++|.||+|+..  ++.||+|++.....   .....+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999874  47899999875432   22234455555443 44899999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++..  ...+++..+..++.|+++||.|||+.   +++||||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            999999975  45689999999999999999999998   999999999999999999999999999875422      2


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....++..|+|||.+.+..++.++||||||++++||++|..||.........      .. +..+...      ......
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~------~~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF------DN-ILSRRIN------WPEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH------HH-HHhcccC------CCCccc
Confidence            2345788999999998888999999999999999999999999765543211      11 1111110      000111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ......+.+++.+||+.+|++||++.++.+.|+
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            123356889999999999999998876655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=2.8e-31  Score=291.38  Aligned_cols=264  Identities=23%  Similarity=0.301  Sum_probs=192.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCC--------c
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN--------Q  635 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--------~  635 (878)
                      +.+.+.||+|+||.||+++..  +..||||.+....  ......+.+|++++++++||||++++++|....        .
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            345678999999999999875  4889999886432  222345678999999999999999999886544        3


Q ss_pred             ceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          636 TALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       636 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      .++||||+. ++|.+.+... ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        94 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          94 FYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             EEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            499999996 4888877642 34689999999999999999999998   999999999999999999999999999976


Q ss_pred             cccCCCC--cccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          716 FATDANT--HVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       716 ~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      +......  .......++..|+|||.+.+. .++.++||||||++++||++|++||..............+.........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            6432211  112234577889999988664 4788999999999999999999999876654333222221111000000


Q ss_pred             ccc-----cCC-cccccc---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 KSI-----VDP-RLQEDF---------DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 ~~i-----id~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...     .+. .+....         .......+.+++.+||..+|++||+++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000     000 000000         00112356789999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=275.29  Aligned_cols=265  Identities=23%  Similarity=0.354  Sum_probs=208.7

Q ss_pred             CCCHHHHHHHHhhhcccccccccEEEEEEE--EcceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCC
Q 002809          557 HLSYSDVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDED  633 (878)
Q Consensus       557 ~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~--~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~  633 (878)
                      .-+++|+.+.|.   +.||+|+++.|--++  .++.++|||++.+.....+.+..+|++++.+.+ |+||++|+.+|+++
T Consensus        72 ~g~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   72 SGKFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             cchHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            345889988885   689999999998664  456899999999998888899999999999995 99999999999999


Q ss_pred             CcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---cEEEeec
Q 002809          634 NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---QAKLADF  710 (878)
Q Consensus       634 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~DF  710 (878)
                      ...|||||-|.||.|..++++  +..+++.++.++.++|+.||.+||.+   +|.|||+||+|||-....   -+||+||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence            999999999999999999987  77899999999999999999999998   999999999999997654   4799999


Q ss_pred             CCccccccCC-----CCcccccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH----
Q 002809          711 GLSKSFATDA-----NTHVSTVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK----  776 (878)
Q Consensus       711 Gla~~~~~~~-----~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~----  776 (878)
                      .+...+....     ....-...+|+..|||||+..     ...|++++|.||||||+|-|++|.+||.+.-.++-    
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            9875442111     122223467889999999863     34689999999999999999999999987432110    


Q ss_pred             ----HHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          777 ----IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       777 ----~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                          ..=.+-....+++|.. ++-|+.     ......+..+++...+..++.+|-++.+++.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccHHHHHHHHHHHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                0001112233344432 111111     1234456678888889999999999999887

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2.6e-31  Score=296.23  Aligned_cols=262  Identities=25%  Similarity=0.372  Sum_probs=195.0

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHh-cccceeeeeecccCC--CcceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDED--NQTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~--~~~~lV~  640 (878)
                      +.+.+.||+|+||.||+|...  +..+|+|++...  .......+.+|+.++.++ +|+||++++++|...  ...++||
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            455688999999999999874  488999988642  333456778899999999 999999999988643  4679999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||++ ++|.+++..   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        89 e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          89 EYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             cccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            9997 599988865   2788999999999999999999998   99999999999999999999999999998664332


Q ss_pred             CC---cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHH--------HHh
Q 002809          721 NT---HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNS--------LIA  788 (878)
Q Consensus       721 ~~---~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~--------~~~  788 (878)
                      ..   .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..........        .+.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence            21   12233458899999998764 4678899999999999999999999976554322111000000        000


Q ss_pred             cCCcccccC----Cccc--cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          789 KGDIKSIVD----PRLQ--EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       789 ~~~~~~iid----~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ......+++    ....  .........++.+++.+|++.+|++||++.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000110    0000  00011134578899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=3.8e-31  Score=286.25  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=192.4

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhc-ccceeeeeecccCC--CcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDED--NQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~--~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+++..  +..+|+|++.... ........+|+.++.++. |+|++++++++.+.  +..++|+||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            35678999999999999874  4789999987542 222334567999999985 99999999999877  889999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      ++ |+|.+++... ...+++..++.++.|++.||+|||+.   +++||||||+||+++. +.+||+|||+++....... 
T Consensus        82 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          82 MD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             CC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            96 5888887652 35689999999999999999999998   9999999999999999 9999999999986633221 


Q ss_pred             cccccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHH-----------hcC
Q 002809          723 HVSTVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLI-----------AKG  790 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~-----------~~~  790 (878)
                        .....++..|+|||++. +..++.++|||||||+++||++|++||...+..+.   ..+.....           ...
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhccc
Confidence              12245788999999765 45678899999999999999999999977654321   11111111           111


Q ss_pred             CcccccCCccc-c---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 DIKSIVDPRLQ-E---DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 ~~~~iid~~l~-~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .......+... .   .........+.+++.+||+.+|++||+++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            10010000000 0   0011235688999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=5e-31  Score=288.63  Aligned_cols=258  Identities=27%  Similarity=0.362  Sum_probs=193.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCC---------
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN---------  634 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~---------  634 (878)
                      +.+.+.||+|+||.||+|...  ++.||+|++....  ......+.+|++++++++|||++++++++.+..         
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~   88 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK   88 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence            445689999999999999985  4789999987543  223456788999999999999999999886654         


Q ss_pred             -cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCc
Q 002809          635 -QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS  713 (878)
Q Consensus       635 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla  713 (878)
                       ..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++
T Consensus        89 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          89 GAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             CcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccc
Confidence             78999999976 777776542 34689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC--
Q 002809          714 KSFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG--  790 (878)
Q Consensus       714 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~--  790 (878)
                      ........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||......+..  ... .......  
T Consensus       164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~--~~~-~~~~~~~~~  239 (302)
T cd07864         164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--ELI-SRLCGSPCP  239 (302)
T ss_pred             ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH-HHHhCCCCh
Confidence            86643322 11122345778999998865 45788999999999999999999999865543221  111 1111000  


Q ss_pred             -Cccccc--------CC------ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          791 -DIKSIV--------DP------RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       791 -~~~~ii--------d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       ....+.        ++      ...... ......+.+++..||+.+|++||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             000000        00      000000 112457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=5.5e-31  Score=287.79  Aligned_cols=243  Identities=20%  Similarity=0.344  Sum_probs=197.4

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      ..||+|+||.||++...  +..||+|++..........+.+|+.++++++|+|++++++.+...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999874  4889999987655556678999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      +++..   ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......  .......
T Consensus       106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            98753   3589999999999999999999998   99999999999999999999999999987653322  1223345


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHH
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV  809 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~  809 (878)
                      |+..|+|||.+.+..++.++||||||++++||++|+.||..........   ......         .+.+..  .....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~~~~---------~~~~~~--~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNL---------PPKLKN--LHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhhC---------CcccCC--cccCC
Confidence            8899999999988889999999999999999999999997654432211   111100         011110  01122


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          810 WKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       810 ~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..+.+++.+||+.+|.+||++.++++.
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            356789999999999999999998873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.3e-31  Score=280.72  Aligned_cols=244  Identities=27%  Similarity=0.476  Sum_probs=200.4

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+++...  ..|++|.+.....  .....+.+|++++.+++|+|++++++++..++..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            346789999999999998753  7899999986644  456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.........  
T Consensus        83 ~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          83 NGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             CCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            9999999876  36789999999999999999999988   9999999999999999999999999999876433221  


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      .....++..|+|||...+...+.++||||+|+++++|++|+.|+.........    |  .... ...     +.    .
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~--~~~~-~~~-----~~----~  219 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----F--RIVQ-DDH-----PP----L  219 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----H--HHhc-cCC-----CC----C
Confidence            23345788999999998888899999999999999999999999765432211    1  1111 110     11    1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +......+.+++.+||..+|++||++.+++.
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1122346779999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=4e-31  Score=286.15  Aligned_cols=240  Identities=25%  Similarity=0.353  Sum_probs=190.4

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      ||+|+||+||++...  ++.+|+|.+....   ......+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999765  4789999987532   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      .+++.......+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            9999765555799999999999999999999998   99999999999999999999999999987653211   12234


Q ss_pred             cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      .++..|+|||.+.+..++.++|||||||++++|++|+.||..........  + ........          ....+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~~~~~~~----------~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-LKRRTLEM----------AVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-HHhccccc----------cccCCccC
Confidence            57789999999988889999999999999999999999997654311100  0 00000000          00111122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHH
Q 002809          809 VWKAVELAMACLSPTGNQRPTMSQ  832 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPsm~e  832 (878)
                      ...+.+++.+||+.+|++||+.++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCc
Confidence            346789999999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=3.8e-31  Score=286.75  Aligned_cols=258  Identities=23%  Similarity=0.389  Sum_probs=196.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|++|.||+|+..  +..||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            34678999999999999985  47899999876532 2346778899999999999999999999999999999999985


Q ss_pred             CChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          646 GNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       646 gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                       +|.+++.... ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.++|+|||++........  .
T Consensus        83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  156 (284)
T cd07836          83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--T  156 (284)
T ss_pred             -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--c
Confidence             8888886533 35689999999999999999999988   999999999999999999999999999876532211  1


Q ss_pred             cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHH-------HHHhcCCcccc
Q 002809          725 STVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVN-------SLIAKGDIKSI  795 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~-------~~~~~~~~~~i  795 (878)
                      .....++..|++||++.+. .++.++|||||||+++||++|++||......+... +.+...       +.+.  .....
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  234 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QLPEY  234 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cCchh
Confidence            1223468899999998654 57889999999999999999999998765432211 111100       0000  00000


Q ss_pred             cCCccc-------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          796 VDPRLQ-------EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       796 id~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       .....       ..........+.+++.+|++.+|++||+++|+++
T Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 -KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             -cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             00000       0011123456789999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=3e-31  Score=282.42  Aligned_cols=245  Identities=26%  Similarity=0.426  Sum_probs=201.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+++..  +..+++|.+...  .......+.+|++++++++|+||+++.+++..+...++|+||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            34578999999999999765  378999998754  23445678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|.+++.+..  ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++......   
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            999999986532  45689999999999999999999988   9999999999999999999999999999776433   


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                       ......++..|++||.+.+..++.++|+||||++++||++|+.||......+.   ..    ....+...         
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~---------  219 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RY----KVQRGKYP---------  219 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHhcCCCC---------
Confidence             12234578899999999998999999999999999999999999987654321   11    11111111         


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ........++.+++.+|++.+|++||++.|+++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1112334568899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=7.4e-31  Score=284.34  Aligned_cols=261  Identities=26%  Similarity=0.361  Sum_probs=196.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+|+..  ++.|++|++..... .......+|+..+.+++ |+|++++++++..++..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            35678999999999999985  47899999875432 22334567999999999 999999999999999999999999 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.+++.......+++..++.++.|++.+|.|||+.   +++|+||||+||++++++.++|+|||++........   
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---  154 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---  154 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence            88999998765456789999999999999999999998   999999999999999999999999999876532211   


Q ss_pred             cccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHH---------HHHHHHhcCCcc
Q 002809          725 STVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQ---------WVNSLIAKGDIK  793 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~---------~v~~~~~~~~~~  793 (878)
                      .....++..|+|||.+. ...++.++|+||||++++||++|++||......+... ...         |...........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            12245788999999875 4557899999999999999999999997665432211 111         111110001111


Q ss_pred             cccCCccc---cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          794 SIVDPRLQ---EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       794 ~iid~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..+.....   ..........+.+++.+|++.+|++||+++|++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000   00001113578899999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-31  Score=297.95  Aligned_cols=258  Identities=23%  Similarity=0.369  Sum_probs=192.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCC-----CcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED-----NQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|+..  ++.||+|.+.... ......+.+|+.++++++|+||+++++++...     ...++|+
T Consensus         8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   87 (336)
T cd07849           8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ   87 (336)
T ss_pred             EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence            45688999999999999864  4889999987532 33456788999999999999999999876543     3579999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||++ ++|.+++.   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        88 e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          88 ELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             hhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            9996 48877775   35699999999999999999999998   99999999999999999999999999987653322


Q ss_pred             C-CcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC---cccc
Q 002809          721 N-THVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD---IKSI  795 (878)
Q Consensus       721 ~-~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~---~~~i  795 (878)
                      . ........|+..|+|||.+.+ ..++.++|||||||+++||++|++||.........   .++........   ...+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHHHh
Confidence            1 111223468899999998754 56889999999999999999999999765432211   11111111100   0000


Q ss_pred             cCCcc---------cccc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          796 VDPRL---------QEDF-----DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       796 id~~l---------~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+...         ....     ......++.+++.+||+.+|++||++.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000         0000     01123468899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-31  Score=285.87  Aligned_cols=256  Identities=24%  Similarity=0.331  Sum_probs=197.6

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ..+.||+|++|.||+++..  +..+++|.+.....  .....+.+|++++++++|+||+++++++..+...++|+||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            4568999999999999875  47899999875432  2456788999999999999999999999999999999999975


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                       +|.+++... ...+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.++|+|||.+.......  ...
T Consensus        83 -~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~  155 (283)
T cd05118          83 -DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY  155 (283)
T ss_pred             -CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence             888888653 25789999999999999999999998   99999999999999999999999999987664432  112


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC---CcccccC----
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG---DIKSIVD----  797 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~---~~~~iid----  797 (878)
                      ....++..|+|||.+.+. ..+.++||||||+++++|+||+.||...+..+....   ........   ......+    
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhhh
Confidence            224577889999998876 789999999999999999999999977654332111   00000000   0000000    


Q ss_pred             --Cccc-------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 --PRLQ-------EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 --~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ....       .........++.+++.+|++.+|.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              0000       0111234567889999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-33  Score=285.08  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=203.4

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      ++.+.||+|++|.||++.+..  ..+|+|.+...  ...+++..|+.+|++.+.|++|+++|.+.....+++|||||..|
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            345789999999999997754  77899987654  34688999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      ++.++++. +++.+++.++..+++..++||+|||..   .-||||||+.|||++.+|.+||+|||.+..+...  -....
T Consensus       114 SiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN  187 (502)
T KOG0574|consen  114 SISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN  187 (502)
T ss_pred             cHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence            99999874 577899999999999999999999987   7899999999999999999999999999776322  12234


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      .+.||+.|||||++..-.|..++||||+|+...||..|++||.+..+-....       ++....-     |.+  ..+.
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------MIPT~PP-----PTF--~KPE  253 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------MIPTKPP-----PTF--KKPE  253 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------eccCCCC-----CCC--CChH
Confidence            5779999999999999999999999999999999999999998754321100       0111110     111  1233


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .-..++-+++++||-..|++|-++.++++.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            345578899999999999999999998773

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.5e-31  Score=282.85  Aligned_cols=246  Identities=25%  Similarity=0.403  Sum_probs=193.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC-----ChhhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-----SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-----~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV  639 (878)
                      .+.+.||+|+||.||+++..  +..||+|.+...     ..+..+.+.+|++++++++|+||+++++++...  ...++|
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF   84 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence            45689999999999999864  478999987532     233456889999999999999999999988654  457899


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      +||+++++|.+++..  ...+++...+.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.....
T Consensus        85 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          85 VEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            999999999999875  34588999999999999999999988   9999999999999999999999999999765321


Q ss_pred             CC-CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          720 AN-THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       720 ~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .. ........++..|+|||++.+...+.++|||||||+++||++|+.||........  +    ...... ..      
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~-~~------  226 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--I----FKIATQ-PT------  226 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--H----HHHHcC-CC------
Confidence            11 1111234588899999999988899999999999999999999999976543221  1    111111 10      


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ....+......+.+++.+|+. .|.+||+..+++.
T Consensus       227 --~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 --KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              011222333567899999999 4799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=4.2e-31  Score=288.38  Aligned_cols=258  Identities=21%  Similarity=0.315  Sum_probs=193.4

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+|+..  ++.||+|.+.....  ...+.+.+|++++++++|+||+++++++..+...++||||++
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD   84 (294)
T ss_pred             EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence            34578999999999999875  47899999865432  334678899999999999999999999999999999999995


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-CCcEEEeecCCccccccCCCCc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~  723 (878)
                       ++|.+++.......+++..+..++.||+.||+|||+.   +++||||||+||+++. ++.+||+|||++........  
T Consensus        85 -~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--  158 (294)
T PLN00009         85 -LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--  158 (294)
T ss_pred             -ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--
Confidence             5888887654444568889999999999999999998   9999999999999985 55799999999976533211  


Q ss_pred             ccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc------
Q 002809          724 VSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV------  796 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii------  796 (878)
                      ......++..|+|||++.+. .++.++|||||||++++|+||++||......+...  +.. ...... .....      
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~~~-~~~~~~-~~~~~~~~~~~  234 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--KIF-RILGTP-NEETWPGVTSL  234 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HHhCCC-Chhhccccccc
Confidence            11223467899999998664 57899999999999999999999997655432211  100 000000 00000      


Q ss_pred             -C-----Ccccc----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          797 -D-----PRLQE----DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       797 -d-----~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       +     +....    ........++.+++.+|++.+|++||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0     00000    0011223467899999999999999999999863

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=6.8e-31  Score=284.88  Aligned_cols=258  Identities=24%  Similarity=0.349  Sum_probs=195.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHh---cccceeeeeecccCCCc-----c
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRV---HHRNLTSLVGHCDEDNQ-----T  636 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~~~~-----~  636 (878)
                      ++.+.||+|+||.||+|+..  +..+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            34578999999999999986  48899999874322  2234567788877776   59999999999987766     8


Q ss_pred             eeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      +++|||+. ++|.+++.......+++..++.++.|+++||+|||+.   +++|+||||+||++++++.+||+|||++..+
T Consensus        82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            99999996 5899988765455699999999999999999999998   9999999999999999999999999998766


Q ss_pred             ccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc----
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI----  792 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~----  792 (878)
                      .....   .....++..|+|||.+.+..++.++|||||||+++||++|++||......+.  +..+.......+..    
T Consensus       158 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         158 SFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             cCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcCC
Confidence            33221   1123478899999999998999999999999999999999999987654332  22222111100000    


Q ss_pred             -----ccccCCccccc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          793 -----KSIVDPRLQED---FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       793 -----~~iid~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                           ...........   ...+....+.+++.+||+.+|++||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 00000000000   11123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=5e-31  Score=287.68  Aligned_cols=258  Identities=19%  Similarity=0.276  Sum_probs=191.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhc-ccceeeeeecccCCCc-----cee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQ-----TAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~-----~~l  638 (878)
                      ...+.||+|+||.||+|+..  ++.||+|.+.....  .....+.+|+.++.+++ |+||+++++++...+.     .++
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            34578999999999999875  48899998765432  23467889999999995 6999999999876665     899


Q ss_pred             EeeeccCCChhhhhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-CCcEEEeecCCcc
Q 002809          639 IYEFMANGNLQEYLSDIS---KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSK  714 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~  714 (878)
                      ||||+++ +|.+++....   ...+++..++.++.||++||+|||+.   +|+||||||+||+++. ++.+||+|||+++
T Consensus        84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence            9999985 8988886532   34689999999999999999999998   9999999999999999 8899999999987


Q ss_pred             ccccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC--
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD--  791 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~--  791 (878)
                      .+......  .....+++.|+|||.+.+ ..++.++||||||++++||++|.+||.........  ..... .+....  
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~-~~~~~~~~  234 (295)
T cd07837         160 AFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFK-LLGTPTEQ  234 (295)
T ss_pred             ecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHH-HhCCCChh
Confidence            65322111  122346788999998865 45789999999999999999999999765442211  11111 000000  


Q ss_pred             -cccccC-------Cccc----cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          792 -IKSIVD-------PRLQ----EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       792 -~~~iid-------~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       .....+       +...    .........++.+++.+||..+|++||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             000000       0000    0000123456889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=2.3e-31  Score=296.38  Aligned_cols=262  Identities=19%  Similarity=0.307  Sum_probs=195.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccC----CCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE----DNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV~  640 (878)
                      .+.+.||+|++|.||+++..  +..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....++|+
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~   87 (334)
T cd07855           8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM   87 (334)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence            34578999999999999875  4889999987542  2345678889999999999999999998753    34689999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+. |+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||++.......
T Consensus        88 e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          88 DLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             ehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            9995 689999865  45599999999999999999999998   99999999999999999999999999987653322


Q ss_pred             CC--cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--------HHHHhc
Q 002809          721 NT--HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWV--------NSLIAK  789 (878)
Q Consensus       721 ~~--~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v--------~~~~~~  789 (878)
                      ..  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.............-.        ......
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            21  11223468889999999865 46899999999999999999999999775543221110000        000000


Q ss_pred             CCcccccCC-cccccc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          790 GDIKSIVDP-RLQEDF-----DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       790 ~~~~~iid~-~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..+.+..+. ......     ......++.+++.+|++.+|++||+++++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            001111000 000000     11234578899999999999999999999885

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=1.2e-30  Score=293.09  Aligned_cols=258  Identities=22%  Similarity=0.299  Sum_probs=193.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC------Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~  637 (878)
                      +...+.||+|+||.||+++..  ++.||+|.+...  .....+.+.+|+.++++++|+||+++++++...      ...+
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   97 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY   97 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence            344578999999999999874  488999998643  334456788999999999999999999987543      3568


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+. ++|.+.+..    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        98 lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          98 LVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             EEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            9999995 588887753    288999999999999999999998   99999999999999999999999999997653


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HH--------HH------
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IR--------QW------  782 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~--------~~------  782 (878)
                      ...   ......++..|+|||.+.+..++.++|||||||++++|++|+.||...+...... +.        ++      
T Consensus       170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         170 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            221   1223457889999999999999999999999999999999999997654322110 00        00      


Q ss_pred             -HHHHHhcCC------cccccCCccc----cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          783 -VNSLIAKGD------IKSIVDPRLQ----EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       783 -v~~~~~~~~------~~~iid~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .........      ..+.+.....    .........++.+++.+||+.||++||++.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000000000      0011111100    00011234567899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=3.2e-31  Score=295.66  Aligned_cols=262  Identities=23%  Similarity=0.377  Sum_probs=196.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC-----CcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED-----NQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~lV  639 (878)
                      ...+.||+|+||.||+++..  ++.||||.+...  .......+.+|+.++++++|+||+++++++...     ...++|
T Consensus         8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv   87 (337)
T cd07858           8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV   87 (337)
T ss_pred             eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence            44578999999999999875  488999998753  233456778899999999999999999987544     357999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      +||+. ++|.+++..  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          88 YELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            99995 689888875  45699999999999999999999998   9999999999999999999999999999865332


Q ss_pred             CCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHH-------HHhcC
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNS-------LIAKG  790 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~~-------~~~~~  790 (878)
                      .  .......++..|+|||.+.. ..++.++|||||||++++|++|++||...+...... +.+....       .+..+
T Consensus       162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         162 G--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             c--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            1  11223457889999998864 468899999999999999999999997654322111 1110000       00000


Q ss_pred             Cccccc-------CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHH
Q 002809          791 DIKSIV-------DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME--LSE  839 (878)
Q Consensus       791 ~~~~ii-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~--L~~  839 (878)
                      .....+       ++.+. ........++.+++.+||+.+|++||+++|+++.  ++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         240 KARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             hhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            000000       00000 0011234567899999999999999999999987  554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=5.2e-31  Score=290.05  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=192.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~Ey  642 (878)
                      ++.+.||+|+||.||+|+..  ++.||+|.+.....  .....+.+|+.++++++|+|++++++++...  +..++||||
T Consensus        10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (309)
T cd07845          10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY   89 (309)
T ss_pred             eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence            44578999999999999875  48899999874422  2234567899999999999999999998654  568999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      ++ ++|.+++... ...+++.++..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          90 CE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             CC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            96 4888888653 35689999999999999999999998   9999999999999999999999999999876432211


Q ss_pred             cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHH-------HHHhcCCcc
Q 002809          723 HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI-RQWVN-------SLIAKGDIK  793 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~v~-------~~~~~~~~~  793 (878)
                        .....++..|+|||.+.+ ..++.++||||+||++|||++|++||...+..+.... .++..       .........
T Consensus       165 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         165 --MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             --CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence              122335778999999865 4578999999999999999999999987655332211 11100       000000000


Q ss_pred             ccc--CCcccccc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          794 SIV--DPRLQEDF---DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       794 ~ii--d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...  ........   ......++.+++.+|++.||++||+++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000  00000000   00123467789999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=8.4e-31  Score=286.58  Aligned_cols=253  Identities=18%  Similarity=0.250  Sum_probs=181.1

Q ss_pred             HhhhcccccccccEEEEEEEEcce-----eEEEEEeccCChhhH-----------HHHHHHHHHHHHhcccceeeeeecc
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNEI-----DVAVKMLSSSSAQGF-----------QQFQAEVKLLMRVHHRNLTSLVGHC  630 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~~-----~vAvK~l~~~~~~~~-----------~~f~~Ei~~L~~l~H~nIv~l~g~~  630 (878)
                      .+.+.+.||+|+||.||+|+..+.     .+|+|+.........           .....+...+..+.|+|++++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            345678999999999999987543     466665432221110           1122334455566899999999876


Q ss_pred             cCCC----cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEE
Q 002809          631 DEDN----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK  706 (878)
Q Consensus       631 ~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~k  706 (878)
                      ....    ..++++|++. .++.+.+..  ....++..+..++.|+++||+|||+.   +|+||||||+|||++.++.++
T Consensus        93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence            5443    2356677663 356666553  23457888999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCCC-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH-HHH--
Q 002809          707 LADFGLSKSFATDANT-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE-KIH--  778 (878)
Q Consensus       707 L~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~--  778 (878)
                      |+|||+++.+......     .......||+.|+|||++.+..++.++|||||||+++||++|+.||....... ...  
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999999876432211     11223469999999999999999999999999999999999999998763221 111  


Q ss_pred             HHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          779 IRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       779 l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      ..++.... ..+.+        .   ...+...+.+++..|+..+|++||++.++++.|
T Consensus       247 ~~~~~~~~-~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        247 KCDFIKRL-HEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHHh-hhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11222211 11111        0   011235688999999999999999999999876

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=301.44  Aligned_cols=272  Identities=24%  Similarity=0.366  Sum_probs=208.2

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCC------CcceeEee
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTALIYE  641 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~lV~E  641 (878)
                      .+.||+|+||.||+|+.+  |+.||||.+... .....+...+|+++|++++|+|||++++.-...      ....+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            467999999999999864  588999999874 344567788999999999999999999876544      36789999


Q ss_pred             eccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc--CCC--cEEEeecCCcccc
Q 002809          642 FMANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN--EKL--QAKLADFGLSKSF  716 (878)
Q Consensus       642 y~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~--~~~--~~kL~DFGla~~~  716 (878)
                      ||.+|+|...|.+-. ...+++.+.+.++.+++.||.|||++   +|+||||||.||++-  ++|  ..||+|||.|+.+
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999998644 55799999999999999999999988   999999999999983  334  4799999999987


Q ss_pred             ccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      ..+.   ......||..|.+||++.. +.|+..+|.|||||++||.+||..||..........-..|....-....+...
T Consensus       175 ~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  175 DDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             CCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            5433   5566789999999999994 88999999999999999999999999876543221112222211111111111


Q ss_pred             cCCcccc------cc------CHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHHHHHHHHhhc
Q 002809          796 VDPRLQE------DF------DANSVWKAVELAMACLSPTGNQRP--TMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       796 id~~l~~------~~------~~~~~~~l~~l~~~Cl~~dP~~RP--sm~evl~~L~~~~~~e~~~~  848 (878)
                      .++...+      .+      .......+-.....+|..+|++|.  ...+....+..++.....+.
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhi  318 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHI  318 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEE
Confidence            1222111      11      122233555777788889999999  88888888888887655544

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=6.8e-31  Score=292.56  Aligned_cols=256  Identities=23%  Similarity=0.309  Sum_probs=193.3

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCChhh--------------HHHHHHHHHHHHHhcccceeeeeecccCC
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQG--------------FQQFQAEVKLLMRVHHRNLTSLVGHCDED  633 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~--------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~  633 (878)
                      +.+.||+|+||.||+++..  ++.||||.+.......              ...+.+|++++.+++|+||+++++++..+
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            3467999999999999865  4889999986542211              12578999999999999999999999999


Q ss_pred             CcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCc
Q 002809          634 NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS  713 (878)
Q Consensus       634 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla  713 (878)
                      +..++||||+. |+|.+++..  ...+++.....++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence            99999999996 699999865  45689999999999999999999988   9999999999999999999999999998


Q ss_pred             cccccCC------------CCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002809          714 KSFATDA------------NTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR  780 (878)
Q Consensus       714 ~~~~~~~------------~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  780 (878)
                      .......            .........++..|+|||.+.+. .++.++|||||||+++||++|++||......+...  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--  244 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG--  244 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence            7654111            01111223467889999998764 46899999999999999999999998765433211  


Q ss_pred             HHHHHHHhcCC---cccc--------cC----CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          781 QWVNSLIAKGD---IKSI--------VD----PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       781 ~~v~~~~~~~~---~~~i--------id----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       .+........   ....        ..    +.+.. .......++.+++.+|++.+|++||+++|++.
T Consensus       245 -~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        245 -RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             -HHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence             1111111100   0000        00    00000 01122456889999999999999999999985

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.7e-31  Score=311.22  Aligned_cols=266  Identities=19%  Similarity=0.263  Sum_probs=185.3

Q ss_pred             HHhhhcccccccccEEEEEEEEcc---eeEEEEE--------------ec---cCChhhHHHHHHHHHHHHHhcccceee
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLNE---IDVAVKM--------------LS---SSSAQGFQQFQAEVKLLMRVHHRNLTS  625 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~~---~~vAvK~--------------l~---~~~~~~~~~f~~Ei~~L~~l~H~nIv~  625 (878)
                      ..+.+.+.||+|+||.||++....   ...+.|.              +.   .........+.+|+++|.+++|+||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            345667899999999999987542   1122221              10   111223456889999999999999999


Q ss_pred             eeecccCCCcceeEeeeccCCChhhhhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC
Q 002809          626 LVGHCDEDNQTALIYEFMANGNLQEYLSDIS---KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK  702 (878)
Q Consensus       626 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~  702 (878)
                      +++++...+..++|+|++. ++|.+++....   ........+..++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD  303 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence            9999999999999999984 57777765322   22234567788999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCC-CCCCCChHHHHHHHH
Q 002809          703 LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP-AISRINEEEKIHIRQ  781 (878)
Q Consensus       703 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~  781 (878)
                      +.+||+|||+++.+..... .......|+..|+|||++.+..++.++|||||||++|||++|+. |+..........+.+
T Consensus       304 ~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            9999999999987643221 12223569999999999999999999999999999999999874 444332222222222


Q ss_pred             HHHHHHh-cCCc-------ccccCCc-c---cccc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          782 WVNSLIA-KGDI-------KSIVDPR-L---QEDF-----DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       782 ~v~~~~~-~~~~-------~~iid~~-l---~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ....... ....       .+.++.. +   ....     .......+.+++.+||+.||++||++.|+++.
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111000 0000       0000000 0   0000     00112346678899999999999999999874

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.3e-30  Score=282.58  Aligned_cols=240  Identities=25%  Similarity=0.352  Sum_probs=186.2

Q ss_pred             cccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHH---HHhcccceeeeeecccCCCcceeEeeecc
Q 002809          573 TLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLL---MRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L---~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .||+|+||.||+++..  ++.||+|.+.....   .....+..|..++   ....||||+++.+++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875  47899999875422   1222344454443   34479999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++..+....    
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            9999998865  45799999999999999999999998   99999999999999999999999999987553221    


Q ss_pred             cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....|+..|+|||.+.++ .++.++||||+||+++||++|+.||...........    ......      ....+.  
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~~--  219 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVELP--  219 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCCC--
Confidence            1234689999999998754 689999999999999999999999976533221111    011110      011111  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRP-----TMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~  835 (878)
                        .....++.+++.+|+..+|++||     ++.++++
T Consensus       220 --~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 --DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              11234788999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=9.8e-31  Score=284.62  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=196.7

Q ss_pred             hhcccccccccEEEEEEEEc-----ceeEEEEEeccCC----hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSSS----AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~----~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      .+.+.||+|++|.||+++..     ++.||||.+....    ....+.+.+|++++.++ +|+||+++.+.+..+...++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            35678999999999998752     3679999987532    22346788999999999 59999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+++|+|.+++..  ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          83 ILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            9999999999999875  45689999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCCCcccccccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      ... .......|+..|+|||.+.+..  .+.++||||||++++||++|+.||.......  ...++.......       
T Consensus       158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~-------  227 (288)
T cd05583         158 EEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS-------  227 (288)
T ss_pred             ccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-------
Confidence            321 1122345889999999987665  7889999999999999999999986432211  111111111111       


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .+...    ......+.+++.+|++.+|++|||++++.+.|+.
T Consensus       228 ~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 KPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            01111    1122357789999999999999999988777655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=6.7e-31  Score=287.34  Aligned_cols=249  Identities=22%  Similarity=0.359  Sum_probs=192.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|++|.||+++..  +..||||.+.... ......+..|+.++.+.+ |+||++++++|..+...++||||+.
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   97 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS   97 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence            45689999999999999987  5889999987543 334566778888777775 9999999999999999999999985


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                       ++|.+++... ...+++..+..++.|+++||+|||+.  .+|+||||+|+||++++++.+||+|||++..+.....   
T Consensus        98 -~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---  170 (296)
T cd06618          98 -TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---  170 (296)
T ss_pred             -cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---
Confidence             5777776542 34789999999999999999999973  2899999999999999999999999999876532211   


Q ss_pred             cccccCCCCccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          725 STVVAGTPGYLDPEYYTSNR----LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      .....++..|+|||.+.+..    ++.++||||||++++||++|+.||........ .+.    ..... ....     +
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~~~~-~~~~-----~  239 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLT----KILQE-EPPS-----L  239 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHH----HHhcC-CCCC-----C
Confidence            12234778999999987654    78899999999999999999999975432211 111    11111 1111     1


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      ..  ......++.+++.+|++.+|++||++.+++++-
T Consensus       240 ~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         240 PP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            00  011234688999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.2e-30  Score=287.36  Aligned_cols=244  Identities=30%  Similarity=0.445  Sum_probs=192.9

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ...+.||+|++|.||+|+...  ..+|+|.+...   .....+++.+|+++++.++|+|++++.+++......++|+||+
T Consensus        18 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   97 (308)
T cd06634          18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC   97 (308)
T ss_pred             HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEcc
Confidence            334679999999999998753  77999988642   3334567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      . |+|.+++... ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......    
T Consensus        98 ~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----  168 (308)
T cd06634          98 L-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (308)
T ss_pred             C-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence            6 6888777532 45689999999999999999999988   9999999999999999999999999998765321    


Q ss_pred             ccccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          724 VSTVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                        ....++..|+|||.+.   ...++.++|||||||+++||++|+.||......+...      .. ..+....     .
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~-~~~~~~~-----~  234 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HI-AQNESPA-----L  234 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HH-hhcCCCC-----c
Confidence              2245788999999974   3567889999999999999999999987654322111      11 1111111     1


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      .   .......+.+++.+||+.+|++||++.++++.-.
T Consensus       235 ~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         235 Q---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             C---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            0   1123346778999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.4e-30  Score=280.78  Aligned_cols=233  Identities=22%  Similarity=0.321  Sum_probs=183.1

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccCCChhh
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQE  650 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  650 (878)
                      ||+|+||.||+++..  +..+|+|.+.......     .|+.....+ +|+|++++++.+...+..++||||+++++|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            599999999999865  3779999986542221     122222222 69999999999999999999999999999999


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCCCCccccccc
Q 002809          651 YLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       651 ~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      ++..  ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||+++.....      ....
T Consensus        99 ~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~  167 (267)
T PHA03390         99 LLKK--EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYD  167 (267)
T ss_pred             HHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCC
Confidence            9976  34799999999999999999999998   899999999999999998 9999999998765322      1235


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHH
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV  809 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~  809 (878)
                      ++..|+|||++.+..++.++||||||++++||++|+.||.....+ ......|.... . ...          .......
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~-~~~----------~~~~~~~  234 (267)
T PHA03390        168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-Q-KKL----------PFIKNVS  234 (267)
T ss_pred             CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-c-ccC----------CcccccC
Confidence            889999999999889999999999999999999999999854432 22223332222 1 100          0111233


Q ss_pred             HHHHHHHHHccCCCCCCCCC-HHHHHH
Q 002809          810 WKAVELAMACLSPTGNQRPT-MSQVVM  835 (878)
Q Consensus       810 ~~l~~l~~~Cl~~dP~~RPs-m~evl~  835 (878)
                      ..+.+++.+||+.+|.+||+ ++|+++
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        235 KNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHHHHhccChhhCCchHHHHhc
Confidence            46789999999999999995 688874

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.8e-31  Score=295.88  Aligned_cols=246  Identities=25%  Similarity=0.413  Sum_probs=203.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      +.+.+.||+|.|+.|..++..  +.+||+|.+.+..  ....+.+.+|+++|..+.|||||+++.+......+++||||.
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya  137 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence            345689999999999999875  5899999998763  334456899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      .+|.+++++..  ...+.+..+..++.|+.+|++|||++   .|||||||++||||+.+.++||+|||++..+..   ..
T Consensus       138 ~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---~~  209 (596)
T KOG0586|consen  138 SGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY---GL  209 (596)
T ss_pred             cCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc---cc
Confidence            99999999986  44566688899999999999999999   999999999999999999999999999988753   34


Q ss_pred             ccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .....+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++..-.+-               -..++-.+++-
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---------------r~rvl~gk~rI  274 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---------------RPRVLRGKYRI  274 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc---------------cchheeeeecc
Confidence            4566889999999999998876 6799999999999999999999986443210               01111111221


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      .+.  ...+..+++++++..+|.+|++++++.+.-.
T Consensus       275 p~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  275 PFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             cce--eechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            221  1224568999999999999999999988644

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.5e-31  Score=290.97  Aligned_cols=264  Identities=22%  Similarity=0.373  Sum_probs=202.0

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCC-----cceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN-----QTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~lV  639 (878)
                      .+.+.||+|++|.||+++...  ..||+|++....  ....+.+.+|+++++.++|+||+++.+++....     ..++|
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            456789999999999998754  889999987643  345578999999999999999999999987765     78999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||++ ++|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.++|+|||++......
T Consensus        83 ~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          83 TELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            99997 589888875  44799999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCC-cccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC-------
Q 002809          720 ANT-HVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG-------  790 (878)
Q Consensus       720 ~~~-~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~-------  790 (878)
                      ... .......++..|+|||.+.+. .++.++|+||||+++++|++|++||......+....   +.......       
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~  233 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEEDLKF  233 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhHhhh
Confidence            210 112234578899999999887 789999999999999999999999987665332111   11100000       


Q ss_pred             ----CcccccC---Cccc---cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHH
Q 002809          791 ----DIKSIVD---PRLQ---EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME--LSECL  841 (878)
Q Consensus       791 ----~~~~iid---~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~--L~~~~  841 (878)
                          .....+.   ....   ..........+.+++.+||+.+|++||+++++++.  +++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                0000000   0000   00011124567899999999999999999999985  65533

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=285.52  Aligned_cols=240  Identities=25%  Similarity=0.334  Sum_probs=194.7

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      -++||+|+||.||-++..  ++.+|.|.+.+..   .++..-.+.|-++|.++..+.||.+--.|+..+.+++|+..|.|
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            479999999999977654  5789999886542   23345578899999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.-+|.......++++.++.++.+|+.||++||..   +||.||+||+|||||+.|+++|+|.|+|..+.....   .
T Consensus       270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~---~  343 (591)
T KOG0986|consen  270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP---I  343 (591)
T ss_pred             CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc---c
Confidence            9999999887778899999999999999999999998   999999999999999999999999999988754322   2


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...+||.+|||||++....|+...|.||+||++|||+.|+.||....+....   +-+.+.+.+..          ..++
T Consensus       344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~~~----------~ey~  410 (591)
T KOG0986|consen  344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLEDP----------EEYS  410 (591)
T ss_pred             ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhcch----------hhcc
Confidence            3347999999999999999999999999999999999999999764432111   01222222111          1122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPT  829 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPs  829 (878)
                      ..-..+...+....|+.||++|-.
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhcc
Confidence            233346667888889999998853

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2.2e-30  Score=282.08  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=192.7

Q ss_pred             hhcccccccccEEEEEEEE-----cceeEEEEEeccCCh----hhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLSSSSA----QGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~~----~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      .+.+.||+|+||.||+++.     .+..||+|++.....    ...+.+.+|++++.++ +|+||+++.+.+..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            3467899999999999876     357899999875322    2346788899999999 59999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      |+||+++++|.+++..  ...+++..+..++.|+++||.|||+.   +++||||||+|||+++++.+||+|||++.....
T Consensus        83 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          83 ILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            9999999999999975  45688999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCCCcccccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSN--RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      ... .......|+..|+|||.+...  .++.++||||||+++++|++|+.||.......  ...++........      
T Consensus       158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~------  228 (290)
T cd05613         158 DEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE------  228 (290)
T ss_pred             ccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC------
Confidence            221 112234588899999998753  46789999999999999999999986432211  1111121111111      


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                       +.    .+......+.+++.+|++.+|++||     ++++++..
T Consensus       229 -~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 -PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence             01    1112234677899999999999997     66666553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.6e-30  Score=280.72  Aligned_cols=245  Identities=25%  Similarity=0.428  Sum_probs=197.9

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|++|.||+++..  +..||+|++...   .....+.+.+|++++.+++ |+||+++++.+..++..++||||
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY   83 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence            45678999999999999874  488999998753   2334567889999999998 99999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.+++..  ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++|||++.........
T Consensus        84 ~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          84 APNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999999976  44799999999999999999999998   9999999999999999999999999998766432211


Q ss_pred             ------------------cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002809          723 ------------------HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN  784 (878)
Q Consensus       723 ------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~  784 (878)
                                        .......++..|+|||......++.++||||||++++|+++|+.||........  .    .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~----~  232 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--F----Q  232 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--H----H
Confidence                              112234578899999999888899999999999999999999999987653221  1    1


Q ss_pred             HHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 002809          785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTM----SQVVM  835 (878)
Q Consensus       785 ~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm----~evl~  835 (878)
                      ... ...      .    ..+......+.+++.+||+.+|++||++    +++++
T Consensus       233 ~~~-~~~------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 KIL-KLE------Y----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH-hcC------C----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            111 100      0    1111123467899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=321.93  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=196.5

Q ss_pred             cccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          571 ERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      ...||.|.||.||-+...+  .-.|+|-+.-.  .....+...+|+.++..++|||+|+.+|.-.+++..++.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            3589999999999997654  66899977643  3445677889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC--cc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT--HV  724 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~  724 (878)
                      +|.+.+..  +...++.....+..|++.|++|||++   +||||||||.||+|+.+|.+|++|||.|..+......  ..
T Consensus      1320 sLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1320 SLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             cHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            99999975  44566667777889999999999999   9999999999999999999999999999887544211  11


Q ss_pred             cccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          725 STVVAGTPGYLDPEYYTSNR---LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      -....||+.|||||++.+..   ..-+.||||+|||++||+||++||...+.+-.  +.    -.+..|...        
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--IM----y~V~~gh~P-------- 1460 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--IM----YHVAAGHKP-------- 1460 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--HH----hHHhccCCC--------
Confidence            22467999999999997643   56689999999999999999999987765431  11    122333322        


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       ..+.....+-.+++.+||+.||++|.++.|+++
T Consensus      1461 -q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 -QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             -CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence             122334446678999999999999988886654

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.6e-30  Score=278.33  Aligned_cols=247  Identities=25%  Similarity=0.414  Sum_probs=193.8

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccC-----ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-----SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-----~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      +.+.+.||+|+||.||+++...  ..+++|+++..     ......++..|+.++++++||||+++++++......++|+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            3456889999999999998754  44666665532     2223446778999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          641 EFMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||+++++|.+++...  ....+++..++.++.|+++||.|||+.   +++|+||||+||+++. +.+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            999999999988642  245799999999999999999999998   9999999999999976 5699999999876533


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ...  ......|+..|+|||.+.+..++.++|+||||+++++|++|+.||.......      ..... ..+..     +
T Consensus       158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~-~~~~~-----~  223 (260)
T cd08222         158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRI-VEGPT-----P  223 (260)
T ss_pred             Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH-HcCCC-----C
Confidence            221  2223457889999999988888999999999999999999999986543221      11111 11111     1


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          ..+.....++.+++.+|+..+|++||++.|+++.
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                1122334578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=2.3e-30  Score=284.31  Aligned_cols=261  Identities=24%  Similarity=0.350  Sum_probs=190.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCC--------cc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN--------QT  636 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--------~~  636 (878)
                      .+.+.||+|++|.||+|+..  +..+|+|++.....  .....+.+|++++++++|+||+++++++....        ..
T Consensus        11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   90 (311)
T cd07866          11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV   90 (311)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence            45678999999999999875  47899998865422  22346788999999999999999999874433        46


Q ss_pred             eeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      ++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        91 ~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          91 YMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             EEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            899999964 67776654 245699999999999999999999998   9999999999999999999999999999765


Q ss_pred             ccCCCC---------cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHH
Q 002809          717 ATDANT---------HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL  786 (878)
Q Consensus       717 ~~~~~~---------~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~  786 (878)
                      ......         .......++..|+|||.+.+ ..++.++|||||||+++||++|++||..................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            332211         11123356788999998765 45889999999999999999999999876543322111100000


Q ss_pred             Hhc------CCccccc--------CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          787 IAK------GDIKSIV--------DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       787 ~~~------~~~~~ii--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ...      ..+....        .+.+...+ ......+.+++.+|++.+|++||++.|++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000      0000000        00110000 112246789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=4.6e-30  Score=283.34  Aligned_cols=240  Identities=29%  Similarity=0.450  Sum_probs=190.8

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.||+|+||.||+|+..  +..|++|++...   .....+.+.+|++++++++|||++++++++.++...++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            356999999999999874  478999998743   22344678899999999999999999999999999999999995 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++... ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....      .
T Consensus       105 ~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~  174 (313)
T cd06633         105 GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------A  174 (313)
T ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC------C
Confidence            5787777542 45689999999999999999999998   999999999999999999999999998764321      1


Q ss_pred             ccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          726 TVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ....|+..|+|||++.   ...++.++|||||||+++||++|++|+..........      .... ........     
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-~~~~~~~~-----  242 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NDSPTLQS-----  242 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHh-cCCCCCCc-----
Confidence            2345888999999984   4568889999999999999999999987654322111      1111 11111111     


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         ......+.+++.+|++.+|.+||++.++++.
T Consensus       243 ---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         243 ---NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1112357789999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=2.5e-30  Score=287.80  Aligned_cols=261  Identities=24%  Similarity=0.346  Sum_probs=190.4

Q ss_pred             hhcccccccccEEEEEEEEc----ceeEEEEEeccC--ChhhHHHHHHHHHHHHHh-cccceeeeeecccC----CCcce
Q 002809          569 NFERTLGKGGFGTVYYGRLN----EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDE----DNQTA  637 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~----~~~~~  637 (878)
                      .+.+.||+|+||.||+++..    +..||+|++...  .....+.+.+|++++.++ +||||+++++.+..    ....+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            45678999999999999875    357999998753  222356788999999999 49999999987532    24567


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +++||+. ++|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.
T Consensus        83 ~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          83 LYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            8888885 689998865  55789999999999999999999998   99999999999999999999999999998654


Q ss_pred             cCCCC--cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HH--------HHHHH
Q 002809          718 TDANT--HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IR--------QWVNS  785 (878)
Q Consensus       718 ~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~--------~~v~~  785 (878)
                      .....  .......|+..|+|||.+.+ ..++.++||||+||++++|++|++||.......... +.        ++...
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32211  11123468899999998765 468999999999999999999999997655322111 00        00000


Q ss_pred             HHhcCC------cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          786 LIAKGD------IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       786 ~~~~~~------~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ......      ....-...+. .........+.+++.+|++.+|++||++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000      0000000000 0011123468899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4e-30  Score=278.06  Aligned_cols=258  Identities=26%  Similarity=0.344  Sum_probs=196.6

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.||+|++|.||+|+...  +.+|+|++....  ....+.+..|++++++++|+|++++++++...+..++|+||++ 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            34679999999999998864  889999988653  3345678899999999999999999999999999999999997 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.... ..+++..++.++.|+++||+|||+.   +|+||||+|+||++++++.+||+|||++........  ..
T Consensus        82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  155 (282)
T cd07829          82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY  155 (282)
T ss_pred             cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence            59999997632 4699999999999999999999998   999999999999999999999999999876543221  11


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHH-------HHHh-----cCC
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVN-------SLIA-----KGD  791 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~-------~~~~-----~~~  791 (878)
                      ....++..|+|||.+.+. .++.++|||||||+++||++|++||......+... +.....       ....     ...
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            223456789999998766 78999999999999999999999997655322111 111000       0000     000


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ............. ......+.+++.+||..+|++||++++++.
T Consensus       236 ~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         236 FPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000000000 111457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.6e-30  Score=288.95  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=190.6

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC------cceeE
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN------QTALI  639 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~lV  639 (878)
                      ..+.||+|+||.||+|+..  +..||+|++...  .......+.+|++++++++|+||+++++++....      ..++|
T Consensus        19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence            3578999999999999864  488999998653  2223456889999999999999999999886543      45899


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      +||+.. +|.+++    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        99 ~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          99 MPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             eccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            999964 666654    33589999999999999999999998   9999999999999999999999999998754221


Q ss_pred             CCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH--------HHHhcC
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN--------SLIAKG  790 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~--------~~~~~~  790 (878)
                           .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||................        ......
T Consensus       171 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         171 -----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             -----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence                 122357888999999876 468899999999999999999999998755432211100000        000000


Q ss_pred             Cccccc-------CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHHH
Q 002809          791 DIKSIV-------DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME--LSECLA  842 (878)
Q Consensus       791 ~~~~ii-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~--L~~~~~  842 (878)
                      ......       ...+.... .....++.+++.+||+.+|++||+++++++.  ++....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             chHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000000       00000000 1123467899999999999999999999965  766543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=273.78  Aligned_cols=251  Identities=27%  Similarity=0.390  Sum_probs=211.0

Q ss_pred             cccccccccEEEEEEEEc------c-eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCC-CcceeEee
Q 002809          571 ERTLGKGGFGTVYYGRLN------E-IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED-NQTALIYE  641 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~------~-~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-~~~~lV~E  641 (878)
                      ..++-+|.||.||+|.+.      + +.|-||.++.. +......++.|--.+..+.|||+.++.+.+.++ ...+++|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            457889999999999553      3 55778877654 444567788999999999999999999998654 56788899


Q ss_pred             eccCCChhhhhcccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          642 FMANGNLQEYLSDIS------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       642 y~~~gsL~~~l~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      ++.-|+|..+|...+      .+.++-.+...++.|++.|++|||+.   ++||.||.++|.+||+..++||+|=.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccc
Confidence            999999999997322      56688889999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      +-+.+.............||+||.+....|+.++|||||||++|||+| |+.|+.+.++.+..       ..+.+|.   
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-------~ylkdGy---  515 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-------HYLKDGY---  515 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-------HHHhccc---
Confidence            876666555666667889999999999999999999999999999998 99999988876632       2333332   


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                          ++.  -+.+|+.++..++.-||...|++||+.+|++..|.+-
T Consensus       516 ----Rla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  516 ----RLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ----eec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                222  3456778999999999999999999999999999874

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=7e-30  Score=271.14  Aligned_cols=235  Identities=29%  Similarity=0.412  Sum_probs=192.6

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      ||+|++|.||+++..  ++.+|+|++.....   .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999886  48899999876432   2456789999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV  728 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  728 (878)
                      .+++..  ...+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            999976  34689999999999999999999997   99999999999999999999999999987653321  122345


Q ss_pred             cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       729 ~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      .++..|++||...+...+.++|+||||++++||++|+.||.......   +   ...... +.      ..    .+...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~---~~~~~~-~~------~~----~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---I---YEKILK-DP------LR----FPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHhc-CC------CC----CCCCC
Confidence            67889999999988888999999999999999999999997655321   1   111111 11      01    11112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHH
Q 002809          809 VWKAVELAMACLSPTGNQRPTMSQ  832 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPsm~e  832 (878)
                      ...+.+++.+|+..+|++||++++
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            346789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=263.05  Aligned_cols=255  Identities=21%  Similarity=0.368  Sum_probs=198.7

Q ss_pred             CCCHHHHHHHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccC-ChhhHHHHHHHHHHHHHhc-ccceeeeeecccC
Q 002809          557 HLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDE  632 (878)
Q Consensus       557 ~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~  632 (878)
                      .....|+..     ...||+|..|.|++.+...  .-.|||.+... +.++.++++..+.++.+-+ +|.||+.+|||..
T Consensus        88 ~~dindl~~-----l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   88 QADINDLEN-----LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             ccChHHhhh-----HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            344555533     3569999999999999876  78999998765 4566788888888877775 8999999999999


Q ss_pred             CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       633 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      +....+.||.|. ..++.++++ ..+++++..+-++...+..||.||.+++  +|+|||+||+|||+|+.|++|+||||+
T Consensus       163 n~dV~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI  238 (391)
T KOG0983|consen  163 NTDVFICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI  238 (391)
T ss_pred             CchHHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence            999999999984 355555554 3566899999999999999999999875  999999999999999999999999999


Q ss_pred             ccccccCCCCcccccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTS---NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      +..+-..   ...+...|.+.|||||.+.-   .+|+-++||||||+.++||.||+.||.....+-.. +    ...+.+
T Consensus       239 sGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-l----tkvln~  310 (391)
T KOG0983|consen  239 SGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-L----TKVLNE  310 (391)
T ss_pred             cceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-H----HHHHhc
Confidence            9876432   22344568999999999964   46888999999999999999999999875543211 1    111111


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .  .    |.+....  .-...+.+++..||..|+.+||...+++++
T Consensus       311 e--P----P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 E--P----PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             C--C----CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            1  1    2232221  123467899999999999999999998874

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=2.4e-30  Score=289.18  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=191.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCC------------
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------------  633 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------------  633 (878)
                      +.+.+.||+|+||.||+|+..  +..||+|.+........+.+.+|++++++++||||+++++.+...            
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT   86 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence            345678999999999999875  478999998776666677899999999999999999999876543            


Q ss_pred             --CcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-CCcEEEeec
Q 002809          634 --NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADF  710 (878)
Q Consensus       634 --~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-~~~~kL~DF  710 (878)
                        ...++|+||++ ++|.+++..   ..+++..++.++.|+++||.|||+.   +|+||||||+||+++. ++.+|++||
T Consensus        87 ~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          87 ELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             ccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence              35789999997 588888753   4589999999999999999999998   9999999999999984 567899999


Q ss_pred             CCccccccCCCC-cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh
Q 002809          711 GLSKSFATDANT-HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA  788 (878)
Q Consensus       711 Gla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~  788 (878)
                      |+++........ .......++..|+|||.+.. ..++.++|||||||+++||++|+.||......+.............
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            998765322111 11122357889999998654 5688899999999999999999999987654322111000000000


Q ss_pred             c---C----CcccccC-Ccccc-----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          789 K---G----DIKSIVD-PRLQE-----DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       789 ~---~----~~~~iid-~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .   .    .+..... .....     ........++.+++.+|++.+|++||++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            0   0    0000000 00000     0001123467899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.2e-29  Score=281.99  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=191.2

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC-CCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-DNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~  644 (878)
                      +.+.||+|+||.||+++..  +..||+|++...  .....+.+.+|++++.+++||||+++.+++.. ....++|+||+ 
T Consensus        14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-   92 (328)
T cd07856          14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-   92 (328)
T ss_pred             EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence            4579999999999999865  478999987643  22345678899999999999999999998865 56788999998 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.++++.   ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++|+|||++......     
T Consensus        93 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----  161 (328)
T cd07856          93 GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----  161 (328)
T ss_pred             ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-----
Confidence            5689888763   4578889999999999999999998   9999999999999999999999999998754221     


Q ss_pred             cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHH--------HHHHHHhcCCccc
Q 002809          725 STVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQ--------WVNSLIAKGDIKS  794 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~--------~v~~~~~~~~~~~  794 (878)
                      .....++..|+|||.+.+ ..++.++|||||||+++||++|++||.......... +.+        |...........-
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            122346788999998765 568999999999999999999999997665422111 111        1111111100000


Q ss_pred             ccCCccccccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDFD-----ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +..-......+     ......+.+++.+|++.+|++||++++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000111     1123578899999999999999999999775

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.6e-31  Score=269.06  Aligned_cols=236  Identities=28%  Similarity=0.384  Sum_probs=194.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      +|.++||+|.||.|-.++-+  ++-+|+|++++...   .....-+.|-.+|...+||.+..+.-.|+..+++++||||.
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA  250 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence            56789999999999988765  47899999987532   33445567889999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      .||.|.-+|.+  .+.+++.....+-.+|..||.|||++   +||.||||.+|.|+|.+|++||+|||+++.--.  ...
T Consensus       251 nGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~  323 (516)
T KOG0690|consen  251 NGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGD  323 (516)
T ss_pred             cCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc--ccc
Confidence            99999999986  66789999999999999999999998   999999999999999999999999999975322  223


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ....+|||+.|+|||++....|..++|.|.+||++|||++|+.||...+.+.-..+       +--++      -+    
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL-------Il~ed------~k----  386 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL-------ILMED------LK----  386 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH-------HHhhh------cc----
Confidence            45568999999999999999999999999999999999999999986554321111       11111      11    


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCC
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRP  828 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RP  828 (878)
                      ++.....+...|+...|..||.+|-
T Consensus       387 FPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  387 FPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             CCccCCHHHHHHHHHHhhcChHhhc
Confidence            2222334566788889999999995

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=266.85  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=196.5

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeeccc----CCCcceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCD----EDNQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~----~~~~~~lV~Ey~~  644 (878)
                      ++||-|-.|.|-.+..+  +.++|+|++...     ....+|+++--.. .|||||.+++.+.    ....+++|||.|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            68999999999888664  478999998755     3456777765555 5999999999874    3457889999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~~  721 (878)
                      ||.|.+.+++...+.+++.++..|+.||+.|++|||+.   +|.||||||+|+|...   |..+||+|||+|+.-..   
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---  216 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---  216 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC---
Confidence            99999999988888899999999999999999999998   9999999999999964   45799999999985432   


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||......   .+.--++..+..|..      .+.
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy------~FP  287 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY------EFP  287 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc------cCC
Confidence            22234457799999999999999999999999999999999999999875431   122223344444432      112


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ............++++.+|..+|++|-|+.|++..
T Consensus       288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            22223456677899999999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=275.77  Aligned_cols=237  Identities=24%  Similarity=0.366  Sum_probs=193.5

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+|..+||+|+||.|..+..++  +-+|||++++..   ....+.-+.|-++|... +-|.++++..+|+.-+.+++|||
T Consensus       351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME  430 (683)
T KOG0696|consen  351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME  430 (683)
T ss_pred             cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence            4788999999999999998776  669999998752   22334445666777665 57889999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+.||+|--++++  -..+.+..+..+|.+||-||-+||++   +||.||||.+|||||.+|++||+|||+++.---  .
T Consensus       431 yvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~--~  503 (683)
T KOG0696|consen  431 YVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF--D  503 (683)
T ss_pred             EecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc--C
Confidence            9999999999987  45688889999999999999999999   999999999999999999999999999974322  2


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .......+||+.|+|||.+..++|+..+|.|||||+||||+.|++||++.++++-.       +.+.+..        . 
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-------~aI~ehn--------v-  567 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QAIMEHN--------V-  567 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHHcc--------C-
Confidence            23455689999999999999999999999999999999999999999987765421       1111111        1 


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCC
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRP  828 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP  828 (878)
                       .++..-..+...+....+...|.+|-
T Consensus       568 -syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 -SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -cCcccccHHHHHHHHHHhhcCCcccc
Confidence             23334445677788888889999884

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.8e-30  Score=285.06  Aligned_cols=261  Identities=22%  Similarity=0.348  Sum_probs=190.6

Q ss_pred             HHHHHhhh--cccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCC---
Q 002809          563 VVKITNNF--ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED---  633 (878)
Q Consensus       563 l~~~t~~f--~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~---  633 (878)
                      +..++++|  .+.||+|+||.||++...  +..||+|++....  ....+.+.+|++++.+++|+||+++.+++...   
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            33344444  468999999999999764  4889999987532  23356788999999999999999999987532   


Q ss_pred             ---CcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          634 ---NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       634 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                         ...+++++++ +++|.+++..   ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~df  164 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  164 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecc
Confidence               3467788876 7899888763   3589999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHHH-----
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI-RQWV-----  783 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~v-----  783 (878)
                      |+++.....     .....++..|+|||.+.+ ..++.++|||||||+++||++|++||........... ....     
T Consensus       165 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (345)
T cd07877         165 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  239 (345)
T ss_pred             ccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            998754221     123457889999999866 5688899999999999999999999976544321111 0000     


Q ss_pred             --HHHHhcCC-------cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          784 --NSLIAKGD-------IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       784 --~~~~~~~~-------~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        ...+....       +.......+. ........++.+++.+|++.+|++||++.+++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         240 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence              00000000       0000000000 0000123467899999999999999999998875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=4e-30  Score=303.07  Aligned_cols=249  Identities=29%  Similarity=0.440  Sum_probs=186.4

Q ss_pred             hhhc--ccccccccEEEEEEEE--cceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccC----------
Q 002809          568 NNFE--RTLGKGGFGTVYYGRL--NEIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE----------  632 (878)
Q Consensus       568 ~~f~--~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----------  632 (878)
                      .+|+  +.||+||||.||+++.  +++.+|||++.-. +.+....+.+|+..|.+|+|||||+++..+.+          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            3454  4899999999999964  6799999998755 44456788999999999999999998732210          


Q ss_pred             ---------------------------------------------C----------------------------------
Q 002809          633 ---------------------------------------------D----------------------------------  633 (878)
Q Consensus       633 ---------------------------------------------~----------------------------------  633 (878)
                                                                   .                                  
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                         0                                  


Q ss_pred             ------------------------------CcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 002809          634 ------------------------------NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC  683 (878)
Q Consensus       634 ------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~  683 (878)
                                                    ..+|+-||||+...|.++++++.... .-...++++.+|++||+|+|++ 
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~-  716 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ-  716 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC-
Confidence                                          12356688888888888776532111 3667889999999999999998 


Q ss_pred             CCCeEecCCCCccEEEcCCCcEEEeecCCccccc----------------cCCCCcccccccCCCCccCccccccC---C
Q 002809          684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA----------------TDANTHVSTVVAGTPGYLDPEYYTSN---R  744 (878)
Q Consensus       684 ~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~APE~~~~~---~  744 (878)
                        +||||||||.||+++++..+||+|||++....                .+......+...||.-|+|||++.+.   +
T Consensus       717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence              99999999999999999999999999998721                01112234557899999999999765   4


Q ss_pred             CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCC
Q 002809          745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTG  824 (878)
Q Consensus       745 ~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP  824 (878)
                      |+.|+|+||+|||++||+.   ||....+  ...    +-..++++.+..-      ..+....+..-.+++.++++.||
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP  859 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSME--RAS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDP  859 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHH--HHH----HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCC
Confidence            9999999999999999996   4543322  111    2233344544332      12233334455689999999999


Q ss_pred             CCCCCHHHHHH
Q 002809          825 NQRPTMSQVVM  835 (878)
Q Consensus       825 ~~RPsm~evl~  835 (878)
                      .+|||+.|++.
T Consensus       860 ~kRPtA~eLL~  870 (1351)
T KOG1035|consen  860 SKRPTATELLN  870 (1351)
T ss_pred             ccCCCHHHHhh
Confidence            99999999986

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.8e-29  Score=282.38  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=191.9

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCc------cee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQ------TAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~------~~l  638 (878)
                      .+.+.||+|++|.||+|+..  +..||+|++...  .....+.+.+|+.++++++|+|++++++++...+.      .++
T Consensus        18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07851          18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL   97 (343)
T ss_pred             EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence            34578999999999999885  478999998653  23344678889999999999999999998866554      899


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      |+||+ +++|.+++..   ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||++.....
T Consensus        98 v~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          98 VTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             EEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            99998 6799998864   4699999999999999999999998   999999999999999999999999999876532


Q ss_pred             CCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHH--------HHHHHHh
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQ--------WVNSLIA  788 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~--------~v~~~~~  788 (878)
                      .     .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||.......... +.+        +..... 
T Consensus       171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  244 (343)
T cd07851         171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS-  244 (343)
T ss_pred             c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc-
Confidence            2     123457889999999865 367889999999999999999999997655432111 000        000000 


Q ss_pred             cCCcccccC-------CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          789 KGDIKSIVD-------PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       789 ~~~~~~iid-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .......+.       +.+... ......++.+++.+|++.+|++||++.+|++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000000000       000000 01124578899999999999999999999764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.3e-29  Score=283.35  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=190.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC------ccee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN------QTAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~l  638 (878)
                      .+.+.||+|+||.||++...  +..||||++...  .....+.+.+|++++++++||||+++++.+..+.      ..++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07880          18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL   97 (343)
T ss_pred             EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence            34578999999999999864  488999998643  2333467889999999999999999999886553      3589


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+ +++|.+++..   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        98 v~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          98 VMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             EEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            99998 7799888763   4689999999999999999999998   999999999999999999999999999876532


Q ss_pred             CCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HH--------HHHHHHHh
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IR--------QWVNSLIA  788 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~--------~~v~~~~~  788 (878)
                      .     .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.......... +.        +|.... .
T Consensus       171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  244 (343)
T cd07880         171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL-Q  244 (343)
T ss_pred             C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh-c
Confidence            2     122357889999999876 458899999999999999999999998655322110 00        010000 0


Q ss_pred             cCC-------cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          789 KGD-------IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       789 ~~~-------~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ...       +.......+. .........+.+++.+|++.+|++||++.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             chhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000       0000000000 011122346789999999999999999999995

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=4e-31  Score=266.04  Aligned_cols=259  Identities=24%  Similarity=0.350  Sum_probs=201.4

Q ss_pred             CCCCHHHHHHHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCCh-hhHHHHHHHHHHHHHh-cccceeeeeeccc
Q 002809          556 RHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA-QGFQQFQAEVKLLMRV-HHRNLTSLVGHCD  631 (878)
Q Consensus       556 ~~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~  631 (878)
                      ..|+-+++...     ..||.|+||+|+|-.++.  +..|||+++.... .+.++++.|.+...+- +.||||+++|.+.
T Consensus        59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            44555555433     469999999999988764  8899999987654 5678899999877665 6999999999999


Q ss_pred             CCCcceeEeeeccCCChhhhh---ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          632 EDNQTALIYEFMANGNLQEYL---SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       632 ~~~~~~lV~Ey~~~gsL~~~l---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      .++.+++.||.|+ -+|+.+-   .......+++...-.|..-...||.||...  ..|||||+||+|||++..|.+|||
T Consensus       134 ~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  134 SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeee
Confidence            9999999999995 4665543   334467899999999999999999999976  489999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN--RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL  786 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~  786 (878)
                      |||++..+...   ...+...|...|||||.+...  .|+-++||||||++|+|+.||+.||...+.     +.+-+...
T Consensus       211 DFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~V  282 (361)
T KOG1006|consen  211 DFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQV  282 (361)
T ss_pred             cccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHH
Confidence            99998766432   234456788999999999643  488999999999999999999999986543     22222222


Q ss_pred             HhcCCcccccCCcccccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          787 IAKGDIKSIVDPRLQEDF-DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       787 ~~~~~~~~iid~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +. |+-..     +..+. ..+....+.+++..||.+|-++||+..++.++
T Consensus       283 v~-gdpp~-----l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  283 VI-GDPPI-----LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             Hc-CCCCe-----ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            22 22221     21111 13345578899999999999999999998775

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=4.5e-29  Score=301.56  Aligned_cols=141  Identities=30%  Similarity=0.455  Sum_probs=127.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+|...  ++.||||++....   ......+.+|+.++..++|+||+++++.+......++||||+
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~   86 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL   86 (669)
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence            45678999999999999987  5889999987542   334467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      .+++|.+++..  ...+++..++.++.||+.||+|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999975  44688999999999999999999998   99999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1e-29  Score=260.79  Aligned_cols=201  Identities=25%  Similarity=0.351  Sum_probs=167.7

Q ss_pred             hhhcccccccccEEEEEEEEcc------eeEEEEEeccCChh--hHHHHHHHHHHHHHhcccceeeeeecccC-CCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE------IDVAVKMLSSSSAQ--GFQQFQAEVKLLMRVHHRNLTSLVGHCDE-DNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~~~~--~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~l  638 (878)
                      ++..+.||+|.+|.||++.-++      +.+|+|+++..+..  ......+|+.+++.++|||++.|...+.. +...++
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            3445789999999999995432      36899999865332  23567899999999999999999999876 778999


Q ss_pred             EeeeccCCChhhhhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC----CcEEEeecC
Q 002809          639 IYEFMANGNLQEYLSDIS---KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFG  711 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~----~~~kL~DFG  711 (878)
                      ++||.+. +|..+++-++   .+.++-.....|+.||+.|+.|||++   =|+||||||.|||+..+    |.+||+|||
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999976 8888886433   45789999999999999999999998   69999999999999887    899999999


Q ss_pred             CccccccCCCC-cccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002809          712 LSKSFATDANT-HVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRIN  772 (878)
Q Consensus       712 la~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~  772 (878)
                      +++.+...-.. .....++-|..|.|||++.+. .||.+.|||+.||++.||+|-++.|....
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            99988543322 133446678999999998875 58999999999999999999988887643

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=4.2e-29  Score=264.26  Aligned_cols=220  Identities=20%  Similarity=0.178  Sum_probs=175.4

Q ss_pred             cccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChhhhhcc
Q 002809          577 GGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD  654 (878)
Q Consensus       577 G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  654 (878)
                      |.+|.||+++..  ++.+|+|++....     .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999874  4789999987653     234455555666799999999999999999999999999999999865


Q ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCc
Q 002809          655 ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY  734 (878)
Q Consensus       655 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y  734 (878)
                        ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++++|||.+......     .....++..|
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y  148 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY  148 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence              34589999999999999999999988   9999999999999999999999999987655321     1223456789


Q ss_pred             cCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHH
Q 002809          735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVE  814 (878)
Q Consensus       735 ~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~  814 (878)
                      +|||.+.+..++.++||||+|++++||++|+.|+.......                 .......    .+......+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTLN----IPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccccC----CcccCCHHHHH
Confidence            99999988889999999999999999999998765321110                 0000001    11112346778


Q ss_pred             HHHHccCCCCCCCCCHHH
Q 002809          815 LAMACLSPTGNQRPTMSQ  832 (878)
Q Consensus       815 l~~~Cl~~dP~~RPsm~e  832 (878)
                      ++.+|++.||++||++.+
T Consensus       208 li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         208 LLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHccCCHHHhcCCCc
Confidence            999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=284.41  Aligned_cols=236  Identities=24%  Similarity=0.335  Sum_probs=191.3

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+...+|.|+|+.|-++....  +..+||++.+..    .+-.+|+.++... +||||+++.+.+.++.+.++|||.+.
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             hccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            3456779999999999887754  789999998762    2335677666666 59999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE-cCCCcEEEeecCCccccccCCCCc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL-NEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl-~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++-|.+.+...  . ....++..|+.+|+.|+.|||.+   ++|||||||+|||+ ++.++++|+|||.++.....    
T Consensus       400 g~ell~ri~~~--~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  400 GGELLRRIRSK--P-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             ccHHHHHHHhc--c-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            99888877642  2 22377888999999999999998   99999999999999 68899999999999876443    


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                       ....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+.  .    +...+..+..           
T Consensus       470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--e----i~~~i~~~~~-----------  531 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--E----IHTRIQMPKF-----------  531 (612)
T ss_pred             -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--H----HHHhhcCCcc-----------
Confidence             223456789999999999999999999999999999999999998765541  1    2222333322           


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .........+|+.+||+.+|.+||+|.++...
T Consensus       532 -s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  532 -SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             -ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence             23344567899999999999999999999765

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.5e-30  Score=258.20  Aligned_cols=259  Identities=25%  Similarity=0.353  Sum_probs=196.2

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC--------CCcceeE
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--------DNQTALI  639 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--------~~~~~lV  639 (878)
                      ..||+|.||.||+++.++  +.||+|++.-.  ...-.....+|+.+|..++|+|++.++..|..        ...+++|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            479999999999998754  77898875432  22234567899999999999999999999853        2358999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      +++|+. +|.-+|.. ....++..++.+++.++..||.|+|..   .|+|||+|+.|+||+.++.+||+|||+++.+...
T Consensus       103 f~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~  177 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTS  177 (376)
T ss_pred             HHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence            999976 88888865 346799999999999999999999998   9999999999999999999999999999877433


Q ss_pred             CCC--cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          720 ANT--HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       720 ~~~--~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      .+.  ...+...-|..|.+||.+.+ ..++++.|||..||++.||+||.+-++...+....++..-....+..+-..++.
T Consensus       178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d  257 (376)
T KOG0669|consen  178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD  257 (376)
T ss_pred             cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence            221  12233456889999999875 579999999999999999999999999988777666544332222221111111


Q ss_pred             CCccccc----------cC--HHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          797 DPRLQED----------FD--ANS------VWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       797 d~~l~~~----------~~--~~~------~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .-.+...          +.  .+.      ..+.++++..++..||.+|+.+.+++.
T Consensus       258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            1111100          00  011      126778999999999999999988765

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7e-30  Score=298.69  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=199.8

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.++||+|+||.|...++++  +-+|+|++.+.   .......|..|-.+|..-..+-|+.+.-.|+++.++|+|||||
T Consensus        78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~  157 (1317)
T KOG0612|consen   78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM  157 (1317)
T ss_pred             HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence            446899999999999999876  67999999873   3345578999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      +||+|-.+|....  .+++..+..++..|.-||.-||+.   |+|||||||+|||||..|++||+|||.+..+..++. -
T Consensus       158 pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V  231 (1317)
T KOG0612|consen  158 PGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-V  231 (1317)
T ss_pred             cCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCc-E
Confidence            9999999998744  799999999999999999999988   999999999999999999999999999988754443 3


Q ss_pred             ccccccCCCCccCccccc----c-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          724 VSTVVAGTPGYLDPEYYT----S-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~----~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .+...+|||-|++||++.    + +.|+..+|.||+||++|||+.|..||...+-      ++-..+...-.   +    
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm~hk---~----  298 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIMNHK---E----  298 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHhchh---h----
Confidence            345567999999999985    2 5789999999999999999999999976432      22222211110   0    


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPT---MSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~evl~~  836 (878)
                      .+.-+-..+...+..+|+.+.+. +|+.|-.   ++++-.+
T Consensus       299 ~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  299 SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            11111112345577788888777 4788877   8877654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1e-28  Score=259.23  Aligned_cols=237  Identities=28%  Similarity=0.421  Sum_probs=192.9

Q ss_pred             ccEEEEEEEEcc--eeEEEEEeccCChhh-HHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChhhhhcc
Q 002809          578 GFGTVYYGRLNE--IDVAVKMLSSSSAQG-FQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD  654 (878)
Q Consensus       578 ~fG~Vy~~~~~~--~~vAvK~l~~~~~~~-~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  654 (878)
                      +||.||+|+..+  ..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999865  889999998765544 68999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCc
Q 002809          655 ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY  734 (878)
Q Consensus       655 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y  734 (878)
                      .  ..+++..+..++.++++++.+||+.   +++|+||+|+||++++++.++|+|||.+.......   ......++..|
T Consensus        81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 R--GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             c--cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            3  2389999999999999999999998   99999999999999999999999999988764332   22334578899


Q ss_pred             cCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHH
Q 002809          735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVE  814 (878)
Q Consensus       735 ~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~  814 (878)
                      ++||.+....++.++||||||+++++|++|..||.......  .+.++.    ..+.... .      ........++.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~----~~~~~~~-~------~~~~~~~~~~~~  219 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKI----GKPKPPF-P------PPEWKISPEAKD  219 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH----hccCCCC-c------cccccCCHHHHH
Confidence            99999998889999999999999999999999997632211  122211    1111100 0      000002347889


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 002809          815 LAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       815 l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=274.59  Aligned_cols=244  Identities=25%  Similarity=0.378  Sum_probs=195.8

Q ss_pred             cccccccccEEEEEEEE--cceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          571 ERTLGKGGFGTVYYGRL--NEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +++||+|.||+||-|++  +++.||||++.+.  ..+...+..+|+.+|++++||.||.+-..|+..+..++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            47999999999998876  4599999999764  233347789999999999999999999999999999999999955 


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC---CcEEEeecCCccccccCCCCc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~~~~~~~~~~  723 (878)
                      +..+.+-.....++++..-..++.||+.||.|||.+   +|+|+||||+|||+...   -++||||||.|+.++...   
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence            555544444567899999999999999999999998   99999999999999754   379999999999885433   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ....+.||+.|+|||++..+.|...-|+||.||++|--++|.-||.+...     +.+    .++...  -..-    ..
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----Ind----QIQNAa--FMyP----p~  786 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----IND----QIQNAA--FMYP----PN  786 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhH----Hhhccc--cccC----CC
Confidence            33457899999999999999999999999999999999999999986432     111    111100  0111    11


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...+.....++++...|+..-.+|-+..+.+..
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            123445577889999999998999998877653

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-28  Score=233.61  Aligned_cols=257  Identities=22%  Similarity=0.332  Sum_probs=197.6

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      +.||+|.+|+||+|+..+  +-||+|+.+-.  ...-.....+|+-+|+.++|+|||++++....+..+-+|+|||. .+
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd   86 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD   86 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence            579999999999998765  67999988743  23334578999999999999999999999999999999999994 47


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |..+.... +..++.+....++.|+++||.++|++   ++.|||+||+|.|++.+|+.|++|||+++.++....  ....
T Consensus        87 lkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr--cysa  160 (292)
T KOG0662|consen   87 LKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSA  160 (292)
T ss_pred             HHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeec
Confidence            77777654 45688899999999999999999998   999999999999999999999999999998754322  2223


Q ss_pred             ccCCCCccCccccccCC-CCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCccc---ccCCcccc
Q 002809          728 VAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKS---IVDPRLQE  802 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~-~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~---iid~~l~~  802 (878)
                      ..-|..|.+|+++.+.+ |+...|+||-||++.|+.. |++.|.+.+..++..-.-|+.....+.....   +-|-....
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            34688999999998765 7889999999999999987 6777777666555544445544444433322   22222222


Q ss_pred             ccCHHHH---------HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          803 DFDANSV---------WKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       803 ~~~~~~~---------~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      -++....         ..-.++..+.+.-+|.+|.++++.++
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2222111         12346777778889999999988765

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=265.84  Aligned_cols=266  Identities=18%  Similarity=0.273  Sum_probs=204.0

Q ss_pred             HHHHHHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcc--c----ceeeeeecccC
Q 002809          561 SDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH--R----NLTSLVGHCDE  632 (878)
Q Consensus       561 ~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H--~----nIv~l~g~~~~  632 (878)
                      .|.....+.+.+.+|+|.||.|-.+....  ..||||+++.... -.+..+-|+++|.++.+  |    -+|++.++|.-
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            34445555667889999999999886544  7899999876532 23556789999999942  2    27888999999


Q ss_pred             CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc------------
Q 002809          633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN------------  700 (878)
Q Consensus       633 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~------------  700 (878)
                      .++.++|+|.+ |-|+.++|..+.-.+++..++..|+.|+++++++||+.   +++|.||||+|||+.            
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence            99999999998 66999999988888899999999999999999999998   999999999999993            


Q ss_pred             --------CCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002809          701 --------EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRIN  772 (878)
Q Consensus       701 --------~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~  772 (878)
                              .+..+||+|||.|+.-...     ......|..|.|||++.+-..+.++||||+||||.|+.||...|+..+
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                    2346899999999754222     134668999999999999999999999999999999999999998776


Q ss_pred             hHHHHHHHHHHHH-----H---------HhcCCc-----------ccccCCccc----cccCHHHHHHHHHHHHHccCCC
Q 002809          773 EEEKIHIRQWVNS-----L---------IAKGDI-----------KSIVDPRLQ----EDFDANSVWKAVELAMACLSPT  823 (878)
Q Consensus       773 ~~~~~~l~~~v~~-----~---------~~~~~~-----------~~iid~~l~----~~~~~~~~~~l~~l~~~Cl~~d  823 (878)
                      ..+.+.+.+-+..     +         ...+++           ..+.++-..    ......+..++.+|+..||..|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            5454433332211     1         111111           011110000    0112345668999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 002809          824 GNQRPTMSQVVME  836 (878)
Q Consensus       824 P~~RPsm~evl~~  836 (878)
                      |.+|+|+.|+++.
T Consensus       394 P~~RiTl~EAL~H  406 (415)
T KOG0671|consen  394 PARRITLREALSH  406 (415)
T ss_pred             ccccccHHHHhcC
Confidence            9999999998763

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-28  Score=280.58  Aligned_cols=247  Identities=24%  Similarity=0.434  Sum_probs=201.6

Q ss_pred             hhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeeccc-----CCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCD-----EDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~-----~~~~~~lV~  640 (878)
                      .|.++||.|.+|.||+++.  .++.+|+|++...... .+++..|.++|+.. .|||++.++|++.     .+++++|||
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            4568999999999998865  4588999988765443 36788899999888 5999999999883     467899999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      |||.+|+..|+++...+..+.|+.+..|++.++.|+.+||..   .++|||||=.|||++.++.+|++|||++..+... 
T Consensus       101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT-  176 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST-  176 (953)
T ss_pred             eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc-
Confidence            999999999999988888999999999999999999999998   9999999999999999999999999999876332 


Q ss_pred             CCcccccccCCCCccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSN-----RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                       ........||+.|||||++...     .|+..+|+||||++..||.-|.+|+.++.+-..+.      ...+.      
T Consensus       177 -~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF------~IpRN------  243 (953)
T KOG0587|consen  177 -VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPRN------  243 (953)
T ss_pred             -cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc------cCCCC------
Confidence             2333456799999999998643     46779999999999999999999998766532111      11111      


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        |...-.-+..-..++.+++..||..|-++||++.++++
T Consensus       244 --PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  244 --PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence              11111123445568889999999999999999998875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-29  Score=268.11  Aligned_cols=254  Identities=24%  Similarity=0.395  Sum_probs=207.2

Q ss_pred             CCCCHHHHHHHHhhhcccccccccEEEEEEEEccee--EEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecc
Q 002809          556 RHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHC  630 (878)
Q Consensus       556 ~~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~~~--vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~  630 (878)
                      ....++|+.++     ..||-|+||.|=..+.++..  +|+|++++.   .....+....|-.+|...+.|.||+++..|
T Consensus       415 a~v~l~dl~~i-----aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf  489 (732)
T KOG0614|consen  415 AQVKLSDLKRI-----ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF  489 (732)
T ss_pred             cccchhhhhhh-----hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence            34555666443     47999999999999888744  788888754   334456788899999999999999999999


Q ss_pred             cCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       631 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                      .+....|+.||-|-||.|...|++  +..++..+...++..+.+|++|||.+   +||.|||||+|.+|+.+|-+||.||
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDF  564 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDF  564 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeeh
Confidence            999999999999999999999987  77899999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      |.|+.+..+..   .-+++||+.|.|||.+.....+.++|.||+|++++||++|.+||...++-...++       +-+|
T Consensus       565 GFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------ILkG  634 (732)
T KOG0614|consen  565 GFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------ILKG  634 (732)
T ss_pred             hhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------HHhh
Confidence            99998865543   3458999999999999999999999999999999999999999998776432221       1111


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT-----MSQVVMEL  837 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~~L  837 (878)
                           +|.   -+++........+++.+....+|.+|-.     +.+|-++-
T Consensus       635 -----id~---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  635 -----IDK---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             -----hhh---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence                 110   1223333345668888888889999875     56665543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=1e-27  Score=283.06  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=164.2

Q ss_pred             hhcccccccccEEEEEEEEc------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeec------ccCCCcc
Q 002809          569 NFERTLGKGGFGTVYYGRLN------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH------CDEDNQT  636 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~------~~~~~~~  636 (878)
                      .+.+.||+|+||.||+|++.      +..||+|++......  +.+..|  .+....+.++..++..      +..+...
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence            45689999999999999875      467999987653321  111111  1122222222222221      2456789


Q ss_pred             eeEeeeccCCChhhhhccccC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEE
Q 002809          637 ALIYEFMANGNLQEYLSDISK------------------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNIL  698 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NIL  698 (878)
                      ++|+||+.+++|.+++.....                  .......+..++.|++.||+|||+.   +|+||||||+|||
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL  287 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII  287 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence            999999999999999865321                  0112344668999999999999998   9999999999999


Q ss_pred             EcC-CCcEEEeecCCccccccCCCCcccccccCCCCccCccccccC----------------------CCCCccchhhHH
Q 002809          699 LNE-KLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN----------------------RLTEKSDVYSFG  755 (878)
Q Consensus       699 l~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----------------------~~t~ksDV~S~G  755 (878)
                      +++ ++.+||+|||+++.+.... ........+++.|+|||.+...                      .++.++||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            986 5799999999998653322 2223345689999999965322                      234567999999


Q ss_pred             HHHHHHHhCCCCCCCCChHH-------HHHHHHHHHHHHhcCCcccccCCccccccC--HHHHHHHHHHHHHccCCCCCC
Q 002809          756 VVILEIITCKPAISRINEEE-------KIHIRQWVNSLIAKGDIKSIVDPRLQEDFD--ANSVWKAVELAMACLSPTGNQ  826 (878)
Q Consensus       756 vvl~elltG~~p~~~~~~~~-------~~~l~~~v~~~~~~~~~~~iid~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~  826 (878)
                      |++|||+++..+.+.....-       ...+..|.......      ..+.+...+.  ........+|+.+||+.||++
T Consensus       367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k  440 (566)
T PLN03225        367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ  440 (566)
T ss_pred             HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence            99999999776644211100       00112221111100      0000000000  001123458999999999999


Q ss_pred             CCCHHHHHHH
Q 002809          827 RPTMSQVVME  836 (878)
Q Consensus       827 RPsm~evl~~  836 (878)
                      |||++|++++
T Consensus       441 R~ta~e~L~H  450 (566)
T PLN03225        441 RISAKAALAH  450 (566)
T ss_pred             CCCHHHHhCC
Confidence            9999999874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.7e-27  Score=274.69  Aligned_cols=254  Identities=19%  Similarity=0.269  Sum_probs=176.6

Q ss_pred             hhcccccccccEEEEEEEE------------------cceeEEEEEeccCChhhHHH--------------HHHHHHHHH
Q 002809          569 NFERTLGKGGFGTVYYGRL------------------NEIDVAVKMLSSSSAQGFQQ--------------FQAEVKLLM  616 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~------------------~~~~vAvK~l~~~~~~~~~~--------------f~~Ei~~L~  616 (878)
                      .+.+.||+|+||.||+|..                  .++.||||++........++              +..|+.++.
T Consensus       148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~  227 (507)
T PLN03224        148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA  227 (507)
T ss_pred             eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence            4467999999999999964                  12569999987544333333              344777778


Q ss_pred             Hhcccce-----eeeeecccC--------CCcceeEeeeccCCChhhhhcccc----------------------CCCCC
Q 002809          617 RVHHRNL-----TSLVGHCDE--------DNQTALIYEFMANGNLQEYLSDIS----------------------KKVLS  661 (878)
Q Consensus       617 ~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~  661 (878)
                      +++|.++     ++++++|..        ++..++||||+++|+|.++++...                      ...++
T Consensus       228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~  307 (507)
T PLN03224        228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD  307 (507)
T ss_pred             HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence            8876654     677787753        356899999999999999987421                      12356


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccc
Q 002809          662 SQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT  741 (878)
Q Consensus       662 ~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~  741 (878)
                      +..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++.+...... ......+++.|+|||.+.
T Consensus       308 ~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        308 INVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhc
Confidence            788999999999999999998   9999999999999999999999999999765332211 111223578999999875


Q ss_pred             cCCC----------------------CCccchhhHHHHHHHHHhCCC-CCCCCChHH------HHHHHHHHHHHHhcCCc
Q 002809          742 SNRL----------------------TEKSDVYSFGVVILEIITCKP-AISRINEEE------KIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       742 ~~~~----------------------t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~------~~~l~~~v~~~~~~~~~  792 (878)
                      ....                      ..+.||||+||+++||++|.. |+.......      ...+..|..  ......
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~~  461 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQKY  461 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccCC
Confidence            4321                      234799999999999999874 665422111      111222221  111110


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTG---NQRPTMSQVVME  836 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPsm~evl~~  836 (878)
                          +  +  ...........+++.+||..+|   .+|+|++|++++
T Consensus       462 ----~--~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        462 ----D--F--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ----C--c--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                0  0  0111223467788999998765   689999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=278.80  Aligned_cols=242  Identities=29%  Similarity=0.429  Sum_probs=187.9

Q ss_pred             cccccccccE-EEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          571 ERTLGKGGFG-TVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       571 ~~~LG~G~fG-~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      .+++|.|+.| .||+|...++.||||++....   ..-..+|++.|+.- +|||||++++.-.++...|+..|.| ..+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence            3678999886 579999999999999986543   24567899999888 5999999999999999999999999 5699


Q ss_pred             hhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---C--CcEEEeecCCccccccCCC
Q 002809          649 QEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---K--LQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       649 ~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~--~~~kL~DFGla~~~~~~~~  721 (878)
                      .+++...  ..........+.++.|++.||++||+.   +||||||||+||||+.   +  .+++|+|||+++.+..+..
T Consensus       590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            9999763  222222245578899999999999997   9999999999999976   2  4799999999998865433


Q ss_pred             Cc-ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          722 TH-VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       722 ~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .. ......||.||+|||++....-+.++||||+|||+|+.++| ..||...-..+. ++        -.+.. .+.  .
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI--------l~~~~-~L~--~  734 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI--------LTGNY-TLV--H  734 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh--------hcCcc-cee--e
Confidence            21 13456799999999999998888999999999999999996 799986543221 11        11110 000  0


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +..  ..++  +..+|+.+|++.+|..||++.+|+.
T Consensus       735 L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            110  1112  7789999999999999999999976

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.2e-28  Score=256.11  Aligned_cols=252  Identities=26%  Similarity=0.391  Sum_probs=194.3

Q ss_pred             hcccccccccEEEEEEEE--cceeEEEEEeccCCh-------hhHHHHHHHHHHHHHhcccceeeeeecccC-CCcceeE
Q 002809          570 FERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSA-------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-DNQTALI  639 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV  639 (878)
                      +..+||+|||+.||++..  .++-||||+-.....       .-.+...+|..+-+.|.||.||++++++.- .+.++-|
T Consensus       467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV  546 (775)
T KOG1151|consen  467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV  546 (775)
T ss_pred             HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence            457899999999999965  347899998653211       123567889999999999999999999964 4567899


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCcccc
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSF  716 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~  716 (878)
                      +|||+|-+|+-+|+.  .+.+++.++..|+.||+.||.||.+. +++|||-||||.||||-.   -|.+||.|||+++.+
T Consensus       547 LEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM  623 (775)
T KOG1151|consen  547 LEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM  623 (775)
T ss_pred             eeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence            999999999999987  66799999999999999999999986 889999999999999954   478999999999998


Q ss_pred             ccCCCCc-----ccccccCCCCccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHH
Q 002809          717 ATDANTH-----VSTVVAGTPGYLDPEYYTS----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       717 ~~~~~~~-----~~~~~~gt~~Y~APE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      ..+...+     ......||..|++||++.-    .+.+.|+||||.||++|+.+.|+.||.......  ++.+      
T Consensus       624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILq------  695 (775)
T KOG1151|consen  624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQ------  695 (775)
T ss_pred             cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHh------
Confidence            6554432     2334679999999999853    367889999999999999999999998654322  2221      


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       +..+...-.-.+.  .-+....+...++++||+.--++|....++..
T Consensus       696 -eNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 -ENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -hhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence             1111111100111  11223346678999999998888988777654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=9.5e-28  Score=264.67  Aligned_cols=199  Identities=24%  Similarity=0.407  Sum_probs=171.5

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCChh---hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQ---GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~---~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||-|+||.|.+++..+  ..+|.|.+.+.+.-   .....++|-.||.....+-||+|+-.|.+++.+|+||||++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            579999999999998766  55899998876432   3456788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc---------
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA---------  717 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~---------  717 (878)
                      ++-.+|-+  -..+++..+..++.++..|+++.|..   |+|||||||+|||||.+|++||.||||+.-+.         
T Consensus       715 DmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq  789 (1034)
T KOG0608|consen  715 DMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  789 (1034)
T ss_pred             cHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence            99999876  56788999999999999999999987   99999999999999999999999999986431         


Q ss_pred             cCCC-------------------------------CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 002809          718 TDAN-------------------------------THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP  766 (878)
Q Consensus       718 ~~~~-------------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~  766 (878)
                      .+..                               ........||..|+|||++....++..+|.||.||||+||+.|++
T Consensus       790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~  869 (1034)
T KOG0608|consen  790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP  869 (1034)
T ss_pred             CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence            1100                               001123579999999999999999999999999999999999999


Q ss_pred             CCCCCChHH
Q 002809          767 AISRINEEE  775 (878)
Q Consensus       767 p~~~~~~~~  775 (878)
                      ||......+
T Consensus       870 pf~~~tp~~  878 (1034)
T KOG0608|consen  870 PFLADTPGE  878 (1034)
T ss_pred             CccCCCCCc
Confidence            998876543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7e-28  Score=242.81  Aligned_cols=261  Identities=22%  Similarity=0.361  Sum_probs=196.6

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC-----CcceeEee
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED-----NQTALIYE  641 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~lV~E  641 (878)
                      ++.||-|+||.||..+..  ++.||.|++...  +-...+.+.+|+++|...+|.|++..++...-.     +++|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            468999999999988764  488999998754  333567899999999999999999998876433     36788999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      .|. .+|..++-.  .+.++...++-++.||++||.|||+.   +|.||||||.|.|++.|...||+|||+++.-..+..
T Consensus       138 LmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  138 LMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            985 488888765  78899999999999999999999998   999999999999999999999999999987654444


Q ss_pred             CcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH-HHH-------HHHHhcCCc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR-QWV-------NSLIAKGDI  792 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~v-------~~~~~~~~~  792 (878)
                      .+... ..-|..|.|||.+++. .|+.+.||||.||++.||+.++..|+..++-+...+. +..       .+.-.+|.-
T Consensus       212 ~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  212 LNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            44433 3357899999999875 6899999999999999999999888876654443321 110       011111211


Q ss_pred             ccccC-----Cccccc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          793 KSIVD-----PRLQED----FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       793 ~~iid-----~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                      ..++.     |.+..-    -+...-.+.+.+.+.++..||++|.+.++.+..+-
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            11111     111100    01122335667888899999999999999887653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-27  Score=242.79  Aligned_cols=243  Identities=20%  Similarity=0.366  Sum_probs=194.9

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      ++.++||+|+++.|-.+++..  +-+|+|++++.   ..+...-.+.|-.+.... +||.+|-+..+|+.+..+++|.||
T Consensus       253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey  332 (593)
T KOG0695|consen  253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY  332 (593)
T ss_pred             eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence            345799999999999998865  77999998764   333445566777777666 699999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|--++++  .+.++++.+..+..+|.-||.|||+.   +||.||||.+|||+|.+|.+|+.|+|+++.-..  ..
T Consensus       333 v~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~--~g  405 (593)
T KOG0695|consen  333 VNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PG  405 (593)
T ss_pred             ecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC--CC
Confidence            999999988876  66799999999999999999999998   999999999999999999999999999975322  23


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE-EKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .....++||+.|+|||.+.+..|...+|.|++||+++||+.|+.||+....+ ...+..++..+.+-+..+.      + 
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------i-  478 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------I-  478 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc------c-
Confidence            3455689999999999999999999999999999999999999999864321 1223344544444433321      1 


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCC
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRP  828 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP  828 (878)
                         +.....+...++..-|++||.+|-
T Consensus       479 ---prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  479 ---PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---cceeehhhHHHHHHhhcCCcHHhc
Confidence               111223455677888999999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=6.6e-26  Score=231.56  Aligned_cols=209  Identities=35%  Similarity=0.639  Sum_probs=183.0

Q ss_pred             ccccccEEEEEEEEc--ceeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChhh
Q 002809          574 LGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQE  650 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  650 (878)
                      ||+|.+|.||+++..  +..+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999997  688999998866543 45689999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-CCcEEEeecCCccccccCCCCccccccc
Q 002809          651 YLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       651 ~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      ++.... ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            987532 4689999999999999999999998   9999999999999999 89999999999876643321  122345


Q ss_pred             CCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHH
Q 002809          730 GTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS  808 (878)
Q Consensus       730 gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~  808 (878)
                      +...|++||..... ..+.+.|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            77899999999887 888999999999999998                                               


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          809 VWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       809 ~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ..+.+++..|++.+|++||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             256689999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=8.9e-27  Score=227.08  Aligned_cols=196  Identities=26%  Similarity=0.423  Sum_probs=163.6

Q ss_pred             ccccccccEEEEEEEE--cceeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccCCC
Q 002809          572 RTLGKGGFGTVYYGRL--NEIDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      ..||+|++|.|-+-++  .++-.|+|.+... +.+..++.+.|+.+..+- .+|.+|+++|....+...++.||.|+ -|
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tS  130 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TS  130 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hh
Confidence            4699999999876665  5588999999865 455667888888877665 69999999999999999999999995 47


Q ss_pred             hhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          648 LQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       648 L~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+.+-++.  .+..+++.-+-+|+..+.+||.|||++  ..+||||+||+|||++.+|++|+||||++..+...   -..
T Consensus       131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---iAk  205 (282)
T KOG0984|consen  131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---IAK  205 (282)
T ss_pred             HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh---hHH
Confidence            77665432  367899999999999999999999987  48999999999999999999999999998776432   223


Q ss_pred             ccccCCCCccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 002809          726 TVVAGTPGYLDPEYYTS----NRLTEKSDVYSFGVVILEIITCKPAISRINE  773 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  773 (878)
                      +...|...|||||.+..    ..|+-|+||||||+.+.||.+++.||+....
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            33568899999999853    3689999999999999999999999986543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-25  Score=240.17  Aligned_cols=269  Identities=22%  Similarity=0.329  Sum_probs=198.5

Q ss_pred             CHHHHHH-HHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhc--------ccceeeee
Q 002809          559 SYSDVVK-ITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVH--------HRNLTSLV  627 (878)
Q Consensus       559 s~~dl~~-~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~--------H~nIv~l~  627 (878)
                      ...|+.. ..|-+.+.||-|-|++||++....  +-||+|+.+... .-.+..+.||++|++++        ...||+|+
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            3344444 556667899999999999997654  789999987542 22356789999999995        24699999


Q ss_pred             eccc----CCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-
Q 002809          628 GHCD----EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-  702 (878)
Q Consensus       628 g~~~----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-  702 (878)
                      ++|.    .+.+.++|+|++ |-+|..+|....-+.++...+.+|++||+.||.|||.+|  +|||.||||+|||+..+ 
T Consensus       149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccc
Confidence            9995    456899999999 779999998888888999999999999999999999998  99999999999999210 


Q ss_pred             --------------------------------------------------------------------------------
Q 002809          703 --------------------------------------------------------------------------------  702 (878)
Q Consensus       703 --------------------------------------------------------------------------------  702 (878)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 002809          703 --------------------------------------------------------------------------------  702 (878)
Q Consensus       703 --------------------------------------------------------------------------------  702 (878)
                                                                                                      
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                                                                            


Q ss_pred             -----CcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCh----
Q 002809          703 -----LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINE----  773 (878)
Q Consensus       703 -----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~----  773 (878)
                           .++||+|||-|......     .+....|..|+|||++.+..|+..+||||++|+++||+||...|+..+.    
T Consensus       386 ~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~  460 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS  460 (590)
T ss_pred             CCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence                 01233333333322110     1122456779999999999999999999999999999999988876442    


Q ss_pred             HHHHHHHHHH-------HHHHhcCCc-ccccCC----------ccc---------cccCHHHHHHHHHHHHHccCCCCCC
Q 002809          774 EEKIHIRQWV-------NSLIAKGDI-KSIVDP----------RLQ---------EDFDANSVWKAVELAMACLSPTGNQ  826 (878)
Q Consensus       774 ~~~~~l~~~v-------~~~~~~~~~-~~iid~----------~l~---------~~~~~~~~~~l~~l~~~Cl~~dP~~  826 (878)
                      .+..++...+       +.+...|.. .++++.          +.+         -.++.++..++.+++.-||+.+|++
T Consensus       461 rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeK  540 (590)
T KOG1290|consen  461 RDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEK  540 (590)
T ss_pred             ccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccc
Confidence            2333443332       122222321 222221          111         1235677888999999999999999


Q ss_pred             CCCHHHHHHH
Q 002809          827 RPTMSQVVME  836 (878)
Q Consensus       827 RPsm~evl~~  836 (878)
                      |||+.++++.
T Consensus       541 R~tA~~cl~h  550 (590)
T KOG1290|consen  541 RPTAAQCLKH  550 (590)
T ss_pred             cccHHHHhcC
Confidence            9999999974

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.2e-24  Score=226.35  Aligned_cols=197  Identities=34%  Similarity=0.529  Sum_probs=171.4

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|++|.||++...+  ..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            345789999999999999865  88999999876554 678899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++..... .+++..+..++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus        82 ~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       82 GDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            999999976322 188999999999999999999998   999999999999999999999999999887643321 122


Q ss_pred             ccccCCCCccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002809          726 TVVAGTPGYLDPEYY-TSNRLTEKSDVYSFGVVILEIITCKPAISR  770 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~~~  770 (878)
                      ....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334577889999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=8.5e-26  Score=233.80  Aligned_cols=248  Identities=25%  Similarity=0.318  Sum_probs=186.7

Q ss_pred             ccccccccEEEEEEE--EcceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC------CCcceeEee
Q 002809          572 RTLGKGGFGTVYYGR--LNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE------DNQTALIYE  641 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~--~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~------~~~~~lV~E  641 (878)
                      +.+|.|+- .|..+-  ..+++||+|++...  .....++..+|...+..+.|+|+++++.++.-      ..+.++|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            45777777 454443  34688999987643  34567888999999999999999999999843      346899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      +| .++|...+.    -.++-..+..|..|++.|++|||+.   +|+||||||+||++..++.+||.|||+++.-...  
T Consensus       102 ~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--  171 (369)
T KOG0665|consen  102 LM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--  171 (369)
T ss_pred             hh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--
Confidence            99 458888776    2467788899999999999999998   9999999999999999999999999999854322  


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC----------
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD----------  791 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~----------  791 (878)
                       -..+-...+..|.|||++.+..+.+.+||||.||++.||++|+..|.+..     ++.+|.+-.-.-|.          
T Consensus       172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHHHHHHhh
Confidence             23334557889999999998889999999999999999999998877432     34444321111110          


Q ss_pred             -----------------ccccc-CCccccc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          792 -----------------IKSIV-DPRLQED--FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       792 -----------------~~~ii-d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                                       ..+.+ |..+...  .+.-....+.+++.+||..+|++|-+++++++.
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                             00111 1111111  111234467789999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=247.29  Aligned_cols=190  Identities=24%  Similarity=0.408  Sum_probs=164.5

Q ss_pred             cccccccccEEEEEEEEcc--eeEEEEEeccCCh--------hhHHHHHHHHHHHHHhc---ccceeeeeecccCCCcce
Q 002809          571 ERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA--------QGFQQFQAEVKLLMRVH---HRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~--------~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~~~  637 (878)
                      .+.+|+|+||.|+.+.++.  ..|+||.+.+...        ...-..-.|+++|..++   |+||++++++|++++..+
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            3689999999999998875  7899999876421        11234567999999997   999999999999999999


Q ss_pred             eEeeec-cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          638 LIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       638 lV~Ey~-~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      |+||-. ++-+|.+++..  ...+++.++..|++|++.|+++||++   +|||||||-+||.++.+|-+||+|||.+...
T Consensus       646 l~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             EEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhh
Confidence            999976 45699999976  56799999999999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCCCcccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCC
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAIS  769 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~  769 (878)
                      ..+    ....+.||..|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus       721 ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  721 KSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            332    2345789999999999999887 556899999999999998888875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=2.8e-25  Score=241.15  Aligned_cols=273  Identities=22%  Similarity=0.263  Sum_probs=209.3

Q ss_pred             CCCCCHHHHHHHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhc------ccceeee
Q 002809          555 SRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVH------HRNLTSL  626 (878)
Q Consensus       555 ~~~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~------H~nIv~l  626 (878)
                      ...+.+.|++.-.|.+....|+|-|++|.+|+...  ..||||++...... .+.=+.|+++|.+|.      .-|.+++
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            34556778888888888889999999999998653  78999999876433 355678999999995      4578999


Q ss_pred             eecccCCCcceeEeeeccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-c
Q 002809          627 VGHCDEDNQTALIYEFMANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-Q  704 (878)
Q Consensus       627 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~  704 (878)
                      +-+|...++++||+|-+ ..+|.+.|+... .-.|....+..++.|+.-||..|..-   +|+|.||||.|||+++.. .
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence            99999999999999987 569999998754 45688889999999999999999976   999999999999999865 6


Q ss_pred             EEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH---
Q 002809          705 AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQ---  781 (878)
Q Consensus       705 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---  781 (878)
                      +||||||.|.......-+.    ..-+..|.|||++.+..|+...|+||.||+||||.||+..|.+......+.+.-   
T Consensus       576 LKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            7999999997664332211    123457999999999999999999999999999999999998876544332211   


Q ss_pred             --HHHHHHhcCCc-ccccCCcc--------------------------------c-----cccCHHHHHHHHHHHHHccC
Q 002809          782 --WVNSLIAKGDI-KSIVDPRL--------------------------------Q-----EDFDANSVWKAVELAMACLS  821 (878)
Q Consensus       782 --~v~~~~~~~~~-~~iid~~l--------------------------------~-----~~~~~~~~~~l~~l~~~Cl~  821 (878)
                        +-..++.+|.. ..-+|..+                                .     ..-......++.+|+..|+.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence              11233333321 11111111                                0     01123345678899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 002809          822 PTGNQRPTMSQVVME  836 (878)
Q Consensus       822 ~dP~~RPsm~evl~~  836 (878)
                      .||++|.+..|.++.
T Consensus       732 LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  732 LDPEKRITVNQALKH  746 (752)
T ss_pred             cChhhcCCHHHHhcC
Confidence            999999999998763

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=9.6e-25  Score=215.67  Aligned_cols=252  Identities=21%  Similarity=0.378  Sum_probs=189.1

Q ss_pred             hhhcccccccccEEEEEEE--EcceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCC--CcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDED--NQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~--~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~--~~~~lV~Ey  642 (878)
                      +.+.+.+|+|-++.||.|.  .++.+++||+++...   .+.+.+|+.+|..++ ||||+++++...+.  ....||+||
T Consensus        40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             HHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            3455789999999999997  345889999998654   367889999999997 99999999998654  467899999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDAN  721 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~  721 (878)
                      +.+.+...+-.     .++...+...+.+++.||.|+|+.   ||+|||+||.|+++|... .++|+|+|+|.++.++..
T Consensus       117 v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e  188 (338)
T KOG0668|consen  117 VNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  188 (338)
T ss_pred             hccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence            99877766643     478888999999999999999998   999999999999999754 699999999998865543


Q ss_pred             CcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH--------HHHhcCCc
Q 002809          722 THVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN--------SLIAKGDI  792 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~--------~~~~~~~~  792 (878)
                      ..   ....+..|.-||++-. +.|+..-|+|||||++..|+..+.||........ .++..+.        ..+.+-.+
T Consensus       189 Yn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  189 YN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             ee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHHHcc
Confidence            32   2345667888999854 5688899999999999999999988865443211 1221111        11111111


Q ss_pred             ccccCCcccc-----------cc----CH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 KSIVDPRLQE-----------DF----DA-NSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 ~~iid~~l~~-----------~~----~~-~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .+||++..           .+    +. -...++++++.+.|.-|-++|+|++|.+..
T Consensus       265 --~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  265 --DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             --CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence              12222211           11    00 112478899999999999999999998874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-24  Score=241.42  Aligned_cols=247  Identities=25%  Similarity=0.404  Sum_probs=199.9

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      ....+|+|.+|.|||++..  ++..|+|+++-......+-.++|+-+++..+|+|||.++|.+...+..+++||||.+|+
T Consensus        19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            3467999999999999875  47899999987777777888999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |++.-+.  ...+++.++..+.++.++||+|||+.   +=+|||||-.|||+++.|.+|++|||.+..+...  ......
T Consensus        99 lQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~Krks  171 (829)
T KOG0576|consen   99 LQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKS  171 (829)
T ss_pred             ccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh--hhhhhc
Confidence            9998775  66799999999999999999999998   8899999999999999999999999998765322  122344


Q ss_pred             ccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          728 VAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       728 ~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      +.||+.|||||+..   .+.|..++|||+.|+...|+---++|.....+.....+       ..+    +..++--..+.
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mTk----S~~qpp~lkDk  240 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MTK----SGFQPPTLKDK  240 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hhc----cCCCCCcccCC
Confidence            67999999999873   56799999999999999999988888766554332222       111    11221111111


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       ..-...+-+++..|+..+|++||+++.+++
T Consensus       241 -~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  241 -TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             111235668999999999999999998765

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2e-23  Score=211.18  Aligned_cols=256  Identities=20%  Similarity=0.377  Sum_probs=185.6

Q ss_pred             CCCHHHHHHHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeec-ccC
Q 002809          557 HLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGH-CDE  632 (878)
Q Consensus       557 ~~s~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~-~~~  632 (878)
                      .+++.|.    +++.+.||+|.||.+-.+++.+  +.+++|.+..... ..++|.+|..---.| .|.||+.-++. |+.
T Consensus        19 kv~l~d~----y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   19 KVDLEDV----YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             ccchhhh----hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            3444444    4667899999999999999876  7789998765533 357899998765555 59999988764 677


Q ss_pred             CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE-cCC-CcEEEeec
Q 002809          633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL-NEK-LQAKLADF  710 (878)
Q Consensus       633 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl-~~~-~~~kL~DF  710 (878)
                      .+..++++||++.|+|.+-+..   ..+-+....+++.|++.|+.|+|++   ++||||||.+|||| +.+ .++|||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             CceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence            7788899999999999988764   5577888899999999999999999   99999999999999 333 38999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHH
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN-----RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNS  785 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~  785 (878)
                      |+.+..+...     ....-+..|.+||.....     ...+.+|||.||++++.++||+.||+.....+. .-.+|.  
T Consensus       168 G~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~--  239 (378)
T KOG1345|consen  168 GLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWE--  239 (378)
T ss_pred             ccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHH--
Confidence            9987543211     123345689999987532     356789999999999999999999985433222 122222  


Q ss_pred             HHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          786 LIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       786 ~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      ....+.     .+++...+.. -...++++..+-+..+|++|-...++.++.
T Consensus       240 ~w~~rk-----~~~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  240 QWLKRK-----NPALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             HHhccc-----CccCchhhcc-cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            111111     1122222211 112566788889999999995555555543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=3.2e-24  Score=265.29  Aligned_cols=197  Identities=17%  Similarity=0.258  Sum_probs=140.3

Q ss_pred             Hhcc-cceeeeeecc-------cCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 002809          617 RVHH-RNLTSLVGHC-------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV  688 (878)
Q Consensus       617 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iv  688 (878)
                      .++| +||++++++|       .+....++++|++ +++|.++|... ...+++.+++.++.||++||+|||++   +|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            4556 6888888887       2334677888887 66999999742 45699999999999999999999998   999


Q ss_pred             ecCCCCccEEEcCC-------------------CcEEEeecCCccccccCCC--------------CcccccccCCCCcc
Q 002809          689 HRDVKSTNILLNEK-------------------LQAKLADFGLSKSFATDAN--------------THVSTVVAGTPGYL  735 (878)
Q Consensus       689 HrDLKp~NILl~~~-------------------~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y~  735 (878)
                      ||||||+||||+..                   +.+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   4455666666543211000              00011235788899


Q ss_pred             CccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHH
Q 002809          736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVEL  815 (878)
Q Consensus       736 APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l  815 (878)
                      |||++.+..++.++|||||||+||||++|.+|+.....    .+..+...         .+.+..     .....+...+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhh-----hhcCHHHHHH
Confidence            99999999999999999999999999999888643211    11111110         011111     1112345678


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 002809          816 AMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       816 ~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.+||+.+|.+||+|.|+++.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            889999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=7.3e-23  Score=205.90  Aligned_cols=170  Identities=22%  Similarity=0.264  Sum_probs=128.7

Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.++++.. +..+++.+++.++.|+++||+|||++   +      ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence            6899998752 45699999999999999999999987   3      999999999999999  99987653321     


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                        ..|++.|||||++.+..++.++|||||||++|||+||+.||....... ..+..+...... .      ++.-. ...
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~-~------~~~~~-~~~  132 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA-D------DPRDR-SNL  132 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc-C------Ccccc-ccH
Confidence              258899999999999999999999999999999999999997543211 111122111111 0      00000 011


Q ss_pred             HHHH--HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          806 ANSV--WKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       806 ~~~~--~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ....  .++.+++.+|++.+|++||++.|+++.+......
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            1112  2588999999999999999999999999876544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.88  E-value=7.3e-23  Score=219.77  Aligned_cols=255  Identities=23%  Similarity=0.356  Sum_probs=190.1

Q ss_pred             cccccccccEEEEEEEE-----cceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeecc
Q 002809          571 ERTLGKGGFGTVYYGRL-----NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.||+|.|++||++.+     .++.||+|.+...+..  ..+.+|+++|..+. +.||+++.+++..++...+|+||++
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~  118 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE  118 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence            57899999999999965     3377999998766433  56889999999995 9999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEEeecCCccccccCC---
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSFATDA---  720 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~---  720 (878)
                      .....++...     ++...+..+++.+..||+++|++   |||||||||+|+|.+.. +.-.|.|||+|.......   
T Consensus       119 H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  119 HDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             ccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence            9998888765     77889999999999999999999   99999999999999864 578999999987221000   


Q ss_pred             ---------------------------------------CCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHH
Q 002809          721 ---------------------------------------NTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILE  760 (878)
Q Consensus       721 ---------------------------------------~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~e  760 (878)
                                                             .........||+||.|||++.. ...+.++||||.||+++-
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                                                   0001123579999999999864 567899999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHH--------HHH-HhcCC--ccc------c---------cC-Ccccc---------cc
Q 002809          761 IITCKPAISRINEEEKIHIRQWV--------NSL-IAKGD--IKS------I---------VD-PRLQE---------DF  804 (878)
Q Consensus       761 lltG~~p~~~~~~~~~~~l~~~v--------~~~-~~~~~--~~~------i---------id-~~l~~---------~~  804 (878)
                      +++++.||.....+- ..+.+.+        ++. ...|.  +.+      +         ++ ..+..         ..
T Consensus       271 lls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~  349 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG  349 (418)
T ss_pred             hhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence            999999987654321 1111111        110 00111  100      0         00 00000         00


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .......+.+++.+|++.+|.+|.++++.++.
T Consensus       350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  350 SDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            01112367899999999999999999999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.5e-23  Score=208.94  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=196.5

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      ++...|.+.-.|..|+|++.+..+++|++...  .....+.|..|.-.|+-..||||+.++|.|.......++..||+.|
T Consensus       193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            34456888999999999999988888988754  3444578999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|+..|++...-..+..++.+++.++|+|++|||+. .+-|.---|.+..|++|++.+++|+- +-+++-      ....
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs------fqe~  344 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQEV  344 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee------eecc
Confidence            999999987777788899999999999999999986 44444456889999999999988862 111110      1111


Q ss_pred             cccCCCCccCccccccCCC---CCccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHHHHhcCCcccccCCcccc
Q 002809          727 VVAGTPGYLDPEYYTSNRL---TEKSDVYSFGVVILEIITCKPAISRINEEEK-IHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~---t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ...-.+.||+||.++..+-   -.++|+|||.+++|||.|...||.+..+-+- ..+        .        -+.++.
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki--------a--------leglrv  408 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI--------A--------LEGLRV  408 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--------h--------hccccc
Confidence            2234578999999987653   3478999999999999999999988765331 111        1        112333


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      ..++.....+.+++.-|++.||.+||.+..|+-.|++++
T Consensus       409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            344445557788999999999999999999999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.8e-20  Score=207.70  Aligned_cols=269  Identities=18%  Similarity=0.284  Sum_probs=200.7

Q ss_pred             HhhhcccccccccEEEEEEEEcc---eeEEEEEeccCChhhHHHHHHHHHHHHHhcc----cceeeeeecc-cCCCccee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE---IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH----RNLTSLVGHC-DEDNQTAL  638 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~---~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H----~nIv~l~g~~-~~~~~~~l  638 (878)
                      .+.+.+.||+|+||.||.+....   ..+|+|............+..|+.++..+.+    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            34567899999999999998765   3688888776544333378889999999873    5888888888 57778899


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-----CcEEEeecCCc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-----LQAKLADFGLS  713 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-----~~~kL~DFGla  713 (878)
                      ||+.+ |.+|.++......+.++..+.+.|+.|++.+|++||+.   +++||||||+|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99987 78999988665568899999999999999999999998   99999999999999865     46999999999


Q ss_pred             c--ccccCCCC---cc---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHH
Q 002809          714 K--SFATDANT---HV---STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK-IHIRQWVN  784 (878)
Q Consensus       714 ~--~~~~~~~~---~~---~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~v~  784 (878)
                      +  .+......   ..   .....||..|.+++...+...+.+.|+||++.++.|+..|..||........ ..+.+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  33222211   11   2235599999999999999999999999999999999999999866543221 11111111


Q ss_pred             HHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhcCCCC
Q 002809          785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGR  852 (878)
Q Consensus       785 ~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~~~~~  852 (878)
                      ..        ....     ........+.++...+-..+..++|....+...|+++...+.....+..
T Consensus       255 ~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~  309 (322)
T KOG1164|consen  255 KL--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPF  309 (322)
T ss_pred             hh--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCC
Confidence            10        0110     1111223444555555557889999999999999998877644444333

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=8.9e-21  Score=210.42  Aligned_cols=160  Identities=18%  Similarity=0.145  Sum_probs=124.0

Q ss_pred             hhhcccccccccEEEEEEEEc---ceeEEEEEeccC-----ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN---EIDVAVKMLSSS-----SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~-----~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||+||+|...   +..||||++...     .....+.|.+|+++|.+++|+|+++.+..+   +..++|
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~LV   96 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGLV   96 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEEE
Confidence            455689999999999999763   466899987533     223456799999999999999998533222   457999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCccEEEcCCCcEEEeecCCcccccc
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDV-KSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL-Kp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      |||+++++|... ..  .   .   ...++.++++||+|||+.   +|+|||| ||+|||++.++.+||+|||+++.+..
T Consensus        97 mE~~~G~~L~~~-~~--~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         97 RGWTEGVPLHLA-RP--H---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             EEccCCCCHHHh-Cc--c---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            999999999732 11  1   1   146788999999999998   9999999 99999999999999999999997754


Q ss_pred             CCCCcc------cccccCCCCccCcccccc
Q 002809          719 DANTHV------STVVAGTPGYLDPEYYTS  742 (878)
Q Consensus       719 ~~~~~~------~~~~~gt~~Y~APE~~~~  742 (878)
                      ......      -....+++.|+|||.+..
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            321111      134668889999999864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=3.7e-19  Score=193.26  Aligned_cols=259  Identities=28%  Similarity=0.435  Sum_probs=196.8

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChh---hHHHHHHHHHHHHHhccc-ceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQ---GFQQFQAEVKLLMRVHHR-NLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~---~~~~f~~Ei~~L~~l~H~-nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ...+.||.|+||.||++... ..+++|.+......   ....|.+|+.++..+.|+ +++++.+.+......+++++++.
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            34568999999999999888 78899998765332   467899999999999988 79999999977777899999999


Q ss_pred             CCChhhhhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~  722 (878)
                      ++++.+++..... ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++.+......
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9999977664221 2689999999999999999999998   899999999999999998 7999999999865433222


Q ss_pred             c----ccccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHHHHhcCCccc
Q 002809          723 H----VSTVVAGTPGYLDPEYYTS---NRLTEKSDVYSFGVVILEIITCKPAISRINEE-EKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       723 ~----~~~~~~gt~~Y~APE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~v~~~~~~~~~~~  794 (878)
                      .    ......|+..|+|||.+.+   .......|+||+|++++++++|..|+...... ......+.+..    .... 
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~-  233 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LPTP-  233 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cCCc-
Confidence            1    2355679999999999987   57889999999999999999999997665431 00111111111    1100 


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .................+.+++..|+..+|..|.++.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000001100001223467789999999999999999988775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=2.3e-20  Score=220.15  Aligned_cols=253  Identities=20%  Similarity=0.253  Sum_probs=187.9

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEec----cC-Chh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLS----SS-SAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~----~~-~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ..+.+|.|++|.|+......  ...+.|...    .. ... ....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            35689999999777664321  323333222    11 111 12236678888888999999999888877777777799


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++ +|..++.+  ...+...++..+++|+..|++|+|+.   +|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus       402 ~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9999 99999875  35688899999999999999999998   999999999999999999999999999987765544


Q ss_pred             C--cccccccCCCCccCccccccCCCCC-ccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          722 T--HVSTVVAGTPGYLDPEYYTSNRLTE-KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       722 ~--~~~~~~~gt~~Y~APE~~~~~~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .  ......+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||.....++...     ......++.. +.. 
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~-~~~-  548 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRN-IFE-  548 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccc-ccc-
Confidence            4  5666788999999999999999877 5899999999999999999998765543221     0000000000 000 


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       -..............++.++|+.+|.+|.+|++|++.
T Consensus       549 -~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  549 -GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             -ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence             0001112233456689999999999999999999863

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=8.6e-19  Score=182.40  Aligned_cols=276  Identities=15%  Similarity=0.248  Sum_probs=206.0

Q ss_pred             HhhhcccccccccEEEEEEE--EcceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeec
Q 002809          567 TNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~--~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      -+.+.+.||+|.||.++.|+  +++..||||.-...+.  ..++..|....+.|. .+.|...+-+-.++.+-.||+|++
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            34667899999999999997  4679999998654432  356778888888884 788998888888888899999998


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-----CcEEEeecCCcccccc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-----LQAKLADFGLSKSFAT  718 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-----~~~kL~DFGla~~~~~  718 (878)
                       |-+|+|++.- -++.++.++...+|.|++.-++|+|++   .+|.|||||+|+||...     ..+.|+|||+|+.+..
T Consensus       107 -GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  107 -GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             -CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence             7799988754 356799999999999999999999998   99999999999999743     3689999999998854


Q ss_pred             CCC-----CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          719 DAN-----THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       719 ~~~-----~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      ...     ........||.+||+-....+.+-+...|.=|+|.++...+-|..||++........--+-+...-+.-.+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            321     122345679999999999999999999999999999999999999999876533211111111111111111


Q ss_pred             cccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhcCCCCCcCCCC
Q 002809          794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHSKG  858 (878)
Q Consensus       794 ~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~~~~~~~~~~~  858 (878)
                      ++     ...+ +++....++.++   ..+=.+-|..+-+...+.++++.-....+..+.|+...
T Consensus       262 ~L-----c~g~-P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln  317 (449)
T KOG1165|consen  262 VL-----CEGF-PEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN  317 (449)
T ss_pred             HH-----HhcC-HHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence            11     1112 233334444444   44556779999998888998888777777777666554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=5.1e-20  Score=215.82  Aligned_cols=245  Identities=21%  Similarity=0.255  Sum_probs=181.0

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChh-hHHHHHHHHHH--HHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQ-GFQQFQAEVKL--LMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~--L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||++.|=+|.+++..+..|+||++.+..+. ....|.++++-  ...++|||.+++...-..+..-|+|-+|..+
T Consensus        26 ~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh  105 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH  105 (1431)
T ss_pred             eeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence            45678999999999999998878999998876533 34444444433  4555899999998887778888899999855


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc-cCCCCcc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA-TDANTHV  724 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~-~~~~~~~  724 (878)
                       +|+|.+..  +..+...+.+.|+.|++.||.-+|..   +|+|||||.+|||++.-.-+.|+||..-+..- +.++...
T Consensus       106 -nLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  106 -NLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             -hhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence             99999875  66788889999999999999999998   99999999999999999999999998765321 1111111


Q ss_pred             ----cccccCCCCccCccccccC-----------CCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHH-H
Q 002809          725 ----STVVAGTPGYLDPEYYTSN-----------RLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSL-I  787 (878)
Q Consensus       725 ----~~~~~gt~~Y~APE~~~~~-----------~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~-~  787 (878)
                          ..+...-.+|+|||.+...           ..+++.||||+||++.||++ |+++|.-.      .+..+-+.. .
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~~~~  253 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSGNAD  253 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhccCcc
Confidence                1222344589999987431           26789999999999999988 68887532      111111100 0


Q ss_pred             h-cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          788 A-KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       788 ~-~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      . +.-++++-|+            .+.++++.|++.||++|-++++.++.=
T Consensus       254 ~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  254 DPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             CHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence            0 0001111121            456899999999999999999999983

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.77  E-value=7.8e-19  Score=181.79  Aligned_cols=172  Identities=12%  Similarity=0.125  Sum_probs=131.0

Q ss_pred             HHHHHhhhcccccccccEEEEEEEEcceeEEEEEeccCChhhH---HH------HHHHHHHHHHhcccceeeeeecccCC
Q 002809          563 VVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGF---QQ------FQAEVKLLMRVHHRNLTSLVGHCDED  633 (878)
Q Consensus       563 l~~~t~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~---~~------f~~Ei~~L~~l~H~nIv~l~g~~~~~  633 (878)
                      ...-.++..++||.|+||.||.....+..+|||++........   ..      +.+|++.+.+++|++|..+..++...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            3444455578999999999999777668899999975433222   22      68999999999999999998875432


Q ss_pred             --------CcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcE
Q 002809          634 --------NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA  705 (878)
Q Consensus       634 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~  705 (878)
                              ...++||||++|.+|.++..      ++.    ....+++.++..+|+.   +++|||+||+||++++++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence                    35789999999999988732      222    2456999999999998   999999999999999998 9


Q ss_pred             EEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHH
Q 002809          706 KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII  762 (878)
Q Consensus       706 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ell  762 (878)
                      +|+|||..+........              ..+.....+..++|+||||+.+..+.
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999987654211111              01333445667999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.76  E-value=2.8e-18  Score=175.11  Aligned_cols=138  Identities=17%  Similarity=0.176  Sum_probs=106.5

Q ss_pred             cccccccccEEEEEEEEc-ceeEEEEEeccCChh--h-------HHH-----------------HHHHHHHHHHhcccce
Q 002809          571 ERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQ--G-------FQQ-----------------FQAEVKLLMRVHHRNL  623 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~--~-------~~~-----------------f~~Ei~~L~~l~H~nI  623 (878)
                      .+.||+|+||.||+|... ++.||||+++.....  .       ...                 ...|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            367999999999999875 589999998754211  1       112                 2359999999988776


Q ss_pred             eeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCccEEEcCC
Q 002809          624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEK  702 (878)
Q Consensus       624 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDLKp~NILl~~~  702 (878)
                      .....+.  ....++||||++++++...+..  ...++......++.|++.+|.++ |+.   +|+||||||+|||++ +
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence            4333221  1234899999998877655322  35688999999999999999999 676   999999999999998 4


Q ss_pred             CcEEEeecCCcccc
Q 002809          703 LQAKLADFGLSKSF  716 (878)
Q Consensus       703 ~~~kL~DFGla~~~  716 (878)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=9.3e-18  Score=167.74  Aligned_cols=204  Identities=21%  Similarity=0.324  Sum_probs=167.8

Q ss_pred             hhhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHhcc-cceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH-RNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.+|.|..  .+.+||||+-+.....  .+...|..+...++| ..|..+..+..++..-.+||+.+ 
T Consensus        17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-   93 (341)
T KOG1163|consen   17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-   93 (341)
T ss_pred             eEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence            45678999999999999975  4599999997654322  467788899988874 66777888888999999999998 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC---CcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~~~~~~~~  721 (878)
                      |.+|++++.-+ .+.++..+.+-++-|++.-++|+|.+   ++|||||||+|+|..-+   ..+.++|||+++.+.....
T Consensus        94 GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   94 GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence            78999987643 45689999999999999999999998   99999999999999644   4689999999998753321


Q ss_pred             -----CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 002809          722 -----THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH  778 (878)
Q Consensus       722 -----~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  778 (878)
                           ........||.+|.+-....+...+...|+=|+|.+|..+--|..||++........
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence                 222345679999999888888888899999999999999999999999987655433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=5.1e-18  Score=191.66  Aligned_cols=217  Identities=26%  Similarity=0.381  Sum_probs=165.4

Q ss_pred             HHHhcccceeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecCCC
Q 002809          615 LMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI-VHRDVK  693 (878)
Q Consensus       615 L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i-vHrDLK  693 (878)
                      |+.+.|.|+.+++|.+..+...+.|.+|+..|+|.|.+.. ....++|.-...++++|+.||+|||+.   +| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence            3567899999999999999999999999999999999976 456789999999999999999999987   55 999999


Q ss_pred             CccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccC-------CCCCccchhhHHHHHHHHHhCCC
Q 002809          694 STNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN-------RLTEKSDVYSFGVVILEIITCKP  766 (878)
Q Consensus       694 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-------~~t~ksDV~S~Gvvl~elltG~~  766 (878)
                      ++|.++|....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998766321111111112234579999998763       14778999999999999999999


Q ss_pred             CCCCCChHHH-HHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          767 AISRINEEEK-IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       767 p~~~~~~~~~-~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      ||........ ..+..++..     .....+-|.+....  +....+..++..||..+|.+||++++|-..++.+..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9987443221 223333322     11222223332111  333378899999999999999999999988887553

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.74  E-value=1.9e-17  Score=169.30  Aligned_cols=138  Identities=19%  Similarity=0.236  Sum_probs=109.1

Q ss_pred             cccccccccEEEEEEEEc-ceeEEEEEeccCChh--------------------------hHHHHHHHHHHHHHhcccce
Q 002809          571 ERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQ--------------------------GFQQFQAEVKLLMRVHHRNL  623 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~--------------------------~~~~f~~Ei~~L~~l~H~nI  623 (878)
                      .+.||+|++|.||+|+.. ++.||||++......                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            367999999999999875 699999998764211                          01224678999999999987


Q ss_pred             eeeeecccCCCcceeEeeeccCCChhhh-hccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcC
Q 002809          624 TSLVGHCDEDNQTALIYEFMANGNLQEY-LSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNE  701 (878)
Q Consensus       624 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~  701 (878)
                      .....+...  ..++||||++++++... +.   ...++......++.|++.++.++|+ .   +|+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            544333322  24899999998865443 33   3457788999999999999999999 7   999999999999999 


Q ss_pred             CCcEEEeecCCccccc
Q 002809          702 KLQAKLADFGLSKSFA  717 (878)
Q Consensus       702 ~~~~kL~DFGla~~~~  717 (878)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=1.9e-17  Score=167.94  Aligned_cols=185  Identities=17%  Similarity=0.142  Sum_probs=140.9

Q ss_pred             cccccccccEEEEEEEEcceeEEEEEeccCChh----hHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeeccC
Q 002809          571 ERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQ----GFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~----~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ...|++|+||+||.+...+.+++.+.+.....-    ....|.+|+++|.+++ |+++++++++    +..+++|||++|
T Consensus         7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            468999999999988877788888887765431    2235889999999995 5889999886    446999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCccEEEcCCCcEEEeecCCccccccCCCC--
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDV-KSTNILLNEKLQAKLADFGLSKSFATDANT--  722 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL-Kp~NILl~~~~~~kL~DFGla~~~~~~~~~--  722 (878)
                      .+|...+..         ....++.|++++|+++|+.   +|+|||| ||+|||++.++.++|+|||++.........  
T Consensus        83 ~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         83 AAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             ccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            998754321         1235778999999999998   9999999 799999999999999999999855432210  


Q ss_pred             --c---c----cccccCCCCccCccccccC-CCC-CccchhhHHHHHHHHHhCCCCCCCC
Q 002809          723 --H---V----STVVAGTPGYLDPEYYTSN-RLT-EKSDVYSFGVVILEIITCKPAISRI  771 (878)
Q Consensus       723 --~---~----~~~~~gt~~Y~APE~~~~~-~~t-~ksDV~S~Gvvl~elltG~~p~~~~  771 (878)
                        .   .    ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+....
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence              0   0    1123467788888764422 222 4668899999999999999876543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=7.5e-18  Score=189.94  Aligned_cols=224  Identities=26%  Similarity=0.315  Sum_probs=175.5

Q ss_pred             cccccccEEEEEEE-----EcceeEEEEEeccCChh--hHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeecc
Q 002809          573 TLGKGGFGTVYYGR-----LNEIDVAVKMLSSSSAQ--GFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~-----~~~~~vAvK~l~~~~~~--~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ++|+|++|.|+..+     ..+.-+|.|++.+....  .......|..++..++ ||.+|++.-.++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999998542     33466888887754221  1124566888899997 9999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|.|...+..  ...+...........++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+++..-....   
T Consensus        81 gg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            9999998875  55677777778888999999999998   999999999999999999999999999986643321   


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                         .+||..|||||++.  ......|.||||++++||+||-.||..   +.       +...+..           ...+
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~-------~~~Il~~-----------~~~~  206 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DT-------MKRILKA-----------ELEM  206 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HH-------HHHHhhh-----------ccCC
Confidence               28999999999998  567899999999999999999999976   11       1111111           1112


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                      +.+....+.+++..++..+|.+|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            33334456677888888888888655

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.68  E-value=2.5e-16  Score=168.01  Aligned_cols=227  Identities=20%  Similarity=0.259  Sum_probs=145.6

Q ss_pred             cccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhc----------ccceeeeeecc-----
Q 002809          571 ERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVH----------HRNLTSLVGHC-----  630 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~----------H~nIv~l~g~~-----  630 (878)
                      .+.||.|+++.||.++..+  +++|||+.....   ....+++.+|.-....+.          |-.++..++..     
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            4689999999999999976  899999875432   235677777776555532          21222222111     


Q ss_pred             ----cCCC--------cceeEeeeccCCChhhhhcc---cc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 002809          631 ----DEDN--------QTALIYEFMANGNLQEYLSD---IS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVK  693 (878)
Q Consensus       631 ----~~~~--------~~~lV~Ey~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLK  693 (878)
                          ....        ..+++|+-+ .++|.+.+..   ..  ...+....++.+..|+.+.+++||+.   +++|+|||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence                1111        235566666 5688877542   11  12345566777889999999999999   99999999


Q ss_pred             CccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCcccccc--------CCCCCccchhhHHHHHHHHHhCC
Q 002809          694 STNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS--------NRLTEKSDVYSFGVVILEIITCK  765 (878)
Q Consensus       694 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~t~ksDV~S~Gvvl~elltG~  765 (878)
                      |+|++++++|.++|+||+.....+..  ...   ...+..|.+||....        ..++.+.|.|++|+++|.|++|+
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTR--YRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEE--EEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCce--eec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999876644221  111   234578999998744        25788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCC
Q 002809          766 PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQR  827 (878)
Q Consensus       766 ~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  827 (878)
                      .||.....+....   |                . ..... +.++.+..|+..+|+.+|.+|
T Consensus       248 lPf~~~~~~~~~~---~----------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPE---W----------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSG---G----------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCcccccc---c----------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9998654322100   0                1 11223 556688899999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.68  E-value=2.7e-16  Score=162.26  Aligned_cols=133  Identities=18%  Similarity=0.262  Sum_probs=104.5

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHh-----cccceeeeeecccCCC---c-ceeEeee
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-----HHRNLTSLVGHCDEDN---Q-TALIYEF  642 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-----~H~nIv~l~g~~~~~~---~-~~lV~Ey  642 (878)
                      +.||+|+||.||... .....+||++........+.+.+|+.++.++     .||||++++|++..+.   . ..+|+||
T Consensus         8 ~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~   86 (210)
T PRK10345          8 SPLGTGRHRKCYAHP-EDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF   86 (210)
T ss_pred             ceecCCCceEEEECC-CCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence            689999999999622 2333479988765444567899999999999     5799999999998763   3 3378999


Q ss_pred             --ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCccEEEcC----CCcEEEeecCCc
Q 002809          643 --MANGNLQEYLSDISKKVLSSQERLRIAVESAQGL-EYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLS  713 (878)
Q Consensus       643 --~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivHrDLKp~NILl~~----~~~~kL~DFGla  713 (878)
                        +.+|+|.+++.+   ..+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +.+++|+||+.+
T Consensus        87 ~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         87 DGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence              557999999965   235555  35677888777 999998   9999999999999974    348999995543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=7.8e-16  Score=185.20  Aligned_cols=247  Identities=19%  Similarity=0.262  Sum_probs=182.1

Q ss_pred             HhhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhc---ccceeeeeecccCCCcceeEeee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVH---HRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.+.||+|++|+||+|...+ +.||+|+-+..+...   |.--.+++.+|+   -+.|.++...+.-.+..+||+||
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey  775 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY  775 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence            34567899999999999998766 889999987765542   222223333443   34455566666677888999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc-------CCCcEEEeecCCccc
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-------EKLQAKLADFGLSKS  715 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~-------~~~~~kL~DFGla~~  715 (878)
                      .+-|+|.+++..  .+.++|...+.+..|+++.+++||..   +||||||||+|.||.       ++..++|+|||.+-.
T Consensus       776 ~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  776 SPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             cccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            999999999974  67899999999999999999999998   999999999999994       234689999999876


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      +..-........+++|-.+-.+|...+...+.+.|-|.+.-+++-|+-|+..                .  ...|. ...
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------------q--~~~g~-~~~  911 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------------E--VKNGS-SWM  911 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------------H--hcCCc-cee
Confidence            6544444455567889999999999999999999999999999999998741                1  11222 122


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ++..+++....+ +  .-++...+|+.+-..=|...++...|++++..
T Consensus       912 ~~~~~~Ry~~~~-~--W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  912 VKTNFPRYWKRD-M--WNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             ccccchhhhhHH-H--HHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            222232222222 1  22455666665555558888888888887654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=6.5e-16  Score=160.30  Aligned_cols=134  Identities=18%  Similarity=0.328  Sum_probs=114.6

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChh--------hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQ--------GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~--------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      +.||+|++|.||+|...+..+++|+.......        ....+.+|++++..++|+++.....++...+..++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            57899999999999998899999987643211        1246788999999999999887777777777889999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      ++++|.+++...     .+ .+..++.+++.+|.++|+.   +++|||++|+|||++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998642     12 7889999999999999998   999999999999999 78999999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=1e-15  Score=157.33  Aligned_cols=130  Identities=22%  Similarity=0.340  Sum_probs=108.3

Q ss_pred             cccccccEEEEEEEEcceeEEEEEeccCCh--------hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          573 TLGKGGFGTVYYGRLNEIDVAVKMLSSSSA--------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .||+|++|.||+|.+.+..+++|+......        ....++.+|++++..++|+++.....++......++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            489999999999998889999998654321        123567889999999998876655555556667799999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      +++|.+++.....         .++.+++++|.+||+.   +++|||++|+||+++ ++.+++.|||+++.
T Consensus        81 g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998754110         7899999999999998   999999999999999 88999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.62  E-value=3.1e-15  Score=157.94  Aligned_cols=138  Identities=17%  Similarity=0.198  Sum_probs=107.0

Q ss_pred             hhcccccccccEEEEEEE---EcceeEEEEEeccCChh------------------------hHHHHHHHHHHHHHhccc
Q 002809          569 NFERTLGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQ------------------------GFQQFQAEVKLLMRVHHR  621 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~---~~~~~vAvK~l~~~~~~------------------------~~~~f~~Ei~~L~~l~H~  621 (878)
                      .+.+.||+|++|.||+|.   ..++.||+|++......                        ....+..|++.+.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            456889999999999998   24589999998743210                        112356899999999763


Q ss_pred             c--eeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCccEE
Q 002809          622 N--LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP-IVHRDVKSTNIL  698 (878)
Q Consensus       622 n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDLKp~NIL  698 (878)
                      .  +.+.+++    ...++||||+++++|......  ...+.......++.|++.++.+||+.   + ++||||||+||+
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl  181 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL  181 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence            3  3344443    235899999999888776532  23455666789999999999999998   8 999999999999


Q ss_pred             EcCCCcEEEeecCCcccc
Q 002809          699 LNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       699 l~~~~~~kL~DFGla~~~  716 (878)
                      ++ ++.++|+|||.+...
T Consensus       182 i~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-CCCEEEEEChhhhcc
Confidence            99 889999999988654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.61  E-value=2.6e-15  Score=177.70  Aligned_cols=132  Identities=20%  Similarity=0.309  Sum_probs=111.5

Q ss_pred             hcccccccccEEEEEEEEcceeEEEEEeccCC--------hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSS--------AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--------~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ..+.||+|+||.||+|.+.+..+++|+.....        ....+.+.+|++++.+++|++++....++......++|||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            35789999999999999888766666543211        1123568899999999999999988877777778899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      |+++++|.+++.          ....++.+++++|.+||+.   +++||||||+|||+ +++.++|+|||+++.
T Consensus       417 ~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        417 YIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999875          3567999999999999998   99999999999999 678999999999865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.60  E-value=3.1e-16  Score=173.88  Aligned_cols=173  Identities=27%  Similarity=0.425  Sum_probs=130.8

Q ss_pred             CcceeEeeeccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          634 NQTALIYEFMANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       634 ~~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      ...++.|++|+..+|.+||.+.. ....++...+.++.|++.|++|   +   +.+|+|+||.||+...+.++||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            35789999999999999997433 5668889999999999999999   4   899999999999999999999999999


Q ss_pred             ccccccCC----CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHH
Q 002809          713 SKSFATDA----NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       713 a~~~~~~~----~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      ........    .....+...||..||+||.+.+..|+.|+||||||++|+|+++ -...++...          ...-+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence            88765443    1223345679999999999999999999999999999999997 222211100          01112


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMS  831 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~  831 (878)
                      +.+.    ++|....+++.     -..++.+++.+.|.+||+..
T Consensus       473 r~g~----ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  473 RDGI----IPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hcCC----CChHHhhcCcH-----HHHHHHHhcCCCcccCchHH
Confidence            2232    22233333332     23688899999999999443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.59  E-value=1.1e-14  Score=149.96  Aligned_cols=135  Identities=17%  Similarity=0.176  Sum_probs=106.5

Q ss_pred             hhhcccccccccEEEEEEEEc-ceeEEEEEeccCChh----------------------hHHHHHHHHHHHHHhcccc--
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQ----------------------GFQQFQAEVKLLMRVHHRN--  622 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~----------------------~~~~f~~Ei~~L~~l~H~n--  622 (878)
                      +.+.+.||+|+||.||++... ++.||||++......                      ....+..|+.++.++.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            455688999999999999885 589999987643210                      1123678899999998874  


Q ss_pred             eeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC
Q 002809          623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK  702 (878)
Q Consensus       623 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~  702 (878)
                      +.+.++.    ...++||||+++++|.+....        .....++.++++++.++|+.   +|+||||||+||+++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence            4444432    345899999999998776431        34567889999999999997   99999999999999999


Q ss_pred             CcEEEeecCCccccc
Q 002809          703 LQAKLADFGLSKSFA  717 (878)
Q Consensus       703 ~~~kL~DFGla~~~~  717 (878)
                      +.++|+|||++....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            999999999986553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=1.1e-14  Score=154.86  Aligned_cols=197  Identities=22%  Similarity=0.265  Sum_probs=135.0

Q ss_pred             cccceeeeeecccC---------------------------CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHH
Q 002809          619 HHRNLTSLVGHCDE---------------------------DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVE  671 (878)
Q Consensus       619 ~H~nIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~q  671 (878)
                      +|||||++.+.|.+                           ...+|+||.-.+ .+|.+++..   +..+...+.-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHH
Confidence            59999998876632                           235677777663 488888763   34566677889999


Q ss_pred             HHHHHHHHHhCCCCCeEecCCCCccEEEc--CCC--cEEEeecCCccccccCC----CCcccccccCCCCccCccccccC
Q 002809          672 SAQGLEYLHNGCKPPIVHRDVKSTNILLN--EKL--QAKLADFGLSKSFATDA----NTHVSTVVAGTPGYLDPEYYTSN  743 (878)
Q Consensus       672 ia~gL~yLH~~~~~~ivHrDLKp~NILl~--~~~--~~kL~DFGla~~~~~~~----~~~~~~~~~gt~~Y~APE~~~~~  743 (878)
                      +++|+.|||.+   +|.|||+|++|||+.  ++.  ...|+|||.+-.-....    ...-.....|...-||||+....
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999998   999999999999993  333  57999999874321100    00011123477789999998643


Q ss_pred             C------CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHH
Q 002809          744 R------LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAM  817 (878)
Q Consensus       744 ~------~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~  817 (878)
                      +      --.|+|.|+.|-+.||+++...||....+ ...+...+     ++..+     |    ..+..+...+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Y-----qe~qL-----P----alp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTY-----QESQL-----P----ALPSRVPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhh-----hhhhC-----C----CCcccCChHHHHHHH
Confidence            2      23589999999999999999999976321 11111111     11111     1    223344557789999


Q ss_pred             HccCCCCCCCCCHHHHHHHH
Q 002809          818 ACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       818 ~Cl~~dP~~RPsm~evl~~L  837 (878)
                      ..|+.+|++|++..=....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999876544444

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=5.4e-14  Score=136.31  Aligned_cols=133  Identities=22%  Similarity=0.243  Sum_probs=115.9

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcc--cceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH--RNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      +.||+|.++.||+++..+..+++|.......  ...+.+|+..+..++|  .++.+++++...++..++++||++++.+.
T Consensus         4 ~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            5799999999999999888999999876543  4678999999999987  48999999988888999999999887776


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      .+         +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus        82 ~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          82 EV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            54         5567788899999999999986445799999999999999999999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.52  E-value=8.1e-15  Score=172.82  Aligned_cols=202  Identities=25%  Similarity=0.318  Sum_probs=137.2

Q ss_pred             cccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          571 ERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      .++|..|++|.||..+++.  +.+|+|+ .+....     .+-  ++.....|.+|                     |+-
T Consensus        88 IklisngAygavylvrh~~trqrfa~ki-Nkq~li-----lRn--ilt~a~npfvv---------------------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-----LRN--ILTFAGNPFVV---------------------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcc-cccchh-----hhc--cccccCCccee---------------------chh
Confidence            3789999999999998875  6788743 322111     000  22222233222                     444


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC--------
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--------  720 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--------  720 (878)
                      ...++.  -..++..        ++.+++|||+.   +|+|||+||+|.+|+.-|.+|+.|||+.+......        
T Consensus       139 ~tllk~--~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~  205 (1205)
T KOG0606|consen  139 ATLLKN--IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH  205 (1205)
T ss_pred             hhhccc--CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence            444543  2233332        27789999998   99999999999999999999999999986432110        


Q ss_pred             -----CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          721 -----NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       721 -----~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                           .......++||+.|+|||++....|.+.+|+|++|+++||.+.|..||.+..+++-..  +.+...+        
T Consensus       206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg--~visd~i--------  275 (1205)
T KOG0606|consen  206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG--QVISDDI--------  275 (1205)
T ss_pred             hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh--hhhhhhc--------
Confidence                 1111234689999999999999999999999999999999999999999887765321  1111110        


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCC
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRP  828 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  828 (878)
                          .+.+.+.....++.+++...|+.+|..|-
T Consensus       276 ----~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  276 ----EWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ----cccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                01111222234677888889999999884

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.48  E-value=2.6e-13  Score=143.56  Aligned_cols=135  Identities=19%  Similarity=0.249  Sum_probs=106.9

Q ss_pred             cccc-ccccEEEEEEEEcceeEEEEEeccCC-------------hhhHHHHHHHHHHHHHhcccce--eeeeecccCCCc
Q 002809          572 RTLG-KGGFGTVYYGRLNEIDVAVKMLSSSS-------------AQGFQQFQAEVKLLMRVHHRNL--TSLVGHCDEDNQ  635 (878)
Q Consensus       572 ~~LG-~G~fG~Vy~~~~~~~~vAvK~l~~~~-------------~~~~~~f~~Ei~~L~~l~H~nI--v~l~g~~~~~~~  635 (878)
                      ..|| .|+.|+||.....+..++||......             ......+.+|++++.+++|+++  ++.+++...+..
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            5788 89999999999988999999875321             1223567899999999998885  667776543322


Q ss_pred             ----ceeEeeeccC-CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          636 ----TALIYEFMAN-GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       636 ----~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                          .++|+|++++ .+|.+++..   ..++..    .+.+++++|.+||+.   +|+||||||.|||++.++.++|+||
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence                2599999997 689888764   234443    367899999999998   9999999999999999999999999


Q ss_pred             CCcccc
Q 002809          711 GLSKSF  716 (878)
Q Consensus       711 Gla~~~  716 (878)
                      |.+...
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            988653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.48  E-value=2.2e-13  Score=138.47  Aligned_cols=134  Identities=19%  Similarity=0.266  Sum_probs=96.8

Q ss_pred             cccccccccEEEEEEEEc-ceeEEEEEeccCChh--hHHH----------------------HHHHHHHHHHhcccc--e
Q 002809          571 ERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQ--GFQQ----------------------FQAEVKLLMRVHHRN--L  623 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~--~~~~----------------------f~~Ei~~L~~l~H~n--I  623 (878)
                      .+.||+|+||.||+++.. ++.||||++......  ....                      ...|.+.+.++++..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999887 589999998753221  1111                      135666666665443  3


Q ss_pred             eeeeecccCCCcceeEeeeccCCChhhh-hccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcC
Q 002809          624 TSLVGHCDEDNQTALIYEFMANGNLQEY-LSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNE  701 (878)
Q Consensus       624 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~  701 (878)
                      .+.++.    ...++||||++++.+... +....   . ......++.+++.++.++|. .   +|+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            334432    245899999998654322 22110   1 15678899999999999998 6   999999999999999 


Q ss_pred             CCcEEEeecCCcccc
Q 002809          702 KLQAKLADFGLSKSF  716 (878)
Q Consensus       702 ~~~~kL~DFGla~~~  716 (878)
                      ++.++++|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PLN03150 hypothetical protein; Provisional

Probab=99.47  E-value=3.9e-12  Score=152.62  Aligned_cols=67  Identities=31%  Similarity=0.454  Sum_probs=60.1

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc--ceEEEecCCcCCCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP--LRTLNLQGNKLNGSVP  471 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~--L~~L~ls~N~l~g~iP  471 (878)
                      ..++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..++.+.  +..+++++|...+.+|
T Consensus       464 ~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            456899999999999999999999999999999999999999999988754  8899999998665454

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.3e-14  Score=171.55  Aligned_cols=251  Identities=21%  Similarity=0.305  Sum_probs=188.5

Q ss_pred             hhcccccccccEEEEEEEEcc---eeEEEEEeccCC--hhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE---IDVAVKMLSSSS--AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~---~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+|+.|-......   ..+|+|.+....  .........|..+-..+. |+|++++++...+.+..+++.||
T Consensus        23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~  102 (601)
T KOG0590|consen   23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY  102 (601)
T ss_pred             cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence            445679999999998765532   556777665443  223344555777777776 99999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCccEEEcCCC-cEEEeecCCcccccc-C
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFAT-D  719 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~-~  719 (878)
                      ..++++.+.+........+....-....|+..++.|+| ..   ++.|+||||+|.+++..+ ..+++|||+|..+.. .
T Consensus       103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             ccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            99999999884222325667777889999999999999 66   999999999999999999 999999999998866 4


Q ss_pred             CCCcccccccC-CCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          720 ANTHVSTVVAG-TPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       720 ~~~~~~~~~~g-t~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      .........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++.......              ....+.+
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------~~~~~~~  245 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------RYSSWKS  245 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--------------cceeecc
Confidence            44444555678 9999999999885 446788999999999999999999876554331              1111111


Q ss_pred             Cccc--cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          798 PRLQ--EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       798 ~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ....  ............++..+++..+|..|.+.+++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             cccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence            1100  11111223356678888998999999999887654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.2e-12  Score=136.97  Aligned_cols=202  Identities=23%  Similarity=0.408  Sum_probs=142.4

Q ss_pred             HHHHHHhcccceeeeeecccCC-----CcceeEeeeccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 002809          612 VKLLMRVHHRNLTSLVGHCDED-----NQTALIYEFMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCK  684 (878)
Q Consensus       612 i~~L~~l~H~nIv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~  684 (878)
                      ..-|-.+.|.|||++..|+.+.     .+..++.|||..|+|..+|++..  ...+......+++.||..||.|||+ |.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            3455667799999999998543     45788999999999999998754  5568888889999999999999997 69


Q ss_pred             CCeEecCCCCccEEEcCCCcEEEeecCCccccccCC---CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHH
Q 002809          685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA---NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI  761 (878)
Q Consensus       685 ~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~el  761 (878)
                      |+|+|+++..+.|++..++-+|++--.-.. .....   .........+.++|.+||+-.....+.++|||+||+..+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            999999999999999999988886322110 10000   01111223467899999998888888999999999999999


Q ss_pred             HhCCCC-CCCCCh-HHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          762 ITCKPA-ISRINE-EEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       762 ltG~~p-~~~~~~-~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..+..- -...+. .....+..    .     +.. +...+.           ..++..|++..|..||+|++++..
T Consensus       276 ailEiq~tnseS~~~~ee~ia~----~-----i~~-len~lq-----------r~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIAN----V-----IIG-LENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCCcceeehhhhhhh----h-----eee-ccCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence            887632 221111 00000000    0     000 011111           246778999999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.31  E-value=9.7e-12  Score=142.89  Aligned_cols=139  Identities=19%  Similarity=0.196  Sum_probs=98.7

Q ss_pred             ccccccccEEEEEEEEc-ceeEEEEEeccCChhhH----------------------------------------HHHHH
Q 002809          572 RTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGF----------------------------------------QQFQA  610 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~~----------------------------------------~~f~~  610 (878)
                      +.||+|++|+||+|++. ++.||||+.+.......                                        -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999999986 49999999865421110                                        02455


Q ss_pred             HHHHHHHhc-----ccceeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 002809          611 EVKLLMRVH-----HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ-GLEYLHNGCK  684 (878)
Q Consensus       611 Ei~~L~~l~-----H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~-gL~yLH~~~~  684 (878)
                      |...+.+++     ++++.-..-+....+..++||||++|++|.+....... ..   .+.+++.++++ .+..+|..  
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC--
Confidence            666666653     33332222222334567999999999999987653111 12   23456666665 46788887  


Q ss_pred             CCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       685 ~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                       +++|+|+||.||+++++++++++|||++..+.
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             99999999999999999999999999987764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.20  E-value=7.5e-11  Score=117.69  Aligned_cols=129  Identities=17%  Similarity=0.102  Sum_probs=97.9

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhccccee-eeeecccCCCcceeEeeeccCCChhh
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLT-SLVGHCDEDNQTALIYEFMANGNLQE  650 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL~~  650 (878)
                      +.|+.|.++.||+.+..+..+++|+...... ....+.+|+.++..+.+.+++ +++.+..  ...++||||+++.++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence            4688999999999999889999999765432 224568899999999766654 4444432  34589999999988765


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          651 YLSDISKKVLSSQERLRIAVESAQGLEYLHNGC--KPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       651 ~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ..          .....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        81 ~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          81 ED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            30          111345678999999999872  22369999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=5.6e-11  Score=134.98  Aligned_cols=252  Identities=22%  Similarity=0.221  Sum_probs=179.3

Q ss_pred             HHHHHHhhhcccccc--cccEEEEEEEEc----ceeEEEEEec--cCChhhHHHHHHHHHHHHHhc-ccceeeeeecccC
Q 002809          562 DVVKITNNFERTLGK--GGFGTVYYGRLN----EIDVAVKMLS--SSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDE  632 (878)
Q Consensus       562 dl~~~t~~f~~~LG~--G~fG~Vy~~~~~----~~~vAvK~l~--~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~  632 (878)
                      +......++.+.+|.  |.+|.||.++..    ...+|+|.-+  ...+...+.=.+|+...++++ |+|.++....+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            344445566788999  999999998872    2678888733  232333344466777777775 9999998888899


Q ss_pred             CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEE
Q 002809          633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ----GLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKL  707 (878)
Q Consensus       633 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL  707 (878)
                      .+..++-+|++. .+|.++.+. ....++....+....+..+    ||.++|+.   .++|-|+||.||+...+ ...++
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             CCcceeeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence            999999999985 688777664 2334777888888888888    99999998   99999999999999999 89999


Q ss_pred             eecCCccccccCCCCcc---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002809          708 ADFGLSKSFATDANTHV---STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN  784 (878)
Q Consensus       708 ~DFGla~~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~  784 (878)
                      +|||+...+....-...   .....|...|++||...+ -++.+.|+|++|.++++..++.......-..      .|. 
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~-  336 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SWS-  336 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccc-
Confidence            99999988765432211   112257889999998774 5788999999999999999887544322100      111 


Q ss_pred             HHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       785 ~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       ..+.+.        +..++......++......+++.+|..|++.+.+..
T Consensus       337 -~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 -QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             001110        111111112224445788899999999998776654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.10  E-value=1.4e-09  Score=126.65  Aligned_cols=136  Identities=17%  Similarity=0.205  Sum_probs=87.9

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhh----------------------------------HH------HHH
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQG----------------------------------FQ------QFQ  609 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~----------------------------------~~------~f~  609 (878)
                      +.||+|++|+||+|++.  ++.||||+.++...+.                                  .+      +|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            47999999999999985  5899999997542110                                  11      134


Q ss_pred             HHHHHHHHhc----ccceeeeeecc-cCCCcceeEeeeccCCChhhhh--cccc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 002809          610 AEVKLLMRVH----HRNLTSLVGHC-DEDNQTALIYEFMANGNLQEYL--SDIS--KKVLSSQERLRIAVESAQGLEYLH  680 (878)
Q Consensus       610 ~Ei~~L~~l~----H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l--~~~~--~~~l~~~~~~~i~~qia~gL~yLH  680 (878)
                      +|+..+.+++    +.+.+.+-..+ .-....++||||++|+.+.+.-  ....  ...+.......++.|+       +
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            4444444443    22223222222 2245678999999999998742  2111  1123333333333443       3


Q ss_pred             hCCCCCeEecCCCCccEEEcCCC----cEEEeecCCccccc
Q 002809          681 NGCKPPIVHRDVKSTNILLNEKL----QAKLADFGLSKSFA  717 (878)
Q Consensus       681 ~~~~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~~~~  717 (878)
                      ..   +++|+|+||.||+++.++    ++++.|||++..+.
T Consensus       278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            34   999999999999999988    99999999987663

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.06  E-value=1e-09  Score=125.81  Aligned_cols=163  Identities=21%  Similarity=0.258  Sum_probs=125.0

Q ss_pred             ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHH
Q 002809          589 EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI  668 (878)
Q Consensus       589 ~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i  668 (878)
                      +.+|.|...+...........+-++.|+.+|||||++++..+..++..|+|+|-+.  -|..++++     +........
T Consensus        37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v~~G  109 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEVCLG  109 (690)
T ss_pred             CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHHHHH
Confidence            37788888776655444566778899999999999999999999999999999874  46666665     335566777


Q ss_pred             HHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCc
Q 002809          669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK  748 (878)
Q Consensus       669 ~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~k  748 (878)
                      +.||+.||.+||+.|  +++|++|..+.|++++.|+.||++|.++.....-..  ......--..|..|+.+....  -.
T Consensus       110 l~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  110 LFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             HHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cc
Confidence            899999999999876  899999999999999999999999998754321111  111111223466666554322  34


Q ss_pred             cchhhHHHHHHHHHhC
Q 002809          749 SDVYSFGVVILEIITC  764 (878)
Q Consensus       749 sDV~S~Gvvl~elltG  764 (878)
                      .|.|-|||+++|++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            6999999999999999

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.01  E-value=5.5e-10  Score=142.30  Aligned_cols=83  Identities=30%  Similarity=0.643  Sum_probs=53.2

Q ss_pred             cccccchHHHHHHHHHhhC----CCCCCCC--CCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccccchhhhhccCC
Q 002809          359 LQTEQIDVDAITNIKATYG----LKKNWQG--DPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTS  432 (878)
Q Consensus       359 ~~t~~~d~~al~~lk~~~~----~~~~w~~--~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~  432 (878)
                      ..+.|.|..||.++|+.+.    ...+|+.  ++|     .|.||+|+.    ..+++.|+|++|+++|.+|+.|..|++
T Consensus        24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-----~w~gv~c~~----~~~v~~L~L~~~~i~~~~~~~~~~l~~   94 (968)
T PLN00113         24 SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC-----LWQGITCNN----SSRVVSIDLSGKNISGKISSAIFRLPY   94 (968)
T ss_pred             cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-----cCcceecCC----CCcEEEEEecCCCccccCChHHhCCCC
Confidence            3457899999999999874    2457853  556     799999974    235555555555555555555555555


Q ss_pred             CCEEeCcCCcccCcCCcc
Q 002809          433 LQFLDLSNNNLTGSVPDF  450 (878)
Q Consensus       433 L~~L~Ls~N~l~g~iP~~  450 (878)
                      |+.|+|++|+++|.+|..
T Consensus        95 L~~L~Ls~n~~~~~ip~~  112 (968)
T PLN00113         95 IQTINLSNNQLSGPIPDD  112 (968)
T ss_pred             CCEEECCCCccCCcCChH
Confidence            555555555555555543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.97  E-value=8.5e-09  Score=104.92  Aligned_cols=134  Identities=16%  Similarity=0.203  Sum_probs=97.5

Q ss_pred             ccccccccEEEEEEEEc--------ceeEEEEEeccC-------------C---------hhhHHHH----HHHHHHHHH
Q 002809          572 RTLGKGGFGTVYYGRLN--------EIDVAVKMLSSS-------------S---------AQGFQQF----QAEVKLLMR  617 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--------~~~vAvK~l~~~-------------~---------~~~~~~f----~~Ei~~L~~  617 (878)
                      ..||.|--+.||.|...        +..+|||+.+..             .         ....+.+    .+|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            57899999999999754        268999987521             0         0012223    389999999


Q ss_pred             hcc--cceeeeeecccCCCcceeEeeeccCCChhh-hhccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCC
Q 002809          618 VHH--RNLTSLVGHCDEDNQTALIYEFMANGNLQE-YLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPPIVHRDVK  693 (878)
Q Consensus       618 l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDLK  693 (878)
                      ++.  -++.+++++    ...++||||+.+..+.. .+++   ..++.++...+..+++.+|..| |..   ++|||||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            963  355566654    46789999997654422 2222   2345566778889999999999 766   99999999


Q ss_pred             CccEEEcCCCcEEEeecCCcccc
Q 002809          694 STNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       694 p~NILl~~~~~~kL~DFGla~~~  716 (878)
                      +.|||++ ++.+.|+|||.+...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.97  E-value=6e-09  Score=108.50  Aligned_cols=140  Identities=19%  Similarity=0.273  Sum_probs=110.7

Q ss_pred             ccccccccEEEEEEEEcc-eeEEEEEeccCCh-hhHHHHHHHHHHHHHhccc--ceeeeeecccCCC---cceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHR--NLTSLVGHCDEDN---QTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~--nIv~l~g~~~~~~---~~~lV~Ey~~  644 (878)
                      +.|+.|..+.||+++..+ ..+++|....... .....+.+|.+++..+++.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            468999999999998887 8899999765432 2346789999999999764  4566777776543   5689999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC-----------------------------------------  683 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----------------------------------------  683 (878)
                      +.++.+.+..   ..++...+..++.+++++|..||+..                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988876532   34677888888999999999998521                                         


Q ss_pred             ------------CCCeEecCCCCccEEEcC--CCcEEEeecCCcc
Q 002809          684 ------------KPPIVHRDVKSTNILLNE--KLQAKLADFGLSK  714 (878)
Q Consensus       684 ------------~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~  714 (878)
                                  ...++|+|+++.||+++.  ++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                        245799999999999998  6678999999775

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.94  E-value=7.2e-11  Score=113.09  Aligned_cols=145  Identities=22%  Similarity=0.315  Sum_probs=115.6

Q ss_pred             ceeEEEEEecCCCCCchhhh---hhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCC
Q 002809          327 GNYSFSLYKTGNSTLPPIIN---AIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGD  403 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~in---alEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~  403 (878)
                      --+.++|..+..+.+||-|.   .+|++.+.+ .+++.+|..+..|.+||.+-.-.+..+..|-+              -
T Consensus        34 ~ITrLtLSHNKl~~vppnia~l~nlevln~~n-nqie~lp~~issl~klr~lnvgmnrl~~lprg--------------f   98 (264)
T KOG0617|consen   34 NITRLTLSHNKLTVVPPNIAELKNLEVLNLSN-NQIEELPTSISSLPKLRILNVGMNRLNILPRG--------------F   98 (264)
T ss_pred             hhhhhhcccCceeecCCcHHHhhhhhhhhccc-chhhhcChhhhhchhhhheecchhhhhcCccc--------------c
Confidence            34688999999999999876   666666666 45999999999999999876444444445542              2


Q ss_pred             CCCCcEEEEEecCCCccc-cchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCC
Q 002809          404 SSSPRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNG  481 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~  481 (878)
                      ++.+.|+.|||+.|+|+. .+|..|..++.|+-|+|++|.|. .+|..+++|+ |+.|.|..|+|- ++|.+++.+..|+
T Consensus        99 gs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lr  176 (264)
T KOG0617|consen   99 GSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLR  176 (264)
T ss_pred             CCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHH
Confidence            567889999999999874 57888888899999999999988 8888889988 999999999888 8898888888877


Q ss_pred             CcccccCCC
Q 002809          482 SLSLSVGGN  490 (878)
Q Consensus       482 ~l~l~~~~n  490 (878)
                      .|  ...||
T Consensus       177 el--hiqgn  183 (264)
T KOG0617|consen  177 EL--HIQGN  183 (264)
T ss_pred             HH--hcccc
Confidence            54  44455

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.94  E-value=7.5e-09  Score=101.31  Aligned_cols=141  Identities=18%  Similarity=0.243  Sum_probs=107.1

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCC---h-----hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSS---A-----QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~---~-----~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ..+-||+-+.|+++.+.++...||.-....   +     -..++-.+|+..|.+++--.|.-..-++.+...-.++|||+
T Consensus        13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~   92 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI   92 (229)
T ss_pred             eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence            578899999999999999888888643221   1     13456788999999987555544444555556668999999


Q ss_pred             cC-CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---cEEEeecCCccc
Q 002809          644 AN-GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---QAKLADFGLSKS  715 (878)
Q Consensus       644 ~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~DFGla~~  715 (878)
                      ++ .++.+++..........+....++..|-+.+.-||.+   .|+||||.++||++..++   .+.++|||++..
T Consensus        93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            76 4788887654443444444478899999999999998   999999999999997665   458999998753

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.90  E-value=1.4e-08  Score=100.06  Aligned_cols=131  Identities=18%  Similarity=0.289  Sum_probs=102.7

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCC---hh-----hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSS---AQ-----GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~---~~-----~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ..+++|+-+.+|.+.+.+.++.+|.-.+..   +.     ....-.+|..++.+++--.|.-..=+..+.....++|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            357899999999998888777888644321   11     1234578999999987655555555556677788999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      +|-.|.+.+...         +..++..+-.-+.-||..   +|+|+||.++||++..+. +.++||||+..
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888752         356777888888899998   999999999999998875 99999999863

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=9.6e-08  Score=102.51  Aligned_cols=140  Identities=16%  Similarity=0.145  Sum_probs=102.6

Q ss_pred             cccccccEEEEEEEEcceeEEEEEeccCChh-hHH----------HHHHHHHHHHHhcccce--eeeeecccC-----CC
Q 002809          573 TLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQ-GFQ----------QFQAEVKLLMRVHHRNL--TSLVGHCDE-----DN  634 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~-~~~----------~f~~Ei~~L~~l~H~nI--v~l~g~~~~-----~~  634 (878)
                      .+-.-....|.+..+.++.+.||........ ..+          .+.+|...+.++...+|  ..++++...     ..
T Consensus        29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            3333344457788888889999977543311 111          47899999988864443  344555432     23


Q ss_pred             cceeEeeeccCC-ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-------CCcEE
Q 002809          635 QTALIYEFMANG-NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-------KLQAK  706 (878)
Q Consensus       635 ~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-------~~~~k  706 (878)
                      .-++|+|++++. +|.+++........+...+..++.++++.+.-||..   +|+|+|++++|||++.       +..+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEE
Confidence            568999999886 899888543234456677889999999999999999   9999999999999985       46899


Q ss_pred             EeecCCccc
Q 002809          707 LADFGLSKS  715 (878)
Q Consensus       707 L~DFGla~~  715 (878)
                      ++||+.+..
T Consensus       186 LIDl~r~~~  194 (268)
T PRK15123        186 VIDLHRAQI  194 (268)
T ss_pred             EEECCcccc
Confidence            999998753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.73  E-value=1.1e-08  Score=116.46  Aligned_cols=239  Identities=23%  Similarity=0.261  Sum_probs=169.2

Q ss_pred             cccccccccEEEEEEEEc---ceeEEEEEeccCChhhHHH--HHHHHHHHHHh-cccceeeeeecccCCCcceeEeeecc
Q 002809          571 ERTLGKGGFGTVYYGRLN---EIDVAVKMLSSSSAQGFQQ--FQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~~~~~~~~--f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ...||.|.|+.|++....   +..+++|.+.+.......+  -..|+.+...+ .|.+++.....+..-...++--||++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            467999999999987543   3778888877654332222  24566666666 48888988888877778889999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEEeecCCccccccCCCCc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++++.....  -...+....++.+..|++.++.++|+.   .++|+|+||+||++..+ +..+++|||.+..+.-..   
T Consensus       350 ~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---  421 (524)
T KOG0601|consen  350 GGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---  421 (524)
T ss_pred             CcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec---
Confidence            998887662  256678888999999999999999987   99999999999999886 788999999986432111   


Q ss_pred             ccccccCCCCcc--CccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          724 VSTVVAGTPGYL--DPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       724 ~~~~~~gt~~Y~--APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                        ....+.-+++  +++......+..+.|++|||.-+.|.+++.+.-....        +|.  .+..+.+     +.+.
T Consensus       422 --~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~--~i~~~~~-----p~~~  484 (524)
T KOG0601|consen  422 --GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL--TIRSGDT-----PNLP  484 (524)
T ss_pred             --ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--eeecccc-----cCCC
Confidence              1112233444  5666667788899999999999999999875322111        111  1111111     1111


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                          ..- .++..++..+...++..||.+.++....+.
T Consensus       485 ----~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  485 ----GLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ----chH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                111 456677888899999999999888766544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.73  E-value=3.7e-09  Score=125.86  Aligned_cols=241  Identities=20%  Similarity=0.274  Sum_probs=159.0

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +-+-+|+++.++.++-..  ...+.|+.....   ....+....+-.++...+||-++....-+.......||++|..++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            356678888887654332  112222222111   111222333334444455677776655556677889999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC-------
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-------  719 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-------  719 (878)
                      +|...|+..  ...+.+........+.+++++||..   .+.|+|++|.|+|...++..+++|||.......-       
T Consensus       890 ~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s  964 (1205)
T KOG0606|consen  890 DLPSKLHNS--GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS  964 (1205)
T ss_pred             CchhhhhcC--CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence            999999863  3455555566667788999999987   6899999999999999999999999843322100       


Q ss_pred             --------------C--------CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 002809          720 --------------A--------NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI  777 (878)
Q Consensus       720 --------------~--------~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  777 (878)
                                    .        .........||+.|.+||...+......+|.|+.|++++|.++|.+||.....+...
T Consensus       965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen  965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF 1044 (1205)
T ss_pred             cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh
Confidence                          0        001122356899999999999999999999999999999999999999887665421


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMS  831 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~  831 (878)
                             +.+..+.+.       +...+......+.+++...+..+|.+|-.|.
T Consensus      1045 -------~ni~~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1045 -------ENILNRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             -------hccccCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence                   111111110       1112233334555677777777888876665

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.64  E-value=1.2e-06  Score=97.99  Aligned_cols=166  Identities=14%  Similarity=0.198  Sum_probs=127.6

Q ss_pred             cEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeeccc----CCCcceeEeeeccC-CChhhh
Q 002809          579 FGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD----EDNQTALIYEFMAN-GNLQEY  651 (878)
Q Consensus       579 fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~  651 (878)
                      -.+.|++..  ++..+++|+++.........-..-++..+++.|+|+|++...+.    .+..+++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357788864  45889999996544433334456688999999999999998875    44578899999986 477775


Q ss_pred             hcccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          652 LSDIS-------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       652 l~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      -....             +...++..++.++.|+..||.++|+.   |+..+-|.+++||++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            43211             33578899999999999999999999   999999999999999999999999998766544


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP  766 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~  766 (878)
                      +...                -+.   --.+-|.=.||.+++.|.||..
T Consensus       446 d~~~----------------~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DPTE----------------PLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCc----------------chh---HHhhhhHHHHHHHHHHHhhccc
Confidence            3211                111   1246799999999999999964

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.58  E-value=6.2e-09  Score=99.96  Aligned_cols=82  Identities=33%  Similarity=0.445  Sum_probs=77.6

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      ...++.|-||+|+|+ .+|+.|++|.+|+.|+|+||++. .+|.+++.|+ |+.|+++-|+|. .+|..+++++.|..|+
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld  108 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD  108 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence            457889999999999 99999999999999999999999 9999999999 999999999999 9999999999999999


Q ss_pred             cccCCC
Q 002809          485 LSVGGN  490 (878)
Q Consensus       485 l~~~~n  490 (878)
                      +.|++-
T Consensus       109 ltynnl  114 (264)
T KOG0617|consen  109 LTYNNL  114 (264)
T ss_pred             cccccc
Confidence            998854

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.53  E-value=7.5e-08  Score=79.00  Aligned_cols=60  Identities=48%  Similarity=0.636  Sum_probs=53.9

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcC
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL  466 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l  466 (878)
                      ++|+.|+|++|+|+..-+..|.++++|+.|+|++|+++..-|..|..++ |+.|+|++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4799999999999955557899999999999999999976677899999 99999999986

...

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.52  E-value=4.9e-08  Score=109.74  Aligned_cols=141  Identities=22%  Similarity=0.300  Sum_probs=102.5

Q ss_pred             ceeEEEEEecCCCCCchhhhhh---hhheeccccccccccchHHHHHHHHHhhCCCCCCC--CCCCCCCCCcccceecCC
Q 002809          327 GNYSFSLYKTGNSTLPPIINAI---EVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQ--GDPCAPLAYWWDGLNCSY  401 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~inal---Ei~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~--~~pc~~~~~~w~gv~C~~  401 (878)
                      ...=++|..|..-.+|..+.++   |-+++.. +++.++--++..|..|++...-.++..  |-|-              
T Consensus        33 ~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~H-N~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~--------------   97 (1255)
T KOG0444|consen   33 QMTWLKLNRTKLEQVPEELSRLQKLEHLSMAH-NQLISVHGELSDLPRLRSVIVRDNNLKNSGIPT--------------   97 (1255)
T ss_pred             heeEEEechhhhhhChHHHHHHhhhhhhhhhh-hhhHhhhhhhccchhhHHHhhhccccccCCCCc--------------
Confidence            3345678888888888887754   4444544 346677777777777777664444442  3332              


Q ss_pred             CCCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCcc-CCCCc-ceEEEecCCcCCCCCchhhhhccc
Q 002809          402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF-LSKLP-LRTLNLQGNKLNGSVPVELLERSK  479 (878)
Q Consensus       402 ~~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~  479 (878)
                      ..-.+..|+.||||+|+|+ ..|..+-+-+++..|+||+|++. +||.. +-+|. |-.||||+|+|. .+|+.+..+..
T Consensus        98 diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~  174 (1255)
T KOG0444|consen   98 DIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSM  174 (1255)
T ss_pred             hhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhh
Confidence            1133567889999999998 88999999999999999999998 88866 45777 889999999998 88888877777


Q ss_pred             CCCccc
Q 002809          480 NGSLSL  485 (878)
Q Consensus       480 l~~l~l  485 (878)
                      |+.|.+
T Consensus       175 LqtL~L  180 (1255)
T KOG0444|consen  175 LQTLKL  180 (1255)
T ss_pred             hhhhhc
Confidence            665443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.50  E-value=2.4e-08  Score=107.43  Aligned_cols=143  Identities=24%  Similarity=0.301  Sum_probs=113.2

Q ss_pred             eEEEEEecCCCCCchhhhhhhhheecc--ccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          329 YSFSLYKTGNSTLPPIINAIEVYSVKE--FLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~inalEi~~l~~--~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      ..+-+..+....+||.+.++.-+.=.+  ....+|+|+|++.|.++..+|...+...--|-.|        .|+      
T Consensus       163 ~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~lPef~--------gcs------  228 (565)
T KOG0472|consen  163 SKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIRFLPEFP--------GCS------  228 (565)
T ss_pred             HHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccccCCCCC--------ccH------
Confidence            445556677777888776666665432  2338899999999999999887666555445321        133      


Q ss_pred             CcEEEEEecCCCccccchhhhh-ccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          407 PRITYLNLSSSGLKGDITSYVS-NLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                       .|..|.++.|+|. .+|.+.+ +|.+|..|||..|+|. +.|+.+..|. |..||||+|.++ .+|.+++++ .+.  .
T Consensus       229 -~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~--~  301 (565)
T KOG0472|consen  229 -LLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLK--F  301 (565)
T ss_pred             -HHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eee--e
Confidence             5888999999998 9999888 8999999999999999 9999999999 999999999999 799999998 555  4


Q ss_pred             cccCCCCC
Q 002809          485 LSVGGNPG  492 (878)
Q Consensus       485 l~~~~n~~  492 (878)
                      +...|||.
T Consensus       302 L~leGNPl  309 (565)
T KOG0472|consen  302 LALEGNPL  309 (565)
T ss_pred             hhhcCCch
Confidence            66788875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.46  E-value=1.1e-06  Score=89.12  Aligned_cols=124  Identities=22%  Similarity=0.271  Sum_probs=79.7

Q ss_pred             EEEEEEEc-ceeEEEEEeccCC---------------------hh-----hHHHHHHHHHHHHHhccc--ceeeeeeccc
Q 002809          581 TVYYGRLN-EIDVAVKMLSSSS---------------------AQ-----GFQQFQAEVKLLMRVHHR--NLTSLVGHCD  631 (878)
Q Consensus       581 ~Vy~~~~~-~~~vAvK~l~~~~---------------------~~-----~~~~f~~Ei~~L~~l~H~--nIv~l~g~~~  631 (878)
                      .||.|... +..+|||+.+...                     ..     ......+|.+.|.++..-  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            38989875 4889999875310                     00     123467899999999755  45566544  


Q ss_pred             CCCcceeEeeecc--CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          632 EDNQTALIYEFMA--NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       632 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                        ....+||||++  +..+..+... .   ++......++.+++..+..+ |..   +|+||||.+.|||++++ .+.|+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence              24579999998  5445443322 1   11344566777888866664 666   99999999999999988 99999


Q ss_pred             ecCCcccc
Q 002809          709 DFGLSKSF  716 (878)
Q Consensus       709 DFGla~~~  716 (878)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.42  E-value=2.2e-06  Score=87.68  Aligned_cols=138  Identities=16%  Similarity=0.172  Sum_probs=106.2

Q ss_pred             ccccccEEEEEEEEcceeEEEEEeccCC------hhhHHHHHHHHHHHHHhcccc--eeeeeeccc-C----CCcceeEe
Q 002809          574 LGKGGFGTVYYGRLNEIDVAVKMLSSSS------AQGFQQFQAEVKLLMRVHHRN--LTSLVGHCD-E----DNQTALIY  640 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~~~~vAvK~l~~~~------~~~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~-~----~~~~~lV~  640 (878)
                      -|.||.+.|++-.+.+..+-+|.-...-      +.....|.+|+..|.++...+  +.+.+ ++. .    .-.-.||+
T Consensus        26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            3678999999988888778888865221      335678999999999996433  44444 332 1    22467899


Q ss_pred             eeccC-CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc--EEEeecCCccc
Q 002809          641 EFMAN-GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ--AKLADFGLSKS  715 (878)
Q Consensus       641 Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~  715 (878)
                      |-+++ -+|.+++.+..-...+...+..++.++++.++-||+.   ++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97754 4898888664445667888899999999999999998   9999999999999986666  99999986553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.37  E-value=1.9e-06  Score=89.31  Aligned_cols=107  Identities=21%  Similarity=0.245  Sum_probs=84.1

Q ss_pred             HHHHHHHHHHHHHhcccc--eeeeeecccCC----CcceeEeeeccCC-ChhhhhccccCCCCCHHHHHHHHHHHHHHHH
Q 002809          605 FQQFQAEVKLLMRVHHRN--LTSLVGHCDED----NQTALIYEFMANG-NLQEYLSDISKKVLSSQERLRIAVESAQGLE  677 (878)
Q Consensus       605 ~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~~~----~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~  677 (878)
                      ...+.+|...+..++...  ..+.+++....    ...++|+|++++. +|.+++....  ..+......++.++++.++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            346788888888886433  34555655442    2357999999874 8999887522  2666778899999999999


Q ss_pred             HHHhCCCCCeEecCCCCccEEEcCCC---cEEEeecCCcccc
Q 002809          678 YLHNGCKPPIVHRDVKSTNILLNEKL---QAKLADFGLSKSF  716 (878)
Q Consensus       678 yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~DFGla~~~  716 (878)
                      -||..   +|+|+|++++|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   999999999999999887   8999999977643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=2.7e-06  Score=98.75  Aligned_cols=144  Identities=17%  Similarity=0.217  Sum_probs=93.6

Q ss_pred             hhc-ccccccccEEEEEEEEc-ceeEEEEEeccCChhh------------------------------HH----------
Q 002809          569 NFE-RTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQG------------------------------FQ----------  606 (878)
Q Consensus       569 ~f~-~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~------------------------------~~----------  606 (878)
                      .|+ +.|+.++-|+||+|++. ++.||||+.+..-.+.                              .+          
T Consensus       127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El  206 (517)
T COG0661         127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL  206 (517)
T ss_pred             HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence            344 57999999999999998 5999999986532111                              01          


Q ss_pred             HHHHHHHHHHHhc-----ccceeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 002809          607 QFQAEVKLLMRVH-----HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN  681 (878)
Q Consensus       607 ~f~~Ei~~L~~l~-----H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~  681 (878)
                      ++.+|...+.+++     .+++.-.-=|.+-.+...|+|||++|-.+.+...-. ...++.+.+.....++.  +..+-.
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-~~g~d~k~ia~~~~~~f--~~q~~~  283 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-SAGIDRKELAELLVRAF--LRQLLR  283 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-hcCCCHHHHHHHHHHHH--HHHHHh
Confidence            1344555555553     333332222334456789999999999998884221 23344333322222221  122222


Q ss_pred             CCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       682 ~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      .   +++|.|.+|.||+++.++++.+.|||+...+.+
T Consensus       284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            3   899999999999999999999999999876643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.31  E-value=1.9e-07  Score=107.95  Aligned_cols=151  Identities=23%  Similarity=0.294  Sum_probs=101.9

Q ss_pred             HHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc-------ccccccCCCCccCcccccc
Q 002809          670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH-------VSTVVAGTPGYLDPEYYTS  742 (878)
Q Consensus       670 ~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-------~~~~~~gt~~Y~APE~~~~  742 (878)
                      .+++.|+.|+|..  .++||++|.|++|.++.++..||+.|+.+..........       ..........|.|||++..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455999999976  599999999999999999999999999876543321111       1111224457999999999


Q ss_pred             CCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccC
Q 002809          743 NRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLS  821 (878)
Q Consensus       743 ~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~  821 (878)
                      ...+.++|+||+||+++-+.. |+.-+.............      ...      +... ..+..+...++.+=+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~------~~~------~~~~-~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR------NLL------NAGA-FGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh------ccc------cccc-ccccccCcHHHHHHHHHHhc
Confidence            888999999999999999984 554444332211111100      000      0000 11123344567778888999


Q ss_pred             CCCCCCCCHHHHHH
Q 002809          822 PTGNQRPTMSQVVM  835 (878)
Q Consensus       822 ~dP~~RPsm~evl~  835 (878)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.30  E-value=5.9e-06  Score=86.43  Aligned_cols=134  Identities=19%  Similarity=0.201  Sum_probs=95.5

Q ss_pred             hhcccccccccEEEEEEEEc-ceeEEEEEeccCCh----------------------hhHHHHHHHHHHHHHhccc--ce
Q 002809          569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSA----------------------QGFQQFQAEVKLLMRVHHR--NL  623 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~----------------------~~~~~f~~Ei~~L~~l~H~--nI  623 (878)
                      .+.+.||-|--+.||.|... +.++|||.-+....                      -.....++|.++|.++.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45678999999999999886 59999997642110                      0123467899999999644  56


Q ss_pred             eeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       624 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      .+.+++    +..++||||+++--|...-       ++.+....++..|++-+.-+-..   +|||+|+.+-||+++++|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence            555543    5678999999886665432       12233334444455444444444   999999999999999999


Q ss_pred             cEEEeecCCcccc
Q 002809          704 QAKLADFGLSKSF  716 (878)
Q Consensus       704 ~~kL~DFGla~~~  716 (878)
                      .+.++||-.+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999876543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.19  E-value=2.4e-07  Score=104.34  Aligned_cols=80  Identities=34%  Similarity=0.369  Sum_probs=66.6

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCccc-CcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT-GSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~-g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .+|+.|+||.|+|+ .+|+.+++|++|+.|.+.+|+|+ ..||..+|.|. |+.+++++|+|. -+|++++.+.+|+.|.
T Consensus       268 ~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~  345 (1255)
T KOG0444|consen  268 ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLK  345 (1255)
T ss_pred             hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhc
Confidence            46788888888888 88888888888888888888876 46888888888 888888888888 8888888888888776


Q ss_pred             cccC
Q 002809          485 LSVG  488 (878)
Q Consensus       485 l~~~  488 (878)
                      ++.+
T Consensus       346 L~~N  349 (1255)
T KOG0444|consen  346 LDHN  349 (1255)
T ss_pred             cccc
Confidence            6655

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=98.19  E-value=3.3e-06  Score=84.86  Aligned_cols=138  Identities=21%  Similarity=0.354  Sum_probs=72.6

Q ss_pred             eEeccCCCCCCCCccCCCceeeecCccccccCccc-----------eeeccccccccccc-CceeccCCCCcceeEeecc
Q 002809           28 ISLDCGLPKDSNYTETTTGINYISDDAFVETGIGK-----------SILQEFQTGQQKQM-RRVRSFPDGIRNCYRFNLT   95 (878)
Q Consensus        28 ~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~~-----------~~~~~~~~~~~~~~-~tlR~Fp~g~~nCY~l~~~   95 (878)
                      +.|+||++.   | ++..|+.|.+|..|..++..-           ............++ +|-|+=|.  ...|.+|+.
T Consensus         3 ~~IN~Gg~~---~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--~f~Y~ip~~   76 (174)
T PF11721_consen    3 LRINAGGPA---Y-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--SFSYDIPVV   76 (174)
T ss_dssp             EEEEETSSS---E-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--SEEEEEE--
T ss_pred             EEEECCCCc---c-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--ceEEEEecC
Confidence            479999733   3 567899999999997433300           01111111122234 88898333  578999988


Q ss_pred             CCCeeEEEEEe---eecCCCCCCCCC---ceeEEEccc-eeeEEEecCCc--cc-eeeeeE-EEEccCCceEEEEee---
Q 002809           96 KGSRYLIRTNF---MYGNYDEKNSVP---GFDMFIGPN-KWLSVTFENNA--SF-VAIGEI-IHILPSDYLHICLVN---  161 (878)
Q Consensus        96 ~~~~ylvR~~f---~ygnyd~~~~~p---~Fd~~~~~~-~w~~v~~~~~~--~~-~~~~e~-~~~~~~~~~~vCl~~---  161 (878)
                      +.|.|-||..|   +++. ++..+.|   .||+.++|+ ....+++-...  .. ....+. -+.+.+..+.++|..   
T Consensus        77 ~~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~  155 (174)
T PF11721_consen   77 PNGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGK  155 (174)
T ss_dssp             S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--
T ss_pred             CCcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCC
Confidence            99999999999   3333 3333333   699999996 44444443222  11 111233 234578889999985   


Q ss_pred             --------cCCCCcceeee
Q 002809          162 --------TGLGTPFISAL  172 (878)
Q Consensus       162 --------~~~~~Pfis~l  172 (878)
                              ...|.|.||+|
T Consensus       156 ~~~~i~~~~~~~~p~IsaI  174 (174)
T PF11721_consen  156 GTLCIPFIGSYGNPLISAI  174 (174)
T ss_dssp             SEEEEEEESSSSSSSEEEE
T ss_pred             CcEEeeccccCCCcEEeeC
Confidence                    44566888886

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.16  E-value=2.3e-06  Score=103.61  Aligned_cols=76  Identities=29%  Similarity=0.387  Sum_probs=50.3

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCcceEEEecCCcCCCCCchhhhhcccCCCcccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLS  486 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~  486 (878)
                      ..|+.|+|++|+|+ .+|..   .++|+.|+|++|+|+ .||..+.  .|+.|+|++|+|+ .||.++++++.+..|  .
T Consensus       382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~~--~L~~L~Ls~NqLt-~LP~sl~~L~~L~~L--d  451 (788)
T PRK15387        382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLPS--GLLSLSVYRNQLT-RLPESLIHLSSETTV--N  451 (788)
T ss_pred             cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcchh--hhhhhhhccCccc-ccChHHhhccCCCeE--E
Confidence            35777788888877 46653   256777788888877 4665321  1677777888877 777777777776643  4


Q ss_pred             cCCCCC
Q 002809          487 VGGNPG  492 (878)
Q Consensus       487 ~~~n~~  492 (878)
                      +.+|+.
T Consensus       452 Ls~N~L  457 (788)
T PRK15387        452 LEGNPL  457 (788)
T ss_pred             CCCCCC
Confidence            455554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.16  E-value=2.4e-05  Score=85.61  Aligned_cols=259  Identities=19%  Similarity=0.170  Sum_probs=151.3

Q ss_pred             hcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecc-------cCCCcceeEee
Q 002809          570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHC-------DEDNQTALIYE  641 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~-------~~~~~~~lV~E  641 (878)
                      ..+.||+|+-+.+|----- ...+-|+.+........+-   ++.|.+. .||-+-.-+.+-       ..+....+.|.
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecchh-hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            3568999999999843211 2223466665443322222   2233333 355433212111       12222556677


Q ss_pred             eccCC-Chhhhhcc-ccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          642 FMANG-NLQEYLSD-ISK---KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       642 y~~~g-sL~~~l~~-~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      .+.+. -...+..- .++   ....|+-.++.+..+|.+.+.||..   |.+-+|+.++|+|+++++.+.|.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            66553 12222211 112   2478999999999999999999998   9999999999999999999999985533222


Q ss_pred             ccCCCCcccccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhC-CCCCCCCChHHHH-HHHHHHHHHHhc
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKI-HIRQWVNSLIAK  789 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~-~l~~~v~~~~~~  789 (878)
                         .+........|...|.+||.-.     +..-+...|-|.+||++++++.| +.||.+....... .-   ....+..
T Consensus       168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p---~E~~Ia~  241 (637)
T COG4248         168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP---LETDIAH  241 (637)
T ss_pred             ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc---chhhhhc
Confidence               2222233345888999999854     34567789999999999999886 8999874321000 00   0001111


Q ss_pred             CCcccccCCcc-----ccccCHH-HHHHHHHHHHHccCCC--CCCCCCHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRL-----QEDFDAN-SVWKAVELAMACLSPT--GNQRPTMSQVVMELSECL  841 (878)
Q Consensus       790 ~~~~~iid~~l-----~~~~~~~-~~~~l~~l~~~Cl~~d--P~~RPsm~evl~~L~~~~  841 (878)
                      |.....-|.+.     ....+.+ -...+..+..+|+...  +.-||+++.-+..|.++.
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            11111111110     0111111 1234556777888653  568999998877776533

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.13  E-value=7.4e-07  Score=105.28  Aligned_cols=125  Identities=25%  Similarity=0.315  Sum_probs=66.9

Q ss_pred             eeEEEEEecCCCCCchh----hhh-hhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCC
Q 002809          328 NYSFSLYKTGNSTLPPI----INA-IEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYG  402 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~----ina-lEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~  402 (878)
                      .-++.|.++....+|+.    .++ ++.+....+........+-..+..|+.++...+.+ +|-|.      .-+.|-  
T Consensus       312 L~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~L-td~c~------p~l~~~--  382 (1081)
T KOG0618|consen  312 LRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHL-TDSCF------PVLVNF--  382 (1081)
T ss_pred             eeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcc-cccch------hhhccc--
Confidence            45788999999999974    334 66666666553333334444555666666554444 44553      223332  


Q ss_pred             CCCCCcEEEEEecCCCccccch-hhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCC
Q 002809          403 DSSSPRITYLNLSSSGLKGDIT-SYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN  467 (878)
Q Consensus       403 ~~~~~~l~~l~l~~n~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~  467 (878)
                          .+|+.|+|++|+|. ++| ..+.+|..|+.|+||+|+|+ .||+++..+. |++|...+|+|.
T Consensus       383 ----~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~  443 (1081)
T KOG0618|consen  383 ----KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL  443 (1081)
T ss_pred             ----cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence                35555555555554 333 23455555555555555555 4444444443 333333333333

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.11  E-value=1.6e-06  Score=97.51  Aligned_cols=149  Identities=19%  Similarity=0.184  Sum_probs=104.4

Q ss_pred             CceeEEEEEecCCCCCchh----hhhhhhheeccccccccc-cchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecC
Q 002809          326 GGNYSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTE-QIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCS  400 (878)
Q Consensus       326 ~~~~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~-~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~  400 (878)
                      +...++.|..+..++||+-    ++.||.+.|-.|. +... ---+..|..|+.+-...++...---+    .+.     
T Consensus       197 nsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~-irive~ltFqgL~Sl~nlklqrN~I~kL~DG----~Fy-----  266 (873)
T KOG4194|consen  197 NSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNR-IRIVEGLTFQGLPSLQNLKLQRNDISKLDDG----AFY-----  266 (873)
T ss_pred             chheeeecccCcccccCHHHhhhcchhhhhhccccc-eeeehhhhhcCchhhhhhhhhhcCcccccCc----cee-----
Confidence            4567889999999999985    6788888887653 2222 12233444444433322322110000    111     


Q ss_pred             CCCCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhccc
Q 002809          401 YGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSK  479 (878)
Q Consensus       401 ~~~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~  479 (878)
                          ...+++.|+|+.|+++..=...+.+|++|+.|+||+|.+.-.-++.++..+ |+.|+|++|+++.--|.++..+..
T Consensus       267 ----~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~  342 (873)
T KOG4194|consen  267 ----GLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ  342 (873)
T ss_pred             ----eecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence                234789999999999977788899999999999999999977788888888 999999999999555567777777


Q ss_pred             CCCcccccC
Q 002809          480 NGSLSLSVG  488 (878)
Q Consensus       480 l~~l~l~~~  488 (878)
                      |..|.++.+
T Consensus       343 Le~LnLs~N  351 (873)
T KOG4194|consen  343 LEELNLSHN  351 (873)
T ss_pred             hhhhccccc
Confidence            777766554

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.09  E-value=3.5e-07  Score=98.72  Aligned_cols=155  Identities=18%  Similarity=0.171  Sum_probs=117.6

Q ss_pred             ceeEEEEEecCCCCCchhhhhhhhh---eeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCC
Q 002809          327 GNYSFSLYKTGNSTLPPIINAIEVY---SVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGD  403 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~inalEi~---~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~  403 (878)
                      ..+.+.+..+..+.+||.|-.+|-+   .++.+. ...+|+++..+.+++.++-..+..              +.|..++
T Consensus        69 ~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~-ls~lp~~i~s~~~l~~l~~s~n~~--------------~el~~~i  133 (565)
T KOG0472|consen   69 CLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNK-LSELPEQIGSLISLVKLDCSSNEL--------------KELPDSI  133 (565)
T ss_pred             ceeEEEeccchhhhCCHHHHHHHHHHHhhcccch-HhhccHHHhhhhhhhhhhccccce--------------eecCchH
Confidence            4466788889999999987755554   455544 788999999988888877443332              2333333


Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      +..-.+..|+..+|+++ ++|+.++++.+|..|++.+|++. .+|+..-.++ |+.||...|.|+ ++|++++.+.++..
T Consensus       134 ~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~  210 (565)
T KOG0472|consen  134 GRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLEL  210 (565)
T ss_pred             HHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHH
Confidence            44557888999999999 99999999999999999999999 5555555588 999999999998 99999999998887


Q ss_pred             cccccCCCCCCCCCccc
Q 002809          483 LSLSVGGNPGLCSKISC  499 (878)
Q Consensus       483 l~l~~~~n~~lc~~~~c  499 (878)
                      |++.-+.-..+..-+.|
T Consensus       211 LyL~~Nki~~lPef~gc  227 (565)
T KOG0472|consen  211 LYLRRNKIRFLPEFPGC  227 (565)
T ss_pred             HHhhhcccccCCCCCcc
Confidence            77765544443333334

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.04  E-value=1.9e-06  Score=104.40  Aligned_cols=140  Identities=21%  Similarity=0.237  Sum_probs=90.7

Q ss_pred             eeEEEEEecCCCCCchhhhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCC-----
Q 002809          328 NYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYG-----  402 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~-----  402 (878)
                      ...+.+..+..+.+|++...|+.+.+..|. +..+|.....|..|   ....+....-|-.+.  .-.-+.++.+     
T Consensus       324 L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~-Ls~LP~lp~~L~~L---~Ls~N~L~~LP~l~~--~L~~LdLs~N~Lt~L  397 (788)
T PRK15387        324 LCKLWAYNNQLTSLPTLPSGLQELSVSDNQ-LASLPTLPSELYKL---WAYNNRLTSLPALPS--GLKELIVSGNRLTSL  397 (788)
T ss_pred             ccccccccCccccccccccccceEecCCCc-cCCCCCCCccccee---hhhccccccCccccc--ccceEEecCCcccCC
Confidence            344556666666777666677777777654 55566543333222   211122222221110  0011122111     


Q ss_pred             CCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcc
Q 002809          403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERS  478 (878)
Q Consensus       403 ~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~  478 (878)
                      .....+|+.|+|++|+|+ .||...   .+|+.|+|++|+|+ .||..++.++ |+.|+|++|+|+|.+|..+..+.
T Consensus       398 P~l~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~  469 (788)
T PRK15387        398 PVLPSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  469 (788)
T ss_pred             CCcccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence            012357999999999999 588643   56788999999999 8999999999 99999999999999999886654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.04  E-value=5.4e-05  Score=79.57  Aligned_cols=138  Identities=14%  Similarity=0.183  Sum_probs=84.6

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccce--eeeeecccCCCcceeEeeeccCCC-h
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL--TSLVGHCDEDNQTALIYEFMANGN-L  648 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~gs-L  648 (878)
                      ..||+|..+.||+.  .+..+++|......  ......+|.+++..+..-.+  .+.++++...+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            46899999999984  35567788876533  23456889999999874444  566777777777889999998863 2


Q ss_pred             hhhh---------------------ccccCCCCCHHHHHHHH-H----------HHHH-HHHHHHhC-CCCCeEecCCCC
Q 002809          649 QEYL---------------------SDISKKVLSSQERLRIA-V----------ESAQ-GLEYLHNG-CKPPIVHRDVKS  694 (878)
Q Consensus       649 ~~~l---------------------~~~~~~~l~~~~~~~i~-~----------qia~-gL~yLH~~-~~~~ivHrDLKp  694 (878)
                      ...+                     |..............-. .          .+.+ ...+|... ..+.++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            2111                     11100111111100000 0          0011 11222211 134578999999


Q ss_pred             ccEEEcCCCcEEEeecCCcc
Q 002809          695 TNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       695 ~NILl~~~~~~kL~DFGla~  714 (878)
                      .||++++++ +.|+||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999988 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.03  E-value=1.6e-06  Score=97.57  Aligned_cols=159  Identities=22%  Similarity=0.251  Sum_probs=116.8

Q ss_pred             EEEEEecCCCCCchhhhhhhhh---eeccccccccccchHHHHHHHHHhhCCCCCCCCCC---CC-CCC---Ccccceec
Q 002809          330 SFSLYKTGNSTLPPIINAIEVY---SVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDP---CA-PLA---YWWDGLNC  399 (878)
Q Consensus       330 ~~~l~~t~~s~lpp~inalEi~---~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~p---c~-~~~---~~w~gv~C  399 (878)
                      ...|..+..+.||-...++-.+   .+..|. ..++|.-+..|..+..++...+..+-.|   |. |+.   -.-+-++|
T Consensus        79 ~aDlsrNR~~elp~~~~~f~~Le~liLy~n~-~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~sNNkl~~  157 (722)
T KOG0532|consen   79 FADLSRNRFSELPEEACAFVSLESLILYHNC-IRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVSNNKLTS  157 (722)
T ss_pred             hhhccccccccCchHHHHHHHHHHHHHHhcc-ceecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEecCcccc
Confidence            3456667888888776654444   444443 8899999999988887776555554332   32 211   01122333


Q ss_pred             C-CCCCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCcceEEEecCCcCCCCCchhhhhcc
Q 002809          400 S-YGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERS  478 (878)
Q Consensus       400 ~-~~~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~L~~L~ls~N~l~g~iP~~l~~~~  478 (878)
                      - ...+..+.|..||.+.|+|. ++|+.++.|++|+.|.+..|++. .+|.+++.|+|..||+|+|+++ .||..+.++.
T Consensus       158 lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~  234 (722)
T KOG0532|consen  158 LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMR  234 (722)
T ss_pred             CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee-ecchhhhhhh
Confidence            2 12245678888999999998 89999999999999999999999 8999999999999999999999 9999999999


Q ss_pred             cCCCcccccCCCCCCC
Q 002809          479 KNGSLSLSVGGNPGLC  494 (878)
Q Consensus       479 ~l~~l~l~~~~n~~lc  494 (878)
                      .|+.|  ...+||...
T Consensus       235 ~Lq~l--~LenNPLqS  248 (722)
T KOG0532|consen  235 HLQVL--QLENNPLQS  248 (722)
T ss_pred             hheee--eeccCCCCC
Confidence            99854  556777653

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.98  E-value=5.4e-05  Score=87.82  Aligned_cols=160  Identities=21%  Similarity=0.279  Sum_probs=102.4

Q ss_pred             cccCCCCCHHHHHHHHh------------hhc-ccccccccEEEEEEEEcc-eeEEEEEeccCChhh-------------
Q 002809          552 EAKSRHLSYSDVVKITN------------NFE-RTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQG-------------  604 (878)
Q Consensus       552 ~~~~~~~s~~dl~~~t~------------~f~-~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~-------------  604 (878)
                      ..+...++++|+.+.-.            .|+ +.||..+.|+||+|++.+ +.||||+-++.-...             
T Consensus       134 qD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~  213 (538)
T KOG1235|consen  134 QDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAK  213 (538)
T ss_pred             hccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence            34556667776554432            233 679999999999999987 789999976532211             


Q ss_pred             ------------------HH------HHHHHHHHHHHh----cccce---eeeeec-ccCCCcceeEeeeccCCChhhhh
Q 002809          605 ------------------FQ------QFQAEVKLLMRV----HHRNL---TSLVGH-CDEDNQTALIYEFMANGNLQEYL  652 (878)
Q Consensus       605 ------------------~~------~f~~Ei~~L~~l----~H~nI---v~l~g~-~~~~~~~~lV~Ey~~~gsL~~~l  652 (878)
                                        .+      +|.+|.+-..+.    +|-+.   |.+=.. ..-.....|+||||+|..+.|.-
T Consensus       214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~  293 (538)
T KOG1235|consen  214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLD  293 (538)
T ss_pred             HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHH
Confidence                              00      245565555444    34441   111122 23345789999999999887763


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC----CCcEEEeecCCccccc
Q 002809          653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFA  717 (878)
Q Consensus       653 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~----~~~~kL~DFGla~~~~  717 (878)
                      . ..+..++...+..-+.++..-+-+-|     |++|+|=+|.||+++.    ++++.+-|||+.....
T Consensus       294 ~-i~~~gi~~~~i~~~l~~~~~~qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  294 A-IDKRGISPHDILNKLVEAYLEQIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             H-HHHcCCCHHHHHHHHHHHHHHHHHhc-----CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            2 22444665555444444433233333     8999999999999994    6789999999987653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.96  E-value=9.4e-05  Score=76.10  Aligned_cols=129  Identities=11%  Similarity=0.125  Sum_probs=86.0

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHH---------HHHHHHHHHhcccc---eeeeee-----cccCCC
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQF---------QAEVKLLMRVHHRN---LTSLVG-----HCDEDN  634 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f---------~~Ei~~L~~l~H~n---Iv~l~g-----~~~~~~  634 (878)
                      +++-......|.+-..+++.+.+|..........+.|         .+++..+.+++...   ...++.     .+....
T Consensus        37 kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~  116 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTS  116 (229)
T ss_pred             EeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecccee
Confidence            4555566667777777888999998876544332222         34455555554222   222222     122234


Q ss_pred             cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          635 QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ..+++|||++|..|.+...      ++.    .++..+++++.-||..   |++|+|.+|.|+++++++ +++.||+..+
T Consensus       117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            5568999999988877642      222    2456677889999998   999999999999999655 9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.92  E-value=8e-05  Score=77.79  Aligned_cols=141  Identities=16%  Similarity=0.220  Sum_probs=84.9

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccc--eeeeeeccc---CCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN--LTSLVGHCD---EDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~---~~~~~~lV~Ey~~~g  646 (878)
                      +.|+.|..+.||+....+..+++|.....  .....+.+|..++..+....  +.+++.++.   .....+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            46889999999999998889999997655  44567788999998886443  445665432   233468999999998


Q ss_pred             Chhh----------------hh---cccc--CCCCCHHH---------HHHH------------HHHHHH-HHHHHHh--
Q 002809          647 NLQE----------------YL---SDIS--KKVLSSQE---------RLRI------------AVESAQ-GLEYLHN--  681 (878)
Q Consensus       647 sL~~----------------~l---~~~~--~~~l~~~~---------~~~i------------~~qia~-gL~yLH~--  681 (878)
                      .+..                .+   +...  .....+..         ....            ...+.+ .++.++.  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            7777                11   1110  01111100         0000            111222 3333332  


Q ss_pred             --CCCCCeEecCCCCccEEEc-CCCcEEEeecCCcc
Q 002809          682 --GCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSK  714 (878)
Q Consensus       682 --~~~~~ivHrDLKp~NILl~-~~~~~kL~DFGla~  714 (878)
                        .....++|+|+.|+|||++ +++.+.|.||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              2345799999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.91  E-value=8.4e-06  Score=61.94  Aligned_cols=36  Identities=36%  Similarity=0.569  Sum_probs=24.1

Q ss_pred             cEEEEEecCCCccccchhhhhccCCCCEEeCcCCccc
Q 002809          408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT  444 (878)
Q Consensus       408 ~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~  444 (878)
                      +|+.|+|++|+|+ .||+.|++|++|+.|+|++|+|+
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            5667777777777 66666777777777777777766

...

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=97.90  E-value=1.5e-05  Score=96.96  Aligned_cols=122  Identities=24%  Similarity=0.369  Sum_probs=57.9

Q ss_pred             ceeEEEEEecCCCCCchhh-hhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCC
Q 002809          327 GNYSFSLYKTGNSTLPPII-NAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSS  405 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~i-nalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~  405 (878)
                      +...+.+..+..+.+|..+ ..|+.+.+..|. ...+|..+.  ..|+.+....+.+..-|-                ..
T Consensus       263 ~L~~L~Ls~N~L~~LP~~l~~sL~~L~Ls~N~-Lt~LP~~lp--~sL~~L~Ls~N~Lt~LP~----------------~l  323 (754)
T PRK15370        263 ALQSLDLFHNKISCLPENLPEELRYLSVYDNS-IRTLPAHLP--SGITHLNVQSNSLTALPE----------------TL  323 (754)
T ss_pred             CCCEEECcCCccCccccccCCCCcEEECCCCc-cccCcccch--hhHHHHHhcCCccccCCc----------------cc
Confidence            3445566666666666533 367777776654 556665432  234444433334433221                11


Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhh
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVEL  474 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l  474 (878)
                      +++|+.|++++|+|++ ||..+.  ++|+.|+|++|+|+ .+|..+.  + |+.|+|++|+|+ .+|..+
T Consensus       324 ~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l  386 (754)
T PRK15370        324 PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENL  386 (754)
T ss_pred             cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhH
Confidence            2345555555555542 444332  44555555555554 3444331  2 555555555554 344433

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=97.90  E-value=9.5e-06  Score=98.75  Aligned_cols=132  Identities=17%  Similarity=0.217  Sum_probs=78.3

Q ss_pred             eeEEEEEecCCCCCchhh-hhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          328 NYSFSLYKTGNSTLPPII-NAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~i-nalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      ...+.|..+..+.||+.+ ..|+.+.+..+. ...+|..+.  ..|+.+....++...-|-                ..+
T Consensus       201 L~~L~Ls~N~LtsLP~~l~~nL~~L~Ls~N~-LtsLP~~l~--~~L~~L~Ls~N~L~~LP~----------------~l~  261 (754)
T PRK15370        201 ITTLILDNNELKSLPENLQGNIKTLYANSNQ-LTSIPATLP--DTIQEMELSINRITELPE----------------RLP  261 (754)
T ss_pred             CcEEEecCCCCCcCChhhccCCCEEECCCCc-cccCChhhh--ccccEEECcCCccCcCCh----------------hHh
Confidence            456677777777787643 366777776654 556665332  122222222222211111                112


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCcceEEEecCCcCCCCCchhhhhcccCCCcccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLS  486 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~  486 (878)
                      ..|+.|+|++|+|+ .||..+.  ++|+.|+|++|+|+ .+|..+.. .|+.|+|++|+|+ .+|..+.  ++|+.|.++
T Consensus       262 s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp~-sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls  333 (754)
T PRK15370        262 SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLPS-GITHLNVQSNSLT-ALPETLP--PGLKTLEAG  333 (754)
T ss_pred             CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccchh-hHHHHHhcCCccc-cCCcccc--ccceecccc
Confidence            36888888888888 5777664  57888888888888 56754421 2888888888888 4665543  345554443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.81  E-value=0.00016  Score=76.74  Aligned_cols=136  Identities=15%  Similarity=0.128  Sum_probs=84.0

Q ss_pred             cccc-EEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeeccCCChhhhh-
Q 002809          576 KGGF-GTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL-  652 (878)
Q Consensus       576 ~G~f-G~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l-  652 (878)
                      .|.. ..||+....+..+.||+.....   .....+|++++..+. +--+.+++++....+..++|||+++|.+|.... 
T Consensus         8 ~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~   84 (244)
T cd05150           8 EGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE   84 (244)
T ss_pred             CCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhc
Confidence            3444 7899988776778888876543   345678999998885 333556777776666789999999988776432 


Q ss_pred             ------------------ccccCC--CCC--HHHHHHHHH--------------------HHHHHHHHHHh----CCCCC
Q 002809          653 ------------------SDISKK--VLS--SQERLRIAV--------------------ESAQGLEYLHN----GCKPP  686 (878)
Q Consensus       653 ------------------~~~~~~--~l~--~~~~~~i~~--------------------qia~gL~yLH~----~~~~~  686 (878)
                                        +.....  .+.  .........                    .+...+..|-.    ...+.
T Consensus        85 ~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  164 (244)
T cd05150          85 ELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLV  164 (244)
T ss_pred             ccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceE
Confidence                              111000  111  000000000                    01111222211    12356


Q ss_pred             eEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          687 IVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       687 ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ++|+|+.|.|||++++..+.|+||+.+.
T Consensus       165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         165 VTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EECCCCCCccEEEeCCcEEEEEEccccc
Confidence            8999999999999998788999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.80  E-value=1.5e-05  Score=60.58  Aligned_cols=39  Identities=49%  Similarity=0.730  Sum_probs=33.6

Q ss_pred             CCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCc
Q 002809          431 TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVP  471 (878)
Q Consensus       431 ~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP  471 (878)
                      ++|++|+|++|+|+ .||..+++|+ |+.|+|++|+++ .+|
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            57999999999999 8999899999 999999999998 443

...

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.78  E-value=9.2e-06  Score=93.07  Aligned_cols=180  Identities=22%  Similarity=0.237  Sum_probs=131.7

Q ss_pred             cccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccc-eeeeeecccCCCcceeEeeeccCC-Chh
Q 002809          573 TLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN-LTSLVGHCDEDNQTALIYEFMANG-NLQ  649 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~g-sL~  649 (878)
                      .+++|+.++++|.+-.. +....+.+...     ....-++++|.+++||| .+..++-++.+....++++++..+ +..
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            46788999999887654 33334444433     34456889999999999 777778888888899999999877 322


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccccc
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA  729 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  729 (878)
                      ..+.. ....+...+...+...-+++++++|+.   .=+|+|    ||+..+ ...+..||+....+....   ......
T Consensus       324 ~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~  391 (829)
T KOG0576|consen  324 LEMTV-SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI  391 (829)
T ss_pred             ccCCh-hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence            22211 122344455566777788999999976   458998    777665 678999999887664332   234466


Q ss_pred             CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 002809          730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAIS  769 (878)
Q Consensus       730 gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~  769 (878)
                      +++.++|||+.....+..+.|+|+.|+--.++.-|-+|-.
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            8999999999999999999999999987777777766643

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.77  E-value=2.2e-06  Score=101.47  Aligned_cols=139  Identities=24%  Similarity=0.319  Sum_probs=100.7

Q ss_pred             eEEEEEecCCCCCchh---hhhhhhheeccccccccccchHHHHHHH-HHhhCC-CCCCCCCCCCCCCCcccceecCCCC
Q 002809          329 YSFSLYKTGNSTLPPI---INAIEVYSVKEFLQLQTEQIDVDAITNI-KATYGL-KKNWQGDPCAPLAYWWDGLNCSYGD  403 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~---inalEi~~l~~~~~~~t~~~d~~al~~l-k~~~~~-~~~w~~~pc~~~~~~w~gv~C~~~~  403 (878)
                      ..+.+..+..+-+||.   ++.++.+.|..|. +..+|+-+.+.... -..++. .+.....||.             +.
T Consensus       290 ~~l~~~~nel~yip~~le~~~sL~tLdL~~N~-L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~-------------~e  355 (1081)
T KOG0618|consen  290 VSLSAAYNELEYIPPFLEGLKSLRTLDLQSNN-LPSLPDNFLAVLNASLNTLNVSSNKLSTLPSY-------------EE  355 (1081)
T ss_pred             HHHHhhhhhhhhCCCcccccceeeeeeehhcc-ccccchHHHhhhhHHHHHHhhhhccccccccc-------------cc
Confidence            3445555666667765   4467777777755 67777744333222 112222 2222334552             22


Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCcc-CCCCc-ceEEEecCCcCCCCCchhhhhcccCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF-LSKLP-LRTLNLQGNKLNGSVPVELLERSKNG  481 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~  481 (878)
                      ...+.|+.|.|.+|.|+-..=+-|-+..+|+.|+|++|+|. ++|+. +.++. |+.|+||+|+|+ .||.++.+++.|+
T Consensus       356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~  433 (1081)
T KOG0618|consen  356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH  433 (1081)
T ss_pred             hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH
Confidence            45678999999999999999889999999999999999999 88865 78888 999999999999 9999998887766


Q ss_pred             Cc
Q 002809          482 SL  483 (878)
Q Consensus       482 ~l  483 (878)
                      .|
T Consensus       434 tL  435 (1081)
T KOG0618|consen  434 TL  435 (1081)
T ss_pred             HH
Confidence            43

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.76  E-value=0.00011  Score=74.96  Aligned_cols=104  Identities=22%  Similarity=0.211  Sum_probs=82.1

Q ss_pred             HHHHHHHHHhcc-cceeeeeecccCCCcceeEeeeccCCChhhhhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 002809          609 QAEVKLLMRVHH-RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD-ISKKVLSSQERLRIAVESAQGLEYLHNGCKPP  686 (878)
Q Consensus       609 ~~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~  686 (878)
                      ..|.-+++.+++ +++.+++|+|-    .++|.||...+++...-.. ..-..-+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888876 69999999994    4789999987766432000 00123689999999999999999999865556


Q ss_pred             eEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          687 IVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       687 ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      +.-.|++++|+-+++++++|+.|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.70  E-value=2.2e-05  Score=78.51  Aligned_cols=81  Identities=33%  Similarity=0.477  Sum_probs=33.8

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccC-CCCc-ceEEEecCCcCCCCCc--hhhhhcccCC
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFL-SKLP-LRTLNLQGNKLNGSVP--VELLERSKNG  481 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~l~-L~~L~ls~N~l~g~iP--~~l~~~~~l~  481 (878)
                      ..+|+.|+|++|+|+ .|+ .+..|++|+.|+|++|+++ .+++.+ ..++ |+.|+|++|++.. +-  ..+..+++|.
T Consensus        41 l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~  116 (175)
T PF14580_consen   41 LDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLR  116 (175)
T ss_dssp             -TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--
T ss_pred             hcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcc
Confidence            458999999999998 565 5888999999999999999 566544 3577 9999999999873 22  2344555555


Q ss_pred             CcccccCCCCC
Q 002809          482 SLSLSVGGNPG  492 (878)
Q Consensus       482 ~l~l~~~~n~~  492 (878)
                      .  ++..|||-
T Consensus       117 ~--L~L~~NPv  125 (175)
T PF14580_consen  117 V--LSLEGNPV  125 (175)
T ss_dssp             E--EE-TT-GG
T ss_pred             e--eeccCCcc
Confidence            3  55667764

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=97.66  E-value=2.2e-05  Score=64.33  Aligned_cols=57  Identities=42%  Similarity=0.504  Sum_probs=46.8

Q ss_pred             CCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccccc
Q 002809          431 TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSV  487 (878)
Q Consensus       431 ~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~  487 (878)
                      ++|+.|+|++|+|+..-+..|..++ |+.|+|++|+++..-|..+..+++++.|+++.
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~   58 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSN   58 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETS
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcC
Confidence            5799999999999944446789999 99999999999955556788999988665543

...

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.64  E-value=0.00037  Score=68.72  Aligned_cols=128  Identities=18%  Similarity=0.187  Sum_probs=87.9

Q ss_pred             hcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceee-eeecccCCCcceeEeeeccCCCh
Q 002809          570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTS-LVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~-l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      ..+.|++|.+|.||.|.+.+..+|+|+-...++  ...+..|.++|..+.-.++-+ ++.|-.    -.+.|||+.|-.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeeccCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence            356899999999999999999999999776654  478899999999998666553 333322    2344999998788


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC-ccEEEcCCCcEEEeecCCccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKS-TNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp-~NILl~~~~~~kL~DFGla~~  715 (878)
                      .+.-...     +-++    +..+++.---|...   +|-|+.|.- ..+++-.+..+.|+||.-|+.
T Consensus       100 ~~~~~~~-----~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG-----DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc-----cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7764421     1222    23344443333333   888988863 444444444999999998763

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=97.62  E-value=4.5e-05  Score=76.64  Aligned_cols=106  Identities=23%  Similarity=0.359  Sum_probs=56.7

Q ss_pred             EEEEeeccCCCceeecCCCCCCceeec---CCCCCceeeccc----cccccCCCCCCCChhhhhccccccCCCCccceee
Q 002809          193 FTRLDVASTTNLTIRYNDDVHDRSWFP---YNSANWARINTS----LTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFY  265 (878)
Q Consensus       193 ~~r~~~g~~~~~~~ryp~D~~dR~W~~---~~~~~~~~~~t~----~~~~~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~  265 (878)
                      +.|.|+|+.     .| +|..++.|.+   +....|.=....    .............+..++||+=...+   .+.+.
T Consensus         2 ~~~IN~Gg~-----~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~---~f~Y~   72 (174)
T PF11721_consen    2 VLRINAGGP-----AY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS---SFSYD   72 (174)
T ss_dssp             EEEEEETSS-----SE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS---SEEEE
T ss_pred             EEEEECCCC-----cc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC---ceEEE
Confidence            568999976     34 8999999985   333334100000    00111223335577799999987432   34444


Q ss_pred             ccCCCCCceEEEEEeecccccccc------CceeEEEEEECCccccCCCC
Q 002809          266 LETEDPSIQFYVYMHFAEVQILQA------NQSRQFNISLNGEHWYGPFS  309 (878)
Q Consensus       266 ~~~~~~~~~~~~~l~Fae~~~~~~------~~~R~F~i~in~~~~~~~~~  309 (878)
                      .+ ..++-.|-|-|||||+.. ..      .++|+|||+|||+...+.|.
T Consensus        73 ip-~~~~G~Y~V~L~FaE~~~-~~~~~~~~~G~RvFdV~v~g~~vl~~~D  120 (174)
T PF11721_consen   73 IP-VVPNGTYTVRLHFAELYF-GASGGASGPGQRVFDVYVNGETVLKNFD  120 (174)
T ss_dssp             EE---S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-
T ss_pred             Ee-cCCCcEEEEEEEeccccc-cccccccCCCceEEEEEecceEEEeccC
Confidence            33 256678999999999974 44      67999999999998765443

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.62  E-value=3.3e-05  Score=77.32  Aligned_cols=78  Identities=33%  Similarity=0.479  Sum_probs=26.4

Q ss_pred             CCcEEEEEecCCCccccchhhhh-ccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhh-hcccCCC
Q 002809          406 SPRITYLNLSSSGLKGDITSYVS-NLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELL-ERSKNGS  482 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~-~~~~l~~  482 (878)
                      +.+++.|+|.+|+|+ .|. .++ .|++|+.||||+|+++ .|+. +..++ |+.|+|++|+++ .++..+. .+++|..
T Consensus        18 ~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   18 PVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQE   92 (175)
T ss_dssp             --------------------S--TT-TT--EEE-TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--E
T ss_pred             ccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCCE
Confidence            447899999999998 564 576 6899999999999999 6664 77788 999999999999 6766664 6888887


Q ss_pred             cccccC
Q 002809          483 LSLSVG  488 (878)
Q Consensus       483 l~l~~~  488 (878)
                      |.++.+
T Consensus        93 L~L~~N   98 (175)
T PF14580_consen   93 LYLSNN   98 (175)
T ss_dssp             EE-TTS
T ss_pred             EECcCC
Confidence            766543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.60  E-value=5.4e-05  Score=85.69  Aligned_cols=143  Identities=22%  Similarity=0.301  Sum_probs=98.4

Q ss_pred             eEEEEEecCCCCCchh---hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCC--CCCCCCCCCcccceecCCCC
Q 002809          329 YSFSLYKTGNSTLPPI---INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQ--GDPCAPLAYWWDGLNCSYGD  403 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~---inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~--~~pc~~~~~~w~gv~C~~~~  403 (878)
                      ..+.+.++....+|-.   ...+|-+.|..|.-.+-...++.++..++.+-...+...  ..||.|              
T Consensus       105 q~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp--------------  170 (873)
T KOG4194|consen  105 QEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFP--------------  170 (873)
T ss_pred             eeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCC--------------
Confidence            4456666666666543   346788888877644444666777777777665544443  245543              


Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCc-cCCCCc-ceEEEecCCcCCCCC-chhhhhcccC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD-FLSKLP-LRTLNLQGNKLNGSV-PVELLERSKN  480 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~-L~~L~ls~N~l~g~i-P~~l~~~~~l  480 (878)
                       ...+|++|+|++|.|+..=-..|.+|.+|..|.|++|+++ .+|. .|..|+ |+.|+|..|++. .+ =..+..++++
T Consensus       171 -~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl  247 (873)
T KOG4194|consen  171 -AKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSL  247 (873)
T ss_pred             -CCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhcccccee-eehhhhhcCchhh
Confidence             3457999999999999666788999999999999999999 6664 466699 999999999986 22 2234455555


Q ss_pred             CCcccccC
Q 002809          481 GSLSLSVG  488 (878)
Q Consensus       481 ~~l~l~~~  488 (878)
                      +.|.+.-+
T Consensus       248 ~nlklqrN  255 (873)
T KOG4194|consen  248 QNLKLQRN  255 (873)
T ss_pred             hhhhhhhc
Confidence            55544433

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.58  E-value=0.00074  Score=70.35  Aligned_cols=135  Identities=19%  Similarity=0.213  Sum_probs=90.2

Q ss_pred             ccccccccEEEEEEEEc-ceeEEEEEeccCChhh-------------------H-----HHHHHHHHHHHHhc--cccee
Q 002809          572 RTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQG-------------------F-----QQFQAEVKLLMRVH--HRNLT  624 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~-------------------~-----~~f~~Ei~~L~~l~--H~nIv  624 (878)
                      ..|.+|--+.||+|.-. +..+|||+........                   .     .-..+|+.-|.++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            46778888999999875 4899999986431110                   0     11245666676663  33333


Q ss_pred             eeeecccCCCcceeEeeeccCC-ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          625 SLVGHCDEDNQTALIYEFMANG-NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       625 ~l~g~~~~~~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      +.+++.    .-.|||||+... .-.-.|++   -.+.......+..++++.+.-|-..+  ++||+||+.=|||+. ++
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence            444332    346899998643 22223332   12333356677788888888887633  999999999999999 88


Q ss_pred             cEEEeecCCcccc
Q 002809          704 QAKLADFGLSKSF  716 (878)
Q Consensus       704 ~~kL~DFGla~~~  716 (878)
                      .+.|+|||.+...
T Consensus       204 ~p~iID~~QaV~~  216 (268)
T COG1718         204 EPYIIDVSQAVTI  216 (268)
T ss_pred             eEEEEECcccccc
Confidence            9999999988654

>PRK10593 hypothetical protein; Provisional

Probab=97.54  E-value=0.0012  Score=72.30  Aligned_cols=75  Identities=12%  Similarity=0.045  Sum_probs=56.8

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcc---cceeeeeecccC---CCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH---RNLTSLVGHCDE---DNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H---~nIv~l~g~~~~---~~~~~lV~Ey~~~  645 (878)
                      +.||.|..+.||+....+..+.+|..+...  ....|.+|.+.|+.+..   -.+.++++.|..   .+..++|||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            579999999999988766667778754321  22578999999998853   357788887754   3668999999998


Q ss_pred             CCh
Q 002809          646 GNL  648 (878)
Q Consensus       646 gsL  648 (878)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>PLN02876 acyl-CoA dehydrogenase

Probab=97.52  E-value=0.001  Score=83.19  Aligned_cols=77  Identities=12%  Similarity=0.254  Sum_probs=56.2

Q ss_pred             ccccccccEEEEEEEEcc----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhc-ccce--eeeeecccCC---CcceeEe
Q 002809          572 RTLGKGGFGTVYYGRLNE----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVH-HRNL--TSLVGHCDED---NQTALIY  640 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~-H~nI--v~l~g~~~~~---~~~~lV~  640 (878)
                      +.++.|.+..+|+....+    ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            467889999999887654    367777754332 223357889999999996 6665  6778887654   4678999


Q ss_pred             eeccCCCh
Q 002809          641 EFMANGNL  648 (878)
Q Consensus       641 Ey~~~gsL  648 (878)
                      ||+++..+
T Consensus       124 E~v~G~~~  131 (822)
T PLN02876        124 EYLEGRIF  131 (822)
T ss_pred             EecCCccc
Confidence            99987654

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.51  E-value=2.2e-05  Score=73.53  Aligned_cols=75  Identities=32%  Similarity=0.446  Sum_probs=63.4

Q ss_pred             CCcEEEEEecCCCccccchhhhhcc-CCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNL-TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l-~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ...|+.++|++|+|. .+|+.|... +.++.|+|++|.|+ .+|.++..++ |+.||+++|.|+ ..|.-+..+.++-.|
T Consensus        52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L  128 (177)
T KOG4579|consen   52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML  128 (177)
T ss_pred             CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence            457889999999998 777777765 48999999999999 8999999999 999999999999 788888877765543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.45  E-value=0.0013  Score=67.29  Aligned_cols=127  Identities=20%  Similarity=0.373  Sum_probs=90.0

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCC----------------hhhHHHHHHHHHHHHHhc------ccceeeeeec
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSS----------------AQGFQQFQAEVKLLMRVH------HRNLTSLVGH  629 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~----------------~~~~~~f~~Ei~~L~~l~------H~nIv~l~g~  629 (878)
                      ..||+|+.-.||.-- .+....||+.....                ....++..+|+.-...+.      +.+|.+++|+
T Consensus         7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~   85 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF   85 (199)
T ss_pred             cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence            579999999998532 23567788877654                223466777777766665      8889999999


Q ss_pred             ccCCCcceeEeeeccC--C----ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          630 CDEDNQTALIYEFMAN--G----NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       630 ~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      .+.+....+|+|.+.+  |    +|.+++.+   ..++. ...+.+.   +-.+||-+.   .|+.+|++|+||++..+.
T Consensus        86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   86 VETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEEecC
Confidence            9999999999998754  2    67777743   33554 3333333   444566666   899999999999996432


Q ss_pred             ----cEEEee
Q 002809          704 ----QAKLAD  709 (878)
Q Consensus       704 ----~~kL~D  709 (878)
                          .+.|+|
T Consensus       156 ~~~~~lvlID  165 (199)
T PF10707_consen  156 SGEFRLVLID  165 (199)
T ss_pred             CCceEEEEEe
Confidence                466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.42  E-value=4.5e-05  Score=82.77  Aligned_cols=90  Identities=24%  Similarity=0.275  Sum_probs=77.0

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ..+++|+.|+|++|+|++.-+..|..+.+|+.|.|..|+|.-.--..|..+. |++|+|.+|+++---|..+..+..++.
T Consensus       271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~  350 (498)
T KOG4237|consen  271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST  350 (498)
T ss_pred             hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence            4678999999999999999999999999999999999999843345577788 999999999999777888877777764


Q ss_pred             cccccCCCCCCCC
Q 002809          483 LSLSVGGNPGLCS  495 (878)
Q Consensus       483 l~l~~~~n~~lc~  495 (878)
                        +..-+||+.|.
T Consensus       351 --l~l~~Np~~Cn  361 (498)
T KOG4237|consen  351 --LNLLSNPFNCN  361 (498)
T ss_pred             --eehccCcccCc
Confidence              55678999887

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.41  E-value=0.0015  Score=69.09  Aligned_cols=74  Identities=15%  Similarity=0.229  Sum_probs=45.7

Q ss_pred             ccccccccE-EEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhccc---ceeeeeecccCC---CcceeEeeecc
Q 002809          572 RTLGKGGFG-TVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHR---NLTSLVGHCDED---NQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG-~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~---nIv~l~g~~~~~---~~~~lV~Ey~~  644 (878)
                      +.|+.|+.. .||+.   +..+.+|......  ....+.+|.++|..+...   -+.+.++.....   ...+++||+++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            346766665 58864   2356777654422  235788999999888632   233444444332   23478999999


Q ss_pred             CCChhh
Q 002809          645 NGNLQE  650 (878)
Q Consensus       645 ~gsL~~  650 (878)
                      |.++.+
T Consensus        78 G~~l~~   83 (235)
T cd05155          78 GETATA   83 (235)
T ss_pred             CCCCCc
Confidence            877643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.37  E-value=5.5e-05  Score=82.12  Aligned_cols=84  Identities=23%  Similarity=0.283  Sum_probs=67.9

Q ss_pred             eecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc--ceEEEecCCcCCC
Q 002809          397 LNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP--LRTLNLQGNKLNG  468 (878)
Q Consensus       397 v~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~--L~~L~ls~N~l~g  468 (878)
                      |.|+..+      ..++..+.|+|..|+|+-.-|..|+.|++|+.||||+|+++-.-|+.|..|.  ++.+++++|+++ 
T Consensus        51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-  129 (498)
T KOG4237|consen   51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-  129 (498)
T ss_pred             EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-
Confidence            7887543      4567889999999999955567899999999999999999988899999998  566667779999 


Q ss_pred             CCchh-hhhcccCC
Q 002809          469 SVPVE-LLERSKNG  481 (878)
Q Consensus       469 ~iP~~-l~~~~~l~  481 (878)
                      .+|.. ++.+..++
T Consensus       130 ~l~k~~F~gL~slq  143 (498)
T KOG4237|consen  130 DLPKGAFGGLSSLQ  143 (498)
T ss_pred             hhhhhHhhhHHHHH
Confidence            78864 44555444

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.30  E-value=0.0013  Score=70.50  Aligned_cols=136  Identities=15%  Similarity=0.083  Sum_probs=80.1

Q ss_pred             ccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccce-eeeeecccCCCcceeEeeeccCCChhhh-
Q 002809          574 LGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL-TSLVGHCDEDNQTALIYEFMANGNLQEY-  651 (878)
Q Consensus       574 LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-  651 (878)
                      +..|-...+|+....+..+++|..............+|.++++.+....+ .++++.+.    -.+|+||++|..+... 
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~   79 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ   79 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence            55677889999887778888987654322211245789999998864433 33444432    3689999998765431 


Q ss_pred             ----------------hcccc--CCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEecCCCCccEE
Q 002809          652 ----------------LSDIS--KKVLSSQER-LRIAVE---------SAQGLEYLHNG-----CKPPIVHRDVKSTNIL  698 (878)
Q Consensus       652 ----------------l~~~~--~~~l~~~~~-~~i~~q---------ia~gL~yLH~~-----~~~~ivHrDLKp~NIL  698 (878)
                                      +|...  ...++...+ .....+         +.+.+..+...     ..+.++|+|+.|.||+
T Consensus        80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil  159 (256)
T TIGR02721        80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV  159 (256)
T ss_pred             ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence                            11111  111221111 111111         11112222211     1335899999999999


Q ss_pred             EcCCCcEEEeecCCcc
Q 002809          699 LNEKLQAKLADFGLSK  714 (878)
Q Consensus       699 l~~~~~~kL~DFGla~  714 (878)
                      +++++ +++.||..+.
T Consensus       160 ~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       160 VTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EeCCC-CEEEeccccC
Confidence            99877 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.28  E-value=4.7e-05  Score=86.07  Aligned_cols=131  Identities=23%  Similarity=0.265  Sum_probs=96.8

Q ss_pred             EEEEEecCCCCCchhhh--hhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCC
Q 002809          330 SFSLYKTGNSTLPPIIN--AIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSP  407 (878)
Q Consensus       330 ~~~l~~t~~s~lpp~in--alEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~  407 (878)
                      =+.|..+..|.||+.|.  -|.++-+.+|. .+.+|.++.-+..+..+....++...-|-.              ...+.
T Consensus       125 ~l~ls~NqlS~lp~~lC~lpLkvli~sNNk-l~~lp~~ig~~~tl~~ld~s~nei~slpsq--------------l~~l~  189 (722)
T KOG0532|consen  125 FLDLSSNQLSHLPDGLCDLPLKVLIVSNNK-LTSLPEEIGLLPTLAHLDVSKNEIQSLPSQ--------------LGYLT  189 (722)
T ss_pred             HhhhccchhhcCChhhhcCcceeEEEecCc-cccCCcccccchhHHHhhhhhhhhhhchHH--------------hhhHH
Confidence            34455577788887655  56677677655 788888888667777666555554443321              12345


Q ss_pred             cEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhccc
Q 002809          408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSK  479 (878)
Q Consensus       408 ~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~  479 (878)
                      .|..|++..|++. .+|++++ .-.|..||+|.|+++ .||-+|.+|+ |++|-|.+|-|. +-|..++...+
T Consensus       190 slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGk  258 (722)
T KOG0532|consen  190 SLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGK  258 (722)
T ss_pred             HHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccc
Confidence            7788888899988 8899988 446889999999999 8999999999 999999999998 77777766543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	878
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-51
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-51
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-46
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-34
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-28
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-28
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-22
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-22
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-22
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-22
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-22
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-22
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-22
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-22
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-22
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-22
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-22
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-22
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-21
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-19
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-19
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-18
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-18
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-18
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-17
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-17
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-17
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-17
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-17
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-17
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-17
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-17
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-17
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-17
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-14
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-14
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-05
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-05
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		8e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-04

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  199 bits (506), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 114/285 (40%), Positives = 163/285 (57%), Gaps = 8/285 (2%)
Query: 562 DVVKITNNFERT--LGKGGFGTVYYGRLNE-IDVAVKMLXXXXXXXXXXXXXEVKLLMRV 618
           D+ + TNNF+    +G G FG VY G L +   VA+K               E++ L   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGL 676
            H +L SL+G CDE N+  LIY++M NGNL+ +L  SD+    +S ++RL I + +A+GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            YLH      I+HRDVKS NILL+E    K+ DFG+SK       TH+  VV GT GY+D
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV 796
           PEY+   RLTEKSDVYSFGVV+ E++  + AI +    E +++ +W       G ++ IV
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
           DP L +     S+ K  + A+ CL+ +   RP+M  V+ +L   L
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  198 bits (504), Expect = 8e-51,   Method: Compositional matrix adjust.
 Identities = 114/285 (40%), Positives = 163/285 (57%), Gaps = 8/285 (2%)
Query: 562 DVVKITNNFERT--LGKGGFGTVYYGRLNE-IDVAVKMLXXXXXXXXXXXXXEVKLLMRV 618
           D+ + TNNF+    +G G FG VY G L +   VA+K               E++ L   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGL 676
            H +L SL+G CDE N+  LIY++M NGNL+ +L  SD+    +S ++RL I + +A+GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            YLH      I+HRDVKS NILL+E    K+ DFG+SK       TH+  VV GT GY+D
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV 796
           PEY+   RLTEKSDVYSFGVV+ E++  + AI +    E +++ +W       G ++ IV
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
           DP L +     S+ K  + A+ CL+ +   RP+M  V+ +L   L
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  183 bits (464), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 172/291 (59%), Gaps = 9/291 (3%)
Query: 556 RHLSYSDVVKITNNF--ERTLGKGGFGTVYYGRLNE-IDVAVKMLXXXXXXXXXXX-XXE 611
           +  S  ++   ++NF  +  LG+GGFG VY GRL +   VAVK L              E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 612 VKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI--SKKVLSSQERLRIA 669
           V+++    HRNL  L G C    +  L+Y +MANG++   L +   S+  L   +R RIA
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
           + SA+GL YLH+ C P I+HRDVK+ NILL+E+ +A + DFGL+K      + HV   V 
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVR 204
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA--ISRINEEEKIHIRQWVNSLI 787
           GT G++ PEY ++ + +EK+DV+ +GV++LE+IT + A  ++R+  ++ + +  WV  L+
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
            +  ++++VD  LQ ++    V + +++A+ C   +  +RP MS+VV  L 
Sbjct: 265 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  181 bits (459), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 170/291 (58%), Gaps = 9/291 (3%)
Query: 556 RHLSYSDVVKITNNF--ERTLGKGGFGTVYYGRLNEID-VAVKMLXXXXXXXXXXX-XXE 611
           +  S  ++   ++NF  +  LG+GGFG VY GRL +   VAVK L              E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 612 VKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI--SKKVLSSQERLRIA 669
           V+++    HRNL  L G C    +  L+Y +MANG++   L +   S+  L   +R RIA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
           + SA+GL YLH+ C P I+HRDVK+ NILL+E+ +A + DFGL+K      + HV   V 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVR 196
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA--ISRINEEEKIHIRQWVNSLI 787
           G  G++ PEY ++ + +EK+DV+ +GV++LE+IT + A  ++R+  ++ + +  WV  L+
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
            +  ++++VD  LQ ++    V + +++A+ C   +  +RP MS+VV  L 
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  153 bits (386), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/299 (33%), Positives = 156/299 (52%), Gaps = 19/299 (6%)
Query: 558 LSYSDVVKITNNFER--------TLGKGGFGTVYYGRLNEIDVAVK----MLXXXXXXXX 605
            S+ ++  +TNNF+          +G+GGFG VY G +N   VAVK    M+        
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDIS-KKVLSSQE 664
                E+K++ +  H NL  L+G   + +   L+Y +M NG+L + LS +     LS   
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           R +IA  +A G+ +LH       +HRD+KS NILL+E   AK++DFGL+++    A T +
Sbjct: 135 RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN 784
            + + GT  Y+ PE      +T KSD+YSFGVV+LEIIT  PA+   + E ++ +     
Sbjct: 192 XSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLDIKEE 249
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
               +  I+  +D ++  D D+ SV     +A  CL    N+RP + +V   L E  A+
Sbjct: 250 IEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (385), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 100/299 (33%), Positives = 155/299 (51%), Gaps = 19/299 (6%)
Query: 558 LSYSDVVKITNNFER--------TLGKGGFGTVYYGRLNEIDVAVK----MLXXXXXXXX 605
            S+ ++  +TNNF+          +G+GGFG VY G +N   VAVK    M+        
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDIS-KKVLSSQE 664
                E+K++ +  H NL  L+G   + +   L+Y +M NG+L + LS +     LS   
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           R +IA  +A G+ +LH       +HRD+KS NILL+E   AK++DFGL+++    A T +
Sbjct: 135 RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN 784
              + GT  Y+ PE      +T KSD+YSFGVV+LEIIT  PA+   + E ++ +     
Sbjct: 192 XXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLDIKEE 249
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
               +  I+  +D ++  D D+ SV     +A  CL    N+RP + +V   L E  A+
Sbjct: 250 IEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  150 bits (379), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/299 (33%), Positives = 154/299 (51%), Gaps = 19/299 (6%)
Query: 558 LSYSDVVKITNNFER--------TLGKGGFGTVYYGRLNEIDVAVK----MLXXXXXXXX 605
            S+ ++  +TNNF+          +G+GGFG VY G +N   VAVK    M+        
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDIS-KKVLSSQE 664
                E+K++ +  H NL  L+G   + +   L+Y +M NG+L + LS +     LS   
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           R +IA  +A G+ +LH       +HRD+KS NILL+E   AK++DFGL+++    A   +
Sbjct: 129 RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVM 185
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN 784
              + GT  Y+ PE      +T KSD+YSFGVV+LEIIT  PA+   + E ++ +     
Sbjct: 186 XXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLDIKEE 243
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
               +  I+  +D ++  D D+ SV     +A  CL    N+RP + +V   L E  A+
Sbjct: 244 IEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  143 bits (361), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/299 (33%), Positives = 151/299 (50%), Gaps = 19/299 (6%)
Query: 558 LSYSDVVKITNNF-ERTL-------GKGGFGTVYYGRLNEIDVAVK----MLXXXXXXXX 605
            S+ ++  +TNNF ER +       G+GGFG VY G +N   VAVK    M+        
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDIS-KKVLSSQE 664
                E+K+  +  H NL  L+G   + +   L+Y +  NG+L + LS +     LS   
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           R +IA  +A G+ +LH       +HRD+KS NILL+E   AK++DFGL+++    A    
Sbjct: 126 RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVX 182
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN 784
            + + GT  Y  PE      +T KSD+YSFGVV+LEIIT  PA+   + E ++ +     
Sbjct: 183 XSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLDIKEE 240
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
               +  I+  +D +   D D+ SV     +A  CL    N+RP + +V   L E  A+
Sbjct: 241 IEDEEKTIEDYIDKKXN-DADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXTAS 298

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  124 bits (310), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 115/212 (54%), Gaps = 6/212 (2%)
Query: 569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLXXX--XXXXXXXXXXEVKLLMRVHHRNLTSL 626
           N +  +G G FGTV+    +  DVAVK+L               EV ++ R+ H N+   
Sbjct: 40  NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDI-SKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           +G   +    +++ E+++ G+L   L    +++ L  + RL +A + A+G+ YLHN   P
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
           PIVHRD+KS N+L+++K   K+ DFGLS+  A+      S   AGTP ++ PE       
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 746 TEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
            EKSDVYSFGV++ E+ T +     +N  + +
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  122 bits (307), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 118/213 (55%), Gaps = 8/213 (3%)
Query: 569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLXXX--XXXXXXXXXXEVKLLMRVHHRNLTSL 626
           N +  +G G FGTV+    +  DVAVK+L               EV ++ R+ H N+   
Sbjct: 40  NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDI-SKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           +G   +    +++ E+++ G+L   L    +++ L  + RL +A + A+G+ YLHN   P
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST-VVAGTPGYLDPEYYTSNR 744
           PIVHR++KS N+L+++K   K+ DFGLS+     A+T +S+   AGTP ++ PE      
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
             EKSDVYSFGV++ E+ T +     +N  + +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 144/278 (51%), Gaps = 23/278 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 32  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L   S+     ++ + IA ++A+G++YLH      I+HRD
Sbjct: 91  KP-QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E    K+ DFGL+   +  + +H    ++G+  ++ PE      SN  + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G +     P L +   +N 
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSL----SPDLSK-VRSNC 254
Query: 809 VWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA 846
             +   L   CL    ++RP+  +++ E+ E LA E++
Sbjct: 255 PKRMKRLMAECLKKKRDERPSFPRILAEIEE-LARELS 291

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 144/278 (51%), Gaps = 23/278 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 20  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L   S+     ++ + IA ++A+G++YLH      I+HRD
Sbjct: 79  KP-QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E    K+ DFGL+   +  + +H    ++G+  ++ PE      SN  + +
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G +     P L +   +N 
Sbjct: 194 SDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSL----SPDLSK-VRSNC 242
Query: 809 VWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA 846
             +   L   CL    ++RP+  +++ E+ E LA E++
Sbjct: 243 PKRMKRLMAECLKKKRDERPSFPRILAEIEE-LARELS 279

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 25/282 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 36  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 94
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 95  KP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIHRD 149
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 210 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 257
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMARAN 849
             KA++  MA CL    ++RP   Q++  + E LA  + + +
Sbjct: 258 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPKIH 298

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 144/280 (51%), Gaps = 25/280 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 16  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 237
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMAR 847
             KA++  MA CL    ++RP   Q++  + E LA  + +
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPK 276

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 25/282 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 44  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 265
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMARAN 849
             KA++  MA CL    ++RP   Q++  + E LA  + + +
Sbjct: 266 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPKIH 306

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 25/282 (8%)
Query: 572 RTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGH 629
           + +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+
Sbjct: 19  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
             +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+H
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLT 746
           RD+KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  +
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 747 EKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA 806
            +SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    
Sbjct: 193 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VR 240
Query: 807 NSVWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMAR 847
           ++  KA++  MA CL    ++RP   Q++  + E LA  + +
Sbjct: 241 SNCPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPK 281

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 25/282 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 21  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 242
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMARAN 849
             KA++  MA CL    ++RP   Q++  + E LA  + + +
Sbjct: 243 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPKIH 283

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 25/282 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 18  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 76
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 77  KP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIHRD 131
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 192 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 239
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMARAN 849
             KA++  MA CL    ++RP   Q++  + E LA  + + +
Sbjct: 240 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPKIH 280

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 141/276 (51%), Gaps = 23/276 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 32  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
              Q A++ ++    +L  +L   S+     ++ + IA ++A+G++YLH      I+HRD
Sbjct: 91  AP-QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E    K+ DFGL+   +  + +H    ++G+  ++ PE      SN  + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G +     P L +   +N 
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSL----SPDLSK-VRSNC 254
Query: 809 VWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE 844
             +   L   CL    ++RP+  +++ E+ E LA E
Sbjct: 255 PKRMKRLMAECLKKKRDERPSFPRILAEIEE-LARE 289

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 25/282 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 44  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 265
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMARAN 849
             KA++  MA CL    ++RP   Q++  + E LA  + + +
Sbjct: 266 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPKIH 306

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 25/282 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 43  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 101
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 102 KP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIHRD 156
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 217 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 264
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMARAN 849
             KA++  MA CL    ++RP   Q++  + E LA  + + +
Sbjct: 265 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPKIH 305

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 143/280 (51%), Gaps = 25/280 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 16  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
              Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 75  AP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 237
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEMAR 847
             KA++  MA CL    ++RP   Q++  + E LA  + +
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSLPK 276

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 143/278 (51%), Gaps = 25/278 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXX--XXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVKML               EV +L +  H N+   +G+  
Sbjct: 16  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +  Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I+HRD
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N  + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVY+FG+V+ E++T +   S IN  ++I        ++ +G     + P L +    ++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRG----YLSPDLSK--VRSN 237
Query: 809 VWKAVELAMA-CLSPTGNQRPTMSQVVMELSECLAAEM 845
             KA++  MA CL    ++RP   Q++  + E LA  +
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSL 274

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 28/265 (10%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + LG G FG V YG+   + DVA+KM+             E K++M + H  L  L 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLY 85
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C +     +I E+MANG L  YL ++  +   +Q+ L +  +  + +EYL +      
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 141
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+ + N L+N++   K++DFGLS+    D  T  S+V +  P  +  PE    ++ +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEET--SSVGSKFPVRWSPPEVLMYSKFS 199
Query: 747 EKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            KSD+++FGV++ EI +    P     N E   HI Q +           +  P L  + 
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LYRPHLASE- 248
Query: 805 DANSVWKAVELAMACLSPTGNQRPT 829
                 K   +  +C     ++RPT
Sbjct: 249 ------KVYTIMYSCWHEKADERPT 267

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 28/265 (10%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + LG G FG V YG+   + DVA+KM+             E K++M + H  L  L 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLY 85
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C +     +I E+MANG L  YL ++  +   +Q+ L +  +  + +EYL +      
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 141
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+ + N L+N++   K++DFGLS+    D  T  S+V +  P  +  PE    ++ +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFS 199
Query: 747 EKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            KSD+++FGV++ EI +    P     N E   HI Q +           +  P L  + 
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LYRPHLASE- 248
Query: 805 DANSVWKAVELAMACLSPTGNQRPT 829
                 K   +  +C     ++RPT
Sbjct: 249 ------KVYTIMYSCWHEKADERPT 267

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 28/265 (10%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + LG G FG V YG+   + DVA+KM+             E K++M + H  L  L 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLY 70
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C +     +I E+MANG L  YL ++  +   +Q+ L +  +  + +EYL +      
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+ + N L+N++   K++DFGLS+    D  T  S+V +  P  +  PE    ++ +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFS 184
Query: 747 EKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            KSD+++FGV++ EI +    P     N E   HI Q +           +  P L  + 
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LYRPHLASE- 233
Query: 805 DANSVWKAVELAMACLSPTGNQRPT 829
                 K   +  +C     ++RPT
Sbjct: 234 ------KVYTIMYSCWHEKADERPT 252

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 569 NFERTLGKGGFGTVYYGR-LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + +G G FG V+ G  LN+  VA+K +             E +++M++ H  L  L 
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 71
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C E     L++EFM +G L +YL    + + +++  L + ++  +G+ YL   C   +
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+ E    K++DFG+++ F  D     ST       +  PE ++ +R + 
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS---IVDPRLQEDF 804
           KSDV+SFGV++ E+ +          E KI      NS + + DI +   +  PRL    
Sbjct: 187 KSDVWSFGVLMWEVFS----------EGKIPYENRSNSEVVE-DISTGFRLYKPRLAST- 234
Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
                    ++   C       RP  S+++ +L+E
Sbjct: 235 ------HVYQIMNHCWRERPEDRPAFSRLLRQLAE 263

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 28/265 (10%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + LG G FG V YG+   + DVA+KM+             E K++M + H  L  L 
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLY 76
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C +     +I E+MANG L  YL ++  +   +Q+ L +  +  + +EYL +      
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 132
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+ + N L+N++   K++DFGLS+    D  T  S+V +  P  +  PE    ++ +
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFS 190
Query: 747 EKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            KSD+++FGV++ EI +    P     N E   HI Q +           +  P L  + 
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LYRPHLASE- 239
Query: 805 DANSVWKAVELAMACLSPTGNQRPT 829
                 K   +  +C     ++RPT
Sbjct: 240 ------KVYTIMYSCWHEKADERPT 258

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 28/265 (10%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + LG G FG V YG+   + DVA+KM+             E K++M + H  L  L 
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLY 69
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C +     +I E+MANG L  YL ++  +   +Q+ L +  +  + +EYL +      
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+ + N L+N++   K++DFGLS+    D  T  S+V +  P  +  PE    ++ +
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFS 183
Query: 747 EKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            KSD+++FGV++ EI +    P     N E   HI Q +           +  P L  + 
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LYRPHLASE- 232
Query: 805 DANSVWKAVELAMACLSPTGNQRPT 829
                 K   +  +C     ++RPT
Sbjct: 233 ------KVYTIMYSCWHEKADERPT 251

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 569 NFERTLGKGGFGTVYYGR-LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + +G G FG V+ G  LN+  VA+K +             E +++M++ H  L  L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 66
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C E     L++EFM +G L +YL    + + +++  L + ++  +G+ YL   C   +
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+ E    K++DFG+++ F  D     ST       +  PE ++ +R + 
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS---IVDPRLQEDF 804
           KSDV+SFGV++ E+ +          E KI      NS + + DI +   +  PRL    
Sbjct: 182 KSDVWSFGVLMWEVFS----------EGKIPYENRSNSEVVE-DISTGFRLYKPRLAST- 229
Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
                    ++   C       RP  S+++ +L+E
Sbjct: 230 ------HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 569 NFERTLGKGGFGTVYYGR-LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + +G G FG V+ G  LN+  VA+K +             E +++M++ H  L  L 
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE-EAEVMMKLSHPKLVQLY 88
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C E     L++EFM +G L +YL    + + +++  L + ++  +G+ YL   C   +
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+ E    K++DFG+++ F  D     ST       +  PE ++ +R + 
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 203
Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS---IVDPRLQEDF 804
           KSDV+SFGV++ E+ +          E KI      NS + + DI +   +  PRL    
Sbjct: 204 KSDVWSFGVLMWEVFS----------EGKIPYENRSNSEVVE-DISTGFRLYKPRLAST- 251
Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
                    ++   C       RP  S+++ +L+E
Sbjct: 252 ------HVYQIMNHCWKERPEDRPAFSRLLRQLAE 280

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 569 NFERTLGKGGFGTVYYGR-LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + +G G FG V+ G  LN+  VA+K +             E +++M++ H  L  L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 68
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C E     L++EFM +G L +YL    + + +++  L + ++  +G+ YL   C   +
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+ E    K++DFG+++ F  D     ST       +  PE ++ +R + 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS---IVDPRLQEDF 804
           KSDV+SFGV++ E+ +          E KI      NS + + DI +   +  PRL    
Sbjct: 184 KSDVWSFGVLMWEVFS----------EGKIPYENRSNSEVVE-DISTGFRLYKPRLAST- 231
Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
                    ++   C       RP  S+++ +L+E
Sbjct: 232 ------HVYQIMNHCWKERPEDRPAFSRLLRQLAE 260

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 28/265 (10%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + LG G FG V YG+   + DVA+KM+             E K++M + H  L  L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLY 65
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C +     +I E+MANG L  YL ++  +   +Q+ L +  +  + +EYL +      
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+ + N L+N++   K++DFGLS+    D  T  S+V +  P  +  PE    ++ +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFS 179
Query: 747 EKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            KSD+++FGV++ EI +    P     N E   HI Q +           +  P L  + 
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LYRPHLASE- 228
Query: 805 DANSVWKAVELAMACLSPTGNQRPT 829
                 K   +  +C     ++RPT
Sbjct: 229 ------KVYTIMYSCWHEKADERPT 247

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 28/275 (10%)
Query: 569 NFERTLGKGGFGTVYYGR-LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + +G G FG V+ G  LN+  VA+K +             E +++M++ H  L  L 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 69
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C E     L+ EFM +G L +YL    + + +++  L + ++  +G+ YL   C   +
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+ E    K++DFG+++ F  D     ST       +  PE ++ +R + 
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS---IVDPRLQEDF 804
           KSDV+SFGV++ E+ +          E KI      NS + + DI +   +  PRL    
Sbjct: 185 KSDVWSFGVLMWEVFS----------EGKIPYENRSNSEVVE-DISTGFRLYKPRLAST- 232
Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
                    ++   C       RP  S+++ +L+E
Sbjct: 233 ------HVYQIMNHCWRERPEDRPAFSRLLRQLAE 261

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 124/265 (46%), Gaps = 28/265 (10%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + LG G FG V YG+   + DVA+KM+             E K++M + H  L  L 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLY 70
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C +     +I E+MANG L  YL ++  +   +Q+ L +  +  + +EYL +      
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+ + N L+N++   K++DFGLS+    D  T  S+  +  P  +  PE    ++ +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSRGSKFPVRWSPPEVLMYSKFS 184
Query: 747 EKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            KSD+++FGV++ EI +    P     N E   HI Q +           +  P L  + 
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LYRPHLASE- 233
Query: 805 DANSVWKAVELAMACLSPTGNQRPT 829
                 K   +  +C     ++RPT
Sbjct: 234 ------KVYTIMYSCWHEKADERPT 252

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 140/287 (48%), Gaps = 38/287 (13%)
Query: 569 NFERTLGKGGFGTVYYGRL--NEIDVAVKML-------XXXXXXXXXXXXXEVKLLMRVH 619
            +E+ +GKGGFG V+ GRL  ++  VA+K L                    EV ++  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           H N+  L G     N   ++ EF+  G+L   L D +  +  S  +LR+ ++ A G+EY+
Sbjct: 82  HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSV-KLRLMLDIALGIEYM 138
Query: 680 HNGCKPPIVHRDVKSTNILL-----NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
            N   PPIVHRD++S NI L     N  + AK+ADFGLS+      + H  + + G   +
Sbjct: 139 QNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192
Query: 735 LDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
           + PE   +     TEK+D YSF +++  I+T +       +E      +++N +  +G  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF----DEYSYGKIKFINMIREEG-- 246
Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              + P + ED     +   +EL   C S    +RP  S +V ELSE
Sbjct: 247 ---LRPTIPEDCPPR-LRNVIEL---CWSGDPKKRPHFSYIVKELSE 286

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 137/281 (48%), Gaps = 23/281 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXX--XXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G G FGTVY G+ +  DVAVK+L               EV +L +  H N+   +G+  
Sbjct: 44  IGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           +DN  A++ ++    +L ++L  + +      + + IA ++AQG++YLH      I+HRD
Sbjct: 103 KDN-LAIVTQWCEGSSLYKHLH-VQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRD 157
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEK 748
           +KS NI L+E L  K+ DFGL+   +  + +       G+  ++ PE      +N  + +
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDVYS+G+V+ E++T +   S IN  ++I        ++ +G       P L + +  N 
Sbjct: 218 SDVYSYGIVLYELMTGELPYSHINNRDQIIF------MVGRG----YASPDLSKLY-KNC 266
Query: 809 VWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARAN 849
                 L   C+     +RP   Q++  + E L   + + N
Sbjct: 267 PKAMKRLVADCVKKVKEERPLFPQILSSI-ELLQHSLPKIN 306

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 103/196 (52%), Gaps = 7/196 (3%)
Query: 569 NFERTLGKGGFGTVYYGR-LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            F + +G G FG V+ G  LN+  VA+K +             E +++M++ H  L  L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 68
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C E     L++EFM +G L +YL    + + +++  L + ++  +G+ YL       +
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA---SV 124
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+ E    K++DFG+++ F  D     ST       +  PE ++ +R + 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFGV++ E+ +
Sbjct: 184 KSDVWSFGVLMWEVFS 199

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/193 (34%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G FG VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 77
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T  +   A  P  +  PE    N+ + KSD
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXT--AHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 79
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 79
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 79
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 84
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLX----XXXXXXXXXXXXEVKLLMRVHHRNLTS 625
            E  +G GGFG VY       +VAVK                   E KL   + H N+ +
Sbjct: 11  LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G C ++    L+ EF   G L   LS    K +     +  AV+ A+G+ YLH+    
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 686 PIVHRDVKSTNILLNEKLQ--------AKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           PI+HRD+KS+NIL+ +K++         K+ DFGL++ +     T +S   AG   ++ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSA--AGAYAWMAP 183
Query: 738 EYYTSNRLTEKSDVYSFGVVILEIIT 763
           E   ++  ++ SDV+S+GV++ E++T
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 79
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 77
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HRD
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T  +   A  P  +  PE    N+ + KSD
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXT--AHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 84
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 139/287 (48%), Gaps = 38/287 (13%)
Query: 569 NFERTLGKGGFGTVYYGRL--NEIDVAVKML-------XXXXXXXXXXXXXEVKLLMRVH 619
            +E+ +GKGGFG V+ GRL  ++  VA+K L                    EV ++  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           H N+  L G     N   ++ EF+  G+L   L D +  +  S  +LR+ ++ A G+EY+
Sbjct: 82  HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSV-KLRLMLDIALGIEYM 138
Query: 680 HNGCKPPIVHRDVKSTNILL-----NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
            N   PPIVHRD++S NI L     N  + AK+ADFG S+      + H  + + G   +
Sbjct: 139 QNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ-----SVHSVSGLLGNFQW 192
Query: 735 LDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
           + PE   +     TEK+D YSF +++  I+T +       +E      +++N +  +G  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF----DEYSYGKIKFINMIREEG-- 246
Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              + P + ED     +   +EL   C S    +RP  S +V ELSE
Sbjct: 247 ---LRPTIPEDCPPR-LRNVIEL---CWSGDPKKRPHFSYIVKELSE 286

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 83
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 199 VWAFGVLLWEIAT 211

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 77
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T  +   A  P  +  PE    N+ + KSD
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGD--TFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 80
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 84
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 84
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 81
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 79
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 79
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 139/287 (48%), Gaps = 38/287 (13%)
Query: 569 NFERTLGKGGFGTVYYGRL--NEIDVAVKML-------XXXXXXXXXXXXXEVKLLMRVH 619
            +E+ +GKGGFG V+ GRL  ++  VA+K L                    EV ++  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           H N+  L G     N   ++ EF+  G+L   L D +  +  S  +LR+ ++ A G+EY+
Sbjct: 82  HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSV-KLRLMLDIALGIEYM 138
Query: 680 HNGCKPPIVHRDVKSTNILL-----NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
            N   PPIVHRD++S NI L     N  + AK+ADF LS+      + H  + + G   +
Sbjct: 139 QNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ-----SVHSVSGLLGNFQW 192
Query: 735 LDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
           + PE   +     TEK+D YSF +++  I+T +       +E      +++N +  +G  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF----DEYSYGKIKFINMIREEG-- 246
Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              + P + ED     +   +EL   C S    +RP  S +V ELSE
Sbjct: 247 ---LRPTIPEDCPPR-LRNVIEL---CWSGDPKKRPHFSYIVKELSE 286

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 92
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 208 VWAFGVLLWEIAT 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 81
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 286
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K   +HR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 402 VWAFGVLLWEIAT 414

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 81
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ + KSD
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 84
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T  +   A  P  +  PE    N+ + KSD
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTXT--AHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCT 80
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   +HRD
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSD 750
           + + N L+ E    K+ADFGLS+    D  T  +   A  P  +  PE    N+ + KSD
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTXT--AHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 751 VYSFGVVILEIIT 763
           V++FGV++ EI T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXX-XXXEVKLLMR 617
           NN E  R +G+G FG V+  R   +        VAVKML              E  L+  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL-------------SDISKKV----- 659
             + N+  L+G C       L++E+MA G+L E+L             SD+S +      
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS 715
               LS  E+L IA + A G+ YL        VHRD+ + N L+ E +  K+ADFGLS++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 716 ------FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT--CKPA 767
                 +  D N  +         ++ PE    NR T +SDV+++GVV+ EI +   +P 
Sbjct: 224 IYSADYYKADGNDAIPI------RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 768 ISRINEEEKIHIR 780
               +EE   ++R
Sbjct: 278 YGMAHEEVIYYVR 290

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 572 RTLGKGGFGTVYYGRLN-EID-----VAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLT 624
           R LG+G FG V   R + E D     VAVK L              E+++L  ++H N+ 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 625 SLVGHCDED--NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C ED  N   LI EF+ +G+L+EYL   +K  ++ +++L+ AV+  +G++YL + 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
                VHRD+ + N+L+  + Q K+ DFGL+K+  TD           +P +   PE   
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
            ++    SDV+SFGV + E++T
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 572 RTLGKGGFGTVYYGRLN-EID-----VAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLT 624
           R LG+G FG V   R + E D     VAVK L              E+++L  ++H N+ 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 625 SLVGHCDED--NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C ED  N   LI EF+ +G+L+EYL   +K  ++ +++L+ AV+  +G++YL + 
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
                VHRD+ + N+L+  + Q K+ DFGL+K+  TD           +P +   PE   
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
            ++    SDV+SFGV + E++T
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
            +  LG G +G VY G   +  + VAVK L             E  ++  + H NL  L+
Sbjct: 263 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLL 321
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C  +    +I EFM  GNL +YL + +++ +++   L +A + +  +EYL    K   
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 378
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HR++ + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ +
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 747 EKSDVYSFGVVILEIIT 763
            KSDV++FGV++ EI T
Sbjct: 437 IKSDVWAFGVLLWEIAT 453

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 111/216 (51%), Gaps = 18/216 (8%)
Query: 574 LGKGGFGTVYYG--RLNEIDVAVKMLXXXXXX-XXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           LG G + TVY G  +   + VA+K +              E+ L+  + H N+  L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV------ESAQGLEYLHNGCK 684
             +N+  L++EFM N +L++Y+   S+ V ++   L + +      +  QGL + H    
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMD--SRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-- 127
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I+HRD+K  N+L+N++ Q KL DFGL+++F    NT  S VV  T  Y  P+    +R
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAPDVLMGSR 184
Query: 745 LTEKS-DVYSFGVVILEIITCKPAISRINEEEKIHI 779
               S D++S G ++ E+IT KP     N+EE++ +
Sbjct: 185 TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 25/266 (9%)
Query: 571 ERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           E  +G+G FG V   +    DVA+K +             E++ L RV+H N+  L G C
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIV--ELRQLSRVNHPNIVKLYGAC 71
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
              N   L+ E+   G+L   L         ++   +   ++ +QG+ YLH+     ++H
Sbjct: 72  L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 690 RDVKSTNILLNEKLQA-KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           RD+K  N+LL       K+ DFG     A D  TH+ T   G+  ++ PE +  +  +EK
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHM-TNNKGSAAWMAPEVFEGSNYSEK 184
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
            DV+S+G+++ E+IT +     I       I   V++      IK++  P          
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIG-GPAFRIMWAVHNGTRPPLIKNLPKP---------- 233
Query: 809 VWKAVELAMACLSPTGNQRPTMSQVV 834
                 L   C S   +QRP+M ++V
Sbjct: 234 ---IESLMTRCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 25/266 (9%)
Query: 571 ERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           E  +G+G FG V   +    DVA+K +             E++ L RV+H N+  L G C
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIV--ELRQLSRVNHPNIVKLYGAC 70
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
              N   L+ E+   G+L   L         ++   +   ++ +QG+ YLH+     ++H
Sbjct: 71  L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 690 RDVKSTNILLNEKLQA-KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           RD+K  N+LL       K+ DFG     A D  TH+ T   G+  ++ PE +  +  +EK
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHM-TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
            DV+S+G+++ E+IT +     I       I   V++      IK++  P          
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIG-GPAFRIMWAVHNGTRPPLIKNLPKP---------- 232
Query: 809 VWKAVELAMACLSPTGNQRPTMSQVV 834
                 L   C S   +QRP+M ++V
Sbjct: 233 ---IESLMTRCWSKDPSQRPSMEEIV 255

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSL 626
             +  LG G +G VY G   +  + VAVK L             E  ++  + H NL  L
Sbjct: 35  TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQL 93
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
           +G C  +    ++ E+M  GNL +YL + +++ +++   L +A + +  +EYL    K  
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKN 150
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRL 745
            +HRD+ + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N  
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNTF 208
Query: 746 TEKSDVYSFGVVILEIIT 763
           + KSDV++FGV++ EI T
Sbjct: 209 SIKSDVWAFGVLLWEIAT 226

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 11/191 (5%)
Query: 572 RTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH-C 630
           +T+GKG FG V  G      VAVK +             E  ++ ++ H NL  L+G   
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLA--EASVMTQLRHSNLVQLLGVIV 256
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
           +E     ++ E+MA G+L +YL    + VL     L+ +++  + +EYL        VHR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 313
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+ + N+L++E   AK++DFGL+K  ++  +T    V      +  PE     + + KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSD 368
Query: 751 VYSFGVVILEI 761
           V+SFG+++ EI
Sbjct: 369 VWSFGILLWEI 379

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 11/191 (5%)
Query: 572 RTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH-C 630
           +T+GKG FG V  G      VAVK +             E  ++ ++ H NL  L+G   
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLA--EASVMTQLRHSNLVQLLGVIV 84
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
           +E     ++ E+MA G+L +YL    + VL     L+ +++  + +EYL        VHR
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 141
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+ + N+L++E   AK++DFGL+K  ++  +T    V      +  PE     + + KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSD 196
Query: 751 VYSFGVVILEI 761
           V+SFG+++ EI
Sbjct: 197 VWSFGILLWEI 207

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 138/301 (45%), Gaps = 49/301 (16%)
Query: 569 NFERTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-H 619
           N  + LG+G FG V       ID       VAVKML              E+K+L+ + H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 620 HRNLTSLVGHCDEDNQTAL-IYEFMANGNLQEYL----------SDISKKVLSSQERLRI 668
           H N+ +L+G C +     + I EF   GNL  YL           D+ K  L+ +  +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
           + + A+G+E+L        +HRD+ + NILL+EK   K+ DFGL++    D + +V    
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD-YVRKGD 205
Query: 729 AGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQWV 783
           A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE    +++  
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFXRRLKEGT 264
Query: 784 NSLIAKGDIKSIVDPRLQE-DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
                          R++  D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 265 ---------------RMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 306
Query: 843 A 843
           A
Sbjct: 307 A 307

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 11/191 (5%)
Query: 572 RTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH-C 630
           +T+GKG FG V  G      VAVK +             E  ++ ++ H NL  L+G   
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLA--EASVMTQLRHSNLVQLLGVIV 69
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
           +E     ++ E+MA G+L +YL    + VL     L+ +++  + +EYL        VHR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 126
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+ + N+L++E   AK++DFGL+K  ++  +T    V      +  PE     + + KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSD 181
Query: 751 VYSFGVVILEI 761
           V+SFG+++ EI
Sbjct: 182 VWSFGILLWEI 192

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 28/232 (12%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGR----LNEID---VAVKMLXXXXXXX 604
           +A   H+   D+V      +  LG+G FG V+       L E D   VAVK L       
Sbjct: 32  DACVHHIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA 86
Query: 605 XXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------------ 652
                 E +LL  + H+++    G C E     +++E+M +G+L  +L            
Sbjct: 87  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 653 -SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG 711
             D++   L   + L +A + A G+ YL        VHRD+ + N L+ + L  K+ DFG
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFG 203
Query: 712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +S+   +     V         ++ PE     + T +SDV+SFGVV+ EI T
Sbjct: 204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 28/232 (12%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGR----LNEID---VAVKMLXXXXXXX 604
           +A   H+   D+V      +  LG+G FG V+       L E D   VAVK L       
Sbjct: 3   DACVHHIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA 57
Query: 605 XXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------------ 652
                 E +LL  + H+++    G C E     +++E+M +G+L  +L            
Sbjct: 58  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 117
Query: 653 -SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG 711
             D++   L   + L +A + A G+ YL        VHRD+ + N L+ + L  K+ DFG
Sbjct: 118 GEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFG 174
Query: 712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +S+   +     V         ++ PE     + T +SDV+SFGVV+ EI T
Sbjct: 175 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 28/232 (12%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGR----LNEID---VAVKMLXXXXXXX 604
           +A   H+   D+V      +  LG+G FG V+       L E D   VAVK L       
Sbjct: 9   DACVHHIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA 63
Query: 605 XXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------------ 652
                 E +LL  + H+++    G C E     +++E+M +G+L  +L            
Sbjct: 64  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 123
Query: 653 -SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG 711
             D++   L   + L +A + A G+ YL        VHRD+ + N L+ + L  K+ DFG
Sbjct: 124 GEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFG 180
Query: 712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +S+   +     V         ++ PE     + T +SDV+SFGVV+ EI T
Sbjct: 181 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F R LGKG FG+V   R + +       VAVK L     
Sbjct: 6   DPTQFEERHLK----------FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 55
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI EF+  G+L+EYL    K+ +
Sbjct: 56  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK-HKERI 114
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 115 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 139/294 (47%), Gaps = 40/294 (13%)
Query: 565 KITNNFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-V 618
           ++  + +R +GKG FG VY+G       N I  A+K L                LLMR +
Sbjct: 20  RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 619 HHRNLTSLVG-HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
           +H N+ +L+G     +    ++  +M +G+L +++    +   + ++ +   ++ A+G+E
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP-TVKDLISFGLQVARGME 138
Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS------FATDANTHVSTVVAGT 731
           YL    +   VHRD+ + N +L+E    K+ADFGL++       ++   + H    V  T
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 732 PGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG 790
                 E   + R T KSDV+SFGV++ E++T   P    I+  +  H        +A+G
Sbjct: 196 AL----ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-------FLAQG 244
Query: 791 DIKSIVDPRL-QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
                   RL Q ++  +S+++ ++    C       RPT   +V E+ + ++A
Sbjct: 245 R-------RLPQPEYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVEQIVSA 288

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 131/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL        +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-----HIDY 246
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 301
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 302 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
Query: 840 CLA 842
            +A
Sbjct: 350 IVA 352

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDX 205
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 260
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 261 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308
Query: 840 CLA 842
            +A
Sbjct: 309 IVA 311

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 47/300 (15%)
Query: 569 NFERTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-H 619
           N  + LG+G FG V       ID       VAVKML              E+K+L+ + H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 620 HRNLTSLVGHCDEDNQTAL-IYEFMANGNLQEYL----------SDISKKVLSSQERLRI 668
           H N+ +L+G C +     + I EF   GNL  YL           D+ K  L+ +  +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
           + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D + +V    
Sbjct: 150 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 205
Query: 729 AGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQWV 783
           A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       + 
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------FC 257
Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
             L     +++        D+    +++ +   + C     +QRPT S++V  L   L A
Sbjct: 258 RRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQA 307

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 29/234 (12%)
Query: 548 IDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRL-------NEIDVAVKMLXXX 600
           +D+F    +H+   ++V      +R LG+G FG V+           ++I VAVK L   
Sbjct: 3   MDTF---VQHIKRHNIV-----LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA 54
Query: 601 XXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E +LL  + H ++    G C E +   +++E+M +G+L ++L        
Sbjct: 55  SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAV 114
Query: 660 ----------LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD 709
                     L+  + L IA + A G+ YL        VHRD+ + N L+ E L  K+ D
Sbjct: 115 LMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGD 171
Query: 710 FGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           FG+S+   +     V         ++ PE     + T +SDV+S GVV+ EI T
Sbjct: 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 572 RTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH-C 630
           +T+GKG FG V  G      VAVK +             E  ++ ++ H NL  L+G   
Sbjct: 18  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLA--EASVMTQLRHSNLVQLLGVIV 75
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
           +E     ++ E+MA G+L +YL    + VL     L+ +++  + +EYL        VHR
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 132
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+ + N+L++E   AK++DFGL+K  ++  +T    V      +  PE       + KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREAAFSTKSD 187
Query: 751 VYSFGVVILEI 761
           V+SFG+++ EI
Sbjct: 188 VWSFGILLWEI 198

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 143 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDY 194
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 249
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 250 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 297
Query: 840 CLA 842
            +A
Sbjct: 298 IVA 300

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 147 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDY 198
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 253
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 254 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 301
Query: 840 CLA 842
            +A
Sbjct: 302 IVA 304

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 146 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDY 197
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 252
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 253 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 300
Query: 840 CLA 842
            +A
Sbjct: 301 IVA 303

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDY 190
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 246 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 840 CLA 842
            +A
Sbjct: 294 IVA 296

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDY 205
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 260
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 261 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308
Query: 840 CLA 842
            +A
Sbjct: 309 IVA 311

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDY 205
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 260
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 261 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308
Query: 840 CLA 842
            +A
Sbjct: 309 IVA 311

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       +D         VAVKML                 +M++   H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++ +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             A + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++        H+  
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDY 205
Query: 727 VVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
               T G     ++ PE       T +SDV+SFGV++ EI T    P      EE     
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 260
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              +  L+ +G          + D  +N   +   +   C     +QRPT  Q+V +L  
Sbjct: 261 ---LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308
Query: 840 CLA 842
            +A
Sbjct: 309 IVA 311

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 148
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF--ATDANTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 258
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 259 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 556 RHLSYSDVVKITNNFERTLGKGGFGTVYYGRL-------NEIDVAVKMLXXXXXXXXXXX 608
           +H+   D+V      +R LG+G FG V+           +++ VAVK L           
Sbjct: 10  QHIKRRDIV-----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF 64
Query: 609 XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLS--------------D 654
             E +LL  + H ++    G C + +   +++E+M +G+L ++L                
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 655 ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK 714
            +K  L   + L IA + A G+ YL        VHRD+ + N L+   L  K+ DFG+S+
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
              +     V         ++ PE     + T +SDV+SFGV++ EI T
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 144
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 254
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 255 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 287

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 167
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 277
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 278 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 310

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 168
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 278
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 279 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 311

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 149
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 259
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 260 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 141
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 251
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 252 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 284

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 147
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 257
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 258 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 148
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 258
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 259 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 50/303 (16%)
Query: 569 NFERTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-H 619
           N  + LG+G FG V       ID       VAVKML              E+K+L+ + H
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 620 HRNLTSLVGHCDEDNQTAL-IYEFMANGNLQEYL-------------SDISKKVLSSQER 665
           H N+ +L+G C +     + I EF   GNL  YL              D+ K  L+ +  
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           +  + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D +  V 
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-VR 206
Query: 726 TVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIR 780
              A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE      
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE------ 259
Query: 781 QWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC 840
            +   L     +++        D+    +++ +   + C     +QRPT S++V  L   
Sbjct: 260 -FCRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNL 308
Query: 841 LAA 843
           L A
Sbjct: 309 LQA 311

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 146
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 256
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 257 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G++YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 149
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 259
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 260 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 571 ERTLGKGGFGTVYYGRLN------EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNL 623
           ++ +G G FG VY G L       E+ VA+K L              E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLHN 681
             L G   +     +I E+M NG L ++L   D    VL     LR     A G++YL N
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYLAN 165
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYY 740
                 VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE  
Sbjct: 166 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 741 TSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
           +  + T  SDV+SFG+V+ E++T   +P     N E                 +K+I D 
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----------------MKAINDG 266
Query: 799 -RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
            RL    D  S     +L M C      +RP  + +V  L + + A
Sbjct: 267 FRLPTPMDCPSA--IYQLMMQCWQQERARRPKFADIVSILDKLIRA 310

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 136/299 (45%), Gaps = 49/299 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL------------SDISKKVLSSQERLRIA 669
           + +L+G C +     + I EF   GNL  YL             D+ K  L+ +  +  +
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D +  V    A
Sbjct: 155 FQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-VRKGDA 210
Query: 730 GTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQWVN 784
             P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +  
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------FCR 262
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
            L     +++        D+    +++ +   + C     +QRPT S++V  L   L A
Sbjct: 263 RLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 140/308 (45%), Gaps = 55/308 (17%)
Query: 570 FERTLGKGGFGTVYYGRLNE----IDVAVK-MLXXXXXXXXXXXXXEVKLLMRV-HHRNL 623
           F+  +G+G FG V   R+ +    +D A+K M              E+++L ++ HH N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERLRIA 669
            +L+G C+      L  E+  +GNL ++L              ++ +   LSSQ+ L  A
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            + A+G++YL    +   +HRD+ + NIL+ E   AK+ADFGLS+        +V   + 
Sbjct: 139 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMG 191
Query: 730 GTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT------CKPAISRINEEEKIHIRQW 782
             P  ++  E    +  T  SDV+S+GV++ EI++      C    + + E+        
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-------- 243
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
               + +G        RL++  + +   +  +L   C      +RP+ +Q+++ L+  L 
Sbjct: 244 ----LPQG-------YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290
Query: 843 AEMARANS 850
                 N+
Sbjct: 291 ERKTYVNT 298

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 140/309 (45%), Gaps = 55/309 (17%)
Query: 569 NFERTLGKGGFGTVYYGRLNE----IDVAVK-MLXXXXXXXXXXXXXEVKLLMRV-HHRN 622
            F+  +G+G FG V   R+ +    +D A+K M              E+++L ++ HH N
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERLRI 668
           + +L+G C+      L  E+  +GNL ++L              ++ +   LSSQ+ L  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
           A + A+G++YL    +   +HRD+ + NIL+ E   AK+ADFGLS+        +V   +
Sbjct: 148 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTM 200
Query: 729 AGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT------CKPAISRINEEEKIHIRQ 781
              P  ++  E    +  T  SDV+S+GV++ EI++      C    + + E+       
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------- 253
Query: 782 WVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
                + +G        RL++  + +   +  +L   C      +RP+ +Q+++ L+  L
Sbjct: 254 -----LPQG-------YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRML 299
Query: 842 AAEMARANS 850
                  N+
Sbjct: 300 EERKTYVNT 308

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 97/222 (43%), Gaps = 19/222 (8%)
Query: 550 SFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX-- 605
           + E+K R  +  D         R LGKG FG VY  R  +    +A+K+L          
Sbjct: 2   AMESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 56
Query: 606 -XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
                 EV++   + H N+  L G+  +  +  LI E+   G + + L  +SK     Q 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQR 114
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
                 E A  L Y H+     ++HRD+K  N+LL    + K+ADFG S      A +  
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSR 167
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            T + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 168 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G+++L  
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 154
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 264
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 265 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 297

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G+++L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 150
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 260
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 261 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G+++L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 150
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 260
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 261 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G+++L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 149
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 259
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 260 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G+++L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 149
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 259
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 260 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G+++L  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 147
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 257
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 258 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L                ++M+   H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 623 LTSLVGHCDEDNQTALI-YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           + SL+G C     + L+   +M +G+L+ ++ + +    + ++ +   ++ A+G+++L  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 208
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAGTPGYLDPEY 739
                 VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++  E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
             + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + ++ P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP 318
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS 838
               D          E+ + C  P    RP+ S++V  +S
Sbjct: 319 EYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 351

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 139/323 (43%), Gaps = 49/323 (15%)
Query: 548 IDSFEAKS------RHLSYSDVVKITNN---FERTLGKGGFGTVY----YGRLNE---ID 591
           I+S+E  S        L Y++  +   N   F +TLG G FG V     +G   E   + 
Sbjct: 19  IESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK 78
Query: 592 VAVKMLXXXXXX-XXXXXXXEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQ 649
           VAVKML              E+K++  +  H N+ +L+G C       +I E+   G+L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 650 EYLSD------------ISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTN 696
            +L              I+   LS+++ L  + + AQG+ +L +  C    +HRDV + N
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARN 194
Query: 697 ILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGV 756
           +LL     AK+ DFGL++    D+N  V         ++ PE       T +SDV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 757 VILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELA 816
           ++ EI +       +N    I +      L+  G   +      Q  F   +++  ++  
Sbjct: 255 LLWEIFSLG-----LNPYPGILVNSKFYKLVKDGYQMA------QPAFAPKNIYSIMQ-- 301
Query: 817 MACLSPTGNQRPTMSQVVMELSE 839
            AC +     RPT  Q+   L E
Sbjct: 302 -ACWALEPTHRPTFQQICSFLQE 323

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 131/298 (43%), Gaps = 49/298 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWV 783
                P  ++ PE       T +SDV+SFGV++ EI T    P      EE        +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------L 268
Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
             L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 269 FKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D + +V   
Sbjct: 155 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 210
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 262
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 263 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 312
Query: 843 A 843
           A
Sbjct: 313 A 313

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D + +V   
Sbjct: 190 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 245
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 297
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 298 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 347
Query: 843 A 843
           A
Sbjct: 348 A 348

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           ++ + +   E  LG+G FG V+ G  N    VA+K L             E +++ ++ H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRH 321
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+ 
Sbjct: 322 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
              +   VHRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 381 ---RMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEA 435
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               R T KSDV+SFG+++ E+ T
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTT 459

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D + +V   
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 208
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 260
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 261 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 310
Query: 843 A 843
           A
Sbjct: 311 A 311

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D +  V   
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-VRKG 199
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 251
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 252 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 301
Query: 843 A 843
           A
Sbjct: 302 A 302

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 572 RTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           + LG G FG V+ G  N    VAVK L             E  L+  + H  L  L    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE-EANLMKTLQHDKLVRLYAVV 77
Query: 631 DEDNQTALIYEFMANGNLQEYL-SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
             +    +I E+MA G+L ++L SD   KVL  +  +  + + A+G+ Y+    +   +H
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK-LIDFSAQIAEGMAYIE---RKNYIH 133
Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEK 748
           RD+++ N+L++E L  K+ADFGL++    + N + +   A  P  +  PE       T K
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 749 SDVYSFGVVILEIIT 763
           SDV+SFG+++ EI+T
Sbjct: 192 SDVWSFGILLYEIVT 206

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D + +V   
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 199
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 251
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 252 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 301
Query: 843 A 843
           A
Sbjct: 302 A 302

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 572 RTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           + LG G FG V+ G  N    VAVK L             E  L+  + H  L  L    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE-EANLMKTLQHDKLVRLYAVV 76
Query: 631 DEDNQTALIYEFMANGNLQEYL-SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
            ++    +I EFMA G+L ++L SD   KVL  +  +  + + A+G+ Y+    +   +H
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPK-LIDFSAQIAEGMAYIE---RKNYIH 132
Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEK 748
           RD+++ N+L++E L  K+ADFGL++    + N + +   A  P  +  PE       T K
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 749 SDVYSFGVVILEIIT 763
           S+V+SFG+++ EI+T
Sbjct: 191 SNVWSFGILLYEIVT 205

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D + +V   
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 199
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 251
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 252 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 301
Query: 843 A 843
           A
Sbjct: 302 A 302

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
             E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLY 245
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+    +   
Sbjct: 246 AVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           VHRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 747 EKSDVYSFGVVILEIIT 763
            KSDV+SFG+++ E+ T
Sbjct: 360 IKSDVWSFGILLTELTT 376

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D +  V   
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-VRKG 208
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 260
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 261 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 310
Query: 843 A 843
           A
Sbjct: 311 A 311

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
             E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLY 245
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+    +   
Sbjct: 246 AVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           VHRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 747 EKSDVYSFGVVILEIIT 763
            KSDV+SFG+++ E+ T
Sbjct: 360 IKSDVWSFGILLTELTT 376

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + + +T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKNT 216
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 269
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 270 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D +  V   
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-VRKG 199
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 251
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 252 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 301
Query: 843 A 843
           A
Sbjct: 302 A 302

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           ++ + +   E  LG+G FG V+ G  N    VA+K L             E +++ ++ H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKIRH 72
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+ 
Sbjct: 73  EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
              +   VHRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 132 ---RMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               R T KSDV+SFG+++ E+ T
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 131/298 (43%), Gaps = 49/298 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWV 783
                P  ++ PE       T +SDV+SFGV++ EI T    P      EE        +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------L 268
Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
             L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 269 FKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
             E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLY 245
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+    +   
Sbjct: 246 AVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           VHRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 747 EKSDVYSFGVVILEIIT 763
            KSDV+SFG+++ E+ T
Sbjct: 360 IKSDVWSFGILLTELTT 376

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 51/301 (16%)
Query: 572 RTLGKGGFGTVYYGRLNEID-------VAVKMLXX-XXXXXXXXXXXEVKLLMRV-HHRN 622
           + LG+G FG V       ID       VAVKML              E+K+L+ + HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 623 LTSLVGHCDEDNQTAL-IYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           + +L+G C +     + I EF   GNL  YL               D+ K  L+ +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D +  V   
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX-VRKG 208
Query: 728 VAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQW 782
            A  P  ++ PE       T +SDV+SFGV++ EI +      P + +I+EE       +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE-------F 260
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
              L     +++        D+    +++ +   + C     +QRPT S++V  L   L 
Sbjct: 261 CRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 310
Query: 843 A 843
           A
Sbjct: 311 A 311

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/325 (26%), Positives = 140/325 (43%), Gaps = 51/325 (15%)
Query: 548 IDSFEAKS------RHLSYSDVVKITNN---FERTLGKGGFGTVY----YGRLNE---ID 591
           I+S+E  S        L Y++  +   N   F +TLG G FG V     +G   E   + 
Sbjct: 19  IESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK 78
Query: 592 VAVKMLXXXXXX-XXXXXXXEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQ 649
           VAVKML              E+K++  +  H N+ +L+G C       +I E+   G+L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 650 EYL--------------SDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKS 694
            +L              S   ++ LSS++ L  + + AQG+ +L +  C    +HRDV +
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRDVAA 194
Query: 695 TNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSF 754
            N+LL     AK+ DFGL++    D+N  V         ++ PE       T +SDV+S+
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 254
Query: 755 GVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVE 814
           G+++ EI +       +N    I +      L+  G   +      Q  F   +++  ++
Sbjct: 255 GILLWEIFSLG-----LNPYPGILVNSKFYKLVKDGYQMA------QPAFAPKNIYSIMQ 303
Query: 815 LAMACLSPTGNQRPTMSQVVMELSE 839
              AC +     RPT  Q+   L E
Sbjct: 304 ---ACWALEPTHRPTFQQICSFLQE 325

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 140/308 (45%), Gaps = 55/308 (17%)
Query: 570 FERTLGKGGFGTVYYGRLNE----IDVAVK-MLXXXXXXXXXXXXXEVKLLMRV-HHRNL 623
           F+  +G+G FG V   R+ +    +D A+K M              E+++L ++ HH N+
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERLRIA 669
            +L+G C+      L  E+  +GNL ++L              ++ +   LSSQ+ L  A
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            + A+G++YL    +   +HR++ + NIL+ E   AK+ADFGLS+        +V   + 
Sbjct: 146 ADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMG 198
Query: 730 GTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT------CKPAISRINEEEKIHIRQW 782
             P  ++  E    +  T  SDV+S+GV++ EI++      C    + + E+        
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-------- 250
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
               + +G        RL++  + +   +  +L   C      +RP+ +Q+++ L+  L 
Sbjct: 251 ----LPQG-------YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 297
Query: 843 AEMARANS 850
                 N+
Sbjct: 298 ERKTYVNT 305

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 111/235 (47%), Gaps = 26/235 (11%)
Query: 538 GKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------ 591
           G V R S N +  FE   RHL           F + LGKG FG+V   R + +       
Sbjct: 13  GLVPRGSHN-MTQFE--ERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEV 59
Query: 592 VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQ 649
           VAVK L             E+++L  + H N+    G C    +    LI E++  G+L+
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD 709
           +YL    K+ +   + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ D
Sbjct: 120 DYLQK-HKERIDHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGD 175
Query: 710 FGLSKSFATDANTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           FGL+K    D           +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 176 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 2   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 51
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 52  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 110
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 111 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 167
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 168 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 96/222 (43%), Gaps = 19/222 (8%)
Query: 550 SFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX-- 605
           + E+K R  +  D         R LGKG FG VY  R  +    +A+K+L          
Sbjct: 2   AMESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 56
Query: 606 -XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
                 EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQR 114
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
                 E A  L Y H+     ++HRD+K  N+LL    + K+ADFG S      A +  
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSR 167
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            T + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 168 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 165 DMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 111/235 (47%), Gaps = 26/235 (11%)
Query: 538 GKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------ 591
           G V R S N +  FE   RHL           F + LGKG FG+V   R + +       
Sbjct: 13  GLVPRGSHN-MTQFE--ERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEV 59
Query: 592 VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQ 649
           VAVK L             E+++L  + H N+    G C    +    LI E++  G+L+
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD 709
           +YL    K+ +   + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ D
Sbjct: 120 DYLQK-HKERIDHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGD 175
Query: 710 FGLSKSFATDANTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           FGL+K    D           +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 176 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++          +T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVN 784
                  ++ PE       T +SDV+SFGV++ EI T    P      EE        + 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LF 269
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 270 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 1   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 50
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 51  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 109
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 110 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 166
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 3   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 52
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 53  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 111
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 112 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 34  DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 83
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 84  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 142
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 143 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 200 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 100/229 (43%), Gaps = 19/229 (8%)
Query: 543 ESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXX 600
           E  +K  + E+K R  +  D         R LGKG FG VY  R  +    +A+K+L   
Sbjct: 16  ELASKQKNEESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA 70
Query: 601 XXXXX---XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK 657
                        EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK
Sbjct: 71  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 130
Query: 658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
                Q       E A  L Y H+     ++HRD+K  N+LL    + K+ADFG    ++
Sbjct: 131 --FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG----WS 181
Query: 718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
             A +   T + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 182 VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++          +T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVN 784
                  ++ PE       T +SDV+SFGV++ EI T    P      EE        + 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LF 269
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 270 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 140/319 (43%), Gaps = 45/319 (14%)
Query: 548 IDSFEAKS------RHLSYSDVVKITNN---FERTLGKGGFGTVY----YGRLNE---ID 591
           I+S+E  S        L Y++  +   N   F +TLG G FG V     +G   E   + 
Sbjct: 11  IESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK 70
Query: 592 VAVKMLXXXXXX-XXXXXXXEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQ 649
           VAVKML              E+K++  +  H N+ +L+G C       +I E+   G+L 
Sbjct: 71  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 130
Query: 650 EYL-----SDISK---KVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLN 700
            +L     +D+ K   + L  ++ L  + + AQG+ +L +  C    +HRDV + N+LL 
Sbjct: 131 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLT 186
Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE 760
               AK+ DFGL++    D+N  V         ++ PE       T +SDV+S+G+++ E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 761 IITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACL 820
           I +       +N    I +      L+  G   +      Q  F   +++  ++   AC 
Sbjct: 247 IFSLG-----LNPYPGILVNSKFYKLVKDGYQMA------QPAFAPKNIYSIMQ---ACW 292
Query: 821 SPTGNQRPTMSQVVMELSE 839
           +     RPT  Q+   L E
Sbjct: 293 ALEPTHRPTFQQICSFLQE 311

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 7   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 56
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 57  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 115
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 116 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 172
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 173 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 131/297 (44%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+  L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 269
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 270 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 3   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 52
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 53  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 111
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 112 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 6   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 55
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 56  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 114
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 115 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           ++ + +   E  LG+G FG V+ G  N    VA+K L             E +++ ++ H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRH 72
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+ 
Sbjct: 73  EKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
              +   VHRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 132 ---RMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               R T KSDV+SFG+++ E+ T
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 10  DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 59
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 60  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 118
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 119 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 175
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 176 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 133/317 (41%), Gaps = 46/317 (14%)
Query: 538 GKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLN-----EIDV 592
           G V R S   +  F   ++ L  +++     + ++ +G G FG V  GRL      EI V
Sbjct: 13  GLVPRGSTQTVHEF---AKELDATNI-----SIDKVVGAGEFGEVCSGRLKLPSKKEISV 64
Query: 593 AVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEY 651
           A+K L              E  ++ +  H N+  L G   +     ++ E+M NG+L  +
Sbjct: 65  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 124
Query: 652 LS--DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD 709
           L   D    V+     LR     A G++YL +      VHRD+ + NIL+N  L  K++D
Sbjct: 125 LRKHDAQFTVIQLVGMLR---GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSD 178
Query: 710 FGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KP 766
           FGLS+    D     +T     P  +  PE     + T  SDV+S+G+V+ E+++   +P
Sbjct: 179 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238
Query: 767 AISRINEEEKIHIRQWVNSLIAKGDIKSIVDP--RLQEDFDANSVWKAVELAMACLSPTG 824
                N+                 D+   VD   RL    D  +     +L + C     
Sbjct: 239 YWEMSNQ-----------------DVIKAVDEGYRLPPPMDCPAA--LYQLMLDCWQKDR 279
Query: 825 NQRPTMSQVVMELSECL 841
           N RP   Q+V  L + +
Sbjct: 280 NNRPKFEQIVSILDKLI 296

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 123/285 (43%), Gaps = 36/285 (12%)
Query: 570 FERTLGKGGFGTVYYGRLN-----EIDVAVKMLXX-XXXXXXXXXXXEVKLLMRVHHRNL 623
            E+ +G G FG V  G L      EI VA+K L              E  ++ +  H N+
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLHN 681
             L G   +     +I EFM NG+L  +L  +D    V+     LR     A G++YL +
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLAD 153
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN--THVSTVVAGTP-GYLDPE 738
                 VHRD+ + NIL+N  L  K++DFGLS+    D +  T+ S +    P  +  PE
Sbjct: 154 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 739 YYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIV 796
                + T  SDV+S+G+V+ E+++   +P     N++    I Q               
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--------------- 255
Query: 797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
           D RL    D  S     +L + C     N RP   Q+V  L + +
Sbjct: 256 DYRLPPPMDCPSALH--QLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 8   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 57
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 58  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 116
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 117 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 173
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 174 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 73
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 74  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 133 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 187
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 77
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 78  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 136
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 137 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 191
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 9   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 58
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 59  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 117
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 118 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 174
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 175 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 150 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 205
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 258
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 259 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 135
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 136 D---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 235
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 236 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 140/319 (43%), Gaps = 45/319 (14%)
Query: 548 IDSFEAKS------RHLSYSDVVKITNN---FERTLGKGGFGTVY----YGRLNE---ID 591
           I+S+E  S        L Y++  +   N   F +TLG G FG V     +G   E   + 
Sbjct: 19  IESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK 78
Query: 592 VAVKMLXXXXXX-XXXXXXXEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQ 649
           VAVKML              E+K++  +  H N+ +L+G C       +I E+   G+L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 650 EYL-----SDISK---KVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLN 700
            +L     +D+ K   + L  ++ L  + + AQG+ +L +  C    +HRDV + N+LL 
Sbjct: 139 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLT 194
Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILE 760
               AK+ DFGL++    D+N  V         ++ PE       T +SDV+S+G+++ E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 761 IITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACL 820
           I +       +N    I +      L+  G   +      Q  F   +++  ++   AC 
Sbjct: 255 IFSLG-----LNPYPGILVNSKFYKLVKDGYQMA------QPAFAPKNIYSIMQ---ACW 300
Query: 821 SPTGNQRPTMSQVVMELSE 839
           +     RPT  Q+   L E
Sbjct: 301 ALEPTHRPTFQQICSFLQE 319

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 72
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 73  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 131
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 132 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 186
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 95/221 (42%), Gaps = 19/221 (8%)
Query: 551 FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX--- 605
            E+K R  +  D         R LGKG FG VY  R  +    +A+K+L           
Sbjct: 1   MESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
                EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRT 113
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
                E A  L Y H+     ++HRD+K  N+LL    + K+ADFG S      A +   
Sbjct: 114 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 166
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           T + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 51/299 (17%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 667 RIAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
               + A+G+EYL    C    +HRD+ + N+L+ E    K+ADFGL++    + + +  
Sbjct: 207 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 261
Query: 726 TVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQW 782
           T     P  ++ PE       T +SDV+SFGV++ EI T    P      EE        
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------- 313
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
           +  L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 314 LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 148 SCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 203
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 256
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 257 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    ++ADFGL++    + + +  T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDI-NNIDYYKKT 216
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 269
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 270 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 68  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 181
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++ +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 153 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 208
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 261
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 262 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 3   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 52
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 53  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 111
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 112 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 15  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 73
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+    +   V
Sbjct: 74  VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 188 KSDVWSFGILLTELTT 203

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 46  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 105
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 106 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 162
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 163 DMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 219
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 220 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 262
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 263 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---X 606
           E+K R  +  D         R LGKG FG VY  R  +    +A+K+L            
Sbjct: 4   ESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 58
Query: 607 XXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL 666
               EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q   
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTA 116
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               E A  L Y H+     ++HRD+K  N+LL    + K+ADFG S      A +   T
Sbjct: 117 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRT 169
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 170 TLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 98/222 (44%), Gaps = 23/222 (10%)
Query: 552 EAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXX-- 605
           E+K R  +  D       FE  R LGKG FG VY  R  +    +A+K+L          
Sbjct: 16  ESKKRQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 68
Query: 606 -XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
                 EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q 
Sbjct: 69  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQR 126
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
                 E A  L Y H+     ++HRD+K  N+LL    + K+ADFG    ++  A +  
Sbjct: 127 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSR 179
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            T + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 180 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 221

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 126
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG    ++  A +   T ++GT  YL PE  
Sbjct: 127 SK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPPEMI 179
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 6   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 55
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL   ++++ 
Sbjct: 56  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI- 114
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HRD+ + NIL+  + + K+ DFGL+K    D 
Sbjct: 115 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                     +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 19/222 (8%)
Query: 550 SFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX-- 605
           + E+K R  +  D         R LGKG FG VY  R  +    +A+K+L          
Sbjct: 2   AMESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 56
Query: 606 -XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
                 EV++   + H N+  L G+  +  +  LI E+   G + + L  +SK     Q 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQR 114
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
                 E A  L Y H+     ++HRD+K  N+LL    + K+ADFG S      A +  
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSR 167
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
              + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 168 RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 95/221 (42%), Gaps = 19/221 (8%)
Query: 551 FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX--- 605
            E+K R  +  D         R LGKG FG VY  R  +    +A+K+L           
Sbjct: 1   MESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
                EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRT 113
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
                E A  L Y H+     ++HRD+K  N+LL    + K+ADFG S      A +   
Sbjct: 114 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 166
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           T + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 49/323 (15%)
Query: 548 IDSFEAKS------RHLSYSDVVKITNN---FERTLGKGGFGTVY----YGRLNE---ID 591
           I+S+E  S        L Y++  +   N   F +TLG G FG V     +G   E   + 
Sbjct: 19  IESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK 78
Query: 592 VAVKMLXXXXXX-XXXXXXXEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQ 649
           VAVKML              E+K++  +  H N+ +L+G C       +I E+   G+L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 650 EYLSD------------ISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTN 696
            +L              I+    S+++ L  + + AQG+ +L +  C    +HRDV + N
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARN 194
Query: 697 ILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGV 756
           +LL     AK+ DFGL++    D+N  V         ++ PE       T +SDV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 757 VILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELA 816
           ++ EI +       +N    I +      L+  G   +      Q  F   +++  ++  
Sbjct: 255 LLWEIFSLG-----LNPYPGILVNSKFYKLVKDGYQMA------QPAFAPKNIYSIMQ-- 301
Query: 817 MACLSPTGNQRPTMSQVVMELSE 839
            AC +     RPT  Q+   L E
Sbjct: 302 -ACWALEPTHRPTFQQICSFLQE 323

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 75
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 76  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 134
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 135 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 189
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 126 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI 178
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 71
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 129
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 130 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI 182
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGKP 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 76
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 77  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 135
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 136 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 190
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVT 214

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 124
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 125 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI 177
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 178 EGRMHDEKVDLWSLGVLCYEFLVGKP 203

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLTSLVGHC 630
           +G+G FG V+ GRL   +  VAVK                E ++L +  H N+  L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +     ++ E +  G+   +L     + L  +  L++  ++A G+EYL + C    +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+ + N L+ EK   K++DFG+S+  A         +      +  PE     R + +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 751 VYSFGVVILEIIT--CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           V+SFG+++ E  +    P  +  N++ +          + KG    +  P L  D    +
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQTR--------EFVEKGG--RLPCPELCPD----A 343
Query: 809 VWKAVELAMACLSPTGNQRPTMSQVVMEL 837
           V++ +E    C +    QRP+ S +  EL
Sbjct: 344 VFRLME---QCWAYEPGQRPSFSTIYQEL 369

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
             E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L 
Sbjct: 188 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQ-EAQVMKKLRHEKLVQLY 246
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+    +   
Sbjct: 247 AVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 302
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           VHRD+++ NIL+ E L  K+ADFGL +    + N + +   A  P  +  PE     R T
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 747 EKSDVYSFGVVILEIIT 763
            KSDV+SFG+++ E+ T
Sbjct: 361 IKSDVWSFGILLTELTT 377

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           ++ + +   E  LG+G FG V+ G  N    VA+K L             E +++ ++ H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRH 72
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+ 
Sbjct: 73  EKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
              +   VHRD+++ NIL+ E L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 132 ---RMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEA 186
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               R T KSDV+SFG+++ E+ T
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 73
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 74  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 133 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 187
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 62
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 63  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 121
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 122 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 176
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVT 200

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 12  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 70
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+    +   V
Sbjct: 71  VVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N   +   A  P  +  PE     R T 
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 185 KSDVWSFGILLTELTT 200

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 126 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTXLCGTLDYLPPEMI 178
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 68  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 181
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 122
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 123 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI 175
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 176 EGRMHDEKVDLWSLGVLCYEFLVGKP 201

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLTSLVGHC 630
           +G+G FG V+ GRL   +  VAVK                E ++L +  H N+  L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +     ++ E +  G+   +L     + L  +  L++  ++A G+EYL + C    +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+ + N L+ EK   K++DFG+S+  A         +      +  PE     R + +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 751 VYSFGVVILEIIT--CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           V+SFG+++ E  +    P  +  N++ +          + KG    +  P L  D    +
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQTR--------EFVEKGG--RLPCPELCPD----A 343
Query: 809 VWKAVELAMACLSPTGNQRPTMSQVVMEL 837
           V++ +E    C +    QRP+ S +  EL
Sbjct: 344 VFRLME---QCWAYEPGQRPSFSTIYQEL 369

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 572 RTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           + LG G FG V  G+   + DVAVKM+             E + +M++ H  L    G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLSHPKLVKFYGVC 72
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            ++    ++ E+++NG L  YL    K +  SQ  L +  +  +G+ +L +      +HR
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ-LLEMCYDVCEGMAFLESH---QFIHR 128
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKS 749
           D+ + N L++  L  K++DFG+++    D   +VS+V    P  +  PE +   + + KS
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 750 DVYSFGVVILEIIT 763
           DV++FG+++ E+ +
Sbjct: 187 DVWAFGILMWEVFS 200

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 69
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 70  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 128
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 129 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 183
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVT 207

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 23/224 (10%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXX 602
           D  + + RHL           F + LGKG FG+V   R + +       VAVK L     
Sbjct: 4   DPTQFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 53
Query: 603 XXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQT--ALIYEFMANGNLQEYLSDISKKVL 660
                   E+++L  + H N+    G C    +    LI E++  G+L++YL    K+ +
Sbjct: 54  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 112
Query: 661 SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA 720
              + L+   +  +G+EYL  G K   +HR++ + NIL+  + + K+ DFGL+K    D 
Sbjct: 113 DHIKLLQYTSQICKGMEYL--GTKR-YIHRNLATRNILVENENRVKIGDFGLTKVLPQDK 169
Query: 721 NTHVSTVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             +       +P +   PE  T ++ +  SDV+SFGVV+ E+ T
Sbjct: 170 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGL++    D     +T     P  +  PE 
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 68  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 181
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 126 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTELCGTLDYLPPEMI 178
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 68
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 69  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 127
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+++ NIL+++ L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 128 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 182
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I  + + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 269
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 270 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 11  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 69
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+    +   V
Sbjct: 70  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 184 KSDVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 13  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+    +   V
Sbjct: 72  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 186 KSDVWSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 80
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+    +   V
Sbjct: 81  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           ++ + +   E  LG+G FG V+ G  N    VA+K L             E +++ ++ H
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRH 69
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     E+    ++ E+M  G+L ++L   + K L   + + ++ + A G+ Y+ 
Sbjct: 70  EKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
              +   VHRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 129 ---RMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEA 183
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               R T KSDV+SFG+++ E+ T
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 126
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 127 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI 179
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 165 DMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E+M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGL +    D     +T     P  +  PE 
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 80
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+    +   V
Sbjct: 81  VVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRL--NEIDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R   ++  +A+K+L                EV++   + H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 68  PNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +     + GT  YL PE  
Sbjct: 126 SK---KVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEMI 178
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 135
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 136 D---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 235
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 236 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 130
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 131 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI 183
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 126 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI 178
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE  
Sbjct: 126 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI 178
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + ++ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     ++ E M NG+L  +L   D    V+     LR     A G++YL 
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS 164
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 740 YTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
               + T  SDV+S+G+V+ E+++   +P     N+                 D+   VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVD 264
Query: 798 P--RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              RL    D  +     +L + C     N RP   Q+V  L + +
Sbjct: 265 EGYRLPPPMDCPAA--LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 47/297 (15%)
Query: 572 RTLGKGGFGTVYYGRLNEID---------VAVKMLXXXXXXXXXXXXXEVKLLMRV--HH 620
           + LG+G FG V       ID         VAVKML                 +M++   H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERL 666
           +N+ +L+G C +D    +I  + + GNL+EYL              + + ++ ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               + A+G+EYL +      +HRD+ + N+L+ E    K+ADFGL++    + + +  T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 727 VVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVN 784
                P  ++ PE       T +SDV+SFGV++ EI T   +    I  EE       + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF 269
Query: 785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            L+ +G          + D  AN   +   +   C     +QRPT  Q+V +L   L
Sbjct: 270 KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 572 RTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           + LG G FG V+ G  N    VA+K L             E +++ ++ H  L  L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLE-EAQIMKKLKHDKLVQLYAVV 73
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            E+    ++ E+M  G+L ++L D   + L     + +A + A G+ Y+    +   +HR
Sbjct: 74  SEE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKS 749
           D++S NIL+   L  K+ADFGL++    + N   +   A  P  +  PE     R T KS
Sbjct: 130 DLRSANILVGNGLICKIADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 750 DVYSFGVVILEIIT 763
           DV+SFG+++ E++T
Sbjct: 188 DVWSFGILLTELVT 201

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 19/221 (8%)
Query: 551 FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX--- 605
            E+K R  +  D         R LGKG FG VY  R  +    +A+K+L           
Sbjct: 1   MESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
                EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRT 113
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
                E A  L Y H+     ++HRD+K  N+LL    + K+A+FG S      A +   
Sbjct: 114 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRR 166
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           T + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---X 606
           E+K R  +  D         R LGKG FG VY  R  +    +A+K+L            
Sbjct: 1   ESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 55
Query: 607 XXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL 666
               EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q   
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTA 113
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               E A  L Y H+     ++HRD+K  N+LL    + K+A+FG S      A +   T
Sbjct: 114 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRT 166
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 167 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 128
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +     + GT  YL PE  
Sbjct: 129 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEMI 181
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +     + GT  YL PE  
Sbjct: 126 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEMI 178
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           ++ + +   E  LG+G FG V+ G  N    VA+K L             E +++ ++ H
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRH 69
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     E+    ++ E+M  G+L ++L   + K L   + + ++ + A G+ Y+ 
Sbjct: 70  EKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
              +   VHRD+++ NIL+ E L  K+ADFGL++    + N   +   A  P  +  PE 
Sbjct: 129 ---RMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEWTARQGAKFPIKWTAPEA 183
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               R T KSDV+SFG+++ E+ T
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 19/220 (8%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---X 606
           E+K R  +  D         R LGKG FG VY  R  +    +A+K+L            
Sbjct: 1   ESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 55
Query: 607 XXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL 666
               EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q   
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTA 113
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               E A  L Y H+     ++HRD+K  N+LL    + K+ADFG S      A +    
Sbjct: 114 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRX 166
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 167 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 570 FERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNL 623
            ER +G G FG V  GRL      E+ VA+K L              E  ++ +  H N+
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 85
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLHN 681
             L G   +     ++ E+M NG+L  +L  +D    V+     LR     + G++YL +
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GISAGMKYLSD 142
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYY 740
                 VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE  
Sbjct: 143 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 741 TSNRLTEKSDVYSFGVVILEIIT 763
              + T  SDV+S+G+V+ E+++
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 11/198 (5%)
Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHHRNLTSLVG 628
           LGKG F  VY        ++VA+KM+                EVK+  ++ H ++  L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
           + ++ N   L+ E   NG +  YL +   K  S  E      +   G+ YLH+     I+
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH---GIL 134
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+  +N+LL   +  K+ADFGL+         H +  + GTP Y+ PE  T +    +
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLE 192
Query: 749 SDVYSFGVVILEIITCKP 766
           SDV+S G +   ++  +P
Sbjct: 193 SDVWSLGCMFYTLLIGRP 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 80
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G L ++L     K L   + + +A + A G+ Y+    +   V
Sbjct: 81  VVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 80
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L     K L   + + +A + A G+ Y+    +   V
Sbjct: 81  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+ + NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 126
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +     + GT  YL PE  
Sbjct: 127 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRDTLCGTLDYLPPEMI 179
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 19/221 (8%)
Query: 551 FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX--- 605
            E+K R  +  D         R LGKG FG VY  R  +    +A+K+L           
Sbjct: 1   MESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
                EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRT 113
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
                E A  L Y H+     ++HRD+K  N+LL    + K+ADFG S      A +   
Sbjct: 114 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 166
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
             + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 167 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 27/264 (10%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKML-XXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +GKG FG V+ G  N     VA+K++              E+ +L +     +T   G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +D +  +I E++  G+  + L       L   +   I  E  +GL+YLH+  K   +HR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKK---IHR 128
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+K+ N+LL+E  + KLADFG++    TD     +T V GTP ++ PE    +    K+D
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 186
Query: 751 VYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVW 810
           ++S G+  +E+   +P  S ++  +       V  LI K +      P L+ ++      
Sbjct: 187 IWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNN-----PPTLEGNYSK---- 230
Query: 811 KAVELAMACLSPTGNQRPTMSQVV 834
              E   ACL+   + RPT  +++
Sbjct: 231 PLKEFVEACLNKEPSFRPTAKELL 254

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 27/264 (10%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKML-XXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +GKG FG V+ G  N     VA+K++              E+ +L +     +T   G  
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +D +  +I E++  G+  + L       L   +   I  E  +GL+YLH+  K   +HR
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKK---IHR 148
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+K+ N+LL+E  + KLADFG++    TD     +T V GTP ++ PE    +    K+D
Sbjct: 149 DIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 206
Query: 751 VYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVW 810
           ++S G+  +E+   +P  S ++  +       V  LI K +  ++         + N   
Sbjct: 207 IWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNPPTL---------EGNYSK 250
Query: 811 KAVELAMACLSPTGNQRPTMSQVV 834
              E   ACL+   + RPT  +++
Sbjct: 251 PLKEFVEACLNKEPSFRPTAKELL 274

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L             E +++ ++ H  L  L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 80
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G L ++L     K L   + + +A + A G+ Y+    +   V
Sbjct: 81  VVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+++ NIL+ E L  K+ADFGL++    + N + +   A  P  +  PE     R T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 748 KSDVYSFGVVILEIIT 763
           KSDV+SFG+++ E+ T
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G FG V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 63
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 64  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 122
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HR++++ NIL+++ L  K+ADFGL++    + N + +   A  P  +  PE 
Sbjct: 123 ERN---YIHRNLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 177
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 T KSDV+SFG+++ EI+T
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVT 201

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 16/274 (5%)
Query: 574 LGKGGFGTVYYGRLNEID------VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           LGKG FG+V   R + +       VAVK L             E+++L  +H   +    
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 628 G--HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           G  +        L+ E++ +G L+++L    +  L +   L  + +  +G+EYL +    
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR--- 133
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             VHRD+ + NIL+  +   K+ADFGL+K    D + +V      +P  +  PE  + N 
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 745 LTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED 803
            + +SDV+SFGVV+ E+ T C  + S   E  ++   +     +++         RL   
Sbjct: 194 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAP 253
Query: 804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
               +  +  EL   C +P+   RP+ S +  +L
Sbjct: 254 PACPA--EVHELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +     + GT  YL PE  
Sbjct: 126 SK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEMI 178
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 570 FERTLGKGGFGTVY----YGRLN---EIDVAVKMLXXXX-XXXXXXXXXEVKLLMRV-HH 620
           F + LG G FG V     YG       I VAVKML              E+K++ ++  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK---------------------V 659
            N+ +L+G C       LI+E+   G+L  YL    +K                     V
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 660 LSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT 718
           L+ ++ L  A + A+G+E+L    C    VHRD+ + N+L+      K+ DFGL++   +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           D+N  V         ++ PE       T KSDV+S+G+++ EI +
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 36/285 (12%)
Query: 570 FERTLGKGGFGTVYYGRLN-----EIDVAVKMLXX-XXXXXXXXXXXEVKLLMRVHHRNL 623
            E+ +G G FG V  G L      EI VA+K L              E  ++ +  H N+
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLHN 681
             L G   +     +I EFM NG+L  +L  +D    V+     LR     A G++YL +
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLAD 127
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN--THVSTVVAGTP-GYLDPE 738
                 VHR + + NIL+N  L  K++DFGLS+    D +  T+ S +    P  +  PE
Sbjct: 128 M---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 739 YYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIV 796
                + T  SDV+S+G+V+ E+++   +P     N++    I Q               
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--------------- 229
Query: 797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
           D RL    D  S     +L + C     N RP   Q+V  L + +
Sbjct: 230 DYRLPPPMDCPSALH--QLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 128/294 (43%), Gaps = 26/294 (8%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXXXXXXX 607
           + RHL Y             LGKG FG+V   R + +       VAVK L          
Sbjct: 9   EERHLKYIS----------QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 58
Query: 608 XXXEVKLLMRVHHRNLTSLVG--HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
              E+++L  +H   +    G  +        L+ E++ +G L+++L    +  L +   
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRL 117
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           L  + +  +G+EYL +      VHRD+ + NIL+  +   K+ADFGL+K    D + +V 
Sbjct: 118 LLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 174
Query: 726 TVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWV 783
                +P  +  PE  + N  + +SDV+SFGVV+ E+ T C  + S   E  ++   +  
Sbjct: 175 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 234
Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
              + +         RL       +  +  EL   C +P+   RP+ S +  +L
Sbjct: 235 VPALCRLLELLEEGQRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQL 286

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 7/203 (3%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-EIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           +V + T      LG G  G V+ G  N    VAVK L             E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQH 67
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           + L  L     ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++ 
Sbjct: 68  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                  +HRD+++ NIL+++ L  K+ADFGL++    DA             +  PE  
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAI 182
Query: 741 TSNRLTEKSDVYSFGVVILEIIT 763
                T KSDV+SFG+++ EI+T
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXX---X 606
           E+K R  +  D         R LGKG FG VY  R  +    +A+K+L            
Sbjct: 25  ESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 79
Query: 607 XXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL 666
               EV++   + H N+  L G+  +  +  LI E+   G +   L  +SK     Q   
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTA 137
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
               E A  L Y H+     ++HRD+K  N+LL    + K+ADFG    ++  A +    
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRD 190
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            + GT  YL PE        EK D++S GV+  E +  KP
Sbjct: 191 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 573 TLGKGGFG---TVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
            LGKG FG    V +    E+ + +K L             EVK++  + H N+   +G 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEV-MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
             +D +   I E++  G L+  +  +  +   SQ R+  A + A G+ YLH+     I+H
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ-RVSFAKDIASGMAYLHSM---NIIH 131
Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV-------------VAGTPGYLD 736
           RD+ S N L+ E     +ADFGL++    D  T    +             V G P ++ 
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLAR-LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 737 PEYYTSNRLTEKSDVYSFGVVILEII 762
           PE        EK DV+SFG+V+ EII
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 129/294 (43%), Gaps = 26/294 (8%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXXXXXXX 607
           + RHL Y             LGKG FG+V   R + +       VAVK L          
Sbjct: 21  EERHLKYIS----------QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 608 XXXEVKLLMRVHHRNLTSLVG--HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
              E+++L  +H   +    G  +        L+ E++ +G L+++L    +  L +   
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRL 129
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           L  + +  +G+EYL +      VHRD+ + NIL+  +   K+ADFGL+K    D + +V 
Sbjct: 130 LLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 726 TVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWV 783
                +P  +  PE  + N  + +SDV+SFGVV+ E+ T C  + S   E  ++   +  
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
              +++         RL       +  +  EL   C +P+   RP+ S +  +L
Sbjct: 247 VPALSRLLELLEEGQRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQL 298

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
             ER +G G FG V  GRL      ++ VA+K L              E  ++ +  H N
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G         ++ EFM NG L  +L   D    V+     LR     A G+ YL 
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYLA 162
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFGLS+    D     +T     P  +  PE 
Sbjct: 163 DMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               + T  SDV+S+G+V+ E+++
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 35/223 (15%)
Query: 572 RTLGKGGFGTV-------YYGRLNEIDVAVKMLXX-XXXXXXXXXXXEVKLLMRVHHRNL 623
           +TLG+G FG V         GR     VAVKML              E  +L +V+H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK----------------------KVLS 661
             L G C +D    LI E+   G+L+ +L +  K                      + L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 662 SQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN 721
             + +  A + +QG++YL    +  +VHRD+ + NIL+ E  + K++DFGLS+    + +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-VYEED 204
Query: 722 THVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           ++V       P  ++  E    +  T +SDV+SFGV++ EI+T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
            +FE  R LGKG FG VY  R  +    +A+K+L                EV++   + H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 128
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     ++HRD+K  N+LL    + K+ADFG S      A +     + GT  YL PE  
Sbjct: 129 SKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRDDLCGTLDYLPPEMI 181
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
             E+ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 91
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     +I E+M NG+L  +L  +D    V+     LR       G++YL 
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLS 148
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFG+S+    D     +T     P  +  PE 
Sbjct: 149 DMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               + T  SDV+S+G+V+ E+++
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXX---XXXEVKLLMRVHHRNLTSL 626
           R +G G FG VY+ R   N   VA+K +                EV+ L ++ H N    
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G    ++   L+ E+   G+  + L ++ KK L   E   +   + QGL YLH+     
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 174
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS---N 743
           ++HRDVK+ NILL+E    KL DFG S S    AN  V     GTP ++ PE   +    
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFV-----GTPYWMAPEVILAMDEG 228
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQ 781
           +   K DV+S G+  +E+   KP +  +N    + HI Q
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 17/232 (7%)
Query: 548 IDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDV--AVKMLXXXXXXXX 605
           +  +E  +R L+  D  +I       LG G FG VY  +  E  V  A K++        
Sbjct: 23  MKQYEHVTRDLNPEDFWEIIGE----LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL 78
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
                E+ +L    H N+  L+     +N   ++ EF A G +   + ++ + +  SQ +
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ 138
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           + +  ++   L YLH+     I+HRD+K+ NIL       KLADFG+S           S
Sbjct: 139 V-VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS 194
Query: 726 TVVAGTPGYLDPEYYTSNRLTE-----KSDVYSFGVVILEIITCKPAISRIN 772
            +  GTP ++ PE        +     K+DV+S G+ ++E+   +P    +N
Sbjct: 195 FI--GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 118/270 (43%), Gaps = 25/270 (9%)
Query: 573 TLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
            LGKG +G VY GR   N++ +A+K +             E+ L   + H+N+   +G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESA-QGLEYLHNGCKPPIVH 689
            E+    +  E +  G+L   L      +  +++ +    +   +GL+YLH+     IVH
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 131
Query: 690 RDVKSTNILLNEKLQA-KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR--LT 746
           RD+K  N+L+N      K++DFG SK  A       +    GT  Y+ PE          
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 747 EKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA 806
           + +D++S G  I+E+ T KP    + E +         ++   G  K  V P + E   A
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGEPQA--------AMFKVGMFK--VHPEIPESMSA 239
Query: 807 NSVWKAVELAMACLSPTGNQRPTMSQVVME 836
               +A    + C  P  ++R   + ++++
Sbjct: 240 ----EAKAFILKCFEPDPDKRACANDLLVD 265

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 17/232 (7%)
Query: 548 IDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDV--AVKMLXXXXXXXX 605
           +  +E  +R L+  D  +I       LG G FG VY  +  E  V  A K++        
Sbjct: 23  MKQYEHVTRDLNPEDFWEIIGE----LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL 78
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
                E+ +L    H N+  L+     +N   ++ EF A G +   + ++ + +  SQ +
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ 138
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           + +  ++   L YLH+     I+HRD+K+ NIL       KLADFG+S           S
Sbjct: 139 V-VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 194
Query: 726 TVVAGTPGYLDPEYYTSNRLTE-----KSDVYSFGVVILEIITCKPAISRIN 772
            +  GTP ++ PE        +     K+DV+S G+ ++E+   +P    +N
Sbjct: 195 FI--GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
             E+ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 76
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     +I E+M NG+L  +L  +D    V+     LR       G++YL 
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLS 133
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFG+S+    D     +T     P  +  PE 
Sbjct: 134 D---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               + T  SDV+S+G+V+ E+++
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
             E+ +G G FG V  GRL      EI VA+K L              E  ++ +  H N
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G   +     +I E+M NG+L  +L  +D    V+     LR       G++YL 
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLS 127
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + NIL+N  L  K++DFG+S+    D     +T     P  +  PE 
Sbjct: 128 D---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               + T  SDV+S+G+V+ E+++
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 27/264 (10%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKML-XXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +GKG FG V+ G  N     VA+K++              E+ +L +     +T   G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +D +  +I E++  G+  + L       L   +   I  E  +GL+YLH+  K   +HR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKK---IHR 128
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+K+ N+LL+E  + KLADFG++    TD     +  V GTP ++ PE    +    K+D
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFV-GTPFWMAPEVIKQSAYDSKAD 186
Query: 751 VYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVW 810
           ++S G+  +E+   +P  S ++  +       V  LI K +      P L+ ++      
Sbjct: 187 IWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNN-----PPTLEGNYSK---- 230
Query: 811 KAVELAMACLSPTGNQRPTMSQVV 834
              E   ACL+   + RPT  +++
Sbjct: 231 PLKEFVEACLNKEPSFRPTAKELL 254

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKML-XXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +GKG FG V+ G  N     VA+K++              E+ +L +     +T   G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +D +  +I E++  G+  + L       L   +   I  E  +GL+YLH+  K   +HR
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKK---IHR 143
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+K+ N+LL+E  + KLADFG++    TD     +  V GTP ++ PE    +    K+D
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFV-GTPFWMAPEVIKQSAYDSKAD 201
Query: 751 VYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVW 810
           ++S G+  +E+   +P  S ++  +       V  LI K +  ++         + N   
Sbjct: 202 IWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNPPTL---------EGNYSK 245
Query: 811 KAVELAMACLSPTGNQRPTMSQVV 834
              E   ACL+   + RPT  +++
Sbjct: 246 PLKEFVEACLNKEPSFRPTAKELL 269

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 118/270 (43%), Gaps = 25/270 (9%)
Query: 573 TLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
            LGKG +G VY GR   N++ +A+K +             E+ L   + H+N+   +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESA-QGLEYLHNGCKPPIVH 689
            E+    +  E +  G+L   L      +  +++ +    +   +GL+YLH+     IVH
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 690 RDVKSTNILLNEKLQA-KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR--LT 746
           RD+K  N+L+N      K++DFG SK  A       +    GT  Y+ PE          
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 747 EKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA 806
           + +D++S G  I+E+ T KP    + E +         ++   G  K  V P + E   A
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQA--------AMFKVGMFK--VHPEIPESMSA 253
Query: 807 NSVWKAVELAMACLSPTGNQRPTMSQVVME 836
               +A    + C  P  ++R   + ++++
Sbjct: 254 ----EAKAFILKCFEPDPDKRACANDLLVD 279

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHHRNLTSL 626
           R LGKG FG VY  R   ++  +A+K+L                EV++   + H N+  L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G+  +  +  LI E+   G +   L  +S+     Q       E A  L Y H+     
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITELANALSYCHSK---R 132
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           ++HRD+K  N+LL    + K+ADFG S      A +   T + GT  YL PE        
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 747 EKSDVYSFGVVILEIITCKP 766
           EK D++S GV+  E +   P
Sbjct: 189 EKVDLWSLGVLCYEFLVGMP 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXX---XXXEVKLLMRVHHRNLTSL 626
           R +G G FG VY+ R   N   VA+K +                EV+ L ++ H N    
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G    ++   L+ E+   G+  + L ++ KK L   E   +   + QGL YLH+     
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS---N 743
           ++HRDVK+ NILL+E    KL DFG S S    AN  V     GTP ++ PE   +    
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFV-----GTPYWMAPEVILAMDEG 189
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQ 781
           +   K DV+S G+  +E+   KP +  +N    + HI Q
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 562 DVVKITNNFERT--LGKGGFGTVYYGR---LNEIDVAVKMLXXXXXXXXX-----XXXXE 611
           DV      +E+   LG+G F TVY  R    N+I VA+K +                  E
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALRE 62
Query: 612 VKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVE 671
           +KLL  + H N+  L+      +  +L+++FM   +L+  + D S  VL+        + 
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL-VLTPSHIKAYMLM 120
Query: 672 SAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGT 731
           + QGLEYLH      I+HRD+K  N+LL+E    KLADFGL+KSF +    +   VV  T
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--T 175
Query: 732 PGYLDPEYYTSNRLTEKS-DVYSFGVVILEIITCKP 766
             Y  PE     R+     D+++ G ++ E++   P
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 572 RTLGKGGFGTV-------YYGRLNEIDVAVKMLXX-XXXXXXXXXXXEVKLLMRVHHRNL 623
           +TLG+G FG V         GR     VAVKML              E  +L +V+H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK----------------------KVLS 661
             L G C +D    LI E+   G+L+ +L +  K                      + L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 662 SQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN 721
             + +  A + +QG++YL    +  +VHRD+ + NIL+ E  + K++DFGLS+    + +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-VYEED 204
Query: 722 THVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           + V       P  ++  E    +  T +SDV+SFGV++ EI+T
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 572 RTLGKGGFGTV-------YYGRLNEIDVAVKMLXX-XXXXXXXXXXXEVKLLMRVHHRNL 623
           +TLG+G FG V         GR     VAVKML              E  +L +V+H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK----------------------KVLS 661
             L G C +D    LI E+   G+L+ +L +  K                      + L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 662 SQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN 721
             + +  A + +QG++YL    +  +VHRD+ + NIL+ E  + K++DFGLS+    + +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRD-VYEED 204
Query: 722 THVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           + V       P  ++  E    +  T +SDV+SFGV++ EI+T
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 138/332 (41%), Gaps = 58/332 (17%)
Query: 548 IDSFEAKS------RHLSYSDVVKITNN---FERTLGKGGFGTVY----YGRLNE---ID 591
           I+S+E  S        L Y++  +   N   F +TLG G FG V     +G   E   + 
Sbjct: 4   IESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK 63
Query: 592 VAVKMLXXXXXX-XXXXXXXEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQ 649
           VAVKML              E+K++  +  H N+ +L+G C       +I E+   G+L 
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 650 EYLSDISKKVLSS---------------------QERLRIAVESAQGLEYLHN-GCKPPI 687
            +L   ++ +L                       ++ L  + + AQG+ +L +  C    
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC---- 179
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRDV + N+LL     AK+ DFGL++    D+N  V         ++ PE       T 
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDAN 807
           +SDV+S+G+++ EI +       +N    I +      L+  G   +      Q  F   
Sbjct: 240 QSDVWSYGILLWEIFSLG-----LNPYPGILVNSKFYKLVKDGYQMA------QPAFAPK 288
Query: 808 SVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
           +++  ++   AC +     RPT  Q+   L E
Sbjct: 289 NIYSIMQ---ACWALEPTHRPTFQQICSFLQE 317

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 561 SDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKML-XXXXXXXXXXXXXEVKLLMR 617
           +D  ++    ER +GKG FG V+ G  N     VA+K++              E+ +L +
Sbjct: 19  ADPEELFTKLER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV---ESAQ 674
                +T   G   + ++  +I E++  G+  + L           +  +IA    E  +
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR------AGPFDEFQIATMLKEILK 131
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           GL+YLH+  K   +HRD+K+ N+LL+E+   KLADFG++    TD     +T V GTP +
Sbjct: 132 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFW 186
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS 794
           + PE    +    K+D++S G+  +E+   +P  S ++          V  LI K +   
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLIPKNN--- 236
Query: 795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
              P L  DF  +      E   ACL+   + RPT  +++
Sbjct: 237 --PPTLVGDFTKS----FKEFIDACLNKDPSFRPTAKELL 270

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 17/232 (7%)
Query: 548 IDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDV--AVKMLXXXXXXXX 605
           +  +E  +R L+  D  +I       LG G FG VY  +  E  V  A K++        
Sbjct: 23  MKQYEHVTRDLNPEDFWEIIGE----LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL 78
Query: 606 XXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
                E+ +L    H N+  L+     +N   ++ EF A G +   + ++ + +  SQ +
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ 138
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           + +  ++   L YLH+     I+HRD+K+ NIL       KLADFG+S            
Sbjct: 139 V-VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDX 194
Query: 726 TVVAGTPGYLDPEYYTSNRLTE-----KSDVYSFGVVILEIITCKPAISRIN 772
            +  GTP ++ PE        +     K+DV+S G+ ++E+   +P    +N
Sbjct: 195 FI--GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 17/219 (7%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX 605
           +A+ R L  +++ ++     + LG G FGTVY G         +I VA+K+L        
Sbjct: 29  QAQLRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA 83
Query: 606 XXXXXEVKLLM-RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
                +  L+M  + H +L  L+G C       L+ + M +G L EY+ +  K  + SQ 
Sbjct: 84  NVEFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHE-HKDNIGSQL 141
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
            L   V+ A+G+ YL       +VHRD+ + N+L+      K+ DFGL++    D   + 
Sbjct: 142 LLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 198
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +        ++  E     + T +SDV+S+GV I E++T
Sbjct: 199 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 17/219 (7%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX 605
           +A+ R L  +++ ++     + LG G FGTVY G         +I VA+K+L        
Sbjct: 6   QAQLRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA 60
Query: 606 XXXXXEVKLLM-RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
                +  L+M  + H +L  L+G C       L+ + M +G L EY+ +  K  + SQ 
Sbjct: 61  NVEFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHE-HKDNIGSQL 118
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
            L   V+ A+G+ YL       +VHRD+ + N+L+      K+ DFGL++    D   + 
Sbjct: 119 LLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 175
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +        ++  E     + T +SDV+S+GV I E++T
Sbjct: 176 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 127/286 (44%), Gaps = 28/286 (9%)
Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVK---MLXXXXXXXXXXXXXEVKLLMRVHHRNLT 624
            E+ +G+G F  VY     L+ + VA+K   +              E+ LL +++H N+ 
Sbjct: 36  IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 95
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL--RIAVESAQGLEYLHNG 682
                  EDN+  ++ E    G+L   +    K+     ER   +  V+    LE++H+ 
Sbjct: 96  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               ++HRD+K  N+ +      KL D GL + F++   T  +  + GTP Y+ PE    
Sbjct: 156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHE 210
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE 802
           N    KSD++S G ++ E+     A+      +K+++     SL  K  I+    P L  
Sbjct: 211 NGYNFKSDIWSLGCLLYEMA----ALQSPFYGDKMNL----YSLCKK--IEQCDYPPLPS 260
Query: 803 DFDANSVWKAVELAMACLSPTGNQRPTMS---QVVMELSECLAAEM 845
           D  +  + + V +   C++P   +RP ++    V   +  C A+ +
Sbjct: 261 DHYSEELRQLVNM---CINPDPEKRPDVTYVYDVAKRMHACTASSL 303

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID------VAVKMLXXXXXXXXXX 607
           + RHL Y             LGKG FG+V   R + +       VAVK L          
Sbjct: 5   EERHLKYIS----------QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 54
Query: 608 XXXEVKLLMRVHHRNLTSL--VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
              E+++L  +H   +     V +     +  L+ E++ +G L+++L    +  L +   
Sbjct: 55  FQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR-HRARLDASRL 113
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           L  + +  +G+EYL  G +   VHRD+ + NIL+  +   K+ADFGL+K    D +  V 
Sbjct: 114 LLYSSQICKGMEYL--GSRR-CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVV 170
Query: 726 TVVAGTPGY-LDPEYYTSNRLTEKSDVYSFGVVILEIIT-----CKPA 767
                +P +   PE  + N  + +SDV+SFGVV+ E+ T     C P+
Sbjct: 171 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 218

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 574 LGKGGFGTVYYGRLNEID-VAVKM--LXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G VY  + ++   VA+K   L             E+ LL  +HH N+ SL+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
             +    L++EFM   +L++ L +    +  SQ ++ +  +  +G+ + H      I+HR
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL-YQLLRGVAHCHQH---RILHR 143
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKS 749
           D+K  N+L+N     KLADFGL+++F     ++   VV  T  Y  P+    S + +   
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYSTSV 201
Query: 750 DVYSFGVVILEIITCKPAISRINEEEKI 777
           D++S G +  E+IT KP    + +++++
Sbjct: 202 DIWSIGCIFAEMITGKPLFPGVTDDDQL 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 574 LGKGGFGTVYYGRLNEID-VAVKM--LXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G VY  + ++   VA+K   L             E+ LL  +HH N+ SL+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
             +    L++EFM   +L++ L +    +  SQ ++ +  +  +G+ + H      I+HR
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL-YQLLRGVAHCHQH---RILHR 143
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKS 749
           D+K  N+L+N     KLADFGL+++F     ++   VV  T  Y  P+    S + +   
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYSTSV 201
Query: 750 DVYSFGVVILEIITCKPAISRINEEEKI 777
           D++S G +  E+IT KP    + +++++
Sbjct: 202 DIWSIGCIFAEMITGKPLFPGVTDDDQL 229

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 73  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 130
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 131 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 116/235 (49%), Gaps = 21/235 (8%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+KLL ++ H NL +L+  C +  +  L++EF+ +  L +   ++    L  Q   +   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQKYLF 131
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           +   G+ + H+     I+HRD+K  NIL+++    KL DFG +++ A     +   V   
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--A 186
Query: 731 TPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-HIRQWVNSLIA 788
           T  Y  PE    + +  +  DV++ G ++ E+   +P     ++ +++ HI   + +LI 
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI- 245
Query: 789 KGDIKSIVDPRLQEDFDANSVWKAVEL-AMACLSPTGNQRPTMSQVVMELS-ECL 841
                    PR QE F+ N V+  V L  +    P   + P +S+VV++L+ +CL
Sbjct: 246 ---------PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCL 291

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 147
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 33/274 (12%)
Query: 574 LGKGGFGTVYYGR-LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRV-HHRNLTSLVGHCD 631
           +G G +G VY GR +    +A   +             E+ +L +  HHRN+ +  G   
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 632 E------DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           +      D+Q  L+ EF   G++ + + +     L  +    I  E  +GL +LH   + 
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QH 148
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            ++HRD+K  N+LL E  + KL DFG+S     D          GTP ++ PE    +  
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDEN 206
Query: 746 TE-----KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
            +     KSD++S G+  +E+    P +  ++    + +            I     PRL
Sbjct: 207 PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------------IPRNPAPRL 254
Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           +    +      +E   +CL    +QRP   Q++
Sbjct: 255 KSKKWSKKFQSFIE---SCLVKNHSQRPATEQLM 285

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLX---XXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           LG GG  TVY      LN I VA+K +                EV    ++ H+N+ S++
Sbjct: 19  LGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
              +ED+   L+ E++    L EY+   S   LS    +    +   G+++ H+     I
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           VHRD+K  NIL++     K+ DFG++K+ +  + T  + V+ GT  Y  PE        E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATDE 191
Query: 748 KSDVYSFGVVILEIITCKP 766
            +D+YS G+V+ E++  +P
Sbjct: 192 CTDIYSIGIVLYEMLVGEP 210

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 152
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 153 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 210 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 129
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 130 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 152
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 153 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 150
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 151 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 149
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 207 TEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 149
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDED 633
           LG+G +G+VY     E    V +              E+ ++ +    ++    G   ++
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 634 NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVK 693
               ++ E+   G++ + +  +  K L+  E   I   + +GLEYLH   K   +HRD+K
Sbjct: 97  TDLWIVMEYCGAGSVSDIIR-LRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIK 152
Query: 694 STNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           + NILLN +  AKLADFG++    TD     + V+ GTP ++ PE          +D++S
Sbjct: 153 AGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVI-GTPFWMAPEVIQEIGYNCVADIWS 210
Query: 754 FGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAV 813
            G+  +E+   KP  + I+    I        +I      +   P L  D          
Sbjct: 211 LGITAIEMAEGKPPYADIHPMRAIF-------MIPTNPPPTFRKPELWSD-------NFT 256
Query: 814 ELAMACLSPTGNQRPTMSQVV 834
           +    CL  +  QR T +Q++
Sbjct: 257 DFVKQCLVKSPEQRATATQLL 277

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 147
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 147
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 22/225 (9%)
Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
            + ++GKG FG V+ G+    +VAVK+              E+   + + H N+   +  
Sbjct: 46  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 104
Query: 630 CDEDN----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
            ++DN    Q  L+ ++  +G+L +YL+   +  ++ +  +++A+ +A GL +LH     
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+     ATD          GT  Y+ PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 739 YYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
               +         +++D+Y+ G+V  EI   + +I  I+E+ ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL 265

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 100 VKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 157
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 158 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 149
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHHRNLTSL 626
           R LGKG FG VY  R   ++  +A+K+L                EV++   + H N+  L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G+  +  +  LI E+   G +   L  +S+     Q       E A  L Y H+     
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITELANALSYCHSK---R 132
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           ++HRD+K  N+LL    + K+ADFG S      A +     + GT  YL PE        
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWS----VHAPSSRRDTLCGTLDYLPPEMIEGRMHD 188
Query: 747 EKSDVYSFGVVILEIITCKP 766
           EK D++S GV+  E +   P
Sbjct: 189 EKVDLWSLGVLCYEFLVGMP 208

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 149
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 127
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 128 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 128
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 129 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 22/225 (9%)
Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
            + ++GKG FG V+ G+    +VAVK+              E+   + + H N+   +  
Sbjct: 8   LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 66
Query: 630 CDEDN----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
            ++DN    Q  L+ ++  +G+L +YL+   +  ++ +  +++A+ +A GL +LH     
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+     ATD          GT  Y+ PE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 739 YYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
               +         +++D+Y+ G+V  EI   + +I  I+E+ ++
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL 227

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 22/225 (9%)
Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
            + ++GKG FG V+ G+    +VAVK+              E+   + + H N+   +  
Sbjct: 33  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 91
Query: 630 CDEDN----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
            ++DN    Q  L+ ++  +G+L +YL+   +  ++ +  +++A+ +A GL +LH     
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+     ATD          GT  Y+ PE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 739 YYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
               +         +++D+Y+ G+V  EI   + +I  I+E+ ++
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL 252

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 149
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T    ++ SD+++ G +I +++   P     NE
Sbjct: 207 TEKSASKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 150
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 151 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 22/225 (9%)
Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
            + ++GKG FG V+ G+    +VAVK+              E+   + + H N+   +  
Sbjct: 10  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 68
Query: 630 CDEDN----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
            ++DN    Q  L+ ++  +G+L +YL+   +  ++ +  +++A+ +A GL +LH     
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+     ATD          GT  Y+ PE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 739 YYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
               +         +++D+Y+ G+V  EI   + +I  I+E+ ++
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL 229

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 22/225 (9%)
Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
            + ++GKG FG V+ G+    +VAVK+              E+   + + H N+   +  
Sbjct: 13  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 71
Query: 630 CDEDN----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
            ++DN    Q  L+ ++  +G+L +YL+   +  ++ +  +++A+ +A GL +LH     
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+     ATD          GT  Y+ PE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 739 YYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
               +         +++D+Y+ G+V  EI   + +I  I+E+ ++
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL 232

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 22/225 (9%)
Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
            + ++GKG FG V+ G+    +VAVK+              E+   + + H N+   +  
Sbjct: 7   LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 65
Query: 630 CDEDN----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
            ++DN    Q  L+ ++  +G+L +YL+   +  ++ +  +++A+ +A GL +LH     
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+     ATD          GT  Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 739 YYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
               +         +++D+Y+ G+V  EI   + +I  I+E+ ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL 226

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE---RLRIAVESAQGLEYLH 680
             L     +D +      +  NG L +Y+    +K+ S  E   R   A E    LEYLH
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA-EIVSALEYLH 131
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  
Sbjct: 132 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINE 773
           T     + SD+++ G +I +++   P     NE
Sbjct: 189 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 149
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 150 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 575 GKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH----C 630
            +G FG V+  +L    VAVK+              EV  L  + H N+   +G      
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFIGAEKRGT 91
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-------NGC 683
             D    LI  F   G+L ++L      V+S  E   IA   A+GL YLH       +G 
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
           KP I HRD+KS N+LL   L A +ADFGL+  F    +   +    GT  Y+ PE     
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208
Query: 744 RLTEKS-----DVYSFGVVILEIIT-CKPAISRINE 773
              ++      D+Y+ G+V+ E+ + C  A   ++E
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK------VLSSQE 664
           E++ + + HH N+ S        ++  L+ + ++ G++ + +  I  K      VL    
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-- 722
              I  E  +GLEYLH   +   +HRDVK+ NILL E    ++ADFG+S   AT  +   
Sbjct: 118 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 723 -HVSTVVAGTPGYLDPEYYTSNRLTE-KSDVYSFGVVILEIIT 763
             V     GTP ++ PE     R  + K+D++SFG+  +E+ T
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 217

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
             E+ LG G FG V+    N+   VAVK +             E  ++  + H  L  L 
Sbjct: 18  KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLH 76
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               ++    +I EFMA G+L ++L           + +  + + A+G+ ++        
Sbjct: 77  AVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 132
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+++ NIL++  L  K+ADFGL++    + N + +   A  P  +  PE       T
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 747 EKSDVYSFGVVILEIIT 763
            KSDV+SFG++++EI+T
Sbjct: 191 IKSDVWSFGILLMEIVT 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L                E  ++ R+ H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 149
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 150 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLL 615
           +S  D  K    FE+ +G+G  GTVY         +VA++ +             E+ ++
Sbjct: 13  VSVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
               + N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQA 128
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH+     ++HRD+KS NILL      KL DFG      T   +  ST+V GTP ++
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMV-GTPYWM 183
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE  T      K D++S G++ +E+I  +P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 32/235 (13%)
Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRL-------NEIDVAVKMLXXXXX-X 603
           +AK + +S S V      F   LG+  FG VY G L           VA+K L       
Sbjct: 17  QAKLKEISLSAV-----RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP 71
Query: 604 XXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------SDIS- 656
                  E  L  R+ H N+  L+G   +D   ++I+ + ++G+L E+L      SD+  
Sbjct: 72  LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 131
Query: 657 -------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD 709
                  K  L   + + +  + A G+EYL +     +VH+D+ + N+L+ +KL  K++D
Sbjct: 132 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD 188
Query: 710 FGLSKS-FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            GL +  +A D    +   +     ++ PE     + +  SD++S+GVV+ E+ +
Sbjct: 189 LGLFREVYAADYYKLLGNSLLPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 128/302 (42%), Gaps = 43/302 (14%)
Query: 553 AKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXX 607
           AK   +SY   VKI    E  +G G FG V  GRL      E  VA+K L          
Sbjct: 8   AKEIDVSY---VKI----EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR 60
Query: 608 X-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQE 664
               E  ++ +  H N+  L G         ++ EFM NG L  +L  +D    V+    
Sbjct: 61  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVG 120
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN--T 722
            LR     A G+ YL    +   VHRD+ + NIL+N  L  K++DFGLS+    +++  T
Sbjct: 121 MLR---GIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 174
Query: 723 HVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
           + S++    P  +  PE     + T  SD +S+G+V+ E+++   +P     N++    I
Sbjct: 175 YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 234
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
            Q               D RL    D  +     +L + C     N RP   QVV  L +
Sbjct: 235 EQ---------------DYRLPPPPDCPT--SLHQLMLDCWQKDRNARPRFPQVVSALDK 277
Query: 840 CL 841
            +
Sbjct: 278 MI 279

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK------VLSSQE 664
           E++ + + HH N+ S        ++  L+ + ++ G++ + +  I  K      VL    
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-- 722
              I  E  +GLEYLH   +   +HRDVK+ NILL E    ++ADFG+S   AT  +   
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 723 -HVSTVVAGTPGYLDPEYYTSNRLTE-KSDVYSFGVVILEIIT 763
             V     GTP ++ PE     R  + K+D++SFG+  +E+ T
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 572 RTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH-- 629
           + +GKG +G V+ G+     VAVK+              E+   + + H N+   +    
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRET-EIYQTVLMRHENILGFIAADI 101
Query: 630 --CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC---- 683
                  Q  LI ++  NG+L +YL   +   L ++  L++A  S  GL +LH       
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 684 -KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH--VSTVVAGTPGYLDPEYY 740
            KP I HRD+KS NIL+ +     +AD GL+  F +D N          GT  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 741 --TSNRLTEKS----DVYSFGVVILEI 761
             + NR   +S    D+YSFG+++ E+
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + E+ +G G  G V YGRL      ++ VA+K L              E  ++ +  H N
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G         ++ E+M NG+L  +L   D    ++     LR       G+ YL 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV---GAGMRYLS 168
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + N+L++  L  K++DFGLS+    D +   +T     P  +  PE 
Sbjct: 169 D---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 +  SDV+SFGVV+ E++ 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 10/210 (4%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNL 623
            F + LG+G F T    R      + A+K+L                E  ++ R+ H   
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L     +D +      +  NG L +Y+  I      +  R   A E    LEYLH   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLHGKG 150
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T  
Sbjct: 151 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINE 773
              + SD+++ G +I +++   P     NE
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 574 LGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXX--XEVKLLMRVHHRNLTSLVGH 629
           LGKG FG V     R+ + + AVK++               EV+LL ++ H N+  L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
            ++ +   ++ E    G L + +  I +K  S  +  RI  +   G+ Y+H   K  IVH
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 690 RDVKSTNILLNEK---LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           RD+K  NILL  K      K+ DFGLS  F    NT +   + GT  Y+ PE        
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI-GTAYYIAPEVLRGT-YD 200
Query: 747 EKSDVYSFGVVILEIITCKPAISRINE 773
           EK DV+S GV++  +++  P     NE
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
             E+ LG G FG V+    N+   VAVK +             E  ++  + H  L  L 
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLH 249
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               ++    +I EFMA G+L ++L           + +  + + A+G+ ++        
Sbjct: 250 AVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 305
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+++ NIL++  L  K+ADFGL++    + N + +   A  P  +  PE       T
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 747 EKSDVYSFGVVILEIIT 763
            KSDV+SFG++++EI+T
Sbjct: 364 IKSDVWSFGILLMEIVT 380

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
           SF  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 14  SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 73
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ +++H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 74  SEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 133
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 134 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 191 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 250
Query: 771 INEE 774
            N+E
Sbjct: 251 SNQE 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRN 622
           + E+ +G G  G V YGRL      ++ VA+K L              E  ++ +  H N
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLS--DISKKVLSSQERLRIAVESAQGLEYLH 680
           +  L G         ++ E+M NG+L  +L   D    ++     LR       G+ YL 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV---GAGMRYLS 168
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
           +      VHRD+ + N+L++  L  K++DFGLS+    D +   +T     P  +  PE 
Sbjct: 169 D---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
                 +  SDV+SFGVV+ E++ 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 574 LGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXX--XEVKLLMRVHHRNLTSLVGH 629
           LGKG FG V     R+ + + AVK++               EV+LL ++ H N+  L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
            ++ +   ++ E    G L + +  I +K  S  +  RI  +   G+ Y+H   K  IVH
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 690 RDVKSTNILLNEK---LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           RD+K  NILL  K      K+ DFGLS  F    NT +   + GT  Y+ PE        
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI-GTAYYIAPEVLRGT-YD 200
Query: 747 EKSDVYSFGVVILEIITCKPAISRINE 773
           EK DV+S GV++  +++  P     NE
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 574 LGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXX--XEVKLLMRVHHRNLTSLVGH 629
           LGKG FG V     R+ + + AVK++               EV+LL ++ H N+  L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
            ++ +   ++ E    G L + +  I +K  S  +  RI  +   G+ Y+H   K  IVH
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 690 RDVKSTNILLNEK---LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           RD+K  NILL  K      K+ DFGLS  F    NT +   + GT  Y+ PE        
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI-GTAYYIAPEVLRGT-YD 200
Query: 747 EKSDVYSFGVVILEIITCKPAISRINE 773
           EK DV+S GV++  +++  P     NE
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 11/210 (5%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLTSLVGHC 630
           LG+G + TVY G+    D  VA+K +              EV LL  + H N+ +L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
             +    L++E++ + +L++YL D    +     +L +  +  +GL Y H   +  ++HR
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCH---RQKVLHR 124
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKS 749
           D+K  N+L+NE+ + KLADFGL+++ +    T+ + VV  T  Y  P+    S   + + 
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYSTQI 182
Query: 750 DVYSFGVVILEIITCKPAISRINEEEKIHI 779
           D++  G +  E+ T +P       EE++H 
Sbjct: 183 DMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 11/211 (5%)
Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLL 615
           +S  D  K    FE+ +G+G  GTVY         +VA++ +             E+ ++
Sbjct: 13  VSVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
               + N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQA 128
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH+     ++HRD+KS NILL      KL DFG       + +     V  GTP ++
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV--GTPYWM 183
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE  T      K D++S G++ +E+I  +P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXXXXXEVKLLMR---VHHR 621
           R LG+G FG VY G   +I        VAVK +                 +M+    HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESA 673
            +  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E A
Sbjct: 82  -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            G+ YL N  K   VHRD+ + N ++      K+ DFG+++     A             
Sbjct: 141 DGMAYL-NAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           ++ PE       T  SD++SFGVV+ EI +
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
           SF  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 14  SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 73
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 74  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 133
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 134 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 191 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 250
Query: 771 INEE 774
            N+E
Sbjct: 251 SNQE 254

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
           SF  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 20  SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 79
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 80  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 139
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 140 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 196
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 197 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 256
Query: 771 INEE 774
            N+E
Sbjct: 257 SNQE 260

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 11/211 (5%)
Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLL 615
           +S  D  K    FE+ +G+G  GTVY         +VA++ +             E+ ++
Sbjct: 13  VSVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
               + N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQA 128
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH+     ++HRD+KS NILL      KL DFG       + +     V  GTP ++
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTPYWM 183
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE  T      K D++S G++ +E+I  +P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLL 615
           +S  D  K    FE+ +G+G  GTVY         +VA++ +             E+ ++
Sbjct: 14  VSVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
               + N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q 
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQA 129
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH+     ++HRD+KS NILL      KL DFG       + +    + + GTP ++
Sbjct: 130 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWM 184
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE  T      K D++S G++ +E+I  +P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 89/317 (28%), Positives = 132/317 (41%), Gaps = 48/317 (15%)
Query: 553 AKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLXXX-XXXXXX 606
           AK   +SY   VKI    E  +G G FG V  GRL      E  VA+K L          
Sbjct: 10  AKEIDVSY---VKI----EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR 62
Query: 607 XXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQE 664
               E  ++ +  H N+  L G         ++ EFM NG L  +L  +D    V+    
Sbjct: 63  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVG 122
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN--T 722
            LR     A G+ YL    +   VHRD+ + NIL+N  L  K++DFGLS+    +++  T
Sbjct: 123 MLR---GIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 176
Query: 723 HVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHI 779
             S++    P  +  PE     + T  SD +S+G+V+ E+++   +P     N++    I
Sbjct: 177 ETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 236
Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
            Q               D RL    D  +     +L + C     N RP   QVV  L +
Sbjct: 237 EQ---------------DYRLPPPPDCPTSLH--QLMLDCWQKDRNARPRFPQVVSALDK 279
Query: 840 CLAAE-----MARANSG 851
            +        +AR N G
Sbjct: 280 MIRNPASLKIVARENGG 296

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 115/281 (40%), Gaps = 38/281 (13%)
Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXXXXXEVKLLMR---VHHR 621
           R LG+G FG VY G   +I        VAVK +                 +M+    HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESA 673
            +  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E A
Sbjct: 82  -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            G+ YL N  K   VHRD+ + N ++      K+ DFG+++                   
Sbjct: 141 DGMAYL-NAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK 793
           ++ PE       T  SD++SFGVV+ EI +                 Q    L  +  +K
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLA--------------EQPYQGLSNEQVLK 243
Query: 794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
            ++D    +  D N   +  +L   C     N RPT  ++V
Sbjct: 244 FVMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
           SF  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 14  SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 73
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 74  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 133
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 134 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 191 AQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 250
Query: 771 INEE 774
            N+E
Sbjct: 251 SNQE 254

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 569 NFERTLGKGGFGTVYYGRL-------NEIDVAVKMLXXXXX-XXXXXXXXEVKLLMRVHH 620
            F   LG+  FG VY G L           VA+K L              E  L  R+ H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------SDIS--------KKVLSSQERL 666
            N+  L+G   +D   ++I+ + ++G+L E+L      SD+         K  L   + +
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVS 725
            +  + A G+EYL +     +VH+D+ + N+L+ +KL  K++D GL +  +A D    + 
Sbjct: 132 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             +     ++ PE     + +  SD++S+GVV+ E+ +
Sbjct: 189 NSLLPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 574 LGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G+G  G V   R       VAVKM+             EV ++    H N+  +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESA-QGLEYLHNGCKPPIVHR 690
              +  ++ EF+  G L    +DI  +V  ++E++    E+  Q L YLH      ++HR
Sbjct: 113 VGEELWVLMEFLQGGAL----TDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHR 165
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+KS +ILL    + KL+DFG     + D       V  GTP ++ PE  + +    + D
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV--GTPYWMAPEVISRSLYATEVD 223
Query: 751 VYSFGVVILEIITCKP 766
           ++S G++++E++  +P
Sbjct: 224 IWSLGIMVIEMVDGEP 239

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXXXXXEVKLLMR---VHHR 621
           R LG+G FG VY G   +I        VAVK +                 +M+    HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESA 673
            +  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E A
Sbjct: 82  -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            G+ YL N  K   VHRD+ + N ++      K+ DFG+++                   
Sbjct: 141 DGMAYL-NAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           ++ PE       T  SD++SFGVV+ EI +
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXXXXXEVKLLMR---VHHR 621
           R LG+G FG VY G   +I        VAVK +                 +M+    HH 
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 78
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESA 673
            +  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E A
Sbjct: 79  -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            G+ YL N  K   VHRD+ + N ++      K+ DFG+++                   
Sbjct: 138 DGMAYL-NAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           ++ PE       T  SD++SFGVV+ EI +
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 28  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 87
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ +++H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 88  SEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 147
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 148 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 771 INEE 774
            N+E
Sbjct: 265 SNQE 268

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
           SF  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 40  SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 99
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 100 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 159
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 160 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 216
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 217 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 276
Query: 771 INEE 774
            N+E
Sbjct: 277 SNQE 280

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 5   CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 64
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 65  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 124
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 125 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 181
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 182 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 241
Query: 771 INEE 774
            N+E
Sbjct: 242 SNQE 245

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKML-XXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +GKG FG VY G  N     VA+K++              E+ +L +     +T   G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            +  +  +I E++  G+  + L       L       I  E  +GL+YLH+  K   +HR
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSERK---IHR 140
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+K+ N+LL+E+   KLADFG++    TD     +  V GTP ++ PE    +    K+D
Sbjct: 141 DIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFV-GTPFWMAPEVIKQSAYDFKAD 198
Query: 751 VYSFGVVILEIITCKPAISRIN 772
           ++S G+  +E+   +P  S ++
Sbjct: 199 IWSLGITAIELAKGEPPNSDLH 220

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 118/290 (40%), Gaps = 39/290 (13%)
Query: 572 RTLGKGGFGTVYYGRLNEID-----VAVKMLXXXXXXXXXXXX--XEVKLLMRVHHRNLT 624
           R LGKG FG+V   +L + D     VAVKML               E   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 625 SLVGHCDEDNQTA------LIYEFMANGNLQEYLSDISKKV------LSSQERLRIAVES 672
            LVG               +I  FM +G+L  +L  ++ ++      L  Q  +R  V+ 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPFNLPLQTLVRFMVDI 146
Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
           A G+EYL +      +HRD+ + N +L E +   +ADFGLS+   +              
Sbjct: 147 ACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
            +L  E    N  T  SDV++FGV + EI+T         E  +I+     N LI    +
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-----NYLIGGNRL 258
Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
           K    P   E+          +L   C S    QRP+ + + MEL   L 
Sbjct: 259 KQ--PPECMEE--------VYDLMYQCWSADPKQRPSFTCLRMELENILG 298

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 13  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 73  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 771 INEE 774
            N+E
Sbjct: 250 SNQE 253

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 28  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 87
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 88  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 147
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 148 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 771 INEE 774
            N+E
Sbjct: 265 SNQE 268

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 572 RTLGKGGFGTVYYGRLNEID-----VAVKM--LXXXXXXXXXXXXXEVKLLMRVHHRNLT 624
           + LG+G FG+V  G L + D     VAVK   L             E   +    H N+ 
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 625 SLVGHCDEDNQTAL-----IYEFMANGNLQEYLS----DISKKVLSSQERLRIAVESAQG 675
            L+G C E +   +     I  FM  G+L  YL     +   K +  Q  L+  V+ A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           +EYL N      +HRD+ + N +L + +   +ADFGLSK   +        +      ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             E       T KSDV++FGV + EI T
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 572 RTLGKGGFGTVYY-GRLNEIDV----AVKMLXXXXXXXX--XXXXXEVKLLMRVHHRNLT 624
           + LG+G FG V+   +++  D     A+K+L               E  +L+ V+H  + 
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNGC 683
            L      + +  LI +F+  G+L    + +SK+V+ ++E ++  + E A  L++LH+  
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I++RD+K  NILL+E+   KL DFGLSK          S    GT  Y+ PE     
Sbjct: 147 ---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRR 201
Query: 744 RLTEKSDVYSFGVVILEIIT 763
             T+ +D +SFGV++ E++T
Sbjct: 202 GHTQSADWWSFGVLMFEMLT 221

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 28  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVY 87
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 88  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 147
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 148 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 771 INEE 774
            N+E
Sbjct: 265 SNQE 268

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 13  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 73  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 132
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 771 INEE 774
            N+E
Sbjct: 250 SNQE 253

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLL 615
           +S  D  K    FE+ +G+G  GTVY         +VA++ +             E+ ++
Sbjct: 14  VSVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
               + N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q 
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQA 129
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LE+LH+     ++HR++KS NILL      KL DFG      T   +  ST+V GTP ++
Sbjct: 130 LEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMV-GTPYWM 184
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            PE  T      K D++S G++ +E+I  +P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 17/236 (7%)
Query: 544 SKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDV--AVKMLXXXX 601
           S  K   +E   R L  ++V +I       LG G FG VY  +  E     A K++    
Sbjct: 1   SMRKSREYEHVRRDLDPNEVWEIVGE----LGDGAFGKVYKAKNKETGALAAAKVIETKS 56
Query: 602 XXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLS 661
                    E+++L    H  +  L+G    D +  ++ EF   G +   + ++ + +  
Sbjct: 57  EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE 116
Query: 662 SQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN 721
            Q ++ +  +  + L +LH+     I+HRD+K+ N+L+  +   +LADFG+S        
Sbjct: 117 PQIQV-VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172
Query: 722 THVSTVVAGTPGYLDPEYYTSNRLTE-----KSDVYSFGVVILEIITCKPAISRIN 772
              S +  GTP ++ PE      + +     K+D++S G+ ++E+   +P    +N
Sbjct: 173 KRDSFI--GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 30  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 89
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 90  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 149
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 150 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 206
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++     +             ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 207 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 266
Query: 771 INEE 774
            N+E
Sbjct: 267 SNQE 270

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXXXXXEVKLLMR---VHHR 621
           R LG+G FG VY G   +I        VAVK +                 +M+    HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESA 673
            +  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E A
Sbjct: 82  -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTVVAGTP 732
            G+ YL N  K   VHRD+ + N ++      K+ DFG+++  + TD        +    
Sbjct: 141 DGMAYL-NAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 196
Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            ++ PE       T  SD++SFGVV+ EI +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 574 LGKGGFGTVYYG----RLNEIDVAVKMLXX-XXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
           LG G FG+V  G    R  +IDVA+K+L              E +++ ++ +  +  L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
            C  +    L+ E    G L ++L    +++  S     +  + + G++YL    +   V
Sbjct: 78  VCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLE---EKNFV 132
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HRD+ + N+LL  +  AK++DFGLSK+   D + + +      P  +  PE     + + 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 748 KSDVYSFGVVILEIIT 763
           +SDV+S+GV + E ++
Sbjct: 193 RSDVWSYGVTMWEALS 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 572 RTLGKGGFGTVYY-GRLNEIDV----AVKMLXXXXXXXX--XXXXXEVKLLMRVHHRNLT 624
           + LG+G FG V+   +++  D     A+K+L               E  +L+ V+H  + 
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNGC 683
            L      + +  LI +F+  G+L    + +SK+V+ ++E ++  + E A  L++LH+  
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 147
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I++RD+K  NILL+E+   KL DFGLSK          S    GT  Y+ PE     
Sbjct: 148 ---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRR 202
Query: 744 RLTEKSDVYSFGVVILEIIT 763
             T+ +D +SFGV++ E++T
Sbjct: 203 GHTQSADWWSFGVLMFEMLT 222

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 54  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 113
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 173
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 174 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++                   ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
Query: 771 INEE 774
            N+E
Sbjct: 291 SNQE 294

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 22/244 (9%)
Query: 550 SFEAKSRHLS-YSDVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXX 601
            F  K+  +S   +V +      R LG G FG VY G+++        + VAVK L    
Sbjct: 31  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 90
Query: 602 XXXXXXX-XXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV- 659
                     E  ++ + +H+N+   +G   +     ++ E MA G+L+ +L +   +  
Sbjct: 91  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 150
Query: 660 ----LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGL 712
               L+  + L +A + A G +YL        +HRD+ + N LL        AK+ DFG+
Sbjct: 151 QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 207
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISR 770
           ++                   ++ PE +     T K+D +SFGV++ EI +    P  S+
Sbjct: 208 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 267
Query: 771 INEE 774
            N+E
Sbjct: 268 SNQE 271

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 15/214 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXX---XXXXXXEVKLL-MRVHHRNLTS 625
           + LGKG FG V+     + +   A+K L                E ++L +   H  LT 
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           +            + E++  G+L  ++    K  LS       A E   GL++LH+    
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQFLHSKG-- 138
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSK-SFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
            IV+RD+K  NILL++    K+ADFG+ K +   DA T       GTP Y+ PE     +
Sbjct: 139 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NXFCGTPDYIAPEILLGQK 194
Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIH 778
                D +SFGV++ E++  +      +EEE  H
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 572 RTLGKGGFGTVYY-GRLNEIDV----AVKMLXXXXXXXX--XXXXXEVKLLMRVHHRNLT 624
           + LG+G FG V+   +++  D     A+K+L               E  +L+ V+H  + 
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNGC 683
            L      + +  LI +F+  G+L    + +SK+V+ ++E ++  + E A  L++LH+  
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              I++RD+K  NILL+E+   KL DFGLSK          S    GT  Y+ PE     
Sbjct: 147 ---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRR 201
Query: 744 RLTEKSDVYSFGVVILEIIT 763
             T+ +D +SFGV++ E++T
Sbjct: 202 GHTQSADWWSFGVLMFEMLT 221

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXXXXXEVKLLMR---VHHR 621
           R LG+G FG VY G   +I        VAVK +                 +M+    HH 
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 80
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESA 673
            +  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E A
Sbjct: 81  -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTVVAGTP 732
            G+ YL N  K   VHRD+ + N ++      K+ DFG+++  + TD        +    
Sbjct: 140 DGMAYL-NAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 195
Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            ++ PE       T  SD++SFGVV+ EI +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 571 ERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTS 625
           +R LGKG FG V     ++   + AVK++                EV+LL ++ H N+  
Sbjct: 54  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 113
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    ++     L+ E    G L + +  IS+K  S  +  RI  +   G+ Y+H   K 
Sbjct: 114 LYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMH---KN 168
Query: 686 PIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+LL  K +    ++ DFGLS  F  +A+  +   + GT  Y+ PE    
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAYYIAPEVLHG 225
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINE 773
               EK DV+S GV++  +++  P  +  NE
Sbjct: 226 T-YDEKCDVWSTGVILYILLSGCPPFNGANE 255

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 571 ERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTS 625
           +R LGKG FG V     ++   + AVK++                EV+LL ++ H N+  
Sbjct: 55  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 114
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    ++     L+ E    G L + +  IS+K  S  +  RI  +   G+ Y+H   K 
Sbjct: 115 LYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMH---KN 169
Query: 686 PIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+LL  K +    ++ DFGLS  F  +A+  +   + GT  Y+ PE    
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAYYIAPEVLHG 226
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINE 773
               EK DV+S GV++  +++  P  +  NE
Sbjct: 227 T-YDEKCDVWSTGVILYILLSGCPPFNGANE 256

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 571 ERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTS 625
           +R LGKG FG V     ++   + AVK++                EV+LL ++ H N+  
Sbjct: 37  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 96
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    ++     L+ E    G L + +  IS+K  S  +  RI  +   G+ Y+H   K 
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMH---KN 151
Query: 686 PIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+LL  K +    ++ DFGLS  F  +A+  +   + GT  Y+ PE    
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAYYIAPEVLHG 208
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINE 773
               EK DV+S GV++  +++  P  +  NE
Sbjct: 209 T-YDEKCDVWSTGVILYILLSGCPPFNGANE 238

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 568 NNFE--RTLGKGGFGTVYYGR-LNEID----VAVKMLXXXXXXXX--XXXXXEVKLLMRV 618
           ++FE  + LG+G FG V+  R +   D     A+K+L               E  +L  V
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLE 677
           +H  +  L      + +  LI +F+  G+L    + +SK+V+ ++E ++  + E A GL+
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           +LH+     I++RD+K  NILL+E+   KL DFGLSK  A D      +   GT  Y+ P
Sbjct: 145 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDHEKKAYS-FCGTVEYMAP 199
Query: 738 EYYTSNRLTEKSDVYSFGVVILEIIT 763
           E       +  +D +S+GV++ E++T
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 571 ERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTS 625
           +R LGKG FG V     ++   + AVK++                EV+LL ++ H N+  
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    ++     L+ E    G L + +  IS+K  S  +  RI  +   G+ Y+H   K 
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMH---KN 145
Query: 686 PIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+LL  K +    ++ DFGLS  F  +A+  +   + GT  Y+ PE    
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAYYIAPEVLHG 202
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINE 773
               EK DV+S GV++  +++  P  +  NE
Sbjct: 203 T-YDEKCDVWSTGVILYILLSGCPPFNGANE 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXX---XXXXXXEVKLL-MRVHHRNLTS 625
           + LGKG FG V+     + +   A+K L                E ++L +   H  LT 
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           +            + E++  G+L  ++    K  LS       A E   GL++LH+    
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQFLHSKG-- 139
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTVVAGTPGYLDPEYYTSNR 744
            IV+RD+K  NILL++    K+ADFG+ K     DA T       GTP Y+ PE     +
Sbjct: 140 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCGTPDYIAPEILLGQK 195
Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIH 778
                D +SFGV++ E++  +      +EEE  H
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 229

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 13/220 (5%)
Query: 572 RTLGKGGFGTVYYGRLNEID-----VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           R LG+GGFG V+  ++           +                E K+L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI--AVESAQGLEYLHNGCK 684
               +      L+   M  G+++ ++ ++ +     QE   I    +   GLE+LH   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I++RD+K  N+LL++    +++D GL+      A    +   AGTPG++ PE      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 745 LTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWV 783
                D ++ GV + E+I  + P  +R  + E   ++Q V
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 574 LGKGGFGTVYYG----RLNEIDVAVKMLXX-XXXXXXXXXXXEVKLLMRVHHRNLTSLVG 628
           LG G FG+V  G    R  +IDVA+K+L              E +++ ++ +  +  L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
            C  +    L+ E    G L ++L    +++  S     +  + + G++YL        V
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEK---NFV 458
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTE 747
           HR++ + N+LL  +  AK++DFGLSK+   D + + +      P  +  PE     + + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 748 KSDVYSFGVVILEIIT 763
           +SDV+S+GV + E ++
Sbjct: 519 RSDVWSYGVTMWEALS 534

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXX--XXXXXXXXEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VA+K++               EV+++  ++H N+  L 
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              + +    LI E+ + G + +YL    + K   ++ + R  V + Q   Y H   +  
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCH---QKR 131
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K+ N+LL+  +  K+ADFG S  F             G+P Y  PE +   +  
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DTFCGSPPYAAPELFQGKKYD 188
Query: 747 -EKSDVYSFGVVILEIIT 763
             + DV+S GV++  +++
Sbjct: 189 GPEVDVWSLGVILYTLVS 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 13/220 (5%)
Query: 572 RTLGKGGFGTVYYGRLNEID-----VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           R LG+GGFG V+  ++           +                E K+L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI--AVESAQGLEYLHNGCK 684
               +      L+   M  G+++ ++ ++ +     QE   I    +   GLE+LH   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I++RD+K  N+LL++    +++D GL+      A    +   AGTPG++ PE      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 745 LTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWV 783
                D ++ GV + E+I  + P  +R  + E   ++Q V
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 124
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 185 EPVDVWSCGIVLTAMLA 201

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 13/220 (5%)
Query: 572 RTLGKGGFGTVYYGRLNEID-----VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           R LG+GGFG V+  ++           +                E K+L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI--AVESAQGLEYLHNGCK 684
               +      L+   M  G+++ ++ ++ +     QE   I    +   GLE+LH   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I++RD+K  N+LL++    +++D GL+      A    +   AGTPG++ PE      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 745 LTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWV 783
                D ++ GV + E+I  + P  +R  + E   ++Q V
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXX--XXXXXXXXEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VA+K++               EV+++  ++H N+  L 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              + +    LI E+ + G + +YL    + K   ++ + R  V + Q   Y H   +  
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCH---QKR 134
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K+ N+LL+  +  K+ADFG S  F             G P Y  PE +   +  
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYD 191
Query: 747 -EKSDVYSFGVVILEIIT 763
             + DV+S GV++  +++
Sbjct: 192 GPEVDVWSLGVILYTLVS 209

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 40/282 (14%)
Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXXXXXEVKLLMR---VHHR 621
           R LG+G FG VY G   +I        VAVK +                 +M+    HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESA 673
            +  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E A
Sbjct: 82  -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTVVAGTP 732
            G+ YL N  K   VHR++ + N ++      K+ DFG+++  + TD        +    
Sbjct: 141 DGMAYL-NAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 196
Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
            ++ PE       T  SD++SFGVV+ EI +                 Q    L  +  +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA--------------EQPYQGLSNEQVL 242
Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           K ++D    +  D N   +  +L   C     N RPT  ++V
Sbjct: 243 KFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 13/220 (5%)
Query: 572 RTLGKGGFGTVYYGRLNEID-----VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           R LG+GGFG V+  ++           +                E K+L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI--AVESAQGLEYLHNGCK 684
               +      L+   M  G+++ ++ ++ +     QE   I    +   GLE+LH   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I++RD+K  N+LL++    +++D GL+      A    +   AGTPG++ PE      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 745 LTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWV 783
                D ++ GV + E+I  + P  +R  + E   ++Q V
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 40/282 (14%)
Query: 572 RTLGKGGFGTVYYGRLNEI-------DVAVKMLXXXXXXXXXXXXXEVKLLMR---VHHR 621
           R LG+G FG VY G   +I        VAVK +                 +M+    HH 
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 82
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSS--------QERLRIAVESA 673
            +  L+G   +   T ++ E MA+G+L+ YL  +  +  ++        QE +++A E A
Sbjct: 83  -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTVVAGTP 732
            G+ YL N  K   VHR++ + N ++      K+ DFG+++  + TD        +    
Sbjct: 142 DGMAYL-NAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 197
Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
            ++ PE       T  SD++SFGVV+ EI +                 Q    L  +  +
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA--------------EQPYQGLSNEQVL 243
Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           K ++D    +  D N   +  +L   C     N RPT  ++V
Sbjct: 244 KFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXX---XXXXEVKLLMRVHHRNLTSLVG 628
           LG GG   V+  R   +  DVAVK+L                E +    ++H  + ++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 629 HCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
             + +        ++ E++    L++ +   ++  ++ +  + +  ++ Q L + H NG 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG- 136
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV-VAGTPGYLDPEYYTS 742
              I+HRDVK  NIL++     K+ DFG++++ A   N+   T  V GT  YL PE    
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 743 NRLTEKSDVYSFGVVILEIITCKP 766
           + +  +SDVYS G V+ E++T +P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 126
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 26/228 (11%)
Query: 565 KITNNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRV 618
           +   NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESA 673
           +H N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLL 120
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
           QGL + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  
Sbjct: 121 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 175
Query: 734 YLDPEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           Y  PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 223

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
             E+ LG G FG V+    N+   VAVK +             E  ++  + H  L  L 
Sbjct: 185 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLH 243
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               ++    +I EFMA G+L ++L           + +  + + A+G+ ++        
Sbjct: 244 AVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 299
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLT 746
           +HRD+++ NIL++  L  K+ADFGL++            V A  P  +  PE       T
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLAR------------VGAKFPIKWTAPEAINFGSFT 347
Query: 747 EKSDVYSFGVVILEIIT 763
            KSDV+SFG++++EI+T
Sbjct: 348 IKSDVWSFGILLMEIVT 364

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + 
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++           
Sbjct: 135 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 191
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                   ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 192 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 573 TLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH--- 629
            +GKG +G V+ G  +   VAVK+              E+   + + H N+   +     
Sbjct: 15  CVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRET-EIYNTVLLRHDNILGFIASDMT 73
Query: 630 -CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-----NGC 683
             +   Q  LI  +  +G+L ++L    ++ L     LR+AV +A GL +LH        
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQ---RQTLEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPEYYT 741
           KP I HRD KS N+L+   LQ  +AD GL+   S  +D     +    GT  Y+ PE   
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 742 SNRLTE------KSDVYSFGVVILEI 761
               T+       +D+++FG+V+ EI
Sbjct: 191 EQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 14/221 (6%)
Query: 562 DVVKITN-NFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXX---XXXXXXEVKLL 615
           D VK+T+ NF   LGKG FG V     +  E   A+K+L                E ++L
Sbjct: 14  DRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVL 73
Query: 616 MRVHHRNLTSLVGHCDED-NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
             +      + +  C +  ++   + E++  G+L  ++  + K      + +  A E + 
Sbjct: 74  ALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISI 131
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           GL +LH   K  I++RD+K  N++L+ +   K+ADFG+ K    D  T  +    GTP Y
Sbjct: 132 GLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT--TREFCGTPDY 186
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           + PE        +  D +++GV++ E++  +P     +E+E
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 574 LGKGGFGTVYYGRLNEIDV--AVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G FG VY  +  E     A K++             E+++L    H  +  L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
            D +  ++ EF   G +   + ++ + +   Q ++ +  +  + L +LH+     I+HRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHSK---RIIHRD 134
Query: 692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE---- 747
           +K+ N+L+  +   +LADFG+S           S +  GTP ++ PE      + +    
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTPYD 192
Query: 748 -KSDVYSFGVVILEIITCKPAISRIN 772
            K+D++S G+ ++E+   +P    +N
Sbjct: 193 YKADIWSLGITLIEMAQIEPPHHELN 218

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLXXXXXXXXXXX-XXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + 
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++           
Sbjct: 126 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                   ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 575 GKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH----C 630
            +G FG V+  +L    VAVK+              E+     + H NL   +       
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSER-EIFSTPGMKHENLLQFIAAEKRGS 82
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN--------G 682
           + + +  LI  F   G+L +YL      +++  E   +A   ++GL YLH         G
Sbjct: 83  NLEVELWLITAFHDKGSLTDYLKG---NIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            KP I HRD KS N+LL   L A LADFGL+  F        +    GT  Y+ PE    
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEG 199
Query: 743 NRLTEKS-----DVYSFGVVILEIIT-CKPAISRINE 773
               ++      D+Y+ G+V+ E+++ CK A   ++E
Sbjct: 200 AINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G +G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 26/228 (11%)
Query: 565 KITNNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRV 618
           +   NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESA 673
           +H N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLL 120
Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
           QGL + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  
Sbjct: 121 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 175
Query: 734 YLDPEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           Y  PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 223

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF++  +L+++     L+ I   ++ S        +  QGL
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY-----LFQLLQGL 119
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 120 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 572 RTLGKGGFGTVYYG-----RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R LG+G FG VY G     +  +I+VAVK                  ++M+ + H ++  
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCK 684
           L+G  +E+  T +I E    G L  YL   +K  L     +  +++  + + YL +  C 
Sbjct: 90  LIGIIEEE-PTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESINC- 146
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
              VHRD+   NIL+      KL DFGLS+ +  D + + ++V      ++ PE     R
Sbjct: 147 ---VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRR 202
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T  SDV+ F V + EI++
Sbjct: 203 FTTASDVWMFAVCMWEILS 221

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXX---XXXXXXEVKLL-MRVH 619
           +NFE  R LGKG FG V   R+ E     AVK+L                E ++L +  +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEY 678
           H  LT L       ++   + EF+  G+L   +  I K     + R R  A E    L +
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH+     I++RD+K  N+LL+ +   KLADFG+ K    +  T  +    GTP Y+ PE
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPE 194
Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
                      D ++ GV++ E++         NE++
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 SFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 170
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 117
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 118 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 172
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXX---XXXXEVKLLMRVHHRNLTSLVG 628
           LG GG   V+  R   +  DVAVK+L                E +    ++H  + ++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 629 HCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
             + +        ++ E++    L++ +   ++  ++ +  + +  ++ Q L + H NG 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG- 136
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV-VAGTPGYLDPEYYTS 742
              I+HRDVK  NI+++     K+ DFG++++ A   N+   T  V GT  YL PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 743 NRLTEKSDVYSFGVVILEIITCKP 766
           + +  +SDVYS G V+ E++T +P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 118
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 119 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 173
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF++  +L+++     L+ I   ++ S        +  QGL
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY-----LFQLLQGL 118
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 119 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 173
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 120
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 121 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 175
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXX---XXXXXXXXXXEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L                E ++L 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQG 675
              H  LT+L       ++   + E+ ANG   E    +S++ + ++ER R    E    
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFTEERARFYGAEIVSA 120
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LEYLH+     +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL
Sbjct: 121 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 175
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEII 762
            PE    N      D +  GVV+ E++
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMM 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 119
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 120 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 118
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 119 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 173
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXX--XXXXXXXXEVKLLMRVHHRNLTS 625
            ++T+GKG F  V   R  L   +VAVK++               EV+++  ++H N+  
Sbjct: 19  LQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCK 684
           L    + +    L+ E+ + G + +YL    + K   ++ + R  V + Q   Y H    
Sbjct: 79  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKY- 134
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             IVHRD+K+ N+LL+  +  K+ADFG S  F             G+P Y  PE +   +
Sbjct: 135 --IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL---DTFCGSPPYAAPELFQGKK 189
Query: 745 LT-EKSDVYSFGVVILEIIT 763
               + DV+S GV++  +++
Sbjct: 190 YDGPEVDVWSLGVILYTLVS 209

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + 
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD     
Sbjct: 141 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
              +     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 198 GKGLLPV-RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXX---XXXXXXXXXXEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L                E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQG 675
              H  LT+L       ++   + E+ ANG   E    +S++ + ++ER R    E    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LEYLH+     +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 172
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEII 762
            PE    N      D +  GVV+ E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTSL 626
           +TLG+G FG V   Y       VA+K++                E+  L  + H ++  L
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                  ++  ++ E+  N  L +Y+  + +  +S QE  R   +    +EY H   +  
Sbjct: 79  YDVIKSKDEIIMVIEYAGN-ELFDYI--VQRDKMSEQEARRFFQQIISAVEYCH---RHK 132
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K  N+LL+E L  K+ADFGLS +  TD N   ++   G+P Y  PE  +     
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS--CGSPNYAAPEVISGKLYA 189
Query: 747 -EKSDVYSFGVVILEIITCK 765
             + DV+S G VIL ++ C+
Sbjct: 190 GPEVDVWSCG-VILYVMLCR 208

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 572 RTLGKGGFGTVYYG-----RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R LG+G FG VY G     +  +I+VAVK                  ++M+ + H ++  
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCK 684
           L+G  +E+  T +I E    G L  YL   +K  L     +  +++  + + YL +  C 
Sbjct: 78  LIGIIEEE-PTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESINC- 134
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
              VHRD+   NIL+      KL DFGLS+ +  D + + ++V      ++ PE     R
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T  SDV+ F V + EI++
Sbjct: 191 FTTASDVWMFAVCMWEILS 209

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 574 LGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXX---XXXXEVKLLMRVHHRNLTSLVG 628
           LG GG   V+  R   +  DVAVK+L                E +    ++H  + ++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 629 HCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
             + +        ++ E++    L++ +   ++  ++ +  + +  ++ Q L + H NG 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG- 136
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV-VAGTPGYLDPEYYTS 742
              I+HRDVK  NI+++     K+ DFG++++ A   N+   T  V GT  YL PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 743 NRLTEKSDVYSFGVVILEIITCKP 766
           + +  +SDVYS G V+ E++T +P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 117
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 118 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 172
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 120
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 121 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 175
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 220

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 119
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 120 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTSL 626
           +TLG+G FG V   Y       VA+K++                E+  L  + H ++  L
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                  ++  ++ E+  N  L +Y+  + +  +S QE  R   +    +EY H   +  
Sbjct: 80  YDVIKSKDEIIMVIEYAGN-ELFDYI--VQRDKMSEQEARRFFQQIISAVEYCH---RHK 133
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K  N+LL+E L  K+ADFGLS +  TD N   ++   G+P Y  PE  +     
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS--CGSPNYAAPEVISGKLYA 190
Query: 747 -EKSDVYSFGVVILEIITCK 765
             + DV+S G VIL ++ C+
Sbjct: 191 GPEVDVWSCG-VILYVMLCR 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 170
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 572 RTLGKGGFGTVYYG-----RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R LG+G FG VY G     +  +I+VAVK                  ++M+ + H ++  
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCK 684
           L+G  +E+  T +I E    G L  YL   +K  L     +  +++  + + YL +  C 
Sbjct: 74  LIGIIEEE-PTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESINC- 130
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
              VHRD+   NIL+      KL DFGLS+ +  D + + ++V      ++ PE     R
Sbjct: 131 ---VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRR 186
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T  SDV+ F V + EI++
Sbjct: 187 FTTASDVWMFAVCMWEILS 205

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 21/219 (9%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVL--------SSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +   +         S  + 
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD     
Sbjct: 141 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
              +     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 198 GKGLLPV-RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 170
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXX---XXXXXXXXXXEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L                E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQG 675
              H  LT+L       ++   + E+ ANG   E    +S++ + ++ER R    E    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LEYLH+     +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 172
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEII 762
            PE    N      D +  GVV+ E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXX---XXXXXXXXXXEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L                E ++L 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQG 675
              H  LT+L       ++   + E+ ANG   E    +S++ + ++ER R    E    
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFTEERARFYGAEIVSA 122
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LEYLH+     +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL
Sbjct: 123 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 177
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
            PE    N      D +  GVV+ E++  +
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 118
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 119 AFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 173
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + 
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD     
Sbjct: 132 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 187
Query: 725 STVVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                G  G     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 188 -----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 574 LGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXX---XXXXEVKLLMRVHHRNLTSLVG 628
           LG GG   V+  R   +  DVAVK+L                E +    ++H  + ++  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 629 HCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
             + +        ++ E++    L++ +   ++  ++ +  + +  ++ Q L + H NG 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG- 136
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV-VAGTPGYLDPEYYTS 742
              I+HRDVK  NI+++     K+ DFG++++ A   N+   T  V GT  YL PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 743 NRLTEKSDVYSFGVVILEIITCKP 766
           + +  +SDVYS G V+ E++T +P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVL--------SSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +   +         S  + 
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD     
Sbjct: 131 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 186
Query: 725 STVVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                G  G     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 187 -----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF++  +L+++     L+ I   ++ S        +  QGL
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 119
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 120 AFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 170
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 565 KITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVKLLM 616
           KIT    R LG+G FG VY G          E  VA+K +              E  ++ 
Sbjct: 19  KIT--MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 76
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQERLRI 668
             +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + +++
Sbjct: 77  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTV 727
           A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD        
Sbjct: 137 AGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK---- 189
Query: 728 VAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             G  G     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 190 --GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 117
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 118 AFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 172
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 569 NFERTLGKGGFGTVY----YGRLNE---IDVAVKMLX-XXXXXXXXXXXXEVKLLMRV-H 619
           +F +TLG G FG V     YG +     + VAVKML              E+K+L  + +
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI----------- 668
           H N+ +L+G C     T +I E+   G+L  +L       + S+    I           
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 669 -----AVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
                + + A+G+ +L +  C    +HRD+ + NILL      K+ DFGL++    D+N 
Sbjct: 162 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            V         ++ PE   +   T +SDV+S+G+ + E+ +
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXX---XXXXXXXXXXEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L                E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQG 675
              H  LT+L       ++   + E+ ANG   E    +S++ + ++ER R    E    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LEYLH+     +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEII 762
            PE    N      D +  GVV+ E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 117
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 118 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 172
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + 
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD     
Sbjct: 128 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 183
Query: 725 STVVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                G  G     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 184 -----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTSL 626
           +TLG+G FG V   Y       VA+K++                E+  L  + H ++  L
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                  ++  ++ E+  N  L +Y+  + +  +S QE  R   +    +EY H   +  
Sbjct: 70  YDVIKSKDEIIMVIEYAGN-ELFDYI--VQRDKMSEQEARRFFQQIISAVEYCH---RHK 123
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K  N+LL+E L  K+ADFGLS +  TD N   ++   G+P Y  PE  +     
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS--CGSPNYAAPEVISGKLYA 180
Query: 747 -EKSDVYSFGVVILEIITCK 765
             + DV+S G VIL ++ C+
Sbjct: 181 GPEVDVWSCG-VILYVMLCR 199

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 69/245 (28%), Positives = 100/245 (40%), Gaps = 25/245 (10%)
Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXX----XXEVKLLMRVHHRNLTS 625
           F+  +G+G F TVY G   E  V V                    E + L  + H N+  
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 626 LVGHCDEDNQ----TALIYEFMANGNLQEYLS--DISK-KVLSSQERLRIAVESAQGLEY 678
                +   +      L+ E   +G L+ YL    + K KVL S  R     +  +GL++
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR-----QILKGLQF 144
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           LH    PPI+HRD+K  NI +       K+ D GL    AT      +  V GTP +  P
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGL----ATLKRASFAKAVIGTPEFXAP 199
Query: 738 EYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
           E Y   +  E  DVY+FG   LE  T +   S      +I+ R  V S +       +  
Sbjct: 200 EXY-EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRR--VTSGVKPASFDKVAI 256
Query: 798 PRLQE 802
           P ++E
Sbjct: 257 PEVKE 261

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTSL 626
           +TLG+G FG V   Y       VA+K++                E+  L  + H ++  L
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                  ++  ++ E+  N  L +Y+  + +  +S QE  R   +    +EY H   +  
Sbjct: 74  YDVIKSKDEIIMVIEYAGN-ELFDYI--VQRDKMSEQEARRFFQQIISAVEYCH---RHK 127
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K  N+LL+E L  K+ADFGLS +  TD N   ++   G+P Y  PE  +     
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS--CGSPNYAAPEVISGKLYA 184
Query: 747 -EKSDVYSFGVVILEIITCK 765
             + DV+S G VIL ++ C+
Sbjct: 185 GPEVDVWSCG-VILYVMLCR 203

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + 
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD     
Sbjct: 135 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 190
Query: 725 STVVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                G  G     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 191 -----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVL--------SSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + 
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           +++A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD     
Sbjct: 134 IQMAGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 189
Query: 725 STVVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                G  G     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 190 -----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF++  +L+++     L+ I   ++ S        +  QGL
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 117
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 118 AFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 172
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXX---XXXXXXXXXXEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L                E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQG 675
              H  LT+L       ++   + E+ ANG   E    +S++ + ++ER R    E    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LEYLH+     +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEII 762
            PE    N      D +  GVV+ E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 569 NFERTLGKGGFGTVY----YGRLNE---IDVAVKMLX-XXXXXXXXXXXXEVKLLMRV-H 619
           +F +TLG G FG V     YG +     + VAVKML              E+K+L  + +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI----------- 668
           H N+ +L+G C     T +I E+   G+L  +L       + S+    I           
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 669 -----AVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
                + + A+G+ +L +  C    +HRD+ + NILL      K+ DFGL++    D+N 
Sbjct: 146 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            V         ++ PE   +   T +SDV+S+G+ + E+ +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR---LNEIDVAVKM-LXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R     E+    K+ L             E+ LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 116
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 171
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR---LNEIDVAVKM-LXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R     E+    K+ L             E+ LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+++     L+ I   ++ S        +  QGL
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 170
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXX---XXXXXXXXXXEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L                E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQG 675
              H  LT+L       ++   + E+ ANG   E    +S++ + ++ER R    E    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LEYLH+     +V+RD+K  N++L++    K+ DFGL K   +D  T       GTP YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
            PE    N      D +  GVV+ E++  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 569 NFERTLGKGGFGTVY----YGRLNE---IDVAVKMLX-XXXXXXXXXXXXEVKLLMRV-H 619
           +F +TLG G FG V     YG +     + VAVKML              E+K+L  + +
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI----------- 668
           H N+ +L+G C     T +I E+   G+L  +L       + S+    I           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 669 -----AVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
                + + A+G+ +L +  C    +HRD+ + NILL      K+ DFGL++    D+N 
Sbjct: 169 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            V         ++ PE   +   T +SDV+S+G+ + E+ +
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXX--XXXXXXXXXEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VAVK++               EV+++  ++H N+  L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              + +    L+ E+ + G + +YL    + K   ++ + R  V + Q   Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF--- 133
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K+ N+LL+  +  K+ADFG S  F             G+P Y  PE +   +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DTFCGSPPYAAPELFQGKKYD 190
Query: 747 -EKSDVYSFGVVILEIIT 763
             + DV+S GV++  +++
Sbjct: 191 GPEVDVWSLGVILYTLVS 208

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 565 KITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVKLLM 616
           KIT    R LG+G FG VY G          E  VA+K +              E  ++ 
Sbjct: 48  KIT--MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 105
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQERLRI 668
             +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + +++
Sbjct: 106 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 165
Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVSTV 727
           A E A G+ YL N  K   VHRD+ + N ++ E    K+ DFG+++  + TD        
Sbjct: 166 AGEIADGMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK---- 218
Query: 728 VAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             G  G     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 219 --GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 569 NFERTLGKGGFGTVY----YGRLNE---IDVAVKMLX-XXXXXXXXXXXXEVKLLMRV-H 619
           +F +TLG G FG V     YG +     + VAVKML              E+K+L  + +
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI----------- 668
           H N+ +L+G C     T +I E+   G+L  +L       + S+    I           
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 669 -----AVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
                + + A+G+ +L +  C    +HRD+ + NILL      K+ DFGL++    D+N 
Sbjct: 164 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            V         ++ PE   +   T +SDV+S+G+ + E+ +
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXX--XXXXXXXXXEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VAVK++               EV+++  ++H N+  L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              + +    L+ E+ + G + +YL    + K   ++ + R  V + Q   Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF--- 133
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K+ N+LL+  +  K+ADFG S  F             G+P Y  PE +   +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DTFCGSPPYAAPELFQGKKYD 190
Query: 747 -EKSDVYSFGVVILEIIT 763
             + DV+S GV++  +++
Sbjct: 191 GPEVDVWSLGVILYTLVS 208

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 569 NFERTLGKGGFGTVY----YGRLNE---IDVAVKMLX-XXXXXXXXXXXXEVKLLMRV-H 619
           +F +TLG G FG V     YG +     + VAVKML              E+K+L  + +
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI----------- 668
           H N+ +L+G C     T +I E+   G+L  +L       + S+    I           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 669 -----AVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
                + + A+G+ +L +  C    +HRD+ + NILL      K+ DFGL++    D+N 
Sbjct: 169 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            V         ++ PE   +   T +SDV+S+G+ + E+ +
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 571 ERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTS 625
           +R LGKG FG V     ++   + AVK++                EV+LL ++ H N+  
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXK 90
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    ++     L+ E    G L + +  IS+K  S  +  RI  +   G+ Y H   K 
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYXH---KN 145
Query: 686 PIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+LL  K +    ++ DFGLS  F             GT  Y+ PE    
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI---GTAYYIAPEVLHG 202
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINE 773
               EK DV+S GV++  +++  P  +  NE
Sbjct: 203 T-YDEKCDVWSTGVILYILLSGCPPFNGANE 232

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++EF+ + +L+ +     L+ I   ++ S        +  QGL
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY-----LFQLLQGL 119
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 120 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXX--XXXXXXXXXEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VAVK++               EV+++  ++H N+  L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              + +    L+ E+ + G + +YL    + K   ++ + R  V + Q   Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF--- 133
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K+ N+LL+  +  K+ADFG S  F             G P Y  PE +   +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAPELFQGKKYD 190
Query: 747 -EKSDVYSFGVVILEIIT 763
             + DV+S GV++  +++
Sbjct: 191 GPEVDVWSLGVILYTLVS 208

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 574 LGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXX---XXXXEVKLLMRVHHRNLTSLVG 628
           LG GG   V+  R   +  DVAVK+L                E +    ++H  + ++  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 629 HCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
             + +        ++ E++    L++ +   ++  ++ +  + +  ++ Q L + H NG 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG- 136
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV-VAGTPGYLDPEYYTS 742
              I+HRDVK  NI+++     K+ DFG++++ A   N+   T  V GT  YL PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 743 NRLTEKSDVYSFGVVILEIITCKP 766
           + +  +SDVYS G V+ E++T +P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 82  RLLGIC-LTSTVQLIMQLMPFGXLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 137
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 138 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 197 YTHQSDVWSYGVTVWELMT 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 73/131 (55%), Gaps = 8/131 (6%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTN 696
           ++ E++    L++ +   ++  ++ +  + +  ++ Q L + H NG    I+HRDVK  N
Sbjct: 110 IVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPAN 163
Query: 697 ILLNEKLQAKLADFGLSKSFATDANTHVSTV-VAGTPGYLDPEYYTSNRLTEKSDVYSFG 755
           I+++     K+ DFG++++ A   N+   T  V GT  YL PE    + +  +SDVYS G
Sbjct: 164 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 223
Query: 756 VVILEIITCKP 766
            V+ E++T +P
Sbjct: 224 CVLYEVLTGEP 234

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 85  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 140
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 141 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 200 YTHQSDVWSYGVTVWELMT 218

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 572 RTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXX-XXXEVKLLMRVHHRNLTSLVG 628
           +TLG+G  G V     R+ E  VAVK++              E+ +   ++H N+    G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 629 HCDEDNQTALIYEFMANGNLQEYLS-DISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           H  E N   L  E+ + G L + +  DI      +Q   R   +   G+ YLH      I
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGIG---I 125
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-T 746
            HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE         
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 747 EKSDVYSFGVVILEIIT 763
           E  DV+S G+V+  ++ 
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 120/292 (41%), Gaps = 40/292 (13%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHH 620
           ++FE  R LGKG FG VY  R  +    VA+K+L                E+++   +HH
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L  +  +  +  LI E+   G L + L          Q    I  E A  L Y H
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC--TFDEQRTATIMEELADALMYCH 140
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
            G K  ++HRD+K  N+LL  K + K+ADFG    ++  A +     + GT  YL PE  
Sbjct: 141 -GKK--VIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPEMI 193
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
                 EK D++  GV+  E++   P     +  E           I K D+K       
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE-------TYRRIVKVDLK------- 239
Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGR 852
              F A+    A +L    L    ++R  ++QV        A    RANS R
Sbjct: 240 ---FPASVPTGAQDLISKLLRHNPSERLPLAQVS-------AHPWVRANSRR 281

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 82  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 137
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 138 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 197 YTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 81  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 39/237 (16%)
Query: 572 RTLGKGGFGTVYYG---RLNEIDVAVKML--XXXXXXXXXXXXXEVKLLMRVH-HRNLTS 625
           + LGKG +G V+     R  E+ VAVK +               E+ +L  +  H N+ +
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEV-VAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 626 L--VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
           L  V   D D    L++++M      +  + I   +L    +  +  +  + ++YLH+G 
Sbjct: 74  LLNVLRADNDRDVYLVFDYMET----DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT-------------------DANTHV 724
              ++HRD+K +NILLN +   K+ADFGLS+SF                     D +  +
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 725 STVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEIITCKPAI---SRINEEEKI 777
            T    T  Y  PE    S + T+  D++S G ++ EI+  KP     S +N+ E+I
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 84  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 199 YTHQSDVWSYGVTVWELMT 217

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 34/274 (12%)
Query: 572 RTLGKGGFGTVYYGRLNEIDV-------AVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLT 624
           R LGKGGF   Y   + ++D         V                E+ +   + + ++ 
Sbjct: 48  RFLGKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
              G  ++D+   ++ E     +L E      +K ++  E      ++ QG++YLHN   
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHK--RRKAVTEPEARYFMRQTIQGVQYLHNN-- 161
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K  N+ LN+ +  K+ DFGL+     D        + GTP Y+ PE      
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKTLCGTPNYIAPEVLCKKG 218
Query: 745 LTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLI----- 787
            + + D++S G ++  ++  KP            RI + E     HI    ++LI     
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLH 278
Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLS 821
           A   ++  V   L ++F   S +  + L  +CL+
Sbjct: 279 ADPTLRPSVAELLTDEF-FTSGYAPMRLPTSCLT 311

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 83  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 198 YTHQSDVWSYGVTVWELMT 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXX--XXXXXXXXXEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VAVK++               EV+++  ++H N+  L 
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
              + +    L+ E+ + G + +YL  ++   +  +E      +    ++Y H      I
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFRQIVSAVQYCHQKF---I 127
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT- 746
           VHRD+K+ N+LL+  +  K+ADFG S  F             G+P Y  PE +   +   
Sbjct: 128 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DTFCGSPPYAAPELFQGKKYDG 184
Query: 747 EKSDVYSFGVVILEIIT 763
            + DV+S GV++  +++
Sbjct: 185 PEVDVWSLGVILYTLVS 201

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGXLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 78  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAEGMNYLEDR-- 133
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 134 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 192
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 193 YTHQSDVWSYGVTVWELMT 211

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 106 RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 161
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 162 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 220
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 221 YTHQSDVWSYGVTVWELMT 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 34/274 (12%)
Query: 572 RTLGKGGFGTVYYGRLNEIDV-------AVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLT 624
           R LGKGGF   Y   + ++D         V                E+ +   + + ++ 
Sbjct: 48  RFLGKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
              G  ++D+   ++ E     +L E      +K ++  E      ++ QG++YLHN   
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHK--RRKAVTEPEARYFMRQTIQGVQYLHNN-- 161
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K  N+ LN+ +  K+ DFGL+     D        + GTP Y+ PE      
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVLCKKG 218
Query: 745 LTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLI----- 787
            + + D++S G ++  ++  KP            RI + E     HI    ++LI     
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLH 278
Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLS 821
           A   ++  V   L ++F   S +  + L  +CL+
Sbjct: 279 ADPTLRPSVAELLTDEF-FTSGYAPMRLPTSCLT 311

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 84  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 199 YTHQSDVWSYGVTVWELMT 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXX--XXXXXXXXXEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VAV+++               EV+++  ++H N+  L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              + +    L+ E+ + G + +YL    + K   ++ + R  V + Q   Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF--- 133
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K+ N+LL+  +  K+ADFG S  F             G+P Y  PE +   +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DTFCGSPPYAAPELFQGKKYD 190
Query: 747 -EKSDVYSFGVVILEIIT 763
             + DV+S GV++  +++
Sbjct: 191 GPEVDVWSLGVILYTLVS 208

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHHRNLTSL 626
           R LGKG FG VY  R   N+  +A+K+L                E+++   + H N+  +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
             +  +  +  L+ EF   G L + L    +     Q       E A  L Y H   +  
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH---ERK 134
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           ++HRD+K  N+L+  K + K+ADFG S      A +     + GT  YL PE        
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTHD 190
Query: 747 EKSDVYSFGVVILEIITCKP 766
           EK D++  GV+  E +   P
Sbjct: 191 EKVDLWCAGVLCYEFLVGMP 210

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHHRNLTSL 626
           R LGKG FG VY  R   N+  +A+K+L                E+++   + H N+  +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
             +  +  +  L+ EF   G L + L    +     Q       E A  L Y H   +  
Sbjct: 81  YNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH---ERK 135
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           ++HRD+K  N+L+  K + K+ADFG S      A +     + GT  YL PE        
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTHD 191
Query: 747 EKSDVYSFGVVILEIITCKP 766
           EK D++  GV+  E +   P
Sbjct: 192 EKVDLWCAGVLCYEFLVGMP 211

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 87  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 142
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 143 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 201
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 202 YTHQSDVWSYGVTVWELMT 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 84  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 199 YTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 8/171 (4%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISK--KVLSSQERL 666
           EV LL  + H N+        +   T L  + E+   G+L   ++  +K  + L  +  L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 667 RIAVESAQGLEYLHNGCK--PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           R+  +    L+  H        ++HRD+K  N+ L+ K   KL DFGL++    D  T  
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSF 172
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           +    GTP Y+ PE        EKSD++S G ++ E+    P  +  +++E
Sbjct: 173 AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLN-------EIDVAVKML-XXXXXXXXXXXXXEVK 613
           +V +      R LG+G FG VY G          E  VA+K +              E  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 614 LLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQER 665
           ++   +  ++  L+G   +   T +I E M  G+L+ YL  +  ++         S  + 
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHV 724
           +++A E A G+ YL N  K   VHRD+ + N  + E    K+ DFG+++  + TD     
Sbjct: 128 IQMAGEIADGMAYL-NANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK- 183
Query: 725 STVVAGTPG-----YLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                G  G     ++ PE       T  SDV+SFGVV+ EI T
Sbjct: 184 -----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 8/171 (4%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISK--KVLSSQERL 666
           EV LL  + H N+        +   T L  + E+   G+L   ++  +K  + L  +  L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 667 RIAVESAQGLEYLHNGCK--PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           R+  +    L+  H        ++HRD+K  N+ L+ K   KL DFGL++    D  T  
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSF 172
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           +    GTP Y+ PE        EKSD++S G ++ E+    P  +  +++E
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 88  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 203 YTHQSDVWSYGVTVWELMT 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 75  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 130
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 131 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 190 YTHQSDVWSYGVTVWELMT 208

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYGRL------NEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K+L              E  ++  V    ++
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   L+ + M  G L +++ + ++  L SQ+ L   ++ A+G+ YL +   
Sbjct: 83  RLLGIC-LTSTVQLVTQLMPYGCLLDHVRE-NRGRLGSQDLLNWCMQIAKGMSYLEDV-- 138
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL++    D   + +        ++  E     R
Sbjct: 139 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 198 FTHQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 84  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 199 YTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 91  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 146
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 147 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 205
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 206 YTHQSDVWSYGVTVWELMT 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 83  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 198 YTHQSDVWSYGVTVWELMT 216

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 572 RTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           RTLG G FG V+    R N    A+K+L                E  +L  V H  +  +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G   +  Q  +I +++  G L   L   S++  +   +   A E    LEYLH+     
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKF-YAAEVCLALEYLHSK---D 126
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           I++RD+K  NILL++    K+ DFG +K +  D    V+  + GTP Y+ PE  ++    
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAK-YVPD----VTYXLCGTPDYIAPEVVSTKPYN 181
Query: 747 EKSDVYSFGVVILEIIT 763
           +  D +SFG++I E++ 
Sbjct: 182 KSIDWWSFGILIYEMLA 198

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/315 (25%), Positives = 128/315 (40%), Gaps = 44/315 (13%)
Query: 574 LGKGGFGTVYYGR-------LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH---HRNL 623
           +G G +GTVY  R       +    V V                EV LL R+    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 624 TSLVGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
             L+  C     D + +  L++E + + +L+ YL       L ++    +  +  +GL++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH  C   IVHRD+K  NIL+      KLADFGL++ ++        T V  T  Y  PE
Sbjct: 136 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPE 189
Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
               +      D++S G +  E+   KP     +E +++            G I  ++  
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL------------GKIFDLIGL 237
Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC---LAAEMARANSGRGFH 855
             ++D+      + V L      P G  RP  S VV E+ E    L  EM   N  +   
Sbjct: 238 PPEDDWP-----RDVSLPRGAFPPRG-PRPVQS-VVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 856 SKGSIDHLMMSMNLG 870
           +  ++ H  +  + G
Sbjct: 291 AFRALQHSYLHKDEG 305

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 34/274 (12%)
Query: 572 RTLGKGGFGTVYYGRLNEIDV-------AVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLT 624
           R LGKGGF   Y   + ++D         V                E+ +   + + ++ 
Sbjct: 32  RFLGKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 89
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
              G  ++D+   ++ E     +L E      +K ++  E      ++ QG++YLHN   
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLELHK--RRKAVTEPEARYFMRQTIQGVQYLHNN-- 145
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K  N+ LN+ +  K+ DFGL+     D        + GTP Y+ PE      
Sbjct: 146 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKG 202
Query: 745 LTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLI----- 787
            + + D++S G ++  ++  KP            RI + E     HI    ++LI     
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLH 262
Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLS 821
           A   ++  V   L ++F   S +  + L  +CL+
Sbjct: 263 ADPTLRPSVAELLTDEF-FTSGYAPMRLPTSCLT 295

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 115/264 (43%), Gaps = 26/264 (9%)
Query: 574 LGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +G+G  G V           VAVK +             EV ++   HH N+  +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNGCKPPIVHR 690
             ++  ++ EF+  G L    +DI      ++E++  + +   + L YLHN     ++HR
Sbjct: 113 VGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHR 165
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+KS +ILL    + KL+DFG     + +       V  GTP ++ PE  +      + D
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV--GTPYWMAPEVISRLPYGTEVD 223
Query: 751 VYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVW 810
           ++S G++++E+I  +P     NE            L A   I+  + PR+++    +SV 
Sbjct: 224 IWSLGIMVIEMIDGEPPY--FNEP----------PLQAMRRIRDSLPPRVKDLHKVSSVL 271
Query: 811 KAVELAMACLSPTGNQRPTMSQVV 834
           +     M    P+  QR T  +++
Sbjct: 272 RGFLDLMLVREPS--QRATAQELL 293

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 16/215 (7%)
Query: 572 RTLGKGGFGTVYY---------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN 622
           R LGKGG+G V+          G++  + V  K +             E  +L  V H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L+       +  LI E+++ G L  ++    + +           E +  L +LH  
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLH-- 138
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            +  I++RD+K  NI+LN +   KL DFGL K    D    V+    GT  Y+ PE    
Sbjct: 139 -QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMR 195
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
           +      D +S G ++ +++T  P  +  N ++ I
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 11/193 (5%)
Query: 569 NFERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           +    LG G FG V+    R    + A K +             E++ +  + H  L +L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
               ++DN+  +IYEFM+ G L E ++D   K +S  E +    +  +GL ++H      
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN--- 275
Query: 687 IVHRDVKSTNILLNEKL--QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
            VH D+K  NI+   K   + KL DFGL+       +  V+T   GT  +  PE      
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 332
Query: 745 LTEKSDVYSFGVV 757
           +   +D++S GV+
Sbjct: 333 VGYYTDMWSVGVL 345

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 34/274 (12%)
Query: 572 RTLGKGGFGTVYYGRLNEIDV-------AVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLT 624
           R LGKGGF   Y   + ++D         V                E+ +   + + ++ 
Sbjct: 48  RFLGKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
              G  ++D+   ++ E     +L E      +K ++  E      ++ QG++YLHN   
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHK--RRKAVTEPEARYFMRQTIQGVQYLHNN-- 161
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K  N+ LN+ +  K+ DFGL+     D        + GTP Y+ PE      
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKG 218
Query: 745 LTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLI----- 787
            + + D++S G ++  ++  KP            RI + E     HI    ++LI     
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLH 278
Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLS 821
           A   ++  V   L ++F   S +  + L  +CL+
Sbjct: 279 ADPTLRPSVAELLTDEF-FTSGYAPMRLPTSCLT 311

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXX--XXXXXXXXXEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VAV+++               EV+++  ++H N+  L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              + +    L+ E+ + G + +YL    + K   ++ + R  V + Q   Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF--- 133
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K+ N+LL+  +  K+ADFG S  F             G+P Y  PE +   +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYD 190
Query: 747 -EKSDVYSFGVVILEIIT 763
             + DV+S GV++  +++
Sbjct: 191 GPEVDVWSLGVILYTLVS 208

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 16/215 (7%)
Query: 572 RTLGKGGFGTVYY---------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN 622
           R LGKGG+G V+          G++  + V  K +             E  +L  V H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L+       +  LI E+++ G L  ++    + +           E +  L +LH  
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLH-- 138
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            +  I++RD+K  NI+LN +   KL DFGL K    D    V+    GT  Y+ PE    
Sbjct: 139 -QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEILMR 195
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
           +      D +S G ++ +++T  P  +  N ++ I
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 11/193 (5%)
Query: 569 NFERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           +    LG G FG V+    R    + A K +             E++ +  + H  L +L
Sbjct: 54  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 113
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
               ++DN+  +IYEFM+ G L E ++D   K +S  E +    +  +GL ++H      
Sbjct: 114 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN--- 169
Query: 687 IVHRDVKSTNILLNEKL--QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
            VH D+K  NI+   K   + KL DFGL+       +  V+T   GT  +  PE      
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 226
Query: 745 LTEKSDVYSFGVV 757
           +   +D++S GV+
Sbjct: 227 VGYYTDMWSVGVL 239

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 5/157 (3%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+       +E+    ++ ++   G+L + ++     +    + L   V
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           +    L+++H+     I+HRD+KS NI L +    +L DFG+++    ++   ++    G
Sbjct: 133 QICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELARACIG 187
Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA 767
           TP YL PE   +     KSD+++ G V+ E+ T K A
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 568 NNFE--RTLGKGGFGTVYY------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH 619
           N FE  + LGKG FG V        GR   + + +K               E ++L    
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEY 678
           H  LT+L       ++   + E+ ANG   E    +S++ + S++R R    E    L+Y
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH+  +  +V+RD+K  N++L++    K+ DFGL K    D  T       GTP YL PE
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPE 319
Query: 739 YYTSNRLTEKSDVYSFGVVILEII 762
               N      D +  GVV+ E++
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMM 343

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 568 NNFE--RTLGKGGFGTVYY------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH 619
           N FE  + LGKG FG V        GR   + + +K               E ++L    
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEY 678
           H  LT+L       ++   + E+ ANG   E    +S++ + S++R R    E    L+Y
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFSEDRARFYGAEIVSALDY 266
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH+  +  +V+RD+K  N++L++    K+ DFGL K    D  T       GTP YL PE
Sbjct: 267 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPE 322
Query: 739 YYTSNRLTEKSDVYSFGVVILEII 762
               N      D +  GVV+ E++
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMM 346

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 28/239 (11%)
Query: 542 RESKNKIDSFEAKSRHLSYSDVVKI-TNNFE--RTLGKGGFGTVYYGRLNEID--VAVKM 596
           R  KN ++  E      S    +++   +FE  + +G+G FG V   +L   D   A+K+
Sbjct: 47  RREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI 106
Query: 597 L---XXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLS 653
           L                E  +L+    + +T+L     +DN   L+ ++   G+L   LS
Sbjct: 107 LNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS 166
Query: 654 DISKKVLSSQER-----LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA 708
               ++     R     + IA++S   L Y         VHRD+K  NIL++     +LA
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLA 217
Query: 709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS-----NRLTEKSDVYSFGVVILEII 762
           DFG       D     S+V  GTP Y+ PE   +      R   + D +S GV + E++
Sbjct: 218 DFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++E + + +L+++     L+ I   ++ S        +  QGL
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 119
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 120 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXX--XEVKLLMRVHHRNLTSLV 627
           +T+GKG F  V   R  L   +VAVK++               EV++   ++H N+  L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              + +    L+ E+ + G + +YL    + K   ++ + R  V + Q   Y H      
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQKF--- 133
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHRD+K+ N+LL+     K+ADFG S  F             G P Y  PE +   +  
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAPELFQGKKYD 190
Query: 747 -EKSDVYSFGVVILEIIT 763
             + DV+S GV++  +++
Sbjct: 191 GPEVDVWSLGVILYTLVS 208

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 83  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFG +K    +   + +        ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 198 YTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 85  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 140
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFG +K    +   + +        ++  E      
Sbjct: 141 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 200 YTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 83  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFG +K    +   + +        ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 198 YTHQSDVWSYGVTVWELMT 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 8/171 (4%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISK--KVLSSQERL 666
           EV LL  + H N+        +   T L  + E+   G+L   ++  +K  + L  +  L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 667 RIAVESAQGLEYLHNGCK--PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           R+  +    L+  H        ++HRD+K  N+ L+ K   KL DFGL++    D +   
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--F 172
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           +    GTP Y+ PE        EKSD++S G ++ E+    P  +  +++E
Sbjct: 173 AKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 573 TLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTSLV 627
           TLG G FG V  G+  L    VAVK+L                E++ L    H ++  L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
                 +   ++ E+++ G L +Y+    +  L  +E  R+  +   G++Y H      +
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           VHRD+K  N+LL+  + AK+ADFGLS   +       S    G+P Y  PE   S RL  
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPE-VISGRLYA 193
Query: 748 --KSDVYSFGVVILEIIT 763
             + D++S GV++  ++ 
Sbjct: 194 GPEVDIWSSGVILYALLC 211

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 574 LGKGGFGT-----------VYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN 622
           LGKGGF             V+ G++    + +K               E+ +   + H++
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQH 102
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +    G  ++++   ++ E     +L E      +K L+  E      +   G +YLH  
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               ++HRD+K  N+ LNE L+ K+ DFGL+     D       V+ GTP Y+ PE  + 
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSK 215
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLIAK 789
              + + DV+S G ++  ++  KP            RI + E     HI     SLI K
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 568 NNFE--RTLGKGGFGTVYY------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH 619
           N FE  + LGKG FG V        GR   + + +K               E ++L    
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEY 678
           H  LT+L       ++   + E+ ANG   E    +S++ + S++R R    E    L+Y
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFSEDRARFYGAEIVSALDY 124
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH+  +  +V+RD+K  N++L++    K+ DFGL K    D  T       GTP YL PE
Sbjct: 125 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPE 180
Query: 739 YYTSNRLTEKSDVYSFGVVILEII 762
               N      D +  GVV+ E++
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMM 204

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 132/312 (42%), Gaps = 41/312 (13%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLXXX--XXXXXXXXXXEVKLLMRVH---HRNLTSL 626
           +G G +GTVY  R       VA+K +               EV LL R+    H N+  L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 627 VGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           +  C     D + +  L++E + + +L+ YL       L ++    +  +  +GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
            C   IVHRD+K  NIL+      KLADFGL++ ++      ++ VV  T  Y  PE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALAPVVV-TLWYRAPEVLL 184
Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ 801
            +      D++S G +  E+   KP     +E +++            G I  ++    +
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL------------GKIFDLIGLPPE 232
Query: 802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC---LAAEMARANSGRGFHSKG 858
           +D+      + V L      P G  RP  S VV E+ E    L  EM   N  +   +  
Sbjct: 233 DDWP-----RDVSLPRGAFPPRG-PRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFR 285
Query: 859 SIDHLMMSMNLG 870
           ++ H  +  + G
Sbjct: 286 ALQHSYLHKDEG 297

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 574 LGKGGFGT-----------VYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN 622
           LGKGGF             V+ G++    + +K               E+ +   + H++
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQH 100
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +    G  ++++   ++ E     +L E      +K L+  E      +   G +YLH  
Sbjct: 101 VVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               ++HRD+K  N+ LNE L+ K+ DFGL+     D       V+ GTP Y+ PE  + 
Sbjct: 159 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSK 213
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLIAK 789
              + + DV+S G ++  ++  KP            RI + E     HI     SLI K
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 272

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 568 NNFE--RTLGKGGFGTVYY------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH 619
           N FE  + LGKG FG V        GR   + + +K               E ++L    
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEY 678
           H  LT+L       ++   + E+ ANG   E    +S++ + S++R R    E    L+Y
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFSEDRARFYGAEIVSALDY 123
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH+  +  +V+RD+K  N++L++    K+ DFGL K    D  T       GTP YL PE
Sbjct: 124 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPE 179
Query: 739 YYTSNRLTEKSDVYSFGVVILEII 762
               N      D +  GVV+ E++
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMM 203

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 568 NNFE--RTLGKGGFGTVYY------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH 619
           N FE  + LGKG FG V        GR   + + +K               E ++L    
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEY 678
           H  LT+L       ++   + E+ ANG   E    +S++ + S++R R    E    L+Y
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFSEDRARFYGAEIVSALDY 125
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           LH+  +  +V+RD+K  N++L++    K+ DFGL K    D  T       GTP YL PE
Sbjct: 126 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPE 181
Query: 739 YYTSNRLTEKSDVYSFGVVILEII 762
               N      D +  GVV+ E++
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMM 205

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + L  G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 88  RLLGIC-LTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 203 YTHQSDVWSYGVTVWELMT 221

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXXXXX-EVKLLMRVHHRNLTS 625
           +F   LG G F  V     +  +  VA+K +              E+ +L ++ H N+ +
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    +      LI + ++ G L + +  + K   + ++  R+  +    ++YLH+    
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD---L 135
Query: 686 PIVHRDVKSTNIL---LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+L   L+E  +  ++DFGLSK    D  + +ST   GTPGY+ PE    
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTA-CGTPGYVAPEVLAQ 192
Query: 743 NRLTEKSDVYSFGVVILEIITC 764
              ++  D +S GV+   I+ C
Sbjct: 193 KPYSKAVDCWSIGVIAY-ILLC 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 129/312 (41%), Gaps = 41/312 (13%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLXXX--XXXXXXXXXXEVKLLMRVH---HRNLTSL 626
           +G G +GTVY  R       VA+K +               EV LL R+    H N+  L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 627 VGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           +  C     D + +  L++E + + +L+ YL       L ++    +  +  +GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
            C   IVHRD+K  NIL+      KLADFGL++ ++         V   T  Y  PE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV---TLWYRAPEVLL 184
Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ 801
            +      D++S G +  E+   KP     +E +++            G I  ++    +
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL------------GKIFDLIGLPPE 232
Query: 802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC---LAAEMARANSGRGFHSKG 858
           +D+      + V L      P G  RP  S VV E+ E    L  EM   N  +   +  
Sbjct: 233 DDWP-----RDVSLPRGAFPPRG-PRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFR 285
Query: 859 SIDHLMMSMNLG 870
           ++ H  +  + G
Sbjct: 286 ALQHSYLHKDEG 297

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXX-XXXXEVKLLMRVHHRNLTS 625
           +F   LG G F  V     +  +  VA+K +              E+ +L ++ H N+ +
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    +      LI + ++ G L + +  + K   + ++  R+  +    ++YLH+    
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD---L 135
Query: 686 PIVHRDVKSTNIL---LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+L   L+E  +  ++DFGLSK    D  + +ST   GTPGY+ PE    
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTA-CGTPGYVAPEVLAQ 192
Query: 743 NRLTEKSDVYSFGVVILEIITC 764
              ++  D +S GV+   I+ C
Sbjct: 193 KPYSKAVDCWSIGVIAY-ILLC 213

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXX-XXXXEVKLLMRVHHRNLTS 625
           +F   LG G F  V     +  +  VA+K +              E+ +L ++ H N+ +
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    +      LI + ++ G L + +  + K   + ++  R+  +    ++YLH+    
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD---L 135
Query: 686 PIVHRDVKSTNIL---LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+L   L+E  +  ++DFGLSK    D  + +ST   GTPGY+ PE    
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTA-CGTPGYVAPEVLAQ 192
Query: 743 NRLTEKSDVYSFGVVILEIITC 764
              ++  D +S GV+   I+ C
Sbjct: 193 KPYSKAVDCWSIGVIAY-ILLC 213

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXXXXX-EVKLLMRVHHRNLTS 625
           +F   LG G F  V     +  +  VA+K +              E+ +L ++ H N+ +
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    +      LI + ++ G L + +  + K   + ++  R+  +    ++YLH+    
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD---L 135
Query: 686 PIVHRDVKSTNIL---LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+L   L+E  +  ++DFGLSK    D  + +ST   GTPGY+ PE    
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTA-CGTPGYVAPEVLAQ 192
Query: 743 NRLTEKSDVYSFGVVILEIITC 764
              ++  D +S GV+   I+ C
Sbjct: 193 KPYSKAVDCWSIGVIAY-ILLC 213

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH---- 629
           +G+G +G VY G L+E  VAVK+                ++ +  H      +VG     
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH------NGC 683
            D   +  L+ E+  NG+L +YLS  +   +SS    R+A    +GL YLH      +  
Sbjct: 81  ADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSS---CRLAHSVTRGLAYLHTELPRGDHY 137
Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF--------ATDANTHVSTVVAGTPGYL 735
           KP I HRD+ S N+L+       ++DFGLS             + N  +S V  GT  Y+
Sbjct: 138 KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--GTIRYM 195
Query: 736 DPEYYTS-------NRLTEKSDVYSFGVVILEII 762
            PE               ++ D+Y+ G++  EI 
Sbjct: 196 APEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 574 LGKGGFGT-----------VYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN 622
           LGKGGF             V+ G++    + +K               E+ +   + H++
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQH 76
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +    G  ++++   ++ E     +L E      +K L+  E      +   G +YLH  
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               ++HRD+K  N+ LNE L+ K+ DFGL+     D       V+ GTP Y+ PE  + 
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSK 189
Query: 743 NRLTEKSDVYSFGVVILEIITCKP 766
              + + DV+S G ++  ++  KP
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKP 213

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFG +K    +   + +        ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 88  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFG +K    +   + +        ++  E      
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 203 YTHQSDVWSYGVTVWELMT 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 572 RTLGKGGFGTV---YYGRLNEID---VAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLT 624
           R LG+G FG V    Y   N+     VAVK L              E+ +L  ++H ++ 
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 625 SLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C++    +L  + E++  G+L++YL    +  +   + L  A +  +G+ YLH  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLH-- 151
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
                +HRD+ + N+LL+     K+ DFGL+K+       +       +P +   PE   
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
             +    SDV+SFGV + E++T
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 83  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFG +K    +   + +        ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 198 YTHQSDVWSYGVTVWELMT 216

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 129/312 (41%), Gaps = 41/312 (13%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLXXX--XXXXXXXXXXEVKLLMRVH---HRNLTSL 626
           +G G +GTVY  R       VA+K +               EV LL R+    H N+  L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 627 VGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           +  C     D + +  L++E + + +L+ YL       L ++    +  +  +GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
            C   IVHRD+K  NIL+      KLADFGL++ ++         V   T  Y  PE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV---TLWYRAPEVLL 184
Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ 801
            +      D++S G +  E+   KP     +E +++            G I  ++    +
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL------------GKIFDLIGLPPE 232
Query: 802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC---LAAEMARANSGRGFHSKG 858
           +D+      + V L      P G  RP  S VV E+ E    L  EM   N  +   +  
Sbjct: 233 DDWP-----RDVSLPRGAFPPRG-PRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFR 285
Query: 859 SIDHLMMSMNLG 870
           ++ H  +  + G
Sbjct: 286 ALQHSYLHKDEG 297

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + L  G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 88  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 203 YTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + L  G FGTVY G         +I VA+K L              E  ++  V + ++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 25/227 (11%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+ LL  + H N+  L    ++     L+ EF   G L E +  I++      +   I  
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMK 153
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKSFATDANTHVSTV 727
           +   G+ YLH   K  IVHRD+K  NILL  K   L  K+ DFGLS  F+ D        
Sbjct: 154 QILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL- 209
Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLI 787
             GT  Y+ PE     +  EK DV+S GV++  ++   P     N+++ I   +      
Sbjct: 210 --GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266
Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
              D K+I D              A EL    L+   N+R T  + +
Sbjct: 267 DFNDWKNISDE-------------AKELIKLMLTYDYNKRCTAEEAL 300

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLT 624
           + LG G FGTVY G         +I VA+  L              E  ++  V + ++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +   
Sbjct: 115 RLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-- 170
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E      
Sbjct: 171 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 229
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 230 YTHQSDVWSYGVTVWELMT 248

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC--- 630
           +G GGFG V+  + + ID    ++             EVK L ++ H N+    G C   
Sbjct: 19  IGSGGFGQVFKAK-HRIDGKTYVIKRVKYNNEKAER-EVKALAKLDHVNIVHYNG-CWDG 75
Query: 631 -DEDNQTA-------------LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
            D D +T+             +  EF   G L++++     + L     L +  +  +G+
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           +Y+H+     +++RD+K +NI L +  Q K+ DFGL  S   D     S    GT  Y+ 
Sbjct: 136 DYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS---KGTLRYMS 189
Query: 737 PEYYTSNRLTEKSDVYSFGVVILEII-TCKPAIS 769
           PE  +S    ++ D+Y+ G+++ E++  C  A  
Sbjct: 190 PEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 568 NNFERT--LGKGGFGTVYYGR--LNEIDVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHR 621
            NF++   +G+G +G VY  R  L    VA+K   L             E+ LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGL 676
           N+  L+     +N+  L++E + + +L+ +     L+ I   ++ S        +  QGL
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H+     ++HRD+K  N+L+N +   KLADFGL+++F     T+   VV  T  Y  
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 170
Query: 737 PEYYTSNRLTEKS-DVYSFGVVILEIITCK---PAISRINEEEKI 777
           PE     +    + D++S G +  E++T +   P  S I++  +I
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 572 RTLGKGGFGTV---YYGRLNEID---VAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLT 624
           R LG+G FG V    Y   N+     VAVK L              E+ +L  ++H ++ 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 625 SLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C++  + +L  + E++  G+L++YL    +  +   + L  A +  +G+ YLH+ 
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
                +HR++ + N+LL+     K+ DFGL+K+       +       +P +   PE   
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
             +    SDV+SFGV + E++T
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 564 VKITNNFERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHR 621
           ++ T  F   LG G F  V+    RL     A+K +             E+ +L ++ H 
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
           N+ +L    +      L+ + ++ G L + +  + + V + ++   +  +    ++YLH 
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 681 NGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           NG    IVHRD+K  N+L     E  +  + DFGLSK    + N  +ST   GTPGY+ P
Sbjct: 125 NG----IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTA-CGTPGYVAP 176
Query: 738 EYYTSNRLTEKSDVYSFGVVILEIITC 764
           E       ++  D +S GV+   I+ C
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITY-ILLC 202

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 565 KITNNFE--RTLGKGGFGTVY--YGRLNEIDVAVKMLXXXXXXXX--XXXXXEVKLLMRV 618
           K ++N++    LGKG F  V     +   ++ A K++               E ++  ++
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
            H N+  L     E++   L+++ +  G L E +  ++++  S  +      +  + + Y
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAY 120
Query: 679 LH-NGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGY 734
            H NG    IVHR++K  N+LL  K +    KLADFGL+         H     AGTPGY
Sbjct: 121 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGY 173
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           L PE    +  ++  D+++ GV++  ++   P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 565 KITNNFE--RTLGKGGFGTVY--YGRLNEIDVAVKMLXXXXXXXX--XXXXXEVKLLMRV 618
           K ++N++    LGKG F  V     +   ++ A K++               E ++  ++
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
            H N+  L     E++   L+++ +  G L E +  ++++  S  +      +  + + Y
Sbjct: 86  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAY 143
Query: 679 LH-NGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGY 734
            H NG    IVHR++K  N+LL  K +    KLADFGL+         H     AGTPGY
Sbjct: 144 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGY 196
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           L PE    +  ++  D+++ GV++  ++   P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 565 KITNNFE--RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXX--XXXXXEVKLLMRV 618
           K ++N++    LGKG F  V     +   ++ A K++               E ++  ++
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
            H N+  L     E++   L+++ +  G L E +  ++++  S  +      +  + + Y
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAY 120
Query: 679 LH-NGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGY 734
            H NG    IVHR++K  N+LL  K +    KLADFGL+         H     AGTPGY
Sbjct: 121 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGY 173
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           L PE    +  ++  D+++ GV++  ++   P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 565 KITNNFE--RTLGKGGFGTVY--YGRLNEIDVAVKMLXXXXXXXX--XXXXXEVKLLMRV 618
           K ++N++    LGKG F  V     +   ++ A K++               E ++  ++
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
            H N+  L     E++   L+++ +  G L E +  ++++  S  +      +  + + Y
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAY 119
Query: 679 LH-NGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGY 734
            H NG    IVHR++K  N+LL  K +    KLADFGL+         H     AGTPGY
Sbjct: 120 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGY 172
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           L PE    +  ++  D+++ GV++  ++   P
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYP 204

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKML-XXXXXXXXXXXXXEVKLLMRV 618
           D+ KI   F+ TLG G F  V            AVK +              E+ +L ++
Sbjct: 19  DIKKIFE-FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
            H N+ +L    +  N   L+ + ++ G L + +  + K   + ++   +  +    + Y
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDASTLIRQVLDAVYY 135
Query: 679 LHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LH   +  IVHRD+K  N+L    +E+ +  ++DFGLSK    +    V +   GTPGY+
Sbjct: 136 LH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK---MEGKGDVMSTACGTPGYV 189
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITC 764
            PE       ++  D +S GV+   I+ C
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAY-ILLC 217

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 14/153 (9%)
Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           H ++ +L+   +  +   L+++ M  G L +YL++  K  LS +E   I     + + +L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFL 216
Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           H      IVHRD+K  NILL++ +Q +L+DFG S              + GTPGYL PE 
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEI 270
Query: 740 Y------TSNRLTEKSDVYSFGVVILEIITCKP 766
                  T     ++ D+++ GV++  ++   P
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 173
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     
Sbjct: 174 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 226
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 258

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 13/153 (8%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISKKVLSSQERLRI 668
           E+ +L ++ H N+  LV   D+ N+  L  ++E +  G + E     + K LS  +    
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSEDQARFY 142
Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
             +  +G+EYLH      I+HRD+K +N+L+ E    K+ADFG+S  F        +TV 
Sbjct: 143 FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV- 198
Query: 729 AGTPGYLDPEYYTSNRLT---EKSDVYSFGVVI 758
            GTP ++ PE  +  R     +  DV++ GV +
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 130
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     
Sbjct: 131 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 183
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 572 RTLGKGGFGTV---YYGRLNEID---VAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLT 624
           R LG+G FG V    Y   N+     VAVK L              E+ +L  ++H ++ 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 625 SLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C++  + +L  + E++  G+L++YL    +  +   + L  A +  +G+ YLH  
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
                +HR++ + N+LL+     K+ DFGL+K+       +       +P +   PE   
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
             +    SDV+SFGV + E++T
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 104 LIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESK--- 158
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 164
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 164
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 164
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 114
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S     + AN  V     
Sbjct: 115 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV----- 167
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 199

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 164
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 164
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 36/239 (15%)
Query: 574 LGKGGFGT-----------VYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN 622
           LGKGGF             V+ G++    + +K               E+ +   + H++
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQH 82
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +    G  ++++   ++ E     +L E      +K L+  E      +   G +YLH  
Sbjct: 83  VVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               ++HRD+K  N+ LNE L+ K+ DFGL+     D        + GTP Y+ PE  + 
Sbjct: 141 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSK 195
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLIAK 789
              + + DV+S G ++  ++  KP            RI + E     HI     SLI K
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 254

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 79  LIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESK--- 133
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 20/240 (8%)
Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXX--------XXXXX 609
           L    V K T    R LGKGGFG V      ++    KM                     
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVC---ACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 610 XEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
            E ++L +V+ R + SL    +  +   L+   M  G+L+ ++  + +        +  A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            E   GLE LH   +  IV+RD+K  NILL++    +++D GL+     +  T    V  
Sbjct: 293 AEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-- 346
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK 789
           GT GY+ PE   + R T   D ++ G ++ E+I      S   + +K   R+ V  L+ +
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA---GQSPFQQRKKKIKREEVERLVKE 403

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 81  LIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 20/240 (8%)
Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXX--------XXXXX 609
           L    V K T    R LGKGGFG V      ++    KM                     
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVC---ACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 610 XEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
            E ++L +V+ R + SL    +  +   L+   M  G+L+ ++  + +        +  A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            E   GLE LH   +  IV+RD+K  NILL++    +++D GL+     +  T    V  
Sbjct: 293 AEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-- 346
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK 789
           GT GY+ PE   + R T   D ++ G ++ E+I      S   + +K   R+ V  L+ +
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA---GQSPFQQRKKKIKREEVERLVKE 403

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 73  LIGVITE-NPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 78  LIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESK--- 132
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 568 NNFERT----LGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXX-XXXXEVKLLMRVHHRN 622
           ++FER      G GG  T    R + + +A K++              E+++L   +   
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSD---ISKKVLSSQERLRIAVESAQGLEYL 679
           +    G    D + ++  E M  G+L + L +   I +++L      ++++   +GL YL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 130
Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVAGTPGYLDPE 738
               K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     GT  Y+ PE
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMAPE 183
Query: 739 YYTSNRLTEKSDVYSFGVVILEI 761
                  + +SD++S G+ ++E+
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVEL 206

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKM--LXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           +G+G +GTV+  +  E    VA+K   L             E+ LL  + H+N+  L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 630 CDEDNQTALIYEFMANGNLQEYLS----DISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
              D +  L++EF  + +L++Y      D+  +++ S        +  +GL + H+    
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKS-----FLFQLLKGLGFCHSR--- 120
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            ++HRD+K  N+L+N   + KLADFGL+++F      + + VV  T  Y  P+     +L
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKL 178
Query: 746 TEKS-DVYSFGVVILEI 761
              S D++S G +  E+
Sbjct: 179 YSTSIDMWSAGCIFAEL 195

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 36/239 (15%)
Query: 574 LGKGGFGT-----------VYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN 622
           LGKGGF             V+ G++    + +K               E+ +   + H++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQH 78
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +    G  ++++   ++ E     +L E      +K L+  E      +   G +YLH  
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               ++HRD+K  N+ LNE L+ K+ DFGL+     D        + GTP Y+ PE  + 
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSK 191
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLIAK 789
              + + DV+S G ++  ++  KP            RI + E     HI     SLI K
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH---- 629
           +GKG +G V+ G     +VAVK+                  +M + H N+   +      
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVM-LRHENILGFIASDMTS 74
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-----NGCK 684
                Q  LI  +   G+L +YL   +   +S    LRI +  A GL +LH        K
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASGLAHLHIEIFGTQGK 131
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPEYYTS 742
           P I HRD+KS NIL+ +  Q  +AD GL+   S +T+     +    GT  Y+ PE    
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 743 NRLTE------KSDVYSFGVVILEI 761
               +      + D+++FG+V+ E+
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 36/239 (15%)
Query: 574 LGKGGFGT-----------VYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN 622
           LGKGGF             V+ G++    + +K               E+ +   + H++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQH 78
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +    G  ++++   ++ E     +L E      +K L+  E      +   G +YLH  
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               ++HRD+K  N+ LNE L+ K+ DFGL+     D        + GTP Y+ PE  + 
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSK 191
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAIS---------RINEEE---KIHIRQWVNSLIAK 789
              + + DV+S G ++  ++  KP            RI + E     HI     SLI K
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL    +
Sbjct: 76  RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---E 129
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH---- 629
           +GKG +G V+ G     +VAVK+                  +M + H N+   +      
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVM-LRHENILGFIASDMTS 74
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-----NGCK 684
                Q  LI  +   G+L +YL   +   +S    LRI +  A GL +LH        K
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASGLAHLHIEIFGTQGK 131
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPEYYTS 742
           P I HRD+KS NIL+ +  Q  +AD GL+   S +T+     +    GT  Y+ PE    
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 743 NRLTE------KSDVYSFGVVILEI 761
               +      + D+++FG+V+ E+
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+++L   +   +    G    D + ++  E M  G+L + L    +  +  Q   ++++
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 138
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVA 729
              +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S       AN+ V     
Sbjct: 139 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 191
Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           GT  Y+ PE       + +SD++S G+ ++E+
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH---- 629
           +GKG +G V+ G     +VAVK+                  +M + H N+   +      
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVM-LRHENILGFIASDMTS 103
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-----NGCK 684
                Q  LI  +   G+L +YL   +   +S    LRI +  A GL +LH        K
Sbjct: 104 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASGLAHLHIEIFGTQGK 160
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPEYYTS 742
           P I HRD+KS NIL+ +  Q  +AD GL+   S +T+     +    GT  Y+ PE    
Sbjct: 161 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 220
Query: 743 NRLTE------KSDVYSFGVVILEI 761
               +      + D+++FG+V+ E+
Sbjct: 221 TIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL    +
Sbjct: 70  RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---E 123
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS 203

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC--- 630
           +G GGFG V+  + + ID    ++             EVK L ++ H N+    G C   
Sbjct: 20  IGSGGFGQVFKAK-HRIDGKTYVIRRVKYNNEKAER-EVKALAKLDHVNIVHYNG-CWDG 76
Query: 631 -DEDNQTA--------------------------LIYEFMANGNLQEYLSDISKKVLSSQ 663
            D D +T+                          +  EF   G L++++     + L   
Sbjct: 77  FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 136
Query: 664 ERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
             L +  +  +G++Y+H+     ++HRD+K +NI L +  Q K+ DFGL  S   D    
Sbjct: 137 LALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-- 191
Query: 724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII-TCKPAI 768
             T   GT  Y+ PE  +S    ++ D+Y+ G+++ E++  C  A 
Sbjct: 192 -RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 236

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL     
Sbjct: 92  RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES-- 146
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 147 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL     
Sbjct: 92  RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES-- 146
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 147 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL    +
Sbjct: 72  RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL    +
Sbjct: 76  RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---E 129
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL     
Sbjct: 90  RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES-- 144
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 145 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+    ++       ++ PE     R 
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL     
Sbjct: 434 RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN- 489
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 490 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 548 KFSSKSDVWSFGVLMWEAFS 567

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL    +
Sbjct: 82  RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 149
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 150
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 211 YTKSIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 141
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 202 YTKSIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 148
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRP 230

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 89/213 (41%), Gaps = 13/213 (6%)
Query: 569 NFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVK----LLMRVHHRN 622
           +F + +GKG FG V   R    E+  AVK+L              +     LL  V H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           L  L       ++   + +++  G L  +L    +  L  + R   A E A  L YLH+ 
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARF-YAAEIASALGYLHSL 158
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               IV+RD+K  NILL+ +    L DFGL K    + N+  ST   GTP YL PE    
Sbjct: 159 N---IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTST-FCGTPEYLAPEVLHK 213
Query: 743 NRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
                  D +  G V+ E++   P     N  E
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRP 230

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 571 ERTLGKGGFGTV---YYGRLNEIDVAVKMLXXXXX---XXXXXXXXEVKLLMRVHHRNLT 624
           ++ LG G FGTV   YY     +      +                E  ++ ++ +  + 
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL     
Sbjct: 435 RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN- 490
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE     
Sbjct: 491 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 744 RLTEKSDVYSFGVVILEIIT 763
           + + KSDV+SFGV++ E  +
Sbjct: 549 KFSSKSDVWSFGVLMWEAFS 568

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 142
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRP 224

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRP 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 142
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRP 224

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 631 DEDNQTALIYEFMANGNLQEYL--SDISKKV----LSSQERLRIAVESAQGLEYLHNGCK 684
             D   A   E M +  + + L  +D+ K +    LS+        +  +GL+Y+H+   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA-- 147
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSN 743
             ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   ++
Sbjct: 148 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 744 RLTEKS-DVYSFGVVILEIITCKP 766
           +   KS D++S G ++ E+++ +P
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 631 DEDNQTALIYEFMANGNLQEYL--SDISKKV----LSSQERLRIAVESAQGLEYLHNGCK 684
             D   A   E M +  L  +L  +D+ K +    LS+        +  +GL+Y+H+   
Sbjct: 107 -NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 164
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSN 743
             ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   ++
Sbjct: 165 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 744 RLTEKS-DVYSFGVVILEIITCKP 766
           +   KS D++S G ++ E+++ +P
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 573 TLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXX---XXXXXEVKLLMRVHHRNLTSLV 627
           TLG+G FG V        +  VA+K +                E+  L  + H ++  L 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
                     ++ E+ A G L +Y+  + KK ++  E  R   +    +EY H   +  I
Sbjct: 76  DVITTPTDIVMVIEY-AGGELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCH---RHKI 129
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT- 746
           VHRD+K  N+LL++ L  K+ADFGLS +  TD N   ++   G+P Y  PE         
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTS--CGSPNYAAPEVINGKLYAG 186
Query: 747 EKSDVYSFGVVI 758
            + DV+S G+V+
Sbjct: 187 PEVDVWSCGIVL 198

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 456 LIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 572 RTLGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXXXEVKLLMR-VHHRNLTS 625
           R +G+G FG V+ G         + VA+K               +  L MR   H ++  
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G   E N   +I E    G L+ +L  + K  L     +  A + +  L YL +    
Sbjct: 456 LIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     R 
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 746 TEKSDVYSFGVVILEII 762
           T  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA++ +              E+K+L+R  H N+  +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 148
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRP 230

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 570 FERTLGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXX-XXXXXXEVKLLMRVHHRNLTSL 626
           F+R LG G FG V+    R + ++  +K +              E+++L  + H N+  +
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
               ++ +   ++ E    G L E +  +    K LS      +  +    L Y H+   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-- 143
Query: 685 PPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
             +VH+D+K  NIL  +       K+ DFGL++ F +D +   ST  AGT  Y+ PE + 
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK 199
Query: 742 SNRLTEKSDVYSFGVVILEIIT-CKP 766
            + +T K D++S GVV+  ++T C P
Sbjct: 200 RD-VTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 14/221 (6%)
Query: 562 DVVKITN-NFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXX---XXXXXXEVKLL 615
           D +K+T+ NF   LGKG FG V        D   AVK+L                E ++L
Sbjct: 15  DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 616 MRVHHRNLTSLVGHCDED-NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
                    + +  C +  ++   + E++  G+L  ++  + +        +  A E A 
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAI 132
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           GL +L +     I++RD+K  N++L+ +   K+ADFG+ K    D  T  +    GTP Y
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDY 187
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           + PE        +  D ++FGV++ E++  +      +E+E
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKM--LXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           +G+G +GTV+  +  E    VA+K   L             E+ LL  + H+N+  L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 630 CDEDNQTALIYEFMANGNLQEYLS----DISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
              D +  L++EF  + +L++Y      D+  +++ S        +  +GL + H+    
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKS-----FLFQLLKGLGFCHSR--- 120
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            ++HRD+K  N+L+N   + KLA+FGL+++F      + + VV  T  Y  P+     +L
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKL 178
Query: 746 TEKS-DVYSFGVVILEI 761
              S D++S G +  E+
Sbjct: 179 YSTSIDMWSAGCIFAEL 195

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 572 RTLGKGGFGTVY---YGRLNEID---VAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLT 624
           R LG+G FG V    Y   N+     VAVK L              E+++L  ++H ++ 
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 625 SLVGHCDEDNQTA--LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C++  + +  L+ E++  G+L++YL    +  +   + L  A +  +G+ YLH  
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP---RHCVGLAQLLLFAQQICEGMAYLH-- 128
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
                +HR + + N+LL+     K+ DFGL+K+       +       +P +   PE   
Sbjct: 129 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
             +    SDV+SFGV + E++T
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 572 RTLGKGGFGTVY---YGRLNEID---VAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLT 624
           R LG+G FG V    Y   N+     VAVK L              E+++L  ++H ++ 
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 625 SLVGHCDEDNQTA--LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
              G C++  + +  L+ E++  G+L++YL    +  +   + L  A +  +G+ YLH  
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP---RHCVGLAQLLLFAQQICEGMAYLH-- 129
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY-LDPEYYT 741
                +HR + + N+LL+     K+ DFGL+K+       +       +P +   PE   
Sbjct: 130 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
             +    SDV+SFGV + E++T
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT 210

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 146
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRP 228

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 14/221 (6%)
Query: 562 DVVKITN-NFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXX---XXXXXXEVKLL 615
           D +K+T+ NF   LGKG FG V        D   AVK+L                E ++L
Sbjct: 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 395
Query: 616 MRVHHRNLTSLVGHCDED-NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
                    + +  C +  ++   + E++  G+L  ++  + +        +  A E A 
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAI 453
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           GL +L +     I++RD+K  N++L+ +   K+ADFG+ K    D  T  +    GTP Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDY 508
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           + PE        +  D ++FGV++ E++  +      +E+E
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 144
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRP 226

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRP 246

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRP 226

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNR- 744
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 745 LTEKSDVYSFGVVILEIITCKP 766
            T+  D++S G ++ E+++ +P
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRP 226

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 569 NFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLXXX-XXXXXXXXXXEVKLLMRVHHRNL 623
           +FE  + LG+GGFG V+  +  +++ + A+K +              EVK L ++ H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 624 TSLVGHCDEDNQTALI------------YEFMANGNLQEYLSDISKKVLSSQER---LRI 668
                   E N T  +             +     NL+++++   +  +  +ER   L I
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN--GRCTIEERERSVCLHI 123
Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
            ++ A+ +E+LH+     ++HRD+K +NI        K+ DFGL    A D +    TV+
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT--AMDQDEEEQTVL 178
Query: 729 ------------AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII 762
                        GT  Y+ PE    N  + K D++S G+++ E++
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 152
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 213 YTKSIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 144
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRP 226

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 112/245 (45%), Gaps = 25/245 (10%)
Query: 538 GKVKRESKNKIDSFEAKSRHL----SYSDVVKITNNFE--RTLGKGGFGTVYYGR--LNE 589
           G VK E  +   S  AK+  L    S+     + + +E   T+G G +G V   R  L  
Sbjct: 21  GPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTG 80
Query: 590 IDVAVKMLXXX--XXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN 647
             VA+K +               E+K+L    H N+ ++    D    T    EF +   
Sbjct: 81  QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK---DILRPTVPYGEFKSVYV 137
Query: 648 LQEYL-SDISKKVLSSQ----ERLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE 701
           + + + SD+ + + SSQ    E +R  + +  +GL+Y+H+     ++HRD+K +N+L+NE
Sbjct: 138 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNE 194
Query: 702 KLQAKLADFGLSKSFATDANTH--VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVI 758
             + K+ DFG+++   T    H    T    T  Y  PE   S +  T+  D++S G + 
Sbjct: 195 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 254
Query: 759 LEIIT 763
            E++ 
Sbjct: 255 GEMLA 259

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDV-AVK--MLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G VY  + N  +  A+K   L             E+ +L  + H N+  L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
               +  L++E + + +L++ L D+ +  L S       ++   G+ Y H+     ++HR
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKS 749
           D+K  N+L+N + + K+ADFGL+++F      +   VV  T  Y  P+    S + +   
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYSTTI 182
Query: 750 DVYSFGVVILEIITCKPAISRINEEEKI----------HIRQWVN-SLIAKGDIK-SIVD 797
           D++S G +  E++   P    ++E +++          + + W N + + K D   ++ +
Sbjct: 183 DIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           P   E F        ++L    L    NQR T  Q +
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDV-AVK--MLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G VY  + N  +  A+K   L             E+ +L  + H N+  L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
               +  L++E + + +L++ L D+ +  L S       ++   G+ Y H+     ++HR
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKS 749
           D+K  N+L+N + + K+ADFGL+++F      +   VV  T  Y  P+    S + +   
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYSTTI 182
Query: 750 DVYSFGVVILEIITCKPAISRINEEEKI----------HIRQWVN-SLIAKGDIK-SIVD 797
           D++S G +  E++   P    ++E +++          + + W N + + K D   ++ +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           P   E F        ++L    L    NQR T  Q +
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXX-XXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRP 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T        T  Y  PE   +++ 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRP 230

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 568 NNFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           +NF + +G+G  G V     R +   VAVK +             EV ++    H N+  
Sbjct: 34  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNGCK 684
           +       ++  ++ EF+  G L    +DI      ++E++  + +   Q L  LH    
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG- 147
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+KS +ILL    + KL+DFG     + +       V  GTP ++ PE  +   
Sbjct: 148 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLP 203
Query: 745 LTEKSDVYSFGVVILEIITCKP 766
              + D++S G++++E++  +P
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGEP 225

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  LN++ VA+K +              E+K+L+R  H N+  +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T        T  Y  PE   +++ 
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRP 231

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 568 NNFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           +NF + +G+G  G V     R +   VAVK +             EV ++    H N+  
Sbjct: 154 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNGCK 684
           +       ++  ++ EF+  G     L+DI      ++E++  + +   Q L  LH    
Sbjct: 213 MYNSYLVGDELWVVMEFLEGG----ALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG- 267
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+KS +ILL    + KL+DFG     + +       V  GTP ++ PE  +   
Sbjct: 268 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLP 323
Query: 745 LTEKSDVYSFGVVILEIITCKP 766
              + D++S G++++E++  +P
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEP 345

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 568 NNFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           +NF + +G+G  G V     R +   VAVK +             EV ++    H N+  
Sbjct: 23  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNGCK 684
           +       ++  ++ EF+  G L    +DI      ++E++  + +   Q L  LH    
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG- 136
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+KS +ILL    + KL+DFG     + +       V  GTP ++ PE  +   
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLP 192
Query: 745 LTEKSDVYSFGVVILEIITCKP 766
              + D++S G++++E++  +P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEP 214

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 568 NNFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           +NF + +G+G  G V     R +   VAVK +             EV ++    H N+  
Sbjct: 32  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNGCK 684
           +       ++  ++ EF+  G L    +DI      ++E++  + +   Q L  LH    
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG- 145
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+KS +ILL    + KL+DFG     + +       V  GTP ++ PE  +   
Sbjct: 146 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLP 201
Query: 745 LTEKSDVYSFGVVILEIITCKP 766
              + D++S G++++E++  +P
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGEP 223

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 568 NNFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           +NF + +G+G  G V     R +   VAVK +             EV ++    H N+  
Sbjct: 77  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNGCK 684
           +       ++  ++ EF+  G L    +DI      ++E++  + +   Q L  LH    
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG- 190
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+KS +ILL    + KL+DFG     + +       V  GTP ++ PE  +   
Sbjct: 191 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLP 246
Query: 745 LTEKSDVYSFGVVILEIITCKP 766
              + D++S G++++E++  +P
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGEP 268

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 574 LGKGGFGTVYYGRLNEIDV-AVK--MLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G VY  + N  +  A+K   L             E+ +L  + H N+  L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
               +  L++E + + +L++ L D+ +  L S       ++   G+ Y H+     ++HR
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT-SNRLTEKS 749
           D+K  N+L+N + + K+ADFGL+++F      +   +V  T  Y  P+    S + +   
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKYSTTI 182
Query: 750 DVYSFGVVILEIITCKPAISRINEEEKI----------HIRQWVN-SLIAKGDIK-SIVD 797
           D++S G +  E++   P    ++E +++          + + W N + + K D   ++ +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           P   E F        ++L    L    NQR T  Q +
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 572 RTLGKGGFGTVYY------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH-HRNLT 624
           R L +GGF  VY       GR    + A+K L             EV  + ++  H N+ 
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGR----EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 625 SL-----VGHCDEDNQTA--LIYEFMANGNLQEYLSDI-SKKVLSSQERLRIAVESAQGL 676
                  +G  + D   A  L+   +  G L E+L  + S+  LS    L+I  ++ + +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK--------SFATDANTHVSTVV 728
           +++H   KPPI+HRD+K  N+LL+ +   KL DFG +         S++      V   +
Sbjct: 150 QHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 729 A--GTPGYLDPE---YYTSNRLTEKSDVYSFGVVI 758
               TP Y  PE    Y++  + EK D+++ G ++
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 77/324 (23%), Positives = 133/324 (41%), Gaps = 43/324 (13%)
Query: 533 RKRQVG-KVKRESKNKIDSFEAKSRHLSYSDVVKITN-NFE---------RTLGKGGFGT 581
           +KR  G K+ +E+  +  +     R L     + I N NFE           LG+G +G 
Sbjct: 7   KKRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGV 66
Query: 582 VYYGR---LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLT-SLVGHCDEDNQTA 637
           V   R     +I    ++              ++ + MR      T +  G    +    
Sbjct: 67  VEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 126
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERL--RIAVESAQGLEYLHNGCKPPIVHRDVKST 695
           +  E M + +L ++   +  K  +  E +  +IAV   + LE+LH+  K  ++HRDVK +
Sbjct: 127 ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPS 183
Query: 696 NILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY----YTSNRLTEKSDV 751
           N+L+N   Q K+ DFG+S       ++   T+ AG   Y+ PE           + KSD+
Sbjct: 184 NVLINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDI 240
Query: 752 YSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED-FDANSVW 810
           +S G+ ++E+     AI R   +       W         +     P+L  D F A    
Sbjct: 241 WSLGITMIEL-----AILRFPYDS------WGTPFQQLKQVVEEPSPQLPADKFSA---- 285
Query: 811 KAVELAMACLSPTGNQRPTMSQVV 834
           + V+    CL     +RPT  +++
Sbjct: 286 EFVDFTSQCLKKNSKERPTYPELM 309

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 611 EVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
           EV +L +V  H N+  L    + +    L+++ M  G L +YL++  K  LS +E  +I 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIM 130
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
               + +  LH   K  IVHRD+K  NILL++ +  KL DFG S     D    + + V 
Sbjct: 131 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRS-VC 184
Query: 730 GTPGYLDPEYYTSNR------LTEKSDVYSFGVVILEIITCKP 766
           GTP YL PE    +         ++ D++S GV++  ++   P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 568 NNFERTLGKGGFGTVYYG--RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           +NF + +G+G  G V     R +   VAVK +             EV ++    H N+  
Sbjct: 27  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNGCK 684
           +       ++  ++ EF+  G L    +DI      ++E++  + +   Q L  LH    
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG- 140
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+KS +ILL    + KL+DFG     + +       V  GTP ++ PE  +   
Sbjct: 141 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLP 196
Query: 745 LTEKSDVYSFGVVILEIITCKP 766
              + D++S G++++E++  +P
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEP 218

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 573 TLGKGGFGTVYYG--RLNEIDVAVKML---XXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           TLG G FG V  G  +L    VAVK+L                E++ L    H ++  L 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
                     ++ E+++ G L +Y+    +  +   E  R+  +    ++Y H   +  +
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCH---RHMV 132
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           VHRD+K  N+LL+  + AK+ADFGLS   +       S    G+P Y  PE   S RL  
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE-VISGRLYA 188
Query: 748 --KSDVYSFGVVILEIIT 763
             + D++S GV++  ++ 
Sbjct: 189 GPEVDIWSCGVILYALLC 206

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLM-RVHHRNLT 624
           + LG G FGTV+ G         +I V +K++             +  L +  + H ++ 
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   L+ +++  G+L +++    +  L  Q  L   V+ A+G+ YL     
Sbjct: 97  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHG- 153
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHR++ + N+LL    Q ++ADFG++     D    + +       ++  E     +
Sbjct: 154 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 212 YTHQSDVWSYGVTVWELMT 230

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 611 EVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
           EV +L +V  H N+  L    + +    L+++ M  G L +YL++  K  LS +E  +I 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIM 117
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
               + +  LH   K  IVHRD+K  NILL++ +  KL DFG S     D    +   V 
Sbjct: 118 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRE-VC 171
Query: 730 GTPGYLDPEYYTSNR------LTEKSDVYSFGVVILEIITCKP 766
           GTP YL PE    +         ++ D++S GV++  ++   P
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E ++   + H N+  L     E+    LI++ +  G L E   DI  +   S+      +
Sbjct: 71  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE---DIVAREYYSEADASHCI 127
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTV 727
           +  Q LE + +  +  +VHRD+K  N+LL  KL+    KLADFGL+     +        
Sbjct: 128 Q--QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFG 183
Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            AGTPGYL PE    +   +  D+++ GV++  ++   P
Sbjct: 184 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 222

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 557 HLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLM 616
           HL+ +D      +  R +G+GGFG VY  R  +     KM              + + L 
Sbjct: 185 HLTMNDF-----SVHRIIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLA 236
Query: 617 RVHHRNLTSLV--GHC----------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
            ++ R + SLV  G C             ++ + I + M  G+L  +LS     V S  +
Sbjct: 237 -LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAD 293
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
               A E   GLE++HN     +V+RD+K  NILL+E    +++D GL+  F+     H 
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 349
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKS-DVYSFGVVILEII 762
           S    GT GY+ PE        + S D +S G ++ +++
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 557 HLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLM 616
           HL+ +D      +  R +G+GGFG VY  R  +     KM              + + L 
Sbjct: 185 HLTMNDF-----SVHRIIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLA 236
Query: 617 RVHHRNLTSLV--GHC----------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
            ++ R + SLV  G C             ++ + I + M  G+L  +LS     V S  +
Sbjct: 237 -LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAD 293
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
               A E   GLE++HN     +V+RD+K  NILL+E    +++D GL+  F+     H 
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 349
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKS-DVYSFGVVILEII 762
           S    GT GY+ PE        + S D +S G ++ +++
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 557 HLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLM 616
           HL+ +D      +  R +G+GGFG VY  R  +      M               + L  
Sbjct: 184 HLTMNDF-----SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 238
Query: 617 RVHHRNLTSLV--GHC----------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           R+    + SLV  G C             ++ + I + M  G+L  +LS     V S  +
Sbjct: 239 RI----MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAD 292
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
               A E   GLE++HN     +V+RD+K  NILL+E    +++D GL+  F+     H 
Sbjct: 293 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 348
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKS-DVYSFGVVILEII 762
           S    GT GY+ PE        + S D +S G ++ +++
Sbjct: 349 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 557 HLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLM 616
           HL+ +D      +  R +G+GGFG VY  R  +      M               + L  
Sbjct: 185 HLTMNDF-----SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 617 RVHHRNLTSLV--GHC----------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           R+    + SLV  G C             ++ + I + M  G+L  +LS     V S  +
Sbjct: 240 RI----MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAD 293
Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
               A E   GLE++HN     +V+RD+K  NILL+E    +++D GL+  F+     H 
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 349
Query: 725 STVVAGTPGYLDPEYYTSNRLTEKS-DVYSFGVVILEII 762
           S    GT GY+ PE        + S D +S G ++ +++
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 112/245 (45%), Gaps = 25/245 (10%)
Query: 538 GKVKRESKNKIDSFEAKSRHL----SYSDVVKITNNFE--RTLGKGGFGTVYYGR--LNE 589
           G VK E  +   S  AK+  L    S+     + + +E   T+G G +G V   R  L  
Sbjct: 20  GPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTG 79
Query: 590 IDVAVKMLXXX--XXXXXXXXXXEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN 647
             VA+K +               E+K+L    H N+ ++    D    T    EF +   
Sbjct: 80  QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK---DILRPTVPYGEFKSVYV 136
Query: 648 LQEYL-SDISKKVLSSQ----ERLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE 701
           + + + SD+ + + SSQ    E +R  + +  +GL+Y+H+     ++HRD+K +N+L+NE
Sbjct: 137 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNE 193
Query: 702 KLQAKLADFGLSKSFATDANTH--VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVI 758
             + K+ DFG+++   T    H    T    T  Y  PE   S +  T+  D++S G + 
Sbjct: 194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253
Query: 759 LEIIT 763
            E++ 
Sbjct: 254 GEMLA 258

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 572 RTLGKGGFGTVYYG------RLNEIDVAVKMLXXXXXXXXXXXXXEVKLLM-RVHHRNLT 624
           + LG G FGTV+ G         +I V +K++             +  L +  + H ++ 
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L+G C   +   L+ +++  G+L +++    +  L  Q  L   V+ A+G+ YL     
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             +VHR++ + N+LL    Q ++ADFG++     D    + +       ++  E     +
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 745 LTEKSDVYSFGVVILEIIT 763
            T +SDV+S+GV + E++T
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 611 EVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
           EV +L +V  H N+  L    + +    L+++ M  G L +YL++  K  LS +E  +I 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIM 130
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
               + +  LH   K  IVHRD+K  NILL++ +  KL DFG S     D    +   V 
Sbjct: 131 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRE-VC 184
Query: 730 GTPGYLDPEYYTSNR------LTEKSDVYSFGVVILEIITCKP 766
           GTP YL PE    +         ++ D++S GV++  ++   P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 611 EVKLLMRVHHRNLTSLVG--HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI 668
           E++LL R+ H+N+  LV   + +E  +  ++ E+   G +QE L  + +K     +    
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGY 114
Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
             +   GLEYLH+     IVH+D+K  N+LL      K++  G++++    A        
Sbjct: 115 FCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 729 AGTPGYLDPEYYTSNRLTE----KSDVYSFGVVILEIIT 763
            G+P +  PE   +N L      K D++S GV +  I T
Sbjct: 172 QGSPAFQPPE--IANGLDTFSGFKVDIWSAGVTLYNITT 208

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  T+G G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E+M  G++  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   K+ADFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  T+G G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E+M  G++  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   K+ADFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 83/198 (41%), Gaps = 14/198 (7%)
Query: 571 ERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           E  LG+G    VY  +         +              E+ +L+R+ H N+  L    
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVH 689
           +   + +L+ E +  G L + +  + K   S ++      +  + + YLH NG    IVH
Sbjct: 118 ETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLHENG----IVH 171
Query: 690 RDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           RD+K  N+L          K+ADFGLSK         +   V GTPGY  PE        
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYG 228
Query: 747 EKSDVYSFGVVILEIITC 764
            + D++S G++   I+ C
Sbjct: 229 PEVDMWSVGIITY-ILLC 245

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 573 TLGKGGFGTVYYG--RLNEIDVAVKML---XXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           TLG G FG V  G  +L    VAVK+L                E++ L    H ++  L 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
                     ++ E+++ G L +Y+    +  +   E  R+  +    ++Y H   +  +
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCH---RHMV 132
Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           VHRD+K  N+LL+  + AK+ADFGLS   +       S    G+P Y  PE   S RL  
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPE-VISGRLYA 188
Query: 748 --KSDVYSFGVVILEIIT 763
             + D++S GV++  ++ 
Sbjct: 189 GPEVDIWSCGVILYALLC 206

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
           +IAV   + LE+LH+  K  ++HRDVK +N+L+N   Q K+ DFG+S     D    +  
Sbjct: 113 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID- 169
Query: 727 VVAGTPGYLDPEY----YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
             AG   Y+ PE           + KSD++S G+ ++E+     AI R   +       W
Sbjct: 170 --AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL-----AILRFPYD------SW 216
Query: 783 VNSLIAKGDIKSIVDPRLQED-FDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
                    +     P+L  D F A    + V+    CL     +RPT  +++
Sbjct: 217 GTPFQQLKQVVEEPSPQLPADKFSA----EFVDFTSQCLKKNSKERPTYPELM 265

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 27/200 (13%)
Query: 649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA 708
           +E   D+ K  L+ +  +  + + A+G+E+L +      +HRD+ + NILL+EK   K+ 
Sbjct: 186 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKIC 242
Query: 709 DFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-- 765
           DFGL++    D + +V    A  P  ++ PE       T +SDV+SFGV++ EI +    
Sbjct: 243 DFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 301
Query: 766 --PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPT 823
             P + +I+EE       +   L     +++        D+    +++ +   + C    
Sbjct: 302 PYPGV-KIDEE-------FCRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGE 343
Query: 824 GNQRPTMSQVVMELSECLAA 843
            +QRPT S++V  L   L A
Sbjct: 344 PSQRPTFSELVEHLGNLLQA 363

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 27/200 (13%)
Query: 649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA 708
           +E   D+ K  L+ +  +  + + A+G+E+L +      +HRD+ + NILL+EK   K+ 
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKIC 235
Query: 709 DFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-- 765
           DFGL++    D + +V    A  P  ++ PE       T +SDV+SFGV++ EI +    
Sbjct: 236 DFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 294
Query: 766 --PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPT 823
             P + +I+EE       +   L     +++        D+    +++ +   + C    
Sbjct: 295 PYPGV-KIDEE-------FCRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGE 336
Query: 824 GNQRPTMSQVVMELSECLAA 843
            +QRPT S++V  L   L A
Sbjct: 337 PSQRPTFSELVEHLGNLLQA 356

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 27/200 (13%)
Query: 649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA 708
           +E   D+ K  L+ +  +  + + A+G+E+L +      +HRD+ + NILL+EK   K+ 
Sbjct: 177 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKIC 233
Query: 709 DFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-- 765
           DFGL++    D + +V    A  P  ++ PE       T +SDV+SFGV++ EI +    
Sbjct: 234 DFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 292
Query: 766 --PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPT 823
             P + +I+EE       +   L     +++        D+    +++ +   + C    
Sbjct: 293 PYPGV-KIDEE-------FCRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGE 334
Query: 824 GNQRPTMSQVVMELSECLAA 843
            +QRPT S++V  L   L A
Sbjct: 335 PSQRPTFSELVEHLGNLLQA 354

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 27/200 (13%)
Query: 649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA 708
           +E   D+ K  L+ +  +  + + A+G+E+L +      +HRD+ + NILL+EK   K+ 
Sbjct: 184 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKIC 240
Query: 709 DFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-- 765
           DFGL++    D + +V    A  P  ++ PE       T +SDV+SFGV++ EI +    
Sbjct: 241 DFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 299
Query: 766 --PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPT 823
             P + +I+EE       +   L     +++        D+    +++ +   + C    
Sbjct: 300 PYPGV-KIDEE-------FCRRLKEGTRMRA-------PDYTTPEMYQTM---LDCWHGE 341
Query: 824 GNQRPTMSQVVMELSECLAA 843
            +QRPT S++V  L   L A
Sbjct: 342 PSQRPTFSELVEHLGNLLQA 361

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXX--XEVKLLMRVHHRNLTSLV 627
           + LG G +G V   R  +  ++ A+K++               EV +L  + H N+  L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
              ++     L+ E    G L + +  I +   +  +   I  +   G+ YLH   K  I
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLH---KHNI 157
Query: 688 VHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
           VHRD+K  N+LL  K +    K+ DFGLS  F    N        GT  Y+ PE     +
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPE-VLRKK 213
Query: 745 LTEKSDVYSFGVVILEIITCKP 766
             EK DV+S GV++  ++   P
Sbjct: 214 YDEKCDVWSIGVILFILLAGYP 235

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 566 ITNNFERT--LGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXX---XXXXEVKLLMRV 618
           +++ ++R   LG G +G V     +L   + A+K++                EV +L ++
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
            H N+  L    ++     L+ E    G L + +  I ++  S  +   I  +   G  Y
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEVDAAVIMKQVLSGTTY 136
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LH   K  IVHRD+K  N+LL  K +    K+ DFGLS  F             GT  Y+
Sbjct: 137 LH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYI 190
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITC 764
            PE     +  EK DV+S G VIL I+ C
Sbjct: 191 APE-VLRKKYDEKCDVWSCG-VILYILLC 217

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+   H N+  +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA---N 146
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRP 228

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 574 LGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTS 625
           LG G FG V  G  +      + VAVK L                EV  +  + HRNL  
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G         ++ E    G+L + L       L      R AV+ A+G+ YL +    
Sbjct: 80  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLESK--- 134
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             +HRD+ + N+LL  +   K+ DFGL ++   + + +V       P  +  PE   +  
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 745 LTEKSDVYSFGVVILEIIT 763
            +  SD + FGV + E+ T
Sbjct: 195 FSHASDTWMFGVTLWEMFT 213

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 574 LGKGGFGTVYYGRLNEI--DVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           +G+G FG V+  R  +    VA+K  ++             E+K+L  + H N+ +L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 630 CDED--------NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           C               L+++F  + +L   LS++  K   S+ + R+      GL Y+H 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNGLYYIHR 143
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA----TDANTHVSTVVAGTPGYLDP 737
                I+HRD+K+ N+L+      KLADFGL+++F+    +  N + + VV  T  Y  P
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV--TLWYRPP 198
Query: 738 EYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
           E     R      D++  G ++ E+ T  P +    E+ ++ +
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN------- 622
           + LG GG G V+    N+ D  VA+K +             E+K++ R+ H N       
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 623 -------LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQ 674
                  LT  VG   E N   ++ E+M        L+++ ++    +E  R+ + +  +
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLR 131
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAG--T 731
           GL+Y+H+     ++HRD+K  N+ +N E L  K+ DFGL++       +H   +  G  T
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR-IMDPHYSHKGHLSEGLVT 187
Query: 732 PGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
             Y  P    S N  T+  D+++ G +  E++T K   +  +E E++ +
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 574 LGKGGFGTVYYGRLNEI--DVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           +G+G FG V+  R  +    VA+K  ++             E+K+L  + H N+ +L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 630 CDED--------NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           C               L+++F  + +L   LS++  K   S+ + R+      GL Y+H 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNGLYYIHR 143
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA----TDANTHVSTVVAGTPGYLDP 737
                I+HRD+K+ N+L+      KLADFGL+++F+    +  N + + VV  T  Y  P
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV--TLWYRPP 198
Query: 738 EYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
           E     R      D++  G ++ E+ T  P +    E+ ++ +
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 574 LGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTS 625
           LG G FG V  G  +      + VAVK L                EV  +  + HRNL  
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G         ++ E    G+L + L       L      R AV+ A+G+ YL +    
Sbjct: 86  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLESK--- 140
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             +HRD+ + N+LL  +   K+ DFGL ++   + + +V       P  +  PE   +  
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 745 LTEKSDVYSFGVVILEIIT 763
            +  SD + FGV + E+ T
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E ++   + H N+  L     E+    LI++ +  G L E   DI  +   S+      +
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE---DIVAREYYSEADASHCI 116
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTV 727
           +  Q LE + +  +  +VHR++K  N+LL  KL+    KLADFGL+     +        
Sbjct: 117 Q--QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFG 172
Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            AGTPGYL PE    +   +  D+++ GV++  ++   P
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 574 LGKGGFGTVYYGRLNEI--DVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           +G+G FG V+  R  +    VA+K  ++             E+K+L  + H N+ +L+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 630 CDED--------NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           C               L+++F  + +L   LS++  K   S+ + R+      GL Y+H 
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNGLYYIHR 142
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA----TDANTHVSTVVAGTPGYLDP 737
                I+HRD+K+ N+L+      KLADFGL+++F+    +  N + + VV  T  Y  P
Sbjct: 143 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV--TLWYRPP 197
Query: 738 EYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
           E     R      D++  G ++ E+ T  P +    E+ ++ +
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 574 LGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTS 625
           LG G FG V  G  +      + VAVK L                EV  +  + HRNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G         ++ E    G+L + L       L      R AV+ A+G+ YL +    
Sbjct: 76  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLESK--- 130
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             +HRD+ + N+LL  +   K+ DFGL ++   + + +V       P  +  PE   +  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 745 LTEKSDVYSFGVVILEIIT 763
            +  SD + FGV + E+ T
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 574 LGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXX---XXEVKLLMRVHHRNLTS 625
           LG G FG V  G  +      + VAVK L                EV  +  + HRNL  
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G         ++ E    G+L + L       L      R AV+ A+G+ YL +    
Sbjct: 80  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLESK--- 134
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             +HRD+ + N+LL  +   K+ DFGL ++   + + +V       P  +  PE   +  
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 745 LTEKSDVYSFGVVILEIIT 763
            +  SD + FGV + E+ T
Sbjct: 195 FSHASDTWMFGVTLWEMFT 213

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 11/188 (5%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG G FG V+        + +A K++             E+ ++ ++ H NL  L    +
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
             N   L+ E++  G L + + D S   L+  + +    +  +G+ ++H   +  I+H D
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMH---QMYILHLD 212
Query: 692 VKSTNILL--NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKS 749
           +K  NIL    +  Q K+ DFGL++ +       V+    GTP +L PE    + ++  +
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVSFPT 269
Query: 750 DVYSFGVV 757
           D++S GV+
Sbjct: 270 DMWSVGVI 277

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKML---XXXXXXXXXXXXXEVKLLMRVHH 620
            +FE  + +G+G FG V   ++   +   A+K+L                E  +L+    
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-----AVESAQG 675
           + +T+L     ++N   L+ ++   G+L   LS    K+     R  I     A++S   
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           L Y         VHRD+K  N+LL+     +LADFG       D     S+V  GTP Y+
Sbjct: 194 LHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ-SSVAVGTPDYI 243
Query: 736 DPEYYTS-----NRLTEKSDVYSFGVVILEII 762
            PE   +      +   + D +S GV + E++
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E ++   + H N+  L     E+    L+++ +  G L E   DI  +   S+      +
Sbjct: 53  EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCI 109
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTV 727
           +  Q LE + +  +  +VHRD+K  N+LL  K +    KLADFGL+     D        
Sbjct: 110 Q--QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG-- 165
Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            AGTPGYL PE        +  D+++ GV++  ++   P
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYP 204

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 574 LGKGGFGTVYYGRLNEI--DVAVK--MLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           +G+G FG V+  R  +    VA+K  ++             E+K+L  + H N+ +L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 630 CDEDNQ--------TALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           C               L+++F  + +L   LS++  K   S+ + R+      GL Y+H 
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNGLYYIHR 143
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA----TDANTHVSTVVAGTPGYLDP 737
                I+HRD+K+ N+L+      KLADFGL+++F+    +  N + + VV  T  Y  P
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV--TLWYRPP 198
Query: 738 EYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
           E     R      D++  G ++ E+ T  P +    E+ ++ +
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKML---XXXXXXXXXXXXXEVKLLMRVHH 620
            +FE  + +G+G FG V   ++   +   A+K+L                E  +L+    
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-----AVESAQG 675
           + +T+L     ++N   L+ ++   G+L   LS    K+     R  I     A++S   
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           L Y         VHRD+K  N+LL+     +LADFG       D     S+V  GTP Y+
Sbjct: 210 LHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ-SSVAVGTPDYI 259
Query: 736 DPEYYTS-----NRLTEKSDVYSFGVVILEII 762
            PE   +      +   + D +S GV + E++
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXX--XEVKLLMRVHHRNLTSL 626
           NF   L +   G ++ GR    D+ VK+L               E   L    H N+  +
Sbjct: 13  NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 627 VGHCDEDN--QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
           +G C         LI  +M  G+L   L + +  V+   + ++ A++ A+G+ +LH   +
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LE 131
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
           P I    + S +++++E + A+++   +  SF +    +    VA  P  L  +   +NR
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVA--PEALQKKPEDTNR 189
Query: 745 LTEKSDVYSFGVVILEIIT 763
               +D++SF V++ E++T
Sbjct: 190 --RSADMWSFAVLLWELVT 206

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 574 LGKGGFGTVYYGRLNEI----DVAVKMLXXXXXXXX--XXXXXEVKLLMRVHHRNLTSLV 627
           LGKG F  V   R  +I    + A K++               E ++   + H N+  L 
Sbjct: 12  LGKGAFSVVR--RCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPP 686
               E+    L+++ +  G L E +  ++++  S  +      +  + + + H NG    
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIQQILESVNHCHLNG---- 123
Query: 687 IVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
           IVHRD+K  N+LL  K +    KLADFGL+     D         AGTPGYL PE    +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKD 181
Query: 744 RLTEKSDVYSFGVVILEIITCKP 766
              +  D+++ GV++  ++   P
Sbjct: 182 PYGKPVDMWACGVILYILLVGYP 204

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 566 ITNNFERT--LGKGGFGTVYY--GRLNEIDVAVKMLXXXXXXXXX---XXXXEVKLLMRV 618
           +++ ++R   LG G +G V     +L   + A+K++                EV +L ++
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
            H N+  L    ++     L+ E    G L + +  I ++  S  +   I  +   G  Y
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEVDAAVIMKQVLSGTTY 119
Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LH   K  IVHRD+K  N+LL  K +    K+ DFGLS  F             GT  Y+
Sbjct: 120 LH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYI 173
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITC 764
            PE     +  EK DV+S G VIL I+ C
Sbjct: 174 APEVL-RKKYDEKCDVWSCG-VILYILLC 200

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLX-XXXXXXXXXXXXEVKLLMRVHHRNLTSL---- 626
           +G+G +G V   Y  +N++ VA+K +              E+K+L+   H N+  +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                E  +   I + +   +L + L     + LS+        +  +GL+Y+H+     
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVAGTPGYLDPEYYTSNRL 745
           ++HRD+K +N+LLN     K+ DFGL++    D + T   T    T  Y  PE   +++ 
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 746 TEKS-DVYSFGVVILEIITCKP 766
             KS D++S G ++ E+++ +P
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRP 228

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXX---XEVKLLMRVHH 620
           ++FE  R +GKG FG V   + N+     A+K +                E++++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYL 679
             L +L     ++    ++ + +  G+L+ +L    + V   +E +++ + E    L+YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYL 131
Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
            N     I+HRD+K  NILL+E     + DF ++     +      T +AGT  Y+ PE 
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEM 185
Query: 740 YTSNRLTEKS---DVYSFGVVILEII 762
           ++S +    S   D +S GV   E++
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELL 211

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  +AGTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 620 HRNLTSLVGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
           H N+  L   C     D + +  L++E + + +L  YL  + +  + ++    +  +  +
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           GL++LH+     +VHRD+K  NIL+    Q KLADFGL++ ++        T V  T  Y
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 185
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
             PE    +      D++S G +  E+   KP
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 574 LGKGGFGTVYYGRLNEI----DVAVKMLXXXXXXXX--XXXXXEVKLLMRVHHRNLTSLV 627
           LGKG F  V   R  +I    + A K++               E ++   + H N+  L 
Sbjct: 12  LGKGAFSVVR--RCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPP 686
               E+    L+++ +  G L E +  ++++  S  +      +  + + + H NG    
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIQQILESVNHCHLNG---- 123
Query: 687 IVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
           IVHRD+K  N+LL  K +    KLADFGL+     D         AGTPGYL PE    +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKD 181
Query: 744 RLTEKSDVYSFGVVILEIITCKP 766
              +  D+++ GV++  ++   P
Sbjct: 182 PYGKPVDMWACGVILYILLVGYP 204

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 563 VVKITNNFERTLGKGGFGT-VYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRV-HH 620
           V KI+   +  LG G  GT VY G  +  DVAVK +             EV+LL     H
Sbjct: 21  VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEH 77
Query: 621 RNLTSLVGHCDE-DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
            N+      C E D Q   I   +    LQEY+       L   E + +  ++  GL +L
Sbjct: 78  PNVIRYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL-EPITLLQQTTSGLAHL 134
Query: 680 HNGCKPPIVHRDVKSTNILL-----NEKLQAKLADFGLSKSFATDANTHV-STVVAGTPG 733
           H+     IVHRD+K  NIL+     + K++A ++DFGL K  A   ++    + V GT G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 734 YLDPEYYTSN---RLTEKSDVYSFGVVILEIIT 763
           ++ PE  + +     T   D++S G V   +I+
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  T+G G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   K+ADFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 620 HRNLTSLVGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
           H N+  L   C     D + +  L++E + + +L  YL  + +  + ++    +  +  +
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           GL++LH+     +VHRD+K  NIL+    Q KLADFGL++ ++        T V  T  Y
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 185
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
             PE    +      D++S G +  E+   KP
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 569 NFERTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLTS 625
             +  LG GGFG V  +  +     VA+K                E++++ +++H N+ S
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 626 LVGHCDEDNQTA------LIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEY 678
                D   + A      L  E+   G+L++YL+         +  +R  + + +  L Y
Sbjct: 78  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 679 LHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LH      I+HRD+K  NI+L    ++L  K+ D G +K         + T   GT  YL
Sbjct: 138 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYL 191
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            PE     + T   D +SFG +  E IT
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECIT 219

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
           ++ V   + L YL    K  ++HRDVK +NILL+E+ Q KL DFG+S     D     S 
Sbjct: 128 KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 727 VVAG--TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             A    P  +DP   T      ++DV+S G+ ++E+ T
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E ++   + H N+  L     E+    L+++ +  G L E   DI  +   S+      +
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCI 136
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTV 727
              Q LE +++  +  IVHRD+K  N+LL  K +    KLADFGL+     +        
Sbjct: 137 H--QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG-- 192
Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            AGTPGYL PE    +   +  D+++ GV++  ++   P
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYP 231

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 117/273 (42%), Gaps = 27/273 (9%)
Query: 563 VVKITNNFE--RTLGKGGFGTVY---YGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMR 617
           V  I+++F+    LG+G +G V    +    EI    K+              E+K+L  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 618 VHHRNLTSLVGHCDED-----NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES 672
             H N+ ++      D     N+  +I E M   +L      IS ++LS         ++
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRV---ISTQMLSDDHIQYFIYQT 121
Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAG 730
            + ++ LH      ++HRD+K +N+L+N     K+ DFGL++     A  N+  +   +G
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 731 TPGYLDPEYY-------TSNRLTEKSDVYSFGVVILEIITCKPAIS-RINEEEKIHIRQW 782
              Y+   +Y       TS + +   DV+S G ++ E+   +P    R    + + I   
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVEL 815
           + +  +  D++ I  PR +E   +  ++ A  L
Sbjct: 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL 271

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 620 HRNLTSLVGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
           H N+  L   C     D + +  L++E + + +L  YL  + +  + ++    +  +  +
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           GL++LH+     +VHRD+K  NIL+    Q KLADFGL++ ++        T V  T  Y
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 185
Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
             PE    +      D++S G +  E+   KP
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 569 NFERTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXX-XXEVKLLMRVHHRNLTS 625
             +  LG GGFG V  +  +     VA+K                E++++ +++H N+ S
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 626 LVGHCDEDNQTA------LIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEY 678
                D   + A      L  E+   G+L++YL+         +  +R  + + +  L Y
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 679 LHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           LH      I+HRD+K  NI+L    ++L  K+ D G +K         + T   GT  YL
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYL 190
Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            PE     + T   D +SFG +  E IT
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECIT 218

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++A G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 148
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++E+   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 203
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 204 KAVDWWALGVLIYEMAAGYP 223

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             LT L     +++   ++ E+   G +  +L  I +   S       A +     EYLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 159
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   K+ DFG +K          +  + GTP YL PE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 211
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             LT L     +++   ++ E+   G +  +L  I +   S       A +     EYLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 159
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   K+ DFG +K          +  + GTP YL PE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 211
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 182
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K       T     + GTP YL PE   S    
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAPEIILSKGYN 237
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 238 KAVDWWALGVLIYEMAAGYP 257

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 60/128 (46%), Gaps = 5/128 (3%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E  +L+    R +T L     ++N   L+ E+   G+L   LS   +++ +   R  +A 
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA- 169
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           E    ++ +H   +   VHRD+K  NILL+     +LADFG       D     S V  G
Sbjct: 170 EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVG 225
Query: 731 TPGYLDPE 738
           TP YL PE
Sbjct: 226 TPDYLSPE 233

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 86/192 (44%), Gaps = 19/192 (9%)
Query: 574 LGKGGFGTVYY------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           LG G FG V+       GR+       K +             E+ ++ ++HH  L +L 
Sbjct: 59  LGSGAFGVVHRCVEKATGRV----FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
              ++  +  LI EF++ G L + ++    K +S  E +    ++ +GL+++H      I
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 688 VHRDVKSTNILLNEKLQA--KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
           VH D+K  NI+   K  +  K+ DFGL+     D    V+T  A    +  PE      +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA---EFAAPEIVDREPV 227
Query: 746 TEKSDVYSFGVV 757
              +D+++ GV+
Sbjct: 228 GFYTDMWAIGVL 239

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX-XXXXXXXXXXXEVKLLMRVHHRNLTSLVGHC 630
           +G+G +G V   Y  + +  VA+K +              E+++L+R  H N+  +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 631 DEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
                 A+   ++    ++  L  + K + LS+        +  +GL+Y+H+     ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS--TVVAGTPGYLDPEYYTSNRLTE 747
           RD+K +N+L+N     K+ DFGL++  A   + H    T    T  Y  PE   +++   
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 748 KS-DVYSFGVVILEIITCKP 766
           KS D++S G ++ E+++ +P
Sbjct: 227 KSIDIWSVGCILAEMLSNRP 246

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 144
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K       T     + GTP YL PE  
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEII 196
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAGYP 222

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFER--TLGKGGFGTVYYGRLNEI- 590
           K  + K K +   K +S    + HL         + FER  TLG G FG V   +  E  
Sbjct: 9   KEFLAKAKEDFLKKWESPAQNTAHL---------DQFERIKTLGTGSFGRVMLVKHKETG 59
Query: 591 -DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG 646
              A+K+L                E ++L  V+   L  L     +++   ++ E++  G
Sbjct: 60  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 119
Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK 706
            +  +L  I +   S       A +     EYLH+     +++RD+K  N+L++++   +
Sbjct: 120 EMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 174
Query: 707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           + DFG +K          +  + GTP YL PE   S    +  D ++ GV+I E+    P
Sbjct: 175 VTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 159
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K       T     + GTP YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEII 211
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E ++ G L ++L++  K+ L+  E  +   
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLK 136
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +K     + KL DFG++     +A      
Sbjct: 137 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKN 191
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 192 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E ++ G L ++L++  K+ L+  E  +   
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLK 122
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +K     + KL DFG++     +A      
Sbjct: 123 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKN 177
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 178 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFER--TLGKGGFGTVYYGRLNEI- 590
           K  + K K +   K +S    + HL         + FER  TLG G FG V   +  E  
Sbjct: 17  KEFLAKAKEDFLKKWESPAQNTAHL---------DQFERIKTLGTGSFGRVMLVKHKETG 67
Query: 591 -DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG 646
              A+K+L                E ++L  V+   L  L     +++   ++ E++  G
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK 706
            +  +L  I +   S       A +     EYLH+     +++RD+K  N+L++++   +
Sbjct: 128 EMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 182
Query: 707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           + DFG +K          +  + GTP YL PE   S    +  D ++ GV+I E+    P
Sbjct: 183 VTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E+   G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   K+ DFGL+K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPAFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 22/238 (9%)
Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEI--D 591
           K  + K K +   K +S    + HL   + +       RTLG G FG V   +  E    
Sbjct: 17  KEFLAKAKEDFLKKWESPAQNTAHLDQFERI-------RTLGTGSFGRVMLVKHKETGNH 69
Query: 592 VAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL 648
            A+K+L                E ++   V+   L  L     +++   ++ E+   G +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM 129
Query: 649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA 708
             +L  I +   S       A +     EYLH+     +++RD+K  N+L++++   K+A
Sbjct: 130 FSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVA 184
Query: 709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           DFG +K          +  + GTP YL PE   S    +  D ++ GV+I E+    P
Sbjct: 185 DFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E ++ G L ++L++  K+ L+  E  +   
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLK 115
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +K     + KL DFG++     +A      
Sbjct: 116 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKN 170
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 171 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFER--TLGKGGFGTVYYGRLNEI- 590
           K  + K K +   K +S    + HL         + FER  TLG G FG V   +  E  
Sbjct: 17  KEFLAKAKEDFLKKWESPAQNTAHL---------DQFERIKTLGTGSFGRVMLVKHKETG 67
Query: 591 -DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG 646
              A+K+L                E ++L  V+   L  L     +++   ++ E++  G
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK 706
            +  +L  I +   S       A +     EYLH+     +++RD+K  N+L++++   +
Sbjct: 128 EMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 182
Query: 707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           + DFG +K          +  + GTP YL PE   S    +  D ++ GV+I E+    P
Sbjct: 183 VTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 111/251 (44%), Gaps = 29/251 (11%)
Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLXXXXX--XXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           +G+G +G V+  R  +    VA+K                 E+++L ++ H NL +L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 630 CDEDNQTALIYEFMANGNLQE---YLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +  L++E+  +  L E   Y   + + ++ S     I  ++ Q + + H   K  
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS-----ITWQTLQAVNFCH---KHN 122
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN-RL 745
            +HRDVK  NIL+ +    KL DFG ++     ++ +   V   T  Y  PE    + + 
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--ATRWYRSPELLVGDTQY 180
Query: 746 TEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNSLIAKGDIKSIVDPRLQEDF 804
               DV++ G V  E+++  P     ++ ++++ IR+ +  LI          PR Q+ F
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI----------PRHQQVF 230
Query: 805 DANSVWKAVEL 815
             N  +  V++
Sbjct: 231 STNQYFSGVKI 241

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E+   G +  +L  I +   S       A +     EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 159
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   K+ DFG +K          +  + GTP YL PE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 211
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 217
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 218 KAVDWWALGVLIYEMAAGYP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFER--TLGKGGFGTVYYGRLNEI- 590
           K  + K K +   K +S    + HL         + FER  TLG G FG V   +  E  
Sbjct: 17  KEFLAKAKEDFLKKWESPAQNTAHL---------DQFERIKTLGTGSFGRVMLVKHKETG 67
Query: 591 -DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG 646
              A+K+L                E ++L  V+   L  L     +++   ++ E++  G
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK 706
            +  +L  I +   S       A +     EYLH+     +++RD+K  N+L++++   +
Sbjct: 128 EMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 182
Query: 707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           + DFG +K          +  + GTP YL PE   S    +  D ++ GV+I E+    P
Sbjct: 183 VTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 179
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 231
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L +V H N+ +L    +      LI E ++ G L ++L+   K+ LS +E      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIK 122
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH      I H D+K  NI+L +K       KL DFGL+             
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
            + GTP ++ PE      L  ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L +V H N+ +L    +      LI E ++ G L ++L+   K+ LS +E      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIK 122
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH      I H D+K  NI+L +K       KL DFGL+             
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
            + GTP ++ PE      L  ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L +V H N+ +L    +      LI E ++ G L ++L+   K+ LS +E      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIK 122
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH      I H D+K  NI+L +K       KL DFGL+             
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
            + GTP ++ PE      L  ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 574 LGKGGFGTVYYG--RLNEIDVAVKM--LXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           LG+G +G VY     +    VA+K   L             EV LL  + HRN+  L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 630 CDEDNQTALIYEFMANGNLQEYLS---DISKKVLSSQERLRIAVESAQGLEYLHN-GCKP 685
              +++  LI+E+  N +L++Y+    D+S +V+ S        +   G+ + H+  C  
Sbjct: 102 IHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKS-----FLYQLINGVNFCHSRRC-- 153
Query: 686 PIVHRDVKSTNILL-----NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
             +HRD+K  N+LL     +E    K+ DFGL+++F          ++  T  Y  PE  
Sbjct: 154 --LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRPPEIL 209
Query: 741 TSNRLTEKS-DVYSFGVVILEIITCKP 766
             +R    S D++S   +  E++   P
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTP 236

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L +V H N+ +L    +      LI E ++ G L ++L+   K+ LS +E      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIK 122
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH      I H D+K  NI+L +K       KL DFGL+             
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
            + GTP ++ PE      L  ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 29/274 (10%)
Query: 563 VVKITNNFE--RTLGKGGFGTVY---YGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMR 617
           V  I+++F+    LG+G +G V    +    EI    K+              E+K+L  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 618 VHHRNLTSLVGHCDED-----NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES 672
             H N+ ++      D     N+  +I E M   +L      IS ++LS         ++
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRV---ISTQMLSDDHIQYFIYQT 121
Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK---------SFATDANTH 723
            + ++ LH      ++HRD+K +N+L+N     K+ DFGL++         S  T   + 
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 724 VSTVVAGTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKPAIS-RINEEEKIHIRQ 781
           ++  VA T  Y  PE   TS + +   DV+S G ++ E+   +P    R    + + I  
Sbjct: 179 MTEXVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 782 WVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVEL 815
            + +  +  D++ I  PR +E   +  ++ A  L
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL 271

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 574 LGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXX---XEVKLLMRVHHRNLTS 625
           LG G FG V  G  +      + VAVK L                EV  +  + HRNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G         ++ E    G+L + L       L      R AV+ A+G+ YL +    
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES---K 130
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             +HRD+ + N+LL  +   K+ DFGL ++   + + +V       P  +  PE   +  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 745 LTEKSDVYSFGVVILEIIT 763
            +  SD + FGV + E+ T
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L +V H N+ +L    +      LI E ++ G L ++L+   K+ LS +E      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIK 122
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH      I H D+K  NI+L +K       KL DFGL+             
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
            + GTP ++ PE      L  ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 117/273 (42%), Gaps = 27/273 (9%)
Query: 563 VVKITNNFE--RTLGKGGFGTVY---YGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMR 617
           V  I+++F+    LG+G +G V    +    EI    K+              E+K+L  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 618 VHHRNLTSLVGHCDED-----NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES 672
             H N+ ++      D     N+  +I E M   +L      IS ++LS         ++
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRV---ISTQMLSDDHIQYFIYQT 121
Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--NTHVSTVVAG 730
            + ++ LH      ++HRD+K +N+L+N     K+ DFGL++     A  N+  +   +G
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 731 TPGYLDPEYY-------TSNRLTEKSDVYSFGVVILEIITCKPAIS-RINEEEKIHIRQW 782
              ++   +Y       TS + +   DV+S G ++ E+   +P    R    + + I   
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
Query: 783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVEL 815
           + +  +  D++ I  PR +E   +  ++ A  L
Sbjct: 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL 271

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 74/172 (43%), Gaps = 25/172 (14%)
Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
           +IAV   + LE+LH+  K  ++HRDVK +N+L+N   Q K  DFG+S     D    +  
Sbjct: 140 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID- 196
Query: 727 VVAGTPGYLDPEY----YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
             AG   Y  PE           + KSD++S G+  +E+     AI R   +       W
Sbjct: 197 --AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL-----AILRFPYD------SW 243
Query: 783 VNSLIAKGDIKSIVDPRLQED-FDANSVWKAVELAMACLSPTGNQRPTMSQV 833
                    +     P+L  D F A    + V+    CL     +RPT  ++
Sbjct: 244 GTPFQQLKQVVEEPSPQLPADKFSA----EFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             LT L     +++   ++ E+   G +  +L  I +       R   A +     EYLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLH 159
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   K+ DFG +K          +  + GTP YL PE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 211
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 634 NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVK 693
           ++  LI E+ A G +         +++S  + +R+  +  +G+ YLH      IVH D+K
Sbjct: 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLK 158
Query: 694 STNILLNEKL---QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
             NILL+        K+ DFG+S+             + GTP YL PE    + +T  +D
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATD 215
Query: 751 VYSFGVVILEIIT-CKPAISRINEEEKIHIRQ 781
           +++ G++   ++T   P +   N+E  ++I Q
Sbjct: 216 MWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 159
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 211
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N++++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIISKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 120
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 121 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 175
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 176 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 205

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E+   G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   K+ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 120
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 121 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 175
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 176 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 205

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 611 EVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           E++LL  + H N+  L+         D+     L+  FM        L  + K     ++
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-----LGKLMKHEKLGED 128
Query: 665 RLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
           R++  V +  +GL Y+H      I+HRD+K  N+ +NE  + K+ DFGL++     A++ 
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSE 181
Query: 724 VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK 765
           +   V  T  Y  PE   +  R T+  D++S G ++ E+IT K
Sbjct: 182 MXGXVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   +       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FAEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFER--TLGKGGFGTVYYGRLNEI- 590
           K  + K K +   K +S    + HL         + FER  TLG G FG V   +  E  
Sbjct: 9   KEFLAKAKEDFLKKWESPAQNTAHL---------DQFERIKTLGTGSFGRVMLVKHKETG 59
Query: 591 -DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG 646
              A+K+L                E ++L  V+   L  L     +++   ++ E++  G
Sbjct: 60  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 119
Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK 706
            +  +L  I +       R   A +     EYLH+     +++RD+K  N+L++++   +
Sbjct: 120 EMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 174
Query: 707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           + DFG +K          +  + GTP YL PE   S    +  D ++ GV+I E+    P
Sbjct: 175 VTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I ++    P
Sbjct: 217 KAVDWWALGVLIYQMAAGYP 236

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E+   G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   ++ DFGL+K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L +V H N+ +L    +      LI E ++ G L ++L+   K+ LS +E      
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIK 122
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH      I H D+K  NI+L +K       KL DFGL+             
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
            + GTP ++ PE      L  ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +       R   A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +       R   A +     EYLH+     
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLHS---LD 156
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 211
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 212 KAVDWWALGVLIYEMAAGYP 231

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +       R   A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +       R   A +     EYLH+     
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLHS---LD 182
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 237
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 238 KAVDWWALGVLIYEMAAGYP 257

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 572 RTLGKGGFGTV---YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           R +G G +G+V   Y  RL +  VAVK L               E++LL  + H N+  L
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQ-KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 627 VG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYL 679
           +         ++ ++  L+   M        L++I K    S E ++  V +  +GL+Y+
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGAD-----LNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           H+     I+HRD+K +N+ +NE  + ++ DFGL++     A+  ++  VA T  Y  PE 
Sbjct: 140 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ----ADEEMTGYVA-TRWYRAPEI 191
Query: 740 YTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI 777
             +     +  D++S G ++ E++  K   P    I++ ++I
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 233

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +       R   A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 572 RTLGKGGFGTV---YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           R +G G +G+V   Y  RL +  VAVK L               E++LL  + H N+  L
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQ-KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 627 VG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYL 679
           +         ++ ++  L+   M        L++I K    S E ++  V +  +GL+Y+
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGAD-----LNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           H+     I+HRD+K +N+ +NE  + ++ DFGL++     A+  ++  VA T  Y  PE 
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQ----ADEEMTGYVA-TRWYRAPEI 199
Query: 740 YTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI 777
             +     +  D++S G ++ E++  K   P    I++ ++I
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 574 LGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXX---XEVKLLMRVHHRNLTS 625
           LG G FG V  G  +      + VAVK L                EV  +  + HRNL  
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G         ++ E    G+L + L       L      R AV+ A+G+ YL +    
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES---K 140
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             +HRD+ + N+LL  +   K+ DFGL ++   + +  V       P  +  PE   +  
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 200
Query: 745 LTEKSDVYSFGVVILEIIT 763
            +  SD + FGV + E+ T
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 574 LGKGGFGTVYYGRLNE-----IDVAVKMLXXXXXXXXXXXX---XEVKLLMRVHHRNLTS 625
           LG G FG V  G  +      + VAVK L                EV  +  + HRNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G         ++ E    G+L + L       L      R AV+ A+G+ YL +    
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES---K 130
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNR 744
             +HRD+ + N+LL  +   K+ DFGL ++   + +  V       P  +  PE   +  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 190
Query: 745 LTEKSDVYSFGVVILEIIT 763
            +  SD + FGV + E+ T
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           EV +L  + H N+ +L    +      LI E +A G L ++L++  K+ L+ +E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAE--KESLTEEEATEFLK 121
Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVST 726
           +   G+ YLH+     I H D+K  NI+L +    K + K+ DFGL+     D       
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +  GTP ++ PE      L  ++D++S GV+
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 560 YSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMR 617
           + D+ K+T+     LG+G +  V       N  + AVK++             EV+ L +
Sbjct: 10  FEDMYKLTSEL---LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQ 66
Query: 618 VH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
              ++N+  L+   ++D +  L++E +  G++  ++    +K  + +E  R+  + A  L
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQ--KQKHFNEREASRVVRDVAAAL 124
Query: 677 EYLHNGCKPPIVHRDVKSTNILLN--EKLQ-AKLADFGLSKSF-----ATDANTHVSTVV 728
           ++LH      I HRD+K  NIL    EK+   K+ DF L          T   T   T  
Sbjct: 125 DFLHT---KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP 181
Query: 729 AGTPGYLDPEYYT--SNRLT---EKSDVYSFGVVILEIITCKP 766
            G+  Y+ PE     +++ T   ++ D++S GVV+  +++  P
Sbjct: 182 CGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +       R   A +     EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLH 159
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 211
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 47/211 (22%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLS------------DISKK 658
           EV+L+ ++HH N+  L    +++    L+ E    G+L + L+            D+ K 
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 659 VLS------------------------SQERL--RIAVESAQGLEYLHNGCKPPIVHRDV 692
            +                          +E+L   I  +    L YLHN     I HRD+
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDI 194
Query: 693 KSTNILL--NEKLQAKLADFGLSKSF--ATDANTHVSTVVAGTPGYLDPEYY--TSNRLT 746
           K  N L   N+  + KL DFGLSK F    +   +  T  AGTP ++ PE    T+    
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254
Query: 747 EKSDVYSFGVVILEIITCKPAISRINEEEKI 777
            K D +S GV++  ++        +N+ + I
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E+   G +  +L  I +   S       A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +       R   A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E++  G +  +L  I +       R   A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP YL P    S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPAIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 568 NNFER--TLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHH 620
           + FER  TLG G FG V   +  E     A+K+L                E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L  L     +++   ++ E+   G +  +L  I +       R   A +     EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHARF-YAAQIVLTFEYLH 158
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     +++RD+K  N++++++   K+ DFG +K          +  + GTP YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 210
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
            S    +  D ++ GV+I E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 23/211 (10%)
Query: 562 DVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXX---XEVKLLM 616
           DVVK+       +G+G FG V   R   ++   A+K+L                E  ++ 
Sbjct: 78  DVVKV-------IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
             +   +  L     +D    ++ E+M  G+L   +S+    V     +   A E    L
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTA-EVVLAL 187
Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           + +H+     ++HRDVK  N+LL++    KLADFG           H  T V GTP Y+ 
Sbjct: 188 DAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYIS 243
Query: 737 PEYYTSN----RLTEKSDVYSFGVVILEIIT 763
           PE   S         + D +S GV + E++ 
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 274

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 572 RTLGKGGFGTV---YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSL 626
           R +G G +G+V   Y  RL +  VAVK L               E++LL  + H N+  L
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQ-KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 627 VG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYL 679
           +         ++ ++  L+   M        L++I K    S E ++  V +  +GL+Y+
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGAD-----LNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           H+     I+HRD+K +N+ +NE  + ++ DFGL++     A+  ++  VA T  Y  PE 
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQ----ADEEMTGYVA-TRWYRAPEI 199
Query: 740 YTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI 777
             +     +  D++S G ++ E++  K   P    I++ ++I
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 568 NNFE--RTLGKGGFGTVYY---------GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLM 616
            NFE  + LG G +G V+          G+L  + V  K               E ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 617 RVHHRN-LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQ 674
            +     L +L      + +  LI +++  G L    + +S++   ++  ++I V E   
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEVQIYVGEIVL 170
Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
            LE+LH   K  I++RD+K  NILL+      L DFGLSK F  D  T  +    GT  Y
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTIEY 226
Query: 735 LDPEYYTSNR--LTEKSDVYSFGVVILEIIT 763
           + P+          +  D +S GV++ E++T
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 574 LGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   Y   + + +AVK L               E++LL  + H N+  L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 173
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG-YLDPEYYT 741
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+T     P   L+  +Y 
Sbjct: 174 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 230
Query: 742 SNRLTEKSDVYSFGVVILEIITCK---PAISRINEEEKI 777
                   D++S G ++ E++T +   P    IN+ ++I
Sbjct: 231 MT-----VDIWSVGCIMAELLTGRTLFPGTDHINQLQQI 264

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 22/131 (16%)
Query: 649 QEYLSDISKKVLSSQER-----LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL 703
           +E L D   +  S ++R     L I ++ A+ +E+LH+     ++HRD+K +NI      
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDD 201
Query: 704 QAKLADFGLSKSFATDAN------------THVSTVVAGTPGYLDPEYYTSNRLTEKSDV 751
             K+ DFGL  +   D              TH   V  GT  Y+ PE    N  + K D+
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV--GTKLYMSPEQIHGNNYSHKVDI 259
Query: 752 YSFGVVILEII 762
           +S G+++ E++
Sbjct: 260 FSLGLILFELL 270

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 84/200 (42%), Gaps = 13/200 (6%)
Query: 572 RTLGKGGFGTVYYGRLNEID------VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           R +G+G +  V   RL + D      V  K L             +       +H  L  
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L      +++   + E++  G+L  ++    ++ L  +     + E +  L YLH     
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERG-- 130
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I++RD+K  N+LL+ +   KL D+G+ K      +T  ++   GTP Y+ PE       
Sbjct: 131 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRGEDY 187
Query: 746 TEKSDVYSFGVVILEIITCK 765
               D ++ GV++ E++  +
Sbjct: 188 GFSVDWWALGVLMFEMMAGR 207

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++  A +   +V+     T  Y  PE   +
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-----TRWYRAPEIMLN 203
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 572 RTLGKGGFGTVYYGRLNEI--DVAVKMLXXXXXXXXXXXXX---EVKLLMRVHHRNLTSL 626
           +TLG G FG V   +  E     A+K+L                E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
                +++   ++ E++A G +  +L  I +   S       A +     EYLH+     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +++RD+K  N+L++++   ++ DFG +K          +  + GTP  L PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEALAPEIILSKGYN 216
Query: 747 EKSDVYSFGVVILEIITCKP 766
           +  D ++ GV+I E+    P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++  A +   +V+     T  Y  PE   +
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-----TRWYRAPEIMLN 203
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++  A +   +V+     T  Y  PE   +
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-----TRWYRAPEIMLN 203
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 85/200 (42%), Gaps = 13/200 (6%)
Query: 572 RTLGKGGFGTVYYGRLNEID------VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           R +G+G +  V   RL + D      V  K L             +       +H  L  
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L      +++   + E++  G+L  ++    ++ L  +     + E +  L YLH   + 
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLH---ER 172
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I++RD+K  N+LL+ +   KL D+G+ K      +T  ++   GTP Y+ PE       
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDY 230
Query: 746 TEKSDVYSFGVVILEIITCK 765
               D ++ GV++ E++  +
Sbjct: 231 GFSVDWWALGVLMFEMMAGR 250

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 84/200 (42%), Gaps = 13/200 (6%)
Query: 572 RTLGKGGFGTVYYGRLNEID------VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           R +G+G +  V   RL + D      V  K L             +       +H  L  
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L      +++   + E++  G+L  ++    ++ L  +     + E +  L YLH     
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERG-- 126
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I++RD+K  N+LL+ +   KL D+G+ K      +T  ++   GTP Y+ PE       
Sbjct: 127 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRGEDY 183
Query: 746 TEKSDVYSFGVVILEIITCK 765
               D ++ GV++ E++  +
Sbjct: 184 GFSVDWWALGVLMFEMMAGR 203

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 574 LGKGGFGTVYYGRLNEIDVAVKMLXXXX--XXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           +GKG FG VY+GR +  +VA++++               EV    +  H N+   +G C 
Sbjct: 41  IGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
                A+I        L   + D +K VL   +  +IA E  +G+ YLH      I+H+D
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 692 VKSTNILLNEKLQAKLADFGL---SKSFATDANTHVSTVVAGTPGYLDPEYY-------T 741
           +KS N+  +   +  + DFGL   S             +  G   +L PE          
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 742 SNRL--TEKSDVYSFGVVILEI 761
            ++L  ++ SDV++ G +  E+
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL 236

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 112/261 (42%), Gaps = 46/261 (17%)
Query: 532 KRKR--QVGKVKRESK-NKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYY-GRL 587
           KRKR  + GK  R+S+   I +FE   ++L  S         E+ LG G  GTV + G  
Sbjct: 5   KRKRGSRGGKKGRKSRIANIPNFEQSLKNLVVS---------EKILGYGSSGTVVFQGSF 55
Query: 588 NEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEF-MAN 645
               VAVK +             E+KLL     H N+     +C E     L     + N
Sbjct: 56  QGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCN 110
Query: 646 GNLQEYL-----SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN 700
            NLQ+ +     SD + K+      + +  + A G+ +LH+     I+HRD+K  NIL++
Sbjct: 111 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVS 167
Query: 701 -------------EKLQAKLADFGLSKSFATDANTHVSTV--VAGTPGYLDPEYY---TS 742
                        E L+  ++DFGL K   +        +   +GT G+  PE     T 
Sbjct: 168 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTK 227
Query: 743 NRLTEKSDVYSFGVVILEIIT 763
            RLT   D++S G V   I++
Sbjct: 228 RRLTRSIDIFSMGCVFYYILS 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 112/261 (42%), Gaps = 46/261 (17%)
Query: 532 KRKR--QVGKVKRESK-NKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYY-GRL 587
           KRKR  + GK  R+S+   I +FE   ++L  S         E+ LG G  GTV + G  
Sbjct: 5   KRKRGSRGGKKGRKSRIANIPNFEQSLKNLVVS---------EKILGYGSSGTVVFQGSF 55
Query: 588 NEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEF-MAN 645
               VAVK +             E+KLL     H N+     +C E     L     + N
Sbjct: 56  QGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCN 110
Query: 646 GNLQEYL-----SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN 700
            NLQ+ +     SD + K+      + +  + A G+ +LH+     I+HRD+K  NIL++
Sbjct: 111 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVS 167
Query: 701 -------------EKLQAKLADFGLSKSFATDANTHVSTV--VAGTPGYLDPEYY---TS 742
                        E L+  ++DFGL K   +        +   +GT G+  PE     T 
Sbjct: 168 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTK 227
Query: 743 NRLTEKSDVYSFGVVILEIIT 763
            RLT   D++S G V   I++
Sbjct: 228 RRLTRSIDIFSMGCVFYYILS 248

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 85/200 (42%), Gaps = 13/200 (6%)
Query: 572 RTLGKGGFGTVYYGRLNEID------VAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTS 625
           R +G+G +  V   RL + D      V  K L             +       +H  L  
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L      +++   + E++  G+L  ++    ++ L  +     + E +  L YLH   + 
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLH---ER 140
Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I++RD+K  N+LL+ +   KL D+G+ K      +T  ++   GTP Y+ PE       
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRGEDY 198
Query: 746 TEKSDVYSFGVVILEIITCK 765
               D ++ GV++ E++  +
Sbjct: 199 GFSVDWWALGVLMFEMMAGR 218

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      LS + +  L  +    +  +   G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN------LSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
                 E  D++S GV++ E+I         +     HI QW
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKGGVLFPGTD-----HIDQW 234

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 106 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 162
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 163 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 218
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 219 LG-VIMYILLC 228

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 98  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 154
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 155 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 210
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 211 LG-VIMYILLC 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 96  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 152
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 153 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 208
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 209 LG-VIMYILLC 218

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 97  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 153
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 154 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 209
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 210 LG-VIMYILLC 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 91  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 147
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 148 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 203
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 204 LG-VIMYILLC 213

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      LS + +  L  +    +  +   G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN------LSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
                 E  D++S GV++ E+I         +     HI QW
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKGGVLFPGTD-----HIDQW 234

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 90  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 146
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 147 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 203 LG-VIMYILLC 212

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 192
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 193 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 249 LG-VIMYILLC 258

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 148
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 149 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 205 LG-VIMYILLC 214

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 53/238 (22%)
Query: 564 VKITNNFER--TLGKGGFGTVYYGRLNEID---VAVKMLXXXXXXXXXXXXXEVKLLMRV 618
           ++  ++FE    LG+G FG V   R N +D    A+K +             EV LL  +
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILS-EVMLLASL 59
Query: 619 HH-------------RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQ-- 663
           +H             RN    +    + +   +  E+  NG L +    I  + L+ Q  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL---IHSENLNQQRD 116
Query: 664 ERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
           E  R+  +  + L Y+H+     I+HRD+K  NI ++E    K+ DFGL+K      N H
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK------NVH 167
Query: 724 VS------------------TVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEII 762
            S                  T   GT  Y+  E    +    EK D+YS G++  E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF-MANGNLQEYLSDISKKVLSSQERLRIA 669
           E+ LL  + H N+  L+      +     Y+F +    +Q  L  I     S ++   + 
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            +  +GL+Y+H+     +VHRD+K  N+ +NE  + K+ DFGL++    +   +V T   
Sbjct: 151 YQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-- 205
Query: 730 GTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK 765
               Y  PE   S     +  D++S G ++ E++T K
Sbjct: 206 ---WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 148
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 149 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 205 LG-VIMYILLC 214

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 142 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 198
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 199 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 254
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 255 LG-VIMYILLC 264

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+T     P  +      +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM----LNA 197
Query: 743 NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
               +  D++S G ++ E++T +   P    I++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 121/297 (40%), Gaps = 51/297 (17%)
Query: 574 LGKGGFGTVYYG-RL-NEIDVAVKM------LXXXXXXXXXXXXXEVKLLMRVH----HR 621
           LGKGGFGTV+ G RL + + VA+K+      L             EV LL +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 622 NLTSLVGHCDEDNQTALIYEF-MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            +  L+   +      L+ E  +   +L +Y+++  K  L          +    +++ H
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 681 NGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           +     +VHRD+K  NIL++  +  AKL DFG       +  T       GT  Y  PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYSPPEW 209
Query: 740 YTSNRLTE-KSDVYSFGVVILEIITCKPAISRINE--EEKIHIRQWVNSLIAKGDIKSIV 796
            + ++     + V+S G+++ +++       R  E  E ++H                  
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELH------------------ 251
Query: 797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRG 853
                  F A+       L   CL+P  + RP++ +++++      AE    N  +G
Sbjct: 252 -------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXX 606
           DSF  +     + DV ++    E  LG+G    V      +   + AVK++         
Sbjct: 4   DSFSGR-----FEDVYQLQ---EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS 55
Query: 607 XXXXEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
               EV++L +   HRN+  L+   +E+++  L++E M  G++   LS I K+   ++  
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELE 112
Query: 666 LRIAVES-AQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDAN 721
             + V+  A  L++LHN     I HRD+K  NIL    N+    K+ DFGL      + +
Sbjct: 113 ASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGD 169
Query: 722 -THVST----VVAGTPGYLDPEYY-----TSNRLTEKSDVYSFGVVILEIITCKP 766
            + +ST       G+  Y+ PE        ++   ++ D++S GV++  +++  P
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTV--YYGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL +  
Sbjct: 61  FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQ-- 117
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 118 --VIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 173 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 34/234 (14%)
Query: 557 HLS-YSDVVKITNNFERTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXXXX--- 610
           H+S Y   ++      +TLG G  G V   + R     VA+K++                
Sbjct: 6   HMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA 65
Query: 611 -----EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
                E+++L +++H  +  +    D ++   ++ E M  G L + +  +  K L     
Sbjct: 66  LNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATC 122
Query: 666 LRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDAN 721
                +    ++YLH NG    I+HRD+K  N+LL+   E    K+ DFG SK       
Sbjct: 123 KLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 175
Query: 722 THVSTVVAGTPGYLDPEYYTS------NRLTEKSDVYSFGVVILEIITCKPAIS 769
           T +   + GTP YL PE   S      NR     D +S GV++   ++  P  S
Sbjct: 176 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV---DCWSLGVILFICLSGYPPFS 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/300 (21%), Positives = 125/300 (41%), Gaps = 55/300 (18%)
Query: 570 FERTLGKGGFGTVY---------YGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           F  +LG+G F  ++         YG+L+E +V +K+L                ++ ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           ++L    G C   ++  L+ EF+  G+L  YL   +K  ++   +L +A + A  + +L 
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLE 130
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQ--------AKLADFGLSKSFATDANTHVSTVVAGTP 732
                 ++H +V + NILL  +           KL+D G+S +           ++    
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERI 181
Query: 733 GYLDPEYYTSNR-LTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAK 789
            ++ PE   + + L   +D +SFG  + EI +   KP +S ++ + K+   +  + L A 
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFYEDRHQLPAP 240
Query: 790 GDIKSIVDPRLQEDFDANSVWKAVELAMA---CLSPTGNQRPTMSQVVMELSECLAAEMA 846
                                KA ELA     C+    + RP+   ++ +L+     ++ 
Sbjct: 241 ---------------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/300 (21%), Positives = 125/300 (41%), Gaps = 55/300 (18%)
Query: 570 FERTLGKGGFGTVY---------YGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHH 620
           F  +LG+G F  ++         YG+L+E +V +K+L                ++ ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           ++L    G C   ++  L+ EF+  G+L  YL   +K  ++   +L +A + A  + +L 
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAWAMHFLE 130
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQ--------AKLADFGLSKSFATDANTHVSTVVAGTP 732
                 ++H +V + NILL  +           KL+D G+S +           ++    
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERI 181
Query: 733 GYLDPEYYTSNR-LTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAK 789
            ++ PE   + + L   +D +SFG  + EI +   KP +S ++ + K+   +  + L A 
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFYEDRHQLPAP 240
Query: 790 GDIKSIVDPRLQEDFDANSVWKAVELAMA---CLSPTGNQRPTMSQVVMELSECLAAEMA 846
                                KA ELA     C+    + RP+   ++ +L+     ++ 
Sbjct: 241 ---------------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 574 LGKGGFGTVYYGRLNEID------VAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTS 625
           +G G +G+V     + ID      VA+K L               E+ LL  + H N+  
Sbjct: 32  VGSGAYGSV----CSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 626 LVGHCDEDNQTALIYEF-MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
           L+      +     Y+F +    +Q  L  I     S ++   +  +  +GL+Y+H+   
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG- 146
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS-N 743
             +VHRD+K  N+ +NE  + K+ DFGL++    +   +V T       Y  PE   S  
Sbjct: 147 --VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWM 199
Query: 744 RLTEKSDVYSFGVVILEIITCK 765
              +  D++S G ++ E++T K
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 90  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 146
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D++S
Sbjct: 147 LYTSKRPNAILKLTDFG----FAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 754 FGVVILEIITC 764
            G VI+ I+ C
Sbjct: 203 LG-VIMYILLC 212

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 21/235 (8%)
Query: 542 RESKNKIDSFEAKSRHL--SYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEID--VAVK 595
           R++KN ID+F ++ +       D+     ++E  + +G+G FG V   R        A+K
Sbjct: 47  RKNKN-IDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 105
Query: 596 MLXXXXXXXXXXXX---XEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL 652
           +L                E  ++   +   +  L     +D    ++ E+M  G+L   +
Sbjct: 106 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 165
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
           S+    V     R   A E    L+ +H+      +HRDVK  N+LL++    KLADFG 
Sbjct: 166 SNYD--VPEKWARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 219
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSN----RLTEKSDVYSFGVVILEIIT 763
                 +      T V GTP Y+ PE   S         + D +S GV + E++ 
Sbjct: 220 CMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 208
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 243

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 150 ---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 201
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 236

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 21/235 (8%)
Query: 542 RESKNKIDSFEAKSRHL--SYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEID--VAVK 595
           R++KN ID+F ++ +       D+     ++E  + +G+G FG V   R        A+K
Sbjct: 42  RKNKN-IDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100
Query: 596 MLXXXXXXXXXXXX---XEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL 652
           +L                E  ++   +   +  L     +D    ++ E+M  G+L   +
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
           S+    V     R   A E    L+ +H+      +HRDVK  N+LL++    KLADFG 
Sbjct: 161 SNYD--VPEKWARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSN----RLTEKSDVYSFGVVILEIIT 763
                 +      T V GTP Y+ PE   S         + D +S GV + E++ 
Sbjct: 215 CMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXXXX--------EVKLLMRVHHR 621
           +TLG G  G V   + R     VA+K++                     E+++L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
            +  +    D ++   ++ E M  G L + +  +  K L          +    ++YLH 
Sbjct: 76  CIIKIKNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 681 NGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           NG    I+HRD+K  N+LL+   E    K+ DFG SK       T +   + GTP YL P
Sbjct: 133 NG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 185
Query: 738 EYYTS------NRLTEKSDVYSFGVVILEIITCKPAIS 769
           E   S      NR     D +S GV++   ++  P  S
Sbjct: 186 EVLVSVGTAGYNRAV---DCWSLGVILFICLSGYPPFS 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 142
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 143 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 194
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 229

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+T       Y  PE   +
Sbjct: 147 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 198
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 233

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 208
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 243

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 147 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 198
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 233

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 208
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 243

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXXXX--------EVKLLMRVHHR 621
           +TLG G  G V   + R     VA+K++                     E+++L +++H 
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
            +  +    D ++   ++ E M  G L + +  +  K L          +    ++YLH 
Sbjct: 75  CIIKIKNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHE 131
Query: 681 NGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           NG    I+HRD+K  N+LL+   E    K+ DFG SK       T +   + GTP YL P
Sbjct: 132 NG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 184
Query: 738 EYYTS------NRLTEKSDVYSFGVVILEIITCKPAIS 769
           E   S      NR     D +S GV++   ++  P  S
Sbjct: 185 EVLVSVGTAGYNRAV---DCWSLGVILFICLSGYPPFS 219

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 150 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 201
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 236

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTV--YYGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL +  
Sbjct: 61  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQ-- 117
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 118 --VIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 173 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 143
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 144 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 195
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 230

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXXXX--------EVKLLMRVHHR 621
           +TLG G  G V   + R     VA+K++                     E+++L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
            +  +    D ++   ++ E M  G L + +  +  K L          +    ++YLH 
Sbjct: 76  CIIKIKNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 681 NGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           NG    I+HRD+K  N+LL+   E    K+ DFG SK       T +   + GTP YL P
Sbjct: 133 NG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 185
Query: 738 EYYTS------NRLTEKSDVYSFGVVILEIITCKPAIS 769
           E   S      NR     D +S GV++   ++  P  S
Sbjct: 186 EVLVSVGTAGYNRAV---DCWSLGVILFICLSGYPPFS 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 150 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 201
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 236

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 147 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 198
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 233

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXXXX--------EVKLLMRVHHR 621
           +TLG G  G V   + R     VA++++                     E+++L +++H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
            +  +    D ++   ++ E M  G L + +  +  K L          +    ++YLH 
Sbjct: 201 CIIKIKNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 681 NGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           NG    I+HRD+K  N+LL+   E    K+ DFG SK       T +   + GTP YL P
Sbjct: 258 NG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 310
Query: 738 EYYTS------NRLTEKSDVYSFGVVILEIITCKPAIS 769
           E   S      NR     D +S GV++   ++  P  S
Sbjct: 311 EVLVSVGTAGYNRAV---DCWSLGVILFICLSGYPPFS 345

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 192
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 142 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 193
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 228

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 21/235 (8%)
Query: 542 RESKNKIDSFEAKSRHL--SYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEID--VAVK 595
           R++KN ID+F ++ +       D+     ++E  + +G+G FG V   R        A+K
Sbjct: 47  RKNKN-IDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 105
Query: 596 MLXXXXXXXXXXXX---XEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL 652
           +L                E  ++   +   +  L     +D    ++ E+M  G+L   +
Sbjct: 106 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 165
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
           S+    V     R   A E    L+ +H+      +HRDVK  N+LL++    KLADFG 
Sbjct: 166 SNYD--VPEKWARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 219
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSN----RLTEKSDVYSFGVVILEIIT 763
                 +      T V GTP Y+ PE   S         + D +S GV + E++ 
Sbjct: 220 CMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 164 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 215
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 250

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 156 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 207
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 242

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXXXX--------EVKLLMRVHHR 621
           +TLG G  G V   + R     VA+K++                     E+++L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
            +  +    D ++   ++ E M  G L + +  +  K L          +    ++YLH 
Sbjct: 76  CIIKIKNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 681 NGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           NG    I+HRD+K  N+LL+   E    K+ DFG SK       T +   + GTP YL P
Sbjct: 133 NG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 185
Query: 738 EYYTS------NRLTEKSDVYSFGVVILEIITCKPAIS 769
           E   S      NR     D +S GV++   ++  P  S
Sbjct: 186 EVLVSVGTAGYNRAV---DCWSLGVILFICLSGYPPFS 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 216
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 251

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 203
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 11/130 (8%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           +I E M  G L   + +   +  + +E   I  +    +++LH+     I HRDVK  N+
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENL 140
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSF 754
           L   K +    KL DFG    FA +   +       TP Y+ PE     +  +  D++S 
Sbjct: 141 LYTSKEKDAVLKLTDFG----FAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 196
Query: 755 GVVILEIITC 764
           G VI+ I+ C
Sbjct: 197 G-VIMYILLC 205

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 142 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 193
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 228

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 168 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 219
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 254

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 156 ---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 207
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 242

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 150 ---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 201
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 236

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 11/130 (8%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           +I E M  G L   + +   +  + +E   I  +    +++LH+     I HRDVK  N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENL 159
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSF 754
           L   K +    KL DFG    FA +   +       TP Y+ PE     +  +  D++S 
Sbjct: 160 LYTSKEKDAVLKLTDFG----FAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 755 GVVILEIITC 764
           G VI+ I+ C
Sbjct: 216 G-VIMYILLC 224

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 168 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVA-----TRWYRAPEIMLN 219
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 254

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXXXX--------EVKLLMRVHHR 621
           +TLG G  G V   + R     VA++++                     E+++L +++H 
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
            +  +    D ++   ++ E M  G L + +  +  K L          +    ++YLH 
Sbjct: 215 CIIKIKNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHE 271
Query: 681 NGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           NG    I+HRD+K  N+LL+   E    K+ DFG SK       T +   + GTP YL P
Sbjct: 272 NG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 324
Query: 738 EYYTS------NRLTEKSDVYSFGVVILEIITCKPAIS 769
           E   S      NR     D +S GV++   ++  P  S
Sbjct: 325 EVLVSVGTAGYNRAV---DCWSLGVILFICLSGYPPFS 359

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 202
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 237

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTV--YYGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL +  
Sbjct: 61  FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQ-- 117
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 118 --VIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 173 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 571 ERTLGKGGFGTVYY-GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH-HRNLTSLVG 628
           E+ LG G  GTV + G      VAVK +             E+KLL     H N+     
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRY-- 74
Query: 629 HCDEDNQTALIYEF-MANGNLQEYL-----SDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +C E     L     + N NLQ+ +     SD + K+      + +  + A G+ +LH+ 
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 683 CKPPIVHRDVKSTNILLN-------------EKLQAKLADFGLSKSFATDANTHVSTV-- 727
               I+HRD+K  NIL++             E L+  ++DFGL K   +  ++  + +  
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 728 VAGTPGYLDPEYY-------TSNRLTEKSDVYSFGVVILEIIT 763
            +GT G+  PE         T  RLT   D++S G V   I++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 202
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 237

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      LS + +  L  +    +  +   G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN------LSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197
Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
                 E  D++S G ++ E+I         +     HI QW
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-----HIDQW 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + + +VA+K L               E+ L+  V+H+N+ SL+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     L+ E M + NL +    + +  L  +    +  +   G+++LH+
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELM-DANLXQ----VIQMELDHERMSYLLYQMLXGIKHLHS 137
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE   
Sbjct: 138 AG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 191
Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
                E  D++S G ++ E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++   TD      T    T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGXVATRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      LS + +  L  +    +  +   G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN------LSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197
Query: 741 TSNRLTEKSDVYSFGVVILEII 762
                 E  D++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL +    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 611 EVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
           E+++L+R   H N+ +L    D+     L+ E M  G L + +  + +K  S +E   + 
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASFVL 127
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ----AKLADFGLSKSFATDANTHVS 725
               + +EYLH+     +VHRD+K +NIL  ++       ++ DFG +K    +    ++
Sbjct: 128 HTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII 762
                T  ++ PE        E  D++S G+++  ++
Sbjct: 185 PCY--TANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 9/118 (7%)
Query: 650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD 709
           +Y+  +   V+  +   +I + + + L +L    K  I+HRD+K +NILL+     KL D
Sbjct: 112 KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD 169
Query: 710 FGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE----KSDVYSFGVVILEIIT 763
           FG+S       ++   T  AG   Y+ PE    +   +    +SDV+S G+ + E+ T
Sbjct: 170 FGISGQL---VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 147 ---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 198
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 233

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      LS + +  L  +    +  +   G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN------LSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197
Query: 741 TSNRLTEKSDVYSFGVVILEII 762
                 E  D++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 611 EVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
           E+++L+R   H N+ +L    D+     L+ E M  G L + +  + +K  S +E   + 
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASFVL 127
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ----AKLADFGLSKSFATDANTHVS 725
               + +EYLH+     +VHRD+K +NIL  ++       ++ DFG +K    +    ++
Sbjct: 128 HTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII 762
                T  ++ PE        E  D++S G+++  ++
Sbjct: 185 PCY--TANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTV--YYGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL    
Sbjct: 61  FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL---- 115
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 173 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 59/131 (45%), Gaps = 12/131 (9%)
Query: 638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           ++ E +  G L   + D   +  + +E   I     + ++YLH+     I HRDVK  N+
Sbjct: 136 IVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI---NIAHRDVKPENL 192
Query: 698 LLNEKLQ---AKLADFGLSKSFATDANTHVS-TVVAGTPGYLDPEYYTSNRLTEKSDVYS 753
           L   K      KL DFG    FA +  +H S T    TP Y+ PE     +  +  D +S
Sbjct: 193 LYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWS 248
Query: 754 FGVVILEIITC 764
            GV+   I+ C
Sbjct: 249 LGVIXY-ILLC 258

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 1   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 59
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL    
Sbjct: 60  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL---- 114
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 115 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 171
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 172 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     ++ E M + NL    S + +  L  +    +  +   G+++LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANL----SQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 198
Query: 742 SNRLTEKSDVYSFGVVILEII 762
                E  D++S G ++ E+I
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL    
Sbjct: 61  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL---- 115
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 173 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 61
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL    
Sbjct: 62  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL---- 116
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 117 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 174 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 84/174 (48%), Gaps = 24/174 (13%)
Query: 611 EVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           E++LL  + H N+  L+         +E N   L+   M        L++I K    + +
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCAKLTDD 121
Query: 665 RLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            ++  + +  +GL+Y+H+     I+HRD+K +N+ +NE  + K+ DFGL++    +   +
Sbjct: 122 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 724 VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
           V+     T  Y  PE   +     +  D++S G ++ E++T +   P    I++
Sbjct: 179 VA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 611 EVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
           E+++L+R   H N+ +L    D+     ++ E M  G L + +  + +K  S +E   + 
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVL 122
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL----QAKLADFGLSKSFATDANTHVS 725
               + +EYLH      +VHRD+K +NIL  ++       ++ DFG +K    +    ++
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                T  ++ PE           D++S GV++  ++T
Sbjct: 180 PCY--TANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL    
Sbjct: 61  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL---- 115
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 173 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 151 ---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 202
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 237

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL    
Sbjct: 99  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL---- 153
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 154 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 211 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL + +
Sbjct: 99  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI 157
Query: 653 SDISKKVLSSQERLR-IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG 711
                ++    ER+  +  +   G+++LH+     I+HRD+K +NI++      K+ DFG
Sbjct: 158 -----QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209
Query: 712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           L+++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 210 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 544 SKNKIDS-FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVY--YGRLNEIDVAVKMLXX- 599
           SK+K+D+ F +     S   V+K   N  + +G G  G V   Y  + + +VA+K L   
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 61
Query: 600 -XXXXXXXXXXXEVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYL 652
                       E+ L+  V+H+N+ SL+         +E     L+ E M + NL    
Sbjct: 62  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL---- 116
Query: 653 SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             + +  L  +    +  +   G+++LH+     I+HRD+K +NI++      K+ DFGL
Sbjct: 117 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK 765
           +++  T   + + T    T  Y  PE        E  D++S G ++ E++  K
Sbjct: 174 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   +  +  I+VAVK L               E+ LL  V+H+N+ SL+
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     L+ E M + NL      +    L  +    +  +   G+++LH+
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELM-DANL----CQVIHMELDHERMSYLLYQMLCGIKHLHS 142
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++ +T+    + T    T  Y  PE   
Sbjct: 143 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN---FMMTPYVVTRYYRAPEVIL 196
Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW 782
                E  D++S G ++ E++         +     HI QW
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKGSVIFQGTD-----HIDQW 232

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 38/75 (50%), Gaps = 4/75 (5%)
Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           +VH DVK  NI L  + + KL DFGL     T     V     G P Y+ PE    +  T
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQGSYGT 234
Query: 747 EKSDVYSFGVVILEI 761
             +DV+S G+ ILE+
Sbjct: 235 -AADVFSLGLTILEV 248

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ D+GL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + + +VA+K L               E+ L+  V+H+N+ SL+
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     L+ E M + NL      + +  L  +    +  +   G+++LH+
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELM-DANL----CQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE   
Sbjct: 139 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 192
Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
                E  D++S G ++ E++  K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + + +VA+K L               E+ L+  V+H+N+ SL+
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     L+ E M + NL      + +  L  +    +  +   G+++LH+
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELM-DANL----CQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE   
Sbjct: 139 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 192
Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
                E  D++S G ++ E++  K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + + +VA+K L               E+ L+  V+H+N+ SL+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     L+ E M + NL      + +  L  +    +  +   G+++LH+
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELM-DANL----CQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE   
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 191
Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
                E  D++S G ++ E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 61/108 (56%), Gaps = 5/108 (4%)
Query: 657 KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF 716
           K+ ++ ++ +  + + A+G+E+L +      +HRD+ + NILL+E    K+ DFGL++  
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 717 ATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             + + +V       P  ++ PE       + KSDV+S+GV++ EI +
Sbjct: 250 YKNPD-YVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 84/174 (48%), Gaps = 24/174 (13%)
Query: 611 EVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           E++LL  + H N+  L+         +E N   L+   M        L++I K    + +
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDD 121
Query: 665 RLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            ++  + +  +GL+Y+H+     I+HRD+K +N+ +NE  + K+ DFGL++    +   +
Sbjct: 122 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 724 VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
           V+     T  Y  PE   +     +  D++S G ++ E++T +   P    I++
Sbjct: 179 VA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 53/238 (22%)
Query: 564 VKITNNFER--TLGKGGFGTVYYGRLNEID---VAVKMLXXXXXXXXXXXXXEVKLLMRV 618
           ++  ++FE    LG+G FG V   R N +D    A+K +             EV LL  +
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILS-EVMLLASL 59
Query: 619 HH-------------RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQ-- 663
           +H             RN    +    + +   +  E+  N  L +    I  + L+ Q  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDL---IHSENLNQQRD 116
Query: 664 ERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
           E  R+  +  + L Y+H+     I+HRD+K  NI ++E    K+ DFGL+K      N H
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK------NVH 167
Query: 724 VS------------------TVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEII 762
            S                  T   GT  Y+  E    +    EK D+YS G++  E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 84/174 (48%), Gaps = 24/174 (13%)
Query: 611 EVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           E++LL  + H N+  L+         +E N   L+   M        L++I K    + +
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDD 145
Query: 665 RLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            ++  + +  +GL+Y+H+     I+HRD+K +N+ +NE  + K+ DFGL++    +   +
Sbjct: 146 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 202
Query: 724 VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
           V+     T  Y  PE   +     +  D++S G ++ E++T +   P    I++
Sbjct: 203 VA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 251

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 84/174 (48%), Gaps = 24/174 (13%)
Query: 611 EVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           E++LL  + H N+  L+         +E N   L+   M        L++I K    + +
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDD 144
Query: 665 RLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            ++  + +  +GL+Y+H+     I+HRD+K +N+ +NE  + K+ DFGL++    +   +
Sbjct: 145 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 201
Query: 724 VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
           V+     T  Y  PE   +     +  D++S G ++ E++T +   P    I++
Sbjct: 202 VA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 250

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      L  + +  L  +    +  +   G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN------LCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197
Query: 741 TSNRLTEKSDVYSFGVVILEII 762
                 E  D++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 549 DSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXX 606
           DSF  +     + DV ++    E  LG+G    V      +   + AVK++         
Sbjct: 4   DSFSGR-----FEDVYQLQ---EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS 55
Query: 607 XXXXEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
               EV++L +   HRN+  L+   +E+++  L++E M  G++   LS I K+   ++  
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELE 112
Query: 666 LRIAVES-AQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDAN 721
             + V+  A  L++LHN     I HRD+K  NIL    N+    K+ DF L      + +
Sbjct: 113 ASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 722 -THVST----VVAGTPGYLDPEYY-----TSNRLTEKSDVYSFGVVILEIITCKP 766
            + +ST       G+  Y+ PE        ++   ++ D++S GV++  +++  P
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      L  + +  L  +    +  +   G+++LH
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDAN------LCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 198
Query: 741 TSNRLTEKSDVYSFGVVILEII 762
                 E  D++S G ++ E+I
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMI 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +       VAVK L               E++LL  + H N+  L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 154
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 155 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 206
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 241

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +       VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 572 RTLGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      L  + +  L  +    +  +   G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN------LCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197
Query: 741 TSNRLTEKSDVYSFGVVILEII 762
                 E  D++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 30/177 (16%)
Query: 611 EVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           E++LL  + H N+  L+         +E N   L+   M        L++I K    + +
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDD 121
Query: 665 RLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            ++  + +  +GL+Y+H+     I+HRD+K +N+ +NE  + K+ DFGL++        H
Sbjct: 122 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------H 170
Query: 724 VSTVVAG---TPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
               +AG   T  Y  PE   +     +  D++S G ++ E++T +   P    I++
Sbjct: 171 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     ++ E M + NL      + +  L  +    +  +   G+++LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANL----CQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPEVVTRYYRAPEVIL 198
Query: 742 SNRLTEKSDVYSFGVVILEII 762
                E  D++S G ++ E+I
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +       VAVK L               E++LL  + H N+  L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ DFGL++    +   +V+     T  Y  PE   +
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 202
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 237

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 93/223 (41%), Gaps = 38/223 (17%)
Query: 571 ERTLGKGGFGTVYY-GRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVH-HRNLTSLVG 628
           E+ LG G  GTV + G      VAVK +             E+KLL     H N+     
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRY-- 74
Query: 629 HCDEDNQTALIYEF-MANGNLQEYL-----SDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +C E     L     + N NLQ+ +     SD + K+      + +  + A G+ +LH+ 
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 683 CKPPIVHRDVKSTNILLN-------------EKLQAKLADFGLSKSFATDANTHVSTV-- 727
               I+HRD+K  NIL++             E L+  ++DFGL K   +        +  
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 728 VAGTPGYLDPEYY-------TSNRLTEKSDVYSFGVVILEIIT 763
            +GT G+  PE         T  RLT   D++S G V   I++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +       VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG---TPGYLDPEY 739
               I+HRD+K +N+ +NE  + K+ DFGL++        H    +AG   T  Y  PE 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATRWYRAPEI 193
Query: 740 YTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
             +     +  D++S G ++ E++T +   P    I++
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL---QEYLSDISKK--VLSSQER 665
           E++++  + +    +  G     ++  +IYE+M N ++    EY   + K        + 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 666 LRIAVESA-QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           ++  ++S      Y+HN  +  I HRDVK +NIL+++  + KL+DFG S+ +  D     
Sbjct: 153 IKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIKG 209
Query: 725 STVVAGTPGYLDPEYYT--SNRLTEKSDVYSFGVVI 758
           S    GT  ++ PE+++  S+    K D++S G+ +
Sbjct: 210 S---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +       VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG---TPGYLDPEY 739
               I+HRD+K +N+ +NE  + K+ DFGL++        H    +AG   T  Y  PE 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATRWYRAPEI 193
Query: 740 YTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
             +     +  D++S G ++ E++T +   P    I++
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     ++ E M + NL      + +  L  +    +  +   G+++LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANL----CQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T        V   T  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAPEVIL 198
Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
                E  D++S G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 77/189 (40%), Gaps = 25/189 (13%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK-----VLSSQER 665
           E  +   + H ++  L+     D    +++EFM   +L     +I K+     V S    
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVA 132
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKSFATDANT 722
                +  + L Y H+     I+HRDVK  N+LL  K      KL DFG++         
Sbjct: 133 SHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLV 189
Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISR--------INE 773
               V  GTP ++ PE        +  DV+  GV++  +++ C P            I  
Sbjct: 190 AGGRV--GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG 247
Query: 774 EEKIHIRQW 782
           + K++ RQW
Sbjct: 248 KYKMNPRQW 256

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 35  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     ++ E M + NL      + +  L  +    +  +   G+++LH+
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELM-DANL----CQVIQMELDHERMSYLLYQMLCGIKHLHS 149
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE   
Sbjct: 150 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 203
Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
                E  D++S G ++ E++  K
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 24  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     ++ E M + NL      + +  L  +    +  +   G+++LH+
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELM-DANL----CQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T   + + T    T  Y  PE   
Sbjct: 139 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 192
Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
                E  D++S G ++ E++  K
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRDVK  NIL++    A L DFG++ +   +  T +   V GT  Y  PE ++ +  T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 749 SDVYSFGVVILEIITCKP 766
           +D+Y+   V+ E +T  P
Sbjct: 216 ADIYALTCVLYECLTGSP 233

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 571 ERTLGKGGFG---TVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           ++ LG+G F       + + N+   AVK++              +KL     H N+  L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQA-FAVKIISKRMEANTQKEITALKLCEG--HPNIVKLH 72
Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
               +   T L+ E +  G L E +    KK  S  E   I  +    + ++H+     +
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKLVSAVSHMHD---VGV 127
Query: 688 VHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
           VHRD+K  N+L    N+ L+ K+ DFG ++    D N  + T    T  Y  PE    N 
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCF-TLHYAAPELLNQNG 185
Query: 745 LTEKSDVYSFGVVILEIIT 763
             E  D++S GV++  +++
Sbjct: 186 YDESCDLWSLGVILYTMLS 204

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 32  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 628 G------HCDEDNQTALIYEFM-ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
                    +E     ++ E M AN      L  + +  L  +    +  +   G+++LH
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDAN------LCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+K +NI++      K+ DFGL+++  T +   V  VV  T  Y  PE  
Sbjct: 146 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMVPFVV--TRYYRAPEVI 199
Query: 741 TSNRLTEKSDVYSFGVVILEII 762
                 E  D++S G ++ E+I
Sbjct: 200 LGMGYKENVDIWSVGCIMGEMI 221

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+  FGL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 21/202 (10%)
Query: 574 LGKGGFGTVYYGRLNE----IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           LG+G FG V+  R+ +       AVK +             E+     +    +  L G 
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGA 134
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
             E     +  E +  G+L + + +  +  L     L    ++ +GLEYLH+     I+H
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKE--QGCLPEDRALYYLGQALEGLEYLHSR---RILH 189
Query: 690 RDVKSTNILL-NEKLQAKLADFGLSKSFATDA---NTHVSTVVAGTPGYLDPEYYTSNRL 745
            DVK+ N+LL ++   A L DFG +     D    +      + GT  ++ PE       
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 746 TEKSDVYSFGVVILEIIT-CKP 766
             K DV+S   ++L ++  C P
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 9/199 (4%)
Query: 569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLXXX--XXXXXXXXXXEVKLLMRVHHRNLTSL 626
           NF   L +   G ++ GR    D+ VK+L               E   L    H N+  +
Sbjct: 13  NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 627 VGHCDEDN--QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
           +G C         LI  +   G+L   L + +  V+   + ++ A++ A+G  +LH   +
Sbjct: 73  LGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-LE 131
Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
           P I    + S ++ ++E   A+++   +  SF +    +    VA  P  L  +   +NR
Sbjct: 132 PLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVA--PEALQKKPEDTNR 189
Query: 745 LTEKSDVYSFGVVILEIIT 763
               +D +SF V++ E++T
Sbjct: 190 --RSADXWSFAVLLWELVT 206

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 83/174 (47%), Gaps = 24/174 (13%)
Query: 611 EVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           E++LL  + H N+  L+         +E N   L+   M        L++I K    + +
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDD 145
Query: 665 RLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            ++  + +  +GL+Y+H+     I+HRD+K +N+ +NE  + K+ DFGL++    +    
Sbjct: 146 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGX 202
Query: 724 VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
           V+     T  Y  PE   +     +  D++S G ++ E++T +   P    I++
Sbjct: 203 VA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 251

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   Y  + E +VA+K L               E+ L+  V+H+N+  L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     ++ E M + NL      + +  L  +    +  +   G+++LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANL----CQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T        V   T  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAPEVIL 198
Query: 742 SNRLTEKSDVYSFGVVILEIITCK 765
                E  D++S G ++ E++  K
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           + +G G  G V   +  +  I+VAVK L               E+ LL  V+H+N+ SL+
Sbjct: 30  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 628 G------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                    +E     L+ E M + NL      +    L  +    +  +   G+++LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANL----CQVIHMELDHERMSYLLYQMLCGIKHLHS 144
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                I+HRD+K +NI++      K+ DFGL+++  T+    + T    T  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVIL 198
Query: 742 SNRLTEKSDVYSFGVVILEII 762
                   D++S G ++ E++
Sbjct: 199 GMGYAANVDIWSVGCIMGELV 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ D GL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 21/202 (10%)
Query: 574 LGKGGFGTVYYGRLNE----IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGH 629
           LG+G FG V+  R+ +       AVK +             E+     +    +  L G 
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGA 153
Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
             E     +  E +  G+L + + +  +  L     L    ++ +GLEYLH+     I+H
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKE--QGCLPEDRALYYLGQALEGLEYLHSR---RILH 208
Query: 690 RDVKSTNILL-NEKLQAKLADFGLSKSFATDA---NTHVSTVVAGTPGYLDPEYYTSNRL 745
            DVK+ N+LL ++   A L DFG +     D    +      + GT  ++ PE       
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 746 TEKSDVYSFGVVILEIIT-CKP 766
             K DV+S   ++L ++  C P
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ D GL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 29/215 (13%)
Query: 570 FERTLGKGGFGTV--YYGRLNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLV 627
           F + LG+GGF  V    G  +    A+K +             E  +    +H N+  LV
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 628 GHCDED----NQTALIYEFMANGNLQEYLSDISKK--VLSSQERLRIAVESAQGLEYLHN 681
            +C  +    ++  L+  F   G L   +  +  K   L+  + L + +   +GLE +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS-----------TVVAG 730
                  HRD+K TNILL ++ Q  L D G        A  HV                 
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLG----SMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 731 TPGYLDPEYYTSNR---LTEKSDVYSFGVVILEII 762
           T  Y  PE ++      + E++DV+S G V+  ++
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 574 LGKGGFGTVYYGRLNE--IDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRNLTSLVGHCD 631
           LG+G FG V+  +  +     AVK +             E+     +    +  L G   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 134
Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD 691
           E     +  E +  G+L + +  +    L     L    ++ +GLEYLH      I+H D
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT---RRILHGD 189
Query: 692 VKSTNILL-NEKLQAKLADFGLSKSFATDA---NTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           VK+ N+LL ++  +A L DFG +     D    +      + GT  ++ PE         
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 249
Query: 748 KSDVYSFGVVILEIIT-CKP 766
           K D++S   ++L ++  C P
Sbjct: 250 KVDIWSSCCMMLHMLNGCHP 269

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 574 LGKGGFGTV--YYGRLNEIDVAVKMLXX--XXXXXXXXXXXEVKLLMRVHHRNLTSLVG- 628
           +G G +G+V   +     + VAVK L               E++LL  + H N+  L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 629 -----HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV-ESAQGLEYLHNG 682
                  +E N   L+   M        L++I K    + + ++  + +  +GL+Y+H+ 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I+HRD+K +N+ +NE  + K+ D GL++    +   +V+     T  Y  PE   +
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVA-----TRWYRAPEIMLN 196
Query: 743 -NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
                +  D++S G ++ E++T +   P    I++
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 10/150 (6%)
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
            +  L G   E     +  E +  G+L + +  +    L     L    ++ +GLEYLH 
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT 168
Query: 682 GCKPPIVHRDVKSTNILL-NEKLQAKLADFGLSKSFATDA---NTHVSTVVAGTPGYLDP 737
                I+H DVK+ N+LL ++  +A L DFG +     D    +      + GT  ++ P
Sbjct: 169 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 738 EYYTSNRLTEKSDVYSFGVVILEIIT-CKP 766
           E         K D++S   ++L ++  C P
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 10/150 (6%)
Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
            +  L G   E     +  E +  G+L + +  +    L     L    ++ +GLEYLH 
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT 184
Query: 682 GCKPPIVHRDVKSTNILL-NEKLQAKLADFGLSKSFATDA---NTHVSTVVAGTPGYLDP 737
                I+H DVK+ N+LL ++  +A L DFG +     D    +      + GT  ++ P
Sbjct: 185 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 241
Query: 738 EYYTSNRLTEKSDVYSFGVVILEIIT-CKP 766
           E         K D++S   ++L ++  C P
Sbjct: 242 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 611 EVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
           E+++L+R   H N+ +L    D+     ++ E    G L + +  + +K  S +E   + 
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKI--LRQKFFSEREASAVL 122
Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVS 725
               + +EYLH      +VHRD+K +NIL  ++       ++ DFG +K     A   + 
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLL 177
Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                T  ++ PE           D++S GV++   +T
Sbjct: 178 XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLT 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 83/174 (47%), Gaps = 24/174 (13%)
Query: 611 EVKLLMRVHHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
           E++LL  + H N+  L+         +E N   L+   M        L++I K    + +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDD 125
Query: 665 RLRIAV-ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            ++  + +  +GL+Y+H+     I+HRD+K +N+ +NE  + K+ DF L++    +   +
Sbjct: 126 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY 182
Query: 724 VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK---PAISRINE 773
           V+     T  Y  PE   +     +  D++S G ++ E++T +   P    I++
Sbjct: 183 VA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 564 VKITNNFE--RTLGKGGFGTVY--YGRLNEIDVAVKMLXXXXXXXX--XXXXXEVKLLMR 617
           VK+ +N+E    +G+G +G VY  Y +    +VA+K +               E+ +L R
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 618 VHHRNLTSLVGHC-DED----NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES 672
           +    +  L      ED    ++  ++ E +A+ +L++     +   L+ Q    I    
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFK--TPIFLTEQHVKTILYNL 140
Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
             G +++H      I+HRD+K  N LLN+    K+ DFGL+++  +D + H+
Sbjct: 141 LLGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHI 189

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXXX------XXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E M    +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 76  IRLLDWFERPDSFVLILERME--PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 132
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 133 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 186
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVC 209

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 93/238 (39%), Gaps = 53/238 (22%)
Query: 564 VKITNNFER--TLGKGGFGTVYYGRLNEID---VAVKMLXXXXXXXXXXXXXEVKLLMRV 618
           ++  ++FE    LG+G FG V   R N +D    A+K +             EV LL  +
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILS-EVXLLASL 59
Query: 619 HH-------------RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQ-- 663
           +H             RN         + +   +  E+  N  L +    I  + L+ Q  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDL---IHSENLNQQRD 116
Query: 664 ERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
           E  R+  +  + L Y+H+     I+HR++K  NI ++E    K+ DFGL+K      N H
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK------NVH 167
Query: 724 VS------------------TVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEII 762
            S                  T   GT  Y+  E    +    EK D YS G++  E I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%), Gaps = 1/57 (1%)
Query: 419 LKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVEL 474
           L G+I S +SN T+L ++ LSNN LTG +P ++ +L  L  L L  N  +G++P EL
Sbjct: 475 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 531

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 16/162 (9%)
Query: 611 EVKLLMRVHHRN---LTSLVGHCDED--NQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           E++LL   HH N   L  +  H +E   ++  L+ E M   +L + + D  + V+S Q  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHD-QRIVISPQHI 136
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THV 724
                    GL  LH      +VHRD+   NILL +     + DF L++    DAN TH 
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY 193
Query: 725 STVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCK 765
            T       Y  PE     +  T+  D++S G V+ E+   K
Sbjct: 194 VT----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%), Gaps = 1/57 (1%)
Query: 419 LKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVEL 474
           L G+I S +SN T+L ++ LSNN LTG +P ++ +L  L  L L  N  +G++P EL
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 16/162 (9%)
Query: 611 EVKLLMRVHHRN---LTSLVGHCDED--NQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           E++LL   HH N   L  +  H +E   ++  L+ E M   +L + + D  + V+S Q  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHD-QRIVISPQHI 136
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THV 724
                    GL  LH      +VHRD+   NILL +     + DF L++    DAN TH 
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY 193
Query: 725 STVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCK 765
            T       Y  PE     +  T+  D++S G V+ E+   K
Sbjct: 194 VT----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 56/227 (24%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN------- 622
           R LG G F TV+  +  +N   VA+K++             E+KLL RV+  +       
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDSM 83
Query: 623 ----LTSLVGHCDE----------------DNQTALIYEFMANGNLQEYLSDISKKVLSS 662
               +  L+ H +                 +N  ALI ++   G    Y+  ISK++L  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL-- 141
Query: 663 QERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL------NEKLQAKLADFGLSKSF 716
                       GL+Y+H  C   I+H D+K  N+L+         +Q K+AD G +  +
Sbjct: 142 -----------LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
               + H +  +  T  Y  PE          +D++S   +I E+IT
Sbjct: 189 ----DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 56/227 (24%)
Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLXXXXXXXXXXXXXEVKLLMRVHHRN------- 622
           R LG G F TV+  +  +N   VA+K++             E+KLL RV+  +       
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDSM 83
Query: 623 ----LTSLVGHCDE----------------DNQTALIYEFMANGNLQEYLSDISKKVLSS 662
               +  L+ H +                 +N  ALI ++   G    Y+  ISK++L  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL-- 141
Query: 663 QERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL------NEKLQAKLADFGLSKSF 716
                       GL+Y+H  C   I+H D+K  N+L+         +Q K+AD G +  +
Sbjct: 142 -----------LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
               + H +  +  T  Y  PE          +D++S   +I E+IT
Sbjct: 189 ----DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXEVKLL--MRVHHRNLTSLV 627
           + +GKG FG V     +++   VA+KM+             E+++L  +R   ++ T  V
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161
Query: 628 GHCDED----NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
            H  E+    N   + +E ++  NL E +     +  S     + A    Q L+ LH   
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217
Query: 684 KPPIVHRDVKSTNILLNEKLQA--KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           K  I+H D+K  NILL ++ ++  K+ DFG S        T + +       Y  PE   
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-----YRAPEVIL 272
Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
             R     D++S G ++ E++T  P +   +E +++
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 25/189 (13%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK-----VLSSQER 665
           E  +   + H ++  L+     D    +++EFM   +L     +I K+     V S    
Sbjct: 78  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVA 134
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKSFATDANT 722
                +  + L Y H+     I+HRDVK   +LL  K      KL  FG++         
Sbjct: 135 SHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 191
Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISR--------INE 773
               V  GTP ++ PE        +  DV+  GV++  +++ C P            I  
Sbjct: 192 AGGRV--GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG 249
Query: 774 EEKIHIRQW 782
           + K++ RQW
Sbjct: 250 KYKMNPRQW 258

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXEVKLL--MRVHHRNLTSLV 627
           + +GKG FG V     +++   VA+KM+             E+++L  +R   ++ T  V
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161
Query: 628 GHCDED----NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
            H  E+    N   + +E ++  NL E +     +  S     + A    Q L+ LH   
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217
Query: 684 KPPIVHRDVKSTNILLNEKLQA--KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           K  I+H D+K  NILL ++ ++  K+ DFG S        T + +       Y  PE   
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-----YRAPEVIL 272
Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI 777
             R     D++S G ++ E++T  P +   +E +++
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 25/189 (13%)
Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK-----VLSSQER 665
           E  +   + H ++  L+     D    +++EFM   +L     +I K+     V S    
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVA 132
Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKSFATDANT 722
                +  + L Y H+     I+HRDVK   +LL  K      KL  FG++         
Sbjct: 133 SHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISR--------INE 773
               V  GTP ++ PE        +  DV+  GV++  +++ C P            I  
Sbjct: 190 AGGRV--GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG 247
Query: 774 EEKIHIRQW 782
           + K++ RQW
Sbjct: 248 KYKMNPRQW 256

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 77  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 133
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 134 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 187
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVC 210

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 92  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 149 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 202
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVC 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 91  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 147
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 148 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 201
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVC 224

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 92  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 149 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 202
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVC 225

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 91  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 147
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 148 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 201
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVC 224

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 99  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 155
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 156 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 209
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVC 232

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 111 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 167
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 168 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 221
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVC 244

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 29/224 (12%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 16  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 63
Query: 612 VKLLMRVHHRNLTSL-VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-- 668
           ++++ ++ H N+  L         +  ++Y  +    + E +  +++    +++ L +  
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 669 ----AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFATDANTH 723
                 +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K        +
Sbjct: 124 VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPN 179
Query: 724 VSTVVAGTPGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
           VS + +    Y  PE  + +   T   DV+S G V+ E++  +P
Sbjct: 180 VSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXXX------XXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 76  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 132
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 133 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 186
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVC 209

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXXX------XXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 77  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 133
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 134 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 187
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVC 210

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 92  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 149 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 202
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVC 225

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 105 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 162 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 215
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVC 238

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 104 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 161 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 214
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVC 237

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 119 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 175
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 176 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 229
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVC 252

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 104 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 161 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 214
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVC 237

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 105 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 162 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 215
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVC 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 104 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 161 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 214
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVC 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 104 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 161 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 214
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVC 237

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 105 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 162 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 215
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVC 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 105 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 162 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 215
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVC 238

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXXX------XXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 77  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 133
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 134 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 187
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVC 210

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 119 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 175
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 176 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 229
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVC 252

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 52  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 99
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 100 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 154
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 155 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 208
Query: 719 DANTHVSTVVAGTP--GYLDPEYYTSNRL-------TEKSDVYSFGVVILEIITCKP 766
                   +V G P   Y+   YY +  L       T   DV+S G V+ E++  +P
Sbjct: 209 --------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 54  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 101
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 102 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 156
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 157 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 210
Query: 719 DANTHVSTVVAGTP--GYLDPEYYTSNRL-------TEKSDVYSFGVVILEIITCKP 766
                   +V G P   Y+   YY +  L       T   DV+S G V+ E++  +P
Sbjct: 211 --------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 574 LGKGGFGTVYYG-RLNE-IDVAVKMLXXXXXXX------XXXXXXEVKLLMRVH--HRNL 623
           LG GGFG+VY G R+++ + VA+K +                   EV LL +V      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVESAQGLEYLHNG 682
             L+   +  +   LI E      +Q+    I+++    +E  R    +  + + + HN 
Sbjct: 124 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 180
Query: 683 CKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           C   ++HRD+K  NIL++  + + KL DFG S +   D    V T   GT  Y  PE+  
Sbjct: 181 CG--VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDT---VYTDFDGTRVYSPPEWIR 234
Query: 742 SNRLTEKS-DVYSFGVVILEIIT 763
            +R   +S  V+S G+++ +++ 
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVC 257

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 50  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 97
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 98  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 152
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 206
Query: 719 DANTHVSTVVAGTP--GYLDPEYYTSNRL-------TEKSDVYSFGVVILEIITCKP 766
                   +V G P   Y+   YY +  L       T   DV+S G V+ E++  +P
Sbjct: 207 --------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 95  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 142
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 143 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 197
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 198 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 251
Query: 719 DANTHVSTVVAGTP--GYLDPEYYTSNRL-------TEKSDVYSFGVVILEIITCKP 766
                   +V G P   Y+   YY +  L       T   DV+S G V+ E++  +P
Sbjct: 252 --------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 44  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 91
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 92  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 146
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 147 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 200
Query: 719 DANTHVSTVVAGTP--GYLDPEYYTSNRL-------TEKSDVYSFGVVILEIITCKP 766
                   +V G P   Y+   YY +  L       T   DV+S G V+ E++  +P
Sbjct: 201 --------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 564 VKITNNF--ERTLGKGGFGTVY--YGRLNEIDVAVKMLXXXXXXXX--XXXXXEVKLLMR 617
           V + +N+  +  +G+G +G VY  Y +  E +VA+K +               E+ +L R
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 618 VHHRNLTSLVGHCDEDN-----QTALIYEFMANGNLQEYLSDISKKVLSSQERLR-IAVE 671
           +    +  L      D+     +  ++ E +A+ +L++        +  ++E ++ I   
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFK---TPIFLTEEHIKTILYN 137
Query: 672 SAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
              G  ++H      I+HRD+K  N LLN+    K+ DFGL+++  ++ +T++
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 50  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 97
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 98  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 152
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 719 DANTHVSTVVAGTPGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
               +VS + +    Y  PE  + +   T   DV+S G V+ E++  +P
Sbjct: 210 -GEPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 25/224 (11%)
Query: 571 ERTLGKGGFGTVYYGRLNEIDVAVKMLXXXXXXXXXXXXXEV-KLLMRVHHRNLTSLVGH 629
           ER  G+G FGTV  G+     ++V +              ++ + L  +HH N+  L  +
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 630 C----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN---- 681
                + D +   +   M      EY+ D   +   +  R ++A        +L      
Sbjct: 88  FYTLGERDRRDIYLNVVM------EYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 682 -GC----KPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFATDANTHVSTVVAGTPGYL 735
            GC       + HRD+K  N+L+NE     KL DFG +K  +  +  +V+ + +    Y 
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP-SEPNVAYICSRY--YR 198
Query: 736 DPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIH 778
            PE    N+  T   D++S G +  E++  +P     N   ++H
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 21  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 68
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 69  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 123
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 124 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 177
Query: 719 DANTHVSTVVAGTP--GYLDPEYYTSNRL-------TEKSDVYSFGVVILEIITCKP 766
                   +V G P   Y+   YY +  L       T   DV+S G V+ E++  +P
Sbjct: 178 --------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 28  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 75
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 76  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 130
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 719 DANTHVSTVVAGTPGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
               +VS + +    Y  PE  + +   T   DV+S G V+ E++  +P
Sbjct: 188 -GEPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 28  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 75
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 76  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 130
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 719 DANTHVSTVVAGTPGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
               +VS + +    Y  PE  + +   T   DV+S G V+ E++  +P
Sbjct: 188 -GEPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 35  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 82
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 83  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 137
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 138 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 194
Query: 719 DANTHVSTVVAGTPGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
               +VS + +    Y  PE  + +   T   DV+S G V+ E++  +P
Sbjct: 195 -GEPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 240

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 19/181 (10%)
Query: 611 EVKLLMRVHHRNLTSL--VGHCDEDNQTALIYEFMANGNLQEYL-----SDISKKVLSSQ 663
           E+ LL  + H N+ SL  V     D +  L++++ A  +L   +     S  +KK +   
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 126
Query: 664 ERL--RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSKSFA 717
             +   +  +   G+ YLH      ++HRD+K  NIL+     E+ + K+AD G ++ F 
Sbjct: 127 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 718 TDANTHVS-TVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           +          V  T  Y  PE     R  T+  D+++ G +  E++T +P      E+ 
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 776 K 776
           K
Sbjct: 244 K 244

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEID--VAVKMLXXXXXXXXXXXXXE 611
           + + +SY+D         + +G G FG VY  +L +    VA+K +             E
Sbjct: 29  RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----E 76
Query: 612 VKLLMRVHHRNLTSL------VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER 665
           ++++ ++ H N+  L       G   ++    L+ +++      E +  +++    +++ 
Sbjct: 77  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT 131
Query: 666 LRI------AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-KLADFGLSKSFAT 718
           L +        +  + L Y+H+     I HRD+K  N+LL+      KL DFG +K    
Sbjct: 132 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 185
Query: 719 DANTHVSTVVAGTP--GYLDPEYYTSNRL-------TEKSDVYSFGVVILEIITCKP 766
                   +V G P   Y+   YY +  L       T   DV+S G V+ E++  +P
Sbjct: 186 --------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 234
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	878
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-153
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-120
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-119
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-86
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-64
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-62
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-61
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-60
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-55
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-38
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-38
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-16
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-16
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-15
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-13
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-13
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-08
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-05
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-07
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-07
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-06
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  452 bits (1166), Expect = e-153
 Identities = 121/308 (39%), Positives = 181/308 (58%), Gaps = 8/308 (2%)

Query: 542 RESKNKIDSFEAKSRHLSYSDVVKITNNF--ERTLGKGGFGTVYYGRLNE-IDVAVKMLS 598
            ++ +       +S  +   D+ + TNNF  +  +G G FG VY G L +   VA+K  +
Sbjct: 13  NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72

Query: 599 SSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDIS 656
             S+QG ++F+ E++ L    H +L SL+G CDE N+  LIY++M NGNL+ +L  SD+ 
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132

Query: 657 KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF 716
              +S ++RL I + +A+GL YLH      I+HRDVKS NILL+E    K+ DFG+SK  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189

Query: 717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK 776
                TH+STVV GT GY+DPEY+   RLTEKSDVYSFGVV+ E++  + AI +    E 
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249

Query: 777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME 836
           +++ +W       G ++ IVDP L +     S+ K  + A+ CL+ +   RP+M  V+ +
Sbjct: 250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309

Query: 837 LSECLAAE 844
           L   L  +
Sbjct: 310 LEYALRLQ 317

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  366 bits (943), Expect = e-120
 Identities = 103/310 (33%), Positives = 167/310 (53%), Gaps = 21/310 (6%)

Query: 548 IDSFEAKSRHLSYSDVVKITNNFERT--------LGKGGFGTVYYGRLNEIDVAVKMLSS 599
           ++  + +    S+ ++  +TNNF+          +G+GGFG VY G +N   VAVK L++
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA 64

Query: 600 ----SSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI 655
               ++ +  QQF  E+K++ +  H NL  L+G   + +   L+Y +M NG+L + LS +
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 656 SK-KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK 714
                LS   R +IA  +A G+ +LH       +HRD+KS NILL+E   AK++DFGL++
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE 774
           +    A T +++ + GT  Y+ PE      +T KSD+YSFGVV+LEIIT  PA+    E 
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

Query: 775 EKIHIRQWVNSLIA-KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
           +   +      +   +  I+  +D ++  D D+ SV     +A  CL    N+RP + +V
Sbjct: 241 Q--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

Query: 834 VMELSECLAA 843
              L E  A+
Sbjct: 298 QQLLQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  363 bits (933), Expect = e-119
 Identities = 111/287 (38%), Positives = 177/287 (61%), Gaps = 9/287 (3%)

Query: 556 RHLSYSDVVKITNNF--ERTLGKGGFGTVYYGRL-NEIDVAVKMLSSSSAQGFQ-QFQAE 611
           +  S  ++   ++NF  +  LG+GGFG VY GRL +   VAVK L     QG + QFQ E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 612 VKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--SDISKKVLSSQERLRIA 669
           V+++    HRNL  L G C    +  L+Y +MANG++   L     S+  L   +R RIA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
           + SA+GL YLH+ C P I+HRDVK+ NILL+E+ +A + DFGL+K      +THV+T V 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVR 196

Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAI--SRINEEEKIHIRQWVNSLI 787
           GT G++ PEY ++ + +EK+DV+ +GV++LE+IT + A   +R+  ++ + +  WV  L+
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
            +  ++++VD  LQ ++    V + +++A+ C   +  +RP MS+VV
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  278 bits (712), Expect = 1e-86
 Identities = 75/309 (24%), Positives = 126/309 (40%), Gaps = 28/309 (9%)

Query: 555 SRHLSYSDVVKITNNFERT--LGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEV 612
              L   ++   +   +      +G FG V+  +L    VAVK+      Q +Q  + EV
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQ-NEYEV 69

Query: 613 KLLMRVHHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRI 668
             L  + H N+   +G             LI  F   G+L ++L      V+S  E   I
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHI 126

Query: 669 AVESAQGLEYLH-------NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN 721
           A   A+GL YLH       +G KP I HRD+KS N+LL   L A +ADFGL+  F    +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 722 THVSTVVAGTPGYLDPEY-----YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK 776
              +    GT  Y+ PE              + D+Y+ G+V+ E+ +   A     +E  
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 777 IHIRQWVNSLIAKGDIKSIV-----DPRLQEDFDANSVWKAV-ELAMACLSPTGNQRPTM 830
           +   + +    +  D++ +V      P L++ +  ++    + E    C       R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 831 SQVVMELSE 839
             V   +++
Sbjct: 307 GCVGERITQ 315

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  220 bits (563), Expect = 2e-65
 Identities = 81/275 (29%), Positives = 141/275 (51%), Gaps = 29/275 (10%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLV 627
            +  +G G FGTV+    +  DVAVK+L      A+   +F  EV ++ R+ H N+   +
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 628 GHCDEDNQTALIYEFMANGNLQEYL-SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
           G   +    +++ E+++ G+L   L    +++ L  + RL +A + A+G+ YLHN   PP
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           IVHR++KS N+L+++K   K+ DFGLS+  A+   +  S   AGTP ++ PE        
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSN 217

Query: 747 EKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWVNSLIAKG---DIKSIVDPRLQE 802
           EKSDVYSFGV++ E+ T + P          ++  Q V ++  K    +I   ++P++  
Sbjct: 218 EKSDVYSFGVILWELATLQQPW-------GNLNPAQVVAAVGFKCKRLEIPRNLNPQV-- 268

Query: 803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
                       +   C +    +RP+ + ++  L
Sbjct: 269 ----------AAIIEGCWTNEPWKRPSFATIMDLL 293

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  219 bits (559), Expect = 2e-64
 Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 37/303 (12%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
               +G+G +G VY G L+E  VAVK+ S ++ Q F   +  +  +  + H N+   +  
Sbjct: 17  LLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNIARFIVG 75

Query: 630 CDEDNQTA-----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN--- 681
            +           L+ E+  NG+L +YLS             R+A    +GL YLH    
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCRLAHSVTRGLAYLHTELP 132

Query: 682 ---GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA------TDANTHVSTVVAGTP 732
                KP I HRD+ S N+L+       ++DFGLS               + +    GT 
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192

Query: 733 GYLDPEYYTS-------NRLTEKSDVYSFGVVILEIIT-CKPAIS-RINEEEKIHIRQWV 783
            Y+ PE               ++ D+Y+ G++  EI   C          E ++  +  V
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252

Query: 784 NSLIAKGDIKSIVD-----PRLQEDFDANSVWKAV--ELAMACLSPTGNQRPTMSQVVME 836
            +     D++ +V      P+  E +  NS+      E    C       R T       
Sbjct: 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312

Query: 837 LSE 839
           ++E
Sbjct: 313 MAE 315

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  211 bits (540), Expect = 7e-62
 Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 28/298 (9%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
             + +GKG +G V+ G+     VAVK+  ++    +   + E+   + + H N+   +  
Sbjct: 41  MVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAA 99

Query: 630 CDEDN----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
             +      Q  LI ++  NG+L +YL       L ++  L++A  S  GL +LH     
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH--VSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+  F +D N          GT  Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 739 ------YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
                      +    +D+YSFG+++ E+         I EE ++     V S  +  D+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRC-VSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 793 KSIVD-----PRLQEDFDANSVWKAV-ELAMACLSPTGNQRPTMSQVVMELSECLAAE 844
           + IV      P     + ++   + + +L   C +     R T  +V   L++   ++
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  208 bits (531), Expect = 2e-61
 Identities = 57/280 (20%), Positives = 114/280 (40%), Gaps = 38/280 (13%)

Query: 569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSL 626
           NF   L +   G ++ GR    D+ VK+L     S +  + F  E   L    H N+  +
Sbjct: 13  NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 627 VGHCDE--DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
           +G C         LI  +M  G+L   L + +  V+   + ++ A++ A+G+ +LH   +
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LE 131

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT--- 741
           P I    + S +++++E + A+++   +  SF        S      P ++ PE      
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKP 184

Query: 742 SNRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWVNSLIAKG---DIKSIVD 797
            +     +D++SF V++ E++T + P          +   +    +  +G    I   + 
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPF-------ADLSNMEIGMKVALEGLRPTIPPGIS 237

Query: 798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
           P +             +L   C++    +RP    +V  L
Sbjct: 238 PHVS------------KLMKICMNEDPAKRPKFDMIVPIL 265

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  208 bits (531), Expect = 4e-61
 Identities = 87/289 (30%), Positives = 139/289 (48%), Gaps = 44/289 (15%)

Query: 570 FERTLGKGGFGTVYYGRL--NEIDVAVKML-------SSSSAQGFQQFQAEVKLLMRVHH 620
           +E+ +GKGGFG V+ GRL  ++  VA+K L        +   + FQ+FQ EV ++  ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G     N   ++ EF+  G+L   L D     +    +LR+ ++ A G+EY+ 
Sbjct: 83  PNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 681 NGCKPPIVHRDVKSTNILLNEK-----LQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           N   PPIVHRD++S NI L        + AK+ADFGLS+      + H  + + G   ++
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWM 193

Query: 736 DPE--YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG--- 790
            PE         TEK+D YSF +++  I+T +      +  +     +++N +  +G   
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRP 249

Query: 791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
            I     PRL              +   C S    +RP  S +V ELSE
Sbjct: 250 TIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKELSE 286

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (530), Expect = 7e-61
 Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 31/277 (11%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
            E  +G+G FG V   +    DVA+K + S S +  + F  E++ L RV+H N+  L G 
Sbjct: 12  VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKV-LSSQERLRIAVESAQGLEYLHNGCKPPIV 688
           C   N   L+ E+   G+L   L         ++   +   ++ +QG+ YLH+     ++
Sbjct: 70  CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 689 HRDVKSTNILLNEKLQ-AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           HRD+K  N+LL       K+ DFG +    T       T   G+  ++ PE +  +  +E
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSE 182

Query: 748 KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG---DIKSIVDPRLQEDF 804
           K DV+S+G+++ E+IT +     I           +   +  G    +   +   +    
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIG-----GPAFRIMWAVHNGTRPPLIKNLPKPI---- 233

Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
                     L   C S   +QRP+M ++V  ++  +
Sbjct: 234 --------ESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  206 bits (527), Expect = 2e-60
 Identities = 71/293 (24%), Positives = 128/293 (43%), Gaps = 28/293 (9%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
               +GKG +G V+ G     +VAVK+ SS   + + + + E+   + + H N+   +  
Sbjct: 12  LLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIAS 70

Query: 630 C----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
                    Q  LI  +   G+L +YL       L +   LRI +  A GL +LH     
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS--KSFATDANTHVSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +  Q  +AD GL+   S +T+     +    GT  Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 739 ------YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
                         ++ D+++FG+V+ E+     + + I E+ K      V +  +  D+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-NGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 793 KSIVD-----PRLQEDFDANSVWKAV-ELAMACLSPTGNQRPTMSQVVMELSE 839
           + +V      P +   + ++    ++ +L   C     + R T  ++   L++
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  205 bits (523), Expect = 3e-60
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 42/286 (14%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKML----SSSSAQGFQQFQAEVKLLMRVHHRNLTS 625
            E  +G GGFG VY       +VAVK          +Q  +  + E KL   + H N+ +
Sbjct: 11  LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L G C ++    L+ EF   G L   LS    K +     +  AV+ A+G+ YLH+    
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 686 PIVHRDVKSTNILLNEKLQ--------AKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           PI+HRD+KS+NIL+ +K++         K+ DFGL++ +            AG   ++ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS----AAGAYAWMAP 183

Query: 738 EYYTSNRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWVNSLIAKG---DIK 793
           E   ++  ++ SDV+S+GV++ E++T + P          I        +        I 
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPF-------RGIDGLAVAYGVAMNKLALPIP 236

Query: 794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
           S                   +L   C +P  + RP+ + ++ +L+ 
Sbjct: 237 STCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTT 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  205 bits (523), Expect = 5e-60
 Identities = 78/275 (28%), Positives = 145/275 (52%), Gaps = 22/275 (8%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKML--SSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
             + +G G FGTVY G+ +  DVAVKML  ++ + Q  Q F+ EV +L +  H N+   +
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G+       A++ ++    +L  +L   S+     ++ + IA ++A+G++YLH      I
Sbjct: 87  GYSTAPQ-LAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE---YYTSNR 744
           +HRD+KS NI L+E    K+ DFGL+   +  + +H    ++G+  ++ PE      SN 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            + +SDVY+FG+V+ E++T +   S IN  ++I I       + +G +   +  +++ + 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IEM-----VGRGSLSPDL-SKVRSNC 254

Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
                 +   L   CL    ++RP+  +++ E+ E
Sbjct: 255 PK----RMKRLMAECLKKKRDERPSFPRILAEIEE 285

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  204 bits (521), Expect = 4e-59
 Identities = 71/293 (24%), Positives = 140/293 (47%), Gaps = 28/293 (9%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
            + ++GKG FG V+ G+    +VAVK+ SS   + + + +AE+   + + H N+   +  
Sbjct: 46  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 104

Query: 630 CDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH----- 680
            ++DN T     L+ ++  +G+L +YL+   +  ++ +  +++A+ +A GL +LH     
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH--VSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+    +  +T         GT  Y+ PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 739 ------YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
                         +++D+Y+ G+V  EI     +I  I+E+ ++     V S  +  ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPSVEEM 280

Query: 793 KSIVD-----PRLQEDFDANSVWKAV-ELAMACLSPTGNQRPTMSQVVMELSE 839
           + +V      P +   + +    + + ++   C    G  R T  ++   LS+
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  199 bits (508), Expect = 1e-57
 Identities = 61/321 (19%), Positives = 122/321 (38%), Gaps = 45/321 (14%)

Query: 531 LKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEI 590
           L   R   +   ++   +  ++     + +  +          +GKG FG VY+GR +  
Sbjct: 8   LLSARSFPRKASQTSIFLQEWD-----IPFEQLE-----IGELIGKGRFGQVYHGRWHG- 56

Query: 591 DVAVKML--SSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL 648
           +VA++++     +    + F+ EV    +  H N+   +G C      A+I        L
Sbjct: 57  EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116

Query: 649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA 708
              + D +K VL   +  +IA E  +G+ YLH      I+H+D+KS N+  +   +  + 
Sbjct: 117 YSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNG-KVVIT 171

Query: 709 DFGLSKSFATDANTHVS---TVVAGTPGYLDPEYYTSNRL---------TEKSDVYSFGV 756
           DFGL                 +  G   +L PE                ++ SDV++ G 
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231

Query: 757 VILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELA 816
           +  E+   +        E  I         +  G   ++    + ++          ++ 
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQ-------MGTGMKPNLSQIGMGKEI--------SDIL 276

Query: 817 MACLSPTGNQRPTMSQVVMEL 837
           + C +    +RPT ++++  L
Sbjct: 277 LFCWAFEQEERPTFTKLMDML 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  192 bits (489), Expect = 5e-55
 Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 43/301 (14%)

Query: 554 KSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAE 611
             R    SD++         LGKG FG        E    + +K L     +  + F  E
Sbjct: 3   PHRIFRPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57

Query: 612 VKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVE 671
           VK++  + H N+   +G   +D +   I E++  G L+  +           +R+  A +
Sbjct: 58  VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKD 116

Query: 672 SAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT--------- 722
            A G+ YLH      I+HRD+ S N L+ E     +ADFGL++    +            
Sbjct: 117 IASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 723 ---HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK---PAISRINEEEK 776
                   V G P ++ PE        EK DV+SFG+V+ EII      P       +  
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233

Query: 777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME 836
           +++R +++             P                + + C      +RP+  ++   
Sbjct: 234 LNVRGFLDRYCPPN-----CPPSF------------FPITVRCCDLDPEKRPSFVKLEHW 276

Query: 837 L 837
           L
Sbjct: 277 L 277

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  154 bits (392), Expect = 3e-42
 Identities = 66/269 (24%), Positives = 113/269 (42%), Gaps = 33/269 (12%)

Query: 574 LGKGGFGTVYYGRLNE---IDVAVK--MLSSSSAQGFQQFQAEVKLLMRVHHRN----LT 624
           +G+G F TVY G L+    ++VA         +    Q+F+ E ++L  + H N      
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
           S            L+ E M +G L+ YL     KV+  +       +  +GL++LH    
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT-RT 149

Query: 685 PPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
           PPI+HRD+K  NI +       K+ D GL+        +    V+ GTP ++ PE Y   
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVI-GTPEFMAPEMYE-E 204

Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED 803
           +  E  DVY+FG+ +LE+ T +   S    +    I + V S +       +  P ++ +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAIPEVK-E 261

Query: 804 FDANSVWKAVELAMACLSPTGNQRPTMSQ 832
                          C+    ++R ++  
Sbjct: 262 I-----------IEGCIRQNKDERYSIKD 279

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  152 bits (386), Expect = 3e-41
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
            +  LG G +G VY G      + VAVK L   + +  ++F  E  ++  + H NL  L+
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HNGCKP 685
           G C  +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL   N    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 131

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL-----DPEYY 740
             +HRD+ + N L+ E    K+ADFGLS+    D  T      A            PE  
Sbjct: 132 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESL 184

Query: 741 TSNRLTEKSDVYSFGVVILEIIT 763
             N+ + KSDV++FGV++ EI T
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  156 bits (396), Expect = 9e-41
 Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 11/198 (5%)

Query: 570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
            +  LG G +G VY G      + VAVK L   + +  ++F  E  ++  + H NL  L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPP 686
           G C  +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL        
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 339

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRL 745
            +HR++ + N L+ E    K+ADFGLS+    D  T+ +   A  P  +  PE    N+ 
Sbjct: 340 -IHRNLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKF 396

Query: 746 TEKSDVYSFGVVILEIIT 763
           + KSDV++FGV++ EI T
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  150 bits (381), Expect = 9e-41
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 23/201 (11%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
             +T+GKG FG V  G      VAVK + + +    Q F AE  ++ ++ H NL  L+G 
Sbjct: 25  LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 630 C-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPPI 687
             +E     ++ E+MA G+L +YL    + VL     L+ +++  + +EYL  N      
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---- 138

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG-----TPGYLDPEYYTS 742
           VHRD+ + N+L++E   AK++DFGL+K          +          T     PE    
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTA----PEALRE 188

Query: 743 NRLTEKSDVYSFGVVILEIIT 763
            + + KSDV+SFG+++ EI +
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  153 bits (388), Expect = 1e-40
 Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 38/286 (13%)

Query: 570 FERTLGKGGFGTVYYGRLN--EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
               +G+G FG V+ GRL      VAVK    +       +F  E ++L +  H N+  L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
           +G C +     ++ E +  G+   +L       L  +  L++  ++A G+EYL       
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLE---SKC 233

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV----VAGTPGYLDPEYYTS 742
            +HRD+ + N L+ EK   K++DFG+S+  A         +    V  T     PE    
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEALNY 289

Query: 743 NRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
            R + +SDV+SFG+++ E  +      P +S  N++            + KG        
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLS--NQQ--------TREFVEKGG------- 332

Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE 844
           RL              L   C +    QRP+ S +  EL       
Sbjct: 333 RLPCPELCPD--AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  154 bits (392), Expect = 1e-40
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 27/203 (13%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
             +T+GKG FG V  G      VAVK + + +    Q F AE  ++ ++ H NL  L+G 
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 630 C-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPPI 687
             +E     ++ E+MA G+L +YL    + VL     L+ +++  + +EYL  N      
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---- 310

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG-------TPGYLDPEYY 740
           VHRD+ + N+L++E   AK++DFGL+K          S+           T     PE  
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTA----PEAL 358

Query: 741 TSNRLTEKSDVYSFGVVILEIIT 763
              + + KSDV+SFG+++ EI +
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  149 bits (379), Expect = 2e-40
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 570 FERTLGKGGFGTVYYGRLN------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL 623
           F + LGKG FG+V   R +         VAVK L  S+ +  + F+ E+++L  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 624 TSLVGHCDEDNQTA--LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
               G C    +    LI E++  G+L++YL    K+ +   + L+   +  +G+EYL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+ + NIL+  + + K+ DFGL+K    D           +P  +  PE 
Sbjct: 133 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
            T ++ +  SDV+SFGVV+ E+ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  148 bits (377), Expect = 4e-40
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)

Query: 571 ERTLGKGGFGTVYYGRLN----EIDVAVKML--SSSSAQGFQQFQAEVKLLMRVHHRNLT 624
           ++ LG G FGTV  G          VAVK+L   ++      +  AE  ++ ++ +  + 
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HNG 682
            ++G C+ +    L+ E    G L +YL     + +  +  + +  + + G++YL   N 
Sbjct: 82  RMIGICEAE-SWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN- 137

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYT 741
                VHRD+ + N+LL  +  AK++DFGLSK+   D N + +      P  +  PE   
Sbjct: 138 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
             + + KSDV+SFGV++ E  +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  149 bits (378), Expect = 7e-40
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 15/204 (7%)

Query: 570 FERTLGKGGFGTVYYGRLN------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL 623
           F + LGKG FG+V   R +         VAVK L  S+ +  + F+ E+++L  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 624 TSLVGHCDEDNQTA--LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
               G C    +    LI E++  G+L++YL    K+ +   + L+   +  +G+EYL  
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                  +HRD+ + NIL+  + + K+ DFGL+K    D   +       +P  +  PE 
Sbjct: 164 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
            T ++ +  SDV+SFGVV+ E+ T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  148 bits (375), Expect = 7e-40
 Identities = 57/232 (24%), Positives = 90/232 (38%), Gaps = 28/232 (12%)

Query: 543 ESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLN-----EIDVAVKML 597
           E   +  +     + L               LG G FG V  G  +      + VAVK L
Sbjct: 5   EGPLQSLTCLIGEKDLR----------LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL 54

Query: 598 ---SSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD 654
                S  +    F  EV  +  + HRNL  L G         ++ E    G+L + L  
Sbjct: 55  KPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRK 113

Query: 655 ISKKVLSSQERLRIAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
             +         R AV+ A+G+ YL          +HRD+ + N+LL  +   K+ DFGL
Sbjct: 114 -HQGHFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGL 167

Query: 713 SKSFATDANTHVSTVVAGTP-GYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            ++   + + +V       P  +  PE   +   +  SD + FGV + E+ T
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  148 bits (376), Expect = 8e-40
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 570 FERTLGKGGFGTVYYGRL------NEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
             R LG+G FG V   R           VAVK L   S        + E+++L  ++H N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 623 LTSLVGHCDEDNQTA--LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           +    G C ED      LI EF+ +G+L+EYL   +K  ++ +++L+ AV+  +G++YL 
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLG 143

Query: 681 N-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPE 738
           +       VHRD+ + N+L+  + Q K+ DFGL+K+  TD   +       +P  +  PE
Sbjct: 144 SRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 739 YYTSNRLTEKSDVYSFGVVILEIIT 763
               ++    SDV+SFGV + E++T
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  149 bits (378), Expect = 8e-40
 Identities = 76/306 (24%), Positives = 133/306 (43%), Gaps = 50/306 (16%)

Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRL------NEIDVAVKML-SSSSAQG 604
           +A  R L  ++  KI     + LG G FGTVY G         +I VA+K L  ++S + 
Sbjct: 6   QALLRILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 605 FQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
            ++   E  ++  V + ++  L+G C   +   LI + M  G L +Y+ +  K  + SQ 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQY 118

Query: 665 RLRIAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
            L   V+ A+G+ YL         +VHRD+ + N+L+      K+ DFGL+K    +   
Sbjct: 119 LLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

Query: 723 HVSTV----VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEK 776
           + +      +         E       T +SDV+S+GV + E++T   KP       E  
Sbjct: 174 YHAEGGKVPIKWMA----LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 227

Query: 777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDA-NSVWKAVELAMACLSPTGNQRPTMSQVVM 835
                 ++S++ KG+       RL +       V+    +   C     + RP   ++++
Sbjct: 228 ------ISSILEKGE-------RLPQPPICTIDVY---MIMRKCWMIDADSRPKFRELII 271

Query: 836 ELSECL 841
           E S+  
Sbjct: 272 EFSKMA 277

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  148 bits (376), Expect = 1e-39
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 15/204 (7%)

Query: 570 FERTLGKGGFGTVYYGRLN------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL 623
           +   LGKG FG+V   R +         VAVK L  S     + FQ E+++L  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 624 TSLVGHCDEDNQTA--LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
               G      + +  L+ E++ +G L+++L    +  L +   L  + +  +G+EYL  
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGS 145

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
             C    VHRD+ + NIL+  +   K+ADFGL+K    D + +V      +P  +  PE 
Sbjct: 146 RRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
            + N  + +SDV+SFGVV+ E+ T
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  147 bits (374), Expect = 2e-39
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 26/209 (12%)

Query: 570 FERTLGKGGFGTVYYGRLN------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
             R LG+G FG V     +         VAVK L + +  Q    ++ E+ +L  ++H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 623 LTSLVGHCDEDNQTA--LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           +    G C++    +  L+ E++  G+L++YL    +  +   + L  A +  +G+ YLH
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLH 151

Query: 681 -NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL---- 735
                   +HRD+ + N+LL+     K+ DFGL+K+       +         G      
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFW 203

Query: 736 -DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             PE     +    SDV+SFGV + E++T
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT 232

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  146 bits (370), Expect = 2e-39
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 25/204 (12%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           F + +G G FG V+ G    +  VA+K +   + ++  + F  E +++M++ H  L  L 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLY 69

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPP 686
           G C E     L+ EFM +G L +YL    + + +++  L + ++  +G+ YL        
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACV--- 125

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG-------TPGYLDPEY 739
            +HRD+ + N L+ E    K++DFG+++    D      T   G             PE 
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWAS----PEV 176

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
           ++ +R + KSDV+SFGV++ E+ +
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFS 200

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  147 bits (373), Expect = 4e-39
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)

Query: 570 FERTLGKGGFGTVYYGRL-----NEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNL 623
            E+ +G G  G V YGRL      ++ VA+K L +  + +  + F +E  ++ +  H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HN 681
             L G         ++ E+M NG+L  +L        +  + + +      G+ YL    
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG-----TPGYLD 736
                 VHRD+ + N+L++  L  K++DFGLS+    D +   +T         T     
Sbjct: 172 -----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA---- 222

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIIT 763
           PE       +  SDV+SFGVV+ E++ 
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLA 249

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  145 bits (369), Expect = 4e-39
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 25/204 (12%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           F + LG G FG V YG+   + DVA+KM+   S ++   +F  E K++M + H  L  L 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLY 85

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPP 686
           G C +     +I E+MANG L  YL +  +    +Q+ L +  +  + +EYL        
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG-------TPGYLDPEY 739
            +HRD+ + N L+N++   K++DFGLS+    D      T   G       +P    PE 
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSP----PEV 192

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
              ++ + KSD+++FGV++ EI +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYS 216

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  145 bits (369), Expect = 6e-39
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 40/223 (17%)

Query: 570 FERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN 622
            +R LG+G FG V+            ++ VAVK L   +    + FQ E +LL  + H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERLRI 668
           +    G C + +   +++E+M +G+L ++L                 +K  L   + L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 669 AVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS-FATDANTHVS 725
           A + A G+ YL   +      VHRD+ + N L+   L  K+ DFG+S+  ++TD      
Sbjct: 139 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--- 190

Query: 726 TVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
               G    L      PE     + T +SDV+SFGV++ EI T
Sbjct: 191 ---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (379), Expect = 7e-39
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L   +    + F  E +++ ++ H  L  L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+        V
Sbjct: 247 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV---VAGTPGYLDPEYYTSNRL 745
           HRD+++ NIL+ E L  K+ADFGL++    +  T        +  T     PE     R 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 358

Query: 746 TEKSDVYSFGVVILEIIT 763
           T KSDV+SFG+++ E+ T
Sbjct: 359 TIKSDVWSFGILLTELTT 376

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  145 bits (367), Expect = 9e-39
 Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 571 ERTLGKGGFGTVYYGRLN----EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTS 625
           +  LG G FG+V  G       +IDVA+K+L   +     ++   E +++ ++ +  +  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HNGC 683
           L+G C  +    L+ E    G L ++L    ++ +       +  + + G++YL   N  
Sbjct: 75  LIGVCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-- 130

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV-----VAGTPGYLDPE 738
               VHRD+ + N+LL  +  AK++DFGLSK+   D + + +       +        PE
Sbjct: 131 ---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PE 183

Query: 739 YYTSNRLTEKSDVYSFGVVILEIIT 763
                + + +SDV+S+GV + E ++
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  146 bits (370), Expect = 9e-39
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 37/221 (16%)

Query: 570 FERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN 622
            +  LG+G FG V+    +       ++ VAVK L  +S    Q FQ E +LL  + H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYL-------------SDISKKVLSSQERLRIA 669
           +    G C E     +++E+M +G+L  +L              D++   L   + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 670 VESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
            + A G+ YL   +      VHRD+ + N L+ + L  K+ DFG+S+   +     V   
Sbjct: 165 SQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV--- 216

Query: 728 VAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             G    L      PE     + T +SDV+SFGVV+ EI T
Sbjct: 217 --GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  143 bits (364), Expect = 1e-38
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
             + LG G FG V  G+   + DVAVKM+   S     +F  E + +M++ H  L    G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPPI 687
            C ++    ++ E+++NG L  YL     K L   + L +  +  +G+ +L  +      
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQF---- 125

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG-------TPGYLDPEYY 740
           +HRD+ + N L++  L  K++DFG+++    D          G       +     PE +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSA----PEVF 177

Query: 741 TSNRLTEKSDVYSFGVVILEIIT 763
              + + KSDV++FG+++ E+ +
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  143 bits (364), Expect = 2e-38
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
               LG G FG V+ G  N    VAVK L   S      F AE  L+ ++ H+ L  L  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNGCKPPI 687
              ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++         
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---- 130

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG-------TPGYLDPEYY 740
           +HRD+++ NIL+++ L  K+ADFGL++    +  T       G       T     PE  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTA----PEAI 182

Query: 741 TSNRLTEKSDVYSFGVVILEIIT 763
                T KSDV+SFG+++ EI+T
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  144 bits (365), Expect = 3e-38
 Identities = 67/248 (27%), Positives = 108/248 (43%), Gaps = 43/248 (17%)

Query: 539 KVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLN-----EIDVA 593
           +   E +NK++        +  + ++       + LG+G FG+V  G L       + VA
Sbjct: 17  RGSEELQNKLEDVV-----IDRNLLI-----LGKILGEGEFGSVMEGNLKQEDGTSLKVA 66

Query: 594 VKML--SSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTA-----LIYEFMANG 646
           VK +   +SS +  ++F +E   +    H N+  L+G C E +        +I  FM  G
Sbjct: 67  VKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG 126

Query: 647 NLQEYL----SDISKKVLSSQERLRIAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLN 700
           +L  YL     +   K +  Q  L+  V+ A G+EYL   N      +HRD+ + N +L 
Sbjct: 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLR 181

Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFG 755
           + +   +ADFGLSK   +           G    +       E       T KSDV++FG
Sbjct: 182 DDMTVCVADFGLSKKIYSG-----DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236

Query: 756 VVILEIIT 763
           V + EI T
Sbjct: 237 VTMWEIAT 244

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  143 bits (364), Expect = 3e-38
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 25/209 (11%)

Query: 570 FERTLGKGGFGTVYYGRL-----NEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNL 623
            +R +GKG FG VY+G       N I  A+K L   +  Q  + F  E  L+  ++H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 624 TSLVGHC-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--H 680
            +L+G     +    ++  +M +G+L +++    ++  + ++ +   ++ A+G+EYL   
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG------TPGY 734
                  VHRD+ + N +L+E    K+ADFGL++         V            T   
Sbjct: 144 K-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA-- 196

Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
              E   + R T KSDV+SFGV++ E++T
Sbjct: 197 --LESLQTYRFTTKSDVWSFGVLLWELLT 223

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  144 bits (365), Expect = 3e-38
 Identities = 68/224 (30%), Positives = 103/224 (45%), Gaps = 39/224 (17%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKML-SSSSAQGFQQFQAEVKLLMRV-HH 620
             + LG+G FG V       ID       VAVKML   ++    +   +E+K+L+ + HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 621 RNLTSLVGHC-DEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQER 665
            N+ +L+G C        +I EF   GNL  YL               D+ K  L+ +  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 666 LRIAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           +  + + A+G+E+L    C    +HRD+ + NILL+EK   K+ DFGL++    D     
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKD----- 201

Query: 725 STVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
              V      L      PE       T +SDV+SFGV++ EI +
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  143 bits (363), Expect = 3e-38
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 23/209 (11%)

Query: 569 NFERTLGKGGFGTVYYGRL-----NEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
           +F   +G+G FG VY+G L      +I  AVK L   +      QF  E  ++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 623 LTSLVGHC-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
           + SL+G C   +    ++  +M +G+L+ ++ +      + ++ +   ++ A+G++YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL----- 735
                  VHRD+ + N +L+EK   K+ADFGL++    D        V    G       
Sbjct: 147 KKF----VHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198

Query: 736 -DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
              E   + + T KSDV+SFGV++ E++T
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  144 bits (365), Expect = 3e-38
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 18/204 (8%)

Query: 570 FERTLGKGGFGTVYYGRL------NEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
             + LG G FGTV+ G         +I V +K++   S  Q FQ     +  +  + H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--H 680
           +  L+G C       L+ +++  G+L +++    +  L  Q  L   V+ A+G+ YL  H
Sbjct: 77  IVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEY 739
                 +VHR++ + N+LL    Q ++ADFG++     D +  +    A TP  ++  E 
Sbjct: 135 G-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIKWMALES 188

Query: 740 YTSNRLTEKSDVYSFGVVILEIIT 763
               + T +SDV+S+GV + E++T
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  144 bits (366), Expect = 4e-38
 Identities = 55/273 (20%), Positives = 113/273 (41%), Gaps = 29/273 (10%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID---VAVKM--LSSSSAQGFQQFQAEVKLLMRVHH 620
             +   + +G+G FG     + +  D     +K   +S  S++  ++ + EV +L  + H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVK-STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+       +E+    ++ ++   G+L + ++     +    + L   V+    L+++H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+KS NI L +    +L DFG+++   +         + GTP YL PE  
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACI-GTPYYLSPEIC 197

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
            +     KSD+++ G V+ E+ T K A    + +  +         I  G       P +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-------LKIISGSF-----PPV 245

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
              +  +       L           RP+++ +
Sbjct: 246 SLHYSYD----LRSLVSQLFKRNPRDRPSVNSI 274

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  142 bits (361), Expect = 5e-38
 Identities = 64/278 (23%), Positives = 114/278 (41%), Gaps = 30/278 (10%)

Query: 568 NNFE--RTLGKGGFGTVYYGR--LNEIDVAVKM--LSSSSAQGFQQFQAEVKLLMRVHHR 621
            ++E   T+G G +G     R   +   +  K     S +    Q   +EV LL  + H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 622 NLTSLVGH-CDEDNQTALIY-EFMANGNLQEYLSDISKKVLSSQER--LRIAVESAQGLE 677
           N+        D  N T  I  E+   G+L   ++  +K+     E   LR+  +    L+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 678 YLH--NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
             H  +     ++HRD+K  N+ L+ K   KL DFGL++    + +T  +    GTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYM 183

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI 795
            PE        EKSD++S G ++ E+    P  +  +++E       +   I +G     
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKF--- 233

Query: 796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
              R+   +         E+    L+     RP++ ++
Sbjct: 234 --RRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEI 265

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (363), Expect = 5e-38
 Identities = 64/270 (23%), Positives = 117/270 (43%), Gaps = 27/270 (10%)

Query: 572 RTLGKGGFGTVYYGRLNEID---VAVK---MLSSSSAQGFQQFQAEVKLLMRVHHRNLTS 625
           + +G+G F  VY      +D   VA+K   +     A+       E+ LL +++H N+  
Sbjct: 38  KKIGRGQFSEVYRAA-CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER--LRIAVESAQGLEYLHNGC 683
                 EDN+  ++ E    G+L   +    K+     ER   +  V+    LE++H+  
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-- 154

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              ++HRD+K  N+ +      KL D GL + F++   T   ++V GTP Y+ PE    N
Sbjct: 155 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLV-GTPYYMSPERIHEN 211

Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED 803
               KSD++S G ++ E+   +         +K+++       I + D   +      E+
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCK-KIEQCDYPPLPSDHYSEE 266

Query: 804 FDANSVWKAVELAMACLSPTGNQRPTMSQV 833
                     +L   C++P   +RP ++ V
Sbjct: 267 L--------RQLVNMCINPDPEKRPDVTYV 288

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  145 bits (367), Expect = 5e-38
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 28/283 (9%)

Query: 500 KKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKRESKNKIDSFEAKSRHLS 559
           +      ++    S           L+     K   +    +  +   ID        + 
Sbjct: 18  RASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQ 77

Query: 560 YSDVVKITNN-----FERTLGKGGFGTVYYGRL-----NEIDVAVKML-SSSSAQGFQQF 608
               V I  +     F   +G+G FG VY+G L      +I  AVK L   +      QF
Sbjct: 78  AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 137

Query: 609 QAEVKLLMRVHHRNLTSLVGHC-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR 667
             E  ++    H N+ SL+G C   +    ++  +M +G+L+ ++ +      + ++ + 
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIG 196

Query: 668 IAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST 726
             ++ A+G+++L         VHRD+ + N +L+EK   K+ADFGL++         V  
Sbjct: 197 FGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 252

Query: 727 VVAG------TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                            E   + + T KSDV+SFGV++ E++T
Sbjct: 253 KTGAKLPVKWMA----LESLQTQKFTTKSDVWSFGVLLWELMT 291

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  148 bits (375), Expect = 6e-38
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L   +    + F  E +++ ++ H  L  L  
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+        V
Sbjct: 330 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 385

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV---VAGTPGYLDPEYYTSNRL 745
           HRD+++ NIL+ E L  K+ADFGL++    +  T        +  T     PE     R 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 441

Query: 746 TEKSDVYSFGVVILEIIT 763
           T KSDV+SFG+++ E+ T
Sbjct: 442 TIKSDVWSFGILLTELTT 459

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  142 bits (360), Expect = 7e-38
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 22/205 (10%)

Query: 570 FERTLGKGGFGTVYYGRLN-----EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNL 623
             R LG+G FG VY G        +I+VAVK      +    ++F +E  ++  + H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HN 681
             L+G  +E+  T +I E    G L  YL   +K  L     +  +++  + + YL   N
Sbjct: 76  VKLIGIIEEE-PTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESIN 133

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV---VAGTPGYLDPE 738
                 VHRD+   NIL+      KL DFGLS+    +     S     +        PE
Sbjct: 134 -----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS----PE 184

Query: 739 YYTSNRLTEKSDVYSFGVVILEIIT 763
                R T  SDV+ F V + EI++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILS 209

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  143 bits (363), Expect = 8e-38
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 570 FERTLGKGGFGTVYYGRLN------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRN 622
            ++ +G G FG VY G L       E+ VA+K L +  + +    F  E  ++ +  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HN 681
           +  L G   +     +I E+M NG L ++L +      S  + + +    A G++YL + 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG-----TPGYLD 736
                 VHRD+ + NIL+N  L  K++DFGLS+    D     +T         T     
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA---- 218

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIIT 763
           PE  +  + T  SDV+SFG+V+ E++T
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMT 245

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  143 bits (362), Expect = 9e-38
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 38/220 (17%)

Query: 570 FERTLGKGGFGTVYYGRLN----EIDVAVKML-SSSSAQGFQQFQAEVKLLMRV-HHRNL 623
           F+  +G+G FG V   R+      +D A+K +   +S    + F  E+++L ++ HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERLRIA 669
            +L+G C+      L  E+  +GNL ++L              ++ +   LSSQ+ L  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 670 VESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
            + A+G++YL         +HRD+ + NIL+ E   AK+ADFGLS+             V
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRG--------QEVYV 196

Query: 729 AGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             T G L       E    +  T  SDV+S+GV++ EI++
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  143 bits (362), Expect = 1e-37
 Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 34/218 (15%)

Query: 570 FERTLGKGGFGTVYYGRLN-----EIDVAVKML--SSSSAQGFQQFQAEVKLLMRVHHRN 622
             R LGKG FG+V   +L       + VAVKML     ++   ++F  E   +    H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 623 LTSLVGHCDEDNQTA------LIYEFMANGNLQEYL----SDISKKVLSSQERLRIAVES 672
           +  LVG               +I  FM +G+L  +L       +   L  Q  +R  V+ 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 673 AQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           A G+EYL   N      +HRD+ + N +L E +   +ADFGLS+   +           G
Sbjct: 147 ACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG-----DYYRQG 196

Query: 731 TPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
               L       E    N  T  SDV++FGV + EI+T
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  142 bits (360), Expect = 2e-37
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 29/215 (13%)

Query: 570 FERTLGKGGFGTVYYGRLN-------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHR 621
             R LG+G FG VY G          E  VA+K +  ++S +   +F  E  ++   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------SDISKKVLSSQERLRIAVESA 673
           ++  L+G   +   T +I E M  G+L+ YL        ++      S  + +++A E A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            G+ YL+       VHRD+ + N ++ E    K+ DFG+++               G  G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-----DYYRKGGKG 200

Query: 734 YL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            L      PE       T  SDV+SFGVV+ EI T
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  144 bits (364), Expect = 2e-37
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)

Query: 570 FERTLGKGGFGTVYYGRLN-----EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNL 623
            ++ +G G FG V  GRL      EI VA+K L    + +  + F  E  ++ +  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNG 682
             L G   +     ++ E+M NG+L  +L        +  + + +    A G++YL   G
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMG 167

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYT 741
                VHRD+ + NIL+N  L  K++DFGL +    D     +T     P  +  PE   
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 742 SNRLTEKSDVYSFGVVILEIIT 763
             + T  SDV+S+G+V+ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  141 bits (358), Expect = 3e-37
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 35/288 (12%)

Query: 570 FERTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
           F + LG+GGF  V    G  +    A+K +     Q  ++ Q E  +    +H N+  LV
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 628 GHC-DEDNQTALIY---EFMANGNLQEYLSDISKKV--LSSQERLRIAVESAQGLEYLHN 681
            +C  E       +    F   G L   +  +  K   L+  + L + +   +GLE +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA-------GTPGY 734
                  HRD+K TNILL ++ Q  L D G               +          T  Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 735 LDPE---YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD 791
             PE     +   + E++DV+S G V+  ++  +         + +  +    +L  +  
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DMVFQKGDSVALAVQNQ 263

Query: 792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
           +     PR              +L  + ++   +QRP +  ++ +L  
Sbjct: 264 LSIPQSPRHSSAL--------WQLLNSMMTVDPHQRPHIPLLLSQLEA 303

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  140 bits (355), Expect = 3e-37
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 24/206 (11%)

Query: 570 FERTLGKGGFGTVYYGRL-----NEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNL 623
             R +G+G FG V+ G         + VA+K   + +S    ++F  E   + +  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL-HNG 682
             L+G   E+    +I E    G L+ +L    K  L     +  A + +  L YL    
Sbjct: 79  VKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR 136

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL-----DP 737
                VHRD+ + N+L++     KL DFGLS+           T    + G L      P
Sbjct: 137 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAP 186

Query: 738 EYYTSNRLTEKSDVYSFGVVILEIIT 763
           E     R T  SDV+ FGV + EI+ 
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM 212

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  141 bits (358), Expect = 4e-37
 Identities = 76/309 (24%), Positives = 133/309 (43%), Gaps = 50/309 (16%)

Query: 552 EAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRL------NEIDVAVKML-SSSSAQG 604
           +A  R L  ++  KI     + LG G FGTVY G         +I VA+K L  ++S + 
Sbjct: 6   QALLRILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 605 FQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE 664
            ++   E  ++  V + ++  L+G C       LI + M  G L +Y+ +  K  + SQ 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE-HKDNIGSQY 118

Query: 665 RLRIAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
            L   V+ A+G+ YL         +VHRD+ + N+L+      K+ DFGL+K    +   
Sbjct: 119 LLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

Query: 723 HVSTV----VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEK 776
           + +      +         E       T +SDV+S+GV + E++T   KP       E  
Sbjct: 174 YHAEGGKVPIKWMA----LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 227

Query: 777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDA-NSVWKAVELAMACLSPTGNQRPTMSQVVM 835
                 ++S++ KG+       RL +       V+    + + C     + RP   ++++
Sbjct: 228 ------ISSILEKGE-------RLPQPPICTIDVY---MIMVKCWMIDADSRPKFRELII 271

Query: 836 ELSECLAAE 844
           E S+     
Sbjct: 272 EFSKMARDP 280

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  140 bits (356), Expect = 4e-37
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 45/230 (19%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKML-SSSSAQGFQQFQAEVKLLMRVHHR 621
             +TLG+G FG V       +        VAVKML  ++S    +   +E  +L +V+H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYL----------------------SDISKKV 659
           ++  L G C +D    LI E+   G+L+ +L                          ++ 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 660 LSSQERLRIAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT 718
           L+  + +  A + +QG++YL         VHRD+ + NIL+ E  + K++DFGLS+    
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 719 DANTHVSTVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +      + V  + G +       E    +  T +SDV+SFGV++ EI+T
Sbjct: 203 E-----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (364), Expect = 6e-37
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 17/200 (8%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            E+ LG G FG V+    N    VAVK +   S    + F AE  ++  + H  L  L  
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HNGCKPP 686
              ++    +I EFMA G+L ++L           + +  + + A+G+ ++   N     
Sbjct: 251 VVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----- 304

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV---VAGTPGYLDPEYYTSN 743
            +HRD+++ NIL++  L  K+ADFGL++    +  T        +  T     PE     
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFG 360

Query: 744 RLTEKSDVYSFGVVILEIIT 763
             T KSDV+SFG++++EI+T
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  139 bits (352), Expect = 7e-37
 Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 53/290 (18%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH 620
           +   +F+    +G GGFG V+  +  ++     +K +  ++    ++ + EVK L ++ H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH 63

Query: 621 RNLTSLVGHCDEDNQTA----------------LIYEFMANGNLQEYLSDISKKVLSSQE 664
            N+    G  D  +                   +  EF   G L++++     + L    
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
            L +  +  +G++Y+H+     +++RD+K +NI L +  Q K+ DFGL  S   D     
Sbjct: 124 ALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178

Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWV 783
           +    GT  Y+ PE  +S    ++ D+Y+ G+++ E++  C  A                
Sbjct: 179 TRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------F 227

Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
            + +  G I  I D + +             L    LS     RP  S++
Sbjct: 228 FTDLRDGIISDIFDKKEK------------TLLQKLLSKKPEDRPNTSEI 265

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  140 bits (355), Expect = 8e-37
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 36/221 (16%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKML-SSSSAQGFQQFQAEVKLLMRV-HH 620
           F +TLG G FG V       +        VAVKML S++ A   +   +E+K++  +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------------SDISKKVLSSQERLRI 668
            N+ +L+G C       +I E+   G+L  +L              I+    S+++ L  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 669 AVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
           + + AQG+ +L    C    +HRDV + N+LL     AK+ DFGL++    D     S  
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND-----SNY 220

Query: 728 VAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +      L      PE       T +SDV+S+G+++ EI +
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  140 bits (355), Expect = 1e-36
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 42/226 (18%)

Query: 570 FERTLGKGGFGTVYYGRLNEID---------VAVKML-SSSSAQGFQQFQAEVKLLMRV- 618
             + LG+G FG V       ID         VAVKML   ++ +      +E++++  + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQE 664
            H+N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 665 RLRIAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
            +    + A+G+EYL          +HRD+ + N+L+ E    K+ADFGL++        
Sbjct: 159 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNI--- 210

Query: 723 HVSTVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                   T G L      PE       T +SDV+SFGV++ EI T
Sbjct: 211 --DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  145 bits (367), Expect = 2e-36
 Identities = 51/201 (25%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 571 ERTLGKGGFGTVYYGRLN----EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNLTS 625
           +  LG G FG+V  G       +IDVA+K+L   +     ++   E +++ ++ +  +  
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HNGC 683
           L+G C  +    L+ E    G L ++L    ++ +       +  + + G++YL   N  
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-- 456

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP-GYLDPEYYTS 742
               VHR++ + N+LL  +  AK++DFGLSK+   D + + +      P  +  PE    
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 743 NRLTEKSDVYSFGVVILEIIT 763
            + + +SDV+S+GV + E ++
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  140 bits (354), Expect = 2e-36
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 42/226 (18%)

Query: 570 FERTLGKGGFGTVYYGRLNEID---------VAVKML-SSSSAQGFQQFQAEVKLLMRV- 618
             + LG+G FG V       ID         VAVKML   ++ +      +E++++  + 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQE 664
            H+N+ +L+G C +D    +I E+ + GNL+EYL              + + ++ ++ ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 665 RLRIAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
            +    + A+G+EYL          +HRD+ + N+L+ E    K+ADFGL++        
Sbjct: 205 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNI--- 256

Query: 723 HVSTVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                   T G L      PE       T +SDV+SFGV++ EI T
Sbjct: 257 --DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  138 bits (350), Expect = 4e-36
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 570 FERTLGKGGFGTVYYGRLN-------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHR 621
             R LG G FG VY G+++        + VAVK L    S Q    F  E  ++ + +H+
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYL-----SDISKKVLSSQERLRIAVESAQGL 676
           N+   +G   +     ++ E MA G+L+ +L            L+  + L +A + A G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 677 EYL-HNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
           +YL  N      +HRD+ + N LL        AK+ DFG+++          S    G  
Sbjct: 154 QYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGC 204

Query: 733 GYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             L      PE +     T K+D +SFGV++ EI +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  136 bits (346), Expect = 5e-36
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 570 FERTLGKGGFGTVYYGRLN-------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHR 621
           F   LG+  FG VY G L           VA+K L   +     ++F+ E  L  R+ H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQERLR 667
           N+  L+G   +D   ++I+ + ++G+L E+L                  K  L   + + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 668 IAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           +  + A G+EYL  H+     +VH+D+ + N+L+ +KL  K++D GL +           
Sbjct: 133 LVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-----D 182

Query: 726 TVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                    L      PE     + +  SD++S+GVV+ E+ +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  138 bits (349), Expect = 7e-36
 Identities = 70/231 (30%), Positives = 103/231 (44%), Gaps = 47/231 (20%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKML-SSSSAQGFQQFQAEVKLLMRVHHR 621
           + R +G+G FG V+  R   +        VAVKML   +SA     FQ E  L+    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYL----------------------SDISKKV 659
           N+  L+G C       L++E+MA G+L E+L                      S      
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 660 LSSQERLRIAVESAQGLEYL--HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
           LS  E+L IA + A G+ YL          VHRD+ + N L+ E +  K+ADFGLS++  
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225

Query: 718 TDANTHVSTVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           +          A     +      PE    NR T +SDV+++GVV+ EI +
Sbjct: 226 SA-----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  136 bits (345), Expect = 1e-35
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 40/225 (17%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKML-SSSSAQGFQQFQAEVKLLMRV-HH 620
           F +TLG G FG V       +        VAVKML  S+     +   +E+K+L  + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL----------------SDISKKVLSSQE 664
            N+ +L+G C     T +I E+   G+L  +L                 +  +  L  ++
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 665 RLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            L  + + A+G+ +L    C    +HRD+ + NILL      K+ DFGL++    D    
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND---- 198

Query: 724 VSTVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            S  V      L      PE   +   T +SDV+S+G+ + E+ +
Sbjct: 199 -SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  135 bits (343), Expect = 2e-35
 Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 32/214 (14%)

Query: 570 FERTLGKGGFGTVYYGRLN---------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH 620
           F  +LG+G F  ++ G            E +V +K+L  +     + F     ++ ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL- 679
           ++L    G C   ++  L+ EF+  G+L  YL   +K  ++   +L +A + A  + +L 
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLE 130

Query: 680 -HNGCKPPIVHRDVKSTNILLN--------EKLQAKLADFGLSKSFATDANTHVSTVVAG 730
            +      ++H +V + NILL              KL+D G+S +            +  
Sbjct: 131 ENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER--IPW 183

Query: 731 TPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIIT 763
            P    PE       L   +D +SFG  + EI +
Sbjct: 184 VP----PECIENPKNLNLATDKWSFGTTLWEICS 213

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  138 bits (349), Expect = 2e-35
 Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 40/225 (17%)

Query: 570 FERTLGKGGFGTVYYGRLNEID---------VAVKML-SSSSAQGFQQFQAEVKLLMRV- 618
             + LG+G FG V       +D         VAVKML S ++ +      +E++++  + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQE 664
            H+N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 665 RLRIAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH 723
            +  A + A+G+EYL    C    +HRD+ + N+L+ E    K+ADFGL++         
Sbjct: 193 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 244

Query: 724 VSTVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
                  T G L      PE       T +SDV+SFGV++ EI T
Sbjct: 245 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  137 bits (347), Expect = 2e-35
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 570 FERTLGKGGFGTVYYGRLN-------EIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHR 621
             R LG G FG VY G+++        + VAVK L    S Q    F  E  ++ + +H+
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYL-----SDISKKVLSSQERLRIAVESAQGL 676
           N+   +G   +     ++ E MA G+L+ +L            L+  + L +A + A G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 677 EYL-HNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
           +YL  N      +HRD+ + N LL        AK+ DFG+++               G  
Sbjct: 195 QYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGC 245

Query: 733 GYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
             L      PE +     T K+D +SFGV++ EI +
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  142 bits (359), Expect = 3e-35
 Identities = 55/207 (26%), Positives = 86/207 (41%), Gaps = 26/207 (12%)

Query: 570 FERTLGKGGFGTVYYGRL-----NEIDVAVKML-SSSSAQGFQQFQAEVKLLMRVHHRNL 623
             R +G+G FG V+ G         + VA+K   + +S    ++F  E   + +  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL--HN 681
             L+G   E+    +I E    G L+ +L    K  L     +  A + +  L YL    
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKR 511

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL-----D 736
                 VHRD+ + N+L++     KL DFGLS+                + G L      
Sbjct: 512 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST------YYKASKGKLPIKWMA 560

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIIT 763
           PE     R T  SDV+ FGV + EI+ 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  136 bits (344), Expect = 3e-35
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 45/230 (19%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKML-SSSSAQGFQQFQAEVKLLMRV-HH 620
           F + LG G FG V       I        VAVKML   + +   +   +E+K++ ++  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYL---------------------SDISKKV 659
            N+ +L+G C       LI+E+   G+L  YL                      +    V
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 660 LSSQERLRIAVESAQGLEYL-HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT 718
           L+ ++ L  A + A+G+E+L    C    VHRD+ + N+L+      K+ DFGL++   +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 719 DANTHVSTVVAGTPGYL-----DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
           D     S  V      L      PE       T KSDV+S+G+++ EI +
Sbjct: 225 D-----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (340), Expect = 6e-35
 Identities = 67/315 (21%), Positives = 105/315 (33%), Gaps = 53/315 (16%)

Query: 533 RKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEI 590
           + R+V      S+         SR  S+        +F+    LG G +G V+  R ++ 
Sbjct: 27  QPRRVSFRGEASETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSYGEVFKVR-SKE 80

Query: 591 D---VAVK--MLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMA 644
           D    AVK  M      +   +  AEV    +V  H     L    +E     L  E   
Sbjct: 81  DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-C 139

Query: 645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKL 703
             +LQ++        L   +      ++   L +LH  G    +VH DVK  NI L  + 
Sbjct: 140 GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQG----LVHLDVKPANIFLGPRG 194

Query: 704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-----YYTSNRLTEKSDVYSFGVVI 758
           + KL DFGL     T           G P Y+ PE     Y         +DV+S G+ I
Sbjct: 195 RCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPELLQGSY------GTAADVFSLGLTI 245

Query: 759 LEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMA 818
           LE+             +++               +  + P       +        + + 
Sbjct: 246 LEVACNMELPHGGEGWQQL--------------RQGYLPPEFTAGLSSE----LRSVLVM 287

Query: 819 CLSPTGNQRPTMSQV 833
            L P    R T   +
Sbjct: 288 MLEPDPKLRATAEAL 302

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  132 bits (334), Expect = 3e-34
 Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 64/306 (20%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH 620
           +  ++FE    LG+G FG V   R  L+    A+K +  +  +      +EV LL  ++H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNH 61

Query: 621 RNLTSLVGHCDEDNQTAL----------IY---EFMANGNLQEYLSDISKKVLSSQERLR 667
           + +        E                ++   E+  NG L + +           E  R
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWR 120

Query: 668 IAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF---------- 716
           +  +  + L Y+H  G    I+HRD+K  NI ++E    K+ DFGL+K+           
Sbjct: 121 LFRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 717 ---ATDANTHVSTVVAGTPGYLDPE------YYTSNRLTEKSDVYSFGVVILEIITCKPA 767
                 ++ ++++ + GT  Y+  E      +Y      EK D+YS G++  E+    P 
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEM--IYPF 228

Query: 768 ISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQR 827
                  E+++I +          ++S+       DFD N +    ++    +    N+R
Sbjct: 229 ---STGMERVNILK---------KLRSV-SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275

Query: 828 PTMSQV 833
           P    +
Sbjct: 276 PGARTL 281

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  135 bits (342), Expect = 3e-34
 Identities = 67/282 (23%), Positives = 114/282 (40%), Gaps = 36/282 (12%)

Query: 565 KITNNFERTLGKGGFGTVYY-GRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRN 622
           KI+   +  LG G  GT+ Y G  +  DVAVK +         +   EV+LL     H N
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPN 79

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-N 681
           +        +     +  E  A   LQEY+           E + +  ++  GL +LH  
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 682 GCKPPIVHRDVKSTNILLNEK-----LQAKLADFGLSKSFATDANT-HVSTVVAGTPGYL 735
                IVHRD+K  NIL++       ++A ++DFGL K  A   ++    + V GT G++
Sbjct: 138 N----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 736 DPEYYTSN---RLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGD 791
            PE  + +     T   D++S G V   +I+       +  + +        N L+    
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS 246

Query: 792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
           +  +   + ++         A EL    ++    +RP+   V
Sbjct: 247 LDCLHPEKHEDV-------IARELIEKMIAMDPQKRPSAKHV 281

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  129 bits (327), Expect = 2e-33
 Identities = 62/297 (20%), Positives = 115/297 (38%), Gaps = 55/297 (18%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID---VAVKMLS-SSSAQGFQQFQAEVKLLMRVHHR 621
            +FE  + LG+GGFG V+  + N++D    A+K +   +     ++   EVK L ++ H 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAK-NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 622 NLTSLVGHCDEDN---------QTALIY---EFMANGNLQEYLSDISKKVLSSQER---L 666
            +        E N             +Y   +     NL+++++   +  +  +ER   L
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121

Query: 667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD------- 719
            I ++ A+ +E+LH+     ++HRD+K +NI        K+ DFGL  +   D       
Sbjct: 122 HIFLQIAEAVEFLHS-KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 720 ---ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK 776
                    T   GT  Y+ PE    N  + K D++S G+++ E+    P          
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPF-------ST 229

Query: 777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
              R    + +       +   +               +    LSP+  +RP    +
Sbjct: 230 QMERVRTLTDVRNLKFPPLFTQKYPC---------EYVMVQDMLSPSPMERPEAINI 277

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  129 bits (327), Expect = 3e-33
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 571 ERTLGKGGFGTVYYG---RLNEIDVAVKMLSSSSA--QGFQQ-FQAEVKLLMRVHHRNLT 624
            R +G+GG G VY           VA+K++S + +    F+   Q E +   R+   ++ 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRER-IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 625 SL--VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-N 681
            +   G  + D Q  +    +   +L   L    +  L+    + I  +    L+  H  
Sbjct: 98  PIHDFG--EIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA 153

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           G      HRDVK  NIL++    A L DFG++ +   +  T +   V GT  Y+ PE ++
Sbjct: 154 G----ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFS 208

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP 766
            +  T ++D+Y+   V+ E +T  P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSP 233

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  129 bits (326), Expect = 3e-33
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 31/224 (13%)

Query: 571 ERTLGKGGFGTVYYG---RLNEIDVAVKMLSSSSA--QGFQQ-FQAEVKLLMRVHHRNLT 624
              LG GG  TVY      LN   VA+K +       +   + F+ EV    ++ H+N+ 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNI-KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 625 SL--VGHCDEDNQTA-LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
           S+  V    E++    L+ E++    L EY+       LS    +    +   G+++ H 
Sbjct: 75  SMIDVD---EEDDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHD 129

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 IVHRD+K  NIL++     K+ DFG++K+ +  + T  + V+ GT  Y  PE  
Sbjct: 130 MR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQA 184

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP----------AISRINEE 774
                 E +D+YS G+V+ E++  +P          AI  I + 
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS 228

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  135 bits (341), Expect = 5e-33
 Identities = 51/208 (24%), Positives = 79/208 (37%), Gaps = 30/208 (14%)

Query: 571 ERTLGKGGFGTVYYG---RLNEIDVAVKMLSSSSAQGFQQ-FQAEVKLLMRVHHRNLTSL 626
           +  +  GG G +Y      +N   V +K L  S     Q    AE + L  V H ++  +
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 627 --VGHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVESAQGLEYL 679
                  + +   + Y  M      EY     L     + L   E +   +E    L YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVM------EYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198

Query: 680 H-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           H  G    +V+ D+K  NI+L E+ Q KL D G               +  GTPG+  PE
Sbjct: 199 HSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVSRI-----NSFGYLY-GTPGFQAPE 247

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKP 766
              +   T  +D+Y+ G  +  +    P
Sbjct: 248 IVRT-GPTVATDIYTVGRTLAALTLDLP 274

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  128 bits (325), Expect = 5e-33
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 31/227 (13%)

Query: 571 ERTLGKGGFGTVYYG---RLNEIDVAVKMLSSSSA--QGFQQ-FQAEVKLLMRVHHRNLT 624
              LG GG   V+     R +  DVAVK+L +  A    F   F+ E +    ++H  + 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHR-DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 625 SL--VGHCDEDNQTALIY---EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           ++   G   E     L Y   E++    L++ +    +  ++ +  + +  ++ Q L + 
Sbjct: 76  AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFS 132

Query: 680 H-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST-VVAGTPGYLDP 737
           H NG    I+HRDVK  NI+++     K+ DFG++++ A   N+   T  V GT  YL P
Sbjct: 133 HQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 738 EYYTSNRLTEKSDVYSFGVVILEIITCKP----------AISRINEE 774
           E    + +  +SDVYS G V+ E++T +P          A   + E+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (322), Expect = 8e-33
 Identities = 69/265 (26%), Positives = 111/265 (41%), Gaps = 31/265 (11%)

Query: 574 LGKGGFGTVYYGRLNEID---VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC 630
           LGKG +G VY G  +  +   +A+K +    ++  Q    E+ L   + H+N+   +G  
Sbjct: 30  LGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ---GLEYLHNGCKPPI 687
            E+    +  E +  G+L   L       L   E+  I   + Q   GL+YLH+     I
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQT-IGFYTKQILEGLKYLHDNQ---I 143

Query: 688 VHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE--YYTSNR 744
           VHRD+K  N+L+N      K++DFG SK  A   N    T   GT  Y+ PE        
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFT-GTLQYMAPEIIDKGPRG 201

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
             + +D++S G  I+E+ T KP    + E +    +      +    +     P + E  
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK------VGMFKVH----PEIPESM 251

Query: 805 DANSVWKAVELAMACLSPTGNQRPT 829
            A     A    + C  P  ++R  
Sbjct: 252 SAE----AKAFILKCFEPDPDKRAC 272

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  128 bits (324), Expect = 1e-32
 Identities = 66/293 (22%), Positives = 120/293 (40%), Gaps = 44/293 (15%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLV 627
            R L +GGF  VY  +   +  + A+K L S+  +  +    EV  + ++  H N+    
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 628 GHCDEDNQTA-------LIYEFMANGNLQEYLSDI-SKKVLSSQERLRIAVESAQGLEYL 679
                  + +       L+   +  G L E+L  + S+  LS    L+I  ++ + ++++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA---------- 729
           H   KPPI+HRD+K  N+LL+ +   KL DFG + + +   +   S              
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 730 GTPGYLDPE---YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL 786
            TP Y  PE    Y++  + EK D+++ G ++  +   +        E+   +R      
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-----EDGAKLR------ 260

Query: 787 IAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
           I  G             F          L  A L     +R ++++VV +L E
Sbjct: 261 IVNGKYSIPPHDTQYTVF--------HSLIRAMLQVNPEERLSIAEVVHQLQE 305

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (322), Expect = 1e-32
 Identities = 59/310 (19%), Positives = 116/310 (37%), Gaps = 43/310 (13%)

Query: 544 SKNKIDSFEAKSRHLSYSDVVKITNNFER--TLGKGGFGTVYYGR--LNEIDVAVKM--L 597
             +     +  + +L +  +      +     +G GG   V+       +I  A+K   L
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNL 62

Query: 598 SSSSAQGFQQFQAEVKLLMRVHHRNLT--SLVGHCDEDNQTALIYEFMANGNLQEYLSDI 655
             +  Q    ++ E+  L ++   +     L  +   D    ++ E   N +L  +L   
Sbjct: 63  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--K 119

Query: 656 SKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK 714
            KK +   ER        + +  +H +G    IVH D+K  N L+ +    KL DFG++ 
Sbjct: 120 KKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIAN 174

Query: 715 SFATDANTHVSTVVAGTPGYLDPE-----------YYTSNRLTEKSDVYSFGVVILEIIT 763
               D  + V     GT  Y+ PE             + ++++ KSDV+S G ++  +  
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

Query: 764 CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPT 823
            K    +I  +                 + +I+DP  + +F         ++   CL   
Sbjct: 235 GKTPFQQIINQISK--------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRD 280

Query: 824 GNQRPTMSQV 833
             QR ++ ++
Sbjct: 281 PKQRISIPEL 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (322), Expect = 2e-32
 Identities = 58/294 (19%), Positives = 113/294 (38%), Gaps = 44/294 (14%)

Query: 561 SDVVKITNN---FERTLGKGGFGTVYYGR--LNEIDVAVKM--LSSSSAQGFQQFQAEVK 613
           ++ + +        + +G GG   V+       +I  A+K   L  +  Q    ++ E+ 
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIA 59

Query: 614 LLMRVHHRNLT--SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVE 671
            L ++   +     L  +   D    ++ E   N +L  +L    KK +   ER      
Sbjct: 60  YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKN 116

Query: 672 SAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
             + +  +H +G    IVH D+K  N L+ +    KL DFG++     D  + V     G
Sbjct: 117 MLEAVHTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 731 TPGYLDPE-----------YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
           T  Y+ PE             + ++++ KSDV+S G ++  +   K    +I  +     
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-- 229

Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
                       + +I+DP  + +F         ++   CL     QR ++ ++
Sbjct: 230 ------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  129 bits (325), Expect = 5e-32
 Identities = 71/307 (23%), Positives = 119/307 (38%), Gaps = 53/307 (17%)

Query: 559 SYSDVVKITNNFERTLGKGGFGTVYY-GRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR 617
           ++   +K     E+ LG G  GTV + G      VAVK +             E+KLL  
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTE 64

Query: 618 V-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL-----SDISKKVLSSQERLRIAVE 671
              H N+         D    +  E   N NLQ+ +     SD + K+      + +  +
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 672 SAQGLEYLH-NGCKPPIVHRDVKSTNILLNEK-------------LQAKLADFGLSKSFA 717
            A G+ +LH       I+HRD+K  NIL++               L+  ++DFGL K   
Sbjct: 124 IASGVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 718 TDANTHVSTV--VAGTPGYLDPE-------YYTSNRLTEKSDVYSFGVVILEIITCK--P 766
           +  ++  + +   +GT G+  PE         T  RLT   D++S G V   I++    P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 767 AISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQ 826
              + + E            I +G         ++   D + + +A +L    +     +
Sbjct: 240 FGDKYSRESN----------IIRGIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLK 286

Query: 827 RPTMSQV 833
           RPT  +V
Sbjct: 287 RPTAMKV 293

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (320), Expect = 6e-32
 Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 22/241 (9%)

Query: 541 KRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVK-ML 597
           +R+      + + K   L   D  KI       LG G  G V+        + +A K + 
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKI-----SELGAGNGGVVFKVSHKPSGLVMARKLIH 67

Query: 598 SSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK 657
                    Q   E+++L   +   +    G    D + ++  E M  G+L      + K
Sbjct: 68  LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLK 123

Query: 658 KVLSSQERL--RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS 715
           K     E++  ++++   +GL YL    K  I+HRDVK +NIL+N + + KL DFG+S  
Sbjct: 124 KAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181

Query: 716 F-ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE 774
              + AN+ V     GT  Y+ PE       + +SD++S G+ ++E+   +  I   + +
Sbjct: 182 LIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236

Query: 775 E 775
           E
Sbjct: 237 E 237

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  124 bits (314), Expect = 7e-32
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 16/206 (7%)

Query: 568 NNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGF---QQFQAEVKLLMRVHH 620
            +FE  R LGKG FG VY  R   ++  +A+K+L  +  +      Q + EV++   + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L G+  +  +  LI E+   G +   L          Q       E A  L Y H
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH 126

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 ++HRD+K  N+LL    + K+ADFG S      ++        GT  YL PE  
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLC--GTLDYLPPEMI 179

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++S GV+  E +  KP
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKP 205

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  126 bits (319), Expect = 1e-31
 Identities = 63/324 (19%), Positives = 120/324 (37%), Gaps = 46/324 (14%)

Query: 533 RKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNN-----FERTLGKGGFGTVYYGR- 586
           ++    K +R+  +  D         S S    I+         + +G GG   V+    
Sbjct: 18  KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77

Query: 587 -LNEIDVAVKM--LSSSSAQGFQQFQAEVKLLMRVHHRNLT--SLVGHCDEDNQTALIYE 641
              +I  A+K   L  +  Q    ++ E+  L ++   +     L  +   D    ++ E
Sbjct: 78  EKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136

Query: 642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLN 700
              N +L  +L    KK +   ER        + +  +H +G    IVH D+K  N L+ 
Sbjct: 137 C-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV 189

Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-----------YYTSNRLTEKS 749
           +    KL DFG++     D  + V     G   Y+ PE             + ++++ KS
Sbjct: 190 DG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248

Query: 750 DVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV 809
           DV+S G ++  +   K    +I  +                 + +I+DP  + +F     
Sbjct: 249 DVWSLGCILYYMTYGKTPFQQIINQISK--------------LHAIIDPNHEIEFPDIPE 294

Query: 810 WKAVELAMACLSPTGNQRPTMSQV 833
               ++   CL     QR ++ ++
Sbjct: 295 KDLQDVLKCCLKRDPKQRISIPEL 318

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  125 bits (314), Expect = 3e-31
 Identities = 33/303 (10%), Positives = 71/303 (23%), Gaps = 55/303 (18%)

Query: 570 FERTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLT 624
               L  G    V+  R  E     A+K+ +     S    ++         R+   +  
Sbjct: 66  LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125

Query: 625 SLVGHC-----------------------DEDNQTALIYEFM--ANGNLQEYLSDISKKV 659
                                         +D   A     M  A+ +L+   S +    
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185

Query: 660 -----LSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS 713
                        +  +  +    L   G    +VH      N+ +    +  L D    
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 714 KSFATDANTHVSTVVAGTPGYLDPEYYTSNRL--TEKSDVYSFGVVILEIITCKPAISRI 771
               T          +    Y   E+  ++    T   + +  G+ I  +         +
Sbjct: 242 WKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296

Query: 772 NEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMS 831
               K   ++    +     +       L +            L    L+    +R    
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF--------VKTLIGRFLNFDRRRRLLPL 348

Query: 832 QVV 834
           + +
Sbjct: 349 EAM 351

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  123 bits (310), Expect = 6e-31
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 28/218 (12%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHRNLTS 625
                LG+G    V+ G  +      A+K+ +  S  +       E ++L +++H+N+  
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 626 LVGHCDEDNQTALIY---EFMANGNLQEYLSDISKKV-LSSQERLRIAVESAQGLEYLH- 680
           L    +E+  T       EF   G+L   L + S    L   E L +  +   G+ +L  
Sbjct: 72  LF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 681 NGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           NG    IVHR++K  NI+     + +   KL DFG ++    + +    ++  GT  YL 
Sbjct: 131 NG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLY-GTEEYLH 183

Query: 737 PEYYTSNRL--------TEKSDVYSFGVVILEIITCKP 766
           P+ Y    L            D++S GV      T   
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (307), Expect = 9e-31
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGF---QQFQAEVKLLMRVHHRNLTSL 626
           R LGKGGF   +     +     A K++  S        ++   E+ +   + H+++   
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G  ++++   ++ E     +L E      +K L+  E      +   G +YLH      
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNR--- 135

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           ++HRD+K  N+ LNE L+ K+ DFGL+     D       V+ GTP Y+ PE  +    +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHS 193

Query: 747 EKSDVYSFGVVILEIITCKP 766
            + DV+S G ++  ++  KP
Sbjct: 194 FEVDVWSIGCIMYTLLVGKP 213

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  122 bits (308), Expect = 1e-30
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGF---QQFQAEVKLLMRVHHRNLTSL 626
           R LGKGGF   +     +     A K++  S        ++   E+ +   + H+++   
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G  ++++   ++ E     +L E      +K L+  E      +   G +YLH      
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNR--- 161

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           ++HRD+K  N+ LNE L+ K+ DFGL+     D       V+ GTP Y+ PE  +    +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHS 219

Query: 747 EKSDVYSFGVVILEIITCKP 766
            + DV+S G ++  ++  KP
Sbjct: 220 FEVDVWSIGCIMYTLLVGKP 239

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (306), Expect = 4e-30
 Identities = 34/218 (15%), Positives = 68/218 (31%), Gaps = 24/218 (11%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN 622
               LG+G F  VY     +++         +K+   ++   F      ++ L       
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI---SKKVLSSQERLRIAVESAQGLEYL 679
                      N + L+ E  + G L   ++      +KV+     +  A+     +E +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQA-----------KLADFGLSKSFATDANTHVSTVV 728
           H+     I+H D+K  N +L                  L D G S          + T  
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
             T G+   E  ++     + D +     +  ++    
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  119 bits (300), Expect = 6e-30
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 13/206 (6%)

Query: 568 NNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGF---QQFQAEVKLLMRVHH 620
            +F+    LGKG F  VY        ++VA+KM+   +       Q+ Q EVK+  ++ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            ++  L  + ++ N   L+ E   NG +  YL +   K  S  E      +   G+ YLH
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLH 129

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +     I+HRD+  +N+LL   +  K+ADFGL+         H  T + GTP Y+ PE  
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEIA 184

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
           T +    +SDV+S G +   ++  +P
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRP 210

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  121 bits (306), Expect = 6e-30
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 28/215 (13%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHRNLTS 625
                LG+G    V+ G  +      A+K+ +  S  +       E ++L +++H+N+  
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 626 LVGHCDEDNQTALIY---EFMANGNLQEYLSDISKKV-LSSQERLRIAVESAQGLEYLH- 680
           L    +E+  T       EF   G+L   L + S    L   E L +  +   G+ +L  
Sbjct: 72  LF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 681 NGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           NG    IVHR++K  NI+     + +   KL DFG ++    + +    ++  GT  YL 
Sbjct: 131 NG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLY-GTEEYLH 183

Query: 737 PEYYTSNRL--------TEKSDVYSFGVVILEIIT 763
           P+ Y    L            D++S GV      T
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  119 bits (300), Expect = 7e-30
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 11/210 (5%)

Query: 559 SYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLM 616
           S  D  K    FE+ +G+G  GTVY         +VA++ ++       +    E+ ++ 
Sbjct: 14  SVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
              + N+ + +      ++  ++ E++A G+L +    +++  +   +   +  E  Q L
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQAL 129

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           E+LH+      +HRD+KS NILL      KL DFG      T   +  ST+V GTP ++ 
Sbjct: 130 EFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMV-GTPYWMA 184

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           PE  T      K D++S G++ +E+I  +P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  119 bits (300), Expect = 7e-30
 Identities = 52/300 (17%), Positives = 105/300 (35%), Gaps = 61/300 (20%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGRLNEID---VAVK--MLSSSSAQGFQQFQAEVKLLMR 617
           + T  F     +G G FG+V+      +D    A+K      + +   Q    EV     
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCV-KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 618 V-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER--LRIAVESAQ 674
           +  H ++        ED+   +  E+   G+L + +S+  + +   +E     + ++  +
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 675 GLEYLH-NGCKPPIVHRDVKSTNILLNE-------------------KLQAKLADFGLSK 714
           GL Y+H       +VH D+K +NI ++                    K+  K+ D G   
Sbjct: 127 GLRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINE 773
              +           G   +L  E    N     K+D+++  + ++     +P     ++
Sbjct: 183 RI-SSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236

Query: 774 EEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
               H        I +G +     PR+ +           EL    + P   +RP+   +
Sbjct: 237 ---WHE-------IRQGRL-----PRIPQVLSQE----FTELLKVMIHPDPERRPSAMAL 277

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  118 bits (299), Expect = 9e-30
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 24/207 (11%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVK-MLSSSSAQGFQQFQAEVKLLMR-VHHRNLTSLVGH 629
           LG+G +G V   R       +AVK + ++ ++Q  ++   ++ + MR V      +  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERL------RIAVESAQGLEYLHNGC 683
              +    +  E M        L    K+V+   + +      +IAV   + LE+LH+  
Sbjct: 75  LFREGDVWICMELMDTS-----LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE----Y 739
              ++HRDVK +N+L+N   Q K+ DFG+S       +     + AG   Y+ PE     
Sbjct: 130 S--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPE 184

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKP 766
                 + KSD++S G+ ++E+   + 
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRF 211

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  120 bits (302), Expect = 9e-30
 Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 25/245 (10%)

Query: 532 KRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYG---RLN 588
            + +++G    +++  + + + K     Y + V    +  R +G+G FG V+     +  
Sbjct: 25  AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR-VGRGSFGEVHRMKDKQTG 83

Query: 589 EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL 648
               AVK +     +       E+     +    +  L G   E     +  E +  G+L
Sbjct: 84  FQ-CAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137

Query: 649 QEYLSDISKKVLSSQERLRIAVESAQ---GLEYLHNGCKPPIVHRDVKSTNILLNEK-LQ 704
                 + K++    E         Q   GLEYLH      I+H DVK+ N+LL+    +
Sbjct: 138 ----GQLIKQMGCLPEDR-ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSR 189

Query: 705 AKLADFGLSKSFATDANTHVSTV---VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           A L DFG +     D           + GT  ++ PE         K D++S   ++L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 762 ITCKP 766
           +    
Sbjct: 250 LNGCH 254

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  118 bits (299), Expect = 1e-29
 Identities = 49/203 (24%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD 631
           LG G FG VY  +  E     A K++ + S +  + +  E+++L    H  +  L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86

Query: 632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV---ESAQGLEYLHNGCKPPIV 688
            D +  ++ EF   G +   + ++ + +   Q    I V   +  + L +LH+      +
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ----IQVVCRQMLEALNFLHSKRI---I 139

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE- 747
           HRD+K+ N+L+  +   +LADFG+S +          + + GTP ++ PE      + + 
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDT 197

Query: 748 ----KSDVYSFGVVILEIITCKP 766
               K+D++S G+ ++E+   +P
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEP 220

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (300), Expect = 2e-29
 Identities = 47/223 (21%), Positives = 92/223 (41%), Gaps = 33/223 (14%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEIDVAVKMLS-----------------SSSAQGFQQF 608
           N++   RTL +G F  +     +    A+K                     S    +  F
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 609 QAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------SDISKKVLSS 662
           + E++++  + +    +  G     ++  +IYE+M N ++ ++              +  
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150

Query: 663 QERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT 722
           Q    I         Y+HN  +  I HRDVK +NIL+++  + KL+DFG S+ +  D   
Sbjct: 151 QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKI 207

Query: 723 HVSTVVAGTPGYLDPEYYTSNRLT--EKSDVYSFGVVILEIIT 763
             S    GT  ++ PE++++       K D++S G+ +  +  
Sbjct: 208 KGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (297), Expect = 2e-29
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 21/201 (10%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQG-FQQFQAEVKLLMRVHHRNLTSLVGH 629
           +GKG FG V+ G      ++ VA+K++    A+   +  Q E+ +L +     +T   G 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISK-KVLSSQERLRIAV---ESAQGLEYLHNGCKP 685
             +D +  +I E++  G+      D+ +   L   +   IA    E  +GL+YLH+  K 
Sbjct: 89  YLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQ---IATILREILKGLDYLHSEKK- 140

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
             +HRD+K+ N+LL+E  + KLADFG++    TD     +T V GTP ++ PE    +  
Sbjct: 141 --IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIKQSAY 196

Query: 746 TEKSDVYSFGVVILEIITCKP 766
             K+D++S G+  +E+   +P
Sbjct: 197 DSKADIWSLGITAIELARGEP 217

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (298), Expect = 2e-29
 Identities = 63/305 (20%), Positives = 117/305 (38%), Gaps = 41/305 (13%)

Query: 543 ESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS 600
           ES  K+     +    +  D+  +       +G+G +G+V           +AVK + S+
Sbjct: 4   ESSGKLKISPEQHWDFTAEDLKDL-----GEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58

Query: 601 SA-QGFQQFQAEVKLLMR-VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK 658
              +  +Q   ++ ++MR      +    G    +    +  E M+            K 
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS-----FDKFYKY 113

Query: 659 VLSSQERL-------RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG 711
           V S  + +       +I + + + L +L    K  I+HRD+K +NILL+     KL DFG
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG 171

Query: 712 LSKSFATDANTHVSTVVAGTPGYLDPE----YYTSNRLTEKSDVYSFGVVILEIITCKPA 767
           +S       ++   T  AG   Y+ PE      +      +SDV+S G+ + E+ T +  
Sbjct: 172 ISGQL---VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

Query: 768 ISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQR 827
                   K +      + + KGD      P+L    +       +     CL+   ++R
Sbjct: 229 YP------KWNSVFDQLTQVVKGDP-----PQLSNSEEREFSPSFINFVNLCLTKDESKR 277

Query: 828 PTMSQ 832
           P   +
Sbjct: 278 PKYKE 282

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (297), Expect = 3e-29
 Identities = 54/236 (22%), Positives = 104/236 (44%), Gaps = 12/236 (5%)

Query: 534 KRQVGKVKRESKNKIDSFEAKSRHL-SYSDVVKITNNFERTLGKGGFGTVYYGRLNE--I 590
                   +      + F+A  R +    D   + +++ + +G+G  G V   R      
Sbjct: 13  LGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK-IGEGSTGIVCLAREKHSGR 71

Query: 591 DVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQE 650
            VAVKM+     Q  +    EV ++    H N+  +        +  ++ EF+  G L +
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131

Query: 651 YLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF 710
               +S+  L+ ++   +     Q L YLH       +HRD+KS +ILL    + KL+DF
Sbjct: 132 I---VSQVRLNEEQIATVCEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDF 185

Query: 711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           G      +       ++V GTP ++ PE  + +    + D++S G++++E++  +P
Sbjct: 186 GFCAQI-SKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  116 bits (293), Expect = 9e-29
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 17/202 (8%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
            F   LG G F  V+    RL     A+K +  S A      + E+ +L ++ H N+ +L
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKP 685
               +      L+ + ++ G L + +  + + V + ++   +  +    ++YLH NG   
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLVIQQVLSAVKYLHENG--- 126

Query: 686 PIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
            IVHRD+K  N+L     E  +  + DFGLSK         + +   GTPGY+ PE    
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEVLAQ 181

Query: 743 NRLTEKSDVYSFGVVILEIITC 764
              ++  D +S G VI  I+ C
Sbjct: 182 KPYSKAVDCWSIG-VITYILLC 202

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  115 bits (291), Expect = 1e-28
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 16/206 (7%)

Query: 568 NNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGF---QQFQAEVKLLMRVHH 620
           ++F+  R LGKG FG VY  R   N+  +A+K+L  S  +      Q + E+++   + H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  +  +  +  +  L+ EF   G L + L          Q       E A  L Y H
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADALHYCH 131

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
              +  ++HRD+K  N+L+  K + K+ADFG S   A            GT  YL PE  
Sbjct: 132 ---ERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRTM---CGTLDYLPPEMI 184

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKP 766
                 EK D++  GV+  E +   P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMP 210

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  116 bits (293), Expect = 1e-28
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 31/239 (12%)

Query: 550 SFEAKSRHLSYSDVVKITN---NFER--TLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA 602
           + ++ +R L   D+  + +    FE    +G G +G VY GR  +     A+K++  +  
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG- 61

Query: 603 QGFQQFQAEVKLLMRV-HHRNLTSLVG------HCDEDNQTALIYEFMANGNLQEYLSDI 655
              ++ + E+ +L +  HHRN+ +  G          D+Q  L+ EF   G++ + + + 
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121

Query: 656 SKKVLSSQERLRIAV---ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL 712
               L  +    IA    E  +GL +LH       +HRD+K  N+LL E  + KL DFG+
Sbjct: 122 KGNTLKEEW---IAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE-----KSDVYSFGVVILEIITCKP 766
           S           +T + GTP ++ PE    +   +     KSD++S G+  +E+    P
Sbjct: 176 SAQL-DRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  119 bits (300), Expect = 2e-28
 Identities = 73/317 (23%), Positives = 119/317 (37%), Gaps = 45/317 (14%)

Query: 533 RKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYG--RLN 588
                    RE+       +A       S    ++  ++  + LG G +G V     ++ 
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 589 EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG 646
            ++ A+K++  +  S     +   EV +L  + H N+  L    ++     L+ E    G
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121

Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILL---NEK 702
            L + +  I +   +  +   I  +   G+ YLH +     IVHRD+K  N+LL    + 
Sbjct: 122 ELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHKHN----IVHRDLKPENLLLESKEKD 175

Query: 703 LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEII 762
              K+ DFGLS  F    N        GT  Y+ PE        EK DV+S G VIL I+
Sbjct: 176 ALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIG-VILFIL 230

Query: 763 TC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWK-----AVELA 816
               P      ++E +         + KG             FD+   WK     A +L 
Sbjct: 231 LAGYPPFGGQTDQEILR-------KVEKGKY----------TFDSP-EWKNVSEGAKDLI 272

Query: 817 MACLSPTGNQRPTMSQV 833
              L     +R +  Q 
Sbjct: 273 KQMLQFDSQRRISAQQA 289

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (295), Expect = 2e-28
 Identities = 36/235 (15%), Positives = 68/235 (28%), Gaps = 49/235 (20%)

Query: 572 RTLGKGGFGTVYYGR---LNEIDVAVKMLSSS---SAQGFQQFQAEVKLL---------- 615
             LG+               E    V +   +    +   +Q + EV  L          
Sbjct: 84  TVLGQEDPYAYLEATDQETGE-SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142

Query: 616 -MRVHHRNLTSL-------------VGHCDEDNQTALIYEFM--ANGNLQEYLSDISKKV 659
             +VH R +                V   + D      +        NLQ +   +    
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 660 -----LSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS 713
                L    RL++ ++  + L  LH  G    +VH  ++  +I+L+++    L  F   
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 714 KSFATDANTHVSTVVAGTPGYLDPE-----YYTSNRLTEKSDVYSFGVVILEIIT 763
                 A + +       P            +    +T   D ++ G+ I  I  
Sbjct: 259 VRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (302), Expect = 3e-28
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 21/208 (10%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
            +  LG GGFG V           VA+K      S +  +++  E++++ +++H N+ S 
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 627 V------GHCDEDNQTALIYEFMANGNLQEYLSDISKK-VLSSQERLRIAVESAQGLEYL 679
                       ++   L  E+   G+L++YL+       L       +  + +  L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 680 H-NGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           H N     I+HRD+K  NI+L    ++L  K+ D G +K    D     +  V GT  YL
Sbjct: 138 HENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFV-GTLQYL 190

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIIT 763
            PE     + T   D +SFG +  E IT
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECIT 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  114 bits (288), Expect = 3e-28
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLT 624
           + +  LGKG F  V     +   ++ A K++++   SA+ FQ+ + E ++  ++ H N+ 
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
            L     E++   L+++ +  G L E +  ++++  S  +      +  + + Y H NG 
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNG- 125

Query: 684 KPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
              IVHR++K  N+LL  K +    KLADFGL+     + +        GTPGYL PE  
Sbjct: 126 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFA-GTPGYLSPEVL 179

Query: 741 TSNRLTEKSDVYSFGVVILEIITC 764
             +  ++  D+++ G VIL I+  
Sbjct: 180 KKDPYSKPVDIWACG-VILYILLV 202

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  117 bits (296), Expect = 5e-28
 Identities = 75/280 (26%), Positives = 114/280 (40%), Gaps = 44/280 (15%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLS---SSSAQGFQQFQAEVKLLMRVHHRNL 623
             +R LGKG FG V     ++   + AVK++S          +    EV+LL ++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NG 682
             L    ++     L+ E    G L + +  IS+K  S  +  RI  +   G+ Y+H N 
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 683 CKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
               IVHRD+K  N+LL   ++    ++ DFGLS  F             GT  Y+ PE 
Sbjct: 147 ----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIGTAYYIAPEV 199

Query: 740 YTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
                  EK DV+S G VIL I+    P  +  NE + +         + KG        
Sbjct: 200 LHGT-YDEKCDVWSTG-VILYILLSGCPPFNGANEYDILK-------KVEKGKY------ 244

Query: 799 RLQEDFDANSVWK-----AVELAMACLSPTGNQRPTMSQV 833
                F+    WK     A +L    L+   + R +    
Sbjct: 245 ----TFELP-QWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  114 bits (287), Expect = 5e-28
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 12/196 (6%)

Query: 574 LGKGGFGTVYYG---RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC 630
           LG+G +G+VY        +I VA+K +        Q+   E+ ++ +    ++    G  
Sbjct: 37  LGEGSYGSVYKAIHKETGQI-VAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            ++    ++ E+   G++ + +  +  K L+  E   I   + +GLEYLH   K   +HR
Sbjct: 94  FKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHR 149

Query: 691 DVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSD 750
           D+K+ NILLN +  AKLADFG++    TD     +TV+ GTP ++ PE          +D
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQL-TDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVAD 207

Query: 751 VYSFGVVILEIITCKP 766
           ++S G+  +E+   KP
Sbjct: 208 IWSLGITAIEMAEGKP 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  116 bits (291), Expect = 6e-28
 Identities = 50/227 (22%), Positives = 83/227 (36%), Gaps = 29/227 (12%)

Query: 559 SYSDVVKITNNFERTLGKG--GFGTVYYGR---LNEIDVAVKM--LSSSSAQGFQQFQAE 611
           S+             +GKG     TV   R     E  V V+   L + S +     Q E
Sbjct: 19  SFLPEGGCYELLTV-IGKGFEDLMTVNLARYKPTGEY-VTVRRINLEACSNEMVTFLQGE 76

Query: 612 VKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV- 670
           + +    +H N+         DN+  ++  FMA G+ ++ +       ++  E   IA  
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN--ELA-IAYI 133

Query: 671 --ESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
                + L+Y+H  G     VHR VK+++IL++   +  L+    + S           V
Sbjct: 134 LQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSM-ISHGQRQRVV 188

Query: 728 ------VAGTPGYLDPEYYTSNRL--TEKSDVYSFGVVILEIITCKP 766
                       +L PE    N      KSD+YS G+   E+     
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  112 bits (282), Expect = 2e-27
 Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 29/214 (13%)

Query: 570 FERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGF---------QQFQAEVKLLMRV 618
            +  LG+G    V     +    + AVK++  +    F         +    EV +L +V
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 619 -HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
             H N+  L    + +    L+++ M  G L +YL    K  LS +E  +I     + + 
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVIC 138

Query: 678 YLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            LH       IVHRD+K  NILL++ +  KL DFG S     D    +  V  GTP YL 
Sbjct: 139 ALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVC-GTPSYLA 191

Query: 737 PE------YYTSNRLTEKSDVYSFGVVILEIITC 764
           PE              ++ D++S G VI+  +  
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLA 224

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  115 bits (291), Expect = 3e-27
 Identities = 78/289 (26%), Positives = 116/289 (40%), Gaps = 54/289 (18%)

Query: 570 FERTLGKGGFGTVYYG--RLNEIDVAVKMLS-------------SSSAQGFQQFQAEVKL 614
             R LG G +G V     +    + A+K++               +  +  ++   E+ L
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 615 LMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
           L  + H N+  L    ++     L+ EF   G L E +  I++      +   I  +   
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQILS 157

Query: 675 GLEYLH-NGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           G+ YLH +     IVHRD+K  NILL   N  L  K+ DFGLS  F+ D   +      G
Sbjct: 158 GICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLG 210

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAK 789
           T  Y+ PE        EK DV+S G VI+ I+ C  P     N+++ I         + K
Sbjct: 211 TAYYIAPEVLKKK-YNEKCDVWSCG-VIMYILLCGYPPFGGQNDQDIIK-------KVEK 261

Query: 790 GDIKSIVDPRLQEDFDANSVWK-----AVELAMACLSPTGNQRPTMSQV 833
           G             FD N  WK     A EL    L+   N+R T  + 
Sbjct: 262 GKY----------YFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  114 bits (287), Expect = 3e-27
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 34/232 (14%)

Query: 556 RHLSYSDVVKITNNFE------RTLGKGGFGTVYYG--RLNEIDVAVKMLS--------S 599
             L+  D               +TLG G  G V     R     VA++++S        +
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178

Query: 600 SSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV 659
             A      + E+++L +++H  +  +    D ++   ++ E M  G L + +  +  K 
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV--VGNKR 235

Query: 660 LSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKS 715
           L          +    ++YLH NG    I+HRD+K  N+LL+ +      K+ DFG SK 
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291

Query: 716 FATDANTHVSTVVAGTPGYLDPE---YYTSNRLTEKSDVYSFGVVILEIITC 764
                 + + T+  GTP YL PE      +       D +S G VIL I   
Sbjct: 292 L--GETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLS 339

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  111 bits (280), Expect = 3e-27
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 574 LGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGH 629
           +G G    V         E  VA+K ++    Q    +   E++ + + HH N+ S    
Sbjct: 23  IGSGATAVVQAAYCAPKKEK-VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR---IAV---ESAQGLEYLH-NG 682
               ++  L+ + ++ G++ + +  I  K       L    IA    E  +GLEYLH NG
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS----TVVAGTPGYLDPE 738
                +HRDVK+ NILL E    ++ADFG+S   AT  +   +    T V GTP ++ PE
Sbjct: 142 ----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPE 196

Query: 739 YYTSNRL-TEKSDVYSFGVVILEIITCKP 766
                R    K+D++SFG+  +E+ T   
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAA 225

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  110 bits (278), Expect = 5e-27
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 27/207 (13%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
             E T+G+G +G V     +   I  A K +     +   +F+ E++++  + H N+  L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKP 685
               +++    L+ E    G L E +  + K+V    +  RI  +    + Y H      
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCHKLN--- 126

Query: 686 PIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE---- 738
            + HRD+K  N L    +     KL DFGL+  F       + T V GTP Y+ P+    
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKV-GTPYYVSPQVLEG 182

Query: 739 -YYTSNRLTEKSDVYSFGVVILEIITC 764
            Y        + D +S G V++ ++ C
Sbjct: 183 LY------GPECDEWSAG-VMMYVLLC 202

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  115 bits (290), Expect = 6e-27
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 21/245 (8%)

Query: 532 KRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITN-------NFERTLGKGGFGTVYY 584
             + ++ + K    +  D++        Y   V+I +       +    LG G FG V+ 
Sbjct: 116 DEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR 175

Query: 585 G--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF 642
              R    + A K + +      +  + E++ +  + H  L +L    ++DN+  +IYEF
Sbjct: 176 VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235

Query: 643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNE 701
           M+ G L E ++D     +S  E +    +  +GL ++H N      VH D+K  NI+   
Sbjct: 236 MSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTT 290

Query: 702 KLQA--KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVIL 759
           K     KL DFGL+             V  GT  +  PE      +   +D++S G V+ 
Sbjct: 291 KRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLS 346

Query: 760 EIITC 764
            I+  
Sbjct: 347 YILLS 351

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (281), Expect = 9e-27
 Identities = 59/253 (23%), Positives = 106/253 (41%), Gaps = 30/253 (11%)

Query: 532 KRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYG--RL 587
            +K    + K        S   +     ++   +    ++    +G+G    V     R 
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117

Query: 588 NEIDVAVKMLS--------SSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTAL 638
              + AVK++             +  +  + E  +L +V  H ++ +L+   +  +   L
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177

Query: 639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNI 697
           +++ M  G L +YL    K  LS +E   I     + + +LH N     IVHRD+K  NI
Sbjct: 178 VFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLEAVSFLHANN----IVHRDLKPENI 231

Query: 698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE------YYTSNRLTEKSDV 751
           LL++ +Q +L+DFG S     +    +  +  GTPGYL PE        T     ++ D+
Sbjct: 232 LLDDNMQIRLSDFGFSCHL--EPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDL 288

Query: 752 YSFGVVILEIITC 764
           ++ G VIL  +  
Sbjct: 289 WACG-VILFTLLA 300

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  109 bits (275), Expect = 1e-26
 Identities = 79/284 (27%), Positives = 121/284 (42%), Gaps = 53/284 (18%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQG--FQQFQAEVKLLMRVHHRNLT 624
           N    LGKG FG V     R+ + + AVK+++ +SA+         EV+LL ++ H N+ 
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
            L    ++ +   ++ E    G L + +  I +K  S  +  RI  +   G+ Y+H +  
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN- 141

Query: 684 KPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-- 738
              IVHRD+K  NILL    +    K+ DFGLS  F    NT +   + GT  Y+ PE  
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI-GTAYYIAPEVL 195

Query: 739 ---YYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKS 794
              Y       EK DV+S G VIL I+    P     NE +       +   +  G    
Sbjct: 196 RGTY------DEKCDVWSAG-VILYILLSGTPPFYGKNEYD-------ILKRVETGKY-- 239

Query: 795 IVDPRLQEDFDANSVWKAV-----ELAMACLSPTGNQRPTMSQV 833
                    FD    W+ +     +L    L+   + R T +Q 
Sbjct: 240 --------AFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  111 bits (279), Expect = 1e-26
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 570 FERTLGKGGFGTVYYG--RLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTS 625
            +  LGKG F  V     +   ++ A K++++   SA+ FQ+ + E ++  ++ H N+  
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCK 684
           L     E++   L+++ +  G L E +  ++++  S  +      +  + + Y H NG  
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNG-- 148

Query: 685 PPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
             IVHR++K  N+LL  K +    KLADFGL+       ++      AGTPGYL PE   
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLK 203

Query: 742 SNRLTEKSDVYSFGVVILEIITC 764
            +  ++  D+++ G VIL I+  
Sbjct: 204 KDPYSKPVDIWACG-VILYILLV 225

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (279), Expect = 1e-26
 Identities = 34/241 (14%), Positives = 69/241 (28%), Gaps = 60/241 (24%)

Query: 572 RTLGKGGFGTVYYGR---LNEIDVAVKMLSSSS--------------------------- 601
             LG+               E    V +   +                            
Sbjct: 79  TVLGQEDPYAYLEATDQETGES-FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137

Query: 602 -AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM-ANGNLQEYLSDIS--- 656
            A+   +F     L+     + +  +     +    +  + +     NLQ +   +    
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197

Query: 657 --KKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS 713
              K L    RL++ ++  + L  LH  G    +VH  ++  +I+L+++    L  F   
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 714 KSFATDANTHVSTVVAGTPGYLDPEY-----------YTSNRLTEKSDVYSFGVVILEII 762
                        V + + G+  PE                 +T   D ++ G+VI  I 
Sbjct: 254 VRDGAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 763 T 763
            
Sbjct: 308 C 308

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  110 bits (277), Expect = 1e-26
 Identities = 63/341 (18%), Positives = 115/341 (33%), Gaps = 98/341 (28%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID---VAVKMLS-SSSAQGFQQFQAEVKLLMRVHHR 621
            +FE  + +G+GGFG V+  + N++D    A+K +   +     ++   EVK L ++ H 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAK-NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 622 NLTSLVG---------------------------------------------HCDEDNQT 636
            +                                                       N  
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 637 ALIYEFMANGNL---QEY-----LSDISKKVLSSQER-----LRIAVESAQGLEYLH-NG 682
             +        L    +      L D   +  S ++R     L I ++ A+ +E+LH  G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH----------VSTVVAGTP 732
               ++HRD+K +NI        K+ DFGL  +   D                T   GT 
Sbjct: 185 ----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
            Y+ PE    N  + K D++S G+++ E++            E++ I            I
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRI------------I 283

Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
             + + +    F      +   +    LSP+  +RP  + +
Sbjct: 284 TDVRNLKFPLLFTQKYP-QEHMMVQDMLSPSPTERPEATDI 323

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  110 bits (276), Expect = 2e-26
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 22/205 (10%)

Query: 574 LGKGGFGTVYYGRLNE--IDVAVK-MLSSSSAQGFQQFQAEVKLLMR-VHHRNLTSLVGH 629
           +G G  G V+  R  +    +AVK M  S + +  ++   ++ ++++      +    G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 630 CDEDNQTALIYEFMANGNLQEYLSD---ISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
              +    +  E M     +        I +++L      ++ V   + L YL       
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKEKHG-- 145

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-----YYT 741
           ++HRDVK +NILL+E+ Q KL DFG+S       +       AG   Y+ PE       T
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP 766
                 ++DV+S G+ ++E+ T + 
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQF 227

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  113 bits (284), Expect = 2e-26
 Identities = 78/284 (27%), Positives = 118/284 (41%), Gaps = 53/284 (18%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQG--FQQFQAEVKLLMRVHHRNLT 624
           N    LGKG FG V     R+ + + AVK+++ +SA+         EV+LL ++ H N+ 
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
            L    ++ +   ++ E    G L + +  I +K  S  +  RI  +   G+ Y+H +  
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN- 141

Query: 684 KPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-- 738
              IVHRD+K  NILL    +    K+ DFGLS  F  +          GT  Y+ PE  
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVL 195

Query: 739 ---YYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKS 794
              Y       EK DV+S G VIL I+    P     NE + +         +  G    
Sbjct: 196 RGTY------DEKCDVWSAG-VILYILLSGTPPFYGKNEYDILK-------RVETGKY-- 239

Query: 795 IVDPRLQEDFDANSVWK-----AVELAMACLSPTGNQRPTMSQV 833
                    FD    W+     A +L    L+   + R T +Q 
Sbjct: 240 --------AFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  110 bits (278), Expect = 2e-26
 Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 33/234 (14%)

Query: 552 EAKSRHLSYSDVVKITNN------FERT--LGKGGFGTVYYGRLNEID--VAVKMLS--- 598
             ++  L   DV ++         F     +G G FG VY+ R       VA+K +S   
Sbjct: 32  GGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG 91

Query: 599 SSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK 658
             S + +Q    EV+ L ++ H N     G    ++   L+ E+          SD+ + 
Sbjct: 92  KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS-----ASDLLEV 146

Query: 659 VLSSQERLRIAV---ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS 715
                + + IA     + QGL YLH+      +HRDVK+ NILL+E    KL DFG + S
Sbjct: 147 HKKPLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSA-S 202

Query: 716 FATDANTHVSTVVAGTPGYLDPE---YYTSNRLTEKSDVYSFGVVILEIITCKP 766
               AN+ V     GTP ++ PE        +   K DV+S G+  +E+   KP
Sbjct: 203 IMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  111 bits (279), Expect = 2e-26
 Identities = 53/250 (21%), Positives = 96/250 (38%), Gaps = 31/250 (12%)

Query: 532 KRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITN-------NFERTLGKGGFGTVYY 584
              +  GK      N  D F            V++         +    LG G FG V+ 
Sbjct: 10  HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR 69

Query: 585 G--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF 642
              +        K +++         + E+ ++ ++HH  L +L    ++  +  LI EF
Sbjct: 70  CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129

Query: 643 MANGNLQEYLSDISKKVLSSQER-----LRIAVESAQGLEYLH-NGCKPPIVHRDVKSTN 696
           ++ G   E    I+ +     E      +R A E   GL+++H +     IVH D+K  N
Sbjct: 130 LSGG---ELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEHS----IVHLDIKPEN 179

Query: 697 ILLNEKLQA--KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSF 754
           I+   K  +  K+ DFGL+     D    +  V   T  +  PE      +   +D+++ 
Sbjct: 180 IMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236

Query: 755 GVVILEIITC 764
           G V+  ++  
Sbjct: 237 G-VLGYVLLS 245

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  110 bits (276), Expect = 3e-26
 Identities = 55/273 (20%), Positives = 98/273 (35%), Gaps = 59/273 (21%)

Query: 546 NKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYG--RLNEIDVAVKM----- 596
           +   S   ++ +     ++++   +     +G+G +G V            A+K+     
Sbjct: 4   HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63

Query: 597 LSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDIS 656
           +   + +  ++ + EV+L+ ++HH N+  L    +++    L+ E    G+L + L+   
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123

Query: 657 KKVLSSQERLRIAVESA--------------------------------------QGLEY 678
                      +  +                                          L Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 679 LH-NGCKPPIVHRDVKSTNILLNEKLQA--KLADFGLSKSFATDANTHVS--TVVAGTPG 733
           LH  G    I HRD+K  N L +       KL DFGLSK F    N      T  AGTP 
Sbjct: 184 LHNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 734 YLDPE--YYTSNRLTEKSDVYSFGVVILEIITC 764
           ++ PE    T+     K D +S G V+L ++  
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLM 271

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  111 bits (279), Expect = 4e-26
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 570 FERTLGKGGFGTVYYG--RLNEIDVAVKML--SSSSAQGFQQFQAEVKLLMRVHHRNLTS 625
               LGKG F  V      L   + A  ++     SA+  Q+ + E ++   + H N+  
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCK 684
           L     E+    LI++ +  G L E +  ++++  S  +      +  + + + H  G  
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCIQQILEAVLHCHQMG-- 130

Query: 685 PPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
             +VHR++K  N+LL  KL+    KLADFGL+     +         AGTPGYL PE   
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPGYLSPEVLR 186

Query: 742 SNRLTEKSDVYSFGVVILEIITC 764
            +   +  D+++ G VIL I+  
Sbjct: 187 KDPYGKPVDLWACG-VILYILLV 208

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (273), Expect = 5e-26
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 28/213 (13%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLS--------SSSAQGFQQFQAEVKLLMRV 618
              +TLG G  G V     R     VA+K++S        +  A      + E+++L ++
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
           +H  +  +    D ++   ++ E M  G L + +  +  K L          +    ++Y
Sbjct: 73  NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQY 129

Query: 679 LH-NGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           LH NG    I+HRD+K  N+LL    E    K+ DFG SK       + + T+  GTP Y
Sbjct: 130 LHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTY 182

Query: 735 LDPE---YYTSNRLTEKSDVYSFGVVILEIITC 764
           L PE      +       D +S G VIL I   
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLG-VILFICLS 214

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  107 bits (270), Expect = 6e-26
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 23/209 (11%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVK------MLSSSSAQGFQQFQAEVKLLMRVHH 620
                LG G F  V     +    + A K      + SS      ++ + EV +L  + H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+ +L    +      LI E ++ G L ++L    K+ L+  E  +   +   G+ YLH
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLH 125

Query: 681 -NGCKPPIVHRDVKSTNILLNEKLQA----KLADFGLSKSFATDANTHVSTVVAGTPGYL 735
                  I H D+K  NI+L +K       KL DFG++     +A      +  GTP ++
Sbjct: 126 SKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF-GTPEFV 178

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITC 764
            PE      L  ++D++S G VI  I+  
Sbjct: 179 APEIVNYEPLGLEADMWSIG-VITYILLS 206

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  108 bits (272), Expect = 6e-26
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 23/209 (11%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLS------SSSAQGFQQFQAEVKLLMRVHH 620
           +    LG G F  V     +   ++ A K +       S      ++ + EV +L +V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+ +L    +      LI E ++ G L ++L    K+ LS +E      +   G+ YLH
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH 132

Query: 681 -NGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
                  I H D+K  NI+L +K       KL DFGL+     +       +  GTP ++
Sbjct: 133 TKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTPEFV 185

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITC 764
            PE      L  ++D++S G VI  I+  
Sbjct: 186 APEIVNYEPLGLEADMWSIG-VITYILLS 213

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  107 bits (269), Expect = 7e-26
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHRNLTS 625
            F+R LG G FG V+    R + ++  +K ++   S    +Q +AE+++L  + H N+  
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER--LRIAVESAQGLEYLH-NG 682
           +    ++ +   ++ E    G L E +     +  +  E     +  +    L Y H   
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144

Query: 683 CKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
               +VH+D+K  NIL    +     K+ DFGL++ F +D     ST  AGT  Y+ PE 
Sbjct: 145 ----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPEV 197

Query: 740 YTSNRLTEKSDVYSFGVVILEIITC 764
           +  + +T K D++S G V++  +  
Sbjct: 198 FKRD-VTFKCDIWSAG-VVMYFLLT 220

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  107 bits (270), Expect = 1e-25
 Identities = 62/320 (19%), Positives = 125/320 (39%), Gaps = 51/320 (15%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR-VHHRNLTS 625
             +  +G G +        +   ++ AVK++  S     +    E+++L+R   H N+ +
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIIT 80

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCK 684
           L    D+     ++ E M  G L + +  + +K  S +E   +     + +EYLH  G  
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVLFTITKTVEYLHAQG-- 136

Query: 685 PPIVHRDVKSTNILLNEKLQA----KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
             +VHRD+K +NIL  ++       ++ DFG +K    + N  + T    T  ++ PE  
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPC-YTANFVAPEVL 192

Query: 741 TSNRLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
                    D++S G V+L  +     P  +  ++  +  + +     I  G        
Sbjct: 193 ERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILAR-----IGSGKF------ 240

Query: 799 RLQEDFDANSVWKAV-----ELAMACLSPTGNQRPTMSQV-----VMELSECLAAEMARA 848
                      W +V     +L    L    +QR T + V     ++   +    ++ R 
Sbjct: 241 ----SLSGG-YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQ 295

Query: 849 NSGRGFHSKGSIDHLMMSMN 868
           ++      KG++     ++N
Sbjct: 296 DAPHLV--KGAMAATYSALN 313

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  108 bits (271), Expect = 2e-25
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 23/209 (11%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGF------QQFQAEVKLLMRVHH 620
           +    LG G F  V     +   ++ A K +    ++        ++ + EV +L +V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+ +L    +      LI E ++ G L ++L    K+ LS +E      +   G+ YLH
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH 132

Query: 681 -NGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
                  I H D+K  NI+L +K       KL DFGL+     +       +  GTP ++
Sbjct: 133 TKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTPEFV 185

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITC 764
            PE      L  ++D++S G VI  I+  
Sbjct: 186 APEIVNYEPLGLEADMWSIG-VITYILLS 213

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  107 bits (269), Expect = 2e-25
 Identities = 50/233 (21%), Positives = 96/233 (41%), Gaps = 20/233 (8%)

Query: 544 SKNKIDSFEAKSRHLSYSDVVKITNNFE---RTLGKGGFGTVYYG--RLNEIDVAVKML- 597
             +     +  + +L +  +    N +    + LG+G F  V     +    + A K L 
Sbjct: 4   HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63

Query: 598 -SSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI 655
                     +   E+ +L        + +L    +  ++  LI E+ A G +       
Sbjct: 64  KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123

Query: 656 SKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILL---NEKLQAKLADFG 711
             +++S  + +R+  +  +G+ YLH N     IVH D+K  NILL         K+ DFG
Sbjct: 124 LAEMVSENDVIRLIKQILEGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFG 179

Query: 712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC 764
           +S+         +  ++ GTP YL PE    + +T  +D+++ G +I  ++  
Sbjct: 180 MSRKI--GHACELREIM-GTPEYLAPEILNYDPITTATDMWNIG-IIAYMLLT 228

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (270), Expect = 2e-25
 Identities = 51/211 (24%), Positives = 80/211 (37%), Gaps = 26/211 (12%)

Query: 570 FERTLGKGGFGTVYYG--RLNEIDVAVKM-----LSSSSAQGFQQFQAEVKLLMRVHHRN 622
               +GKG F  V     R      AVK+      +SS     +  + E  +   + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER-----LRIAVESAQGLE 677
           +  L+     D    +++EFM   +L   +   +       E      +R  +E    L 
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---ALR 144

Query: 678 YLH-NGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
           Y H N     I+HRDVK   +LL         KL  FG++       +  V+    GTP 
Sbjct: 145 YCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPH 198

Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIITC 764
           ++ PE        +  DV+  G VIL I+  
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCG-VILFILLS 228

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  105 bits (263), Expect = 7e-25
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 15/205 (7%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLS----SSSAQGFQQFQAEVKLLMRVHHRNL 623
               LG+G +G V            AVK+L          G    + E++LL R+ H+N+
Sbjct: 9   MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68

Query: 624 TSL--VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
             L  V + +E  +  ++ E+     +QE L  + +K     +      +   GLEYLH+
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEY-CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS 127

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                IVH+D+K  N+LL      K++  G++++    A         G+P +  PE   
Sbjct: 128 QG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 742 SNRLTE--KSDVYSFGVVILEIITC 764
                   K D++S G V L  IT 
Sbjct: 185 GLDTFSGFKVDIWSAG-VTLYNITT 208

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (263), Expect = 1e-24
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 15/194 (7%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTS 625
             +T+GKG F  V   R  L   +VA+K++  +  +    Q+   EV+++  ++H N+  
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L    + +    LI E+ + G + +YL  ++   +  +E      +    ++Y H     
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKR-- 134

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            IVHRD+K+ N+LL+  +  K+ADFG S  F             G P Y  PE +   + 
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYAAPELF-QGKK 189

Query: 746 TE--KSDVYSFGVV 757
            +  + DV+S GV+
Sbjct: 190 YDGPEVDVWSLGVI 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  104 bits (262), Expect = 2e-24
 Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 43/277 (15%)

Query: 570 FERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
            E  LG+G    VY    +  +   A+K+L  +  +  +  + E+ +L+R+ H N+  L 
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLK 114

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPP 686
              +   + +L+ E +  G L + +  + K   S ++      +  + + YLH NG    
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLHENG---- 168

Query: 687 IVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
           IVHRD+K  N+L          K+ADFGLSK    +    + TV  GTPGY  PE     
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVC-GTPGYCAPEILRGC 225

Query: 744 RLTEKSDVYSFGVVILEIITC--KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ 801
               + D++S G +I  I+ C  +P      ++        +   I   +          
Sbjct: 226 AYGPEVDMWSVG-IITYILLCGFEPFYDERGDQF-------MFRRILNCEY--------- 268

Query: 802 EDFDANSVWKAV-----ELAMACLSPTGNQRPTMSQV 833
             F +   W  V     +L    +     +R T  Q 
Sbjct: 269 -YFISPW-WDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 2e-24
 Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 33/214 (15%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVK------MLSSSSAQGFQQFQAEVKLLMRVHH 620
           +    LG G F  V     +   +  A K        SS      +  + EV +L  + H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER-----LRIAVESAQG 675
            N+ +L    +      LI E +A G L ++L    K+ L+  E      L+  +    G
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLT--EEEATEFLKQILN---G 126

Query: 676 LEYLH-NGCKPPIVHRDVKSTNILLNEKLQA----KLADFGLSKSFATDANTHVSTVVAG 730
           + YLH       I H D+K  NI+L ++       K+ DFGL+     D       +  G
Sbjct: 127 VYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF-G 179

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC 764
           TP ++ PE      L  ++D++S G VI  I+  
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIG-VITYILLS 212

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  104 bits (262), Expect = 3e-24
 Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 33/250 (13%)

Query: 533 RKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--------RTLGKGGFGTVYY 584
            +R   K KR S   +D   A      +  V                  LG G FG V+ 
Sbjct: 49  TERMPVKSKRTSALAVDI-PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK 107

Query: 585 GRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF 642
                  + +A K++ +   +  ++ + E+ ++ ++ H NL  L    +  N   L+ E+
Sbjct: 108 CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167

Query: 643 MANGNLQEYLSDISKKVLSSQER-----LRIAVESAQGLEYLH-NGCKPPIVHRDVKSTN 696
           +  G   E    I  +  +  E      ++   E   G+ ++H       I+H D+K  N
Sbjct: 168 VDGG---ELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQMY----ILHLDLKPEN 217

Query: 697 ILLNEKLQA--KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSF 754
           IL   +     K+ DFGL++ +       +     GTP +L PE    + ++  +D++S 
Sbjct: 218 ILCVNRDAKQIKIIDFGLARRY--KPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSV 274

Query: 755 GVVILEIITC 764
           G VI  ++  
Sbjct: 275 G-VIAYMLLS 283

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  102 bits (257), Expect = 6e-24
 Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 51/295 (17%)

Query: 571 ERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLV 627
           E  LG+G    V      +   + AVK++         +   EV++L +   HRN+  L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDI-SKKVLSSQERLRIAVESAQGLEYLH-NGCKP 685
              +E+++  L++E M  G++   LS I  ++  +  E   +  + A  L++LH  G   
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG--- 131

Query: 686 PIVHRDVKSTNILL---NEKLQAKLADFGLSKSF-----ATDANTHVSTVVAGTPGYLDP 737
            I HRD+K  NIL    N+    K+ DF L          +  +T       G+  Y+ P
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 738 E-----YYTSNRLTEKSDVYSFGVVILEIITC---------KPAISRINEEEKIHIRQWV 783
           E        ++   ++ D++S G VIL I+                    E     +  +
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAV-----ELAMACLSPTGNQRPTMSQV 833
              I +G            +F     W  +     +L    L     QR + +QV
Sbjct: 250 FESIQEGKY----------EFPDKD-WAHISCAAKDLISKLLVRDAKQRLSAAQV 293

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  100 bits (252), Expect = 1e-23
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRNLTSL 626
             +TLG+G +G V      + E  VAVK++    A    +  + E+ +   ++H N+   
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKP 685
            GH  E N   L  E+ + G L + +       +   +  R   +   G+ YLH  G   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--- 125

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE     R 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRRE 183

Query: 746 --TEKSDVYSFGVV 757
              E  DV+S G+V
Sbjct: 184 FHAEPVDVWSCGIV 197

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  101 bits (254), Expect = 1e-23
 Identities = 69/276 (25%), Positives = 107/276 (38%), Gaps = 36/276 (13%)

Query: 571 ERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLV 627
           ++ LG+G F        + +    AVK++S       Q+   E+  L     H N+  L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPP 686
               +   T L+ E +  G L E +    KK  S  E   I  +    + ++H  G    
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMHDVG---- 126

Query: 687 IVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
           +VHRD+K  N+L    N+ L+ K+ DFG ++    D N  + T    T  Y  PE    N
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPC-FTLHYAAPELLNQN 184

Query: 744 RLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE 802
              E  D++S G VIL  +   +      +          +   I KGD           
Sbjct: 185 GYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---------- 233

Query: 803 DFDANSVWKAV-----ELAMACLSPTGNQRPTMSQV 833
            F+    WK V     +L    L+   N+R  MS +
Sbjct: 234 SFE-GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  101 bits (253), Expect = 1e-23
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 14/205 (6%)

Query: 569 NFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQ---AEVKLLMRVHHRNL 623
            F + LG+G F TV   R      + A+K+L         +      E  ++ R+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLH-N 681
             L     +D +      +  NG   E L  I K     +   R    E    LEYLH  
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNG---ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           G    I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP 766
                + SD+++ G +I +++   P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLP 230

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (254), Expect = 1e-23
 Identities = 38/206 (18%), Positives = 81/206 (39%), Gaps = 25/206 (12%)

Query: 569 NFERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
                LG+G FG V+      ++     K +           + E+ +L    HRN+  L
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHL 66

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQER-----LRIAVESAQGLEYLH- 680
               +   +  +I+EF++     +    I+       ER     +    E    L++LH 
Sbjct: 67  HESFESMEELVMIFEFISGL---DIFERINTSAFELNEREIVSYVHQVCE---ALQFLHS 120

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQA--KLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           +     I H D++  NI+   +  +  K+ +FG ++        +   +    P Y  PE
Sbjct: 121 HN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLF-TAPEYYAPE 173

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITC 764
            +  + ++  +D++S G  ++ ++  
Sbjct: 174 VHQHDVVSTATDMWSLG-TLVYVLLS 198

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  100 bits (250), Expect = 5e-23
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRNLTSL 626
             +TLG+G +G V      + E  VAVK++    A    +  + E+ +   ++H N+   
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKP 685
            GH  E N   L  E+ + G L + +       +   +  R   +   G+ YLH  G   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--- 125

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            I HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE     R 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRRE 183

Query: 746 --TEKSDVYSFGVV 757
              E  DV+S G+V
Sbjct: 184 FHAEPVDVWSCGIV 197

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 45/221 (20%)

Query: 572 RTLGKGGFGTVYYGRLNEID---VAVKMLSSSSAQGFQQFQA------------------ 610
             +GKG +G V     NE D    A+K+LS         F                    
Sbjct: 19  DEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 611 --------EVKLLMRVHHRNLTSLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISKKVL 660
                   E+ +L ++ H N+  LV   D+ N+  L  ++E +  G + E     + K L
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPL 134

Query: 661 SSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD 719
           S  +      +  +G+EYLH       I+HRD+K +N+L+ E    K+ADFG+S  F   
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KG 189

Query: 720 ANTHVSTVVAGTPGYLDPEYYTSNRLT---EKSDVYSFGVV 757
           ++  +S    GTP ++ PE  +  R     +  DV++ GV 
Sbjct: 190 SDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 26/203 (12%)

Query: 570 FERTLGKGGFGTVYYGRLNEID---VAVKML------SSSSAQGFQQFQAEVKLLMRVHH 620
               LG GGFG+VY G     D   VA+K +               +   EV LL +V  
Sbjct: 47  VGPLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 621 R--NLTSLVGHCDEDNQTALIYEFMAN-GNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
               +  L+   +  +   LI E      +L +++    +  L  +       +  + + 
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVR 163

Query: 678 YLH-NGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           + H  G    ++HRD+K  NIL++  + + KL DFG   +   D          GT  Y 
Sbjct: 164 HCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF---DGTRVYS 215

Query: 736 DPEYYTSNRLT-EKSDVYSFGVV 757
            PE+   +R     + V+S G++
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGIL 238

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 46/207 (22%), Positives = 74/207 (35%), Gaps = 21/207 (10%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVKML--------SSSSAQGFQQFQAEVKLLMRVHH 620
              LG G FG V+         +V VK +                 +   E+ +L RV H
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGN-LQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
            N+  ++   +      L+ E   +G  L  ++       L       I  +    + YL
Sbjct: 89  ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
                  I+HRD+K  NI++ E    KL DFG +         +      GT  Y  PE 
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEYCAPEV 200

Query: 740 YTSNRLT-EKSDVYSFGVVILEIITCK 765
              N     + +++S G V L  +  +
Sbjct: 201 LMGNPYRGPELEMWSLG-VTLYTLVFE 226

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 60/254 (23%), Positives = 100/254 (39%), Gaps = 36/254 (14%)

Query: 531 LKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLN 588
           L + + V    + ++  +     K   L   D       FE  + +G+G F  V   ++ 
Sbjct: 33  LAQDKYVADFLQWAEPIVV--RLKEVRLQRDD-------FEILKVIGRGAFSEVAVVKMK 83

Query: 589 EID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHC---DEDNQTALIY 640
           +     A+K+++            F+ E  +L+    R +T L  H    DE+    L+ 
Sbjct: 84  QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENY-LYLVM 140

Query: 641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVKSTNILL 699
           E+   G+L   LS   +++ +   R  +A E    ++ +H  G     VHRD+K  NILL
Sbjct: 141 EYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG----YVHRDIKPDNILL 195

Query: 700 NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVY------- 752
           +     +LADFG       D        V GTP YL PE   +      +  Y       
Sbjct: 196 DRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWW 254

Query: 753 SFGVVILEIITCKP 766
           + GV   E+   + 
Sbjct: 255 ALGVFAYEMFYGQT 268

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (252), Expect = 3e-22
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEIDV--AVKMLSSS---SAQGFQQFQAEVKLLMRVHH 620
           N F   R LGKGGFG V   ++       A K L        +G      E ++L +V+ 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 621 RNLTSLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLE 677
           R + SL      + + AL  +   M  G+L+ ++  + +     + R    A E   GLE
Sbjct: 244 RFVVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLE 300

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
            LH   +  IV+RD+K  NILL++    +++D GL+                GT GY+ P
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAP 354

Query: 738 EYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           E   + R T   D ++ G ++ E+I  + 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 53/204 (25%), Positives = 82/204 (40%), Gaps = 28/204 (13%)

Query: 571 ERTLGKGGFGTVYYGRLNEID---VAVKML------SSSSAQGFQQFQAEVKLLMRVH-- 619
              LGKGGFGTV+ G     D   VA+K++        S          EV LL +V   
Sbjct: 36  GPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94

Query: 620 --HRNLTSLVGHCDEDNQTALIYEFMANGN-LQEYLSDISKKVLSSQERLRIAVESAQGL 676
             H  +  L+   +      L+ E       L +Y+    K  L          +    +
Sbjct: 95  GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAI 152

Query: 677 EYLH-NGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           ++ H  G    +VHRD+K  NIL++  +  AKL DFG   +   D          GT  Y
Sbjct: 153 QHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDF---DGTRVY 204

Query: 735 LDPEYYTSNRLT-EKSDVYSFGVV 757
             PE+ + ++     + V+S G++
Sbjct: 205 SPPEWISRHQYHALPATVWSLGIL 228

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 99.1 bits (247), Expect = 5e-22
 Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 32/251 (12%)

Query: 531 LKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLN 588
           L+R++ + +    +K      + K   L   D       FE  + +G+G FG V   +L 
Sbjct: 46  LRREKNILEYLEWAKPFTS--KVKQMRLHRED-------FEILKVIGRGAFGEVAVVKLK 96

Query: 589 EID--VAVKMLSSSSAQGFQQ---FQAEVKLLMRVHHRNLTSLVGHC---DEDNQTALIY 640
             D   A+K+L+        +   F+ E  +L+    + +T+L  H    D++N   L+ 
Sbjct: 97  NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNN-LYLVM 153

Query: 641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN 700
           ++   G+L   LS    ++     R  +A E    ++ +H   +   VHRD+K  NIL++
Sbjct: 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMD 209

Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKS-----DVYSFG 755
                +LADFG       D     S  V GTP Y+ PE   +    +       D +S G
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLG 268

Query: 756 VVILEIITCKP 766
           V + E++  + 
Sbjct: 269 VCMYEMLYGET 279

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.5 bits (248), Expect = 8e-22
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 18/210 (8%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEIDV--AVKMLSSS---SAQGFQQFQAEVKLLMRVHH 620
           + F   R LG+GGFG V+  ++       A K L+       +G+Q    E K+L +VH 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 621 RNLTSLVGHCDEDNQTAL--IYEFMANGNLQEYLSDISKKVLS-SQERLRI-AVESAQGL 676
           R + SL      + +T L  +   M  G+++ ++ ++ +      + R      +   GL
Sbjct: 245 RFIVSL--AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           E+LH      I++RD+K  N+LL++    +++D GL+                GTPG++ 
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMA 357

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           PE           D ++ GV + E+I  + 
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARG 387

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 16/194 (8%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTS 625
             TLG G FG V  G   L    VAVK+L+     S     + + E++ L    H ++  
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L           ++ E+++ G L +Y+       +   E  R+  +    ++Y H     
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCHRHM-- 131

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            +VHRD+K  N+LL+  + AK+ADFGLS   +       S    G+P Y  PE   S RL
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVI-SGRL 186

Query: 746 TE--KSDVYSFGVV 757
               + D++S GV+
Sbjct: 187 YAGPEVDIWSCGVI 200

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 95.8 bits (238), Expect = 2e-21
 Identities = 59/270 (21%), Positives = 90/270 (33%), Gaps = 81/270 (30%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKML-SSSSAQGFQQFQAEVKLLMRV-HH 620
             + LG+G FG V       ID       VAVKML   ++    +   +E+K+L+ + HH
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 621 RNLTSLVGHC-DEDNQTALIYEFMANGNLQEYLSDISKKVL------------------- 660
            N+ +L+G C        +I EF   GNL  YL     + +                   
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 661 ------------SSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ---- 704
                       SSQ          + L  +     P  +++D  +   L+    Q    
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 705 --------------------------AKLADFGLSKSFATDANTHVSTVVAGTPGYLD-- 736
                                      K+ DFGL++    D        V      L   
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-----PDYVRKGDARLPLK 260

Query: 737 ---PEYYTSNRLTEKSDVYSFGVVILEIIT 763
              PE       T +SDV+SFGV++ EI +
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 30/287 (10%), Positives = 70/287 (24%), Gaps = 60/287 (20%)

Query: 571 ERTLGKGGFGTVYYG---RLNEIDVAVKMLSSSSA--QGFQQ-FQAEVKLLMRVHHRNLT 624
               G       +      L+   VA+  +           Q   +    L R+    + 
Sbjct: 36  LIFHGGVPPLQFWQALDTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGC 683
            ++          ++ E++  G+LQE          S    +R     A   +  H  G 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAG- 149

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              +       + + +                      +    VV   P  +        
Sbjct: 150 ---VALSIDHPSRVRV----------------------SIDGDVVLAYPATMPDA----- 179

Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK--SIVDPRLQ 801
               + D+   G  +  ++  +  +        +   +        G     + +D  + 
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----RDTAGQPIEPADIDRDIP 233

Query: 802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA 848
               A        +A   +   G  R   S ++  + +  A      
Sbjct: 234 FQISA--------VAARSVQGDGGIRSA-STLLNLMQQATAVADRTE 271

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.3 bits (235), Expect = 9e-21
 Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQQFQ---AEVKLLMRVHH 620
           ++FE  R +GKG FG V   + N+     A+K ++        + +    E++++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 621 RNLTSLVGHC---DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGL 676
             L +L       DE++   ++ + +  G+L+ +L    + V   +E +++   E    L
Sbjct: 75  PFLVNL--WYSFQDEED-MFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMAL 128

Query: 677 EYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           +YL        I+HRD+K  NILL+E     + DF ++     +      T +AGT  Y+
Sbjct: 129 DYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYM 181

Query: 736 DPEYYTSNRLTEKS---DVYSFGVVILEIITCKP 766
            PE ++S +    S   D +S GV   E++  + 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.6 bits (233), Expect = 1e-20
 Identities = 62/282 (21%), Positives = 105/282 (37%), Gaps = 49/282 (17%)

Query: 571 ERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLV 627
           ++ LG G  G V     R      A+K+L  S      + + EV    +     ++  ++
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88

Query: 628 G-HCDEDNQTALIY---EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NG 682
             + +  +    +    E M  G L   + +   +  + +E   I  +    +++LH + 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148

Query: 683 CKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
               I HRDVK  N+L     +    KL DFG +K    +A   + T    TP Y+ PE 
Sbjct: 149 ----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAPEV 200

Query: 740 YTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
               +  +  D++S G VI+ I+ C  P       +    I   +   I  G        
Sbjct: 201 LGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQA---ISPGMKRRIRLGQY------ 250

Query: 799 RLQEDFDANSVWKAV-ELA------MACLSPTGNQRPTMSQV 833
                F  N  W  V E A      +    P   +R T++Q 
Sbjct: 251 ----GFP-NPEWSEVSEDAKQLIRLLLKTDP--TERLTITQF 285

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 65/287 (22%), Positives = 105/287 (36%), Gaps = 56/287 (19%)

Query: 570 FERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSL 626
             + LG G  G V     +  +   A+KML         + + EV+L  R     ++  +
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120

Query: 627 VGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSS---QERLRIAVESAQGLEYL 679
           V   +          ++ E +  G   E  S I  +   +   +E   I     + ++YL
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGG---ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177

Query: 680 H-NGCKPPIVHRDVKSTNILLNEKLQA---KLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           H       I HRDVK  N+L   K      KL DFG +K     ++  ++T    TP Y+
Sbjct: 178 HSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPC-YTPYYV 230

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIITC-KP---AISRINEEEKIHIRQWVNSLIAKGD 791
            PE     +  +  D++S G VI+ I+ C  P   +   +     +  R      I  G 
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTR------IRMGQ 283

Query: 792 IKSIVDPRLQEDFDANSVWKAV-----ELAMACLSPTGNQRPTMSQV 833
                      +F  N  W  V      L    L     QR T+++ 
Sbjct: 284 Y----------EFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQ---AEVKLLMRVHH 620
           + F+  +TLG G FG V   +  E     A+K+L        +Q +    E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYL 679
             L  L     +++   ++ E++A G +  +L  I +    S+   R  A +     EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
           H+     +++RD+K  N+L++++   ++ DFG +K       T     + GTP  L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKP 766
             S    +  D ++ GV+I E+    P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 17/194 (8%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQG---FQQFQAEVKLLMRVHHRNLTS 625
             TLG+G FG V        +  VA+K +S    +      + + E+  L  + H ++  
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L           ++ E+ A G L +Y+  + KK ++  E  R   +    +EY H     
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCHRHK-- 128

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            IVHRD+K  N+LL++ L  K+ADFGLS           S    G+P Y  PE   + +L
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVI-NGKL 183

Query: 746 TE--KSDVYSFGVV 757
               + DV+S G+V
Sbjct: 184 YAGPEVDVWSCGIV 197

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.7 bits (228), Expect = 6e-20
 Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 16/193 (8%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            + +G G FG     R  L +  VAVK +   +A   +  Q E+     + H N+     
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKE 83

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
                   A+I E+ + G L E +   +    S  E      +   G+ Y H+     I 
Sbjct: 84  VILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSYCHSMQ---IC 138

Query: 689 HRDVKSTNILL--NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
           HRD+K  N LL  +   + K+ DFG SKS    +     + V GTP Y+ PE     +  
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEVL-LRQEY 194

Query: 747 E--KSDVYSFGVV 757
           +   +DV+S GV 
Sbjct: 195 DGKIADVWSCGVT 207

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.8 bits (233), Expect = 9e-20
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 35/228 (15%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEIDV--AVKMLSSS---SAQGFQQFQAEVKLLMRVH- 619
           N+F   R +G+GGFG VY  R  +     A+K L        QG      E  +L  V  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 620 --HRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVES 672
                +  +         T      I + M  G+L      +S+  + S+  +R  A E 
Sbjct: 249 GDCPFIVCMSYA----FHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMRFYAAEI 301

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVAGT 731
             GLE++H      +V+RD+K  NILL+E    +++D GL+  F+    +  V     GT
Sbjct: 302 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GT 353

Query: 732 PGYLDPEYYTSNRLTEKS-DVYSFGVVILEIITCKP---AISRINEEE 775
            GY+ PE        + S D +S G ++ +++            ++ E
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.5 bits (230), Expect = 9e-20
 Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 16/194 (8%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTS 625
             TLG G FG V  G+  L    VAVK+L+     S     + + E++ L    H ++  
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L       +   ++ E+++ G L +Y+       L  +E  R+  +   G++Y H     
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            +VHRD+K  N+LL+  + AK+ADFGLS   +       S    G+P Y  PE   S RL
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVI-SGRL 191

Query: 746 TE--KSDVYSFGVV 757
               + D++S GV+
Sbjct: 192 YAGPEVDIWSSGVI 205

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 66/258 (25%), Positives = 106/258 (41%), Gaps = 24/258 (9%)

Query: 531 LKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKIT-NNFE--RTLGKGGFGTVYYGRL 587
           LK++       R      +S   +          ++T N FE  + LGKG FG V   + 
Sbjct: 110 LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKE 169

Query: 588 NEIDV--AVKMLSSSSAQGFQQF---QAEVKLLMRVHHRNLTSLVGHCDEDNQTA----L 638
                  A+K+L         +      E ++L    H  LT+L        QT      
Sbjct: 170 KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL--KYS--FQTHDRLCF 225

Query: 639 IYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGCKPPIVHRDVKSTNI 697
           + E+   G L      +S++ + S++R R    E    L+YLH+  +  +V+RD+K  N+
Sbjct: 226 VMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENL 280

Query: 698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVV 757
           +L++    K+ DFGL K    D  T       GTP YL PE    N      D +  GVV
Sbjct: 281 MLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338

Query: 758 ILEIITCKPAISRINEEE 775
           + E++  +      + E+
Sbjct: 339 MYEMMCGRLPFYNQDHEK 356

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.5 bits (225), Expect = 3e-19
 Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 29/248 (11%)

Query: 531 LKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLN 588
           L++ + +       K+ I+  + +   +   D       +E  + +G+G FG V   R  
Sbjct: 41  LRKNKNIDNFLSRYKDTIN--KIRDLRMKAED-------YEVVKVIGRGAFGEVQLVRHK 91

Query: 589 EID--VAVKMLSSSSAQGFQQ---FQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM 643
                 A+K+LS            F  E  ++   +   +  L     +D    ++ E+M
Sbjct: 92  STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151

Query: 644 ANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK 702
             G+L   ++ +S   +  ++  R    E    L+ +H       +HRDVK  N+LL++ 
Sbjct: 152 PGGDL---VNLMSNYDVP-EKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS 204

Query: 703 LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK----SDVYSFGVVI 758
              KLADFG       +      T V GTP Y+ PE   S           D +S GV +
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263

Query: 759 LEIITCKP 766
            E++    
Sbjct: 264 YEMLVGDT 271

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.8 bits (221), Expect = 3e-19
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 19/208 (9%)

Query: 568 NNFER--TLGKGGFGTVYYGRL---NEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHH 620
             + +   LG+G + TVY G+    + + VA+K +     +G     A  EV LL  + H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAP-CTAIREVSLLKDLKH 59

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+ +L      +    L++E++ + +L++YL D    +++         +  +GL Y H
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 681 -NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
                  ++HRD+K  N+L+NE+ + KLADFGL+++ +    T+ + VV  T  Y  P+ 
Sbjct: 118 RQK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDI 171

Query: 740 -YTSNRLTEKSDVYSFGVVILEIITCKP 766
              S   + + D++  G +  E+ T +P
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRP 199

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 88.0 bits (219), Expect = 5e-19
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 21/208 (10%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQ---AEVKLLMRVHH 620
            +F+  RTLG G FG V+  R        A+K+L        +Q +    E  +L  V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYL 679
             +  + G   +  Q  +I +++  G L   L    K         +  A E    LEYL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYL 122

Query: 680 H-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           H       I++RD+K  NILL++    K+ DFG +K       T     + GTP Y+ PE
Sbjct: 123 HSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPE 173

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKP 766
             ++    +  D +SFG++I E++    
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYT 201

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 87.6 bits (218), Expect = 6e-19
 Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 32/217 (14%)

Query: 568 NNFER--TLGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHH 620
           + F++   LG G + TVY G         VA+K +   S +G     A  E+ L+  + H
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVY-VALKEVKLDSEEGTP-STAIREISLMKELKH 62

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV----LSSQERLRIAVESAQGL 676
            N+  L      +N+  L++EFM + +L++Y+   +       L          +  QGL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            + H      I+HRD+K  N+L+N++ Q KL DFGL+++F    NT  S VV  T  Y  
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176

Query: 737 PE-------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
           P+       Y TS       D++S G ++ E+IT KP
Sbjct: 177 PDVLMGSRTYSTS------IDIWSCGCILAEMITGKP 207

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.8 bits (216), Expect = 9e-19
 Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)

Query: 568 NNFER--TLGKGGFGTVYYGR--LNEIDVAVKMLS-SSSAQGFQQFQA--EVKLLMRVHH 620
             +     +G+G +G VY  +    E   A+K +      +G        E+ +L  + H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIP-STTIREISILKELKH 59

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+  L        +  L++E + + +L++ L D+ +  L S       ++   G+ Y H
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-- 738
           +     ++HRD+K  N+L+N + + K+ADFGL+++F      +   +V  T  Y  P+  
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVL 172

Query: 739 -----YYTSNRLTEKSDVYSFGVVILEIITCKP 766
                Y T+       D++S G +  E++   P
Sbjct: 173 MGSKKYSTT------IDIWSVGCIFAEMVNGTP 199

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.8 bits (216), Expect = 1e-18
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 31/214 (14%)

Query: 568 NNFER--TLGKGGFGTVYYGR--LNEIDVAVKMLS-SSSAQGFQQFQA--EVKLLMRVHH 620
             +++   +G+G +G VY  +     I VA+K +   +  +G     A  E+ LL  +HH
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIP-STAIREISLLKELHH 78

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+ SL+     +    L++EFM   +L++ L +    +  SQ ++    +  +G+ + H
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI-YLYQLLRGVAHCH 136

Query: 681 -NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE- 738
            +     I+HRD+K  N+L+N     KLADFGL+++F     ++   VV  T  Y  P+ 
Sbjct: 137 QHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDV 190

Query: 739 ------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
                 Y TS       D++S G +  E+IT KP
Sbjct: 191 LMGSKKYSTS------VDIWSIGCIFAEMITGKP 218

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.8 bits (216), Expect = 1e-18
 Identities = 51/220 (23%), Positives = 97/220 (44%), Gaps = 38/220 (17%)

Query: 566 ITNNFER--TLGKGGFGTVYYGR---LNEIDVAVK-MLSSSSAQGFQQFQA--EVKLLMR 617
           +   +E+   +G+G +G V+  R     +I VA+K  L S      +   A  E+++L +
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQI-VAIKKFLESEDDPVIK-KIALREIRMLKQ 58

Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
           + H NL +L+       +  L++E+  +  +   L D  ++ +       I  ++ Q + 
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVN 116

Query: 678 YLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA--TDANTH-VST------- 726
           + H +      +HRDVK  NIL+ +    KL DFG ++     +D     V+T       
Sbjct: 117 FCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172

Query: 727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           ++ G     D +Y          DV++ G V  E+++  P
Sbjct: 173 LLVG-----DTQYGPP------VDVWAIGCVFAELLSGVP 201

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 32/215 (14%)

Query: 568 NNFER--TLGKGGFGTVYYGR---LNEIDVAVK-MLSSSSAQGFQQFQA--EVKLLMRVH 619
             +E    +G+G +G V   R      I VA+K  L S   +  +   A  E+KLL ++ 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRI-VAIKKFLESDDDKMVK-KIAMREIKLLKQLR 82

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           H NL +L+  C +  +  L++EF+ +  + + L      +     + +   +   G+ + 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQ-KYLFQIINGIGFC 140

Query: 680 H-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           H +     I+HRD+K  NIL+++    KL DFG +++ A     +   V   T  Y  PE
Sbjct: 141 HSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPE 194

Query: 739 -------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
                  Y  +       DV++ G ++ E+   +P
Sbjct: 195 LLVGDVKYGKA------VDVWAIGCLVTEMFMGEP 223

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 45/229 (19%)

Query: 562 DVVKITNNFER--TLGKGGFGTVYYGRL---NEIDVAVKML----SSSSAQGFQQFQA-- 610
           DV      +E+   LG+G F TVY  R    N+I VA+K +     S +  G     A  
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGIN-RTALR 61

Query: 611 EVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
           E+KLL  + H N+  L+      +  +L+++FM   +L+  + D S  +  S       +
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSH------I 114

Query: 671 ES-----AQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
           ++      QGLEYLH +     I+HRD+K  N+LL+E    KLADFGL+KSF +    + 
Sbjct: 115 KAYMLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170

Query: 725 STVVAGTPGYLDPE-------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
             VV  T  Y  PE       Y          D+++ G ++ E++   P
Sbjct: 171 HQVV--TRWYRAPELLFGARMYGVG------VDMWAVGCILAELLLRVP 211

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 40/224 (17%)

Query: 568 NNFER--TLGKGGFGTVYYGR---LNEIDVAVKMLS-SSSAQGFQQFQA----EVKLLMR 617
           + +E    +G G +GTVY  R        VA+K +   +   G          EV LL R
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHF-VALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 618 VH---HRNLTSL--VGHCDEDNQTALIY---EFMANGNLQEYLSDISKKVLSSQERLRIA 669
           +    H N+  L  V      ++   +    E +   +L+ YL       L ++    + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126

Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVV 728
            +  +GL++LH  C   IVHRD+K  NIL+      KLADFGL++ ++     T V  VV
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV 181

Query: 729 AGTPGYLDPE------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
             T  Y  PE      Y T        D++S G +  E+   KP
Sbjct: 182 --TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRKP 217

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 27/225 (12%)

Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQF---QAEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L         +      E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 617 RVHHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVE 671
              H  LT+L        QT      + E+   G L      +S++ + ++ER R    E
Sbjct: 61  NTRHPFLTAL--KYA--FQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE 113

Query: 672 SAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
               LEYLH       +V+RD+K  N++L++    K+ DFGL K   +D  T       G
Sbjct: 114 IVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 167

Query: 731 TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           TP YL PE    N      D +  GVV+ E++  +      + E 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.5 bits (210), Expect = 5e-18
 Identities = 55/229 (24%), Positives = 106/229 (46%), Gaps = 34/229 (14%)

Query: 568 NNFER--TLGKGGFGTVYYGR---LNEIDVAVKMLS-SSSAQGFQQFQA--EVKLLMRVH 619
             +E+   +G+G +GTV+  +    +EI VA+K +      +G     A  E+ LL  + 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEI-VALKRVRLDDDDEGVP-SSALREICLLKELK 59

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES-----AQ 674
           H+N+  L      D +  L++EF  + +L++Y    +  +          V+S      +
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEI------VKSFLFQLLK 112

Query: 675 GLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
           GL + H       ++HRD+K  N+L+N   + KLA+FGL+++F      + + VV  T  
Sbjct: 113 GLGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLW 166

Query: 734 YLDPEY-YTSNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKI 777
           Y  P+  + +   +   D++S G +  E+        P     ++ ++I
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 84.9 bits (211), Expect = 7e-18
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 28/214 (13%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEIDV-----AVKMLSSSSAQGFQQFQ--AEVKLLMRV 618
           + FE  + LG+G FG V+  +           A+K+L  ++ +   + +   E  +L+ V
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 619 HHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESA 673
           +H  +  L  H     QT     LI +F+  G+L   LS   K+V+ ++E ++    E A
Sbjct: 84  NHPFIVKL--HYA--FQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELA 136

Query: 674 QGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
             L++LH  G    I++RD+K  NILL+E+   KL DFGLSK          +    GT 
Sbjct: 137 LALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTV 190

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
            Y+ PE       T+ +D +SFGV++ E++T   
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 40/223 (17%)

Query: 568 NNFER--TLGKGGFGTVYYGR----LNEIDVAVKMLS-SSSAQGFQQFQA--EVKLLMRV 618
             +E    +G+G +G V+  R         VA+K +   +  +G        EV +L  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRF-VALKRVRVQTGEEGMP-LSTIREVAVLRHL 68

Query: 619 H---HRNLTSL-----VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
               H N+  L     V   D + +  L++E + + +L  YL  + +  + ++    +  
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127

Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN-THVSTVVA 729
           +  +GL++LH+     +VHRD+K  NIL+    Q KLADFGL++ ++     T V  VV 
Sbjct: 128 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV- 181

Query: 730 GTPGYLDPE------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
            T  Y  PE      Y T        D++S G +  E+   KP
Sbjct: 182 -TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRKP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 83.5 bits (207), Expect = 3e-17
 Identities = 67/236 (28%), Positives = 99/236 (41%), Gaps = 30/236 (12%)

Query: 543 ESKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDV--AVKMLSSS 600
               +I+   + + H   SD      +F + +GKG FG V   R    +V  AVK+L   
Sbjct: 20  APSQQINLGPSSNPHAKPSDF-----HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKK 74

Query: 601 SAQGFQQF---QAEVK-LLMRVHHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYL 652
           +    ++     +E   LL  V H  L  L  H     QTA     + +++  G L    
Sbjct: 75  AILKKKEEKHIMSERNVLLKNVKHPFLVGL--HFS--FQTADKLYFVLDYINGGEL---F 127

Query: 653 SDISKKVLSSQERLRI-AVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADF 710
             + ++    + R R  A E A  L YLH       IV+RD+K  NILL+ +    L DF
Sbjct: 128 YHLQRERCFLEPRARFYAAEIASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDF 183

Query: 711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           GL K      +T  ++   GTP YL PE           D +  G V+ E++   P
Sbjct: 184 GLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 83.1 bits (206), Expect = 4e-17
 Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 39/248 (15%)

Query: 539 KVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEIDV---- 592
            +  + + +  +    +  +   +       FE  + LG G +G V+  R          
Sbjct: 32  LLTVKHELRTANLTGHAEKVGIEN-------FELLKVLGTGAYGKVFLVRKISGHDTGKL 84

Query: 593 -AVKMLSSSS----AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTA----LIYEF 642
            A+K+L  ++    A+  +  + E ++L  +     L +L  H     QT     LI ++
Sbjct: 85  YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL--HYA--FQTETKLHLILDY 140

Query: 643 MANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLH-NGCKPPIVHRDVKSTNILLN 700
           +  G L  +LS   ++   ++  ++I   E    LE+LH  G    I++RD+K  NILL+
Sbjct: 141 INGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG----IIYRDIKLENILLD 193

Query: 701 EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL--TEKSDVYSFGVVI 758
                 L DFGLSK F  D          GT  Y+ P+          +  D +S GV++
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252

Query: 759 LEIITCKP 766
            E++T   
Sbjct: 253 YELLTGAS 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 53/220 (24%), Positives = 82/220 (37%), Gaps = 40/220 (18%)

Query: 572 RTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQ--FQA---------EVKLLMRVH 619
           R +  G +G V  G  +E I VA+K + ++ + G                 E++LL   H
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 620 HRNLTSLV-----GHCDEDNQTALIYEFMANGNL-------QEYLSDISKKVLSSQERLR 667
           H N+  L            ++  L+ E M   +L       +  +S    +       L 
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH-ILL 145

Query: 668 IAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
                  GL  LH      +VHRD+   NILL +     + DF L++    DAN    T 
Sbjct: 146 -------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTH 192

Query: 728 VAGTPGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
                 Y  PE        T+  D++S G V+ E+   K 
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.7 bits (207), Expect = 6e-17
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLLMRVHHRNL 623
           + +G G  G V   Y  + + +VA+K LS    + FQ Q  A     E+ L+  V+H+N+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLS----RPFQNQTHAKRAYRELVLMKCVNHKNI 123

Query: 624 TSLV------GHCDEDNQTALIYEFMA---NGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
            SL+         +E     L+ E M       +Q  L       L  Q  L        
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ-MLC------- 175

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGY 734
           G+++LH+     I+HRD+K +NI++      K+ DFGL+++  T     + T    T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 229

Query: 735 LDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
             PE        E  D++S G ++ E++  K 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 82.2 bits (204), Expect = 6e-17
 Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 37/235 (15%)

Query: 549 DSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEIDV-----AVKMLSSSS 601
            S       +           FE  R LGKGG+G V+  R           A+K+L  + 
Sbjct: 5   TSVNRGPEKIRPEC-------FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM 57

Query: 602 ----AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLS 653
               A+     +AE  +L  V H  +  L        QT     LI E+++ G L     
Sbjct: 58  IVRNAKDTAHTKAERNILEEVKHPFIVDL--IYA--FQTGGKLYLILEYLSGGEL---FM 110

Query: 654 DISKKVLSSQERLRI-AVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFG 711
            + ++ +  ++       E +  L +LH  G    I++RD+K  NI+LN +   KL DFG
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFG 166

Query: 712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           L K    D     +    GT  Y+ PE    +      D +S G ++ +++T  P
Sbjct: 167 LCKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 84.3 bits (208), Expect = 7e-17
 Identities = 65/254 (25%), Positives = 109/254 (42%), Gaps = 24/254 (9%)

Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITN-NFERTLGKGGFGTVYYGRLNEID- 591
           + ++G+  +  + K  +  +K  +    D +K+T+ NF   LGKG FG V        D 
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367

Query: 592 -VAVKMLSSSSAQGFQQF---QAEVKLLMRV-HHRNLTSLVGHCDEDNQTA----LIYEF 642
             AVK+L                E ++L        LT L  H     QT      + E+
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL--HSC--FQTMDRLYFVMEY 423

Query: 643 MANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE 701
           +  G+L   +  I +     +      A E A GL +L       I++RD+K  N++L+ 
Sbjct: 424 VNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDS 477

Query: 702 KLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEI 761
           +   K+ADFG+ K    D  T  +    GTP Y+ PE        +  D ++FGV++ E+
Sbjct: 478 EGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535

Query: 762 ITCKPAISRINEEE 775
           +  +      +E+E
Sbjct: 536 LAGQAPFEGEDEDE 549

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 39/221 (17%)

Query: 566 ITNNFE--RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLL 615
           +   ++  + +G G  G V   Y  + E +VA+K LS    + FQ Q  A     E+ L+
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS----RPFQNQTHAKRAYRELVLM 78

Query: 616 MRVHHRNLTSLV------GHCDEDNQTALIYEFMANGNLQEY----LSDISKKVLSSQER 665
             V+H+N+  L+         +E     ++ E M + NL +     L       L  Q  
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQ-M 136

Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           L        G+++LH+     I+HRD+K +NI++      K+ DFGL+++  T     + 
Sbjct: 137 LC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMM 183

Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           T    T  Y  PE        E  D++S G ++ E+I    
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 568 NNFER--TLGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQ-GFQQFQA--EVKLLMRVH 619
           + + R   LG+G +G VY       NE  VA+K +     + G     A  EV LL  + 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNET-VAIKRIRLEHEEEGVP-GTAIREVSLLKELQ 91

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
           HRN+  L      +++  LI+E+  N +L++Y+       +S +       +   G+ + 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFC 148

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQA-----KLADFGLSKSFATDANTHVSTVVAGTPGY 734
           H       +HRD+K  N+LL+    +     K+ DFGL+++F          ++  T  Y
Sbjct: 149 H---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWY 203

Query: 735 LDPE-------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
             PE       Y TS       D++S   +  E++   P
Sbjct: 204 RPPEILLGSRHYSTS------VDIWSIACIWAEMLMKTP 236

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 70/237 (29%), Positives = 103/237 (43%), Gaps = 26/237 (10%)

Query: 552 EAKSRHLSYSDVVKITN-NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQF 608
           E     ++ S+ + I N  F R LGKG FG V   R+ E     AVK+L           
Sbjct: 8   EGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV 67

Query: 609 ---QAEVKLLMRV-HHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVL 660
                E ++L    +H  LT L   C    QT      + EF+  G+L   +  I K   
Sbjct: 68  ECTMTEKRILSLARNHPFLTQL--FCC--FQTPDRLFFVMEFVNGGDL---MFHIQKSRR 120

Query: 661 SSQERLRI-AVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT 718
             + R R  A E    L +LH  G    I++RD+K  N+LL+ +   KLADFG+ K    
Sbjct: 121 FDEARARFYAAEIISALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176

Query: 719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           +  T  +T   GTP Y+ PE           D ++ GV++ E++         NE++
Sbjct: 177 NGVT-TATFC-GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 79.6 bits (197), Expect = 5e-16
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 26/219 (11%)

Query: 561 SDVVKITN-NFERTLGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQQF---QAEVKL 614
            D + + + +  R +G+G +  V   RL + D   A+K++        +     Q E  +
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 615 LMRV-HHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRI- 668
             +  +H  L  L  H     QT      + E++  G+L   +  + ++    +E  R  
Sbjct: 63  FEQASNHPFLVGL--HSC--FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFY 115

Query: 669 AVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV 727
           + E +  L YLH  G    I++RD+K  N+LL+ +   KL D+G+ K      +T  ST 
Sbjct: 116 SAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTF 170

Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
             GTP Y+ PE           D ++ GV++ E++  + 
Sbjct: 171 C-GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 5e-16
 Identities = 53/231 (22%), Positives = 88/231 (38%), Gaps = 49/231 (21%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQ------AEVKL 614
           K  + F+  R  G+G FGTV  G+       VA+K +        Q  +        ++ 
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQIMQD 72

Query: 615 LMRVHHRNLTSLVGHC--------DEDNQTALIYEFM---------ANGNLQEYLSDISK 657
           L  +HH N+  L              D    ++ E++              Q     I  
Sbjct: 73  LAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSF 716
           KV   Q  +R        +  LH      + HRD+K  N+L+NE     KL DFG +K  
Sbjct: 132 KVFLFQ-LIR-------SIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 717 ATDANTHVSTVVAGTPGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
           +     +V+ +   +  Y  PE  + +   T   D++S G +  E++  +P
Sbjct: 183 SPS-EPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.2 bits (198), Expect = 6e-16
 Identities = 39/195 (20%), Positives = 79/195 (40%), Gaps = 35/195 (17%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQQFQA------EVKLLMRVHHRNL 623
             +G+G +G VY  Y +  E +VA+K ++      F+          E+ +L R+    +
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM----FEDLIDCKRILREITILNRLKSDYI 87

Query: 624 TSLV-----GHCDEDNQTALIYEFMANGNL------QEYLSDISKKVLSSQERLRIAVES 672
             L          + ++  ++ E   + +L        +L++   K +     L      
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYN-LLL----- 140

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
             G  ++H      I+HRD+K  N LLN+    K+ DFGL+++  ++ +T++   +    
Sbjct: 141 --GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 733 GYLDPEYYTSNRLTE 747
                      +LT 
Sbjct: 196 EPGPHNKNLKKQLTS 210

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLLMRVHHRNL 623
             +G G +G+V     + +   VA+K LS    + FQ +  A     E+ LL  + H N+
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLS----RPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 624 TSLV------GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
             L+                L+  FM     Q  L  I     S ++   +  +  +GL+
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQMLKGLK 140

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           Y+H+     +VHRD+K  N+ +NE  + K+ DFGL++    +   +V T       Y  P
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAP 192

Query: 738 E-YYTSNRLTEKSDVYSFGVVILEIITCKP 766
           E   +     +  D++S G ++ E++T K 
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 79.2 bits (196), Expect = 6e-16
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 25/219 (11%)

Query: 569 NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQF---QAEVKLLMRV-HHRN 622
           NF   LGKG FG V        D   AVK+L                E ++L        
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82

Query: 623 LTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQGLE 677
           LT L  H     QT      + E++  G+L   +  I +     +      A E A GL 
Sbjct: 83  LTQL--HSC--FQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 678 YLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
           +L   G    I++RD+K  N++L+ +   K+ADFG+ K    D  T  +    GTP Y+ 
Sbjct: 136 FLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIA 189

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
           PE        +  D ++FGV++ E++  +      +E+E
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 78.3 bits (194), Expect = 8e-16
 Identities = 25/82 (30%), Positives = 48/82 (58%), Gaps = 2/82 (2%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++ YL ++ + + G I  ++S + +L  LD S N L+G++P  +S LP L  +   GN+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160

Query: 466 LNGSVPVELLERSKNG-SLSLS 486
           ++G++P      SK   S+++S
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTIS 182

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 29/109 (26%)

Query: 394 WDGLNCSYGDSSSPRITYLNLSSSGLK---------------------------GDITSY 426
           W G+ C   D+ + R+  L+LS   L                            G I   
Sbjct: 38  WLGVLCD-TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96

Query: 427 VSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVEL 474
           ++ LT L +L +++ N++G++PDFLS++  L TL+   N L+G++P  +
Sbjct: 97  IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 1/84 (1%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSL-QFLDLSNNNLTGSVPDFLSKLPLRTLNLQ 462
           SS P +  +    + + G I     + + L   + +S N LTG +P   + L L  ++L 
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS 205

Query: 463 GNKLNGSVPVELLERSKNGSLSLS 486
            N L G   V          + L+
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLA 229

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 70.6 bits (174), Expect = 3e-13
 Identities = 24/108 (22%), Positives = 45/108 (41%), Gaps = 21/108 (19%)

Query: 409 ITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNG 468
           + +++LS + L+GD +    +  + Q + L+ N+L   +        L  L+L+ N++ G
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258

Query: 469 SVPVEL-----LER---SKN---------GSLS----LSVGGNPGLCS 495
           ++P  L     L     S N         G+L      +   N  LC 
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 56.4 bits (137), Expect = 1e-08
 Identities = 15/62 (24%), Positives = 27/62 (43%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQG 463
             S  +  L+L ++ + G +   ++ L  L  L++S NNL G +P   +           
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN 300

Query: 464 NK 465
           NK
Sbjct: 301 NK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 47.1 bits (113), Expect = 1e-05
 Identities = 18/67 (26%), Positives = 28/67 (41%), Gaps = 4/67 (5%)

Query: 412 LNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGS--VPDFLSKLP-LRTLNLQG-NKLN 467
            +  +    G +    +    +  LDLS  NL     +P  L+ LP L  L + G N L 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 468 GSVPVEL 474
           G +P  +
Sbjct: 91  GPIPPAI 97

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 81.1 bits (201), Expect = 8e-16
 Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 5/91 (5%)

Query: 402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
             +    +  L L ++G  G I   +SN + L  L LS N L+G++P  L  L  LR L 
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448

Query: 461 LQGNKLNGSVPVELLERSKNGSL-SLSVGGN 490
           L  N L G +P EL       +L +L +  N
Sbjct: 449 LWLNMLEGEIPQEL---MYVKTLETLILDFN 476

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 78.4 bits (194), Expect = 5e-15
 Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 4/85 (4%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF-LSKLPLRTLNLQ 462
                + +L++S + L GD +  +S  T L+ L++S+N   G +P   L    L+ L+L 
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS--LQYLSLA 277

Query: 463 GNKLNGSVPVELLERSKN-GSLSLS 486
            NK  G +P  L         L LS
Sbjct: 278 ENKFTGEIPDFLSGACDTLTGLDLS 302

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 78.0 bits (193), Expect = 7e-15
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 15/96 (15%)

Query: 381 NWQG--DPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLK---GDITSYVSNLTSLQF 435
           +W    +PC      +DG+ C        ++T ++LSS  L      ++S + +LT L+ 
Sbjct: 32  DWSSNKNPCT-----FDGVTCRDD-----KVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81

Query: 436 LDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVP 471
           L LSN+++ GSV  F     L +L+L  N L+G V 
Sbjct: 82  LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVT 117

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 78.0 bits (193), Expect = 7e-15
 Identities = 27/72 (37%), Positives = 41/72 (56%), Gaps = 1/72 (1%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
                +  L L  + L G+I S +SN T+L ++ LSNN LTG +P ++ +L  L  L L 
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522

Query: 463 GNKLNGSVPVEL 474
            N  +G++P EL
Sbjct: 523 NNSFSGNIPAEL 534

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.9 bits (190), Expect = 1e-14
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 5/92 (5%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVS--NLTSLQFLDLSNNNLTGSVPD-FLSKLP-LRTL 459
             S  +T L+LS + L G +T+  S  + + L+FL++S+N L          KL  L  L
Sbjct: 97  KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156

Query: 460 NLQGNKLNGSVPVELLERSKNGSL-SLSVGGN 490
           +L  N ++G+  V  +     G L  L++ GN
Sbjct: 157 DLSANSISGANVVGWVLSDGCGELKHLAISGN 188

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.5 bits (189), Expect = 2e-14
 Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 4/87 (4%)

Query: 409 ITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN 467
           +  LNL  + + G I   V +L  L  LDLS+N L G +P  +S L  L  ++L  N L+
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717

Query: 468 GSVPVELLERSKNGSLSLSVGGNPGLC 494
           G +P      +   +       NPGLC
Sbjct: 718 GPIPEMGQFETFPPA---KFLNNPGLC 741

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.5 bits (189), Expect = 2e-14
 Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 3/87 (3%)

Query: 407 PRITYLNLSSSGLKGDI-TSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP--LRTLNLQG 463
             +  L LSS+   G++    +  +  L+ LDLS N  +G +P+ L+ L   L TL+L  
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377

Query: 464 NKLNGSVPVELLERSKNGSLSLSVGGN 490
           N  +G +   L +  KN    L +  N
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNN 404

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.5 bits (189), Expect = 2e-14
 Identities = 25/87 (28%), Positives = 40/87 (45%), Gaps = 3/87 (3%)

Query: 403 DSSSPRITYLNLSSSGLKGDI-TSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
                 + YL+L+ +   G+I         +L  LDLS N+  G+VP F      L +L 
Sbjct: 265 PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLA 324

Query: 461 LQGNKLNGSVPVELLERSKN-GSLSLS 486
           L  N  +G +P++ L + +    L LS
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLS 351

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 75.7 bits (187), Expect = 3e-14
 Identities = 23/72 (31%), Positives = 40/72 (55%), Gaps = 4/72 (5%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
                + +L +S + + GD+   VS   +L+FLD+S+NN +  +P FL     L+ L++ 
Sbjct: 175 DGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDIS 231

Query: 463 GNKLNGSVPVEL 474
           GNKL+G     +
Sbjct: 232 GNKLSGDFSRAI 243

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.9 bits (185), Expect = 5e-14
 Identities = 24/84 (28%), Positives = 45/84 (53%), Gaps = 1/84 (1%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG 468
            +++LS++ L G+I  ++  L +L  L LSNN+ +G++P  L     L  L+L  N  NG
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552

Query: 469 SVPVELLERSKNGSLSLSVGGNPG 492
           ++P  + ++S   + +   G    
Sbjct: 553 TIPAAMFKQSGKIAANFIAGKRYV 576

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.9 bits (185), Expect = 6e-14
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
            S  ++  L L  + L+G+I   +  + +L+ L L  N+LTG +P  LS    L  ++L 
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498

Query: 463 GNKLNGSVPVELLERSKNGSLS-LSVGGN 490
            N+L G +P  +    +  +L+ L +  N
Sbjct: 499 NNRLTGEIPKWI---GRLENLAILKLSNN 524

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.6 bits (184), Expect = 7e-14
 Identities = 27/86 (31%), Positives = 47/86 (54%), Gaps = 3/86 (3%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNL 461
            +   +T L+LS +   G +  +  + + L+ L LS+NN +G +P D L K+  L+ L+L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350

Query: 462 QGNKLNGSVPVELLERSKN-GSLSLS 486
             N+ +G +P  L   S +  +L LS
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLS 376

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.6 bits (184), Expect = 8e-14
 Identities = 23/72 (31%), Positives = 37/72 (51%), Gaps = 1/72 (1%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           +        N++S    G  +    N  S+ FLD+S N L+G +P  +  +P L  LNL 
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664

Query: 463 GNKLNGSVPVEL 474
            N ++GS+P E+
Sbjct: 665 HNDISGSIPDEV 676

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.2 bits (178), Expect = 5e-13
 Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSN--LTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           S  +  L+LSS+   G I   +      +LQ L L NN  TG +P  LS    L +L+L 
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426

Query: 463 GNKLNGSVPVELLERSKNGSLSLS 486
            N L+G++P  L   SK   L L 
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLW 450

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.9 bits (177), Expect = 5e-13
 Identities = 29/100 (29%), Positives = 42/100 (42%), Gaps = 10/100 (10%)

Query: 396 GLNCSYGDSSS-----PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF 450
            LN  +   SS       +  L LS+S + G ++       SL  LDLS N+L+G V   
Sbjct: 61  PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTL 119

Query: 451 --LSKLP-LRTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
             L     L+ LN+  N L+    V    +  +   L LS
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 69.9 bits (172), Expect = 2e-12
 Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 4/84 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLT-SLQFLDLSNNNLTGSVPDFLSKLP---LRTLNLQ 462
             +  L+LS +   G++   ++NL+ SL  LDLS+NN +G +   L + P   L+ L LQ
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402

Query: 463 GNKLNGSVPVELLERSKNGSLSLS 486
            N   G +P  L   S+  SL LS
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLS 426

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.0 bits (167), Expect = 9e-12
 Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 3/87 (3%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQG 463
                +  L LS++   G+I + + +  SL +LDL+ N   G++P  + K    +  +  
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ---SGKIAA 567

Query: 464 NKLNGSVPVELLERSKNGSLSLSVGGN 490
           N + G   V +           +    
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLL 594

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 1e-11
 Identities = 23/74 (31%), Positives = 36/74 (48%), Gaps = 5/74 (6%)

Query: 407 PRITYLNLSSSGLKGDI-TSYVSNLTSLQFLDLSNNNLTGSVPD---FLSKLP-LRTLNL 461
             + +LN+SS+ L      S    L SL+ LDLS N+++G+             L+ L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185

Query: 462 QGNKLNGSVPVELL 475
            GNK++G V V   
Sbjct: 186 SGNKISGDVDVSRC 199

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 65.3 bits (160), Expect = 6e-11
 Identities = 9/76 (11%), Positives = 29/76 (38%), Gaps = 1/76 (1%)

Query: 400 SYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRT 458
              +    +  +   +    +G  +  ++ L++    ++++    G           +  
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636

Query: 459 LNLQGNKLNGSVPVEL 474
           L++  N L+G +P E+
Sbjct: 637 LDMSYNMLSGYIPKEI 652

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 78.8 bits (195), Expect = 9e-16
 Identities = 65/237 (27%), Positives = 98/237 (41%), Gaps = 26/237 (10%)

Query: 552 EAKSRHLSYSDVVKITN-NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQF 608
           E      S    +KI +    + LGKG FG V+     + +   A+K L           
Sbjct: 2   ELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 61

Query: 609 ---QAEVKLLMRV-HHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVL 660
                E ++L     H  LT +   C    QT      + E++  G+L   +  I     
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHM--FCT--FQTKENLFFVMEYLNGGDL---MYHIQSCHK 114

Query: 661 SSQERLRI-AVESAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT 718
               R    A E   GL++LH  G    IV+RD+K  NILL++    K+ADFG+ K    
Sbjct: 115 FDLSRATFYAAEIILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170

Query: 719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE 775
                 +T   GTP Y+ PE     +     D +SFGV++ E++  +      +EEE
Sbjct: 171 GDAK-TNTFC-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.5 bits (194), Expect = 2e-15
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 46/219 (21%)

Query: 571 ERTLGKGGFGTVYYGRLNEID-VAVKMLSSSSAQGFQQFQA-EVKLLMRVHHRNLTSL-- 626
            + +G G FG V+  +L E D VA+K +        ++F+  E++++  V H N+  L  
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKA 99

Query: 627 ----VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES-----AQGLE 677
                G   ++    L+ E++    +       +K     Q    + ++       + L 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAK---LKQTMPMLLIKLYMYQLLRSLA 155

Query: 678 YLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSF-ATDANTH-VST-------V 727
           Y+H+     I HRD+K  N+LL+      KL DFG +K   A + N   + +       +
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212

Query: 728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           + G   Y           T   D++S G V+ E++  +P
Sbjct: 213 IFGATNY-----------TTNIDIWSTGCVMAELMQGQP 240

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 27/213 (12%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEIDV--AVKMLSSSSAQGFQQF---QAEVKLLMRV-H 619
            +F+  R +G+G +  V   RL + D   A++++        +     Q E  +  +  +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 620 HRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRI-AVESAQ 674
           H  L  L  H     QT      + E++  G+L   +  + ++    +E  R  + E + 
Sbjct: 112 HPFLVGL--HSC--FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISL 164

Query: 675 GLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            L YLH  G    I++RD+K  N+LL+ +   KL D+G+ K      +T  ++   GTP 
Sbjct: 165 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 218

Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           Y+ PE           D ++ GV++ E++  + 
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 42/226 (18%)

Query: 568 NNFER--TLGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQ-GFQQFQA--EVKLLMRVH 619
           + +E+   +G+G FG V+  R     +  VA+K +   + + GF    A  E+K+L  + 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQK-VALKKVLMENEKEGFP-ITALREIKILQLLK 74

Query: 620 HRNLTSLVGHCDEDNQTA--------LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVE 671
           H N+ +L+  C               L+++F  + +L   LS++  K  +  E  R+   
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK-FTLSEIKRVMQM 132

Query: 672 SAQGLEYLH-NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV----ST 726
              GL Y+H N     I+HRD+K+ N+L+      KLADFGL+++F+   N+      + 
Sbjct: 133 LLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 727 VVAGTPGYLDPE------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
           VV  T  Y  PE       Y         D++  G ++ E+ T  P
Sbjct: 189 VV--TLWYRPPELLLGERDYGP-----PIDLWGAGCIMAEMWTRSP 227

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 51/230 (22%), Positives = 92/230 (40%), Gaps = 60/230 (26%)

Query: 572 RTLGKGGFGTV---YYGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLLMRVHHRN 622
             LG+G +G V    +    EI VA+K +       F     A     E+K+L    H N
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEI-VAIKKIEP-----FDKPLFALRTLREIKILKHFKHEN 70

Query: 623 LTSLV-----GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQE------------R 665
           + ++         +  N+  +I E M         +D+ + V+S+Q              
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQ--------TDLHR-VISTQMLSDDHIQYFIYQT 121

Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           LR        ++ LH      ++HRD+K +N+L+N     K+ DFGL++     A  +  
Sbjct: 122 LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 726 TVVAGTP--GYLDPEYY-------TSNRLTEKSDVYSFGVVILEIITCKP 766
                +    ++   +Y       TS + +   DV+S G ++ E+   +P
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 77.4 bits (191), Expect = 4e-15
 Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 55/224 (24%)

Query: 571 ERTLGKGGFGTVYYGRLNEI--DVAVKMLSSSSAQGFQQFQA-EVKLLMRVHHRNLTSL- 626
            + +G G FG VY  +L +    VA+K +        ++F+  E++++ ++ H N+  L 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLR 113

Query: 627 -----VGHCDEDNQTALIYEFM---------ANGNLQEYLSDISKKVLSSQERLRIAVES 672
                 G   ++    L+ +++              ++ L  I  K+   Q   R     
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR----- 167

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFA-TDANTH-VST--- 726
              L Y+H+     I HRD+K  N+LL+ +    KL DFG +K     + N   + +   
Sbjct: 168 --SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222

Query: 727 ----VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
               ++ G   Y           T   DV+S G V+ E++  +P
Sbjct: 223 RAPELIFGATDY-----------TSSIDVWSAGCVLAELLLGQP 255

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 41/215 (19%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLLMRVHHRNL 623
             +G G +G+V   +     + VAVK LS      FQ    A     E++LL  + H N+
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP----FQSIIHAKRTYRELRLLKHMKHENV 90

Query: 624 TSLV------GHCDEDNQTALIYEFMANGNLQEY-----LSDISKKVLSSQERLRIAVES 672
             L+         +E N   L+   M   +L        L+D   + L  Q  LR     
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQ-ILR----- 143

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
             GL+Y+H+     I+HRD+K +N+ +NE  + K+ DFGL++  A +   +V+     T 
Sbjct: 144 --GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-----TR 193

Query: 733 GYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKP 766
            Y  PE         +  D++S G ++ E++T + 
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.2 bits (188), Expect = 8e-15
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 39/216 (18%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLLMRVHHRNL 623
             +G+G +G V   Y  LN++ VA+K +S      F+ Q        E+K+L+R  H N+
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP-----FEHQTYCQRTLREIKILLRFRHENI 87

Query: 624 TSLV-----GHCDEDNQTALIYEFMANGNLQ-----EYLSDISKKVLSSQERLRIAVESA 673
             +         ++     ++ + M   +L      ++LS+        Q  LR      
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQ-ILR------ 139

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT--HVSTVVAGT 731
            GL+Y+H+     ++HRD+K +N+LLN     K+ DFGL++    D +    ++  VA T
Sbjct: 140 -GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-T 194

Query: 732 PGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
             Y  PE    S   T+  D++S G ++ E+++ +P
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.8 bits (187), Expect = 9e-15
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQ-QFQA-----EVKLLMRVHHRNL 623
           + +G G +G V           VA+K L     + FQ +  A     E++LL  + H N+
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 624 TSLV------GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
             L+         D+     L+  FM   +L +    +  + L       +  +  +GL 
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKL---MKHEKLGEDRIQFLVYQMLKGLR 142

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           Y+H      I+HRD+K  N+ +NE  + K+ DFGL++   ++   +V      T  Y  P
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV-----TRWYRAP 194

Query: 738 EY-YTSNRLTEKSDVYSFGVVILEIITCKP 766
           E      R T+  D++S G ++ E+IT K 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.6 bits (186), Expect = 2e-14
 Identities = 42/240 (17%), Positives = 96/240 (40%), Gaps = 52/240 (21%)

Query: 539 KVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVY--YGRLNEIDVAV 594
           + + + + +  S +  +         +I + +E    +G G +G V   Y +L +  VA+
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83

Query: 595 KMLSSSSAQGFQQFQA---------EVKLLMRVHHRNLTSLV-----GHCDEDNQTALIY 640
           K +        + F+          E+ +L R++H ++  ++        ++ ++  ++ 
Sbjct: 84  KKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ--------GLEYLHNGCKPPIVHRDV 692
           E           SD  KK+  +   L       +        G++Y+H+     I+HRD+
Sbjct: 137 EIAD--------SDF-KKLFRTPVYLTE--LHIKTLLYNLLVGVKYVHSA---GILHRDL 182

Query: 693 KSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR-----LTE 747
           K  N L+N+    K+ DFGL+++     N +    ++     ++   +   +     LT 
Sbjct: 183 KPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 40/221 (18%)

Query: 572 RTLGKGGFGTV---YYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL-- 626
           + LG GG G V        ++  VA+K +  +  Q  +    E+K++ R+ H N+  +  
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKR-VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFE 75

Query: 627 ------------VGHCDEDNQTALIYEFMANGNL-----QEYLSDISKKVLSSQERLRIA 669
                       VG   E N   ++ E+M   +L     Q  L +   ++   Q  LR  
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQ-LLR-- 131

Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDA--NTHVST 726
                GL+Y+H+     ++HRD+K  N+ +N E L  K+ DFGL++          H+S 
Sbjct: 132 -----GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 727 VVAGTPGYLDPE-YYTSNRLTEKSDVYSFGVVILEIITCKP 766
            +  T  Y  P    + N  T+  D+++ G +  E++T K 
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 55/240 (22%), Positives = 105/240 (43%), Gaps = 52/240 (21%)

Query: 561 SDVVKITNNFER---TLGKGGFGTVYYGRLNEID----VAVKMLS----SSSAQGFQQFQ 609
           S+  ++ + FE     +G+G +G VY  +  +       A+K +     S SA       
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----- 67

Query: 610 AEVKLLMRVHHRNLTSL--VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLR 667
            E+ LL  + H N+ SL  V     D +  L++++  + +L   +    +   ++++ ++
Sbjct: 68  -EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII-KFHRASKANKKPVQ 124

Query: 668 IAVESA--------QGLEYLH-NGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSK 714
           +              G+ YLH N     ++HRD+K  NIL+     E+ + K+AD G ++
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180

Query: 715 SFATDAN--THVSTVVAGTPGYLDPE------YYTSNRLTEKSDVYSFGVVILEIITCKP 766
            F +       +  VV  T  Y  PE      +YT        D+++ G +  E++T +P
Sbjct: 181 LFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTK-----AIDIWAIGCIFAELLTSEP 234

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 58/277 (20%), Positives = 104/277 (37%), Gaps = 50/277 (18%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
           R LG G F TV+     +N   VA+K++        +  + E+KLL RV+  + T     
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTK-EDS 82

Query: 630 CDEDNQTALIYEFMANG---------------NLQEYLSDISKKVLSSQERLRIAVESAQ 674
              ++   L+  F   G               NL   +     + +      +I+ +   
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNE------KLQAKLADFGLSKSFATDANTHVSTVV 728
           GL+Y+H  C   I+H D+K  N+L+         +Q K+AD G     A   + H +  +
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN----ACWYDEHYTNSI 196

Query: 729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP----AISRINEEEKIHIRQWV- 783
             T  Y  PE          +D++S   +I E+IT              ++  HI Q + 
Sbjct: 197 Q-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 784 ------NSLIAKGDIKSIVDPRLQEDFDANSVWKAVE 814
                 + L+  G          +  F++  + + + 
Sbjct: 256 LLGELPSYLLRNG-------KYTRTFFNSRGLLRNIS 285

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 59/285 (20%), Positives = 94/285 (32%), Gaps = 73/285 (25%)

Query: 570 FERTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSL 626
             + LG G  G V     +  +   A+KML         + + EV+L  R     ++  +
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76

Query: 627 VGHCDEDNQTA-----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH- 680
           V    E+         ++ E +  G L   + D   +  + +E   I     + ++YLH 
Sbjct: 77  VDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135

Query: 681 NGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
                 I HRDVK  N+L          KL DFG +K                   Y   
Sbjct: 136 IN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-----------TTGE--KY--- 175

Query: 738 EYYTSNRLTEKSDVYSFGVVILEIITC-KP---AISRINEEEKIHIRQWVNSLIAKGDIK 793
                    +  D++S G VI+ I+ C  P   +   +     +  R      I  G   
Sbjct: 176 --------DKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTR------IRMGQY- 219

Query: 794 SIVDPRLQEDFDANSVWKAV-----ELAMACLSPTGNQRPTMSQV 833
                    +F  N  W  V      L    L     QR T+++ 
Sbjct: 220 ---------EFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 58/234 (24%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQQFQA---------EVKLLMRVH- 619
           + LGKG +G V+    R     VAVK +       F  FQ          E+ +L  +  
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSG 67

Query: 620 HRNLTSL--VGHCDEDNQTALIYEFMANGNLQ-----EYLSDISKKVLSSQERLRIAVES 672
           H N+ +L  V   D D    L++++M   +L        L  + K+ +  Q  ++     
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQ-LIK----- 120

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
              ++YLH+G    ++HRD+K +NILLN +   K+ADFGLS+SF        +  ++   
Sbjct: 121 --VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 733 GYLDPE-------------YY-------TSNRLTEKSDVYSFGVVILEIITCKP 766
              + +             +Y        S + T+  D++S G ++ EI+  KP
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 51/237 (21%), Positives = 97/237 (40%), Gaps = 53/237 (22%)

Query: 559 SYSDVVKITNNFE--------RTLGKGGFGTVYYG--RLNEIDVAVKMLSSSSAQGFQQF 608
            Y D       +         R LG+G +  V+      N   V VK+L     +  ++ 
Sbjct: 21  EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR- 79

Query: 609 QAEVKLL--MRVHHRNLTSL--VGHCDEDNQTALIYEFMANGNLQEY---LSDISKKVLS 661
             E+K+L  +R    N+ +L  +         AL++E + N + ++    L+D   +   
Sbjct: 80  --EIKILENLR-GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM 136

Query: 662 SQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSF--AT 718
            +  L+        L+Y H+     I+HRDVK  N++++ E  + +L D+GL++ +    
Sbjct: 137 YE-ILK-------ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185

Query: 719 DANTHVSTVVAGTPGYLDPE------YYTSNRLTEKS-DVYSFGVVILEIITCKPAI 768
           + N  V++       +  PE       Y        S D++S G ++  +I  K   
Sbjct: 186 EYNVRVASRY-----FKGPELLVDYQMYD------YSLDMWSLGCMLASMIFRKEPF 231

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 40/174 (22%), Positives = 73/174 (41%), Gaps = 20/174 (11%)

Query: 561 SDVVKITNNF--ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLM 616
             V+ +  NF   + +G G FG +  G+       VA+K+    S     Q   E +   
Sbjct: 2   MGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYK 59

Query: 617 RVHH-RNLTSLVGHCDEDNQTALIYEFMANG-NLQEYLSDISKKVLSSQERLRIAVESAQ 674
           ++     +  +          A++ E +  G +L E L D+  +  S +  L IA++   
Sbjct: 60  QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSL-EDLFDLCDRTFSLKTVLMIAIQLIS 116

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILL-----NEKLQAKLADFGLSKSFATDANTH 723
            +EY+H+     +++RDVK  N L+       +    + DF L+K +  D  T 
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-IDPETK 166

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 72.4 bits (178), Expect = 4e-13
 Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 4/94 (4%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           +    +T+L+LS   L+    +  ++L+SLQ L++S+NN           L  L+ L+  
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526

Query: 463 GNKLNGSVPVELLERSKNGSLS-LSVGGNPGLCS 495
            N +  S   EL  +    SL+ L++  N   C+
Sbjct: 527 LNHIMTSKKQEL--QHFPSSLAFLNLTQNDFACT 558

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 70.1 bits (172), Expect = 2e-12
 Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 3/86 (3%)

Query: 404 SSSPRITYLNLSSSGLKGDI-TSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
               ++ +L+   S LK     S   +L +L +LD+S+ +   +     + L  L  L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452

Query: 462 QGNKLNGSVPVELLERSKN-GSLSLS 486
            GN    +   ++    +N   L LS
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLS 478

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 68.5 bits (168), Expect = 5e-12
 Identities = 22/92 (23%), Positives = 42/92 (45%), Gaps = 4/92 (4%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNL 461
           S    +  L    + L       + +L +L+ L++++N +    +P++ S L  L  L+L
Sbjct: 97  SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 462 QGNKLNGSVPVEL--LERSKNGSLSLSVGGNP 491
             NK+      +L  L +    +LSL +  NP
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.4 bits (160), Expect = 5e-11
 Identities = 17/67 (25%), Positives = 24/67 (35%), Gaps = 1/67 (1%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
                 L+LS + L+   +    +   LQ LDLS   +          L  L TL L GN
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 465 KLNGSVP 471
            +     
Sbjct: 87  PIQSLAL 93

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 64.7 bits (158), Expect = 7e-11
 Identities = 17/73 (23%), Positives = 33/73 (45%), Gaps = 2/73 (2%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSV-PDFLSKLP-LRTLNL 461
            S   + YL++S +  +       + L+SL+ L ++ N+   +  PD  ++L  L  L+L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 462 QGNKLNGSVPVEL 474
              +L    P   
Sbjct: 478 SQCQLEQLSPTAF 490

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 64.3 bits (157), Expect = 9e-11
 Identities = 25/93 (26%), Positives = 42/93 (45%), Gaps = 3/93 (3%)

Query: 397 LNCSYGDSSSPRITYLNLSSSGL--KGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKL 454
              ++ +   P + +L+LS +GL  KG  +      TSL++LDLS N +     +FL   
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLE 396

Query: 455 PLRTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
            L  L+ Q + L       +    +N   L +S
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 63.9 bits (156), Expect = 1e-10
 Identities = 24/94 (25%), Positives = 34/94 (36%), Gaps = 2/94 (2%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP--LRTLNL 461
           +S   +  LN+S +      T     L SLQ LD S N++  S    L   P  L  LNL
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550

Query: 462 QGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
             N    +   +   +       L V      C+
Sbjct: 551 TQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.7 bits (153), Expect = 3e-10
 Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 2/82 (2%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             ++ L L+ + ++       S L+SLQ L     NL       +  L  L+ LN+  N 
Sbjct: 76  SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 466 LNGSVPVELLERSKN-GSLSLS 486
           +      E      N   L LS
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLS 157

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 61.2 bits (149), Expect = 9e-10
 Identities = 18/86 (20%), Positives = 30/86 (34%), Gaps = 5/86 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P +  L+LS   ++        +L+ L  L L+ N +        S L  L+ L      
Sbjct: 52  PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111

Query: 466 LNGSVPVELLERSKNGSL-SLSVGGN 490
           L       +       +L  L+V  N
Sbjct: 112 LASLENFPI---GHLKTLKELNVAHN 134

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 19/95 (20%), Positives = 39/95 (41%), Gaps = 5/95 (5%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQF----LDLSNNNLTGSVPDFLSKLPLRTL 459
           S+   + +L+LSS+ ++    + +  L  +      LDLS N +    P    ++ L  L
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 205

Query: 460 NLQGNKLNGSVPVELLER-SKNGSLSLSVGGNPGL 493
            L+ N  + +V    ++  +      L +G     
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 49.6 bits (119), Expect = 4e-06
 Identities = 21/76 (27%), Positives = 33/76 (43%), Gaps = 4/76 (5%)

Query: 397 LNCSYGD-SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT--GSVPDFLSK 453
           +NC +G   +    +   L+ +  KG       +L SL+FLDLS N L+  G        
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 454 LP-LRTLNLQGNKLNG 468
              L+ L+L  N +  
Sbjct: 372 TTSLKYLDLSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 44.2 bits (105), Expect = 2e-04
 Identities = 17/95 (17%), Positives = 30/95 (31%), Gaps = 8/95 (8%)

Query: 398 NCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLPL 456
                     R+ YL+        DI    + LT++    L +  +       +      
Sbjct: 253 GLCNLTIEEFRLAYLDYYL----DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW-- 306

Query: 457 RTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNP 491
           + L L   K     P   L+  K  + + + GGN 
Sbjct: 307 QHLELVNCKFGQ-FPTLKLKSLKRLTFTSNKGGNA 340

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 17/81 (20%), Positives = 26/81 (32%), Gaps = 8/81 (9%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             ++  +L S  ++       S     Q L+L N          L  L  L   + +G  
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339

Query: 466 LNGSVPVELLERSKNGSLSLS 486
               V +  LE      L LS
Sbjct: 340 AFSEVDLPSLE-----FLDLS 355

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 37/178 (20%), Positives = 68/178 (38%), Gaps = 30/178 (16%)

Query: 571 ERTLGKGGFGTVYYGR----------LNEIDVAVKMLSSSS----AQGFQQFQAEV---- 612
           +    +   G +Y               +   ++K+ +        Q F Q  A+     
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 613 --KLLMRVHHRNLTSLVGH-CDEDNQTALIYEFMANG-NLQEYLSDISKKVLSSQERLRI 668
             K L       + + +G    +D    L+   +  G +LQ  L    K VLS +  L++
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQV 164

Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK--LADFGLSKSFATDANTHV 724
           A      LE+LH       VH +V + NI ++ + Q++  LA +G +  +   +  HV
Sbjct: 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY-CPSGKHV 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 48/258 (18%), Positives = 83/258 (32%), Gaps = 77/258 (29%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQA---EVKLLMR 617
             +  +   +TLG G FG V      E     A+K +        Q  +    E+ ++  
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKV 56

Query: 618 VHHRNLTSL--VGHCDEDNQTA------------------------------------LI 639
           + H N+  L    +   D +                                      +I
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 640 YEFM---------ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHR 690
            E++         +       +      +   Q   R        + ++H+     I HR
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFR-------AVGFIHSL---GICHR 165

Query: 691 DVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-YYTSNRLTEK 748
           D+K  N+L+N +    KL DFG +K         V+ +   +  Y  PE    +   T  
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYIC--SRFYRAPELMLGATEYTPS 222

Query: 749 SDVYSFGVVILEIITCKP 766
            D++S G V  E+I  KP
Sbjct: 223 IDLWSIGCVFGELILGKP 240

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 70.4 bits (173), Expect = 1e-12
 Identities = 23/90 (25%), Positives = 37/90 (41%), Gaps = 2/90 (2%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  LNL S+G          +L  L+ +DL  NNL        +    L++LNLQ N 
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595

Query: 466 LNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
           +   V  ++   +      L +  NP  C+
Sbjct: 596 ITS-VEKKVFGPAFRNLTELDMRFNPFDCT 624

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 64.3 bits (157), Expect = 1e-10
 Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 3/90 (3%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           +    +T L+L S+ ++    +      +L  LDLS+N L+ +      +L  L+ L L 
Sbjct: 94  AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153

Query: 463 GNKLNGSVPVELLERSKNGSL-SLSVGGNP 491
            NK+   +  E L+   N SL  L +  N 
Sbjct: 154 NNKIQA-LKSEELDIFANSSLKKLELSSNQ 182

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 61.9 bits (151), Expect = 6e-10
 Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 9/98 (9%)

Query: 397 LNCSYG------DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF 450
            +CS+       D     IT LNL+ + L+    +  +  + L  LD+  N ++   P+ 
Sbjct: 9   ADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 451 LSKLP-LRTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
             KLP L+ LNLQ N+L+  +  +      N   L L 
Sbjct: 69  CQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLM 105

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 60.8 bits (148), Expect = 1e-09
 Identities = 19/79 (24%), Positives = 33/79 (41%), Gaps = 1/79 (1%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T L+LS + L        + L  L++  L  NN+       L  L  +R LNL+ + 
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307

Query: 466 LNGSVPVELLERSKNGSLS 484
              S+ +  L +  + S  
Sbjct: 308 TKQSISLASLPKIDDFSFQ 326

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 60.0 bits (146), Expect = 2e-09
 Identities = 24/64 (37%), Positives = 28/64 (43%), Gaps = 3/64 (4%)

Query: 407 PRITYLNLSSSGLKG--DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
           P +  L L    LK      S    L +L  LDLSNNN+     D L  L  L  L+LQ 
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513

Query: 464 NKLN 467
           N L 
Sbjct: 514 NNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 59.2 bits (144), Expect = 4e-09
 Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 3/82 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P +  LNL  + L        +  T+L  L L +N++     +   K   L TL+L  N 
Sbjct: 73  PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132

Query: 466 LNGSVPVELLERSKN-GSLSLS 486
           L+ S  +    + +N   L LS
Sbjct: 133 LS-STKLGTQVQLENLQELLLS 153

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.9 bits (143), Expect = 5e-09
 Identities = 17/74 (22%), Positives = 24/74 (32%), Gaps = 3/74 (4%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG--SVPDFLSKLP-LRTLN 460
                I  + LS +       +  + + SLQ L L    L    S P     L  L  L+
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486

Query: 461 LQGNKLNGSVPVEL 474
           L  N +       L
Sbjct: 487 LSNNNIANINDDML 500

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.9 bits (143), Expect = 6e-09
 Identities = 25/85 (29%), Positives = 35/85 (41%), Gaps = 3/85 (3%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNL--TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
           ++  I  L+LS+S L     +    L  T+L  LDLS NNL     D  + LP L    L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279

Query: 462 QGNKLNGSVPVELLERSKNGSLSLS 486
           + N +       L        L+L 
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLK 304

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.1 bits (141), Expect = 9e-09
 Identities = 19/71 (26%), Positives = 28/71 (39%), Gaps = 3/71 (4%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP---LRTLN 460
                +  L+LS +GL          L +LQ L LSNN +     + L       L+ L 
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177

Query: 461 LQGNKLNGSVP 471
           L  N++    P
Sbjct: 178 LSSNQIKEFSP 188

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.5 bits (137), Expect = 3e-08
 Identities = 20/86 (23%), Positives = 37/86 (43%), Gaps = 6/86 (6%)

Query: 407 PRITYLNLSSSGLK-GDITSYV---SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
             + YL+LS+S      +T+        + L  L+L+ N ++    D  S L  L  L+L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412

Query: 462 QGNKLNGSVPVELLERSKN-GSLSLS 486
             N++   +  +     +N   + LS
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIYLS 438

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.5 bits (137), Expect = 3e-08
 Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 11/90 (12%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT--------GSVPDFLSKLP-LR 457
             +T L+LS++ +       +  L  L+ LDL +NNL         G    FL  L  L 
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539

Query: 458 TLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
            LNL+ N  +  +PVE+ +       + L 
Sbjct: 540 ILNLESNGFDE-IPVEVFKDLFELKIIDLG 568

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 15/76 (19%), Positives = 28/76 (36%), Gaps = 2/76 (2%)

Query: 398 NCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLP- 455
           N ++   +   +  LNL+ + +    +   S L  L+ LDL  N +   +       L  
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431

Query: 456 LRTLNLQGNKLNGSVP 471
           +  + L  NK      
Sbjct: 432 IFEIYLSYNKYLQLTR 447

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 11/93 (11%)

Query: 404 SSSPRITYLNLSS--------SGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP 455
               ++  L+L              G    ++  L+ L  L+L +N       +    L 
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560

Query: 456 -LRTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
            L+ ++L  N LN  +P  +     +  SL+L 
Sbjct: 561 ELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQ 592

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.2 bits (131), Expect = 2e-07
 Identities = 19/67 (28%), Positives = 34/67 (50%), Gaps = 5/67 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNN-----NLTGSVPDFLSKLPLRTLNL 461
             + +LN+  + + G  ++  + L +L++L LSN+      LT      L+  PL  LNL
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388

Query: 462 QGNKLNG 468
             NK++ 
Sbjct: 389 TKNKISK 395

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 16/71 (22%), Positives = 32/71 (45%), Gaps = 4/71 (5%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD----FLSKLPLRTLN 460
           ++  +  L LSS+ +K         +  L  L L+N  L  S+ +     L+   +R L+
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228

Query: 461 LQGNKLNGSVP 471
           L  ++L+ +  
Sbjct: 229 LSNSQLSTTSN 239

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 13/68 (19%), Positives = 26/68 (38%), Gaps = 2/68 (2%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP--LRTLNL 461
                +  ++L  + L     S  +N  SL+ L+L  N +T             L  L++
Sbjct: 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM 616

Query: 462 QGNKLNGS 469
           + N  + +
Sbjct: 617 RFNPFDCT 624

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 16/85 (18%), Positives = 36/85 (42%), Gaps = 3/85 (3%)

Query: 409 ITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN 467
            T  ++S + L          L  L+ L++ +N++ G   +  + L  L+ L+L  +  +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

Query: 468 -GSVPVELLERSKNGSL-SLSVGGN 490
             ++  E      +  L  L++  N
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKN 391

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 49.6 bits (119), Expect = 4e-06
 Identities = 13/78 (16%), Positives = 31/78 (39%), Gaps = 10/78 (12%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNN---------NLTGSVPDFLSKL 454
           +  P++ Y  L  + ++   +  +  L ++++L+L  +         +L          L
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328

Query: 455 P-LRTLNLQGNKLNGSVP 471
             L  LN++ N + G   
Sbjct: 329 KCLEHLNMEDNDIPGIKS 346

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.1 bits (172), Expect = 2e-12
 Identities = 19/120 (15%), Positives = 39/120 (32%), Gaps = 9/120 (7%)

Query: 381 NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSN 440
           NW  +    +     G++ +    S+ R+T L+L   G  G +   +  LT L+ L L +
Sbjct: 59  NWNFNKELDMWGAQPGVSLN----SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114

Query: 441 NNLTGSVPDFLSK-----LPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
           +    +   F  K     +              +          +  +   +  +P   S
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 19/90 (21%), Positives = 37/90 (41%), Gaps = 7/90 (7%)

Query: 404 SSSPRITYLNLSSSGLK-GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
               +I  + +  + LK   + + +  +  L  L+   N L G +P F      L +LNL
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNL 360

Query: 462 QGNKLNGSVPVELLERSKNGSL-SLSVGGN 490
             N++   +P      ++   + +LS   N
Sbjct: 361 AYNQITE-IPANFCGFTEQ--VENLSFAHN 387

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 58.1 bits (141), Expect = 9e-09
 Identities = 11/86 (12%), Positives = 23/86 (26%), Gaps = 2/86 (2%)

Query: 402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
                  +    ++S   +  I            +   +NN+T  V   + +L  LR   
Sbjct: 154 PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFY 212

Query: 461 LQGNKLNGSVPVELLERSKNGSLSLS 486
           +  +        E  E   +      
Sbjct: 213 MGNSPFVAENICEAWENENSEYAQQY 238

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 15/96 (15%), Positives = 31/96 (32%), Gaps = 7/96 (7%)

Query: 402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
            ++        N   +           NL  L  +++ N      +P FL  LP ++ +N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279

Query: 461 LQGNKLNG-----SVPVELLERSKNGSL-SLSVGGN 490
           +  N+             L +      +  + +G N
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 14/98 (14%), Positives = 33/98 (33%), Gaps = 14/98 (14%)

Query: 404 SSSPRITYLNLS-------SSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP- 455
            S   ++ ++ S              +        ++  ++LSNN ++    +  S    
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458

Query: 456 LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGL 493
           L ++NL GN L        + ++     + +      L
Sbjct: 459 LSSINLMGNMLTE------IPKNSLKDENENFKNTYLL 490

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 14/73 (19%), Positives = 29/73 (39%), Gaps = 9/73 (12%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-------SVPDFLSKLP-LRTLNL 461
           + +NLS++ +        S  + L  ++L  N LT           +       L +++L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495

Query: 462 QGNKLNGSVPVEL 474
           + NKL   +  + 
Sbjct: 496 RFNKLT-KLSDDF 507

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.0 bits (133), Expect = 7e-08
 Identities = 14/93 (15%), Positives = 34/93 (36%), Gaps = 11/93 (11%)

Query: 404 SSSPRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP------- 455
             + ++  L+ + + LK         +++ +  +D S N +          L        
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433

Query: 456 -LRTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
            + ++NL  N+++     EL        S++L 
Sbjct: 434 NVSSINLSNNQISKFPK-ELFSTGSPLSSINLM 465

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.0 bits (133), Expect = 7e-08
 Identities = 8/76 (10%), Positives = 23/76 (30%), Gaps = 2/76 (2%)

Query: 411 YLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSV 470
             +   +    +    ++   SL  L + +N++            +  L+++ N      
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN--ISVLDIKDNPNISID 603

Query: 471 PVELLERSKNGSLSLS 486
              +    + G   L 
Sbjct: 604 LSYVCPYIEAGMYMLF 619

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 16/75 (21%), Positives = 27/75 (36%), Gaps = 10/75 (13%)

Query: 407 PRITYLNLSS--------SGLKGDITSYVSNLTSLQFLDLSNNNL-TGSVPDFLSKLP-L 456
           P +  +N++                 +       +Q + +  NNL T  V   L K+  L
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332

Query: 457 RTLNLQGNKLNGSVP 471
             L    N+L G +P
Sbjct: 333 GMLECLYNQLEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 20/98 (20%), Positives = 35/98 (35%), Gaps = 17/98 (17%)

Query: 404 SSSPRITYLNLSS---SGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP----- 455
            ++  +T ++L     + L  D     + L  L  +DLS N+ +   P            
Sbjct: 485 KNTYLLTSIDLRFNKLTKLSDDFR--ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF 541

Query: 456 --LRTLNLQGNKLNGSVPVELLERSKNGSL-SLSVGGN 490
                 + QGN+     P  +   +   SL  L +G N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGI---TLCPSLTQLQIGSN 576

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 8/68 (11%), Positives = 25/68 (36%), Gaps = 4/68 (5%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD--FLSKLP-LRTLNLQGNKL 466
             LNL+ + +     ++      ++ L  ++N L   +P+      +  +  ++   N++
Sbjct: 356 ASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEI 414

Query: 467 NGSVPVEL 474
                   
Sbjct: 415 GSVDGKNF 422

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 10/91 (10%), Positives = 24/91 (26%), Gaps = 21/91 (23%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-------- 455
             + + T +   S+ +   ++  V  LT L+   + N+           +          
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238

Query: 456 ------------LRTLNLQGNKLNGSVPVEL 474
                       L  + +        +P  L
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 42.3 bits (100), Expect = 7e-04
 Identities = 9/61 (14%), Positives = 22/61 (36%), Gaps = 4/61 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P +T L + S+ ++  +        ++  LD+ +N        ++          L  +K
Sbjct: 566 PSLTQLQIGSNDIRK-VNE--KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

Query: 466 L 466
            
Sbjct: 623 T 623

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.5 bits (165), Expect = 5e-12
 Identities = 46/221 (20%), Positives = 81/221 (36%), Gaps = 42/221 (19%)

Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNF--ERTLGKGGFGTVYYGRL---- 587
           + +  +  R+S  K    E  +     +D+      +     +G+GGFG +Y   +    
Sbjct: 3   RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAA--AAWKVGLPIGQGGFGCIYLADMNSSE 60

Query: 588 ---NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLT---------------SLVGH 629
              ++    VK+  S +   F     E+K   R                         G 
Sbjct: 61  SVGSDAPCVVKVEPSDNGPLFT----ELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116

Query: 630 CDEDNQTALIYEFMA----NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
              D      Y FM       +LQ+     +K+  S +  L++++     LEY+H     
Sbjct: 117 GLHDKNGKS-YRFMIMDRFGSDLQKIYEANAKR-FSRKTVLQLSLRILDILEYIHEHE-- 172

Query: 686 PIVHRDVKSTNILLNEKLQAK--LADFGLSKSFATDANTHV 724
             VH D+K++N+LLN K   +  L D+GL+  +      H 
Sbjct: 173 -YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY-CPEGVHK 211

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 18/170 (10%)

Query: 564 VKITNNF--ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH 619
           +++ N +   R +G G FG +Y G       +VA+K+    +     Q   E K+   + 
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 62

Query: 620 H-RNLTSLVGHCDEDNQTALIYEFMANG-NLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
               + ++     E +   ++ E +  G +L E L +   +  S +  L +A +    +E
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELL--GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIE 119

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAK---LADFGLSKSFATDANTHV 724
           Y+H+      +HRDVK  N L+    +     + DFGL+K +  DA TH 
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY-RDARTHQ 165

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 36/163 (22%), Positives = 65/163 (39%), Gaps = 18/163 (11%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH-RNLTSL 626
             R +G+G FG ++ G   LN   VA+K     S     Q + E +    +     + ++
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNV 71

Query: 627 VGHCDEDNQTALIYEFMANG-NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
                E     L+ + +  G +L E L D+  +  S +     A +    ++ +H     
Sbjct: 72  YYFGQEGLHNVLVIDLL--GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 126

Query: 686 PIVHRDVKSTNILLNEKLQAK-----LADFGLSKSFATDANTH 723
            +V+RD+K  N L+            + DFG+ K +  D  T 
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTK 167

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.5 bits (156), Expect = 4e-11
 Identities = 36/220 (16%), Positives = 60/220 (27%), Gaps = 60/220 (27%)

Query: 544 SKNKIDSFEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKML------ 597
           S+     F             KI        G+G FG V+    +   VA+K++      
Sbjct: 6   SQKGPVPFSHCLPTEKLQRCEKI--------GEGVFGEVFQTIADHTPVAIKIIAIEGPD 57

Query: 598 --SSSSAQGFQQFQAEVKLLMRVH---------HRNLTSLVGHC---------------- 630
             + S  + F++   E+ +   +                L                    
Sbjct: 58  LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117

Query: 631 --------------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
                          +D+Q  ++ EF   G     L  +  K+ S      I  +    L
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASL 174

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF 716
                       HRD+   N+LL +    KL      KS 
Sbjct: 175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 36/174 (20%), Positives = 60/174 (34%), Gaps = 25/174 (14%)

Query: 571 ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            + +G GGFG +Y           A  ++     +    F  E+K   RV  ++      
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWI 100

Query: 629 HCDEDNQTAL--IYEF-MANGNLQEY-----------LSDI--SKKVLSSQERLRIAVES 672
              + +   +   Y   +     + Y           L  I            L++ +  
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRM 160

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK--LADFGLSKSFATDANTHV 724
              LEY+H       VH D+K+ N+LL  K   +  LAD+GLS  +      H 
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY-CPNGNHK 210

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 62/264 (23%), Positives = 115/264 (43%), Gaps = 25/264 (9%)

Query: 527 IFFVLKRKRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVY- 583
           ++F           K+E K   D ++  +      +  K  + +E    +GKG FG V  
Sbjct: 18  LYFQSMSSH-----KKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVK 72

Query: 584 -YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHR------NLTSLVGHCDEDNQT 636
            Y R+ +  VA+K++ +  A    Q Q EV+LL  ++         +  L  H    N  
Sbjct: 73  AYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131

Query: 637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTN 696
            L++E ++  NL + L + + + +S     + A +    L +L    +  I+H D+K  N
Sbjct: 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPEN 189

Query: 697 ILL--NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSF 754
           ILL   ++   K+ DFG S   +      +   +  +  Y  PE           D++S 
Sbjct: 190 ILLCNPKRSAIKIVDFG-S---SCQLGQRIYQYIQ-SRFYRSPEVLLGMPYDLAIDMWSL 244

Query: 755 GVVILEIITCKPAISRINEEEKIH 778
           G +++E+ T +P  S  NE ++++
Sbjct: 245 GCILVEMHTGEPLFSGANEVDQMN 268

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 16/169 (9%)

Query: 564 VKITNNF--ERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH 619
            ++ N F   R +G G FG +Y G       +VA+K+ +  +     Q   E K+   + 
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQ 60

Query: 620 -HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
               + ++     E +   L+ + +   +L++  +  S+K LS +  L +A +    +E+
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118

Query: 679 LHNGCKPPIVHRDVKSTNILLNEKLQAK---LADFGLSKSFATDANTHV 724
           +H+      +HRD+K  N L+    +A    + DFGL+K +  D +TH 
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQ 163

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 20/205 (9%)

Query: 572 RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHR------NL 623
           + +GKG FG V   Y       VA+KM+ +      +Q   E+++L  +  +      N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-HRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             ++ +    N   + +E ++  NL E +     +  S     + A    Q L+ LH   
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217

Query: 684 KPPIVHRDVKSTNILLNEKLQA--KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
           K  I+H D+K  NILL ++ ++  K+ DFG     +   +  V T +  +  Y  PE   
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGS----SCYEHQRVYTYIQ-SRFYRAPEVIL 272

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP 766
             R     D++S G ++ E++T  P
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYP 297

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.9 bits (156), Expect = 1e-10
 Identities = 22/90 (24%), Positives = 39/90 (43%), Gaps = 3/90 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T+L+LS   L+         L  LQ L++S+NNL        ++L  L TL+   N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532

Query: 466 LNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
           +  +    L    K+ +   ++  N   C 
Sbjct: 533 IE-TSKGILQHFPKSLA-FFNLTNNSVACI 560

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.0 bits (151), Expect = 6e-10
 Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 4/89 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGN 464
             +  L    + L    +  +  L +L+ L++++N +    +P + S L  L  ++L  N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163

Query: 465 KLNGSVPVEL--LERSKNGSLSLSVGGNP 491
            +      +L  L  +   +LSL +  NP
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNP 192

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 58.5 bits (142), Expect = 7e-09
 Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 2/67 (2%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNL 461
            S  ++ YL++S +  K D       LTSL  L ++ N+   +   +  +    L  L+L
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480

Query: 462 QGNKLNG 468
              +L  
Sbjct: 481 SKCQLEQ 487

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.6 bits (137), Expect = 3e-08
 Identities = 18/65 (27%), Positives = 27/65 (41%), Gaps = 1/65 (1%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
            +  R+  LN+S + L    +S+ + L SL  LD S N +  S          L   NL 
Sbjct: 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT 553

Query: 463 GNKLN 467
            N + 
Sbjct: 554 NNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 22/98 (22%), Positives = 32/98 (32%), Gaps = 9/98 (9%)

Query: 397 LNCSYG------DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF 450
             C         D        ++LS + LK   +   SN + LQ+LDLS   +       
Sbjct: 16  YQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75

Query: 451 LSKLP-LRTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
              L  L  L L GN +  S          +  +L   
Sbjct: 76  WHGLHHLSNLILTGNPIQ-SFSPGSFSGLTSLENLVAV 112

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 14/63 (22%), Positives = 27/63 (42%), Gaps = 1/63 (1%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             ++ L L+ + ++       S LTSL+ L      L       + +L  L+ LN+  N 
Sbjct: 80  HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139

Query: 466 LNG 468
           ++ 
Sbjct: 140 IHS 142

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.7 bits (127), Expect = 4e-07
 Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 5/94 (5%)

Query: 397 LNCSYGDSSSPRITYLNLSSSGLK--GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKL 454
            + S+   + P ++YL+LS + L   G  +       SL+ LDLS N     +      L
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398

Query: 455 P-LRTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
             L+ L+ Q + L            +    L +S
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 49.3 bits (118), Expect = 5e-06
 Identities = 15/95 (15%), Positives = 34/95 (35%), Gaps = 5/95 (5%)

Query: 404 SSSPRITYLNLSS---SGLKGDITSYVSNLT-SLQFLDLSNNNLTGSVPDFLSKLPLRTL 459
           S+   + +++LS      +  +   ++         LD+S N +          + L  L
Sbjct: 150 SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHEL 209

Query: 460 NLQGNKLNGSVPVELLER-SKNGSLSLSVGGNPGL 493
            L+GN  + ++    L+  +      L +G     
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 23/63 (36%), Positives = 30/63 (47%), Gaps = 5/63 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP---LRTLNLQG 463
           P +  L L+ +  KG I+     L SL +LDLS N L+ S     S L    LR L+L  
Sbjct: 328 PFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385

Query: 464 NKL 466
           N  
Sbjct: 386 NGA 388

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 8/61 (13%), Positives = 22/61 (36%), Gaps = 1/61 (1%)

Query: 408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLN 467
            I    L+ +    D       L ++  + L+  ++   + D       ++L++   +L 
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLK 320

Query: 468 G 468
            
Sbjct: 321 Q 321

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 42.3 bits (100), Expect = 6e-04
 Identities = 19/86 (22%), Positives = 31/86 (36%), Gaps = 6/86 (6%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
             +   L++    LK   T    +L  L+ L L+ N  + S    ++   L  L+L  N 
Sbjct: 306 HFKWQSLSIIRCQLKQFPTL---DLPFLKSLTLTMNKGSIS-FKKVALPSLSYLDLSRNA 361

Query: 466 LNGSVPVELLERSKNGSL-SLSVGGN 490
           L+              SL  L +  N
Sbjct: 362 LS-FSGCCSYSDLGTNSLRHLDLSFN 386

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 62.0 bits (151), Expect = 6e-10
 Identities = 25/89 (28%), Positives = 40/89 (44%), Gaps = 2/89 (2%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKL 466
            R+  L LS   L        ++L  +  +DLS+N LT S  + LS L    LNL  N +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535

Query: 467 NGSVPVELLERSKNGSLSLSVGGNPGLCS 495
           +  +   LL        ++++  NP  C+
Sbjct: 536 S-IILPSLLPILSQQR-TINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.5 bits (142), Expect = 7e-09
 Identities = 14/78 (17%), Positives = 31/78 (39%), Gaps = 2/78 (2%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
            S  R+  L L+++ L     + +S   +L+ L      ++      L     L +L L 
Sbjct: 78  QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137

Query: 463 GNKLNGSVPVELLERSKN 480
            N ++ S+ +     ++ 
Sbjct: 138 SNHIS-SIKLPKGFPTEK 154

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.3 bits (139), Expect = 2e-08
 Identities = 19/75 (25%), Positives = 35/75 (46%), Gaps = 2/75 (2%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L+L+++ L  ++ S +  L++L+ L LS N          S  P L  L+++GN 
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336

Query: 466 LNGSVPVELLERSKN 480
               +    LE  +N
Sbjct: 337 KRLELGTGCLENLEN 351

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 56.2 bits (136), Expect = 4e-08
 Identities = 22/98 (22%), Positives = 29/98 (29%), Gaps = 9/98 (9%)

Query: 397 LNCSYG------DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF 450
            NC          +       L  S + L     +  S L +L FLDL+   +     D 
Sbjct: 17  YNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 451 LSKLP-LRTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
                 L TL L  N L   +    L   K    L   
Sbjct: 77  FQSQHRLDTLVLTANPLI-FMAETALSGPKALKHLFFI 113

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 22/88 (25%), Positives = 31/88 (35%), Gaps = 6/88 (6%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG---SVPDFLSKLP-LRTL 459
            +   +  LNLS S L          L +LQ L+L  N+         + L  L  L  L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481

Query: 460 NLQGNKLNGSVPVELLERSKN-GSLSLS 486
            L    L+ S+        K    + LS
Sbjct: 482 VLSFCDLS-SIDQHAFTSLKMMNHVDLS 508

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.0 bits (133), Expect = 7e-08
 Identities = 16/65 (24%), Positives = 25/65 (38%), Gaps = 2/65 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSV-PDFLSKLP-LRTLNLQGN 464
             +  L LS++  +       SN  SL  L +  N     +    L  L  LR L+L  +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360

Query: 465 KLNGS 469
            +  S
Sbjct: 361 DIETS 365

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 2/65 (3%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
               +  +NL         ++     + LQ LDL+  +L+  +P  L  L  L+ L L  
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310

Query: 464 NKLNG 468
           NK   
Sbjct: 311 NKFEN 315

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 18/66 (27%), Positives = 36/66 (54%), Gaps = 4/66 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGS--VPDFLSKLP-LRTLNLQ 462
           P +T+L++  +  + ++ +    NL +L+ LDLS++++  S      L  L  L++LNL 
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384

Query: 463 GNKLNG 468
            N+   
Sbjct: 385 YNEPLS 390

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 3/77 (3%)

Query: 407 PRITYLNLSSSGLKG-DITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
             +  L+LS   ++  D  +    NL+ LQ L+LS N       +   + P L  L+L  
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409

Query: 464 NKLNGSVPVELLERSKN 480
            +L         +    
Sbjct: 410 TRLKVKDAQSPFQNLHL 426

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 18/75 (24%), Positives = 27/75 (36%), Gaps = 2/75 (2%)

Query: 399 CSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD-FLSKLP-L 456
           C+    +   +  LNLS +      T        L+ LDL+   L           L  L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 457 RTLNLQGNKLNGSVP 471
           + LNL  + L+ S  
Sbjct: 428 KVLNLSHSLLDISSE 442

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 52.7 bits (127), Expect = 4e-07
 Identities = 16/86 (18%), Positives = 30/86 (34%), Gaps = 4/86 (4%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD---FLSKLPLRTLN 460
            +   +  L L S+ +             L+ LD  NN +     +    L +    +LN
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185

Query: 461 LQGNKLNGSVPVELLERSKNGSLSLS 486
           L GN +   +     + +   SL+  
Sbjct: 186 LNGNDI-AGIEPGAFDSAVFQSLNFG 210

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.2 bits (105), Expect = 2e-04
 Identities = 14/74 (18%), Positives = 30/74 (40%), Gaps = 4/74 (5%)

Query: 404 SSSPRITYLNLSS---SGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLN 460
             + ++  L+  +     L  +  S +   T+L  L+L+ N++ G  P        ++LN
Sbjct: 150 FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGIEPGAFDSAVFQSLN 208

Query: 461 LQGNKLNGSVPVEL 474
             G +    +   L
Sbjct: 209 FGGTQNLLVIFKGL 222

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 12/72 (16%), Positives = 25/72 (34%), Gaps = 5/72 (6%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSN--LTSLQFLDLSNNNLTG---SVPDFLSKLPLRTL 459
            S     LN   +     I   + N  + SL      + +      +V + L ++ + ++
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259

Query: 460 NLQGNKLNGSVP 471
           NLQ +       
Sbjct: 260 NLQKHYFFNISS 271

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 27/133 (20%), Positives = 50/133 (37%), Gaps = 14/133 (10%)

Query: 365 DVDAITNIKATYGLKKNWQGDP----CAPLAYWWDGLN--CSYGD------SSSPRITYL 412
           D  A+  I      K NW+           +  W+       +GD       ++ R+T L
Sbjct: 270 DYKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328

Query: 413 NLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF-LSKLPLRTLNLQGNKLNGSVP 471
           +L+  G KG +   +  LT L+ L    ++ T S   F   +L       + +++     
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388

Query: 472 VELLERSKNGSLS 484
              L+  +  +LS
Sbjct: 389 KMFLDYDQRLNLS 401

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.1 bits (143), Expect = 6e-09
 Identities = 17/74 (22%), Positives = 29/74 (39%), Gaps = 1/74 (1%)

Query: 412 LNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSV 470
            N   +    +     SNL  L  ++L N      +PDFL  LP L++LN+  N+   + 
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531

Query: 471 PVELLERSKNGSLS 484
            ++           
Sbjct: 532 QLKADWTRLADDED 545

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.0 bits (140), Expect = 1e-08
 Identities = 18/89 (20%), Positives = 35/89 (39%), Gaps = 9/89 (10%)

Query: 394 WDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT-------GS 446
              ++CS  D      + + LS + ++   T   +  + +  + LSNN +T         
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719

Query: 447 VPDFLSKLP-LRTLNLQGNKLNGSVPVEL 474
                     L T++L+ NKL  S+  + 
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDF 747

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 55.3 bits (133), Expect = 7e-08
 Identities = 9/84 (10%), Positives = 25/84 (29%), Gaps = 2/84 (2%)

Query: 412 LNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVP 471
            +   + +     + ++   SL  L + +N++         +  L  L++  N       
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQ--LYILDIADNPNISIDV 844

Query: 472 VELLERSKNGSLSLSVGGNPGLCS 495
             +    + G   L       +  
Sbjct: 845 TSVCPYIEAGMYVLLYDKTQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 11/91 (12%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG---------SVPDFLSKLP-L 456
             +T + L +      +  ++ +L  LQ L+++ N              + D     P +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

Query: 457 RTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
           +   +  N L        L++    G L   
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 15/82 (18%), Positives = 33/82 (40%), Gaps = 4/82 (4%)

Query: 407 PRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
           P+I    +  + L+    ++ +  +  L  LD  +N +   +  F + + L  L L  N+
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQ 606

Query: 466 LNGSVPVELLERSKN-GSLSLS 486
           +   +P +    +     L  S
Sbjct: 607 IE-EIPEDFCAFTDQVEGLGFS 627

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.3 bits (120), Expect = 3e-06
 Identities = 11/84 (13%), Positives = 31/84 (36%), Gaps = 4/84 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD--FLSKLP-LRTLNLQG 463
            ++T L L  + ++     + +    ++ L  S+N L   +P+      +  + +++   
Sbjct: 595 VKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY 653

Query: 464 NKLNGSVPVELLERSKNGSLSLSV 487
           NK+                ++ S 
Sbjct: 654 NKIGSEGRNISCSMDDYKGINAST 677

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.9 bits (119), Expect = 4e-06
 Identities = 14/79 (17%), Positives = 30/79 (37%), Gaps = 9/79 (11%)

Query: 404 SSSPRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
            ++  +T ++L  + L         + L  L  +D+S N  + S P        L+   +
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGI 783

Query: 462 Q------GNKLNGSVPVEL 474
           +      GN++    P  +
Sbjct: 784 RHQRDAEGNRILRQWPTGI 802

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 15/91 (16%), Positives = 32/91 (35%), Gaps = 9/91 (9%)

Query: 404 SSSPRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP------L 456
           + + ++  L  S + LK         ++  +  +D S N +     +    +        
Sbjct: 616 AFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675

Query: 457 RTLNLQGNKLNGSVPVELLERSKN-GSLSLS 486
            T+ L  N++    P EL        ++ LS
Sbjct: 676 STVTLSYNEIQK-FPTELFATGSPISTIILS 705

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 15/89 (16%), Positives = 28/89 (31%), Gaps = 21/89 (23%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-------------------S 446
           S + T +   ++ +   I+  +  LT LQ +  +N+  T                    +
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482

Query: 447 VPDFLSKLP-LRTLNLQGNKLNGSVPVEL 474
                S L  L  + L        +P  L
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFL 511

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 14/82 (17%), Positives = 28/82 (34%), Gaps = 4/82 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  L+   + ++  + +       L  L L  N +     DF +    +  L    NK
Sbjct: 573 VKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNK 630

Query: 466 LNGSVPVELLERSKN-GSLSLS 486
           L     +   +     GS+  S
Sbjct: 631 LKYIPNIFNAKSVYVMGSVDFS 652

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 5e-09
 Identities = 73/565 (12%), Positives = 165/565 (29%), Gaps = 138/565 (24%)

Query: 258 ASQSMDFYLETEDPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNY--LLT 315
           + + +D  + ++D                L + Q       +           NY  L++
Sbjct: 47  SKEEIDHIIMSKDAVSGTLRLF-----WTLLSKQEEMVQKFVEEVL-----RINYKFLMS 96

Query: 316 T--TVFSPTALIGGNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIK 373
              T     +++   Y     +  N     +     V  ++ +L+L+   +++    N+ 
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRLYND--NQVFAKYNVSRLQPYLKLRQALLELRPAKNV- 153

Query: 374 ATYGLK---KNW-QGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSN 429
              G+    K W   D C         + C        +I +LNL +      +   +  
Sbjct: 154 LIDGVLGSGKTWVALDVCLS-----YKVQCKMDF----KIFWLNLKNCNSPETVLEMLQK 204

Query: 430 LTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGG 489
           L       +  N    S  D  S + LR  ++Q            L +SK     L V  
Sbjct: 205 L----LYQIDPNWT--SRSDHSSNIKLRIHSIQAELRR-------LLKSKPYENCLLVLL 251

Query: 490 NPGLCSK-------ISCKKKKNNVVVPVVASVAGSVFLLAAALAIFFVLKRKRQVGKVKR 542
           N  + +        +SCK         ++ +    V    +A     +      +     
Sbjct: 252 N--VQNAKAWNAFNLSCKI--------LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301

Query: 543 ESKN--------KIDSF--EAKSRH--------LSYSDVVKITNNFERTLGKGGFGTVYY 584
           E K+        +      E  + +         S  D +   +N++          V  
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH---------VNC 352

Query: 585 GRLNE-IDVAVKMLSSSSAQG-FQQ---FQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI 639
            +L   I+ ++ +L  +  +  F +   F     +   +    L+ +     + +   ++
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL----LSLIWFDVIKSDVMVVV 408

Query: 640 YEF----MANGNLQE---YLSDISKKVLSSQERL----RIAVESAQGLE-YLHNGCKPP- 686
            +     +     +E    +  I  ++    E      R  V+     + +  +   PP 
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468

Query: 687 --------IVH---------RDVKSTNILLNEK-LQAKLADFGLSKSFATDANTHVSTVV 728
                   I H         R      + L+ + L+ K+         A +A+  +   +
Sbjct: 469 LDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST----AWNASGSILNTL 524

Query: 729 AGTPGYLDPEYYTSNRLTEKSDVYS 753
                    ++Y    + +    Y 
Sbjct: 525 ------QQLKFY-KPYICDNDPKYE 542

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.2 bits (137), Expect = 2e-08
 Identities = 42/276 (15%), Positives = 79/276 (28%), Gaps = 82/276 (29%)

Query: 575 GKGGFG-TVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED 633
           G  G G T          VA+ +  S   Q    F+        +   N    + +C+  
Sbjct: 157 GVLGSGKTW---------VALDVCLSYKVQCKMDFK--------IFWLN----LKNCNSP 195

Query: 634 -----NQTALIYEFMANGN-LQEYLSDISKKVLSSQERLRIA---------------VES 672
                    L+Y+   N     ++ S+I  ++ S Q  LR                 V++
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255

Query: 673 AQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
           A+     +  CK  +  R  + T+ L          D   S +   D    +        
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH-HSMTLTPDEVKSLLLKYLDCR 314

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP-AISRINEEEKIHIRQWVNSLIAKGD 791
               P                      E++T  P  +S I E  +  +  W N       
Sbjct: 315 PQDLPR---------------------EVLTTNPRRLSIIAESIRDGLATWDNW------ 347

Query: 792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQR 827
                     +  + + +   +E ++  L P   ++
Sbjct: 348 ----------KHVNCDKLTTIIESSLNVLEPAEYRK 373

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 1e-04
 Identities = 48/291 (16%), Positives = 93/291 (31%), Gaps = 82/291 (28%)

Query: 619 HHRNL---TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVES--A 673
           HH ++   T    +  +D  +     F+ N + +  + D+ K +LS +E   I +     
Sbjct: 3   HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCK-DVQDMPKSILSKEEIDHIIMSKDAV 61

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNIL---LNEKLQAKLADFG-LSKSFATDANTHVSTVVA 729
            G   L             K   ++   + E L+    ++  L     T+          
Sbjct: 62  SGTLRLF------WTLLS-KQEEMVQKFVEEVLR---INYKFLMSPIKTEQR-------- 103

Query: 730 GTPGYLDPEY-YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA 788
             P  +   Y    +RL   + V++           K  +SR   +  + +RQ +  L  
Sbjct: 104 -QPSMMTRMYIEQRDRLYNDNQVFA-----------KYNVSR--LQPYLKLRQALLELRP 149

Query: 789 KGDI---------KSIV------DPRLQEDFDANSVWKAVELAMA-CLSPTGNQRPTMSQ 832
             ++         K+ V        ++Q   D    W    L +  C SP          
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW----LNLKNCNSPET-------- 197

Query: 833 VVMELSECLAAEMARANSGRGFHS----------KGSIDHLMMSMNLGTEL 873
            V+E+ + L  ++    + R  HS          +  +  L+ S      L
Sbjct: 198 -VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 2e-04
 Identities = 36/295 (12%), Positives = 88/295 (29%), Gaps = 80/295 (27%)

Query: 551 FEAKSRHLSYSDVVKI-TNNFERTLGKGGFGTVYYGRLNEI-DVAVKMLSSSSAQGFQQF 608
           FE       Y D++ +  + F                  ++ D+   +LS          
Sbjct: 9   FETGEHQYQYKDILSVFEDAFVDNFD-----------CKDVQDMPKSILSK--------- 48

Query: 609 QAEVKLLMRVHHR-NLTSLVGHCDEDNQTALIYEFMANGNLQEY---LSDISKKVLSSQE 664
             E+  ++      + T  +       Q  ++ +F+       Y   +S I  +    ++
Sbjct: 49  -EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE---QRQ 104

Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
              +     +  + L+N         +V      L  KL+  L    L          +V
Sbjct: 105 PSMMTRMYIEQRDRLYND-NQVFAKYNVSRLQPYL--KLRQAL--LELRP------AKNV 153

Query: 725 STVVAGTPGY----LDPEYYTSNRLTEKSD--VY--SFGVV-----ILEIIT--C----- 764
             ++ G  G     +  +   S ++  K D  ++  +         +LE++         
Sbjct: 154 --LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211

Query: 765 ---------KPAISRINEEEK-----IHIRQWVNSLIAKGDIKSIVDPRLQEDFD 805
                         RI+  +      +  + + N L+   +++   + +    F+
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ---NAKAWNAFN 263

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 58.2 bits (141), Expect = 8e-09
 Identities = 21/89 (23%), Positives = 41/89 (46%), Gaps = 4/89 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT-GSVPDFLSKLP-LRTLNLQGN 464
             +  L    + L       + +L +L+ L++++N +    +P++ S L  L  L+L  N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 465 KLNGSVPVEL--LERSKNGSLSLSVGGNP 491
           K+      +L  L +    +LSL +  NP
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 16/66 (24%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSV-PDFLSKLP-LRTLNL 461
            S   + YL++S +  +       + L+SL+ L ++ N+   +  PD  ++L  L  L+L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 462 QGNKLN 467
              +L 
Sbjct: 478 SQCQLE 483

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.4 bits (126), Expect = 5e-07
 Identities = 19/83 (22%), Positives = 29/83 (34%), Gaps = 3/83 (3%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
                 L+LS + L+   +    +   LQ LDLS   +          L  L TL L GN
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 465 KLNGSVPVELLERSKN-GSLSLS 486
            +  S+ +       +   L   
Sbjct: 87  PIQ-SLALGAFSGLSSLQKLVAV 108

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 15/62 (24%), Positives = 26/62 (41%), Gaps = 1/62 (1%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             ++ L L+ + ++       S L+SLQ L     NL       +  L  L+ LN+  N 
Sbjct: 76  SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 466 LN 467
           + 
Sbjct: 136 IQ 137

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 5/84 (5%)

Query: 407 PRITYLNLSSSGL--KGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
           P + +L+LS +GL  KG  +      TSL++LDLS N +  ++      L  L  L+ Q 
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH 405

Query: 464 NKLNGSVPVELLERSKN-GSLSLS 486
           + L       +    +N   L +S
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDIS 429

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.2 bits (110), Expect = 4e-05
 Identities = 19/96 (19%), Positives = 39/96 (40%), Gaps = 5/96 (5%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQF----LDLSNNNLTGSVPDFLSKLPLRTL 459
           S+   + +L+LSS+ ++    + +  L  +      LDLS N +    P    ++ L  L
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 205

Query: 460 NLQGNKLNGSVPVELLER-SKNGSLSLSVGGNPGLC 494
            L+ N  + +V    ++  +      L +G      
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 17/63 (26%), Positives = 27/63 (42%), Gaps = 5/63 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT--GSVPDFLSKLP-LRTLNLQG 463
             +  L  +S+      +    +L SL+FLDLS N L+  G           L+ L+L  
Sbjct: 325 KSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382

Query: 464 NKL 466
           N +
Sbjct: 383 NGV 385

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 25/99 (25%), Positives = 38/99 (38%), Gaps = 14/99 (14%)

Query: 402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
            D++ P    L L S  L          L+ LQ + +    L   +PD + +   L TL 
Sbjct: 76  EDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLT 133

Query: 461 LQGNKLNGSVPVELLERSKNGSLS----LSVGGNPGLCS 495
           L  N L  ++P  +       SL+    LS+   P L  
Sbjct: 134 LARNPLR-ALPASI------ASLNRLRELSIRACPELTE 165

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 14/66 (21%), Positives = 32/66 (48%), Gaps = 3/66 (4%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG 468
            ++ + ++GL  ++   +     L+ L L+ N L  ++P  ++ L  LR L+++      
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164

Query: 469 SVPVEL 474
            +P  L
Sbjct: 165 ELPEPL 170

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 12/89 (13%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG 468
             L + +S L   +   + +L  L+ LDL       + P        L+ L L+      
Sbjct: 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267

Query: 469 SVPVELLERSKNGSLS----LSVGGNPGL 493
           ++P+++        L+    L + G   L
Sbjct: 268 TLPLDI------HRLTQLEKLDLRGCVNL 290

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 16/66 (24%), Positives = 34/66 (51%), Gaps = 3/66 (4%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG 468
             L L  +G++  + + ++NL +L+ L + N+ L+ ++   +  LP L  L+L+G     
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243

Query: 469 SVPVEL 474
           + P   
Sbjct: 244 NYPPIF 249

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 47.2 bits (113), Expect = 1e-05
 Identities = 13/78 (16%), Positives = 29/78 (37%), Gaps = 1/78 (1%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG 468
             L+L       +          L+ L L + +   ++P  + +L  L  L+L+G     
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 469 SVPVELLERSKNGSLSLS 486
            +P  + +   N  + + 
Sbjct: 292 RLPSLIAQLPANCIILVP 309

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.9 bits (107), Expect = 7e-05
 Identities = 15/95 (15%), Positives = 37/95 (38%), Gaps = 22/95 (23%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP----------LRTL 459
             L L+ + L+  + + +++L  L+ L +        +P+ L+             L++L
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188

Query: 460 NLQGNKLNGSVPVELLERSKNGSLS----LSVGGN 490
            L+   +  S+P  +       +L     L +  +
Sbjct: 189 RLEWTGIR-SLPASI------ANLQNLKSLKIRNS 216

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 15/58 (25%), Positives = 28/58 (48%), Gaps = 1/58 (1%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
             L +    +  D    +S LTSL  LD+S++    S+   ++ LP + +++L  N  
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 16/78 (20%), Positives = 36/78 (46%), Gaps = 3/78 (3%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG 468
             L +++     +  + +S L++L+ L +   ++T      LS L  L  L++  +  + 
Sbjct: 69  KDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126

Query: 469 SVPVELLERSKNGSLSLS 486
           S+  ++    K  S+ LS
Sbjct: 127 SILTKINTLPKVNSIDLS 144

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 17/62 (27%), Positives = 32/62 (51%), Gaps = 2/62 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T L++S S     I + ++ L  +  +DLS N     +   L  LP L++LN+Q + 
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170

Query: 466 LN 467
           ++
Sbjct: 171 VH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 15/67 (22%), Positives = 31/67 (46%), Gaps = 5/67 (7%)

Query: 409 ITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN 467
           +TY+ L++  +  D+T  +    +++ L ++N + T   P  +S L  L  L + G  + 
Sbjct: 46  LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101

Query: 468 GSVPVEL 474
                 L
Sbjct: 102 SDKIPNL 108

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 13/63 (20%), Positives = 26/63 (41%), Gaps = 4/63 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P++  ++LS +G   DI   +  L  L+ L++  + +       +   P L  L      
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192

Query: 466 LNG 468
           + G
Sbjct: 193 IGG 195

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 63/317 (19%), Positives = 108/317 (34%), Gaps = 90/317 (28%)

Query: 572 RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRV-----HHRNLT 624
           R LG G F TV+     +    VA+K++ S+     +    E++LL  V     +  N  
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNRE 101

Query: 625 SLVGHCD-------EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
            +V   D             +++E + + +L +++   + + L      +I  +  QGL+
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 678 YLHNGCKPPIVHRDVKSTNILLN------------------------------------- 700
           YLH  C+  I+H D+K  NILL+                                     
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 701 ------------EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
                       EKL+ K+AD G     A   + H +  +  T  Y   E    +     
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGN----ACWVHKHFTEDI-QTRQYRSLEVLIGSGYNTP 273

Query: 749 SDVYSFGVVILEIITCKPAISRINEEE----KIHIRQWVN-------SLIAKGDIKSIVD 797
           +D++S   +  E+ T        + EE    + HI   +         LI  G       
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK------ 327

Query: 798 PRLQEDFDANSVWKAVE 814
              +E F      K + 
Sbjct: 328 -YSKEFFTKKGDLKHIT 343

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 22/90 (24%), Positives = 40/90 (44%), Gaps = 8/90 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            R+  L +S++ L   +  Y   + +L+ LDLS+N+L   V     +   L  L L  N 
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335

Query: 466 LNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
           +  ++ +      KN    L++  N   C+
Sbjct: 336 IV-TLKLSTHHTLKN----LTLSHNDWDCN 360

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 20/83 (24%), Positives = 40/83 (48%), Gaps = 5/83 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
            ++  LNL+   ++ +I +Y  +   ++Q L +  N +    P     +P L  L L+ N
Sbjct: 75  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133

Query: 465 KLNGSVPVELLERSKN-GSLSLS 486
            L+ S+P  +   +    +LS+S
Sbjct: 134 DLS-SLPRGIFHNTPKLTTLSMS 155

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 5/82 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
           P +  ++LS + L+  I  +    +  L+ L +SNN L  ++  +   +P L+ L+L  N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311

Query: 465 KLNGSVPVELLERSKNGSLSLS 486
            L   V     +  +  +L L 
Sbjct: 312 HLL-HVERNQPQFDRLENLYLD 332

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 46.1 bits (109), Expect = 5e-05
 Identities = 16/89 (17%), Positives = 28/89 (31%), Gaps = 7/89 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKL 466
           P +  L+LS + L   +         L+ L L +N++          L  + L L  N  
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTL--KNLTLSHNDW 357

Query: 467 NGSVPVELLERSKNGSLSLSVGGNPGLCS 495
           + +    L           +V      C 
Sbjct: 358 DCNSLRALFRNVAR----PAVDDADQHCK 382

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 45.3 bits (107), Expect = 7e-05
 Identities = 21/73 (28%), Positives = 30/73 (41%), Gaps = 4/73 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
           P +T L L  + L   +   +  N   L  L +SNNNL     D       L+ L L  N
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181

Query: 465 KLNGSVPVELLER 477
           +L   V + L+  
Sbjct: 182 RLT-HVDLSLIPS 193

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 7/68 (10%), Positives = 20/68 (29%), Gaps = 3/68 (4%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVS--NLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTL 459
            +      + ++       D+        L + + +   N+ +       L     +  L
Sbjct: 21  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 80

Query: 460 NLQGNKLN 467
           NL   ++ 
Sbjct: 81  NLNDLQIE 88

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 17/61 (27%), Positives = 27/61 (44%), Gaps = 3/61 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T L L  + L    T+++ N   L  +DLS N L   +     K+  L  L +  N+
Sbjct: 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289

Query: 466 L 466
           L
Sbjct: 290 L 290

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.9 bits (133), Expect = 5e-08
 Identities = 21/70 (30%), Positives = 35/70 (50%), Gaps = 3/70 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  LN+ S+ +  DI+  ++NL+ L  L L+NN L     + +  L  L TL L  N 
Sbjct: 265 TKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322

Query: 466 LNGSVPVELL 475
           +    P+  L
Sbjct: 323 ITDIRPLASL 332

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 50.6 bits (122), Expect = 1e-06
 Identities = 14/61 (22%), Positives = 29/61 (47%), Gaps = 3/61 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  L L+++ L  +    +  LT+L  L LS N++T   P  L+ L  + + +     
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

Query: 466 L 466
           +
Sbjct: 345 I 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.8 bits (120), Expect = 2e-06
 Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 4/70 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L L+   +  DI S ++NLT +  L+L  N+   S    LS +  L  L +  +K
Sbjct: 110 TNLRELYLNEDNIS-DI-SPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESK 166

Query: 466 LNGSVPVELL 475
           +    P+  L
Sbjct: 167 VKDVTPIANL 176

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.9 bits (115), Expect = 9e-06
 Identities = 20/70 (28%), Positives = 31/70 (44%), Gaps = 5/70 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             + YLNL+ + +     S +SNL  L  L +  N +T      L  L  LR L L  + 
Sbjct: 66  TNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDN 121

Query: 466 LNGSVPVELL 475
           ++   P+  L
Sbjct: 122 ISDISPLANL 131

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.5 bits (114), Expect = 1e-05
 Identities = 13/63 (20%), Positives = 35/63 (55%), Gaps = 5/63 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            R+  L + ++ +  D++  ++NL+ L +L++  N ++    + +  L  L+ LN+  N+
Sbjct: 221 TRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQ 276

Query: 466 LNG 468
           ++ 
Sbjct: 277 ISD 279

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.0 bits (110), Expect = 3e-05
 Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 5/62 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             IT L ++   +   I   +  LT+L++L+L+ N +T   P  LS L  L  L +  NK
Sbjct: 44  ESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK 99

Query: 466 LN 467
           + 
Sbjct: 100 IT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 45.2 bits (108), Expect = 5e-05
 Identities = 19/70 (27%), Positives = 33/70 (47%), Gaps = 5/70 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             + YL ++ S +K D+ + ++NLT L  L L+ N +    P  L+ L  L       N+
Sbjct: 155 TGLNYLTVTESKVK-DV-TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210

Query: 466 LNGSVPVELL 475
           +    PV  +
Sbjct: 211 ITDITPVANM 220

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.8 bits (107), Expect = 8e-05
 Identities = 17/61 (27%), Positives = 35/61 (57%), Gaps = 5/61 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++T L + ++ +  DI++ + NLT+L+ L L+ +N++      L+ L  + +LNL  N 
Sbjct: 88  VKLTNLYIGTNKIT-DISA-LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANH 143

Query: 466 L 466
            
Sbjct: 144 N 144

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.5 bits (106), Expect = 1e-04
 Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 5/63 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             + Y     + +  DIT  V+N+T L  L + NN +T      L+ L  L  L +  N+
Sbjct: 199 TSLHYFTAYVNQIT-DITP-VANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQ 254

Query: 466 LNG 468
           ++ 
Sbjct: 255 ISD 257

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 22/90 (24%), Positives = 40/90 (44%), Gaps = 8/90 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            R+  L +S++ L   +  Y   + +L+ LDLS+N+L   V     +   L  L L  N 
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329

Query: 466 LNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
           +  ++ +      KN    L++  N   C+
Sbjct: 330 IV-TLKLSTHHTLKN----LTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 20/83 (24%), Positives = 40/83 (48%), Gaps = 5/83 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
            ++  LNL+   ++ +I +Y  +   ++Q L +  N +    P     +P L  L L+ N
Sbjct: 69  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127

Query: 465 KLNGSVPVELLERSKN-GSLSLS 486
            L+ S+P  +   +    +LS+S
Sbjct: 128 DLS-SLPRGIFHNTPKLTTLSMS 149

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.1 bits (115), Expect = 7e-06
 Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 5/82 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
           P +  ++LS + L+  I  +    +  L+ L +SNN L  ++  +   +P L+ L+L  N
Sbjct: 248 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305

Query: 465 KLNGSVPVELLERSKNGSLSLS 486
            L   V     +  +  +L L 
Sbjct: 306 HLL-HVERNQPQFDRLENLYLD 326

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 22/80 (27%), Positives = 34/80 (42%), Gaps = 4/80 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
           P +T L L  + L   +   +  N   L  L +SNNNL     D       L+ L L  N
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175

Query: 465 KLNGSVPVELLERSKNGSLS 484
           +L   V + L+    + ++S
Sbjct: 176 RLT-HVDLSLIPSLFHANVS 194

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.0 bits (107), Expect = 8e-05
 Identities = 8/88 (9%), Positives = 24/88 (27%), Gaps = 5/88 (5%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVS--NLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTL 459
            +      + ++       D+        L + + +   N+ +       L     +  L
Sbjct: 15  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74

Query: 460 NLQGNKLNGSVPVELLERSKN-GSLSLS 486
           NL   ++   +       +     L + 
Sbjct: 75  NLNDLQIE-EIDTYAFAYAHTIQKLYMG 101

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 17/61 (27%), Positives = 27/61 (44%), Gaps = 3/61 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T L L  + L    T+++ N   L  +DLS N L   +     K+  L  L +  N+
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283

Query: 466 L 466
           L
Sbjct: 284 L 284

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.0 bits (99), Expect = 7e-04
 Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 4/62 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
           P++T L++S++ L+  I        TSLQ L LS+N LT      +    L   N+  N 
Sbjct: 141 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS--LFHANVSYNL 197

Query: 466 LN 467
           L+
Sbjct: 198 LS 199

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 20/70 (28%), Positives = 32/70 (45%), Gaps = 1/70 (1%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            R     ++ S LK  + S   +  +++ LDLS N L+      L+    L  LNL  N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 466 LNGSVPVELL 475
           L  ++ +E L
Sbjct: 70  LYETLDLESL 79

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 7/89 (7%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           +SS  + +LNL  + +  D+   V     L+ LDLS+N L   +         +  ++L+
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222

Query: 463 GNKLNGSVPVELLERSKNGSLSLSVGGNP 491
            NKL   +   L          L   GN 
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLR--GNG 248

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 16/61 (26%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 407 PRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
            R+ YL+L  + +   +     ++  +L+ L+L  N +   V   +    L+TL+L  NK
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNK 202

Query: 466 L 466
           L
Sbjct: 203 L 203

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 7/39 (17%), Positives = 18/39 (46%), Gaps = 1/39 (2%)

Query: 429 NLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
           N    +   +++++L  ++         ++ L+L GN L
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 22/81 (27%), Positives = 40/81 (49%), Gaps = 11/81 (13%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  LNLSS+ L  +    + +L++L+ LDL+NN +       L   P + TL+   N 
Sbjct: 58  TKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNN 110

Query: 466 LNGSVPVELLERSKNGSLSLS 486
           ++  V     +  KN  + L+
Sbjct: 111 IS-RVSCSRGQGKKN--IYLA 128

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 16/82 (19%), Positives = 35/82 (42%), Gaps = 5/82 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P I  L+ +++ +   ++   S     + + L+NN +T            ++ L+L+ N+
Sbjct: 99  PSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155

Query: 466 LNGSVPVELLERSKN-GSLSLS 486
           ++     EL   S     L+L 
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQ 177

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 54.2 bits (131), Expect = 8e-08
 Identities = 20/70 (28%), Positives = 32/70 (45%), Gaps = 1/70 (1%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            R     ++ S LK  + S   +  +++ LDLS N L+      L+    L  LNL  N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 466 LNGSVPVELL 475
           L  ++ +E L
Sbjct: 70  LYETLDLESL 79

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 14/75 (18%), Positives = 31/75 (41%), Gaps = 3/75 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  L+LSS+ L   +     +   + ++ L NN L   +   L     L   +L+GN 
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248

Query: 466 LNGSVPVELLERSKN 480
            +     +   +++ 
Sbjct: 249 FHCGTLRDFFSKNQR 263

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 7/89 (7%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           +SS  + +LNL  + +  D+   V     L+ LDLS+N L   +         +  ++L+
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222

Query: 463 GNKLNGSVPVELLERSKNGSLSLSVGGNP 491
            NKL   +   L          L   GN 
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLR--GNG 248

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 48.4 bits (116), Expect = 5e-06
 Identities = 17/69 (24%), Positives = 32/69 (46%), Gaps = 3/69 (4%)

Query: 407 PRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
            R+ YL+L  + +   +     ++  +L+ L+L  N +   V   +    L+TL+L  NK
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNK 202

Query: 466 LNGSVPVEL 474
           L   +  E 
Sbjct: 203 LA-FMGPEF 210

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 8/45 (17%), Positives = 19/45 (42%), Gaps = 1/45 (2%)

Query: 423 ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
           I     N    +   +++++L  ++         ++ L+L GN L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 12/59 (20%), Positives = 25/59 (42%), Gaps = 2/59 (3%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGNKL 466
             + L+++ +           + +Q+LDL  N +   +  +  +    L  LNLQ N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 22/81 (27%), Positives = 40/81 (49%), Gaps = 11/81 (13%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  LNLSS+ L  +    + +L++L+ LDL+NN +       L   P + TL+   N 
Sbjct: 58  TKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN 110

Query: 466 LNGSVPVELLERSKNGSLSLS 486
           ++  V     +  KN  + L+
Sbjct: 111 IS-RVSCSRGQGKKN--IYLA 128

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.0 bits (107), Expect = 6e-05
 Identities = 11/65 (16%), Positives = 29/65 (44%), Gaps = 4/65 (6%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
              P I  L+ +++ +   ++   S     + + L+NN +T            ++ L+L+
Sbjct: 96  LVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152

Query: 463 GNKLN 467
            N+++
Sbjct: 153 LNEID 157

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.7 bits (132), Expect = 8e-08
 Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 11/91 (12%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD--FLSKLPLRTLNLQGN 464
             +  L++S++ L     S+   L  LQ L +S N L  ++PD        L  + +  N
Sbjct: 431 QTLEVLDVSNNNL----DSFSLFLPRLQELYISRNKLK-TLPDASLFPV--LLVMKISRN 483

Query: 465 KLNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
           +L  SVP  + +R  +    + +  NP  CS
Sbjct: 484 QLK-SVPDGIFDRLTSLQ-KIWLHTNPWDCS 512

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 5/81 (6%)

Query: 407 PRITYLNLSSSGLK--GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
           P +  L LS + L+        +  L +L  LD+S N     +PD       +R LNL  
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419

Query: 464 NKLNGSVPVELLERSKNGSLS 484
             +   V   + +  +   +S
Sbjct: 420 TGIR-VVKTCIPQTLEVLDVS 439

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.1 bits (120), Expect = 3e-06
 Identities = 17/88 (19%), Positives = 34/88 (38%), Gaps = 2/88 (2%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
            +  I  L++    L  D+++  S L  ++ + + N+ +      F   L  L  L+L  
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343

Query: 464 NKLNGSVPVELLERSKNGSL-SLSVGGN 490
           N +          +    SL +L +  N
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQN 371

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 17/83 (20%), Positives = 32/83 (38%), Gaps = 3/83 (3%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
           +  +  L+LS + +       +    +LQ L L ++ +     D    L  L  L+L  N
Sbjct: 25  TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84

Query: 465 KLNGSVPVELLERSKN-GSLSLS 486
            L+ S+         +   L+L 
Sbjct: 85  HLS-SLSSSWFGPLSSLKYLNLM 106

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 17/64 (26%), Positives = 27/64 (42%), Gaps = 3/64 (4%)

Query: 407 PRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNLQG 463
             + YLNL  +  +   +TS   NLT+LQ L + N      +     + L  L  L ++ 
Sbjct: 98  SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157

Query: 464 NKLN 467
             L 
Sbjct: 158 LSLR 161

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 6/67 (8%)

Query: 407 PRITYLNLSS---SGLKGDITSYVSNLTSLQFLDLSNNNLT--GSVPDFLSKLP-LRTLN 460
             + +L+LS           ++      SLQ L LS N+L       + L  L  L +L+
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393

Query: 461 LQGNKLN 467
           +  N  +
Sbjct: 394 ISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 16/76 (21%), Positives = 31/76 (40%), Gaps = 2/76 (2%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGN 464
             + +L+LS + L    +S+   L+SL++L+L  N      V      L  L+TL +   
Sbjct: 74  GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133

Query: 465 KLNGSVPVELLERSKN 480
           +    +         +
Sbjct: 134 ETFSEIRRIDFAGLTS 149

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 10/66 (15%), Positives = 24/66 (36%), Gaps = 1/66 (1%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           +    +  L + +  L+   +  + ++  +  L L  +     +  F   L  +R L L+
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204

Query: 463 GNKLNG 468
              L  
Sbjct: 205 DTNLAR 210

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 21/91 (23%), Positives = 43/91 (47%), Gaps = 4/91 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +T+L+LS   L+  ++    ++L+SLQ L++S+NN           L  L+ L+   N
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233

Query: 465 KLNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
            +  +   + L+   +    L++  N   C+
Sbjct: 234 HIM-TSKKQELQHFPSSLAFLNLTQNDFACT 263

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 18/87 (20%), Positives = 38/87 (43%), Gaps = 5/87 (5%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYV--SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
               ++ +L+   S LK  ++ +    +L +L +LD+S+ +   +     + L  L  L 
Sbjct: 98  LGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156

Query: 461 LQGNKLNGSVPVELLERSKN-GSLSLS 486
           + GN    +   ++    +N   L LS
Sbjct: 157 MAGNSFQENFLPDIFTELRNLTFLDLS 183

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 19/91 (20%), Positives = 35/91 (38%), Gaps = 9/91 (9%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD--FLSKLP-LRTLNLQG 463
             + YL+LS +G+   ++S    L  L+ LD  ++NL   + +      L  L  L++  
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISH 135

Query: 464 NKLNGSVPVELLERSKNGSL-SLSVGGNPGL 493
                     +     +  L  L + GN   
Sbjct: 136 THTR-VAFNGIFNGLSS--LEVLKMAGNSFQ 163

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 47.7 bits (114), Expect = 8e-06
 Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 2/63 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +  L ++ +  + +    + + L +L FLDLS   L    P   + L  L+ LN+  N
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209

Query: 465 KLN 467
              
Sbjct: 210 NFF 212

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 21/63 (33%), Positives = 32/63 (50%), Gaps = 4/63 (6%)

Query: 407 PRITYLNLSSSGLK-GDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
            ++T L+LSS+GL      S      TSL++LDLS N +  ++      L  L  L+ Q 
Sbjct: 52  TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH 110

Query: 464 NKL 466
           + L
Sbjct: 111 SNL 113

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 18/64 (28%), Positives = 25/64 (39%), Gaps = 3/64 (4%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT--GSVPDFLSKLP-LRTLNLQ 462
               T L L S+ L+         LT L  L LS+N L+  G           L+ L+L 
Sbjct: 27  PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86

Query: 463 GNKL 466
            N +
Sbjct: 87  FNGV 90

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 22/73 (30%), Positives = 34/73 (46%), Gaps = 6/73 (8%)

Query: 407 PRITYLNLSSSGLK---GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP--LRTLNL 461
           P +  L L ++G++   G  ++  +    LQ LDLS+N+L  +        P  L +LNL
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260

Query: 462 QGNKLNGSVPVEL 474
               L   VP  L
Sbjct: 261 SFTGLK-QVPKGL 272

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 51.1 bits (122), Expect = 7e-07
 Identities = 21/65 (32%), Positives = 28/65 (43%), Gaps = 8/65 (12%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNL-TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
               ++  LNLS +GL          L   L  LDLS N L    P    +LP +  L+L
Sbjct: 250 DWPSQLNSLNLSFTGL----KQVPKGLPAKLSVLDLSYNRLD-RNPSPD-ELPQVGNLSL 303

Query: 462 QGNKL 466
           +GN  
Sbjct: 304 KGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 19/93 (20%), Positives = 31/93 (33%), Gaps = 8/93 (8%)

Query: 402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-----L 456
                P +  L+++ +         V    +L  LDLS+N   G      +  P     L
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203

Query: 457 RTLNLQGNKLN---GSVPVELLERSKNGSLSLS 486
           + L L+   +    G        R +   L LS
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLS 236

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 9/89 (10%)

Query: 407 PRITYLNLSSSGLKGDITSYVS----NLTSLQFLDLSNNNLT---GSVPDFLSKLP-LRT 458
           P ++ L+LS +   G+     +       +LQ L L N  +    G      +    L+ 
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232

Query: 459 LNLQGNKLNGSVPVELLERSKN-GSLSLS 486
           L+L  N L  +      +      SL+LS
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 7/86 (8%)

Query: 407 PRITYLNLSSSGLKGDI-TSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
            ++  L+LS + L+           + L  L+LS   L   VP  L    L  L+L  N+
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAK-LSVLDLSYNR 285

Query: 466 LNGSVPVELLERSKNGSLSLSVGGNP 491
           L+ +   + L +    +LSL   GNP
Sbjct: 286 LDRNPSPDELPQVG--NLSLK--GNP 307

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 54.4 bits (130), Expect = 1e-07
 Identities = 25/98 (25%), Positives = 47/98 (47%), Gaps = 8/98 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T+L+LS + L+  +   ++ L  L+ L  S+N L  +V   ++ LP L+ L L  N+
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR 519

Query: 466 LNGSVPVELLERSKNGSL-SLSVGGNPGLCSKISCKKK 502
           L       +        L  L++ GN  LC +   +++
Sbjct: 520 LQ-QSA-AIQPLVSCPRLVLLNLQGNS-LCQEEGIQER 554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 50.9 bits (121), Expect = 1e-06
 Identities = 21/129 (16%), Positives = 42/129 (32%), Gaps = 6/129 (4%)

Query: 339 STLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLN 398
             L P      +  +     L     + + +        +            + +    +
Sbjct: 375 QELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENS 434

Query: 399 CSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LR 457
               + +  R   L+L+   L   +  ++  L  +  LDLS+N L  ++P  L+ L  L 
Sbjct: 435 VLKMEYADVR--VLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLE 489

Query: 458 TLNLQGNKL 466
            L    N L
Sbjct: 490 VLQASDNAL 498

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 8/89 (8%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYV-----SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LR 457
           S +P +  L L  + L+    + +       L+ LQ L L++N L    P   S L  LR
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507

Query: 458 TLNLQGNKLNGSVPVELLERSKNGSLSLS 486
            L+L  N+L   +    L  +    L +S
Sbjct: 508 GLSLNSNRLT-VLSHNDLPANLE-ILDIS 534

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 6/93 (6%)

Query: 404 SSSPRITYLNLSSSGLKGDI--TSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTL 459
                +  L L   GL   +    Y  NL +L  LDLS N +    +     KL  L+++
Sbjct: 94  QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153

Query: 460 NLQGNKLNGSVPVELLERSKNGSLS-LSVGGNP 491
           +   N++   V    LE  +  +LS  S+  N 
Sbjct: 154 DFSSNQIF-LVCEHELEPLQGKTLSFFSLAANS 185

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 3/85 (3%)

Query: 406 SPRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPD-FLSKLP-LRTLNLQ 462
           +     ++LS + L+  DI  ++  +  LQ L L+ N  +    D   S+ P L  L L 
Sbjct: 400 NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459

Query: 463 GNKLNGSVPVELLERSKNGSLSLSV 487
            N L  +   EL      G   L V
Sbjct: 460 ENMLQLAWETELCWDVFEGLSHLQV 484

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 21/84 (25%), Positives = 30/84 (35%), Gaps = 4/84 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
            ++  L L S      I      NL +L+ LDL ++ +    PD    L  L  L L   
Sbjct: 48  EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107

Query: 465 KL-NGSVPVELLERSKN-GSLSLS 486
            L +  +        K    L LS
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLS 131

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 49.4 bits (118), Expect = 5e-06
 Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 8/95 (8%)

Query: 404 SSSPRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPD---FLSKLPLRTL 459
            +   +T L+LS + ++   +      L SL+ +D S+N +          L    L   
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179

Query: 460 NLQGNKLNGSVPV---ELLERSKNGSLS-LSVGGN 490
           +L  N L   V V   + +   +N  L  L V GN
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 48.6 bits (116), Expect = 9e-06
 Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 1/62 (1%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  LNLS + L    +S    L  + ++DL  N++          L  L+TL+L+ N 
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373

Query: 466 LN 467
           L 
Sbjct: 374 LT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 1/62 (1%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  LNL+ + +          L +LQ L+LS N L          LP +  ++LQ N 
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 466 LN 467
           + 
Sbjct: 350 IA 351

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 17/60 (28%), Positives = 28/60 (46%), Gaps = 3/60 (5%)

Query: 409 ITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
           + +L+LS   +   + S V   L  L+ L+L+ N +     +    L  L+ LNL  N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 15/77 (19%), Positives = 21/77 (27%), Gaps = 6/77 (7%)

Query: 412 LNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSV 470
                  L    T     L + + L LS N +          L  L+ L L       ++
Sbjct: 9   AFYRFCNL----TQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64

Query: 471 PVELLERSKN-GSLSLS 486
             E      N   L L 
Sbjct: 65  DKEAFRNLPNLRILDLG 81

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 3/67 (4%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNL--TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
             +  I         +K    +  + L  +S++ LDLS+  +          L  L+ LN
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296

Query: 461 LQGNKLN 467
           L  NK+N
Sbjct: 297 LAYNKIN 303

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 38/119 (31%), Positives = 52/119 (43%), Gaps = 18/119 (15%)

Query: 410 TYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN 467
             LNLS + L   I S +  NL  L+ LDLS N++          LP L+ L L  N+L 
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384

Query: 468 GSVPVELLERSKNGSLS-LSVGGNPGLCSKISCKK--------KKNNVVVPVVASVAGS 517
            SVP  + +R    SL  + +  NP  C   SC +         KN+      A  +GS
Sbjct: 385 -SVPDGIFDR--LTSLQKIWLHTNPWDC---SCPRIDYLSRWLNKNSQKEQGSAKCSGS 437

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 21/81 (25%), Positives = 34/81 (41%), Gaps = 5/81 (6%)

Query: 407 PRITYLNLSSSGLKGDI--TSYVSNLTSLQFLDLSNNNLTGSVPD-FLSKLP-LRTLNLQ 462
             +  L L+   L G +   ++   LTSL+ L L +NN+    P  F   +     L+L 
Sbjct: 103 ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT 162

Query: 463 GNKLNGSVPVELLERSKNGSL 483
            NK+  S+  E L   +    
Sbjct: 163 FNKVK-SICEEDLLNFQGKHF 182

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 20/76 (26%), Positives = 33/76 (43%), Gaps = 4/76 (5%)

Query: 398 NCSYGDSSSPRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP- 455
           N ++    +  +   +LS S +   +   V S+ T L+ L L+ N +     +    L  
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324

Query: 456 LRTLNLQGNKLNGSVP 471
           L  LNL  N L GS+ 
Sbjct: 325 LLKLNLSQNFL-GSID 339

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 16/64 (25%), Positives = 28/64 (43%), Gaps = 5/64 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSV--PDFLSKLP-LRTLNLQ 462
             +  L L  +     + +   + L +L+ L L+  NL G+V   +F   L  L  L L+
Sbjct: 79  SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137

Query: 463 GNKL 466
            N +
Sbjct: 138 DNNI 141

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 14/74 (18%), Positives = 26/74 (35%), Gaps = 5/74 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNLQG 463
             + Y++LS + +  ++     S L  LQFL +        +  +    L  L  L L  
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 464 NKLNGSVPVELLER 477
           N+    +       
Sbjct: 89  NQF-LQLETGAFNG 101

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 10/99 (10%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
            ++  L L  + ++  I +   S L +L+ L L NN L+  VP  L  L  L+ + L  N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274

Query: 465 KLNGSVPVE----LLERSKNGSLS-LSVGGNPGLCSKIS 498
            +   V V     +    K    + +S+  NP    ++ 
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 19/72 (26%), Positives = 30/72 (41%), Gaps = 4/72 (5%)

Query: 406 SPRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
           SP  T L+L ++ +  ++       L  L  L L NN ++       S L  L+ L +  
Sbjct: 53  SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111

Query: 464 NKLNGSVPVELL 475
           N L   +P  L 
Sbjct: 112 NHLV-EIPPNLP 122

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 8/87 (9%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
             +  L L ++ +   I     S L  LQ L +S N+L   +P  L    L  L +  N+
Sbjct: 78  QHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS-SLVELRIHDNR 134

Query: 466 LNGSVPVELLERSKNGSL-SLSVGGNP 491
           +   VP  +    +N  +  + +GGNP
Sbjct: 135 IR-KVPKGVFSGLRN--MNCIEMGGNP 158

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 4/70 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +  L+L  + ++  I        + L  L L +N +       LS LP LR L+L  N
Sbjct: 193 ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN 251

Query: 465 KLNGSVPVEL 474
           KL+  VP  L
Sbjct: 252 KLS-RVPAGL 260

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 13/50 (26%), Positives = 21/50 (42%), Gaps = 3/50 (6%)

Query: 428 SNLTSLQFLDLSNNNLTGSV--PDFLSKLPLRTLNLQGNKLNGSVPVELL 475
           S L ++  +++  N L  S   P     L L  L +   KL   +P +L 
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP 192

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 7/92 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +T+L L  + +   +       L SL  L L  N +    P     L  L TL L  N
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 465 KLNGSVPVELLERSKN-GSLSLSVGGNPGLCS 495
            L+ ++P E L   +    L L+   NP +C 
Sbjct: 212 NLS-ALPTEALAPLRALQYLRLN--DNPWVCD 240

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 20/63 (31%), Positives = 33/63 (52%), Gaps = 5/63 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPD-FLSKLP-LRTLNLQG 463
            R+  L+L   GL+ ++   +   L +LQ+L L +N L  ++PD     L  L  L L G
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162

Query: 464 NKL 466
           N++
Sbjct: 163 NRI 165

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 14/63 (22%), Positives = 24/63 (38%), Gaps = 3/63 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             + YL L  + L+  +      +L +L  L L  N ++         L  L  L L  N
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187

Query: 465 KLN 467
           ++ 
Sbjct: 188 RVA 190

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 15/83 (18%), Positives = 24/83 (28%), Gaps = 2/83 (2%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
                 + L  + +     +      +L  L L +N L        + L  L  L+L  N
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 465 KLNGSVPVELLERSKN-GSLSLS 486
               SV            +L L 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLD 113

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 5/72 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNLQG 463
             +  L+LS +     +       L  L  L L    L   +       L  L+ L LQ 
Sbjct: 80  ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQD 138

Query: 464 NKLNGSVPVELL 475
           N L  ++P +  
Sbjct: 139 NALQ-ALPDDTF 149

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 7e-07
 Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 6/87 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             + +L+  + GL   I + +  L  L+ L+LS+N ++G +     K P L  LNL GNK
Sbjct: 42  EELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99

Query: 466 LNGSVPVELLERSKNGSL-SLSVGGNP 491
           +     +E L++ +N  L SL +    
Sbjct: 100 IKDLSTIEPLKKLEN--LKSLDLFNCE 124

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 2/63 (3%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNL 461
               ++  L LS + + G +        +L  L+LS N +   S  + L KL  L++L+L
Sbjct: 61  PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDL 120

Query: 462 QGN 464
              
Sbjct: 121 FNC 123

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 51.6 bits (124), Expect = 7e-07
 Identities = 20/83 (24%), Positives = 37/83 (44%), Gaps = 3/83 (3%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
                 L+L  + +K       ++   L+ L+L+ N ++   P   + L  LRTL L+ N
Sbjct: 31  PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90

Query: 465 KLNGSVPVELLERSKN-GSLSLS 486
           +L   +P+ +     N   L +S
Sbjct: 91  RLK-LIPLGVFTGLSNLTKLDIS 112

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 24/90 (26%), Positives = 37/90 (41%), Gaps = 5/90 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             + +LNLS + +   I   +   L  LQ + L    L    P     L  LR LN+ GN
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306

Query: 465 KLNGSVPVELLERSKNGSLSLSVGGNPGLC 494
           +L  ++   +     N   +L +  NP  C
Sbjct: 307 QLT-TLEESVFHSVGNLE-TLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 20/88 (22%), Positives = 36/88 (40%), Gaps = 7/88 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSV-PDFLSKLPLRTLNLQGN 464
             +  L L    +   I  Y    L  L+ L++S+     ++ P+ L  L L +L++   
Sbjct: 176 HGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234

Query: 465 KLNGSVPVELLERSKNGSL-SLSVGGNP 491
            L  +VP   +       L  L++  NP
Sbjct: 235 NLT-AVPYLAVRHLVY--LRFLNLSYNP 259

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 18/62 (29%), Positives = 28/62 (45%), Gaps = 3/62 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF-LSKLP-LRTLNLQGN 464
            R+  L +S       +T       +L  L +++ NLT +VP   +  L  LR LNL  N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258

Query: 465 KL 466
            +
Sbjct: 259 PI 260

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 1/61 (1%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T L+++   L       V +L  L+FL+LS N ++      L +L  L+ + L G +
Sbjct: 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283

Query: 466 L 466
           L
Sbjct: 284 L 284

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 24/92 (26%), Positives = 37/92 (40%), Gaps = 7/92 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +  L +  + L   I+    S L SL+ L L   NLT    + LS L  L  L L+  
Sbjct: 128 YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186

Query: 465 KLNGSVPVELLERSKN-GSLSLSVGGNPGLCS 495
            +N ++     +R      L +S    P L +
Sbjct: 187 NIN-AIRDYSFKRLYRLKVLEIS--HWPYLDT 215

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 18/62 (29%), Positives = 29/62 (46%), Gaps = 3/62 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +  L L S+ LK  I   V + L++L  LD+S N +   +      L  L++L +  N
Sbjct: 80  FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138

Query: 465 KL 466
            L
Sbjct: 139 DL 140

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 19/72 (26%), Positives = 35/72 (48%), Gaps = 4/72 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +T L++S + +   +  Y+  +L +L+ L++ +N+L        S L  L  L L+  
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162

Query: 465 KLNGSVPVELLE 476
            L  S+P E L 
Sbjct: 163 NLT-SIPTEALS 173

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 10/96 (10%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVP----DFLSKLP-LRTLN 460
             +  L L ++ +   +      ++  LQ L LS N ++   P       +KLP L  L+
Sbjct: 112 QALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169

Query: 461 LQGNKLNGSVPVELLER-SKNGSLSLSVGGNPGLCS 495
           L  NKL   +P+  L++        L +  NP  C 
Sbjct: 170 LSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECD 204

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 19/63 (30%), Positives = 31/63 (49%), Gaps = 5/63 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNLQG 463
             +  L LS + L   I+S     + +L++LDLS+N+L  ++     S L  L  L L  
Sbjct: 64  TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYN 121

Query: 464 NKL 466
           N +
Sbjct: 122 NHI 124

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 23/73 (31%), Positives = 41/73 (56%), Gaps = 6/73 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDF-LSKLP-LRTLNLQG 463
           P + YL+LSS+ L   +  ++ S+L +L+ L L NN++   V       +  L+ L L  
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145

Query: 464 NKLNGSVPVELLE 476
           N+++   PVEL++
Sbjct: 146 NQIS-RFPVELIK 157

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 3/74 (4%)

Query: 406 SPRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
                 L+LS + L      +  + LT+L  L LS+N+L     +    +P LR L+L  
Sbjct: 38  PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97

Query: 464 NKLNGSVPVELLER 477
           N L+ ++   L   
Sbjct: 98  NHLH-TLDEFLFSD 110

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 3/89 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L +S +            L+SL+ L + N+ ++    +    L  L  LNL  N 
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277

Query: 466 LNGSVPVELLERSKNGSLSLSVGGNPGLC 494
           L+ S+P +L    +   + L +  NP  C
Sbjct: 278 LS-SLPHDLFTPLRY-LVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 2/61 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
           P +  L+L        I+      L +L++L+L   N+   +P+    + L  L + GN 
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNH 229

Query: 466 L 466
            
Sbjct: 230 F 230

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 17/62 (27%), Positives = 26/62 (41%), Gaps = 3/62 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +  L L  + ++  I     + L SL  L+L +N LT         L  LR L L+ N
Sbjct: 99  HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157

Query: 465 KL 466
            +
Sbjct: 158 PI 159

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 16/62 (25%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
                YLNL  + ++        +L  L+ L L  N++        + L  L TL L  N
Sbjct: 74  PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133

Query: 465 KL 466
            L
Sbjct: 134 WL 135

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 15/61 (24%), Positives = 29/61 (47%), Gaps = 3/61 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             + YLNL    +K D+ +  + L  L+ L++S N+     P     L  L+ L +  ++
Sbjct: 196 FNLKYLNLGMCNIK-DMPNL-TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253

Query: 466 L 466
           +
Sbjct: 254 V 254

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 50.3 bits (121), Expect = 2e-06
 Identities = 20/70 (28%), Positives = 31/70 (44%), Gaps = 5/70 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++T L     G+K  I   V  L +L  ++ SNN LT   P  L  L  L  + +  N+
Sbjct: 46  DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 101

Query: 466 LNGSVPVELL 475
           +    P+  L
Sbjct: 102 IADITPLANL 111

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.8 bits (117), Expect = 6e-06
 Identities = 25/87 (28%), Positives = 41/87 (47%), Gaps = 11/87 (12%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T L L+ + L+    S +SNL +L +L L  NN++   P  +S L  L+ L    NK
Sbjct: 287 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342

Query: 466 LNGSVPVELLERSKNGSL-SLSVGGNP 491
           ++    +  L      ++  LS G N 
Sbjct: 343 VSDVSSLANLT-----NINWLSAGHNQ 364

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.0 bits (115), Expect = 8e-06
 Identities = 21/72 (29%), Positives = 34/72 (47%), Gaps = 5/72 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +TYL L  + +     S VS+LT LQ L   NN ++      L+ L  +  L+   N+
Sbjct: 309 KNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQ 364

Query: 466 LNGSVPVELLER 477
           ++   P+  L R
Sbjct: 365 ISDLTPLANLTR 376

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.0 bits (115), Expect = 1e-05
 Identities = 24/70 (34%), Positives = 40/70 (57%), Gaps = 5/70 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L+L+ + LK DI + +++LT+L  LDL+NN ++   P  LS L  L  L L  N+
Sbjct: 221 TNLDELSLNGNQLK-DIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276

Query: 466 LNGSVPVELL 475
           ++   P+  L
Sbjct: 277 ISNISPLAGL 286

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 17/70 (24%), Positives = 35/70 (50%), Gaps = 6/70 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L+  +          ++NLT+L+ LD+S+N ++      L+KL  L +L    N+
Sbjct: 156 TSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQ 210

Query: 466 LNGSVPVELL 475
           ++   P+ +L
Sbjct: 211 ISDITPLGIL 220

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 21/70 (30%), Positives = 36/70 (51%), Gaps = 5/70 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++T L L ++ +  +I+  ++ LT+L  L+L+ N L    P  +S L  L  L L  N 
Sbjct: 265 TKLTELKLGANQIS-NISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320

Query: 466 LNGSVPVELL 475
           ++   PV  L
Sbjct: 321 ISDISPVSSL 330

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 4e-05
 Identities = 17/70 (24%), Positives = 33/70 (47%), Gaps = 5/70 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  + ++++ +     + ++NLT+L  L L NN +T    D L  L  L  L L  N 
Sbjct: 90  TKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNT 145

Query: 466 LNGSVPVELL 475
           ++    +  L
Sbjct: 146 ISDISALSGL 155

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 4e-05
 Identities = 12/75 (16%), Positives = 27/75 (36%), Gaps = 5/75 (6%)

Query: 402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
            D++        L  + +   ++   ++L  +  L      +     D +  L  L  +N
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74

Query: 461 LQGNKLNGSVPVELL 475
              N+L    P++ L
Sbjct: 75  FSNNQLTDITPLKNL 89

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.7 bits (109), Expect = 5e-05
 Identities = 16/70 (22%), Positives = 31/70 (44%), Gaps = 5/70 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L  +++ +     + +  LT+L  L L+ N L       L+ L  L  L+L  N+
Sbjct: 199 TNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 254

Query: 466 LNGSVPVELL 475
           ++   P+  L
Sbjct: 255 ISNLAPLSGL 264

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 30/121 (24%), Positives = 44/121 (36%), Gaps = 15/121 (12%)

Query: 385 DPCAPLAYWWDGLNCSYGDSSS--------PRITYLNLSSSGLKGDITSYV-SNLTSLQF 435
           D C P  +   GL C+   +            +T L + +      +       L  L+ 
Sbjct: 3   DACCP--HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 436 LDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLC 494
           L +  + L    PD     P L  LNL  N L  S+  + ++      L LS  GNP  C
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS--GNPLHC 117

Query: 495 S 495
           S
Sbjct: 118 S 118

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 56/241 (23%)

Query: 566 ITNNFE--RTLGKGGFGTVY--YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV--- 618
           + N F   R +G G FG V       N+   AVK++ +      +  + E  +L ++   
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY-TRSAKIEADILKKIQND 91

Query: 619 --HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
             ++ N+    G     +   LI+E +   +L E ++  +      ++     +E  + L
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKAL 150

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQA-------------------------KLADFG 711
            YL       + H D+K  NILL++                             KL DFG
Sbjct: 151 NYLRK-MS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 712 LSKSFATDANTHVSTVVAGTPGYLDPE------YYTSNRLTEKSDVYSFGVVILEIITCK 765
                AT  + +  +++  T  Y  PE      +         SD++SFG V+ E+ T  
Sbjct: 208 -C---ATFKSDYHGSIIN-TRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTGS 256

Query: 766 P 766
            
Sbjct: 257 L 257

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 4/63 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +  L LS + +   + +   +N   L+ L L+NN L   VP  L+    ++ + L  N
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273

Query: 465 KLN 467
            ++
Sbjct: 274 NIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 19/72 (26%), Positives = 32/72 (44%), Gaps = 4/72 (5%)

Query: 406 SPRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
            P    L+L ++ +  +I      NL +L  L L NN ++   P   + L  L  L L  
Sbjct: 51  PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109

Query: 464 NKLNGSVPVELL 475
           N+L   +P ++ 
Sbjct: 110 NQLK-ELPEKMP 120

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 3/62 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
           P +T L+L  + +   + +     L +L  L LS N+++      L+  P LR L+L  N
Sbjct: 192 PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250

Query: 465 KL 466
           KL
Sbjct: 251 KL 252

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 8/84 (9%)

Query: 407 PRITYLNLSSSGLK-GDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
            ++  + L ++ LK   I +     +  L ++ +++ N+T ++P  L   P L  L+L G
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201

Query: 464 NKLNGSVPVELLERSKN-GSLSLS 486
           NK+   V    L+   N   L LS
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLS 224

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 6/87 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             + +L+L + GL   +++ +  L  L+ L+LS N + G +     KLP L  LNL GNK
Sbjct: 49  VNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106

Query: 466 LNGSVPVELLERSKNGSL-SLSVGGNP 491
           L     +E L++ +   L SL +    
Sbjct: 107 LKDISTLEPLKKLEC--LKSLDLFNCE 131

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.6 bits (119), Expect = 3e-06
 Identities = 27/89 (30%), Positives = 36/89 (40%), Gaps = 15/89 (16%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQG 463
              P + YLN SS+    +I S      SL+ L++SNN L   +P    +  L  L    
Sbjct: 294 ELPPNLYYLNASSN----EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR--LERLIASF 346

Query: 464 NKLNGSVPVELLERSKNGSL-SLSVGGNP 491
           N L   VP          +L  L V  NP
Sbjct: 347 NHLA-EVPELP------QNLKQLHVEYNP 368

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.8 bits (109), Expect = 4e-05
 Identities = 16/60 (26%), Positives = 31/60 (51%), Gaps = 5/60 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKL 466
           P + YL +S++ L+  +   + N + L+ +D+ NN+L   +PD      L  +    N+L
Sbjct: 131 PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS--LEFIAAGNNQL 185

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.0 bits (107), Expect = 8e-05
 Identities = 13/60 (21%), Positives = 27/60 (45%), Gaps = 5/60 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKL 466
           P + ++   ++ L+ ++   + NL  L  +   NN+L   +PD      L ++    N L
Sbjct: 173 PSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS--LESIVAGNNIL 227

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 15/83 (18%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG 468
             +++ ++     +        SL+F+   NN L   +P+    LP L  +    N L  
Sbjct: 156 KIIDVDNN----SLKKLPDLPPSLEFIAAGNNQLE-ELPEL-QNLPFLTAIYADNNSLK- 208

Query: 469 SVPVELLERSKNGSL-SLSVGGN 490
            +P          SL S+  G N
Sbjct: 209 KLPDLP------LSLESIVAGNN 225

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 17/67 (25%), Positives = 26/67 (38%), Gaps = 6/67 (8%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
           D    +   L L++ GL    +S       L+ L  S N+LT  +P+    L  L   N 
Sbjct: 67  DCLDRQAHELELNNLGL----SSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNN 121

Query: 462 QGNKLNG 468
               L+ 
Sbjct: 122 NLKALSD 128

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 20/82 (24%), Positives = 35/82 (42%), Gaps = 11/82 (13%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGS 469
             +   ++ L+ ++   + NL  L  +   NN L  ++PD      L  LN++ N L   
Sbjct: 218 ESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPS--LEALNVRDNYLT-D 271

Query: 470 VPVEL-----LERSKNGSLSLS 486
           +P        L+ S+N    LS
Sbjct: 272 LPELPQSLTFLDVSENIFSGLS 293

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 13/94 (13%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +T L+  +S +  D+T  +  LT L  L  ++NN+T ++   LS+   L  L    NK
Sbjct: 42  ATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNK 96

Query: 466 LNGSVPVELLER------SKNGSLSLSVGGNPGL 493
           L  ++ V  L +        N    L V  NP L
Sbjct: 97  LT-NLDVTPLTKLTYLNCDTNKLTKLDVSQNPLL 129

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.8 bits (109), Expect = 4e-05
 Identities = 22/90 (24%), Positives = 34/90 (37%), Gaps = 13/90 (14%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           + + ++ Y      G +      V++ T L  LD     +T  +   LS+ P L  L L 
Sbjct: 272 THNTQLIYFQAE--GCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLN 326

Query: 463 GNKLNGSVPVELLERSKNGSL-SLSVGGNP 491
             +L   + V     S N  L SLS     
Sbjct: 327 NTELT-ELDV-----SHNTKLKSLSCVNAH 350

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 14/97 (14%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           S +  +  LN  ++ +   +   ++    L FLD S+N LT  +   ++ L  L   +  
Sbjct: 188 SQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCS 241

Query: 463 GNKLNGSVPVELLER------SKNGSLSLSVGGNPGL 493
            N L   + V  L +       +   L + +  N  L
Sbjct: 242 VNPLT-ELDVSTLSKLTTLHCIQTDLLEIDLTHNTQL 277

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 13/89 (14%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ 462
           S + ++T L+   +     +   V+  T L  LD S N +T  +   +S+   L  LN  
Sbjct: 145 SHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCD 199

Query: 463 GNKLNGSVPVELLERSKNGSL-SLSVGGN 490
            N +        L+ ++N  L  L    N
Sbjct: 200 TNNITK------LDLNQNIQLTFLDCSSN 222

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 42.4 bits (100), Expect = 6e-04
 Identities = 17/89 (19%), Positives = 31/89 (34%), Gaps = 10/89 (11%)

Query: 412 LNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSV 470
              ++  ++   T     L +L  LD  N+++T  +     KL  L  L    N +  ++
Sbjct: 23  EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNIT-TL 79

Query: 471 PV------ELLERSKNGSLSLSVGGNPGL 493
            +        L    N   +L V     L
Sbjct: 80  DLSQNTNLTYLACDSNKLTNLDVTPLTKL 108

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 47/237 (19%), Positives = 87/237 (36%), Gaps = 52/237 (21%)

Query: 566 ITNNFE--RTLGKGGFGTVY----YGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH 619
           +   +E    LG+G FG V     + R     VA+K++ +      +  + E+ +L ++ 
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQ-VALKIIRNVGKY-REAARLEINVLKKIK 74

Query: 620 HR------NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESA 673
            +          +    +      + +E +   N  E+L + + +         +A +  
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLC 133

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-------------------KLADFGLSK 714
             L +LH   +  + H D+K  NIL                          ++ADFG S 
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-S- 188

Query: 715 SFATDANTHVSTVVAGTPGYLDPE-----YYTSNRLTEKSDVYSFGVVILEIITCKP 766
             AT  + H +T+VA T  Y  PE      +      +  DV+S G ++ E      
Sbjct: 189 --ATFDHEHHTTIVA-TRHYRPPEVILELGW-----AQPCDVWSIGCILFEYYRGFT 237

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 49.1 bits (117), Expect = 6e-06
 Identities = 19/58 (32%), Positives = 27/58 (46%), Gaps = 6/58 (10%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
             L +S + L    TS     + L  L +  N LT  +P+ L  L    T+NL+GN L
Sbjct: 244 KELMVSGNRL----TSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.4 bits (115), Expect = 8e-06
 Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 15/83 (18%)

Query: 409 ITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNG 468
           +  L +  + L    TS       LQ L +S+N L  S+P   S+  L  L    N+L  
Sbjct: 123 LCKLWIFGNQL----TSLPVLPPGLQELSVSDNQLA-SLPALPSE--LCKLWAYNNQLT- 174

Query: 469 SVPVELLERSKNGSL-SLSVGGN 490
           S+P+          L  LSV  N
Sbjct: 175 SLPMLP------SGLQELSVSDN 191

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 6/65 (9%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
           D     IT L +  + L    TS  +    L+ L++S N LT S+P     L  L   + 
Sbjct: 57  DCLPAHITTLVIPDNNL----TSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSN 111

Query: 462 QGNKL 466
               L
Sbjct: 112 PLTHL 116

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 25/79 (31%), Positives = 39/79 (49%), Gaps = 13/79 (16%)

Query: 413 NLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPV 472
            L +   +  +TS  +  + L+ L +S N LT S+P   S+  L+ L + GN+L  S+P+
Sbjct: 205 KLWAYNNR--LTSLPALPSGLKELIVSGNRLT-SLPVLPSE--LKELMVSGNRLT-SLPM 258

Query: 473 ELLERSKNGSL-SLSVGGN 490
                     L SLSV  N
Sbjct: 259 LP------SGLLSLSVYRN 271

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 24/83 (28%), Positives = 33/83 (39%), Gaps = 15/83 (18%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGS 469
             L   ++ L    TS     + LQ L +S+N L  S+P   S+  L  L    N+L  S
Sbjct: 164 CKLWAYNNQL----TSLPMLPSGLQELSVSDNQLA-SLPTLPSE--LYKLWAYNNRLT-S 215

Query: 470 VPVELLERSKNGSL-SLSVGGNP 491
           +P           L  L V GN 
Sbjct: 216 LPALP------SGLKELIVSGNR 232

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 7/92 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
            ++  L+LS + L   I       L  LQ L +  + +     +    L  L  +NL  N
Sbjct: 207 IKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265

Query: 465 KLNGSVPVELLERSKNGSL-SLSVGGNPGLCS 495
            L   +P +L   +    L  + +  NP  C+
Sbjct: 266 NLT-LLPHDLF--TPLHHLERIHLHHNPWNCN 294

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNK 465
           P +  L+L        I+      L++L++L+L+  NL   +P+    + L  L+L GN 
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNH 218

Query: 466 L 466
           L
Sbjct: 219 L 219

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 3/62 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +  L LS + ++  I     + L +L  L+L +N LT         L  L+ L L+ N
Sbjct: 88  RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146

Query: 465 KL 466
            +
Sbjct: 147 PI 148

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 17/61 (27%), Positives = 29/61 (47%), Gaps = 3/61 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             + YLNL+   L+      ++ L  L  LDLS N+L+   P     L  L+ L +  ++
Sbjct: 185 SNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242

Query: 466 L 466
           +
Sbjct: 243 I 243

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 17/62 (27%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
           S     LNL  + ++    +   +L  L+ L LS N++        + L  L TL L  N
Sbjct: 63  STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122

Query: 465 KL 466
           +L
Sbjct: 123 RL 124

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 7/93 (7%)

Query: 407 PRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLP--LRTLNLQ 462
           P + +L + ++GLK     + V +      L++++N    S+P +    L     TL L 
Sbjct: 105 PLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164

Query: 463 GNKLNGSVPVELLERSKNGSLSLSVGGNPGLCS 495
            N    SV       +K  ++ L+   N  L  
Sbjct: 165 NNGFT-SVQGYAFNGTKLDAVYLN--KNKYLTV 194

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 4/90 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNLQG 463
           P I+ + +S       + S+   NL+ +  +++ N      +  D L +LP L+ L +  
Sbjct: 55  PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114

Query: 464 NKLNGSVPVELLERSKNGSLSLSVGGNPGL 493
             L    P      S +    L +  NP +
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYM 143

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 44.2 bits (105), Expect = 8e-05
 Identities = 18/66 (27%), Positives = 26/66 (39%), Gaps = 4/66 (6%)

Query: 428 SNLTSLQFLDLSNNNLTGSVPD---FLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLS 484
             L  L+FL + N  L    PD     S      L +  N    S+PV   +   N +L+
Sbjct: 102 KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160

Query: 485 LSVGGN 490
           L +  N
Sbjct: 161 LKLYNN 166

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 21/91 (23%), Positives = 43/91 (47%), Gaps = 8/91 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQG 463
             +  L    + L   + ++   +L +L+ L++++N +    +P++ S L  L  L+L  
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158

Query: 464 NKLNGSVPVEL---LERSKNGSLSLSVGGNP 491
           NK+  S+       L +    +LSL +  NP
Sbjct: 159 NKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNP 188

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 19/60 (31%), Positives = 26/60 (43%), Gaps = 3/60 (5%)

Query: 409 ITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
              L+LS + L+  + SY   +   LQ LDLS   +          L  L TL L GN +
Sbjct: 30  TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 10/95 (10%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQF----LDLSNNNLTGSVPDFLSKLPLRTLNL 461
             + +L+LSS+ ++  I       L  +      LDLS N +    P    ++ L+ L L
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELAL 207

Query: 462 QGNKLNGSVPVELLERSKNGSL-SLSVGGNPGLCS 495
             N+L  SVP  + +R    SL  + +  NP  CS
Sbjct: 208 DTNQLK-SVPDGIFDR--LTSLQKIWLHTNPWDCS 239

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 29/89 (32%), Positives = 40/89 (44%), Gaps = 8/89 (8%)

Query: 410 TYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFL-SKLP-LRTLNLQGNKL 466
             L L  + LK  +   + +    L+ L L+NNNLT  +P  L + L  L TL LQ N L
Sbjct: 127 QELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184

Query: 467 NGSVPVELLERSKNGSLSLSVGGNPGLCS 495
             ++P             L   GNP LC+
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLH--GNPWLCN 210

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 2/61 (3%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P +  L+LS + L+  +      L +L  LD+S N LT      L  L  L+ L L+GN+
Sbjct: 77  PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135

Query: 466 L 466
           L
Sbjct: 136 L 136

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 23/73 (31%), Positives = 31/73 (42%), Gaps = 4/73 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
           P +T L++S + L   +       L  LQ L L  N L    P  L+  P L  L+L  N
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158

Query: 465 KLNGSVPVELLER 477
            L   +P  LL  
Sbjct: 159 NLT-ELPAGLLNG 170

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 19/62 (30%), Positives = 29/62 (46%), Gaps = 2/62 (3%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGS 469
           T L+LS + L     + +   T L  L+L    LT  +    +   L TL+L  N+L  S
Sbjct: 34  TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ-S 91

Query: 470 VP 471
           +P
Sbjct: 92  LP 93

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 19/91 (20%), Positives = 35/91 (38%), Gaps = 6/91 (6%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
            ++  +   ++ S + ++  +      L  L+ L ++NN +          LP L  L L
Sbjct: 38  GATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95

Query: 462 QGNKLNGSVPVELLERSKNGSL-SLSVGGNP 491
             N L      +L   +   SL  L +  NP
Sbjct: 96  TNNSL--VELGDLDPLASLKSLTYLCILRNP 124

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 10/83 (12%)

Query: 410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGS 469
            Y+N  ++     +T      TSL+ L + NN LT  +P+      L  L++  N L  S
Sbjct: 143 EYINADNN----QLTMLPELPTSLEVLSVRNNQLT-FLPELPES--LEALDVSTNLLE-S 194

Query: 470 VPVEL--LERSKNGSLSLSVGGN 490
           +P        S+   +      N
Sbjct: 195 LPAVPVRNHHSEETEIFFRCREN 217

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 15/85 (17%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKL 466
           P+IT L ++ + L     S      SL++LD  +N L+ ++P+  +   L+ L++  N+L
Sbjct: 80  PQITVLEITQNAL----ISLPELPASLEYLDACDNRLS-TLPELPAS--LKHLDVDNNQL 132

Query: 467 NGSVPVELLERSKNGSL-SLSVGGN 490
              +P           L  ++   N
Sbjct: 133 T-MLPELP------ALLEYINADNN 150

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 45.0 bits (106), Expect = 9e-05
 Identities = 17/62 (27%), Positives = 24/62 (38%), Gaps = 10/62 (16%)

Query: 430 LTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSL-SLSVG 488
           +     L L+  NL+ S+PD L    +  L +  N L  S+P          SL  L   
Sbjct: 58  INQFSELQLNRLNLS-SLPDNLPPQ-ITVLEITQNAL-ISLPELP------ASLEYLDAC 108

Query: 489 GN 490
            N
Sbjct: 109 DN 110

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 19/85 (22%), Positives = 38/85 (44%), Gaps = 15/85 (17%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKL 466
             + +L++ ++ L    T        L++++  NN LT  +P+  +   L  L+++ N+L
Sbjct: 120 ASLKHLDVDNNQL----TMLPELPALLEYINADNNQLT-MLPELPTS--LEVLSVRNNQL 172

Query: 467 NGSVPVELLERSKNGSL-SLSVGGN 490
              +P          SL +L V  N
Sbjct: 173 T-FLPELP------ESLEALDVSTN 190

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 19/78 (24%), Positives = 40/78 (51%), Gaps = 3/78 (3%)

Query: 410 TYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNG 468
             L++S + +  D      S   SL  L++S+N LT ++   L    ++ L+L  NK+  
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR-IKVLDLHSNKIK- 434

Query: 469 SVPVELLERSKNGSLSLS 486
           S+P ++++      L+++
Sbjct: 435 SIPKQVVKLEALQELNVA 452

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 18/77 (23%), Positives = 32/77 (41%), Gaps = 7/77 (9%)

Query: 397 LNCSYGDSSS------PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF 450
           ++ S             + T LN+S + +    TS + +L+ L+ L +S+N +       
Sbjct: 5   VDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64

Query: 451 LSKLP-LRTLNLQGNKL 466
                 L  L+L  NKL
Sbjct: 65  FKFNQELEYLDLSHNKL 81

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 15/80 (18%), Positives = 34/80 (42%), Gaps = 3/80 (3%)

Query: 404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT--GSVPDFLSKLP-LRTLN 460
           S      +L+ S++ L   +     +LT L+ L L  N L     + +  +++  L+ L+
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380

Query: 461 LQGNKLNGSVPVELLERSKN 480
           +  N ++          +K+
Sbjct: 381 ISQNSVSYDEKKGDCSWTKS 400

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 4/64 (6%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD-FLSKLP-LRTLN 460
               PRI  L+L S+ +K  I   V  L +LQ L++++N L  SVPD    +L  L+ + 
Sbjct: 417 RCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIW 474

Query: 461 LQGN 464
           L  N
Sbjct: 475 LHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 19/79 (24%), Positives = 32/79 (40%), Gaps = 2/79 (2%)

Query: 410 TYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNL-QGNKLN 467
            +L+LS +      I     N++ L+FL LS  +L  S    ++ L +  + L  G    
Sbjct: 93  KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152

Query: 468 GSVPVELLERSKNGSLSLS 486
                E L+     SL + 
Sbjct: 153 EKEDPEGLQDFNTESLHIV 171

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 45/236 (19%), Positives = 94/236 (39%), Gaps = 50/236 (21%)

Query: 566 ITNNFE--RTLGKGGFGTV---YYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH 620
           ++  +E   TLG+G FG V      +     VAVK++ +      +  ++E+++L  ++ 
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-CEAARSEIQVLEHLNT 70

Query: 621 R------NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
                      ++   +      +++E +   +  +++ +            ++A +  +
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLNEKLQA-------------------KLADFGLSKS 715
            + +LH+  K  + H D+K  NIL  +                       K+ DFG S  
Sbjct: 130 SVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-S-- 183

Query: 716 FATDANTHVSTVVAGTPGYLDPE-----YYTSNRLTEKSDVYSFGVVILEIITCKP 766
            AT  + H ST+V+ T  Y  PE      +     ++  DV+S G +++E      
Sbjct: 184 -ATYDDEHHSTLVS-TRHYRAPEVILALGW-----SQPCDVWSIGCILIEYYLGFT 232

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 24/90 (26%), Positives = 44/90 (48%), Gaps = 9/90 (10%)

Query: 410 TYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFL-SKLP-LRTLNLQGNKL 466
             + L+S+ L+ ++   +   L SL+ L L +N +T  V +     L  +R L+L  N++
Sbjct: 84  NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141

Query: 467 NGSVPVELLERSKNGSLS-LSVGGNPGLCS 495
             +V     +     SLS L++  NP  C+
Sbjct: 142 T-TVAPGAFDT--LHSLSTLNLLANPFNCN 168

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 23/159 (14%), Positives = 47/159 (29%), Gaps = 24/159 (15%)

Query: 211 DVHDRSWFPYNSANWARINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETED 270
           DVH   +            +   +      S     V+  T    +    S  + +  ++
Sbjct: 19  DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTE---RYNEDSFGYDIPIKE 75

Query: 271 PSIQFYVYMHFAEVQILQANQSRQFNISLNGE---------HWYGPFSPNYLLTTTVFSP 321
              ++ + + FAEV   Q+ Q + F++ +NG             G  + +  +       
Sbjct: 76  EG-EYVLVLKFAEVYFAQSQQ-KVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKK 133

Query: 322 TAL--------IGGNYSFSLYKTGNSTLPPIINAIEVYS 352
             L          G  S    K       P + A+ +  
Sbjct: 134 GKLSVQGEVSTFTGKLSVEFVKGYYDN--PKVCALFIMK 170

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 7/89 (7%)

Query: 410 TYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFL-SKLP-LRTLNLQGNKL 466
             L L  + +  ++   +   L SLQ L L+ N +   +       L  L  L+L  NKL
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140

Query: 467 NGSVPVELLERSKNGSLSLSVGGNPGLCS 495
             ++        +    ++ +  NP +C 
Sbjct: 141 Q-TIAKGTFSPLRAIQ-TMHLAQNPFICD 167

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 4/67 (5%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
            ++  ++LS++ +  ++       L SL  L L  N +T         L  L+ L L  N
Sbjct: 56  KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNAN 114

Query: 465 KLNGSVP 471
           K+N  + 
Sbjct: 115 KIN-CLR 120

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 22/62 (35%), Positives = 30/62 (48%), Gaps = 3/62 (4%)

Query: 407 PRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN 464
             +  L L+S+G+   I     S+L SL+ LDLS N L+     +   L  L  LNL GN
Sbjct: 76  VNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGN 134

Query: 465 KL 466
             
Sbjct: 135 PY 136

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 19/93 (20%), Positives = 38/93 (40%), Gaps = 8/93 (8%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
               +   + S   L    T+ +    + + + +++ +L   V   L+++  L  L    
Sbjct: 230 RDTDLDTFHFSE--LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286

Query: 464 NKLNGSVPVELLERSKN-GSLSLSVGGNPGLCS 495
           N+L  SVP  + +R  +   + L    NP  CS
Sbjct: 287 NQLK-SVPDGIFDRLTSLQKIWLH--TNPWDCS 316

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 22/89 (24%), Positives = 40/89 (44%), Gaps = 7/89 (7%)

Query: 406 SPRITYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
           +  +  L+LS++ +   I++       +LQ L L++N +     D  S L  L  L+L  
Sbjct: 51  TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109

Query: 464 NKLNGSVPVELLERSKN-GSLSLSVGGNP 491
           N L  ++     +   +   L+L   GNP
Sbjct: 110 NYL-SNLSSSWFKPLSSLTFLNLL--GNP 135

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 9/40 (22%), Positives = 18/40 (45%), Gaps = 1/40 (2%)

Query: 428 SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL 466
           + LT L+ L++  ++L    P  L  +  +  L L   + 
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 5e-05
 Identities = 16/88 (18%), Positives = 37/88 (42%), Gaps = 9/88 (10%)

Query: 407 PRITYLNLSSSGLKGDITSYVSN---LTSLQFLDLSNNNLTGS-VPDFLSKLP----LRT 458
           P + +L +  +  +  +         L  L+ +D+S   LT       L  +     L+ 
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 459 LNLQGNKLNGSVPVELLERSKNGSLSLS 486
           +N++ N L+  +  + L++S    + +S
Sbjct: 312 INMKYNYLSDEM-KKELQKSLPMKIDVS 338

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 7/87 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L+L  + +K  I +  +   +L+ L +S N +  S+   + KL  LR L +  NK
Sbjct: 70  ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNK 126

Query: 466 LNGSVPVELLERSKNGSL-SLSVGGNP 491
           +     ++ L       L  L + GNP
Sbjct: 127 ITNWGEIDKLAALDK--LEDLLLAGNP 151

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 20/67 (29%), Positives = 35/67 (52%), Gaps = 6/67 (8%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT--GSVPDFLSKLP-LRTL 459
           D+ +  +  L +S + +   ++  +  L +L+ L +SNN +T  G + D L+ L  L  L
Sbjct: 89  DAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDL 145

Query: 460 NLQGNKL 466
            L GN L
Sbjct: 146 LLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 4/63 (6%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
           +      L+     ++  + + +S L + + L LS NN+   +   LS +  LR L+L  
Sbjct: 23  TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGR 79

Query: 464 NKL 466
           N +
Sbjct: 80  NLI 82

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 5/62 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             IT L+   +G+   I   V  L +L  L+L +N +T   P  L  L  +  L L GN 
Sbjct: 41  DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96

Query: 466 LN 467
           L 
Sbjct: 97  LK 98

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 5/79 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +  L L  + +  +I+  ++ LT+LQ+L + N  ++      L+ L  L TL    NK
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNK 184

Query: 466 LNGSVPVELLERSKNGSLS 484
           ++   P+  L       L 
Sbjct: 185 ISDISPLASLPNLIEVHLK 203

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 17/61 (27%), Positives = 34/61 (55%), Gaps = 5/61 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             I  L+L+S+ +  D+ + ++ L++LQ L L  N +T   P  L+ L  L+ L++   +
Sbjct: 107 QSIKTLDLTSTQIT-DV-TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQ 162

Query: 466 L 466
           +
Sbjct: 163 V 163

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 20/61 (32%), Positives = 37/61 (60%), Gaps = 5/61 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            +IT L LS + LK ++++ ++ L S++ LDL++  +T   P  L+ L  L+ L L  N+
Sbjct: 85  TKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQ 140

Query: 466 L 466
           +
Sbjct: 141 I 141

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 44.7 bits (106), Expect = 8e-05
 Identities = 20/61 (32%), Positives = 34/61 (55%), Gaps = 5/61 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  L+L  +G+  DI   + +L  L+ L L NN +T      LS+L  L TL+L+ N+
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 167

Query: 466 L 466
           +
Sbjct: 168 I 168

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 5/61 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P++  L L ++ +  DIT  +S LT L  L L +N ++  +   L+ L  L+ L L  N 
Sbjct: 134 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNH 189

Query: 466 L 466
           +
Sbjct: 190 I 190

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 5/61 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             I  +  ++S +K  +   +  L ++  L L+ N LT   P  L+ L  L  L L  NK
Sbjct: 46  NSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK 101

Query: 466 L 466
           +
Sbjct: 102 V 102

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 19/62 (30%), Positives = 33/62 (53%), Gaps = 5/62 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P +T L L+ + L  DI   ++NL +L +L L  N +       L  L  L++L+L+ N 
Sbjct: 68  PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNG 123

Query: 466 LN 467
           ++
Sbjct: 124 IS 125

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 44.2 bits (105), Expect = 9e-05
 Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 5/70 (7%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             +   N  +S ++  +   +   T+L+ L LS+N ++      L  L  L  L++  N+
Sbjct: 41  SGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS--DLSPLKDLTKLEELSVNRNR 96

Query: 466 LNGSVPVELL 475
           L     +   
Sbjct: 97  LKNLNGIPSA 106

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 15/60 (25%), Positives = 29/60 (48%), Gaps = 4/60 (6%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKL 466
             +  L+LS + +  D++  + +LT L+ L ++ N L     + +    L  L L  N+L
Sbjct: 63  TNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK--NLNGIPSACLSRLFLDNNEL 118

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 13/66 (19%), Positives = 25/66 (37%), Gaps = 5/66 (7%)

Query: 402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
            D         NL    +  D+ S    L+ +Q  +  N+N+       +     L+ L+
Sbjct: 14  PDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELH 69

Query: 461 LQGNKL 466
           L  N++
Sbjct: 70  LSHNQI 75

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 20/63 (31%), Positives = 34/63 (53%), Gaps = 5/63 (7%)

Query: 405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG 463
            S  ++ L L ++ L+ D  S + +L +L+ L + NN L  S+   L  L  L  L+L G
Sbjct: 104 PSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHG 159

Query: 464 NKL 466
           N++
Sbjct: 160 NEI 162

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 45.1 bits (106), Expect = 9e-05
 Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 5/62 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
             I  +  ++S +K  +   +  L ++  L L+ N LT   P  L+ L  L  L L  NK
Sbjct: 43  NSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK 98

Query: 466 LN 467
           + 
Sbjct: 99  IK 100

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 5/61 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
            ++  L+L  +G+  DI + + +L  L+ L L NN +T      LS+L  L TL+L+ N+
Sbjct: 109 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQ 164

Query: 466 L 466
           +
Sbjct: 165 I 165

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.6 bits (102), Expect = 2e-04
 Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 5/61 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P++  L L ++ +  DIT  +S LT L  L L +N ++  +   L+ L  L+ L L  N 
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNH 186

Query: 466 L 466
           +
Sbjct: 187 I 187

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.2 bits (101), Expect = 4e-04
 Identities = 17/67 (25%), Positives = 29/67 (43%), Gaps = 5/67 (7%)

Query: 402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLN 460
            D +       NL    +   +T   + L S+  +  +N+++  SV   +  LP +  L 
Sbjct: 16  PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 71

Query: 461 LQGNKLN 467
           L GNKL 
Sbjct: 72  LNGNKLT 78

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 42.0 bits (98), Expect = 9e-04
 Identities = 19/62 (30%), Positives = 33/62 (53%), Gaps = 5/62 (8%)

Query: 407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
           P +T L L+ + L  DI   ++NL +L +L L  N +       L  L  L++L+L+ N 
Sbjct: 65  PNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNG 120

Query: 466 LN 467
           ++
Sbjct: 121 IS 122

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 29/110 (26%), Positives = 44/110 (40%), Gaps = 27/110 (24%)

Query: 410 TYLNLSSSGL-KGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLS---------------- 452
             L++S + L         +   S+  L+LS+N LTGSV   L                 
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSI 465

Query: 453 -----KLP-LRTLNLQGNKLNGSVPVELLERSKNGSL-SLSVGGNPGLCS 495
                 L  L+ LN+  N+L  SVP  + +R    SL  + +  NP  C+
Sbjct: 466 PKDVTHLQALQELNVASNQLK-SVPDGVFDRLT--SLQYIWLHDNPWDCT 512

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 23/67 (34%), Positives = 36/67 (53%), Gaps = 10/67 (14%)

Query: 410 TYLNLSSSGLKGDITSYV-SNLTSLQFLDLSNNNLTGSVP----DFLSKLPLRTLNLQGN 464
           T ++LS++ +   +++   SN+T L  L LS N L   +P    D L    LR L+L GN
Sbjct: 57  TLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS--LRLLSLHGN 112

Query: 465 KLNGSVP 471
            ++  VP
Sbjct: 113 DIS-VVP 118

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 16/65 (24%), Positives = 28/65 (43%), Gaps = 3/65 (4%)

Query: 428 SNLTSLQFLDLSNNNLTGSVPD--FLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSL 485
            NL +LQ+L +SN  +   +PD   +  L    L++Q N    ++           S+ L
Sbjct: 101 QNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159

Query: 486 SVGGN 490
            +  N
Sbjct: 160 WLNKN 164

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	878
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.98
3uqc_A	286	Probable conserved transmembrane protein; structur	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.82
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.7
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.51
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.45
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.34
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.31
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.23
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.14
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.06
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.05
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.03
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.02
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.01
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.01
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.01
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.0
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.98
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.96
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	98.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.95
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.95
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.93
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.92
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.91
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.9
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.9
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.89
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.87
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.87
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.87
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.87
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.83
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.81
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.8
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.78
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.78
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.77
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.77
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.75
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.74
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.74
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.74
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.74
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.72
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.72
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.71
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.7
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.7
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.7
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.69
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.68
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.68
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.67
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.67
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.67
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.65
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.64
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.63
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.62
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.62
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.62
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.61
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.6
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.6
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.6
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.6
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.58
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.57
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.56
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.56
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.56
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.54
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.53
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.53
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.53
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.53
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.51
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.51
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.51
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.5
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.49
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.49
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.49
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.49
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.48
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.48
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.47
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.46
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.45
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.45
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.45
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.44
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.43
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.43
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.41
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.41
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.4
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.39
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.39
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.38
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.37
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.37
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.35
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.35
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.35
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.34
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.33
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.32
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.3
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.3
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.27
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.23
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.23
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.21
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.2
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.17
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.17
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.16
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.11
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.1
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.07
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.98
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.96
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.81
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.8
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.78
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.68
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	97.64
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.63
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.62
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.56
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.47
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.46
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.21
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.21
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.19
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.99
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.93
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.85
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.79
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	96.74
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.73
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.66
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.61
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.57
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.52
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.49
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.47
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.28
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	95.92
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	95.91
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	95.87
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.83
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.67
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	95.37
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.0
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	94.69
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	94.36
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	94.07
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	93.99
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.78
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	92.08
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	90.8
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.53
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	87.08
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	81.08

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=444.90  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=208.5

Q ss_pred             hhcccccccccEEEEEEEEc-------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|++.       ++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35678999999999999864       36799999998877788899999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          642 FMANGNLQEYLSDIS-------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       642 y~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      ||++|+|.++++...             ...++|.+++.|+.|||+||+|||+.   +||||||||+||||++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence            999999999997532             24699999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      |||+++.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+.   .    ..+
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~----~~i  273 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---I----DCI  273 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---H----HHH
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---H----HHH
Confidence            9999987754444444455679999999999999999999999999999999999 8999988765432   1    122


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .++...         ..+..+..++.+|+.+||+.||++||||+||++.|+.+.+
T Consensus       274 ~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          274 TQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            222211         1222344578899999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.5e-51  Score=442.98  Aligned_cols=255  Identities=28%  Similarity=0.472  Sum_probs=215.7

Q ss_pred             hhcccccccccEEEEEEEEc-------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|++.       +..||||+++..+....++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            45789999999999999863       36799999998877778899999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcccc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          642 FMANGNLQEYLSDIS-----------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       642 y~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                      ||++|+|.++|+...           ...++|.+++.|+.|||+||+|||++   +||||||||+|||+++++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence            999999999997532           35799999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      |+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+   +.    ..+..
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~----~~i~~  245 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI----ECITQ  245 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HHHHH
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHc
Confidence            99987654433333444579999999999999999999999999999999999 899998876543   11    22223


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      +...         ..+..+..++.+++.+||+.+|++||||+||++.|+++.+
T Consensus       246 ~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          246 GRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            3221         1223344578899999999999999999999999998654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.5e-51  Score=445.91  Aligned_cols=254  Identities=24%  Similarity=0.434  Sum_probs=213.6

Q ss_pred             HhhhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+|.+.||+|+||+||+|++.       ++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3467889999999999999873       3679999997643 3345789999999999999999999999999999999


Q ss_pred             EeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc
Q 002809          639 IYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ  704 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~  704 (878)
                      |||||++|+|.++|+...              ...++|.+++.|+.|||+||+|||++   +||||||||+||||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            999999999999996432              24699999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 002809          705 AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWV  783 (878)
Q Consensus       705 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v  783 (878)
                      +||+|||+++.+.............||+.|||||++.+..++.++|||||||++|||+| |++||...+..+   +.+  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~--  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVE--  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence            99999999987754443344445679999999999999999999999999999999999 899998876543   222  


Q ss_pred             HHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       784 ~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                        .+..+...         ..+..+...+.+++.+||+.+|++||||+||++.|+.
T Consensus       259 --~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          259 --MIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             --HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --HHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence              22333221         1233445678899999999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=430.89  Aligned_cols=255  Identities=29%  Similarity=0.506  Sum_probs=203.7

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||+||+|++.+ .||||+++..  .....+.|.+|+++|++++|||||+++|+|.+ +..++|||||++|
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG  116 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS  116 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred             EEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence            467899999999999999866 5999998743  34566889999999999999999999999865 5689999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.++|+.. ...++|.+++.|+.|||+||+|||++   +||||||||+||||++++++||+|||+|+............
T Consensus       117 sL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~  192 (307)
T 3omv_A          117 SLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE  192 (307)
T ss_dssp             BHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred             CHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence            999999753 45699999999999999999999998   99999999999999999999999999998765443333445


Q ss_pred             cccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          727 VVAGTPGYLDPEYYTS---NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ..+||+.|||||++.+   ..++.++|||||||++|||+||+.||...+....      +...+..+..    .|.+. .
T Consensus       193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~~----~p~~~-~  261 (307)
T 3omv_A          193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGYA----SPDLS-K  261 (307)
T ss_dssp             -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTCC----CCCST-T
T ss_pred             ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCC----CCCcc-c
Confidence            5689999999999864   4689999999999999999999999987654321      1122222211    11111 1


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      .+..+...+.+++.+||+.+|++||||+||++.|+.+
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2233456788999999999999999999999999865

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.7e-48  Score=424.81  Aligned_cols=268  Identities=25%  Similarity=0.416  Sum_probs=203.9

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC----cceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN----QTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||+||+|+++++.||||++...... ...+.+|+..+.+++|||||+++++|.+++    ..++|||||+
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~   84 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence            35689999999999999999999999999754322 223345666667889999999999997654    5789999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC-----KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      +|+|.++|+.   ..++|+.+++++.|+++||+|||+++     .++||||||||+||||+.++++||+|||+++.....
T Consensus        85 ~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  161 (303)
T 3hmm_A           85 HGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             TCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence            9999999974   46999999999999999999999763     568999999999999999999999999999876443


Q ss_pred             CCC--cccccccCCCCccCccccccC------CCCCccchhhHHHHHHHHHhCCCCCCCCChHHH---------HHHHHH
Q 002809          720 ANT--HVSTVVAGTPGYLDPEYYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEK---------IHIRQW  782 (878)
Q Consensus       720 ~~~--~~~~~~~gt~~Y~APE~~~~~------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~  782 (878)
                      ...  ......+||+.|||||++.+.      .++.++|||||||++|||+||++|+........         ....+ 
T Consensus       162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~-  240 (303)
T 3hmm_A          162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE-  240 (303)
T ss_dssp             TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH-
T ss_pred             CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH-
Confidence            321  122345799999999999764      467899999999999999999887654321100         00111 


Q ss_pred             HHHHHhcCCcccccCCcccccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDF-DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      +...+..+    .++|.+.... +.++...+.+++.+||+.||++||||+||++.|+++.+.+.
T Consensus       241 ~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          241 MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            11222211    2233333222 34566788999999999999999999999999999876554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.9e-48  Score=431.89  Aligned_cols=259  Identities=28%  Similarity=0.440  Sum_probs=213.9

Q ss_pred             hhhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcc-cceeeeeecccCC-Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHH-RNLTSLVGHCDED-NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~-~~~~  637 (878)
                      +.+.+.||+|+||.||+|++.+       +.||||++.... ....+.|.+|+++|.+++| ||||+++|+|.+. +..+
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~  145 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  145 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence            3567899999999999998753       569999998654 3456789999999999965 8999999999664 5689


Q ss_pred             eEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          638 LIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      +|||||++|+|.++|+...              ...+++.+++.++.|||+||+|||++   +||||||||+|||+++++
T Consensus       146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCC
Confidence            9999999999999997532              24589999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQW  782 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  782 (878)
                      .+||+|||+|+.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||......+.      
T Consensus       223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~------  296 (353)
T 4ase_A          223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------  296 (353)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------
T ss_pred             CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH------
Confidence            999999999997755444444455679999999999999999999999999999999998 8999987553221      


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      +...+.++...         ..+..+..++.+++.+||+.||++|||++||+++|++++++.
T Consensus       297 ~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          297 FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            22223333211         112233457889999999999999999999999999998653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-47  Score=422.23  Aligned_cols=248  Identities=22%  Similarity=0.383  Sum_probs=202.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      |.+.+.||+|+||.||+|+..  ++.||||++...  .....+.|.+|+++|++++|||||++++++.+++..++|||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            455689999999999999875  488999999754  3445678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.++|.......+++.+++.++.||+.||+|||++   +||||||||+||||++++.+||+|||+++.+...  ..
T Consensus       106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~  180 (350)
T 4b9d_A          106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VE  180 (350)
T ss_dssp             TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HH
T ss_pred             CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC--cc
Confidence            999999999865566789999999999999999999998   9999999999999999999999999999876322  12


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....+||+.|||||++.+..|+.++|||||||++|||+||++||...+..+.      ... +..+....     +   
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~-i~~~~~~~-----~---  245 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLK-IISGSFPP-----V---  245 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH-HHHTCCCC-----C---
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHH-HHcCCCCC-----C---
Confidence            23446799999999999999999999999999999999999999987665331      111 22222211     1   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       +.....++.+|+.+||+.||++|||++|+++.
T Consensus       246 -~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          246 -SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11223467899999999999999999999863

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-46  Score=407.07  Aligned_cols=245  Identities=27%  Similarity=0.502  Sum_probs=198.0

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC----CCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE----DNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV~  640 (878)
                      .|.+.||+|+||.||+|+...  ..||+|++...  .....+.|.+|+++|++++|||||+++++|..    +...++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            456789999999999999864  78999998754  34456789999999999999999999999854    35689999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-CCcEEEeecCCccccccC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSKSFATD  719 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~  719 (878)
                      |||++|+|.+++++  ...+++..+..++.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+.... 
T Consensus       109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  184 (290)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence            99999999999976  56799999999999999999999987 224999999999999984 79999999999975422 


Q ss_pred             CCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                         ......+||+.|||||++.+ .|+.++|||||||++|||+||++||........      +...+..+.....    
T Consensus       185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~~~----  250 (290)
T 3fpq_A          185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPAS----  250 (290)
T ss_dssp             ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGG----
T ss_pred             ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCCCC----
Confidence               22345689999999999875 699999999999999999999999976543221      1122222221111    


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                          .+.....++.+++.+||+.||++|||++|+++
T Consensus       251 ----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          251 ----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11112236789999999999999999999976

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.9e-47  Score=416.66  Aligned_cols=245  Identities=21%  Similarity=0.333  Sum_probs=206.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++|
T Consensus        77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  156 (346)
T 4fih_A           77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  156 (346)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred             EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            44578999999999999985  4889999998665555678899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++..   ..+++..+..++.||+.||+|||++   +||||||||+||||+.++.+||+|||+++.+....  ....
T Consensus       157 ~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~  228 (346)
T 4fih_A          157 ALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK  228 (346)
T ss_dssp             EHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBC
T ss_pred             cHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cccc
Confidence            99999874   4599999999999999999999998   99999999999999999999999999998764332  2234


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..+||+.|||||++.+..|+.++|||||||++|||++|++||...+..+...       .+..+.     .+.+.  ...
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-------~i~~~~-----~~~~~--~~~  294 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIRDNL-----PPRLK--NLH  294 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSS-----CCCCS--CGG
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------HHHcCC-----CCCCC--ccc
Confidence            5689999999999999999999999999999999999999998765543211       111111     11111  111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ....++.+++.+||+.||++|||++|+++
T Consensus       295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          295 KVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            23346789999999999999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4e-47  Score=413.40  Aligned_cols=246  Identities=25%  Similarity=0.379  Sum_probs=208.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||+||+++..  ++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            567789999999999999875  4889999997542   23457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.++++.  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+......
T Consensus       114 ~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          114 AKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            999999999976  45799999999999999999999998   9999999999999999999999999999987554444


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......+||+.|||||++.+..|+.++||||+||++|||+||++||...+..+..       ..+.++..      .+..
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~------~~p~  255 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF-------AKIIKLEY------DFPE  255 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCC------CCCT
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC------CCCc
Confidence            4455678999999999999999999999999999999999999999876653311       11222221      1111


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                          ....++.+++.+||+.||++|||++|++.
T Consensus       256 ----~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          256 ----KFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             ----TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ----ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                22346789999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.3e-47  Score=415.27  Aligned_cols=253  Identities=20%  Similarity=0.256  Sum_probs=206.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||.||+|+..  ++.||||+++....     +.+|+.+|++++|||||++++++.+++..++|||||++|
T Consensus        61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            34568999999999999976  48899999976432     257999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCCCC---
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDANT---  722 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~---  722 (878)
                      +|.+++++  ...+++..+..++.||+.||+|||++   +||||||||+||||+.++ ++||+|||+|+.+......   
T Consensus       136 ~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          136 SLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             BHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            99999976  45799999999999999999999998   999999999999999987 6999999999877543221   


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......+||+.|||||++.+..++.++|||||||++|||+||++||...+.....      .. +..+...       ..
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~-i~~~~~~-------~~  276 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LK-IASEPPP-------IR  276 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HH-HHHSCCG-------GG
T ss_pred             ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HH-HHcCCCC-------ch
Confidence            1223467999999999999999999999999999999999999999875543211      11 1111110       01


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      ..+......+.+++.+||+.||++|||++|+++.|..+++...
T Consensus       277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            1223334578899999999999999999999999999886543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.4e-46  Score=418.34  Aligned_cols=246  Identities=21%  Similarity=0.325  Sum_probs=206.9

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            345578999999999999986  488999999876666667899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.++++.   ..+++.++..++.||+.||+|||++   +||||||||+||||+.++.+||+|||+|+.+....  ...
T Consensus       233 G~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~  304 (423)
T 4fie_A          233 GALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR  304 (423)
T ss_dssp             EEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCB
T ss_pred             CcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccc
Confidence            999999864   4599999999999999999999998   99999999999999999999999999998764332  223


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|++||...+..+...       .+..+..     +.+.  ..
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-------~i~~~~~-----~~~~--~~  370 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIRDNLP-----PRLK--NL  370 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCC-----CCCS--CT
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------HHHcCCC-----CCCc--cc
Confidence            45689999999999999999999999999999999999999998766543221       1222111     1111  11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .....++.+|+.+||+.||++|||++|+++
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            122346789999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.9e-45  Score=394.54  Aligned_cols=242  Identities=24%  Similarity=0.373  Sum_probs=190.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      |.+.+.||+|+||+||+|+..  ++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            456789999999999999875  4889999997542   23356799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      + +|+|.+++..  ...+++.++..++.||+.||+|||++   +|+||||||+|||+++++++||+|||+|+......  
T Consensus        95 ~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--  166 (275)
T 3hyh_A           95 A-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--  166 (275)
T ss_dssp             C-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             C-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence            9 6899999976  56799999999999999999999998   99999999999999999999999999998654322  


Q ss_pred             cccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+....       ...+.++..      .+.
T Consensus       167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-------~~~i~~~~~------~~p  232 (275)
T 3hyh_A          167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-------FKNISNGVY------TLP  232 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC------CCC
T ss_pred             -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCC------CCC
Confidence             2334679999999999998876 5799999999999999999999987654321       112222221      111


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                          .....++.+++.+||+.||++|||++|+++
T Consensus       233 ----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          233 ----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                112346789999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.5e-46  Score=403.17  Aligned_cols=239  Identities=26%  Similarity=0.362  Sum_probs=192.7

Q ss_pred             hhhcccccccccEEEEEEEEc-----ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      +.+.+.||+|+||+||+|+..     ++.||||++.+..  ......+.+|+++|++++|||||++++++.+++..++||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            466789999999999999862     3679999997542  223457889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++|+|.+++.+  ...+++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+......
T Consensus       106 Ey~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          106 DFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             CCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999976  45799999999999999999999998   99999999999999999999999999998653322


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                        ......+||+.|||||++.+..++.++||||+||++|||+||++||...+..+..       ..+.++..      .+
T Consensus       181 --~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~~------~~  245 (304)
T 3ubd_A          181 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM-------TMILKAKL------GM  245 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CC
T ss_pred             --ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH-------HHHHcCCC------CC
Confidence              2233467999999999999999999999999999999999999999876654321       11222221      11


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                          +.....++.+++.+||+.||++|||+
T Consensus       246 ----p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          246 ----PQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ----CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                11223467899999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.2e-44  Score=387.90  Aligned_cols=247  Identities=22%  Similarity=0.370  Sum_probs=185.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCC----------
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN----------  634 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----------  634 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            345689999999999999875  5889999997544 345578999999999999999999999986543          


Q ss_pred             --cceeEeeeccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          635 --QTALIYEFMANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       635 --~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                        ..++||||+++|+|.+++.... ....++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence              3689999999999999997643 23456778899999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCCCc----------ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 002809          712 LSKSFATDANTH----------VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQ  781 (878)
Q Consensus       712 la~~~~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  781 (878)
                      +|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   ||....  +....  
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~--  236 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT--  236 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH--
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH--
Confidence            998774332211          1234579999999999999999999999999999999997   665321  11111  


Q ss_pred             HHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          782 WVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       782 ~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       . ..+.......         ........+.+++.+||+.||++|||+.|+++
T Consensus       237 -~-~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 -L-TDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -H-HHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -H-HHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1 1111111111         11122335678999999999999999999876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-42  Score=380.63  Aligned_cols=271  Identities=42%  Similarity=0.708  Sum_probs=239.6

Q ss_pred             hcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          570 FERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      +.+.||+|+||.||+|+..+ ..||||++........+.+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL  122 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred             ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence            45789999999999999864 88999999877767778999999999999999999999999999999999999999999


Q ss_pred             hhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          649 QEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       649 ~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      .+++....  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++............
T Consensus       123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  199 (321)
T 2qkw_B          123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST  199 (321)
T ss_dssp             GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred             HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence            99997643  34699999999999999999999998   99999999999999999999999999998654333333344


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....+|.......+.+...+++.+......
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (321)
T 2qkw_B          200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP  279 (321)
T ss_dssp             CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCH
T ss_pred             ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCH
Confidence            45689999999999988999999999999999999999999987665555566777777777778888888888777788


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      +....+.+++.+||+.+|++||+++||++.|+.+++.
T Consensus       280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            8899999999999999999999999999999998753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=388.83  Aligned_cols=260  Identities=20%  Similarity=0.335  Sum_probs=200.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeeccc------CCCcce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD------EDNQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~------~~~~~~  637 (878)
                      |.+.+.||+|+||+||+|+..  ++.||||++...  .....+.+.+|+++|++++|||||++++++.      +.+..+
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            455689999999999999875  588999999754  3345578899999999999999999999864      346789


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +|||||+ |+|.+++..  ...+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+++.+.
T Consensus       136 ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            9999995 789999976  56799999999999999999999998   99999999999999999999999999998764


Q ss_pred             cCCC--CcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc-
Q 002809          718 TDAN--THVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK-  793 (878)
Q Consensus       718 ~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~-  793 (878)
                      ....  .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+..+.....   .......... 
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~~~~  286 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPSPAV  286 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCCGGG
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCChHH
Confidence            3221  2233457899999999998875 5699999999999999999999999887654432221   1111110000 


Q ss_pred             --cc-----------cCCcccc---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          794 --SI-----------VDPRLQE---DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       794 --~i-----------id~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .+           +.+....   ........++.+|+.+||+.||++|||++|++++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              00           0000000   0001123467899999999999999999998763

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.1e-41  Score=376.31  Aligned_cols=196  Identities=26%  Similarity=0.396  Sum_probs=166.9

Q ss_pred             hhhcccccccccEEEEEEEEc-----ceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      |.+.+.||+|+||+||+|+..     ++.||+|++.....  ..++.+|+++|.++ +|||||++++++.+++..++|||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            456789999999999999753     47899999876543  35688999999998 69999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEEeecCCccccccCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSFATDA  720 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~  720 (878)
                      |+++|+|.++++     .+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+......
T Consensus       101 ~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A          101 YLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             CCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             CCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            999999999985     389999999999999999999998   99999999999999877 799999999998653221


Q ss_pred             C--------------------------CcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 002809          721 N--------------------------THVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINE  773 (878)
Q Consensus       721 ~--------------------------~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  773 (878)
                      .                          .......+||+.|||||++.+. .++.++||||+||+++||++|+.||.....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence            1                          0112235799999999999775 589999999999999999999999966543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.8e-42  Score=375.98  Aligned_cols=284  Identities=39%  Similarity=0.681  Sum_probs=242.0

Q ss_pred             CCCCCHHHHHHHHhhh--cccccccccEEEEEEEEcc-eeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecc
Q 002809          555 SRHLSYSDVVKITNNF--ERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHC  630 (878)
Q Consensus       555 ~~~~s~~dl~~~t~~f--~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~  630 (878)
                      ...+++.++.....+|  .+.||+|+||.||+|+..+ +.||||++...... ....+.+|++++.+++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            4567888887777666  4789999999999998754 88999999765322 234789999999999999999999999


Q ss_pred             cCCCcceeEeeeccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          631 DEDNQTALIYEFMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       631 ~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      ...+..++||||+++|+|.++++...  ...+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997643  3459999999999999999999999877899999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINE--EEKIHIRQWVNSL  786 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~v~~~  786 (878)
                      |||+++...... ........||+.|+|||++.+..++.++|||||||+++||++|+.||.....  .......+|+...
T Consensus       177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999998764332 2233445699999999999988999999999999999999999999963221  1223466788777


Q ss_pred             HhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          787 IAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       787 ~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      .....+..+.+..+...........+.+++.+||+.+|++|||++||+++|++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            77778888888888888888899999999999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.6e-40  Score=359.25  Aligned_cols=281  Identities=37%  Similarity=0.610  Sum_probs=230.8

Q ss_pred             CCCCCHHHHHHHHhhhc--------ccccccccEEEEEEEEcceeEEEEEeccC----ChhhHHHHHHHHHHHHHhcccc
Q 002809          555 SRHLSYSDVVKITNNFE--------RTLGKGGFGTVYYGRLNEIDVAVKMLSSS----SAQGFQQFQAEVKLLMRVHHRN  622 (878)
Q Consensus       555 ~~~~s~~dl~~~t~~f~--------~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~----~~~~~~~f~~Ei~~L~~l~H~n  622 (878)
                      ...|++.++.+++.+|.        +.||+|+||.||+|+..++.||||++...    .....+.+.+|++++++++|||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            45789999999999986        56999999999999998899999998753    2334678999999999999999


Q ss_pred             eeeeeecccCCCcceeEeeeccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC
Q 002809          623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE  701 (878)
Q Consensus       623 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~  701 (878)
                      |+++++++...+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.   +|+||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence            9999999999999999999999999999997543 45699999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 002809          702 KLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQ  781 (878)
Q Consensus       702 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  781 (878)
                      ++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|++||.......  .+..
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~  245 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLD  245 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BTTH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HHHH
Confidence            99999999999987654333333344578999999998875 58899999999999999999999998754322  1112


Q ss_pred             HHHHHHh-cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          782 WVNSLIA-KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       782 ~v~~~~~-~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      +...... ...+.+.+++.+. ..+......+.+++.+||+.+|++||++++|++.|+++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2222211 1223444554443 3456677889999999999999999999999999998653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-40  Score=393.98  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=207.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      |.+.+.||+|+||.||+++..  ++.||+|++........+.+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            456789999999999999885  488999999887777778899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC--CcEEEeecCCccccccCCCCc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK--LQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~--~~~kL~DFGla~~~~~~~~~~  723 (878)
                      |+|.++|.. ....+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+....   
T Consensus       239 g~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---  311 (573)
T 3uto_A          239 GELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---  311 (573)
T ss_dssp             CBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---
T ss_pred             CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---
Confidence            999999864 245699999999999999999999998   99999999999999854  899999999998774332   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....+||+.|||||++.+..|+.++||||+||++|||++|++||...+..+..       ..+..+...  +.+...  
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-------~~i~~~~~~--~~~~~~--  380 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDWN--MDDSAF--  380 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTTCCC--CCSGGG--
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHhCCCC--CCcccc--
Confidence            233467999999999999999999999999999999999999999877654321       112222110  111111  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        .....++.+|+.+||+.||++||+++|+++
T Consensus       381 --~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          381 --SGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              122346789999999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.5e-40  Score=359.10  Aligned_cols=258  Identities=30%  Similarity=0.500  Sum_probs=204.1

Q ss_pred             hhhcccccccccEEEEEEEEcceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..+..||||++....  ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus        39 y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR  118 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred             ceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence            3456899999999999999999999999987653  34567899999999999999999999999999999999999999


Q ss_pred             CChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          646 GNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPP--IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       646 gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      |+|.+++.... ...+++..++.++.|+++||+|||+.   +  |+||||||+|||++.++.+||+|||+++......  
T Consensus       119 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--  193 (309)
T 3p86_A          119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--  193 (309)
T ss_dssp             CBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred             CcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--
Confidence            99999997633 23499999999999999999999998   7  9999999999999999999999999997543221  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....   +   ......     .    
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~---~---~~~~~~-----~----  258 (309)
T 3p86_A          194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---V---GFKCKR-----L----  258 (309)
T ss_dssp             --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---H---HHSCCC-----C----
T ss_pred             cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H---HhcCCC-----C----
Confidence            122345699999999999999999999999999999999999999987765432111   1   111110     0    


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      ..+.....++.+++.+||+.+|++||+++|+++.|+.+++...
T Consensus       259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            1112233468899999999999999999999999999886543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.7e-40  Score=368.73  Aligned_cols=257  Identities=29%  Similarity=0.480  Sum_probs=212.6

Q ss_pred             hhcccccccccEEEEEEEEc---------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcce
Q 002809          569 NFERTLGKGGFGTVYYGRLN---------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~  637 (878)
                      .+.+.||+|+||.||+|+..         +..||||++.... ....+.+.+|++++.++ +||||++++++|...+..+
T Consensus        84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  163 (370)
T 2psq_A           84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY  163 (370)
T ss_dssp             EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred             EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence            45689999999999999863         2569999997653 34567899999999999 8999999999999999999


Q ss_pred             eEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          638 LIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      +||||+++|+|.+++....              ...+++..++.++.||++||+|||++   +|+||||||+|||++.++
T Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred             EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCC
Confidence            9999999999999997643              24589999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQW  782 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  782 (878)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||+| |+.||......+..     
T Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-----  315 (370)
T 2psq_A          241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-----  315 (370)
T ss_dssp             CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----
T ss_pred             CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence            999999999987644333233334557889999999999999999999999999999999 99999876554321     


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                        ..+..+..         ...+..+...+.+++.+||+.+|++||+++|+++.|++++...
T Consensus       316 --~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          316 --KLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             --HHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence              11222211         1112233457889999999999999999999999999988653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.7e-40  Score=389.87  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCCh------hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.++||+|+||.||+++...  +.||||++.+...      ........++.++..++|||||++++++.+.+.+++|
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            3556899999999999999864  8899999975321      1122233446666777899999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||++||+|.++|..  ...+++..+..++.||+.||+|||++   +||||||||+||||+.+|.+||+|||+|+.+...
T Consensus       271 mEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             ECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            999999999999976  45799999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .    ....+||+.|||||++.. ..|+.++||||+||++|||++|++||..........+.    ..+.....      
T Consensus       346 ~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~i~~~~~------  411 (689)
T 3v5w_A          346 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMAV------  411 (689)
T ss_dssp             C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HHHHHCCC------
T ss_pred             C----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhhcCCCC------
Confidence            2    234689999999999964 57999999999999999999999999764432221111    11111111      


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPT-----MSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~~  836 (878)
                      .+.    .....++.+|+.+||+.||++|++     ++||+++
T Consensus       412 ~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          412 ELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            111    122346789999999999999998     6777653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.7e-40  Score=358.38  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=210.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||.||+++..  +..||+|++........+.|.+|++++.+++||||+++++++.+++..++||||+++|
T Consensus        13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   92 (310)
T 3s95_A           13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG   92 (310)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence            45689999999999999986  4889999998777777889999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc---
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH---  723 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~---  723 (878)
                      +|.++++.. ...+++.+++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.........   
T Consensus        93 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           93 TLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             BHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred             cHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence            999999753 45699999999999999999999998   99999999999999999999999999998764322111   


Q ss_pred             ---------ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHHHHhcCC
Q 002809          724 ---------VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI---HIRQWVNSLIAKGD  791 (878)
Q Consensus       724 ---------~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---~l~~~v~~~~~~~~  791 (878)
                               ......||+.|+|||++.+..++.++||||||+++|||++|..|+.........   .......       
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-------  241 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-------  241 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-------
T ss_pred             ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-------
Confidence                     111456999999999999999999999999999999999999988654321110   0111100       


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                                ...+......+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus       242 ----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          242 ----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             ----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence                      00111222357789999999999999999999999999776543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.2e-40  Score=363.91  Aligned_cols=266  Identities=26%  Similarity=0.379  Sum_probs=208.7

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC----cceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN----QTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+|+..++.||||++..... ....+.+|+.++.+++||||+++++++....    ..++||||++
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~  105 (322)
T 3soc_A           27 QLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE  105 (322)
T ss_dssp             EEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             hhhheecccCceEEEEEEECCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence            4568999999999999999999999999975533 3355677999999999999999999997654    3699999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC-------KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +|+|.++++.   ..+++..++.++.|+++||+|||+.+       .++|+||||||+|||++.++.+||+|||+++.+.
T Consensus       106 ~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~  182 (322)
T 3soc_A          106 KGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE  182 (322)
T ss_dssp             TCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEEC
T ss_pred             CCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccc
Confidence            9999999975   45999999999999999999999752       3489999999999999999999999999998765


Q ss_pred             cCCCCcccccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH----------HHHHH
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTS-----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI----------HIRQW  782 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~----------~l~~~  782 (878)
                      ............||+.|+|||++.+     ..++.++|||||||++|||+||+.||.........          ...++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (322)
T 3soc_A          183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM  262 (322)
T ss_dssp             TTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred             cccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhh
Confidence            4433333344679999999999986     35667899999999999999999999764321111          11111


Q ss_pred             HHHHHhcCCcccccCCcccccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDF-DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ..... ....    .+.+.... .......+.+++.+||+.||++|||++||++.|+++.+.
T Consensus       263 ~~~~~-~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          263 QEVVV-HKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHHT-TSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhh-cccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11111 1111    11222111 234566799999999999999999999999999997654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=358.09  Aligned_cols=256  Identities=25%  Similarity=0.437  Sum_probs=208.8

Q ss_pred             hhhcccccccccEEEEEEEEc-----ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|+..     +..||||++... .....+.|.+|++++.+++||||+++++++..++..++|||
T Consensus        51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  130 (325)
T 3kul_A           51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE  130 (325)
T ss_dssp             EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred             eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence            345688999999999999974     256999999865 44456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.++++.. ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       131 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          131 YMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             CCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             CCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            99999999999653 45699999999999999999999998   999999999999999999999999999987643322


Q ss_pred             C-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          722 T-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       722 ~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      . .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...       .+..+.        
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~~--------  271 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS-------SVEEGY--------  271 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------HHHTTC--------
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHHcCC--------
Confidence            1 12223446778999999999999999999999999999999 999998766543211       111111        


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                       ....+......+.+++.+||+.+|++||+++||++.|+++++.
T Consensus       272 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          272 -RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence             0111223345788999999999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.2e-40  Score=356.35  Aligned_cols=262  Identities=27%  Similarity=0.423  Sum_probs=205.6

Q ss_pred             hhhcccccccccEEEEEEEE------cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRL------NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV  639 (878)
                      +.+.+.||+|+||.||++++      .++.||||++........+.+.+|++++.+++||||+++++++..  ....++|
T Consensus        12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   91 (295)
T 3ugc_A           12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI   91 (295)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred             hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence            45678999999999999985      347899999988777777899999999999999999999998854  4568999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++|+|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           92 MEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred             EEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence            9999999999999753 34599999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH---------HHHHHHHHHHhc
Q 002809          720 ANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI---------HIRQWVNSLIAK  789 (878)
Q Consensus       720 ~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---------~l~~~v~~~~~~  789 (878)
                      ... .......++..|+|||.+.+..++.++||||||+++|||+||..|+.....+...         .........+..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  247 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence            221 1222344677899999999999999999999999999999999988653221100         001111111111


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      +.         ....+.....++.+++.+||+.+|++|||++|+++.|+++.+
T Consensus       248 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          248 NG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            11         111223344578899999999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-39  Score=363.32  Aligned_cols=259  Identities=28%  Similarity=0.444  Sum_probs=209.3

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCC-cce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDN-QTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~-~~~  637 (878)
                      +.+.+.||+|+||.||+|++.       ++.||||++.... ....+.+.+|++++.++ +||||+++++++...+ ..+
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~  103 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  103 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence            345689999999999999842       2789999998653 34457899999999999 7999999999987755 489


Q ss_pred             eEeeeccCCChhhhhccccC------------------------------------------------------------
Q 002809          638 LIYEFMANGNLQEYLSDISK------------------------------------------------------------  657 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------------  657 (878)
                      +||||+++|+|.++++....                                                            
T Consensus       104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3vhe_A          104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE  183 (359)
T ss_dssp             EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence            99999999999999976432                                                            


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCC
Q 002809          658 ----KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG  733 (878)
Q Consensus       658 ----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  733 (878)
                          ..+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++...............||+.
T Consensus       184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence                1289999999999999999999998   999999999999999999999999999987644443334445668899


Q ss_pred             ccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHH
Q 002809          734 YLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKA  812 (878)
Q Consensus       734 Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l  812 (878)
                      |+|||++.+..++.++|||||||++|||+| |+.||........      +...+..+....         .+.....++
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~l  325 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR---------APDYTTPEM  325 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCC---------CCTTCCHHH
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCC---------CCCCCCHHH
Confidence            999999999999999999999999999999 9999987553321      111122221111         111223467


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          813 VELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       813 ~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      .+++.+||+.+|++||+++||+++|+++++..
T Consensus       326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            89999999999999999999999999988653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=363.69  Aligned_cols=262  Identities=30%  Similarity=0.466  Sum_probs=215.5

Q ss_pred             hhhcccccccccEEEEEEEEcc---------eeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcc
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE---------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQT  636 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~  636 (878)
                      +.+.+.||+|+||.||+|+..+         ..||||++.... ....+.+.+|++++.++ +||||+++++++..++..
T Consensus        71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  150 (382)
T 3tt0_A           71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL  150 (382)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence            4567899999999999998632         579999997653 44567899999999999 899999999999999999


Q ss_pred             eeEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC
Q 002809          637 ALIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK  702 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~  702 (878)
                      ++||||+++|+|.+++....              ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.+
T Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED  227 (382)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCC
Confidence            99999999999999997643              24599999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002809          703 LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQ  781 (878)
Q Consensus       703 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  781 (878)
                      +.+||+|||+++...............+++.|+|||++.+..++.++|||||||+++||++ |+.||......+.   . 
T Consensus       228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~---~-  303 (382)
T 3tt0_A          228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---F-  303 (382)
T ss_dssp             CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H-
T ss_pred             CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-
Confidence            9999999999987654333333344567889999999999999999999999999999999 9999987654431   1 


Q ss_pred             HHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          782 WVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       782 ~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                         ..+..+...         ..+.....++.+++.+||+.+|++||+++||++.|++++.......
T Consensus       304 ---~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          304 ---KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             ---HHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             ---HHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence               122222111         1112233468899999999999999999999999999987654333

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.4e-40  Score=368.44  Aligned_cols=255  Identities=25%  Similarity=0.425  Sum_probs=209.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++.... ....+.|.+|++++++++||||+++++++..++..++||||+++
T Consensus       117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  196 (377)
T 3cbl_A          117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG  196 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence            45689999999999999986  4889999987653 33456789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.++++. ....+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++...........
T Consensus       197 g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~  272 (377)
T 3cbl_A          197 GDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG  272 (377)
T ss_dssp             CBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred             CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence            999999975 244689999999999999999999998   9999999999999999999999999999764322111111


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+.   .    ..+..+..         ...
T Consensus       273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~----~~~~~~~~---------~~~  336 (377)
T 3cbl_A          273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---R----EFVEKGGR---------LPC  336 (377)
T ss_dssp             SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---H----HHHHTTCC---------CCC
T ss_pred             CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcCCC---------CCC
Confidence            12235678999999998899999999999999999999 9999987665432   1    12222211         011


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      +..+...+.+++.+||+.+|++|||+++|++.|+++...
T Consensus       337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            222345788999999999999999999999999997653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-39  Score=364.81  Aligned_cols=255  Identities=25%  Similarity=0.456  Sum_probs=199.1

Q ss_pred             hhcccccccccEEEEEEEEc-----ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+|+..     +..||||++... .....+.|.+|++++.+++||||+++++++...+..++||||
T Consensus        48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (373)
T 2qol_A           48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY  127 (373)
T ss_dssp             CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence            45689999999999999875     467999999765 344567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.++++.. ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       128 ~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          128 MENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             CTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            9999999999753 44699999999999999999999998   9999999999999999999999999999876433221


Q ss_pred             c-ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          723 H-VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       723 ~-~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      . ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+..   +    .+..+.         
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~----~i~~~~---------  267 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---K----AVDEGY---------  267 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---H----HHHTTE---------
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcCC---------
Confidence            1 1122335678999999999999999999999999999998 99999876654321   1    111111         


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ....+......+.+++.+||+.+|++||+++||++.|++++..
T Consensus       268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            1111223345788999999999999999999999999998865

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.7e-38  Score=348.56  Aligned_cols=263  Identities=21%  Similarity=0.325  Sum_probs=213.4

Q ss_pred             cccCCCCCHHHHHHHHhh------------hcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHH
Q 002809          552 EAKSRHLSYSDVVKITNN------------FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMR  617 (878)
Q Consensus       552 ~~~~~~~s~~dl~~~t~~------------f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~  617 (878)
                      ......++++++.+++..            ..+.||+|+||.||+|+..  ++.||||++........+.+.+|+.++++
T Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~   98 (321)
T 2c30_A           19 YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD   98 (321)
T ss_dssp             ------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred             eecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence            334467888888888754            2458999999999999885  58899999987766667889999999999


Q ss_pred             hcccceeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccE
Q 002809          618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI  697 (878)
Q Consensus       618 l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NI  697 (878)
                      ++||||+++++++...+..++||||+++|+|.+++..   ..+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  172 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI  172 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999999999999999999999999999999999864   4699999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 002809          698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI  777 (878)
Q Consensus       698 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  777 (878)
                      |++.++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||+++||++|+.||.........
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~  250 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM  250 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999987643322  223457999999999999999999999999999999999999999876543211


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         .    .+.....     +.+..  .......+.+++.+||+.+|++||+++|+++.
T Consensus       251 ---~----~~~~~~~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 ---K----RLRDSPP-----PKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             ---H----HHHHSSC-----CCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---H----HHhcCCC-----CCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1    1111111     11110  11223467899999999999999999999873

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.5e-39  Score=370.74  Aligned_cols=250  Identities=29%  Similarity=0.469  Sum_probs=209.1

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC-cceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN-QTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+|+..++.||||+++...  ..+.|.+|+++|++++||||+++++++.... ..++||||+++|+
T Consensus       196 ~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~  273 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  273 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred             EEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence            456899999999999999999999999998654  4578999999999999999999999986654 7899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++++......+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.....     ...
T Consensus       274 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~  345 (450)
T 1k9a_A          274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT  345 (450)
T ss_dssp             HHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccC
Confidence            99999875555689999999999999999999998   9999999999999999999999999999854321     112


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||.+.+..++.++|||||||++|||+| |+.||......+..       ..+..+..         ...+.
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~~---------~~~p~  409 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGYK---------MDAPD  409 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-------HHHHTTCC---------CCCCT
T ss_pred             CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC---------CCCCC
Confidence            357889999999999999999999999999999999 99999876543311       11222211         11222


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      .+...+.+++.+||+.+|++||+++++++.|+++...+
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            34457889999999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1e-38  Score=347.91  Aligned_cols=246  Identities=21%  Similarity=0.374  Sum_probs=204.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++........+.+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus        23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  102 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence            45678999999999999864  4889999997665555678999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++..   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........  ...
T Consensus       103 ~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  174 (297)
T 3fxz_A          103 SLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS  174 (297)
T ss_dssp             BHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBC
T ss_pred             CHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccC
Confidence            99999975   3589999999999999999999998   999999999999999999999999999987643322  233


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...........      ....+. ...       ..+.
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~~-~~~-------~~~~  240 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT-PEL-------QNPE  240 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHCS-CCC-------SCGG
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCC-CCC-------CCcc
Confidence            45799999999999999999999999999999999999999987655332111      111111 010       0112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .....+.+++.+||+.||++||+++|+++.
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            233467899999999999999999999873

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.1e-39  Score=345.05  Aligned_cols=253  Identities=26%  Similarity=0.479  Sum_probs=208.4

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+++..+ ..||+|++...... .+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (269)
T 4hcu_A           13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   91 (269)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence            456899999999999999854 88999999865433 3679999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.. ....+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus        92 L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  166 (269)
T 4hcu_A           92 LSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTG  166 (269)
T ss_dssp             HHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTS
T ss_pred             HHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc-cccccC
Confidence            9999965 245689999999999999999999998   99999999999999999999999999998653221 112223


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||.+.+..++.++||||||++++||++ |+.||......+..      .. +..+.  ...       .+.
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~------~~-~~~~~--~~~-------~~~  230 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------ED-ISTGF--RLY-------KPR  230 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HH-HHTTC--CCC-------CCT
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH------HH-HhcCc--cCC-------CCC
Confidence            446778999999999999999999999999999999 99999876654321      11 11111  001       111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      .....+.+++.+||+.+|++||+++|+++.|+++.+.
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            1234678999999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=353.12  Aligned_cols=255  Identities=31%  Similarity=0.486  Sum_probs=210.4

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|+..+       +.||||++.... ....+.+.+|++++.+++||||+++++++..++..++||
T Consensus        50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  129 (343)
T 1luf_A           50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF  129 (343)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence            456889999999999999863       789999998653 445678999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhcccc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEE
Q 002809          641 EFMANGNLQEYLSDIS----------------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNIL  698 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NIL  698 (878)
                      ||+++|+|.+++....                      ...+++..++.++.||++||+|||+.   +|+||||||+|||
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl  206 (343)
T 1luf_A          130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  206 (343)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEE
Confidence            9999999999997632                      25799999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 002809          699 LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKI  777 (878)
Q Consensus       699 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  777 (878)
                      ++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+. 
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  285 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-  285 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH-
Confidence            99999999999999986643332223334568889999999999899999999999999999999 9999987655331 


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                            ...+..+....         .+......+.+++.+||+.+|++||+++++++.|+++..
T Consensus       286 ------~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          286 ------IYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             ------HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ------HHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence                  11222222211         112233468899999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=362.43  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=211.8

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|++.       +..||||++... .......+.+|+.++.+++||||+++++++......++|
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  152 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL  152 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence            356789999999999999853       257999999754 344566899999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---cEEEeecC
Q 002809          640 YEFMANGNLQEYLSDIS-----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---QAKLADFG  711 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~DFG  711 (878)
                      |||+++|+|.+++....     ...+++..++.++.||++||+|||+.   +|+||||||+|||++.++   .+||+|||
T Consensus       153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            99999999999997643     24699999999999999999999998   999999999999999555   59999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      +++.+.............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+..       ..+..+
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~-------~~i~~~  302 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-------EFVTSG  302 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHTT
T ss_pred             cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC
Confidence            9986543333333344568899999999999999999999999999999998 99999876654321       111222


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                      ...         ..+......+.+++.+||+.+|++||+++||++.|+.+.+....
T Consensus       303 ~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          303 GRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             CCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence            111         11122334688999999999999999999999999998765443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8e-39  Score=345.22  Aligned_cols=254  Identities=29%  Similarity=0.499  Sum_probs=206.8

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+++..+ ..||+|++...... .+++.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  105 (283)
T 3gen_A           27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC  105 (283)
T ss_dssp             EEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred             HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence            456899999999999999877 68999999865433 3679999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++... ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus       106 L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  180 (283)
T 3gen_A          106 LLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVG  180 (283)
T ss_dssp             HHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTS
T ss_pred             HHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc-cccccC
Confidence            99999753 34699999999999999999999998   99999999999999999999999999998653221 111223


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..+++.|+|||.+.+..++.++||||||+++|||+| |+.||..........       .+..+.     ..    ..+.
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-------~~~~~~-----~~----~~~~  244 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQGL-----RL----YRPH  244 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHTTC-----CC----CCCT
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-------HHhccc-----CC----CCCC
Confidence            346778999999998899999999999999999998 999998766543211       111111     00    0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      .....+.+++.+||+.+|++||+++|+++.|++++..|
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            12346789999999999999999999999999988654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.3e-39  Score=350.78  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=211.8

Q ss_pred             hhhcccccccccEEEEEEEE-------cceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRL-------NEIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+.       .++.||||++.... ....+.+.+|++++.++ +||||+++++++..++..++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  104 (313)
T 1t46_A           25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV  104 (313)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence            35678999999999999985       23789999998654 34567899999999999 89999999999999999999


Q ss_pred             EeeeccCCChhhhhccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC
Q 002809          639 IYEFMANGNLQEYLSDISK----------------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK  702 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~  702 (878)
                      ||||+++|+|.+++.....                ..+++..++.++.|+++||+|||+.   +|+||||||+|||++.+
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence            9999999999999976432                2489999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002809          703 LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQ  781 (878)
Q Consensus       703 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  781 (878)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||+| |+.||........  .. 
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~-  258 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--FY-  258 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--HH-
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--HH-
Confidence            9999999999987654433333334557889999999999999999999999999999999 9999987654321  11 


Q ss_pred             HHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          782 WVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       782 ~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                         .....+.. .        ..+......+.+++.+||+.+|++||+++|+++.|++++..
T Consensus       259 ---~~~~~~~~-~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          259 ---KMIKEGFR-M--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             ---HHHHHTCC-C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHhccCCC-C--------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence               11111110 0        01112234688999999999999999999999999998864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.4e-39  Score=354.89  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=202.7

Q ss_pred             hhcccccccccEEEEEEEEcc------eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|+...      .+||+|.+... .....+.|.+|++++.+++||||++++++|..+. .++|+|
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e   96 (327)
T 3poz_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ   96 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEE
T ss_pred             ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEE
Confidence            456899999999999998742      24688888644 3345678999999999999999999999998754 789999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++... ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        97 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           97 LMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             CCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            99999999999753 45699999999999999999999998   999999999999999999999999999987754443


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........+|..|+|||++.+..++.++|||||||++|||+| |+.||..........       .+..+..        
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~~--------  237 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGER--------  237 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTCC--------
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH-------HHHcCCC--------
Confidence            333344557889999999999999999999999999999999 999998766543211       1111111        


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                       ...+......+.+++.+||+.+|++||+++|+++.|+++...
T Consensus       238 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          238 -LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             -CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence             111222344788999999999999999999999999997654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-39  Score=356.37  Aligned_cols=258  Identities=28%  Similarity=0.443  Sum_probs=208.1

Q ss_pred             hhhcccccccccEEEEEEEE-------cceeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRL-------NEIDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+.       .+..||||++... .....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  126 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  126 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence            45578999999999999986       2367999999754 334567899999999999 89999999999999999999


Q ss_pred             EeeeccCCChhhhhccccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccE
Q 002809          639 IYEFMANGNLQEYLSDISK---------------------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI  697 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NI  697 (878)
                      ||||+++|+|.+++.....                     ..+++..++.++.|+++||+|||+.   +|+||||||+||
T Consensus       127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI  203 (344)
T 1rjb_A          127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV  203 (344)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred             EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence            9999999999999976432                     3489999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHH
Q 002809          698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEK  776 (878)
Q Consensus       698 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~  776 (878)
                      |++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||+| |+.||........
T Consensus       204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  283 (344)
T 1rjb_A          204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  283 (344)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence            999999999999999987654443333444567889999999999999999999999999999998 9999987654321


Q ss_pred             HHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       777 ~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                        +.    ..+..+..         ...+......+.+++.+||+.+|++||++.|+++.|+.++..
T Consensus       284 --~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          284 --FY----KLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             --HH----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             --HH----HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence              11    11222210         111122234788999999999999999999999999997754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.2e-39  Score=350.03  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=211.7

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+++..       +..||||++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  104 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI  104 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence            345689999999999999862       277999999764 345567899999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhccccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccE
Q 002809          640 YEFMANGNLQEYLSDISK----------------------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI  697 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NI  697 (878)
                      |||+++|+|.+++.....                      ..+++..++.++.|+++||+|||+.   +|+||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI  181 (314)
T 2ivs_A          105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI  181 (314)
T ss_dssp             EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence            999999999999976432                      3489999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHH
Q 002809          698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEK  776 (878)
Q Consensus       698 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~  776 (878)
                      |++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||+++||++ |+.||........
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  261 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL  261 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987644333222334457788999999999899999999999999999999 9999987665432


Q ss_pred             HHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       777 ~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      .       ..+..+...         ..+......+.+++.+||+.+|++||+++|+++.|++++..
T Consensus       262 ~-------~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          262 F-------NLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             H-------HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             H-------HHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            1       112222111         11122334788999999999999999999999999998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.2e-38  Score=350.47  Aligned_cols=244  Identities=25%  Similarity=0.436  Sum_probs=204.0

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~   96 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA   96 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence            345689999999999999973  588999998754  4455678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        97 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  168 (328)
T 3fe3_A           97 SGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---  168 (328)
T ss_dssp             TTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence            99999999976  45699999999999999999999998   99999999999999999999999999998664322   


Q ss_pred             ccccccCCCCccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLT-EKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .....+||+.|+|||++.+..+. .++||||+||+++||++|+.||...+..+..       ..+..+..      .+  
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~------~~--  233 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-------ERVLRGKY------RI--  233 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CC--
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC------CC--
Confidence            23456799999999999988765 7999999999999999999999876643311       11222221      11  


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        +......+.+++.+||+.||++|||++|+++.
T Consensus       234 --p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          234 --PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              11123467799999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.2e-39  Score=342.65  Aligned_cols=250  Identities=28%  Similarity=0.486  Sum_probs=195.4

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCCh----hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSA----QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~----~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+|+..+..||||++.....    ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus        10 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (271)
T 3dtc_A           10 TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR   89 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred             eeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence            4568999999999999999999999999875432    235678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC--------CCcEEEeecCCcccc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE--------KLQAKLADFGLSKSF  716 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~--------~~~~kL~DFGla~~~  716 (878)
                      +++|.+++.   ...+++..++.++.|+++||+|||++...+|+||||||+|||++.        ++.+||+|||+++..
T Consensus        90 ~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~  166 (271)
T 3dtc_A           90 GGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW  166 (271)
T ss_dssp             TEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred             CCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence            999999986   457999999999999999999999983233999999999999986        778999999999765


Q ss_pred             ccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      ....    .....|++.|+|||.+.+..++.++||||||++++||++|+.||..........      .. .....    
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~-~~~~~----  231 (271)
T 3dtc_A          167 HRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GV-AMNKL----  231 (271)
T ss_dssp             -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HH-HTSCC----
T ss_pred             cccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hh-hcCCC----
Confidence            4322    123468999999999999999999999999999999999999998765433211      11 11111    


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                          ....+......+.+++.+||+.+|++||+++|+++.|+++
T Consensus       232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 ----ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                1111223335788999999999999999999999999853

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-38  Score=341.22  Aligned_cols=248  Identities=22%  Similarity=0.376  Sum_probs=205.6

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC--CcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+|+..+..||||++...  .....+.|.+|+.++++++||||+++++++...  ...++||||++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (271)
T 3kmu_A           13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP   92 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred             HHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence            45689999999999999999999999999765  344567899999999999999999999999876  78899999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP--IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +|+|.+++.......+++..++.++.|+++||+|||+.   +  |+||||||+|||++.++.++|+|||+......    
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----  165 (271)
T 3kmu_A           93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----  165 (271)
T ss_dssp             TCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc----
Confidence            99999999875555799999999999999999999987   6  99999999999999999999999998754321    


Q ss_pred             cccccccCCCCccCccccccCCCCC---ccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTE---KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~---ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                         ....||+.|+|||.+.+...+.   ++|||||||++|||++|+.||.........      ......+..     +.
T Consensus       166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~-----~~  231 (271)
T 3kmu_A          166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEGLR-----PT  231 (271)
T ss_dssp             ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSCCC-----CC
T ss_pred             ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcCCC-----CC
Confidence               2245889999999998765544   799999999999999999999876653321      111111111     11


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                          .+......+.+++.+||+.+|++||+++|+++.|+++.
T Consensus       232 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          232 ----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                11223346889999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-38  Score=341.61  Aligned_cols=253  Identities=24%  Similarity=0.444  Sum_probs=208.2

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.+.||+|+||.||+++..+ ..||+|++...... .+++.+|++++.+++||||+++++++..++..++||||++++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG   88 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence            3456899999999999999877 68999999765433 467999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++... ...+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++....... .....
T Consensus        89 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~  163 (268)
T 3sxs_A           89 CLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSV  163 (268)
T ss_dssp             BHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEECC
T ss_pred             cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh-hhccc
Confidence            999999753 44699999999999999999999998   99999999999999999999999999998664332 12223


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||.+.+..++.++||||||++++||++ |+.||..........      . +..+.  ....       +
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~-~~~~~--~~~~-------~  227 (268)
T 3sxs_A          164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------K-VSQGH--RLYR-------P  227 (268)
T ss_dssp             SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------H-HHTTC--CCCC-------C
T ss_pred             CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------H-HHcCC--CCCC-------C
Confidence            3446678999999999899999999999999999999 999998766543211      1 11111  0011       1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      ......+.+++.+||+.+|++|||++|+++.|+++.+
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            1122467899999999999999999999999988654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-38  Score=347.22  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=205.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++..  +..||+|++...   .....+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   92 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY   92 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence            355689999999999999875  488999998643   334567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        93 ~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  166 (294)
T 4eqm_A           93 IEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-  166 (294)
T ss_dssp             CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-
Confidence            999999999976  45799999999999999999999998   999999999999999999999999999987643221 


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ....... ...     ....
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-~~~-----~~~~  234 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-SVP-----NVTT  234 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-CCC-----CHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-cCC-----Ccch
Confidence            222345699999999999999999999999999999999999999987664331      1111111 111     1111


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRP-TMSQVVMELSECLA  842 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~evl~~L~~~~~  842 (878)
                      .........+.+++.+|++.+|++|| +++++.+.|++++.
T Consensus       235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            12223345788999999999999998 89999999987653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.2e-39  Score=374.68  Aligned_cols=253  Identities=28%  Similarity=0.458  Sum_probs=211.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|++.  +..||||++..... ..+.|.+|+++|++++||||++++++|...+..++||||+++
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~  300 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY  300 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence            356789999999999999987  47899999976543 357899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.++++......+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus       301 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~  376 (495)
T 1opk_A          301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH  376 (495)
T ss_dssp             CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECC
T ss_pred             CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeec
Confidence            9999999876667799999999999999999999998   99999999999999999999999999998764322 1122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....++..|+|||++.+..++.++|||||||++|||+| |+.||......+.   .+    .+..+.         ....
T Consensus       377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~---------~~~~  440 (495)
T 1opk_A          377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE----LLEKDY---------RMER  440 (495)
T ss_dssp             TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH----HHHTTC---------CCCC
T ss_pred             CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCC---------CCCC
Confidence            23446788999999999999999999999999999999 9999987664431   11    111111         1112


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      +..+...+.+++.+||+.+|++||++++|++.|+++.
T Consensus       441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            2233457889999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.5e-39  Score=371.94  Aligned_cols=251  Identities=26%  Similarity=0.439  Sum_probs=207.9

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+|+..+ ..||||++.... ...+.|.+|+++|++++||||+++++++. .+..++||||+++|+
T Consensus       191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~  268 (454)
T 1qcf_A          191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS  268 (454)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred             EEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence            567899999999999999875 889999998654 34678999999999999999999999987 567899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++++......+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus       269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~  344 (454)
T 1qcf_A          269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREG  344 (454)
T ss_dssp             HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCS
T ss_pred             HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCC
Confidence            99999865555789999999999999999999998   99999999999999999999999999998753221 111223


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||++....++.++|||||||++|||+| |+.||......+..   +    .+..+..         ...+.
T Consensus       345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~----~i~~~~~---------~~~~~  408 (454)
T 1qcf_A          345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R----ALERGYR---------MPRPE  408 (454)
T ss_dssp             SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H----HHHHTCC---------CCCCT
T ss_pred             CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcCCC---------CCCCC
Confidence            346778999999998999999999999999999999 99999876654321   1    1112210         01122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .+...+.+++.+||+.+|++||++++|++.|+++.
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            33457889999999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.1e-38  Score=341.07  Aligned_cols=263  Identities=15%  Similarity=0.213  Sum_probs=210.0

Q ss_pred             hhhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+|+.  .++.||||++.....  .+.+.+|+.++.++ +|+|++++++++..+...++||||+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            34568999999999999995  458999999875432  35688999999999 7999999999999999999999999 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc-----EEEeecCCccccccC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ-----AKLADFGLSKSFATD  719 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~-----~kL~DFGla~~~~~~  719 (878)
                      +++|.+++... +..+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.     +||+|||+++.....
T Consensus        89 ~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            99999999753 34699999999999999999999998   9999999999999987776     999999999876543


Q ss_pred             CCC-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          720 ANT-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       720 ~~~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ...     .......||+.|+|||.+.+..++.++|||||||+++||++|+.||..............+..........+
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  244 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence            221     123345699999999999999999999999999999999999999987543222222111111111111111


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                      .         .......+.+++.+||+.+|++||++++|++.|++++.....
T Consensus       245 ~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          245 L---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             H---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             H---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            1         112234788999999999999999999999999998865443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.2e-38  Score=343.22  Aligned_cols=258  Identities=26%  Similarity=0.407  Sum_probs=200.4

Q ss_pred             hhhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHH--hcccceeeeeecccC----CCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR--VHHRNLTSLVGHCDE----DNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~--l~H~nIv~l~g~~~~----~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|+.+++.||||++...   ..+.+.+|.+++..  ++||||+++++++..    ....++|||
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             EEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            345689999999999999999999999998654   33556677777777  789999999998643    356889999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCccEEEcCCCcEEEeecCCc
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH--------NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLS  713 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla  713 (878)
                      |+++|+|.++++.   ..+++..++.++.|+++||+|||        +.   +|+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           87 YHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             CCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             hccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            9999999999963   46999999999999999999999        66   9999999999999999999999999999


Q ss_pred             cccccCCCCc--ccccccCCCCccCccccccC------CCCCccchhhHHHHHHHHHhC----------CCCCCCCChHH
Q 002809          714 KSFATDANTH--VSTVVAGTPGYLDPEYYTSN------RLTEKSDVYSFGVVILEIITC----------KPAISRINEEE  775 (878)
Q Consensus       714 ~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~------~~t~ksDV~S~Gvvl~elltG----------~~p~~~~~~~~  775 (878)
                      +.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            7664332211  12234699999999999876      455799999999999999999          88886543211


Q ss_pred             HHHHHHHHHHHHhcCCcccccCCcccc-ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          776 KIHIRQWVNSLIAKGDIKSIVDPRLQE-DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       776 ~~~l~~~v~~~~~~~~~~~iid~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      . .... .........    ..+.+.. .........+.+++.+||+.+|++|||++||++.|+++
T Consensus       241 ~-~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 P-SFED-MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             C-CHHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             c-chhh-hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            1 0111 111111111    1111111 12345667899999999999999999999999999874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-38  Score=350.78  Aligned_cols=262  Identities=29%  Similarity=0.422  Sum_probs=197.0

Q ss_pred             hhhcccccccccEEEEEEEEcce-----eEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcc----
Q 002809          568 NNFERTLGKGGFGTVYYGRLNEI-----DVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQT----  636 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~~-----~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~----  636 (878)
                      +.+.+.||+|+||.||+|+....     .||||++...  .....+.+.+|++++++++||||+++++++......    
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP  104 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence            45678999999999999987542     7999999764  344568899999999999999999999999777655    


Q ss_pred             --eeEeeeccCCChhhhhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          637 --ALIYEFMANGNLQEYLSDIS----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       637 --~lV~Ey~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                        ++||||+++|+|.+++....    ...+++..++.++.|+++||+|||+.   +|+||||||+|||+++++.+||+||
T Consensus       105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence              89999999999999996532    22599999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      |+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+...      .. ..
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~-~~  254 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN------YL-IG  254 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HH-HT
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH------HH-hc
Confidence            99987644333333334457789999999999999999999999999999999 999998766543211      11 11


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                      +...         ..+......+.+++.+||+.+|++||++.++++.|++++.......
T Consensus       255 ~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~  304 (323)
T 3qup_A          255 GNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS  304 (323)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred             CCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence            1110         1112233478899999999999999999999999999886544333

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.7e-38  Score=342.77  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=199.3

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|+...     ..||+|++... .....+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   95 (281)
T 1mp8_A           17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME   95 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence            4567899999999999998742     46999998764 3445678999999999999999999999985 457899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++... ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           96 LCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             CCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence            99999999999752 44699999999999999999999998   999999999999999999999999999987643221


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                       .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..   .    .+..+...       
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~----~i~~~~~~-------  236 (281)
T 1mp8_A          172 -YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G----RIENGERL-------  236 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H----HHHTTCCC-------
T ss_pred             -cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H----HHHcCCCC-------
Confidence             12223456789999999998899999999999999999997 99999876554321   1    11111111       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                        ..+......+.+++.+||+.+|++||++.|+++.|++++..+..
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  280 (281)
T 1mp8_A          237 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  280 (281)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence              11222335688999999999999999999999999999887653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.7e-39  Score=345.61  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=214.9

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+...  ..||+|++.... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus        15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   93 (288)
T 3kfa_A           15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   93 (288)
T ss_dssp             EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence            3556899999999999999874  789999997643 3457899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....... ....
T Consensus        94 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~  169 (288)
T 3kfa_A           94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH  169 (288)
T ss_dssp             EEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEE
T ss_pred             CcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccc
Confidence            9999999876677799999999999999999999998   99999999999999999999999999998764332 2223


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....+++.|+|||.+.+..++.++||||||++++||++ |+.||..........   .    +....         ....
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~---~----~~~~~---------~~~~  233 (288)
T 3kfa_A          170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---L----LEKDY---------RMER  233 (288)
T ss_dssp             TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---H----HHTTC---------CCCC
T ss_pred             cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H----HhccC---------CCCC
Confidence            34457889999999999999999999999999999999 999998765443211   1    11111         1111


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                      +......+.+++.+||+.+|++||+++|+++.|+++......
T Consensus       234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~  275 (288)
T 3kfa_A          234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI  275 (288)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            122335788999999999999999999999999998866443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-38  Score=352.19  Aligned_cols=260  Identities=28%  Similarity=0.438  Sum_probs=211.6

Q ss_pred             hhhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+..+       ..||+|++.... ....+.+.+|++++.++ +||||+++++++..++..++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            3456899999999999998743       369999997653 34567899999999999 89999999999999999999


Q ss_pred             EeeeccCCChhhhhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEE
Q 002809          639 IYEFMANGNLQEYLSDIS------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK  706 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~k  706 (878)
                      ||||+++|+|.+++....            ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence            999999999999997532            34589999999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHH
Q 002809          707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNS  785 (878)
Q Consensus       707 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~  785 (878)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|||+| |..||........  +..    
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~----  278 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYK----  278 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHH----
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHH----
Confidence            999999987654433333334557889999999999899999999999999999999 9999987553321  111    


Q ss_pred             HHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          786 LIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       786 ~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      ....+...         ..+......+.+++.+||+.+|++||+++||++.|+++...+.
T Consensus       279 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          279 LVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence            11111100         0111123467899999999999999999999999999876644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.8e-38  Score=346.89  Aligned_cols=270  Identities=15%  Similarity=0.214  Sum_probs=213.9

Q ss_pred             hhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+.  .++.||||++.....  .+.+.+|+++++++ +||||+++++++..++..++||||+ +
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~   88 (330)
T 2izr_A           12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G   88 (330)
T ss_dssp             EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence            4568999999999999996  458899999875533  34688999999999 8999999999999999999999999 9


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc-----EEEeecCCccccccCC
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ-----AKLADFGLSKSFATDA  720 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~-----~kL~DFGla~~~~~~~  720 (878)
                      ++|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++.+....
T Consensus        89 ~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           89 PSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            9999999753 45799999999999999999999998   9999999999999999887     9999999998764332


Q ss_pred             CCc-----ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          721 NTH-----VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       721 ~~~-----~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      ...     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........... 
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-  243 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV-  243 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH-
Confidence            211     12356799999999999999999999999999999999999999987543322222111111111100000 


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhcCCCCCcC
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFH  855 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~~~~~~~~  855 (878)
                              ...... ++.+++..|++.+|.+||++++|++.|+++.............+.
T Consensus       244 --------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          244 --------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             --------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             --------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence                    001112 788999999999999999999999999998877655554444444

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-38  Score=338.79  Aligned_cols=261  Identities=23%  Similarity=0.421  Sum_probs=213.9

Q ss_pred             ccccccccEEEEEEEEc----ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          572 RTLGKGGFGTVYYGRLN----EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.||+|+||.||+|+..    +..||||++.... ....+.+.+|++++.+++||||+++++++ ..+..++||||++++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            48999999999999863    4779999998753 44567899999999999999999999999 456789999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-ccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-HVS  725 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~  725 (878)
                      +|.+++.. ....+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++........ ...
T Consensus        95 ~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  170 (287)
T 1u59_A           95 PLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  170 (287)
T ss_dssp             EHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             CHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence            99999964 345699999999999999999999998   9999999999999999999999999999876433221 112


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....+++.|+|||++.+..++.++||||||++++||++ |+.||......+.   ..    .+..+...         ..
T Consensus       171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~i~~~~~~---------~~  234 (287)
T 1u59_A          171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA----FIEQGKRM---------EC  234 (287)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH----HHHTTCCC---------CC
T ss_pred             ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HH----HHhcCCcC---------CC
Confidence            23446889999999998889999999999999999999 9999987654331   11    12222111         11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhcCCCCC
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRG  853 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~~~~~~  853 (878)
                      +......+.+++.+||+.+|++||++.++++.|+++..+.......++.
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~  283 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH  283 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCcc
Confidence            2233457889999999999999999999999999999888777765554

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=341.17  Aligned_cols=268  Identities=22%  Similarity=0.315  Sum_probs=209.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCC--cceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN--QTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence            345689999999999999986  4889999997543 334577889999999999999999999987655  77999999


Q ss_pred             ccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE----cCCCcEEEeecCCccccc
Q 002809          643 MANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       643 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl----~~~~~~kL~DFGla~~~~  717 (878)
                      +++|+|.+++.... ...+++..++.++.|+++||+|||+.   +|+||||||+|||+    +.++.+||+|||+++...
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            99999999997643 23499999999999999999999998   99999999999999    788889999999998764


Q ss_pred             cCCCCcccccccCCCCccCccccc--------cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYT--------SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~--------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      ....   .....||..|+|||++.        +..++.++|||||||++|||++|+.||.........  .+.+......
T Consensus       168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~  242 (319)
T 4euu_A          168 DDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITG  242 (319)
T ss_dssp             TTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHH
T ss_pred             CCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcC
Confidence            3321   22356999999999986        567899999999999999999999999754432211  1111122211


Q ss_pred             C---Cccccc---------CCccc--cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          790 G---DIKSIV---------DPRLQ--EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       790 ~---~~~~ii---------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      .   .+..+.         .+.+.  ..........+.+++.+||+.||++||+++|+++...+....
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            1   111110         01111  123456677888999999999999999999999999875533

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.7e-38  Score=340.02  Aligned_cols=253  Identities=21%  Similarity=0.404  Sum_probs=202.7

Q ss_pred             hhhcccccccccEEEEEEEEcc---------eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE---------IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+...         ..||+|++........+.+.+|++++.+++||||+++++++..++..++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL   89 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence            3556899999999999998754         4699999987766677889999999999999999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc--------EEEeec
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ--------AKLADF  710 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~--------~kL~DF  710 (878)
                      ||||+++|+|.+++... ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.        +||+||
T Consensus        90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           90 VQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             EEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            99999999999999763 34599999999999999999999998   9999999999999998887        999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHHHHHh
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWVNSLIA  788 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~v~~~~~  788 (878)
                      |++.....      .....|+..|+|||++.+ ..++.++|||||||++|||++|. +|+...........   .   ..
T Consensus       166 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~---~---~~  233 (289)
T 4fvq_A          166 GISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF---Y---ED  233 (289)
T ss_dssp             CSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---H---HT
T ss_pred             cccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH---h---hc
Confidence            99865422      123457899999999987 67899999999999999999954 55555443321111   1   11


Q ss_pred             cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       789 ~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                      ........            ..++.+++.+||+.+|++||+++|+++.|++++..+....
T Consensus       234 ~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~  281 (289)
T 4fvq_A          234 RHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR  281 (289)
T ss_dssp             TCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred             cCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence            11111111            1246789999999999999999999999999887655544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.5e-38  Score=348.34  Aligned_cols=258  Identities=29%  Similarity=0.479  Sum_probs=211.4

Q ss_pred             hhhcccccccccEEEEEEEEc---------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN---------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQT  636 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~  636 (878)
                      +.+.+.||+|+||.||+|+..         +..||||++.... ....+.+.+|++++.++ +||||+++++++...+..
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  116 (334)
T 2pvf_A           37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL  116 (334)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred             eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence            456789999999999999863         3579999997653 44567899999999999 899999999999999999


Q ss_pred             eeEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC
Q 002809          637 ALIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK  702 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~  702 (878)
                      ++||||+++|+|.+++....              ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.+
T Consensus       117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  193 (334)
T 2pvf_A          117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN  193 (334)
T ss_dssp             EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCC
Confidence            99999999999999997643              13489999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002809          703 LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQ  781 (878)
Q Consensus       703 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  781 (878)
                      +.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+..    
T Consensus       194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----  269 (334)
T 2pvf_A          194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF----  269 (334)
T ss_dssp             CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----
T ss_pred             CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH----
Confidence            9999999999987644332222333457789999999998889999999999999999999 99999876543321    


Q ss_pred             HHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          782 WVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       782 ~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                         ..+..+...         ..+......+.+++.+||+.+|++||+++|+++.|++++...
T Consensus       270 ---~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          270 ---KLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             ---HHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---HHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence               111222111         111223346889999999999999999999999999988653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-38  Score=350.32  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=201.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+++..  ++.||||++..... ...+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus        10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~   89 (323)
T 3tki_A           10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   89 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence            45689999999999999876  48899999875432 3346789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.........
T Consensus        90 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           90 GELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             EEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             CcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            999999975  55699999999999999999999998   9999999999999999999999999999876443333333


Q ss_pred             ccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF  804 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~  804 (878)
                      ....||+.|+|||++.+..+ +.++|||||||+++||++|+.||........ ....|..    ...   ...      .
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~----~~~---~~~------~  230 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KKT---YLN------P  230 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT----TCT---TST------T
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc----ccc---cCC------c
Confidence            45679999999999987765 7799999999999999999999987554321 1222211    110   000      0


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          805 DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       805 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .......+.+++.+||+.+|++|||++|+++.
T Consensus       231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11223467789999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.5e-38  Score=337.36  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=208.2

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.+.||+|+||.||+|+..+ ..||||++..... ..+.+.+|++++++++||||+++++++.. +..++||||++++
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~   92 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG   92 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred             hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCC
Confidence            3556899999999999999876 7899999976532 35789999999999999999999999864 5689999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++.......+++..++.++.|+++||+|||+.   +|+||||||+||++++++.+||+|||++....... .....
T Consensus        93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  168 (279)
T 1qpc_A           93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTARE  168 (279)
T ss_dssp             BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCT
T ss_pred             CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-ccccc
Confidence            999999764445799999999999999999999998   99999999999999999999999999998764322 11222


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...++..|+|||.+.+..++.++||||||++++||++ |+.||......+..       ..+..+..     .    ..+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~~~-----~----~~~  232 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------QNLERGYR-----M----VRP  232 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCC-----C----CCC
T ss_pred             CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-------HHHhcccC-----C----CCc
Confidence            3456789999999998889999999999999999999 99999876543311       11111110     0    111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ......+.+++.+|++.+|++||+++++++.|+++...
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            12234788999999999999999999999999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.4e-38  Score=345.24  Aligned_cols=263  Identities=25%  Similarity=0.426  Sum_probs=213.5

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|+..       ++.||||++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  106 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  106 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence            455789999999999999765       3679999997653 34556799999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          640 YEFMANGNLQEYLSDIS--------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      |||+++|+|.+++....        ...+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence            99999999999997532        14579999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      +++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........       ..+..+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~  256 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------RFVMEG  256 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------HHHHTT
T ss_pred             cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH-------HHHHcC
Confidence            9986644332223334457889999999999999999999999999999999 89999876543311       112222


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhcC
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARAN  849 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~~  849 (878)
                      ....         .+......+.+++.+||+.+|++||++.|+++.|++.+........
T Consensus       257 ~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          257 GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             CcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            2111         1122334688999999999999999999999999987665444433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-38  Score=366.89  Aligned_cols=251  Identities=26%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+|++.+ ..||||++..... ..+.|.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs  264 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS  264 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred             eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence            456899999999999999987 7799999986543 34789999999999999999999999876 67899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++++......+++..++.++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus       265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~  340 (452)
T 1fmk_A          265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQG  340 (452)
T ss_dssp             HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccC
Confidence            99999865556799999999999999999999998   99999999999999999999999999998764322 112223


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..       ..+..+..         ...+.
T Consensus       341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~~---------~~~~~  404 (452)
T 1fmk_A          341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGYR---------MPCPP  404 (452)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCC---------CCCCT
T ss_pred             CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC---------CCCCC
Confidence            446789999999999999999999999999999999 99999876654321       11222211         11122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .+...+.+++.+||+.+|++|||+++|++.|+++.
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            33457889999999999999999999999999865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-37  Score=346.32  Aligned_cols=244  Identities=27%  Similarity=0.383  Sum_probs=202.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++.+.   .......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~   87 (337)
T 1o6l_A            8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            45689999999999999885  488999999754   2234567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++..  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        88 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~  160 (337)
T 1o6l_A           88 NGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--A  160 (337)
T ss_dssp             TTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--C
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--C
Confidence            99999999975  45799999999999999999999998   99999999999999999999999999998643222  2


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........      .. +..+..      .+   
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~-i~~~~~------~~---  224 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------EL-ILMEEI------RF---  224 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HHHCCC------CC---
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH------HH-HHcCCC------CC---
Confidence            233467999999999999999999999999999999999999999876543311      11 111111      11   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                       +.....++.+++.+||+.+|++||     +++|+++.
T Consensus       225 -p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          225 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence             112234678999999999999999     89999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.8e-38  Score=338.27  Aligned_cols=257  Identities=30%  Similarity=0.534  Sum_probs=195.5

Q ss_pred             hhhcccccccccEEEEEEEEcceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..+ .||||++...  .....+.|.+|++++++++||||+++++++ .....++||||+++
T Consensus        26 y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~  103 (289)
T 3og7_A           26 ITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEG  103 (289)
T ss_dssp             CEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCE
T ss_pred             eeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCC
Confidence            3566899999999999998766 5999998754  344567899999999999999999999965 45568999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...........
T Consensus       104 ~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          104 SSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             EEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             CcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence            9999999653 45699999999999999999999998   9999999999999999999999999999866433333333


Q ss_pred             ccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          726 TVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ....||+.|+|||.+.   +..++.++||||||++++||++|+.||......+.  +.    ..+..+.......     
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~-----  248 (289)
T 3og7_A          180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----EMVGRGSLSPDLS-----  248 (289)
T ss_dssp             ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HH----HHHHHTSCCCCTT-----
T ss_pred             cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HH----HHhcccccCcchh-----
Confidence            4456999999999986   56788899999999999999999999987654321  11    2222222211111     


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .........+.+++.+||+.+|++||+++|+++.|+++.
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            111233457889999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=342.41  Aligned_cols=249  Identities=22%  Similarity=0.381  Sum_probs=204.5

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChh------hHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ------GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      .+.+.+.||+|+||.||+++..  +..||+|++......      ..+.+.+|++++.+++||||+++++++......++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4566789999999999999986  488999998754322      35789999999999999999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC----cEEEeecCCcc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL----QAKLADFGLSK  714 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~  714 (878)
                      ||||+++|+|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||+++
T Consensus        92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           92 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999975  56799999999999999999999998   999999999999999887    89999999998


Q ss_pred             ccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...      . +.....  
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~-~~~~~~--  234 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------N-VSAVNY--  234 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------H-HHHTCC--
T ss_pred             ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------H-HHhcCC--
Confidence            764322   1233569999999999999999999999999999999999999998765433211      1 111110  


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          .+...........+.+++.+||+.+|++|||++|+++.
T Consensus       235 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          235 ----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                01101111223467899999999999999999999973

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-38  Score=352.15  Aligned_cols=268  Identities=26%  Similarity=0.380  Sum_probs=209.0

Q ss_pred             hhhcccccccccEEEEEEEE------cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeeccc--CCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRL------NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD--EDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||++++      .+..||||++........+.+.+|++++++++||||+++++++.  .....++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv  104 (327)
T 3lxl_A           25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV  104 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred             hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence            35568999999999999985      34789999998887777788999999999999999999999875  45668899


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++++|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          105 MEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             EeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            9999999999999753 34699999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH--------HHHHHHHHHhcC
Q 002809          720 ANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH--------IRQWVNSLIAKG  790 (878)
Q Consensus       720 ~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~--------l~~~v~~~~~~~  790 (878)
                      ... .......|+..|+|||++.+..++.++||||||++++||++|+.||.....+....        ....+......+
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            221 12233457888999999999899999999999999999999999987533221000        000011111111


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                               .....+......+.+++.+||+.+|++||+++|+++.|+.+......-.
T Consensus       261 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  309 (327)
T 3lxl_A          261 ---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE  309 (327)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred             ---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence                     1112223344578899999999999999999999999999876544333

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-38  Score=347.87  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=199.4

Q ss_pred             hhcccccccccEEEEEEEEcc--e----eEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--I----DVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~----~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|+...  .    +||+|.+... .....+.+.+|+.++.+++||||+++++++..+. .++|+|
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~   96 (327)
T 3lzb_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ   96 (327)
T ss_dssp             EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred             eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence            456899999999999998743  3    3678877543 3445678999999999999999999999998764 789999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+.+|+|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        97 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           97 LMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             CCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            99999999999753 45699999999999999999999998   999999999999999999999999999987654433


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+...       .+..+..        
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~~~--------  237 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGER--------  237 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTCC--------
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCC--------
Confidence            333334557789999999999999999999999999999999 999998766543211       1111111        


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                       ...+......+.+++.+||+.+|++||+++|+++.|+++...
T Consensus       238 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 -LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence             011122334688999999999999999999999999998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.5e-38  Score=350.97  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=203.7

Q ss_pred             hhcccccccccEEEEEEEEcc--e----eEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--I----DVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~----~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|+...  .    +||+|.+.... ....+.+.+|+.++.+++||||+++++++. ++..++|||
T Consensus        16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   94 (325)
T 3kex_A           16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ   94 (325)
T ss_dssp             EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred             eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence            456789999999999998743  3    38888876443 334467889999999999999999999986 456899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++... +..+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        95 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           95 YLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK  170 (325)
T ss_dssp             CCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred             eCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence            99999999999753 45789999999999999999999998   999999999999999999999999999988755444


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........|+..|+|||++.+..++.++|||||||++|||+| |+.||......+...       .+..+....      
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~------  237 (325)
T 3kex_A          171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-------LLEKGERLA------  237 (325)
T ss_dssp             CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-------HHHTTCBCC------
T ss_pred             cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCCCCC------
Confidence            444455668889999999999999999999999999999999 999998765443211       112221100      


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                         .+......+.+++.+||+.+|++||+++|+++.|+++....
T Consensus       238 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          238 ---QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             ---CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             ---CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence               01111224668999999999999999999999999976543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.8e-38  Score=335.70  Aligned_cols=253  Identities=26%  Similarity=0.456  Sum_probs=207.9

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+++..+ ..||+|++...... .+.+.+|++++++++||||+++++++..++..++||||+++++
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (267)
T 3t9t_A           11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC   89 (267)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred             eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence            456889999999999999855 78999999865433 3689999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++... ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++...... ......
T Consensus        90 L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~  164 (267)
T 3t9t_A           90 LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTG  164 (267)
T ss_dssp             HHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTS
T ss_pred             HHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc-cccccc
Confidence            99999753 45689999999999999999999998   99999999999999999999999999987653211 111223


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||.+.+..++.++||||||++++||++ |+.||......+..      . .+..+..  .       ..+.
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~-~i~~~~~--~-------~~~~  228 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------E-DISTGFR--L-------YKPR  228 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------H-HHHTTCC--C-------CCCT
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH------H-HHhcCCc--C-------CCCc
Confidence            456778999999998899999999999999999999 89999876543311      1 1111110  0       0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      .....+.+++.+||+.+|++||+++|+++.|+++.+.
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1234678999999999999999999999999998753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.4e-38  Score=345.45  Aligned_cols=260  Identities=28%  Similarity=0.443  Sum_probs=209.9

Q ss_pred             hhhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCC-cce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDN-QTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~-~~~  637 (878)
                      +.+.+.||+|+||.||+|+..       ++.||||++.... ....+.+.+|++++.++ +||||+++++++...+ ..+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            345689999999999999852       3789999997653 34557899999999999 7999999999987654 589


Q ss_pred             eEeeeccCCChhhhhccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          638 LIYEFMANGNLQEYLSDISK--------------KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      +||||+++|+|.+++.....              ..+++..++.++.|+++||.|||+.   +|+||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence            99999999999999976432              2289999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQW  782 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  782 (878)
                      .+||+|||+++...............|++.|+|||++.+..++.++||||||++++||+| |+.||........  +   
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~---  260 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F---  260 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--H---
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH--H---
Confidence            999999999987654433333344567889999999999999999999999999999998 9999977553221  1   


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                       ...+..+....         .+......+.+++.+||+.+|++||+++|+++.|+++++...
T Consensus       261 -~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          261 -CRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             -HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -HHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence             11112221111         111123467899999999999999999999999999987643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-38  Score=347.37  Aligned_cols=261  Identities=24%  Similarity=0.379  Sum_probs=207.9

Q ss_pred             hhcccccccccEEEEEEEE------cceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRL------NEIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV  639 (878)
                      .+.+.||+|+||.||++++      .++.||||++.... ....+.+.+|++++++++||||+++++++..  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            4568999999999998875      34789999998653 3456789999999999999999999999976  4567899


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++|+|.+++..   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       114 ~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             ECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999975   3499999999999999999999998   9999999999999999999999999999876443


Q ss_pred             CCC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH---------HHHHHHHHHHHhc
Q 002809          720 ANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK---------IHIRQWVNSLIAK  789 (878)
Q Consensus       720 ~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~v~~~~~~  789 (878)
                      ... .......++..|+|||.+.+..++.++||||||++++||++|+.||........         ..... ....+..
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  266 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLER  266 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH-HHHHHHT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH-HHHHHhc
Confidence            221 122344578889999999998999999999999999999999999875332110         00111 1111111


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      +         .....+......+.+++.+||+.+|++||+++|+++.|+++.+.-.
T Consensus       267 ~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          267 G---------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             c---------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            1         1112223334578899999999999999999999999999876543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-37  Score=348.75  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=203.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChh------hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ------GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+++..  ++.||+|++......      ..+.+.+|+.++.+++||||+++++++......++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            456789999999999999986  488999999765322      347899999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC----cEEEeecCCccc
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL----QAKLADFGLSKS  715 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~~  715 (878)
                      |||+++|+|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++    .+||+|||+++.
T Consensus        94 ~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           94 LELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            999999999999975  55799999999999999999999998   999999999999998877    799999999987


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|++||......+..      . .+..+...  
T Consensus       169 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~------~-~i~~~~~~--  236 (361)
T 2yab_A          169 IEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------A-NITAVSYD--  236 (361)
T ss_dssp             CCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------H-HHHTTCCC--
T ss_pred             cCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-HHHhcCCC--
Confidence            64322   223456999999999999999999999999999999999999999876554321      1 11111110  


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +++...    ......+.+++.+||..||++||+++|+++
T Consensus       237 ~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          237 FDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111111    112346789999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=343.89  Aligned_cols=251  Identities=28%  Similarity=0.501  Sum_probs=198.1

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      .+.+.||+|+||.||+++..++.||||++...  ...+.|.+|++++++++||||+++++++.+  ..++||||+++|+|
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L   86 (307)
T 2eva_A           11 EVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL   86 (307)
T ss_dssp             EEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred             eeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence            45689999999999999999999999998754  345789999999999999999999999874  48999999999999


Q ss_pred             hhhhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc-EEEeecCCccccccCCCCcccc
Q 002809          649 QEYLSDISK-KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ-AKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       649 ~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      .+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......     ..
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~  161 (307)
T 2eva_A           87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MT  161 (307)
T ss_dssp             HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred             HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cc
Confidence            999976432 35789999999999999999999943348999999999999998886 799999998765322     12


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...|++.|+|||++.+..++.++||||||++++||++|+.||........ .+ .|  . ...+...     ....    
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~-~~--~-~~~~~~~-----~~~~----  227 (307)
T 2eva_A          162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RI-MW--A-VHNGTRP-----PLIK----  227 (307)
T ss_dssp             ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HH-HH--H-HHTTCCC-----CCBT----
T ss_pred             cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HH-HH--H-HhcCCCC-----Cccc----
Confidence            34589999999999999999999999999999999999999976543221 11 11  1 1111111     1111    


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .....+.+++.+||+.+|++||+++++++.|+.+.+
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            123467899999999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.6e-38  Score=338.56  Aligned_cols=250  Identities=29%  Similarity=0.463  Sum_probs=201.1

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC-CCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-DNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+++..++.||||++....  ..+.+.+|++++.+++||||+++++++.+ .+..++||||+++|+
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~  101 (278)
T 1byg_A           24 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  101 (278)
T ss_dssp             EEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             eEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence            556899999999999999999999999997543  45789999999999999999999998654 457899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.......+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++......     ...
T Consensus       102 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~  173 (278)
T 1byg_A          102 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT  173 (278)
T ss_dssp             HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-----ccC
Confidence            99999765445589999999999999999999998   9999999999999999999999999998755322     122


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||.+.+..++.++||||||++++||+| |+.||......+..       ..+..+..     .    ..+.
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~~~-----~----~~~~  237 (278)
T 1byg_A          174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGYK-----M----DAPD  237 (278)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHTTTCC-----C----CCCT
T ss_pred             CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCCC-----C----CCcc
Confidence            357889999999999999999999999999999998 99999876543311       11122211     1    1122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      .....+.+++.+||+.+|++||+++|+++.|+++...+
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            23347889999999999999999999999999987654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.9e-38  Score=351.32  Aligned_cols=278  Identities=18%  Similarity=0.232  Sum_probs=210.7

Q ss_pred             hhhcccccccccEEEEEEEEcc-------eeEEEEEeccCChhhH-----------HHHHHHHHHHHHhcccceeeeeec
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSSAQGF-----------QQFQAEVKLLMRVHHRNLTSLVGH  629 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~~~~~-----------~~f~~Ei~~L~~l~H~nIv~l~g~  629 (878)
                      +.+.+.||+|+||.||+|+...       +.||||++........           ..+..|+..+..++||||++++++
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  116 (364)
T 3op5_A           37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS  116 (364)
T ss_dssp             EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred             EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence            4567899999999999998743       6799999876543211           223455666777789999999999


Q ss_pred             ccCC----CcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc--CCC
Q 002809          630 CDED----NQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN--EKL  703 (878)
Q Consensus       630 ~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~--~~~  703 (878)
                      +...    ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+.   +|+||||||+|||++  .++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred             eeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence            8664    4589999999 9999999976 346799999999999999999999998   999999999999999  889


Q ss_pred             cEEEeecCCccccccCCCC-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 002809          704 QAKLADFGLSKSFATDANT-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH  778 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  778 (878)
                      .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||+||+.||........  
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~--  269 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK--  269 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH--
Confidence            9999999999876432211     111334599999999999999999999999999999999999999986433221  


Q ss_pred             HHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhcCCCCCcCC
Q 002809          779 IRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANSGRGFHS  856 (878)
Q Consensus       779 l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~~~~~~~~~  856 (878)
                      ...+...... ..+.+++++.+..   .....++.+++..|++.+|++||++++|++.|++++............+..
T Consensus       270 ~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  343 (364)
T 3op5_A          270 YVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSV  343 (364)
T ss_dssp             HHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC--
T ss_pred             HHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEe
Confidence            1111111111 1223333332221   112346789999999999999999999999999999876666655555543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.2e-38  Score=337.15  Aligned_cols=255  Identities=27%  Similarity=0.415  Sum_probs=205.0

Q ss_pred             hhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+|+..+     ..||+|.+... .....+.+.+|+.++++++||||+++++++..+ ..++||||
T Consensus        15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~   93 (281)
T 3cc6_A           15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMEL   93 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEEC
T ss_pred             EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEec
Confidence            456899999999999998643     35999998865 344567899999999999999999999998754 56899999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.+++... ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        94 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  168 (281)
T 3cc6_A           94 YPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-  168 (281)
T ss_dssp             CTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             CCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc-
Confidence            9999999999752 45689999999999999999999998   999999999999999999999999999986643221 


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...       .+..+...        
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-------~~~~~~~~--------  233 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-------VLEKGDRL--------  233 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-------HHHHTCCC--------
T ss_pred             cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-------HHhcCCCC--------
Confidence            12233457789999999998899999999999999999998 999998665443211       11111110        


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                       ..+......+.+++.+||+.+|++||++.|+++.|+++.+.+.
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  276 (281)
T 3cc6_A          234 -PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK  276 (281)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence             0111223467899999999999999999999999999887754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=334.73  Aligned_cols=245  Identities=24%  Similarity=0.369  Sum_probs=193.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--------------------------hhHHHHHHHHHHHHHhc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--------------------------QGFQQFQAEVKLLMRVH  619 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--------------------------~~~~~f~~Ei~~L~~l~  619 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.....                          ...+.+.+|++++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   94 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD   94 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred             eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence            345689999999999999875  48899999875431                          12356899999999999


Q ss_pred             ccceeeeeecccC--CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccE
Q 002809          620 HRNLTSLVGHCDE--DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNI  697 (878)
Q Consensus       620 H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NI  697 (878)
                      ||||+++++++..  .+..++||||+++++|.+++.   ...+++..++.++.|+++||+|||+.   +|+||||||+||
T Consensus        95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL  168 (298)
T ss_dssp             CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            9999999999876  567899999999999998765   45699999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 002809          698 LLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR---LTEKSDVYSFGVVILEIITCKPAISRINEE  774 (878)
Q Consensus       698 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  774 (878)
                      |++.++.+||+|||+++......  .......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            99999999999999998764322  1223456999999999998765   477899999999999999999999876543


Q ss_pred             HHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          775 EKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       775 ~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ..      . ..+........        ........+.+++.+||+.+|++||+++|+++
T Consensus       247 ~~------~-~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          247 CL------H-SKIKSQALEFP--------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HH------H-HHHHHCCCCCC--------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HH------H-HHHhcccCCCC--------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            21      1 11111211100        01112346789999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-37  Score=344.33  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=202.9

Q ss_pred             hcccccccccEEEEEEEEcc------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          570 FERTLGKGGFGTVYYGRLNE------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.||+|+||.||+|+...      ..||||++.... ......+.+|++++.+++||||+++++++...+..++||||
T Consensus        48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  127 (333)
T 1mqb_A           48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY  127 (333)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence            45789999999999998753      359999997653 34556899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++... ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       128 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          128 MENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             CTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             CCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence            9999999999752 45699999999999999999999998   9999999999999999999999999999876433221


Q ss_pred             -cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          723 -HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       723 -~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                       .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.   .    ..+..+...       
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~----~~~~~~~~~-------  269 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M----KAINDGFRL-------  269 (333)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----HHHHTTCCC-------
T ss_pred             ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHHCCCcC-------
Confidence             11222346778999999999999999999999999999999 9999987654331   1    112222100       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                        ..+......+.+++.+||+.+|++||+++++++.|++++....
T Consensus       270 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          270 --PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             --CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             --CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence              1112233468899999999999999999999999999886533

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3e-37  Score=342.00  Aligned_cols=270  Identities=24%  Similarity=0.416  Sum_probs=212.0

Q ss_pred             HHHHHHHhhhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHH--hcccceeeeeecccCCC----
Q 002809          561 SDVVKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMR--VHHRNLTSLVGHCDEDN----  634 (878)
Q Consensus       561 ~dl~~~t~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~--l~H~nIv~l~g~~~~~~----  634 (878)
                      .+.....+.+.+.||+|+||.||+|+..++.||||++...   ....+.+|++++..  ++||||+++++++....    
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            4445556677899999999999999999999999998654   34577889999988  68999999999998775    


Q ss_pred             cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCccEEEcCCCcEE
Q 002809          635 QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH--------NGCKPPIVHRDVKSTNILLNEKLQAK  706 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDLKp~NILl~~~~~~k  706 (878)
                      ..++||||+++|+|.+++..   ..+++..++.++.|+++||+|||        +.   +|+||||||+|||++.++.+|
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred             eeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence            78999999999999999974   46899999999999999999999        66   999999999999999999999


Q ss_pred             EeecCCccccccCCCCc--ccccccCCCCccCccccccC------CCCCccchhhHHHHHHHHHhC----------CCCC
Q 002809          707 LADFGLSKSFATDANTH--VSTVVAGTPGYLDPEYYTSN------RLTEKSDVYSFGVVILEIITC----------KPAI  768 (878)
Q Consensus       707 L~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~------~~t~ksDV~S~Gvvl~elltG----------~~p~  768 (878)
                      |+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||          +.||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999998764332211  12345699999999999765      234689999999999999999          6777


Q ss_pred             CCCChHHHHHHHHHHHHHHhcCCcccccCCccccc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          769 SRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED-FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       769 ~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      ........ ....+... +....    ..+.+... ...++...+.+++.+||+.+|++||+++||++.|+++.+.+.
T Consensus       268 ~~~~~~~~-~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          268 YDLVPSDP-SVEEMRKV-VCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             TTTSCSSC-CHHHHHHH-HTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             cccCcCcc-cHHHHHHH-HHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            65432110 11112111 11111    12222211 134567789999999999999999999999999999876543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-37  Score=336.41  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=203.7

Q ss_pred             hcccccccccEEEEEEEEcc-----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcc-eeEeee
Q 002809          570 FERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQT-ALIYEF  642 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~-~lV~Ey  642 (878)
                      ..+.||+|+||.||+|+..+     ..||+|++.... ....+.+.+|++++++++||||+++++++...+.. ++|+||
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence            35789999999999998632     369999987643 34567899999999999999999999999766655 999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC--
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA--  720 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--  720 (878)
                      +.+|+|.+++.. ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus       105 ~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          105 MCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             CTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             ccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999999999975 345689999999999999999999998   99999999999999999999999999998653322  


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .........++..|+|||.+.+..++.++||||||++++||++|+ +|+.......   +...    +..+..       
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~----~~~~~~-------  246 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHF----LAQGRR-------  246 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHH----HHTTCC-------
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHH----hhcCCC-------
Confidence            111223345788999999999999999999999999999999955 5555444332   1111    111110       


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                        ...+......+.+++.+||+.+|++|||++++++.|++++..
T Consensus       247 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          247 --LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              011112234688999999999999999999999999998765

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-37  Score=341.42  Aligned_cols=248  Identities=18%  Similarity=0.308  Sum_probs=203.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+++..  +..||+|.+.... .....+.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g   85 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence            345689999999999999886  4889999987543 3456789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC--CCcEEEeecCCccccccCCCCc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE--KLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      |+|.+++.. ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.  ++.+||+|||+++.+....   
T Consensus        86 ~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---  158 (321)
T 1tki_A           86 LDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---  158 (321)
T ss_dssp             CBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred             CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---
Confidence            999999975 234699999999999999999999998   9999999999999997  7899999999998764322   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......||+.|+|||++.+..++.++|||||||++|||++|++||......+..      .... .+...  .+....  
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~-~~~~~--~~~~~~--  227 (321)
T 1tki_A          159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------ENIM-NAEYT--FDEEAF--  227 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-HTCCC--CCHHHH--
T ss_pred             ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHH-cCCCC--CChhhh--
Confidence            223456899999999999888999999999999999999999999876653311      1111 11110  000000  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .....++.+++.+||+.||++|||+.|+++.
T Consensus       228 --~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          228 --KEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              1123467899999999999999999999884

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-37  Score=337.29  Aligned_cols=256  Identities=27%  Similarity=0.500  Sum_probs=202.7

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecc-cCCCcceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHC-DEDNQTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~-~~~~~~~lV~  640 (878)
                      +.+.+.||+|+||.||+|+..+     ..+|+|.+... .....+.+.+|+.++++++||||+++++++ ..++..++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            3456899999999999998643     35899998764 344567899999999999999999999985 5566789999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++|+|.++++. ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       107 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          107 PYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             ECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             eCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            99999999999975 345689999999999999999999998   99999999999999999999999999998664322


Q ss_pred             C--CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          721 N--THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       721 ~--~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      .  ........+++.|+|||.+.+..++.++||||||++++||++ |.+||......+..   .    ....+..  .. 
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~----~~~~~~~--~~-  252 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---V----YLLQGRR--LL-  252 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---H----HHHTTCC--CC-
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---H----HHhcCCC--CC-
Confidence            1  112233457789999999999999999999999999999999 56676655443211   1    1111110  00 


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                            .+......+.+++.+||+.+|++||+++|+++.|++++..
T Consensus       253 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          253 ------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                  1111234688999999999999999999999999998753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.1e-37  Score=344.96  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             HHhhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ..+.+.+.||+|+||.||+++..  +..||+|++...  .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34566789999999999999875  488999999754  33456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---cEEEeecCCcccccc
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---QAKLADFGLSKSFAT  718 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~DFGla~~~~~  718 (878)
                      |+++|+|.+++..  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++   .+||+|||+++....
T Consensus       109 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          109 LVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999875  56799999999999999999999998   999999999999998654   599999999987643


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|++||........   .    ..+..+... ...+
T Consensus       184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~----~~i~~~~~~-~~~~  252 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---Y----AQIKAGAYD-YPSP  252 (362)
T ss_dssp             CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHTCCC-CCTT
T ss_pred             Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHhCCCC-CCcc
Confidence            22   22345799999999999999999999999999999999999999987654321   1    112222211 0000


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ..    .....++.+++.+||+.+|++||++.|+++.
T Consensus       253 -~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          253 -EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             01    1223467899999999999999999998864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-38  Score=347.83  Aligned_cols=248  Identities=22%  Similarity=0.366  Sum_probs=194.5

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcc--cceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHH--RNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H--~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||++...+ +.||||++...  .....+.+.+|++++.+++|  +||+++++++..++..++||| 
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence            3456899999999999998765 78999998754  34456789999999999986  999999999999999999999 


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +.+|+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus        90 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           90 CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            568899999986  56799999999999999999999998   999999999999997 578999999999877544333


Q ss_pred             cccccccCCCCccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          723 HVSTVVAGTPGYLDPEYYTS-----------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||........ .    .....    
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~----~~~~~----  234 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K----LHAII----  234 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHHHH----
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-H----HHHHh----
Confidence            33445679999999999865           6788999999999999999999999976543211 1    11111    


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                           ++.....++......+.+++.+||+.+|++|||++|+++.
T Consensus       235 -----~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 -----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                 1111112222223467899999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-37  Score=339.86  Aligned_cols=269  Identities=25%  Similarity=0.428  Sum_probs=204.6

Q ss_pred             HHHHhhhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHh--cccceeeeeecccCC----Ccce
Q 002809          564 VKITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV--HHRNLTSLVGHCDED----NQTA  637 (878)
Q Consensus       564 ~~~t~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l--~H~nIv~l~g~~~~~----~~~~  637 (878)
                      ....+.+.+.||+|+||.||+|+..++.||||++....   ...+..|.+++..+  +||||+++++++...    ...+
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            34455677899999999999999999999999986543   24455566666554  899999999998776    6789


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC-----KPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      +||||+++|+|.++++.   ..+++..++.++.|++.||+|||+.+     .++|+||||||+|||++.++.+||+|||+
T Consensus       112 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             EEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            99999999999999964   46999999999999999999999752     44899999999999999999999999999


Q ss_pred             ccccccCCCCc--ccccccCCCCccCccccccCCCCCc------cchhhHHHHHHHHHhC----------CCCCCCCChH
Q 002809          713 SKSFATDANTH--VSTVVAGTPGYLDPEYYTSNRLTEK------SDVYSFGVVILEIITC----------KPAISRINEE  774 (878)
Q Consensus       713 a~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~k------sDV~S~Gvvl~elltG----------~~p~~~~~~~  774 (878)
                      ++.+.......  ......||+.|+|||++.+...+.+      +|||||||++|||+||          +.||......
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~  268 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS  268 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence            97664332211  1123569999999999988776665      9999999999999999          6666553321


Q ss_pred             HHHHHHHHHHHHHhcCCcccccCCcccccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          775 EKIHIRQWVNSLIAKGDIKSIVDPRLQEDF-DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       775 ~~~~l~~~v~~~~~~~~~~~iid~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      .. .... .........    ..+.+.... ...+..++.+++.+||+.+|++||+++||++.|+++.+..
T Consensus       269 ~~-~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          269 DP-SYED-MREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SC-CHHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CC-chhh-hHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            11 0011 111111111    112222111 2356778999999999999999999999999999987653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.3e-37  Score=352.33  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=203.3

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.+.||+|+||.||+++..  ++.+|+|++....  ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   91 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL   91 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence            4566789999999999999874  4889999987653  33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc---CCCcEEEeecCCccccccC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~  719 (878)
                      +++|+|.+.+..  +..+++..+..++.||++||+|||+.   +|+||||||+|||++   .++.+||+|||+++.....
T Consensus        92 ~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           92 VTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999976  56799999999999999999999998   999999999999998   4678999999999876432


Q ss_pred             CCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|++||......+..       ..+..+... ...+.
T Consensus       167 ~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~-~~~~~  236 (444)
T 3soa_A          167 Q--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-------QQIKAGAYD-FPSPE  236 (444)
T ss_dssp             C--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTCCC-CCTTT
T ss_pred             C--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHhCCCC-CCccc
Confidence            2  2223457999999999999999999999999999999999999999876543311       112222211 00111


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                           ......++.+++.+||+.||++||+++|+++.
T Consensus       237 -----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          237 -----WDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 11223467899999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.3e-37  Score=338.23  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=197.8

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+++..+ +.||+|++....  ....+.+.+|++++++++||||+++++++..++..++||||++ 
T Consensus        24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-  102 (311)
T 3niz_A           24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-  102 (311)
T ss_dssp             EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-
T ss_pred             HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-
Confidence            456899999999999999854 889999987543  2235678999999999999999999999999999999999997 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++... ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus       103 ~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~  176 (311)
T 3niz_A          103 KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSY  176 (311)
T ss_dssp             EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C--
T ss_pred             CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc--ccc
Confidence            4888887652 45699999999999999999999998   99999999999999999999999999998764222  222


Q ss_pred             ccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc---cc-------
Q 002809          726 TVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI---KS-------  794 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~---~~-------  794 (878)
                      ....||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+...  . +.........   ..       
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~-i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP--K-IFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH--H-HHHHHCCCCTTTSGGGTTSHHH
T ss_pred             cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHHCCCChHHhhhhhccchh
Confidence            33568999999999876 568999999999999999999999998766543221  1 1111111100   00       


Q ss_pred             ------ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 ------IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 ------iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                            ..+.............++.+++.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  00000000011122346789999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=348.29  Aligned_cols=244  Identities=24%  Similarity=0.360  Sum_probs=198.3

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+++...  +.||||++.+.   .....+.+.+|..++..+ +||||+++++++...+..++|||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E  104 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME  104 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence            3456899999999999998864  78999999754   223456788999999998 69999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++..  ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       105 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~--  177 (353)
T 3txo_A          105 FVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--  177 (353)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC--
Confidence            9999999999976  45699999999999999999999998   9999999999999999999999999999754222  


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|++||...+..+..       ..+..+..      .  
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~~~------~--  242 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILNDEV------V--  242 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------C--
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC------C--
Confidence            12234467999999999999989999999999999999999999999876654321       11112211      1  


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTM------SQVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm------~evl~  835 (878)
                        ++......+.+++.+||+.+|++||++      +|+++
T Consensus       243 --~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 --YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              111223467899999999999999998      77766

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.7e-38  Score=344.17  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=204.2

Q ss_pred             hhhcccccccccEEEEEEEE------cceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCC--Cccee
Q 002809          568 NNFERTLGKGGFGTVYYGRL------NEIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED--NQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~l  638 (878)
                      +.+.+.||+|+||.||++++      .++.||||++.... ....+.+.+|++++.+++||||+++++++...  ...++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            45678999999999999984      34889999997543 33457899999999999999999999999776  66899


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+++|+|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       103 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  178 (302)
T ss_dssp             EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence            99999999999999653 45699999999999999999999998   999999999999999999999999999987644


Q ss_pred             CCCC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH---------HHHHHHHHHHHHh
Q 002809          719 DANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE---------KIHIRQWVNSLIA  788 (878)
Q Consensus       719 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~---------~~~l~~~v~~~~~  788 (878)
                      .... .......||..|+|||.+.+..++.++||||||++++||++|+.|+.......         ........ ....
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  257 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NTLK  257 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HHHH
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HHHh
Confidence            3221 22334557888999999999999999999999999999999998864321100         00111111 1111


Q ss_pred             cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       789 ~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .+.         ....+......+.+++.+||+.+|++|||++|+++.|++++
T Consensus       258 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111         11122233457889999999999999999999999999876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.8e-37  Score=344.85  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=201.7

Q ss_pred             HHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-----hhhHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-----AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      ..+.+.+.||+|+||.||+++..  ++.||||++....     ....+.+.+|++++++++||||+++++++..++..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34667789999999999999875  4889999986421     1235789999999999999999999999999999999


Q ss_pred             EeeeccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc---EEEeecCCc
Q 002809          639 IYEFMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ---AKLADFGLS  713 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~---~kL~DFGla  713 (878)
                      ||||+++|+|.+++....  ...+++..+..++.||++||+|||++   +|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999998886532  34589999999999999999999998   9999999999999987654   999999999


Q ss_pred             cccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          714 KSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       714 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      +......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    +   . ..+..+...
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~---~-~~i~~~~~~  250 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----L---F-EGIIKGKYK  250 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----H---H-HHHHHTCCC
T ss_pred             eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----H---H-HHHHcCCCC
Confidence            8764322  2233456999999999999999999999999999999999999999864321    1   1 111112110


Q ss_pred             cccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       794 ~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ..+....    .....+.+++.+||+.||++||++.|+++
T Consensus       251 --~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 --MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             --CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              0111111    12346789999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-37  Score=335.62  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=207.0

Q ss_pred             hhcc-cccccccEEEEEEEEc----ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFER-TLGKGGFGTVYYGRLN----EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~-~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+ .||+|+||.||+|...    ++.||||++....  ....+.+.+|++++.+++||||+++++++ ..+..++|||
T Consensus        19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e   97 (291)
T 1xbb_A           19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME   97 (291)
T ss_dssp             EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred             hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence            3445 8999999999999653    3789999997643  33467899999999999999999999999 5667899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++++|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        98 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           98 MAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             CCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             eCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            9999999999976  45699999999999999999999998   999999999999999999999999999987643322


Q ss_pred             Cc-ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          722 TH-VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       722 ~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .. ......++..|+|||.+.+..++.++||||||++++||++ |+.||......+.   .    ..+..+...      
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~~~------  239 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T----AMLEKGERM------  239 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H----HHHHTTCCC------
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCCCC------
Confidence            11 1222346788999999998889999999999999999999 9999987665331   1    122222211      


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                         ..+......+.+++.+||+.+|++||++.++++.|+++...+....
T Consensus       240 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  285 (291)
T 1xbb_A          240 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG  285 (291)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence               1122233578899999999999999999999999999887755443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3e-37  Score=349.46  Aligned_cols=246  Identities=20%  Similarity=0.364  Sum_probs=197.0

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+++...  +.||+|++.+..   ....+.+.+|..++.++ +||||+++++++..++..++|||
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E  133 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE  133 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence            3556899999999999999864  789999997642   23345688999999887 89999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       134 ~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-  207 (396)
T 4dc2_A          134 YVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  207 (396)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence            9999999999976  45799999999999999999999998   99999999999999999999999999998532221 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHHHHhcCCcccccCCc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK--IHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|++||......+.  ....+++...+..+.+      .
T Consensus       208 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~  280 (396)
T 4dc2_A          208 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R  280 (396)
T ss_dssp             -CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------C
T ss_pred             -CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------C
Confidence             223456799999999999999999999999999999999999999975332111  1111222222222221      1


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                          ++.....++.+++.+||+.+|++||++
T Consensus       281 ----~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 ----IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                112223467899999999999999995

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5e-38  Score=370.47  Aligned_cols=251  Identities=26%  Similarity=0.431  Sum_probs=207.8

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+|++.+ ..||||++..... ..+.|.+|+++|++++|+||+++++++.+ +..++||||+++|+
T Consensus       270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs  347 (535)
T 2h8h_A          270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS  347 (535)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred             hhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence            567899999999999999987 7899999986543 34789999999999999999999999876 67899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.++++......+++..++.++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus       348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~  423 (535)
T 2h8h_A          348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQG  423 (535)
T ss_dssp             HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCS
T ss_pred             HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccC
Confidence            99999865556799999999999999999999998   99999999999999999999999999998653211 111223


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||......+..       ..+..+..         ...+.
T Consensus       424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~~---------~~~~~  487 (535)
T 2h8h_A          424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGYR---------MPCPP  487 (535)
T ss_dssp             TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-------HHHHTTCC---------CCCCT
T ss_pred             CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC---------CCCCC
Confidence            346788999999999999999999999999999999 99999876654321       11222211         01122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      .+...+.+++.+||+.+|++||++++|++.|+++.
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            33457889999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-37  Score=337.78  Aligned_cols=247  Identities=25%  Similarity=0.316  Sum_probs=195.5

Q ss_pred             HHHHHHhhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcc
Q 002809          562 DVVKITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQT  636 (878)
Q Consensus       562 dl~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~  636 (878)
                      ++....+.+.+.||+|+||+||+|+..  ++.||||++...  .......+..|+..+.++ +||||++++++|.+++..
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            445556667789999999999999986  488999998654  233445666777777666 899999999999999999


Q ss_pred             eeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      ++||||+ +++|.+++... +..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       133 ~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            9999999 77999988753 45699999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      ...   .......||+.|+|||++.+ .++.++|||||||++|||++|..++.....        |  ..+..+...   
T Consensus       208 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~--~~~~~~~~~---  270 (311)
T 3p1a_A          208 GTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------W--QQLRQGYLP---  270 (311)
T ss_dssp             C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------H--HHHTTTCCC---
T ss_pred             ccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------H--HHHhccCCC---
Confidence            332   22334569999999999876 789999999999999999999776643211        0  111111111   


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                       +    .........+.+++.+||+.+|++||+++|+++
T Consensus       271 -~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 -P----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -c----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence             1    111122347889999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3e-37  Score=349.17  Aligned_cols=264  Identities=19%  Similarity=0.277  Sum_probs=202.8

Q ss_pred             hhhccccccc--ccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKG--GFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G--~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|  +||.||+++..  ++.||||++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  106 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS  106 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence            3567899999  99999999986  4889999997543  4456778899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++.......+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||.+........
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred             ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence            99999999999876557799999999999999999999998   999999999999999999999999998865432211


Q ss_pred             -----CcccccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh------
Q 002809          722 -----THVSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA------  788 (878)
Q Consensus       722 -----~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~------  788 (878)
                           ........||..|+|||++.+  ..++.++|||||||++|||++|+.||..........  ........      
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~  261 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPCLLDTS  261 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCcccccc
Confidence                 111223468899999999987  679999999999999999999999998754432110  00000000      


Q ss_pred             ----------------cCCcccccC---Ccc------ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          789 ----------------KGDIKSIVD---PRL------QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       789 ----------------~~~~~~iid---~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                                      .......+.   +..      ...........+.+++.+||+.||++|||++|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                            000000000   000      000112223468899999999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.5e-37  Score=335.40  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=197.0

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC-----c
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN-----Q  635 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~  635 (878)
                      +.+.+.||+|+||.||+|+...     ..||+|++...  .....+.+.+|+.++.+++||||+++++++...+     .
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  115 (313)
T 3brb_A           36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK  115 (313)
T ss_dssp             EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred             eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence            3456889999999999997642     47999998754  3445678999999999999999999999987655     3


Q ss_pred             ceeEeeeccCCChhhhhccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          636 TALIYEFMANGNLQEYLSDI----SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       636 ~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      .++||||+++|+|.+++...    ....+++..++.++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence            49999999999999998432    245799999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      +++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........   .    .+..+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~----~~~~~  265 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---D----YLLHG  265 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H----HHHTT
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H----HHHcC
Confidence            9987644332233344557889999999999999999999999999999999 88999876543311   1    11111


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ...         ..+......+.+++.+||+.+|++||+++++++.|++++..
T Consensus       266 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          266 HRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             CCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111         11122334688999999999999999999999999998753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.7e-38  Score=344.87  Aligned_cols=263  Identities=27%  Similarity=0.422  Sum_probs=208.0

Q ss_pred             hhhcccccccccEEEEEEEE------cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC--cceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRL------NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN--QTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV  639 (878)
                      +.+.+.||+|+||.||+++.      .++.||||++........+.+.+|++++++++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            34568999999999999985      34789999998877777789999999999999999999999886544  78999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++|+|.+++... ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       123 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             ECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             EECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            9999999999999753 35699999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH---------HHHHHHHHHHHhc
Q 002809          720 ANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK---------IHIRQWVNSLIAK  789 (878)
Q Consensus       720 ~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~v~~~~~~  789 (878)
                      ... .......++..|+|||.+.+..++.++||||||++++||+||+.|+.....+-.         ......+...+..
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  278 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence            221 112234567789999999988899999999999999999999998764311100         0001111111111


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      +.         ....+.....++.+++.+||+.+|++||+++|+++.|+++.+.
T Consensus       279 ~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          279 NG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11         1111223345788999999999999999999999999997643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5e-37  Score=345.65  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=201.2

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      .+.||+|+||.||+|+..  ++.||+|++........+.+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            457999999999999875  488999999887767778899999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE--cCCCcEEEeecCCccccccCCCCcccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL--NEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      .+++.. ....+++..++.++.||++||+|||+.   +|+||||||+|||+  +.++.+||+|||+++.+.....   ..
T Consensus       174 ~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~  246 (373)
T 2x4f_A          174 FDRIID-ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK  246 (373)
T ss_dssp             HHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred             HHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence            998864 245689999999999999999999998   99999999999999  5678999999999987643322   23


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  +.    ..... .. . +.+...    .
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~----~i~~~-~~-~-~~~~~~----~  313 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LN----NILAC-RW-D-LEDEEF----Q  313 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHHT-CC-C-SCSGGG----T
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhc-cC-C-CChhhh----c
Confidence            34699999999999998999999999999999999999999987665432  11    11111 10 0 001111    1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVM--ELSECL  841 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~--~L~~~~  841 (878)
                      ....++.+++.+||+.+|++||+++|+++  .+++..
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            12346789999999999999999999998  455543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.8e-37  Score=333.88  Aligned_cols=248  Identities=32%  Similarity=0.513  Sum_probs=198.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChh-------hHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ-------GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+..  ++.||+|++......       ..+.+.+|++++.+++||||+++++++....  ++
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l   98 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM   98 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred             ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence            355689999999999999984  488999998654322       1267899999999999999999999987655  69


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCccEEEcCCCc-----EEEeecC
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP--IVHRDVKSTNILLNEKLQ-----AKLADFG  711 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLKp~NILl~~~~~-----~kL~DFG  711 (878)
                      ||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.     +||+|||
T Consensus        99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             EEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            9999999999998865 245799999999999999999999998   7  999999999999988776     9999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYT--SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      +++....     ......|++.|+|||.+.  ...++.++|||||||++|||++|+.||...........    ......
T Consensus       175 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~  245 (287)
T 4f0f_A          175 LSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----NMIREE  245 (287)
T ss_dssp             TCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH----HHHHHS
T ss_pred             ccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH----HHHhcc
Confidence            9875422     223356899999999984  45678999999999999999999999987654332111    111111


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                       ...    +    ..+......+.+++.+||+.+|++||+++|+++.|++
T Consensus       246 -~~~----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          246 -GLR----P----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -CCC----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -CCC----C----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             111    1    1122233578899999999999999999999999985

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.8e-37  Score=341.47  Aligned_cols=245  Identities=21%  Similarity=0.378  Sum_probs=197.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++.+.   .....+.+.+|..++.++ +||||+++++++...+..++||||
T Consensus        12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~   91 (345)
T 3a8x_A           12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   91 (345)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence            45689999999999999986  488999999754   334456788999999998 899999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        92 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--  164 (345)
T 3a8x_A           92 VNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--  164 (345)
T ss_dssp             CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC--
Confidence            999999999975  45699999999999999999999998   99999999999999999999999999997542221  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHHHHhcCCcccccCCcc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK--IHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..........+..+..      .+
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~  238 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI  238 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------CC
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------CC
Confidence            223446799999999999999999999999999999999999999975322110  0111122222222221      11


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTM  830 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm  830 (878)
                          +......+.+++.+||+.+|++||++
T Consensus       239 ----p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          239 ----PRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                11223467899999999999999996

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-37  Score=345.66  Aligned_cols=249  Identities=20%  Similarity=0.330  Sum_probs=205.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..  ++.||+|++..........+.+|++++.+++||||+++++++......++||||+++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            456789999999999999885  478999999877666667899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC--CCcEEEeecCCccccccCCCCc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE--KLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      |+|.+++... ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++......   
T Consensus       133 g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---  205 (387)
T 1kob_A          133 GELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---  205 (387)
T ss_dssp             CBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred             CcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc---
Confidence            9999998752 34699999999999999999999998   9999999999999974  4689999999998764322   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      .. +......  .++..   
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~------~~-i~~~~~~--~~~~~---  273 (387)
T 1kob_A          206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------QN-VKRCDWE--FDEDA---  273 (387)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HH-HHHCCCC--CCSST---
T ss_pred             ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH------HH-HHhCCCC--CCccc---
Confidence            223356999999999999999999999999999999999999999876543211      11 1111110  11111   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ......++.+++.+||+.+|++||+++|+++.
T Consensus       274 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          274 -FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             11223467899999999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=343.99  Aligned_cols=266  Identities=16%  Similarity=0.199  Sum_probs=207.7

Q ss_pred             hhhcccccccccEEEEEEEEc----------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceee------------
Q 002809          568 NNFERTLGKGGFGTVYYGRLN----------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTS------------  625 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~----------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~------------  625 (878)
                      +.+.+.||+|+||.||+|+..          ++.||||++...     +.+.+|++++.+++||||++            
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            456789999999999999874          478999998754     46889999999999999998            


Q ss_pred             ---eeecccC-CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC
Q 002809          626 ---LVGHCDE-DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE  701 (878)
Q Consensus       626 ---l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~  701 (878)
                         +++++.. +...++||||+ +++|.+++.......+++..++.++.|+++||+|||++   +|+||||||+|||++.
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP  194 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence               4555544 67889999999 99999999875457899999999999999999999998   9999999999999999


Q ss_pred             CC--cEEEeecCCccccccCCCC-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 002809          702 KL--QAKLADFGLSKSFATDANT-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEE  774 (878)
Q Consensus       702 ~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  774 (878)
                      ++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            98  9999999999876433211     1123347999999999999999999999999999999999999999876422


Q ss_pred             HHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          775 EKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       775 ~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                      . ..+.........  ....+.+.....   ......+.+++.+||+.+|++||++++|++.|++++.......
T Consensus       275 ~-~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  342 (352)
T 2jii_A          275 T-EDIMKQKQKFVD--KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP  342 (352)
T ss_dssp             H-HHHHHHHHHHHH--SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred             H-HHHHHHHHhccC--Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence            1 122222222211  112222211110   1112468899999999999999999999999999887654433

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-37  Score=351.32  Aligned_cols=248  Identities=22%  Similarity=0.361  Sum_probs=195.2

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccC--ChhhHHHHHHHHHHHHHhc--ccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVH--HRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||++.... +.||||++...  .....+.+.+|+++|.+++  ||||+++++++..++..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            4556899999999999998765 78999998754  3445678999999999996  5999999999999999999999 


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +.+++|.+++..  ...+++..++.++.||++||+|||+.   +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus       137 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          137 CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            568899999976  45789999999999999999999998   999999999999995 579999999999876543333


Q ss_pred             cccccccCCCCccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          723 HVSTVVAGTPGYLDPEYYTS-----------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      .......||+.|+|||++.+           ..++.++|||||||++|||++|++||........ .    .....    
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~----~~~~~----  281 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K----LHAII----  281 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H----HHHHH----
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-H----HHHHh----
Confidence            33345679999999999865           3688999999999999999999999976543211 1    11111    


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                           ++.....++......+.+++.+||+.+|++||+++|+++.
T Consensus       282 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          282 -----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                 1111111111223467899999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=369.25  Aligned_cols=252  Identities=23%  Similarity=0.427  Sum_probs=204.0

Q ss_pred             cccccccEEEEEEEEc----ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          573 TLGKGGFGTVYYGRLN----EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .||+|+||.||+|.+.    +..||||+++... ....+.|.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999874    3679999998653 3456889999999999999999999999976 56899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc-ccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH-VST  726 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~  726 (878)
                      |.+++... +..+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus       422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            99999753 55699999999999999999999998   99999999999999999999999999998764332211 122


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.   .    ..+..+..         ...+
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~----~~i~~~~~---------~~~p  561 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M----AFIEQGKR---------MECP  561 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---H----HHHHTTCC---------CCCC
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcCCC---------CCCC
Confidence            2345689999999999999999999999999999998 9999987665431   1    12222221         1122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      ..+...+.+++.+||+.+|++||++++|++.|+.+.....
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            2344578899999999999999999999999999876543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-37  Score=336.96  Aligned_cols=241  Identities=25%  Similarity=0.370  Sum_probs=201.4

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++.+..   ....+.+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus         9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   88 (318)
T 1fot_A            9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI   88 (318)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence            45689999999999999885  4889999997542   223567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....    
T Consensus        89 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----  159 (318)
T 1fot_A           89 EGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  159 (318)
T ss_dssp             CSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence            99999999976  45799999999999999999999998   9999999999999999999999999999865321    


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                       ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....      ..... .+..      .+.  
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i~-~~~~------~~p--  223 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKIL-NAEL------RFP--  223 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH-HCCC------CCC--
T ss_pred             -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hCCC------CCC--
Confidence             2345799999999999999999999999999999999999999987654321      11111 1111      111  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                        .....++.+++.+||+.+|++||     +++|+++.
T Consensus       224 --~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          224 --PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence              11224678999999999999999     88888863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-37  Score=342.29  Aligned_cols=248  Identities=24%  Similarity=0.320  Sum_probs=179.6

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      +.||+|+||.||+++..  ++.||||++...   ....+.+|+.++.+++ ||||+++++++.++...++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            68999999999999986  488999999754   3467789999999997 99999999999999999999999999999


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---cEEEeecCCccccccCCCCccc
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---QAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      .+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++   .+||+|||+++......  ...
T Consensus        94 ~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           94 FERIKK--KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            999976  56799999999999999999999998   999999999999998765   89999999998654322  222


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....||+.|+|||++.+..++.++|||||||+++||++|+.||..............+...+..+...      +.....
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~  240 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAW  240 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcccc
Confidence            34568999999999999999999999999999999999999998654321111011112222222211      010111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .....++.+++.+||+.||++||+++|+++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            122357889999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=341.19  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=187.7

Q ss_pred             hhhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecc--------cCCCcc
Q 002809          568 NNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHC--------DEDNQT  636 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~--------~~~~~~  636 (878)
                      +.+.+.||+|+||.||+++.  .++.||||++........+.+.+|+.++.++. ||||+++++++        ......
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            45678999999999999998  45889999998777777788999999999996 99999999988        344457


Q ss_pred             eeEeeeccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCccEEEcCCCcEEEeecCCc
Q 002809          637 ALIYEFMANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPP--IVHRDVKSTNILLNEKLQAKLADFGLS  713 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLKp~NILl~~~~~~kL~DFGla  713 (878)
                      ++|+||+. |+|.+++.... ...+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|||++
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  185 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSA  185 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred             EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence            89999995 79999886532 45699999999999999999999988   6  999999999999999999999999999


Q ss_pred             cccccCCCCc----------ccccccCCCCccCcccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002809          714 KSFATDANTH----------VSTVVAGTPGYLDPEYY---TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR  780 (878)
Q Consensus       714 ~~~~~~~~~~----------~~~~~~gt~~Y~APE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  780 (878)
                      +.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||.......     
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----  260 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----  260 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----
Confidence            8764322111          11134589999999998   56678999999999999999999999997533211     


Q ss_pred             HHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          781 QWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       781 ~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                       ...     +..        ...........+.+++.+||+.+|++||+++|+++.|+++....
T Consensus       261 -~~~-----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          261 -IVN-----GKY--------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             -----------C--------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -hhc-----Ccc--------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence             000     000        00001111224678999999999999999999999999987653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.4e-37  Score=331.83  Aligned_cols=264  Identities=18%  Similarity=0.270  Sum_probs=205.4

Q ss_pred             hhhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecc-cCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC-DEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~-~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+|+.  .++.||||++.....  ...+.+|++++.+++|++++..+..+ ...+..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 4hgt_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence            45678999999999999996  348899998765432  24688999999999988887777666 6667789999999 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE---cCCCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      +++|.+++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.......
T Consensus        88 ~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           88 GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            99999998742 45699999999999999999999998   99999999999999   7899999999999987644322


Q ss_pred             C-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHHHHhcCCcccc
Q 002809          722 T-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI-RQWVNSLIAKGDIKSI  795 (878)
Q Consensus       722 ~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~v~~~~~~~~~~~i  795 (878)
                      .     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ......... ..... 
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~-  241 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIEV-  241 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCHHH-
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-chhhh-
Confidence            1     122345799999999999999999999999999999999999999987543221111 111111111 11000 


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                      +        .......+.+++.+||+.+|++||++++|++.|+++........
T Consensus       242 ~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~  286 (296)
T 4hgt_A          242 L--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             H--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred             h--------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence            0        01112468899999999999999999999999999887655443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=350.74  Aligned_cols=255  Identities=27%  Similarity=0.500  Sum_probs=195.7

Q ss_pred             hhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeeccc-CCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD-EDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|+..+     ..||||.+... .....+.|.+|+.++++++||||++++++|. .++..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            456789999999999998632     45899998754 3455688999999999999999999999865 4567899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.++++. ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       172 ~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          172 YMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             CCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             CCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999999999975 345688999999999999999999998   999999999999999999999999999986643221


Q ss_pred             C--cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          722 T--HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       722 ~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .  .......+++.|+|||.+.+..++.++|||||||++|||+| |.+||......+.   ...    +..+..  ..  
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~----~~~~~~--~~--  316 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LLQGRR--LL--  316 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH----HHTTCC--CC--
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH----HHcCCC--CC--
Confidence            1  11233457789999999999999999999999999999999 6788876544321   111    111211  00  


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                           .+......+.+++.+||+.+|++||+++|+++.|++++..
T Consensus       317 -----~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          317 -----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                 1112334688999999999999999999999999998743

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=341.88  Aligned_cols=250  Identities=16%  Similarity=0.205  Sum_probs=203.7

Q ss_pred             hhhcccccccccEEEEEEE-------EcceeEEEEEeccCChhhHHHHHHHHHHHHHhc---ccceeeeeecccCCCcce
Q 002809          568 NNFERTLGKGGFGTVYYGR-------LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH---HRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~-------~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~~~  637 (878)
                      +.+.+.||+|+||.||+|+       ..++.||||++.....   .++..|++++.+++   |+||+++++++..++..+
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            3456789999999999994       2347899999976543   46777888887776   999999999999999999


Q ss_pred             eEeeeccCCChhhhhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-----------CC
Q 002809          638 LIYEFMANGNLQEYLSDI---SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-----------KL  703 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-----------~~  703 (878)
                      +||||+++|+|.+++...   ....+++..++.++.||++||+|||+.   +|+||||||+|||++.           ++
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence            999999999999999753   246799999999999999999999998   9999999999999998           89


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWV  783 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v  783 (878)
                      .+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.......        
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------  292 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------  292 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--------
Confidence            999999999987643333444455679999999999999999999999999999999999999986532211        


Q ss_pred             HHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHHHHHHH
Q 002809          784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQR-PTMSQVVMELSECLAAE  844 (878)
Q Consensus       784 ~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Psm~evl~~L~~~~~~e  844 (878)
                                ..+...+....   ....+.+++..|++.+|.+| |+++++.+.|++.+...
T Consensus       293 ----------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 ----------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                      00111111111   13356688899999999998 68889999999988653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-36  Score=330.26  Aligned_cols=263  Identities=19%  Similarity=0.277  Sum_probs=205.3

Q ss_pred             hhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecc-cCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC-DEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~-~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+.  .++.||||++.....  .+.+.+|+.++.+++|++++..+.++ ..+...++||||+ +
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   88 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   88 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence            4568999999999999996  458999999876543  24688999999999998877766665 5667789999999 9


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE---cCCCcEEEeecCCccccccCCCC
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      ++|.+++... ...+++..++.++.|+++||+|||++   +|+||||||+|||+   +.++.+||+|||+++........
T Consensus        89 ~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           89 PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            9999999742 45699999999999999999999998   99999999999999   48889999999999876443221


Q ss_pred             -----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHHHHhcCCccccc
Q 002809          723 -----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       723 -----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~~~~~~~~~~~ii  796 (878)
                           .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... +......... .....  
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~--  241 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIEV--  241 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCHHH--
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-CchHH--
Confidence                 11234579999999999999999999999999999999999999998644321111 1111111111 11000  


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                         +    .......+.+++.+||+.+|++||++++|++.|+++........
T Consensus       242 ---~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~  286 (296)
T 3uzp_A          242 ---L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             ---H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             ---H----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence               0    01122468899999999999999999999999999886654433

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-37  Score=371.59  Aligned_cols=250  Identities=26%  Similarity=0.447  Sum_probs=202.3

Q ss_pred             ccccccccEEEEEEEEc----ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLN----EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||.||+|.+.    ++.||||+++...  ....++|.+|+++|.+++|||||+++++|.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653    3779999997643  3346789999999999999999999999964 468899999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-cc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-HV  724 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~  724 (878)
                      |+|.+++..  ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus       454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            999999975  56799999999999999999999998   9999999999999999999999999999876433221 12


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.       ...+..+...         .
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~~---------~  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGERM---------G  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCC---------C
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCC---------C
Confidence            233456788999999999999999999999999999999 9999987765432       1222222211         1


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      .+..+..++.+++..||+.+|++||++++|++.|+++...
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            1223345788999999999999999999999999987643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-37  Score=341.93  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=206.5

Q ss_pred             HhhhcccccccccEEEEEEEEc-------ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      .+.+.+.||+|+||.||+|+..       +..||||++... .......+.+|+.++.+++||||+++++++......++
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI  110 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence            3456789999999999999843       357999999754 34456789999999999999999999999999999999


Q ss_pred             EeeeccCCChhhhhccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeec
Q 002809          639 IYEFMANGNLQEYLSDISK-----KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADF  710 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DF  710 (878)
                      ||||+++|+|.+++.....     ..+++..++.++.|+++||.|||+.   +|+||||||+|||++.   +..+||+||
T Consensus       111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECcc
Confidence            9999999999999976432     4589999999999999999999998   9999999999999994   456999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      |+++...............|++.|+|||.+.+..++.++||||||+++|||+| |+.||......+.   .+    .+..
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~~~  260 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LE----FVTS  260 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH----HHHT
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HH----HHhc
Confidence            99876543333233334567899999999998899999999999999999998 9999987654331   11    1122


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                      +...         ..+......+.+++.+||+.+|++||++.++++.|+.+.....
T Consensus       261 ~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          261 GGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            2111         1112223467899999999999999999999999998776543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=341.18  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=195.9

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHH--HHHhcccceeeeeecc-----cCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKL--LMRVHHRNLTSLVGHC-----DEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~--L~~l~H~nIv~l~g~~-----~~~~~~~lV~E  641 (878)
                      .+.+.||+|+||.||+|+..++.||||++.....   ..+..|.++  +..++||||+++++.+     ......++|||
T Consensus        16 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   92 (336)
T 3g2f_A           16 KLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME   92 (336)
T ss_dssp             EEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred             heeeecccCCCeEEEEEEECCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence            4568999999999999999999999999975432   344444444  4558999999999743     33446789999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC------KPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      |+++|+|.+++..   ...++..++.++.|+++||+|||+.+      .++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~  169 (336)
T 3g2f_A           93 YYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR  169 (336)
T ss_dssp             CCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence            9999999999964   34589999999999999999999763      33899999999999999999999999999987


Q ss_pred             cccCCC------CcccccccCCCCccCcccccc-------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH-----
Q 002809          716 FATDAN------THVSTVVAGTPGYLDPEYYTS-------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKI-----  777 (878)
Q Consensus       716 ~~~~~~------~~~~~~~~gt~~Y~APE~~~~-------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-----  777 (878)
                      +.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|+.|+.........     
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  249 (336)
T 3g2f_A          170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ  249 (336)
T ss_dssp             CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred             cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence            643211      112224569999999999986       45677999999999999999997665432211000     


Q ss_pred             -------HHHHHHHHHHhcCCcccccCCccccc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          778 -------HIRQWVNSLIAKGDIKSIVDPRLQED--FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       778 -------~l~~~v~~~~~~~~~~~iid~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                             ...+ ..........    .+.+...  ........+.+++.+||+.+|++|||++|+++.|++++..
T Consensus       250 ~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          250 TEVGNHPTFED-MQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             HHHCSSCCHHH-HHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccCCCchHHH-HHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence                   0001 1111111111    1111111  1234566799999999999999999999999999998844

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-36  Score=327.60  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             HhhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          567 TNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.+.||+|+||.||+|+..+  ..||+|++........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT   89 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence            35567899999999999999865  6799999987655667889999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE---cCCCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      +++|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||++....... 
T Consensus        90 ~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           90 GGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             SCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            9999999876  45699999999999999999999998   99999999999999   788999999999998764332 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                        ......||+.|+|||.+.+. ++.++||||||++++||++|+.||......+..       ..+.++...      ..
T Consensus       164 --~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~------~~  227 (277)
T 3f3z_A          164 --MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-------LKIREGTFT------FP  227 (277)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCC------CC
T ss_pred             --chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCC------CC
Confidence              22345699999999998764 899999999999999999999999876653311       111122110      00


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..........+.+++.+||+.+|++||++.|+++.
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000123467899999999999999999999873

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.6e-37  Score=331.60  Aligned_cols=257  Identities=22%  Similarity=0.358  Sum_probs=197.7

Q ss_pred             hhcccccccccEEEEEEEEc-ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+.. ++.||+|++.....  ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence            45688999999999999986 48899999875432  2346788999999999999999999999999999999999975


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                       +|.+++... ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        85 -~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  157 (288)
T 1ob3_A           85 -DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKY  157 (288)
T ss_dssp             -EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             -CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc--ccc
Confidence             999988753 35689999999999999999999998   99999999999999999999999999997653221  122


Q ss_pred             ccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC---ccc-----cc
Q 002809          726 TVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD---IKS-----IV  796 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~---~~~-----ii  796 (878)
                      ....||+.|+|||++.+ ..++.++|||||||+++||++|++||......+..  .... .......   ...     ..
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MRIF-RILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHH-HHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-HHHCCCChhhchhhhccccc
Confidence            33468999999999876 45899999999999999999999999876654321  1111 1111110   000     01


Q ss_pred             CCccc-------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          797 DPRLQ-------EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       797 d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ++.+.       ..........+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11111       1111223456789999999999999999999976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.4e-37  Score=343.01  Aligned_cols=257  Identities=21%  Similarity=0.261  Sum_probs=201.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-----ccceeeeeecccCCCcceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-----HRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-----H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++... ....+.+..|++++.+++     ||||+++++++...+..++||
T Consensus        37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~  115 (360)
T 3llt_A           37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF  115 (360)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence            455689999999999999984  488999999753 344567888999999997     999999999999999999999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-------------------
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-------------------  701 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-------------------  701 (878)
                      ||+ +++|.+++.......+++..++.++.||+.||+|||+.   +|+||||||+|||++.                   
T Consensus       116 e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~  191 (360)
T 3llt_A          116 EPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI  191 (360)
T ss_dssp             CCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred             cCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccc
Confidence            999 99999999876556799999999999999999999998   9999999999999975                   


Q ss_pred             ------CCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 002809          702 ------KLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE  775 (878)
Q Consensus       702 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  775 (878)
                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       192 ~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  266 (360)
T 3llt_A          192 QIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME  266 (360)
T ss_dssp             EEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence                  789999999999864322     223568999999999999999999999999999999999999998766544


Q ss_pred             HHHHHHHH---------HHHHhcCCcccccC-Cccc----cccC----------------HHHHHHHHHHHHHccCCCCC
Q 002809          776 KIHIRQWV---------NSLIAKGDIKSIVD-PRLQ----EDFD----------------ANSVWKAVELAMACLSPTGN  825 (878)
Q Consensus       776 ~~~l~~~v---------~~~~~~~~~~~iid-~~l~----~~~~----------------~~~~~~l~~l~~~Cl~~dP~  825 (878)
                      ........         ....... ....++ ..+.    ....                ......+.+++.+||+.||+
T Consensus       267 ~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  345 (360)
T 3llt_A          267 HLAMMESIIQPIPKNMLYEATKTN-GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT  345 (360)
T ss_dssp             HHHHHHHHTCCCCHHHHHHHTTSG-GGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHhhhhhcc-CccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence            32221111         0000000 000000 0000    0000                00114677999999999999


Q ss_pred             CCCCHHHHHH
Q 002809          826 QRPTMSQVVM  835 (878)
Q Consensus       826 ~RPsm~evl~  835 (878)
                      +|||++|+++
T Consensus       346 ~Rpta~elL~  355 (360)
T 3llt_A          346 LRPSPAELLK  355 (360)
T ss_dssp             GSCCHHHHTT
T ss_pred             hCCCHHHHhc
Confidence            9999999975

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-37  Score=344.01  Aligned_cols=243  Identities=24%  Similarity=0.370  Sum_probs=200.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++.+..   ....+.+..|..++.++ +||||+++++++...+..++||||
T Consensus        20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~   99 (345)
T 1xjd_A           20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY   99 (345)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            45689999999999999986  4889999997542   23356788899999987 899999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......  
T Consensus       100 ~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  172 (345)
T 1xjd_A          100 LNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--  172 (345)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--
Confidence            999999999976  45699999999999999999999998   99999999999999999999999999997543221  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+..+..      . .+..+.      +.+. 
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~-~i~~~~------~~~p-  238 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------H-SIRMDN------PFYP-  238 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------H-HHHHCC------CCCC-
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH------H-HHHhCC------CCCC-
Confidence            2234567999999999999999999999999999999999999999876653321      1 111111      1111 


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMS-QVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~-evl~  835 (878)
                         ......+.+++.+||+.+|++||++. ++++
T Consensus       239 ---~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          239 ---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence               11234678999999999999999997 6653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-37  Score=339.53  Aligned_cols=255  Identities=22%  Similarity=0.387  Sum_probs=195.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcc----ee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQT----AL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~----~l  638 (878)
                      +.+.+.||+|+||.||+++..  ++.||||++...   .......+.+|++++.+++||||+++++++......    ++
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l   93 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   93 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence            455789999999999999964  488999999764   334456889999999999999999999998766544    99


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+++|+|.++++.  ...+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        94 v~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           94 VMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            9999999999999975  45699999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCC-cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          719 DANT-HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       719 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........      ............   
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~---  239 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPP---  239 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCH---
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCCc---
Confidence            3221 122335689999999999999999999999999999999999999987665331      111122111110   


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM-ELSEC  840 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~-~L~~~  840 (878)
                          ..........+.+++.+||+.+|++||++.++++ .|.++
T Consensus       240 ----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          240 ----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                0001112346789999999999999997776654 44443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.6e-37  Score=331.65  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=196.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++....  ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence            45688999999999999985  4789999997543  3345788999999999999999999999999999999999997


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      + +|.+.+.. ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        85 ~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  157 (292)
T 3o0g_A           85 Q-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RC  157 (292)
T ss_dssp             E-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SC
T ss_pred             C-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--cc
Confidence            5 56555543 245699999999999999999999998   99999999999999999999999999998764222  22


Q ss_pred             cccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC---ccccc---C
Q 002809          725 STVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD---IKSIV---D  797 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~---~~~ii---d  797 (878)
                      .....||+.|+|||++.+.. ++.++|||||||+++||++|+.|+........ .+.... .......   .....   +
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~-~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIF-RLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHH-HHHCCCCTTTCTTGGGSTT
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH-HHhCCCChhhhhhhccccc
Confidence            23456899999999998765 79999999999999999998877544332221 111111 1111110   00000   0


Q ss_pred             C---------ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 P---------RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 ~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .         .............+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0         0000111223457789999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-37  Score=335.28  Aligned_cols=261  Identities=25%  Similarity=0.354  Sum_probs=199.9

Q ss_pred             HHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-----hhhHHHHHHHHHHHHHhc---ccceeeeeecccCCC-
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-----AQGFQQFQAEVKLLMRVH---HRNLTSLVGHCDEDN-  634 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~-  634 (878)
                      ..+.+.+.||+|+||.||+|+..  ++.||||++....     ......+.+|++++++++   ||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            34556789999999999999964  4889999987432     112356777888777775   999999999987654 


Q ss_pred             ----cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          635 ----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       635 ----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                          ..++||||+. |+|.+++.......+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeC
Confidence                4789999996 6999999876666699999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      |+++......   ......||+.|+|||++.+..++.++|||||||+++||++|++||......+...  ... ......
T Consensus       165 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~i~-~~~~~~  238 (308)
T 3g33_A          165 GLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG--KIF-DLIGLP  238 (308)
T ss_dssp             SCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH--HHH-HHHCCC
T ss_pred             ccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HHhCCC
Confidence            9998653322   2234568999999999999999999999999999999999999998776543221  111 111111


Q ss_pred             ---CcccccC-C--ccc-------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 ---DIKSIVD-P--RLQ-------EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 ---~~~~iid-~--~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         ....... +  .+.       .....+....+.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence               0000000 0  000       00111233577899999999999999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9e-37  Score=335.59  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=192.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+..  ++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||++ 
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-   86 (317)
T 2pmi_A            8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-   86 (317)
T ss_dssp             -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred             eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence            45678999999999999875  4889999987543 2345778999999999999999999999999999999999998 


Q ss_pred             CChhhhhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          646 GNLQEYLSDIS----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       646 gsL~~~l~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+|.+++....    ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred             CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence            69999986532    24689999999999999999999998   999999999999999999999999999987643221


Q ss_pred             CcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC---cccc--
Q 002809          722 THVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD---IKSI--  795 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~---~~~i--  795 (878)
                        ......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+....   +........   ...+  
T Consensus       164 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          164 --TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL---IFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             --CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCTTTCGGGGG
T ss_pred             --cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChhHhhhhhh
Confidence              2233568999999999976 4689999999999999999999999987765432211   111111000   0000  


Q ss_pred             ---cCCccc------------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          796 ---VDPRLQ------------EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       796 ---id~~l~------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         ..+.+.            ..........+.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence               000000            00011223468899999999999999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.5e-37  Score=351.76  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=200.5

Q ss_pred             hcccccccccEEEEEEEEcc--eeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.||+|+||.||+++...  +.||+|++.+...   .....+.+|+.++.+++||||++++++|.+++..++||||++
T Consensus        78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~  157 (437)
T 4aw2_A           78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV  157 (437)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence            45799999999999999864  7899999975321   223458899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus       158 gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~  232 (437)
T 4aw2_A          158 GGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQ  232 (437)
T ss_dssp             TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEE
T ss_pred             CCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-Ccc
Confidence            99999999752 45699999999999999999999998   99999999999999999999999999998764332 223


Q ss_pred             cccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHHHHhcCCcccccCC
Q 002809          725 STVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~~~~~~~~~~~iid~  798 (878)
                      ....+||+.|+|||++.     ...++.++|||||||++|||++|++||...+..+... +..+.    ..-..     +
T Consensus       233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----~~~~~-----p  303 (437)
T 4aw2_A          233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK----ERFQF-----P  303 (437)
T ss_dssp             CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----HHCCC-----C
T ss_pred             cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc----ccccC-----C
Confidence            34467999999999987     5678999999999999999999999998766543211 11110    00011     1


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQ--RPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~evl~~  836 (878)
                      ...    .....++.+++.+||+.+|++  ||+++|+++.
T Consensus       304 ~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          304 TQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             SSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            110    112346778999999988888  9999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.2e-37  Score=338.72  Aligned_cols=247  Identities=21%  Similarity=0.357  Sum_probs=193.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCC----------
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN----------  634 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----------  634 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.... ....+.+.+|++++++++||||+++++++.+..          
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~   87 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE   87 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence            445689999999999999985  4889999997543 345678999999999999999999999885443          


Q ss_pred             -----------------------------------------------cceeEeeeccCCChhhhhcccc-CCCCCHHHHH
Q 002809          635 -----------------------------------------------QTALIYEFMANGNLQEYLSDIS-KKVLSSQERL  666 (878)
Q Consensus       635 -----------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~  666 (878)
                                                                     ..++||||+++|+|.+++.... ....++..++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  167 (332)
T 3qd2_B           88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL  167 (332)
T ss_dssp             --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred             hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence                                                           2789999999999999997643 3456777899


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC----------cccccccCCCCccC
Q 002809          667 RIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT----------HVSTVVAGTPGYLD  736 (878)
Q Consensus       667 ~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~Y~A  736 (878)
                      .++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........          .......||+.|+|
T Consensus       168 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            9999999999999998   9999999999999999999999999999876443211          12233569999999


Q ss_pred             ccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHH
Q 002809          737 PEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELA  816 (878)
Q Consensus       737 PE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~  816 (878)
                      ||++.+..++.++|||||||+++||++|..|+..     ....    ..........         .........+.+++
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~----~~~~~~~~~~---------~~~~~~~~~~~~li  306 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRI----ITDVRNLKFP---------LLFTQKYPQEHMMV  306 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHH----HHHHHTTCCC---------HHHHHHCHHHHHHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHH----HHHhhccCCC---------cccccCChhHHHHH
Confidence            9999999999999999999999999998876421     1111    1111111111         01122334668899


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 002809          817 MACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       817 ~~Cl~~dP~~RPsm~evl~  835 (878)
                      .+||+.+|++||+++|+++
T Consensus       307 ~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          307 QDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCSSGGGSCCHHHHHH
T ss_pred             HHHccCCCCcCCCHHHHhh
Confidence            9999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.1e-37  Score=341.43  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=201.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++....   ....+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus        44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  123 (350)
T 1rdq_E           44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV  123 (350)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence            45689999999999999985  4889999987542   233567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++..  ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....    
T Consensus       124 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----  194 (350)
T 1rdq_E          124 AGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----  194 (350)
T ss_dssp             TTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence            99999999976  45699999999999999999999998   9999999999999999999999999999866322    


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                       ....+||+.|+|||++.+..++.++|||||||++|||++|++||......+.      . ..+..+..      .+   
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~-~~i~~~~~------~~---  257 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------Y-EKIVSGKV------RF---  257 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-HHHHHCCC------CC---
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------H-HHHHcCCC------CC---
Confidence             2235799999999999999999999999999999999999999987654331      1 11222221      11   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPT-----MSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~~  836 (878)
                       +......+.+++.+||+.+|++||+     ++||++.
T Consensus       258 -p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          258 -PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence             1122346789999999999999998     8888764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.3e-37  Score=337.15  Aligned_cols=245  Identities=27%  Similarity=0.389  Sum_probs=192.2

Q ss_pred             hhhcccccccccEEEEEEEE-----cceeEEEEEeccCC----hhhHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRL-----NEIDVAVKMLSSSS----AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+++.     .++.||+|++....    ......+.+|++++++++||||+++++++..++..++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            45678999999999999987     34889999997642    2344668899999999999999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        99 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           99 ILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            9999999999999975  45689999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........      .... .+..      
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~-~~~~------  238 (327)
T 3a62_A          174 DG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DKIL-KCKL------  238 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHH-HTCC------
T ss_pred             CC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-hCCC------
Confidence            21  1223457999999999999999999999999999999999999999876543311      1111 1111      


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                      .+    +......+.+++.+||+.+|++||     +++|+++.
T Consensus       239 ~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            11    112234678999999999999999     67787763

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.4e-37  Score=341.10  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=200.9

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+++...  +.||+|++.+..   ....+.+..|..++..+ +||||+++++++...+..++|||
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E  101 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  101 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence            3456899999999999999865  779999997542   23456788999999988 79999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++..  ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       102 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  175 (353)
T 2i0e_A          102 YVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-  175 (353)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence            9999999999975  45699999999999999999999998   99999999999999999999999999998542221 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+..+.      .... ..+..      .  
T Consensus       176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i-~~~~~------~--  239 (353)
T 2i0e_A          176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSI-MEHNV------A--  239 (353)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HHCCC------C--
T ss_pred             -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------HHHH-HhCCC------C--
Confidence             223446799999999999999999999999999999999999999987654331      1111 11211      1  


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPT-----MSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~~  836 (878)
                        ++.....++.+++.+||+.+|++||+     ++|+++.
T Consensus       240 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          240 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              11122346789999999999999996     4666653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.2e-37  Score=339.37  Aligned_cols=253  Identities=28%  Similarity=0.490  Sum_probs=203.4

Q ss_pred             hhcccccccccEEEEEEEEcc--e--eEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--I--DVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~--~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+++...  .  .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~  107 (327)
T 1fvr_A           28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY  107 (327)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence            567899999999999998753  4  4599988754 333456789999999999 899999999999999999999999


Q ss_pred             ccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          643 MANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       643 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      +++|+|.+++....              ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~  184 (327)
T 1fvr_A          108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  184 (327)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEc
Confidence            99999999997632              34799999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      |||+++.....   .......++..|+|||.+.+..++.++|||||||+++||+| |+.||......+.      . ..+
T Consensus       185 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~-~~~  254 (327)
T 1fvr_A          185 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------Y-EKL  254 (327)
T ss_dssp             CTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------H-HHG
T ss_pred             ccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------H-HHh
Confidence            99998743221   11223457889999999998889999999999999999998 9999987654331      1 112


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ..+..     .    ..+......+.+++.+||+.+|++||+++|+++.|++++..
T Consensus       255 ~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          255 PQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             GGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hcCCC-----C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            22210     0    11122334688999999999999999999999999998864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-36  Score=331.30  Aligned_cols=263  Identities=22%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++...   .....+.+.+|++++++++||||+++++++..++..++||||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  113 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence            456789999999999999864  588999998753   344567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          643 MANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       643 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      +++|+|.+++...  ....+++..++.++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            9999999998653  256689999999999999999999998   99999999999999999999999999987653322


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                        .......|+..|+|||.+.+..++.++||||||++++||++|+.||.......    ..... .+..+......    
T Consensus       191 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~-~~~~~~~~~~~----  259 (310)
T 2wqm_A          191 --TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK-KIEQCDYPPLP----  259 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHH-HHHTTCSCCCC----
T ss_pred             --ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHH-HhhcccCCCCc----
Confidence              12233468999999999999999999999999999999999999997543211    11111 12222211111    


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARA  848 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~  848 (878)
                          .......+.+++.+||+.||++||++++|++.|+++...+...-
T Consensus       260 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          260 ----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             ----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             ----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence                11123467899999999999999999999999999877654443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.9e-37  Score=330.72  Aligned_cols=249  Identities=24%  Similarity=0.406  Sum_probs=204.1

Q ss_pred             HHHHHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC--------
Q 002809          563 VVKITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--------  632 (878)
Q Consensus       563 l~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--------  632 (878)
                      .....+.+.+.||+|+||.||+++..  ++.||+|++....    ..+.+|++++.+++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            33444566789999999999999986  5889999997654    357789999999999999999998753        


Q ss_pred             --------CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc
Q 002809          633 --------DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ  704 (878)
Q Consensus       633 --------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~  704 (878)
                              ....++||||+++|+|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                    44579999999999999999875567899999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002809          705 AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN  784 (878)
Q Consensus       705 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~  784 (878)
                      +||+|||++.......   ......|++.|+|||.+.+..++.++||||||++++||++|..|+....        .+. 
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~-  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFF-  228 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHH-
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHH-
Confidence            9999999998764332   1233468999999999999999999999999999999999998864211        111 


Q ss_pred             HHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          785 SLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       785 ~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      ..+..+.+.        ..+    ...+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       229 ~~~~~~~~~--------~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          229 TDLRDGIIS--------DIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HHHHTTCCC--------TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             HHhhccccc--------ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            111222211        111    2356789999999999999999999999988653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-36  Score=327.11  Aligned_cols=255  Identities=23%  Similarity=0.377  Sum_probs=204.2

Q ss_pred             HHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh------hhHHHHHHHHHHHHHhcccceeeeeecccCCCcce
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~  637 (878)
                      -.+.+.+.||+|+||.||+++..  ++.||+|++.....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            34566789999999999999986  48899999875422      13578999999999999999999999999999999


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC----cEEEeecCCc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL----QAKLADFGLS  713 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~----~~kL~DFGla  713 (878)
                      +||||+++++|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999975  45799999999999999999999998   999999999999998877    8999999999


Q ss_pred             cccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          714 KSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       714 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      .......   ......|++.|+|||++.+..++.++||||||++++||++|+.||......+...       .+..... 
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~-  228 (283)
T 3bhy_A          160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT-------NISAVNY-  228 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTCC-
T ss_pred             eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH-------HhHhccc-
Confidence            8664322   1223468999999999999999999999999999999999999998766533211       1111110 


Q ss_pred             cccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHH
Q 002809          794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME--LSECL  841 (878)
Q Consensus       794 ~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~--L~~~~  841 (878)
                           .............+.+++.+||+.+|++||+++|+++.  ++++.
T Consensus       229 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          229 -----DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             -----CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             -----CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                 00000111223467899999999999999999999983  55543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.9e-37  Score=341.93  Aligned_cols=246  Identities=23%  Similarity=0.354  Sum_probs=186.5

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..+  +.||||++....  ..+.+.+|++++.+++||||+++++++...+..++||||+++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            3456899999999999999864  779999998653  346788999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCccccccCCCC
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~~~  722 (878)
                      |+|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.   ++.+||+|||+++.....   
T Consensus       133 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---  204 (349)
T 2w4o_A          133 GELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---  204 (349)
T ss_dssp             CBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc---
Confidence            999999976  45699999999999999999999998   9999999999999975   889999999999865322   


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||........      ....+..+... ...     
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~~-~~~-----  272 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEYY-FIS-----  272 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCCC-CCT-----
T ss_pred             cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCCc-cCC-----
Confidence            122345689999999999999999999999999999999999999976544321      11111121111 111     


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .........+.+++.+||+.||++||++.|+++
T Consensus       273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111123346789999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.1e-37  Score=344.68  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++...  +.||+|++....   ....+.+.+|++++.+++||||+++++++...+..++||||
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   96 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL   96 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence            3456899999999999998865  779999987542   23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +.+|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+...   
T Consensus        97 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---  168 (384)
T 4fr4_A           97 LLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---  168 (384)
T ss_dssp             CTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC---
Confidence            999999999976  55799999999999999999999998   9999999999999999999999999999876432   


Q ss_pred             cccccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          723 HVSTVVAGTPGYLDPEYYTS---NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      ......+||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+....    .....       
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~~~~-------  237 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF----ETTVV-------  237 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH----HHCCC-------
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hhccc-------
Confidence            22344679999999999874   45899999999999999999999999764433222221111    11110       


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPT-MSQVVM  835 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~evl~  835 (878)
                         .++......+.+++.+||+.+|++||+ ++++.+
T Consensus       238 ---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 ---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               111222346889999999999999998 666654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.5e-37  Score=340.96  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++....   ......+.+|+++++.++||||+++++++...+..++||||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY   90 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence            345689999999999999974  4889999987532   12246789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      + +|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++.......  
T Consensus        91 ~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           91 A-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             C-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred             C-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence            9 7899998875  45699999999999999999999998   99999999999999999999999999998664322  


Q ss_pred             cccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......               ....+....  
T Consensus       163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------~~~~i~~~~--  224 (336)
T 3h4j_B          163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------LFKKVNSCV--  224 (336)
T ss_dssp             -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------CBCCCCSSC--
T ss_pred             -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHHcCC--
Confidence             2234579999999999988776 789999999999999999999997643221               001111100  


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...+......+.+++.+||+.||.+|||++|+++.
T Consensus       225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            01122233467899999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.1e-37  Score=339.67  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=198.4

Q ss_pred             HHhhhcccccccccEEEEEEEEcc--eeEEEEEeccC-----ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS-----SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-----~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      ..+.+.+.||+|+||.||+|+...  ..||+|++...     .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            345567899999999999998754  78999998643     33456789999999999999999999999999999999


Q ss_pred             EeeeccCCChhhhhcccc--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 002809          639 IYEFMANGNLQEYLSDIS--------------------------------------KKVLSSQERLRIAVESAQGLEYLH  680 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qia~gL~yLH  680 (878)
                      ||||+++|+|.+++....                                      ...+++..++.++.|+++||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            999999999999985211                                      122467788899999999999999


Q ss_pred             hCCCCCeEecCCCCccEEEcCCC--cEEEeecCCccccccCCCC--cccccccCCCCccCcccccc--CCCCCccchhhH
Q 002809          681 NGCKPPIVHRDVKSTNILLNEKL--QAKLADFGLSKSFATDANT--HVSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSF  754 (878)
Q Consensus       681 ~~~~~~ivHrDLKp~NILl~~~~--~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~  754 (878)
                      +.   +|+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||.+.+  ..++.++|||||
T Consensus       186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            98   999999999999998776  8999999999876432211  12334569999999999975  678999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002809          755 GVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV  834 (878)
Q Consensus       755 Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl  834 (878)
                      ||++|||++|+.||......+..      ........  ....+.     .......+.+++.+||+.+|++||++.|++
T Consensus       263 G~il~el~~g~~pf~~~~~~~~~------~~~~~~~~--~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADTI------SQVLNKKL--CFENPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC--CTTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCChHHHH------HHHHhccc--ccCCcc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            99999999999999877654321      11111111  000011     111234678999999999999999999998


Q ss_pred             HH
Q 002809          835 ME  836 (878)
Q Consensus       835 ~~  836 (878)
                      +.
T Consensus       330 ~h  331 (345)
T 3hko_A          330 QH  331 (345)
T ss_dssp             HS
T ss_pred             cC
Confidence            73

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=344.88  Aligned_cols=268  Identities=22%  Similarity=0.312  Sum_probs=209.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCC--cceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN--QTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||||
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~   90 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred             eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence            345689999999999999986  4889999997543 234577889999999999999999999987655  67999999


Q ss_pred             ccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE----cCCCcEEEeecCCccccc
Q 002809          643 MANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       643 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl----~~~~~~kL~DFGla~~~~  717 (878)
                      +++|+|.+++.... ...+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++...
T Consensus        91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            99999999997643 23499999999999999999999998   99999999999999    788889999999998764


Q ss_pred             cCCCCcccccccCCCCccCcccccc--------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTS--------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      ...   ......||..|+|||++.+        ..++.++|||||||++|||++|+.||.........  .+........
T Consensus       168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~  242 (396)
T 4eut_A          168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITG  242 (396)
T ss_dssp             CGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHHS
T ss_pred             CCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhcC
Confidence            322   2233569999999999865        56788999999999999999999999754321110  1111222221


Q ss_pred             CC---ccccc---------CCcc--ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          790 GD---IKSIV---------DPRL--QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       790 ~~---~~~ii---------d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ..   +..+.         ...+  ...........+.+++.+||+.||++||+++|+++.+++++..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11   11000         0011  1123456677888999999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.5e-37  Score=328.58  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=202.9

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+++..  ++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence            456789999999999999885  4889999987543 3445788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++..+........
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           89 GGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             TEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            9999999975  45699999999999999999999998   999999999999999999999999999987643332223


Q ss_pred             cccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....|+..|+|||.+.+..+ +.++||||||++++||++|+.||........ ....|..    ...   ...      
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~~~---~~~------  229 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KKT---YLN------  229 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT----TCT---TST------
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh----ccc---ccC------
Confidence            344568999999999987765 7799999999999999999999987554221 1222211    100   000      


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ........+.+++.+||+.+|++||+++|+++
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            01122346778999999999999999999876

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-36  Score=332.21  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=204.3

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChh------hHHHHHHHHHHHHHhcccceeeeeecccCCCccee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ------GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTAL  638 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l  638 (878)
                      .+.+.+.||+|+||.||+++..  ++.||+|++......      ..+.+.+|++++.+++||||+++++++...+..++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4567789999999999999985  488999998754322      35789999999999999999999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC----cEEEeecCCcc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL----QAKLADFGLSK  714 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~  714 (878)
                      ||||+++++|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||+++
T Consensus        93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            9999999999999975  55789999999999999999999998   999999999999999888    79999999998


Q ss_pred             ccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ......   ......||+.|+|||.+.+..++.++||||||++++||++|+.||......+..      .. +.....  
T Consensus       168 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~-i~~~~~--  235 (321)
T 2a2a_A          168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------AN-ITSVSY--  235 (321)
T ss_dssp             ECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HH-HHTTCC--
T ss_pred             ecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH------HH-HHhccc--
Confidence            764322   123356899999999999999999999999999999999999999876543321      11 111110  


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..++...    ......+.+++.+||+.+|++||+++|+++.
T Consensus       236 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0111111    1123467899999999999999999999873

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=331.74  Aligned_cols=261  Identities=22%  Similarity=0.320  Sum_probs=198.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++....  ....+.+.+|++++.+++||||+++++++...+..++||||++
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD   85 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence            45689999999999999986  4889999986543  2345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        86 ~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  158 (311)
T 4agu_A           86 HTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DY  158 (311)
T ss_dssp             EEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             CchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cc
Confidence            9999998865  45699999999999999999999998   99999999999999999999999999998764322  12


Q ss_pred             cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--------HHHHhcCCc-c-
Q 002809          725 STVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWV--------NSLIAKGDI-K-  793 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v--------~~~~~~~~~-~-  793 (878)
                      .....|+..|+|||++.+ ..++.++||||||++++||++|++||......+........        ......... . 
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            234568999999999876 67899999999999999999999999887654433221110        000000000 0 


Q ss_pred             -cccCCccccc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          794 -SIVDPRLQED---FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       794 -~iid~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ..-++.-...   ........+.+++.+||+.+|++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             0001000000   001233467899999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.4e-36  Score=324.56  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=202.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+|+..  ++.||+|++...  .....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   88 (284)
T 3kk8_A            9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   88 (284)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence            45689999999999999875  478999998754  34456788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc---EEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~---~kL~DFGla~~~~~~~~  721 (878)
                      +++|.+++..  +..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||++....... 
T Consensus        89 ~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-  162 (284)
T 3kk8_A           89 GGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  162 (284)
T ss_dssp             SCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence            9999998875  46699999999999999999999998   9999999999999987655   9999999997654322 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                        ......|++.|+|||.+.+..++.++||||||++++||++|+.||..........       .+..+.... ..+   
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~-~~~---  229 (284)
T 3kk8_A          163 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA-------QIKAGAYDY-PSP---  229 (284)
T ss_dssp             --BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCCC-CTT---
T ss_pred             --cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH-------HHHhccccC-Cch---
Confidence              2233568999999999999999999999999999999999999998765433211       111121110 000   


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        ........+.+++.+||+.+|++||+++|+++.
T Consensus       230 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          230 --EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             --TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              011223467899999999999999999999884

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=337.55  Aligned_cols=257  Identities=21%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             hhhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeeccc----CCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD----EDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~----~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+++.  .++.||||++........+.+.+|++++++++||||+++++++.    .....++|||
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  110 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP  110 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence            34568999999999999996  34889999998777777788999999999999999999999986    3457889999


Q ss_pred             eccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          642 FMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       642 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |+++|+|.+++...  ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            99999999999753  246799999999999999999999998   9999999999999999999999999998765321


Q ss_pred             CCCc-------ccccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          720 ANTH-------VSTVVAGTPGYLDPEYYTSNR---LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       720 ~~~~-------~~~~~~gt~~Y~APE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      ....       ......|++.|+|||.+.+..   ++.++||||||+++|||++|+.||........ .+..    ....
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~~  262 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----AVQN  262 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----HHHC
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----Hhhc
Confidence            1110       012345799999999987554   68999999999999999999999854211110 1111    1111


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                       ..        ...........+.+++.+||+.+|++||+++++++.|+.+.
T Consensus       263 -~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          263 -QL--------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             -C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             -cC--------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence             00        00111122346889999999999999999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.8e-37  Score=352.96  Aligned_cols=248  Identities=23%  Similarity=0.311  Sum_probs=199.3

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++...  +.||+|++.+...   ...+.+.+|+.++..++||||+++++++.+++..++||||+
T Consensus        72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  151 (410)
T 3v8s_A           72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM  151 (410)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            345799999999999999864  7899999875321   22345889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.++++.   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       152 ~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~  224 (410)
T 3v8s_A          152 PGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV  224 (410)
T ss_dssp             TTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EE
T ss_pred             CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cc
Confidence            99999999874   3589999999999999999999998   99999999999999999999999999998764322 12


Q ss_pred             ccccccCCCCccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNR----LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .....+||+.|+|||++.+..    ++.++|||||||++|||++|++||...+..+...  ....... .-..     +.
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--~i~~~~~-~~~~-----p~  296 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS--KIMNHKN-SLTF-----PD  296 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHTHHH-HCCC-----CT
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH--HHHhccc-cccC-----CC
Confidence            233567999999999998665    7899999999999999999999998766533211  1111000 0000     00


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQ--RPTMSQVVME  836 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~evl~~  836 (878)
                           ......++.+++.+||+.+|.+  ||+++||+++
T Consensus       297 -----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          297 -----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                 0112246789999999999988  9999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8e-37  Score=340.11  Aligned_cols=261  Identities=18%  Similarity=0.242  Sum_probs=196.0

Q ss_pred             hhhcccccccccEEEEEEEEc-----ceeEEEEEeccCChh-----------hHHHHHHHHHHHHHhcccceeeeeeccc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN-----EIDVAVKMLSSSSAQ-----------GFQQFQAEVKLLMRVHHRNLTSLVGHCD  631 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~~~-----------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~  631 (878)
                      +.+.+.||+|+||.||+|+..     +..+|||+.......           ....+.+|+..+..++||||+++++++.
T Consensus        39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~  118 (345)
T 2v62_A           39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL  118 (345)
T ss_dssp             EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred             EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence            456789999999999999984     478999998765322           1234678889999999999999999987


Q ss_pred             C----CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC--cE
Q 002809          632 E----DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL--QA  705 (878)
Q Consensus       632 ~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~--~~  705 (878)
                      .    ....++||||+ +++|.+++..  ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++  .+
T Consensus       119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          119 TEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred             cccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence            7    77899999999 9999999986  33799999999999999999999998   999999999999999887  99


Q ss_pred             EEeecCCccccccCCCC-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002809          706 KLADFGLSKSFATDANT-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR  780 (878)
Q Consensus       706 kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  780 (878)
                      ||+|||+++.+......     .......||..|+|||++.+..++.++|||||||++|||++|+.||........ .+.
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~  271 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-AVQ  271 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-HHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-HHH
Confidence            99999999876432211     112345799999999999999999999999999999999999999965322111 111


Q ss_pred             HHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          781 QWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       781 ~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                      ...... .. .+...+.....   ......++.+++.+||+.+|++||++++|++.|+++
T Consensus       272 ~~~~~~-~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          272 TAKTNL-LD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHH-HH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHhh-cc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            111111 11 11111000000   012234788999999999999999999999999873

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.2e-37  Score=353.19  Aligned_cols=245  Identities=26%  Similarity=0.363  Sum_probs=192.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++..  ++.||||++...   .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  229 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY  229 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence            345689999999999999875  478999999753   333456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      +++|+|.+++..  ...+++..+..++.|+++||+|||+ .   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       230 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  303 (446)
T 4ejn_A          230 ANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-  303 (446)
T ss_dssp             CSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence            999999999976  4579999999999999999999997 7   99999999999999999999999999997643221 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........      . +..+..      .+ 
T Consensus       304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~-i~~~~~------~~-  368 (446)
T 4ejn_A          304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------L-ILMEEI------RF-  368 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHHCCC------CC-
T ss_pred             -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH------H-HHhCCC------CC-
Confidence             22334679999999999999999999999999999999999999998765533211      1 111111      11 


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                         +.....++.+++.+||+.||++||     +++|+++.
T Consensus       369 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          369 ---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence               112234678999999999999999     99999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-36  Score=325.97  Aligned_cols=242  Identities=29%  Similarity=0.427  Sum_probs=198.3

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++...  ..||+|++....   ......+.+|++++++++||||+++++++...+..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (279)
T 3fdn_A           12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA   91 (279)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence            456899999999999998865  679999986532   123467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......    
T Consensus        92 ~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----  162 (279)
T 3fdn_A           92 PLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----  162 (279)
T ss_dssp             TTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc----
Confidence            99999999976  45699999999999999999999988   9999999999999999999999999988654322    


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|+..|+|||.+.+..++.++||||||++++||++|+.||......+...       .+.....      .    
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~------~----  225 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RISRVEF------T----  225 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTCC------C----
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-------HHHhCCC------C----
Confidence            1233568999999999999999999999999999999999999998766543211       1111110      1    


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+......+.+++.+||+.+|++||+++|+++.
T Consensus       226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            111123467799999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-36  Score=330.63  Aligned_cols=256  Identities=21%  Similarity=0.271  Sum_probs=197.6

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++..  ++.||+|++....   ....+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL  115 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence            345689999999999999875  4889999987542   33457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus       116 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  189 (309)
T 2h34_A          116 INGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-  189 (309)
T ss_dssp             CCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-
Confidence            999999999976  45699999999999999999999998   999999999999999999999999999876543221 


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......       ....+.... ..      ..
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~------~~  255 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQAI-PR------PS  255 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSCC-CC------GG
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccCC-CC------cc
Confidence            12233568999999999999999999999999999999999999998654321       111111111 00      00


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRP-TMSQVVMELSECLAA  843 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~evl~~L~~~~~~  843 (878)
                      .........+.+++.+||+.+|++|| +++++++.|++++..
T Consensus       256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            11112233677899999999999999 999999999986543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.2e-36  Score=335.90  Aligned_cols=243  Identities=28%  Similarity=0.432  Sum_probs=198.0

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +...+.||+|+||.||+|+..  ++.||||++....   ....+.+.+|++++.+++||||+++++++..++..++||||
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  135 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY  135 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence            445678999999999999863  5889999997542   33456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +. |+|.+++... ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus       136 ~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          136 CL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             CS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            97 6888887542 45799999999999999999999998   9999999999999999999999999999765322   


Q ss_pred             cccccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          723 HVSTVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                         ....||+.|+|||++.   ...++.++|||||||+++||++|++||.........      ..... +.......  
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~-~~~~~~~~--  275 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NESPALQS--  275 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SCCCCCCC--
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh-cCCCCCCC--
Confidence               2346899999999984   567899999999999999999999999876543321      11111 11111111  


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                            ......+.+++.+||+.+|++||+++++++.
T Consensus       276 ------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          276 ------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  1122467789999999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.1e-37  Score=344.11  Aligned_cols=249  Identities=23%  Similarity=0.320  Sum_probs=190.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+++..  ++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  100 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG  100 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence            456789999999999999985  48899999976432 236788999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc--EEEeecCCccccccCCCCc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ--AKLADFGLSKSFATDANTH  723 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~  723 (878)
                      |+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.  +||+|||+++......   
T Consensus       101 ~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---  172 (361)
T 3uc3_A          101 GELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  172 (361)
T ss_dssp             CBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---
Confidence            999999975  45699999999999999999999998   9999999999999988765  9999999987432221   


Q ss_pred             ccccccCCCCccCccccccCCCCCc-cchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEK-SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~k-sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........  .......... ....      +. 
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~-~~~~------~~-  242 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILS-VKYS------IP-  242 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHT-TCCC------CC-
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhc-CCCC------CC-
Confidence            2233569999999999988887665 8999999999999999999986543211  1111222111 1100      00 


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ........+.+++.+||+.+|++|||++|+++.
T Consensus       243 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 -DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             011123467899999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-36  Score=332.53  Aligned_cols=254  Identities=23%  Similarity=0.350  Sum_probs=194.9

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccCCC
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      ++.||+|+||.||+++..  ++.||||++........+.+.+|++++.++ +||||+++++++..++..++||||+++|+
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            367999999999999864  488999999877666678899999999995 79999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc---EEEeecCCccccccCCC---
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ---AKLADFGLSKSFATDAN---  721 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~---~kL~DFGla~~~~~~~~---  721 (878)
                      |.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.   +||+|||+++.......   
T Consensus        98 L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (316)
T 2ac3_A           98 ILSHIHK--RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP  172 (316)
T ss_dssp             HHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred             HHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence            9999976  45699999999999999999999998   9999999999999998776   99999999876532211   


Q ss_pred             --CcccccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH--------HHHHHHHHHH
Q 002809          722 --THVSTVVAGTPGYLDPEYYTS-----NRLTEKSDVYSFGVVILEIITCKPAISRINEEEK--------IHIRQWVNSL  786 (878)
Q Consensus       722 --~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~--------~~l~~~v~~~  786 (878)
                        ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+.        .....-....
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (316)
T 2ac3_A          173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES  252 (316)
T ss_dssp             ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred             ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence              111223459999999999875     5688999999999999999999999976542110        0000011112


Q ss_pred             HhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          787 IAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       787 ~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +..+...      +...........+.+++.+||+.||++||+++|+++
T Consensus       253 i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          253 IQEGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            2222110      000000112346889999999999999999999987

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=347.03  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.||+|+||.||+++..  ++.||+|++.+..   ....+.+.+|..++.+++||||+++++++.+.+..++||||++
T Consensus        65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~  144 (412)
T 2vd5_A           65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV  144 (412)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence            4578999999999999985  4889999997532   2234568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.+++... +..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus       145 gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-~~~  219 (412)
T 2vd5_A          145 GGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVR  219 (412)
T ss_dssp             SCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEE
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCC-ccc
Confidence            99999999753 34799999999999999999999998   99999999999999999999999999998764332 222


Q ss_pred             cccccCCCCccCccccc-------cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHHHHhcCCccccc
Q 002809          725 STVVAGTPGYLDPEYYT-------SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH-IRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~-------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~v~~~~~~~~~~~ii  796 (878)
                      ....+||+.|+|||++.       ...++.++|||||||++|||++|++||...+..+... +..+.    ..-..    
T Consensus       220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----~~~~~----  291 (412)
T 2vd5_A          220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----EHLSL----  291 (412)
T ss_dssp             CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----HHCCC----
T ss_pred             cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----cCcCC----
Confidence            33467999999999987       4578999999999999999999999998766543211 11110    00000    


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQR---PTMSQVVME  836 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Psm~evl~~  836 (878)
                       +...    .....++.+++.+||+ +|++|   |+++|++++
T Consensus       292 -p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          292 -PLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             -C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             -Cccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence             1111    1123467899999999 99998   688888764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.1e-36  Score=327.83  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=201.8

Q ss_pred             HHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      ..+.+.+.||+|+||.||+++..  ++.||+|++........+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            34566789999999999999975  5889999998765555577899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE---cCCCcEEEeecCCccccccCC
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ++++|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++..... 
T Consensus        89 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           89 SGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999875  45689999999999999999999998   99999999999999   78899999999998754321 


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                         ......|++.|+|||.+.+..++.++||||||++++||++|+.||.........       ..+.++...  ...  
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~~~--~~~--  228 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF-------EKIKEGYYE--FES--  228 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHCCCC--CCT--
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCCC--CCc--
Confidence               223346899999999999999999999999999999999999999876543211       112222211  011  


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .........+.+++.+||+.+|++||+++|+++.
T Consensus       229 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          229 --PFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             --TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              1111223468899999999999999999999873

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.2e-37  Score=331.97  Aligned_cols=257  Identities=23%  Similarity=0.371  Sum_probs=196.9

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|++..     ..||||++...   .....+.+.+|++++.+++||||+++++++.... .++|
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v   98 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV   98 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence            3556899999999999998632     35899998754   3345678999999999999999999999998765 8899


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      +||+++|+|.+++... ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        99 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           99 TELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             EecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            9999999999999753 35689999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCCc-ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          720 ANTH-VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       720 ~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      .... ......++..|+|||.+.+..++.++||||||++++||++ |+.||......+.      .......+...    
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~~~----  244 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGERL----  244 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCCC----
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccCCCC----
Confidence            2211 2233457788999999998889999999999999999999 9999987665331      11111111110    


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                           ..+......+.+++.+||+.+|++||+++++++.|+++....
T Consensus       245 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          245 -----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                 111223357889999999999999999999999999876543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.1e-37  Score=345.62  Aligned_cols=259  Identities=26%  Similarity=0.407  Sum_probs=189.6

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCC--cceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDN--QTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~--~~~lV~  640 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  ..++||
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~   90 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF   90 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence            455689999999999999875  488999998653  3455678889999999997 999999999986543  689999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||++ |+|.+++..   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        91 e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           91 DYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             ECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             cccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            9997 689998874   4689999999999999999999998   99999999999999999999999999998653211


Q ss_pred             -------------------CCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002809          721 -------------------NTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR  780 (878)
Q Consensus       721 -------------------~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  780 (878)
                                         .........||+.|+|||++.+ ..++.++|||||||+++||++|++||...+..+.... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~-  242 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER-  242 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence                               1112234579999999999976 6789999999999999999999999987765433221 


Q ss_pred             HHHHHHHhcCCcc---ccc------------------CCcccccc------------CHHHHHHHHHHHHHccCCCCCCC
Q 002809          781 QWVNSLIAKGDIK---SIV------------------DPRLQEDF------------DANSVWKAVELAMACLSPTGNQR  827 (878)
Q Consensus       781 ~~v~~~~~~~~~~---~ii------------------d~~l~~~~------------~~~~~~~l~~l~~~Cl~~dP~~R  827 (878)
                       .. ..+......   .+-                  .......+            ......++.+++.+||+.||++|
T Consensus       243 -i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          243 -II-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             -HH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             -HH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence             11 111000000   000                  00000000            00223468899999999999999


Q ss_pred             CCHHHHHHH
Q 002809          828 PTMSQVVME  836 (878)
Q Consensus       828 Psm~evl~~  836 (878)
                      ||++|+++.
T Consensus       321 ~t~~e~l~H  329 (388)
T 3oz6_A          321 ISANDALKH  329 (388)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhCC
Confidence            999999865

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2e-36  Score=336.64  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=198.9

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeec
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.+.||+|+||.||+++..  ++.||||++.....    .+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            3456789999999999999986  48899999976542    345788899888 7999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC----CcEEEeecCCccccccC
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKSFATD  719 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~----~~~kL~DFGla~~~~~~  719 (878)
                      ++|+|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||+.++    +.+||+|||+++.....
T Consensus        99 ~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           99 KGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999975  45699999999999999999999998   99999999999998543    35999999999876433


Q ss_pred             CCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.    ..+..+...      
T Consensus       174 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~------  241 (342)
T 2qr7_A          174 NG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS------  241 (342)
T ss_dssp             TC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC------
T ss_pred             CC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc------
Confidence            22  223457899999999999888999999999999999999999999864322211221    122222221      


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +...........+.+++.+||+.||++||+++|+++.
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111112233467899999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-36  Score=323.64  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=196.7

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.+.||+|+||.||+++..  +..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            3566789999999999999875  4789999987643 334678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE---cCCCcEEEeecCCcccccc
Q 002809          644 ANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       644 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~  718 (878)
                      ++|+|.+++....  ...+++..++.++.|+++||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus       103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            9999999986532  46799999999999999999999998   99999999999999   4567899999999976543


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ..   ......|++.|+|||.+. ..++.++||||||++++||++|+.||......+....      ...........  
T Consensus       180 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~------~~~~~~~~~~~--  247 (285)
T 3is5_A          180 DE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK------ATYKEPNYAVE--  247 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCCCCCC---
T ss_pred             cc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh------hccCCcccccc--
Confidence            22   223456899999999986 5688999999999999999999999987665432111      11111100000  


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ...    ....+.+++.+||+.+|++||+++|+++
T Consensus       248 --~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          248 --CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              001    1246779999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.7e-36  Score=325.58  Aligned_cols=244  Identities=25%  Similarity=0.404  Sum_probs=203.0

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++...  +.||+|++...   .....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   97 (294)
T 2rku_A           18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC   97 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence            456899999999999999864  78999998754   3345678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++++|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++.......  .
T Consensus        98 ~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~  170 (294)
T 2rku_A           98 RRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--E  170 (294)
T ss_dssp             TTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc--c
Confidence            99999999875  45799999999999999999999998   99999999999999999999999999998764322  1


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|++.|+|||.+.+..++.++||||||++++||++|+.||......+...       .+..+..      .+.  
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~------~~~--  235 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------RIKKNEY------SIP--  235 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTCC------CCC--
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhhccC------CCc--
Confidence            2234568999999999999899999999999999999999999998765433211       1111111      111  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        ......+.+++.+||+.+|++||+++|+++.
T Consensus       236 --~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          236 --KHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              1122467789999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-36  Score=327.73  Aligned_cols=243  Identities=27%  Similarity=0.489  Sum_probs=195.9

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC----CCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE----DNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|....  ..||+|++...  .....+.+.+|+.++++++||||+++++++..    +...++||
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  108 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence            456789999999999998864  77999998754  34556789999999999999999999998754    45689999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCccEEEc-CCCcEEEeecCCccccc
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP--IVHRDVKSTNILLN-EKLQAKLADFGLSKSFA  717 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~  717 (878)
                      ||+++|+|.+++..  ...+++..++.++.|++.||+|||+.   +  |+||||||+|||++ .++.+||+|||++....
T Consensus       109 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            99999999999975  45689999999999999999999998   6  99999999999998 78999999999987543


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ..    ......|++.|+|||.+.+ .++.++||||||++++||++|+.||.........     . ..+..+.....  
T Consensus       184 ~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~-~~~~~~~~~~~--  250 (290)
T 1t4h_A          184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----Y-RRVTSGVKPAS--  250 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----H-HHHTTTCCCGG--
T ss_pred             cc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----H-HHHhccCCccc--
Confidence            22    2234568999999998874 5899999999999999999999999875443211     1 11111211111  


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                            .+......+.+++.+||+.+|++||+++|+++
T Consensus       251 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 ------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  11112246889999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.1e-36  Score=330.45  Aligned_cols=256  Identities=21%  Similarity=0.331  Sum_probs=203.2

Q ss_pred             HHHHHHhhhc-ccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCc
Q 002809          562 DVVKITNNFE-RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQ  635 (878)
Q Consensus       562 dl~~~t~~f~-~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~  635 (878)
                      +.....+.+. +.||+|+||.||+++..  ++.||+|++....  ......+.+|+.++.+++ ||||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3333344444 78999999999999886  4889999987543  334578999999999995 6999999999999999


Q ss_pred             ceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCC
Q 002809          636 TALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGL  712 (878)
Q Consensus       636 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGl  712 (878)
                      .++||||+++|+|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999999765567899999999999999999999998   9999999999999998   78999999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      ++......   ......|++.|+|||++.+..++.++|||||||+++||++|+.||......+....       +.....
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~~~~~  250 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-------ISQVNV  250 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCC
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-------HHhccc
Confidence            98764322   12335699999999999999999999999999999999999999987665432111       111110


Q ss_pred             ccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 ~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                            .............+.+++.+||+.+|++||+++|+++.
T Consensus       251 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          251 ------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                  01111112233467899999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-36  Score=342.96  Aligned_cols=246  Identities=26%  Similarity=0.384  Sum_probs=191.9

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHH-HHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKL-LMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~-L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+++...  +.||+|++.+..   ......+.+|..+ ++.++||||+++++++...+..++|||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            3567899999999999999864  779999997643   2234566777776 467899999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++..  ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       120 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          120 YINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence            9999999999976  45689999999999999999999998   99999999999999999999999999998643221 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+..+..      .... .+..      .+.
T Consensus       194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~-~~~~------~~~  259 (373)
T 2r5t_A          194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNIL-NKPL------QLK  259 (373)
T ss_dssp             -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH------HHHH-HSCC------CCC
T ss_pred             -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHH-hccc------CCC
Confidence             2234567999999999999999999999999999999999999999876543311      1111 1111      111


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                      .    .....+.+++.+||+.+|++||++.+.++.+
T Consensus       260 ~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          260 P----NITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             S----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             C----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence            1    1224678999999999999999986444433

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=324.72  Aligned_cols=244  Identities=27%  Similarity=0.440  Sum_probs=179.4

Q ss_pred             hhcccccccccEEEEEEEE--cceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+|+.  .++.||||++.....   ...+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus        14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (278)
T 3cok_A           14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC   93 (278)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence            4567899999999999987  358899999865421   23467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++++|.+++... ...+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++........  
T Consensus        94 ~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  167 (278)
T 3cok_A           94 HNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--  167 (278)
T ss_dssp             TTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence            999999999752 35689999999999999999999998   999999999999999999999999999986642221  


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|++.|+|||.+.+..++.++||||||++++||++|+.||.........               ..+.....  .
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~--~  230 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADY--E  230 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC--C
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhccc--C
Confidence            122356899999999999989999999999999999999999999765432210               00010000  1


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .+.....++.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            11222346789999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.8e-36  Score=325.90  Aligned_cols=249  Identities=23%  Similarity=0.387  Sum_probs=200.9

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecc--cCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHC--DEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~--~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++...  .....+.+.+|++++++++||||+++++++  ......++||||
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   88 (279)
T 2w5a_A            9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY   88 (279)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred             eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence            45689999999999999985  488999999754  344567899999999999999999999987  446788999999


Q ss_pred             ccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          643 MANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPP-----IVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       643 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      +++|+|.+++....  ...+++..++.++.|++.||+|||+.   +     |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            99999999997533  34599999999999999999999998   6     99999999999999999999999999876


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      .....  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.   .    ..+..+.... 
T Consensus       166 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~i~~~~~~~-  235 (279)
T 2w5a_A          166 LNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---A----GKIREGKFRR-  235 (279)
T ss_dssp             C---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHTCCCC-
T ss_pred             ecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---H----HHHhhccccc-
Confidence            53321  122335689999999999998999999999999999999999999987654321   1    1222232211 


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELS  838 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~  838 (878)
                          +    +.....++.+++.+||+.+|++||+++||++.+.
T Consensus       236 ----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          236 ----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ----C----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                1    1122346889999999999999999999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.6e-36  Score=331.87  Aligned_cols=244  Identities=25%  Similarity=0.409  Sum_probs=203.1

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..+  +.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  123 (335)
T 2owb_A           44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC  123 (335)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence            456899999999999999864  78999998754   3345678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++++|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus       124 ~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~  196 (335)
T 2owb_A          124 RRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--E  196 (335)
T ss_dssp             TTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             CCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc--c
Confidence            99999999875  45799999999999999999999998   99999999999999999999999999998764322  1


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.||......+...      . +..+..      .+.. 
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~-~~~~~~------~~~~-  262 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------R-IKKNEY------SIPK-  262 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H-HHHTCC------CCCT-
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------H-HhcCCC------CCCc-
Confidence            2234568999999999999999999999999999999999999998765433211      1 111111      1111 


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         .....+.+++.+||+.||++||+++|+++.
T Consensus       263 ---~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          263 ---HINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               122367789999999999999999999874

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.4e-36  Score=343.25  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=188.0

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccC----CCcceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDE----DNQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~----~~~~~lV~Ey~~  644 (878)
                      +.||+|+||.||+++..  ++.||||++...     ..+.+|++++.++ +||||+++++++..    ....++||||++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~  142 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD  142 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence            68999999999999886  478999999643     4577888887554 89999999998864    567899999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~~  721 (878)
                      +|+|.+++.......+++..+..++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++.....  
T Consensus       143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--  217 (400)
T 1nxk_A          143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--  217 (400)
T ss_dssp             SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC--
Confidence            99999999875556799999999999999999999998   9999999999999998   789999999999865322  


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........   .....+..+...      +.
T Consensus       218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~i~~~~~~------~~  287 (400)
T 1nxk_A          218 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYE------FP  287 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHHHHHTCCC------CC
T ss_pred             -CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHHHHcCccc------CC
Confidence             12234578999999999999999999999999999999999999997654321000   001111112111      00


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .........++.+++.+||+.||++|||++|+++.
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00011233468899999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7e-36  Score=325.59  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=199.0

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC----hhhHHHHHHHHHHHHHhcccceeeeeecc--cCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS----AQGFQQFQAEVKLLMRVHHRNLTSLVGHC--DEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~--~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+++...  ..||+|++....    ....+.+.+|++++++++||||+++++++  .+....++|
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV   86 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred             eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence            3556899999999999999854  789999987542    23457899999999999999999999998  455688999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||++++ |.+++.......+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999876 77877765667899999999999999999999998   9999999999999999999999999999876443


Q ss_pred             CCCcccccccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ..........|+..|+|||++.+..  .+.++||||||++++||++|+.||.........       ..+..+..     
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~~-----  230 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-------ENIGKGSY-----  230 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHCCC-----
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------HHHhcCCC-----
Confidence            3333334556999999999997644  377999999999999999999999876543211       11222211     


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .+.    ......+.+++.+||+.+|++||+++|+++.
T Consensus       231 -~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 -AIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -CCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -CCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             111    1223467799999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.4e-36  Score=324.05  Aligned_cols=245  Identities=26%  Similarity=0.442  Sum_probs=196.0

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      ..||+|+||.||+|+..  +..||||.+........+.+.+|+.++.+++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            48999999999999974  3789999998776666788999999999999999999999999999999999999999999


Q ss_pred             hhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-CCcEEEeecCCccccccCCCCccccc
Q 002809          650 EYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       650 ~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      +++.... ...+++..+..++.|+++||+|||+.   +|+||||||+||+++. ++.+||+|||+++......  .....
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  182 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTET  182 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Ccccc
Confidence            9997643 34577999999999999999999998   9999999999999988 8999999999998654321  12234


Q ss_pred             ccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          728 VAGTPGYLDPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ..|+..|+|||++.+..  ++.++||||||+++|||++|+.||..........   + ..... .     ..+.+    +
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~-~~~~~-~-----~~~~~----~  248 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---F-KVGMF-K-----VHPEI----P  248 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---H-HHHHH-C-----CCCCC----C
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---H-hhccc-c-----ccccc----c
Confidence            56899999999997643  7899999999999999999999997644322111   0 00010 0     01111    1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ......+.+++.+||+.+|++||+++|+++
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          249 ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222346789999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-36  Score=333.84  Aligned_cols=261  Identities=23%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++..  ++.||||++....  ....+.+.+|++++.+++||||+++++++...+..++||||++
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  107 (331)
T 4aaa_A           28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD  107 (331)
T ss_dssp             EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence            45679999999999999986  4789999986543  3345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus       108 ~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  180 (331)
T 4aaa_A          108 HTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EV  180 (331)
T ss_dssp             EEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             cchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cc
Confidence            9999988764  45699999999999999999999998   99999999999999999999999999997654322  12


Q ss_pred             cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHH-------HHHHHhcCC-ccc
Q 002809          725 STVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI-RQW-------VNSLIAKGD-IKS  794 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~-------v~~~~~~~~-~~~  794 (878)
                      .....|+..|+|||++.+. .++.++|||||||++|||++|++||......+.... ...       ......... ...
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            2335689999999999875 789999999999999999999999987765432211 100       000000100 011


Q ss_pred             ccCCccccc-----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQED-----FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...+.+...     ........+.+++.+||+.||++||+++|+++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            111111111     111234578899999999999999999999874

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-36  Score=347.83  Aligned_cols=244  Identities=24%  Similarity=0.375  Sum_probs=202.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.....   .....+.+|+++++.++||||+++++++...+..++||||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~   97 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY   97 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            355689999999999999985  58899999975422   2346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        98 ~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--  170 (476)
T 2y94_A           98 VSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  170 (476)
T ss_dssp             CSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence            999999999975  56799999999999999999999998   99999999999999999999999999998764322  


Q ss_pred             cccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........      . ..+..+...        
T Consensus       171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~-~~i~~~~~~--------  234 (476)
T 2y94_A          171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------F-KKICDGIFY--------  234 (476)
T ss_dssp             -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------H-HHHHTTCCC--------
T ss_pred             -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------H-HHHhcCCcC--------
Confidence             2234579999999999988765 6899999999999999999999987654321      1 112222110        


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .+......+.+++.+||+.||++|||++|+++.
T Consensus       235 --~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          235 --TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence              011122367899999999999999999999873

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-35  Score=343.64  Aligned_cols=190  Identities=22%  Similarity=0.361  Sum_probs=152.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeeccc-----CCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD-----EDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-----~~~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|+++|.+++||||+++++++.     .....++
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            456789999999999999865  488999998753  3445678999999999999999999999984     3357899


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+ +|+|.+++..  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       135 v~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          135 VLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            99998 5799999875  56799999999999999999999998   999999999999999999999999999987642


Q ss_pred             CCCC-------------------------cccccccCCCCccCcccc-ccCCCCCccchhhHHHHHHHHHh
Q 002809          719 DANT-------------------------HVSTVVAGTPGYLDPEYY-TSNRLTEKSDVYSFGVVILEIIT  763 (878)
Q Consensus       719 ~~~~-------------------------~~~~~~~gt~~Y~APE~~-~~~~~t~ksDV~S~Gvvl~ellt  763 (878)
                      ....                         ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            2111                         122345689999999986 56679999999999999999999

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=335.82  Aligned_cols=239  Identities=22%  Similarity=0.361  Sum_probs=198.2

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--------hhHHHHHHHHHHHHHhcccceeeeeecccCCCcc
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQT  636 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~  636 (878)
                      .+.+.+.||+|+||.||+|+..  ++.||||++.....        ...+.+.+|++++.+++||||+++++++...+..
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            3455689999999999999864  48899999976531        1334678899999999999999999999999999


Q ss_pred             eeEeeeccCC-ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          637 ALIYEFMANG-NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       637 ~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      ++||||+.+| +|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            9999999777 99999976  45699999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      .....   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......                    
T Consensus       180 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------  236 (335)
T 3dls_A          180 LERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------  236 (335)
T ss_dssp             CCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------
T ss_pred             CCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------
Confidence            64332   2233569999999999988776 78999999999999999999999753211                    


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ......  .+......+.+++.+||+.+|++||+++|+++.
T Consensus       237 -~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000000  011123467899999999999999999999885

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.7e-36  Score=322.19  Aligned_cols=243  Identities=26%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++...  ..||+|++....   ....+.+.+|++++.+++||||+++++++...+..++||||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   95 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF   95 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence            3456899999999999999864  789999986532   22346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++......   
T Consensus        96 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---  167 (284)
T 2vgo_A           96 APRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---  167 (284)
T ss_dssp             CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence            999999999976  45689999999999999999999998   9999999999999999999999999998755322   


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                       ......|+..|+|||.+.+..++.++||||||++++||++|+.||......+..       ..+....      ..+. 
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~------~~~~-  232 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-------RRIVNVD------LKFP-  232 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC------CCCC-
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-------HHHhccc------cCCC-
Confidence             123356899999999999999999999999999999999999999876543311       1111111      1111 


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         ......+.+++.+||+.+|++||+++|+++.
T Consensus       233 ---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          233 ---PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ---CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence               1223467899999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-35  Score=345.24  Aligned_cols=263  Identities=18%  Similarity=0.279  Sum_probs=206.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcc-cceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH-RNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++......  .++.+|++++..++| +++..+..++...+..++||||+ 
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            345689999999999999975  588999988754332  468899999999987 45555666667788889999999 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE---cCCCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      +++|.+++... ...+++..++.|+.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.+.....
T Consensus        86 g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            99999999743 45699999999999999999999998   99999999999999   6889999999999987654322


Q ss_pred             C-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          722 T-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       722 ~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      .     .......||..|+|||++.+..++.++|||||||++|||++|+.||..............+........+..+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~  241 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC  241 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence            1     11225679999999999999999999999999999999999999998765433222222222111111111111


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                           .    ....++.+++..||+.+|++||++++|++.|++++..+..
T Consensus       242 -----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~  282 (483)
T 3sv0_A          242 -----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF  282 (483)
T ss_dssp             -----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             -----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence                 1    1124788999999999999999999999999998876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-35  Score=344.41  Aligned_cols=258  Identities=21%  Similarity=0.278  Sum_probs=192.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC------Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~  637 (878)
                      +.+.+.||+|+||.||+++..  ++.||||++...  .....+.+.+|+.++++++||||+++++++...      ...+
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            345688999999999999875  488999999754  444567889999999999999999999998654      3569


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+++ +|.+.+..    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       144 lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             EEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             EEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            99999976 46666542    489999999999999999999998   99999999999999999999999999998654


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHH--------------
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI-RQW--------------  782 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~--------------  782 (878)
                      ..   .......||+.|+|||++.+..++.++|||||||+++||++|++||...+..+.... .+.              
T Consensus       216 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          216 TS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             -C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             CC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            32   123346799999999999999999999999999999999999999987665332211 100              


Q ss_pred             -HHHHHhcCC-cc-----cccCCccccc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          783 -VNSLIAKGD-IK-----SIVDPRLQED---FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       783 -v~~~~~~~~-~~-----~iid~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ......... ..     ..+...+...   .......++.+|+.+||+.||++|||++|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             000000000 00     0000000000   011124578899999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-36  Score=338.77  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=199.2

Q ss_pred             hhhcccccccccEEEEEEEE-----cceeEEEEEeccCC----hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcce
Q 002809          568 NNFERTLGKGGFGTVYYGRL-----NEIDVAVKMLSSSS----AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~  637 (878)
                      +.+.+.||+|+||.||+++.     .++.||||++....    ....+.+.+|++++.++ +||||+++++++..++..+
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  135 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  135 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence            45678999999999999987     45889999987532    23345678899999999 5999999999999999999


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+++|+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       136 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999999976  45699999999999999999999998   99999999999999999999999999998653


Q ss_pred             cCCCCcccccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      ... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........  ............     
T Consensus       211 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~-----  282 (355)
T 1vzo_A          211 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE-----  282 (355)
T ss_dssp             GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC-----
T ss_pred             cCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC-----
Confidence            322 222334579999999999985  3578999999999999999999999975432211  111112211111     


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVMEL  837 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~L  837 (878)
                        +.    .+......+.+++.+||+.+|++||     +++|+++..
T Consensus       283 --~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 --PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             --CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             --CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence              11    1122234677999999999999999     999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.4e-36  Score=354.08  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      .+.+.||+|+||.||+++..  ++.||+|++....   ......+.+|+++|.+++||||+++++++...+..++||||+
T Consensus       187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~  266 (576)
T 2acx_A          187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM  266 (576)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence            44679999999999999985  4889999997532   223467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++|+|.+++.......+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+....   
T Consensus       267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---  340 (576)
T 2acx_A          267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---  340 (576)
T ss_dssp             CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc---
Confidence            999999999875556699999999999999999999998   99999999999999999999999999998764322   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE-KIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|++||....... ...+..    .+.....      .   
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----~i~~~~~------~---  407 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEVPE------E---  407 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH----HHHHCCC------C---
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH----Hhhcccc------c---
Confidence            2233579999999999999999999999999999999999999998754311 111111    1111110      1   


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                       ++.....++.+++.+||+.||++||     +++||+++
T Consensus       408 -~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          408 -YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence             1112234678999999999999999     77888764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.7e-36  Score=333.60  Aligned_cols=258  Identities=22%  Similarity=0.287  Sum_probs=190.6

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeec
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFM  643 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  643 (878)
                      +.+.+.||+|+||.||+++..  ++.||||++.....  ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  115 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA  115 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence            445689999999999999865  48899999975432  23467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE-----cCCCcEEEeecCCcccccc
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL-----NEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl-----~~~~~~kL~DFGla~~~~~  718 (878)
                      + |+|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||+     ++++.+||+|||+++....
T Consensus       116 ~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          116 E-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             S-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             C-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            7 599999976  45699999999999999999999998   99999999999999     4555699999999986642


Q ss_pred             CCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh--cCCcccc
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA--KGDIKSI  795 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~--~~~~~~i  795 (878)
                      ..  .......||..|+|||++.+. .++.++|||||||+++||++|++||......+..  .......-.  .......
T Consensus       190 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          190 PI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTTSTTG
T ss_pred             cc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCCCchhhhhhh
Confidence            21  122334689999999999874 4899999999999999999999999876654322  111111100  0000000


Q ss_pred             -------------cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          796 -------------VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       796 -------------id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                                   ....+..........++.+++.+||+.||++|||++|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                         0000000001112357789999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.4e-36  Score=333.92  Aligned_cols=260  Identities=22%  Similarity=0.330  Sum_probs=201.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+++..  +..||+|++... .....+.+.+|++++.+++||||+++++++..++..++||||+++
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  115 (360)
T 3eqc_A           36 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG  115 (360)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             eeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCC
Confidence            45678999999999999987  488999998865 344567899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.+  +|+||||||+|||++.++.+||+|||++......    ..
T Consensus       116 ~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~  187 (360)
T 3eqc_A          116 GSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA  187 (360)
T ss_dssp             CBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C-
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cc
Confidence            999999976  456999999999999999999999731  7999999999999999999999999998765322    12


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHH---------HHhcC------
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNS---------LIAKG------  790 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~---------~~~~~------  790 (878)
                      ....||+.|+|||++.+..++.++|||||||+++||++|+.||......+..........         ....+      
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF  267 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence            235689999999999999999999999999999999999999987665432211100000         00000      


Q ss_pred             --------CcccccC----CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 --------DIKSIVD----PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 --------~~~~iid----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                              ...+.++    ..............+.+++.+||+.+|++|||++|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                    0000000    000000011123468899999999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=335.39  Aligned_cols=258  Identities=22%  Similarity=0.367  Sum_probs=194.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChh-hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ-GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++...... ....+.+|++++++++||||+++++++..++..++||||++ 
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   83 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   83 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred             EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence            45678999999999999986  478999998754322 22356689999999999999999999999999999999997 


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++... +..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        84 ~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~  157 (324)
T 3mtl_A           84 KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY  157 (324)
T ss_dssp             EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc--ccc
Confidence            5999988753 45699999999999999999999998   99999999999999999999999999987653221  222


Q ss_pred             ccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC---CcccccCC---
Q 002809          726 TVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG---DIKSIVDP---  798 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~---~~~~iid~---  798 (878)
                      ....||..|+|||++.+ ..++.++|||||||+++||++|+.||......+....   +.......   ........   
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHhchhhhcchhh
Confidence            33468999999999876 5689999999999999999999999988765443221   22211111   11111100   


Q ss_pred             ------ccc----cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          799 ------RLQ----EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       799 ------~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                            ...    ..........+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                  000    00011223467899999999999999999999873

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-35  Score=322.65  Aligned_cols=245  Identities=27%  Similarity=0.472  Sum_probs=203.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ...+.||+|+||.||+|+..  ++.||||++.... ....+.+.+|+.++.+++||||+++++++..+...++||||+++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  104 (303)
T 3a7i_A           25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG  104 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence            44678999999999999875  4889999987553 34567899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++..   ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......  ...
T Consensus       105 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  176 (303)
T 3a7i_A          105 GSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR  176 (303)
T ss_dssp             EEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCB
T ss_pred             CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc--ccc
Confidence            999999864   5699999999999999999999998   99999999999999999999999999998764322  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|+..|+|||.+.+..++.++||||||++++||++|+.||..........       .+..+..     +.+.... 
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~-----~~~~~~~-  243 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-------LIPKNNP-----PTLEGNY-  243 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCC-----CCCCSSC-
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-------HhhcCCC-----CCCcccc-
Confidence            34568999999999999999999999999999999999999998765433211       1111111     1111122 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMEL  837 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L  837 (878)
                         ...+.+++.+||+.+|++||++.|+++..
T Consensus       244 ---~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          244 ---SKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             ---CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ---CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence               23678999999999999999999998854

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-36  Score=334.43  Aligned_cols=253  Identities=24%  Similarity=0.335  Sum_probs=192.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC------cce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN------QTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~  637 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|++++++++||||+++++++...+      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  106 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY  106 (367)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence            345678999999999999875  488999998653  3344678899999999999999999999987653      459


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+ +++|.++++.   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       107 lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          107 LVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             EEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            999999 8899999874   4689999999999999999999998   99999999999999999999999999998653


Q ss_pred             cCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC------
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG------  790 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~------  790 (878)
                      ..     .....+|..|+|||++.+ ..++.++||||+||+++||++|++||......+....  ... .....      
T Consensus       180 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~--i~~-~~g~~~~~~~~  251 (367)
T 1cm8_A          180 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE--IMK-VTGTPPAEFVQ  251 (367)
T ss_dssp             SS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH-HHCCCCHHHHH
T ss_pred             cc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHH-hcCCCCHHHHH
Confidence            22     223568999999999887 6799999999999999999999999987665332211  100 00000      


Q ss_pred             ------------CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 ------------DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 ------------~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                                  .+...-...+. .........+.+++.+||+.||++|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                        00000001111 1112234578899999999999999999999873

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.8e-36  Score=321.34  Aligned_cols=242  Identities=20%  Similarity=0.309  Sum_probs=196.2

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEee
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.+.+.||+|+||.||+|+..  ++.||+|++...  .......+.+|+..+.++ +||||+++++++.+++..++|||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e   91 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE   91 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence            3455689999999999999985  588999998764  334567889999999999 89999999999999999999999


Q ss_pred             eccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-----------------
Q 002809          642 FMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-----------------  702 (878)
Q Consensus       642 y~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-----------------  702 (878)
                      |+++|+|.+++....  ...+++..++.++.|+++||+|||++   +|+||||||+|||++.+                 
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------------------
T ss_pred             ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            999999999997643  26699999999999999999999998   99999999999999844                 


Q ss_pred             --CcEEEeecCCccccccCCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002809          703 --LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI  779 (878)
Q Consensus       703 --~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  779 (878)
                        ..+||+|||++.......      ...|+..|+|||.+.+. .++.++|||||||+++||++|.+++......     
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----  237 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-----  237 (289)
T ss_dssp             -CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-----
T ss_pred             CceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-----
Confidence              479999999998764321      23589999999999866 5678999999999999999999876543211     


Q ss_pred             HHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       780 ~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                           ..+..+...     .+.    ......+.+++.+||+.+|++||+++|+++.
T Consensus       238 -----~~~~~~~~~-----~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          238 -----HEIRQGRLP-----RIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -----HHHHTTCCC-----CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -----HHHHcCCCC-----CCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                 111222221     111    1223467899999999999999999999863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=333.64  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=198.5

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||.||+|+..+ .+|+|++....  ....+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~  114 (319)
T 2y4i_B           36 EIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR  114 (319)
T ss_dssp             ECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred             EEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence            456899999999999999866 59999987542  233467889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC---CCc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA---NTH  723 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---~~~  723 (878)
                      +|.+++... +..+++..++.++.|+++||+|||+.   +|+||||||+|||++ ++.+||+|||+++......   ...
T Consensus       115 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~  189 (319)
T 2y4i_B          115 TLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED  189 (319)
T ss_dssp             EHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CC
T ss_pred             cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccccc
Confidence            999999752 34689999999999999999999998   999999999999998 6799999999987653211   112


Q ss_pred             ccccccCCCCccCcccccc---------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          724 VSTVVAGTPGYLDPEYYTS---------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~---------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ......|+..|+|||.+..         ..++.++||||||+++|||++|+.||.........       ..+..+....
T Consensus       190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~  262 (319)
T 2y4i_B          190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-------WQMGTGMKPN  262 (319)
T ss_dssp             SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-------HHHHTTCCCC
T ss_pred             ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHhccCCCCC
Confidence            2233458899999999874         45788999999999999999999999876654321       1112222111


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhcCC
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARANS  850 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~~~  850 (878)
                      .....        ....+.+++.+||+.+|++||+++++++.|+++..........
T Consensus       263 ~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~  310 (319)
T 2y4i_B          263 LSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP  310 (319)
T ss_dssp             CCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred             CCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence            11111        1225778999999999999999999999999987665444433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-36  Score=330.88  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=183.7

Q ss_pred             hhcccccccccEEEEEEEE--cceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||.||+++.  .++.||||++.... ....+.+.+|++++.+++||||+++++++...+..++||||+++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   97 (303)
T 2vwi_A           18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG   97 (303)
T ss_dssp             EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred             hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence            4568999999999999987  45889999987543 33456789999999999999999999999999999999999999


Q ss_pred             CChhhhhccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          646 GNLQEYLSDI------SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       646 gsL~~~l~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      ++|.+++...      ....+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            9999998642      245699999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CC---CcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc-
Q 002809          720 AN---THVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS-  794 (878)
Q Consensus       720 ~~---~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~-  794 (878)
                      ..   ........|++.|+|||.+.+ ..++.++||||||++++||++|+.||..........      .... +.... 
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~-~~~~~~  247 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQ-NDPPSL  247 (303)
T ss_dssp             -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHT-SSCCCT
T ss_pred             CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhc-cCCCcc
Confidence            21   112234568999999999875 568999999999999999999999998765533211      1111 11111 


Q ss_pred             ---ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 ---IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 ---iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                         ..++....    .....+.+++.+||+.+|++||+++|+++
T Consensus       248 ~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          248 ETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence               11111111    22346789999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=326.16  Aligned_cols=246  Identities=26%  Similarity=0.460  Sum_probs=193.8

Q ss_pred             hhcccccccccEEEEEEEE--cceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccC------CCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDE------DNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~------~~~~~lV  639 (878)
                      .+.+.||+|+||.||+|+.  .++.||||++..... ..+.+.+|+.++.++ +||||+++++++..      .+..++|
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv  105 (326)
T 2x7f_A           27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV  105 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence            4568999999999999998  458899999875432 347889999999999 79999999999865      5678999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++|+|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  182 (326)
T 2x7f_A          106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  182 (326)
T ss_dssp             EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred             EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence            9999999999999876567799999999999999999999998   9999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      .  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||..........       .+.......
T Consensus       183 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~  253 (326)
T 2x7f_A          183 V--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LIPRNPAPR  253 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCCCC
T ss_pred             c--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-------HhhcCcccc
Confidence            1  1223356899999999987     5678999999999999999999999998765433211       111111111


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ....        .....+.+++.+||..+|++||+++|+++
T Consensus       254 ~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          254 LKSK--------KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CSCS--------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCcc--------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111        12246789999999999999999999988

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.1e-35  Score=325.86  Aligned_cols=259  Identities=17%  Similarity=0.275  Sum_probs=203.5

Q ss_pred             hhhcccccccccEEEEEEEE---cceeEEEEEeccCChhhHHHHHHHHHHHHHhcccc------eeeeeecccCCCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRL---NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN------LTSLVGHCDEDNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~---~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~n------Iv~l~g~~~~~~~~~l  638 (878)
                      +.+.+.||+|+||.||++..   .++.||||++... ....+.+.+|++++.+++|++      ++++++++...+..++
T Consensus        16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l   94 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI   94 (339)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence            45678999999999999986   3488999999754 344577899999999998775      9999999999999999


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-----------------
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-----------------  701 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-----------------  701 (878)
                      ||||+ +++|.+++.......+++..+..++.|+++||+|||+.   +|+||||||+|||++.                 
T Consensus        95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            99999 89999999875556799999999999999999999998   9999999999999987                 


Q ss_pred             --CCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002809          702 --KLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI  779 (878)
Q Consensus       702 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  779 (878)
                        ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||+++||++|+.||......+....
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  245 (339)
T 1z57_A          171 LINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM  245 (339)
T ss_dssp             ESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred             ccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence              678999999999764322     2235689999999999999999999999999999999999999987765443222


Q ss_pred             HHHHHH-----HHhcCCcccccC--------------------Cccc--cccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002809          780 RQWVNS-----LIAKGDIKSIVD--------------------PRLQ--EDFDANSVWKAVELAMACLSPTGNQRPTMSQ  832 (878)
Q Consensus       780 ~~~v~~-----~~~~~~~~~iid--------------------~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e  832 (878)
                      ......     ............                    ..+.  ..........+.+++.+||+.||++|||++|
T Consensus       246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  325 (339)
T 1z57_A          246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE  325 (339)
T ss_dssp             HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence            111100     000000000000                    0000  0112345678899999999999999999999


Q ss_pred             HHHH
Q 002809          833 VVME  836 (878)
Q Consensus       833 vl~~  836 (878)
                      +++.
T Consensus       326 ll~h  329 (339)
T 1z57_A          326 ALKH  329 (339)
T ss_dssp             HTTS
T ss_pred             HhcC
Confidence            9863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.6e-37  Score=344.12  Aligned_cols=241  Identities=18%  Similarity=0.177  Sum_probs=185.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC---ChhhHHHHHHHH---HHHHHhcccceeeee-------ecccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS---SAQGFQQFQAEV---KLLMRVHHRNLTSLV-------GHCDED  633 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ei---~~L~~l~H~nIv~l~-------g~~~~~  633 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++...   .....+.+.+|+   +.+++++||||++++       +++...
T Consensus        76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~  155 (377)
T 3byv_A           76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  155 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred             EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence            34678999999999999864  589999999743   344567899999   455556899999998       444433


Q ss_pred             C-----------------cceeEeeeccCCChhhhhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 002809          634 N-----------------QTALIYEFMANGNLQEYLSDIS-----KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRD  691 (878)
Q Consensus       634 ~-----------------~~~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrD  691 (878)
                      +                 ..++||||+ +|+|.+++....     ...+++..++.++.||++||+|||+.   +|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD  231 (377)
T 3byv_A          156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY  231 (377)
T ss_dssp             TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            2                 378999999 689999997532     12344688899999999999999998   999999


Q ss_pred             CCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccC-----------CCCCccchhhHHHHHHH
Q 002809          692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN-----------RLTEKSDVYSFGVVILE  760 (878)
Q Consensus       692 LKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----------~~t~ksDV~S~Gvvl~e  760 (878)
                      |||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||++||
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999999999999999985321     2234567 999999999887           89999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHH
Q 002809          761 IITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM--ELS  838 (878)
Q Consensus       761 lltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~--~L~  838 (878)
                      |++|+.||.......               ....+.. ..     ......+.+++.+||+.||++||++.|+++  .++
T Consensus       306 lltg~~Pf~~~~~~~---------------~~~~~~~-~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  364 (377)
T 3byv_A          306 IWCADLPITKDAALG---------------GSEWIFR-SC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  364 (377)
T ss_dssp             HHHSSCCC------C---------------CSGGGGS-SC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred             HHHCCCCCccccccc---------------chhhhhh-hc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence            999999996543211               1111111 00     112346789999999999999999999997  344


Q ss_pred             HH
Q 002809          839 EC  840 (878)
Q Consensus       839 ~~  840 (878)
                      ++
T Consensus       365 ~~  366 (377)
T 3byv_A          365 QL  366 (377)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-35  Score=357.88  Aligned_cols=256  Identities=25%  Similarity=0.365  Sum_probs=205.6

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|+...     ..||||++... .....+.|.+|+.++.+++||||+++++++. ++..++|||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E  470 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME  470 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence            3456789999999999998742     56999998764 3445578999999999999999999999985 456899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.++++.. ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       471 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~-  545 (656)
T 2j0j_A          471 LCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-  545 (656)
T ss_dssp             CCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             cCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc-
Confidence            99999999999752 44689999999999999999999998   99999999999999999999999999998764322 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.   ...    +..+...       
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~----i~~~~~~-------  611 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----IENGERL-------  611 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----HHHTCCC-------
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHcCCCC-------
Confidence            122233457789999999998899999999999999999997 9999987655431   111    1112111       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM  845 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~  845 (878)
                        ..+......+.+++.+||+.+|++||++.|+++.|++++..+.
T Consensus       612 --~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k  654 (656)
T 2j0j_A          612 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  654 (656)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence              1122233578899999999999999999999999999987764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.7e-36  Score=331.73  Aligned_cols=255  Identities=21%  Similarity=0.310  Sum_probs=202.9

Q ss_pred             hhhcccccccccEEEEEEEEcceeEEEEEeccCChh-----------------hHHHHHHHHHHHHHhcccceeeeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQ-----------------GFQQFQAEVKLLMRVHHRNLTSLVGHC  630 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~  630 (878)
                      +.+.+.||+|+||.||+++..++.||||++......                 ..+.+.+|++++.+++||||+++++++
T Consensus        33 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  112 (348)
T 2pml_X           33 YRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII  112 (348)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred             eEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            345689999999999999997799999998753221                 127899999999999999999999999


Q ss_pred             cCCCcceeEeeeccCCChhhh------hccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcCCC
Q 002809          631 DEDNQTALIYEFMANGNLQEY------LSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       631 ~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      ...+..++||||+++|+|.++      +.......+++..++.++.|++.||+|||+ .   +|+||||||+||+++.++
T Consensus       113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTS
T ss_pred             eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCC
Confidence            999999999999999999999      655446789999999999999999999998 7   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccC-CCCC-ccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN-RLTE-KSDVYSFGVVILEIITCKPAISRINEEEKIHIRQ  781 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  781 (878)
                      .+||+|||++......    ......|+..|+|||.+.+. .++. ++||||||++++||++|+.||.......  .+. 
T Consensus       190 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~-  262 (348)
T 2pml_X          190 RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--ELF-  262 (348)
T ss_dssp             CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HHH-
T ss_pred             cEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHH-
Confidence            9999999999865332    22345689999999999877 6666 9999999999999999999998765421  111 


Q ss_pred             HHHHHHhcCCcccccC------Cccc---cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          782 WVNSLIAKGDIKSIVD------PRLQ---EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       782 ~v~~~~~~~~~~~iid------~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                         ..+..+...-..+      +...   ..........+.+++.+||+.+|++||+++|+++
T Consensus       263 ---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          263 ---NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ---HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               1122222111000      0000   0001223457889999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-35  Score=331.49  Aligned_cols=247  Identities=24%  Similarity=0.412  Sum_probs=199.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh--------hhHHHHHHHHHHHHHh-cccceeeeeecccCCCcc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA--------QGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQT  636 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--------~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~  636 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.....        ...+.+.+|+.++.++ +||||+++++++......
T Consensus        96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  175 (365)
T 2y7j_A           96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM  175 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred             cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence            344589999999999999985  58999999875431        1245688999999999 799999999999999999


Q ss_pred             eeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      ++||||+++++|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..+
T Consensus       176 ~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          176 FLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             EEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            999999999999999975  45799999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCCcccccccCCCCccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTS------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      ....   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||.........       ..+..+
T Consensus       251 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-------~~i~~~  320 (365)
T 2y7j_A          251 EPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML-------RMIMEG  320 (365)
T ss_dssp             CTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHT
T ss_pred             CCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhC
Confidence            4332   2234579999999999863      35888999999999999999999999876543211       111112


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .... ..+. .    ......+.+++.+||+.+|++||+++|+++
T Consensus       321 ~~~~-~~~~-~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          321 QYQF-SSPE-W----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CCCC-CHHH-H----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC-CCcc-c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1100 0000 0    012246789999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-35  Score=334.47  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=200.9

Q ss_pred             HHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc--------ccceeeeeeccc----
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH--------HRNLTSLVGHCD----  631 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~--------H~nIv~l~g~~~----  631 (878)
                      -.+.+.+.||+|+||.||+|+..  ++.||||++... ....+.+.+|++++++++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            34566789999999999999875  488999999754 344578899999999996        788999999987    


Q ss_pred             CCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC--------
Q 002809          632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL--------  703 (878)
Q Consensus       632 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~--------  703 (878)
                      .....++||||+ +++|.+++.......+++..++.++.||++||+|||+++  +|+||||||+|||++.++        
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence            566899999999 667777776545567999999999999999999999854  899999999999999775        


Q ss_pred             -----------------------------------------cEEEeecCCccccccCCCCcccccccCCCCccCcccccc
Q 002809          704 -----------------------------------------QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS  742 (878)
Q Consensus       704 -----------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~  742 (878)
                                                               .+||+|||+++.....     .....||..|+|||++.+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHT
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcC
Confidence                                                     7999999999866432     223468999999999999


Q ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHHHHHh--------cCCc-ccccCC----------c
Q 002809          743 NRLTEKSDVYSFGVVILEIITCKPAISRINEEE----KIHIRQWVNSLIA--------KGDI-KSIVDP----------R  799 (878)
Q Consensus       743 ~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~----~~~l~~~v~~~~~--------~~~~-~~iid~----------~  799 (878)
                      ..++.++|||||||++|||++|+.||.......    ...+.. +.....        .+.. .+.+..          .
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL-IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHH-HHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHH-HHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            999999999999999999999999997654221    111111 111110        0110 001100          0


Q ss_pred             c---------ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          800 L---------QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       800 l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .         ....+......+.+++.+||+.||++|||++|+++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0         00124556678899999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5e-36  Score=342.86  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=189.6

Q ss_pred             HHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCC--------hhhHHHHHHHHHHHHHhcccceeeeeecccCCCc
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS--------AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQ  635 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~--------~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~  635 (878)
                      ..+.+.+.||+|+||.||+|....  +.||||++....        ......+.+|+++|++++||||+++++++.. +.
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            345567899999999999998754  789999987532        1123358899999999999999999999864 45


Q ss_pred             ceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---cEEEeecCC
Q 002809          636 TALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---QAKLADFGL  712 (878)
Q Consensus       636 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~DFGl  712 (878)
                      .++||||+++|+|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++   .+||+|||+
T Consensus       214 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             eEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence            7899999999999999875  56799999999999999999999998   999999999999997544   599999999


Q ss_pred             ccccccCCCCcccccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTS---NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      ++.....   .......||+.|+|||++.+   ..++.++|||||||++|||++|++||........  +.    ..+..
T Consensus       289 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~----~~i~~  359 (419)
T 3i6u_A          289 SKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQITS  359 (419)
T ss_dssp             TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH----HHHHT
T ss_pred             ceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH----HHHhc
Confidence            9876432   22334679999999999853   5688899999999999999999999976543211  11    11112


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +....  .+...    ......+.+++.+||+.+|++||+++|+++.
T Consensus       360 ~~~~~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          360 GKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             TCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCC--Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            21110  00000    1123468899999999999999999999873

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.7e-36  Score=331.80  Aligned_cols=264  Identities=23%  Similarity=0.312  Sum_probs=198.0

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccC--------CCc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--------DNQ  635 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--------~~~  635 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++....  ......+.+|++++++++||||+++++++..        .+.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   98 (351)
T 3mi9_A           19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   98 (351)
T ss_dssp             EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred             eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence            455689999999999999984  4889999986543  2235678899999999999999999999876        446


Q ss_pred             ceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          636 TALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       636 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      .++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        99 ~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           99 IYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             EEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence            8999999975 777777542 34699999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCC--CcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc
Q 002809          716 FATDAN--THVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI  792 (878)
Q Consensus       716 ~~~~~~--~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  792 (878)
                      +.....  ........||+.|+|||++.+ ..++.++|||||||+++||++|++||........................
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            642221  122234568999999999876 45899999999999999999999999887654432221111110000000


Q ss_pred             ccccCCcccc--------ccC-HHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 KSIVDPRLQE--------DFD-ANS------VWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 ~~iid~~l~~--------~~~-~~~------~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...-+.....        ... ...      ...+.+++.+||+.||++|||++|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            1100000000        000 011      2357899999999999999999999873

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-35  Score=341.11  Aligned_cols=198  Identities=25%  Similarity=0.336  Sum_probs=172.9

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHh------cccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRV------HHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l------~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|+...  +.||||++... ....+.+.+|++++..+      +|+||+++++++...+..++|
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  177 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT  177 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence            4567899999999999998754  88999999754 33446788899999888      467999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc--EEEeecCCccccc
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ--AKLADFGLSKSFA  717 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~  717 (878)
                      |||+. ++|.+++.......+++..++.++.||++||+|||+.   +|+||||||+|||++.++.  +||+|||+++...
T Consensus       178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~  253 (429)
T 3kvw_A          178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH  253 (429)
T ss_dssp             ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence            99995 6999999876666799999999999999999999998   9999999999999999987  9999999997543


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE  775 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  775 (878)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|++||......+
T Consensus       254 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          254 QR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             CC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             Cc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            22     223568999999999999999999999999999999999999998876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-35  Score=345.01  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=200.5

Q ss_pred             HHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      ..+.+.+.||+|+||.||+++..  +..||+|++....  ......+.+|+.++++++||||+++++++......++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34567789999999999999985  4789999987643  3345788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC---CcEEEeecCCcccccc
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKSFAT  718 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~~~~~  718 (878)
                      |+++|+|.+++..  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.+   +.+||+|||+++.+..
T Consensus       117 ~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          117 CYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999998875  45699999999999999999999998   99999999999999764   4599999999987643


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ..   ......||+.|+|||++. ..++.++||||+||++|||++|++||......+..       ..+..+...  .+.
T Consensus       192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~--~~~  258 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL-------RKVEKGKYT--FDS  258 (494)
T ss_dssp             TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCC--CCS
T ss_pred             Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC--CCc
Confidence            22   223456999999999986 46999999999999999999999999877654321       112222211  011


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME--LSEC  840 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~--L~~~  840 (878)
                      ...    ......+.+++.+||+.+|++|||++|+++.  +++.
T Consensus       259 ~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          259 PEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             GGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             hhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            111    1123467899999999999999999999974  5543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-35  Score=330.36  Aligned_cols=259  Identities=25%  Similarity=0.336  Sum_probs=197.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChh-----hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ-----GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-----~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++......     ..+.+.+|++++.+++||||+++++++...+..++||
T Consensus        12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (346)
T 1ua2_A           12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   91 (346)
T ss_dssp             -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence            455689999999999999885  478999998753221     2346889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++ +|.+++.. ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        92 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           92 DFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             ECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            99975 88888865 245688999999999999999999998   99999999999999999999999999998764322


Q ss_pred             CCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC---cccc-
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD---IKSI-  795 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~---~~~i-  795 (878)
                        .......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+.  +...... .....   .... 
T Consensus       167 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~-~~~~~~~~~~~~~  241 (346)
T 1ua2_A          167 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFET-LGTPTEEQWPDMC  241 (346)
T ss_dssp             --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH-HCCCCTTTSSSTT
T ss_pred             --ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHH-cCCCChhhhhhhc
Confidence              222345689999999999754 588999999999999999999999987665332  1111111 11100   0000 


Q ss_pred             -----cCCccccccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          796 -----VDPRLQEDFD-----ANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       796 -----id~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                           +...-....+     ......+.+++.+||+.+|++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                 0000000001     1223578899999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.9e-36  Score=342.15  Aligned_cols=194  Identities=23%  Similarity=0.388  Sum_probs=162.8

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC-----Cccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED-----NQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~l  638 (878)
                      +.+.+.||+|+||.||+|+...  +.||||++...  .....+.+.+|+++|++++||||+++++++...     ...++
T Consensus        28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  107 (432)
T 3n9x_A           28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI  107 (432)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence            4557899999999999998754  78999999753  344567899999999999999999999998765     57899


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||++ |+|.++++.  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       108 v~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          108 VLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             EEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             EEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            999986 699999975  56799999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCC--------------------cccccccCCCCccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCC
Q 002809          719 DANT--------------------HVSTVVAGTPGYLDPEYY-TSNRLTEKSDVYSFGVVILEIITCKPA  767 (878)
Q Consensus       719 ~~~~--------------------~~~~~~~gt~~Y~APE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p  767 (878)
                      ....                    .......||+.|+|||++ ....++.++|||||||+++||++|..|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            3211                    112456799999999986 566799999999999999999985443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-35  Score=348.50  Aligned_cols=248  Identities=22%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.||+|+||.||+++..  ++.||+|++.+...   ...+.+.+|++++.+++||||+++++++...+..++||||++
T Consensus       189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~  268 (543)
T 3c4z_A          189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN  268 (543)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence            3578999999999999985  48899999975422   234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +|+|.+++....  ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-  344 (543)
T 3c4z_A          269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-  344 (543)
T ss_dssp             TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-
Confidence            999999997643  45799999999999999999999998   999999999999999999999999999987643321 


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                       .....+||+.|+|||++.+..++.++|||||||++|||++|++||........  ..+...... .+..      .   
T Consensus       345 -~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~-~~~~------~---  411 (543)
T 3c4z_A          345 -KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVL-EQAV------T---  411 (543)
T ss_dssp             -CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHH-HCCC------C---
T ss_pred             -ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHh-hccc------C---
Confidence             22345799999999999999999999999999999999999999986532110  111111111 1111      1   


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTM-----SQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm-----~evl~  835 (878)
                       ++......+.+++.+||+.+|++||++     +++++
T Consensus       412 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          412 -YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             112223467899999999999999975     56654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8e-36  Score=326.91  Aligned_cols=248  Identities=21%  Similarity=0.349  Sum_probs=192.8

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccC--ChhhHHHHHHHHHHHHHhc--ccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVH--HRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++..+ +.||||++...  .....+.+.+|++++.+++  |+||+++++++..++..++||| 
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-  108 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  108 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence            3456899999999999998765 78999998754  3445678999999999997  4999999999999999999999 


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +.+++|.+++..  ...+++..++.++.|+++||.|||+.   +|+||||||+|||+++ +.+||+|||+++........
T Consensus       109 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          109 CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            568899999976  45789999999999999999999998   9999999999999965 89999999999876443332


Q ss_pred             cccccccCCCCccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          723 HVSTVVAGTPGYLDPEYYTS-----------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      .......|++.|+|||.+.+           ..++.++||||||++++||++|+.||........ .    .......  
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~----~~~~~~~--  255 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K----LHAIIDP--  255 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHHHHCT--
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-H----HHHHHhc--
Confidence            23334568999999999875           4688899999999999999999999976543211 1    1111111  


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                             .....++......+.+++.+||+.+|++||+++|+++.
T Consensus       256 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          256 -------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                   11111111223467899999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-35  Score=318.41  Aligned_cols=244  Identities=23%  Similarity=0.371  Sum_probs=193.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++....   ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY   92 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence            345689999999999999985  5889999987542   22356789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.+++..  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.......  
T Consensus        93 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  165 (276)
T 2h6d_A           93 VSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  165 (276)
T ss_dssp             CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             cCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence            999999999976  45689999999999999999999998   99999999999999999999999999997654321  


Q ss_pred             cccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       ......|++.|+|||.+.+..+ +.++||||||++++||++|+.||.........       ..+..+..      .+ 
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~------~~-  230 (276)
T 2h6d_A          166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF-------KKIRGGVF------YI-  230 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CC-
T ss_pred             -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-------HHhhcCcc------cC-
Confidence             1233468999999999987765 68999999999999999999999876543211       11122211      01 


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         +......+.+++.+||+.+|++||+++|+++.
T Consensus       231 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          231 ---PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               11122467899999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-35  Score=345.56  Aligned_cols=249  Identities=27%  Similarity=0.381  Sum_probs=204.2

Q ss_pred             HHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      ..+.+.+.||+|+||.||+++..  ++.||||++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            45667789999999999999885  4889999986542   334678999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE---cCCCcEEEeecCCccccc
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL---NEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~  717 (878)
                      ||+.+|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       106 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          106 EVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             CCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999875  56799999999999999999999998   99999999999999   567899999999998764


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ...   ......||+.|+|||++.+ .++.++||||+||++|||++|++||......+..       ..+..+...-  .
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~--~  247 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-------KKVEKGKYTF--E  247 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCC--C
T ss_pred             ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCCCC--C
Confidence            322   2233569999999999876 6999999999999999999999999876654321       1122222110  0


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          ..........+.+++.+||+.+|++|||++|+++.
T Consensus       248 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          248 ----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                00111233467899999999999999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.6e-35  Score=343.47  Aligned_cols=250  Identities=27%  Similarity=0.384  Sum_probs=202.0

Q ss_pred             HHHhhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          565 KITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       565 ~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      ...+.+.+.||+|+||.||+++..  ++.||||++...  .......+.+|++++++++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            345677899999999999999985  488999998643  2234578899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc---CCCcEEEeecCCccccc
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFA  717 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~  717 (878)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||+++.+.
T Consensus       101 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          101 ELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999875  45699999999999999999999998   999999999999995   45679999999998664


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ...   ......||+.|+|||++.+ .++.++||||+||++|||++|++||......+..       ..+..+....  +
T Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~--~  242 (486)
T 3mwu_A          176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-------KRVETGKYAF--D  242 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCS--C
T ss_pred             CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCC--C
Confidence            322   2234569999999999876 5899999999999999999999999876654321       1122222110  0


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .    .........+.+++.+||+.+|++|||+.|+++.
T Consensus       243 ~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 L----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             S----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             C----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0    0011223467899999999999999999999874

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.4e-35  Score=318.16  Aligned_cols=246  Identities=26%  Similarity=0.367  Sum_probs=200.0

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccCC---------hhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcc
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSS---------AQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQT  636 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---------~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~  636 (878)
                      .+.+.||+|+||.||+++...  +.||||++....         ....+.+.+|++++.+++ ||||+++++++..++..
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   99 (298)
T 1phk_A           20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   99 (298)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence            456889999999999999853  889999997543         123467889999999996 99999999999999999


Q ss_pred             eeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      ++||||+++++|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       100 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A          100 FLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            999999999999999976  45799999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCCcccccccCCCCccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYT------SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      ....   ......|++.|+|||++.      ...++.++||||||++++||++|+.||.........       ..+..+
T Consensus       175 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~  244 (298)
T 1phk_A          175 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMIMSG  244 (298)
T ss_dssp             CTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHT
T ss_pred             CCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH-------HHHhcC
Confidence            4322   223356899999999985      456889999999999999999999999876543211       111112


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ... ...+     ........+.+++.+||+.+|++||+++|+++
T Consensus       245 ~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Ccc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111 0001     11123346889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8e-36  Score=324.63  Aligned_cols=248  Identities=21%  Similarity=0.397  Sum_probs=196.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..  +..||+|++........+.+.+|++++.+++||||+++++++..++..++||||+++
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG  100 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred             eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence            345688999999999999986  478999999877666678899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++... ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++.......  ...
T Consensus       101 ~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  174 (302)
T 2j7t_A          101 GAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKR  174 (302)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-
T ss_pred             CcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--ccc
Confidence            9999998652 45699999999999999999999998   99999999999999999999999999875432111  112


Q ss_pred             ccccCCCCccCcccc-----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          726 TVVAGTPGYLDPEYY-----TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~-----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ....|+..|+|||++     ....++.++||||||++++||++|+.||........      ...... +......    
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~~~----  243 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK-SDPPTLL----  243 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SCCCCCS----
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhc-cCCcccC----
Confidence            234689999999998     366789999999999999999999999987664321      111111 1111111    


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                         .+......+.+++.+||+.+|++||+++|+++
T Consensus       244 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          244 ---TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ---CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               11122346789999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.2e-35  Score=320.97  Aligned_cols=246  Identities=25%  Similarity=0.395  Sum_probs=198.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..  ++.||+|++....  ..+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus        31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  108 (314)
T 3com_A           31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA  108 (314)
T ss_dssp             EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence            455689999999999999986  4889999997643  346789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      ++|.+++.. ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......  ...
T Consensus       109 ~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~  182 (314)
T 3com_A          109 GSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKR  182 (314)
T ss_dssp             EEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCB
T ss_pred             CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--ccc
Confidence            999999863 245799999999999999999999998   99999999999999999999999999997664322  122


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....|+..|+|||.+.+..++.++||||||++++||++|+.||..........       ...........       .+
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~-------~~  248 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-------MIPTNPPPTFR-------KP  248 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCCCCCS-------SG
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHhcCCCcccC-------Cc
Confidence            33568999999999999999999999999999999999999998765433211       11111111110       01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            112346789999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.7e-35  Score=321.20  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=195.9

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccC--CCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDE--DNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~--~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++....   .+.+.+|++++.+++ ||||+++++++..  ....++||||
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            345689999999999999874  4889999997543   467899999999997 9999999999987  6678999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDAN  721 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~  721 (878)
                      +++++|.+++..     +++..+..++.|+++||+|||+.   +|+||||||+|||++.++ .+||+|||+++.......
T Consensus       115 ~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~  186 (330)
T 3nsz_A          115 VNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE  186 (330)
T ss_dssp             CCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             cCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence            999999999854     88999999999999999999998   999999999999999777 899999999987643322


Q ss_pred             CcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH--------HHHhcCCc
Q 002809          722 THVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVN--------SLIAKGDI  792 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~--------~~~~~~~~  792 (878)
                         .....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||........ .+.....        ..+.....
T Consensus       187 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          187 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHhcc
Confidence               233568999999999877 6789999999999999999999999965433211 1111110        01111100


Q ss_pred             c------cc--------cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          793 K------SI--------VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       793 ~------~i--------id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .      +.        ...............++.+++.+||+.||++|||++|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0      00        00000011111234578899999999999999999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.8e-36  Score=337.22  Aligned_cols=249  Identities=12%  Similarity=0.059  Sum_probs=178.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHh--cccceeeeee-------cccCC-
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRV--HHRNLTSLVG-------HCDED-  633 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l--~H~nIv~l~g-------~~~~~-  633 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++.....   ...+.+.+|++++..+  +||||++++.       .+... 
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~  144 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS  144 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred             eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence            45689999999999999975  48899999987543   3456778886666555  5999888553       22221 


Q ss_pred             ----------------CcceeEeeeccCCChhhhhccccCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEecC
Q 002809          634 ----------------NQTALIYEFMANGNLQEYLSDISKKVLSSQER------LRIAVESAQGLEYLHNGCKPPIVHRD  691 (878)
Q Consensus       634 ----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~ivHrD  691 (878)
                                      ...++||||++ |+|.+++.... ..+++..+      ..++.||++||+|||++   +|+|||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD  219 (371)
T 3q60_A          145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH  219 (371)
T ss_dssp             SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence                            33799999998 89999997642 23456666      78889999999999998   999999


Q ss_pred             CCCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 002809          692 VKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAIS  769 (878)
Q Consensus       692 LKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~  769 (878)
                      |||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999865321     113456799999999987  679999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          770 RINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       770 ~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .........        .............+...........+.+++.+||+.+|++||+++|+++
T Consensus       295 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          295 LVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             BCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            764321100        0000000011111111111233457889999999999999999999976

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-35  Score=356.72  Aligned_cols=244  Identities=23%  Similarity=0.346  Sum_probs=201.9

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccC---ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS---SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+++..+  +.||||++.+.   .....+.+..|..++..+ +||+|+++++++...+..++|||
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E  422 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  422 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence            3456899999999999999865  67999999753   223456788999999988 79999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.++++.  ...+++..++.++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++...... 
T Consensus       423 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-  496 (674)
T 3pfq_A          423 YVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-  496 (674)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred             CcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence            9999999999986  45699999999999999999999998   99999999999999999999999999998643222 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+..+.      .. .+.++.+         
T Consensus       497 -~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------~~-~i~~~~~---------  559 (674)
T 3pfq_A          497 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQ-SIMEHNV---------  559 (674)
T ss_dssp             -CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH-HHHSSCC---------
T ss_pred             -cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------HH-HHHhCCC---------
Confidence             223456799999999999999999999999999999999999999987665331      11 1112211         


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTM-----SQVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm-----~evl~  835 (878)
                       .++.....++.+|+.+||+.+|++||++     +||++
T Consensus       560 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence             1122233468899999999999999998     66654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.6e-35  Score=343.83  Aligned_cols=247  Identities=29%  Similarity=0.396  Sum_probs=198.5

Q ss_pred             hhhcccccccccEEEEEEEEcc--eeEEEEEeccCCh-------------hhHHHHHHHHHHHHHhcccceeeeeecccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA-------------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDE  632 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~-------------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~  632 (878)
                      +.+.+.||+|+||.||+++...  ..||+|++.....             ...+.+.+|++++++++||||+++++++..
T Consensus        38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  117 (504)
T 3q5i_A           38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED  117 (504)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4556899999999999999854  7899999875421             234678999999999999999999999999


Q ss_pred             CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC---cEEEee
Q 002809          633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL---QAKLAD  709 (878)
Q Consensus       633 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~---~~kL~D  709 (878)
                      ....++||||+++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .+||+|
T Consensus       118 ~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          118 KKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             CCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            9999999999999999999875  45699999999999999999999998   999999999999999876   699999


Q ss_pred             cCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc
Q 002809          710 FGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK  789 (878)
Q Consensus       710 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~  789 (878)
                      ||+++.+....   ......||+.|+|||++. ..++.++||||+||++|+|++|++||......+..       ..+..
T Consensus       193 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~  261 (504)
T 3q5i_A          193 FGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII-------KKVEK  261 (504)
T ss_dssp             CTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHH
T ss_pred             CCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHc
Confidence            99998764332   223456999999999987 46999999999999999999999999876654321       11222


Q ss_pred             CCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       790 ~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +....  +....    .....++.+++.+||+.+|.+|||++|+++.
T Consensus       262 ~~~~~--~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          262 GKYYF--DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCCC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCC--Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            22110  00000    1123468899999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.3e-35  Score=324.76  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=195.2

Q ss_pred             HHHhhhcccccccccEEEEEEEEcc--eeEEEEEeccCCh--------hhHHHHHHHHHHHHHhcccceeeeeecccCCC
Q 002809          565 KITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSA--------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN  634 (878)
Q Consensus       565 ~~t~~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~--------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~  634 (878)
                      .-.+.+.+.||+|+||.||+|+...  +.||||++.....        .....+.+|++++.+++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            3456677899999999999998754  8899999875421        22346889999999999999999999987655


Q ss_pred             cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc---EEEeecC
Q 002809          635 QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ---AKLADFG  711 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~---~kL~DFG  711 (878)
                       .++||||+++|+|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.   +||+|||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             -eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence             8999999999999999875  56799999999999999999999998   9999999999999987664   9999999


Q ss_pred             CccccccCCCCcccccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA  788 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~  788 (878)
                      +++.....   .......|++.|+|||++.   ...++.++|||||||++|||++|+.||........  +..    .+.
T Consensus       163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~~~  233 (322)
T 2ycf_A          163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----QIT  233 (322)
T ss_dssp             TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----HHH
T ss_pred             cceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----HHH
Confidence            99865322   2223456899999999974   56789999999999999999999999976543211  111    111


Q ss_pred             cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       789 ~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .+....  .+...    ......+.+++.+||+.+|++||+++|+++
T Consensus       234 ~~~~~~--~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SGKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HTCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCcccc--Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            121110  00111    112346789999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-35  Score=332.75  Aligned_cols=256  Identities=20%  Similarity=0.254  Sum_probs=194.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC-------------
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-------------  632 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-------------  632 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.....    ...+|+++++.++||||+++++++..             
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            455689999999999999874  48899999875432    23479999999999999999998833             


Q ss_pred             -------------------------CCcceeEeeeccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 002809          633 -------------------------DNQTALIYEFMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKP  685 (878)
Q Consensus       633 -------------------------~~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~  685 (878)
                                               ....++||||++ |+|.+.+...  ....+++..+..++.|+++||+|||+.   
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---  160 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---  160 (383)
T ss_dssp             -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence                                     334789999998 5888877642  356799999999999999999999998   


Q ss_pred             CeEecCCCCccEEEc-CCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHh
Q 002809          686 PIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIIT  763 (878)
Q Consensus       686 ~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~ellt  763 (878)
                      +|+||||||+|||++ .++.+||+|||+++.+....   ......||..|+|||++.+. .++.++||||+||+++||++
T Consensus       161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            999999999999998 68899999999998764332   22335689999999998765 58999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHHH--------h-cC-----CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCC
Q 002809          764 CKPAISRINEEEKIHIRQWVNSLI--------A-KG-----DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT  829 (878)
Q Consensus       764 G~~p~~~~~~~~~~~l~~~v~~~~--------~-~~-----~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  829 (878)
                      |++||......+..  ...+...-        . ..     .........+...++......+.+++.+||+.+|++|||
T Consensus       238 g~~pf~~~~~~~~~--~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          238 GKPLFSGETSIDQL--VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             SSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             CCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99999886654322  11111000        0 00     011111111111122334456889999999999999999


Q ss_pred             HHHHHHH
Q 002809          830 MSQVVME  836 (878)
Q Consensus       830 m~evl~~  836 (878)
                      +.|+++.
T Consensus       316 ~~e~l~h  322 (383)
T 3eb0_A          316 PYEAMAH  322 (383)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhcC
Confidence            9999863

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.9e-35  Score=329.96  Aligned_cols=259  Identities=22%  Similarity=0.351  Sum_probs=198.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCC-----CcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED-----NQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~lV  639 (878)
                      +.+.+.||+|+||.||+++..  +..||||++.... ....+.+.+|++++.+++||||+++++++...     ...++|
T Consensus        29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  108 (364)
T 3qyz_A           29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV  108 (364)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence            455689999999999999875  4889999997543 34457899999999999999999999998654     468999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      +||++ |+|.+++..   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       109 ~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          109 QDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            99997 599998864   4599999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCC-cccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc---cc
Q 002809          720 ANT-HVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI---KS  794 (878)
Q Consensus       720 ~~~-~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~---~~  794 (878)
                      ... .......||+.|+|||++.+ ..++.++|||||||+++||++|++||......+.....  . ........   ..
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~-~~~~~~~~~~~~~  258 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI--L-GILGSPSQEDLNC  258 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH--H-HHHCSCCHHHHHT
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH--H-HHhCCCCHHHHHH
Confidence            221 11234579999999998754 45899999999999999999999999876654322111  1 11000000   00


Q ss_pred             ------------ccCCc-c-ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 ------------IVDPR-L-QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 ------------iid~~-l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                                  ...+. . ..........++.+++.+||+.||++|||++|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                        00000 0 000111223468899999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.2e-35  Score=322.56  Aligned_cols=258  Identities=23%  Similarity=0.359  Sum_probs=198.7

Q ss_pred             hhhcccccccccEEEEEEEEc---ceeEEEEEeccCCh--hhHHHHHHHHHHHHHh---cccceeeeeeccc-----CCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN---EIDVAVKMLSSSSA--QGFQQFQAEVKLLMRV---HHRNLTSLVGHCD-----EDN  634 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~-----~~~  634 (878)
                      +.+.+.||+|+||.||+++..   ++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.     ...
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   92 (326)
T 1blx_A           13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   92 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence            345689999999999999873   47899999874322  2234567788877777   7999999999986     567


Q ss_pred             cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          635 QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       635 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ..++||||++ |+|.+++.......+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            7899999997 6999999876566799999999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC---
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD---  791 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~---  791 (878)
                      .....   .......|+..|+|||++.+..++.++|||||||++|||++|++||.........  ...+ .......   
T Consensus       169 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~i~-~~~~~~~~~~  242 (326)
T 1blx_A          169 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKIL-DVIGLPGEED  242 (326)
T ss_dssp             CCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHH-HHHCCCCGGG
T ss_pred             cccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHH-HHcCCCCccc
Confidence            65322   1223456899999999999999999999999999999999999999876654321  1111 1111000   


Q ss_pred             ccc-------ccC---CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          792 IKS-------IVD---PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       792 ~~~-------iid---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ...       .+.   ..............+.+++.+||+.+|++||+++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000       000   00001111223456789999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=324.89  Aligned_cols=259  Identities=23%  Similarity=0.331  Sum_probs=192.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeeccc--------------C
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCD--------------E  632 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--------------~  632 (878)
                      .+.+.||+|+||.||+|+..  ++.||+|++........+.+.+|++++++++||||+++++++.              .
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   93 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE   93 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence            45678999999999999986  4889999998877777889999999999999999999998763              4


Q ss_pred             CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc-CCCcEEEeecC
Q 002809          633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFG  711 (878)
Q Consensus       633 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~-~~~~~kL~DFG  711 (878)
                      ....++||||++ |+|.+++..   ..+++..++.++.|+++||+|||+.   +|+||||||+|||++ +++.+||+|||
T Consensus        94 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           94 LNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             CSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence            467899999997 699999864   5689999999999999999999998   999999999999997 56799999999


Q ss_pred             CccccccCCC-CcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh-
Q 002809          712 LSKSFATDAN-THVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA-  788 (878)
Q Consensus       712 la~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~-  788 (878)
                      +++....... ........++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+...  ........ 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~  244 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ--LILESIPVV  244 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHSCCC
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCC
Confidence            9987643211 111223457899999998865 678999999999999999999999998776533211  11110000 


Q ss_pred             --------cCCcccccCCccc------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          789 --------KGDIKSIVDPRLQ------EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       789 --------~~~~~~iid~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                              ...+...+.....      .........++.+++.+||+.+|++||+++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence                    0000000000000      00111234578899999999999999999999863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-35  Score=332.10  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=180.9

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCC------Cccee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~l  638 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|++++++++||||+++++++...      ...++
T Consensus        32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l  111 (367)
T 2fst_X           32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  111 (367)
T ss_dssp             EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence            45688999999999999864  488999998753  344567889999999999999999999998654      56799


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      |+|++ +++|.++++.   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       112 v~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          112 VTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             EEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             Eeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            99999 7899998864   5699999999999999999999998   999999999999999999999999999976532


Q ss_pred             CCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC---ccc
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD---IKS  794 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~---~~~  794 (878)
                      .     .....||..|+|||++.+ ..++.++|||||||+++||++|++||......+....   +........   +..
T Consensus       185 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          185 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLKK  256 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHTT
T ss_pred             c-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHHHHH
Confidence            1     233568999999999877 6789999999999999999999999987765432211   111111000   000


Q ss_pred             cc---------------CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IV---------------DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 ii---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.               ...+. .........+.+|+.+||+.||++|||++|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00               00000 0001123467899999999999999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.2e-36  Score=322.81  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=182.7

Q ss_pred             hhcccccccccEEEEEEEE--cceeEEEEEeccCC-hhh-HHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRL--NEIDVAVKMLSSSS-AQG-FQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~-~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++.  .++.||+|++.... ... .+.+.++...++.++||||+++++++..++..++||||++
T Consensus        10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (290)
T 3fme_A           10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD   89 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred             hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence            4568999999999999998  45889999997653 222 2334455556788899999999999999999999999997


Q ss_pred             CCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          645 NGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       645 ~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                       |+|.+++...  ....+++..++.++.|++.||+|||+++  +|+||||||+|||++.++.+||+|||+++......  
T Consensus        90 -~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  164 (290)
T 3fme_A           90 -TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV--  164 (290)
T ss_dssp             -EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred             -cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccc--
Confidence             5888887542  3567999999999999999999999842  89999999999999999999999999998664322  


Q ss_pred             cccccccCCCCccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          723 HVSTVVAGTPGYLDPEYY----TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                       ......|++.|+|||++    .+..++.++|||||||+++||++|+.||........ .+.    ....... ....  
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~~~~-~~~~--  235 (290)
T 3fme_A          165 -AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLK----QVVEEPS-PQLP--  235 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHH----HHHHSCC-CCCC--
T ss_pred             -cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHH----HHhccCC-CCcc--
Confidence             22234689999999996    566789999999999999999999999986433221 111    1111111 1110  


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                            ......++.+++.+||+.+|++|||++|+++
T Consensus       236 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          236 ------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                  1112346789999999999999999999988

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-34  Score=325.89  Aligned_cols=258  Identities=21%  Similarity=0.288  Sum_probs=190.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC------cce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN------QTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~  637 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|+.++++++||||+++++++...+      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            345689999999999999875  488999998753  3445678899999999999999999999987654      679


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||++ |+|.+.+.    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       107 lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          107 IVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             EEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            9999997 57888775    3489999999999999999999998   99999999999999999999999999998653


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH-H---------------
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR-Q---------------  781 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~---------------  781 (878)
                      ..   .......||+.|+|||++.+..++.++|||||||+++||++|+.||...+..+..... +               
T Consensus       179 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          179 TS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            22   1223356899999999999999999999999999999999999999876653321100 0               


Q ss_pred             HHHHHHhcCC------cccccCCccccc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          782 WVNSLIAKGD------IKSIVDPRLQED---FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       782 ~v~~~~~~~~------~~~iid~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .+........      ....+.......   ........+.+++.+||+.||++|||++|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0000000000      000000000000   011235678899999999999999999999884

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.7e-35  Score=325.39  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=196.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCC-----CcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED-----NQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++.... ......+.+|++++++++||||+++++++...     ...++||
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   93 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ   93 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred             EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence            45689999999999999986  5889999997543 34456788999999999999999999987654     6789999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||++ |+|.+++..   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        94 e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           94 ELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             CCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             eccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            9997 699998874   4699999999999999999999998   99999999999999999999999999998764322


Q ss_pred             CCc--------ccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          721 NTH--------VSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       721 ~~~--------~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      ...        ......||+.|+|||++.+ ..++.++|||||||+++||++|++||...........   +........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~  243 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL---IFGIIGTPH  243 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHHHhCCCc
Confidence            111        1123468999999998764 6789999999999999999999999988765432211   111111100


Q ss_pred             ----cccccCCc-------c---c----cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          792 ----IKSIVDPR-------L---Q----EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       792 ----~~~iid~~-------l---~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                          ...+..++       +   .    .........++.+++.+||+.||++||+++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                00000000       0   0    0001123356789999999999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3e-35  Score=333.62  Aligned_cols=257  Identities=21%  Similarity=0.282  Sum_probs=192.1

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCC------cceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN------QTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~lV~  640 (878)
                      |.+.+.||+|+||.||+|+... ..||+|++.....    ...+|+++++.++||||+++++++...+      ..++||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            4567899999999999999865 6699998865432    2247999999999999999999985433      378999


Q ss_pred             eeccCCChhhhhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc-CCCcEEEeecCCcccccc
Q 002809          641 EFMANGNLQEYLSD-ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       641 Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~  718 (878)
                      ||++++.+...... .....+++..++.++.|+++||+|||+.   +|+||||||+|||++ .++.+||+|||+++.+..
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            99986544333321 1256799999999999999999999998   999999999999999 799999999999987643


Q ss_pred             CCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHH----------H
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL----------I  787 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~----------~  787 (878)
                      ...   .....||+.|+|||++.+. .++.++|||||||++|||++|++||......+..  .+.+...          .
T Consensus       195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          195 GEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             TCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHH
T ss_pred             CCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHHHhh
Confidence            322   2235689999999998764 5899999999999999999999999887654322  1111110          0


Q ss_pred             ----hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          788 ----AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       788 ----~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          ........-...+...+......++.+++.+||+.||++|||+.|+++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                0000111111111111222234578899999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-35  Score=329.36  Aligned_cols=257  Identities=24%  Similarity=0.311  Sum_probs=189.9

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCCh-----------hhHHHHHHHHHHHHHhcccceeeeeeccc-----
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSA-----------QGFQQFQAEVKLLMRVHHRNLTSLVGHCD-----  631 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~-----------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-----  631 (878)
                      .+.+.||+|+||.||+|+... ..||||++.....           ...+.+.+|++++.+++||||+++++++.     
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (362)
T 3pg1_A           25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP  104 (362)
T ss_dssp             EEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTT
T ss_pred             EEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCC
Confidence            345899999999999998755 8899999864321           22478999999999999999999999983     


Q ss_pred             CCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          632 EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       632 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      .....++||||++ |+|.+++.. .+..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          105 AMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             CcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecC
Confidence            3446799999997 688888874 345799999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          712 LSKSFATDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       712 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      +++......   ......|++.|+|||++.+ ..++.++|||||||+++||++|+.||......+...  ..+ ......
T Consensus       180 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~i~-~~~~~~  253 (362)
T 3pg1_A          180 LAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN--KIV-EVVGTP  253 (362)
T ss_dssp             C------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHH-HHHCCC
T ss_pred             ccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HHcCCC
Confidence            997543221   2233568899999999876 678999999999999999999999998766433221  111 111000


Q ss_pred             Ccc-----------ccc-------CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 DIK-----------SIV-------DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 ~~~-----------~ii-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...           ..+       ...............+.+++.+||+.+|++|||++|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            000           000       0000011112234468899999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=337.67  Aligned_cols=259  Identities=22%  Similarity=0.313  Sum_probs=180.8

Q ss_pred             cccccccccEEEEEEEEc----ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecc--cCCCcceeEeeecc
Q 002809          571 ERTLGKGGFGTVYYGRLN----EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHC--DEDNQTALIYEFMA  644 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~--~~~~~~~lV~Ey~~  644 (878)
                      .+.||+|+||.||+|+..    +..||||++.....  ...+.+|+++|++++||||+++++++  ..+...++||||++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            458999999999999965    47799999975532  35788999999999999999999999  45778999999996


Q ss_pred             CCChhhhhcccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE----cCCCcEEEeecCCc
Q 002809          645 NGNLQEYLSDIS-------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL----NEKLQAKLADFGLS  713 (878)
Q Consensus       645 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl----~~~~~~kL~DFGla  713 (878)
                       |+|.+++....       ...+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus       104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence             58888875322       22499999999999999999999998   99999999999999    77889999999999


Q ss_pred             cccccCCC-CcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHH-------HHHHHHHHH
Q 002809          714 KSFATDAN-THVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEE-------KIHIRQWVN  784 (878)
Q Consensus       714 ~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------~~~l~~~v~  784 (878)
                      +.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|++||.......       ...+.....
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            87643211 1222346789999999999874 58999999999999999999999997654321       011111111


Q ss_pred             HHHhcCC---cccccC------------Ccccccc---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          785 SLIAKGD---IKSIVD------------PRLQEDF---------DANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       785 ~~~~~~~---~~~iid------------~~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .+....   ...+..            .......         .......+.+|+.+||+.||++|||++|+++.
T Consensus       260 -~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          260 -VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             -HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             111000   000000            0000000         00013467899999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.4e-35  Score=334.36  Aligned_cols=256  Identities=21%  Similarity=0.298  Sum_probs=192.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCC------CcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDED------NQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++....    ..+.+|+++|++++||||+++++++...      ...++|
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            345689999999999999985  4889999987543    2235799999999999999999988432      236789


Q ss_pred             eeeccCCChhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEEeecCCcccc
Q 002809          640 YEFMANGNLQEYLSDI--SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSF  716 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~  716 (878)
                      |||+++ +|.+.+...  ....+++..+..++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|||+++.+
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999975 666665432  256799999999999999999999998   99999999999999965 57899999999876


Q ss_pred             ccCCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHH-------Hh
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL-------IA  788 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~-------~~  788 (878)
                      .....   .....||+.|+|||++.+. .++.++|||||||++|||++|++||......+.  +.+.+...       +.
T Consensus       208 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          208 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHH
T ss_pred             ccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHH
Confidence            43321   2235689999999998764 799999999999999999999999988665332  22222110       00


Q ss_pred             --cCCcccccCCccc-----cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          789 --KGDIKSIVDPRLQ-----EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       789 --~~~~~~iid~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                        .....+..-+.+.     ..+......++.+|+.+||+.||++||++.|+++.
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence              0111111111111     11122234578899999999999999999999863

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.3e-34  Score=322.62  Aligned_cols=200  Identities=27%  Similarity=0.356  Sum_probs=170.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-cc-----ceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HR-----NLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~-----nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++... .....++..|+.++..++ |+     +|+++.+++...+..++|
T Consensus        56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  134 (382)
T 2vx3_A           56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV  134 (382)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence            445689999999999999875  478999999754 334567888999998885 44     499999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc--CCCcEEEeecCCccccc
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN--EKLQAKLADFGLSKSFA  717 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~--~~~~~kL~DFGla~~~~  717 (878)
                      |||++ |+|.+++.......+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||+++...
T Consensus       135 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~  212 (382)
T 2vx3_A          135 FEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG  212 (382)
T ss_dssp             EECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             EecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence            99995 5999999876556799999999999999999999953 33899999999999995  47789999999998763


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE  775 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  775 (878)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|++||......+
T Consensus       213 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~  265 (382)
T 2vx3_A          213 QR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD  265 (382)
T ss_dssp             CC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            22     223568999999999999999999999999999999999999998876543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-34  Score=321.69  Aligned_cols=259  Identities=19%  Similarity=0.269  Sum_probs=201.2

Q ss_pred             HhhhcccccccccEEEEEEEEc--c-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccc------eeeeeecccCCCcce
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--E-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN------LTSLVGHCDEDNQTA  637 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~n------Iv~l~g~~~~~~~~~  637 (878)
                      .+.+.+.||+|+||.||+++..  + ..||+|++... ....+.+.+|++++++++|++      ++.+.+++...+..+
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            3456789999999999999874  3 67999999754 344577889999999998877      899999999999999


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEE------------------
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL------------------  699 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl------------------  699 (878)
                      +||||+ +++|.+++.......+++..++.++.||+.||+|||+.   +|+||||||+|||+                  
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence            999999 67888888765556799999999999999999999998   99999999999999                  


Q ss_pred             -cCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 002809          700 -NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH  778 (878)
Q Consensus       700 -~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  778 (878)
                       +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence             67889999999999764322     223568999999999999999999999999999999999999998776543322


Q ss_pred             HHHHHHH-----HHhcCCcccc-cCC-------------------ccc--cccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002809          779 IRQWVNS-----LIAKGDIKSI-VDP-------------------RLQ--EDFDANSVWKAVELAMACLSPTGNQRPTMS  831 (878)
Q Consensus       779 l~~~v~~-----~~~~~~~~~i-id~-------------------~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~  831 (878)
                      .......     .......... ...                   .+.  .........++.+++.+||+.||++|||++
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            1111100     0000000000 000                   000  011223455788999999999999999999


Q ss_pred             HHHH
Q 002809          832 QVVM  835 (878)
Q Consensus       832 evl~  835 (878)
                      |+++
T Consensus       330 e~l~  333 (355)
T 2eu9_A          330 EALL  333 (355)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-34  Score=323.44  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=197.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-----------ccceeeeeecccCCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-----------HRNLTSLVGHCDEDN  634 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-----------H~nIv~l~g~~~~~~  634 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++... ....+.+.+|++++.+++           |+||+++++++...+
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~   99 (373)
T 1q8y_A           21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   99 (373)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence            456789999999999999964  488999999754 334567889999999886           899999999987544


Q ss_pred             ----cceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc------CCCc
Q 002809          635 ----QTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN------EKLQ  704 (878)
Q Consensus       635 ----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~------~~~~  704 (878)
                          ..++||||+ +++|.+++.......+++..++.++.||+.||+|||+++  +|+||||||+|||++      ..+.
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A          100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcce
Confidence                789999999 899999998766667999999999999999999999853  899999999999994      4458


Q ss_pred             EEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH----HHHHH
Q 002809          705 AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEE----KIHIR  780 (878)
Q Consensus       705 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~----~~~l~  780 (878)
                      +||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ...+.
T Consensus       177 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  251 (373)
T 1q8y_A          177 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  251 (373)
T ss_dssp             EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             EEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence            999999999866432     223468999999999999999999999999999999999999998654211    11111


Q ss_pred             HHHHHH-------HhcCC-----------cccccCCcc---------ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002809          781 QWVNSL-------IAKGD-----------IKSIVDPRL---------QEDFDANSVWKAVELAMACLSPTGNQRPTMSQV  833 (878)
Q Consensus       781 ~~v~~~-------~~~~~-----------~~~iid~~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ev  833 (878)
                      +.....       ...+.           ...+.....         ...++.....++.+++.+||+.||++|||++|+
T Consensus       252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  331 (373)
T 1q8y_A          252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  331 (373)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence            111100       00000           000000000         012345667789999999999999999999999


Q ss_pred             HH
Q 002809          834 VM  835 (878)
Q Consensus       834 l~  835 (878)
                      ++
T Consensus       332 l~  333 (373)
T 1q8y_A          332 VN  333 (373)
T ss_dssp             HT
T ss_pred             hh
Confidence            87

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=321.68  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=193.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCc------cee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQ------TAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~------~~l  638 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|+.++++++||||+++++++.....      .++
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l  106 (353)
T 3coi_A           27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  106 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence            45678999999999999875  489999999754  33445788999999999999999999999977654      499


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||++ |+|.+++..    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       107 v~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          107 VMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             EEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             Eecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            999997 688888743    489999999999999999999998   999999999999999999999999999976532


Q ss_pred             CCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC-------
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG-------  790 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~-------  790 (878)
                      .     .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+...  .... .....       
T Consensus       179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~i~~-~~~~~~~~~~~~  250 (353)
T 3coi_A          179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILK-VTGVPGTEFVQK  250 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH--HHHH-HHCBCCHHHHTT
T ss_pred             C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHH-HhCCCCHHHHHH
Confidence            2     223468999999999877 678999999999999999999999998766433211  1111 00000       


Q ss_pred             -----------CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 -----------DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 -----------~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                                 .+.....+.+. .........+.+++.+||+.||++||+++|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                       00000000010 1112334578899999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.1e-35  Score=316.36  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=189.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC-------------
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-------------  632 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-------------  632 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++... ....+.+.+|++++++++||||+++++++.+             
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK   86 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence            455689999999999999974  488999998653 3445789999999999999999999998754             


Q ss_pred             CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          633 DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       633 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      ....++||||+++|+|.+++.. ....+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           87 KSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             CCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence            4567899999999999999975 245688899999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCC------------CcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002809          713 SKSFATDAN------------THVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI  779 (878)
Q Consensus       713 a~~~~~~~~------------~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  779 (878)
                      ++.......            ........|+..|+|||.+.+. .++.++|||||||++|||++   ||....  ....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~~~~  237 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ERVNI  237 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hHHHH
Confidence            986532210            1122345689999999999864 68999999999999999998   443211  11111


Q ss_pred             HHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       780 ~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         ... +....      ..+....+......+.+++.+||+.||++||+++|+++.
T Consensus       238 ---~~~-~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          238 ---LKK-LRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             ---HHH-HHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---HHh-ccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence               111 11111      112222333444567899999999999999999999873

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-34  Score=325.14  Aligned_cols=251  Identities=24%  Similarity=0.316  Sum_probs=193.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcc------ee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQT------AL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~------~l  638 (878)
                      .+.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|+.++++++||||+++++++...+..      ++
T Consensus        45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  124 (371)
T 4exu_A           45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  124 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred             EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence            45678999999999999875  489999999764  334467889999999999999999999999877655      99


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+. ++|.+++.    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       125 v~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          125 VMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             EEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             EEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            999997 68888774    3499999999999999999999998   999999999999999999999999999976532


Q ss_pred             CCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc-
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV-  796 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii-  796 (878)
                      .     .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+...  .... ..... ..+.. 
T Consensus       197 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~-~~~~~-~~~~~~  267 (371)
T 4exu_A          197 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILK-VTGVP-GTEFVQ  267 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHH-HHCCC-CHHHHT
T ss_pred             C-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHH-HhCCC-cHHHHH
Confidence            2     223568999999999987 688999999999999999999999998766433211  1111 00000 00000 


Q ss_pred             --------------CCcccc---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          797 --------------DPRLQE---DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       797 --------------d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                                    ......   .........+.+++.+||+.+|++|||++|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                          000000   0011224578899999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2e-34  Score=311.72  Aligned_cols=251  Identities=28%  Similarity=0.395  Sum_probs=201.5

Q ss_pred             HHHHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          564 VKITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       564 ~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      ....+.+.+.||+|+||.||+++..  ++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3445667789999999999999985  4889999986542  33467899999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC---CcEEEeecCCcccc
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK---LQAKLADFGLSKSF  716 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~~~  716 (878)
                      +||+++++|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.+   +.+||+|||++...
T Consensus       100 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            999999999998875  45699999999999999999999998   99999999999999764   47999999998866


Q ss_pred             ccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      .....   .....|+..|+|||.+.+ .++.++||||||++++||++|+.||......+..       ..+..+....  
T Consensus       175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~--  241 (287)
T 2wei_A          175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-------KRVETGKYAF--  241 (287)
T ss_dssp             CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCC--
T ss_pred             cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCCCC--
Confidence            43221   122357889999999876 4899999999999999999999999876543311       1122222110  


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +....    ......+.+++.+||+.+|++||+++|+++.
T Consensus       242 ~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          242 DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Cchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            00000    1123467899999999999999999999873

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.9e-34  Score=320.57  Aligned_cols=258  Identities=21%  Similarity=0.282  Sum_probs=183.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCc-------ceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQ-------TALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~-------~~lV  639 (878)
                      .+.+.||+|+||.||+|+..  +..||||++.... .....+.+|++.+..++||||+++++++...+.       .++|
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv  104 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV  104 (360)
T ss_dssp             EEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence            44689999999999999985  4889999986543 223567788899999999999999999854333       7899


Q ss_pred             eeeccCCChhhhhcc--ccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCccEEEcC-CCcEEEeecCCcc
Q 002809          640 YEFMANGNLQEYLSD--ISKKVLSSQERLRIAVESAQGLEYLH--NGCKPPIVHRDVKSTNILLNE-KLQAKLADFGLSK  714 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~  714 (878)
                      |||+++ +|.+.+..  .....+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.+||+|||+++
T Consensus       105 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          105 MEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             eecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            999976 55544432  13567899999999999999999999  66   9999999999999997 8999999999998


Q ss_pred             ccccCCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHH-------
Q 002809          715 SFATDANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL-------  786 (878)
Q Consensus       715 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~-------  786 (878)
                      ......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........  ...+...       
T Consensus       181 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          181 KLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRVLGCPSREV  255 (360)
T ss_dssp             CCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHH
T ss_pred             ecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHHHcCCCCHHH
Confidence            764332   22335689999999998655 4899999999999999999999999887654322  1211110       


Q ss_pred             ----HhcCCcccccCCc------cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          787 ----IAKGDIKSIVDPR------LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       787 ----~~~~~~~~iid~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                          ..........+..      ...........++.+++.+||+.||++|||+.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                0000000000000      0011122245678999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.6e-34  Score=320.55  Aligned_cols=245  Identities=21%  Similarity=0.292  Sum_probs=168.6

Q ss_pred             cccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHH-HHHHHhcccceeeeeecccC----CCcceeEeeec
Q 002809          571 ERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEV-KLLMRVHHRNLTSLVGHCDE----DNQTALIYEFM  643 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei-~~L~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~  643 (878)
                      .+.||+|+||.||+++..  ++.||||++....     ...+|+ ..+..++||||+++++++..    +...++||||+
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~  108 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM  108 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence            357999999999999986  5899999987542     222333 34566789999999999865    45589999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCccccccCC
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~  720 (878)
                      ++|+|.+++.......+++..++.++.|+++||+|||+.   +|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       109 ~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-  184 (336)
T 3fhr_A          109 EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-  184 (336)
T ss_dssp             TTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc-
Confidence            999999999876566899999999999999999999998   9999999999999986   455999999999765322 


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........   .....+..+..      .+
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~------~~  252 (336)
T 3fhr_A          185 ---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY------GF  252 (336)
T ss_dssp             ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CC
T ss_pred             ---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc------cc
Confidence               1233568999999999988889999999999999999999999997654322100   00011111100      01


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ...........+.+++.+||+.+|++||+++|+++.
T Consensus       253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            111112234468899999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=317.14  Aligned_cols=241  Identities=25%  Similarity=0.450  Sum_probs=190.0

Q ss_pred             HHHHhhhcccccccccEEEEEEEEc--ceeEEEEEeccCChh------hHHHHHHHHHHHHHh----cccceeeeeeccc
Q 002809          564 VKITNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ------GFQQFQAEVKLLMRV----HHRNLTSLVGHCD  631 (878)
Q Consensus       564 ~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ei~~L~~l----~H~nIv~l~g~~~  631 (878)
                      ....+.+.+.||+|+||.||+|+..  ++.||||++......      ....+.+|+.++.++    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3444667789999999999999874  478999999754321      234567899999999    8999999999999


Q ss_pred             CCCcceeEeee-ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc-CCCcEEEee
Q 002809          632 EDNQTALIYEF-MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLAD  709 (878)
Q Consensus       632 ~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~-~~~~~kL~D  709 (878)
                      ..+..++|+|+ +.+++|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+||+++ .++.+||+|
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence            99999999999 789999999976  45699999999999999999999998   999999999999999 889999999


Q ss_pred             cCCccccccCCCCcccccccCCCCccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh
Q 002809          710 FGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT-EKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA  788 (878)
Q Consensus       710 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~  788 (878)
                      ||+++......    .....|+..|+|||++.+..+. .++||||||++++||++|+.||.....     +       . 
T Consensus       184 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~-------~-  246 (312)
T 2iwi_A          184 FGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I-------L-  246 (312)
T ss_dssp             CSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------H-
T ss_pred             cchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H-------h-
Confidence            99998764322    2335689999999999876664 589999999999999999999965211     0       0 


Q ss_pred             cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       789 ~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ....      .    ++......+.+++.+||+.+|++||+++|+++.
T Consensus       247 ~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          247 EAEL------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HTCC------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hhcc------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0110      1    111223467899999999999999999999873

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-34  Score=317.29  Aligned_cols=251  Identities=20%  Similarity=0.328  Sum_probs=176.3

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHH-HHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVK-LLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++..  ++.||||++.... .....++..|+. +++.++||||+++++++...+..++||||++
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~  104 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS  104 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence            34578999999999999986  5889999997653 334456666766 6677899999999999999999999999997


Q ss_pred             CCChhhhhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSD---ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      + +|.+++..   .....+++..+..++.|+++||.|||+.  .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  180 (327)
T 3aln_A          105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-  180 (327)
T ss_dssp             E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence            5 88877753   2256799999999999999999999984  279999999999999999999999999998664321 


Q ss_pred             CcccccccCCCCccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          722 THVSTVVAGTPGYLDPEYY----TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                        ......|+..|+|||++    .+..++.++|||||||++|||++|+.||........     ...      .+.....
T Consensus       181 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~------~~~~~~~  247 (327)
T 3aln_A          181 --AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLT------QVVKGDP  247 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C------CCCCSCC
T ss_pred             --ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHH------HHhcCCC
Confidence              12234689999999998    456789999999999999999999999976432110     000      0000011


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      +.+...........+.+++.+||+.+|++||+++|+++.
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            111111112234578899999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.2e-34  Score=328.36  Aligned_cols=246  Identities=26%  Similarity=0.368  Sum_probs=184.1

Q ss_pred             cccccccccEEEEE-EEEcceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          571 ERTLGKGGFGTVYY-GRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~-~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      .+.||+|+||+||. +...++.||||++....   .+.+.+|++++.++ +||||+++++++..++..++||||+. |+|
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence            47899999999964 45567999999986532   35678999999987 89999999999999999999999995 699


Q ss_pred             hhhhccccCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-------------CcEEEeec
Q 002809          649 QEYLSDISKK-----VLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-------------LQAKLADF  710 (878)
Q Consensus       649 ~~~l~~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-------------~~~kL~DF  710 (878)
                      .+++......     ..++..++.++.||+.||+|||+.   +|+||||||+|||++.+             +.+||+||
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            9999764321     113335678999999999999998   99999999999999754             48999999


Q ss_pred             CCccccccCCCCc--ccccccCCCCccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002809          711 GLSKSFATDANTH--VSTVVAGTPGYLDPEYYTS-------NRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIR  780 (878)
Q Consensus       711 Gla~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~  780 (878)
                      |+++.+.......  ......||+.|+|||++.+       ..++.++|||||||+++||+| |+.||........ .+ 
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-~i-  250 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-NI-  250 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-HH-
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-HH-
Confidence            9998764332211  1234579999999999975       578999999999999999999 9999976543221 11 


Q ss_pred             HHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          781 QWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       781 ~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ..     +...   .+.+....+.....++.+++.+||+.+|++||++.||++
T Consensus       251 --~~-----~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          251 --IR-----GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --HH-----TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --hc-----CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence              11     1110   011111123445678899999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-34  Score=319.37  Aligned_cols=237  Identities=24%  Similarity=0.406  Sum_probs=194.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChh------hHHHHHHHHHHHHHhc--ccceeeeeecccCCCcce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ------GFQQFQAEVKLLMRVH--HRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~~~~~  637 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++......      ..+.+.+|+.++.+++  |+||+++++++...+..+
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~  124 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV  124 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence            456789999999999999874  488999998754321      2356788999999996  599999999999999999


Q ss_pred             eEeeeccC-CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc-CCCcEEEeecCCccc
Q 002809          638 LIYEFMAN-GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKS  715 (878)
Q Consensus       638 lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~  715 (878)
                      +|+|++.+ ++|.+++..  ...+++..++.++.|+++||+|||+.   +|+||||||+|||++ +++.+||+|||+++.
T Consensus       125 lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          125 LILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             EEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            99999986 899999976  45799999999999999999999998   999999999999999 788999999999987


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ....    ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....     +       . .+..  
T Consensus       200 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~-------~-~~~~--  260 (320)
T 3a99_A          200 LKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------I-RGQV--  260 (320)
T ss_dssp             CCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------H-HCCC--
T ss_pred             cccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-------h-cccc--
Confidence            6432    1223568999999999987665 6789999999999999999999965211     0       0 1111  


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ..    ..    ....++.+++.+||+.+|++||+++|+++.
T Consensus       261 ~~----~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          261 FF----RQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CC----SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc----cc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01    11    122467899999999999999999999873

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.7e-33  Score=306.80  Aligned_cols=247  Identities=21%  Similarity=0.302  Sum_probs=175.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhH-HHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGF-QQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~-~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||.||+++..  ++.||||++..... ... +.+.++..+++.++||||+++++++...+..++||||+ 
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-  106 (318)
T 2dyl_A           28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-  106 (318)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence            44578999999999999985  58899999976532 222 33445555778889999999999999999999999999 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      ++.+..+.. .....+++..+..++.|+++||+|||+ .   +|+||||||+|||++.++.+||+|||++.......   
T Consensus       107 ~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---  179 (318)
T 2dyl_A          107 GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---  179 (318)
T ss_dssp             SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---
Confidence            444444443 335679999999999999999999997 4   89999999999999999999999999997653322   


Q ss_pred             ccccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          724 VSTVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ......|++.|+|||++.     ...++.++|||||||++|||++|+.||........ .    ......... ..    
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~~~~~~~~~-~~----  249 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-V----LTKVLQEEP-PL----  249 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHHHHHSCC-CC----
T ss_pred             cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-H----HHHHhccCC-CC----
Confidence            122346899999999984     45688999999999999999999999986433211 1    111122111 11    


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       +..  .......+.+++.+||+.+|.+||+++|+++.
T Consensus       250 -~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          250 -LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             110  01122467899999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.3e-34  Score=325.10  Aligned_cols=245  Identities=27%  Similarity=0.378  Sum_probs=184.5

Q ss_pred             hhcccccccccEE-EEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGT-VYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~-Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      ...+.||+|+||+ ||++..+++.||||++.....   ..+.+|+++|+++ +||||+++++++......++||||+. |
T Consensus        27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g  102 (432)
T 3p23_A           27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A  102 (432)
T ss_dssp             EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence            4457899999998 566677779999999975432   3467899999999 79999999999999999999999996 6


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-----CCcEEEeecCCccccccCCC
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-----KLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-----~~~~kL~DFGla~~~~~~~~  721 (878)
                      +|.+++.... ..+.+..++.++.||++||+|||+.   +|+||||||+|||++.     ...+||+|||+++.......
T Consensus       103 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          103 TLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             EHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             CHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            9999997533 3344556789999999999999998   9999999999999953     34688999999987643321


Q ss_pred             C-cccccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCccccc
Q 002809          722 T-HVSTVVAGTPGYLDPEYYT---SNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV  796 (878)
Q Consensus       722 ~-~~~~~~~gt~~Y~APE~~~---~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ii  796 (878)
                      . .......||+.|+|||++.   ...++.++|||||||+++||++ |+.||.........       ........ ...
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~~-~~~  250 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGACSL-DCL  250 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCCCC-TTS
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccCCc-ccc
Confidence            1 2233467999999999997   4567889999999999999999 89998654432211       11111111 111


Q ss_pred             CCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       797 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                            .........+.+++.+||+.+|++||+++||++
T Consensus       251 ------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          251 ------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                  111233456789999999999999999999995

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-33  Score=333.76  Aligned_cols=266  Identities=25%  Similarity=0.335  Sum_probs=204.7

Q ss_pred             HhhhcccccccccEEEEEEEEc--ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccC------CCcce
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE------DNQTA  637 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~------~~~~~  637 (878)
                      .+.+.+.||+|+||.||+|+..  +..||||++... .....+.+.+|++++.+++||||+++++++..      ++..+
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            3566789999999999999874  488999998764 44556789999999999999999999998765      67789


Q ss_pred             eEeeeccCCChhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCc---EEEeecCCc
Q 002809          638 LIYEFMANGNLQEYLSDIS-KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQ---AKLADFGLS  713 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~---~kL~DFGla  713 (878)
                      +||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||++
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            9999999999999997643 33689999999999999999999998   9999999999999997764   999999999


Q ss_pred             cccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCc-
Q 002809          714 KSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI-  792 (878)
Q Consensus       714 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~-  792 (878)
                      .......   ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......     .|.......... 
T Consensus       172 ~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~~  243 (676)
T 3qa8_A          172 KELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNEH  243 (676)
T ss_dssp             CBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC------
T ss_pred             ccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccchh
Confidence            8764332   2234579999999999999999999999999999999999999997653321     221111111100 


Q ss_pred             ---ccccC------Ccc--ccccCHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHHHHHHH
Q 002809          793 ---KSIVD------PRL--QEDFDANSVWKAVELAMACLSPTGNQRPTMSQ-----VVMELSECLAA  843 (878)
Q Consensus       793 ---~~iid------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e-----vl~~L~~~~~~  843 (878)
                         .+...      ..+  ...........+.+++..||..||++||+++|     ..+.+++++..
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence               00000      010  11233456678999999999999999999988     55667776643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.9e-33  Score=337.42  Aligned_cols=240  Identities=23%  Similarity=0.324  Sum_probs=192.5

Q ss_pred             HhhhcccccccccEEEEEEEEc---ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCc-----ce
Q 002809          567 TNNFERTLGKGGFGTVYYGRLN---EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQ-----TA  637 (878)
Q Consensus       567 t~~f~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~-----~~  637 (878)
                      .+.+.+.||+|+||.||+++..   ++.||||++... .......+.+|++++.+++||||+++++++...+.     .+
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            3456789999999999999874   488999998754 34456788999999999999999999999987665     69


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+++++|.+++..    .+++.+++.++.||++||.|||++   +|+||||||+|||++.+ .+||+|||+++...
T Consensus       161 lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            99999999999988753    699999999999999999999998   99999999999999986 89999999998763


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ..      ....||+.|+|||++.+.. +.++|||||||+++||++|.+|+......                .+.    
T Consensus       233 ~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~~----  285 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GLP----  285 (681)
T ss_dssp             CC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SCC----
T ss_pred             cC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------------ccc----
Confidence            32      3356999999999987654 88999999999999999999887642110                000    


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRP-TMSQVVMELSECLAAE  844 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~evl~~L~~~~~~e  844 (878)
                         ...........+.+++.+||+.+|++|| +++++.+.|..++...
T Consensus       286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  330 (681)
T 2pzi_A          286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV  330 (681)
T ss_dssp             ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred             ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence               0000112234678999999999999999 5667777787766543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.98  E-value=1e-32  Score=314.72  Aligned_cols=235  Identities=17%  Similarity=0.140  Sum_probs=177.3

Q ss_pred             hcccccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHHHHHHHHHhcc-cceeeeeec--------------
Q 002809          570 FERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHH-RNLTSLVGH--------------  629 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ei~~L~~l~H-~nIv~l~g~--------------  629 (878)
                      ..+.||+|+||.||+|+..  ++.||||++.....   ...+.|.+|+.++..++| +|......+              
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence            3578999999999999976  58999999884322   236789999999999976 322111111              


Q ss_pred             -------ccC-----CCcceeEeeeccCCChhhhhcc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 002809          630 -------CDE-----DNQTALIYEFMANGNLQEYLSD-----ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDV  692 (878)
Q Consensus       630 -------~~~-----~~~~~lV~Ey~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL  692 (878)
                             +..     ....+++|+++ +++|.++++.     .....+++..++.++.|+++||+|||++   +|+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi  237 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL  237 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence                   111     12345566654 7899998852     2245688999999999999999999998   9999999


Q ss_pred             CCccEEEcCCCcEEEeecCCccccccCCCCcccccccCCCCccCcccc----------ccCCCCCccchhhHHHHHHHHH
Q 002809          693 KSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY----------TSNRLTEKSDVYSFGVVILEII  762 (878)
Q Consensus       693 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~----------~~~~~t~ksDV~S~Gvvl~ell  762 (878)
                      ||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++|||+
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999998765322     234567 999999999          5556888999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          763 TCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       763 tG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +|+.||.......               ....++...  ...    ...+.+++.+||+.+|++||++.|+++
T Consensus       312 tg~~Pf~~~~~~~---------------~~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          312 CADLPNTDDAALG---------------GSEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HSSCCCCTTGGGS---------------CSGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCCCCcchhh---------------hHHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999997654321               111111100  111    246889999999999999999998865

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.98  E-value=2.4e-32  Score=297.52  Aligned_cols=222  Identities=22%  Similarity=0.286  Sum_probs=175.2

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHH-HHhcccceeeeeecccC----CCcceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLL-MRVHHRNLTSLVGHCDE----DNQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L-~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~  644 (878)
                      +.||+|+||.||+++..  ++.||+|++...     ..+.+|++++ +..+||||+++++++..    +...++||||++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            67999999999999874  488999999653     4677899888 55589999999999876    677899999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~~  721 (878)
                      +|+|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||++....    
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----  171 (299)
T 3m2w_A           99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----  171 (299)
T ss_dssp             SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence            99999999876566799999999999999999999998   9999999999999998   7899999999986432    


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc-
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL-  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l-  800 (878)
                                          +..++.++|||||||++|||++|+.||........           .......+..... 
T Consensus       172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~~~~  220 (299)
T 3m2w_A          172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMGQYE  220 (299)
T ss_dssp             --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCCS
T ss_pred             --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhcccc
Confidence                                23467899999999999999999999976443210           0000111111111 


Q ss_pred             -ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          801 -QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       801 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       ..........++.+++.+||+.+|++||+++|+++.
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             000001234578899999999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.98  E-value=2.2e-32  Score=296.45  Aligned_cols=227  Identities=11%  Similarity=0.115  Sum_probs=181.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++....   ....+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            456789999999999999986  5899999997653   33457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.++++.   . ....++.+++.|+++||+|||++   +|+||||||+|||++.++.+||+++|           
T Consensus       113 ~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          113 IRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             CCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             cCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            999999999964   2 35567899999999999999998   99999999999999999999998543           


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc-
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ-  801 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~-  801 (878)
                                 |++       .++.++|||||||++|||+||+.||..........            .....+..... 
T Consensus       175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~~~~  224 (286)
T 3uqc_A          175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQPIE  224 (286)
T ss_dssp             -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSCBCC
T ss_pred             -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccCCCC
Confidence                       233       36789999999999999999999998754321000            00000011000 


Q ss_pred             -cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          802 -EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       802 -~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                       ..........+.+++.+||+.||++| |++|+++.|+++...
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence             01112334568899999999999999 999999999997644

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=9.6e-33  Score=305.80  Aligned_cols=241  Identities=17%  Similarity=0.191  Sum_probs=184.0

Q ss_pred             HHhhhcccccccccEEEEEEEEcceeEEEEEeccCC--------hhhHHHHHHHHHHHHHhc------------------
Q 002809          566 ITNNFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSS--------AQGFQQFQAEVKLLMRVH------------------  619 (878)
Q Consensus       566 ~t~~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--------~~~~~~f~~Ei~~L~~l~------------------  619 (878)
                      ..+.+.+.||+|+||.||+|+.+++.||||++....        ....+.+.+|+.++++++                  
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~   99 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS   99 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred             ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence            345667899999999999999988999999997642        223478999999999997                  


Q ss_pred             --------ccceeeeeecccC-------------CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHH
Q 002809          620 --------HRNLTSLVGHCDE-------------DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY  678 (878)
Q Consensus       620 --------H~nIv~l~g~~~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~y  678 (878)
                              ||||+++++++..             .+..++||||+++|++.+.+.+   ..+++..++.++.||+.||+|
T Consensus       100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A          100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHH
T ss_pred             eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHH
Confidence                    5666666666654             7889999999999987777643   568999999999999999999


Q ss_pred             HH-hCCCCCeEecCCCCccEEEcCCC--------------------cEEEeecCCccccccCCCCcccccccCCCCccCc
Q 002809          679 LH-NGCKPPIVHRDVKSTNILLNEKL--------------------QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP  737 (878)
Q Consensus       679 LH-~~~~~~ivHrDLKp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP  737 (878)
                      || +.   +|+||||||+|||++.++                    .+||+|||+++.....       ...||+.|+||
T Consensus       177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP  246 (336)
T 2vuw_A          177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred             HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence            99 88   999999999999999887                    8999999999876422       34699999999


Q ss_pred             cccccCCCCCccchhhHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHH
Q 002809          738 EYYTSNRLTEKSDVYSFGVV-ILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELA  816 (878)
Q Consensus       738 E~~~~~~~t~ksDV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~  816 (878)
                      |++.+.. +.++||||+|++ .+++++|..||....     .+.............    ..............++.+++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhcc----CcccchhhhhhcCHHHHHHH
Confidence            9998766 889999998777 777888999874210     000011111111111    11111112234567899999


Q ss_pred             HHccCCCCCCCCCHHHHH
Q 002809          817 MACLSPTGNQRPTMSQVV  834 (878)
Q Consensus       817 ~~Cl~~dP~~RPsm~evl  834 (878)
                      .+||+.+     |++|++
T Consensus       317 ~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          317 RTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHGGGSS-----SHHHHH
T ss_pred             HHHhccC-----CHHHHH
Confidence            9999975     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=7.4e-27  Score=276.32  Aligned_cols=182  Identities=16%  Similarity=0.133  Sum_probs=129.6

Q ss_pred             cccccccEEEEEEEE--cceeEEEEEeccC----------ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeE
Q 002809          573 TLGKGGFGTVYYGRL--NEIDVAVKMLSSS----------SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~----------~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      ..+.|+.|.+..++.  -+..+|+|++...          .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            456777776665443  4688999998754          123456799999999999 699999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||++|++|.++|.+  ...++..   +|+.||+.||+|||++   +||||||||+|||+++++++||+|||+++.....
T Consensus       321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999986  4556654   5889999999999999   9999999999999999999999999999876433


Q ss_pred             CCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK  765 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~  765 (878)
                      .  ......+||++|||||++.+ .+..++|+||+|++++++.++.
T Consensus       393 ~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          393 C--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             C--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence            2  22334679999999999976 4667899999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=9.9e-25  Score=256.67  Aligned_cols=184  Identities=16%  Similarity=0.215  Sum_probs=148.8

Q ss_pred             cccccccccEEEEEEEEcceeEEEEEeccCCh--------hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          571 ERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSA--------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       571 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.||+|+||.||+++..+..+++|+......        ...+.+.+|++++++++||||+++..++...+..++||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~  420 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY  420 (540)
T ss_dssp             -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred             CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence            46899999999999988889999998754321        1235689999999999999999777776677888999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++++|.++++.          +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+++........
T Consensus       421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            999999999875          568999999999999998   9999999999999999  9999999999876432211


Q ss_pred             c-----ccccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 002809          723 H-----VSTVVAGTPGYLDPEYYTS--NRLTEKSDVYSFGVVILEIITCKPAIS  769 (878)
Q Consensus       723 ~-----~~~~~~gt~~Y~APE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~  769 (878)
                      .     ......||+.|||||++..  ..|+.++|+|+..+-.++.+.++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            1     1235679999999999986  568889999999999888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.82  E-value=1e-20  Score=204.14  Aligned_cols=141  Identities=14%  Similarity=0.128  Sum_probs=114.6

Q ss_pred             hcccccccccEEEEEEEEc-ceeEEEEEeccCCh------------------hhHHHHHHHHHHHHHhcccceeeeeecc
Q 002809          570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSA------------------QGFQQFQAEVKLLMRVHHRNLTSLVGHC  630 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~------------------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~  630 (878)
                      +.+.||+|+||.||+|+.. ++.||||+++....                  .....+.+|++++.+++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            3489999999999999984 48999999964321                  13467899999999999  5 6666655


Q ss_pred             cCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeec
Q 002809          631 DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF  710 (878)
Q Consensus       631 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DF  710 (878)
                      .. +..++||||+++|+|.+ +..        .....++.|+++||+|||+.   +|+||||||+|||++ ++.+||+||
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             ec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            43 56799999999999998 432        12457999999999999998   999999999999999 999999999


Q ss_pred             CCccccccCCCCcccccccCCCCccCcccccc
Q 002809          711 GLSKSFATDANTHVSTVVAGTPGYLDPEYYTS  742 (878)
Q Consensus       711 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~  742 (878)
                      |+++.               +..++|||++..
T Consensus       237 G~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          237 PQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             TTCEE---------------TTSTTHHHHHHH
T ss_pred             CCCeE---------------CCCCCHHHHHHH
Confidence            99863               345788998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.70  E-value=2.9e-17  Score=174.75  Aligned_cols=133  Identities=19%  Similarity=0.278  Sum_probs=103.3

Q ss_pred             hcccccccccEEEEEEEE--ccee--EEEEEeccCChh------------------------hHHHHHHHHHHHHHhccc
Q 002809          570 FERTLGKGGFGTVYYGRL--NEID--VAVKMLSSSSAQ------------------------GFQQFQAEVKLLMRVHHR  621 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~--~~~~--vAvK~l~~~~~~------------------------~~~~f~~Ei~~L~~l~H~  621 (878)
                      +.+.||+|+||.||+|+.  .++.  ||||+++.....                        ....+.+|+..|.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            457899999999999988  5688  999987543111                        123688999999999988


Q ss_pred             ce--eeeeecccCCCcceeEeeeccC-C----ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCC
Q 002809          622 NL--TSLVGHCDEDNQTALIYEFMAN-G----NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH-NGCKPPIVHRDVK  693 (878)
Q Consensus       622 nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDLK  693 (878)
                      ++  ..++..    ...++||||+.+ |    +|.++...     .++..+..++.|++.||.||| +.   +|+|||||
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk  198 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS  198 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence            64  333332    367899999952 5    55554332     234567889999999999999 77   99999999


Q ss_pred             CccEEEcCCCcEEEeecCCcccc
Q 002809          694 STNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       694 p~NILl~~~~~~kL~DFGla~~~  716 (878)
                      |+|||+++  .++|+|||++...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.51  E-value=1.4e-14  Score=161.12  Aligned_cols=136  Identities=11%  Similarity=0.096  Sum_probs=93.5

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCCh--------------hhHHHHHHHHHHHHHhcccceeeeeecccC-
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSA--------------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-  632 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~--------------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-  632 (878)
                      .+.+.||+|++|.||+|...+ +.||||+++....              ........+.++.....|+|+.++...... 
T Consensus        98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v  177 (397)
T 4gyi_A           98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV  177 (397)
T ss_dssp             EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred             EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            456789999999999998754 8999998753210              001112222222222334444433322111 


Q ss_pred             -----CCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC----
Q 002809          633 -----DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL----  703 (878)
Q Consensus       633 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~----  703 (878)
                           ....++||||+++++|.++...        +....++.|++.+|.+||+.   +||||||||.|||+++++    
T Consensus       178 p~p~~~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          178 PEPIAQSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CCEEEEETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSC
T ss_pred             CeeeeccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccc
Confidence                 1234799999999888766432        12356889999999999998   999999999999998877    


Q ss_pred             ------cEEEeecCCccc
Q 002809          704 ------QAKLADFGLSKS  715 (878)
Q Consensus       704 ------~~kL~DFGla~~  715 (878)
                            .+.|+||+.+..
T Consensus       247 ~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECCCTTCEE
T ss_pred             ccccccceEEEEeCCccc
Confidence                  389999998764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.45  E-value=9.1e-14  Score=151.91  Aligned_cols=124  Identities=30%  Similarity=0.473  Sum_probs=106.9

Q ss_pred             cccchHHHHHHHHHhhCC---CCCCC--CCCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccc--cchhhhhccCCC
Q 002809          361 TEQIDVDAITNIKATYGL---KKNWQ--GDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKG--DITSYVSNLTSL  433 (878)
Q Consensus       361 t~~~d~~al~~lk~~~~~---~~~w~--~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g--~ip~~~~~l~~L  433 (878)
                      ..+.|..||.++|+.+..   ..+|.  .+||..   .|.||+|+.. ....+|+.|+|++|+|+|  .+|+.|++|++|
T Consensus         3 c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~---~w~gv~C~~~-~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L   78 (313)
T 1ogq_A            3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNR---TWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTT---CSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcC---CCcceEeCCC-CCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence            467899999999998853   45896  367721   4999999742 123689999999999999  999999999999


Q ss_pred             CEEeCcC-CcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccC
Q 002809          434 QFLDLSN-NNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       434 ~~L~Ls~-N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      +.|+|++ |+++|.+|..++.++ |++|+|++|+++|.+|..+.++++|+.|+++.+
T Consensus        79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N  135 (313)
T 1ogq_A           79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN  135 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred             CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCC
Confidence            9999994 999999999999999 999999999999999999999999997776544

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.34  E-value=3.8e-13  Score=165.05  Aligned_cols=96  Identities=30%  Similarity=0.557  Sum_probs=85.4

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .+.|+.|+|++|+|+|.||.+|++|++|+.|+|++|+|+|.||..++.++ |+.|||++|+|+|.||.++.+++.|+.|+
T Consensus       631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~  710 (768)
T 3rgz_A          631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID  710 (768)
T ss_dssp             SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred             cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence            46789999999999999999999999999999999999999999999999 99999999999999999999988877665


Q ss_pred             c---------------------ccCCCCCCCCCc--cccC
Q 002809          485 L---------------------SVGGNPGLCSKI--SCKK  501 (878)
Q Consensus       485 l---------------------~~~~n~~lc~~~--~c~~  501 (878)
                      +                     +|.||+++||.+  .|..
T Consensus       711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~  750 (768)
T 3rgz_A          711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP  750 (768)
T ss_dssp             CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred             CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence            4                     456899999863  5764

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.31  E-value=1.2e-12  Score=161.19  Aligned_cols=121  Identities=20%  Similarity=0.273  Sum_probs=104.5

Q ss_pred             cccccchHHHHHHHHHhhCCCCCCCC-------CC--CCCCCCcc------------cceecCCCCCCCCcEEEEEecCC
Q 002809          359 LQTEQIDVDAITNIKATYGLKKNWQG-------DP--CAPLAYWW------------DGLNCSYGDSSSPRITYLNLSSS  417 (878)
Q Consensus       359 ~~t~~~d~~al~~lk~~~~~~~~w~~-------~p--c~~~~~~w------------~gv~C~~~~~~~~~l~~l~l~~n  417 (878)
                      ..+..+|..||.++|+.+..+ +|+.       +|  |     .|            .||+|+.    ..+|+.|+|++|
T Consensus       264 ~~~~~~d~~ALl~~k~~l~~~-~W~~~~~~~~~~~~~C-----~W~~~~~~~~w~~~~GV~C~~----~~~V~~L~Ls~~  333 (876)
T 4ecn_A          264 TAEYIKDYKALKAIWEALDGK-NWRYYSGTINNTIHSL-----NWNFNKELDMWGDQPGVDLDN----NGRVTGLSLAGF  333 (876)
T ss_dssp             CCHHHHHHHHHHHHHHHTTGG-GCCCCCSSCSSCCCCC-----SCCCSSCGGGTTCCTTEEECT----TSCEEEEECTTT
T ss_pred             cccchHHHHHHHHHHHHcCCC-CCCcCCCcccccCCcc-----ccccccccccccCcCceEecC----CCCEEEEECccC
Confidence            345578999999999998655 8852       46  5     68            9999974    369999999999


Q ss_pred             CccccchhhhhccCCCCEEeC-cCCcccCc--------------------------------------------------
Q 002809          418 GLKGDITSYVSNLTSLQFLDL-SNNNLTGS--------------------------------------------------  446 (878)
Q Consensus       418 ~l~g~ip~~~~~l~~L~~L~L-s~N~l~g~--------------------------------------------------  446 (878)
                      +|+|.||++|++|++|+.||| ++|.|+|.                                                  
T Consensus       334 ~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~  413 (876)
T 4ecn_A          334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE  413 (876)
T ss_dssp             CCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTT
T ss_pred             CCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcc
Confidence            999999999999999999999 88877766                                                  


Q ss_pred             --------------------------CCccCCCCc-ceEEEecCCcCCC-----------------CCchhhh--hcccC
Q 002809          447 --------------------------VPDFLSKLP-LRTLNLQGNKLNG-----------------SVPVELL--ERSKN  480 (878)
Q Consensus       447 --------------------------iP~~~~~l~-L~~L~ls~N~l~g-----------------~iP~~l~--~~~~l  480 (878)
                                                ||..+++|+ |+.|+|++|+|+|                 .||.+++  ++++|
T Consensus       414 ~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L  493 (876)
T 4ecn_A          414 MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDL  493 (876)
T ss_dssp             SCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTC
T ss_pred             ccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCC
Confidence                                      899999999 9999999999999                 4999988  99999


Q ss_pred             CCcccccCC
Q 002809          481 GSLSLSVGG  489 (878)
Q Consensus       481 ~~l~l~~~~  489 (878)
                      +.|+++.+.
T Consensus       494 ~~L~Ls~N~  502 (876)
T 4ecn_A          494 TDVELYNCP  502 (876)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECcCCC
Confidence            987776554

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.31  E-value=1.3e-12  Score=156.71  Aligned_cols=120  Identities=22%  Similarity=0.276  Sum_probs=102.3

Q ss_pred             ccccchHHHHHHHHHhhCCC------------CCCCC--CCCCCCCCcc---cceecCCCCCCCCcEEEEEecCCCcccc
Q 002809          360 QTEQIDVDAITNIKATYGLK------------KNWQG--DPCAPLAYWW---DGLNCSYGDSSSPRITYLNLSSSGLKGD  422 (878)
Q Consensus       360 ~t~~~d~~al~~lk~~~~~~------------~~w~~--~pc~~~~~~w---~gv~C~~~~~~~~~l~~l~l~~n~l~g~  422 (878)
                      .....|..||.++++..+..            .+|+.  ++|     .|   .||+|+..    .+|+.|+|++|+|+|.
T Consensus        26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-----~w~~~~GV~C~~~----~~V~~L~L~~~~l~g~   96 (636)
T 4eco_A           26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-----MWGAQPGVSLNSN----GRVTGLSLEGFGASGR   96 (636)
T ss_dssp             CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-----GTTCCTTEEECTT----CCEEEEECTTSCCEEE
T ss_pred             hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-----cccCCCCeEEcCC----CCEEEEEecCcccCCc
Confidence            34567999999999887432            25752  455     68   99999742    6999999999999999


Q ss_pred             chhhhhccCCCCEEeCcCC-------------------------------------------------------------
Q 002809          423 ITSYVSNLTSLQFLDLSNN-------------------------------------------------------------  441 (878)
Q Consensus       423 ip~~~~~l~~L~~L~Ls~N-------------------------------------------------------------  441 (878)
                      +|++|++|++|+.|||++|                                                             
T Consensus        97 lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~  176 (636)
T 4eco_A           97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK  176 (636)
T ss_dssp             ECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCC
T ss_pred             CChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccc
Confidence            9999999999999999998                                                             


Q ss_pred             -----------------cccCcCCccCCCCc-ceEEEecCCcCCCC-----------------Cchhhh--hcccCCCcc
Q 002809          442 -----------------NLTGSVPDFLSKLP-LRTLNLQGNKLNGS-----------------VPVELL--ERSKNGSLS  484 (878)
Q Consensus       442 -----------------~l~g~iP~~~~~l~-L~~L~ls~N~l~g~-----------------iP~~l~--~~~~l~~l~  484 (878)
                                       +|+| ||..+++++ |+.|+|++|+|+|.                 +|.+++  ++++|+.|+
T Consensus       177 ~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~  255 (636)
T 4eco_A          177 KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE  255 (636)
T ss_dssp             CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred             cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEE
Confidence                             4556 999999999 99999999999996                 999999  999999877


Q ss_pred             cccCC
Q 002809          485 LSVGG  489 (878)
Q Consensus       485 l~~~~  489 (878)
                      ++.+.
T Consensus       256 L~~n~  260 (636)
T 4eco_A          256 VYNCP  260 (636)
T ss_dssp             EECCT
T ss_pred             ecCCc
Confidence            76553

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.23  E-value=1.6e-12  Score=151.06  Aligned_cols=138  Identities=13%  Similarity=0.106  Sum_probs=70.2

Q ss_pred             eeEEEEEecCCCCCchh----hhhhhhheeccccccccccchHH-HHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCC
Q 002809          328 NYSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQIDVD-AITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYG  402 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d~~-al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~  402 (878)
                      ...+.|..+..+.++|.    +..|+.+.+..+...+..|..+. .|..|+.+....+...+.|.               
T Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~---------------  186 (487)
T 3oja_A          122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG---------------  186 (487)
T ss_dssp             CEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC---------------
T ss_pred             CCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc---------------
Confidence            45556666666665442    33555666655543333344432 23333333322222221111               


Q ss_pred             CCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCC-CCCchhhhhcccC
Q 002809          403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN-GSVPVELLERSKN  480 (878)
Q Consensus       403 ~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~-g~iP~~l~~~~~l  480 (878)
                      ....++|+.|+|++|+|+| +|+.++.+++|+.|+|++|+|++ +|..++.++ |+.|+|++|.+. |.+|..+..++.+
T Consensus       187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L  264 (487)
T 3oja_A          187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV  264 (487)
T ss_dssp             CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHH
T ss_pred             cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCC
Confidence            0124456666666666664 44446666666666666666663 565566665 666666666665 5555555555544


Q ss_pred             CC
Q 002809          481 GS  482 (878)
Q Consensus       481 ~~  482 (878)
                      ..
T Consensus       265 ~~  266 (487)
T 3oja_A          265 QT  266 (487)
T ss_dssp             HH
T ss_pred             cE
Confidence            43

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.14  E-value=1.5e-10  Score=115.11  Aligned_cols=143  Identities=14%  Similarity=0.104  Sum_probs=92.4

Q ss_pred             eEeccCCCCCCCCccCCCceeeecCccccccCccceeec----cccccccccc-CceeccCCCCcceeEeeccCCCeeEE
Q 002809           28 ISLDCGLPKDSNYTETTTGINYISDDAFVETGIGKSILQ----EFQTGQQKQM-RRVRSFPDGIRNCYRFNLTKGSRYLI  102 (878)
Q Consensus        28 ~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~~~~----~~~~~~~~~~-~tlR~Fp~g~~nCY~l~~~~~~~ylv  102 (878)
                      ..||||++..   + +..+++|.+|..|...|.......    ........+. +|-|+||.  .-||.+|+.++|+|+|
T Consensus         8 ~~INcGg~~~---~-d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~--~~tY~f~v~~~G~Y~V   81 (174)
T 2jwp_A            8 WAVNAGGESH---V-DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED--SFGYDIPIKEEGEYVL   81 (174)
T ss_dssp             EEEEETSSSE---E-ETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS--CEEEEEECCSCEEEEE
T ss_pred             EEEECCCCCc---c-CCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC--CeEEEEEeCCCeEEEE
Confidence            3799997543   2 357899999998864443221110    0001112223 99999996  6799999999999999


Q ss_pred             EEEeeecCCCCCCCCCceeEEEcccee-eEEEecCCc--cceeeeeEEEE-------------ccCCceEEEEeecCCCC
Q 002809          103 RTNFMYGNYDEKNSVPGFDMFIGPNKW-LSVTFENNA--SFVAIGEIIHI-------------LPSDYLHICLVNTGLGT  166 (878)
Q Consensus       103 R~~f~ygnyd~~~~~p~Fd~~~~~~~w-~~v~~~~~~--~~~~~~e~~~~-------------~~~~~~~vCl~~~~~~~  166 (878)
                      |.-|.--.|.. .....||+++++..- ...++....  ......+..+.             ..+..+.|.|.....+.
T Consensus        82 rLhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~  160 (174)
T 2jwp_A           82 VLKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN  160 (174)
T ss_dssp             EEEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCS
T ss_pred             EEEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCC
Confidence            99997766654 455789999999642 333332111  11122344443             24556888888543567


Q ss_pred             cceeeeeeeec
Q 002809          167 PFISALELRPL  177 (878)
Q Consensus       167 Pfis~lel~~l  177 (878)
                      ||||+||+.+-
T Consensus       161 a~inaIEI~~~  171 (174)
T 2jwp_A          161 PKVCALFIMKG  171 (174)
T ss_dssp             SSEEEEEEESS
T ss_pred             cEEEEEEEEeC
Confidence            99999999973

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.14  E-value=2.2e-11  Score=125.93  Aligned_cols=150  Identities=15%  Similarity=0.120  Sum_probs=105.3

Q ss_pred             EEEEEecCCCCCchhhh-hhhhheeccccccccc-cch-HHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          330 SFSLYKTGNSTLPPIIN-AIEVYSVKEFLQLQTE-QID-VDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       330 ~~~l~~t~~s~lpp~in-alEi~~l~~~~~~~t~-~~d-~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      .+.+..+....+|+.+. .++.+.+..+. .+.+ +.+ +..+..|+.+....+...+.+-.    .         ....
T Consensus        15 ~l~~s~n~l~~iP~~~~~~~~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~----~---------~~~l   80 (220)
T 2v70_A           15 TVDCSNQKLNKIPEHIPQYTAELRLNNNE-FTVLEATGIFKKLPQLRKINFSNNKITDIEEG----A---------FEGA   80 (220)
T ss_dssp             EEECCSSCCSSCCSCCCTTCSEEECCSSC-CCEECCCCCGGGCTTCCEEECCSSCCCEECTT----T---------TTTC
T ss_pred             EeEeCCCCcccCccCCCCCCCEEEcCCCc-CCccCchhhhccCCCCCEEECCCCcCCEECHH----H---------hCCC
Confidence            34444444555554322 34555555544 3333 222 44444444444333333322210    1         1346


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      ++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..|..+..+++|+.  +
T Consensus        81 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~--L  158 (220)
T 2v70_A           81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST--L  158 (220)
T ss_dssp             TTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCE--E
T ss_pred             CCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCE--E
Confidence            7899999999999988888899999999999999999998899999999 999999999999888999999988884  5


Q ss_pred             ccCCCCCCCC
Q 002809          486 SVGGNPGLCS  495 (878)
Q Consensus       486 ~~~~n~~lc~  495 (878)
                      .+.+|+..|.
T Consensus       159 ~L~~N~l~c~  168 (220)
T 2v70_A          159 NLLANPFNCN  168 (220)
T ss_dssp             ECCSCCEECS
T ss_pred             EecCcCCcCC
Confidence            6678888775

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.13  E-value=6.9e-11  Score=117.00  Aligned_cols=101  Identities=24%  Similarity=0.210  Sum_probs=86.1

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|+.+.|+.+.      ...+.|+.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..+..++ |+.|+|++|+
T Consensus        10 ~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           10 SGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            68889998542      2357899999999999998899999999999999999999976666788999 9999999999


Q ss_pred             CCCCCchhhhhcccCCCcccccCCCCCCCC
Q 002809          466 LNGSVPVELLERSKNGSLSLSVGGNPGLCS  495 (878)
Q Consensus       466 l~g~iP~~l~~~~~l~~l~l~~~~n~~lc~  495 (878)
                      |++..|..+..+++|+.  +.+.+|+..|.
T Consensus        90 l~~~~~~~~~~l~~L~~--L~L~~N~~~c~  117 (170)
T 3g39_A           90 LKSIPRGAFDNLKSLTH--IWLLNNPWDCA  117 (170)
T ss_dssp             CCCCCTTTTTTCTTCCE--EECCSSCBCTT
T ss_pred             cCEeCHHHhcCCCCCCE--EEeCCCCCCCC
Confidence            99766666888888874  56678888776

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.13  E-value=2.4e-11  Score=149.00  Aligned_cols=115  Identities=30%  Similarity=0.442  Sum_probs=70.9

Q ss_pred             ccccchHHHHHHHHHhhC---CCCCCC--CCCCCCCCCcccceecCCCCCCCCcEEEEEecCCCcccc---chhh-----
Q 002809          360 QTEQIDVDAITNIKATYG---LKKNWQ--GDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGD---ITSY-----  426 (878)
Q Consensus       360 ~t~~~d~~al~~lk~~~~---~~~~w~--~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g~---ip~~-----  426 (878)
                      ...++|..||.++|+.+.   ...+|+  .|+|     .|.||+|+     ..+|+.|+|++++++|.   +|+.     
T Consensus         8 ~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-----~w~gv~C~-----~~~v~~L~L~~~~l~g~~~~l~~~l~~L~   77 (768)
T 3rgz_A            8 QSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-----TFDGVTCR-----DDKVTSIDLSSKPLNVGFSAVSSSLLSLT   77 (768)
T ss_dssp             CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-----GSTTEEEE-----TTEEEEEECTTSCCCEEHHHHHHHTTTCT
T ss_pred             cCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-----CCcceEEC-----CCcEEEEECCCCCcCCccCccChhHhccC
Confidence            346789999999998774   356895  3567     89999997     24777777777777776   5543     


Q ss_pred             ------------------hhccCCCCEEeCcCCcccCcCCc--cCCCCc-ceEEEecCCcCCCCCchhh-hhcccCCCcc
Q 002809          427 ------------------VSNLTSLQFLDLSNNNLTGSVPD--FLSKLP-LRTLNLQGNKLNGSVPVEL-LERSKNGSLS  484 (878)
Q Consensus       427 ------------------~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~-L~~L~ls~N~l~g~iP~~l-~~~~~l~~l~  484 (878)
                                        |++|++|++|||++|+|+|.+|.  .++.++ |++|+|++|+++|.+|..+ .++++|+.|+
T Consensus        78 ~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  157 (768)
T 3rgz_A           78 GLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD  157 (768)
T ss_dssp             TCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEE
T ss_pred             cccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEE
Confidence                              34445555555555555555554  455555 5555555555555544443 3344444333

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.08  E-value=6.7e-11  Score=123.03  Aligned_cols=149  Identities=20%  Similarity=0.200  Sum_probs=109.2

Q ss_pred             EEEEecCCCCCchh-hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcE
Q 002809          331 FSLYKTGNSTLPPI-INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRI  409 (878)
Q Consensus       331 ~~l~~t~~s~lpp~-inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l  409 (878)
                      +.........+|+. ...++.+.+..+......|..+..+..|+.+....+.+..-|..    .+         ...++|
T Consensus        24 v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~----~~---------~~l~~L   90 (229)
T 3e6j_A           24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG----VF---------DSLTQL   90 (229)
T ss_dssp             EECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT----TT---------TTCTTC
T ss_pred             eEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChh----hc---------ccCCCc
Confidence            44444555666653 34777788877664444455566666666655444444433321    11         346789


Q ss_pred             EEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccC
Q 002809          410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       410 ~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      +.|+|++|+|++..+..|..|++|+.|+|++|+|+ .||..+..++ |+.|+|++|+|++..+..+..+++|+  .+.+.
T Consensus        91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~l~  167 (229)
T 3e6j_A           91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT--HAYLF  167 (229)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCC--EEECT
T ss_pred             CEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCC--EEEee
Confidence            99999999999777777899999999999999999 8999999999 99999999999965556688888887  45667


Q ss_pred             CCCCCCC
Q 002809          489 GNPGLCS  495 (878)
Q Consensus       489 ~n~~lc~  495 (878)
                      +|+..|.
T Consensus       168 ~N~~~c~  174 (229)
T 3e6j_A          168 GNPWDCE  174 (229)
T ss_dssp             TSCBCTT
T ss_pred             CCCccCC
Confidence            8888775

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.06  E-value=7.9e-11  Score=129.42  Aligned_cols=80  Identities=19%  Similarity=0.256  Sum_probs=52.2

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|+|++ +|+.+++|++|+.|+|++|++.|.+|..++.++ |+.|+|++|++.|.+|..+.++++|+.|+
T Consensus       205 l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~  283 (328)
T 4fcg_A          205 LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD  283 (328)
T ss_dssp             CTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEE
T ss_pred             CCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEe
Confidence            3466666666666663 555666666666666666666666666666666 66666666666666666666666666444


Q ss_pred             cc
Q 002809          485 LS  486 (878)
Q Consensus       485 l~  486 (878)
                      ++
T Consensus       284 L~  285 (328)
T 4fcg_A          284 LR  285 (328)
T ss_dssp             CT
T ss_pred             CC
Confidence            43

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.06  E-value=1.8e-10  Score=121.94  Aligned_cols=138  Identities=15%  Similarity=0.115  Sum_probs=109.3

Q ss_pred             hcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeeccCCCh
Q 002809          570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       570 f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      +...++.|+.+.||+....+..+++|+...........+.+|+++++.++ |..+.++++++...+..++||||++|.+|
T Consensus        18 ~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   97 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC   97 (263)
T ss_dssp             EEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred             eEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence            45677888889999998878899999987532222346889999999995 66788899998888889999999999998


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 002809          649 QEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG----------------------------------------------  682 (878)
Q Consensus       649 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------------  682 (878)
                      .+.+..       ......++.+++++|+.||+.                                              
T Consensus        98 ~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (263)
T 3tm0_A           98 SEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             HHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred             hhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence            876421       122347889999999999981                                              


Q ss_pred             ----------CCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          683 ----------CKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       683 ----------~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                                ..+.++|+|+++.|||++++..+.|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                      01458999999999999876667899999764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.05  E-value=9.7e-11  Score=128.71  Aligned_cols=127  Identities=13%  Similarity=0.102  Sum_probs=99.4

Q ss_pred             hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccccch
Q 002809          345 INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDIT  424 (878)
Q Consensus       345 inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g~ip  424 (878)
                      +..|+.+.+..+. .+.+|..+..+..|+.+....+.+.+.|.     .+         ...++|+.|+|++|++.|.+|
T Consensus       182 l~~L~~L~L~~n~-l~~lp~~l~~l~~L~~L~L~~N~l~~l~~-----~l---------~~l~~L~~L~Ls~n~~~~~~p  246 (328)
T 4fcg_A          182 LVNLQSLRLEWTG-IRSLPASIANLQNLKSLKIRNSPLSALGP-----AI---------HHLPKLEELDLRGCTALRNYP  246 (328)
T ss_dssp             STTCCEEEEEEEC-CCCCCGGGGGCTTCCEEEEESSCCCCCCG-----GG---------GGCTTCCEEECTTCTTCCBCC
T ss_pred             CCCCCEEECcCCC-cCcchHhhcCCCCCCEEEccCCCCCcCch-----hh---------ccCCCCCEEECcCCcchhhhH
Confidence            3456666666554 44666666655555554443344443332     11         345789999999999999999


Q ss_pred             hhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccc
Q 002809          425 SYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLS  486 (878)
Q Consensus       425 ~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~  486 (878)
                      ..++++++|+.|+|++|++.|.+|..++.++ |+.|+|++|++.|.+|.++++++++..+.+.
T Consensus       247 ~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~  309 (328)
T 4fcg_A          247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP  309 (328)
T ss_dssp             CCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECC
T ss_pred             HHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCC
Confidence            9999999999999999999999999999999 9999999999999999999999998866554

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.05  E-value=1.9e-11  Score=133.40  Aligned_cols=89  Identities=28%  Similarity=0.381  Sum_probs=78.3

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...++|+.|+|++|+++|.+|. +..+++|+.|+|++|+|+|.+|..+..++ |+.|+|++|+|+|.+|.. .+++++. 
T Consensus       218 ~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~-  294 (313)
T 1ogq_A          218 GSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFD-  294 (313)
T ss_dssp             CTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSC-
T ss_pred             hcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccC-
Confidence            3467899999999999987776 88999999999999999999999999999 999999999999999986 7777777 


Q ss_pred             cccccCCCCCCCCC
Q 002809          483 LSLSVGGNPGLCSK  496 (878)
Q Consensus       483 l~l~~~~n~~lc~~  496 (878)
                       .+.+.+|+.+|+.
T Consensus       295 -~l~l~~N~~lc~~  307 (313)
T 1ogq_A          295 -VSAYANNKCLCGS  307 (313)
T ss_dssp             -GGGTCSSSEEEST
T ss_pred             -hHHhcCCCCccCC
Confidence             4567789999985

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.03  E-value=2.1e-10  Score=120.84  Aligned_cols=152  Identities=21%  Similarity=0.183  Sum_probs=104.3

Q ss_pred             eEEEEEecCCCCCchh----hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCC
Q 002809          329 YSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDS  404 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~  404 (878)
                      ..+.|..+..+.++|.    +..|+.+.+..+......+..+..+..|+.+....+...+.|..    .+         .
T Consensus        38 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~~---------~  104 (251)
T 3m19_A           38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLG----VF---------D  104 (251)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT----TT---------T
T ss_pred             CEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChh----Hh---------c
Confidence            3455555555666552    34666666666553322233345555555544433444333321    11         3


Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..++.++ |+.|+|++|+|++..|..+..+++|+. 
T Consensus       105 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-  183 (251)
T 3m19_A          105 HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT-  183 (251)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-
T ss_pred             ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCE-
Confidence            457899999999999976677789999999999999999976666789998 999999999999777778888888874 


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                       +.+.+|+..|.
T Consensus       184 -L~l~~N~~~c~  194 (251)
T 3m19_A          184 -ITLFGNQFDCS  194 (251)
T ss_dssp             -EECCSCCBCTT
T ss_pred             -EEeeCCceeCC
Confidence             56677887765

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.02  E-value=1.1e-10  Score=120.77  Aligned_cols=90  Identities=23%  Similarity=0.228  Sum_probs=75.9

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...++|+.|+|++|+|++..+..|..|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..|..+..+++++ 
T Consensus        77 ~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-  155 (220)
T 2v9t_B           77 QGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ-  155 (220)
T ss_dssp             TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC-
T ss_pred             hCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCC-
Confidence            3457899999999999955555678999999999999999988889999999 99999999999977677788888877 


Q ss_pred             cccccCCCCCCCC
Q 002809          483 LSLSVGGNPGLCS  495 (878)
Q Consensus       483 l~l~~~~n~~lc~  495 (878)
                       .+.+.+|+..|.
T Consensus       156 -~L~L~~N~~~c~  167 (220)
T 2v9t_B          156 -TMHLAQNPFICD  167 (220)
T ss_dssp             -EEECCSSCEECS
T ss_pred             -EEEeCCCCcCCC
Confidence             456778888775

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.01  E-value=3.9e-10  Score=117.16  Aligned_cols=101  Identities=17%  Similarity=0.145  Sum_probs=83.1

Q ss_pred             CCCCCCCCCCcccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-
Q 002809          383 QGDPCAPLAYWWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-  455 (878)
Q Consensus       383 ~~~pc~~~~~~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-  455 (878)
                      ....|     .|++|.|+...      ..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..++ 
T Consensus        15 ~~~~C-----s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~   89 (229)
T 3e6j_A           15 SQCSC-----SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ   89 (229)
T ss_dssp             TTCEE-----ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             CCCEE-----eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCC
Confidence            34577     79999998542      3457899999999999998899999999999999999999855456678898 


Q ss_pred             ceEEEecCCcCCCCCchhhhhcccCCCcccccC
Q 002809          456 LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       456 L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |+.|+|++|+|++..|..+..+++|+.|+++.+
T Consensus        90 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N  122 (229)
T 3e6j_A           90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCN  122 (229)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cCEEECCCCcCCccChhHhCcchhhCeEeccCC
Confidence            999999999999665666788888887666544

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.01  E-value=5.3e-10  Score=111.11  Aligned_cols=100  Identities=21%  Similarity=0.191  Sum_probs=81.5

Q ss_pred             ccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcC
Q 002809          394 WDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL  466 (878)
Q Consensus       394 w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l  466 (878)
                      ..-+.|+...      ...++|+.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|
T Consensus        14 ~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l   93 (174)
T 2r9u_A           14 QTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL   93 (174)
T ss_dssp             SSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence            4456776431      2357899999999999999999999999999999999999975555678999 99999999999


Q ss_pred             CCCCchhhhhcccCCCcccccCCCCCCCC
Q 002809          467 NGSVPVELLERSKNGSLSLSVGGNPGLCS  495 (878)
Q Consensus       467 ~g~iP~~l~~~~~l~~l~l~~~~n~~lc~  495 (878)
                      ++..|..+..+++|+.  +.+.+|+..|.
T Consensus        94 ~~l~~~~~~~l~~L~~--L~L~~N~~~c~  120 (174)
T 2r9u_A           94 KSIPRGAFDNLKSLTH--IYLYNNPWDCE  120 (174)
T ss_dssp             CCCCTTTTTTCTTCSE--EECCSSCBCTT
T ss_pred             ceeCHHHhccccCCCE--EEeCCCCcccc
Confidence            9554445888888884  56678887765

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.01  E-value=2.5e-10  Score=115.24  Aligned_cols=89  Identities=25%  Similarity=0.334  Sum_probs=79.5

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++.+|..|+++++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++.+|..+..+++|+. 
T Consensus        52 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-  130 (192)
T 1w8a_A           52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS-  130 (192)
T ss_dssp             GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE-
T ss_pred             cCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCE-
Confidence            456899999999999999999999999999999999999988888899999 999999999999988999999888874 


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                       +...+|+..|.
T Consensus       131 -L~L~~N~l~c~  141 (192)
T 1w8a_A          131 -LNLASNPFNCN  141 (192)
T ss_dssp             -EECTTCCBCCS
T ss_pred             -EEeCCCCccCc
Confidence             55677887765

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.00  E-value=3e-10  Score=114.84  Aligned_cols=88  Identities=30%  Similarity=0.358  Sum_probs=76.1

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..++ |+.|+|++|+|++..+..+..+++|+  .
T Consensus        53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~  130 (193)
T 2wfh_A           53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALS--H  130 (193)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCC--E
T ss_pred             ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCcccc--E
Confidence            46899999999999988888999999999999999999988888899999 99999999999954444677788877  4


Q ss_pred             cccCCCCCCCC
Q 002809          485 LSVGGNPGLCS  495 (878)
Q Consensus       485 l~~~~n~~lc~  495 (878)
                      +.+.+|+..|.
T Consensus       131 L~L~~N~~~C~  141 (193)
T 2wfh_A          131 LAIGANPLYCD  141 (193)
T ss_dssp             EECCSSCEECS
T ss_pred             EEeCCCCeecC
Confidence            56788888875

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.98  E-value=4.9e-10  Score=123.73  Aligned_cols=100  Identities=25%  Similarity=0.294  Sum_probs=82.5

Q ss_pred             cccceecCCC--------CCCCCcEEEEEecC-CCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEec
Q 002809          393 WWDGLNCSYG--------DSSSPRITYLNLSS-SGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ  462 (878)
Q Consensus       393 ~w~gv~C~~~--------~~~~~~l~~l~l~~-n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls  462 (878)
                      .|..|.|+..        .....+|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|+.|+ |+.|+|+
T Consensus         9 ~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A            9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             cCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            6889999865        23346799999996 999988889999999999999999999999999999999 9999999


Q ss_pred             CCcCCCCCchhhhhcccCCCcccccCCCCCCCC
Q 002809          463 GNKLNGSVPVELLERSKNGSLSLSVGGNPGLCS  495 (878)
Q Consensus       463 ~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~lc~  495 (878)
                      +|+|++ +|..+.....|+  .+.+.+|+..|.
T Consensus        89 ~N~l~~-~~~~~~~~~~L~--~l~l~~N~~~c~  118 (347)
T 2ifg_A           89 FNALES-LSWKTVQGLSLQ--ELVLSGNPLHCS  118 (347)
T ss_dssp             SSCCSC-CCSTTTCSCCCC--EEECCSSCCCCC
T ss_pred             CCccce-eCHHHcccCCce--EEEeeCCCccCC
Confidence            999995 555544433365  456677888775

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.96  E-value=5.7e-10  Score=119.03  Aligned_cols=150  Identities=23%  Similarity=0.225  Sum_probs=103.6

Q ss_pred             EEEEEecCCCCCchh--hhhhhhheeccccccccccch-HHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          330 SFSLYKTGNSTLPPI--INAIEVYSVKEFLQLQTEQID-VDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       330 ~~~l~~t~~s~lpp~--inalEi~~l~~~~~~~t~~~d-~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      .+.+..+....++.+  +..|+.+.+..+. .+.++.+ +..+..|+.+....+.+.+.|..    .         ....
T Consensus        67 ~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~---------~~~l  132 (272)
T 3rfs_A           67 YLALGGNKLHDISALKELTNLTYLILTGNQ-LQSLPNGVFDKLTNLKELVLVENQLQSLPDG----V---------FDKL  132 (272)
T ss_dssp             EEECTTSCCCCCGGGTTCTTCCEEECTTSC-CCCCCTTTTTTCTTCCEEECTTSCCCCCCTT----T---------TTTC
T ss_pred             EEECCCCCCCCchhhcCCCCCCEEECCCCc-cCccChhHhcCCcCCCEEECCCCcCCccCHH----H---------hccC
Confidence            344444444444332  3366666666654 3444433 34555555544444444333221    0         1345


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      ++|+.|+|++|+|++..|..++++++|+.|+|++|+|++..|..++.++ |+.|+|++|+|++..|..+..+++|+.  +
T Consensus       133 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~--L  210 (272)
T 3rfs_A          133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY--I  210 (272)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE--E
T ss_pred             CCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCE--E
Confidence            7899999999999977777889999999999999999987777789999 999999999999877777888888885  4


Q ss_pred             ccCCCCCCCC
Q 002809          486 SVGGNPGLCS  495 (878)
Q Consensus       486 ~~~~n~~lc~  495 (878)
                      .+.+|+..|.
T Consensus       211 ~l~~N~~~~~  220 (272)
T 3rfs_A          211 WLHDNPWDCT  220 (272)
T ss_dssp             ECCSSCBCCC
T ss_pred             EccCCCcccc
Confidence            5567777665

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=98.95  E-value=1.2e-09  Score=108.39  Aligned_cols=145  Identities=14%  Similarity=0.141  Sum_probs=89.0

Q ss_pred             EEEEEeeccCCCceeecCCCCCCceeecCCCCCce--eeccccccccCCCCCCCChhhhhccccccCCCCccceeeccCC
Q 002809          192 LFTRLDVASTTNLTIRYNDDVHDRSWFPYNSANWA--RINTSLTVDAESHNSYQPPAVVMNTAGTPKNASQSMDFYLETE  269 (878)
Q Consensus       192 ~~~r~~~g~~~~~~~ryp~D~~dR~W~~~~~~~~~--~~~t~~~~~~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~~~~~  269 (878)
                      ...|.|||+..   +.   |..+|.|.+-..  +.  ...+...........+..|..|+|||=...     .+++|..+
T Consensus         6 ~~~~INcGg~~---~~---d~~gr~w~~D~~--~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~-----~~~tY~f~   72 (174)
T 2jwp_A            6 VIWAVNAGGES---HV---DVHGIHYRKDPL--EGRVGRASDYGMKLPILRSNPEDQVLYQTERYNE-----DSFGYDIP   72 (174)
T ss_dssp             EEEEEEETSSS---EE---ETTTEEECSSCS--STTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCC-----SCEEEEEE
T ss_pred             EEEEEECCCCC---cc---CCCCCEEcCCcC--cccCCcccccccceEecccCCCCchhhhhhccCC-----CCeEEEEE
Confidence            46799999864   22   678999975321  11  000000000011122457889999997643     24455444


Q ss_pred             -CCCceEEEEEeeccccccccCceeEEEEEECCccccCCCCCCccc----ee-EEEc-----------ce-eecCceeEE
Q 002809          270 -DPSIQFYVYMHFAEVQILQANQSRQFNISLNGEHWYGPFSPNYLL----TT-TVFS-----------PT-ALIGGNYSF  331 (878)
Q Consensus       270 -~~~~~~~~~l~Fae~~~~~~~~~R~F~i~in~~~~~~~~~p~~~~----~~-~~~~-----------~~-~~~~~~~~~  331 (878)
                       +++-.|.|.|||||+.. ++.++|+|||++||+...+.|++....    +. ..|.           .. ...+|..+|
T Consensus        73 v~~~G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I  151 (174)
T 2jwp_A           73 IKEEGEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSV  151 (174)
T ss_dssp             CCSCEEEEEEEEEECCSC-CCSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEE
T ss_pred             eCCCeEEEEEEEEecccc-CCCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEE
Confidence             45689999999999974 567899999999999876555532111    10 0010           00 135677888


Q ss_pred             EEEecCCCCCchhhhhhhhhe
Q 002809          332 SLYKTGNSTLPPIINAIEVYS  352 (878)
Q Consensus       332 ~l~~t~~s~lpp~inalEi~~  352 (878)
                      ++.+.  +.-.|+|||+|++.
T Consensus       152 ~f~p~--~~~~a~inaIEI~~  170 (174)
T 2jwp_A          152 EFVKG--YYDNPKVCALFIMK  170 (174)
T ss_dssp             EEECS--SSCSSSEEEEEEES
T ss_pred             EEecc--CCCCcEEEEEEEEe
Confidence            88764  24469999999975

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.95  E-value=4.1e-10  Score=121.50  Aligned_cols=133  Identities=23%  Similarity=0.210  Sum_probs=97.3

Q ss_pred             hhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccccchh
Q 002809          346 NAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITS  425 (878)
Q Consensus       346 nalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g~ip~  425 (878)
                      ..++.+.+..+. .+.+|..+..+.+|+.+....+.+.+.|-.    .+         ...++|+.|+|++|+|++..+.
T Consensus        77 ~~L~~L~Ls~N~-l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~----~~---------~~l~~L~~L~L~~N~l~~~~~~  142 (290)
T 1p9a_G           77 PVLGTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLTSLPLG----AL---------RGLGELQELYLKGNELKTLPPG  142 (290)
T ss_dssp             TTCCEEECCSSC-CSSCCCCTTTCTTCCEEECCSSCCCCCCSS----TT---------TTCTTCCEEECTTSCCCCCCTT
T ss_pred             CcCCEEECCCCc-CCcCchhhccCCCCCEEECCCCcCcccCHH----HH---------cCCCCCCEEECCCCCCCccChh
Confidence            356666666554 456666555555555444444444433321    11         3457899999999999977777


Q ss_pred             hhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccCCCCCCCC
Q 002809          426 YVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCS  495 (878)
Q Consensus       426 ~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~lc~  495 (878)
                      .|..+++|+.|+|++|+|++..+..+..++ |+.|+|++|+|+ .+|..+..+..++  .+.+.+||..|.
T Consensus       143 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~--~l~L~~Np~~C~  210 (290)
T 1p9a_G          143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP--FAFLHGNPWLCN  210 (290)
T ss_dssp             TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCS--EEECCSCCBCCS
T ss_pred             hcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCC--eEEeCCCCccCc
Confidence            789999999999999999954445568888 999999999999 8999998887776  466789999886

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.95  E-value=4e-10  Score=118.66  Aligned_cols=147  Identities=17%  Similarity=0.126  Sum_probs=108.5

Q ss_pred             eEEEEEecCCCCCchhh-hhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCC
Q 002809          329 YSFSLYKTGNSTLPPII-NAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSP  407 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~i-nalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~  407 (878)
                      ..+.+.......+|+.+ ..++.+.+..+......+..+..+.+|+.+....+...+.+-.    .+         ...+
T Consensus        17 ~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~~---------~~l~   83 (251)
T 3m19_A           17 KEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG----VF---------DDLT   83 (251)
T ss_dssp             TEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT----TT---------TTCT
T ss_pred             eEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh----Hh---------ccCC
Confidence            45566666777777644 4788888888764443444566666666655444454443321    11         3467


Q ss_pred             cEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccc
Q 002809          408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLS  486 (878)
Q Consensus       408 ~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~  486 (878)
                      +|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..|..+..+++|+.|+++
T Consensus        84 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  163 (251)
T 3m19_A           84 ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLS  163 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             cCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECC
Confidence            899999999999987788899999999999999999966666688898 9999999999996666678889988877665


Q ss_pred             cC
Q 002809          487 VG  488 (878)
Q Consensus       487 ~~  488 (878)
                      .+
T Consensus       164 ~N  165 (251)
T 3m19_A          164 TN  165 (251)
T ss_dssp             SS
T ss_pred             CC
Confidence            54

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.93  E-value=9.4e-10  Score=112.17  Aligned_cols=89  Identities=27%  Similarity=0.305  Sum_probs=73.8

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..+..+..+++++. 
T Consensus        74 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~-  152 (208)
T 2o6s_A           74 KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY-  152 (208)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-
T ss_pred             CCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccE-
Confidence            457899999999999976677789999999999999999976667788898 999999999999665656788888875 


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                       +.+.+|+..|.
T Consensus       153 -L~l~~N~~~~~  163 (208)
T 2o6s_A          153 -IWLHDNPWDCT  163 (208)
T ss_dssp             -EECCSCCBCCC
T ss_pred             -EEecCCCeecC
Confidence             45567776654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.92  E-value=1.5e-09  Score=109.65  Aligned_cols=95  Identities=25%  Similarity=0.227  Sum_probs=83.2

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|..+.|+.+.      ..++.|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|..++ |+.|+|++|+
T Consensus        11 ~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           11 LDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             ETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            57888998542      34568999999999998 8999999999999999999999988888899999 9999999999


Q ss_pred             CCCCCchhhhhcccCCCcccccC
Q 002809          466 LNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       466 l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |++..|..+..+++|+.|+++.+
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N  112 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGN  112 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCC
Confidence            99877888999999987766554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.91  E-value=1.6e-09  Score=107.45  Aligned_cols=96  Identities=24%  Similarity=0.226  Sum_probs=78.0

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|.+|.|+...      ...++|+.|+|++|+|++..+..|+++++|+.|+|++|+|++..|..+..++ |+.|+|++|+
T Consensus         8 ~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   87 (177)
T 2o6r_A            8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK   87 (177)
T ss_dssp             ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence            69999998542      2346899999999999977677789999999999999999966666678888 9999999999


Q ss_pred             CCCCCchhhhhcccCCCcccccC
Q 002809          466 LNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       466 l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |++..|..+..+++|+.|+++.+
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~N  110 (177)
T 2o6r_A           88 LQSLPNGVFDKLTQLKELALDTN  110 (177)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSS
T ss_pred             ccccCHHHhhCCcccCEEECcCC
Confidence            99766666788888887666544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.90  E-value=1.1e-09  Score=110.50  Aligned_cols=96  Identities=22%  Similarity=0.212  Sum_probs=82.8

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchh-hhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCC
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITS-YVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN  464 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N  464 (878)
                      .|+.+.|+...      ....+|+.|+|++|+|++..|. .|++|++|+.|+|++|+|++.+|..+..++ |+.|+|++|
T Consensus         9 ~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A            9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            68899998542      2345899999999999966664 499999999999999999999999999999 999999999


Q ss_pred             cCCCCCchhhhhcccCCCcccccC
Q 002809          465 KLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       465 ~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      +|++..|..+..+++|+.|+++.+
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N  112 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDN  112 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSS
T ss_pred             cCCccCHHHhcCCCCCCEEECCCC
Confidence            999888888999999987766544

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.90  E-value=2.7e-09  Score=112.12  Aligned_cols=127  Identities=17%  Similarity=0.093  Sum_probs=96.6

Q ss_pred             cccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccc--eeeeeecccCCCcceeEeeeccCCChhhh
Q 002809          575 GKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN--LTSLVGHCDEDNQTALIYEFMANGNLQEY  651 (878)
Q Consensus       575 G~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~  651 (878)
                      +.|..+.||+....+ ..+++|+....   ....+.+|+++++.+++.+  +.+++++...++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            455669999997654 67999997654   2356789999999997555  445888888777889999999998884  


Q ss_pred             hccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 002809          652 LSDISKKVLSSQERLRIAVESAQGLEYLHNGC------------------------------------------------  683 (878)
Q Consensus       652 l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------------  683 (878)
                      ...     ..   ...++.++++.|+.||+..                                                
T Consensus       104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence            221     11   2367788888888888642                                                


Q ss_pred             -------CCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          684 -------KPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       684 -------~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                             ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                   1129999999999999887667899999875

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.89  E-value=6.8e-10  Score=127.41  Aligned_cols=152  Identities=17%  Similarity=0.094  Sum_probs=108.5

Q ss_pred             eeEEEEEecCCCCCchh----hhhhhhheeccccccccccch-HHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCC
Q 002809          328 NYSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQID-VDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYG  402 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d-~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~  402 (878)
                      ...+.|..+....+|+.    +..|+.+.+..+...+.++.+ +..|.+|+.+....+...+.|-               
T Consensus       149 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~---------------  213 (452)
T 3zyi_A          149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPN---------------  213 (452)
T ss_dssp             CCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCC---------------
T ss_pred             CCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccccc---------------
Confidence            34555555556666552    345666666654445555543 3334444433333333322221               


Q ss_pred             CCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCC
Q 002809          403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNG  481 (878)
Q Consensus       403 ~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~  481 (878)
                      ....++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..+..+..+++|+
T Consensus       214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  293 (452)
T 3zyi_A          214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV  293 (452)
T ss_dssp             CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCC
T ss_pred             ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCC
Confidence            24567899999999999999999999999999999999999999999999999 99999999999966666677788777


Q ss_pred             CcccccCCCCCCCCC
Q 002809          482 SLSLSVGGNPGLCSK  496 (878)
Q Consensus       482 ~l~l~~~~n~~lc~~  496 (878)
                        .+.+.+||..|..
T Consensus       294 --~L~L~~Np~~CdC  306 (452)
T 3zyi_A          294 --ELHLHHNPWNCDC  306 (452)
T ss_dssp             --EEECCSSCEECST
T ss_pred             --EEEccCCCcCCCC
Confidence              4567789988763

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.87  E-value=1.9e-09  Score=114.72  Aligned_cols=91  Identities=31%  Similarity=0.329  Sum_probs=76.0

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...++|+.|+|++|+|++..+..|+.+++|+.|+|++|++++..|..+..++ |+.|+|++|+|++..+..+..+++|+ 
T Consensus       130 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-  208 (270)
T 2o6q_A          130 DSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLK-  208 (270)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC-
T ss_pred             CcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCC-
Confidence            3467899999999999976667799999999999999999976667788998 99999999999965555677788777 


Q ss_pred             cccccCCCCCCCCC
Q 002809          483 LSLSVGGNPGLCSK  496 (878)
Q Consensus       483 l~l~~~~n~~lc~~  496 (878)
                       .+.+.+||..|..
T Consensus       209 -~L~l~~N~~~c~c  221 (270)
T 2o6q_A          209 -MLQLQENPWDCTC  221 (270)
T ss_dssp             -EEECCSSCBCCSS
T ss_pred             -EEEecCCCeeCCC
Confidence             4567888988763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.87  E-value=6.4e-09  Score=115.46  Aligned_cols=140  Identities=16%  Similarity=0.199  Sum_probs=107.5

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEec--cCC-hhhHHHHHHHHHHHHHhc--ccceeeeeecccCC---CcceeEeeec
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLS--SSS-AQGFQQFQAEVKLLMRVH--HRNLTSLVGHCDED---NQTALIYEFM  643 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~--~~~-~~~~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~---~~~~lV~Ey~  643 (878)
                      +.|+.|.++.||+.+..+..+++|+..  ... ......+.+|+.+++.++  +..+.+++.++.+.   +..++||||+
T Consensus        44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v  123 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV  123 (359)
T ss_dssp             EECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred             EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence            468899999999999888889999876  322 123457889999999997  45577888888766   4588999999


Q ss_pred             cCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 002809          644 ANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC----------------------------------------  683 (878)
Q Consensus       644 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------  683 (878)
                      +|..+.+..    -..++..++..++.++++.|+.||...                                        
T Consensus       124 ~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          124 SGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             CCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             CCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence            998875422    123678888999999999999999721                                        


Q ss_pred             ---------------CCCeEecCCCCccEEEcCCCc--EEEeecCCccc
Q 002809          684 ---------------KPPIVHRDVKSTNILLNEKLQ--AKLADFGLSKS  715 (878)
Q Consensus       684 ---------------~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~  715 (878)
                                     .+.++|||+++.|||+++++.  +.|.||+.+..
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                           257999999999999998753  68999998864

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.87  E-value=1.2e-09  Score=116.96  Aligned_cols=152  Identities=18%  Similarity=0.138  Sum_probs=104.2

Q ss_pred             eEEEEEecC-CCCCchh----hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCC
Q 002809          329 YSFSLYKTG-NSTLPPI----INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGD  403 (878)
Q Consensus       329 ~~~~l~~t~-~s~lpp~----inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~  403 (878)
                      ..+.+..+. ...++|.    +..|+.+.+..+......|..+..+.+|+.+....+...+.|-.    .         .
T Consensus        83 ~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~----~---------~  149 (285)
T 1ozn_A           83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD----T---------F  149 (285)
T ss_dssp             CEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT----T---------T
T ss_pred             CEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHh----H---------h
Confidence            344444443 4444332    34566666665543222244444444444444333333332210    0         1


Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..+..++ |+.|+|++|++++..|..+..+++|+.
T Consensus       150 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  229 (285)
T 1ozn_A          150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY  229 (285)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred             ccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCE
Confidence            3457899999999999966666799999999999999999999999999999 999999999999766677888888874


Q ss_pred             cccccCCCCCCCC
Q 002809          483 LSLSVGGNPGLCS  495 (878)
Q Consensus       483 l~l~~~~n~~lc~  495 (878)
                        +.+.+|+..|.
T Consensus       230 --L~l~~N~~~c~  240 (285)
T 1ozn_A          230 --LRLNDNPWVCD  240 (285)
T ss_dssp             --EECCSSCEECS
T ss_pred             --EeccCCCccCC
Confidence              56678887765

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.87  E-value=5.5e-10  Score=107.51  Aligned_cols=82  Identities=21%  Similarity=0.234  Sum_probs=65.4

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccC-cCCccCCCCc-ceEEEecCCcCCCCCc---hhhhhcc
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGNKLNGSVP---VELLERS  478 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~-L~~L~ls~N~l~g~iP---~~l~~~~  478 (878)
                      ...++|+.|+|++|+|++.+|..++++++|+.|+|++|++++ ..|..++.++ |+.|+|++|++++..+   ..+..++
T Consensus        61 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~  140 (149)
T 2je0_A           61 PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP  140 (149)
T ss_dssp             CCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCT
T ss_pred             hcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCC
Confidence            345688889999999988888888888999999999999886 3457788888 8999999998886554   4677788


Q ss_pred             cCCCccc
Q 002809          479 KNGSLSL  485 (878)
Q Consensus       479 ~l~~l~l  485 (878)
                      +|+.|++
T Consensus       141 ~L~~L~l  147 (149)
T 2je0_A          141 QLTYLDG  147 (149)
T ss_dssp             TCCEETT
T ss_pred             CcccccC
Confidence            7776654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.86  E-value=8e-10  Score=126.33  Aligned_cols=152  Identities=16%  Similarity=0.118  Sum_probs=107.1

Q ss_pred             eeEEEEEecCCCCCchh----hhhhhhheeccccccccccch-HHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCC
Q 002809          328 NYSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQID-VDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYG  402 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d-~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~  402 (878)
                      ...+.|..+....+|+.    +..|+.+.+..+...+.++.+ +..|.+|+.+....+....-|-               
T Consensus       138 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~---------------  202 (440)
T 3zyj_A          138 LKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPN---------------  202 (440)
T ss_dssp             CCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCC---------------
T ss_pred             CceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccccc---------------
Confidence            34455555555555542    345666666654444444442 3333333333322233222221               


Q ss_pred             CCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCC
Q 002809          403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNG  481 (878)
Q Consensus       403 ~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~  481 (878)
                      ....++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..+..+..+++|+
T Consensus       203 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  282 (440)
T 3zyj_A          203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE  282 (440)
T ss_dssp             CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCC
T ss_pred             cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCC
Confidence            24567899999999999998899999999999999999999998899999999 99999999999966666677788777


Q ss_pred             CcccccCCCCCCCCC
Q 002809          482 SLSLSVGGNPGLCSK  496 (878)
Q Consensus       482 ~l~l~~~~n~~lc~~  496 (878)
                        .+.+.+||..|..
T Consensus       283 --~L~L~~Np~~CdC  295 (440)
T 3zyj_A          283 --RIHLHHNPWNCNC  295 (440)
T ss_dssp             --EEECCSSCEECSS
T ss_pred             --EEEcCCCCccCCC
Confidence              4667899988863

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.83  E-value=4e-09  Score=107.50  Aligned_cols=96  Identities=26%  Similarity=0.271  Sum_probs=79.6

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|.+|.|+..+      ...++|+.|+|++|+|++..+..|+++++|+.|+|++|+|++..+..+..++ |+.|+|++|+
T Consensus         8 ~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~   87 (208)
T 2o6s_A            8 SGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ   87 (208)
T ss_dssp             ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence            79999998543      2356899999999999977777789999999999999999966666678898 9999999999


Q ss_pred             CCCCCchhhhhcccCCCcccccC
Q 002809          466 LNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       466 l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |++..|..+..+++|+.|+++.+
T Consensus        88 l~~~~~~~~~~l~~L~~L~L~~N  110 (208)
T 2o6s_A           88 LQSLPNGVFDKLTQLKELALNTN  110 (208)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCccCHhHhcCccCCCEEEcCCC
Confidence            99655566788888887766544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.81  E-value=3.4e-09  Score=112.90  Aligned_cols=145  Identities=17%  Similarity=0.148  Sum_probs=102.2

Q ss_pred             eEEEEEecCCCCCchh--hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          329 YSFSLYKTGNSTLPPI--INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~--inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      ..+.+..+....++.+  +..++.+.+..+. ...++ .+..+..|+.+....+.+.+.|..    .         ....
T Consensus        44 ~~L~l~~~~i~~~~~l~~l~~L~~L~l~~n~-l~~~~-~l~~l~~L~~L~L~~n~l~~~~~~----~---------~~~l  108 (272)
T 3rfs_A           44 DQIIANNSDIKSVQGIQYLPNVRYLALGGNK-LHDIS-ALKELTNLTYLILTGNQLQSLPNG----V---------FDKL  108 (272)
T ss_dssp             CEEECTTSCCCCCTTGGGCTTCCEEECTTSC-CCCCG-GGTTCTTCCEEECTTSCCCCCCTT----T---------TTTC
T ss_pred             eeeeeCCCCcccccccccCCCCcEEECCCCC-CCCch-hhcCCCCCCEEECCCCccCccChh----H---------hcCC
Confidence            3444444445555433  4577778887765 33433 454554555444434444433321    0         1345


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..++.++ |+.|+|++|+|++..|..+..+++|+.|++
T Consensus       109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  188 (272)
T 3rfs_A          109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL  188 (272)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEEC
Confidence            7899999999999988888899999999999999999977777788999 999999999999777777788888887766


Q ss_pred             ccC
Q 002809          486 SVG  488 (878)
Q Consensus       486 ~~~  488 (878)
                      +.+
T Consensus       189 ~~N  191 (272)
T 3rfs_A          189 YQN  191 (272)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.80  E-value=1.5e-09  Score=116.98  Aligned_cols=79  Identities=30%  Similarity=0.350  Sum_probs=45.8

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCch-hhhhcccCCCc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPV-ELLERSKNGSL  483 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~-~l~~~~~l~~l  483 (878)
                      .++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|+ .+|. .+..+++|+.|
T Consensus        99 l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L  177 (290)
T 1p9a_G           99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL  177 (290)
T ss_dssp             CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEE
T ss_pred             CCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEE
Confidence            44566666666666655555566666666666666666644444455565 666666666666 3333 33445555544


Q ss_pred             cc
Q 002809          484 SL  485 (878)
Q Consensus       484 ~l  485 (878)
                      ++
T Consensus       178 ~L  179 (290)
T 1p9a_G          178 LL  179 (290)
T ss_dssp             EC
T ss_pred             EC
Confidence            43

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.78  E-value=1.7e-09  Score=109.48  Aligned_cols=77  Identities=23%  Similarity=0.306  Sum_probs=35.2

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      ++|+.|+|++|++++..|..|+.|++|+.|+|++|++++..|..++.++ |+.|+|++|++.+.+| .+..+++|+.|+
T Consensus        88 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~  165 (197)
T 4ezg_A           88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN  165 (197)
T ss_dssp             TTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred             CCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence            3444444444444444444444444444444444444444444444444 4444444444222343 344444444333

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.78  E-value=1.2e-09  Score=129.99  Aligned_cols=90  Identities=23%  Similarity=0.245  Sum_probs=75.4

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcc-cCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERS-KNG  481 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~-~l~  481 (878)
                      ...++|+.|+|++|+|++.+|..|++|++|+.|+|++|++++.+|..++.++ |+.|+|++|+|+ .+|..+..++ +++
T Consensus       470 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~  548 (606)
T 3vq2_A          470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLA  548 (606)
T ss_dssp             TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCC
T ss_pred             ccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCc
Confidence            4557889999999999988888899999999999999999988888898888 999999999998 7888887776 366


Q ss_pred             CcccccCCCCCCCCC
Q 002809          482 SLSLSVGGNPGLCSK  496 (878)
Q Consensus       482 ~l~l~~~~n~~lc~~  496 (878)
                        .+...+|+..|..
T Consensus       549 --~l~l~~N~~~c~c  561 (606)
T 3vq2_A          549 --FFNLTNNSVACIC  561 (606)
T ss_dssp             --EEECCSCCCCCSS
T ss_pred             --EEEccCCCcccCC
Confidence              4567788888763

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.78  E-value=3.1e-09  Score=104.40  Aligned_cols=85  Identities=22%  Similarity=0.241  Sum_probs=72.1

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCc-CCccCCCCc-ceEEEecCCcCCCCCc---hhhhhcc
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGS-VPDFLSKLP-LRTLNLQGNKLNGSVP---VELLERS  478 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~-iP~~~~~l~-L~~L~ls~N~l~g~iP---~~l~~~~  478 (878)
                      ...++|+.|+|++|+|++.+|..+.++++|+.|+|++|+|++. .+..+..++ |+.|+|++|++++..+   ..+..++
T Consensus        68 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~  147 (168)
T 2ell_A           68 PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLP  147 (168)
T ss_dssp             CCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCS
T ss_pred             ccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCc
Confidence            4567899999999999988999999999999999999999963 237889999 9999999999995544   3788889


Q ss_pred             cCCCcccccC
Q 002809          479 KNGSLSLSVG  488 (878)
Q Consensus       479 ~l~~l~l~~~  488 (878)
                      +|+.|+++.+
T Consensus       148 ~L~~L~l~~n  157 (168)
T 2ell_A          148 QLTYLDGYDR  157 (168)
T ss_dssp             SCCEETTEET
T ss_pred             cCcEecCCCC
Confidence            8887766544

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.77  E-value=6.6e-09  Score=107.20  Aligned_cols=95  Identities=25%  Similarity=0.270  Sum_probs=76.2

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|..|.|+...      ..++.|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..++ |+.|+|++|+
T Consensus        12 ~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           12 SNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             ETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             CCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            68889998542      2345789999999999977777899999999999999999988888899998 9999999999


Q ss_pred             CCCCCchh-hhhcccCCCcccccC
Q 002809          466 LNGSVPVE-LLERSKNGSLSLSVG  488 (878)
Q Consensus       466 l~g~iP~~-l~~~~~l~~l~l~~~  488 (878)
                      |+ .+|.. +..+++|+.|+++.+
T Consensus        92 l~-~l~~~~f~~l~~L~~L~L~~N  114 (220)
T 2v9t_B           92 IT-ELPKSLFEGLFSLQLLLLNAN  114 (220)
T ss_dssp             CC-CCCTTTTTTCTTCCEEECCSS
T ss_pred             CC-ccCHhHccCCCCCCEEECCCC
Confidence            99 45554 567888886666544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.77  E-value=5.3e-09  Score=124.38  Aligned_cols=91  Identities=26%  Similarity=0.237  Sum_probs=81.4

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhc-ccCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLER-SKNG  481 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~-~~l~  481 (878)
                      ...++|+.|+|++|+|++.+|..|++|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..|..+..+ ++|+
T Consensus       491 ~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~  570 (635)
T 4g8a_A          491 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA  570 (635)
T ss_dssp             TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCC
T ss_pred             hhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCC
Confidence            4567899999999999999999999999999999999999988888899999 9999999999999999988887 4566


Q ss_pred             CcccccCCCCCCCCC
Q 002809          482 SLSLSVGGNPGLCSK  496 (878)
Q Consensus       482 ~l~l~~~~n~~lc~~  496 (878)
                        .+..++||..|.+
T Consensus       571 --~L~L~~Np~~C~C  583 (635)
T 4g8a_A          571 --FLNLTQNDFACTC  583 (635)
T ss_dssp             --EEECTTCCBCCSG
T ss_pred             --EEEeeCCCCcccC
Confidence              4677899999873

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.75  E-value=5.8e-09  Score=110.95  Aligned_cols=146  Identities=21%  Similarity=0.238  Sum_probs=97.8

Q ss_pred             eEEEEEecCCCCCchh----hhhhhhheeccccccccccchH-HHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCC
Q 002809          329 YSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQIDV-DAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGD  403 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d~-~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~  403 (878)
                      ..+.+..+..+.+|+.    +..|+.+.+..+. .+.+|.+. ..+..|+.+....+...+.|-.    .         .
T Consensus        40 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~----~---------~  105 (270)
T 2o6q_A           40 KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK-LQTLPAGIFKELKNLETLWVTDNKLQALPIG----V---------F  105 (270)
T ss_dssp             SEEECCSSCCSCCCTTSSSSCTTCCEEECCSSC-CSCCCTTTTSSCTTCCEEECCSSCCCCCCTT----T---------T
T ss_pred             CEEECcCCCCCeeCHHHhcCCCCCCEEECCCCc-cCeeChhhhcCCCCCCEEECCCCcCCcCCHh----H---------c
Confidence            3455555555566541    3456666665544 44555443 3344444443333333332210    0         1


Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..+..+..++ |+.|+|++|++++..|..+..+++|+.
T Consensus       106 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  185 (270)
T 2o6q_A          106 DQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKT  185 (270)
T ss_dssp             TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             ccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCE
Confidence            3456899999999999988888899999999999999999965556688888 999999999999766666888888887


Q ss_pred             cccccC
Q 002809          483 LSLSVG  488 (878)
Q Consensus       483 l~l~~~  488 (878)
                      |+++.+
T Consensus       186 L~L~~N  191 (270)
T 2o6q_A          186 LKLDNN  191 (270)
T ss_dssp             EECCSS
T ss_pred             EECCCC
Confidence            666543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.74  E-value=4.2e-09  Score=120.44  Aligned_cols=135  Identities=19%  Similarity=0.128  Sum_probs=96.2

Q ss_pred             hhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccccchhh
Q 002809          347 AIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSY  426 (878)
Q Consensus       347 alEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g~ip~~  426 (878)
                      .++.+.+..+...+..|..+..+.+|+.+....+...+.+..    .+         ...++|+.|+|++|+|++..|..
T Consensus       276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~----~~---------~~l~~L~~L~Ls~N~l~~~~~~~  342 (455)
T 3v47_A          276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN----AF---------WGLTHLLKLNLSQNFLGSIDSRM  342 (455)
T ss_dssp             CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT----TT---------TTCTTCCEEECCSSCCCEECGGG
T ss_pred             CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChh----Hh---------cCcccCCEEECCCCccCCcChhH
Confidence            455555555543333444444444444444333333322110    11         34578999999999999888999


Q ss_pred             hhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccCCCCCCCCC
Q 002809          427 VSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCSK  496 (878)
Q Consensus       427 ~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~lc~~  496 (878)
                      |+++++|+.|+|++|++++..|..+..++ |+.|+|++|+|++..+..+..+++|+.  +...+|+..|..
T Consensus       343 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~--L~l~~N~l~~~~  411 (455)
T 3v47_A          343 FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK--IWLHTNPWDCSC  411 (455)
T ss_dssp             GTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE--EECCSSCBCCCT
T ss_pred             hcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccE--EEccCCCcccCC
Confidence            99999999999999999998899999999 999999999999655556678888874  556778877653

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.74  E-value=1.3e-08  Score=100.88  Aligned_cols=89  Identities=25%  Similarity=0.262  Sum_probs=72.6

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++..+..++++++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..+..+..+++|+. 
T Consensus        50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~-  128 (177)
T 2o6r_A           50 KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQK-  128 (177)
T ss_dssp             TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-
T ss_pred             CcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCE-
Confidence            356899999999999976677789999999999999999977777788998 999999999999544444577887775 


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                       +.+.+|+..|.
T Consensus       129 -L~l~~N~~~~~  139 (177)
T 2o6r_A          129 -IWLHTNPWDCS  139 (177)
T ss_dssp             -EECCSSCBCCC
T ss_pred             -EEecCCCeecc
Confidence             45567777654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.74  E-value=1.8e-09  Score=120.12  Aligned_cols=150  Identities=20%  Similarity=0.150  Sum_probs=91.5

Q ss_pred             EEEEecCCCCCch-----hhhhhhhheeccccccccccc-hHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCC
Q 002809          331 FSLYKTGNSTLPP-----IINAIEVYSVKEFLQLQTEQI-DVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDS  404 (878)
Q Consensus       331 ~~l~~t~~s~lpp-----~inalEi~~l~~~~~~~t~~~-d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~  404 (878)
                      +.|..+..+.+|+     .+..|+.+.+..+. ++.++. .+..|.+|+.+....+.....|-.    .+         .
T Consensus        44 L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~-i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~---------~  109 (361)
T 2xot_A           44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSSNHLHTLDEF----LF---------S  109 (361)
T ss_dssp             EECCSSCCCEECTTSSSSCCTTCCEEECCSSC-CCEECTTTTTTCTTCCEEECCSSCCCEECTT----TT---------T
T ss_pred             EECCCCCCCccChhhhhhcccccCEEECCCCc-CCccChhhccCCCCCCEEECCCCcCCcCCHH----Hh---------C
Confidence            4444444444444     23455666665544 334432 344444444444333333222210    01         3


Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccC----CCCc-ceEEEecCCcCCCCCchhhhhccc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFL----SKLP-LRTLNLQGNKLNGSVPVELLERSK  479 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~----~~l~-L~~L~ls~N~l~g~iP~~l~~~~~  479 (878)
                      ..++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++ +|..+    ..++ |+.|+|++|+|++..+..+..++.
T Consensus       110 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~  188 (361)
T 2xot_A          110 DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA  188 (361)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCH
T ss_pred             CCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccH
Confidence            45688889999999987778888999999999999999984 66543    5677 899999999998544456666654


Q ss_pred             CCCcccccCCCCCCCC
Q 002809          480 NGSLSLSVGGNPGLCS  495 (878)
Q Consensus       480 l~~l~l~~~~n~~lc~  495 (878)
                      +..-.+.+.+||..|.
T Consensus       189 ~~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          189 WVKNGLYLHNNPLECD  204 (361)
T ss_dssp             HHHTTEECCSSCEECC
T ss_pred             hhcceEEecCCCccCC
Confidence            3112467788888876

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.74  E-value=7.2e-09  Score=106.88  Aligned_cols=84  Identities=19%  Similarity=0.207  Sum_probs=59.9

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..++ |+.|+|++|+|++..|..+..+++|+.|
T Consensus        55 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  134 (220)
T 2v70_A           55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL  134 (220)
T ss_dssp             GCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred             cCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence            345677777777777766666777777777777777777766666677777 7777777777776667777777777765


Q ss_pred             ccccC
Q 002809          484 SLSVG  488 (878)
Q Consensus       484 ~l~~~  488 (878)
                      +++.+
T Consensus       135 ~L~~N  139 (220)
T 2v70_A          135 SLYDN  139 (220)
T ss_dssp             ECTTS
T ss_pred             ECCCC
Confidence            55443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.72  E-value=1.9e-09  Score=116.70  Aligned_cols=90  Identities=26%  Similarity=0.243  Sum_probs=73.1

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcc-cCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERS-KNG  481 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~-~l~  481 (878)
                      ...++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..+..++ |+.|+|++|++++..|..+..++ .++
T Consensus       172 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~  251 (306)
T 2z66_A          172 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA  251 (306)
T ss_dssp             TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCC
T ss_pred             hhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCC
Confidence            3457889999999999888888899999999999999999876666788888 99999999999988888888774 666


Q ss_pred             CcccccCCCCCCCC
Q 002809          482 SLSLSVGGNPGLCS  495 (878)
Q Consensus       482 ~l~l~~~~n~~lc~  495 (878)
                      .  +...+|+..|.
T Consensus       252 ~--L~L~~N~~~~~  263 (306)
T 2z66_A          252 F--LNLTQNDFACT  263 (306)
T ss_dssp             E--EECTTCCEECS
T ss_pred             E--EEccCCCeecc
Confidence            3  55567777664

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.72  E-value=5.7e-09  Score=111.79  Aligned_cols=146  Identities=15%  Similarity=0.111  Sum_probs=97.6

Q ss_pred             EEEEEecCCCCCch-h---hhhhhhheeccccccccc-cchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCC
Q 002809          330 SFSLYKTGNSTLPP-I---INAIEVYSVKEFLQLQTE-QIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDS  404 (878)
Q Consensus       330 ~~~l~~t~~s~lpp-~---inalEi~~l~~~~~~~t~-~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~  404 (878)
                      .+.+..+....++| .   +..++.+.+..+...+.+ |..+..+.+|+.+....+.+.+.+-.    .         ..
T Consensus        60 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~----~---------~~  126 (285)
T 1ozn_A           60 ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG----L---------FR  126 (285)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT----T---------TT
T ss_pred             EEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHh----H---------hh
Confidence            44444444444432 2   346777777766434444 44555555555544333333332210    0         13


Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++..+..|+++++|+.|+|++|+|++..+..+..++ |+.|+|++|++++..|..+..+++|+.|
T Consensus       127 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  206 (285)
T 1ozn_A          127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL  206 (285)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             CCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEe
Confidence            457899999999999876677788999999999999999865556688888 9999999999998888888888888866


Q ss_pred             ccccC
Q 002809          484 SLSVG  488 (878)
Q Consensus       484 ~l~~~  488 (878)
                      +++.+
T Consensus       207 ~l~~n  211 (285)
T 1ozn_A          207 YLFAN  211 (285)
T ss_dssp             ECCSS
T ss_pred             eCCCC
Confidence            65543

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.71  E-value=3.8e-09  Score=130.91  Aligned_cols=85  Identities=25%  Similarity=0.273  Sum_probs=71.4

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+.  + |+.|+|++|+|+|.+|..+.++   . 
T Consensus       477 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L---~-  550 (844)
T 3j0a_A          477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSL---S-  550 (844)
T ss_dssp             SCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSC---C-
T ss_pred             cCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCc---C-
Confidence            4568999999999999999999999999999999999999976666555  5 9999999999999999876543   3 


Q ss_pred             cccccCCCCCCCC
Q 002809          483 LSLSVGGNPGLCS  495 (878)
Q Consensus       483 l~l~~~~n~~lc~  495 (878)
                       .+.+.+||..|.
T Consensus       551 -~l~l~~Np~~C~  562 (844)
T 3j0a_A          551 -VLDITHNKFICE  562 (844)
T ss_dssp             -EEEEEEECCCCS
T ss_pred             -EEEecCCCcccc
Confidence             456778888774

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.70  E-value=4.9e-09  Score=116.64  Aligned_cols=143  Identities=22%  Similarity=0.208  Sum_probs=95.8

Q ss_pred             EEEEEecCCCCCchhh-hhhhhheeccccccccccchH-H-HHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          330 SFSLYKTGNSTLPPII-NAIEVYSVKEFLQLQTEQIDV-D-AITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       330 ~~~l~~t~~s~lpp~i-nalEi~~l~~~~~~~t~~~d~-~-al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      .+.+..+....+|..+ ..++.+.+..+. ++.++.+. . .+..|+.+....+...+-|-.    .         ....
T Consensus        22 ~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~-l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~----~---------~~~l   87 (361)
T 2xot_A           22 ILSCSKQQLPNVPQSLPSYTALLDLSHNN-LSRLRAEWTPTRLTNLHSLLLSHNHLNFISSE----A---------FVPV   87 (361)
T ss_dssp             EEECCSSCCSSCCSSCCTTCSEEECCSSC-CCEECTTSSSSCCTTCCEEECCSSCCCEECTT----T---------TTTC
T ss_pred             EEEeCCCCcCccCccCCCCCCEEECCCCC-CCccChhhhhhcccccCEEECCCCcCCccChh----h---------ccCC
Confidence            4555556667777543 357788888765 55555543 2 455555544444444332210    1         1345


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhh----hhcccCC
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVEL----LERSKNG  481 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l----~~~~~l~  481 (878)
                      ++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|..|..++ |+.|+|++|+|+ .+|..+    ..+++|+
T Consensus        88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~  166 (361)
T 2xot_A           88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM  166 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCC
T ss_pred             CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCC
Confidence            6888899999998876677788899999999999999877788888888 999999999988 466655    4577777


Q ss_pred             Cccccc
Q 002809          482 SLSLSV  487 (878)
Q Consensus       482 ~l~l~~  487 (878)
                      .|+++.
T Consensus       167 ~L~L~~  172 (361)
T 2xot_A          167 LLDLSS  172 (361)
T ss_dssp             EEECCS
T ss_pred             EEECCC
Confidence            655543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.70  E-value=8.7e-09  Score=104.15  Aligned_cols=79  Identities=24%  Similarity=0.298  Sum_probs=69.1

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|++++.+|..++++++|+.|+|++|++.+.+| .+..++ |+.|+|++|++++ +| .+..+++|+.|
T Consensus       110 ~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L  186 (197)
T 4ezg_A          110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQL  186 (197)
T ss_dssp             TCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEE
T ss_pred             CCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEE
Confidence            45789999999999999999999999999999999999555787 688899 9999999999995 55 78888888866


Q ss_pred             ccc
Q 002809          484 SLS  486 (878)
Q Consensus       484 ~l~  486 (878)
                      +++
T Consensus       187 ~l~  189 (197)
T 4ezg_A          187 YAF  189 (197)
T ss_dssp             EEC
T ss_pred             Eee
Confidence            554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.70  E-value=1.5e-08  Score=109.80  Aligned_cols=184  Identities=21%  Similarity=0.200  Sum_probs=121.8

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccc--eeeeeecccCCC---cceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRN--LTSLVGHCDEDN---QTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~n--Iv~l~g~~~~~~---~~~lV~Ey~~~  645 (878)
                      +.++.|....||+..   ..+++|+....  .....+.+|.++|..+. +..  +.+++......+   ..++|||+++|
T Consensus        26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458899999999754   56888886432  34567899999999884 333  334454443333   35789999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG-------------------------------------------  682 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------------------------------------------  682 (878)
                      .+|.+...    ..++..++..++.++++.|+.||+.                                           
T Consensus       101 ~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A          101 VPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             EECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             eECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            88875332    2367788888999999999999961                                           


Q ss_pred             ------------CCCCeEecCCCCccEEEcC--CCcEEEeecCCccccccCCCCccccccc--------------CCCCc
Q 002809          683 ------------CKPPIVHRDVKSTNILLNE--KLQAKLADFGLSKSFATDANTHVSTVVA--------------GTPGY  734 (878)
Q Consensus       683 ------------~~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~--------------gt~~Y  734 (878)
                                  ..+.++|+|+++.||++++  ...+.|+||+.+..-...  ........              ...+.
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                        1245899999999999998  456899999987643111  00000000              00011


Q ss_pred             cC-ccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 002809          735 LD-PEYYTSNRLTEKSDVYSFGVVILEIITCKPAI  768 (878)
Q Consensus       735 ~A-PE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~  768 (878)
                      .. |+....  .....+.|++|.+++++.+|+.+|
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11 222111  112258899999999999998765

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.69  E-value=1.4e-08  Score=97.64  Aligned_cols=78  Identities=28%  Similarity=0.373  Sum_probs=49.7

Q ss_pred             CcEEEEEecCCCcc-ccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          407 PRITYLNLSSSGLK-GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       407 ~~l~~l~l~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      ++|+.|+|++|+++ |.+|..++.+++|+.|+|++|++++.  ..++.++ |+.|+|++|++++.+|..+..+++++.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45666666666666 66666666666666666666666644  4566666 66666666666665666666666666544


Q ss_pred             cc
Q 002809          485 LS  486 (878)
Q Consensus       485 l~  486 (878)
                      ++
T Consensus        95 ls   96 (149)
T 2je0_A           95 LS   96 (149)
T ss_dssp             CT
T ss_pred             CC
Confidence            43

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.68  E-value=5.1e-09  Score=119.76  Aligned_cols=142  Identities=15%  Similarity=0.141  Sum_probs=93.6

Q ss_pred             EEecCCCCCchhhhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCC--CCCCCCCcccceecCCCCCCCCcEE
Q 002809          333 LYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGD--PCAPLAYWWDGLNCSYGDSSSPRIT  410 (878)
Q Consensus       333 l~~t~~s~lpp~inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~--pc~~~~~~w~gv~C~~~~~~~~~l~  410 (878)
                      ........+|.+...++.+.+..+......|..+..|.+|+.+....+...+.  |-              .....++|+
T Consensus        17 c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~--------------~~~~l~~L~   82 (455)
T 3v47_A           17 CINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN--------------TFRGLSSLI   82 (455)
T ss_dssp             CCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTT--------------TTTTCTTCC
T ss_pred             cCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcc--------------cccccccCC
Confidence            33345555666446677777776653333355565555555444332222211  11              013456788


Q ss_pred             EEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCcc--CCCCc-ceEEEecCCcCCCCCchh-hhhcccCCCcccc
Q 002809          411 YLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF--LSKLP-LRTLNLQGNKLNGSVPVE-LLERSKNGSLSLS  486 (878)
Q Consensus       411 ~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~--~~~l~-L~~L~ls~N~l~g~iP~~-l~~~~~l~~l~l~  486 (878)
                      .|+|++|++++..|..|++|++|+.|+|++|+++|.+|..  ++.++ |+.|+|++|++++..|.. +..+++|+.|+++
T Consensus        83 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~  162 (455)
T 3v47_A           83 ILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT  162 (455)
T ss_dssp             EEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECT
T ss_pred             EEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCC
Confidence            8888888888777888888888888888888888766655  77887 888888888888777776 6777877766665


Q ss_pred             cC
Q 002809          487 VG  488 (878)
Q Consensus       487 ~~  488 (878)
                      .+
T Consensus       163 ~n  164 (455)
T 3v47_A          163 FN  164 (455)
T ss_dssp             TC
T ss_pred             CC
Confidence            44

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.68  E-value=9.6e-09  Score=122.13  Aligned_cols=137  Identities=17%  Similarity=0.083  Sum_probs=85.2

Q ss_pred             CCCCCchhhh-hhhhheecccccccccc-chHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcEEEEEe
Q 002809          337 GNSTLPPIIN-AIEVYSVKEFLQLQTEQ-IDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNL  414 (878)
Q Consensus       337 ~~s~lpp~in-alEi~~l~~~~~~~t~~-~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l  414 (878)
                      ..+.+|+-|. .++.+.|..|. ++.+| .++..|.+|+.+....+...+-|-.    .         -...++|+.|+|
T Consensus        42 ~l~~vP~~lp~~~~~LdLs~N~-i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~----~---------f~~L~~L~~L~L  107 (635)
T 4g8a_A           42 NFYKIPDNLPFSTKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQTIEDG----A---------YQSLSHLSTLIL  107 (635)
T ss_dssp             CCSSCCSSSCTTCCEEECTTSC-CCEECTTTTTTCTTCCEEECTTCCCCEECTT----T---------TTTCTTCCEEEC
T ss_pred             CcCccCCCCCcCCCEEEeeCCC-CCCCCHHHHhCCCCCCEEECCCCcCCCcChh----H---------hcCCCCCCEEEc
Confidence            3345555443 56667776654 44444 3455555555544433333322110    0         134567888888


Q ss_pred             cCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCC-CCchhhhhcccCCCccccc
Q 002809          415 SSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG-SVPVELLERSKNGSLSLSV  487 (878)
Q Consensus       415 ~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g-~iP~~l~~~~~l~~l~l~~  487 (878)
                      ++|+|++..|..|.+|++|++|+|++|+|++..|..|+.++ |+.|+|++|++++ .+|..+..++.|+.|+++.
T Consensus       108 s~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~  182 (635)
T 4g8a_A          108 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS  182 (635)
T ss_dssp             TTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCS
T ss_pred             cCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccC
Confidence            88888765556678888888888888888865556677777 8888888888765 4677777777777655543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.67  E-value=1.1e-08  Score=108.90  Aligned_cols=84  Identities=24%  Similarity=0.223  Sum_probs=66.5

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCC-CCchhhhhcccCCC
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG-SVPVELLERSKNGS  482 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g-~iP~~l~~~~~l~~  482 (878)
                      ..++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..++.++ |+.|+|++|++++ .+|..+..+++|+.
T Consensus        74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~  153 (276)
T 2z62_A           74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH  153 (276)
T ss_dssp             TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCE
T ss_pred             CCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCE
Confidence            456788888888888877778888888888888888888876666788888 8888888888876 46888888888886


Q ss_pred             cccccC
Q 002809          483 LSLSVG  488 (878)
Q Consensus       483 l~l~~~  488 (878)
                      |+++.+
T Consensus       154 L~Ls~N  159 (276)
T 2z62_A          154 LDLSSN  159 (276)
T ss_dssp             EECCSS
T ss_pred             EECCCC
Confidence            655443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.67  E-value=1.2e-08  Score=111.83  Aligned_cols=143  Identities=20%  Similarity=0.170  Sum_probs=93.5

Q ss_pred             eeEEEEEecCCCCCchh----hhhhhhheecccccc--ccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCC
Q 002809          328 NYSFSLYKTGNSTLPPI----INAIEVYSVKEFLQL--QTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSY  401 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~--~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~  401 (878)
                      ...+.+..+..+.+++.    +..++.+.+..+...  +..+..+..+.+|+.+....+.+..-|-              
T Consensus       123 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~--------------  188 (330)
T 1xku_A          123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--------------  188 (330)
T ss_dssp             CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS--------------
T ss_pred             ccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCc--------------
Confidence            44556666666666653    345666666654421  1334444444444443333333322221              


Q ss_pred             CCCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccC
Q 002809          402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKN  480 (878)
Q Consensus       402 ~~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l  480 (878)
                        ...++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..++ |+.|+|++|+|+ .+|..+..++.|
T Consensus       189 --~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L  265 (330)
T 1xku_A          189 --GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI  265 (330)
T ss_dssp             --SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred             --cccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCc
Confidence              1225788888888888887788888888888888888888877777788887 888888888888 788888888877


Q ss_pred             CCccccc
Q 002809          481 GSLSLSV  487 (878)
Q Consensus       481 ~~l~l~~  487 (878)
                      +.|+++.
T Consensus       266 ~~L~l~~  272 (330)
T 1xku_A          266 QVVYLHN  272 (330)
T ss_dssp             CEEECCS
T ss_pred             CEEECCC
Confidence            7655543

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.67  E-value=2.9e-09  Score=127.72  Aligned_cols=78  Identities=27%  Similarity=0.420  Sum_probs=44.9

Q ss_pred             CCcEEEEEecCCC-ccc-cchhhhhcc------CCCCEEeCcCCcccCcCCc--cCCCCc-ceEEEecCCcCCCCCchhh
Q 002809          406 SPRITYLNLSSSG-LKG-DITSYVSNL------TSLQFLDLSNNNLTGSVPD--FLSKLP-LRTLNLQGNKLNGSVPVEL  474 (878)
Q Consensus       406 ~~~l~~l~l~~n~-l~g-~ip~~~~~l------~~L~~L~Ls~N~l~g~iP~--~~~~l~-L~~L~ls~N~l~g~iP~~l  474 (878)
                      .++|+.|+|++|+ |+| .+|..+++|      ++|+.|+|++|+|+ .||.  .++.++ |+.|+|++|+++|.+| .+
T Consensus       272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~  349 (636)
T 4eco_A          272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF  349 (636)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred             CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence            4455666666665 555 556555555      56666666666665 5555  555555 6666666666665555 55


Q ss_pred             hhcccCCCccc
Q 002809          475 LERSKNGSLSL  485 (878)
Q Consensus       475 ~~~~~l~~l~l  485 (878)
                      ..+++|+.|++
T Consensus       350 ~~l~~L~~L~L  360 (636)
T 4eco_A          350 GSEIKLASLNL  360 (636)
T ss_dssp             EEEEEESEEEC
T ss_pred             CCCCCCCEEEC
Confidence            55555554443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.65  E-value=9.7e-09  Score=122.05  Aligned_cols=76  Identities=18%  Similarity=0.209  Sum_probs=41.5

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccC-cCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCC
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNG  481 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~  481 (878)
                      .++|+.|+|++|++++..|..|++|++|+.|+|++|++++ .+|..+++++ |+.|+|++|++++..|..+..+.+++
T Consensus       103 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  180 (606)
T 3vq2_A          103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP  180 (606)
T ss_dssp             CTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCT
T ss_pred             cccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccc
Confidence            3455555555555554444555555555555555555553 4555555555 55555555555554455555554443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.65  E-value=2e-08  Score=98.60  Aligned_cols=82  Identities=27%  Similarity=0.376  Sum_probs=63.1

Q ss_pred             CCCcEEEEEecCCCcc-ccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          405 SSPRITYLNLSSSGLK-GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      .+++|+.|+|++|+|+ |.+|..+..+++|+.|+|++|+|++.  ..++.++ |+.|+|++|++++.+|..+..+++|+.
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            4467888888888887 78888888888888888888888854  6677777 888888888888777777777777776


Q ss_pred             cccccC
Q 002809          483 LSLSVG  488 (878)
Q Consensus       483 l~l~~~  488 (878)
                      |+++.+
T Consensus       100 L~Ls~N  105 (168)
T 2ell_A          100 LNLSGN  105 (168)
T ss_dssp             EECBSS
T ss_pred             EeccCC
Confidence            665544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.64  E-value=2.2e-08  Score=118.08  Aligned_cols=81  Identities=28%  Similarity=0.324  Sum_probs=72.1

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCC-chhhhhcccCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSV-PVELLERSKNG  481 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~i-P~~l~~~~~l~  481 (878)
                      ...++|+.|+|++|+|+ .||..|++|++|+.|+|++|+|++ || .++.++ |+.|+|++|+|++.+ |..++.+++|+
T Consensus       460 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~  536 (567)
T 1dce_A          460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV  536 (567)
T ss_dssp             GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred             cccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCC
Confidence            34568999999999999 999999999999999999999996 88 799999 999999999999877 99999999998


Q ss_pred             Cccccc
Q 002809          482 SLSLSV  487 (878)
Q Consensus       482 ~l~l~~  487 (878)
                      .|+++.
T Consensus       537 ~L~L~~  542 (567)
T 1dce_A          537 LLNLQG  542 (567)
T ss_dssp             EEECTT
T ss_pred             EEEecC
Confidence            665543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.63  E-value=7e-09  Score=123.27  Aligned_cols=88  Identities=30%  Similarity=0.337  Sum_probs=77.0

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|++++..|..|+++++|+.|+|++|++++.+|..+..++ | .|+|++|++++..|..+..+++++  
T Consensus       474 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~--  550 (606)
T 3t6q_A          474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQR--  550 (606)
T ss_dssp             GCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSS--
T ss_pred             cCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCC--
Confidence            457899999999999988899999999999999999999999999999999 9 999999999988888888888887  


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                      .+.+.+||..|.
T Consensus       551 ~L~l~~N~~~c~  562 (606)
T 3t6q_A          551 TINLRQNPLDCT  562 (606)
T ss_dssp             EEECTTCCEECS
T ss_pred             EEeCCCCCcccc
Confidence            456678888775

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.62  E-value=1.4e-08  Score=125.17  Aligned_cols=152  Identities=11%  Similarity=0.130  Sum_probs=114.9

Q ss_pred             CceeEEEEEecCCCC------------------Cchhh-----hhhhhheeccccccccccchHHHHHHHHHhhCCCCC-
Q 002809          326 GGNYSFSLYKTGNST------------------LPPII-----NAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKN-  381 (878)
Q Consensus       326 ~~~~~~~l~~t~~s~------------------lpp~i-----nalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~-  381 (878)
                      .....+.|..+..+.                  +|+.+     ..|+.+.+..+...+.+|..+..|.+|+.+....+. 
T Consensus       448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~  527 (876)
T 4ecn_A          448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG  527 (876)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred             CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence            456778888888877                  77754     467777787776678888888777777666544443 


Q ss_pred             CCC--CCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccccchh--hhhccCCCCEEeCcCCcccCcCCccCCCCc-c
Q 002809          382 WQG--DPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITS--YVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-L  456 (878)
Q Consensus       382 w~~--~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g~ip~--~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L  456 (878)
                      +.|  -|-     .|..+.-  .....++|+.|+|++|+|+ .||.  .|++|++|+.|+|++|+|+ .|| .++.++ |
T Consensus       528 lsg~~iP~-----~i~~L~~--~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L  597 (876)
T 4ecn_A          528 ISAAQLKA-----DWTRLAD--DEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKL  597 (876)
T ss_dssp             SCHHHHHH-----HHHHHHH--CTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEE
T ss_pred             cccccchH-----HHHhhhh--cccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcc
Confidence            443  221     1211110  1134568999999999999 8998  9999999999999999999 999 889999 9


Q ss_pred             eEEEecCCcCCCCCchhhhhccc-CCCcccccC
Q 002809          457 RTLNLQGNKLNGSVPVELLERSK-NGSLSLSVG  488 (878)
Q Consensus       457 ~~L~ls~N~l~g~iP~~l~~~~~-l~~l~l~~~  488 (878)
                      +.|+|++|+|+ .+|..+..+++ |+.|+++.+
T Consensus       598 ~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N  629 (876)
T 4ecn_A          598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHN  629 (876)
T ss_dssp             SEEECCSSCCS-CCCTTSCEECTTCCEEECCSS
T ss_pred             eEEECcCCccc-cchHHHhhccccCCEEECcCC
Confidence            99999999999 89999999988 887666544

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.62  E-value=8.8e-09  Score=121.26  Aligned_cols=89  Identities=22%  Similarity=0.319  Sum_probs=74.4

Q ss_pred             CCCcEEEEEecCCCcc-ccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          405 SSPRITYLNLSSSGLK-GDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ..++|+.|+|++|.++ |.+|..++.+++|+.|+|++|++++.+|..+..++ |+.|+|++|+|++..|..+..+++|+.
T Consensus       443 ~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  522 (570)
T 2z63_A          443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQK  522 (570)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             cCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcE
Confidence            4578899999999987 68898899999999999999999988888888888 999999999999877777888888774


Q ss_pred             cccccCCCCCCCC
Q 002809          483 LSLSVGGNPGLCS  495 (878)
Q Consensus       483 l~l~~~~n~~lc~  495 (878)
                        +.+.+|+..|.
T Consensus       523 --L~l~~N~~~~~  533 (570)
T 2z63_A          523 --IWLHTNPWDCS  533 (570)
T ss_dssp             --EECCSSCBCCC
T ss_pred             --EEecCCcccCC
Confidence              55567777665

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.62  E-value=7.1e-09  Score=112.19  Aligned_cols=84  Identities=20%  Similarity=0.270  Sum_probs=73.3

Q ss_pred             CCCcEEEEEecCCCccc-cchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          405 SSPRITYLNLSSSGLKG-DITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ..++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++..|..+..++ |+.|+|++|++++..+..+..+++|+.
T Consensus       148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  227 (306)
T 2z66_A          148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  227 (306)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred             cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence            45789999999999998 6899999999999999999999988899999999 999999999999776778888888887


Q ss_pred             cccccC
Q 002809          483 LSLSVG  488 (878)
Q Consensus       483 l~l~~~  488 (878)
                      |+++.+
T Consensus       228 L~L~~N  233 (306)
T 2z66_A          228 LDYSLN  233 (306)
T ss_dssp             EECTTS
T ss_pred             eECCCC
Confidence            666544

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.61  E-value=2.2e-08  Score=117.37  Aligned_cols=95  Identities=20%  Similarity=0.120  Sum_probs=80.3

Q ss_pred             cccceecCCCC--------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecC
Q 002809          393 WWDGLNCSYGD--------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG  463 (878)
Q Consensus       393 ~w~gv~C~~~~--------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~  463 (878)
                      .|.|+ |+...        ...++|+.|+|++|+|++..|..|+++++|++|+|++|++++..|..++.++ |++|+|++
T Consensus         5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~   83 (549)
T 2z81_A            5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD   83 (549)
T ss_dssp             CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence            68887 75321        2346899999999999988889999999999999999999988888999999 99999999


Q ss_pred             CcCCCCCchhhhhcccCCCcccccC
Q 002809          464 NKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       464 N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |++++..|..++.+++|+.|+++.+
T Consensus        84 n~l~~~~~~~~~~l~~L~~L~Ls~n  108 (549)
T 2z81_A           84 NHLSSLSSSWFGPLSSLKYLNLMGN  108 (549)
T ss_dssp             SCCCSCCHHHHTTCTTCCEEECTTC
T ss_pred             CccCccCHHHhccCCCCcEEECCCC
Confidence            9999877777999998887776554

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.60  E-value=1.5e-08  Score=118.82  Aligned_cols=82  Identities=26%  Similarity=0.293  Sum_probs=70.4

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      +++|+.|+|++|+|+|.+    +++++|+.|+|++|+|+ .||. .+.++ |+.|+|++|+|++.+|..+..+++++  .
T Consensus       430 ~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~--~  501 (549)
T 2z81_A          430 PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ--K  501 (549)
T ss_dssp             CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCC--E
T ss_pred             cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccC--E
Confidence            358899999999998753    58999999999999999 8997 46778 99999999999998888899999888  4


Q ss_pred             cccCCCCCCCC
Q 002809          485 LSVGGNPGLCS  495 (878)
Q Consensus       485 l~~~~n~~lc~  495 (878)
                      +..++|+..|.
T Consensus       502 L~l~~N~~~~~  512 (549)
T 2z81_A          502 IWLHTNPWDCS  512 (549)
T ss_dssp             EECCSSCBCCC
T ss_pred             EEecCCCccCC
Confidence            56678888775

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.60  E-value=1.1e-08  Score=109.10  Aligned_cols=87  Identities=23%  Similarity=0.311  Sum_probs=63.2

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccC-cCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ..++|+.|+|++|++++..+..++++++|+.|+|++|++++ .+|..++.++ |+.|+|++|++++..|..+..+.++..
T Consensus        98 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  177 (276)
T 2z62_A           98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL  177 (276)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTT
T ss_pred             CCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccc
Confidence            45678888888888886666678888888888888888876 4677788887 888888888888666667777776664


Q ss_pred             c--ccccCCCC
Q 002809          483 L--SLSVGGNP  491 (878)
Q Consensus       483 l--~l~~~~n~  491 (878)
                      +  .+..++|.
T Consensus       178 l~l~L~ls~n~  188 (276)
T 2z62_A          178 LNLSLDLSLNP  188 (276)
T ss_dssp             CCEEEECCSSC
T ss_pred             cceeeecCCCc
Confidence            4  23444443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.60  E-value=1.3e-08  Score=117.26  Aligned_cols=89  Identities=26%  Similarity=0.286  Sum_probs=76.5

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|.|++..+..|.++++|+.|+|++|++++..|..+..++ |+.|+|++|+|++..+..+..+++|+. 
T Consensus       246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-  324 (477)
T 2id5_A          246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET-  324 (477)
T ss_dssp             TCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCE-
T ss_pred             CccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCE-
Confidence            456899999999999988888899999999999999999998899999999 999999999999765666778888874 


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                       +.+.+|+..|.
T Consensus       325 -L~l~~N~l~c~  335 (477)
T 2id5_A          325 -LILDSNPLACD  335 (477)
T ss_dssp             -EECCSSCEECS
T ss_pred             -EEccCCCccCc
Confidence             56678888775

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.60  E-value=7.8e-09  Score=125.67  Aligned_cols=114  Identities=16%  Similarity=0.186  Sum_probs=85.2

Q ss_pred             hhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccccchhh
Q 002809          347 AIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSY  426 (878)
Q Consensus       347 alEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g~ip~~  426 (878)
                      .|+.+.|..+. ...+|.++..|..|+.+....+.+..-|.     .+         ..+++|+.|+|++|+|+ .||..
T Consensus       225 ~L~~L~Ls~n~-l~~l~~~~~~l~~L~~L~Ls~N~l~~lp~-----~~---------~~l~~L~~L~Ls~N~l~-~lp~~  288 (727)
T 4b8c_D          225 LWHALDLSNLQ-IFNISANIFKYDFLTRLYLNGNSLTELPA-----EI---------KNLSNLRVLDLSHNRLT-SLPAE  288 (727)
T ss_dssp             CCCEEECTTSC-CSCCCGGGGGCCSCSCCBCTTSCCSCCCG-----GG---------GGGTTCCEEECTTSCCS-SCCSS
T ss_pred             CCcEEECCCCC-CCCCChhhcCCCCCCEEEeeCCcCcccCh-----hh---------hCCCCCCEEeCcCCcCC-ccChh
Confidence            45666666654 45677666655555555444444433232     11         34568999999999999 88999


Q ss_pred             hhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhc
Q 002809          427 VSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLER  477 (878)
Q Consensus       427 ~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~  477 (878)
                      |++|++|+.|+|++|+|+ .||..|+.|+ |+.|+|++|+|+|.+|..+..+
T Consensus       289 ~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  339 (727)
T 4b8c_D          289 LGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEK  339 (727)
T ss_dssp             GGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred             hcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence            999999999999999997 8898899998 9999999999999888887654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.58  E-value=1.5e-08  Score=119.49  Aligned_cols=77  Identities=32%  Similarity=0.303  Sum_probs=65.5

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcC-CccCCCCc-ceEEEecCCcCCCCCchh---hhhccc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSV-PDFLSKLP-LRTLNLQGNKLNGSVPVE---LLERSK  479 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i-P~~~~~l~-L~~L~ls~N~l~g~iP~~---l~~~~~  479 (878)
                      .+++|+.|+|++|+|++ || .|++|++|+.|+|++|+|++.+ |..++.++ |+.|+|++|+|+|..|..   +..+++
T Consensus       484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~  561 (567)
T 1dce_A          484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS  561 (567)
T ss_dssp             GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTT
T ss_pred             cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcc
Confidence            45789999999999997 78 8999999999999999999887 99999999 999999999999765532   223555


Q ss_pred             CCCc
Q 002809          480 NGSL  483 (878)
Q Consensus       480 l~~l  483 (878)
                      |+.|
T Consensus       562 L~~L  565 (567)
T 1dce_A          562 VSSI  565 (567)
T ss_dssp             CSEE
T ss_pred             cCcc
Confidence            5544

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.57  E-value=2.1e-08  Score=115.55  Aligned_cols=146  Identities=18%  Similarity=0.087  Sum_probs=92.1

Q ss_pred             EEEEEecCCCCCchh----hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCC
Q 002809          330 SFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSS  405 (878)
Q Consensus       330 ~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~  405 (878)
                      .+.|..+....++|.    +..|+.+.+..+......|..+..|.+|+.+....+.....|..    .         ...
T Consensus        36 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~---------~~~  102 (477)
T 2id5_A           36 LLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG----V---------FTG  102 (477)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT----S---------STT
T ss_pred             EEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc----c---------ccC
Confidence            344444444444431    33566666665543333355555555555544433334333321    0         023


Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|++++.+|..|.++++|+.|+|++|++++..|..+..++ |+.|+|++|++++..+..+..+++|+.|+
T Consensus       103 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  182 (477)
T 2id5_A          103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR  182 (477)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEe
Confidence            56788888888888877788888888888888888888877777788887 88888888888865556677777777665


Q ss_pred             cccC
Q 002809          485 LSVG  488 (878)
Q Consensus       485 l~~~  488 (878)
                      ++.+
T Consensus       183 l~~n  186 (477)
T 2id5_A          183 LRHL  186 (477)
T ss_dssp             EESC
T ss_pred             CCCC
Confidence            5443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.56  E-value=7.4e-08  Score=95.49  Aligned_cols=73  Identities=22%  Similarity=0.225  Sum_probs=60.6

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhc
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLER  477 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~  477 (878)
                      ...++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|.|. ..|..+..+
T Consensus        54 ~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~~~l  127 (174)
T 2r9u_A           54 DHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDIMYL  127 (174)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGGHHH
T ss_pred             cCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc-cccccHHHH
Confidence            3457899999999999976556679999999999999999965555699999 999999999999 455544433

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.56  E-value=1.4e-08  Score=111.41  Aligned_cols=79  Identities=27%  Similarity=0.275  Sum_probs=55.6

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      ++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..++ |+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus       193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l  271 (332)
T 2ft3_A          193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL  271 (332)
T ss_dssp             SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence            4677777777777766667777777777777777777766666677776 777777777777 67777777776665544


Q ss_pred             c
Q 002809          486 S  486 (878)
Q Consensus       486 ~  486 (878)
                      +
T Consensus       272 ~  272 (332)
T 2ft3_A          272 H  272 (332)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.56  E-value=3.2e-08  Score=122.55  Aligned_cols=145  Identities=17%  Similarity=0.091  Sum_probs=85.7

Q ss_pred             eEEEEEecCCCCCch----hhhhhhhheeccccccccc-cchHHHHHHHHHhhCCCCCCCCC-CCCCCCCcccceecCCC
Q 002809          329 YSFSLYKTGNSTLPP----IINAIEVYSVKEFLQLQTE-QIDVDAITNIKATYGLKKNWQGD-PCAPLAYWWDGLNCSYG  402 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp----~inalEi~~l~~~~~~~t~-~~d~~al~~lk~~~~~~~~w~~~-pc~~~~~~w~gv~C~~~  402 (878)
                      ..+.|..+..+.++|    -+..|+.+.+..+.....+ |..+..|..|+.+....+...+. |-     +         
T Consensus        27 ~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~-----~---------   92 (844)
T 3j0a_A           27 ERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD-----A---------   92 (844)
T ss_dssp             CEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT-----S---------
T ss_pred             CEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh-----H---------
Confidence            455555555555533    1345666666655434444 44455555444443333333221 21     1         


Q ss_pred             CCCCCcEEEEEecCCCccccchhh--hhccCCCCEEeCcCCcccCcCC-ccCCCCc-ceEEEecCCcCCCCCchhhhhc-
Q 002809          403 DSSSPRITYLNLSSSGLKGDITSY--VSNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNLQGNKLNGSVPVELLER-  477 (878)
Q Consensus       403 ~~~~~~l~~l~l~~n~l~g~ip~~--~~~l~~L~~L~Ls~N~l~g~iP-~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~-  477 (878)
                      ....++|+.|+|++|+|++.+|..  |++|++|+.|+|++|++++..| ..+++++ |+.|+|++|++++..|..+..+ 
T Consensus        93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~  172 (844)
T 3j0a_A           93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ  172 (844)
T ss_dssp             SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred             ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence            134556777777777777766665  7777777777777777776554 4577777 7777777777777777777666 


Q ss_pred             -ccCCCccccc
Q 002809          478 -SKNGSLSLSV  487 (878)
Q Consensus       478 -~~l~~l~l~~  487 (878)
                       ++|+.|.++.
T Consensus       173 ~~~L~~L~L~~  183 (844)
T 3j0a_A          173 GKTLSFFSLAA  183 (844)
T ss_dssp             HCSSCCCEECC
T ss_pred             CCccceEECCC
Confidence             5566555543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.54  E-value=7.2e-08  Score=95.13  Aligned_cols=67  Identities=22%  Similarity=0.242  Sum_probs=59.6

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVP  471 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP  471 (878)
                      ..++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|.|++..+
T Consensus        52 ~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           52 RLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            457899999999999977777789999999999999999976667799999 9999999999996644

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.53  E-value=7.1e-08  Score=110.48  Aligned_cols=96  Identities=22%  Similarity=0.191  Sum_probs=82.4

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|..|.|+...      +.+++|+.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..+..++ |+.|+|++|+
T Consensus        55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~  134 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW  134 (452)
T ss_dssp             SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence            46789998542      3456899999999999998899999999999999999999988889999999 9999999999


Q ss_pred             CCCCCchhhhhcccCCCcccccC
Q 002809          466 LNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       466 l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |++..|..+..+++|+.|+++.+
T Consensus       135 l~~~~~~~~~~l~~L~~L~L~~N  157 (452)
T 3zyi_A          135 LTVIPSGAFEYLSKLRELWLRNN  157 (452)
T ss_dssp             CSBCCTTTSSSCTTCCEEECCSC
T ss_pred             CCccChhhhcccCCCCEEECCCC
Confidence            99666666888898887766544

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.53  E-value=9.7e-09  Score=119.05  Aligned_cols=80  Identities=23%  Similarity=0.254  Sum_probs=66.5

Q ss_pred             CCcEEEEEecCCCccccchhhhh-ccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVS-NLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      .++|+.|+|++|+|+|.+|..+. +|++|+.|+|++|+|++. |. +..++ |+.|+|++|+|+| +|+.+..++.|..|
T Consensus       143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L  219 (487)
T 3oja_A          143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI  219 (487)
T ss_dssp             GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred             CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEE
Confidence            56899999999999998998887 799999999999999966 43 33577 9999999999996 66678889988877


Q ss_pred             ccccC
Q 002809          484 SLSVG  488 (878)
Q Consensus       484 ~l~~~  488 (878)
                      +++.+
T Consensus       220 ~Ls~N  224 (487)
T 3oja_A          220 SLRNN  224 (487)
T ss_dssp             ECTTS
T ss_pred             EecCC
Confidence            66654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.53  E-value=3.5e-08  Score=117.31  Aligned_cols=129  Identities=19%  Similarity=0.200  Sum_probs=60.8

Q ss_pred             ceeEEEEEecCCCCCchhh----hhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCC
Q 002809          327 GNYSFSLYKTGNSTLPPII----NAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYG  402 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~i----nalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~  402 (878)
                      +...+.+..+....+|+.+    ..|+.+.+..+......|..+..+..|+.+....+...+.|..    .         
T Consensus        52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~---------  118 (597)
T 3oja_B           52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH----V---------  118 (597)
T ss_dssp             CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT----T---------
T ss_pred             CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH----H---------
Confidence            3344555555556666542    3566666655442222222444443333333322333222210    0         


Q ss_pred             CCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCC
Q 002809          403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG  468 (878)
Q Consensus       403 ~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g  468 (878)
                      ....++|+.|+|++|+|++..+..|++|++|+.|+|++|+|++..|..++.++ |+.|+|++|+|++
T Consensus       119 ~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          119 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred             HcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence            02234555555555555533333345555555555555555555555555555 5555555555554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.53  E-value=3.5e-08  Score=119.98  Aligned_cols=79  Identities=28%  Similarity=0.363  Sum_probs=68.1

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      .+++|+.|+|++|+|+ .||..|++|++|+.|+|++|+|+ .||..++.|+ |+.|+|++|+|+ .||.+++.+++|+.|
T Consensus       245 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L  321 (727)
T 4b8c_D          245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFL  321 (727)
T ss_dssp             GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCE
T ss_pred             CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEE
Confidence            3567889999999998 88989999999999999999999 8898898888 999999999987 889888888888866


Q ss_pred             ccc
Q 002809          484 SLS  486 (878)
Q Consensus       484 ~l~  486 (878)
                      +++
T Consensus       322 ~L~  324 (727)
T 4b8c_D          322 GVE  324 (727)
T ss_dssp             ECT
T ss_pred             eCC
Confidence            554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.51  E-value=3.5e-08  Score=107.27  Aligned_cols=175  Identities=21%  Similarity=0.177  Sum_probs=101.0

Q ss_pred             cCceeEEEEEECCccccCCCCCCccceeEEEcceeecCceeEEEEEecCCCCCchhh--------hhhhhheeccccccc
Q 002809          289 ANQSRQFNISLNGEHWYGPFSPNYLLTTTVFSPTALIGGNYSFSLYKTGNSTLPPII--------NAIEVYSVKEFLQLQ  360 (878)
Q Consensus       289 ~~~~R~F~i~in~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~l~~t~~s~lpp~i--------nalEi~~l~~~~~~~  360 (878)
                      -...|..++.-|.-.-.   .|..+.       .........+.|..+..+.+|+.+        ..++.+.+..+...+
T Consensus        94 l~~L~~L~L~~n~l~~~---~~~~~~-------~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~  163 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGT---APPPLL-------EATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN  163 (312)
T ss_dssp             TSCCCEEEEEEEBCBSC---CCCCSS-------SCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCC
T ss_pred             cCCccEEEccCCcccch---hHHHHH-------HhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCcc
Confidence            34678888877754311   121110       011234456777777777776543        355666666655332


Q ss_pred             cccchHHHHHHHHHhhCCCCCCCCC---CCCCCCCcccceecCCCCCCCCcEEEEEecCCCccc--cchh-hhhccCCCC
Q 002809          361 TEQIDVDAITNIKATYGLKKNWQGD---PCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKG--DITS-YVSNLTSLQ  434 (878)
Q Consensus       361 t~~~d~~al~~lk~~~~~~~~w~~~---pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g--~ip~-~~~~l~~L~  434 (878)
                      ..|..+..+.+|+.+....+...+.   |-         -.|.   ...++|+.|+|++|+|++  .++. .+.++++|+
T Consensus       164 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---------~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~  231 (312)
T 1wwl_A          164 FSCEQVRVFPALSTLDLSDNPELGERGLIS---------ALCP---LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ  231 (312)
T ss_dssp             CCTTTCCCCSSCCEEECCSCTTCHHHHHHH---------HSCT---TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCS
T ss_pred             chHHHhccCCCCCEEECCCCCcCcchHHHH---------HHHh---ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCC
Confidence            2234444444444433222222111   00         0010   345688888888888883  3443 346778888


Q ss_pred             EEeCcCCcccCcCC-ccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccC
Q 002809          435 FLDLSNNNLTGSVP-DFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       435 ~L~Ls~N~l~g~iP-~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      .|+|++|+|++.+| ..+..++ |+.|+|++|+|+ .+|..+.  ++++.|+++.+
T Consensus       232 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N  284 (312)
T 1wwl_A          232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYN  284 (312)
T ss_dssp             EEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSS
T ss_pred             EEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCC
Confidence            88888888888776 4455667 888888888888 7888776  55665555443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.51  E-value=7.4e-08  Score=112.20  Aligned_cols=76  Identities=24%  Similarity=0.240  Sum_probs=37.3

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCC-CCchhhhhcccCCCcc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG-SVPVELLERSKNGSLS  484 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g-~iP~~l~~~~~l~~l~  484 (878)
                      ++|+.|+|++|+|++..|..|++|++|++|||++|+|+ .||..  .++ |++|+|++|++++ .+|..++.+++|+.|+
T Consensus        45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~  121 (520)
T 2z7x_B           45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG  121 (520)
T ss_dssp             TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred             ccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence            34555555555555444555555555555555555555 34443  344 5555555555544 3445555555444443


Q ss_pred             c
Q 002809          485 L  485 (878)
Q Consensus       485 l  485 (878)
                      +
T Consensus       122 L  122 (520)
T 2z7x_B          122 L  122 (520)
T ss_dssp             E
T ss_pred             e
Confidence            3

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.51  E-value=4.1e-08  Score=114.35  Aligned_cols=84  Identities=31%  Similarity=0.427  Sum_probs=62.9

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchh-hhhcccCCCc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVE-LLERSKNGSL  483 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~-l~~~~~l~~l  483 (878)
                      .++|+.|+|++|+|+|.+|..+.  ++|+.|+|++|+|+ .||..+..++ |+.|+|++|+|+ .+|.. +..+++++. 
T Consensus       398 l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~-  472 (520)
T 2z7x_B          398 TKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQK-  472 (520)
T ss_dssp             CTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE-
T ss_pred             CccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccE-
Confidence            46788888888888877777665  67888888888888 7887777777 888888888888 67766 666776663 


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                       +...+|+..|.
T Consensus       473 -L~l~~N~~~c~  483 (520)
T 2z7x_B          473 -IWLHTNPWDCS  483 (520)
T ss_dssp             -EECCSSCBCCC
T ss_pred             -EECcCCCCccc
Confidence             45567777665

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.50  E-value=9.2e-08  Score=105.71  Aligned_cols=95  Identities=23%  Similarity=0.178  Sum_probs=78.1

Q ss_pred             cccceecCCCC--------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecC
Q 002809          393 WWDGLNCSYGD--------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG  463 (878)
Q Consensus       393 ~w~gv~C~~~~--------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~  463 (878)
                      .|.|+ |+...        ...++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..++.++ |+.|+|++
T Consensus        31 ~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (353)
T 2z80_A           31 DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY  109 (353)
T ss_dssp             CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence            68886 54221        2346899999999999976666999999999999999999988888899999 99999999


Q ss_pred             CcCCCCCchhhhhcccCCCcccccC
Q 002809          464 NKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       464 N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |++++..+..+..+++|+.|+++.+
T Consensus       110 n~l~~~~~~~~~~l~~L~~L~L~~n  134 (353)
T 2z80_A          110 NYLSNLSSSWFKPLSSLTFLNLLGN  134 (353)
T ss_dssp             SCCSSCCHHHHTTCTTCSEEECTTC
T ss_pred             CcCCcCCHhHhCCCccCCEEECCCC
Confidence            9999544444888999987766544

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.49  E-value=4.8e-08  Score=114.95  Aligned_cols=67  Identities=21%  Similarity=0.318  Sum_probs=33.1

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCcc-------eEEEecCCcCCCCCchhhhhccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPL-------RTLNLQGNKLNGSVPVELLERSK  479 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~L-------~~L~ls~N~l~g~iP~~l~~~~~  479 (878)
                      ++|+.|+|++|+|++ ||. |+  ++|+.|+|++|+|+ .||. +.. .|       +.|+|++|+|+ .||..+.++++
T Consensus       160 ~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~-~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~  231 (571)
T 3cvr_A          160 TSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDP  231 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---------CCEEEECCSSCCC-CCCGGGGGSCT
T ss_pred             CCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH-hhhcccccceEEecCCCcce-ecCHHHhcCCC
Confidence            345555555555554 444 43  55555555555555 4544 322 23       55555555555 45555555554


Q ss_pred             CC
Q 002809          480 NG  481 (878)
Q Consensus       480 l~  481 (878)
                      |.
T Consensus       232 L~  233 (571)
T 3cvr_A          232 TC  233 (571)
T ss_dssp             TE
T ss_pred             CC
Confidence            44

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.49  E-value=6.2e-08  Score=114.22  Aligned_cols=85  Identities=32%  Similarity=0.439  Sum_probs=70.9

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchh-hhhcccCCC
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVE-LLERSKNGS  482 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~-l~~~~~l~~  482 (878)
                      ..++|+.|+|++|+|+|.+|..+.  ++|+.|+|++|+|+ .||..+..++ |+.|+|++|+|+ .+|.. +..+++++.
T Consensus       426 ~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~  501 (562)
T 3a79_B          426 WAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY  501 (562)
T ss_dssp             CCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCC
T ss_pred             CcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCE
Confidence            356889999999999888887765  78999999999998 8998888888 999999999999 68877 777887774


Q ss_pred             cccccCCCCCCCC
Q 002809          483 LSLSVGGNPGLCS  495 (878)
Q Consensus       483 l~l~~~~n~~lc~  495 (878)
                        +...+|+..|.
T Consensus       502 --L~l~~N~~~c~  512 (562)
T 3a79_B          502 --IWLHDNPWDCT  512 (562)
T ss_dssp             --EECCSCCBCCC
T ss_pred             --EEecCCCcCCC
Confidence              56678888775

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.49  E-value=5.2e-08  Score=115.74  Aligned_cols=137  Identities=18%  Similarity=0.221  Sum_probs=81.6

Q ss_pred             ceeEEEEEecCCCCCchh--hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCC
Q 002809          327 GNYSFSLYKTGNSTLPPI--INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDS  404 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~--inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~  404 (878)
                      ....+.|..+..+.+||+  +..|+.+.|..+. +..+| .+..|..|+.+....+...+.|.               ..
T Consensus        66 ~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~-l~~l~-~l~~l~~L~~L~Ls~N~l~~l~~---------------l~  128 (605)
T 1m9s_A           66 NVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENK-IKDLS-SLKDLKKLKSLSLEHNGISDING---------------LV  128 (605)
T ss_dssp             TCCEEECTTSCCCCCGGGGGCTTCCEEECCSSC-CCCCT-TSTTCTTCCEEECTTSCCCCCGG---------------GG
T ss_pred             CCCEEEeeCCCCCCChhhccCCCCCEEECcCCC-CCCCh-hhccCCCCCEEEecCCCCCCCcc---------------cc
Confidence            345566666666677663  2355666665543 33333 33333333333322222221110               12


Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      .+++|+.|+|++|+|++.  +.|+.|++|+.|+|++|+|++..|  +..++ |+.|+|++|+|++ +| .+..+++|+.|
T Consensus       129 ~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L  202 (605)
T 1m9s_A          129 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVL  202 (605)
T ss_dssp             GCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEE
T ss_pred             CCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEE
Confidence            346778888888888754  567788888888888888886655  77777 8888888888875 43 57777777755


Q ss_pred             ccc
Q 002809          484 SLS  486 (878)
Q Consensus       484 ~l~  486 (878)
                      +++
T Consensus       203 ~L~  205 (605)
T 1m9s_A          203 ELF  205 (605)
T ss_dssp             ECC
T ss_pred             Ecc
Confidence            544

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.49  E-value=3.8e-08  Score=116.85  Aligned_cols=75  Identities=35%  Similarity=0.472  Sum_probs=41.7

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      +++|+.|+|++|+|++ + +.+..|++|+.|+|++|+|++.  ..++.++ |+.|+|++|+|++..|  +..+++|+.|+
T Consensus       108 l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~  181 (605)
T 1m9s_A          108 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY  181 (605)
T ss_dssp             CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             CCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence            4456666666666654 2 3455666666666666666643  3455555 6666666666664444  55555555444


Q ss_pred             cc
Q 002809          485 LS  486 (878)
Q Consensus       485 l~  486 (878)
                      ++
T Consensus       182 Ls  183 (605)
T 1m9s_A          182 LS  183 (605)
T ss_dssp             CC
T ss_pred             Cc
Confidence            43

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.48  E-value=5.4e-08  Score=104.78  Aligned_cols=138  Identities=19%  Similarity=0.235  Sum_probs=90.7

Q ss_pred             ceeEEEEEecCCCCCchh--hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCC
Q 002809          327 GNYSFSLYKTGNSTLPPI--INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDS  404 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~--inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~  404 (878)
                      ....+.+..+..+.++|+  +..|+.+.+..+. .+.++ .+..+..|+.+....+...+-+         +      ..
T Consensus        69 ~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~-l~~~~-~l~~l~~L~~L~L~~n~i~~~~---------~------l~  131 (291)
T 1h6t_A           69 NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK-VKDLS-SLKDLKKLKSLSLEHNGISDIN---------G------LV  131 (291)
T ss_dssp             TCCEEECCSSCCCCCGGGTTCTTCCEEECCSSC-CCCGG-GGTTCTTCCEEECTTSCCCCCG---------G------GG
T ss_pred             CCCEEEccCCccCCCcccccCCCCCEEECCCCc-CCCCh-hhccCCCCCEEECCCCcCCCCh---------h------hc
Confidence            345666777777777773  3356666666654 33433 2444444443332222222211         1      13


Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++.  +.++++++|+.|+|++|++++..|  +..++ |+.|+|++|++++ +|. +..+++|+.|
T Consensus       132 ~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L  205 (291)
T 1h6t_A          132 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVL  205 (291)
T ss_dssp             GCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEE
T ss_pred             CCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEE
Confidence            456899999999999865  678999999999999999986555  88888 9999999999984 554 7778877766


Q ss_pred             cccc
Q 002809          484 SLSV  487 (878)
Q Consensus       484 ~l~~  487 (878)
                      +++.
T Consensus       206 ~l~~  209 (291)
T 1h6t_A          206 ELFS  209 (291)
T ss_dssp             EEEE
T ss_pred             ECcC
Confidence            5543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.48  E-value=6e-08  Score=115.33  Aligned_cols=130  Identities=15%  Similarity=0.137  Sum_probs=88.5

Q ss_pred             hhhhhhheeccccccccccchH-HHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccccc
Q 002809          345 INAIEVYSVKEFLQLQTEQIDV-DAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDI  423 (878)
Q Consensus       345 inalEi~~l~~~~~~~t~~~d~-~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g~i  423 (878)
                      +..++++.+..+. .+.+|.++ ..+..|+.+....+...+.|..             .....++|+.|+|++|.|++..
T Consensus        50 l~~l~~l~l~~~~-l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~L~~n~l~~~~  115 (597)
T 3oja_B           50 LNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQIEEIDTY-------------AFAYAHTIQKLYMGFNAIRYLP  115 (597)
T ss_dssp             GCCCSEEEESSCE-ESEECTHHHHHCCCCSEEECTTSCCCEECTT-------------TTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCCceEEEeeCCC-CCCcCHHHHccCCCCcEEECCCCCCCCCChH-------------HhcCCCCCCEEECCCCcCCCCC
Confidence            4566777776654 56677653 3344444443333333332210             1134568888888888888877


Q ss_pred             hhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccC
Q 002809          424 TSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       424 p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |..|++|++|+.|+|++|+|++..|..++.++ |+.|+|++|+|++..|..+..+++|+.|+++.+
T Consensus       116 ~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  181 (597)
T 3oja_B          116 PHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN  181 (597)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTS
T ss_pred             HHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCC
Confidence            77888888888888888888854444568888 888888888888877878888888887666544

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.47  E-value=1.1e-07  Score=114.54  Aligned_cols=148  Identities=20%  Similarity=0.094  Sum_probs=99.9

Q ss_pred             eeEEEEEecCCCCCchh----hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCC
Q 002809          328 NYSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGD  403 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~  403 (878)
                      ...+.|..+....+|+.    +..++.+.+..+...+..|..+..|..|+.+....+...+-|..    .         .
T Consensus        27 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~----~---------~   93 (680)
T 1ziw_A           27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK----T---------F   93 (680)
T ss_dssp             CSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTT----T---------T
T ss_pred             CcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChh----h---------h
Confidence            34566666666777663    34566666766553333355555555555554433444433321    0         1


Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhh--hcccC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELL--ERSKN  480 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~--~~~~l  480 (878)
                      ...++|+.|+|++|++++..|..|++|++|++|+|++|++++..|..++.++ |+.|+|++|++++..|..+.  .+++|
T Consensus        94 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L  173 (680)
T 1ziw_A           94 AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL  173 (680)
T ss_dssp             TTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEE
T ss_pred             ccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccc
Confidence            3456889999999999877778899999999999999999988888888888 99999999999877776654  34667


Q ss_pred             CCcccccC
Q 002809          481 GSLSLSVG  488 (878)
Q Consensus       481 ~~l~l~~~  488 (878)
                      +.|+++.+
T Consensus       174 ~~L~L~~n  181 (680)
T 1ziw_A          174 KKLELSSN  181 (680)
T ss_dssp             SEEECTTC
T ss_pred             cEEECCCC
Confidence            76555443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.46  E-value=1.2e-07  Score=112.70  Aligned_cols=95  Identities=22%  Similarity=0.121  Sum_probs=75.0

Q ss_pred             ccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcC
Q 002809          394 WDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKL  466 (878)
Q Consensus       394 w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l  466 (878)
                      +.-+.|+..+      ..+..++.|+|++|+|++..|..|++|++|++|+|++|++++..|..|+.++ |+.|+|++|++
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            3457786432      2446788889999988877788888888888888888888888888888888 88888888888


Q ss_pred             CCCCchhhhhcccCCCcccccC
Q 002809          467 NGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       467 ~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      ++..|..++.+++|+.|+++.+
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n  115 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQT  115 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTS
T ss_pred             cccChhhhcccccccEeecccc
Confidence            8777888888887776665544

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.46  E-value=7e-08  Score=108.13  Aligned_cols=78  Identities=23%  Similarity=0.264  Sum_probs=39.2

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCcc-CCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDF-LSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      ++|+.|+|++|++++..|..|+++++|+.|+|++|+++ .+|.. ++.++ |+.|+|++|++++..|..+..+++|+.|+
T Consensus        93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  171 (390)
T 3o6n_A           93 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ  171 (390)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE
T ss_pred             CCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE
Confidence            44555555555555444445555555555555555555 33332 34454 55555555555544444455555554443


Q ss_pred             c
Q 002809          485 L  485 (878)
Q Consensus       485 l  485 (878)
                      +
T Consensus       172 l  172 (390)
T 3o6n_A          172 L  172 (390)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.45  E-value=7.2e-08  Score=113.38  Aligned_cols=75  Identities=20%  Similarity=0.287  Sum_probs=43.5

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccC-cCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccC
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKN  480 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l  480 (878)
                      .++|+.|+|++|++++..+..|++|++|++|+|++|++++ .+|..++.++ |+.|+|++|++++..|..+..+.++
T Consensus        99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  175 (570)
T 2z63_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM  175 (570)
T ss_dssp             CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTC
T ss_pred             ccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhcc
Confidence            4456666666666654333356666666666666666654 4566666665 6666666666665555555555554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.45  E-value=7.4e-08  Score=113.52  Aligned_cols=146  Identities=16%  Similarity=0.189  Sum_probs=95.3

Q ss_pred             eEEEEEecCCCCCc--hhhhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          329 YSFSLYKTGNSTLP--PIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       329 ~~~~l~~t~~s~lp--p~inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      ..+.+..+....++  ..+..++.+.+..+...+..|..+..+.+|+.+....+.+.+-|..+           ......
T Consensus       334 ~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-----------~~~~~l  402 (562)
T 3a79_B          334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVA-----------LMTKNM  402 (562)
T ss_dssp             SEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHH-----------HTTTTC
T ss_pred             eEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccch-----------hhhcCC
Confidence            34555555444433  34556777777766544445555555555544443333333211100           001345


Q ss_pred             CcEEEEEecCCCccccchhh-hhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          407 PRITYLNLSSSGLKGDITSY-VSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      ++|+.|+|++|++++.+|.. +..+++|+.|+|++|+|+|.+|..+.  + |+.|+|++|+|+ .||..+..+++|+.|+
T Consensus       403 ~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~  479 (562)
T 3a79_B          403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN  479 (562)
T ss_dssp             TTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEE
T ss_pred             CCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEE
Confidence            68888889888888867764 77888889999999988888887665  5 899999999998 7888888888888766


Q ss_pred             cccC
Q 002809          485 LSVG  488 (878)
Q Consensus       485 l~~~  488 (878)
                      ++.+
T Consensus       480 L~~N  483 (562)
T 3a79_B          480 VASN  483 (562)
T ss_dssp             CCSS
T ss_pred             CCCC
Confidence            6544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.45  E-value=8e-08  Score=103.45  Aligned_cols=137  Identities=21%  Similarity=0.238  Sum_probs=94.2

Q ss_pred             eEEEEEecCCCCCchh--hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          329 YSFSLYKTGNSTLPPI--INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~--inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      ..+.+..+....+|.+  +..++.+.+..+. .+.++. +..+.+|+.+....+...+-|.               ....
T Consensus        49 ~~L~l~~~~i~~~~~~~~l~~L~~L~L~~n~-l~~~~~-l~~l~~L~~L~l~~n~l~~~~~---------------l~~l  111 (291)
T 1h6t_A           49 DQIIANNSDIKSVQGIQYLPNVTKLFLNGNK-LTDIKP-LANLKNLGWLFLDENKVKDLSS---------------LKDL  111 (291)
T ss_dssp             CEEECTTSCCCCCTTGGGCTTCCEEECCSSC-CCCCGG-GTTCTTCCEEECCSSCCCCGGG---------------GTTC
T ss_pred             cEEEccCCCcccChhHhcCCCCCEEEccCCc-cCCCcc-cccCCCCCEEECCCCcCCCChh---------------hccC
Confidence            3445545555555543  3467777777765 455554 5555555544433333322111               1456


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      ++|+.|+|++|+|++ + +.+.+|++|+.|+|++|++++.  ..++.++ |+.|+|++|++++..|  +..+++|+.|++
T Consensus       112 ~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L  185 (291)
T 1h6t_A          112 KKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL  185 (291)
T ss_dssp             TTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC
Confidence            789999999999986 3 5799999999999999999964  5688888 9999999999996544  888888887766


Q ss_pred             ccC
Q 002809          486 SVG  488 (878)
Q Consensus       486 ~~~  488 (878)
                      +.+
T Consensus       186 ~~N  188 (291)
T 1h6t_A          186 SKN  188 (291)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            544

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.44  E-value=4.9e-08  Score=106.12  Aligned_cols=79  Identities=23%  Similarity=0.332  Sum_probs=43.4

Q ss_pred             CCcEEEEEecCCCccccchhhhhcc-----CCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCC--Cchhh--h
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNL-----TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGS--VPVEL--L  475 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~--iP~~l--~  475 (878)
                      .++|+.|+|++|+|++. |..++++     ++|+.|+|++|++++..|..++.++ |+.|+|++|++.|.  +|..+  .
T Consensus       120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  198 (312)
T 1wwl_A          120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL  198 (312)
T ss_dssp             SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred             CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence            34556666666666554 5555555     5666666666666555555555555 66666666665554  23333  4


Q ss_pred             hcccCCCccc
Q 002809          476 ERSKNGSLSL  485 (878)
Q Consensus       476 ~~~~l~~l~l  485 (878)
                      .+++|+.|++
T Consensus       199 ~l~~L~~L~L  208 (312)
T 1wwl_A          199 KFPTLQVLAL  208 (312)
T ss_dssp             SCTTCCEEEC
T ss_pred             cCCCCCEEEC
Confidence            4555554433

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.43  E-value=2.5e-08  Score=108.72  Aligned_cols=143  Identities=13%  Similarity=0.127  Sum_probs=92.2

Q ss_pred             ceeEEEEEecCCCCCchh----hhhhhhheeccccccccccchHH-HHHHHHHhhCCCCCCCCCCCCCCCCcccceecCC
Q 002809          327 GNYSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQIDVD-AITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSY  401 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d~~-al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~  401 (878)
                      ....+.+..+..+.++|.    +..++.+.+..+......+..+. .+..|+.+....+...+.|.              
T Consensus       121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------------  186 (317)
T 3o53_A          121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--------------  186 (317)
T ss_dssp             SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--------------
T ss_pred             CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--------------
Confidence            345666777777777653    34667777766553322333332 33344333322222221111              


Q ss_pred             CCCCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCC-CCCchhhhhccc
Q 002809          402 GDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN-GSVPVELLERSK  479 (878)
Q Consensus       402 ~~~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~-g~iP~~l~~~~~  479 (878)
                       ....++|+.|+|++|+|+ .+|+.+..+++|+.|+|++|+|+ .+|..+..++ |+.|+|++|.++ +.+|..+..++.
T Consensus       187 -~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~  263 (317)
T 3o53_A          187 -QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR  263 (317)
T ss_dssp             -CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHH
T ss_pred             -ccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhcccc
Confidence             123567888888888888 45666888888888888888888 6788888888 888888888888 777877777777


Q ss_pred             CCCcccc
Q 002809          480 NGSLSLS  486 (878)
Q Consensus       480 l~~l~l~  486 (878)
                      ++.+.+.
T Consensus       264 L~~l~l~  270 (317)
T 3o53_A          264 VQTVAKQ  270 (317)
T ss_dssp             HHHHHHH
T ss_pred             ceEEECC
Confidence            6655543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.43  E-value=7.7e-08  Score=102.01  Aligned_cols=74  Identities=26%  Similarity=0.402  Sum_probs=60.3

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      ++|+.|+|++|+|++ +| .++++++|+.|+|++|+|++ +| .++.++ |+.|+|++|++++.  ..+..+++|+.|++
T Consensus       106 ~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l  179 (263)
T 1xeu_A          106 ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL  179 (263)
T ss_dssp             SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred             CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence            578999999999986 44 68999999999999999985 45 578888 99999999999865  66777777775554


Q ss_pred             c
Q 002809          486 S  486 (878)
Q Consensus       486 ~  486 (878)
                      +
T Consensus       180 ~  180 (263)
T 1xeu_A          180 T  180 (263)
T ss_dssp             E
T ss_pred             C
Confidence            3

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.43  E-value=8.7e-08  Score=115.51  Aligned_cols=143  Identities=17%  Similarity=0.078  Sum_probs=104.4

Q ss_pred             EEEecCCCCCchhh-hhhhhheecccccccccc-chHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcE
Q 002809          332 SLYKTGNSTLPPII-NAIEVYSVKEFLQLQTEQ-IDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRI  409 (878)
Q Consensus       332 ~l~~t~~s~lpp~i-nalEi~~l~~~~~~~t~~-~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l  409 (878)
                      .......+.+|+.+ ..++.+.+..+. ...++ .++..+..|+.+....+...+.+-.    .+         ...++|
T Consensus        10 ~cs~~~L~~ip~~~~~~l~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~----~~---------~~l~~L   75 (680)
T 1ziw_A           10 DCSHLKLTQVPDDLPTNITVLNLTHNQ-LRRLPAANFTRYSQLTSLDVGFNTISKLEPE----LC---------QKLPML   75 (680)
T ss_dssp             ECCSSCCSSCCSCSCTTCSEEECCSSC-CCCCCGGGGGGGTTCSEEECCSSCCCCCCTT----HH---------HHCTTC
T ss_pred             ECCCCCccccccccCCCCcEEECCCCC-CCCcCHHHHhCCCcCcEEECCCCccCccCHH----HH---------hcccCc
Confidence            33344556666544 478888888766 44444 4566666665554433333332110    11         235689


Q ss_pred             EEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccC
Q 002809          410 TYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       410 ~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      +.|+|++|+|++..+..|++|++|++|+|++|++++..|..++.++ |++|+|++|++++..|..+.++++|+.|+++.+
T Consensus        76 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  155 (680)
T 1ziw_A           76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN  155 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSS
T ss_pred             CEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCC
Confidence            9999999999955555799999999999999999977778899999 999999999999998999999999987766554

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.43  E-value=1.4e-07  Score=105.79  Aligned_cols=144  Identities=19%  Similarity=0.178  Sum_probs=102.4

Q ss_pred             CceeEEEEEecCCCCCchhh----hhhhhheecccccccccc-chHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecC
Q 002809          326 GGNYSFSLYKTGNSTLPPII----NAIEVYSVKEFLQLQTEQ-IDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCS  400 (878)
Q Consensus       326 ~~~~~~~l~~t~~s~lpp~i----nalEi~~l~~~~~~~t~~-~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~  400 (878)
                      .....+.+..+....+|+.+    ..++.+.+..+. ...++ ..+..+..|+.+....+...+.|..    .       
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~-------  112 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH----V-------  112 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSC-CCEECTTTTTTCTTCCEEECCSSCCCCCCTT----T-------
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCc-ccccChhhccCCCCcCEEECCCCCCCcCCHH----H-------
Confidence            44556777777777787753    467788887765 44443 3556666666555444444443321    0       


Q ss_pred             CCCCCCCcEEEEEecCCCccccchhh-hhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcc
Q 002809          401 YGDSSSPRITYLNLSSSGLKGDITSY-VSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERS  478 (878)
Q Consensus       401 ~~~~~~~~l~~l~l~~n~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~  478 (878)
                        ....++|+.|+|++|+|+ .+|+. |+++++|+.|+|++|++++..|..++.++ |+.|+|++|++++. +  +..++
T Consensus       113 --~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~--~~~l~  186 (390)
T 3o6n_A          113 --FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIP  186 (390)
T ss_dssp             --TTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-C--GGGCT
T ss_pred             --hcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-c--ccccc
Confidence              135678999999999999 56655 69999999999999999988888899999 99999999999964 3  45566


Q ss_pred             cCCCccccc
Q 002809          479 KNGSLSLSV  487 (878)
Q Consensus       479 ~l~~l~l~~  487 (878)
                      +++.|.++.
T Consensus       187 ~L~~L~l~~  195 (390)
T 3o6n_A          187 SLFHANVSY  195 (390)
T ss_dssp             TCSEEECCS
T ss_pred             ccceeeccc
Confidence            666555543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.41  E-value=1e-07  Score=94.42  Aligned_cols=75  Identities=20%  Similarity=0.169  Sum_probs=50.2

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCch--hhhhcccCCCc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPV--ELLERSKNGSL  483 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~--~l~~~~~l~~l  483 (878)
                      ++|+.|+|++|+|++.  +.|++|++|+.|+|++|+|++..|..++.++ |+.|+|++|+|+ .+|.  .+..+++|+.|
T Consensus        42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L  118 (176)
T 1a9n_A           42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL  118 (176)
T ss_dssp             TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred             CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence            3677777777777753  5677777777777777777743333346677 777777777774 5665  66666666643


Q ss_pred             c
Q 002809          484 S  484 (878)
Q Consensus       484 ~  484 (878)
                      +
T Consensus       119 ~  119 (176)
T 1a9n_A          119 C  119 (176)
T ss_dssp             E
T ss_pred             E
Confidence            3

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.41  E-value=1.5e-07  Score=102.08  Aligned_cols=74  Identities=23%  Similarity=0.344  Sum_probs=39.6

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|+|++..+  ++++++|+.|+|++|++++ +|. +..++ |+.|+|++|++++ +|. +..+++|+.|+
T Consensus       128 l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~  201 (308)
T 1h6u_A          128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVH  201 (308)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEE
T ss_pred             CCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEE
Confidence            4456666666666653322  5566666666666666653 333 55555 6666666666653 222 45555555443


Q ss_pred             c
Q 002809          485 L  485 (878)
Q Consensus       485 l  485 (878)
                      +
T Consensus       202 L  202 (308)
T 1h6u_A          202 L  202 (308)
T ss_dssp             C
T ss_pred             c
Confidence            3

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.40  E-value=4.6e-08  Score=106.20  Aligned_cols=59  Identities=32%  Similarity=0.446  Sum_probs=32.6

Q ss_pred             CcEEEEEecCCCccccchhhhhcc---CCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCC
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNL---TSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNG  468 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l---~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g  468 (878)
                      ++|+.|+|++|+|++.+|+.++.+   ++|+.|+|++|+|+ .+|..+.  + |+.|+|++|+|+|
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~  286 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR  286 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC
Confidence            455555555555555555555555   35555555555555 5555443  3 5555555555553

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.39  E-value=1.7e-07  Score=103.18  Aligned_cols=77  Identities=21%  Similarity=0.185  Sum_probs=69.2

Q ss_pred             EEEecCC-CccccchhhhhccCCCCEEeCcC-CcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccccc
Q 002809          411 YLNLSSS-GLKGDITSYVSNLTSLQFLDLSN-NNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSV  487 (878)
Q Consensus       411 ~l~l~~n-~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~  487 (878)
                      .++++++ +|+ .||. |..+++|+.|+|++ |+|++..|..|+.|+ |+.|+|++|+|+|..|..+.++++|+.|+|+.
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4699998 999 5999 99999999999996 999988778999999 99999999999998888999999999877765


Q ss_pred             CC
Q 002809          488 GG  489 (878)
Q Consensus       488 ~~  489 (878)
                      +.
T Consensus        90 N~   91 (347)
T 2ifg_A           90 NA   91 (347)
T ss_dssp             SC
T ss_pred             Cc
Confidence            53

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.39  E-value=1.2e-07  Score=111.68  Aligned_cols=119  Identities=23%  Similarity=0.249  Sum_probs=87.5

Q ss_pred             ceeEEEEEecCCCCCchhhhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          327 GNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      ....+.|..+..+.+|..+..|+.+.+..|. .+.+|. +..  +|+.+....+...+-|-                 .+
T Consensus        81 ~L~~L~Ls~N~l~~ip~~l~~L~~L~Ls~N~-l~~ip~-l~~--~L~~L~Ls~N~l~~lp~-----------------~l  139 (571)
T 3cvr_A           81 QITVLEITQNALISLPELPASLEYLDACDNR-LSTLPE-LPA--SLKHLDVDNNQLTMLPE-----------------LP  139 (571)
T ss_dssp             TCSEEECCSSCCSCCCCCCTTCCEEECCSSC-CSCCCC-CCT--TCCEEECCSSCCSCCCC-----------------CC
T ss_pred             CCCEEECcCCCCcccccccCCCCEEEccCCC-CCCcch-hhc--CCCEEECCCCcCCCCCC-----------------cC
Confidence            3567777778888888667788888888875 555776 432  33333333333333221                 34


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhh
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLE  476 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~  476 (878)
                      ++|+.|+|++|+|++ ||.   .+++|+.|+|++|+|++ ||. ++  + |+.|+|++|+|+ .||. +..
T Consensus       140 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~  200 (571)
T 3cvr_A          140 ALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV  200 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC-
T ss_pred             ccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH
Confidence            689999999999996 887   68999999999999997 888 66  6 999999999999 8888 554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.38  E-value=2.9e-07  Score=105.06  Aligned_cols=96  Identities=23%  Similarity=0.209  Sum_probs=79.2

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|..|.|+...      ..++.++.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|..|..++ |+.|+|++|+
T Consensus        44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~  123 (440)
T 3zyj_A           44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR  123 (440)
T ss_dssp             TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence            46788997532      3446789999999999988889999999999999999999977778899999 9999999999


Q ss_pred             CCCCCchhhhhcccCCCcccccC
Q 002809          466 LNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       466 l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |++..+..+..+++|+.|+++.+
T Consensus       124 l~~~~~~~~~~l~~L~~L~L~~N  146 (440)
T 3zyj_A          124 LTTIPNGAFVYLSKLKELWLRNN  146 (440)
T ss_dssp             CSSCCTTTSCSCSSCCEEECCSC
T ss_pred             CCeeCHhHhhccccCceeeCCCC
Confidence            99555557888888887666543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.37  E-value=2.9e-07  Score=100.79  Aligned_cols=92  Identities=25%  Similarity=0.248  Sum_probs=78.0

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|+.+.|+...      ...++|+.|+|++|+|++..|..|+++++|+.|+|++|++++..|..++.++ |+.|+|++|+
T Consensus        34 ~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  113 (332)
T 2ft3_A           34 HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH  113 (332)
T ss_dssp             ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred             cCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence            68889997542      2346899999999999987788999999999999999999988899999999 9999999999


Q ss_pred             CCCCCchhhhhcccCCCccccc
Q 002809          466 LNGSVPVELLERSKNGSLSLSV  487 (878)
Q Consensus       466 l~g~iP~~l~~~~~l~~l~l~~  487 (878)
                      ++ .+|..+.  ++|+.|+++.
T Consensus       114 l~-~l~~~~~--~~L~~L~l~~  132 (332)
T 2ft3_A          114 LV-EIPPNLP--SSLVELRIHD  132 (332)
T ss_dssp             CC-SCCSSCC--TTCCEEECCS
T ss_pred             CC-ccCcccc--ccCCEEECCC
Confidence            99 7888776  5666555543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.37  E-value=3.5e-07  Score=99.89  Aligned_cols=91  Identities=23%  Similarity=0.293  Sum_probs=77.2

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCc
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~  465 (878)
                      .|+.+.|+...      ..++.|+.|+|++|+|++..+..|+++++|+.|+|++|++++..|..++.++ |+.|+|++|+
T Consensus        32 ~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  111 (330)
T 1xku_A           32 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ  111 (330)
T ss_dssp             ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred             CCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence            68889998532      2356899999999999987777999999999999999999988899999999 9999999999


Q ss_pred             CCCCCchhhhhcccCCCcccc
Q 002809          466 LNGSVPVELLERSKNGSLSLS  486 (878)
Q Consensus       466 l~g~iP~~l~~~~~l~~l~l~  486 (878)
                      ++ .+|..+.  ++|+.|.++
T Consensus       112 l~-~l~~~~~--~~L~~L~l~  129 (330)
T 1xku_A          112 LK-ELPEKMP--KTLQELRVH  129 (330)
T ss_dssp             CS-BCCSSCC--TTCCEEECC
T ss_pred             CC-ccChhhc--ccccEEECC
Confidence            99 7887765  566655544

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.35  E-value=1.5e-07  Score=102.04  Aligned_cols=78  Identities=27%  Similarity=0.368  Sum_probs=62.5

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++ +|+ +..|++|+.|+|++|++++..|  ++.++ |+.|+|++|++++ +|. +..+++|+.|
T Consensus       105 ~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L  178 (308)
T 1h6u_A          105 GLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTL  178 (308)
T ss_dssp             TCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEE
T ss_pred             CCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEE
Confidence            45689999999999986 454 8999999999999999985443  77888 9999999999985 554 7888888876


Q ss_pred             ccccC
Q 002809          484 SLSVG  488 (878)
Q Consensus       484 ~l~~~  488 (878)
                      +++.+
T Consensus       179 ~l~~n  183 (308)
T 1h6u_A          179 KADDN  183 (308)
T ss_dssp             ECCSS
T ss_pred             ECCCC
Confidence            66544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.35  E-value=1.6e-07  Score=103.26  Aligned_cols=77  Identities=30%  Similarity=0.347  Sum_probs=62.1

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|++++.  +.+..+++|+.|+|++|++++..|..++.++ |+.|+|++|++++..|  +..+++|+.|
T Consensus       263 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  338 (347)
T 4fmz_A          263 DLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA  338 (347)
T ss_dssp             TCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEE
T ss_pred             cCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhcccee
Confidence            456888899999988864  4688889999999999999888888888888 9999999999887655  7777777754


Q ss_pred             cc
Q 002809          484 SL  485 (878)
Q Consensus       484 ~l  485 (878)
                      ++
T Consensus       339 ~l  340 (347)
T 4fmz_A          339 DF  340 (347)
T ss_dssp             SS
T ss_pred             eh
Confidence            44

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.35  E-value=2.4e-07  Score=91.67  Aligned_cols=81  Identities=20%  Similarity=0.152  Sum_probs=68.6

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCc--cCCCCc-ceEEEecCCcCCCCCchh----hhh
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD--FLSKLP-LRTLNLQGNKLNGSVPVE----LLE  476 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~-L~~L~ls~N~l~g~iP~~----l~~  476 (878)
                      ...++|+.|+|++|+|++..|..++.+++|+.|+|++|+|+ .+|.  .+..++ |+.|+|++|.++ .+|..    +..
T Consensus        61 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~  138 (176)
T 1a9n_A           61 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYK  138 (176)
T ss_dssp             CCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHH
T ss_pred             ccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHH
Confidence            34578999999999999544455599999999999999996 7887  788999 999999999998 67875    888


Q ss_pred             cccCCCcccc
Q 002809          477 RSKNGSLSLS  486 (878)
Q Consensus       477 ~~~l~~l~l~  486 (878)
                      +++++.|+++
T Consensus       139 l~~L~~Ld~~  148 (176)
T 1a9n_A          139 VPQVRVLDFQ  148 (176)
T ss_dssp             CTTCSEETTE
T ss_pred             CCccceeCCC
Confidence            8888876554

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.34  E-value=1.3e-07  Score=104.54  Aligned_cols=139  Identities=17%  Similarity=0.166  Sum_probs=75.6

Q ss_pred             EecCCCCCchhh-hhhhhheeccccccccccc-hHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCCcEEE
Q 002809          334 YKTGNSTLPPII-NAIEVYSVKEFLQLQTEQI-DVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITY  411 (878)
Q Consensus       334 ~~t~~s~lpp~i-nalEi~~l~~~~~~~t~~~-d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~~l~~  411 (878)
                      ..+....+|..+ ..++.+.+..+. .+.++. .+..+..|+.+....+...+.+..             .....++|+.
T Consensus        39 ~~~~l~~iP~~~~~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~  104 (353)
T 2z80_A           39 SSGSLNSIPSGLTEAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGINTIEED-------------SFSSLGSLEH  104 (353)
T ss_dssp             CSTTCSSCCTTCCTTCCEEECTTSC-CCEECTTTTTTCTTCCEEECTTSCCCEECTT-------------TTTTCTTCCE
T ss_pred             CCCCcccccccccccCcEEECCCCc-CcccCHHHhccCCCCCEEECCCCccCccCHh-------------hcCCCCCCCE
Confidence            344555555532 366666666654 333433 344444444333322222221110             0123456777


Q ss_pred             EEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCc--cCCCCc-ceEEEecCCc-CCCCCchhhhhcccCCCccccc
Q 002809          412 LNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD--FLSKLP-LRTLNLQGNK-LNGSVPVELLERSKNGSLSLSV  487 (878)
Q Consensus       412 l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~-L~~L~ls~N~-l~g~iP~~l~~~~~l~~l~l~~  487 (878)
                      |+|++|+|++..+..++++++|+.|+|++|+++ .+|.  .+..++ |+.|+|++|+ +++..|..+..+++|+.|+++.
T Consensus       105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~  183 (353)
T 2z80_A          105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA  183 (353)
T ss_dssp             EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred             EECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence            777777777544444777777777777777777 4554  566676 7777777774 4433345666666666555443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.33  E-value=5.4e-08  Score=101.29  Aligned_cols=73  Identities=19%  Similarity=0.243  Sum_probs=36.8

Q ss_pred             CcEEEEEecC-CCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ce---EEEecCC-cCCCCCchhhhhcccC
Q 002809          407 PRITYLNLSS-SGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LR---TLNLQGN-KLNGSVPVELLERSKN  480 (878)
Q Consensus       407 ~~l~~l~l~~-n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~---~L~ls~N-~l~g~iP~~l~~~~~l  480 (878)
                      ++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++ +|. ++.++ |+   .|+|++| ++++..|..+..++++
T Consensus        80 ~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L  157 (239)
T 2xwt_C           80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE  157 (239)
T ss_dssp             TTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSS
T ss_pred             cCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcc
Confidence            3555555555 55554334455555555555555555553 554 44444 44   5555555 5553223334444444


Q ss_pred             C
Q 002809          481 G  481 (878)
Q Consensus       481 ~  481 (878)
                      +
T Consensus       158 ~  158 (239)
T 2xwt_C          158 T  158 (239)
T ss_dssp             E
T ss_pred             e
Confidence            4

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.32  E-value=3.3e-07  Score=109.04  Aligned_cols=67  Identities=28%  Similarity=0.333  Sum_probs=35.5

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERS  478 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~  478 (878)
                      ++|+.|+|++|+|+ .||.   .+++|+.|+|++|+|+ .||..+..++ |+.|+|++|.|+|.+|..+..+.
T Consensus       241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            34555555555555 3444   4455555555555555 5555555555 55555555555555555554443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.31  E-value=2.7e-07  Score=105.87  Aligned_cols=74  Identities=26%  Similarity=0.419  Sum_probs=52.2

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCcceEEEecCCcCCCCCchhhhhcccCCCcccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLS  486 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~  486 (878)
                      ++|+.|+|++|+|++ +| +|+++++|+.|+|++|++++ +|..+.  .|+.|+|++|++++ +| ++..+++|+.|+++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~~--~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~  203 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLPP--SLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD  203 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCCT--TCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCcc--cccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence            467788888888875 77 57888888888888888874 665432  37777788887775 66 57777777655554


Q ss_pred             c
Q 002809          487 V  487 (878)
Q Consensus       487 ~  487 (878)
                      .
T Consensus       204 ~  204 (454)
T 1jl5_A          204 N  204 (454)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.30  E-value=6.6e-08  Score=105.34  Aligned_cols=81  Identities=21%  Similarity=0.145  Sum_probs=39.5

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      ++|+.|+|++|+|++. | ....+++|+.|+|++|+|+ .+|..+..++ |+.|+|++|+|+ .+|..+..+++++.  +
T Consensus       169 ~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~--L  242 (317)
T 3o53_A          169 DTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH--F  242 (317)
T ss_dssp             TTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCE--E
T ss_pred             CcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCE--E
Confidence            3455555555555532 2 2223555555555555555 2333355555 555555555555 35555555554442  3


Q ss_pred             ccCCCCCC
Q 002809          486 SVGGNPGL  493 (878)
Q Consensus       486 ~~~~n~~l  493 (878)
                      ..++|+..
T Consensus       243 ~l~~N~~~  250 (317)
T 3o53_A          243 DLRGNGFH  250 (317)
T ss_dssp             ECTTCCCB
T ss_pred             EccCCCcc
Confidence            33444443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.30  E-value=2.8e-07  Score=105.77  Aligned_cols=135  Identities=17%  Similarity=0.187  Sum_probs=92.4

Q ss_pred             ceeEEEEEecCCCCCchhhhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          327 GNYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      ....+.+..+..+.+|.....++.+.+..+. .+.+| ++..+..|+.+....+...+-|-                 ..
T Consensus       112 ~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~-l~~lp-~~~~l~~L~~L~l~~N~l~~lp~-----------------~~  172 (454)
T 1jl5_A          112 SLKSLLVDNNNLKALSDLPPLLEYLGVSNNQ-LEKLP-ELQNSSFLKIIDVDNNSLKKLPD-----------------LP  172 (454)
T ss_dssp             TCCEEECCSSCCSCCCSCCTTCCEEECCSSC-CSSCC-CCTTCTTCCEEECCSSCCSCCCC-----------------CC
T ss_pred             CCcEEECCCCccCcccCCCCCCCEEECcCCC-CCCCc-ccCCCCCCCEEECCCCcCcccCC-----------------Cc
Confidence            3445566666666666665678888887765 45566 46655555555443333333221                 22


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCcceEEEecCCcCCCCCchhhhhcccCCCcccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLS  486 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~  486 (878)
                      .+|+.|+|++|++++ +| .+++|++|+.|+|++|++++ +|....  .|+.|+|++|+++ .+| +++.+++++.|+++
T Consensus       173 ~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~~--~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~  245 (454)
T 1jl5_A          173 PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLPL--SLESIVAGNNILE-ELP-ELQNLPFLTTIYAD  245 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCCT--TCCEEECCSSCCS-SCC-CCTTCTTCCEEECC
T ss_pred             ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCcC--cccEEECcCCcCC-ccc-ccCCCCCCCEEECC
Confidence            478899999999986 67 68899999999999999885 665431  3888888988888 788 47788888766655


Q ss_pred             c
Q 002809          487 V  487 (878)
Q Consensus       487 ~  487 (878)
                      .
T Consensus       246 ~  246 (454)
T 1jl5_A          246 N  246 (454)
T ss_dssp             S
T ss_pred             C
Confidence            4

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.27  E-value=3.4e-07  Score=105.22  Aligned_cols=75  Identities=28%  Similarity=0.334  Sum_probs=56.8

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|++++..|  ++.+++|+.|+|++|++++.  ..+..++ |+.|+|++|+++|.+|  +..+++++.|
T Consensus       307 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  380 (466)
T 1o6v_A          307 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL  380 (466)
T ss_dssp             GCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEE
T ss_pred             CCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEE
Confidence            34678888888888887665  77888888888888888864  3577777 8888888888887776  6777777755


Q ss_pred             cc
Q 002809          484 SL  485 (878)
Q Consensus       484 ~l  485 (878)
                      .+
T Consensus       381 ~l  382 (466)
T 1o6v_A          381 GL  382 (466)
T ss_dssp             EC
T ss_pred             ec
Confidence            44

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.23  E-value=3.1e-07  Score=95.53  Aligned_cols=77  Identities=22%  Similarity=0.144  Sum_probs=43.4

Q ss_pred             EEEEEecCC-CccccchhhhhccCCCC-EEeCcCCcccCcCCccCCCCc-ceEEEecCCc-CCCCCchhhhhc-ccCCCc
Q 002809          409 ITYLNLSSS-GLKGDITSYVSNLTSLQ-FLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK-LNGSVPVELLER-SKNGSL  483 (878)
Q Consensus       409 l~~l~l~~n-~l~g~ip~~~~~l~~L~-~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~-l~g~iP~~l~~~-~~l~~l  483 (878)
                      |+.|+|++| ++++..+..|.++++|+ .|+|++|+++ .||......+ |+.|+|++|+ +++..|..+..+ ++++.|
T Consensus       132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L  210 (239)
T 2xwt_C          132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL  210 (239)
T ss_dssp             EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred             ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence            446666666 66644444566666666 6666666666 5555433334 6666666663 663333445555 555544


Q ss_pred             ccc
Q 002809          484 SLS  486 (878)
Q Consensus       484 ~l~  486 (878)
                      +++
T Consensus       211 ~l~  213 (239)
T 2xwt_C          211 DVS  213 (239)
T ss_dssp             ECT
T ss_pred             ECC
Confidence            443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.23  E-value=4.4e-07  Score=98.39  Aligned_cols=81  Identities=15%  Similarity=0.117  Sum_probs=49.3

Q ss_pred             CCcEEEEEecCCCccccch----hhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCC--Cchh--hhh
Q 002809          406 SPRITYLNLSSSGLKGDIT----SYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGS--VPVE--LLE  476 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip----~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~--iP~~--l~~  476 (878)
                      .++|+.|+|++|++++.+|    ..+..+++|+.|+|++|++++..|..++.++ |+.|+|++|++.|.  +|..  +..
T Consensus       116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  195 (310)
T 4glp_A          116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK  195 (310)
T ss_dssp             CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred             CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence            4566667777777766544    3445666777777777777666666666666 77777777766543  2222  245


Q ss_pred             cccCCCcccc
Q 002809          477 RSKNGSLSLS  486 (878)
Q Consensus       477 ~~~l~~l~l~  486 (878)
                      +++|+.|.++
T Consensus       196 l~~L~~L~Ls  205 (310)
T 4glp_A          196 FPAIQNLALR  205 (310)
T ss_dssp             SCCCCSCBCC
T ss_pred             CCCCCEEECC
Confidence            5556655443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.23  E-value=5.9e-07  Score=103.14  Aligned_cols=73  Identities=26%  Similarity=0.349  Sum_probs=40.8

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|+|++ +|  ++++++|+.|+|++|+|++ +|  ++.++ |+.|+|++|++.|.+  .+..+++|+.|+
T Consensus       105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~  176 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD  176 (457)
T ss_dssp             CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred             CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence            4456666666666654 33  5666666666666666664 33  55555 666666666555555  244555555444


Q ss_pred             cc
Q 002809          485 LS  486 (878)
Q Consensus       485 l~  486 (878)
                      ++
T Consensus       177 ls  178 (457)
T 3bz5_A          177 CS  178 (457)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.21  E-value=3.6e-07  Score=108.70  Aligned_cols=133  Identities=22%  Similarity=0.274  Sum_probs=91.0

Q ss_pred             eeEEEEEecCCCCCchhhhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCCC
Q 002809          328 NYSFSLYKTGNSTLPPIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSP  407 (878)
Q Consensus       328 ~~~~~l~~t~~s~lpp~inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~~  407 (878)
                      ...+.+..+..+.+|..+..|+.+.+..+. ...+|...   .+|+.+....+....-|                 ..++
T Consensus       163 L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~-l~~l~~~~---~~L~~L~L~~N~l~~l~-----------------~~~~  221 (622)
T 3g06_A          163 LCKLWAYNNQLTSLPMLPSGLQELSVSDNQ-LASLPTLP---SELYKLWAYNNRLTSLP-----------------ALPS  221 (622)
T ss_dssp             CCEEECCSSCCSCCCCCCTTCCEEECCSSC-CSCCCCCC---TTCCEEECCSSCCSSCC-----------------CCCT
T ss_pred             CCEEECCCCCCCCCcccCCCCcEEECCCCC-CCCCCCcc---chhhEEECcCCcccccC-----------------CCCC
Confidence            345555566666666666667777776654 44454432   12222221112221111                 1236


Q ss_pred             cEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccc
Q 002809          408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLS  486 (878)
Q Consensus       408 ~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~  486 (878)
                      +|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .||.   .++ |+.|+|++|+|+ .||..+.++++|..|++ 
T Consensus       222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L-  291 (622)
T 3g06_A          222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL-  291 (622)
T ss_dssp             TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC-
T ss_pred             CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe-
Confidence            89999999999996 77   66799999999999999 7887   556 999999999999 89999999999886554 


Q ss_pred             cCCCCC
Q 002809          487 VGGNPG  492 (878)
Q Consensus       487 ~~~n~~  492 (878)
                       .+|+.
T Consensus       292 -~~N~l  296 (622)
T 3g06_A          292 -EGNPL  296 (622)
T ss_dssp             -CSCCC
T ss_pred             -cCCCC
Confidence             55554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.20  E-value=1.1e-06  Score=92.89  Aligned_cols=72  Identities=25%  Similarity=0.306  Sum_probs=36.2

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|+|++. |+ +++|++|+.|+|++|+|++ +|....  + |+.|+|++|++++ +| .+..+++|+.|+
T Consensus        62 l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~  134 (263)
T 1xeu_A           62 FTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILS  134 (263)
T ss_dssp             CTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence            34566666666666533 22 6666666666666666653 343222  3 5555555555553 22 344444444333

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.17  E-value=9.6e-07  Score=93.39  Aligned_cols=80  Identities=31%  Similarity=0.326  Sum_probs=64.1

Q ss_pred             CCCcEEEEEecCCCccc--cchhhhhccCCCCEEeCcCCcccCcC-CccCCCCcceEEEecCCcCCCCCch-------hh
Q 002809          405 SSPRITYLNLSSSGLKG--DITSYVSNLTSLQFLDLSNNNLTGSV-PDFLSKLPLRTLNLQGNKLNGSVPV-------EL  474 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g--~ip~~~~~l~~L~~L~Ls~N~l~g~i-P~~~~~l~L~~L~ls~N~l~g~iP~-------~l  474 (878)
                      ..++|+.|+|++|+|++  .+|..+..|++|+.|+|++|+|++.- -..+..+.|+.|+|++|.+++.+|.       .+
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il  247 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR  247 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence            35789999999999998  78899999999999999999999751 1223444699999999999998873       35


Q ss_pred             hhcccCCCcc
Q 002809          475 LERSKNGSLS  484 (878)
Q Consensus       475 ~~~~~l~~l~  484 (878)
                      ..+++|..|+
T Consensus       248 ~~~P~L~~LD  257 (267)
T 3rw6_A          248 ERFPKLLRLD  257 (267)
T ss_dssp             HHCTTCCEES
T ss_pred             HHCcccCeEC
Confidence            6677776553

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.16  E-value=1e-07  Score=96.38  Aligned_cols=77  Identities=18%  Similarity=0.229  Sum_probs=61.4

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|+|++ +| .+.++++|+.|+|++|+|+ .+|..+..++ |+.|+|++|++++ +| .+..+++|+.|+
T Consensus        47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~  121 (198)
T 1ds9_A           47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY  121 (198)
T ss_dssp             TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred             CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence            4578888888888886 77 8888888888888888888 7887777777 8888888888885 66 677778777665


Q ss_pred             ccc
Q 002809          485 LSV  487 (878)
Q Consensus       485 l~~  487 (878)
                      ++.
T Consensus       122 l~~  124 (198)
T 1ds9_A          122 MSN  124 (198)
T ss_dssp             ESE
T ss_pred             CCC
Confidence            544

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.16  E-value=1.1e-06  Score=100.91  Aligned_cols=134  Identities=19%  Similarity=0.141  Sum_probs=91.2

Q ss_pred             eeEEEEEecCCCCCc-hhhhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCCCC
Q 002809          328 NYSFSLYKTGNSTLP-PIINAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSS  406 (878)
Q Consensus       328 ~~~~~l~~t~~s~lp-p~inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~~~  406 (878)
                      ...+.+..+..+.+| ..+..++.+.+..+. .+.++  +..|.+|+.+....+...+-|                ....
T Consensus        66 L~~L~Ls~n~l~~~~~~~l~~L~~L~Ls~N~-l~~~~--~~~l~~L~~L~L~~N~l~~l~----------------~~~l  126 (457)
T 3bz5_A           66 LTKLICTSNNITTLDLSQNTNLTYLACDSNK-LTNLD--VTPLTKLTYLNCDTNKLTKLD----------------VSQN  126 (457)
T ss_dssp             CSEEECCSSCCSCCCCTTCTTCSEEECCSSC-CSCCC--CTTCTTCCEEECCSSCCSCCC----------------CTTC
T ss_pred             CCEEEccCCcCCeEccccCCCCCEEECcCCC-Cceee--cCCCCcCCEEECCCCcCCeec----------------CCCC
Confidence            345566566666554 123467777777655 44443  444444444433333332221                1456


Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      ++|+.|+|++|+|++ +|  ++++++|+.|+|++|++.|.++  ++.++ |+.|+|++|++++ +|  +..++.++.|.+
T Consensus       127 ~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l  198 (457)
T 3bz5_A          127 PLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNC  198 (457)
T ss_dssp             TTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEEC
T ss_pred             CcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCccce-ec--cccCCCCCEEEC
Confidence            789999999999997 44  8999999999999998888884  77888 9999999999996 66  777888877666


Q ss_pred             ccC
Q 002809          486 SVG  488 (878)
Q Consensus       486 ~~~  488 (878)
                      +.+
T Consensus       199 ~~N  201 (457)
T 3bz5_A          199 DTN  201 (457)
T ss_dssp             CSS
T ss_pred             cCC
Confidence            544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.16  E-value=7.1e-07  Score=98.58  Aligned_cols=96  Identities=18%  Similarity=0.153  Sum_probs=78.0

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccch-hhhhccCCCCEEeCcCCcccCcCCc-cCCCCc--ceEEEec
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDIT-SYVSNLTSLQFLDLSNNNLTGSVPD-FLSKLP--LRTLNLQ  462 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~--L~~L~ls  462 (878)
                      .|..|.|+...      +.+++++.|+|++|+|+ .|| ..|.+|++|+.|+|++|++.+.||. .|.+++  ++.+.++
T Consensus        10 ~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           10 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             ETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             eCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            68889998542      23468999999999999 565 5799999999999999999988885 467887  5568888


Q ss_pred             CCcCCCCCchhhhhcccCCCcccccCC
Q 002809          463 GNKLNGSVPVELLERSKNGSLSLSVGG  489 (878)
Q Consensus       463 ~N~l~g~iP~~l~~~~~l~~l~l~~~~  489 (878)
                      +|+|++..|..+..+++|+.|.++.+.
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~  115 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTG  115 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEEC
T ss_pred             CCcccccCchhhhhccccccccccccc
Confidence            999996667788889999877765543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.16  E-value=7.9e-07  Score=97.62  Aligned_cols=80  Identities=24%  Similarity=0.383  Sum_probs=67.2

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...++|+.|+|++|++++ + +.+..+++|+.|+|++|++++ +| .+..++ |+.|+|++|++++..|..+..+++|+.
T Consensus       240 ~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~  315 (347)
T 4fmz_A          240 ANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT  315 (347)
T ss_dssp             TTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSE
T ss_pred             hcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCE
Confidence            345789999999999986 4 579999999999999999996 44 477888 999999999999888888999998886


Q ss_pred             ccccc
Q 002809          483 LSLSV  487 (878)
Q Consensus       483 l~l~~  487 (878)
                      |+++.
T Consensus       316 L~L~~  320 (347)
T 4fmz_A          316 LFLSQ  320 (347)
T ss_dssp             EECCS
T ss_pred             EEccC
Confidence            65543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.12  E-value=1.7e-05  Score=85.71  Aligned_cols=135  Identities=22%  Similarity=0.237  Sum_probs=95.0

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhccc---ceeeeeeccc-CCCcceeEeeeccCCC
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHR---NLTSLVGHCD-EDNQTALIYEFMANGN  647 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~gs  647 (878)
                      +.++.|....||+.   +..+++|+-.  .......+.+|.++|..+++.   .+.+.+.++. ..+..++|||+++|..
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE---CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888999987   6778888842  233456889999999999753   2455666653 4556789999999988


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG---------------------------------------------  682 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------------------------------------------  682 (878)
                      |.+..-    ..++...+..++.++++.|+.||+.                                             
T Consensus       100 l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A          100 LGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             CHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             Cchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            876321    1234555556666666666666642                                             


Q ss_pred             ------------CCCCeEecCCCCccEEEcC---CCc-EEEeecCCccc
Q 002809          683 ------------CKPPIVHRDVKSTNILLNE---KLQ-AKLADFGLSKS  715 (878)
Q Consensus       683 ------------~~~~ivHrDLKp~NILl~~---~~~-~kL~DFGla~~  715 (878)
                                  ..+.++|+|+++.|||++.   ++. +.|.||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                        2335699999999999998   455 58999997753

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.11  E-value=1.5e-06  Score=99.89  Aligned_cols=76  Identities=29%  Similarity=0.357  Sum_probs=53.4

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|++++..|  ++.+++|+.|+|++|++++..|  ++.++ |+.|+|++|++++.  ..+..+++|+.|
T Consensus       285 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  358 (466)
T 1o6v_A          285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL  358 (466)
T ss_dssp             TCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred             CCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence            34577777777777776444  7777788888888887776655  56677 78888888877754  356677777655


Q ss_pred             ccc
Q 002809          484 SLS  486 (878)
Q Consensus       484 ~l~  486 (878)
                      +++
T Consensus       359 ~l~  361 (466)
T 1o6v_A          359 SAG  361 (466)
T ss_dssp             ECC
T ss_pred             eCC
Confidence            554

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.10  E-value=1.1e-05  Score=89.04  Aligned_cols=79  Identities=3%  Similarity=0.007  Sum_probs=56.3

Q ss_pred             ccc-cccccEEEEEEEEc--------ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhccc---ceeeeeecccCC---
Q 002809          572 RTL-GKGGFGTVYYGRLN--------EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHR---NLTSLVGHCDED---  633 (878)
Q Consensus       572 ~~L-G~G~fG~Vy~~~~~--------~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~---nIv~l~g~~~~~---  633 (878)
                      +.| +.|....+|+....        +..+++|+.....   ......+.+|+.+++.++..   .+.+++.++...   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78889999988775        5778888765432   11124678899999988532   466778777655   


Q ss_pred             CcceeEeeeccCCChhh
Q 002809          634 NQTALIYEFMANGNLQE  650 (878)
Q Consensus       634 ~~~~lV~Ey~~~gsL~~  650 (878)
                      +..++|||+++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877764

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.07  E-value=2e-07  Score=94.12  Aligned_cols=79  Identities=24%  Similarity=0.244  Sum_probs=68.6

Q ss_pred             CcEEEEEecCCCccccchh------hhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhccc
Q 002809          407 PRITYLNLSSSGLKGDITS------YVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSK  479 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~------~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~  479 (878)
                      .+++.++|+.|.|+|.+|.      .++++++|+.|+|++|+|++ +| .+..++ |+.|+|++|+++ .+|..+..+++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            3566777888888888777      99999999999999999996 88 788888 999999999999 89998888888


Q ss_pred             CCCcccccC
Q 002809          480 NGSLSLSVG  488 (878)
Q Consensus       480 l~~l~l~~~  488 (878)
                      |+.|+++.+
T Consensus        95 L~~L~L~~N  103 (198)
T 1ds9_A           95 LEELWISYN  103 (198)
T ss_dssp             CSEEEEEEE
T ss_pred             CCEEECcCC
Confidence            987777654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.96  E-value=1.3e-06  Score=95.27  Aligned_cols=81  Identities=27%  Similarity=0.303  Sum_probs=55.3

Q ss_pred             CCcEEEEEecCCCcccc-chhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCC-cCCCC-CchhhhhcccCC
Q 002809          406 SPRITYLNLSSSGLKGD-ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN-KLNGS-VPVELLERSKNG  481 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N-~l~g~-iP~~l~~~~~l~  481 (878)
                      .++|+.|+|++|++++. +|..+.++++|+.|+|++|++++.+|..++.++ |+.|+|++| .+++. +|..+..+++|+
T Consensus        92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~  171 (336)
T 2ast_B           92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD  171 (336)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred             CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence            35677777777777665 677777777777777777777777777777776 777777777 56652 566666666666


Q ss_pred             Ccccc
Q 002809          482 SLSLS  486 (878)
Q Consensus       482 ~l~l~  486 (878)
                      .|+++
T Consensus       172 ~L~l~  176 (336)
T 2ast_B          172 ELNLS  176 (336)
T ss_dssp             EEECC
T ss_pred             EEcCC
Confidence            55443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.92  E-value=2.7e-05  Score=82.15  Aligned_cols=133  Identities=17%  Similarity=0.095  Sum_probs=95.0

Q ss_pred             ccccccE-EEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeeccCCChh
Q 002809          574 LGKGGFG-TVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       574 LG~G~fG-~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      +..|..| .||+....  +..+.+|+-...   ....+.+|...|+.+. +--+.++++++...+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445444 68877654  367889986533   3457888999998885 333667888888888999999999998877


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------------
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHNG-----------------------------------------------  682 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----------------------------------------------  682 (878)
                      +.....      ......++.++++.|+.||..                                               
T Consensus       109 ~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          109 QVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             ccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            654321      122345666777777777742                                               


Q ss_pred             --------CCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          683 --------CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       683 --------~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                              ..+.++|+|+.+.|||+++++.+-|.||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    012379999999999999887778999998753

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.92  E-value=1.9e-06  Score=96.21  Aligned_cols=82  Identities=20%  Similarity=0.198  Sum_probs=68.1

Q ss_pred             CCCcEEEEEecCCCcc----ccchhhhhccCCCCEEeCcCCcccCc----CCccC--CCCc-ceEEEecCCcCCC----C
Q 002809          405 SSPRITYLNLSSSGLK----GDITSYVSNLTSLQFLDLSNNNLTGS----VPDFL--SKLP-LRTLNLQGNKLNG----S  469 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~----g~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~--~~l~-L~~L~ls~N~l~g----~  469 (878)
                      ..++|+.|+|++|+|+    +.+|..+..+++|+.|+|++|+|++.    +|..+  +.++ |+.|+|++|++++    .
T Consensus       214 ~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~  293 (386)
T 2ca6_A          214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT  293 (386)
T ss_dssp             GCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHH
T ss_pred             cCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHH
Confidence            3568999999999997    78899999999999999999999876    67776  4477 9999999999997    5


Q ss_pred             Cchhh-hhcccCCCcccc
Q 002809          470 VPVEL-LERSKNGSLSLS  486 (878)
Q Consensus       470 iP~~l-~~~~~l~~l~l~  486 (878)
                      +|..+ .++++|+.|+++
T Consensus       294 l~~~l~~~l~~L~~L~l~  311 (386)
T 2ca6_A          294 LKTVIDEKMPDLLFLELN  311 (386)
T ss_dssp             HHHHHHHHCTTCCEEECT
T ss_pred             HHHHHHhcCCCceEEEcc
Confidence            88888 557888865554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.81  E-value=6.1e-06  Score=92.17  Aligned_cols=81  Identities=19%  Similarity=0.276  Sum_probs=62.3

Q ss_pred             CcEEEEEecCCCccccch----hhhhccCCCCEEeCcC---CcccCcCCccC-------CCCc-ceEEEecCCcCCC---
Q 002809          407 PRITYLNLSSSGLKGDIT----SYVSNLTSLQFLDLSN---NNLTGSVPDFL-------SKLP-LRTLNLQGNKLNG---  468 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip----~~~~~l~~L~~L~Ls~---N~l~g~iP~~~-------~~l~-L~~L~ls~N~l~g---  468 (878)
                      ++|+.|+|++|+|++..+    ..|.++++|+.|+|++   |+++|.+|..+       ..++ |+.|+|++|++++   
T Consensus        32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~  111 (386)
T 2ca6_A           32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  111 (386)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence            568888898888887644    4466888888998888   46677777665       6777 8888999988887   


Q ss_pred             -CCchhhhhcccCCCccccc
Q 002809          469 -SVPVELLERSKNGSLSLSV  487 (878)
Q Consensus       469 -~iP~~l~~~~~l~~l~l~~  487 (878)
                       .+|..+..+++|+.|+++.
T Consensus       112 ~~l~~~l~~~~~L~~L~L~~  131 (386)
T 2ca6_A          112 EPLIDFLSKHTPLEHLYLHN  131 (386)
T ss_dssp             HHHHHHHHHCTTCCEEECCS
T ss_pred             HHHHHHHHhCCCCCEEECcC
Confidence             4788888888888665543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.80  E-value=2.8e-06  Score=92.68  Aligned_cols=82  Identities=24%  Similarity=0.278  Sum_probs=69.5

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCC-cccC-cCCccCCCCc-ceEEEecCC-cCCCC-Cchhhhhcc-c
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNN-NLTG-SVPDFLSKLP-LRTLNLQGN-KLNGS-VPVELLERS-K  479 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N-~l~g-~iP~~~~~l~-L~~L~ls~N-~l~g~-iP~~l~~~~-~  479 (878)
                      .++|+.|+|++|++++.+|..++++++|+.|+|++| .+++ .+|..+..++ |+.|+|++| ++++. +|..+..++ +
T Consensus       117 ~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~  196 (336)
T 2ast_B          117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET  196 (336)
T ss_dssp             BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred             CCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccC
Confidence            357999999999999999999999999999999999 7887 3788788888 999999999 89865 788888888 8


Q ss_pred             CCCccccc
Q 002809          480 NGSLSLSV  487 (878)
Q Consensus       480 l~~l~l~~  487 (878)
                      |+.|+++.
T Consensus       197 L~~L~l~~  204 (336)
T 2ast_B          197 ITQLNLSG  204 (336)
T ss_dssp             CCEEECCS
T ss_pred             CCEEEeCC
Confidence            88766543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.78  E-value=6.9e-06  Score=90.97  Aligned_cols=66  Identities=27%  Similarity=0.288  Sum_probs=31.2

Q ss_pred             cEEEEEecCCCccccchhhhhcc-----CCCCEEeCcCCcccCcCCccCCC----C-c-ceEEEecCCcCCCCCchh
Q 002809          408 RITYLNLSSSGLKGDITSYVSNL-----TSLQFLDLSNNNLTGSVPDFLSK----L-P-LRTLNLQGNKLNGSVPVE  473 (878)
Q Consensus       408 ~l~~l~l~~n~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~iP~~~~~----l-~-L~~L~ls~N~l~g~iP~~  473 (878)
                      +|+.|+|++|+|++..+..++.+     ++|+.|+|++|+|++..+..++.    + + |+.|+|++|+|++..+..
T Consensus        52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~  128 (362)
T 3goz_A           52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSE  128 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHH
T ss_pred             ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHH
Confidence            45555555555554444444443     55555555555555444432222    2 3 555555555554443333

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.68  E-value=2.8e-05  Score=85.65  Aligned_cols=73  Identities=21%  Similarity=0.200  Sum_probs=52.4

Q ss_pred             CCCcEEEEEecCCCccccchh-hhhccCCCCE-EeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhc
Q 002809          405 SSPRITYLNLSSSGLKGDITS-YVSNLTSLQF-LDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLER  477 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~-~~~~l~~L~~-L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~  477 (878)
                      ..++|+.|+|++|++.+.||. .|.+|++|+. +++++|+|++..|..+..++ |+.|++++|+|++..+......
T Consensus        52 ~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~  127 (350)
T 4ay9_X           52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS  127 (350)
T ss_dssp             TCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCB
T ss_pred             CCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhccc
Confidence            346788888888888777765 4677877664 66677888866677788888 8888888888885444444333

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=97.64  E-value=1.6e-05  Score=84.06  Aligned_cols=81  Identities=30%  Similarity=0.427  Sum_probs=59.2

Q ss_pred             EEecCCC---ccccchhhhhccCCCCEEeCcCCcccC--cCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccc
Q 002809          412 LNLSSSG---LKGDITSYVSNLTSLQFLDLSNNNLTG--SVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSL  485 (878)
Q Consensus       412 l~l~~n~---l~g~ip~~~~~l~~L~~L~Ls~N~l~g--~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l  485 (878)
                      |+++.|.   +.+.++....+|++|+.|+||+|+|++  .+|..+..++ |+.|+|++|+|++.  .++..+..+..-.+
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L  225 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL  225 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence            4556663   344444445789999999999999998  7788888999 99999999999964  45666663322246


Q ss_pred             ccCCCCCCCC
Q 002809          486 SVGGNPGLCS  495 (878)
Q Consensus       486 ~~~~n~~lc~  495 (878)
                      ...+|| +|+
T Consensus       226 ~L~~Np-l~~  234 (267)
T 3rw6_A          226 WLDGNS-LCD  234 (267)
T ss_dssp             ECTTST-TGG
T ss_pred             EccCCc-Ccc
Confidence            677887 443

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.63  E-value=0.00026  Score=76.97  Aligned_cols=138  Identities=12%  Similarity=0.134  Sum_probs=81.6

Q ss_pred             cccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhccc--ceeeeeec------ccCCCcceeEeeecc
Q 002809          573 TLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHR--NLTSLVGH------CDEDNQTALIYEFMA  644 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~--nIv~l~g~------~~~~~~~~lV~Ey~~  644 (878)
                      .|+.|..+.||+....+..+++|+.... .   ..+..|..++..++..  .+.+++..      ....+..++||||++
T Consensus        39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             ECC----CEEEEEEETTEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             eccccccCcEEEEEeCCCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            4566778899999887777999998752 1   3344566666666422  23344431      123556789999999


Q ss_pred             CCChhh--------------hhccccC------------CCCCHHHH-------------------------------HH
Q 002809          645 NGNLQE--------------YLSDISK------------KVLSSQER-------------------------------LR  667 (878)
Q Consensus       645 ~gsL~~--------------~l~~~~~------------~~l~~~~~-------------------------------~~  667 (878)
                      |..+..              .+|....            ..-.|...                               ..
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            865530              1111100            01123211                               01


Q ss_pred             HHHHHHHHHHHHHh----------CCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          668 IAVESAQGLEYLHN----------GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       668 i~~qia~gL~yLH~----------~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      +...+.+++++|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            11224446666763          124589999999999999888899999999764

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.62  E-value=1.4e-05  Score=88.37  Aligned_cols=81  Identities=27%  Similarity=0.304  Sum_probs=57.0

Q ss_pred             CcEEEEEecCCCccccchhhhhcc-----CCCCEEeCcCCcccCcCCccCC----CC-c-ceEEEecCCcCCCCCchh--
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNL-----TSLQFLDLSNNNLTGSVPDFLS----KL-P-LRTLNLQGNKLNGSVPVE--  473 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~iP~~~~----~l-~-L~~L~ls~N~l~g~iP~~--  473 (878)
                      ++|+.|+|++|+|++..+..++.+     ++|+.|+|++|+|++..+..++    .+ + |+.|+|++|+|++.-+..  
T Consensus        80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~  159 (362)
T 3goz_A           80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI  159 (362)
T ss_dssp             TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence            678888999988888777766665     8888999999888866655443    32 4 888899988888644433  


Q ss_pred             --hhhcc-cCCCccccc
Q 002809          474 --LLERS-KNGSLSLSV  487 (878)
Q Consensus       474 --l~~~~-~l~~l~l~~  487 (878)
                        +...+ +++.|+++.
T Consensus       160 ~~l~~~~~~L~~L~Ls~  176 (362)
T 3goz_A          160 QILAAIPANVNSLNLRG  176 (362)
T ss_dssp             HHHHTSCTTCCEEECTT
T ss_pred             HHHhcCCccccEeeecC
Confidence              34443 666555543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.56  E-value=0.00024  Score=79.45  Aligned_cols=73  Identities=12%  Similarity=0.163  Sum_probs=48.9

Q ss_pred             ccccccccEEEEEEEE--cceeEEEEEeccCCh-------hhHHHHHHHHHHHHHhcc--cce-eeeeecccCCCcceeE
Q 002809          572 RTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSA-------QGFQQFQAEVKLLMRVHH--RNL-TSLVGHCDEDNQTALI  639 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-------~~~~~f~~Ei~~L~~l~H--~nI-v~l~g~~~~~~~~~lV  639 (878)
                      +.||.|..+.||+++.  .++.++||.......       .....+..|.+++..+.+  +.. .+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            4689999999999965  347899998653211       123456789999988853  333 345544  23456899


Q ss_pred             eeeccCC
Q 002809          640 YEFMANG  646 (878)
Q Consensus       640 ~Ey~~~g  646 (878)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.47  E-value=1.9e-05  Score=89.98  Aligned_cols=80  Identities=25%  Similarity=0.232  Sum_probs=66.9

Q ss_pred             CcEEEEEecCCCcccc----chhhhhccCCCCEEeCcCCcccCcCCccCCC-----Cc-ceEEEecCCcCCC----CCch
Q 002809          407 PRITYLNLSSSGLKGD----ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSK-----LP-LRTLNLQGNKLNG----SVPV  472 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~-----l~-L~~L~ls~N~l~g----~iP~  472 (878)
                      ++|+.|+|++|++++.    +|..+.++++|+.|+|++|++++..+..+..     .+ |+.|+|++|++++    .+|.
T Consensus       313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~  392 (461)
T 1z7x_W          313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  392 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence            5899999999999976    7888889999999999999998766655542     55 9999999999997    7899


Q ss_pred             hhhhcccCCCcccc
Q 002809          473 ELLERSKNGSLSLS  486 (878)
Q Consensus       473 ~l~~~~~l~~l~l~  486 (878)
                      .+..+++|+.|+++
T Consensus       393 ~l~~~~~L~~L~l~  406 (461)
T 1z7x_W          393 TLLANHSLRELDLS  406 (461)
T ss_dssp             HHHHCCCCCEEECC
T ss_pred             HHHhCCCccEEECC
Confidence            99888988866554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.46  E-value=0.00044  Score=74.85  Aligned_cols=136  Identities=19%  Similarity=0.168  Sum_probs=92.1

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcc---cceeeeeecccCCCcceeEeeeccCCCh
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH---RNLTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H---~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      +.|+.|....+|+....+..+++|+....   ....+..|.+.|+.+..   ..+.++++++...+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            45889999999999887788999987643   24678899999998852   4577888888777889999999998765


Q ss_pred             hh-----------hhccccC-C-------------------CCCHHHHH---HHH----------------HHHHHH-HH
Q 002809          649 QE-----------YLSDISK-K-------------------VLSSQERL---RIA----------------VESAQG-LE  677 (878)
Q Consensus       649 ~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~----------------~qia~g-L~  677 (878)
                      ..           .||.... .                   .-+|....   ++.                ..+.+. ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            31           1222111 0                   12454321   111                111111 22


Q ss_pred             HHHh-CCCCCeEecCCCCccEEEcCCCcEEEeecC
Q 002809          678 YLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFG  711 (878)
Q Consensus       678 yLH~-~~~~~ivHrDLKp~NILl~~~~~~kL~DFG  711 (878)
                      .|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3321 2357899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.21  E-value=0.0012  Score=74.49  Aligned_cols=78  Identities=8%  Similarity=0.078  Sum_probs=46.2

Q ss_pred             CCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccccc-cCCCCccCccccccC---CCCCccchhhHHHHHH
Q 002809          684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV-AGTPGYLDPEYYTSN---RLTEKSDVYSFGVVIL  759 (878)
Q Consensus       684 ~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~-~gt~~Y~APE~~~~~---~~t~ksDV~S~Gvvl~  759 (878)
                      .+.++|||+++.|||++.++ ++|.||+.+..-....  ...... .-...|++|+.....   .-....++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            45899999999999999876 9999999876432110  000000 001235555554311   1112345557777777


Q ss_pred             HHHhC
Q 002809          760 EIITC  764 (878)
Q Consensus       760 elltG  764 (878)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.21  E-value=4.9e-05  Score=86.52  Aligned_cols=82  Identities=20%  Similarity=0.210  Sum_probs=59.0

Q ss_pred             CCcEEEEEecCCCcccc----chhhhhccCCCCEEeCcCCcccCcCCccCCCC-----c-ceEEEecCCcCCCC----Cc
Q 002809          406 SPRITYLNLSSSGLKGD----ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKL-----P-LRTLNLQGNKLNGS----VP  471 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l-----~-L~~L~ls~N~l~g~----iP  471 (878)
                      .++|+.|+|++|+|++.    +|..+.++++|+.|+|++|++++..+..+...     + |+.|+|++|++++.    +|
T Consensus       255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  334 (461)
T 1z7x_W          255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS  334 (461)
T ss_dssp             TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence            45788888888888864    77778888888888888888876544444322     4 88888888888865    56


Q ss_pred             hhhhhcccCCCccccc
Q 002809          472 VELLERSKNGSLSLSV  487 (878)
Q Consensus       472 ~~l~~~~~l~~l~l~~  487 (878)
                      ..+..++.++.|+++.
T Consensus       335 ~~l~~~~~L~~L~Ls~  350 (461)
T 1z7x_W          335 SVLAQNRFLLELQISN  350 (461)
T ss_dssp             HHHHHCSSCCEEECCS
T ss_pred             HHHhhCCCccEEEccC
Confidence            6666777777665543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.19  E-value=7e-05  Score=83.33  Aligned_cols=81  Identities=23%  Similarity=0.200  Sum_probs=57.1

Q ss_pred             CcEEEEEecCCCccc----cchhhhhccCCCCEEeCcCCcccC----cCCccCCCCc-ceEEEecCCcCCCC----Cchh
Q 002809          407 PRITYLNLSSSGLKG----DITSYVSNLTSLQFLDLSNNNLTG----SVPDFLSKLP-LRTLNLQGNKLNGS----VPVE  473 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g----~iP~~~~~l~-L~~L~ls~N~l~g~----iP~~  473 (878)
                      +.|+.|+|++|+|+.    .++..+..+++|+.|||++|+|+.    .++..+...+ |+.|+|++|+|+..    ++..
T Consensus       155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~  234 (372)
T 3un9_A          155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA  234 (372)
T ss_dssp             CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred             CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence            468888888888875    356666778888888888888874    2355566666 88888888888742    3344


Q ss_pred             hhhcccCCCccccc
Q 002809          474 LLERSKNGSLSLSV  487 (878)
Q Consensus       474 l~~~~~l~~l~l~~  487 (878)
                      +...+.|+.|+++.
T Consensus       235 L~~~~~L~~L~Ls~  248 (372)
T 3un9_A          235 AREHPSLELLHLYF  248 (372)
T ss_dssp             HHHCSSCCEEECTT
T ss_pred             HHhCCCCCEEeccC
Confidence            55556677555543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.99  E-value=0.0021  Score=69.41  Aligned_cols=140  Identities=11%  Similarity=0.119  Sum_probs=81.1

Q ss_pred             cccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccce--eeeeecc------cCCCcceeEeeecc
Q 002809          573 TLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL--TSLVGHC------DEDNQTALIYEFMA  644 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI--v~l~g~~------~~~~~~~lV~Ey~~  644 (878)
                      .|+.|....+|+....+..+++|+.....  ....+..|+.++..++...+  .+++...      ...+..+++++|++
T Consensus        29 ~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             ccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            46678889999998877789999887531  12345678888888753332  3333221      12345688999998


Q ss_pred             CCChhh--------------hhccc----cCC---C---CCHHHHHH------------HHHHHHHHHHHHHhC----CC
Q 002809          645 NGNLQE--------------YLSDI----SKK---V---LSSQERLR------------IAVESAQGLEYLHNG----CK  684 (878)
Q Consensus       645 ~gsL~~--------------~l~~~----~~~---~---l~~~~~~~------------i~~qia~gL~yLH~~----~~  684 (878)
                      |..+..              .+|..    ...   .   ..|.....            +...+.+.++.++..    ..
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            865422              01111    000   0   11322110            011244455555532    23


Q ss_pred             CCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          685 PPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       685 ~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ..++|+|+++.|||++++..+.|+||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            478999999999999987666899998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.93  E-value=0.0027  Score=67.52  Aligned_cols=73  Identities=18%  Similarity=0.138  Sum_probs=52.8

Q ss_pred             ccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhccc---ceeeeeecccCCCcceeEeeeccCCC
Q 002809          572 RTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHR---NLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~---nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      +.+|.|..+.||+.++.+ +.+.+|+-..........|.+|...|+.+...   -+.+++++.    ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            468999999999999876 88999987655444445688899999988522   234444432    3478999998765


Q ss_pred             h
Q 002809          648 L  648 (878)
Q Consensus       648 L  648 (878)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.85  E-value=0.0042  Score=66.47  Aligned_cols=127  Identities=10%  Similarity=0.099  Sum_probs=75.4

Q ss_pred             ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccce-eeeeecccCCCcceeEeeec-cCCChh
Q 002809          572 RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL-TSLVGHCDEDNQTALIYEFM-ANGNLQ  649 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gsL~  649 (878)
                      +.|+.|....+|+.    ..+++|+....... .....+|..++..+....+ .++++++.  +.-++|+||+ ++.+|.
T Consensus        24 ~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~l~   96 (301)
T 3dxq_A           24 LERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQTMS   96 (301)
T ss_dssp             EEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEECC
T ss_pred             eEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCccCC
Confidence            56888999999998    67888887653221 1233568888888764333 35555443  3347899999 554443


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHN------------------------------------------------  681 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~------------------------------------------------  681 (878)
                      ......         +..++.++++.|+-||+                                                
T Consensus        97 ~~~~~~---------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~  167 (301)
T 3dxq_A           97 PEKFKT---------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA  167 (301)
T ss_dssp             HHHHHH---------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred             HhhHhh---------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence            210000         00112222222222222                                                


Q ss_pred             --CCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          682 --GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       682 --~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                        .....++|+|+.+.||+ ..++.+.++||..+..
T Consensus       168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              12335799999999999 5667789999997753

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.79  E-value=0.0003  Score=70.02  Aligned_cols=37  Identities=8%  Similarity=0.086  Sum_probs=17.1

Q ss_pred             cEEEEEecCC-Ccccc----chhhhhccCCCCEEeCcCCccc
Q 002809          408 RITYLNLSSS-GLKGD----ITSYVSNLTSLQFLDLSNNNLT  444 (878)
Q Consensus       408 ~l~~l~l~~n-~l~g~----ip~~~~~l~~L~~L~Ls~N~l~  444 (878)
                      .|+.|+|++| +|...    +...+...++|+.|+|++|+|+
T Consensus        37 ~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~   78 (185)
T 1io0_A           37 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   78 (185)
T ss_dssp             TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             CCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence            4455555555 44321    3333344455555555555544

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=96.74  E-value=0.00031  Score=78.08  Aligned_cols=37  Identities=22%  Similarity=0.129  Sum_probs=16.0

Q ss_pred             cEEEEEecCCCccccchhhhh-ccCCCCEEeCcCCccc
Q 002809          408 RITYLNLSSSGLKGDITSYVS-NLTSLQFLDLSNNNLT  444 (878)
Q Consensus       408 ~l~~l~l~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~  444 (878)
                      +|+.|+|++|+|+..-...+. .|++|+.|+|++|+|+
T Consensus       102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~  139 (372)
T 3un9_A          102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG  139 (372)
T ss_dssp             CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC
T ss_pred             CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC
Confidence            455555555554433222222 2344445555555444

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.73  E-value=0.0042  Score=70.30  Aligned_cols=71  Identities=17%  Similarity=0.256  Sum_probs=49.2

Q ss_pred             ccccccccEEEEEEEEc---------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccce-eeeeecccCCCcceeEee
Q 002809          572 RTLGKGGFGTVYYGRLN---------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL-TSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~E  641 (878)
                      +.|+.|....+|+....         +..+.+|+......  ...+.+|..++..+...++ .++++.+..    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            45778888999999875         36788888744211  1455679999998864444 466666543    38999


Q ss_pred             eccCCCh
Q 002809          642 FMANGNL  648 (878)
Q Consensus       642 y~~~gsL  648 (878)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986444

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.66  E-value=0.00045  Score=68.70  Aligned_cols=80  Identities=14%  Similarity=0.206  Sum_probs=61.0

Q ss_pred             CcEEEEEecCCCccc----cchhhhhccCCCCEEeCcCCcccCc----CCccCCCCc-ceEEEe--cCCcCCCC----Cc
Q 002809          407 PRITYLNLSSSGLKG----DITSYVSNLTSLQFLDLSNNNLTGS----VPDFLSKLP-LRTLNL--QGNKLNGS----VP  471 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~-L~~L~l--s~N~l~g~----iP  471 (878)
                      +.|+.|+|++|+|..    .|...+...++|+.|+|++|+|+..    +...+...+ |+.|+|  ++|.++..    +-
T Consensus        65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~  144 (185)
T 1io0_A           65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA  144 (185)
T ss_dssp             CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred             CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence            579999999999975    3566677779999999999999854    566677777 999999  88999854    33


Q ss_pred             hhhhhcccCCCcccc
Q 002809          472 VELLERSKNGSLSLS  486 (878)
Q Consensus       472 ~~l~~~~~l~~l~l~  486 (878)
                      ..+...+.|+.|+++
T Consensus       145 ~~L~~n~~L~~L~L~  159 (185)
T 1io0_A          145 NMLEKNTTLLKFGYH  159 (185)
T ss_dssp             HHHHHCSSCCEEECC
T ss_pred             HHHHhCCCcCEEecc
Confidence            344445667766554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.61  E-value=0.00035  Score=82.15  Aligned_cols=79  Identities=10%  Similarity=0.102  Sum_probs=51.4

Q ss_pred             CcEEEEEecCCCcccc----chhhhhccCCCCEEeCcCCccc----CcCCccCCCCc-ceEEEecCCcCCCCCchhhhhc
Q 002809          407 PRITYLNLSSSGLKGD----ITSYVSNLTSLQFLDLSNNNLT----GSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLER  477 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~----g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~  477 (878)
                      ++|+.|+|++|.+++.    ++..+.++++|+.|+|++|+++    +.++..+..++ |+.|+|++|.+.+ +|..+..+
T Consensus       164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~  242 (592)
T 3ogk_B          164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA  242 (592)
T ss_dssp             TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred             CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence            4667777777776655    5556666777777777777776    34454455566 7777777777764 66666666


Q ss_pred             ccCCCcccc
Q 002809          478 SKNGSLSLS  486 (878)
Q Consensus       478 ~~l~~l~l~  486 (878)
                      ++|+.|.++
T Consensus       243 ~~L~~L~l~  251 (592)
T 3ogk_B          243 ANLEEFCGG  251 (592)
T ss_dssp             TTCCEEEEC
T ss_pred             hHHHhhccc
Confidence            666655554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.57  E-value=0.011  Score=64.18  Aligned_cols=138  Identities=14%  Similarity=0.083  Sum_probs=71.8

Q ss_pred             cccccccEE-EEEEEEc-ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccc--eeeeeecccCCCcceeEeeeccCCCh
Q 002809          573 TLGKGGFGT-VYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN--LTSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       573 ~LG~G~fG~-Vy~~~~~-~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      .|+.|+... +|+.... +..+++|.......   ..+..|+.++..+....  +.+++.+....+  +++||++.+..+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l   99 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF   99 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence            455555544 6677664 56677776443221   33456777777775323  445666544333  789999977666


Q ss_pred             hhhhcccc---------------------C---CCCCHHHHH-------H-------------HHHHHHHHHHHHH---h
Q 002809          649 QEYLSDIS---------------------K---KVLSSQERL-------R-------------IAVESAQGLEYLH---N  681 (878)
Q Consensus       649 ~~~l~~~~---------------------~---~~l~~~~~~-------~-------------i~~qia~gL~yLH---~  681 (878)
                      .+++....                     .   ..+......       .             ....+.+.++.+.   .
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~  179 (333)
T 3csv_A          100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL  179 (333)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence            54432110                     0   011111000       0             0011112222221   1


Q ss_pred             CCCCCeEecCCCCccEEEcCC----CcEEEeecCCccc
Q 002809          682 GCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSKS  715 (878)
Q Consensus       682 ~~~~~ivHrDLKp~NILl~~~----~~~kL~DFGla~~  715 (878)
                      .....++|||+.+.|||++.+    ..+.|.||+.+..
T Consensus       180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            124478999999999999875    6899999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.52  E-value=0.011  Score=67.22  Aligned_cols=73  Identities=12%  Similarity=0.131  Sum_probs=48.4

Q ss_pred             ccccccccEEEEEEEEcc--eeEEEEEeccCChhhHHHHHHHHHHHHHhcccce-eeeeecccCCCcceeEeeeccCCCh
Q 002809          572 RTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL-TSLVGHCDEDNQTALIYEFMANGNL  648 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL  648 (878)
                      +.|+.|-...+|+....+  ..+.+|+....... ...-.+|..++..+...++ .++++.+..    .+|+||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            467888889999999876  78899987543211 1122589999999875555 466776632    359999987554


Q ss_pred             h
Q 002809          649 Q  649 (878)
Q Consensus       649 ~  649 (878)
                      .
T Consensus       189 ~  189 (458)
T 2qg7_A          189 S  189 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.49  E-value=0.00044  Score=81.35  Aligned_cols=83  Identities=13%  Similarity=0.187  Sum_probs=60.2

Q ss_pred             CCcEEEEEecCC--Cccccchhhhhc-cCCCCEEeCcCCcccC-cCCccCCCCc-ceEEEecCCcCCCC-Cchhhhhccc
Q 002809          406 SPRITYLNLSSS--GLKGDITSYVSN-LTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGNKLNGS-VPVELLERSK  479 (878)
Q Consensus       406 ~~~l~~l~l~~n--~l~g~ip~~~~~-l~~L~~L~Ls~N~l~g-~iP~~~~~l~-L~~L~ls~N~l~g~-iP~~l~~~~~  479 (878)
                      .++|+.|+|+.+  .+++..+..++. +++|+.|+|++|++++ .+|..+..++ |+.|+|++|+|++. ++..+..+++
T Consensus       435 ~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~  514 (592)
T 3ogk_B          435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS  514 (592)
T ss_dssp             CTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSS
T ss_pred             CCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCc
Confidence            457888888743  477777777766 7888888888888886 5566667778 88888888888755 4444556777


Q ss_pred             CCCcccccC
Q 002809          480 NGSLSLSVG  488 (878)
Q Consensus       480 l~~l~l~~~  488 (878)
                      |+.|+++.+
T Consensus       515 L~~L~ls~n  523 (592)
T 3ogk_B          515 LRYLWVQGY  523 (592)
T ss_dssp             CCEEEEESC
T ss_pred             cCeeECcCC
Confidence            776655443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.47  E-value=0.0083  Score=66.55  Aligned_cols=138  Identities=19%  Similarity=0.231  Sum_probs=81.2

Q ss_pred             ccccccccEEEEEEEEc---------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccce-eeeeecccCCCcceeEee
Q 002809          572 RTLGKGGFGTVYYGRLN---------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL-TSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~E  641 (878)
                      +.|..|-...+|+....         +..+.+|+.... ......+.+|..+++.+....+ .++++.+..    .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            34666777888988764         267888885332 2234566789999988863333 466666654    29999


Q ss_pred             eccCCChhhh-h----------------cccc---CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 002809          642 FMANGNLQEY-L----------------SDIS---KKVLS--SQERLRIAVESAQ-------------------GLEYLH  680 (878)
Q Consensus       642 y~~~gsL~~~-l----------------~~~~---~~~l~--~~~~~~i~~qia~-------------------gL~yLH  680 (878)
                      |++|.+|..- +                |...   .....  |.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665421 1                1111   11122  3444444433321                   223332


Q ss_pred             ----h-CCCCCeEecCCCCccEEEcCC----CcEEEeecCCcc
Q 002809          681 ----N-GCKPPIVHRDVKSTNILLNEK----LQAKLADFGLSK  714 (878)
Q Consensus       681 ----~-~~~~~ivHrDLKp~NILl~~~----~~~kL~DFGla~  714 (878)
                          . .....++|+|+.+.|||++++    +.+.++||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                2 123468999999999999887    789999999775

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.28  E-value=0.012  Score=64.76  Aligned_cols=72  Identities=13%  Similarity=0.183  Sum_probs=44.4

Q ss_pred             ccccccccEEEEEEEEcc----------eeEEEEEeccCChhhHHHHHHHHHHHHHhcccce-eeeeecccCCCcceeEe
Q 002809          572 RTLGKGGFGTVYYGRLNE----------IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL-TSLVGHCDEDNQTALIY  640 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~----------~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~  640 (878)
                      +.|+.|....+|+....+          ..+++|+...... .......|.+++..+...++ .++++...    -.+||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            356778888999988764          5788887654322 22234678888888864443 35665442    36899


Q ss_pred             eeccCCCh
Q 002809          641 EFMANGNL  648 (878)
Q Consensus       641 Ey~~~gsL  648 (878)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.95  E-value=0.015  Score=62.69  Aligned_cols=138  Identities=12%  Similarity=0.157  Sum_probs=78.7

Q ss_pred             cccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccc--eeeeeec-----ccCCCcceeEeeecc
Q 002809          573 TLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN--LTSLVGH-----CDEDNQTALIYEFMA  644 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~n--Iv~l~g~-----~~~~~~~~lV~Ey~~  644 (878)
                      .++ |....||+....+ +.+++|+...... ....+..|..++..++...  +.+++..     ...++..++|+|+++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            355 7778999887654 5799999864321 2356677888888885333  3444443     111344578999998


Q ss_pred             CCChhh-----------h---hcccc-------CCCCCHHHH----HHH---------------HHHHHHHHHHHHhC--
Q 002809          645 NGNLQE-----------Y---LSDIS-------KKVLSSQER----LRI---------------AVESAQGLEYLHNG--  682 (878)
Q Consensus       645 ~gsL~~-----------~---l~~~~-------~~~l~~~~~----~~i---------------~~qia~gL~yLH~~--  682 (878)
                      |..+..           .   +|...       ....++...    ..+               ...+.+.++.+...  
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            755431           0   11100       111222111    001               11111223333221  


Q ss_pred             --CCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          683 --CKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       683 --~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                        ....++|+|+++.|||++ + .+.|.||+.+.
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence              234679999999999999 4 89999998765

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=95.92  E-value=0.0012  Score=77.63  Aligned_cols=79  Identities=16%  Similarity=0.178  Sum_probs=54.5

Q ss_pred             CcEEEEEecCCCccccchhhhhc-cCCCCEEeCcCCcccCcCCccC-CCCc-ceEEEecCCcCCCCCchhh-hhcccCCC
Q 002809          407 PRITYLNLSSSGLKGDITSYVSN-LTSLQFLDLSNNNLTGSVPDFL-SKLP-LRTLNLQGNKLNGSVPVEL-LERSKNGS  482 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~-l~~L~~L~Ls~N~l~g~iP~~~-~~l~-L~~L~ls~N~l~g~iP~~l-~~~~~l~~  482 (878)
                      ++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..+ ..++ |+.|+|++|.+++..+..+ ..+++|+.
T Consensus       432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~  510 (594)
T 2p1m_B          432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS  510 (594)
T ss_dssp             TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSE
T ss_pred             CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCE
Confidence            4688888866 777777777776 7888888888888876655444 4566 8888888888854444333 34667776


Q ss_pred             cccc
Q 002809          483 LSLS  486 (878)
Q Consensus       483 l~l~  486 (878)
                      |+++
T Consensus       511 L~l~  514 (594)
T 2p1m_B          511 LWMS  514 (594)
T ss_dssp             EEEE
T ss_pred             Eeee
Confidence            5554

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=95.91  E-value=0.0068  Score=56.45  Aligned_cols=53  Identities=32%  Similarity=0.496  Sum_probs=28.3

Q ss_pred             EEEecCCCcc-ccchhhhhccCCCCEEeCcCCcccCcCC-ccCCCCc-ceEEEecCCcC
Q 002809          411 YLNLSSSGLK-GDITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LRTLNLQGNKL  466 (878)
Q Consensus       411 ~l~l~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~~~~l~-L~~L~ls~N~l  466 (878)
                      .++.++++|+ ..+|..|.  ++|+.|+|++|+|+ .|| ..|..++ |+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence            5666666665 34554321  24666666666666 333 3344455 55555555544

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=95.87  E-value=0.0016  Score=76.45  Aligned_cols=58  Identities=24%  Similarity=0.355  Sum_probs=25.7

Q ss_pred             cEEEEEecCC-Ccccc-chhhhhccCCCCEEeCcCCcccCcCCccC----CCCc-ceEEEecCCc
Q 002809          408 RITYLNLSSS-GLKGD-ITSYVSNLTSLQFLDLSNNNLTGSVPDFL----SKLP-LRTLNLQGNK  465 (878)
Q Consensus       408 ~l~~l~l~~n-~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~----~~l~-L~~L~ls~N~  465 (878)
                      +|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+    ..++ |+.|+|++|.
T Consensus       131 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~  195 (594)
T 2p1m_B          131 NFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA  195 (594)
T ss_dssp             TCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC
T ss_pred             CCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC
Confidence            4555555554 33322 33333345555555555555444332222    2333 5555555554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.83  E-value=0.03  Score=61.03  Aligned_cols=68  Identities=10%  Similarity=0.150  Sum_probs=44.5

Q ss_pred             cccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcc---cceeeeeecc------cCCCcceeEeeeccC
Q 002809          575 GKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH---RNLTSLVGHC------DEDNQTALIYEFMAN  645 (878)
Q Consensus       575 G~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H---~nIv~l~g~~------~~~~~~~lV~Ey~~~  645 (878)
                      |.|....||+....+..+++|+......      ..|+..+..+..   +.+.+.+...      ...+..++||+|++|
T Consensus        32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSESKSYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECSSCEEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeCCCCEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            3444689999987666899998765432      356667766642   2244544332      234667899999998


Q ss_pred             CCh
Q 002809          646 GNL  648 (878)
Q Consensus       646 gsL  648 (878)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.67  E-value=0.048  Score=55.00  Aligned_cols=102  Identities=17%  Similarity=0.202  Sum_probs=67.5

Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.++|.. .++++++++++.++.|.+.+|.-+-.+.. + ..+=+.|..|++..+|.+...+ ..+.            
T Consensus        34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------------
Confidence            78888874 47889999999999999999887732111 1 1233456899999999988874 2110            


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA  767 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p  767 (878)
                        .....+.|||... ...+.+.-|||+|+++|..+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              0122456788764 3556788999999999998864433

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=95.37  E-value=0.0033  Score=69.36  Aligned_cols=63  Identities=22%  Similarity=0.362  Sum_probs=46.8

Q ss_pred             CCCcEEEEEecCCCccccchhhhh---ccCCCCEEeCcCCcccCc----CCccCCCCc-ceEEEecCCcCC
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVS---NLTSLQFLDLSNNNLTGS----VPDFLSKLP-LRTLNLQGNKLN  467 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~---~l~~L~~L~Ls~N~l~g~----iP~~~~~l~-L~~L~ls~N~l~  467 (878)
                      ..++|+.|+|.+|++++..+..+.   .+++|+.|+|+.|+|++.    ++..+..++ |+.|+|++|.++
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            356888888888888866665555   477888888888888763    455445566 888888888776

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=94.69  E-value=0.019  Score=62.03  Aligned_cols=72  Identities=15%  Similarity=0.171  Sum_probs=37.0

Q ss_pred             cEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCC-ccCCCCc-ce-EEEecCCcCCCCCc-hhhhhcccCCCc
Q 002809          408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVP-DFLSKLP-LR-TLNLQGNKLNGSVP-VELLERSKNGSL  483 (878)
Q Consensus       408 ~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~~~~l~-L~-~L~ls~N~l~g~iP-~~l~~~~~l~~l  483 (878)
                      +|+.|+|++|+++..-+..|.+|++|+.|+|++| ++ .|+ ..|..+. |+ .|+|.+ +++ .|+ ..+..+.+|+.+
T Consensus       227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEE
T ss_pred             CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEE
Confidence            4556666666655222334556666666666655 44 333 3355555 65 666655 444 332 344445555443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=94.36  E-value=0.035  Score=51.55  Aligned_cols=40  Identities=20%  Similarity=0.152  Sum_probs=34.3

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCccc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLT  444 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~  444 (878)
                      .+.+|+.|+|++|+|+..-+..|..|++|+.|+|++|.+.
T Consensus        29 lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           29 FPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             CCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3458999999999999544567889999999999999876

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=94.07  E-value=0.037  Score=59.81  Aligned_cols=75  Identities=17%  Similarity=0.106  Sum_probs=60.3

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCC-EEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCch-hhhhcccCCC
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQ-FLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPV-ELLERSKNGS  482 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~-~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~-~l~~~~~l~~  482 (878)
                      ..+|+.|+|++| ++..-+..|.+|++|+ .|+|++ +++-.-+..|..++ |+.|+|++|+++ .|+. .+.++++|+.
T Consensus       249 ~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~-~I~~~aF~~~~~L~~  325 (329)
T 3sb4_A          249 KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT-TLGDELFGNGVPSKL  325 (329)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC-EECTTTTCTTCCCCE
T ss_pred             CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC-ccchhhhcCCcchhh
Confidence            458999999998 7744456899999999 999999 78833357799999 999999999999 5554 6667777665


Q ss_pred             c
Q 002809          483 L  483 (878)
Q Consensus       483 l  483 (878)
                      +
T Consensus       326 l  326 (329)
T 3sb4_A          326 I  326 (329)
T ss_dssp             E
T ss_pred             h
Confidence            4

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=93.99  E-value=0.017  Score=56.57  Aligned_cols=80  Identities=14%  Similarity=0.100  Sum_probs=58.2

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCc-ccCcCCccCCCC----c-ceEEEecCCc-CCCCCchhhhhccc
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNN-LTGSVPDFLSKL----P-LRTLNLQGNK-LNGSVPVELLERSK  479 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~~~~l----~-L~~L~ls~N~-l~g~iP~~l~~~~~  479 (878)
                      .+|+.|||+++.++..==..+..|++|+.|+|+++. ++..==..++.+    + |+.|+|+++. +|..==..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            479999999999886555668899999999999985 764433345554    4 9999999974 66321234566777


Q ss_pred             CCCcccc
Q 002809          480 NGSLSLS  486 (878)
Q Consensus       480 l~~l~l~  486 (878)
                      |+.|+++
T Consensus       141 L~~L~L~  147 (176)
T 3e4g_A          141 LKYLFLS  147 (176)
T ss_dssp             CCEEEEE
T ss_pred             CCEEECC
Confidence            7766554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.78  E-value=0.1  Score=58.56  Aligned_cols=72  Identities=11%  Similarity=0.211  Sum_probs=47.2

Q ss_pred             ccccccccEEEEEEEEc---------ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccce-eeeeecccCCCcceeEee
Q 002809          572 RTLGKGGFGTVYYGRLN---------EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNL-TSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~E  641 (878)
                      +.+..|-...+|+....         +..+.+|+..... .......+|..+++.+...++ .++++.+.    -.+|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            34666778889988876         5778888865432 222234678888888863333 45555432    378999


Q ss_pred             eccCCCh
Q 002809          642 FMANGNL  648 (878)
Q Consensus       642 y~~~gsL  648 (878)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998664

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=92.08  E-value=0.065  Score=58.93  Aligned_cols=81  Identities=19%  Similarity=0.282  Sum_probs=43.1

Q ss_pred             CcEEEEEecCCCccccchhhhh--ccCCCCEEeCcC--CcccCc--C---CccC--CCCc-ceEEEecCCcCCCCCchhh
Q 002809          407 PRITYLNLSSSGLKGDITSYVS--NLTSLQFLDLSN--NNLTGS--V---PDFL--SKLP-LRTLNLQGNKLNGSVPVEL  474 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~--~l~~L~~L~Ls~--N~l~g~--i---P~~~--~~l~-L~~L~ls~N~l~g~iP~~l  474 (878)
                      ++|+.|+|..++++...-..++  +|++|+.|+|+.  |+..|.  +   -..+  ..++ |+.|+|++|++.+..+..+
T Consensus       193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l  272 (362)
T 2ra8_A          193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF  272 (362)
T ss_dssp             TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred             CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence            4667777776666554444454  567777777642  222111  1   1112  1345 7777777777665444444


Q ss_pred             h---hcccCCCccccc
Q 002809          475 L---ERSKNGSLSLSV  487 (878)
Q Consensus       475 ~---~~~~l~~l~l~~  487 (878)
                      .   .+++|+.|++++
T Consensus       273 a~a~~~~~L~~LdLs~  288 (362)
T 2ra8_A          273 LESDILPQLETMDISA  288 (362)
T ss_dssp             HHCSSGGGCSEEECCS
T ss_pred             HhCccCCCCCEEECCC
Confidence            4   245566555543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=90.80  E-value=0.063  Score=53.57  Aligned_cols=37  Identities=11%  Similarity=0.255  Sum_probs=17.3

Q ss_pred             cEEEEEecCC-Cccc----cchhhhhccCCCCEEeCcCCccc
Q 002809          408 RITYLNLSSS-GLKG----DITSYVSNLTSLQFLDLSNNNLT  444 (878)
Q Consensus       408 ~l~~l~l~~n-~l~g----~ip~~~~~l~~L~~L~Ls~N~l~  444 (878)
                      .|+.|+|++| +|..    .|-..+..=+.|+.|+|++|+|.
T Consensus        42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig   83 (197)
T 1pgv_A           42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS   83 (197)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence            3555555553 4432    13333444455555555555554

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.53  E-value=1.5  Score=48.65  Aligned_cols=28  Identities=43%  Similarity=0.593  Sum_probs=24.1

Q ss_pred             eEecCCCCccEEE------cCCCcEEEeecCCcc
Q 002809          687 IVHRDVKSTNILL------NEKLQAKLADFGLSK  714 (878)
Q Consensus       687 ivHrDLKp~NILl------~~~~~~kL~DFGla~  714 (878)
                      ++|+|+.+.|||+      +++..++++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456779999999875

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=87.08  E-value=0.23  Score=49.49  Aligned_cols=59  Identities=14%  Similarity=0.227  Sum_probs=44.7

Q ss_pred             CcEEEEEecCCCcccc----chhhhhccCCCCEEeCcCCcccCc----CCccCCCCc-ceEEEecCCc
Q 002809          407 PRITYLNLSSSGLKGD----ITSYVSNLTSLQFLDLSNNNLTGS----VPDFLSKLP-LRTLNLQGNK  465 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~-L~~L~ls~N~  465 (878)
                      ..|+.|+|++|+|...    |...+..=+.|+.|+|++|+|+..    |-..+..-+ |+.|+|++|.
T Consensus        70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A           70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR  137 (197)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred             CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCc
Confidence            4799999999999843    455566679999999999999843    223344444 9999999763

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=81.08  E-value=1.3  Score=49.24  Aligned_cols=74  Identities=16%  Similarity=0.177  Sum_probs=50.5

Q ss_pred             cEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCch-hhhhcccCCCccc
Q 002809          408 RITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPV-ELLERSKNGSLSL  485 (878)
Q Consensus       408 ~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~-~l~~~~~l~~l~l  485 (878)
                      +|+.|.|.+ +++-.-+..|.+|++|+.|+|++|+++ .||...-... |+.+.|.+| ++ .|+. .+..+.+|+.+.+
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l  233 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEI  233 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CC-EECTTTTTTCTTCCCEEC
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hh-eehhhHhhCCCCCCEEec
Confidence            477888875 666444567888888888888888888 6665433345 888888744 55 4443 4556666665554

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	878
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-73
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-68
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (612), Expect = 2e-73
 Identities = 84/281 (29%), Positives = 142/281 (50%), Gaps = 23/281 (8%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKML--SSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
             + +G G FGTVY G+ +  DVAVKML  ++ + Q  Q F+ EV +L +  H N+   +
Sbjct: 12  VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G+     Q A++ ++    +L  +L  I  K     + + IA ++AQG++YLH      I
Sbjct: 71  GYSTAP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA---KSI 125

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT---SNR 744
           +HRD+KS NI L+E L  K+ DFGL+   +  + +H    ++G+  ++ PE       N 
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
            + +SDVY+FG+V+ E++T +   S IN  ++I               +  + P L +  
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------RGYLSPDLSK-V 234

Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM 845
            +N       L   CL    ++RP   Q++  + E LA  +
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASI-ELLARSL 274

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 5e-68
 Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 26/297 (8%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
            + ++GKG FG V+ G+    +VAVK+ SS   + +   +AE+   + + H N+   +  
Sbjct: 7   LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65

Query: 630 CDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC-- 683
            ++DN T     L+ ++  +G+L +YL+   +  ++ +  +++A+ +A GL +LH     
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 684 ---KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF--ATDANTHVSTVVAGTPGYLDPE 738
              KP I HRD+KS NIL+ +     +AD GL+     ATD          GT  Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 739 YYTSN------RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI----RQWVNSLIA 788
               +         +++D+Y+ G+V  EI           + +  +            + 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 789 KGDIKSIVDPRLQEDFDANSVWKAV-ELAMACLSPTGNQRPTMSQVVMELSECLAAE 844
           K   +  + P +   + +    + + ++   C    G  R T  ++   LS+    E
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 1e-62
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 28/278 (10%)

Query: 570 FERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
             +T+GKG FG V  G      VAVK + + +    Q F AE  ++ ++ H NL  L+G 
Sbjct: 11  LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 68

Query: 630 C-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
             +E     ++ E+MA G+L +YL    + VL     L+ +++  + +EYL        V
Sbjct: 69  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 125

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+ + N+L++E   AK++DFGL+K  ++  +T           +  PE     + + K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTK 180

Query: 749 SDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDAN 807
           SDV+SFG+++ EI +  +    RI  ++ +              ++        +     
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------VEKGYKMDAPDGCPP- 227

Query: 808 SVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM 845
                 E+   C       RP+  Q+  +L      E+
Sbjct: 228 ---AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 8e-62
 Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 24/276 (8%)

Query: 570 FERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
               LG G FG V+ G  N    VAVK L   S      F AE  L+ ++ H+ L  L  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              ++    +I E+M NG+L ++L   S   L+  + L +A + A+G+ ++    +   +
Sbjct: 76  VVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+++ NIL+++ L  K+ADFGL++    D              +  PE       T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 749 SDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDAN 807
           SDV+SFG+++ EI+T  +     +   E I              ++        ++    
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------------LERGYRMVRPDNCPE- 237

Query: 808 SVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
              +  +L   C       RPT   +   L +   A
Sbjct: 238 ---ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (522), Expect = 1e-60
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 22/275 (8%)

Query: 569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
             +  LG G +G VY G   +  + VAVK L   + +  ++F  E  ++  + H NL  L
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
           +G C  +    +I EFM  GNL +YL + +++ +S+   L +A + +  +EYL    K  
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 135

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLT 746
            +HRD+ + N L+ E    K+ADFGLS+    D              +  PE    N+ +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 747 EKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA 806
            KSDV++FGV++ EI T   +     +  +++                +++   + +   
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPE 239

Query: 807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
               K  EL  AC     + RP+ +++        
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-60
 Identities = 72/275 (26%), Positives = 130/275 (47%), Gaps = 24/275 (8%)

Query: 569 NFERTLGKGGFGTVYYGRL-NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
            F + +G G FG V+ G   N+  VA+K +    A   + F  E +++M++ H  L  L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 66

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C E     L++EFM +G L +YL    + + +++  L + ++  +G+ YL    +  +
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYL---EEACV 122

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+ E    K++DFG+++ F  D     ST       +  PE ++ +R + 
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 748 KSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA 806
           KSDV+SFGV++ E+ +  K      +  E +         I+ G    +  PRL      
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-------DISTG--FRLYKPRLAST--- 229

Query: 807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
                  ++   C       RP  S+++ +L+E  
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-60
 Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 24/273 (8%)

Query: 569 NFERTLGKGGFGTVYYGRL-NEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
            F + LG G FG V YG+   + DVA+KM+   S     +F  E K++M + H  L  L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
           G C +     +I E+MANG L  YL    +    +Q+ L +  +  + +EYL +      
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 688 VHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTE 747
           +HRD+ + N L+N++   K++DFGLS+ +  D     S        +  PE    ++ + 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 748 KSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA 806
           KSD+++FGV++ EI +  K    R    E           IA+G    +  P L  +   
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQG--LRLYRPHLASE--- 228

Query: 807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
               K   +  +C     ++RPT   ++  + +
Sbjct: 229 ----KVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 1e-59
 Identities = 74/315 (23%), Positives = 131/315 (41%), Gaps = 48/315 (15%)

Query: 548 IDSFEAKSRHLSYSDVVKITNNF-----------ERTLGKGGFGTVYYGRL-----NEID 591
           ID F       ++ D  +    F           E+ +G G FG V  G L      EI 
Sbjct: 4   IDPF-------TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIF 56

Query: 592 VAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQE 650
           VA+K L S  + +  + F +E  ++ +  H N+  L G   +     +I EFM NG+L  
Sbjct: 57  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116

Query: 651 YLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADF 710
           +L   +    +  + + +    A G++YL +      VHRD+ + NIL+N  L  K++DF
Sbjct: 117 FLRQ-NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDF 172

Query: 711 GLSKSFATDANTHVSTVVAG---TPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC-KP 766
           GLS+    D +    T   G      +  PE     + T  SDV+S+G+V+ E+++  + 
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232

Query: 767 AISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQ 826
               +  ++                + + ++   +     +      +L + C     N 
Sbjct: 233 PYWDMTNQD----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276

Query: 827 RPTMSQVVMELSECL 841
           RP   Q+V  L + +
Sbjct: 277 RPKFGQIVNTLDKMI 291

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (513), Expect = 4e-59
 Identities = 84/307 (27%), Positives = 128/307 (41%), Gaps = 52/307 (16%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID-------VAVKMLSSSSAQGFQ-QFQAEVKLLMR 617
           NN E  R +G+G FG V+  R   +        VAVKML   ++   Q  FQ E  L+  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISK-------------------- 657
             + N+  L+G C       L++E+MA G+L E+L  +S                     
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 658 --KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS 715
               LS  E+L IA + A G+ YL        VHRD+ + N L+ E +  K+ADFGLS++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEE 774
             +          A    ++ PE    NR T +SDV+++GVV+ EI +        +  E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 775 EKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           E I+        +  G+I +  +         N   +   L   C S     RP+   + 
Sbjct: 250 EVIY-------YVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIH 293

Query: 835 MELSECL 841
             L    
Sbjct: 294 RILQRMC 300

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 7e-59
 Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 31/274 (11%)

Query: 570 FERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTS 625
           F+  +G+G F TVY G   E  ++VA   L     +    Q+F+ E ++L  + H N+  
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 626 LVGHC----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
                           L+ E M +G L+ YL     KV+  +       +  +GL++LH 
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 682 GCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
              PPI+HRD+K  NI +       K+ D GL+           +  V GTP ++ PE Y
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMY 185

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
              +  E  DVY+FG+ +LE+ T +   S      +I+              + +     
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--------------RRVTSGVK 230

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
              FD  ++ +  E+   C+    ++R ++  ++
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-58
 Identities = 60/299 (20%), Positives = 114/299 (38%), Gaps = 40/299 (13%)

Query: 567 TNNFE--RTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRVHHR 621
            ++FE    LG G  G V+      + + +A K++          Q   E+++L   +  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
            +    G    D + ++  E M  G+L + L       +  Q   ++++   +GL YL  
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
             K  I+HRDVK +NIL+N + + KL DFG+S          ++    GT  Y+ PE   
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQ 176

Query: 742 SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR---------------QWVNSL 786
               + +SD++S G+ ++E+   +  I   + +E   +                +     
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 787 IAKGDIKSIVDPRLQEDFDANSVWK------------AVELAMACLSPTGNQRPTMSQV 833
           ++   + S     + E  D                    +    CL     +R  + Q+
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 5e-58
 Identities = 70/288 (24%), Positives = 130/288 (45%), Gaps = 30/288 (10%)

Query: 565 KITNNFERTLGKGGFGTVYYGRL-----NEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRV 618
            +  +F   +G+G FG VY+G L      +I  AVK L+  +  G   QF  E  ++   
Sbjct: 26  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85

Query: 619 HHRNLTSLVGHC-DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
            H N+ SL+G C   +    ++  +M +G+L+ +         + ++ +   ++ A+G+ 
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM- 143

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD--ANTHVSTVVAGTPGYL 735
                     VHRD+ + N +L+EK   K+ADFGL++        + H  T       ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 736 DPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKS 794
             E   + + T KSDV+SFGV++ E++T   P    +N  +       +   + +G  + 
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RR 252

Query: 795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
           ++ P    D          E+ + C  P    RP+ S++V  +S   +
Sbjct: 253 LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 6e-58
 Identities = 67/314 (21%), Positives = 126/314 (40%), Gaps = 45/314 (14%)

Query: 557 HLSYSDVVKITNN---FERTLGKGGFGTVYYGRL-------NEIDVAVKMLSSSSAQGF- 605
            L Y    +   N   F +TLG G FG V              + VAVKML  S+     
Sbjct: 11  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70

Query: 606 QQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL------------ 652
           +   +E+K+L  + +H N+ +L+G C     T +I E+   G+L  +L            
Sbjct: 71  EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130

Query: 653 ----SDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA 708
                +  +  L  ++ L  + + A+G+ +L +      +HRD+ + NILL      K+ 
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKIC 187

Query: 709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAI 768
           DFGL++    D+N  V         ++ PE   +   T +SDV+S+G+ + E+ +     
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG--- 244

Query: 769 SRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRP 828
                            +        ++    +     ++  +  ++   C      +RP
Sbjct: 245 -----------SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293

Query: 829 TMSQVVMELSECLA 842
           T  Q+V  + + ++
Sbjct: 294 TFKQIVQLIEKQIS 307

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 9e-58
 Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 28/278 (10%)

Query: 571 ERTLGKGGFGTVYYGRL----NEIDVAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRNLTS 625
           +  LG G FG+V  G       +IDVA+K+L   + +   ++   E +++ ++ +  +  
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 626 LVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKP 685
           L+G C +     L+ E    G L ++L    ++ +       +  + + G++YL      
Sbjct: 74  LIGVC-QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---K 128

Query: 686 PIVHRDVKSTNILLNEKLQAKLADFGLSKSF-ATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             VHRD+ + N+LL  +  AK++DFGLSK+  A D+     +       +  PE     +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188

Query: 745 LTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED 803
            + +SDV+S+GV + E ++  +    ++   E +              I+         +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------IEQGKRMECPPE 236

Query: 804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
                  +   L   C       RP    V   +  C 
Sbjct: 237 CPP----ELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-57
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 27/283 (9%)

Query: 569 NFERTLGKGGFGTVYYGRLN------EIDVAVKMLSSSSAQGFQ-QFQAEVKLLMRVHHR 621
             ++ +G G FG VY G L       E+ VA+K L +   +  +  F  E  ++ +  H 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           N+  L G   +     +I E+M NG L ++L +      S  + + +    A G++YL N
Sbjct: 70  NIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLAN 128

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD-ANTHVSTVVAGTPGYLDPEYY 740
                 VHRD+ + NIL+N  L  K++DFGLS+    D   T+ ++       +  PE  
Sbjct: 129 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
           +  + T  SDV+SFG+V+ E++T                           ++   ++   
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAINDGF 230

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
           +     +      +L M C      +RP  + +V  L + + A
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 1e-57
 Identities = 61/278 (21%), Positives = 115/278 (41%), Gaps = 30/278 (10%)

Query: 569 NFE--RTLGKGGFGTVYYGRLNEID--VAVKML--SSSSAQGFQQFQAEVKLLMRVHHRN 622
           ++E   T+G G +G     R       +  K L   S +    Q   +EV LL  + H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 623 LTSLVGHC--DEDNQTALIYEFMANGNLQEYLSDISK--KVLSSQERLRIAVESAQGLEY 678
           +           +    ++ E+   G+L   ++  +K  + L  +  LR+  +    L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 679 LH--NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            H  +     ++HRD+K  N+ L+ K   KL DFGL++    + +T  +    GTP Y+ 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMS 182

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV 796
           PE        EKSD++S G ++ E+    P  +  +++E           I +G      
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKF---- 231

Query: 797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
             R+   +      +  E+    L+     RP++ +++
Sbjct: 232 -RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-57
 Identities = 67/298 (22%), Positives = 120/298 (40%), Gaps = 47/298 (15%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKMLSSSSAQGF-QQFQAEVKLLMRV-HH 620
           F + LG G FG V       I        VAVKML   +     +   +E+K++ ++  H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKK---------------------V 659
            N+ +L+G C       LI+E+   G+L  YL    +K                     V
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 660 LSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD 719
           L+ ++ L  A + A+G+E+L        VHRD+ + N+L+      K+ DFGL++   +D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI 779
           +N  V         ++ PE       T KSDV+S+G+++ EI +                
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG-------------- 263

Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMEL 837
                 +    +   ++    + D    +  +   +  +C +    +RP+   +   L
Sbjct: 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-57
 Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 31/290 (10%)

Query: 551 FEAKSRHLSYSDVVKITNNFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSSSAQGFQQF 608
           +E  +R L+  D  +I       LG G FG VY  +  E  +  A K++ + S +  + +
Sbjct: 1   YEHVTRDLNPEDFWEI----IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 56

Query: 609 QAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRI 668
             E+ +L    H N+  L+     +N   ++ EF A G +   + +  ++ L+  +   +
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVV 115

Query: 669 AVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVV 728
             ++   L YLH      I+HRD+K+ NIL       KLADFG+S               
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170

Query: 729 AGTPGYLDPEY-----YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWV 783
            GTP ++ PE              K+DV+S G+ ++E+   +P    +N    +      
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL----- 225

Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
              IAK +  ++  P     + +N      +    CL    + R T SQ+
Sbjct: 226 --KIAKSEPPTLAQP---SRWSSN----FKDFLKKCLEKNVDARWTTSQL 266

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 5e-57
 Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 22/275 (8%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVG 628
            E  LG+G FG V+ G  N    VA+K L   +    + F  E +++ ++ H  L  L  
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 629 HCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIV 688
              E+    ++ E+M+ G+L ++L   + K L   + + +A + A G+ Y+        V
Sbjct: 80  VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 135

Query: 689 HRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEK 748
           HRD+++ NIL+ E L  K+ADFGL++    D              +  PE     R T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

Query: 749 SDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANS 808
           SDV+SFG+++ E+ T                           ++   V+   +       
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQVERGYRMPCPPEC 239

Query: 809 VWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA 843
                +L   C      +RPT   +   L +   +
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-56
 Identities = 63/277 (22%), Positives = 119/277 (42%), Gaps = 30/277 (10%)

Query: 571 ERTLGKGGFGTVYYGRLNEID----VAVKMLSSSSAQG--FQQFQAEVKLLMRVHHRNLT 624
           ++ LG G FGTV  G          VAVK+L + +       +  AE  ++ ++ +  + 
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            ++G C+ ++   L+ E    G L +YL     + +  +  + +  + + G++YL     
Sbjct: 72  RMIGICEAESW-MLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEE--- 125

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH-VSTVVAGTPGYLDPEYYTSN 743
              VHRD+ + N+LL  +  AK++DFGLSK+   D N +   T       +  PE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 744 RLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE 802
           + + KSDV+SFGV++ E  +  +     +   E                + ++++   + 
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERM 229

Query: 803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE 839
              A    +  +L   C +     RP  + V + L  
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 5e-56
 Identities = 73/305 (23%), Positives = 138/305 (45%), Gaps = 48/305 (15%)

Query: 558 LSYSDVVKITNNFERTLGKGGFGTVYYGRLNE----IDVAVKMLS-SSSAQGFQQFQAEV 612
           L ++D+      F+  +G+G FG V   R+ +    +D A+K +   +S    + F  E+
Sbjct: 7   LDWNDI-----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 61

Query: 613 KLLMRV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISK 657
           ++L ++ HH N+ +L+G C+      L  E+  +GNL ++L              ++ + 
Sbjct: 62  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121

Query: 658 KVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA 717
             LSSQ+ L  A + A+G++YL    +   +HRD+ + NIL+ E   AK+ADFGLS+   
Sbjct: 122 STLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 178

Query: 718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEK 776
                   T+      ++  E    +  T  SDV+S+GV++ EI++        +   E 
Sbjct: 179 VYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 234

Query: 777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME 836
                          +   +    + +   N   +  +L   C      +RP+ +Q+++ 
Sbjct: 235 ---------------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

Query: 837 LSECL 841
           L+  L
Sbjct: 280 LNRML 284

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (490), Expect = 9e-56
 Identities = 73/271 (26%), Positives = 113/271 (41%), Gaps = 34/271 (12%)

Query: 572 RTLGKGGFGTVYYGRL--NEIDVAVKMLSSSSAQG---FQQFQAEVKLLMRVHHRNLTSL 626
           R +G G FG VY+ R   N   VA+K +S S  Q    +Q    EV+ L ++ H N    
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
            G    ++   L+ E+            + KK L   E   +   + QGL YLH      
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SHN 135

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS---N 743
           ++HRDVK+ NILL+E    KL DFG +   A       +    GTP ++ PE   +    
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189

Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED 803
           +   K DV+S G+  +E+   KP +  +N    ++        IA+ +  ++      E 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPALQSGHWSEY 242

Query: 804 FDANSVWKAVELAMACLSPTGNQRPTMSQVV 834
           F             +CL      RPT   ++
Sbjct: 243 F--------RNFVDSCLQKIPQDRPTSEVLL 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-55
 Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 29/281 (10%)

Query: 569 NFERTLGKGGFGTVYYGRLNE------IDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHR 621
              + LG G FGTVY G          I VA+K L  ++S +  ++   E  ++  V + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           ++  L+G C   +   LI + M  G L +Y+ +  K  + SQ  L   V+ A+G+ YL +
Sbjct: 72  HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                +VHRD+ + N+L+      K+ DFGL+K    +   + +        ++  E   
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 742 SNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
               T +SDV+S+GV + E++T        I   E                I SI++   
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKGE 230

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
           +             + + C     + RP   ++++E S+  
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 5e-55
 Identities = 57/272 (20%), Positives = 109/272 (40%), Gaps = 25/272 (9%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRN 622
            +++  +TLG+G +G V        +  VAVK++    A    +  + E+ +   ++H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +    GH  E N   L  E+ + G L + +       +   +  R   +   G+ YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH-- 120

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               I HRD+K  N+LL+E+   K++DFGL+  F  +    +   + GT  Y+ PE    
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 743 NRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ 801
                E  DV+S G+V+  ++  +    + ++  +                    + +  
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------YSDWKEKKTY 225

Query: 802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
            +         + L    L    + R T+  +
Sbjct: 226 LNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-54
 Identities = 71/270 (26%), Positives = 108/270 (40%), Gaps = 31/270 (11%)

Query: 570 FERTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLT 624
             R LGKG FG VY  R  +    +A+K+L  +    A    Q + EV++   + H N+ 
Sbjct: 10  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L G+  +  +  LI E+   G +   L  +SK     Q       E A  L Y H    
Sbjct: 70  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---S 124

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             ++HRD+K  N+LL    + K+ADFG S    +   T +     GT  YL PE      
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMIEGRM 180

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
             EK D++S GV+  E +  KP       +E      +      +      V    +   
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISRVEFTFPDFVTEGAR--- 232

Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQVV 834
                    +L    L    +QRP + +V+
Sbjct: 233 ---------DLISRLLKHNPSQRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-54
 Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 29/285 (10%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-----VAVKMLSSSSAQGF-QQFQAEVKLLMRVHHRNL 623
             R +G+G FG V+ G     +     VA+K   + ++    ++F  E   + +  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
             L+G    +N   +I E    G L+ +L       L     +  A + +  L YL    
Sbjct: 71  VKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE--- 125

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
               VHRD+ + N+L++     KL DFGLS+ +  D+  + ++       ++ PE     
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 744 RLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE 802
           R T  SDV+ FGV + EI+         +   + I              I++     +  
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR------------IENGERLPMPP 232

Query: 803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMAR 847
           +           L   C +   ++RP  +++  +LS  L  E A+
Sbjct: 233 NCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-53
 Identities = 65/281 (23%), Positives = 106/281 (37%), Gaps = 30/281 (10%)

Query: 570 FERTLGKGGFGTVYYGRLN-----EIDVAVKMLSS---SSAQGFQQFQAEVKLLMRVHHR 621
               LG G FG V  G  +      + VAVK L     S  +    F  EV  +  + HR
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           NL  L G         ++ E    G+L + L    +         R AV+ A+G+ YL +
Sbjct: 72  NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES 129

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV-STVVAGTPGYLDPEYY 740
                 +HRD+ + N+LL  +   K+ DFGL ++   + + +V          +  PE  
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 741 TSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR 799
            +   +  SD + FGV + E+ T  +     +N  + +H        I K   +      
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-------KIDKEGERLPRPED 239

Query: 800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC 840
             +D           + + C +     RPT   +   L E 
Sbjct: 240 CPQDI--------YNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 57/264 (21%), Positives = 112/264 (42%), Gaps = 24/264 (9%)

Query: 572 RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGH 629
             +G+G  GTVY         +VA++ ++       +    E+ ++    + N+ + +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVH 689
               ++  ++ E++A G+L +    +++  +   +   +  E  Q LE+LH      ++H
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 690 RDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKS 749
           RD+KS NILL      KL DFG       + +    + + GTP ++ PE  T      K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197

Query: 750 DVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSV 809
           D++S G++ +E+I  +P     N    ++       LIA      + +P   E   A   
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALY-------LIATNGTPELQNP---EKLSAI-- 245

Query: 810 WKAVELAMACLSPTGNQRPTMSQV 833
               +    CL     +R +  ++
Sbjct: 246 --FRDFLNRCLDMDVEKRGSAKEL 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 6e-53
 Identities = 78/299 (26%), Positives = 134/299 (44%), Gaps = 45/299 (15%)

Query: 570 FERTLGKGGFGTVYYGRLNEID---------VAVKML-SSSSAQGFQQFQAEVKLLMRV- 618
             + LG+G FG V       +D         VAVKML S ++ +      +E++++  + 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYL--------------SDISKKVLSSQE 664
            H+N+ +L+G C +D    +I E+ + GNL+EYL              S   ++ LSS++
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 665 RLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV 724
            +  A + A+G+EYL        +HRD+ + N+L+ E    K+ADFGL++          
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWV 783
           +T       ++ PE       T +SDV+SFGV++ EI T        +  EE        
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 245

Query: 784 NSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA 842
                   +  ++    + D  +N   +   +   C     +QRPT  Q+V +L   +A
Sbjct: 246 --------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 3e-52
 Identities = 80/305 (26%), Positives = 130/305 (42%), Gaps = 46/305 (15%)

Query: 570 FERTLGKGGFGTVYYGRLNEID-------VAVKMLSSSSAQG-FQQFQAEVKLLMR-VHH 620
             + LG+G FG V       ID       VAVKML   +     +   +E+K+L+   HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 621 RNLTSLVGHCDEDNQT-ALIYEFMANGNLQEYL--------------SDISKKVLSSQER 665
            N+ +L+G C +      +I EF   GNL  YL               D+ K  L+ +  
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 666 LRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS 725
           +  + + A+G+E+L +      +HRD+ + NILL+EK   K+ DFGL++    D +    
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNS 785
                   ++ PE       T +SDV+SFGV++ EI +   +         + I +    
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCR 248

Query: 786 LIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEM 845
            + +G      D    E           +  + C     +QRPT S++V  L   L    
Sbjct: 249 RLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGNLL---- 295

Query: 846 ARANS 850
            +AN+
Sbjct: 296 -QANA 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 8e-52
 Identities = 67/288 (23%), Positives = 119/288 (41%), Gaps = 34/288 (11%)

Query: 570 FERTLGKGGFGTVYYGRL-------NEIDVAVKMLS-SSSAQGFQQFQAEVKLLMRVHHR 621
             R LG+G FG VY G          E  VA+K ++ ++S +   +F  E  ++   +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKV--------LSSQERLRIAVESA 673
           ++  L+G   +   T +I E M  G+L+ YL  +   +         S  + +++A E A
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            G+ YL+       VHRD+ + N ++ E    K+ DFG+++                   
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK 793
           ++ PE       T  SDV+SFGVV+ EI T      +    E++              ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--------------LR 246

Query: 794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
            +++  L  D   N      EL   C       RP+  +++  + E +
Sbjct: 247 FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  180 bits (457), Expect = 9e-51
 Identities = 61/274 (22%), Positives = 112/274 (40%), Gaps = 26/274 (9%)

Query: 566 ITNNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHR 621
           + ++++    LG G FG V+           A K + +      +  + E++ +  + H 
Sbjct: 24  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
            L +L    ++DN+  +IYEFM+ G L E ++D     +S  E +    +  +GL ++H 
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 682 GCKPPIVHRDVKSTNILLNEKL--QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEY 739
                 VH D+K  NI+   K   + KL DFGL+       +  V+T   GT  +  PE 
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 196

Query: 740 YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR 799
                +   +D++S GV+   +++        N++E +      N      ++       
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDWNMDDSAFSG 251

Query: 800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
           + ED          +     L    N R T+ Q 
Sbjct: 252 ISED--------GKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 5e-50
 Identities = 58/269 (21%), Positives = 99/269 (36%), Gaps = 27/269 (10%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLT 624
           F + LG+G F TV   R      + A+K+L                E  ++ R+ H    
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71

Query: 625 SLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCK 684
            L     +D +      +  NG L +Y+  I                 A+ +  L     
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYT---AEIVSALEYLHG 126

Query: 685 PPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNR 744
             I+HRD+K  NILLNE +  ++ DFG +K  + ++    +    GT  Y+ PE  T   
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 745 LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDF 804
             + SD+++ G +I +++   P     NE        +   +  + D      P      
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----IFQKIIKLEYDFPEKFFP------ 235

Query: 805 DANSVWKAVELAMACLSPTGNQRPTMSQV 833
                 KA +L    L     +R    ++
Sbjct: 236 ------KARDLVEKLLVLDATKRLGCEEM 258

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (441), Expect = 1e-48
 Identities = 52/275 (18%), Positives = 112/275 (40%), Gaps = 26/275 (9%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHH 620
            + + ++    LG G FG V+             K +++         + E+ ++ ++HH
Sbjct: 26  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             L +L    ++  +  LI EF++ G L + ++      +S  E +    ++ +GL+++H
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH 144

Query: 681 NGCKPPIVHRDVKSTNILL--NEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
              +  IVH D+K  NI+    +    K+ DFGL+     D    V+T    T  +  PE
Sbjct: 145 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPE 198

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
                 +   +D+++ GV+   +++     +  ++ E +         + +       D 
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-------NVKRC------DW 245

Query: 799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
              ED  ++   +A +     L     +R T+   
Sbjct: 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (423), Expect = 1e-46
 Identities = 54/273 (19%), Positives = 107/273 (39%), Gaps = 23/273 (8%)

Query: 566 ITNNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQ-FQAEVKLLMRVHH 620
           I + ++    LG G F  V           VA+K ++  + +G +   + E+ +L ++ H
Sbjct: 7   IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH 66

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
            N+ +L    +      LI + ++ G L + +  + K   + ++  R+  +    ++YLH
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
           +        +        L+E  +  ++DFGLSK         V +   GTPGY+ PE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVL 181

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
                ++  D +S GV+   ++   P     N+ +           I K + +   D   
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-------QILKAEYE--FDSPY 232

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
            +D   +    A +     +     +R T  Q 
Sbjct: 233 WDDISDS----AKDFIRHLMEKDPEKRFTCEQA 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  164 bits (415), Expect = 6e-46
 Identities = 61/286 (21%), Positives = 124/286 (43%), Gaps = 31/286 (10%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQG---FQQFQAEVKLLMR 617
            +++ +E    LG GG   V+  R      DVAVK+L +  A+    + +F+ E +    
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 618 VHHRNLTSLVGHCDEDNQTA----LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESA 673
           ++H  + ++    + +        ++ E++    L++ +       ++ +  + +  ++ 
Sbjct: 64  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 121

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST-VVAGTP 732
           Q L +     +  I+HRDVK  NI+++     K+ DFG++++ A   N+   T  V GT 
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDI 792
            YL PE    + +  +SDVYS G V+ E++T +P  +  +     +       +      
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-----QHVREDPIP 233

Query: 793 KSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRP-TMSQVVMEL 837
            S     L  D D         + +  L+     R  T +++  +L
Sbjct: 234 PSARHEGLSADLD--------AVVLKALAKNPENRYQTAAEMRADL 271

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-44
 Identities = 47/268 (17%), Positives = 102/268 (38%), Gaps = 25/268 (9%)

Query: 570 FERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV 627
               LG+G FG V+             K +           + E+ +L    HRN+  L 
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLH 67

Query: 628 GHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPI 687
              +   +  +I+EF++  ++ E ++  S   L+ +E +    +  + L++LH      I
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH---SHNI 123

Query: 688 VHRDVKSTNILLNEK--LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL 745
            H D++  NI+   +     K+ +FG ++      N     ++   P Y  PE +  + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVV 180

Query: 746 TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD 805
           +  +D++S G ++  +++          ++ I      N + A+          +  +  
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIE-----NIMNAEYTFDEEAFKEISIE-- 233

Query: 806 ANSVWKAVELAMACLSPTGNQRPTMSQV 833
                 A++     L      R T S+ 
Sbjct: 234 ------AMDFVDRLLVKERKSRMTASEA 255

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  159 bits (402), Expect = 3e-44
 Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 39/282 (13%)

Query: 570 FERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGF---------QQFQAEVKLLMRV 618
            +  LG+G    V            AVK++  +    F         +    EV +L +V
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 619 H-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
             H N+  L    + +    L+++ M  G L +YL++  K  LS +E  +I     + + 
Sbjct: 67  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVIC 124

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
            LH   K  IVHRD+K  NILL++ +  KL DFG S              V GTP YL P
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAP 178

Query: 738 EYYTSNRL------TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD 791
           E    +         ++ D++S GV++  ++   P      +   +        +I  G+
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-------MIMSGN 231

Query: 792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
            +        +D+         +L    L     +R T  + 
Sbjct: 232 YQ--FGSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 8e-43
 Identities = 71/280 (25%), Positives = 108/280 (38%), Gaps = 28/280 (10%)

Query: 574 LGKGGFGTVYYGRLNEID--VAVKMLSSSSAQG-----FQQFQAEVKLLMRVHHRNLTSL 626
           LG+G F TVY  R    +  VA+K +             +    E+KLL  + H N+  L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 627 VGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPP 686
           +      +  +L+++FM          +    VL+        + + QGLEYLH      
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120

Query: 687 IVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL- 745
           I+HRD+K  N+LL+E    KLADFGL+KSF +    +  T    T  Y  PE     R+ 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMY 178

Query: 746 TEKSDVYSFGVVILEIITCKP------------AISRINEEEKIHIRQWVNSLIAKGDIK 793
               D+++ G ++ E++   P             I              + SL      K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
           S     L   F A      ++L           R T +Q 
Sbjct: 239 SFPGIPLHHIFSAAGD-DLLDLIQGLFLFNPCARITATQA 277

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 51/290 (17%), Positives = 102/290 (35%), Gaps = 27/290 (9%)

Query: 564 VKITNNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH 619
           +++ N +   R +G G FG +Y G       +VA+K+    +     Q   E K+   + 
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
                  +  C  +    ++   +   +L++  +  S+K  S +  L +A +    +EY+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYI 119

Query: 680 HNGCKPPIVHRDVKSTNILLNEKLQAKLA---DFGLSKSF-----ATDANTHVSTVVAGT 731
           H+      +HRDVK  N L+    +  L    DFGL+K +             +  + GT
Sbjct: 120 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 732 PGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD 791
             Y     +     + + D+ S G V++           +    K    + +        
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-----SEK 231

Query: 792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
             S     L + + +    +       C S   + +P  S +        
Sbjct: 232 KMSTPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 59/294 (20%), Positives = 114/294 (38%), Gaps = 32/294 (10%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGR---LNEIDVAVKMLSSSSAQG-----FQQFQAEVKL 614
           +    +E    +G+G +G V+  R        VA+K +   + +        +  A ++ 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 615 LMRVHHRNLTSLVGHC-----DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIA 669
           L    H N+  L   C     D + +  L++E +       YL  + +  + ++    + 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMM 122

Query: 670 VESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVA 729
            +  +GL++LH+     +VHRD+K  NIL+    Q KLADFGL++ ++        T V 
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 176

Query: 730 GTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH----------I 779
            T  Y  PE    +      D++S G +  E+   KP     ++ +++            
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 780 RQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
             W   +            +  E F  +      +L + CL+    +R +    
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-42
 Identities = 60/273 (21%), Positives = 100/273 (36%), Gaps = 30/273 (10%)

Query: 570 FERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSA---QGFQQFQAEVKLLMRV-HHRNL 623
             + LGKG FG V+     + +   A+K L           +    E ++L     H  L
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 624 TSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC 683
           T +            + E++  G+L  ++   S            A E   GL++L    
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFL---H 120

Query: 684 KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSN 743
              IV+RD+K  NILL++    K+ADFG+ K               GTP Y+ PE     
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQ 178

Query: 744 RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED 803
           +     D +SFGV++ E++  +      +EEE  H  +  N             P     
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------------PFYPRW 225

Query: 804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME 836
            +      A +L +        +R  +   + +
Sbjct: 226 LEKE----AKDLLVKLFVREPEKRLGVRGDIRQ 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-42
 Identities = 58/293 (19%), Positives = 124/293 (42%), Gaps = 25/293 (8%)

Query: 563 VVKITNNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGF-QQFQAEVKLLMR 617
           V  +   +     +G+G +G V      +N++ VA+K +S    Q + Q+   E+K+L+R
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62

Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD-ISKKVLSSQERLRIAVESAQGL 676
             H N+  +           +   ++    +   L   +  + LS+        +  +GL
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTH-VSTVVAGTPGYL 735
           +Y+H      ++HRD+K +N+LLN     K+ DFGL++    D +     T    T  Y 
Sbjct: 123 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 736 DPEY-YTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS 794
            PE    S   T+  D++S G ++ E+++ +P     +  ++++    +    ++ D+  
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 795 IVDPRLQEDFDANSVWK--------------AVELAMACLSPTGNQRPTMSQV 833
           I++ + +    +                   A++L    L+   ++R  + Q 
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  153 bits (386), Expect = 7e-42
 Identities = 46/293 (15%), Positives = 99/293 (33%), Gaps = 29/293 (9%)

Query: 562 DVVKITNNFERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRV- 618
           +VV +     R +G+G FG ++ G   LN   VA+K     S     Q + E +    + 
Sbjct: 1   NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLA 58

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEY 678
               + ++     E     L+ + +  G   E L D+  +  S +     A +    ++ 
Sbjct: 59  GCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 679 LHNGCKPPIVHRDVKSTNILLNEKL-----QAKLADFGLSKSFATDANT-----HVSTVV 728
           +H   +  +V+RD+K  N L+            + DFG+ K +                +
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 729 AGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA 788
           +GT  Y+    +     + + D+ + G V +  +        +         + +     
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233

Query: 789 KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL 841
              ++ +      E+F         +      +   +  P    +    S+ L
Sbjct: 234 STPLRELC-AGFPEEFY--------KYMHYARNLAFDATPDYDYLQGLFSKVL 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  152 bits (384), Expect = 8e-42
 Identities = 59/284 (20%), Positives = 107/284 (37%), Gaps = 25/284 (8%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNE-IDVAVKML--SSSSAQGFQQFQAEVKLLMRVHHRN 622
             +     +G+G +G VY  + N     A+K +               E+ +L  + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L        +  L++E +     +    D+ +  L S       ++   G+ Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH-- 117

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTS 742
               ++HRD+K  N+L+N + + K+ADFGL+++F      +   +V  T  Y  P+    
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMG 174

Query: 743 N-RLTEKSDVYSFGVVILEIITCKP------------AISRINEEEKIHIRQWVNSLIAK 789
           + + +   D++S G +  E++   P             I RI           V  L   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 790 GDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
               ++ +P   E F        ++L    L    NQR T  Q 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-41
 Identities = 54/282 (19%), Positives = 100/282 (35%), Gaps = 33/282 (11%)

Query: 565 KITNNFE---RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRV- 618
            I ++++   + LG G  G V            A+KML         + + EV+L  R  
Sbjct: 8   AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRAS 62

Query: 619 HHRNLTSLVGHCD----EDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQ 674
              ++  +V   +          ++ E +  G L   + D   +  + +E   I     +
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 675 GLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDANTHVSTVVAGT 731
            ++YLH      I HRDVK  N+L          KL DFG +K   +  +         T
Sbjct: 123 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYT 176

Query: 732 PGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD 791
           P Y+ PE     +  +  D++S GV++  ++   P     +              + + +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIRMGQYE 235

Query: 792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
             +     + E+           L    L     QR T+++ 
Sbjct: 236 FPNPEWSEVSEE--------VKMLIRNLLKTEPTQRMTITEF 269

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 3e-41
 Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 25/284 (8%)

Query: 569 NFE--RTLGKGGFGTVYYGRLNEID--VAVKML--SSSSAQGFQQFQAEVKLLMRVHHRN 622
           NF+    +G+G +G VY  R       VA+K +   + +         E+ LL  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 623 LTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNG 682
           +  L+     +N+  L++EF+ + +L++++   +   +          +  QGL +    
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118

Query: 683 CKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE-YYT 741
               ++HRD+K  N+L+N +   KLADFGL+++F     T+   V   T  Y  PE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLG 176

Query: 742 SNRLTEKSDVYSFGVVILEIITCKP---AISRINEEEKIHIRQWVNSLIAKGDIKSIVDP 798
               +   D++S G +  E++T +      S I++  +I         +    + S+ D 
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 799 RLQEDFDANSVWK---------AVELAMACLSPTGNQRPTMSQV 833
           +      A   +             L    L    N+R +    
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (384), Expect = 7e-41
 Identities = 59/276 (21%), Positives = 104/276 (37%), Gaps = 34/276 (12%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQG------FQQFQAEVKLLMR 617
           N+F   R +G+GGFG VY  R  +     A+K L     +           +  + L+  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 618 VHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLE 677
                +  +       ++ + I + M  G+L  +LS     V S  +    A E   GLE
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLE 121

Query: 678 YLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDP 737
           ++H      +V+RD+K  NILL+E    +++D GL+  F+            GT GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAP 174

Query: 738 EYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV 796
           E           +D +S G ++ +++       +   ++K  I +   ++          
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------- 224

Query: 797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQ 832
              L + F          L    L    N+R     
Sbjct: 225 AVELPDSFSPE----LRSLLEGLLQRDVNRRLGCLG 256

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (380), Expect = 8e-41
 Identities = 66/276 (23%), Positives = 107/276 (38%), Gaps = 34/276 (12%)

Query: 568 NNFE--RTLGKGGFGTVYYGRL--NEIDVAVKMLS---SSSAQGFQQFQAEVKLLMRVHH 620
            +F+  RTLG G FG V+  R   N    A+K+L        +  +    E  +L  V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
             +  + G   +  Q  +I +++  G L         +   +      A E    LEYLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEYLH 121

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYY 740
                 I++RD+K  NILL++    K+ DFG +K       T       GTP Y+ PE  
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173

Query: 741 TSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL 800
           ++    +  D +SFG++I E++         N  +           I   +++    P  
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE-------KILNAELR--FPPFF 224

Query: 801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME 836
            ED          +L    ++   +QR    Q   E
Sbjct: 225 NED--------VKDLLSRLITRDLSQRLGNLQNGTE 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 54/282 (19%), Positives = 108/282 (38%), Gaps = 35/282 (12%)

Query: 566 ITNNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGF------QQFQAEVKLL 615
           + + ++    LG G F  V   R        A K +     +        +  + EV +L
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67

Query: 616 MRVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
             + H N+ +L    +      LI E +A G L ++     K+ L+ +E         Q 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFL---KQI 122

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNE----KLQAKLADFGLSKSFATDANTHVSTVVAGT 731
           L  ++      I H D+K  NI+L +    K + K+ DFGL+         +    + GT
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 179

Query: 732 PGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGD 791
           P ++ PE      L  ++D++S GV+   +++         ++E +         ++   
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAV- 231

Query: 792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
                +   ++++ +N+   A +     L     +R T+   
Sbjct: 232 -----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-39
 Identities = 61/298 (20%), Positives = 115/298 (38%), Gaps = 37/298 (12%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQG--FQQFQAEVKLLMRVHHR 621
           + +E    +G+G FG V+  R  +    VA+K +   + +         E+K+L  + H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 622 NLTSLVGHCDE--------DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESA 673
           N+ +L+  C               L+++F  +       + + K   +  E  R+     
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVM---Q 124

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS--TVVAGT 731
             L  L+   +  I+HRD+K+ N+L+      KLADFGL+++F+   N+  +  T    T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 732 PGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG 790
             Y  PE     R      D++  G ++ E+ T  P +    E+ ++ +   +   I   
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 791 DIKSIVDPRLQEDFDANSVWK---------------AVELAMACLSPTGNQRPTMSQV 833
              ++ +  L E  +     K               A++L    L     QR      
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 4e-39
 Identities = 64/276 (23%), Positives = 103/276 (37%), Gaps = 32/276 (11%)

Query: 565 KIT-NNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSS---SAQGFQQFQAEVKLLM 616
           K+T N+F+  + LGKG FG V   R        A+K+L      +         E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 617 RVHHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGL 676
              H  LT+L       ++   + E+   G L  +LS   ++V + +         A+ +
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYG---AEIV 115

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
             L       +V+RD+K  N++L++    K+ DFGL K   +D  T  +    GTP YL 
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLA 173

Query: 737 PEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIV 796
           PE    N      D +  GVV+ E++  +      + E    +       I         
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-------ILME------ 220

Query: 797 DPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQ 832
           + R            A  L    L     QR     
Sbjct: 221 EIRFPRTLSPE----AKSLLAGLLKKDPKQRLGGGP 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 6e-39
 Identities = 52/287 (18%), Positives = 101/287 (35%), Gaps = 31/287 (10%)

Query: 569 NFERTLGKGGFGTVYYGRLNEID--VAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSL 626
              + +G G FG VY  +L +    VA+K +        +    E++++ ++ H N+  L
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRL 78

Query: 627 VGHCDEDNQT------ALIYEFMANGNLQEYLSDI-SKKVLSSQERLRIAVESAQGLEYL 679
                   +        L+ +++     +       +K+ L          +  + L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 680 HNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
           H+     I HRD+K  N+LL+      KL DFG +K           + +          
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPEL 193

Query: 739 YYTSNRLTEKSDVYSFGVVILEIITCKP------------AISRINEEEKIHIRQWVNSL 786
            + +   T   DV+S G V+ E++  +P             I ++         + +N  
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 787 IAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
             +     I      + F   +  +A+ L    L  T   R T  + 
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-38
 Identities = 55/276 (19%), Positives = 98/276 (35%), Gaps = 43/276 (15%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGF------QQFQAEVKLLMRVH-- 619
               LG GGFG+VY G    + + VA+K +       +       +   EV LL +V   
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 620 HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYL 679
              +  L+   +  +   LI E               +  L  +       +  + + + 
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHC 126

Query: 680 HNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPE 738
                  ++HRD+K  NIL++  + + KL DFG            V T   GT  Y  PE
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179

Query: 739 YYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
           +   +R     + V+S G+++ +++          E             I +G +     
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQV--FFR 224

Query: 798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
            R+  +           L   CL+   + RPT  ++
Sbjct: 225 QRVSSE--------CQHLIRWCLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 2e-37
 Identities = 53/285 (18%), Positives = 102/285 (35%), Gaps = 25/285 (8%)

Query: 568 NNFE--RTLGKGGFGTVYYGRLNEID--VAVKML--SSSSAQGFQQFQAEVKLLMRVHHR 621
             +E    +G+G +GTV+  +  E    VA+K +               E+ LL  + H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 622 NLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHN 681
           N+  L      D +  L++EF      + +  D     L  +          Q L+ L  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF--DSCNGDLDPEIVKSFL---FQLLKGLGF 116

Query: 682 GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYT 741
                ++HRD+K  N+L+N   + KLA+FGL+++F        S  V           + 
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFG 175

Query: 742 SNRLTEKSDVYSFGVVILEIITCK----PAISRINEEEKIHIRQWVNSLIAKGDIKSIVD 797
           +   +   D++S G +  E+        P     ++ ++I       +      +  + D
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 798 PRLQEDFDANSVWK---------AVELAMACLSPTGNQRPTMSQV 833
            +    + A +              +L    L     QR +  + 
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (343), Expect = 1e-35
 Identities = 55/256 (21%), Positives = 100/256 (39%), Gaps = 26/256 (10%)

Query: 534 KRQVGKVKRESKNKIDSFEAKSRHLSYSDVVKITNNFE--RTLGKGGFGTVYYGRLNEID 591
           K  + K K +   K ++    +  L         + F+  +TLG G FG V   +  E  
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQL---------DQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 592 --VAVKMLSSSSA---QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG 646
              A+K+L        +  +    E ++L  V+   L  L     +++   ++ E++A G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAK 706
            +  +L        S       A +     EYLH      +++RD+K  N+L++++   +
Sbjct: 127 EMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQ 181

Query: 707 LADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP 766
           + DFG +K       T     + GTP  L PE   S    +  D ++ GV+I E+    P
Sbjct: 182 VTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

Query: 767 AISRINEEEKIHIRQW 782
                   +       
Sbjct: 237 PFFADQPIQIYEKIVS 252

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 4e-35
 Identities = 63/292 (21%), Positives = 112/292 (38%), Gaps = 31/292 (10%)

Query: 565 KITNNFE--RTLGKGGFGTVYYGRLNEID--VAVKML--SSSSAQGFQQFQAEVKLLMRV 618
           ++   +   + +G G +G V           VA+K L     S    ++   E++LL  +
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 619 HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSD--ISKKVLSSQERLRIAVESAQGL 676
            H N+  L+     D       +F              +  + L       +  +  +GL
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 677 EYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLD 736
            Y+H      I+HRD+K  N+ +NE  + K+ DFGL++   ++   +V      T  Y  
Sbjct: 135 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-----VTRWYRA 186

Query: 737 PEYYTSN-RLTEKSDVYSFGVVILEIITCKP------------AISRINEEEKIHIRQWV 783
           PE   +  R T+  D++S G ++ E+IT K              I ++         Q +
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246

Query: 784 NSLIAKGDIKSI--VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
            S  AK  +K +  ++ +       N+   AV L    L     QR T  + 
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-32
 Identities = 63/283 (22%), Positives = 110/283 (38%), Gaps = 33/283 (11%)

Query: 568 NNFE--RTLGKGGFGTVYYGRL-----NEIDVAVKMLS----SSSAQGFQQFQAEVKLLM 616
            NFE  + LG G +G V+  R           A+K+L        A+  +  + E ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 617 RV-HHRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQG 675
            +     L +L      + +  LI +++  G L  +LS   +   +  E         + 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYV---GEI 138

Query: 676 LEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYL 735
           +  L +  K  I++RD+K  NILL+      L DFGLSK F     T  +    GT  Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYM 197

Query: 736 DPEYYTSNR--LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK 793
            P+          +  D +S GV++ E++T     +   E+            I++  +K
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-------EISRRILK 250

Query: 794 SIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME 836
           S  +P   ++  A     A +L    L     +R        +
Sbjct: 251 S--EPPYPQEMSAL----AKDLIQRLLMKDPKKRLGCGPRDAD 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (316), Expect = 3e-32
 Identities = 60/332 (18%), Positives = 127/332 (38%), Gaps = 52/332 (15%)

Query: 538 GKVKRESKNKIDSFEAKSRHLSYSDVVKIT----NNFE--RTLGKGGFGTVYYGR--LNE 589
           G V   ++   D    + R     +   +     ++++  R LG+G +  V+      N 
Sbjct: 1   GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60

Query: 590 IDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHC--DEDNQTALIYEFMANG 646
             V VK+L        ++ + E+K+L  +    N+ +L            AL++E + N 
Sbjct: 61  EKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117

Query: 647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILL-NEKLQA 705
           + ++       + L+  +      E  + L+Y H+     I+HRDVK  N+++ +E  + 
Sbjct: 118 DFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKL 169

Query: 706 KLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITC 764
           +L D+GL++ +          V   +  +  PE     ++     D++S G ++  +I  
Sbjct: 170 RLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226

Query: 765 KPAISRINEEEKIHIR-------QWVNSLIAKGDIKSIVDPRLQEDFDANSVWK------ 811
           K      ++     +R       + +   I K +I+  +DPR  +    +S  +      
Sbjct: 227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE--LDPRFNDILGRHSRKRWERFVH 284

Query: 812 ----------AVELAMACLSPTGNQRPTMSQV 833
                     A++     L      R T  + 
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-30
 Identities = 58/305 (19%), Positives = 114/305 (37%), Gaps = 48/305 (15%)

Query: 566 ITNNFE--RTLGKGGFGTVYYGRLNEID--VAVKMLSSS--SAQGFQQFQAEVKLLMRVH 619
           +   ++  + +G G  G V       +D  VA+K LS    +    ++   E+ L+  V+
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74

Query: 620 HRNLTSLVGHC------DEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESA 673
           H+N+ SL+         +E     L+ E M     Q       +  L  +    +  +  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMELDHERMSYLLYQML 129

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPG 733
            G+++LH+     I+HRD+K +NI++      K+ DFGL+++  T     + T    T  
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRY 183

Query: 734 YLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH--------------- 778
           Y  PE        E  D++S G ++ E++  K      +  ++ +               
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 779 --IRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWK--------AVELAMACLSPTGNQRP 828
                  N +  +     +  P+L  D    +  +        A +L    L     +R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 829 TMSQV 833
           ++   
Sbjct: 304 SVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-29
 Identities = 59/299 (19%), Positives = 120/299 (40%), Gaps = 39/299 (13%)

Query: 562 DVVKITNNFE--RTLGKGGFGTVYYGR--LNEIDVAVKMLSSS--SAQGFQQFQAEVKLL 615
            + ++   ++    +G G +G+V         + VAVK LS    S    ++   E++LL
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71

Query: 616 MRVHHRNLTSLVGHCDE-----DNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAV 670
             + H N+  L+          +     +   +   +L      +  + L+      +  
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIY 128

Query: 671 ESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTVVAG 730
           +  +GL+Y+H+       HRD+K +N+ +NE  + K+ DFGL++    +   +V+     
Sbjct: 129 QILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----- 180

Query: 731 TPGYLDPEYY-TSNRLTEKSDVYSFGVVILEIITCKP------------AISRINEEEKI 777
           T  Y  PE         +  D++S G ++ E++T +              I R+      
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 778 HIRQWVNSLIAKGDIKSIVD---PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV 833
            + + ++S  A+  I+S+           F   +   AV+L    L    ++R T +Q 
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANP-LAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (265), Expect = 2e-25
 Identities = 53/312 (16%), Positives = 100/312 (32%), Gaps = 51/312 (16%)

Query: 570 FERTLGKGGFGTVYYGR--LNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTS-- 625
             R LG G F TV+  +  +N   VA+K++        +  + E+KLL RV+  + T   
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKED 75

Query: 626 ---------LVGHCDEDNQTALIYEFMANGNLQEYLSDISK---KVLSSQERLRIAVESA 673
                    L+ H +      +    +     +  L+ I K   + +      +I+ +  
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 674 QGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATDANTHVSTVVAGTP 732
            GL+Y+H   +  I+H D+K  N+L+        L    ++            T    T 
Sbjct: 136 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 733 GYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP----AISRINEEEKIHIRQWVNSLIA 788
            Y  PE          +D++S   +I E+IT              ++  HI Q +  L  
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 789 KGDIKSIVDPRLQEDFDANSVWK---------------------------AVELAMACLS 821
                       +  F++  + +                             +     L 
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 822 PTGNQRPTMSQV 833
               +R     +
Sbjct: 314 LDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.3 bits (205), Expect = 6e-19
 Identities = 33/201 (16%), Positives = 57/201 (28%), Gaps = 27/201 (13%)

Query: 572 RTLGKGGFGTVYYGRL-NEIDVAVKMLSSSSA----------QGFQQFQAEVKLLMRVHH 620
           + +G+G    V+        +  VK                  G   F        R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLH 680
           R L  L G           Y +  N  L E +       +  +    +     + +   +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 681 NGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT-DANTHVSTVVAGTPGYLDPEY 739
           +     IVH D+   N+L++E+    + DF  S           +   V     Y    Y
Sbjct: 121 H---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176

Query: 740 YTSNRLTEKSDVYSFGVVILE 760
                   + D+ S    IL+
Sbjct: 177 ------RTEKDINSAIDRILQ 191

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.1 bits (144), Expect = 3e-10
 Identities = 16/91 (17%), Positives = 29/91 (31%)

Query: 381 NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSN 440
               +                    S  +  L+L ++ + G +   ++ L  L  L++S 
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277

Query: 441 NNLTGSVPDFLSKLPLRTLNLQGNKLNGSVP 471
           NNL G +P   +           NK     P
Sbjct: 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.1 bits (139), Expect = 2e-09
 Identities = 27/128 (21%), Positives = 50/128 (39%), Gaps = 11/128 (8%)

Query: 358 QLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSS 417
           +L   ++  + I+NI    GL      +           ++          +TYL L  +
Sbjct: 264 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK------NLTYLTLYFN 317

Query: 418 GLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLE 476
            +       VS+LT LQ L  +NN ++      L+ L  +  L+   N+++   P+  L 
Sbjct: 318 NISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLT 373

Query: 477 RSKNGSLS 484
           R     L+
Sbjct: 374 RITQLGLN 381

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 3e-04
 Identities = 12/76 (15%), Positives = 28/76 (36%), Gaps = 5/76 (6%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
           D++        L  + +   ++   ++L  +  L      +     D +  L  L  +N 
Sbjct: 18  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 73

Query: 462 QGNKLNGSVPVELLER 477
             N+L    P++ L +
Sbjct: 74  SNNQLTDITPLKNLTK 89

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.3 bits (126), Expect = 5e-08
 Identities = 17/88 (19%), Positives = 29/88 (32%), Gaps = 7/88 (7%)

Query: 381 NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSN 440
                P                    P +  LN+S++ L        +    L+ L  S 
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL----IELPALPPRLERLIASF 313

Query: 441 NNLTGSVPDFLSKLPLRTLNLQGNKLNG 468
           N+L   VP+    L  + L+++ N L  
Sbjct: 314 NHLA-EVPELPQNL--KQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 24/112 (21%), Positives = 34/112 (30%), Gaps = 11/112 (9%)

Query: 381 NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSN 440
           N+  D                  S    +       +    +I S      SL+ L++SN
Sbjct: 234 NYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN 293

Query: 441 NNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSL-SLSVGGNP 491
           N L   +P    +  L  L    N L   VP          +L  L V  NP
Sbjct: 294 NKLI-ELPALPPR--LERLIASFNHLA-EVPELP------QNLKQLHVEYNP 335

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.1 bits (97), Expect = 2e-04
 Identities = 13/52 (25%), Positives = 22/52 (42%), Gaps = 5/52 (9%)

Query: 409 ITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLN 460
              L L++ GL    +S       L+ L  S N+LT  +P+    L    ++
Sbjct: 40  AHELELNNLGL----SSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVD 86

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 12/62 (19%), Positives = 22/62 (35%), Gaps = 9/62 (14%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQ 462
            +  PR+  L  S +     +        +L+ L +  N L    PD    +     +L+
Sbjct: 300 PALPPRLERLIASFN----HLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVE----DLR 350

Query: 463 GN 464
            N
Sbjct: 351 MN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 14/54 (25%), Positives = 24/54 (44%), Gaps = 5/54 (9%)

Query: 431 TSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLS 484
                L+L+N  L+ S+P+      L +L    N L   +P EL +  K+  + 
Sbjct: 38  RQAHELELNNLGLS-SLPELPPH--LESLVASCNSLT-ELP-ELPQSLKSLLVD 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 1e-07
 Identities = 19/86 (22%), Positives = 31/86 (36%), Gaps = 6/86 (6%)

Query: 406 SPRITYLNLSSSGLK-GDITSYVSNLTSLQFLDLSNNNLTG----SVPDFLSKLP-LRTL 459
           S  I  L++    L        +  L   Q + L +  LT      +   L   P L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 460 NLQGNKLNGSVPVELLERSKNGSLSL 485
           NL+ N+L       +L+  +  S  +
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 17/87 (19%), Positives = 29/87 (33%), Gaps = 10/87 (11%)

Query: 404 SSSPRITYLNLSSSGLKGD----ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKL----- 454
                +  L L+   +       + + +    SL+ LDLSNN L  +    L +      
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 455 -PLRTLNLQGNKLNGSVPVELLERSKN 480
             L  L L     +  +   L    K+
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKD 452

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 15/76 (19%), Positives = 32/76 (42%), Gaps = 5/76 (6%)

Query: 417 SGLKGDITSYVSNLTSLQFLDLSNNNLTG----SVPDFLSKLP-LRTLNLQGNKLNGSVP 471
           +G++          + L+ L L++ +++     S+   L     LR L+L  N L  +  
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414

Query: 472 VELLERSKNGSLSLSV 487
           ++L+E  +     L  
Sbjct: 415 LQLVESVRQPGCLLEQ 430

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 13/68 (19%), Positives = 25/68 (36%), Gaps = 10/68 (14%)

Query: 407 PRITYLNLSSSGLKGD----ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSK------LPL 456
            +   + L   GL       I+S +    +L  L+L +N L       + +        +
Sbjct: 27  QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86

Query: 457 RTLNLQGN 464
           + L+LQ  
Sbjct: 87  QKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 12/64 (18%), Positives = 26/64 (40%), Gaps = 5/64 (7%)

Query: 404 SSSPRITYLNLSS-----SGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRT 458
            ++  +  L+LS+     +G+   + S       L+ L L +   +  + D L  L    
Sbjct: 394 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

Query: 459 LNLQ 462
            +L+
Sbjct: 454 PSLR 457

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.3 bits (116), Expect = 9e-07
 Identities = 19/80 (23%), Positives = 29/80 (36%), Gaps = 7/80 (8%)

Query: 394 WDGLNCSYGDSSS------PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSV 447
              + CS            P    L+L ++ +         NL +L  L L NN ++   
Sbjct: 12  LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71

Query: 448 PDFLSKLP-LRTLNLQGNKL 466
           P   + L  L  L L  N+L
Sbjct: 72  PGAFAPLVKLERLYLSKNQL 91

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 15/108 (13%), Positives = 31/108 (28%), Gaps = 2/108 (1%)

Query: 392 YWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFL 451
                    +   +   +  L  +     G        +  L ++ +++ N+T       
Sbjct: 111 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP 170

Query: 452 SKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNPGLCSKISC 499
               L  L+L GNK+       L   +    L LS      + +    
Sbjct: 171 PS--LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 216

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 21/116 (18%), Positives = 34/116 (29%), Gaps = 12/116 (10%)

Query: 381 NWQGDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKGDITSY-VSNLTSLQFLDLS 439
                     +        S+ +     +    LS+ G    + ++       LQ L L 
Sbjct: 222 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 281

Query: 440 NNNLTGSVPDFL-----SKLP-LRTLNLQGNKLNGSVPV-----ELLERSKNGSLS 484
            N +       L      K+P L  L L GN+ +    V     E+      G L 
Sbjct: 282 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 337

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 1e-04
 Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)

Query: 427 VSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLNGSVPVELLERSKNGSLSLS 486
           VS + S   ++    NLT ++P  L K     L+L  N L       L+  ++   L+L 
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPKD-TTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 3e-04
 Identities = 16/69 (23%), Positives = 21/69 (30%), Gaps = 8/69 (11%)

Query: 399 CSYGDSSSPRITYLNLSSSGLKGDITSYVSNL-TSLQFLDLSNNNLTGSVPDFLSKLP-L 456
           C     +S     +N     L    T+   +L      L LS N L       L     L
Sbjct: 4   CEVSKVAS--HLEVNCDKRNL----TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRL 57

Query: 457 RTLNLQGNK 465
             LNL   +
Sbjct: 58  TQLNLDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.004
 Identities = 11/45 (24%), Positives = 15/45 (33%)

Query: 423 ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPLRTLNLQGNKLN 467
               ++ L +L  L L  N+L      F     L    L GN   
Sbjct: 164 PAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (98), Expect = 1e-04
 Identities = 8/39 (20%), Positives = 12/39 (30%), Gaps = 1/39 (2%)

Query: 428 SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNK 465
              +    LD+S   +       L  L  LR  +    K
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 17/78 (21%), Positives = 36/78 (46%), Gaps = 3/78 (3%)

Query: 409 ITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTG-SVPDFLSKLP-LRTLNLQGNKL 466
           +       S +   +  + S    +Q +DLSN+ +   ++   LS+   L+ L+L+G +L
Sbjct: 25  VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83

Query: 467 NGSVPVELLERSKNGSLS 484
           +  +   L + S    L+
Sbjct: 84  SDPIVNTLAKNSNLVRLN 101

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 2e-04
 Identities = 17/74 (22%), Positives = 30/74 (40%), Gaps = 5/74 (6%)

Query: 403 DSSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
           D +       NL    +   +T   + L S+  +  +N+++       +  LP +  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75

Query: 462 QGNKLNGSVPVELL 475
            GNKL    P+  L
Sbjct: 76  NGNKLTDIKPLANL 89

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 7e-04
 Identities = 21/103 (20%), Positives = 35/103 (33%), Gaps = 25/103 (24%)

Query: 411 YLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLPL-------------- 456
            L+L+   L   +  ++  L  +  LDLS+N L    P   +   L              
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 457 --------RTLNLQGNKLNGSVPVELLERSKNGSLSLSVGGNP 491
                   + L L  N+L  S  ++ L         L++ GN 
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV-LLNLQGNS 101

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.001
 Identities = 6/41 (14%), Positives = 16/41 (39%), Gaps = 2/41 (4%)

Query: 428 SNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN 467
           +N    + LDL    +   + +  + L     ++   N++ 
Sbjct: 15  TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR 54

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 9/36 (25%), Positives = 18/36 (50%), Gaps = 3/36 (8%)

Query: 427 VSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNL 461
           +++L +L  + L NN ++   P  L+    L  + L
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	878
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.81
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.58
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.01
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.91
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.89
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.86
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.84
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.68
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.67
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.63
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.39
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.35
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.31
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.27
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.24
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.21
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.17
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.1
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.08
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.05
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.02
d2ifga3	156	High affinity nerve growth factor receptor, N-term	97.95
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.89
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.84
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	97.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.69
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.64
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.54
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.41
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.36
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.31
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.27
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.8
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	96.77
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.38
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	96.32
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.25
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	95.65
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.63
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.31
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.3
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.02
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	94.66
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	94.05
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	93.64
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	93.31
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	91.3
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	84.44

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-48  Score=418.76  Aligned_cols=266  Identities=26%  Similarity=0.422  Sum_probs=207.9

Q ss_pred             CCHHHHHHHHhhh-----------cccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcc
Q 002809          558 LSYSDVVKITNNF-----------ERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHH  620 (878)
Q Consensus       558 ~s~~dl~~~t~~f-----------~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H  620 (878)
                      ++|+|+.+++.+|           .+.||+|+||+||+|++..     ..||||.+... .....++|.+|+++|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            4556666666555           3689999999999998743     35899988754 44556789999999999999


Q ss_pred             cceeeeeecccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc
Q 002809          621 RNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN  700 (878)
Q Consensus       621 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~  700 (878)
                      ||||+++|+|..++..++||||+++|+|.+++... ...+++.+++.++.|||+||+|||++   +|+||||||+||||+
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~  162 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVN  162 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEEC
Confidence            99999999999999999999999999999988752 44699999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCCCcc---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHH
Q 002809          701 EKLQAKLADFGLSKSFATDANTHV---STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEK  776 (878)
Q Consensus       701 ~~~~~kL~DFGla~~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~  776 (878)
                      .++++||+|||+++.+........   .....||+.|||||.+.+..++.++|||||||++|||+| |++||......+.
T Consensus       163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~  242 (299)
T d1jpaa_         163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV  242 (299)
T ss_dssp             TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999987754332211   122457899999999999999999999999999999998 8999987765432


Q ss_pred             HHHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          777 IHIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       777 ~~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                         ...    +..+.         ....+..+...+.+++.+||+.+|++||||+||++.|+++++.
T Consensus       243 ---~~~----i~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         243 ---INA----IEQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ---HHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---HHH----HHcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence               111    22221         1112233445788999999999999999999999999998865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=409.61  Aligned_cols=257  Identities=32%  Similarity=0.530  Sum_probs=204.0

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||+||+|++++ .||||+++..  .....+.|.+|+++|.+++|||||++++++.+ +..++||||+++|
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g   88 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGS   88 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEE
T ss_pred             EEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCC
Confidence            456889999999999998765 5999998754  44567899999999999999999999998865 5689999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.++++.. +..+++..++.++.|||+||+|||++   +||||||||+|||++.++.+||+|||+++............
T Consensus        89 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~  164 (276)
T d1uwha_          89 SLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE  164 (276)
T ss_dssp             EHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred             CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccc
Confidence            999999753 45699999999999999999999998   99999999999999999999999999998765444444445


Q ss_pred             cccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          727 VVAGTPGYLDPEYYTS---NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ...||+.|||||++.+   ..++.++|||||||++|||+||+.||.........      ...+..+..    .+.+ ..
T Consensus       165 ~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~~----~p~~-~~  233 (276)
T d1uwha_         165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGYL----SPDL-SK  233 (276)
T ss_dssp             -CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTSC----CCCG-GG
T ss_pred             ccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCC----CCcc-hh
Confidence            5679999999999864   35889999999999999999999999876543321      112222221    1111 11


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .+..+...+.+++.+||+.+|++||||+||++.|+.+.+
T Consensus       234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            223344578899999999999999999999999998654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=405.82  Aligned_cols=253  Identities=26%  Similarity=0.468  Sum_probs=199.9

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||+||+|++.+ ..||||++..... ..++|.+|++++++++|||||+++|+|..++..++||||+++|+
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence            456889999999999999865 7899999976443 34789999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.. ....+++..++.++.|||+||+|||+.   +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus        87 L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~  161 (263)
T d1sm2a_          87 LSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTG  161 (263)
T ss_dssp             HHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             HHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc-eeecc
Confidence            9999875 346689999999999999999999998   999999999999999999999999999987643322 22334


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITC-KPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..||+.|+|||++.+..++.++|||||||++|||+|+ ++|+......+   +.+    .+..+..  .       ..+.
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~----~i~~~~~--~-------~~p~  225 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE----DISTGFR--L-------YKPR  225 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHH----HHHHTCC--C-------CCCT
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHhcCC--C-------CCcc
Confidence            5689999999999999999999999999999999995 56665544332   111    1222211  1       1112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      .+..++.+++.+||+.+|++||||+||++.|+++.++
T Consensus       226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            2334788999999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=406.51  Aligned_cols=253  Identities=28%  Similarity=0.436  Sum_probs=207.2

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+|++++ +.||||++..... ..+.|.+|++++.+++|||||+++|++.+ +..++||||+++|+
T Consensus        16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~   93 (272)
T d1qpca_          16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS   93 (272)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred             EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence            456889999999999999976 7899999976543 35789999999999999999999998865 56799999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.......+++..+++|+.||++||+|||+.   +|+||||||+||||++++.+||+|||+++.+... .......
T Consensus        94 L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~~~~  169 (272)
T d1qpca_          94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREG  169 (272)
T ss_dssp             HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEECCTT
T ss_pred             HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC-ccccccc
Confidence            99988766566799999999999999999999998   9999999999999999999999999999877432 2223344


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKP-AISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..||+.|+|||++.+..++.++|||||||++|||+||+. |+......+   +.+    .+..+..     +    ..+.
T Consensus       170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~----~i~~~~~-----~----~~p~  233 (272)
T d1qpca_         170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ----NLERGYR-----M----VRPD  233 (272)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTTCC-----C----CCCT
T ss_pred             cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHhcCC-----C----CCcc
Confidence            568999999999999999999999999999999999654 454443322   111    1222211     1    1112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      ....++.+++.+||+.+|++||||+||++.|++...+
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            2334688999999999999999999999999987643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-47  Score=409.34  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=209.7

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      .+.+.||+|+||+||+|++.  ++.||||+++... ...++|.+|+++|++++|||||+++++|.+++..++||||+++|
T Consensus        20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g   98 (287)
T d1opja_          20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   98 (287)
T ss_dssp             EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence            45789999999999999986  4789999987553 34578999999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++.......+++..++.++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus        99 ~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~  174 (287)
T d1opja_          99 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHA  174 (287)
T ss_dssp             BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEET
T ss_pred             chHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC-ceeec
Confidence            999999876677899999999999999999999998   99999999999999999999999999998764332 22333


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.|+.......  .+.    ..+..+.         ....+.
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~----~~i~~~~---------~~~~~~  239 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----ELLEKDY---------RMERPE  239 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----HHHHTTC---------CCCCCT
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHH----HHHhcCC---------CCCCCc
Confidence            4568899999999999999999999999999999999766654333221  111    1222221         111222


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      ....++.+++.+||+.+|++||||+||++.|+.+.
T Consensus       240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            33457889999999999999999999999998764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-47  Score=403.04  Aligned_cols=249  Identities=24%  Similarity=0.364  Sum_probs=202.0

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence            345689999999999999975  4889999997653 3345679999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +|+|.+++..  ...+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++.+........
T Consensus        87 gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          87 GGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             TEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            9999999975  56799999999999999999999998   999999999999999999999999999998754444444


Q ss_pred             cccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ....+||+.|||||++.+..+ +.++||||+||++|||+||++||......... ...+    .......         .
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~----~~~~~~~---------~  227 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW----KEKKTYL---------N  227 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH----HTTCTTS---------T
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH----hcCCCCC---------C
Confidence            455789999999999988876 57899999999999999999999765543211 1111    1111100         0


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .......++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            01122346778999999999999999999865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=397.72  Aligned_cols=251  Identities=24%  Similarity=0.434  Sum_probs=207.2

Q ss_pred             cccccccEEEEEEEEcc----eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          573 TLGKGGFGTVYYGRLNE----IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       573 ~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .||+|+||.||+|.+..    ..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            49999999999997642    469999997653 4456889999999999999999999999865 46899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-cccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-HVST  726 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~  726 (878)
                      |.+++.. .+..+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus        95 L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (285)
T d1u59a_          95 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  170 (285)
T ss_dssp             HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             HHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence            9999864 245799999999999999999999998   9999999999999999999999999999877543322 2223


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.       ...+.++...         ..+
T Consensus       171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-------~~~i~~~~~~---------~~p  234 (285)
T d1u59a_         171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKRM---------ECP  234 (285)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTCCC---------CCC
T ss_pred             ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCC---------CCC
Confidence            4568999999999999999999999999999999998 8999987664331       1222333211         122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      ..+..++.+++.+||+.+|++||+|.+|++.|+.+...-
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            233457889999999999999999999999999876543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-46  Score=401.10  Aligned_cols=249  Identities=26%  Similarity=0.449  Sum_probs=203.4

Q ss_pred             ccccccccEEEEEEEEcc----eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          572 RTLGKGGFGTVYYGRLNE----IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.||+|+||+||+|.+.+    +.||||+++..  +....++|.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643    57999999753  33445789999999999999999999999965 467899999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC-cc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT-HV  724 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~  724 (878)
                      |+|.++++.  ...+++..++.++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus        92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            999999976  56799999999999999999999998   9999999999999999999999999999876543322 22


Q ss_pred             cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          725 STVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      .....||+.|+|||.+.+..++.++|||||||++|||+| |++||......+.       ...+.++...         .
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-------~~~i~~~~~~---------~  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGERM---------G  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCC---------C
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-------HHHHHcCCCC---------C
Confidence            334568999999999999999999999999999999998 8999987665431       1222233211         1


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .+..+..++.+++.+||+.+|++|||+++|++.|+....
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            222334578899999999999999999999999988653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-46  Score=400.68  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=201.3

Q ss_pred             hhcccccccccEEEEEEEEcc------eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      .+.++||+|+||.||+|++.+      ..||||++... ......+|.+|++++++++|||||+++|+|.+.+..++|||
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e   89 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE   89 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence            456899999999999998753      36999999754 33445689999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+.+|++.+++.. ....+++.+++.++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus        90 ~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          90 YMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             CCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             ecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            9999999998764 345799999999999999999999998   999999999999999999999999999987643322


Q ss_pred             -CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          722 -THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPA-ISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       722 -~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                       ........||+.|||||++.+..++.++|||||||++|||++|+.| +......+   +.+    .+..+.        
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~---~~~----~i~~~~--------  230 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMK----AINDGF--------  230 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH----HHHTTC--------
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH---HHH----HHhccC--------
Confidence             2223345689999999999999999999999999999999996555 44433322   111    122221        


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                       ....+..+..++.+++.+||+.+|++||+|+||++.|+++++.
T Consensus       231 -~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         231 -RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence             1122233445788999999999999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-46  Score=394.10  Aligned_cols=242  Identities=29%  Similarity=0.418  Sum_probs=204.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||+||+|+..  ++.||+|++.+..   ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            456789999999999999986  3789999987532   23356789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus        88 ~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---  159 (263)
T d2j4za1          88 APLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  159 (263)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred             cCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence            999999999976  45799999999999999999999998   9999999999999999999999999999765322   


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                       ......||+.|||||++.+..++.++|||||||++|||++|+.||...+..+..       ..+.++..      .+  
T Consensus       160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~------~~--  223 (263)
T d2j4za1         160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRVEF------TF--  223 (263)
T ss_dssp             -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCC------CC--
T ss_pred             -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC------CC--
Confidence             223457999999999999999999999999999999999999999876654321       11222221      11  


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        +.....++.+++.+||+.||++|||++|+++
T Consensus       224 --p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 --PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              1122346789999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=409.28  Aligned_cols=253  Identities=28%  Similarity=0.451  Sum_probs=207.2

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      .+.+.||+|+||+||+|+..+       ..||||++... .......|.+|+.+|.++ +|||||+++++|.+.+..++|
T Consensus        40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv  119 (325)
T d1rjba_          40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI  119 (325)
T ss_dssp             EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence            567899999999999998743       36999998754 334567899999999999 899999999999999999999


Q ss_pred             eeeccCCChhhhhcccc---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEE
Q 002809          640 YEFMANGNLQEYLSDIS---------------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNIL  698 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NIL  698 (878)
                      |||+++|+|.++|+...                     ...+++..++.++.||++||+|||++   +||||||||+|||
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nil  196 (325)
T d1rjba_         120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVL  196 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEE
T ss_pred             EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccc
Confidence            99999999999997532                     13589999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 002809          699 LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKI  777 (878)
Q Consensus       699 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  777 (878)
                      ++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |++||........ 
T Consensus       197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~-  275 (325)
T d1rjba_         197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-  275 (325)
T ss_dssp             EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred             cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999987755544444445678999999999999999999999999999999998 8999987554321 


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                       +.    ..+..+.         ..+.+.....++.+|+.+||+.+|++||||+||+++|..
T Consensus       276 -~~----~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         276 -FY----KLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             -HH----HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HH----HHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence             11    1222221         111222334578899999999999999999999999964

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=391.03  Aligned_cols=249  Identities=29%  Similarity=0.506  Sum_probs=209.5

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  647 (878)
                      .|.+.||+|+||.||+|++.+ ..||||+++.... ..++|++|++++.+++||||++++|+|.+++..++||||+++|+
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence            456899999999999999976 7899999986543 34789999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++... ...+++..+++++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++.+..... .....
T Consensus        86 l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~  160 (258)
T d1k2pa_          86 LLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVG  160 (258)
T ss_dssp             HHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCC
T ss_pred             HHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeecc
Confidence            99997653 45689999999999999999999998   999999999999999999999999999987644322 23334


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..+.       ...+.++..  .       ..+.
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~~~--~-------~~p~  224 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLR--L-------YRPH  224 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTCC--C-------CCCT
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhCCC--C-------CCcc
Confidence            568999999999999999999999999999999998 8999988775432       122222211  1       1112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSE  839 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~  839 (878)
                      ....++.+++.+||+.+|++|||+++|++.|.+
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            233478899999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-45  Score=394.45  Aligned_cols=246  Identities=21%  Similarity=0.363  Sum_probs=205.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      |.+.+.||+|+||+||+|+..  ++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            345678999999999999865  588999999866555567899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++.+   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+++.+....  ...
T Consensus       102 g~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~  173 (293)
T d1yhwa1         102 GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR  173 (293)
T ss_dssp             CBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCB
T ss_pred             CcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc--ccc
Confidence            999998764   4699999999999999999999998   99999999999999999999999999998764332  223


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ....||+.|+|||++.+..++.++|||||||++|||+||++||...+.....      ......+.. ..       ..+
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~~~~~~~~-~~-------~~~  239 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTP-EL-------QNP  239 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHCSC-CC-------SSG
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH------HHHHhCCCC-CC-------CCc
Confidence            4467999999999999999999999999999999999999999876643321      111122211 11       111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ......+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222346789999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=393.08  Aligned_cols=250  Identities=29%  Similarity=0.464  Sum_probs=202.6

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC-CCcceeEeeeccCCC
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-DNQTALIYEFMANGN  647 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~~gs  647 (878)
                      .+.+.||+|+||.||+|+++++.||||+++...  ..+.|.+|++++++++||||++++|+|.+ .+..++||||+++|+
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            466889999999999999999999999997643  34789999999999999999999999854 566899999999999


Q ss_pred             hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccccc
Q 002809          648 LQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVSTV  727 (878)
Q Consensus       648 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  727 (878)
                      |.+++.......+++..+++++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....     ...
T Consensus        88 L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~  159 (262)
T d1byga_          88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT  159 (262)
T ss_dssp             HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-----Ccc
Confidence            99999765556799999999999999999999998   9999999999999999999999999999865322     223


Q ss_pred             ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccccCH
Q 002809          728 VAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFDA  806 (878)
Q Consensus       728 ~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~~  806 (878)
                      ..++..|+|||++.+..++.++|||||||++|||+| |++|+......+   +..+    +.++...         ..+.
T Consensus       160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~~~---------~~~~  223 (262)
T d1byga_         160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM---------DAPD  223 (262)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTCCC---------CCCT
T ss_pred             ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCC---------CCCc
Confidence            457899999999999999999999999999999998 688887665433   2222    2222111         1222


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          807 NSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       807 ~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      ....++.+++.+||+.||++||||++|+++|+++...|
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence            23357889999999999999999999999999987654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=392.91  Aligned_cols=250  Identities=23%  Similarity=0.385  Sum_probs=193.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC--CCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--DNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~E  641 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++...  .....+.+.+|+++|++++|||||++++++.+  ++..++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            345689999999999999875  478999998764  34456779999999999999999999998854  456899999


Q ss_pred             eccCCChhhhhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          642 FMANGNLQEYLSDIS--KKVLSSQERLRIAVESAQGLEYLHNGC--KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       642 y~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      |+++|+|.+++....  +..+++..++.++.|++.||+|||++.  ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  165 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence            999999999986532  567999999999999999999999862  1259999999999999999999999999998764


Q ss_pred             cCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ...  .......||+.|||||++.+..++.++|||||||++|||+||++||...+..+.       ...+.++....   
T Consensus       166 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------~~~i~~~~~~~---  233 (269)
T d2java1         166 HDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKFRR---  233 (269)
T ss_dssp             ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCCCC---
T ss_pred             cCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCCC---
Confidence            322  223346799999999999999999999999999999999999999987665431       12223333221   


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        +.    .....++.+++.+||+.||++|||++|+++
T Consensus       234 --~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 --IP----YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CC----cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              11    122346889999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=394.53  Aligned_cols=248  Identities=25%  Similarity=0.420  Sum_probs=205.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++........+.|.+|+++|++++|||||++++++.+++..++||||+++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            345678999999999999975  478999999887777778999999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++.+. ...+++.++..++.||++||.|||++   +|+||||||+|||++.++++||+|||+++.....  ....
T Consensus        94 g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~  167 (288)
T d2jfla1          94 GAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR  167 (288)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHH
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC--cccc
Confidence            9999997652 45699999999999999999999998   9999999999999999999999999999765321  1122


Q ss_pred             ccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          726 TVVAGTPGYLDPEYYT-----SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ....||+.|+|||++.     ...++.++|||||||++|||+||+.||...+..+..      .. +..+....+     
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~-i~~~~~~~~-----  235 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LK-IAKSEPPTL-----  235 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HH-HHHSCCCCC-----
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HH-HHcCCCCCC-----
Confidence            3467999999999984     456899999999999999999999999876654321      11 111221111     


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        ..+.....++.+++.+||+.||++|||++|+++
T Consensus       236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              111223347789999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=397.24  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=201.3

Q ss_pred             hhhcccccccccEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccCC
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMANG  646 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  646 (878)
                      +.+.+.||+|+||.||+|++.+ ..||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||||+++|
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g   96 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG   96 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred             EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence            4677899999999999999977 789999997553 335789999999999999999999999855 5689999999999


Q ss_pred             ChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcccc
Q 002809          647 NLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVST  726 (878)
Q Consensus       647 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  726 (878)
                      +|.+++.......++|.+++.++.||++||+|||++   +|+||||||+|||++.++++||+|||+++.+.... .....
T Consensus        97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~  172 (285)
T d1fmka3          97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQ  172 (285)
T ss_dssp             BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC-ceeec
Confidence            999999876666799999999999999999999998   99999999999999999999999999998764332 22333


Q ss_pred             cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHHHHhcCCcccccCCccccccC
Q 002809          727 VVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAI-SRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQEDFD  805 (878)
Q Consensus       727 ~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~-~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~~~  805 (878)
                      ...||+.|+|||++.+..++.++|||||||++|||+||+.|+ ......+   +..++    ..+.         ....+
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~---~~~~i----~~~~---------~~~~~  236 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQV----ERGY---------RMPCP  236 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTTC---------CCCCC
T ss_pred             cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHH----HhcC---------CCCCC
Confidence            456899999999999999999999999999999999966554 4433322   12222    1111         11122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          806 ANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       806 ~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                      ..+..++.+++.+||+.+|++||+|++|+++|++..
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            233457889999999999999999999999988754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-45  Score=387.52  Aligned_cols=245  Identities=28%  Similarity=0.505  Sum_probs=197.2

Q ss_pred             hhcccccccccEEEEEEEEcc--eeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC----CCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE--IDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE----DNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV~  640 (878)
                      .|++.||+|+||+||+|+...  ..||+|++...  .....+.|.+|+++|++++|||||++++++..    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            466789999999999999864  78999998754  34456789999999999999999999999853    45678999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc-CCCcEEEeecCCccccccC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN-EKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~  719 (878)
                      ||+++|+|.+++.+  ...+++..++.++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++.....
T Consensus        92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            99999999999976  46799999999999999999999987 22399999999999996 5789999999999764322


Q ss_pred             CCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                          ......||+.|||||++.+ .++.++|||||||++|||++|+.||........  +    ...+..+.....    
T Consensus       169 ----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~----~~~i~~~~~~~~----  233 (270)
T d1t4ha_         169 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVKPAS----  233 (270)
T ss_dssp             ----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCCCGG----
T ss_pred             ----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H----HHHHHcCCCCcc----
Confidence                2234679999999999875 599999999999999999999999976543321  1    112222211111    


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                          .+.....++.+++.+||+.+|++|||++|+++
T Consensus       234 ----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 ----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                11122335789999999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=395.62  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=203.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++....   ....+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            456789999999999999875  4889999987532   23456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+......
T Consensus        90 ~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          90 AKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            999999999876  56799999999999999999999998   9999999999999999999999999999887544444


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....       ...+..+..      .+. 
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~------~~p-  230 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-------FQKIIKLEY------DFP-  230 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTCC------CCC-
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-------HHHHHcCCC------CCC-
Confidence            344456799999999999999999999999999999999999999987654331       111222221      111 


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                         .....++.+++.+||+.||++|||++|+++.
T Consensus       231 ---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         231 ---EKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence               1223467899999999999999999998653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-44  Score=393.23  Aligned_cols=254  Identities=32%  Similarity=0.500  Sum_probs=210.2

Q ss_pred             hhcccccccccEEEEEEEEcc-------eeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||+||+|+..+       +.||||++.... ....++|.+|+++|++++||||++++++|...+..++||
T Consensus        16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~   95 (301)
T d1lufa_          16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF   95 (301)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence            456889999999999998743       679999997654 334678999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhcccc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEE
Q 002809          641 EFMANGNLQEYLSDIS----------------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNIL  698 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NIL  698 (878)
                      ||+++|+|.++++...                      ...+++..++.|+.|++.||+|||+.   +||||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence            9999999999996422                      23489999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHHH
Q 002809          699 LNEKLQAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKI  777 (878)
Q Consensus       699 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~  777 (878)
                      ++.++.+||+|||+++.+.............|++.|+|||.+.+..++.++|||||||++|||++|. +||......+..
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~  252 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI  252 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH
Confidence            9999999999999998765544444445567899999999999999999999999999999999986 678776554321


Q ss_pred             HHHHHHHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 002809          778 HIRQWVNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECL  841 (878)
Q Consensus       778 ~l~~~v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~  841 (878)
                             ..+.++....         .+...+.++.+|+.+||+.+|++||||.||+++|++++
T Consensus       253 -------~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         253 -------YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             -------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -------HHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                   1233333221         12223347889999999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=387.56  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=201.4

Q ss_pred             hhhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||.||+|++..     ..||||.+... .....+.|.+|++++++++|||||++++++. ++..++|||
T Consensus         9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E   87 (273)
T d1mp8a_           9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME   87 (273)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence            3567899999999999998743     45889988754 3445678999999999999999999999996 467899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.+++.. ....+++..++.++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        88 ~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~-  162 (273)
T d1mp8a_          88 LCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-  162 (273)
T ss_dssp             CCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             eccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc-
Confidence            9999999998764 345689999999999999999999998   99999999999999999999999999998764322 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRL  800 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l  800 (878)
                      ........||+.|+|||++.+..++.++|||||||++|||+| |++||......+.   .    ..+..+...       
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~----~~i~~~~~~-------  228 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I----GRIENGERL-------  228 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCCC-------
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCCCC-------
Confidence            223334568999999999999999999999999999999998 8999987765432   1    112222211       


Q ss_pred             ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          801 QEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       801 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                        ..+.....++.+++.+||+.+|++|||++||++.|+++++.+.+
T Consensus       229 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~  272 (273)
T d1mp8a_         229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  272 (273)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhC
Confidence              11223345788999999999999999999999999999887764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=391.82  Aligned_cols=258  Identities=29%  Similarity=0.451  Sum_probs=200.9

Q ss_pred             hhhcccccccccEEEEEEEEcc-------eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCC-Ccce
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE-------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDED-NQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-~~~~  637 (878)
                      +.+.+.||+|+||.||+|+..+       +.||||+++.. .....+.+.+|+..+.++ +|+||+.+++++.+. ...+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~   94 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   94 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence            3567899999999999998632       57999999754 344567888999988888 689999999987654 5689


Q ss_pred             eEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          638 LIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      +||||+++|+|.++++...              ...+++..++.++.||++||+|||++   +|+||||||+|||+++++
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCC
Confidence            9999999999999996532              24589999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQW  782 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~  782 (878)
                      ++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||. +||......+.      
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~------  245 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------  245 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH------
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH------
Confidence            99999999998765444444444567999999999999999999999999999999999975 67766543221      


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                      +...+.++....         .+.....++.+++.+||+.||++|||++||+++|++++++
T Consensus       246 ~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         246 FCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            122223332111         1122334688999999999999999999999999999865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=394.82  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=205.3

Q ss_pred             hhhcccccccccEEEEEEEEcc------eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          568 NNFERTLGKGGFGTVYYGRLNE------IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      +.+.+.||+|+||+||+|++..      .+||+|++... +.+..++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            3556899999999999998743      25899998754 344568899999999999999999999999865 567889


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+.+|+|.+++.. ....+++..+++++.|||+||+|||++   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        90 e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          90 QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             ECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            99999999998875 356799999999999999999999998   99999999999999999999999999998875544


Q ss_pred             CCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          721 NTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       721 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .........||+.|+|||++.+..++.++|||||||++|||+| |++||......+..       ..+..+..       
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-------~~i~~~~~-------  231 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER-------  231 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-------HHHHHTCC-------
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCC-------
Confidence            4444444568999999999999999999999999999999999 78999876654321       12222211       


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                        ...+..+..++.+++.+||+.+|++|||++||++.|+.+...
T Consensus       232 --~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         232 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             --CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence              111223345788999999999999999999999999987643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=395.42  Aligned_cols=263  Identities=22%  Similarity=0.348  Sum_probs=202.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      .+.+.||+|+||+||+|+..  ++.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.++++.++||||+++
T Consensus         9 ~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~g   88 (322)
T d1s9ja_           9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   88 (322)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            34578999999999999975  488999999764 334457899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      |+|.+++.+  ...+++..+..++.|+++||.|||+++  +|+||||||+|||+++++++||+|||+|+.+...    ..
T Consensus        89 g~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~  160 (322)
T d1s9ja_          89 GSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA  160 (322)
T ss_dssp             EEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC
T ss_pred             CcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC----cc
Confidence            999999976  456999999999999999999999631  7999999999999999999999999999876432    12


Q ss_pred             ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HHHHHhc--------CC--ccc
Q 002809          726 TVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQW-VNSLIAK--------GD--IKS  794 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~-v~~~~~~--------~~--~~~  794 (878)
                      ...+||+.|+|||++.+..++.++||||+||+++||++|+.||...+..+....... .......        +.  ...
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY  240 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence            345799999999999999999999999999999999999999987554321110000 0000000        00  000


Q ss_pred             ccCCcc---------------ccccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHH
Q 002809          795 IVDPRL---------------QEDFD-ANSVWKAVELAMACLSPTGNQRPTMSQVVME--LSE  839 (878)
Q Consensus       795 iid~~l---------------~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~--L~~  839 (878)
                      ..+...               ....+ .....++.+++.+||+.||++|||++|+++.  +++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            000000               00000 0112467899999999999999999999984  554

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.5e-44  Score=388.11  Aligned_cols=242  Identities=28%  Similarity=0.418  Sum_probs=199.9

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +...+.||+|+||.||+|+..  ++.||||++....   ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            445678999999999999875  4889999987643   23456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|..++..  +..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....    
T Consensus        97 ~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          97 CLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             cCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            999999877654  56799999999999999999999998   999999999999999999999999999986532    


Q ss_pred             cccccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          723 HVSTVVAGTPGYLDPEYYTS---NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                        .....||+.|||||++.+   ..++.++|||||||++|||++|+.||......+..      .... .+.......  
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~-~~~~~~~~~--  236 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA-QNESPALQS--  236 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH-HSCCCCCSC--
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-hCCCCCCCC--
Confidence              223569999999999864   46899999999999999999999999876543321      1111 122111111  


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                            ......+.+++.+||+.||++|||++|+++
T Consensus       237 ------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         237 ------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                  112346889999999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-44  Score=387.64  Aligned_cols=256  Identities=30%  Similarity=0.487  Sum_probs=209.2

Q ss_pred             hhcccccccccEEEEEEEEcc---------eeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcce
Q 002809          569 NFERTLGKGGFGTVYYGRLNE---------IDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~  637 (878)
                      .+.+.||+|+||.||+|+..+         ..||||+++... .....++.+|...+.++ +|||||+++++|.+++..+
T Consensus        16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~   95 (299)
T d1fgka_          16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY   95 (299)
T ss_dssp             EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence            456899999999999998643         469999997654 34567899999999999 7999999999999999999


Q ss_pred             eEeeeccCCChhhhhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          638 LIYEFMANGNLQEYLSDIS--------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      +||||+++|+|.+++....              ...+++.++++++.||+.||+|||+.   +||||||||+|||++.++
T Consensus        96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTC
T ss_pred             EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCC
Confidence            9999999999999997542              24689999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQW  782 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  782 (878)
                      .+||+|||+++...............|++.|+|||.+.++.++.++|||||||++|||++ |++||.......   +.  
T Consensus       173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~~--  247 (299)
T d1fgka_         173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LF--  247 (299)
T ss_dssp             CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH--
T ss_pred             CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---HH--
Confidence            999999999998765544444555678999999999999999999999999999999998 688887766543   11  


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                        ..+..+...         ..+.....++.+++.+||+.+|++|||++||++.|+++++.
T Consensus       248 --~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         248 --KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             --HHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence              222222211         11122334688999999999999999999999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-44  Score=389.41  Aligned_cols=247  Identities=23%  Similarity=0.394  Sum_probs=189.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh-hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA-QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            466789999999999999875  47899999976532 334678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc---CCCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN---EKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~  721 (878)
                      +|+|.+++..  ...+++..+..++.||+.||+|||++   +|+||||||+|||+.   +++.+||+|||+++...... 
T Consensus        91 gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          91 GGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             SCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             CCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            9999999976  56799999999999999999999998   999999999999995   57899999999998653322 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                        .....+||+.|||||++.+..++.++|||||||++|||++|++||......+..       ..+..+...      ..
T Consensus       165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~~~------~~  229 (307)
T d1a06a_         165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-------EQILKAEYE------FD  229 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHTTCCC------CC
T ss_pred             --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHhccCCC------CC
Confidence              223457999999999999999999999999999999999999999876543311       111222111      11


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .........++.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111223346789999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-44  Score=388.70  Aligned_cols=255  Identities=26%  Similarity=0.479  Sum_probs=205.5

Q ss_pred             hhcccccccccEEEEEEEEcc-----eeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccC-CCcceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-DNQTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~E  641 (878)
                      +|.++||+|+||+||+|++.+     ..||||+++.. +....++|.+|+++|++++||||++++|+|.. +...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            567899999999999998743     35899999753 55567889999999999999999999999865 567899999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.++++. ....+++..+++++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       110 ~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         110 YMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             CCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999999875 345678999999999999999999998   999999999999999999999999999987643322


Q ss_pred             C--cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCc
Q 002809          722 T--HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPR  799 (878)
Q Consensus       722 ~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~  799 (878)
                      .  .......||+.|+|||.+.+..++.++||||||+++|||+||+.||......  ..+..+    +..+..  ..   
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~----i~~g~~--~~---  254 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY----LLQGRR--LL---  254 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCC--CC---
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH----HHcCCC--CC---
Confidence            1  1223356899999999999999999999999999999999988777643321  112222    222221  11   


Q ss_pred             cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          800 LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       800 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                          .+..+..++.+++.+||+.||++||+|+||++.|++++.
T Consensus       255 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         255 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                112233468899999999999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-43  Score=391.23  Aligned_cols=249  Identities=23%  Similarity=0.364  Sum_probs=207.3

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      |.+.+.||+|+||.||+|+..  ++.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  107 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  107 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            466789999999999999875  588999999887777778899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC--CCcEEEeecCCccccccCCCCc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE--KLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      |+|.+++... ...+++..+..++.||+.||+|||++   +||||||||+|||++.  ++.+||+|||+++.+....   
T Consensus       108 g~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---  180 (350)
T d1koaa2         108 GELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---  180 (350)
T ss_dssp             CBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---
T ss_pred             CCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc---
Confidence            9999998642 45699999999999999999999998   9999999999999964  6789999999998764332   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......||+.|||||++.+..++.++|||||||++|||++|+.||...+..+..      .. +..+...  .....   
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~-i~~~~~~--~~~~~---  248 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RN-VKSCDWN--MDDSA---  248 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HHHTCCC--SCCGG---
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH------HH-HHhCCCC--CCccc---
Confidence            234467999999999999999999999999999999999999999876554321      11 1111110  01111   


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                       .......+.+++.+||+.||++|||++|+++.
T Consensus       249 -~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         249 -FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11223467899999999999999999999873

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=388.86  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=212.1

Q ss_pred             hhcccccccccEEEEEEEEc-------ceeEEEEEeccCC-hhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeE
Q 002809          569 NFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      .+.+.||+|+||.||+|++.       ++.||||+++... ......|.+|+.++.++ +|||||+++++|.++...++|
T Consensus        26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lv  105 (311)
T d1t46a_          26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI  105 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEE
Confidence            56789999999999999863       2679999998653 44566899999999999 699999999999999999999


Q ss_pred             eeeccCCChhhhhcccc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC
Q 002809          640 YEFMANGNLQEYLSDIS----------------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL  703 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~  703 (878)
                      |||+++|+|.++++...                ...+++..++.++.||++||+|||++   +|+||||||+|||++.++
T Consensus       106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTT
T ss_pred             EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccC
Confidence            99999999999997532                23689999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002809          704 QAKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQW  782 (878)
Q Consensus       704 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  782 (878)
                      .+|++|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |++|+......+.  +.+ 
T Consensus       183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--~~~-  259 (311)
T d1t46a_         183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--FYK-  259 (311)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--HHH-
T ss_pred             cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--HHH-
Confidence            999999999998765544445556789999999999999999999999999999999999 5666655443221  111 


Q ss_pred             HHHHHhcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 002809          783 VNSLIAKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAA  843 (878)
Q Consensus       783 v~~~~~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~  843 (878)
                         .+..+.         ....+......+.+|+.+||+.||++||||+||+++|++++..
T Consensus       260 ---~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         260 ---MIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             ---HHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence               222221         1111222334788999999999999999999999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=390.61  Aligned_cols=268  Identities=24%  Similarity=0.405  Sum_probs=204.3

Q ss_pred             hhcccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHH--HHHHHHHhcccceeeeeecccCCC----cceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQA--EVKLLMRVHHRNLTSLVGHCDEDN----QTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~--Ei~~L~~l~H~nIv~l~g~~~~~~----~~~lV~Ey  642 (878)
                      -+.+.||+|+||.||+|+++++.||||++.....   +.+..  |+..+.+++|||||+++++|..++    ..++||||
T Consensus         6 ~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           6 VLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            3567899999999999999999999999865432   33444  455556789999999999997544    57899999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGC-----KPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +++|+|.+++++   ..++|..+++++.|+|.||+|||+.+     .++|+||||||+||||+.++.+||+|||+++...
T Consensus        83 ~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          83 HEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             ccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            999999999975   46999999999999999999999732     3599999999999999999999999999998775


Q ss_pred             cCCCCc--ccccccCCCCccCccccccCC------CCCccchhhHHHHHHHHHhCCCCCCCCChHHHH--------HHHH
Q 002809          718 TDANTH--VSTVVAGTPGYLDPEYYTSNR------LTEKSDVYSFGVVILEIITCKPAISRINEEEKI--------HIRQ  781 (878)
Q Consensus       718 ~~~~~~--~~~~~~gt~~Y~APE~~~~~~------~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--------~l~~  781 (878)
                      ......  ......||+.|+|||++.+..      ++.|+|||||||++|||+||.+|+.........        ...+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            433221  233467999999999987643      577899999999999999998877543211000        0011


Q ss_pred             HHHHHHhcCCcccccCCcccccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002809          782 WVNSLIAKGDIKSIVDPRLQEDF-DANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMA  846 (878)
Q Consensus       782 ~v~~~~~~~~~~~iid~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~  846 (878)
                      ........+    ..+|.+.... ..+....+.+++.+||+.||++||||.||++.|+++.+.+..
T Consensus       240 ~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~  301 (303)
T d1vjya_         240 EMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             HHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence            112222221    1223332222 234667789999999999999999999999999998877654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=381.35  Aligned_cols=247  Identities=23%  Similarity=0.380  Sum_probs=203.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh------hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA------QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++.+...      ...+.|.+|+++|++++|||||++++++.+++..++|
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   91 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            456789999999999999975  48899999875422      2357899999999999999999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC----cEEEeecCCccc
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL----QAKLADFGLSKS  715 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~~  715 (878)
                      |||+++|+|.+++..  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||+++.
T Consensus        92 ~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          92 LELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            999999999999976  45799999999999999999999998   999999999999998876    599999999987


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..       ..+..+..   
T Consensus       167 ~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~~---  233 (293)
T d1jksa_         167 IDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANVSAVNY---  233 (293)
T ss_dssp             CTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHTTCC---
T ss_pred             cCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH-------HHHHhcCC---
Confidence            64332   223456899999999999999999999999999999999999999876654321       11112211   


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                         .+...........+.+++.+||+.||++|||++|+++
T Consensus       234 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 ---EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ---CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1111111122346789999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.6e-43  Score=388.96  Aligned_cols=248  Identities=21%  Similarity=0.339  Sum_probs=207.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            456789999999999999875  488999999877766677899999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEc--CCCcEEEeecCCccccccCCCCc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLN--EKLQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~--~~~~~kL~DFGla~~~~~~~~~~  723 (878)
                      |+|.+++.. ....+++.+++.++.||+.||+|||+.   +|+||||||+|||++  .++.+||+|||+++.+....   
T Consensus       111 g~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---  183 (352)
T d1koba_         111 GELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---  183 (352)
T ss_dssp             CBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred             ChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC---
Confidence            999988764 245699999999999999999999998   999999999999998  57899999999998775432   


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......||+.|+|||++.+..++.++||||+||++|||+||++||......+..       ..+..+...      +...
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~~~------~~~~  250 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRCDWE------FDED  250 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHHCCCC------CCSS
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC------CCcc
Confidence            234467999999999999999999999999999999999999999876654321       111222211      1111


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .......++.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11222346789999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-44  Score=381.92  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=196.5

Q ss_pred             hhcccccccccEEEEEEEEcc-----eeEEEEEeccC---ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-----IDVAVKMLSSS---SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|++..     ..||||++...   ..+..++|.+|+++|++++||||++++|+|.+ ...++||
T Consensus        11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~   89 (273)
T d1u46a_          11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT   89 (273)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence            456789999999999998642     46999998754   33456789999999999999999999999976 4678999


Q ss_pred             eeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCC
Q 002809          641 EFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDA  720 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~  720 (878)
                      ||+++|+|.+++... ...+++..++.++.|||+||.|||++   +|+||||||+|||++.++++||+|||+++.+....
T Consensus        90 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          90 ELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             ECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             eeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            999999999988653 45699999999999999999999998   99999999999999999999999999999875443


Q ss_pred             CCc-ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          721 NTH-VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIIT-CKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       721 ~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      ... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+..+.   .   ......+...     
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~---~~i~~~~~~~-----  234 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---L---HKIDKEGERL-----  234 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H---HHHHTSCCCC-----
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---H---HHHHhCCCCC-----
Confidence            322 2234557889999999999999999999999999999998 8999987765432   1   1122222111     


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSEC  840 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~  840 (878)
                          ..+......+.+++.+||+.+|++||||+||++.|+++
T Consensus       235 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 ----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                11122234688999999999999999999999998874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=386.07  Aligned_cols=252  Identities=29%  Similarity=0.506  Sum_probs=204.0

Q ss_pred             hhcccccccccEEEEEEEEcc----eeEEEEEeccC-ChhhHHHHHHHHHHHHHh-cccceeeeeecccCCCcceeEeee
Q 002809          569 NFERTLGKGGFGTVYYGRLNE----IDVAVKMLSSS-SAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      .+.+.||+|+||.||+|++.+    ..||||++... .....+.|.+|+++|.++ +|||||+++++|.+++..++||||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence            457899999999999998854    35888888654 334567899999999999 799999999999999999999999


Q ss_pred             ccCCChhhhhccc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEe
Q 002809          643 MANGNLQEYLSDI--------------SKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLA  708 (878)
Q Consensus       643 ~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~  708 (878)
                      +++|+|.++++..              ....+++..+++++.|||+||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence            9999999999753              246799999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHHHHH
Q 002809          709 DFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWVNSLI  787 (878)
Q Consensus       709 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~v~~~~  787 (878)
                      |||+++.......   .....||..|+|||.+.+..++.++|||||||++|||++|. +||...+..+   +.    ..+
T Consensus       170 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~----~~i  239 (309)
T d1fvra_         170 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY----EKL  239 (309)
T ss_dssp             CTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----HHG
T ss_pred             ccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH----HHH
Confidence            9999976533221   22346899999999999999999999999999999999976 5676655433   11    122


Q ss_pred             hcCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 002809          788 AKGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLA  842 (878)
Q Consensus       788 ~~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~  842 (878)
                      .++..     +    ..+.....++.+++.+||+.+|++||||+||++.|+++++
T Consensus       240 ~~~~~-----~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         240 PQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             GGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCC-----C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            22211     1    1122334578899999999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-43  Score=381.96  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=212.8

Q ss_pred             hhcccccccccEEEEEEEEc-------ceeEEEEEeccC-ChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEe
Q 002809          569 NFERTLGKGGFGTVYYGRLN-------EIDVAVKMLSSS-SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIY  640 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~  640 (878)
                      .+.+.||+|+||.||+|++.       ++.||||+++.. ..+....|.+|++++++++|||||+++++|..++..++||
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence            45688999999999999874       367999999754 3445567999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCC
Q 002809          641 EFMANGNLQEYLSDIS--------KKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGL  712 (878)
Q Consensus       641 Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGl  712 (878)
                      ||+++|+|.+++....        ...+++..+.+++.|+|+||.|||++   +|+||||||+|||+++++++||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence            9999999999986532        23578999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHHHHHhcCC
Q 002809          713 SKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCK-PAISRINEEEKIHIRQWVNSLIAKGD  791 (878)
Q Consensus       713 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~v~~~~~~~~  791 (878)
                      ++.+.............||+.|+|||.+.+..++.++|||||||++|||+||+ +||...+..+..      . .+.++.
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------~-~i~~~~  252 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------R-FVMEGG  252 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------H-HHHTTC
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------H-HHHhCC
Confidence            98775544444445557899999999999999999999999999999999985 777766554321      1 122222


Q ss_pred             cccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002809          792 IKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAE  844 (878)
Q Consensus       792 ~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e  844 (878)
                      ...         .+......+.+++.+||+.+|++||||+||++.|++.++..
T Consensus       253 ~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         253 LLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             CCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            111         11223347889999999999999999999999998876544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=381.77  Aligned_cols=244  Identities=27%  Similarity=0.382  Sum_probs=204.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+++..  ++.||||++.+..   ....+.+.+|+.+|++++||||+++++++.+++..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            356789999999999999975  4889999997542   23457789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|.+++..  ...+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++......  
T Consensus        87 ~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--  159 (337)
T d1o6la_          87 ANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             CTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             cCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence            999999999876  56789999999999999999999999   99999999999999999999999999998653322  


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                      ......+||+.|+|||++.+..++.++||||+||++|||++|++||...+..+..       ..+..+.+      .+. 
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~i~~~~~------~~p-  225 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEEI------RFP-  225 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CCC-
T ss_pred             cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-------HHHhcCCC------CCC-
Confidence            2234467999999999999999999999999999999999999999887654321       11222221      111 


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRPT-----MSQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~  835 (878)
                         .....++.+++.+||+.||++||+     ++|+++
T Consensus       226 ---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         226 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               122346789999999999999995     778876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-42  Score=371.96  Aligned_cols=256  Identities=22%  Similarity=0.382  Sum_probs=201.0

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCC----ccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN----QTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----~~~l  638 (878)
                      |.+.+.||+|+||.||+|+..  ++.||||+++...   ....+.|.+|++++++++||||+++++++...+    ..++
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            456789999999999999875  5899999997542   344568999999999999999999999986544    3789


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+++|+|.+++..  ...+++.+++.++.||++||+|||++   +|+||||||+|||++.++..+++|||.++....
T Consensus        89 vmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence            9999999999998875  55799999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCC-CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccC
Q 002809          719 DAN-THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVD  797 (878)
Q Consensus       719 ~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid  797 (878)
                      ... ........||+.|+|||++.+..++.++|||||||++|||+||++||...+..+.      ....+..+....   
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~~~---  234 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPP---  234 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCG---
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCCCC---
Confidence            222 2233446799999999999999999999999999999999999999987665432      122222222110   


Q ss_pred             CccccccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHH
Q 002809          798 PRLQEDFDANSVWKAVELAMACLSPTGNQRP-TMSQVVMELSECL  841 (878)
Q Consensus       798 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~evl~~L~~~~  841 (878)
                          .........++.+++.+||+.||++|| |++++++.|.++.
T Consensus       235 ----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 ----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                011112234678999999999999999 8999999988753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-42  Score=376.92  Aligned_cols=242  Identities=25%  Similarity=0.356  Sum_probs=203.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++.+..   ....+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            356789999999999999975  4889999997532   23457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +++|+|..++..  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus        86 ~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          86 IEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             cCCccccccccc--cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            999999999876  66789999999999999999999998   9999999999999999999999999999876432   


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                        ....+||+.|||||++.+..++.++|||||||++|||+||+.||...+..+..       ..+..+..      .+  
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~~------~~--  220 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------EKILNAEL------RF--  220 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHCCC------CC--
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-------HHHHcCCC------CC--
Confidence              23467999999999999999999999999999999999999999876654321       11222221      11  


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVME  836 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~~  836 (878)
                        +.....++.+++.+||+.+|.+||     +++|++++
T Consensus       221 --p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         221 --PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              111224678999999999999996     89999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.7e-42  Score=366.47  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=202.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCCh---------hhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---------QGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQT  636 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---------~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~  636 (878)
                      .+.+.||+|+||+||+|+..  ++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.+++..
T Consensus         6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~   85 (277)
T d1phka_           6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   85 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence            45689999999999999974  48999999875432         12346889999999997 99999999999999999


Q ss_pred             eeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      ++||||+++|+|.++++.  +..+++.+++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEc
Confidence            999999999999999976  55799999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCCcccccccCCCCccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC
Q 002809          717 ATDANTHVSTVVAGTPGYLDPEYYTS------NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG  790 (878)
Q Consensus       717 ~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  790 (878)
                      ....   ......||..|+|||.+.+      ..++.++||||+||+++||++|+.||.........       ..+.++
T Consensus       161 ~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~i~~~  230 (277)
T d1phka_         161 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMIMSG  230 (277)
T ss_dssp             CTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHT
T ss_pred             cCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HHHHhC
Confidence            4332   2334679999999999863      35788999999999999999999999887654321       122222


Q ss_pred             CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          791 DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       791 ~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ...      ...........++.+++.+||+.+|++|||++||++
T Consensus       231 ~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         231 NYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            211      111111123347889999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-42  Score=370.56  Aligned_cols=254  Identities=24%  Similarity=0.306  Sum_probs=195.5

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChh-----hHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQ-----GFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-----~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ++||+|+||+||+|+..  ++.||||++......     ..+.+.+|+++|++++|||||++++++..++..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            57999999999999875  478999998754322     23568999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      ++++..+...  +..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        84 ~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~  156 (299)
T d1ua2a_          84 TDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A  156 (299)
T ss_dssp             EEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred             chHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence            8887777654  56789999999999999999999998   999999999999999999999999999987643322  2


Q ss_pred             cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc---cC---
Q 002809          725 STVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI---VD---  797 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i---id---  797 (878)
                      .....||+.|+|||++... .++.++|||||||++|||+||++||......+....   +............   ..   
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSSTTSSTT
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhccchhccch
Confidence            2345699999999998654 579999999999999999999999987765442211   1111111110000   00   


Q ss_pred             Cc-c--ccccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 PR-L--QEDFD-----ANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 ~~-l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .. .  ....+     .....++.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00 0  00011     122347889999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-42  Score=376.17  Aligned_cols=244  Identities=23%  Similarity=0.300  Sum_probs=194.2

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHh-cccceeeeeecccC----CCcceeEeeecc
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRV-HHRNLTSLVGHCDE----DNQTALIYEFMA  644 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~----~~~~~lV~Ey~~  644 (878)
                      +.||+|+||.||+|+..  ++.||||+++..     ..+.+|++++.++ +|||||++++++..    +...++|||||+
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~   92 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   92 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence            57999999999999874  488999998653     5678899987665 89999999998854    467899999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~~  721 (878)
                      +|+|.+++.......+++.++..++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++...... 
T Consensus        93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-  168 (335)
T d2ozaa1          93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-  168 (335)
T ss_dssp             SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-
T ss_pred             CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC-
Confidence            99999999875556799999999999999999999998   9999999999999985   5579999999998764332 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                        ......||+.|+|||++.+..++.++|||||||++|||+||++||...+......   .....+..+.      ..+.
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~------~~~~  237 (335)
T d2ozaa1         169 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ------YEFP  237 (335)
T ss_dssp             --CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS------SSCC
T ss_pred             --ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCC------CCCC
Confidence              2334679999999999999999999999999999999999999997654322110   0111111110      0111


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .........++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111223457889999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-42  Score=374.05  Aligned_cols=244  Identities=24%  Similarity=0.361  Sum_probs=201.5

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHH-HhcccceeeeeecccCCCcceeEee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLM-RVHHRNLTSLVGHCDEDNQTALIYE  641 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~-~l~H~nIv~l~g~~~~~~~~~lV~E  641 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++++..   ....+.+..|..++. .++|||||++++++.+++..++|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            356789999999999999985  4889999997532   233456777877765 6899999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+++|+|.++++.  ...+++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...... 
T Consensus        84 y~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          84 YLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             ecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence            9999999999976  55689999999999999999999998   99999999999999999999999999998654322 


Q ss_pred             CcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccc
Q 002809          722 THVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQ  801 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~  801 (878)
                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.....       ..+..+.      +.+.
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~------~~~p  223 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMDN------PFYP  223 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC------CCCC
T ss_pred             -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC------CCCC
Confidence             2234467999999999999999999999999999999999999999876654321       1222222      1111


Q ss_pred             cccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002809          802 EDFDANSVWKAVELAMACLSPTGNQRPTMS-QVVM  835 (878)
Q Consensus       802 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~-evl~  835 (878)
                          .....++.+++.+||+.+|++||++. |+++
T Consensus       224 ----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         224 ----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                12234678999999999999999996 6754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-41  Score=370.48  Aligned_cols=247  Identities=18%  Similarity=0.307  Sum_probs=202.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      |.+.+.||+|+||+||+|+..  ++.||||++...... ...+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            356789999999999999875  478999999765433 45688999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC--CcEEEeecCCccccccCCCCc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK--LQAKLADFGLSKSFATDANTH  723 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~--~~~kL~DFGla~~~~~~~~~~  723 (878)
                      |+|.+++... +..+++.++..++.||++||+|||+.   +|+||||||+|||++.+  ..+||+|||+++.....   .
T Consensus        86 g~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~  158 (321)
T d1tkia_          86 LDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---D  158 (321)
T ss_dssp             CBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---C
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC---C
Confidence            9999999752 34699999999999999999999998   99999999999999854  58999999999876332   2


Q ss_pred             ccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCccccc
Q 002809          724 VSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQED  803 (878)
Q Consensus       724 ~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~~  803 (878)
                      ......|++.|+|||.+.+..++.++||||+||++|||++|+.||...+..+..      .. +..+...  ++....  
T Consensus       159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~------~~-i~~~~~~--~~~~~~--  227 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------EN-IMNAEYT--FDEEAF--  227 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HH-HHHTCCC--CCHHHH--
T ss_pred             cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhCCCC--CChhhc--
Confidence            233456899999999999999999999999999999999999999877654321      11 1112110  010001  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          804 FDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       804 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                        .....++.+++.+||+.||++|||++|+++
T Consensus       228 --~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         228 --KEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              112346789999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-41  Score=375.27  Aligned_cols=241  Identities=22%  Similarity=0.305  Sum_probs=202.2

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCC---hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS---AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++....   ....+.+.+|+++|++++|||||++++++......++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            345679999999999999875  5889999987432   23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANT  722 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~  722 (878)
                      +.+|+|.+++..  ...+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+++.+...   
T Consensus       123 ~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         123 VAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             CTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             ccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            999999999976  45799999999999999999999998   9999999999999999999999999999876422   


Q ss_pred             cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCCcccc
Q 002809          723 HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDPRLQE  802 (878)
Q Consensus       723 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~~l~~  802 (878)
                        .....||+.|||||++.+..++.++|||||||++|||+||++||...+....       ...+..+..      ..  
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~------~~--  257 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------YEKIVSGKV------RF--  257 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC------CC--
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-------HHHHhcCCC------CC--
Confidence              2345799999999999999999999999999999999999999987654331       111222221      11  


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002809          803 DFDANSVWKAVELAMACLSPTGNQRP-----TMSQVVM  835 (878)
Q Consensus       803 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~evl~  835 (878)
                        +.....++.+++.+||+.||.+|+     +++|+++
T Consensus       258 --p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 --PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              112234678999999999999994     8999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.9e-41  Score=375.44  Aligned_cols=245  Identities=24%  Similarity=0.337  Sum_probs=194.9

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh---hhHHHHHH---HHHHHHHhcccceeeeeecccCCCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA---QGFQQFQA---EVKLLMRVHHRNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~f~~---Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.+...   .....+.+   |+++++.++|||||++++++...+..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            345689999999999999985  48899999864321   12233444   46667777899999999999999999999


Q ss_pred             eeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccC
Q 002809          640 YEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATD  719 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~  719 (878)
                      |||+++|+|.+++..  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        86 mE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             ECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            999999999999976  56789999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccccCC
Q 002809          720 ANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSIVDP  798 (878)
Q Consensus       720 ~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~iid~  798 (878)
                      .    .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..........+    ........      .
T Consensus       161 ~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~~------~  226 (364)
T d1omwa3         161 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMA------V  226 (364)
T ss_dssp             C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSSCC------C
T ss_pred             c----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccCC------C
Confidence            2    234579999999999874 5689999999999999999999999987554332111    11111111      1


Q ss_pred             ccccccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002809          799 RLQEDFDANSVWKAVELAMACLSPTGNQRPT-----MSQVVM  835 (878)
Q Consensus       799 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~  835 (878)
                      .+.    .....++.+++.+||+.||++||+     ++|+++
T Consensus       227 ~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 ELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCC----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCC----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            111    122346789999999999999999     578775

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=359.90  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=197.6

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      .+.+.||+|+||+||+|+..  ++.||||+++...  ....+++.+|+++|++++|||||++++++.+++..++||||+.
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~   84 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence            34578999999999999875  4889999996543  2335789999999999999999999999999999999999996


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      + ++.+++.......+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||+++......  ..
T Consensus        85 ~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~  158 (298)
T d1gz8a_          85 Q-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT  158 (298)
T ss_dssp             E-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BC
T ss_pred             C-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc--cc
Confidence            5 555555544567799999999999999999999998   99999999999999999999999999998764322  22


Q ss_pred             cccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHh--cCCccccc-CCcc
Q 002809          725 STVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIA--KGDIKSIV-DPRL  800 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~--~~~~~~ii-d~~l  800 (878)
                      .....||+.|+|||.+.... ++.++||||+||++|||++|+.||...+..+...  ........  +....... .+..
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhcccccccccc
Confidence            33457999999999987665 5789999999999999999999998776543221  11111000  00000000 0000


Q ss_pred             ccc------c-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          801 QED------F-----DANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       801 ~~~------~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ...      .     ......++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            000      0     0112346789999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-40  Score=357.08  Aligned_cols=257  Identities=22%  Similarity=0.318  Sum_probs=198.1

Q ss_pred             hhcccccccccEEEEEEEEcc-eeEEEEEeccCCh--hhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeeccC
Q 002809          569 NFERTLGKGGFGTVYYGRLNE-IDVAVKMLSSSSA--QGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMAN  645 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  645 (878)
                      ...+.||+|+||+||+|+... +.||||++.....  ...+.+.+|+.+|++++||||+++++++..++..++++||+.+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence            345789999999999998865 8899999976532  2357899999999999999999999999999999999999988


Q ss_pred             CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCccc
Q 002809          646 GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHVS  725 (878)
Q Consensus       646 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  725 (878)
                      +.+..+...  ...+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+|++|||++........  ..
T Consensus        85 ~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  157 (286)
T d1ob3a_          85 DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KY  157 (286)
T ss_dssp             EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             hhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc--cc
Confidence            777777654  56799999999999999999999998   999999999999999999999999999987643322  22


Q ss_pred             ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc--------c
Q 002809          726 TVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI--------V  796 (878)
Q Consensus       726 ~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i--------i  796 (878)
                      ....|++.|+|||.+.+. .++.++||||+||+++||++|+.||...+..+...  .... ..........        .
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~--~i~~-~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFR-ILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHH-HHCCCCTTTSTTGGGSTTC
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH--HHHH-hhCCCChhhccchhhhhhc
Confidence            334589999999998754 56899999999999999999999998776543221  1111 1111000000        0


Q ss_pred             C-------CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          797 D-------PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       797 d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      +       +.............+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0       00001111222346789999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-41  Score=360.15  Aligned_cols=236  Identities=24%  Similarity=0.388  Sum_probs=192.8

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCCh------hhHHHHHHHHHHHHHhc--ccceeeeeecccCCCcce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSA------QGFQQFQAEVKLLMRVH--HRNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~------~~~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~~~~~  637 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++.....      ....++.+|+++|++++  |||||++++++.+.+..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            456789999999999999975  48899999875321      12345778999999997  899999999999999999


Q ss_pred             eEeeeccC-CChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCC-CcEEEeecCCccc
Q 002809          638 LIYEFMAN-GNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEK-LQAKLADFGLSKS  715 (878)
Q Consensus       638 lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~  715 (878)
                      +||||+.+ +++.+++..  +..+++..+..++.|+++||+|||++   +|+||||||+|||++.+ +.+||+|||+++.
T Consensus        86 lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence            99999976 577788765  56799999999999999999999998   99999999999999855 7999999999986


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRL-TEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ....    ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....     +        ..+..  
T Consensus       161 ~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i--------~~~~~--  221 (273)
T d1xwsa_         161 LKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I--------IRGQV--  221 (273)
T ss_dssp             CCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H--------HHCCC--
T ss_pred             cccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H--------hhccc--
Confidence            5322    2234679999999999987765 5679999999999999999999975211     1        11111  


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      .+.+    ..    ..++.+++.+||+.||++|||++|+++
T Consensus       222 ~~~~----~~----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 FFRQ----RV----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCSS----CC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCC----CC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111    12    246789999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-40  Score=357.36  Aligned_cols=260  Identities=22%  Similarity=0.311  Sum_probs=194.8

Q ss_pred             hhcccccccccEEEEEEEEc---ceeEEEEEeccCC--hhhHHHHHHHHHHHHHh---cccceeeeeeccc-----CCCc
Q 002809          569 NFERTLGKGGFGTVYYGRLN---EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRV---HHRNLTSLVGHCD-----EDNQ  635 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~-----~~~~  635 (878)
                      .+.+.||+|+||+||+|+..   ++.||||++....  ......+.+|+.+|+.+   +||||++++++|.     ....
T Consensus        10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~   89 (305)
T d1blxa_          10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   89 (305)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred             EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence            45678999999999999874   3669999986532  22234567788877776   7999999999884     3457


Q ss_pred             ceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccc
Q 002809          636 TALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKS  715 (878)
Q Consensus       636 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  715 (878)
                      .++++||++++.+..... .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          90 LTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            899999998877654433 3466799999999999999999999998   999999999999999999999999999876


Q ss_pred             cccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc-
Q 002809          716 FATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS-  794 (878)
Q Consensus       716 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~-  794 (878)
                      ....   .......||+.|+|||++.+..++.++||||+||++|||++|++||...+..+................... 
T Consensus       166 ~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         166 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            5322   233456799999999999999999999999999999999999999988765443221111100000000000 


Q ss_pred             ------ccC---CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          795 ------IVD---PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       795 ------iid---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                            ...   ......+.......+.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  000   00001111223346788999999999999999999876

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.9e-39  Score=348.08  Aligned_cols=266  Identities=14%  Similarity=0.203  Sum_probs=209.1

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcc-cceeeeeecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHH-RNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.....  ...+.+|++.+..++| +|++.+++++..+...++||||+ 
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            456789999999999999975  48899999865432  2467889999999975 89999999999999999999999 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC-----CCcEEEeecCCccccccC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE-----KLQAKLADFGLSKSFATD  719 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~-----~~~~kL~DFGla~~~~~~  719 (878)
                      +++|.+++.. ....+++.++..++.|++.||+|||+.   +|+||||||+|||++.     ++.+||+|||+++.+...
T Consensus        84 ~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          84 GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            7899998865 345699999999999999999999998   9999999999999974     578999999999876433


Q ss_pred             CCC-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCccc
Q 002809          720 ANT-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKS  794 (878)
Q Consensus       720 ~~~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  794 (878)
                      ...     .......||+.|||||++.+..++.++|||||||++|||+||+.||..............+..........+
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence            221     123346799999999999999999999999999999999999999986554322222222211111111111


Q ss_pred             ccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhhcC
Q 002809          795 IVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMARAN  849 (878)
Q Consensus       795 iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~~~  849 (878)
                      +     ...    .+.++.+++..|+..+|++||+++.+.+.|+++++......+
T Consensus       240 l-----~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~  285 (293)
T d1csna_         240 L-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED  285 (293)
T ss_dssp             H-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred             h-----cCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCC
Confidence            1     111    224678899999999999999999999999998866544433

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-39  Score=352.30  Aligned_cols=262  Identities=22%  Similarity=0.277  Sum_probs=194.0

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC--------CCcc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE--------DNQT  636 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--------~~~~  636 (878)
                      .+.+.||+|+||+||+|+..  ++.||||++...  .....+++.+|+++|++++||||+++++.+..        +...
T Consensus        13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~   92 (318)
T d3blha1          13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI   92 (318)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence            45678999999999999975  488999998644  33345788999999999999999999998744        3468


Q ss_pred             eeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccc
Q 002809          637 ALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSF  716 (878)
Q Consensus       637 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  716 (878)
                      ++||||++++.+......  ...+++..++.++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          93 YLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             EEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence            899999988777655543  56789999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCC--cccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcc
Q 002809          717 ATDANT--HVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIK  793 (878)
Q Consensus       717 ~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  793 (878)
                      ......  .......||+.|+|||++.+. .++.++||||+||+++||++|++||.........................
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            433221  122335699999999998765 68999999999999999999999998766544332211111111000001


Q ss_pred             cccCCccc--------cccCHH-------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          794 SIVDPRLQ--------EDFDAN-------SVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       794 ~iid~~l~--------~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                      ........        ......       ....+++|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            11000000        001111       1235678999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-39  Score=347.93  Aligned_cols=263  Identities=18%  Similarity=0.247  Sum_probs=199.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeee-ecccCCCcceeEeeecc
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLV-GHCDEDNQTALIYEFMA  644 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~-g~~~~~~~~~lV~Ey~~  644 (878)
                      +.+.+.||+|+||.||+|+..  ++.||||++.....  .+++..|++++++++|+|++..+ .+..+++..++||||+ 
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            456789999999999999875  58999999876533  24688999999999877766554 4557777888999999 


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcC---CCcEEEeecCCccccccCCC
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNE---KLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~~  721 (878)
                      +++|.+.+.. ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..+||+|||+++.+.....
T Consensus        86 ~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          86 GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            5667666543 355799999999999999999999998   9999999999999864   55799999999997754322


Q ss_pred             C-----cccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHHHHhcCCcccc
Q 002809          722 T-----HVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHI-RQWVNSLIAKGDIKSI  795 (878)
Q Consensus       722 ~-----~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~v~~~~~~~~~~~i  795 (878)
                      .     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ..+...... ..... 
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~-  239 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIEV-  239 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCHHH-
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CChhH-
Confidence            1     123346799999999999999999999999999999999999999987654332221 111111111 11111 


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVMELSECLAAEMAR  847 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~L~~~~~~e~~~  847 (878)
                          +    ....+.++.+++..|++.+|++||+++++.+.|+++...+...
T Consensus       240 ----~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~  283 (299)
T d1ckia_         240 ----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  283 (299)
T ss_dssp             ----H----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             ----h----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence                1    1112346789999999999999999999999999887654433

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-39  Score=354.20  Aligned_cols=259  Identities=20%  Similarity=0.243  Sum_probs=192.0

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhcccceeeeeecccC------CCcceeE
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE------DNQTALI  639 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~------~~~~~lV  639 (878)
                      |+..++||+|+||+||+|+..  ++.||||++.....    .+.+|+++|++++||||++++++|..      ....++|
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            344578999999999999985  48899999976532    23479999999999999999998843      2347899


Q ss_pred             eeeccCCChhhhhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccc
Q 002809          640 YEFMANGNLQEYLSD-ISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFA  717 (878)
Q Consensus       640 ~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~  717 (878)
                      |||++++.+..+.+. .....+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++.+.
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            999986644443322 2356799999999999999999999998   999999999999999875 89999999998764


Q ss_pred             cCCCCcccccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH---------HHHHHH
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTS-NRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQ---------WVNSLI  787 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~v~~~~  787 (878)
                      ...   ......|+..|+|||.+.+ ..++.++||||+||++|||++|++||...+..+......         +.....
T Consensus       175 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         175 RGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             TTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             CCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            332   2233569999999998765 578999999999999999999999998776543322110         011100


Q ss_pred             h---cCCcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          788 A---KGDIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       788 ~---~~~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      .   ...........+..........++.+|+.+||+.||++|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0   000111100111111112234468899999999999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=352.79  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=194.1

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC-hhhHHHHHHHHHHHHHhcccceeeeeecccCCC----cceeEee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS-AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN----QTALIYE  641 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----~~~lV~E  641 (878)
                      .+.+.||+|+||+||+|+..  ++.||||++.... ....+.+++|+++|++++||||+++++++....    ..+++++
T Consensus        11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~   90 (345)
T d1pmea_          11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT   90 (345)
T ss_dssp             EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence            45589999999999999875  5889999997653 345678999999999999999999999986543    3355667


Q ss_pred             eccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCC
Q 002809          642 FMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDAN  721 (878)
Q Consensus       642 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~  721 (878)
                      |+.+|+|.+++..   ..+++..++.++.|+++||+|||++   +||||||||+|||++.++.+||+|||+++.......
T Consensus        91 ~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          91 HLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             ECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             eecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            7789999999964   4699999999999999999999998   999999999999999999999999999987643322


Q ss_pred             -CcccccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC---------
Q 002809          722 -THVSTVVAGTPGYLDPEYYT-SNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG---------  790 (878)
Q Consensus       722 -~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~---------  790 (878)
                       ........||+.|+|||++. +..++.++||||+||+++||++|+.||......+...............         
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence             12234467999999999985 4567899999999999999999999998766543222111110000000         


Q ss_pred             ------CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          791 ------DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       791 ------~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                            .........+. ........++.+++.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhcccccCCccCCCCHH-HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00000000000 0001112367899999999999999999999874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-38  Score=350.77  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=193.6

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccCCC------cce
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDN------QTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~  637 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||++...  +....+.+.+|+++|++++|||||+++++|...+      ..+
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            345578999999999999875  588999999753  3345678999999999999999999999987654      569


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+ +.+|..+++   ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+++...
T Consensus       100 lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             EEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence            999999 567777765   35699999999999999999999998   99999999999999999999999999998653


Q ss_pred             cCCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHH-----HhcC-
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSL-----IAKG-  790 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~-----~~~~-  790 (878)
                      ..     .....||+.|+|||.+.+. .++.++||||+||+++||++|++||...+..............     .... 
T Consensus       173 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         173 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             SS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             Cc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            22     2345699999999998764 5689999999999999999999999887654332211110000     0000 


Q ss_pred             ---------CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHH
Q 002809          791 ---------DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVME--LSECL  841 (878)
Q Consensus       791 ---------~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~--L~~~~  841 (878)
                               ...+.-...+. .........+.+|+.+||+.||++|||++|+++.  ++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             chhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                     00000000111 1111223467899999999999999999999975  55543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-38  Score=338.03  Aligned_cols=258  Identities=20%  Similarity=0.278  Sum_probs=199.2

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccCC--hhhHHHHHHHHHHHHHhcccceeeeeecccCCCcceeEeeecc
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSS--AQGFQQFQAEVKLLMRVHHRNLTSLVGHCDEDNQTALIYEFMA  644 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  644 (878)
                      ++.+.||+|+||+||+|+..  ++.||||+++...  ....+++.+|+.+|++++||||+++++++......++|+|++.
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~   84 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence            44579999999999999975  3789999986543  3456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccccCCCCcc
Q 002809          645 NGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFATDANTHV  724 (878)
Q Consensus       645 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  724 (878)
                      +++|..++..  ...+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||.++.......  .
T Consensus        85 ~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~  157 (292)
T d1unla_          85 QDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--C  157 (292)
T ss_dssp             EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--C
T ss_pred             cccccccccc--ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc--c
Confidence            9999888765  56789999999999999999999998   999999999999999999999999999987643322  2


Q ss_pred             cccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhc---CCcccc---cC
Q 002809          725 STVVAGTPGYLDPEYYTSNR-LTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAK---GDIKSI---VD  797 (878)
Q Consensus       725 ~~~~~gt~~Y~APE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~---~~~~~i---id  797 (878)
                      .....++..|+|||.+.... ++.++||||+||+++||++|+.||......... +.. +......   ......   .+
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKR-IFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHH-HHHHHCCCCTTTCTTGGGSTT
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-HHH-HHhhcCCCChhhhhhhhhccc
Confidence            23345778999999987665 689999999999999999999887554332211 111 1111111   000000   00


Q ss_pred             ---------CccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          798 ---------PRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       798 ---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                               ..-...........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     00000111222346789999999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-38  Score=347.01  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=198.3

Q ss_pred             hhhcccccccccEEEEEEEE-----cceeEEEEEeccC----ChhhHHHHHHHHHHHHHhcc-cceeeeeecccCCCcce
Q 002809          568 NNFERTLGKGGFGTVYYGRL-----NEIDVAVKMLSSS----SAQGFQQFQAEVKLLMRVHH-RNLTSLVGHCDEDNQTA  637 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~----~~~~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~  637 (878)
                      +.+.+.||+|+||+||+|+.     .++.||||++...    .....+.+.+|++++++++| |||+++++++......+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            56778999999999999976     2478999998643    22335678899999999977 89999999999999999


Q ss_pred             eEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCccccc
Q 002809          638 LIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFA  717 (878)
Q Consensus       638 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  717 (878)
                      +||||+.+|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       106 ~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999976  45678899999999999999999998   99999999999999999999999999998764


Q ss_pred             cCCCCcccccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcCCcccc
Q 002809          718 TDANTHVSTVVAGTPGYLDPEYYTSN--RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKGDIKSI  795 (878)
Q Consensus       718 ~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~i  795 (878)
                      .... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||......+...  ....... ...    
T Consensus       181 ~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~-~~~----  252 (322)
T d1vzoa_         181 ADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRIL-KSE----  252 (322)
T ss_dssp             GGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHH-HCC----
T ss_pred             cccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcc-cCC----
Confidence            3322 223346799999999999754  46889999999999999999999997765432111  1111111 111    


Q ss_pred             cCCccccccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002809          796 VDPRLQEDFDANSVWKAVELAMACLSPTGNQRPT-----MSQVVM  835 (878)
Q Consensus       796 id~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~evl~  835 (878)
                        +    ..+.....++.+++.+||+.+|++|||     ++|+++
T Consensus       253 --~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 --P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence              0    112233457889999999999999995     788875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-37  Score=339.26  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=193.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccC--CCcceeEeee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDE--DNQTALIYEF  642 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~--~~~~~lV~Ey  642 (878)
                      +.+.+.||+|+||+||+|+..  ++.||||+++...   .+++.+|+++|.+++ ||||+++++++..  ....++||||
T Consensus        37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence            456689999999999999975  4889999997543   467889999999995 9999999999864  4568999999


Q ss_pred             ccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCC-cEEEeecCCccccccCCC
Q 002809          643 MANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKL-QAKLADFGLSKSFATDAN  721 (878)
Q Consensus       643 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~  721 (878)
                      +++++|..+.+     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++...... 
T Consensus       114 ~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-  184 (328)
T d3bqca1         114 VNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  184 (328)
T ss_dssp             CCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred             cCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence            99999987743     489999999999999999999998   999999999999998655 69999999998764332 


Q ss_pred             CcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH--HHHH-----HHHHHhcCCc-
Q 002809          722 THVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIH--IRQW-----VNSLIAKGDI-  792 (878)
Q Consensus       722 ~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~--l~~~-----v~~~~~~~~~-  792 (878)
                        ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||..........  +...     .......... 
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence              22345689999999998765 47999999999999999999999997655322111  1110     0001111000 


Q ss_pred             -----ccccCC----c----cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          793 -----KSIVDP----R----LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       793 -----~~iid~----~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                           ......    .    ...........++.+|+.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 000000    0    000011122346789999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-37  Score=338.82  Aligned_cols=257  Identities=21%  Similarity=0.275  Sum_probs=187.5

Q ss_pred             hhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC------CCccee
Q 002809          569 NFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE------DNQTAL  638 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~------~~~~~l  638 (878)
                      .+.+.||+|+||+||+|+..  ++.||||++...  +....+.+.+|+.++++++|||||++++++..      ....++
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i   99 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL   99 (355)
T ss_dssp             EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence            44579999999999999975  589999999754  34455678999999999999999999999853      467899


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      ||||+.++.+. .+.    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||+++....
T Consensus       100 v~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         100 VMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccc
Confidence            99999765444 442    3589999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH-H--------H-------
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIR-Q--------W-------  782 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~--------~-------  782 (878)
                      .   .......||+.|+|||++.+..++.++||||+||+++||++|++||...+........ +        +       
T Consensus       172 ~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         172 S---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             c---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            2   2334457899999999999999999999999999999999999999876543321110 0        0       


Q ss_pred             HHHHHhcC-Cc-----ccccCCccccc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002809          783 VNSLIAKG-DI-----KSIVDPRLQED---FDANSVWKAVELAMACLSPTGNQRPTMSQVVME  836 (878)
Q Consensus       783 v~~~~~~~-~~-----~~iid~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~~  836 (878)
                      ........ ..     ...+.......   ........+.+|+.+||..||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00111110 00     00011011100   112345678899999999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-37  Score=341.21  Aligned_cols=253  Identities=21%  Similarity=0.321  Sum_probs=191.7

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccC--ChhhHHHHHHHHHHHHHhcccceeeeeecccC-----CCccee
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSS--SAQGFQQFQAEVKLLMRVHHRNLTSLVGHCDE-----DNQTAL  638 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-----~~~~~l  638 (878)
                      |...+.||+|+||+||+|+..  ++.||||++...  +....+.+.+|+++|++++|||+|++++++..     ....++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            345578999999999999864  589999999754  33455788999999999999999999998853     334577


Q ss_pred             EeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEeecCCcccccc
Q 002809          639 IYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLADFGLSKSFAT  718 (878)
Q Consensus       639 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  718 (878)
                      +++|+.+|+|.+++..   +.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++.....
T Consensus       100 i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             EEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence            7888899999999864   4699999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCCCcccccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHHHHhcC-------
Q 002809          719 DANTHVSTVVAGTPGYLDPEYYTSN-RLTEKSDVYSFGVVILEIITCKPAISRINEEEKIHIRQWVNSLIAKG-------  790 (878)
Q Consensus       719 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~-------  790 (878)
                           ......|+..|+|||.+.+. .++.++||||+||+++||++|++||...+........   .......       
T Consensus       174 -----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         174 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAELLKK  245 (348)
T ss_dssp             -----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHHHHTT
T ss_pred             -----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChHHhhh
Confidence                 22345688999999987665 4688999999999999999999999876654322211   1000000       


Q ss_pred             -----------CcccccCCccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002809          791 -----------DIKSIVDPRLQEDFDANSVWKAVELAMACLSPTGNQRPTMSQVVM  835 (878)
Q Consensus       791 -----------~~~~iid~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~evl~  835 (878)
                                 .....-...+.. .......++.+|+.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                       000000000000 00112346789999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-32  Score=305.10  Aligned_cols=263  Identities=22%  Similarity=0.304  Sum_probs=188.4

Q ss_pred             hhhcccccccccEEEEEEEEc--ceeEEEEEeccCChhhHHHHHHHHHHHHHhc-----------ccceeeeeecccCC-
Q 002809          568 NNFERTLGKGGFGTVYYGRLN--EIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-----------HRNLTSLVGHCDED-  633 (878)
Q Consensus       568 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-----------H~nIv~l~g~~~~~-  633 (878)
                      |.+.+.||+|+||+||+|+..  ++.||||++..... ..+.+.+|++++++++           |+||+++++++... 
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            466789999999999999874  58899999976532 3467888999998885           57789998887543 


Q ss_pred             -CcceeEeeeccCCChh-hhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcCCC------c
Q 002809          634 -NQTALIYEFMANGNLQ-EYLSDISKKVLSSQERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKL------Q  704 (878)
Q Consensus       634 -~~~~lV~Ey~~~gsL~-~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~~~------~  704 (878)
                       ....++++++..+... ..........+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++      .
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence             4556667666554433 33333446778999999999999999999998 5   899999999999998765      3


Q ss_pred             EEEeecCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH----HHHH
Q 002809          705 AKLADFGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVILEIITCKPAISRINEEEK----IHIR  780 (878)
Q Consensus       705 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~----~~l~  780 (878)
                      ++++|||.+......     .....||+.|+|||++....++.++||||+||+++||++|+.||........    ..+.
T Consensus       171 ~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         171 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            999999998765322     2345699999999999999999999999999999999999999976443211    1111


Q ss_pred             HHHHHH-------HhcCC----------cccccCC-c---------cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002809          781 QWVNSL-------IAKGD----------IKSIVDP-R---------LQEDFDANSVWKAVELAMACLSPTGNQRPTMSQV  833 (878)
Q Consensus       781 ~~v~~~-------~~~~~----------~~~iid~-~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ev  833 (878)
                      ..+...       ...+.          ....+.. .         ...........++.+|+.+||+.||++|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            111100       00000          0000000 0         0111234566788999999999999999999999


Q ss_pred             HHH--HHH
Q 002809          834 VME--LSE  839 (878)
Q Consensus       834 l~~--L~~  839 (878)
                      +++  +++
T Consensus       326 L~Hp~f~~  333 (362)
T d1q8ya_         326 VNHPWLKD  333 (362)
T ss_dssp             HTCGGGTT
T ss_pred             hcCcccCC
Confidence            764  543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.81  E-value=1.8e-20  Score=187.74  Aligned_cols=168  Identities=15%  Similarity=0.153  Sum_probs=118.1

Q ss_pred             hhcccccccccEEEEEEEEc-ceeEEEEEeccCCh------------------hhHHHHHHHHHHHHHhcccceeeeeec
Q 002809          569 NFERTLGKGGFGTVYYGRLN-EIDVAVKMLSSSSA------------------QGFQQFQAEVKLLMRVHHRNLTSLVGH  629 (878)
Q Consensus       569 ~f~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~------------------~~~~~f~~Ei~~L~~l~H~nIv~l~g~  629 (878)
                      .+.+.||+|+||.||+|+.. ++.||||+++....                  .....+..|...+.+++|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999875 48999998753210                  012345678889999999999888765


Q ss_pred             ccCCCcceeEeeeccCCChhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCccEEEcCCCcEEEee
Q 002809          630 CDEDNQTALIYEFMANGNLQEYLSDISKKVLSSQERLRIAVESAQGLEYLHNGCKPPIVHRDVKSTNILLNEKLQAKLAD  709 (878)
Q Consensus       630 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLKp~NILl~~~~~~kL~D  709 (878)
                      .    ..+++|||+++..+.+         ++......++.|++++|+|||+.   +|+||||||+|||++++ .++|+|
T Consensus        83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred             c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence            3    2479999998765443         33344568999999999999998   99999999999999965 589999


Q ss_pred             cCCccccccCCCCcccccccCCCCccCccccccCCCCCccchhhHHHHH
Q 002809          710 FGLSKSFATDANTHVSTVVAGTPGYLDPEYYTSNRLTEKSDVYSFGVVI  758 (878)
Q Consensus       710 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV~S~Gvvl  758 (878)
                      ||+++............   ..... -.|. ....|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHH---HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            99997653221100000   00000 0011 235678899999975443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.58  E-value=8.2e-16  Score=165.32  Aligned_cols=123  Identities=31%  Similarity=0.491  Sum_probs=106.2

Q ss_pred             cccchHHHHHHHHHhhC---CCCCCC--CCCCCCCCCcccceecCCCCCCCCcEEEEEecCCCccc--cchhhhhccCCC
Q 002809          361 TEQIDVDAITNIKATYG---LKKNWQ--GDPCAPLAYWWDGLNCSYGDSSSPRITYLNLSSSGLKG--DITSYVSNLTSL  433 (878)
Q Consensus       361 t~~~d~~al~~lk~~~~---~~~~w~--~~pc~~~~~~w~gv~C~~~~~~~~~l~~l~l~~n~l~g--~ip~~~~~l~~L  433 (878)
                      ..|+|..||.++|+.+.   ...+|.  +|||.   ..|.||+|+. .....+|+.|+|++|+++|  .||++|++|++|
T Consensus         3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~---~~w~gv~C~~-~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L   78 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDT-DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECC-SSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCC---CcCCCeEEeC-CCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence            46899999999999884   356895  58883   2599999985 2344689999999999999  589999999999


Q ss_pred             CEEeCcC-CcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCccccc
Q 002809          434 QFLDLSN-NNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSV  487 (878)
Q Consensus       434 ~~L~Ls~-N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~  487 (878)
                      ++|+|++ |+|+|.||..+++|+ |++|+|++|+|.|..|..+..+..++.+.++.
T Consensus        79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~  134 (313)
T d1ogqa_          79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY  134 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCS
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccc
Confidence            9999996 999999999999999 99999999999999998898888888665544

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.01  E-value=4.8e-11  Score=127.39  Aligned_cols=92  Identities=28%  Similarity=0.384  Sum_probs=81.0

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...+.++.|++++|+++|.+| .++.+++|+.|+|++|+|+|.||+.+++++ |+.|+|++|+|+|.||. ++++.+|. 
T Consensus       218 ~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~-  294 (313)
T d1ogqa_         218 GSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFD-  294 (313)
T ss_dssp             CTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSC-
T ss_pred             ccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCC-
Confidence            345789999999999998766 699999999999999999999999999999 99999999999999994 57777776 


Q ss_pred             cccccCCCCCCCCC--ccc
Q 002809          483 LSLSVGGNPGLCSK--ISC  499 (878)
Q Consensus       483 l~l~~~~n~~lc~~--~~c  499 (878)
                       .+++.+|+.+|+.  ++|
T Consensus       295 -~l~l~~N~~l~g~plp~c  312 (313)
T d1ogqa_         295 -VSAYANNKCLCGSPLPAC  312 (313)
T ss_dssp             -GGGTCSSSEEESTTSSCC
T ss_pred             -HHHhCCCccccCCCCCCC
Confidence             4677899999985  556

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.91  E-value=3.3e-10  Score=118.02  Aligned_cols=89  Identities=30%  Similarity=0.338  Sum_probs=80.0

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ....++..|++++|.+++..+..+..+++|+.|+|++|+|++..|..+..++ |+.|+|++|+|+ .||.++..+++|+ 
T Consensus       121 ~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~-  198 (266)
T d1p9ag_         121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP-  198 (266)
T ss_dssp             TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCS-
T ss_pred             ccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCC-
Confidence            3457899999999999977778889999999999999999988888899999 999999999999 9999999988887 


Q ss_pred             cccccCCCCCCCC
Q 002809          483 LSLSVGGNPGLCS  495 (878)
Q Consensus       483 l~l~~~~n~~lc~  495 (878)
                       .+...|||..|.
T Consensus       199 -~L~L~~Np~~Cd  210 (266)
T d1p9ag_         199 -FAFLHGNPWLCN  210 (266)
T ss_dssp             -EEECCSCCBCCS
T ss_pred             -EEEecCCCCCCC
Confidence             467789999987

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.89  E-value=5.2e-10  Score=110.53  Aligned_cols=89  Identities=25%  Similarity=0.334  Sum_probs=77.3

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|++.+..+..+..+++|+.|+|++|+|++..|..|.+++ |+.|+|++|+|++..|..+..+++++. 
T Consensus        52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~-  130 (192)
T d1w8aa_          52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS-  130 (192)
T ss_dssp             GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE-
T ss_pred             CCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccc-
Confidence            457899999999999999999999999999999999999977777899999 999999999999666667788888874 


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                       +...+|+..|.
T Consensus       131 -l~L~~N~~~~~  141 (192)
T d1w8aa_         131 -LNLASNPFNCN  141 (192)
T ss_dssp             -EECTTCCBCCS
T ss_pred             -ccccccccccc
Confidence             56678887765

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.86  E-value=1.9e-09  Score=102.70  Aligned_cols=100  Identities=26%  Similarity=0.315  Sum_probs=81.5

Q ss_pred             cccceecCCCC--------CCCCcEEEEEecCCC-ccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEec
Q 002809          393 WWDGLNCSYGD--------SSSPRITYLNLSSSG-LKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQ  462 (878)
Q Consensus       393 ~w~gv~C~~~~--------~~~~~l~~l~l~~n~-l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls  462 (878)
                      .+.+|+|+...        ...++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+..-|..|..++ |+.|+|+
T Consensus         9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3           9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            57789998532        234689999998765 8855567799999999999999999966678899999 9999999


Q ss_pred             CCcCCCCCchhhhhcccCCCcccccCCCCCCCC
Q 002809          463 GNKLNGSVPVELLERSKNGSLSLSVGGNPGLCS  495 (878)
Q Consensus       463 ~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~lc~  495 (878)
                      +|+|+ .+|..+.....+.  .+..++||..|.
T Consensus        89 ~N~l~-~l~~~~~~~~~l~--~L~L~~Np~~C~  118 (156)
T d2ifga3          89 FNALE-SLSWKTVQGLSLQ--ELVLSGNPLHCS  118 (156)
T ss_dssp             SSCCS-CCCSTTTCSCCCC--EEECCSSCCCCC
T ss_pred             CCCCc-ccChhhhcccccc--ccccCCCcccCC
Confidence            99999 8888776655555  567789999876

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.84  E-value=1.1e-09  Score=108.06  Aligned_cols=97  Identities=22%  Similarity=0.201  Sum_probs=82.3

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccc-hhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCC
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDI-TSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN  464 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~i-p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N  464 (878)
                      .|..|.|+...      +.++.++.|+|++|+|++.+ +..|.+|++|+.|+|++|++++..+..+..++ |+.|+|++|
T Consensus         9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_           9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            57889998542      34568999999999999866 56789999999999999999999999999999 999999999


Q ss_pred             cCCCCCchhhhhcccCCCcccccCC
Q 002809          465 KLNGSVPVELLERSKNGSLSLSVGG  489 (878)
Q Consensus       465 ~l~g~iP~~l~~~~~l~~l~l~~~~  489 (878)
                      +|++..|..+.++++|+.|+++.+.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~  113 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             cccccCHHHHhCCCcccccccCCcc
Confidence            9996556678889999977665543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.68  E-value=1e-08  Score=93.60  Aligned_cols=81  Identities=28%  Similarity=0.394  Sum_probs=67.5

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCc--hhhhhcccCC
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVP--VELLERSKNG  481 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP--~~l~~~~~l~  481 (878)
                      ..++|++|+|++|+|+ .+|+.++.+++|+.|+|++|+|+ .+|. ++.++ |+.|++++|+++ .+|  ..+..+++++
T Consensus        18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~   93 (124)
T d1dcea3          18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLV   93 (124)
T ss_dssp             GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCC
T ss_pred             cCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCccC-CCCCchhhcCCCCCC
Confidence            4568999999999998 78999999999999999999999 5664 88898 999999999998 444  4677788877


Q ss_pred             CcccccCCCC
Q 002809          482 SLSLSVGGNP  491 (878)
Q Consensus       482 ~l~l~~~~n~  491 (878)
                      .|  ...+|+
T Consensus        94 ~L--~l~~N~  101 (124)
T d1dcea3          94 LL--NLQGNS  101 (124)
T ss_dssp             EE--ECTTSG
T ss_pred             EE--ECCCCc
Confidence            55  445565

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.67  E-value=6.8e-09  Score=108.71  Aligned_cols=89  Identities=25%  Similarity=0.226  Sum_probs=80.6

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..++ |+.|++++|++++..|..+..+++|+  
T Consensus       151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~--  228 (284)
T d1ozna_         151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ--  228 (284)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC--
T ss_pred             cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC--
Confidence            346899999999999988889999999999999999999999999999999 99999999999988888898988887  


Q ss_pred             ccccCCCCCCCC
Q 002809          484 SLSVGGNPGLCS  495 (878)
Q Consensus       484 ~l~~~~n~~lc~  495 (878)
                      .+.+++|+..|.
T Consensus       229 ~L~l~~N~l~C~  240 (284)
T d1ozna_         229 YLRLNDNPWVCD  240 (284)
T ss_dssp             EEECCSSCEECS
T ss_pred             EEEecCCCCCCC
Confidence            456789998875

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.63  E-value=1.2e-08  Score=92.98  Aligned_cols=73  Identities=27%  Similarity=0.352  Sum_probs=64.3

Q ss_pred             EEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccC
Q 002809          411 YLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       411 ~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      .|+|++|+|+ .+| .+.+|++|++|||++|+|+ .+|+.++.++ |+.|+|++|+|+ .+| .+..+++++.|+++.+
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            6899999998 666 4999999999999999999 7998899999 999999999999 566 5888998887666544

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.39  E-value=1.2e-07  Score=90.41  Aligned_cols=77  Identities=19%  Similarity=0.235  Sum_probs=55.4

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchh-hhhcccCCCc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVE-LLERSKNGSL  483 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~-l~~~~~l~~l  483 (878)
                      +.+++.|+|++|+|+ .||..+..+++|+.||||+|+|+ .++. +..++ |+.|+|++|+++ .+|.. +..++.++.|
T Consensus        17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTEL   92 (162)
T ss_dssp             TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEE
T ss_pred             cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-cccCcchhhhhccccccc-CCCccccccccccccc
Confidence            346788888888887 56766677888888888888887 5643 67777 888888888887 45544 3457777755


Q ss_pred             ccc
Q 002809          484 SLS  486 (878)
Q Consensus       484 ~l~  486 (878)
                      +++
T Consensus        93 ~L~   95 (162)
T d1a9na_          93 ILT   95 (162)
T ss_dssp             ECC
T ss_pred             eec
Confidence            443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.35  E-value=7.9e-08  Score=99.44  Aligned_cols=144  Identities=21%  Similarity=0.155  Sum_probs=96.2

Q ss_pred             eEEEEEecCCCCCchh----hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCC
Q 002809          329 YSFSLYKTGNSTLPPI----INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDS  404 (878)
Q Consensus       329 ~~~~l~~t~~s~lpp~----inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~  404 (878)
                      ..+.|..+..+.+|+.    +..|+.+.+..+. ++++|.. ..|..|+.+....+.+...|-              ...
T Consensus        34 ~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~-l~~l~~~-~~l~~L~~L~Ls~N~l~~~~~--------------~~~   97 (266)
T d1p9ag_          34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAE-LTKLQVD-GTLPVLGTLDLSHNQLQSLPL--------------LGQ   97 (266)
T ss_dssp             CEEECTTSCCSEEEGGGGTTCTTCCEEECTTSC-CCEEECC-SCCTTCCEEECCSSCCSSCCC--------------CTT
T ss_pred             CEEECcCCcCCCcCHHHhhcccccccccccccc-ccccccc-ccccccccccccccccccccc--------------ccc
Confidence            3455556666666642    3356666666654 5555543 334444444333333332221              013


Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|+|++|.+.+..+..+..+.+|+.|++++|.+++..|..+..++ |+.|++++|+|++..|..+..+++|+.|
T Consensus        98 ~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L  177 (266)
T d1p9ag_          98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL  177 (266)
T ss_dssp             TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred             cccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccccee
Confidence            456888888888888877778888888999999999998866566677788 9999999999997667778888888876


Q ss_pred             ccccC
Q 002809          484 SLSVG  488 (878)
Q Consensus       484 ~l~~~  488 (878)
                      +++.+
T Consensus       178 ~Ls~N  182 (266)
T d1p9ag_         178 LLQEN  182 (266)
T ss_dssp             ECCSS
T ss_pred             ecccC
Confidence            66544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=1.4e-07  Score=98.30  Aligned_cols=85  Identities=20%  Similarity=0.218  Sum_probs=75.4

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      .....|+.|++++|+|++..+..|..+++|+.|+|++|+|++..|..+..++ |+.|+|++|++++..|..+..++++..
T Consensus       126 ~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~  205 (284)
T d1ozna_         126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT  205 (284)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             chhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccc
Confidence            3456899999999999977778899999999999999999987788899999 999999999999888999999999887


Q ss_pred             cccccC
Q 002809          483 LSLSVG  488 (878)
Q Consensus       483 l~l~~~  488 (878)
                      |+++.+
T Consensus       206 L~l~~N  211 (284)
T d1ozna_         206 LYLFAN  211 (284)
T ss_dssp             EECCSS
T ss_pred             cccccc
Confidence            766543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.27  E-value=2.1e-07  Score=100.62  Aligned_cols=77  Identities=29%  Similarity=0.348  Sum_probs=64.7

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..+.++.|+|++|+|++. + .+..|++|+.|+|++|+|++ +| .++.++ |+.|+|++|+|++..|  +.++++|+.|
T Consensus       305 ~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L  378 (384)
T d2omza2         305 NLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQL  378 (384)
T ss_dssp             GCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEE
T ss_pred             hhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEe
Confidence            346789999999999975 3 38999999999999999994 66 588999 9999999999996554  8888888877


Q ss_pred             cccc
Q 002809          484 SLSV  487 (878)
Q Consensus       484 ~l~~  487 (878)
                      +++.
T Consensus       379 ~L~~  382 (384)
T d2omza2         379 GLND  382 (384)
T ss_dssp             ECCC
T ss_pred             eCCC
Confidence            6653

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.24  E-value=2.5e-07  Score=92.09  Aligned_cols=137  Identities=18%  Similarity=0.246  Sum_probs=91.5

Q ss_pred             ceeEEEEEecCCCCCchh--hhhhhhheeccccccccccchHHHHHHHHHhhCCCCCCCCCCCCCCCCcccceecCCCCC
Q 002809          327 GNYSFSLYKTGNSTLPPI--INAIEVYSVKEFLQLQTEQIDVDAITNIKATYGLKKNWQGDPCAPLAYWWDGLNCSYGDS  404 (878)
Q Consensus       327 ~~~~~~l~~t~~s~lpp~--inalEi~~l~~~~~~~t~~~d~~al~~lk~~~~~~~~w~~~pc~~~~~~w~gv~C~~~~~  404 (878)
                      ....+.+..+..+.++|+  +..++.+.+..+. .+.+| .+..+.+|+.+....+...         ...++      .
T Consensus        69 ~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~-i~~l~-~l~~l~~L~~L~l~~~~~~---------~~~~l------~  131 (210)
T d1h6ta2          69 NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK-VKDLS-SLKDLKKLKSLSLEHNGIS---------DINGL------V  131 (210)
T ss_dssp             TCCEEECCSSCCCCCGGGTTCTTCCEEECCSSC-CCCGG-GGTTCTTCCEEECTTSCCC---------CCGGG------G
T ss_pred             CCCEEeCCCccccCccccccCcccccccccccc-ccccc-ccccccccccccccccccc---------ccccc------c
Confidence            345666667777777775  3467777776653 44444 2333333332221111111         01111      2


Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..+.++.++++.|++++  +..+++|++|+.|++++|++++ +++ +++++ |+.|+|++|+++ .+| .+..+++|+.|
T Consensus       132 ~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L  205 (210)
T d1h6ta2         132 HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVL  205 (210)
T ss_dssp             GCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEE
T ss_pred             ccccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEE
Confidence            34678999999999974  3468899999999999999995 554 88898 999999999998 576 58888888877


Q ss_pred             ccc
Q 002809          484 SLS  486 (878)
Q Consensus       484 ~l~  486 (878)
                      +++
T Consensus       206 ~Ls  208 (210)
T d1h6ta2         206 ELF  208 (210)
T ss_dssp             EEE
T ss_pred             Ecc
Confidence            664

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.21  E-value=2.8e-07  Score=87.82  Aligned_cols=81  Identities=21%  Similarity=0.218  Sum_probs=63.1

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCch--hhhhcccCCC
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPV--ELLERSKNGS  482 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~--~l~~~~~l~~  482 (878)
                      .++|+.|+|++|+|+ .++ .|..|++|+.|+|++|+++...|..+..++ |+.|+|++|+++ .++.  .+..+++|+.
T Consensus        40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~  116 (162)
T d1a9na_          40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY  116 (162)
T ss_dssp             TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred             cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccch
Confidence            467999999999998 664 589999999999999999944344456788 999999999998 5653  5667777774


Q ss_pred             cccccCCCC
Q 002809          483 LSLSVGGNP  491 (878)
Q Consensus       483 l~l~~~~n~  491 (878)
                      |  .+.+|+
T Consensus       117 L--~l~~N~  123 (162)
T d1a9na_         117 L--CILRNP  123 (162)
T ss_dssp             E--ECCSSG
T ss_pred             h--hcCCCc
Confidence            4  455554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.17  E-value=5.4e-07  Score=90.53  Aligned_cols=76  Identities=22%  Similarity=0.404  Sum_probs=62.8

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSL  483 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l  483 (878)
                      ..++|+.|++++|.+++..+  +++|++|+.|+|++|++++ +|. ++.++ |+.|+|++|+++ .+|. +.++++|..|
T Consensus       149 ~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L  222 (227)
T d1h6ua2         149 GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIV  222 (227)
T ss_dssp             GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEE
T ss_pred             cccccccccccccccccchh--hcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEE
Confidence            34679999999999985433  8999999999999999995 654 78888 999999999999 5653 7788888877


Q ss_pred             ccc
Q 002809          484 SLS  486 (878)
Q Consensus       484 ~l~  486 (878)
                      +++
T Consensus       223 ~ls  225 (227)
T d1h6ua2         223 TLT  225 (227)
T ss_dssp             EEE
T ss_pred             Eee
Confidence            654

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.10  E-value=1e-06  Score=92.45  Aligned_cols=66  Identities=23%  Similarity=0.313  Sum_probs=49.3

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCch
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPV  472 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~  472 (878)
                      ..+.++.|++++|++++..|..+.++++|+.|+|++|+|+ .||..+..++ |+.|+|++|+|+ .|+.
T Consensus       193 ~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~  259 (305)
T d1xkua_         193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS  259 (305)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCT
T ss_pred             ccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccCh
Confidence            3456777778888887776777777888888888888777 6777777777 888888888777 5554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.08  E-value=1.5e-06  Score=91.15  Aligned_cols=83  Identities=24%  Similarity=0.312  Sum_probs=69.9

Q ss_pred             CcccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCC
Q 002809          392 YWWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN  464 (878)
Q Consensus       392 ~~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N  464 (878)
                      ..|++|.|+...      ..++.|+.|+|++|+|+...+..|.+|++|+.|++++|.++...|..|..++ |+.|+|++|
T Consensus        10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n   89 (305)
T d1xkua_          10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN   89 (305)
T ss_dssp             EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred             ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence            379999998532      2347899999999999944445799999999999999999977788899999 999999999


Q ss_pred             cCCCCCchhhh
Q 002809          465 KLNGSVPVELL  475 (878)
Q Consensus       465 ~l~g~iP~~l~  475 (878)
                      +++ .+|..+.
T Consensus        90 ~l~-~l~~~~~   99 (305)
T d1xkua_          90 QLK-ELPEKMP   99 (305)
T ss_dssp             CCS-BCCSSCC
T ss_pred             ccC-cCccchh
Confidence            999 6776543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.05  E-value=1.3e-06  Score=85.78  Aligned_cols=72  Identities=33%  Similarity=0.467  Sum_probs=56.7

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ..++|+.|++++|++. .+| .+..+++|+.|++++|++++ +|. +++++ |+.|+|++|+++ .+| .++++++|+.
T Consensus       126 ~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~~-l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~  198 (199)
T d2omxa2         126 NLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LKP-LANLTTLERLDISSNKVS-DIS-VLAKLTNLES  198 (199)
T ss_dssp             TCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSE
T ss_pred             hhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC-Ccc-ccCCCCCCEEECCCCCCC-CCc-cccCCCCCCc
Confidence            4568899999999987 444 58899999999999999985 443 78888 999999999998 465 4666666553

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.02  E-value=8.4e-06  Score=83.09  Aligned_cols=131  Identities=16%  Similarity=0.129  Sum_probs=94.5

Q ss_pred             cccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhc-ccceeeeeecccCCCcceeEeeeccCCChhhhhccc
Q 002809          577 GGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVH-HRNLTSLVGHCDEDNQTALIYEFMANGNLQEYLSDI  655 (878)
Q Consensus       577 G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~  655 (878)
                      ++.+.||+...++..+.+|+...........+.+|...+..+. +--+.+++.+...++..++||+++++.++.+.... 
T Consensus        25 ~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-  103 (263)
T d1j7la_          25 MSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-  103 (263)
T ss_dssp             CSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT-
T ss_pred             CCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc-
Confidence            3346899988888889999887655444556788999888875 33356777888888889999999999887654321 


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------------
Q 002809          656 SKKVLSSQERLRIAVESAQGLEYLHNGC----------------------------------------------------  683 (878)
Q Consensus       656 ~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------------------  683 (878)
                            ......++.++++.++.||+..                                                    
T Consensus       104 ------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  177 (263)
T d1j7la_         104 ------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE  177 (263)
T ss_dssp             ------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred             ------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence                  1112335556666666666420                                                    


Q ss_pred             ----CCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          684 ----KPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       684 ----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                          ...++|+|+.|.|||+++++..-|.||+.+.
T Consensus       178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                1237899999999999987777899999775

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.95  E-value=3.9e-06  Score=79.16  Aligned_cols=62  Identities=29%  Similarity=0.250  Sum_probs=54.2

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCC-CCcceEEEecCCcCC
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLS-KLPLRTLNLQGNKLN  467 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~-~l~L~~L~ls~N~l~  467 (878)
                      ..++|+.|+|++|+|++.-|..|..+++|+.|+|++|+|+ .+|..+. .++|+.|+|++|.|.
T Consensus        54 ~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          54 GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             SCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             cccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence            4578999999999999777888999999999999999999 7776544 445999999999996

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.89  E-value=3.2e-06  Score=82.94  Aligned_cols=79  Identities=27%  Similarity=0.359  Sum_probs=63.5

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGS  482 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~  482 (878)
                      ...+.|+.|++++|.+...  ..+..|++|+.|++++|++. .+| .+..++ |+.|++++|++++ +| .+.++++|+.
T Consensus       103 ~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~  176 (199)
T d2omxa2         103 ANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLER  176 (199)
T ss_dssp             TTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCE
T ss_pred             ccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC-Cc-cccCCCCCCE
Confidence            3457899999999998853  34889999999999999998 455 477788 9999999999995 54 4888888887


Q ss_pred             cccccC
Q 002809          483 LSLSVG  488 (878)
Q Consensus       483 l~l~~~  488 (878)
                      |+++.+
T Consensus       177 L~ls~N  182 (199)
T d2omxa2         177 LDISSN  182 (199)
T ss_dssp             EECCSS
T ss_pred             EECCCC
Confidence            666543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.84  E-value=5.6e-07  Score=88.70  Aligned_cols=78  Identities=19%  Similarity=0.242  Sum_probs=59.9

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .++|+.|+|++|+|+ .|+ .|.+|++|+.|+|++|+|+ .||.....++ |+.|+|++|+++ .++ .+..+++|+.|+
T Consensus        47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~  121 (198)
T d1m9la_          47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY  121 (198)
T ss_dssp             TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred             ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccc
Confidence            567888899988888 665 5888889999999999887 6776666666 888888888888 454 477777777666


Q ss_pred             cccC
Q 002809          485 LSVG  488 (878)
Q Consensus       485 l~~~  488 (878)
                      ++.+
T Consensus       122 L~~N  125 (198)
T d1m9la_         122 MSNN  125 (198)
T ss_dssp             ESEE
T ss_pred             cccc
Confidence            5543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.73  E-value=6.6e-06  Score=88.40  Aligned_cols=57  Identities=23%  Similarity=0.460  Sum_probs=50.6

Q ss_pred             CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCC
Q 002809          404 SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGN  464 (878)
Q Consensus       404 ~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N  464 (878)
                      ...++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++.+|  +.+++ |+.|+|++|
T Consensus       326 ~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         326 SSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             ccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            346789999999999984 55 69999999999999999997655  88998 999999998

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.69  E-value=2.3e-05  Score=77.28  Aligned_cols=57  Identities=32%  Similarity=0.492  Sum_probs=29.7

Q ss_pred             CcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCC
Q 002809          407 PRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLN  467 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~  467 (878)
                      ++|+.|+|++|+|++ ++ .+++|++|+.|+|++|+|+ .+| .+..++ |+.|++++|.+.
T Consensus        68 ~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~  125 (210)
T d1h6ta2          68 PNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS  125 (210)
T ss_dssp             TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC
T ss_pred             CCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc
Confidence            455555555555553 33 2455555555555555555 244 244455 555555555554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.64  E-value=1.1e-05  Score=81.24  Aligned_cols=96  Identities=17%  Similarity=0.167  Sum_probs=74.0

Q ss_pred             cccceecCCCC------CCCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCc-cCCCCc-ceEEEec-C
Q 002809          393 WWDGLNCSYGD------SSSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPD-FLSKLP-LRTLNLQ-G  463 (878)
Q Consensus       393 ~w~gv~C~~~~------~~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~-L~~L~ls-~  463 (878)
                      .+..|.|+...      ..++.+++|+|++|+|+..-+..|.+|++|+.|+|++|.+...+|. .+..++ ++.|++. .
T Consensus         9 ~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1           9 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            45678887432      2345799999999999844445789999999999999999887764 477788 8888876 5


Q ss_pred             CcCCCCCchhhhhcccCCCcccccC
Q 002809          464 NKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       464 N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      |++....|..+..+++|+.+.+..+
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~  113 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNT  113 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESC
T ss_pred             ccccccccccccccccccccccchh
Confidence            7888666677888888887766543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.54  E-value=2e-06  Score=84.53  Aligned_cols=80  Identities=28%  Similarity=0.342  Sum_probs=60.4

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCc--hhhhhcccCCC
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVP--VELLERSKNGS  482 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP--~~l~~~~~l~~  482 (878)
                      .++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|+++ .++. +..++ |+.|+|++|+++ .++  ..+..+++|+.
T Consensus        69 l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~  144 (198)
T d1m9la_          69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLED  144 (198)
T ss_dssp             HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHH-HHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSE
T ss_pred             CccccChhhcccccc-ccccccccccccccccccccccc-cccc-ccccccccccccccchhc-cccccccccCCCccce
Confidence            357889999999887 77877777788999999999988 4543 66777 999999999988 455  35677777774


Q ss_pred             cccccCCCC
Q 002809          483 LSLSVGGNP  491 (878)
Q Consensus       483 l~l~~~~n~  491 (878)
                      |  .+.+|+
T Consensus       145 L--~L~~N~  151 (198)
T d1m9la_         145 L--LLAGNP  151 (198)
T ss_dssp             E--EECSSH
T ss_pred             e--ecCCCc
Confidence            4  455554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.52  E-value=3.4e-05  Score=76.86  Aligned_cols=77  Identities=23%  Similarity=0.328  Sum_probs=61.9

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      .+.+..+.++++.+.+..  .+.++++|+.|++++|++++..+  +++++ |+.|+|++|++++ +|. +.++++|+.|+
T Consensus       128 ~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~  201 (227)
T d1h6ua2         128 LSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVH  201 (227)
T ss_dssp             CTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEE
T ss_pred             ccchhhhhchhhhhchhh--hhccccccccccccccccccchh--hcccccceecccCCCccCC-Chh-hcCCCCCCEEE
Confidence            457788899999887544  37889999999999999985433  78889 9999999999995 654 88888888766


Q ss_pred             cccC
Q 002809          485 LSVG  488 (878)
Q Consensus       485 l~~~  488 (878)
                      ++.+
T Consensus       202 Ls~N  205 (227)
T d1h6ua2         202 LKNN  205 (227)
T ss_dssp             CTTS
T ss_pred             CcCC
Confidence            5443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.41  E-value=0.00029  Score=70.84  Aligned_cols=128  Identities=16%  Similarity=0.098  Sum_probs=83.7

Q ss_pred             ccccc-cEEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhcccc--eeeeeecccCCCcceeEeeeccCCChh
Q 002809          574 LGKGG-FGTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRN--LTSLVGHCDEDNQTALIYEFMANGNLQ  649 (878)
Q Consensus       574 LG~G~-fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~  649 (878)
                      +..|. -+.||+....+ ..+.+|.-....   ...+..|...++.+....  +.++++++.+++..++||+++++.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            34444 36799988876 557888765443   235677888888775333  456777777888889999999886664


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 002809          650 EYLSDISKKVLSSQERLRIAVESAQGLEYLHN------------------------------------------------  681 (878)
Q Consensus       650 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~------------------------------------------------  681 (878)
                      +...       ..   ...+.++++.|+-||+                                                
T Consensus        95 ~~~~-------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          95 SSHL-------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TSCC-------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc-------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            4211       10   1122233333333332                                                


Q ss_pred             ---C----CCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          682 ---G----CKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       682 ---~----~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                         .    ..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence               1    12237999999999999988777899999764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.36  E-value=1.4e-05  Score=75.66  Aligned_cols=64  Identities=34%  Similarity=0.454  Sum_probs=36.4

Q ss_pred             CcEEEEEecCCCcccc--chhhhhccCCCCEEeCcCCcccCcCCc--cCCCCcceEEEecCCcCCCCCc
Q 002809          407 PRITYLNLSSSGLKGD--ITSYVSNLTSLQFLDLSNNNLTGSVPD--FLSKLPLRTLNLQGNKLNGSVP  471 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~--ip~~~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~L~~L~ls~N~l~g~iP  471 (878)
                      +.|+.|+|++|+|+..  ++..+..|++|+.|||++|+++ .+++  .+..++|+.|+|++|.+++...
T Consensus        65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence            4566666666666632  3445566666666666666666 3432  2233336666666666665443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.31  E-value=0.0001  Score=77.49  Aligned_cols=73  Identities=27%  Similarity=0.397  Sum_probs=53.7

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcc
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLS  484 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~  484 (878)
                      +++|+.|+|++|+|+ .||..+   .+|+.|++++|+++ .|+..   .+ |+.|+|++|+++ .+|. ++.+..|+.|+
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~  126 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID  126 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred             CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeec
Confidence            467888888888888 778654   56788888888887 55532   13 889999999988 6774 56777777766


Q ss_pred             cccC
Q 002809          485 LSVG  488 (878)
Q Consensus       485 l~~~  488 (878)
                      ++.+
T Consensus       127 l~~~  130 (353)
T d1jl5a_         127 VDNN  130 (353)
T ss_dssp             CCSS
T ss_pred             cccc
Confidence            6544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.27  E-value=8.1e-05  Score=78.27  Aligned_cols=65  Identities=26%  Similarity=0.322  Sum_probs=53.1

Q ss_pred             CCCcEEEEEecCCCccccchhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecCCcCCCCCchhhhhcc
Q 002809          405 SSPRITYLNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQGNKLNGSVPVELLERS  478 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~  478 (878)
                      .+++|++|+|++|+|+ .||..   +++|+.|+|++|+|+ .||..   ++ |+.|+|++|+|+ .+|.....+.
T Consensus       282 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~  347 (353)
T d1jl5a_         282 LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVE  347 (353)
T ss_dssp             CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCC
T ss_pred             cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccccccC
Confidence            3578999999999999 78864   678999999999999 78864   34 899999999998 7886444443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.80  E-value=0.002  Score=69.40  Aligned_cols=75  Identities=12%  Similarity=0.133  Sum_probs=47.8

Q ss_pred             ccccccccEEEEEEEEc--ceeEEEEEeccC-------ChhhHHHHHHHHHHHHHhc-c--cceeeeeecccCCCcceeE
Q 002809          572 RTLGKGGFGTVYYGRLN--EIDVAVKMLSSS-------SAQGFQQFQAEVKLLMRVH-H--RNLTSLVGHCDEDNQTALI  639 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-------~~~~~~~f~~Ei~~L~~l~-H--~nIv~l~g~~~~~~~~~lV  639 (878)
                      +.||.|....||+.+..  ++.++||.-...       -+....+...|.+.|..+. +  ..+.+++.+.  .+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            46899999999998764  367899964321       1112234556888887763 2  3455555543  4456899


Q ss_pred             eeeccCCCh
Q 002809          640 YEFMANGNL  648 (878)
Q Consensus       640 ~Ey~~~gsL  648 (878)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999976543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.77  E-value=9.9e-05  Score=69.54  Aligned_cols=79  Identities=33%  Similarity=0.338  Sum_probs=54.6

Q ss_pred             EEecCCCccccchhhhhccCCCCEEeCcCCcccCc--CCccCCCCc-ceEEEecCCcCCCCCchhhhhcccCCCcccccC
Q 002809          412 LNLSSSGLKGDITSYVSNLTSLQFLDLSNNNLTGS--VPDFLSKLP-LRTLNLQGNKLNGSVPVELLERSKNGSLSLSVG  488 (878)
Q Consensus       412 l~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~--iP~~~~~l~-L~~L~ls~N~l~g~iP~~l~~~~~l~~l~l~~~  488 (878)
                      +++.+| +...++....++++|+.|+||+|+|+.-  ++..+..++ |+.|+|++|+++ .+++ +..+..+....+...
T Consensus        47 l~~~~~-~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~-l~~l~~~~L~~L~L~  123 (162)
T d1koha1          47 LNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERE-LDKIKGLKLEELWLD  123 (162)
T ss_dssp             TTSHHH-HHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGG-HHHHTTCCCSSCCCT
T ss_pred             cchhhh-HhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchh-hhhhhccccceeecC
Confidence            344444 3346676677899999999999999942  345566788 999999999999 5664 333322222356677


Q ss_pred             CCCCC
Q 002809          489 GNPGL  493 (878)
Q Consensus       489 ~n~~l  493 (878)
                      |||-.
T Consensus       124 ~Npl~  128 (162)
T d1koha1         124 GNSLS  128 (162)
T ss_dssp             TSTTS
T ss_pred             CCCcC
Confidence            88864

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.38  E-value=0.00036  Score=71.79  Aligned_cols=83  Identities=28%  Similarity=0.305  Sum_probs=66.1

Q ss_pred             CCCcEEEEEecCCCcccc-chhhhhccCCCCEEeCcCCcccCcCCccCCCCc-ceEEEecC-CcCCCC-CchhhhhcccC
Q 002809          405 SSPRITYLNLSSSGLKGD-ITSYVSNLTSLQFLDLSNNNLTGSVPDFLSKLP-LRTLNLQG-NKLNGS-VPVELLERSKN  480 (878)
Q Consensus       405 ~~~~l~~l~l~~n~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-L~~L~ls~-N~l~g~-iP~~l~~~~~l  480 (878)
                      ...+|++|||+++.+++. ++.-+.++++|++|+|+++++++..+..++.++ |+.|+|++ +.++.. +..-...+++|
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L  123 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL  123 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence            345899999999998865 566788999999999999999999999999999 99999999 466522 22223457788


Q ss_pred             CCccccc
Q 002809          481 GSLSLSV  487 (878)
Q Consensus       481 ~~l~l~~  487 (878)
                      +.|+++.
T Consensus       124 ~~L~ls~  130 (284)
T d2astb2         124 DELNLSW  130 (284)
T ss_dssp             CEEECCC
T ss_pred             ccccccc
Confidence            8776654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.32  E-value=0.0014  Score=65.01  Aligned_cols=77  Identities=26%  Similarity=0.285  Sum_probs=58.8

Q ss_pred             CCcEEEEEecCCCccccchhhhhccCCCCEE-eCcCCcccCcCCc-cCCCCc-ceEEEecCCcCCCCCch-hhhhcccCC
Q 002809          406 SPRITYLNLSSSGLKGDITSYVSNLTSLQFL-DLSNNNLTGSVPD-FLSKLP-LRTLNLQGNKLNGSVPV-ELLERSKNG  481 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g~ip~~~~~l~~L~~L-~Ls~N~l~g~iP~-~~~~l~-L~~L~ls~N~l~g~iP~-~l~~~~~l~  481 (878)
                      ...++.|++++|+++ .++....+.++++.+ ++++|+|+ .||. .|..++ |+.|+|++|+|+ .+|. .+.+++.|+
T Consensus       152 ~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~  228 (242)
T d1xwdc1         152 SFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLR  228 (242)
T ss_dssp             BSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEE
T ss_pred             cccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccc
Confidence            357899999999998 677666677776655 57888898 6765 478888 999999999999 6665 466677666


Q ss_pred             Cccc
Q 002809          482 SLSL  485 (878)
Q Consensus       482 ~l~l  485 (878)
                      .+++
T Consensus       229 ~l~~  232 (242)
T d1xwdc1         229 ARST  232 (242)
T ss_dssp             SSSE
T ss_pred             cCcC
Confidence            5443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.25  E-value=0.00057  Score=74.08  Aligned_cols=35  Identities=31%  Similarity=0.400  Sum_probs=16.2

Q ss_pred             EEEEEecCCCcc----ccchhhhhccCCCCEEeCcCCcc
Q 002809          409 ITYLNLSSSGLK----GDITSYVSNLTSLQFLDLSNNNL  443 (878)
Q Consensus       409 l~~l~l~~n~l~----g~ip~~~~~l~~L~~L~Ls~N~l  443 (878)
                      ++.|+|++|+|+    ..|+..+..+++|+.|||++|+|
T Consensus        29 l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i   67 (460)
T d1z7xw1          29 CQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL   67 (460)
T ss_dssp             CSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC
T ss_pred             CCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcC
Confidence            344455555444    12333444445555555555544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.65  E-value=0.0042  Score=63.47  Aligned_cols=58  Identities=34%  Similarity=0.398  Sum_probs=32.4

Q ss_pred             CcEEEEEecCC-CccccchhhhhccCCCCEEeCcC-CcccCcCCccCCCCc-ceEEEecCC
Q 002809          407 PRITYLNLSSS-GLKGDITSYVSNLTSLQFLDLSN-NNLTGSVPDFLSKLP-LRTLNLQGN  464 (878)
Q Consensus       407 ~~l~~l~l~~n-~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~~~~l~-L~~L~ls~N  464 (878)
                      ++|+.|+|+++ .+++.....++++++|++|+|++ +++++.-...+++++ |+.|+++++
T Consensus       175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            35556666553 45555555566666666666665 455555445555555 666665554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.63  E-value=0.025  Score=58.13  Aligned_cols=155  Identities=10%  Similarity=0.097  Sum_probs=80.4

Q ss_pred             CCHHHHHHHHhhh--c-----ccccccccEEEEEEEEcceeEEEEEeccCChhhHHHHHHHHHHHHHhccccee--eeee
Q 002809          558 LSYSDVVKITNNF--E-----RTLGKGGFGTVYYGRLNEIDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLT--SLVG  628 (878)
Q Consensus       558 ~s~~dl~~~t~~f--~-----~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv--~l~g  628 (878)
                      ++-+|+.....++  .     +.|..|.--+.|+.+.++..+++|+.....  ..++...|++++..+.+.++.  ..+.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            3455555554443  2     234566668889998888889999986532  224555677778777543322  1111


Q ss_pred             c------ccCCCcceeEeeeccCCChhhhh--------------ccc----c---CCCCC------------------HH
Q 002809          629 H------CDEDNQTALIYEFMANGNLQEYL--------------SDI----S---KKVLS------------------SQ  663 (878)
Q Consensus       629 ~------~~~~~~~~lV~Ey~~~gsL~~~l--------------~~~----~---~~~l~------------------~~  663 (878)
                      .      .........++.++.+......-              +..    .   .....                  ..
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            1      11233445556666553222110              000    0   00000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          664 ERLRIAVESAQGLEYLHN-GCKPPIVHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       664 ~~~~i~~qia~gL~yLH~-~~~~~ivHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      .....+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222222222332222 224579999999999999998878999999874

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.31  E-value=0.0021  Score=69.42  Aligned_cols=80  Identities=25%  Similarity=0.232  Sum_probs=51.2

Q ss_pred             CcEEEEEecCCCccccchh----hhhccCCCCEEeCcCCcccCc----CCccCCC-Cc-ceEEEecCCcCCCC----Cch
Q 002809          407 PRITYLNLSSSGLKGDITS----YVSNLTSLQFLDLSNNNLTGS----VPDFLSK-LP-LRTLNLQGNKLNGS----VPV  472 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~ip~----~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~-l~-L~~L~ls~N~l~g~----iP~  472 (878)
                      ..|+.+++++|.++..-..    .+...++|+.|+|++|+++..    ++..+.. .+ |+.|+|++|+|+..    ++.
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            3677888888887765333    334556788888888887642    4444443 34 88888888888632    445


Q ss_pred             hhhhcccCCCcccc
Q 002809          473 ELLERSKNGSLSLS  486 (878)
Q Consensus       473 ~l~~~~~l~~l~l~  486 (878)
                      .+..++.|+.|+++
T Consensus       392 ~l~~~~~L~~L~Ls  405 (460)
T d1z7xw1         392 TLLANHSLRELDLS  405 (460)
T ss_dssp             HHHHCCCCCEEECC
T ss_pred             HHhcCCCCCEEECC
Confidence            55566667655543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.30  E-value=0.034  Score=59.27  Aligned_cols=72  Identities=18%  Similarity=0.259  Sum_probs=48.8

Q ss_pred             ccccccccEEEEEEEEcc---------eeEEEEEeccCChhhHHHHHHHHHHHHHhccccee-eeeecccCCCcceeEee
Q 002809          572 RTLGKGGFGTVYYGRLNE---------IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLT-SLVGHCDEDNQTALIYE  641 (878)
Q Consensus       572 ~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv-~l~g~~~~~~~~~lV~E  641 (878)
                      +.|+.|-.-.+|+....+         ..|.+++.....  ......+|..+++.+.-.++. ++++++..    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            467888889999988643         346666655322  234556899999888644444 77777653    68999


Q ss_pred             eccCCChh
Q 002809          642 FMANGNLQ  649 (878)
Q Consensus       642 y~~~gsL~  649 (878)
                      |+++..|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99875443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.02  E-value=0.034  Score=57.57  Aligned_cols=132  Identities=10%  Similarity=0.128  Sum_probs=75.2

Q ss_pred             EEEEEEEEcc-eeEEEEEeccCChhhHHHHHHHHHHHHHhccccee--eeee-----cccCCCcceeEeeeccCCChhh-
Q 002809          580 GTVYYGRLNE-IDVAVKMLSSSSAQGFQQFQAEVKLLMRVHHRNLT--SLVG-----HCDEDNQTALIYEFMANGNLQE-  650 (878)
Q Consensus       580 G~Vy~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~L~~l~H~nIv--~l~g-----~~~~~~~~~lV~Ey~~~gsL~~-  650 (878)
                      -.||+.+.++ ..+++|+.+... ...+++..|...+..|....+.  ..+.     .+..++..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799998865 779999976542 2346788899999888643332  1111     1234456778899987643321 


Q ss_pred             ---h----------hcc----cc---CCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCCe
Q 002809          651 ---Y----------LSD----IS---KKVLSSQ-------------------ERLRIAVESAQGLEYLHN----GCKPPI  687 (878)
Q Consensus       651 ---~----------l~~----~~---~~~l~~~-------------------~~~~i~~qia~gL~yLH~----~~~~~i  687 (878)
                         .          ++.    ..   +..+++.                   .+..+...+.+.++.+..    ....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               0          010    00   1111111                   111122222233333322    224568


Q ss_pred             EecCCCCccEEEcCCCcEEEeecCCcc
Q 002809          688 VHRDVKSTNILLNEKLQAKLADFGLSK  714 (878)
Q Consensus       688 vHrDLKp~NILl~~~~~~kL~DFGla~  714 (878)
                      ||+|+.+.|||++++  ..+.||+-+.
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ecCCCCcccEEEeCC--ceEEechhcc
Confidence            999999999999754  4589999775

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=94.66  E-value=0.0044  Score=64.95  Aligned_cols=62  Identities=23%  Similarity=0.359  Sum_probs=37.7

Q ss_pred             CcEEEEEecCCCcccc-----chhhhhccCCCCEEeCcCCcccCc----CCccCCCCc-ceEEEecCCcCCC
Q 002809          407 PRITYLNLSSSGLKGD-----ITSYVSNLTSLQFLDLSNNNLTGS----VPDFLSKLP-LRTLNLQGNKLNG  468 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~-----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~-L~~L~ls~N~l~g  468 (878)
                      +.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+...+ |+.|+|++|+|++
T Consensus       186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence            3566777777766531     344466667777777777776532    334455555 7777777777664

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=94.05  E-value=0.014  Score=54.35  Aligned_cols=60  Identities=13%  Similarity=0.221  Sum_probs=34.1

Q ss_pred             cEEEEEecCCCccc----cchhhhhccCCCCEEeCcCCcccCc----CCccCCCCc-ceEEEecCCcCC
Q 002809          408 RITYLNLSSSGLKG----DITSYVSNLTSLQFLDLSNNNLTGS----VPDFLSKLP-LRTLNLQGNKLN  467 (878)
Q Consensus       408 ~l~~l~l~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~-L~~L~ls~N~l~  467 (878)
                      .|+.|+|++|+|+.    .+...+...+.|+.|+|++|.++..    +=..+..-+ |+.|+|++|.+.
T Consensus        45 ~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          45 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            56667777776653    2333444556677777777766632    112234444 777777766554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=93.64  E-value=0.0092  Score=62.33  Aligned_cols=81  Identities=16%  Similarity=0.232  Sum_probs=60.3

Q ss_pred             CCcEEEEEecCCCccc----cchhhhhccCCCCEEeCcCCcccCc-----CCccCCCCc-ceEEEecCCcCCCC----Cc
Q 002809          406 SPRITYLNLSSSGLKG----DITSYVSNLTSLQFLDLSNNNLTGS-----VPDFLSKLP-LRTLNLQGNKLNGS----VP  471 (878)
Q Consensus       406 ~~~l~~l~l~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~-----iP~~~~~l~-L~~L~ls~N~l~g~----iP  471 (878)
                      .+.|+.|++++|.++-    .+...+..++.|+.|+|++|+++..     +...+..++ |+.|+|++|+++..    +.
T Consensus       157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~  236 (344)
T d2ca6a1         157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA  236 (344)
T ss_dssp             CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred             Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence            3578899999998863    3566678899999999999998742     344566777 99999999998633    34


Q ss_pred             hhhhhcccCCCcccc
Q 002809          472 VELLERSKNGSLSLS  486 (878)
Q Consensus       472 ~~l~~~~~l~~l~l~  486 (878)
                      ..+...+.|+.|.++
T Consensus       237 ~~l~~~~~L~~L~Ls  251 (344)
T d2ca6a1         237 IALKSWPNLRELGLN  251 (344)
T ss_dssp             HHGGGCTTCCEEECT
T ss_pred             ccccccccchhhhhh
Confidence            455666677755553

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=93.31  E-value=0.013  Score=54.63  Aligned_cols=64  Identities=19%  Similarity=0.360  Sum_probs=47.5

Q ss_pred             CCcEEEEEecCC-Ccccc----chhhhhccCCCCEEeCcCCcccCcCC----ccCCCCc-ceEEEecCCcCCCC
Q 002809          406 SPRITYLNLSSS-GLKGD----ITSYVSNLTSLQFLDLSNNNLTGSVP----DFLSKLP-LRTLNLQGNKLNGS  469 (878)
Q Consensus       406 ~~~l~~l~l~~n-~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP----~~~~~l~-L~~L~ls~N~l~g~  469 (878)
                      .+.|+.|+|+++ .++..    +-..+...+.|+.|+|++|.++..-.    ..+...+ |+.|+|++|+++..
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~   87 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE   87 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchH
Confidence            367999999974 56532    44567778999999999999974322    2333445 99999999998843

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=91.30  E-value=0.026  Score=52.24  Aligned_cols=84  Identities=17%  Similarity=0.210  Sum_probs=50.5

Q ss_pred             CcEEEEEecC-CCcccc----chhhhhccCCCCEEeCcCCcccCcCC----ccCCCCc-ceEEEecCCcCCCCC----ch
Q 002809          407 PRITYLNLSS-SGLKGD----ITSYVSNLTSLQFLDLSNNNLTGSVP----DFLSKLP-LRTLNLQGNKLNGSV----PV  472 (878)
Q Consensus       407 ~~l~~l~l~~-n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP----~~~~~l~-L~~L~ls~N~l~g~i----P~  472 (878)
                      +.|+.|+|++ +.++..    +-..+...++|+.|+|++|.++..--    ..+...+ |+.|++++|.++..-    -.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence            5788888887 456432    34455577888888888888764322    2233345 888888888876331    12


Q ss_pred             hhhhcccCCCcccccCCC
Q 002809          473 ELLERSKNGSLSLSVGGN  490 (878)
Q Consensus       473 ~l~~~~~l~~l~l~~~~n  490 (878)
                      .+...+.++.+.++.++|
T Consensus        97 ~l~~~~~L~~l~L~l~~n  114 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQ  114 (166)
T ss_dssp             GGGGCSSCCEEECCCCSS
T ss_pred             HHHhCccccEEeeccCCC
Confidence            333444455445554444

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=84.44  E-value=0.097  Score=48.10  Aligned_cols=82  Identities=13%  Similarity=0.192  Sum_probs=56.0

Q ss_pred             CcEEEEEecCCCcccc----chhhhhccCCCCEEeCcCCcccCc----CCccCCCCc-ceEEEe--cCCcCCC----CCc
Q 002809          407 PRITYLNLSSSGLKGD----ITSYVSNLTSLQFLDLSNNNLTGS----VPDFLSKLP-LRTLNL--QGNKLNG----SVP  471 (878)
Q Consensus       407 ~~l~~l~l~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~-L~~L~l--s~N~l~g----~iP  471 (878)
                      ++|+.|+|++|+|+..    |-..+...++|+.|++++|.++..    +-..+...+ |+.++|  ++|++..    .|-
T Consensus        46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La  125 (166)
T d1io0a_          46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA  125 (166)
T ss_dssp             CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred             CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence            5799999999999764    445567789999999999998743    224455556 877555  5677753    133


Q ss_pred             hhhhhcccCCCcccccC
Q 002809          472 VELLERSKNGSLSLSVG  488 (878)
Q Consensus       472 ~~l~~~~~l~~l~l~~~  488 (878)
                      ..+...+.+..|++.++
T Consensus       126 ~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_         126 NMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHHHHCSSCCEEECCCS
T ss_pred             HHHHhCCCcCEEeCcCC
Confidence            44556666776665543